	Gene names	Kinetics	EC number	Catalytic activity	Binding site	Activity regulation	Cofactor	pH dependence	Pathway	Site	Gene names  (ORF )	Temperature dependence	Gene ontology (biological process)	Gene ontology (cellular component)	Gene ontology (GO)	Gene ontology (molecular function)	Gene ontology IDs	Subcellular location [CC]	Post-translational modification	Modified residue	Mapped PubMed ID	PubMed ID
2	EGLN2 EIT6	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=20 uM for HIF1A DLDLEMLAPYIPMDDDFQL peptide (at pH 7.5 and 37 degrees Celsius) {ECO:0000269|PubMed:15925519}; KM=50 uM for L-ascorbate (at pH 7.5 and 37 degrees Celsius) {ECO:0000269|PubMed:15925519}; KM=1.0 uM for Fe(2+) (at pH 7.5 and 37 degrees Celsius) {ECO:0000269|PubMed:15925519}; 	1.14.11.29	CATALYTIC ACTIVITY: Hypoxia-inducible factor-L-proline + 2-oxoglutarate + O(2) = hypoxia-inducible factor-trans-4-hydroxy-L-proline + succinate + CO(2). {ECO:0000269|PubMed:11595184, ECO:0000269|PubMed:12039559, ECO:0000269|PubMed:15925519}.	BINDING 367 367 2-oxoglutarate. {ECO:0000255|PROSITE-ProRule:PRU00805}.		COFACTOR: Name=Fe(2+); Xref=ChEBI:CHEBI:29033; Evidence={ECO:0000244|PDB:5V1B, ECO:0000255|PROSITE-ProRule:PRU00805, ECO:0000269|PubMed:15925519, ECO:0000269|PubMed:28594552}; ;  Note=Binds 1 Fe(2+) ion per subunit. {ECO:0000244|PDB:5V1B, ECO:0000255|PROSITE-ProRule:PRU00805, ECO:0000269|PubMed:15925519, ECO:0000269|PubMed:28594552};; COFACTOR: Name=L-ascorbate; Xref=ChEBI:CHEBI:38290; Evidence={ECO:0000269|PubMed:15925519}; 						cell redox homeostasis [GO:0045454]; intracellular estrogen receptor signaling pathway [GO:0030520]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of protein catabolic process [GO:0045732]; regulation of cell growth [GO:0001558]; regulation of neuron apoptotic process [GO:0043523]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; response to hypoxia [GO:0001666]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ferrous iron binding [GO:0008198]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors [GO:0016706]; oxygen sensor activity [GO:0019826]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; cell redox homeostasis [GO:0045454]; intracellular estrogen receptor signaling pathway [GO:0030520]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of protein catabolic process [GO:0045732]; regulation of cell growth [GO:0001558]; regulation of neuron apoptotic process [GO:0043523]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; response to hypoxia [GO:0001666]	ferrous iron binding [GO:0008198]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors [GO:0016706]; oxygen sensor activity [GO:0019826]; peptidyl-proline 4-dioxygenase activity [GO:0031545]	GO:0001558; GO:0001666; GO:0005634; GO:0005654; GO:0008198; GO:0016706; GO:0018401; GO:0019826; GO:0030520; GO:0031418; GO:0031545; GO:0043523; GO:0045454; GO:0045732; GO:0061418	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12163023, ECO:0000269|PubMed:12615973, ECO:0000269|PubMed:19339211, ECO:0000269|PubMed:19631610}.		MOD_RES 130 130 Phosphoserine. {ECO:0000244|PubMed:23186163}.	11574160; 11850811; 14702039; 17974005; 15057824; 15489334; 11595178; 11595184; 12163023; 12039559; 12181324; 12615973; 15247232; 15925519; 16509823; 17114296; 19631610; 19339211; 21410436; 22286099; 23932902; 23186163; 28594552; 11292861; 11292862; 11598268; 12351678; 12538644; 12788921; 12912907; 15231748; 15474027; 16169070; 16511565; 17353276; 17434750; 17986458; 18184961; 18710826; 19208626; 21335549; 23602568; 26644182; 27263528	11574160; 11850811; 14702039; 17974005; 15057824; 15489334; 11595178; 11595184; 12163023; 12039559; 12181324; 12615973; 15247232; 15925519; 16509823; 17114296; 19631610; 19339211; 21410436; 22286099; 23932902; 23186163; 28594552
17	ENOSF1 RTS TYMSAS	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=0.2 mM for L-fuconate {ECO:0000269|PubMed:24697329}; KM=3.0 mM for L-galactonate {ECO:0000269|PubMed:24697329}; KM=2.0 mM for D-arabinonate {ECO:0000269|PubMed:24697329}; KM=4.0 mM for L-arabinonate {ECO:0000269|PubMed:24697329}; KM=0.4 mM for D-ribonate {ECO:0000269|PubMed:24697329}; Note=kcat is 0.5 sec(-1) for L-fuconate. kcat is 0.3 sec(-1) for L-galactonate. kcat is 0.3 sec(-1) for L-arabinonate. kcat is 0.04 sec(-1) for D-arabinonate. kcat is 0.002 sec(-1) for D-ribonate.;	4.2.1.68	CATALYTIC ACTIVITY: L-fuconate = 2-dehydro-3-deoxy-L-fuconate + H(2)O. {ECO:0000269|PubMed:24697329}.	BINDING 34 34 Substrate. {ECO:0000250|UniProtKB:Q8P3K2}.; BINDING 220 220 Substrate. {ECO:0000250|UniProtKB:Q8P3K2}.; BINDING 252 252 Substrate. {ECO:0000250|UniProtKB:Q8P3K2}.; BINDING 276 276 Substrate. {ECO:0000250|UniProtKB:Q8P3K2}.; BINDING 305 305 Substrate. {ECO:0000250|UniProtKB:Q8P3K2}.; BINDING 386 386 Substrate. {ECO:0000250|UniProtKB:Q8P3K2}.		COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:24697329}; ;  Note=Binds 1 Mg(2+) ion per subunit. {ECO:0000269|PubMed:24697329};						cellular amino acid catabolic process [GO:0009063]; cellular carbohydrate catabolic process [GO:0044275]	mitochondrion [GO:0005739]	mitochondrion [GO:0005739]; isomerase activity [GO:0016853]; L-fuconate dehydratase activity [GO:0050023]; magnesium ion binding [GO:0000287]; cellular amino acid catabolic process [GO:0009063]; cellular carbohydrate catabolic process [GO:0044275]	isomerase activity [GO:0016853]; L-fuconate dehydratase activity [GO:0050023]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005739; GO:0009063; GO:0016853; GO:0044275; GO:0050023	SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:16162288}.	PTM: Could be sumoylated. {ECO:0000269|PubMed:15994970}.	MOD_RES 148 148 Phosphoserine. {ECO:0000269|PubMed:15994970}.	8493092; 8764108; 14702039; 16177791; 15489334; 8869746; 12084460; 16162288; 15994970; 21269460; 24275569; 24697329; 20711500	8493092; 8764108; 14702039; 16177791; 15489334; 8869746; 12084460; 16162288; 15994970; 21269460; 24275569; 24697329
25	ENTPD8 UNQ2492/PRO5779	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=81 uM for ATP {ECO:0000269|PubMed:17095758}; KM=137 uM for ADP {ECO:0000269|PubMed:17095758}; KM=480 uM for UTP {ECO:0000269|PubMed:17095758}; KM=241 uM for UDP {ECO:0000269|PubMed:17095758}; Vmax=790 nmol/min/mg enzyme with ATP as substrate {ECO:0000269|PubMed:17095758}; Vmax=163 nmol/min/mg enzyme with ADP as substrate {ECO:0000269|PubMed:17095758}; Vmax=1100 nmol/min/mg enzyme with UTP as substrate {ECO:0000269|PubMed:17095758}; Vmax=110 nmol/min/mg enzyme with UDP as substrate {ECO:0000269|PubMed:17095758}; 	3.6.1.5	CATALYTIC ACTIVITY: A nucleoside 5'-triphosphate + 2 H(2)O = a nucleoside 5'-phosphate + 2 phosphate. {ECO:0000269|PubMed:16752921, ECO:0000269|PubMed:17095758}.		ACTIVITY REGULATION: Not inhibited by ARL 67156. {ECO:0000269|PubMed:17603550}.	COFACTOR: Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000250}; Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250}; ;  Note=Ca(2+) or Mg(2+). Has lower efficiency with Mg(2+). {ECO:0000250};				UNQ2492/PRO5779		nucleobase-containing small molecule catabolic process [GO:0034656]; nucleoside diphosphate biosynthetic process [GO:0009133]; nucleoside monophosphate biosynthetic process [GO:0009124]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; 8-oxo-dGTP phosphohydrolase activity [GO:0102490]; ATP binding [GO:0005524]; dATP phosphohydrolase activity [GO:0102485]; dCTP phosphohydrolase activity [GO:0102486]; dGTP phosphohydrolase activity [GO:0102491]; dTTP phosphohydrolase activity [GO:0102488]; dUTP phosphohydrolase activity [GO:0102487]; GTP phosphohydrolase activity [GO:0102489]; metal ion binding [GO:0046872]; nucleoside-diphosphatase activity [GO:0017110]; nucleoside-triphosphatase activity [GO:0017111]; nucleobase-containing small molecule catabolic process [GO:0034656]; nucleoside diphosphate biosynthetic process [GO:0009133]; nucleoside monophosphate biosynthetic process [GO:0009124]	8-oxo-dGTP phosphohydrolase activity [GO:0102490]; ATP binding [GO:0005524]; dATP phosphohydrolase activity [GO:0102485]; dCTP phosphohydrolase activity [GO:0102486]; dGTP phosphohydrolase activity [GO:0102491]; dTTP phosphohydrolase activity [GO:0102488]; dUTP phosphohydrolase activity [GO:0102487]; GTP phosphohydrolase activity [GO:0102489]; metal ion binding [GO:0046872]; nucleoside-diphosphatase activity [GO:0017110]; nucleoside-triphosphatase activity [GO:0017111]	GO:0005524; GO:0005886; GO:0009124; GO:0009133; GO:0016021; GO:0017110; GO:0017111; GO:0034656; GO:0046872; GO:0102485; GO:0102486; GO:0102487; GO:0102488; GO:0102489; GO:0102490; GO:0102491	SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}.	PTM: N-glycosylated. {ECO:0000269|PubMed:16752921}.		16752921; 17095758; 12975309; 15164053; 15489334; 17603550; 24275569; 10681547; 15122917	16752921; 17095758; 12975309; 15164053; 15489334; 17603550; 24275569
27	COLGALT1 GLT25D1 PSEC0241	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=18.7 uM for UDP-galactose (at 37 degrees Celsius and pH 7.4) {ECO:0000269|PubMed:19075007}; KM=29.9 uM for UDP-galactose (at 37 degrees Celsius and pH 7.4) {ECO:0000269|PubMed:22216269}; 	2.4.1.50	CATALYTIC ACTIVITY: UDP-alpha-D-galactose + [procollagen]-(2S,5R)-5-hydroxy-L-lysine = UDP + [procollagen]-(2S,5R)-5-O-(beta-D-galactosyl)-5-hydroxy-L-lysine. {ECO:0000269|PubMed:19075007}.							PSEC0241		positive regulation of collagen fibril organization [GO:1904028]	endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]	endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; procollagen galactosyltransferase activity [GO:0050211]; positive regulation of collagen fibril organization [GO:1904028]	procollagen galactosyltransferase activity [GO:0050211]	GO:0005788; GO:0016020; GO:0050211; GO:1904028	SUBCELLULAR LOCATION: Endoplasmic reticulum lumen {ECO:0000255|PROSITE-ProRule:PRU10138, ECO:0000269|PubMed:20470363}. Note=Colocalized with PLOD3 and mannose binding lectin/MBL2.	PTM: N-glycosylated. {ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:20470363}.		16303743; 15057824; 15489334; 19159218; 19075007; 20470363; 21269460; 22216269; 25944712; 27402836; 17353931; 20217867; 22190034; 22304920; 22653443; 23606334; 23902751; 26028330; 26496610; 26638075; 28428430	16303743; 15057824; 15489334; 19159218; 19075007; 20470363; 21269460; 22216269; 25944712; 27402836
35	EPHX3 ABHD9	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=30 uM for 8,9-EET {ECO:0000269|PubMed:22798687}; KM=80 uM for 11,12-EET {ECO:0000269|PubMed:22798687}; KM=130 uM for 14,15-EET {ECO:0000269|PubMed:22798687}; KM=25 uM for leukotoxin {ECO:0000269|PubMed:22798687}; Vmax=12 umol/min/mg enzyme with 8,9-EET as substrate {ECO:0000269|PubMed:22798687}; Vmax=50 umol/min/mg enzyme with 11,12-EET as substrate {ECO:0000269|PubMed:22798687}; Vmax=60 umol/min/mg enzyme with 14,15-EET as substrate {ECO:0000269|PubMed:22798687}; Vmax=22 umol/min/mg enzyme with leukotoxin as substrate {ECO:0000269|PubMed:22798687}; 	3.3.2.10	CATALYTIC ACTIVITY: An epoxide + H(2)O = a glycol. {ECO:0000269|PubMed:22798687}.		ACTIVITY REGULATION: Inhibited by 1-(1-acetylpiperidin-4-yl)-3-(4-(trifl uoromethoxy)phenyl)urea (TPAU), 1-cyclohexyl-3-dodecylurea (CDU), 12-(3-adamantan-1-yl-ureido)-dodecanoic acid (AUDA), 1-((3S, 5S, 7S)-adamantan-1-yl)-3-(5-(2-(2-ethoxyethoxy) ethoxy)pentyl)urea (AEPU) and to a lesser extent by 8-(3-((3S, 5S, 7S)-adamantan-1-yl)ureido) octanoic acid (AUOA). {ECO:0000269|PubMed:22798687}.							epoxide metabolic process [GO:0097176]; lipid metabolic process [GO:0006629]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; organelle membrane [GO:0031090]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; organelle membrane [GO:0031090]; epoxide hydrolase activity [GO:0004301]; epoxide metabolic process [GO:0097176]; lipid metabolic process [GO:0006629]	epoxide hydrolase activity [GO:0004301]	GO:0004301; GO:0005783; GO:0006629; GO:0016020; GO:0016021; GO:0031090; GO:0043231; GO:0097176	SUBCELLULAR LOCATION: Microsome membrane {ECO:0000305|PubMed:22798687}; Single-pass membrane protein {ECO:0000255}.			14702039; 15489334; 22798687; 17437806; 20723587; 24718283	14702039; 15489334; 22798687
103	SLC1A2 EAAT2 GLT1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=391 uM for L-glutamate {ECO:0000269|PubMed:26690923}; 			BINDING 401 401 Aspartate. {ECO:0000250|UniProtKB:P43003}.; BINDING 475 475 Aspartate. {ECO:0000250|UniProtKB:P43003}.; BINDING 482 482 Aspartate. {ECO:0000250|UniProtKB:P43003}.								adult behavior [GO:0030534]; cellular response to extracellular stimulus [GO:0031668]; chemical synaptic transmission [GO:0007268]; D-aspartate import across plasma membrane [GO:0070779]; glutamate secretion [GO:0014047]; ion transport [GO:0006811]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; neurotransmitter reuptake [GO:0098810]; positive regulation of glucose import [GO:0046326]; protein homotrimerization [GO:0070207]; response to amino acid [GO:0043200]; response to wounding [GO:0009611]; telencephalon development [GO:0021537]; visual behavior [GO:0007632]	axolemma [GO:0030673]; cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; plasma membrane [GO:0005886]	axolemma [GO:0030673]; cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; adult behavior [GO:0030534]; cellular response to extracellular stimulus [GO:0031668]; chemical synaptic transmission [GO:0007268]; D-aspartate import across plasma membrane [GO:0070779]; glutamate secretion [GO:0014047]; ion transport [GO:0006811]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; neurotransmitter reuptake [GO:0098810]; positive regulation of glucose import [GO:0046326]; protein homotrimerization [GO:0070207]; response to amino acid [GO:0043200]; response to wounding [GO:0009611]; telencephalon development [GO:0021537]; visual behavior [GO:0007632]	amino acid transmembrane transporter activity [GO:0015171]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]	GO:0005313; GO:0005314; GO:0005886; GO:0005887; GO:0006811; GO:0007268; GO:0007632; GO:0009611; GO:0009986; GO:0010259; GO:0014047; GO:0015171; GO:0015501; GO:0015813; GO:0016020; GO:0021537; GO:0030534; GO:0030673; GO:0031668; GO:0035264; GO:0043200; GO:0046326; GO:0046872; GO:0070207; GO:0070779; GO:0098712; GO:0098810; GO:0098978; GO:0099056	SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:14506254, ECO:0000269|PubMed:15265858, ECO:0000269|PubMed:26690923, ECO:0000269|PubMed:7521911}; Multi-pass membrane protein {ECO:0000305}.	PTM: Glycosylated. {ECO:0000269|PubMed:15265858}.; PTM: Palmitoylation at Cys-38 is not required for correct subcellular localization, but is important for glutamate uptake activity. {ECO:0000250|UniProtKB:P43006}.	MOD_RES 3 3 Phosphoserine. {ECO:0000250|UniProtKB:P31596}.; MOD_RES 21 21 Phosphoserine. {ECO:0000250|UniProtKB:P31596}.; MOD_RES 25 25 Phosphoserine. {ECO:0000250|UniProtKB:P31596}.; MOD_RES 506 506 Phosphoserine. {ECO:0000250|UniProtKB:P43006}.; MOD_RES 521 521 Phosphoserine. {ECO:0000250|UniProtKB:P43006}.; MOD_RES 532 532 Phosphoserine. {ECO:0000250|UniProtKB:P43006}.; MOD_RES 534 534 Phosphoserine. {ECO:0000250|UniProtKB:P43006}.; MOD_RES 539 539 Phosphotyrosine. {ECO:0000250|UniProtKB:P43006}.; MOD_RES 544 544 Phosphoserine. {ECO:0000250|UniProtKB:P43006}.; MOD_RES 560 560 Phosphoserine. {ECO:0000250|UniProtKB:P43006}.; MOD_RES 564 564 Phosphoserine. {ECO:0000250|UniProtKB:P43006}.	7521911; 8172925; 7522567; 9463476; 12950454; 14702039; 16554811; 15489334; 14506254; 15265858; 15483603; 20688910; 26483543; 26690923; 27476654; 28777935; 11204345; 11242046; 11792462; 11994293; 12408226; 12578975; 12890621; 14662797; 14730707; 15048885; 15135231; 15246112; 15296513; 15337309; 15494981; 15660126; 16061389; 16116111; 16567804; 16766085; 17311293; 17311320; 17684493; 17920768; 18326497; 18378006; 18519826; 18658151; 18838545; 19023027; 19086053; 19151621; 19156168; 19268276; 19283393; 19338517; 19527721; 19660525; 19910676; 19998491; 20193040; 20235792; 20379614; 20398908; 20399272; 20410850; 20416976; 20936779; 21098017; 21335552; 21471434; 21569822; 21707071; 21711518; 21792905; 21852380; 22069320; 22505712; 22513140; 22522966; 22728822; 22750157; 22764253; 22903028; 23023733; 23356950; 23390085; 23415275; 23596072; 23602887; 23706640; 23949322; 24139280; 24334928; 24412224; 24424098; 24518437; 24578174; 24587631; 24652383; 24753081; 24855648; 25036385; 25064045; 25064059; 25391854; 25406999; 26046374; 26057049; 26233565; 26313486; 26358886; 26459047; 27129805; 27206883; 27456607; 27698371; 27995756; 28658620; 7791878; 7859077; 9108121	7521911; 8172925; 7522567; 9463476; 12950454; 14702039; 16554811; 15489334; 14506254; 15265858; 15483603; 20688910; 26483543; 26690923; 27476654; 28777935
165	POLD1 POLD	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: Note=kcat is 87 sec(-1) for DNA synthesis by Pol-delta4 and 19 sec(-1) for Pol-delta3. kcat for exonuclease activity determined using a 26mer/40mer duplex DNA gives a value of 0.003 sec(-1) for Pol-delta4 and 0.026 sec(-1) for Pol-delta3. When using a 26mer/40mer with a T:G mismatch at the primer terminus, the switching rates from the polymerase to the exonuclease site for Pol-delta4 and Pol-delta3 are increased 20- and 10-fold, respectively, but the rate constant for Pol-delta3 is still 5-fold faster than that for Pol-delta4.;	2.7.7.7; 3.1.11.-	CATALYTIC ACTIVITY: Deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1).		ACTIVITY REGULATION: Regulated by alteration of quaternary structure. Exhibits burst rates of DNA synthesis are about 5 times faster in the presence of POLD4 (Pol-delta4 complex) than in its absence (Pol-delta3 complex), while the affinity of the enzyme for its DNA and dNTP substrates appears unchanged. The Pol-delta3 complex is more likely to proofread DNA synthesis because it cleaves single-stranded DNA twice as fast and transfers mismatched DNA from the polymerase to the exonuclease sites 9 times faster compared to the Pol-delta3 complex. Pol-delta3 also extends mismatched primers 3 times more slowly in the absence of POLD4. The conversion of Pol-delta4 into Pol-delta3 is induced by genotoxic stress or by replication stress leading POLD4 degradation (PubMed:19074196, PubMed:20334433). Stimulated in the presence of PCNA (PubMed:11328591, PubMed:12403614, PubMed:12522211, PubMed:16510448, PubMed:24022480, PubMed:24939902). This stimulation is further increased in the presence of KCTD13/PDIP1, most probably via direct interaction between KCTD13 and POLD2 (By similarity). {ECO:0000250|UniProtKB:P28339, ECO:0000269|PubMed:11328591, ECO:0000269|PubMed:12403614, ECO:0000269|PubMed:12522211, ECO:0000269|PubMed:16510448, ECO:0000269|PubMed:19074196, ECO:0000269|PubMed:20334433, ECO:0000269|PubMed:24022480, ECO:0000269|PubMed:24939902}.	COFACTOR: Name=[4Fe-4S] cluster; Xref=ChEBI:CHEBI:49883; Evidence={ECO:0000250}; ;  Note=Binds 1 [4Fe-4S] cluster. {ECO:0000250};						base-excision repair, gap-filling [GO:0006287]; cellular response to UV [GO:0034644]; DNA damage response, detection of DNA damage [GO:0042769]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; fatty acid homeostasis [GO:0055089]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; response to UV [GO:0009411]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]	aggresome [GO:0016235]; cytosol [GO:0005829]; delta DNA polymerase complex [GO:0043625]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]	aggresome [GO:0016235]; cytosol [GO:0005829]; delta DNA polymerase complex [GO:0043625]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; base-excision repair, gap-filling [GO:0006287]; cellular response to UV [GO:0034644]; DNA damage response, detection of DNA damage [GO:0042769]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; fatty acid homeostasis [GO:0055089]; nucleotide-excision repair, DNA gap filling [GO:0006297]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; response to UV [GO:0009411]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985]	3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]	GO:0000109; GO:0000166; GO:0000723; GO:0000731; GO:0003677; GO:0003682; GO:0003684; GO:0003887; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006281; GO:0006283; GO:0006287; GO:0006296; GO:0006297; GO:0008296; GO:0009411; GO:0016020; GO:0016235; GO:0019985; GO:0032201; GO:0033683; GO:0034644; GO:0042769; GO:0043625; GO:0045004; GO:0046872; GO:0051539; GO:0055089	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11595739, ECO:0000269|PubMed:20227374, ECO:0000269|PubMed:22801543}. Note=Colocalizes with PCNA and POLD3 at S phase replication sites (PubMed:11595739). After UV irradiation, recruited to DNA damage sites within 2 hours, independently on the cell cycle phase, nor on PCNA ubiquitination. This recruitement requires POLD3, PCNA and RFC1-replication factor C complex (PubMed:20227374, PubMed:22801543). {ECO:0000269|PubMed:11595739, ECO:0000269|PubMed:20227374, ECO:0000269|PubMed:22801543}.		MOD_RES 19 19 Omega-N-methylarginine. {ECO:0000244|PubMed:24129315}.	1722322; 1542570; 15489334; 11328591; 11595739; 12403614; 12522211; 15670210; 16510448; 17317665; 18669648; 19074196; 20334433; 20227374; 21269460; 22801543; 23891004; 24035200; 23913683; 24022480; 23770608; 24129315; 24939902; 24310611; 28112733; 23263490; 24501277; 10460157; 10559261; 10744741; 10751307; 10801132; 10856253; 10959839; 11006276; 11250913; 11473323; 11601988; 11687589; 11698410; 11724925; 11923315; 12200445; 12226657; 1328683; 14767555; 15007108; 15113441; 15805117; 15916957; 16143102; 16169070; 16188885; 16314508; 16337601; 16464020; 1671046; 1682322; 16934752; 17203305; 17314511; 17353931; 17474147; 17512402; 17643379; 17720710; 17937914; 18079701; 18270339; 18342608; 18676680; 18701435; 19074197; 19170196; 19223468; 19237606; 19279666; 19329428; 19557333; 19625176; 19692168; 1974050; 19913121; 19941829; 20129063; 20226869; 20467437; 20496165; 20522537; 20574454; 20628086; 20826785; 21044950; 21282463; 21918226; 22465957; 22678361; 22678362; 22761421; 22810585; 22887995; 22915169; 22942285; 22952233; 23000965; 23065663; 23150669; 23447401; 23528559; 23585564; 23606334; 23686288; 23731732; 23871696; 23902751; 23910567; 24485656; 24502978; 24509466; 24725412; 24768535; 25241845; 25370038; 26087769; 26133394; 26172944; 26271349; 26496610; 26648449; 26748215; 26755646; 27320729; 27849570; 27974823; 28218421; 28306219; 28368425; 2842325; 28512192; 28521875; 28605669; 28916777; 28934474; 29768346; 7378348; 7711022; 7713898; 7876218; 8104944; 8131753; 8144677; 9081985; 9099749; 9191022; 9214649; 9649448; 9780000; 9875289; 9882630	1722322; 1542570; 15489334; 11328591; 11595739; 12403614; 12522211; 15670210; 16510448; 17317665; 18669648; 19074196; 20334433; 20227374; 21269460; 22801543; 23891004; 24035200; 23913683; 24022480; 23770608; 24129315; 24939902; 24310611; 28112733; 23263490; 24501277
167	POLN	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=7.0 uM for dATP:T {ECO:0000269|PubMed:16787914}; KM=8.2 uM for dCTP:G {ECO:0000269|PubMed:16787914}; KM=7.7 uM for dGTP:C {ECO:0000269|PubMed:16787914}; KM=7.3 uM for dTTP:A {ECO:0000269|PubMed:16787914}; 	2.7.7.7	CATALYTIC ACTIVITY: Deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1). {ECO:0000269|PubMed:12794064, ECO:0000269|PubMed:16787914}.		ACTIVITY REGULATION: Inhibited by ddTTP. {ECO:0000269|PubMed:16787914}.		BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 8.8. {ECO:0000269|PubMed:16787914};					DNA-dependent DNA replication [GO:0006261]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; translesion synthesis [GO:0019985]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin binding [GO:0030332]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; translesion synthesis [GO:0019985]	cyclin binding [GO:0030332]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]	GO:0000724; GO:0003677; GO:0003887; GO:0005634; GO:0005654; GO:0005737; GO:0006261; GO:0019985; GO:0030332; GO:0036297; GO:0090305	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12794064}.			12794064; 14702039; 15815621; 16787914; 17118716; 19908865; 20102227; 19995904; 25775266; 20379614; 21671477; 21701511; 22008035; 22262850; 22623772; 23045531; 23325218; 25963146; 26740629; 26903512; 27226627; 27694439	12794064; 14702039; 15815621; 16787914; 17118716; 19908865; 20102227; 19995904; 25775266
168	POLQ POLH	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.095 uM for dATP:T {ECO:0000269|PubMed:22135286}; KM=0.622 uM for dATP: abasic site {ECO:0000269|PubMed:22135286}; KM=3.08 uM for dGTP: no template {ECO:0000269|PubMed:22135286}; 	2.7.7.7	CATALYTIC ACTIVITY: Deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1). {ECO:0000269|PubMed:14576298, ECO:0000269|PubMed:22135286}.									base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; protein homooligomerization [GO:0051260]; somatic hypermutation of immunoglobulin genes [GO:0016446]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; identical protein binding [GO:0042802]; single-stranded DNA-dependent ATPase activity [GO:0043142]; base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; protein homooligomerization [GO:0051260]; somatic hypermutation of immunoglobulin genes [GO:0016446]	5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; identical protein binding [GO:0042802]; single-stranded DNA-dependent ATPase activity [GO:0043142]	GO:0000724; GO:0003682; GO:0003684; GO:0003887; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006261; GO:0006281; GO:0006284; GO:0006302; GO:0006974; GO:0016446; GO:0042802; GO:0043142; GO:0051260; GO:0051575; GO:0090305; GO:0097681; GO:2000042	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O18475}. Chromosome {ECO:0000269|PubMed:25642963}. Note=Enriched in chromatin in response to ultaviolet (UV) light (PubMed:25642963). Binds to chromatin during early G1 (PubMed:24989122). {ECO:0000269|PubMed:24989122, ECO:0000269|PubMed:25642963}.		MOD_RES 990 990 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.	10395804; 14576298; 16641997; 18503084; 19188258; 19608861; 20700469; 20624954; 21050863; 22135286; 25409685; 24648516; 24989122; 25642963; 25643323; 11340072; 11440997; 12051913; 14735462; 15135726; 15496986; 16012167; 16188888; 16520097; 16603639; 16824193; 16835218; 17150533; 18270339; 18366182; 19237606; 19661089; 20483915; 23577232; 25417172; 25642960; 25775267; 25789972; 26496610; 26636256; 27533083; 28668117; 28939775; 29243925; 8003475	10395804; 14576298; 16641997; 18503084; 19188258; 19608861; 20700469; 20624954; 21050863; 22135286; 25409685; 24648516; 24989122; 25642963; 25643323
177	DUSP7 PYST2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=6.82 mM for p-nitrophenyl phosphate {ECO:0000269|PubMed:9788880}; KM=0.76 mM for p-nitrophenyl phosphate (in the presence of MAPK1) {ECO:0000269|PubMed:9788880}; 	3.1.3.16; 3.1.3.48	CATALYTIC ACTIVITY: Protein tyrosine phosphate + H(2)O = protein tyrosine + phosphate. {ECO:0000269|PubMed:9788880}.; CATALYTIC ACTIVITY: [a protein]-serine/threonine phosphate + H(2)O = [a protein]-serine/threonine + phosphate. {ECO:0000269|PubMed:9788880}.		ACTIVITY REGULATION: Strongly inhibited by sodium orthovanadate. {ECO:0000269|PubMed:9788880}.							activation of MAPK activity [GO:0000187]; MAPK cascade [GO:0000165]; negative regulation of MAP kinase activity [GO:0043407]; peptidyl-tyrosine dephosphorylation [GO:0035335]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; activation of MAPK activity [GO:0000187]; MAPK cascade [GO:0000165]; negative regulation of MAP kinase activity [GO:0043407]; peptidyl-tyrosine dephosphorylation [GO:0035335]	MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]	GO:0000165; GO:0000187; GO:0004725; GO:0005654; GO:0005829; GO:0008138; GO:0017017; GO:0035335; GO:0043407	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:9788880}.			9788880; 14603440; 16641997; 15489334; 8670865; 14576828; 26057789; 12907755; 14674243; 17208316; 17322878; 20463170; 21900206; 22569528; 24656772; 28253537	9788880; 14603440; 16641997; 15489334; 8670865; 14576828; 26057789
178	DUPD1 DUSP27	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=1.02 mM for para-nitrophenylphosphate (at pH 5.5) {ECO:0000269|PubMed:17498703}; Note=kcat is 0.330 sec(-1) for para-nitrophenylphosphate. {ECO:0000269|PubMed:17498703};	3.1.3.16; 3.1.3.48	CATALYTIC ACTIVITY: Protein tyrosine phosphate + H(2)O = protein tyrosine + phosphate. {ECO:0000269|PubMed:17498703}.; CATALYTIC ACTIVITY: [a protein]-serine/threonine phosphate + H(2)O = [a protein]-serine/threonine + phosphate. {ECO:0000269|PubMed:17498703}.									protein dephosphorylation [GO:0006470]	cytoplasm [GO:0005737]; protein-containing complex [GO:0032991]	cytoplasm [GO:0005737]; protein-containing complex [GO:0032991]; protein homodimerization activity [GO:0042803]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein dephosphorylation [GO:0006470]	protein homodimerization activity [GO:0042803]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0005737; GO:0006470; GO:0008138; GO:0032991; GO:0042803	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17498703}.				17498703; 15489334; 21543850
188	EGLN1 C1orf12 PNAS-118 PNAS-137	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=70 nM for HIF2A {ECO:0000269|PubMed:25129147}; KM=150 uM for O(2) {ECO:0000269|PubMed:25129147}; KM=1.3 uM for 2-oxoglutarate {ECO:0000269|PubMed:25129147}; 	1.14.11.29	CATALYTIC ACTIVITY: Hypoxia-inducible factor-L-proline + 2-oxoglutarate + O(2) = hypoxia-inducible factor-trans-4-hydroxy-L-proline + succinate + CO(2). {ECO:0000269|PubMed:25129147}.	BINDING 383 383 2-oxoglutarate. {ECO:0000305|PubMed:19604478}.	ACTIVITY REGULATION: Following exposure to hypoxia, activated in HeLa cells but not in cardiovascular cells. {ECO:0000269|PubMed:12670503, ECO:0000269|PubMed:20840591}.	COFACTOR: Name=Fe(2+); Xref=ChEBI:CHEBI:29033; Evidence={ECO:0000244|PDB:2G19, ECO:0000244|PDB:3HQU, ECO:0000244|PDB:5V18, ECO:0000255|PROSITE-ProRule:PRU00805, ECO:0000269|PubMed:16782814, ECO:0000269|PubMed:19604478, ECO:0000269|PubMed:28594552}; ;  Note=Binds 1 Fe(2+) ion per subunit. {ECO:0000244|PDB:2G19, ECO:0000244|PDB:3HQU, ECO:0000244|PDB:5V18, ECO:0000255|PROSITE-ProRule:PRU00805, ECO:0000269|PubMed:16782814, ECO:0000269|PubMed:19604478, ECO:0000269|PubMed:28594552};; COFACTOR: Name=L-ascorbate; Xref=ChEBI:CHEBI:38290; Evidence={ECO:0000269|PubMed:19604478}; 				PNAS-118 PNAS-137		cardiac muscle tissue morphogenesis [GO:0055008]; cellular iron ion homeostasis [GO:0006879]; heart trabecula formation [GO:0060347]; labyrinthine layer development [GO:0060711]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; oxygen homeostasis [GO:0032364]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of angiogenesis [GO:0045765]; regulation of neuron death [GO:1901214]; regulation of postsynapse organization [GO:0099175]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]; ventricular septum morphogenesis [GO:0060412]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; enzyme binding [GO:0019899]; ferrous iron binding [GO:0008198]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors [GO:0016706]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; peptidyl-proline dioxygenase activity [GO:0031543]; cardiac muscle tissue morphogenesis [GO:0055008]; cellular iron ion homeostasis [GO:0006879]; heart trabecula formation [GO:0060347]; labyrinthine layer development [GO:0060711]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; oxygen homeostasis [GO:0032364]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of angiogenesis [GO:0045765]; regulation of neuron death [GO:1901214]; regulation of postsynapse organization [GO:0099175]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]; ventricular septum morphogenesis [GO:0060412]	enzyme binding [GO:0019899]; ferrous iron binding [GO:0008198]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors [GO:0016706]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; peptidyl-proline dioxygenase activity [GO:0031543]	GO:0001666; GO:0005634; GO:0005737; GO:0005829; GO:0006879; GO:0008198; GO:0014069; GO:0016706; GO:0018401; GO:0019899; GO:0031418; GO:0031543; GO:0031545; GO:0032364; GO:0043433; GO:0045765; GO:0045944; GO:0051344; GO:0055008; GO:0060347; GO:0060412; GO:0060711; GO:0061418; GO:0071731; GO:0098978; GO:0099175; GO:0099576; GO:1901214	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12615973, ECO:0000269|PubMed:19339211, ECO:0000269|PubMed:19631610}. Nucleus {ECO:0000269|PubMed:12615973, ECO:0000269|PubMed:19339211, ECO:0000269|PubMed:19631610}. Note=Mainly cytoplasmic. Shuttles between the nucleus and cytoplasm (PubMed:19631610). Nuclear export requires functional XPO1. {ECO:0000269|PubMed:19339211, ECO:0000269|PubMed:19631610}.	PTM: S-nitrosylation inhibits the enzyme activity up to 60% under aerobic conditions. Chelation of Fe(2+) has no effect on the S-nitrosylation. It is uncertain whether nitrosylation occurs on Cys-323 or Cys-326. {ECO:0000269|PubMed:21601578}.	MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22814378}.; MOD_RES 12 12 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 125 125 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 201 201 S-nitrosocysteine. {ECO:0000269|PubMed:21601578}.; MOD_RES 208 208 S-nitrosocysteine. {ECO:0000269|PubMed:21601578}.; MOD_RES 302 302 S-nitrosocysteine. {ECO:0000269|PubMed:21601578}.; MOD_RES 323 323 S-nitrosocysteine. {ECO:0000269|PubMed:21601578}.; MOD_RES 326 326 S-nitrosocysteine. {ECO:0000269|PubMed:21601578}.	11056053; 11574160; 12788921; 17974005; 16710414; 11595178; 11595184; 12181324; 12351678; 12163023; 12670503; 12615973; 15247232; 15897452; 18063574; 19413330; 19631610; 19339211; 19208626; 20840591; 20838600; 20068231; 20466884; 21269460; 21792862; 22286099; 22814378; 23186163; 24681946; 25974097; 16782814; 19604478; 21601578; 28594552; 16407130; 17579185; 24711448; 25129147; 10535940; 10823831; 10878807; 10944113; 10973499; 11292861; 11292862; 11358837; 11454738; 11504942; 11598268; 12101228; 12538644; 12821933; 12912907; 15156561; 15474027; 15563275; 15721254; 16155211; 16157596; 16161047; 16489060; 16511565; 16815840; 16880998; 17060326; 17353276; 17434750; 17932321; 17933562; 17986458; 18072750; 18184961; 18337469; 18347341; 18505927; 18776187; 18834144; 19159641; 19304911; 19477431; 19563769; 19639506; 19724277; 19737309; 19915370; 20026900; 20028863; 20156434; 20404338; 20574527; 20711500; 20727020; 20801873; 20856199; 20956315; 20959442; 20961960; 20978146; 21030426; 21251613; 21335549; 21620138; 21748337; 21877141; 21887331; 21933857; 21988832; 22068265; 22236543; 22308030; 22343896; 22395314; 22488178; 22595196; 22747465; 22802519; 22833384; 22946054; 22975349; 23077544; 23088526; 23130672; 23225569; 23334958; 23413029; 23487784; 23683440; 23694817; 23787140; 23836663; 24055079; 24121508; 24195777; 24354513; 24513612; 24900242; 25010988; 25036637; 25120187; 25263965; 25420025; 25431923; 25546659; 25609649; 26047609; 26082309; 26112411; 26147748; 26205124; 26267649; 26323721; 26638075; 26676934; 26740011; 26951539; 27030384; 27368101; 27502280; 27515179; 27561929; 27795296; 28038470; 28199842; 28233034; 28329677; 28506759; 28537846; 28613249; 28805660; 28839461; 28900510; 29435217; 29625625; 9891082	11056053; 11574160; 12788921; 17974005; 16710414; 11595178; 11595184; 12181324; 12351678; 12163023; 12670503; 12615973; 15247232; 15897452; 18063574; 19413330; 19631610; 19339211; 19208626; 20840591; 20838600; 20068231; 20466884; 21269460; 21792862; 22286099; 22814378; 23186163; 24681946; 25974097; 16782814; 19604478; 21601578; 28594552; 16407130; 17579185; 24711448; 25129147
196	GSTA3	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=23 uM for delta(5)-androstene-3,17-dione {ECO:0000269|PubMed:15595823}; Vmax=99 umol/min/mg enzyme for delta(5)-androstene-3,17-dione isomerization {ECO:0000269|PubMed:15595823}; 	2.5.1.18	CATALYTIC ACTIVITY: RX + glutathione = HX + R-S-glutathione.	BINDING 9 9 Glutathione. {ECO:0000269|PubMed:15595823, ECO:0000269|PubMed:20083122}.; BINDING 45 45 Glutathione. {ECO:0000269|PubMed:15595823, ECO:0000269|PubMed:20083122}.								glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutathione transferase activity [GO:0004364]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]	glutathione transferase activity [GO:0004364]	GO:0004364; GO:0005829; GO:0006749; GO:0070062; GO:1901687	SUBCELLULAR LOCATION: Cytoplasm.		MOD_RES 2 2 N-acetylalanine. {ECO:0000250|UniProtKB:P30115}.; MOD_RES 4 4 N6-succinyllysine. {ECO:0000250|UniProtKB:P30115}.	8307579; 11418619; 14574404; 15489334; 9480897; 15595823; 20083122; 10329152; 10587441; 10783391; 11327815; 12042665; 12211029; 12627223; 15454730; 16081649; 16298388; 16548513; 17601350; 18426392; 18977241; 19343046; 20085333; 20200426; 20237496; 21106529; 21668448; 22522127; 23650189; 24739064; 25248748; 28005267; 8182750; 8203914; 8331657; 8431482; 9551553; 9839448	8307579; 11418619; 14574404; 15489334; 9480897; 15595823; 20083122
269	ECHS1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=12.75 uM for crotonyl-CoA {ECO:0000269|PubMed:26251176}; KM=34.04 uM for acryloyl-CoA {ECO:0000269|PubMed:26251176}; KM=45.83 uM for 3-Methylcrotonyl-CoA {ECO:0000269|PubMed:26251176}; KM=57.87 uM for tiglyl-CoA {ECO:0000269|PubMed:26251176}; Vmax=54.64 umol/min/mg enzyme toward crotonyl-CoA {ECO:0000269|PubMed:26251176}; Vmax=42.92 umol/min/mg enzyme toward acryloyl-CoA {ECO:0000269|PubMed:26251176}; Vmax=49.02 umol/min/mg enzyme toward 3-Methylcrotonyl-CoA {ECO:0000269|PubMed:26251176}; Vmax=6.66 umol/min/mg enzyme toward tiglyl-CoA {ECO:0000269|PubMed:26251176}; 	4.2.1.17	CATALYTIC ACTIVITY: (3S)-3-hydroxyacyl-CoA = trans-2(or 3)-enoyl-CoA + H(2)O. {ECO:0000269|PubMed:26251176}.	BINDING 141 141 Substrate; via amide nitrogen.				PATHWAY: Lipid metabolism; fatty acid beta-oxidation. {ECO:0000269|PubMed:26251176}.	SITE 164 164 Important for catalytic activity. {ECO:0000250}.			fatty acid beta-oxidation [GO:0006635]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635]	enoyl-CoA hydratase activity [GO:0004300]	GO:0004300; GO:0005739; GO:0005759; GO:0006635	SUBCELLULAR LOCATION: Mitochondrion matrix.		MOD_RES 46 46 Phosphothreonine. {ECO:0000244|PubMed:24275569}.; MOD_RES 101 101 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8BH95}.; MOD_RES 101 101 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8BH95}.; MOD_RES 114 114 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 115 115 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8BH95}.; MOD_RES 115 115 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8BH95}.; MOD_RES 118 118 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 204 204 N6-succinyllysine. {ECO:0000250|UniProtKB:Q8BH95}.; MOD_RES 211 211 N6-acetyllysine. {ECO:0000250|UniProtKB:Q8BH95}.	8012501; 9073515; 15164054; 15489334; 1286669; 11271497; 19608861; 21269460; 25125611; 24275569; 25393721; 25944712; 26000322; 26251176; 27221955; 26741492; 13295248; 15161933; 16169070; 17353931; 17395278; 18157088; 18624398; 19913121; 20562859; 20628086; 20711500; 20869947; 20877624; 21988832; 23178449; 23275097; 23416296; 23879543; 24510904; 24947832; 25338767; 25525879; 25739098; 25760819; 26099313; 26496610; 27090768; 27905109; 28202214; 28409271; 28878358	8012501; 9073515; 15164054; 15489334; 1286669; 11271497; 19608861; 21269460; 25125611; 24275569; 25393721; 25944712; 26000322; 26251176; 27221955; 26741492
353	DHFR	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=2.7 uM for dihydrofolate {ECO:0000269|PubMed:15039552, ECO:0000269|PubMed:19196009, ECO:0000269|PubMed:21876184}; KM=4.0 uM for NADPH {ECO:0000269|PubMed:15039552, ECO:0000269|PubMed:19196009, ECO:0000269|PubMed:21876184}; 	1.5.1.3	CATALYTIC ACTIVITY: 5,6,7,8-tetrahydrofolate + NADP(+) = 7,8-dihydrofolate + NADPH. {ECO:0000255|PROSITE-ProRule:PRU00660, ECO:0000269|PubMed:12096917, ECO:0000269|PubMed:15039552, ECO:0000269|PubMed:17569517, ECO:0000269|PubMed:19196009, ECO:0000269|PubMed:19478082, ECO:0000269|PubMed:21876184, ECO:0000269|PubMed:9719595}.	BINDING 10 10 NADP; via amide nitrogen and carbonyl oxygen. {ECO:0000269|PubMed:15039552, ECO:0000269|PubMed:16222560, ECO:0000269|PubMed:19478082}.; BINDING 65 65 Substrate. {ECO:0000305|PubMed:2248959}.; BINDING 71 71 Substrate. {ECO:0000305|PubMed:2248959}.				PATHWAY: Cofactor biosynthesis; tetrahydrofolate biosynthesis; 5,6,7,8-tetrahydrofolate from 7,8-dihydrofolate: step 1/1.				axon regeneration [GO:0031103]; dihydrofolate metabolic process [GO:0046452]; folic acid metabolic process [GO:0046655]; negative regulation of translation [GO:0017148]; one-carbon metabolic process [GO:0006730]; oxidation-reduction process [GO:0055114]; positive regulation of nitric-oxide synthase activity [GO:0051000]; regulation of removal of superoxide radicals [GO:2000121]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; response to methotrexate [GO:0031427]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]; tetrahydrofolate metabolic process [GO:0046653]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; dihydrofolate reductase activity [GO:0004146]; drug binding [GO:0008144]; folate reductase activity [GO:0033560]; folic acid binding [GO:0005542]; methotrexate binding [GO:0051870]; mRNA binding [GO:0003729]; NADPH binding [GO:0070402]; sequence-specific mRNA binding [GO:1990825]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; axon regeneration [GO:0031103]; dihydrofolate metabolic process [GO:0046452]; folic acid metabolic process [GO:0046655]; negative regulation of translation [GO:0017148]; one-carbon metabolic process [GO:0006730]; oxidation-reduction process [GO:0055114]; positive regulation of nitric-oxide synthase activity [GO:0051000]; regulation of removal of superoxide radicals [GO:2000121]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; response to methotrexate [GO:0031427]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]; tetrahydrofolate metabolic process [GO:0046653]	dihydrofolate reductase activity [GO:0004146]; drug binding [GO:0008144]; folate reductase activity [GO:0033560]; folic acid binding [GO:0005542]; methotrexate binding [GO:0051870]; mRNA binding [GO:0003729]; NADPH binding [GO:0070402]; sequence-specific mRNA binding [GO:1990825]; translation repressor activity, mRNA regulatory element binding [GO:0000900]	GO:0000083; GO:0000900; GO:0003729; GO:0004146; GO:0005542; GO:0005739; GO:0005829; GO:0006729; GO:0006730; GO:0008144; GO:0017148; GO:0031103; GO:0031427; GO:0033560; GO:0046452; GO:0046653; GO:0046654; GO:0046655; GO:0051000; GO:0051870; GO:0055114; GO:0070402; GO:1990825; GO:2000121	SUBCELLULAR LOCATION: Mitochondrion {ECO:0000250|UniProtKB:P00375}. Cytoplasm {ECO:0000250|UniProtKB:P00375}.			6323448; 6687716; 6235374; 14702039; 15372022; 15489334; 21310276; 21269460; 21876184; 21876188; 3383852; 2248959; 1731871; 7890613; 9374868; 9719595; 12096917; 12657784; 12925791; 15039552; 15681865; 16222560; 17569517; 19196009; 19478082; 19719239; 21310277; 10597240; 11448909; 15755837; 17486595; 19022952; 19064578; 19336370; 19652333; 19666465; 21123866; 21206056; 21550809; 21684339; 21931219; 23035243; 23545530; 24053334; 24077226; 25519916; 25609649; 26057816; 7623816; 9020173; 9627670	6323448; 6687716; 6235374; 14702039; 15372022; 15489334; 21310276; 21269460; 21876184; 21876188; 3383852; 2248959; 1731871; 7890613; 9374868; 9719595; 12096917; 12657784; 12925791; 15039552; 15681865; 16222560; 17569517; 19196009; 19478082; 19719239; 21310277
387	DHFR2 DHFRL1 DHFRP4	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=209 uM for dihydrofolate {ECO:0000269|PubMed:21876184}; KM=20 uM for NADPH {ECO:0000269|PubMed:21876184}; 	1.5.1.3	CATALYTIC ACTIVITY: 5,6,7,8-tetrahydrofolate + NADP(+) = 7,8-dihydrofolate + NADPH. {ECO:0000255|PROSITE-ProRule:PRU00660, ECO:0000269|PubMed:21876184}.	BINDING 10 10 NADP; via amide nitrogen and carbonyl oxygen. {ECO:0000250}.; BINDING 71 71 Substrate. {ECO:0000250}.				PATHWAY: Cofactor biosynthesis; tetrahydrofolate biosynthesis; 5,6,7,8-tetrahydrofolate from 7,8-dihydrofolate: step 1/1.				one-carbon metabolic process [GO:0006730]; tetrahydrofolate biosynthetic process [GO:0046654]; tetrahydrofolate metabolic process [GO:0046653]; thymidine biosynthetic process [GO:0046105]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; dihydrofolate reductase activity [GO:0004146]; mRNA binding [GO:0003729]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate biosynthetic process [GO:0046654]; tetrahydrofolate metabolic process [GO:0046653]; thymidine biosynthetic process [GO:0046105]	dihydrofolate reductase activity [GO:0004146]; mRNA binding [GO:0003729]	GO:0003729; GO:0004146; GO:0005739; GO:0005743; GO:0005759; GO:0006730; GO:0046105; GO:0046653; GO:0046654	SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:21876184, ECO:0000269|PubMed:21876188}. Mitochondrion matrix {ECO:0000269|PubMed:21876188}. Mitochondrion inner membrane {ECO:0000269|PubMed:21876188}.			16641997; 17974005; 15489334; 21876188; 21876184; 25980602; 18447718; 20711500; 21044950; 2248959; 24122410; 6323448	16641997; 17974005; 15489334; 21876188; 21876184; 25980602
392	ECE2 KIAA0604 UNQ403/PRO740	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.4 uM for big ET-1 {ECO:0000269|PubMed:12560336}; KM=1.4 uM for peptide E {ECO:0000269|PubMed:12560336}; KM=27.4 uM for bradykinin {ECO:0000269|PubMed:12560336}; KM=48.4 uM for dynorphin B {ECO:0000269|PubMed:12560336}; 	3.4.24.71	CATALYTIC ACTIVITY: Hydrolysis of the 21-Trp-|-Val-22 bond in big endothelin to form endothelin 1. {ECO:0000269|PubMed:12560336}.			COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250|UniProtKB:P42892}; ;  Note=Binds 1 zinc ion per subunit. {ECO:0000250|UniProtKB:P42892};	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 5.0-5.5. Inactive at neutral pH. {ECO:0000269|PubMed:12560336};			UNQ403/PRO740		peptide hormone processing [GO:0016486]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transport vesicle membrane [GO:0030658]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transport vesicle membrane [GO:0030658]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; methyltransferase activity [GO:0008168]; peptide hormone processing [GO:0016486]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; methyltransferase activity [GO:0008168]	GO:0000139; GO:0004222; GO:0008168; GO:0016021; GO:0016486; GO:0030658; GO:0046872	SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000250|UniProtKB:F1N476}; Single-pass type II membrane protein {ECO:0000305}. Cytoplasmic vesicle, secretory vesicle membrane {ECO:0000250|UniProtKB:F1N476}.			11718899; 9628581; 12975309; 16641997; 15489334; 12560336; 16567585; 17188679; 17545092; 19089949; 19541930; 19626040; 20807771; 22027013; 28171705; 28557628	11718899; 9628581; 12975309; 16641997; 15489334; 12560336
424	GRK7 GPRK7	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.9 uM for rhodopsin {ECO:0000269|PubMed:15946941}; KM=21.4 uM for ATP {ECO:0000269|PubMed:15946941}; Vmax=915 nmol/min/mg enzyme {ECO:0000269|PubMed:15946941}; 	2.7.11.14	CATALYTIC ACTIVITY: ATP + [rhodopsin] = ADP + [rhodopsin] phosphate. {ECO:0000269|PubMed:15946941}.	BINDING 220 220 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.	ACTIVITY REGULATION: Inhibited by phosphorylation of Ser-36. {ECO:0000250}.							protein autophosphorylation [GO:0046777]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; signal transduction [GO:0007165]; visual perception [GO:0007601]	photoreceptor disc membrane [GO:0097381]	photoreceptor disc membrane [GO:0097381]; ATP binding [GO:0005524]; G-protein coupled receptor kinase activity [GO:0004703]; rhodopsin kinase activity [GO:0050254]; protein autophosphorylation [GO:0046777]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; signal transduction [GO:0007165]; visual perception [GO:0007601]	ATP binding [GO:0005524]; G-protein coupled receptor kinase activity [GO:0004703]; rhodopsin kinase activity [GO:0050254]	GO:0004703; GO:0005524; GO:0007165; GO:0007601; GO:0022400; GO:0046777; GO:0050254; GO:0097381	SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:Q8WMV0}; Lipid-anchor {ECO:0000250|UniProtKB:Q8WMV0}.	PTM: Autophosphorylated in vitro at Ser-490. Phosphorylation at Ser-36 is regulated by light and activated by cAMP. {ECO:0000269|PubMed:18803695}.	MOD_RES 36 36 Phosphoserine; by PKA. {ECO:0000269|PubMed:18803695}.; MOD_RES 550 550 Cysteine methyl ester. {ECO:0000255}.	11754336; 11717351; 16641997; 15946941; 18803695; 17344846; 1387789; 18266817; 18617639; 19913121; 20379614; 20430952; 20628086; 22183412; 22658984; 22939624; 3164688; 8626439; 8812493	11754336; 11717351; 16641997; 15946941; 18803695; 17344846
470	ENPP3 PDNP3	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=61.5 uM for ATP; KM=120.3 uM for UTP; KM=120.2 uM for CTP; KM=123.7 uM for GTP; 	3.1.4.1; 3.6.1.9	CATALYTIC ACTIVITY: Hydrolytically removes 5'-nucleotides successively from the 3'-hydroxy termini of 3'-hydroxy-terminated oligonucleotides. {ECO:0000269|PubMed:11342463}.; CATALYTIC ACTIVITY: A nucleoside triphosphate + H(2)O = a nucleotide + diphosphate. {ECO:0000269|PubMed:29717535}.	BINDING 204 204 Substrate. {ECO:0000244|PDB:6C02, ECO:0000269|PubMed:29717535}.; BINDING 226 226 Substrate. {ECO:0000244|PDB:6C02, ECO:0000269|PubMed:29717535}.; BINDING 275 275 Substrate. {ECO:0000244|PDB:6C02, ECO:0000269|PubMed:29717535}.; BINDING 289 289 Substrate. {ECO:0000244|PDB:6C02, ECO:0000269|PubMed:29717535}.		COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000269|PubMed:29717535}; ;  Note=Binds 2 zinc ions per subunit. {ECO:0000269|PubMed:29717535};						ATP metabolic process [GO:0046034]; basophil activation involved in immune response [GO:0002276]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mast cell activation involved in immune response [GO:0033007]; negative regulation of mast cell proliferation [GO:0070667]; nucleoside triphosphate catabolic process [GO:0009143]; phosphate-containing compound metabolic process [GO:0006796]; pyrimidine nucleotide metabolic process [GO:0006220]	apical plasma membrane [GO:0016324]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]	apical plasma membrane [GO:0016324]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; NADH pyrophosphatase activity [GO:0035529]; nucleic acid binding [GO:0003676]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; phosphodiesterase I activity [GO:0004528]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]; zinc ion binding [GO:0008270]; ATP metabolic process [GO:0046034]; basophil activation involved in immune response [GO:0002276]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mast cell activation involved in immune response [GO:0033007]; negative regulation of mast cell proliferation [GO:0070667]; nucleoside triphosphate catabolic process [GO:0009143]; phosphate-containing compound metabolic process [GO:0006796]; pyrimidine nucleotide metabolic process [GO:0006220]	calcium ion binding [GO:0005509]; NADH pyrophosphatase activity [GO:0035529]; nucleic acid binding [GO:0003676]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; phosphodiesterase I activity [GO:0004528]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]; zinc ion binding [GO:0008270]	GO:0002276; GO:0003676; GO:0004528; GO:0005044; GO:0005509; GO:0006220; GO:0006796; GO:0008270; GO:0009143; GO:0009897; GO:0016021; GO:0016324; GO:0030247; GO:0033007; GO:0035529; GO:0046034; GO:0047429; GO:0048471; GO:0050728; GO:0070062; GO:0070667	SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11342463}; Single-pass type II membrane protein {ECO:0000305}. Apical cell membrane {ECO:0000269|PubMed:15072822}; Single-pass type II membrane protein {ECO:0000305}. Secreted {ECO:0000269|PubMed:15072822}. Note=Detected at the cell surface of basophils (PubMed:11342463). Detected at the apical plasma membrane of bile duct cells (PubMed:15072822). Located to the apical surface in intestinal and kidney epithelial cells. Secreted in serum, and in lumen of epithelial cells. {ECO:0000269|PubMed:11342463, ECO:0000269|PubMed:15072822}.	PTM: N-glycosylated. N-glycosylation is necessary for normal transport to the cell membrane, but is not the apical targeting signal. {ECO:0000250|UniProtKB:P97675}.		9344668; 17974005; 14574404; 11342463; 15072822; 15031605; 29717535; 12757929; 14533006; 15886225; 17275019; 19418203; 20047266; 20159259; 20379614; 20467438; 20975283; 22722613; 23581640; 23960081; 24497482; 24947519; 26585435; 7505270	9344668; 17974005; 14574404; 11342463; 15072822; 15031605; 29717535
476	COLGALT2 C1orf17 GLT25D2 KIAA0584	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=33.5 uM for UDP-galactose {ECO:0000269|PubMed:19075007}; 	2.4.1.50	CATALYTIC ACTIVITY: UDP-alpha-D-galactose + [procollagen]-(2S,5R)-5-hydroxy-L-lysine = UDP + [procollagen]-(2S,5R)-5-O-(beta-D-galactosyl)-5-hydroxy-L-lysine. {ECO:0000269|PubMed:19075007}.										endoplasmic reticulum lumen [GO:0005788]	endoplasmic reticulum lumen [GO:0005788]; procollagen galactosyltransferase activity [GO:0050211]	procollagen galactosyltransferase activity [GO:0050211]	GO:0005788; GO:0050211	SUBCELLULAR LOCATION: Endoplasmic reticulum lumen {ECO:0000255|PROSITE-ProRule:PRU10138}.			11318611; 9628581; 16710414; 15489334; 19075007; 21269460; 16959974; 18391951; 18951430; 20189936; 20379614; 20470363; 20546612; 25416956	11318611; 9628581; 16710414; 15489334; 19075007; 21269460; 16959974
489	SELENOI EPT1 KIAA1724 SELI	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.8 uM for CDP-ethanolamine {ECO:0000269|PubMed:17132865}; Vmax=76.3 pmol/min/mg enzyme with CDP-ethanolamine as substrate {ECO:0000269|PubMed:17132865}; 	2.7.8.1	CATALYTIC ACTIVITY: CDP-ethanolamine + 1,2-diacyl-sn-glycerol = CMP + a phosphatidylethanolamine. {ECO:0000269|PubMed:17132865}.			COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:17132865}; Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000269|PubMed:17132865}; 		PATHWAY: Phospholipid metabolism; phosphatidylethanolamine biosynthesis; phosphatidylethanolamine from ethanolamine: step 3/3.				phosphatidylethanolamine biosynthetic process [GO:0006646]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ethanolaminephosphotransferase activity [GO:0004307]; metal ion binding [GO:0046872]; phosphatidylethanolamine biosynthetic process [GO:0006646]	ethanolaminephosphotransferase activity [GO:0004307]; metal ion binding [GO:0046872]	GO:0004307; GO:0005789; GO:0006646; GO:0016021; GO:0046872	SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.		MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22223895}.	12775843; 11214970; 17132865; 19413330; 22223895; 27645994; 10191259; 10893425; 12216837; 12221122; 21988832; 26638075; 28052917; 29101747	12775843; 11214970; 17132865; 19413330; 22223895; 27645994
533	FUT7	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=5 uM for GDP-fucose {ECO:0000269|PubMed:11404359}; 	2.4.1.-	CATALYTIC ACTIVITY: GDP-L-fucose + alpha-2,3-Neu-N-acetyl-1,4-beta-D-galactosyl-N-acetyl-D-glucosaminyl-R = GDP + alpha-2,3-Neu-N-acetyl-1,4-beta-D-galactosyl-(alpha-1,3-L-fucosyl)-N-acetyl-D-glucosaminyl-R. {ECO:0000269|PubMed:11404359, ECO:0000269|PubMed:8207002, ECO:0000269|PubMed:9299472}.					PATHWAY: Protein modification; protein glycosylation.				CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation [GO:0002361]; ceramide metabolic process [GO:0006672]; leukocyte migration involved in immune response [GO:0002522]; L-fucose catabolic process [GO:0042355]; protein glycosylation [GO:0006486]	Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation [GO:0002361]; ceramide metabolic process [GO:0006672]; L-fucose catabolic process [GO:0042355]; leukocyte migration involved in immune response [GO:0002522]; protein glycosylation [GO:0006486]	alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]	GO:0000139; GO:0002361; GO:0002522; GO:0005794; GO:0006486; GO:0006672; GO:0008417; GO:0016020; GO:0016021; GO:0032580; GO:0042355; GO:0046920	SUBCELLULAR LOCATION: Golgi apparatus, Golgi stack membrane; Single-pass type II membrane protein. Note=Membrane-bound form in trans cisternae of Golgi.			8207002; 8051184; 8182079; 14702039; 15164053; 15489334; 9299472; 11425803; 11404359; 12506041; 15262995; 15464988; 15579466; 15926890; 17229154; 17436081; 17760744; 18402946; 18452157; 19851296; 20198315; 20428816; 21197561; 24176542; 27591321; 28585149; 29138114	8207002; 8051184; 8182079; 14702039; 15164053; 15489334; 9299472; 11425803; 11404359
546	G6PD	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=7.07 uM for NADP {ECO:0000269|PubMed:15858258}; KM=52 uM for glucose 6-phosphate {ECO:0000269|PubMed:15858258}; 	1.1.1.49	CATALYTIC ACTIVITY: D-glucose 6-phosphate + NADP(+) = 6-phospho-D-glucono-1,5-lactone + NADPH. {ECO:0000269|PubMed:15858258}.	BINDING 72 72 NADP 1. {ECO:0000269|PubMed:10745013, ECO:0000269|PubMed:15858258}.; BINDING 147 147 NADP 1. {ECO:0000269|PubMed:10745013, ECO:0000269|PubMed:15858258}.; BINDING 171 171 NADP 1; via carbonyl oxygen. {ECO:0000269|PubMed:10745013, ECO:0000269|PubMed:15858258}.; BINDING 171 171 Substrate.; BINDING 239 239 Substrate.; BINDING 258 258 Substrate.; BINDING 357 357 NADP 2. {ECO:0000269|PubMed:10745013, ECO:0000269|PubMed:15858258}.; BINDING 360 360 Substrate.; BINDING 365 365 Substrate.; BINDING 366 366 NADP 2. {ECO:0000269|PubMed:10745013, ECO:0000269|PubMed:15858258}.; BINDING 370 370 NADP 2. {ECO:0000269|PubMed:10745013, ECO:0000269|PubMed:15858258}.; BINDING 393 393 NADP 2. {ECO:0000269|PubMed:10745013, ECO:0000269|PubMed:15858258}.; BINDING 395 395 Substrate.; BINDING 487 487 NADP 2. {ECO:0000269|PubMed:10745013, ECO:0000269|PubMed:15858258}.; BINDING 503 503 NADP 2. {ECO:0000269|PubMed:10745013, ECO:0000269|PubMed:15858258}.; BINDING 509 509 NADP 2. {ECO:0000269|PubMed:10745013, ECO:0000269|PubMed:15858258}.				PATHWAY: Carbohydrate degradation; pentose phosphate pathway; D-ribulose 5-phosphate from D-glucose 6-phosphate (oxidative stage): step 1/3.				cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; lipid metabolic process [GO:0006629]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; oxidation-reduction process [GO:0055114]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; glucose binding [GO:0005536]; glucose-6-phosphate dehydrogenase activity [GO:0004345]; identical protein binding [GO:0042802]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; lipid metabolic process [GO:0006629]; NADP metabolic process [GO:0006739]; NADPH regeneration [GO:0006740]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; oxidation-reduction process [GO:0055114]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]	glucose-6-phosphate dehydrogenase activity [GO:0004345]; glucose binding [GO:0005536]; identical protein binding [GO:0042802]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]	GO:0004345; GO:0005536; GO:0005634; GO:0005737; GO:0005829; GO:0006006; GO:0006098; GO:0006629; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0016020; GO:0019322; GO:0021762; GO:0032094; GO:0034599; GO:0042802; GO:0042803; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0055114; GO:0061052; GO:0070062; GO:1904879; GO:2000378		PTM: Acetylated by ELP3 at Lys-403; acetylation inhibits its homodimerization and enzyme activity. Deacetylated by SIRT2 at Lys-403; deacetylation stimulates its enzyme activity. {ECO:0000269|PubMed:24769394, ECO:0000269|PubMed:7857286}.	MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378, ECO:0000269|PubMed:7857286}.; MOD_RES 8 8 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 10 10 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 89 89 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 171 171 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 403 403 N6-acetyllysine. {ECO:0000244|PubMed:19608861, ECO:0000269|PubMed:24769394}.; MOD_RES 432 432 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 497 497 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 503 503 Phosphotyrosine. {ECO:0000244|PubMed:23186163}.	3515319; 2428611; 2836867; 1889820; 8733135; 15772651; 15489334; 2758468; 8466644; 1874446; 12665801; 1945893; 12524354; 3012556; 3126064; 6696761; 2910917; 7857286; 18669648; 19413330; 19608861; 21269460; 22431005; 22223895; 22814378; 23186163; 24769394; 10745013; 8364584; 11857737; 15858258; 3446582; 3393536; 2912069; 1611091; 1536798; 1303180; 1303182; 8490627; 8193373; 7959695; 7825590; 8533762; 7858267; 9452072; 10627140; 11112389; 20007901; 26479991; 27535533; 10089300; 11024211; 11042039; 11499668; 11793482; 11852882; 11874436; 11876979; 11877026; 11916749; 11920200; 12130518; 12135480; 12378426; 12380870; 12439228; 12497642; 12588050; 12616531; 12641410; 12680285; 12696079; 12737938; 12737940; 12737943; 12768444; 12850494; 12921788; 12972027; 1353664; 14614139; 14757424; 14757426; 15223006; 15282679; 15307413; 15315792; 15330559; 15466166; 15476167; 15506519; 15558953; 15598086; 15622766; 15659240; 15718915; 15727905; 15748456; 15766741; 15864125; 15906717; 15906719; 15914531; 15957246; 16088936; 16136268; 16137669; 16143877; 16155737; 16255851; 16272653; 16331553; 16356170; 16461316; 16483869; 16532971; 16569302; 16607506; 16637741; 16792831; 16859949; 16927025; 16934959; 16944148; 17007653; 17018380; 17077204; 17264545; 17499234; 17524386; 17557555; 17587269; 17611006; 17637841; 17653668; 17660836; 17877203; 17959407; 18043863; 18046504; 18056001; 18066402; 18086567; 18164966; 18173836; 18215251; 18226470; 18302154; 18376107; 18458302; 18493020; 18494377; 18558634; 18660489; 18677765; 18985093; 19219640; 19223928; 19224086; 19272180; 19317913; 19323016; 19336475; 19359662; 19367725; 19419973; 19422023; 19463016; 19465117; 19497363; 19589177; 19594365; 19632868; 19640310; 19738201; 19805454; 19811411; 19858149; 19896395; 19913121; 19941843; 19996424; 20017397; 20113600; 20118060; 20200584; 20203002; 20236109; 20447239; 20459687; 20507315; 20514852; 20520804; 20528626; 20582980; 20602793; 20621077; 20628086; 20684792; 20713184; 20927393; 20949590; 21125776; 21157431; 21180140; 21205543; 21302115; 21376116; 21376267; 21397531; 21507207; 21549219; 22012600; 22117603; 22139979; 22165289; 22307442; 22364808; 22537951; 22552160; 22768742; 22770933; 22848499; 22906047; 22906837; 22958163; 22963789; 23023104; 23065279; 23144702; 23146719; 23185302; 23275194; 23389243; 23485169; 23569738; 23631859; 23640907; 23693134; 23742107; 24066844; 24134566; 24146346; 24223971; 24270845; 24284321; 24460025; 24586352; 24615128; 24636884; 24805191; 24853873; 24958328; 24994855; 25015414; 25169987; 25189226; 25201310; 25261071; 25261933; 25297600; 25407525; 25416956; 25536053; 25616277; 25633909; 25671784; 25818003; 25885177; 25979194; 26004559; 26139767; 26250461; 26399441; 26496610; 26607846; 26621836; 26694452; 26711700; 26715276; 26823837; 26827633; 26829728; 26976705; 27029726; 27064064; 27097228; 27213370; 27217331; 27353740; 27495838; 27586085; 27791036; 27880809; 27914961; 27916496; 27941691; 28028996; 28059001; 28067620; 28370139; 28479150; 28542136; 28591790; 28749773; 28768839; 28887160; 29047080; 29169341; 29240263; 30045279; 3699836; 5666113; 9332310	3515319; 2428611; 2836867; 1889820; 8733135; 15772651; 15489334; 2758468; 8466644; 1874446; 12665801; 1945893; 12524354; 3012556; 3126064; 6696761; 2910917; 7857286; 18669648; 19413330; 19608861; 21269460; 22431005; 22223895; 22814378; 23186163; 24769394; 10745013; 8364584; 11857737; 15858258; 3446582; 3393536; 2912069; 1611091; 1536798; 1303180; 1303182; 8490627; 8193373; 7959695; 7825590; 8533762; 7858267; 9452072; 10627140; 11112389; 20007901; 26479991; 27535533
555	GALT	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.25 mM for alpha-D-galactose 1-phosphate (at pH 8.7) {ECO:0000269|PubMed:22461411}; KM=0.43 mM for UDP-glucose (at pH 8.7) {ECO:0000269|PubMed:22461411}; Vmax=48 umol/min/mg enzyme {ECO:0000269|PubMed:22461411}; 	2.7.7.12	CATALYTIC ACTIVITY: UDP-alpha-D-glucose + alpha-D-galactose 1-phosphate = alpha-D-glucose 1-phosphate + UDP-alpha-D-galactose. {ECO:0000269|PubMed:22461411, ECO:0000269|PubMed:27005423}.	BINDING 81 81 UDP-alpha-D-glucose; via amide nitrogen. {ECO:0000305|PubMed:27005423}.; BINDING 173 173 UDP-alpha-D-glucose; shared with dimeric partner. {ECO:0000305|PubMed:27005423}.; BINDING 188 188 UDP-alpha-D-glucose. {ECO:0000305|PubMed:27005423}.		COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000269|PubMed:27005423}; ;  Note=Binds 2 zinc ions per subunit. {ECO:0000305|PubMed:27005423};		PATHWAY: Carbohydrate metabolism; galactose metabolism. {ECO:0000269|PubMed:22461411, ECO:0000269|PubMed:27005423}.				galactose catabolic process [GO:0019388]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; UDP-glucose catabolic process [GO:0006258]; UDP-glucose metabolic process [GO:0006011]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; UDP-glucose:hexose-1-phosphate uridylyltransferase activity [GO:0008108]; zinc ion binding [GO:0008270]; galactose catabolic process [GO:0019388]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; UDP-glucose catabolic process [GO:0006258]; UDP-glucose metabolic process [GO:0006011]	UDP-glucose:hexose-1-phosphate uridylyltransferase activity [GO:0008108]; zinc ion binding [GO:0008270]	GO:0005794; GO:0005829; GO:0006011; GO:0006012; GO:0006258; GO:0008108; GO:0008270; GO:0019388; GO:0033499				2840550; 2233247; 1427861; 14702039; 15164053; 15489334; 1301925; 10408771; 22461411; 27005423; 1897530; 2011574; 1610789; 1373122; 8499924; 8112740; 7887416; 7887417; 8598637; 7550229; 8741038; 8956044; 8869397; 9222760; 10220154; 11754113; 11919338; 15841485; 17041746; 17876724; 18956253; 23022339; 25614870; 25592817; 11511927; 11678552; 11704127; 11936817; 12370157; 12521227; 12606594; 12851678; 12869412; 14614623; 14707519; 15308134; 15506833; 15749517; 16009197; 16125333; 16189514; 16274605; 16416427; 16507021; 16595241; 17143577; 17303100; 18089596; 18210213; 18454942; 19224951; 19646668; 20008339; 20151200; 20222886; 20237496; 20547145; 20734064; 20800603; 21059483; 21188552; 22749219; 22798028; 22944367; 22963887; 23583749; 23690308; 23924834; 24045215; 25052314; 25124065; 25268296; 25416956; 25920691; 28450132; 28644047; 29252199; 8198125; 9238674	2840550; 2233247; 1427861; 14702039; 15164053; 15489334; 1301925; 10408771; 22461411; 27005423; 1897530; 2011574; 1610789; 1373122; 8499924; 8112740; 7887416; 7887417; 8598637; 7550229; 8741038; 8956044; 8869397; 9222760; 10220154; 11754113; 11919338; 15841485; 17041746; 17876724; 18956253; 23022339; 25614870; 25592817
559	GBP2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=313 uM for GTP {ECO:0000269|PubMed:8706832}; 	3.6.5.-	CATALYTIC ACTIVITY: GTP + H(2)O = GDP + phosphate. {ECO:0000269|PubMed:8706832}.									cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; immune response [GO:0006955]; interferon-gamma-mediated signaling pathway [GO:0060333]; protein localization to nucleus [GO:0034504]; type I interferon signaling pathway [GO:0060337]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; immune response [GO:0006955]; interferon-gamma-mediated signaling pathway [GO:0060333]; protein localization to nucleus [GO:0034504]; type I interferon signaling pathway [GO:0060337]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; protein homodimerization activity [GO:0042803]	GO:0000139; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006955; GO:0015629; GO:0034504; GO:0042803; GO:0048471; GO:0060333; GO:0060337; GO:0071346; GO:0071347; GO:0071356	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:21151871}. Cytoplasm, perinuclear region {ECO:0000269|PubMed:21151871}. Golgi apparatus membrane {ECO:0000269|PubMed:21151871}. Membrane; Lipid-anchor {ECO:0000269|PubMed:21151871}. Note=GBP2-GBP5 dimers localize to the Golgi apparatus. {ECO:0000269|PubMed:21151871}.	PTM: Isoprenylation is required for proper subcellular location. {ECO:0000269|PubMed:21151871}.	MOD_RES 588 588 Cysteine methyl ester. {ECO:0000250}.	1715024; 17974005; 14702039; 16710414; 15489334; 8706832; 17266443; 21151871; 11092454; 11337497; 11404376; 12029096; 12447867; 14769151; 15047845; 1508672; 16009940; 16169070; 1730654; 17517895; 18362138; 18985028; 19003964; 19912588; 20237496; 20711500; 20923658; 21900206; 2211721; 22864358; 23001506; 23086406; 29072687; 6162102; 6548414; 7530745; 8176225; 8483949; 8530158; 9096384; 9143706; 9861020	1715024; 17974005; 14702039; 16710414; 15489334; 8706832; 17266443; 21151871
592	GNPNAT1 GNA1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=26 uM for acetyl-coenzyme A {ECO:0000269|PubMed:18601654}; KM=97 uM for glucosamine-6-phosphate {ECO:0000269|PubMed:18601654}; 	2.3.1.4	CATALYTIC ACTIVITY: Acetyl-CoA + D-glucosamine 6-phosphate = CoA + N-acetyl-D-glucosamine 6-phosphate. {ECO:0000269|PubMed:18601654, ECO:0000269|PubMed:18675810}.	BINDING 61 61 Substrate. {ECO:0000244|PDB:3CXQ, ECO:0000269|PubMed:18675810, ECO:0000305|PubMed:18601654}.; BINDING 175 175 Substrate. {ECO:0000244|PDB:3CXQ, ECO:0000269|PubMed:18675810, ECO:0000305|PubMed:18601654}.; BINDING 181 181 Substrate. {ECO:0000244|PDB:3CXQ, ECO:0000269|PubMed:18675810, ECO:0000305|PubMed:18601654}.				PATHWAY: Nucleotide-sugar biosynthesis; UDP-N-acetyl-alpha-D-glucosamine biosynthesis; N-acetyl-alpha-D-glucosamine 1-phosphate from alpha-D-glucosamine 6-phosphate (route I): step 1/2.				cellular response to leukemia inhibitory factor [GO:1990830]; glucosamine metabolic process [GO:0006041]; liver development [GO:0001889]; N-acetylglucosamine metabolic process [GO:0006044]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]	cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]	cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; glucosamine 6-phosphate N-acetyltransferase activity [GO:0004343]; identical protein binding [GO:0042802]; monosaccharide binding [GO:0048029]; cellular response to leukemia inhibitory factor [GO:1990830]; glucosamine metabolic process [GO:0006041]; liver development [GO:0001889]; N-acetylglucosamine metabolic process [GO:0006044]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]	glucosamine 6-phosphate N-acetyltransferase activity [GO:0004343]; identical protein binding [GO:0042802]; monosaccharide binding [GO:0048029]	GO:0000139; GO:0001889; GO:0004343; GO:0005770; GO:0005793; GO:0005829; GO:0006041; GO:0006044; GO:0006048; GO:0010008; GO:0042802; GO:0048029; GO:1990830	SUBCELLULAR LOCATION: Golgi apparatus membrane; Peripheral membrane protein. Endosome membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}.			14702039; 15489334; 21269460; 24275569; 18675810; 18601654; 21988832; 25416956; 26935656	14702039; 15489334; 21269460; 24275569; 18675810; 18601654
604	GPER1 CEPR CMKRL2 DRY12 GPER GPR30	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: Note=Binds 17-beta-estradiol (E2) in plasma membranes with high affinity (Kd is 3.3 nM) and displays rapid kinetics of association and dissociation. {ECO:0000269|PubMed:15539556, ECO:0000269|PubMed:15705806, ECO:0000269|PubMed:19931550};											adenylate cyclase-activating G-protein coupled receptor signaling pathway [GO:0007189]; apoptotic chromosome condensation [GO:0030263]; cell cycle [GO:0007049]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucose stimulus [GO:0071333]; cellular response to mineralocorticoid stimulus [GO:0071389]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to tumor necrosis factor [GO:0071356]; G-protein coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of cell cycle process [GO:0010948]; negative regulation of cell proliferation [GO:0008285]; negative regulation of DNA metabolic process [GO:0051053]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of leukocyte activation [GO:0002695]; negative regulation of lipid biosynthetic process [GO:0051055]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of vascular smooth muscle cell proliferation [GO:1904706]; neuronal action potential [GO:0019228]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of cardiac vascular smooth muscle cell differentiation [GO:2000724]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of gene expression [GO:0010628]; positive regulation of G-protein coupled receptor protein signaling pathway [GO:0045745]; positive regulation of inositol trisphosphate biosynthetic process [GO:0032962]; positive regulation of insulin secretion [GO:0032024]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neurotransmitter secretion [GO:0001956]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of uterine smooth muscle contraction [GO:0070474]; regulation of cytosolic calcium ion concentration [GO:0051480]; steroid hormone mediated signaling pathway [GO:0043401]	axon [GO:0030424]; axon terminus [GO:0043679]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine head [GO:0044327]; dendritic spine membrane [GO:0032591]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; intracellular [GO:0005622]; keratin filament [GO:0045095]; mitochondrial membrane [GO:0031966]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]	axon [GO:0030424]; axon terminus [GO:0043679]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine head [GO:0044327]; dendritic spine membrane [GO:0032591]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; intracellular [GO:0005622]; keratin filament [GO:0045095]; mitochondrial membrane [GO:0031966]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; chromatin binding [GO:0003682]; estrogen receptor activity [GO:0030284]; G-protein coupled receptor activity [GO:0004930]; mineralocorticoid receptor activity [GO:0017082]; steroid binding [GO:0005496]; steroid hormone binding [GO:1990239]; adenylate cyclase-activating G-protein coupled receptor signaling pathway [GO:0007189]; apoptotic chromosome condensation [GO:0030263]; cell cycle [GO:0007049]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucose stimulus [GO:0071333]; cellular response to mineralocorticoid stimulus [GO:0071389]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to tumor necrosis factor [GO:0071356]; G-protein coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of cell cycle process [GO:0010948]; negative regulation of cell proliferation [GO:0008285]; negative regulation of DNA metabolic process [GO:0051053]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of leukocyte activation [GO:0002695]; negative regulation of lipid biosynthetic process [GO:0051055]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of vascular smooth muscle cell proliferation [GO:1904706]; neuronal action potential [GO:0019228]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of cardiac vascular smooth muscle cell differentiation [GO:2000724]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of G-protein coupled receptor protein signaling pathway [GO:0045745]; positive regulation of gene expression [GO:0010628]; positive regulation of inositol trisphosphate biosynthetic process [GO:0032962]; positive regulation of insulin secretion [GO:0032024]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neurotransmitter secretion [GO:0001956]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of uterine smooth muscle contraction [GO:0070474]; regulation of cytosolic calcium ion concentration [GO:0051480]; steroid hormone mediated signaling pathway [GO:0043401]	chromatin binding [GO:0003682]; estrogen receptor activity [GO:0030284]; G-protein coupled receptor activity [GO:0004930]; mineralocorticoid receptor activity [GO:0017082]; steroid binding [GO:0005496]; steroid hormone binding [GO:1990239]	GO:0000139; GO:0001934; GO:0001956; GO:0002695; GO:0003682; GO:0004930; GO:0005496; GO:0005622; GO:0005634; GO:0005635; GO:0005737; GO:0005769; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0005887; GO:0006954; GO:0007049; GO:0007186; GO:0007189; GO:0007204; GO:0008284; GO:0008285; GO:0010628; GO:0010629; GO:0010948; GO:0014068; GO:0014069; GO:0017082; GO:0019228; GO:0030054; GO:0030263; GO:0030264; GO:0030284; GO:0030335; GO:0030424; GO:0030425; GO:0030518; GO:0030659; GO:0031966; GO:0032024; GO:0032591; GO:0032962; GO:0042734; GO:0043065; GO:0043198; GO:0043280; GO:0043401; GO:0043410; GO:0043679; GO:0044327; GO:0045087; GO:0045095; GO:0045599; GO:0045742; GO:0045745; GO:0045944; GO:0048471; GO:0048786; GO:0050728; GO:0050769; GO:0051053; GO:0051055; GO:0051281; GO:0051480; GO:0051898; GO:0055037; GO:0070373; GO:0070374; GO:0070474; GO:0071157; GO:0071333; GO:0071356; GO:0071375; GO:0071389; GO:0071392; GO:0090200; GO:0097755; GO:0098686; GO:1903078; GO:1904706; GO:1990239; GO:2000353; GO:2000724; GO:2001238	SUBCELLULAR LOCATION: Nucleus. Cytoplasm {ECO:0000250}. Cytoplasm, perinuclear region. Cytoplasm, cytoskeleton. Cell membrane; Multi-pass membrane protein. Basolateral cell membrane; Multi-pass membrane protein. Cytoplasmic vesicle membrane; Multi-pass membrane protein. Early endosome. Recycling endosome. Golgi apparatus membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}. Golgi apparatus, trans-Golgi network. Endoplasmic reticulum membrane; Multi-pass membrane protein. Cell projection, dendrite {ECO:0000250}. Cell projection, dendritic spine membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}. Cell projection, axon {ECO:0000250}. Cell junction, synapse, postsynaptic cell membrane, postsynaptic density {ECO:0000250}. Mitochondrion membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}. Note=Colocalized with BSN to the active zone of presynaptic density. Colocalized with DLG4/PSD95 and neurabin-2 PPP1R9B in neuronal synaptosomes (By similarity). Endocytosed in a agonist- and arrestin-independent manner. Colocalized with RAMP3 and clathrin-coated pits at the plasma membrane. Colocalized with transferrin receptor at the plasma membrane and perinuclear region. Accumulated and colocalized with RAB11 proteins in recycling endosomes and trans-Golgi network (TGN), but does neither recycle back to the cell surface nor traffics to late endosome or lysosome. Colocalized with calnexin in the endoplasmic reticulum. Traffics to intracellular sites via cytokeratin intermediate filaments like KRT7 and KRT8 after constitutive endocytosis in epithelial cells. Colocalized with EGFR in the nucleus of agonist-induced cancer-associated fibroblasts (CAF). {ECO:0000250}.	PTM: Ubiquitinated; ubiquitination occurs at the plasma membrane and leads to proteasome-mediated degradation. {ECO:0000269|PubMed:21540189}.; PTM: Glycosylated. {ECO:0000269|PubMed:21427217}.	MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:22814378}.	8920907; 9070864; 9398636; 9141481; 9367686; 9479505; 14702039; 19054851; 12690205; 15489334; 11043579; 12027886; 15539556; 15705806; 16645038; 17379646; 18566127; 19179659; 19342448; 19749156; 20551055; 20203690; 19931550; 21427217; 21242460; 21540189; 21149639; 21354433; 23135268; 23285008; 22814378; 23283935; 23674134; 22521564; 22495674; 18577758; 19744559; 20711500; 2534964; 2748346; 2834384; 8015379	8920907; 9070864; 9398636; 9141481; 9367686; 9479505; 14702039; 19054851; 12690205; 15489334; 11043579; 12027886; 15539556; 15705806; 16645038; 17379646; 18566127; 19179659; 19342448; 19749156; 20551055; 20203690; 19931550; 21427217; 21242460; 21540189; 21149639; 21354433; 23135268; 23285008; 22814378; 23283935; 23674134; 22521564; 22495674
637	HMGCL	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=200 uM for magnesium ion {ECO:0000269|PubMed:12874287, ECO:0000269|PubMed:15122894}; KM=48 uM for HMG-CoA {ECO:0000269|PubMed:12874287, ECO:0000269|PubMed:15122894}; Vmax=191 umol/min/mg enzyme {ECO:0000269|PubMed:12874287, ECO:0000269|PubMed:15122894}; 	4.1.3.4	CATALYTIC ACTIVITY: (S)-3-hydroxy-3-methylglutaryl-CoA = acetyl-CoA + acetoacetate. {ECO:0000255|PROSITE-ProRule:PRU10115, ECO:0000269|PubMed:22847177, ECO:0000269|PubMed:22865860}.	BINDING 41 41 Substrate.	ACTIVITY REGULATION: Stimulated by reducing agents such as dithiothreitol (DTT). {ECO:0000269|PubMed:12874287}.	COFACTOR: Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240; Evidence={ECO:0000269|PubMed:12874287}; 		PATHWAY: Metabolic intermediate metabolism; (S)-3-hydroxy-3-methylglutaryl-CoA degradation; acetoacetate from (S)-3-hydroxy-3-methylglutaryl-CoA: step 1/1.				acyl-CoA metabolic process [GO:0006637]; ketone body biosynthetic process [GO:0046951]; leucine catabolic process [GO:0006552]; lipid metabolic process [GO:0006629]; liver development [GO:0001889]; mitochondrion organization [GO:0007005]; protein targeting to peroxisome [GO:0006625]; protein tetramerization [GO:0051262]; response to fatty acid [GO:0070542]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; carboxylic acid binding [GO:0031406]; fatty-acyl-CoA binding [GO:0000062]; hydroxymethylglutaryl-CoA lyase activity [GO:0004419]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; acyl-CoA metabolic process [GO:0006637]; ketone body biosynthetic process [GO:0046951]; leucine catabolic process [GO:0006552]; lipid metabolic process [GO:0006629]; liver development [GO:0001889]; mitochondrion organization [GO:0007005]; protein targeting to peroxisome [GO:0006625]; protein tetramerization [GO:0051262]; response to fatty acid [GO:0070542]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]	carboxylic acid binding [GO:0031406]; fatty-acyl-CoA binding [GO:0000062]; hydroxymethylglutaryl-CoA lyase activity [GO:0004419]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]	GO:0000062; GO:0000287; GO:0001889; GO:0004419; GO:0005102; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006552; GO:0006625; GO:0006629; GO:0006637; GO:0007005; GO:0007584; GO:0030145; GO:0031406; GO:0042594; GO:0042803; GO:0046872; GO:0046951; GO:0051262; GO:0070542	SUBCELLULAR LOCATION: Mitochondrion matrix. Peroxisome. Note=Unprocessed form is peroxisomal.		MOD_RES 48 48 N6-acetyllysine; alternate. {ECO:0000244|PubMed:19608861}.; MOD_RES 48 48 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:P38060}.; MOD_RES 111 111 N6-acetyllysine. {ECO:0000250|UniProtKB:P38060}.; MOD_RES 137 137 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:P38060}.; MOD_RES 137 137 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:P38060}.; MOD_RES 179 179 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:P38060}.; MOD_RES 179 179 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:P38060}.; MOD_RES 324 324 N6-acetyllysine. {ECO:0000250|UniProtKB:P38060}.	8440722; 14702039; 16710414; 15489334; 8617516; 21952825; 7527399; 8566388; 12464283; 12874287; 15122894; 19608861; 21269460; 22865860; 22847177; 23186163; 24275569; 25944712; 16330550; 8798725; 9463337; 9784232; 11129331; 12746442; 17173698; 16601870; 17459752; 19036343; 19177531; 11952809; 15164951; 15752612; 15764642; 16169070; 19932602; 20558737; 20711500; 20877624; 21514269; 21900206; 21988832; 23465862; 24333427; 25525879; 25708061; 25872961	8440722; 14702039; 16710414; 15489334; 8617516; 21952825; 7527399; 8566388; 12464283; 12874287; 15122894; 19608861; 21269460; 22865860; 22847177; 23186163; 24275569; 25944712; 16330550; 8798725; 9463337; 9784232; 11129331; 12746442; 17173698; 16601870; 17459752; 19036343; 19177531
674	HPGDS GSTS PGDS PTGDS2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=8 mM for glutathione for the glutathione-conjugating activity {ECO:0000269|PubMed:11672424, ECO:0000269|PubMed:12627223, ECO:0000269|PubMed:15113825}; KM=0.6 mM for glutathione for the prostaglandin D synthase activity in the presence of EDTA {ECO:0000269|PubMed:11672424, ECO:0000269|PubMed:12627223, ECO:0000269|PubMed:15113825}; KM=0.14 mM for glutathione for the prostaglandin D synthase activity in the presence of magnesium ions {ECO:0000269|PubMed:11672424, ECO:0000269|PubMed:12627223, ECO:0000269|PubMed:15113825}; Vmax=8.6 umol/min/mg enzyme with 1-bromo-2,4-dinitrobenzene as substrate {ECO:0000269|PubMed:11672424, ECO:0000269|PubMed:12627223, ECO:0000269|PubMed:15113825}; Vmax=5.1 umol/min/mg enzyme with 1-chloro-2,4-dinitrobenzene as substrate {ECO:0000269|PubMed:11672424, ECO:0000269|PubMed:12627223, ECO:0000269|PubMed:15113825}; Vmax=44.3 umol/min/mg enzyme with 1-fluoro-2,4-dinitrobenzene as substrate {ECO:0000269|PubMed:11672424, ECO:0000269|PubMed:12627223, ECO:0000269|PubMed:15113825}; Vmax=10.7 umol/min/mg enzyme with 1-iodo-2,4-dinitrobenzene as substrate {ECO:0000269|PubMed:11672424, ECO:0000269|PubMed:12627223, ECO:0000269|PubMed:15113825}; Vmax=6.8 umol/min/mg enzyme with allyl isothiocyanate as substrate {ECO:0000269|PubMed:11672424, ECO:0000269|PubMed:12627223, ECO:0000269|PubMed:15113825}; Vmax=6.3 umol/min/mg enzyme with benzyl isothiocyanate as substrate {ECO:0000269|PubMed:11672424, ECO:0000269|PubMed:12627223, ECO:0000269|PubMed:15113825}; Vmax=0.05 umol/min/mg enzyme with cumene hydroperoxide as substrate {ECO:0000269|PubMed:11672424, ECO:0000269|PubMed:12627223, ECO:0000269|PubMed:15113825}; 	5.3.99.2; 2.5.1.18	CATALYTIC ACTIVITY: (5Z,13E,15S)-9-alpha,11-alpha-epidioxy-15-hydroxyprosta-5,13-dienoate = (5Z,13E,15S)-9-alpha,15-dihydroxy-11-oxoprosta-5,13-dienoate. {ECO:0000269|PubMed:10824118, ECO:0000269|PubMed:11672424, ECO:0000269|PubMed:12627223, ECO:0000269|PubMed:16547010, ECO:0000269|PubMed:19939518, ECO:0000269|PubMed:9353279, ECO:0000269|PubMed:9425264}.; CATALYTIC ACTIVITY: RX + glutathione = HX + R-S-glutathione. {ECO:0000269|PubMed:10824118, ECO:0000269|PubMed:11672424, ECO:0000269|PubMed:15113825}.	BINDING 8 8 Glutathione. {ECO:0000269|PubMed:12627223, ECO:0000269|PubMed:15113825, ECO:0000269|PubMed:16547010, ECO:0000269|PubMed:18341273, ECO:0000269|PubMed:19939518}.; BINDING 14 14 Glutathione. {ECO:0000269|PubMed:12627223, ECO:0000269|PubMed:15113825, ECO:0000269|PubMed:16547010, ECO:0000269|PubMed:18341273, ECO:0000269|PubMed:19939518}.; BINDING 39 39 Glutathione. {ECO:0000269|PubMed:12627223, ECO:0000269|PubMed:15113825, ECO:0000269|PubMed:16547010, ECO:0000269|PubMed:18341273, ECO:0000269|PubMed:19939518}.	ACTIVITY REGULATION: Prostaglandin PGD2 synthesis is stimulated by calcium and magnesium ions. One calcium or magnesium ion is bound between the subunits of the homodimer. The interactions with the protein are for the most part mediated via water molecules. Magnesium increases the affinity for glutathione, while calcium has no effect on the affinity for glutathione. {ECO:0000269|PubMed:12627223}.	COFACTOR: Name=glutathione; Xref=ChEBI:CHEBI:57925; Evidence={ECO:0000269|PubMed:10824118, ECO:0000269|PubMed:11672424, ECO:0000269|PubMed:9353279, ECO:0000269|PubMed:9425264}; ;  Note=Glutathione is required for the prostaglandin D synthase activity. {ECO:0000269|PubMed:10824118, ECO:0000269|PubMed:11672424, ECO:0000269|PubMed:9353279, ECO:0000269|PubMed:9425264};						cyclooxygenase pathway [GO:0019371]; glutathione derivative biosynthetic process [GO:1901687]; locomotory behavior [GO:0007626]; negative regulation of male germ cell proliferation [GO:2000255]; prostaglandin metabolic process [GO:0006693]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; calcium ion binding [GO:0005509]; glutathione transferase activity [GO:0004364]; magnesium ion binding [GO:0000287]; prostaglandin-D synthase activity [GO:0004667]; protein homodimerization activity [GO:0042803]; cyclooxygenase pathway [GO:0019371]; glutathione derivative biosynthetic process [GO:1901687]; locomotory behavior [GO:0007626]; negative regulation of male germ cell proliferation [GO:2000255]; prostaglandin metabolic process [GO:0006693]; signal transduction [GO:0007165]	calcium ion binding [GO:0005509]; glutathione transferase activity [GO:0004364]; magnesium ion binding [GO:0000287]; prostaglandin-D synthase activity [GO:0004667]; protein homodimerization activity [GO:0042803]	GO:0000287; GO:0004364; GO:0004667; GO:0005509; GO:0005737; GO:0005829; GO:0006693; GO:0007165; GO:0007626; GO:0019371; GO:0042803; GO:1901687; GO:2000255	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:9353279}.			10824118; 11672424; 14702039; 15489334; 9425264; 9353279; 12627223; 15113825; 16547010; 18341273; 19939518; 10329152; 10587441; 10783391; 11327815; 12002745; 12042665; 12211029; 12707014; 16081649; 16298388; 16548513; 18946232; 19124506; 19181746; 19247692; 19276290; 19913121; 20074808; 20083122; 20085333; 20628086; 21106529; 21668448; 21683347; 21821144; 22049022; 22418579; 22522127; 22546671; 24996417; 25416956; 25978964; 27145233; 27485270; 8182750; 8203914; 8331657; 8431482; 9551553; 9839448	10824118; 11672424; 14702039; 15489334; 9425264; 9353279; 12627223; 15113825; 16547010; 18341273; 19939518
704	IDH1 PICD	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=49 uM for NADP {ECO:0000269|PubMed:19935646}; KM=29 uM for magnesium chloride {ECO:0000269|PubMed:19935646}; KM=65 uM for isocitrate {ECO:0000269|PubMed:19935646}; 	1.1.1.42	CATALYTIC ACTIVITY: Isocitrate + NADP(+) = 2-oxoglutarate + CO(2) + NADPH. {ECO:0000269|PubMed:10521434, ECO:0000269|PubMed:19935646}.	BINDING 77 77 Substrate. {ECO:0000244|PDB:1T0L, ECO:0000269|PubMed:15173171}.; BINDING 82 82 NADP. {ECO:0000244|PDB:1T09, ECO:0000244|PDB:1T0L, ECO:0000244|PDB:3INM, ECO:0000244|PDB:3MAP, ECO:0000244|PDB:3MAR, ECO:0000244|PDB:3MAS, ECO:0000244|PDB:4I3K, ECO:0000244|PDB:4I3L, ECO:0000244|PDB:4KZO, ECO:0000244|PDB:4L03, ECO:0000244|PDB:4L04, ECO:0000244|PDB:4L06, ECO:0000244|PDB:4UMX, ECO:0000244|PDB:4UMY, ECO:0000244|PDB:4XRX, ECO:0000244|PDB:4XS3, ECO:0000244|PDB:5DE1, ECO:0000244|PDB:5L57, ECO:0000244|PDB:5LGE, ECO:0000244|PDB:5SUN, ECO:0000244|PDB:5SVF, ECO:0000244|PDB:5TQH, ECO:0000269|PubMed:15173171, ECO:0000269|PubMed:19935646}.; BINDING 109 109 Substrate. {ECO:0000244|PDB:1T0L, ECO:0000269|PubMed:15173171}.; BINDING 132 132 Substrate. {ECO:0000244|PDB:1T0L, ECO:0000269|PubMed:15173171}.; BINDING 212 212 Substrate; shared with neighboring subunit. {ECO:0000244|PDB:1T0L, ECO:0000269|PubMed:15173171}.; BINDING 260 260 NADP. {ECO:0000244|PDB:1T0L, ECO:0000244|PDB:3INM, ECO:0000269|PubMed:15173171, ECO:0000269|PubMed:19935646}.; BINDING 328 328 NADP; via amide nitrogen and carbonyl oxygen. {ECO:0000244|PDB:1T09, ECO:0000244|PDB:1T0L, ECO:0000244|PDB:3INM, ECO:0000244|PDB:3MAP, ECO:0000244|PDB:3MAR, ECO:0000244|PDB:3MAS, ECO:0000244|PDB:4I3K, ECO:0000244|PDB:4I3L, ECO:0000244|PDB:4KZO, ECO:0000244|PDB:4L03, ECO:0000244|PDB:4L04, ECO:0000244|PDB:4L06, ECO:0000244|PDB:4UMX, ECO:0000244|PDB:4UMY, ECO:0000244|PDB:4XRX, ECO:0000244|PDB:4XS3, ECO:0000244|PDB:5DE1, ECO:0000244|PDB:5L57, ECO:0000244|PDB:5L58, ECO:0000244|PDB:5LGE, ECO:0000244|PDB:5SUN, ECO:0000244|PDB:5SVF, ECO:0000244|PDB:5TQH, ECO:0000269|PubMed:15173171, ECO:0000269|PubMed:19935646}.		COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:19935646}; Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000269|PubMed:19935646}; ;  Note=Binds 1 Mg(2+) or Mn(2+) ion per subunit. {ECO:0000269|PubMed:19935646};			SITE 139 139 Critical for catalysis.; SITE 212 212 Critical for catalysis.			2-oxoglutarate metabolic process [GO:0006103]; female gonad development [GO:0008585]; glutathione metabolic process [GO:0006749]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; NADPH regeneration [GO:0006740]; neutrophil degranulation [GO:0043312]; protein targeting to peroxisome [GO:0006625]; regulation of phospholipid biosynthetic process [GO:0071071]; regulation of phospholipid catabolic process [GO:0060696]; response to oxidative stress [GO:0006979]; response to steroid hormone [GO:0048545]; tricarboxylic acid cycle [GO:0006099]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724]; (R)-2-hydroxyglutarate dehydrogenase activity [GO:0051990]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; 2-oxoglutarate metabolic process [GO:0006103]; female gonad development [GO:0008585]; glutathione metabolic process [GO:0006749]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; NADPH regeneration [GO:0006740]; neutrophil degranulation [GO:0043312]; protein targeting to peroxisome [GO:0006625]; regulation of phospholipid biosynthetic process [GO:0071071]; regulation of phospholipid catabolic process [GO:0060696]; response to oxidative stress [GO:0006979]; response to steroid hormone [GO:0048545]; tricarboxylic acid cycle [GO:0006099]	(R)-2-hydroxyglutarate dehydrogenase activity [GO:0051990]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]	GO:0000287; GO:0004450; GO:0005102; GO:0005576; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006097; GO:0006099; GO:0006102; GO:0006103; GO:0006625; GO:0006740; GO:0006749; GO:0006979; GO:0008585; GO:0034774; GO:0042802; GO:0042803; GO:0043312; GO:0045296; GO:0048545; GO:0050661; GO:0051287; GO:0051990; GO:0060696; GO:0070062; GO:0071071; GO:1904724; GO:1904813	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:10521434}. Peroxisome {ECO:0000269|PubMed:10521434}.	PTM: Acetylation at Lys-374 dramatically reduces catalytic activity. {ECO:0000250}.	MOD_RES 2 2 N-acetylserine. {ECO:0000244|PubMed:22814378}.; MOD_RES 42 42 Phosphotyrosine. {ECO:0000244|PubMed:24275569}.; MOD_RES 81 81 N6-acetyllysine. {ECO:0000250|UniProtKB:O88844}.; MOD_RES 126 126 N6-succinyllysine. {ECO:0000250|UniProtKB:O88844}.; MOD_RES 224 224 N6-acetyllysine. {ECO:0000250|UniProtKB:O88844}.; MOD_RES 233 233 N6-acetyllysine. {ECO:0000250|UniProtKB:O88844}.; MOD_RES 243 243 N6-acetyllysine. {ECO:0000250|UniProtKB:O88844}.; MOD_RES 321 321 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 389 389 Phosphoserine. {ECO:0000250|UniProtKB:O88844}.; MOD_RES 400 400 N6-succinyllysine. {ECO:0000250|UniProtKB:O88844}.	9866202; 10521434; 11230166; 17974005; 15815621; 15489334; 19608861; 21269460; 22814378; 24275569; 25944712; 15173171; 19935646; 16959974; 18772396; 19117336; 26161668; 12923220; 15936593; 16169070; 18985363; 19228619; 19246647; 19340432; 19350208; 19351817; 19359588; 19378339; 19411854; 19435942; 19469031; 19543740; 19554337; 19636000; 19657110; 19667985; 19755387; 19765000; 19805454; 19805672; 19903171; 19915015; 19915484; 19933982; 20077503; 20097881; 20127344; 20129251; 20131059; 20133500; 20142433; 20160062; 20171147; 20171178; 20174854; 20227112; 20367200; 20368538; 20368543; 20376084; 20376086; 20410924; 20427748; 20459648; 20465388; 20473936; 20485375; 20494930; 20508616; 20510884; 20514489; 20534697; 20538800; 20560678; 20567020; 20603105; 20615753; 20625116; 20634891; 20651067; 20659156; 20661018; 20667415; 20678218; 20692206; 20702649; 20711500; 20725730; 20805365; 20874727; 20877624; 20880116; 20944672; 20946881; 20962861; 20972461; 20975057; 20975740; 21045145; 21069360; 21075857; 21079611; 21079649; 21080178; 21083371; 21088844; 21130701; 21163902; 21173122; 21177338; 21181477; 21225914; 21233841; 21284999; 21289278; 21294161; 21301070; 21307773; 21314850; 21316759; 21326241; 21326614; 21343879; 21346257; 21356389; 21383741; 21437454; 21480859; 21506885; 21516116; 21516462; 21539821; 21569770; 21575384; 21598255; 21625441; 21643842; 21643985; 21647152; 21647154; 21690245; 21707716; 21717448; 21755347; 21781445; 21784755; 21845536; 21867611; 21873548; 21874255; 21885076; 21898821; 21904853; 21912393; 21922591; 21929658; 21955925; 21983902; 21996744; 21997850; 22002076; 22015945; 22020636; 22025298; 22033490; 22034964; 22052461; 22057234; 22057236; 22064513; 22072542; 22074484; 22076165; 22101433; 22113362; 22136423; 22144470; 22147457; 22166653; 22172803; 22180306; 22192702; 22197544; 22199315; 22217666; 22238332; 22238333; 22264756; 22270848; 22281465; 22291938; 22322613; 22323113; 22326863; 22343889; 22343901; 22360629; 22360810; 22385606; 22396072; 22396073; 22397365; 22399191; 22410704; 22415316; 22427879; 22432788; 22445362; 22503487; 22520341; 22528790; 22616558; 22668828; 22683334; 22687971; 22688054; 22748659; 22752663; 22763442; 22772731; 22772980; 22781348; 22781800; 22785212; 22790483; 22809434; 22824796; 22844452; 22868530; 22869205; 22885298; 22890969; 22899282; 22904127; 22917530; 22922798; 22922872; 22929312; 22945896; 22968464; 23011765; 23015095; 23035067; 23038259; 23039322; 23041832; 23053494; 23063752; 23064941; 23071358; 23072665; 23074281; 23111198; 23115158; 23135354; 23184331; 23187294; 23192014; 23204232; 23223340; 23232569; 23235339; 23236540; 23264629; 23307057; 23330999; 23358936; 23361564; 23365461; 23373447; 23391413; 23410661; 23412777; 23429602; 23438035; 23451042; 23451940; 23485734; 23486687; 23494632; 23494873; 23504258; 23512379; 23532369; 23558169; 23561624; 23581583; 23598960; 23606334; 23641016; 23650620; 23681562; 23689617; 23731180; 23737489; 23793099; 23795241; 23801081; 23817809; 23840696; 23877318; 23894344; 23904262; 23918605; 23934175; 23934769; 23954893; 23988086; 23996483; 23999441; 24019001; 24046070; 24068788; 24077277; 24089051; 24129546; 24149775; 24160898; 24286310; 24295421; 24305719; 24311631; 24324372; 24333121; 24362902; 24368190; 24376688; 24384677; 24405933; 24443894; 24460285; 24473683; 24478380; 24510240; 24529257; 24531386; 24532263; 24557705; 24565682; 24569570; 24590270; 24606448; 24626950; 24699305; 24722048; 24755473; 24760710; 24771584; 24847087; 24857351; 24860178; 24867810; 24868540; 24877111; 24880135; 24887488; 24889502; 24895549; 24898068; 24922649; 24936872; 24958096; 24970694; 24986863; 24993250; 25005896; 25008158; 25008768; 25029120; 25033601; 25035396; 25040869; 25043045; 25078896; 25135281; 25150284; 25155243; 25164322; 25170661; 25225364; 25243911; 25251602; 25277207; 25355558; 25391653; 25407774; 25432631; 25455102; 25486927; 25496513; 25511738; 25523507; 25524848; 25555220; 25586175; 25586680; 25599133; 25634750; 25648147; 25650121; 25651001; 25652153; 25674227; 25678837; 25701198; 25706986; 25732040; 25783747; 25790191; 25811801; 25818003; 25836588; 25849605; 25862748; 25895133; 25962792; 25964481; 25987093; 26006098; 26008980; 26016385; 26016821; 26022161; 26045167; 26046462; 26049021; 26061753; 26091668; 26095778; 26109200; 26125858; 26138051; 26147657; 26158269; 26185030; 26188014; 26189213; 26228814; 26243269; 26276726; 26280302; 26314843; 26316565; 26324126; 26328938; 26331834; 26337623; 26338964; 26351014; 26395639; 26409566; 26414224; 26436839; 26485760; 26486081; 26503470; 26524630; 26545048; 26562302; 26582645; 26599207; 26617931; 26618343; 26669865; 26678339; 26700815; 26703962; 26780338; 26819452; 26834160; 26877611; 26911558; 26918938; 26927556; 26935296; 26936071; 26945349; 26951332; 26957363; 26960449; 26980223; 26987944; 27063596; 27071442; 27097804; 27120786; 27144334; 27145078; 27155448; 27231123; 27238019; 27245697; 27268645; 27270908; 27353503; 27354064; 27401888; 27406953; 27409829; 27424808; 27428487; 27430238; 27431380; 27460417; 27466503; 27468718; 27548812; 27553275; 27553586; 27576872; 27624942; 27626492; 27655638; 27664011; 27735988; 27764705; 27780605; 27782828; 27820599; 27834917; 27848136; 27849434; 27978414; 27982759; 27997717; 28002956; 28091987; 28110298; 28116838; 28124097; 28132785; 28148839; 28197303; 28218607; 28228392; 28263929; 28297679; 28302331; 28319047; 28330869; 28340142; 28402860; 28403884; 28404805; 28408400; 28445981; 28467784; 28534992; 28549927; 28552826; 28564604; 28653623; 28667042; 28748342; 28765326; 28785587; 28860121; 28869450; 28873367; 28916733; 28948065; 29016871; 29039582; 29057061; 29057925; 29090344; 29091765; 29115585; 29169374; 29288860; 29396294; 29414139; 29537891; 29871819; 30004704	9866202; 10521434; 11230166; 17974005; 15815621; 15489334; 19608861; 21269460; 22814378; 24275569; 25944712; 15173171; 19935646; 16959974; 18772396; 19117336; 26161668
707	ADHFE1 HMFT2263	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.17 mM for GHB {ECO:0000269|PubMed:16435184}; KM=1.2 mM for 2-KG {ECO:0000269|PubMed:16435184}; KM=0.12 mM for D-2-HG {ECO:0000269|PubMed:16435184}; KM=0.04 mM for SSA {ECO:0000269|PubMed:16435184}; KM=0.8 mM for L-3-OHB {ECO:0000269|PubMed:16435184}; Vmax=16 nmol/h/mg enzyme with GHB and 2-KG as substrates {ECO:0000269|PubMed:16435184}; Vmax=0.5 nmol/h/mg enzyme with SSA and D-2-HG as substrates {ECO:0000269|PubMed:16435184}; Vmax=1.8 nmol/h/mg enzyme with L-3-OHB and 2-KG as substrates {ECO:0000269|PubMed:16435184}; 	1.1.99.24	CATALYTIC ACTIVITY: (S)-3-hydroxybutanoate + 2-oxoglutarate = acetoacetate + (R)-2-hydroxyglutarate. {ECO:0000269|PubMed:16435184}.; CATALYTIC ACTIVITY: 4-hydroxybutanoate + 2-oxoglutarate = succinic semialdehyde + (R)-2-hydroxyglutarate. {ECO:0000269|PubMed:16435184}.				BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 7.5. {ECO:0000269|PubMed:16435184};			HMFT2263		2-oxoglutarate metabolic process [GO:0006103]; glutamate catabolic process via 2-oxoglutarate [GO:0006539]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; alcohol dehydrogenase (NAD) activity [GO:0004022]; hydroxyacid-oxoacid transhydrogenase activity [GO:0047988]; metal ion binding [GO:0046872]; 2-oxoglutarate metabolic process [GO:0006103]; glutamate catabolic process via 2-oxoglutarate [GO:0006539]	alcohol dehydrogenase (NAD) activity [GO:0004022]; hydroxyacid-oxoacid transhydrogenase activity [GO:0047988]; metal ion binding [GO:0046872]	GO:0004022; GO:0005739; GO:0005759; GO:0005829; GO:0006103; GO:0006539; GO:0046872; GO:0047988	SUBCELLULAR LOCATION: Mitochondrion {ECO:0000250}.		MOD_RES 445 445 N6-acetyllysine. {ECO:0000250|UniProtKB:Q8R0N6}.; MOD_RES 452 452 Phosphoserine. {ECO:0000250|UniProtKB:Q8R0N6}.	12592711; 14702039; 15489334; 15221005; 16435184; 24275569; 16959974; 19013439; 20877624; 21988832; 23517143; 24886599; 3182820	12592711; 14702039; 15489334; 15221005; 16435184; 24275569; 16959974
758	EPHX1 EPHX EPOX	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.8 uM for 8,9-EET {ECO:0000269|PubMed:22798687}; KM=0.4 uM for 11,12-EET {ECO:0000269|PubMed:22798687}; KM=0.9 uM for 14,15-EET {ECO:0000269|PubMed:22798687}; KM=5.8 uM for leukotoxin {ECO:0000269|PubMed:22798687}; Vmax=0.12 umol/min/mg enzyme with 8,9-EET as substrate {ECO:0000269|PubMed:22798687}; Vmax=0.6 umol/min/mg enzyme with 11,12-EET as substrate {ECO:0000269|PubMed:22798687}; Vmax=0.04 umol/min/mg enzyme with 14,15-EET as substrate {ECO:0000269|PubMed:22798687}; Vmax=0.008 umol/min/mg enzyme with leukotoxin as substrate {ECO:0000269|PubMed:22798687}; 	3.3.2.9	CATALYTIC ACTIVITY: Cis-stilbene oxide + H(2)O = (1R,2R)-1,2-diphenylethane-1,2-diol. {ECO:0000250|UniProtKB:P07687}.; CATALYTIC ACTIVITY: 1-(4-methoxyphenyl)-N-methyl-N-((3-methyloxetan-3-yl)methyl)methanamine + H(2)O = 2-((((4-methoxyphenyl)methyl)(methyl)amino)methyl)-2-methylpropane-1,3-diol. {ECO:0000250|UniProtKB:P07687}.									aromatic compound catabolic process [GO:0019439]; epoxide metabolic process [GO:0097176]; response to organic cyclic compound [GO:0014070]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]; cis-stilbene-oxide hydrolase activity [GO:0033961]; epoxide hydrolase activity [GO:0004301]; aromatic compound catabolic process [GO:0019439]; epoxide metabolic process [GO:0097176]; response to organic cyclic compound [GO:0014070]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805]	cis-stilbene-oxide hydrolase activity [GO:0033961]; epoxide hydrolase activity [GO:0004301]	GO:0004301; GO:0005789; GO:0006805; GO:0009636; GO:0014070; GO:0016021; GO:0019439; GO:0031090; GO:0033961; GO:0097176	SUBCELLULAR LOCATION: Microsome membrane {ECO:0000250|UniProtKB:P07687}; Single-pass type III membrane protein {ECO:0000250|UniProtKB:P07687}. Endoplasmic reticulum membrane {ECO:0000250|UniProtKB:P07687}; Single-pass type III membrane protein {ECO:0000250|UniProtKB:P07687}.		MOD_RES 295 295 Dimethylated arginine; alternate. {ECO:0000250|UniProtKB:P07687}.; MOD_RES 295 295 Omega-N-methylated arginine; alternate. {ECO:0000250}.	2891713; 3502697; 7516776; 7835893; 14702039; 16710414; 15489334; 11058921; 12878321; 21269460; 22798687; 24275569; 25944712; 12173035; 15618730; 15535985; 10601573; 10853854; 11124296; 11154734; 11191882; 11255266; 11283205; 11375900; 11406608; 11440964; 11471167; 11480169; 11489754; 11520401; 11535253; 11551408; 11597790; 11692079; 11751440; 11809533; 11813302; 11849215; 11859435; 11940289; 11967624; 12085365; 12121132; 12141066; 12160895; 12234472; 12359356; 12376511; 12397416; 12419832; 12491039; 12552594; 12579334; 12605384; 12631667; 12670526; 12717779; 12747973; 12760253; 12798882; 12854128; 12915882; 12935919; 14634838; 14642084; 14669306; 14681495; 14719475; 14751678; 14984931; 14988221; 15036125; 15061915; 15138035; 15150264; 15199549; 15256148; 15280903; 15298956; 15352038; 15355699; 15465926; 15466980; 15531751; 15536330; 15582499; 15640066; 15640939; 15654505; 15668489; 15692831; 15702235; 15714076; 15716486; 15719050; 15734960; 15746160; 15774926; 15817713; 15838728; 15894702; 15900282; 15901990; 15924351; 15928955; 15938845; 16005144; 16006997; 16029924; 16039674; 16043197; 16147638; 16201204; 16357600; 16369102; 16456143; 16535827; 16538176; 16585076; 16598069; 16614101; 16614120; 16630050; 16697254; 16926176; 16985026; 17022435; 17035385; 17048007; 17078101; 17082176; 17159790; 17164366; 17167268; 17203192; 17212663; 17273734; 17363767; 17365145; 17380322; 17412371; 17416769; 17416773; 17449559; 17498780; 17526865; 17532303; 17548684; 17548691; 17564249; 17588204; 17590289; 17608547; 17611777; 17686149; 17690329; 17695473; 17711870; 17767854; 17885617; 17896209; 17908297; 17996038; 18093316; 18200441; 18258609; 18298806; 18383527; 18394656; 18406439; 18423013; 18461673; 18495522; 18510611; 18513744; 18550614; 18569587; 18571762; 18614560; 18619701; 18632753; 18636124; 18642288; 18676680; 18680736; 18768509; 18784359; 18811882; 18816171; 18818748; 18836923; 18978678; 18990750; 18992148; 18992263; 19012698; 19017876; 19019335; 19064572; 19074885; 19111454; 19131562; 19162321; 19170196; 19177501; 19181923; 19287329; 19307236; 19330589; 19336370; 19339270; 19343046; 19364907; 19415745; 19479063; 19527514; 19528831; 19589345; 19593802; 19620853; 19625176; 19657367; 19692168; 19736056; 19751749; 19754350; 19789190; 19794411; 19898482; 19913121; 19933216; 19952982; 19956635; 19958090; 20091863; 20095411; 20140262; 20200332; 20233420; 20375710; 20379614; 20403997; 20437850; 20461808; 20516053; 20525719; 20568895; 20602612; 20628086; 20634891; 20637790; 20659238; 20689807; 20716240; 20731606; 20842355; 20847076; 20878130; 20886582; 20932192; 20935060; 20951227; 21044285; 21057703; 21183608; 21192345; 21228414; 21228718; 21254355; 21302624; 21309732; 21445251; 21453055; 21480392; 21593757; 21598178; 21649467; 21651746; 21734345; 21841461; 21883387; 21911578; 21983886; 22103900; 22118311; 22156006; 22188362; 22257321; 22352736; 22447130; 22524818; 22555758; 22593156; 22788361; 22928041; 22986331; 22994552; 23055191; 23378225; 23451147; 23564882; 23580125; 23651475; 23681797; 23797950; 23928928; 23949201; 23955801; 24013430; 24125961; 24222229; 24315822; 24505354; 24615030; 24803829; 24852519; 24861996; 25222243; 25261893; 25312477; 25495409; 25629049; 25714851; 25923690; 25992604; 25999707; 26065263; 26179485; 26216302; 26295053; 26555147; 27173271; 27188524; 27193053; 27256986; 27276192; 27783326; 28018104; 28120429; 28789952; 29054760; 9288046	2891713; 3502697; 7516776; 7835893; 14702039; 16710414; 15489334; 11058921; 12878321; 21269460; 22798687; 24275569; 25944712; 12173035; 15618730; 15535985
850	HYKK AGPHD1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=280 uM for (5R)-5-hydroxy-L-lysine (in the presence of 2 mM ATP) {ECO:0000269|PubMed:22241472}; KM=7.6 uM for (5R)-5-hydroxy-L-lysine (in the presence of 0.2 mM GTP) {ECO:0000269|PubMed:22241472}; KM=810 uM for ATP (in the presence of 0.5 mM (5R)-5-hydroxy-L-lysine) {ECO:0000269|PubMed:22241472}; KM=3.5 uM for GTP (in the presence of 0.5 mM (5R)-5-hydroxy-L-lysine) {ECO:0000269|PubMed:22241472}; Vmax=4.95 umol/min/mg enzyme toward (5R)-5-hydroxy-L-lysine (in the presence of 2 mM ATP) {ECO:0000269|PubMed:22241472}; Vmax=0.49 umol/min/mg enzyme toward (5R)-5-hydroxy-L-lysine (in the presence of 0.2 mM GTP) {ECO:0000269|PubMed:22241472}; Vmax=5.28 umol/min/mg enzyme toward ATP (in the presence of 0.5 mM (5R)-5-hydroxy-L-lysine) {ECO:0000269|PubMed:22241472}; Vmax=0.57 umol/min/mg enzyme toward GTP (in the presence of 0.5 mM (5R)-5-hydroxy-L-lysine) {ECO:0000269|PubMed:22241472}; 	2.7.1.81	CATALYTIC ACTIVITY: GTP + 5-hydroxy-L-lysine = GDP + 5-phosphonooxy-L-lysine. {ECO:0000269|PubMed:22241472}.									lysine catabolic process [GO:0006554]	mitochondrial matrix [GO:0005759]	mitochondrial matrix [GO:0005759]; hydroxylysine kinase activity [GO:0047992]; lysine catabolic process [GO:0006554]	hydroxylysine kinase activity [GO:0047992]	GO:0005759; GO:0006554; GO:0047992	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.			14702039; 16572171; 15489334; 22241472; 18385676; 18385738; 18780872; 19733931; 20548021; 20554942; 20587604; 21081471; 21810735; 22701590; 25074529; 25854352; 27072204	14702039; 16572171; 15489334; 22241472
860	IDO1 IDO INDO	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=21.23 uM for L-tryptophan {ECO:0000269|PubMed:18026683}; KM=4.6 mM for D-tryptophan {ECO:0000269|PubMed:18026683}; Note=Catalytic efficiency for L-tryptophan is 150 times higher than for D-tryptophan.;	1.13.11.52	CATALYTIC ACTIVITY: D-tryptophan + O(2) = N-formyl-D-kynurenine. {ECO:0000269|PubMed:17671174}.; CATALYTIC ACTIVITY: L-tryptophan + O(2) = N-formyl-L-kynurenine. {ECO:0000269|PubMed:17671174}.		ACTIVITY REGULATION: Activity is inhibited by and MTH-trp (methylthiohydantoin-DL-tryptophan), modestly inhibited by L-1MT (1-methyl-L-tryptophan) but not D-1MT (1-methyl-D-tryptophan). {ECO:0000269|PubMed:17671174}.	COFACTOR: Name=heme; Xref=ChEBI:CHEBI:30413; Evidence={ECO:0000269|PubMed:16477023, ECO:0000269|PubMed:25313323}; ;  Note=Binds 1 heme group per subunit (PubMed:16477023, PubMed:25313323). In the active form, the heme iron is in its ferrous state Fe(+2). The catalytic cycle does not alter the oxidation state of the heme, but IDO1 is prone to autoxidation (PubMed:16574111). {ECO:0000269|PubMed:16477023, ECO:0000269|PubMed:16574111, ECO:0000269|PubMed:25313323};		PATHWAY: Amino-acid degradation; L-tryptophan degradation via kynurenine pathway; L-kynurenine from L-tryptophan: step 1/2.				cytokine production involved in inflammatory response [GO:0002534]; female pregnancy [GO:0007565]; immune system process [GO:0002376]; kynurenic acid biosynthetic process [GO:0034276]; multicellular organismal response to stress [GO:0033555]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of T cell apoptotic process [GO:0070233]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of chronic inflammatory response [GO:0002678]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of T cell apoptotic process [GO:0070234]; positive regulation of T cell tolerance induction [GO:0002666]; positive regulation of type 2 immune response [GO:0002830]; response to lipopolysaccharide [GO:0032496]; swimming behavior [GO:0036269]; tryptophan catabolic process [GO:0006569]; tryptophan catabolic process to kynurenine [GO:0019441]	cytosol [GO:0005829]; smooth muscle contractile fiber [GO:0030485]; stereocilium bundle [GO:0032421]	cytosol [GO:0005829]; smooth muscle contractile fiber [GO:0030485]; stereocilium bundle [GO:0032421]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; indoleamine 2,3-dioxygenase activity [GO:0033754]; metal ion binding [GO:0046872]; tryptophan 2,3-dioxygenase activity [GO:0004833]; cytokine production involved in inflammatory response [GO:0002534]; female pregnancy [GO:0007565]; immune system process [GO:0002376]; kynurenic acid biosynthetic process [GO:0034276]; multicellular organismal response to stress [GO:0033555]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of T cell apoptotic process [GO:0070233]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of chronic inflammatory response [GO:0002678]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of T cell apoptotic process [GO:0070234]; positive regulation of T cell tolerance induction [GO:0002666]; positive regulation of type 2 immune response [GO:0002830]; response to lipopolysaccharide [GO:0032496]; swimming behavior [GO:0036269]; tryptophan catabolic process [GO:0006569]; tryptophan catabolic process to kynurenine [GO:0019441]	electron transfer activity [GO:0009055]; heme binding [GO:0020037]; indoleamine 2,3-dioxygenase activity [GO:0033754]; metal ion binding [GO:0046872]; tryptophan 2,3-dioxygenase activity [GO:0004833]	GO:0002376; GO:0002534; GO:0002666; GO:0002678; GO:0002830; GO:0004833; GO:0005829; GO:0006569; GO:0007565; GO:0009055; GO:0019441; GO:0020037; GO:0030485; GO:0032421; GO:0032496; GO:0032693; GO:0032735; GO:0033555; GO:0033754; GO:0034276; GO:0036269; GO:0042130; GO:0046872; GO:0070233; GO:0070234	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250|UniProtKB:P28776, ECO:0000303|PubMed:25691885}.			2109605; 2326172; 1449503; 14702039; 16421571; 15489334; 1907934; 14502282; 16574111; 17671174; 18026683; 18418598; 25394548; 25950090; 26155395; 23103127; 25157255; 25691885; 25970480; 16477023; 25313323; 11867636; 11987129; 12186837; 12228717; 12471139; 12766158; 12938169; 12963490; 13678429; 14871294; 14969766; 15001472; 15070879; 15102781; 15245429; 15254595; 15374002; 15528322; 15711557; 15919929; 15947091; 15950064; 16135011; 16169070; 16176799; 16319139; 16406698; 16421220; 16489067; 16511306; 16513157; 16686756; 16834326; 16842443; 17015408; 17038913; 17170728; 17182891; 17192467; 17202379; 17229698; 17294609; 17318080; 17321596; 17393386; 17433037; 17605849; 17626075; 17674321; 17711549; 17911610; 17951526; 18008147; 18036645; 18045970; 18055547; 18176870; 18205804; 18274832; 18299324; 18332894; 18370410; 18438685; 18622801; 18639339; 18660700; 18776940; 18802343; 18832696; 19010841; 19050070; 19058839; 19074858; 19106591; 19155537; 19168733; 19264674; 19306922; 19353519; 19363598; 19434461; 19448397; 19465693; 19487045; 19489917; 19514129; 19564344; 19597340; 19604093; 19604349; 19693771; 19695096; 19740345; 19783182; 19815714; 19828629; 19829303; 19844741; 19929471; 19933867; 20128646; 20192952; 20201926; 20331378; 20361220; 20386557; 20484731; 20522587; 20570568; 20635895; 20648630; 20663292; 20689575; 20711500; 20801903; 20938662; 21030093; 21044950; 21094802; 21118329; 21176371; 21292009; 21324164; 21328335; 21355883; 21359206; 21361337; 21461563; 21461581; 21487895; 21501890; 21502325; 21517752; 21517753; 21517755; 21517756; 21517757; 21575365; 21592112; 21600662; 21617756; 21690092; 21691274; 21692032; 21693183; 21712776; 21742973; 21755000; 21823214; 21835147; 21835273; 21892828; 21952237; 21980470; 22013481; 22039265; 22069308; 22093628; 22110525; 22112045; 22184722; 22202241; 22301793; 22424783; 22526360; 22592557; 22638210; 22690871; 22722711; 22751107; 22828446; 22860140; 22891315; 22913669; 22923135; 22929065; 22932670; 22936460; 23090116; 23109825; 23179760; 23200754; 23209301; 23232072; 23289444; 23344392; 23358471; 23411497; 23413147; 23440412; 23620105; 23651343; 23669411; 23682557; 23751345; 23752227; 23847296; 23853597; 23940074; 23949777; 23973990; 23986400; 24102581; 24252613; 24268989; 24282429; 24337170; 24391212; 24517146; 24612287; 24687552; 24717869; 24721110; 24732701; 24742251; 24795458; 24870595; 24875753; 24903009; 24988959; 25031694; 25060643; 25063873; 25081660; 25113564; 25200149; 25248875; 25274283; 25283845; 25308308; 25420916; 25450809; 25461397; 25541686; 25572287; 25627660; 25671592; 25683635; 25756191; 25783564; 25792183; 25886742; 25897671; 25899824; 26110930; 26142400; 26186743; 26198597; 26267811; 26285873; 26361229; 26426076; 26449488; 26511316; 26511909; 26517538; 26563749; 26608400; 26636389; 26642377; 26727587; 26762931; 26782048; 26814137; 26887337; 26895379; 26982018; 27106797; 27112409; 27121174; 27174915; 27192116; 27376248; 27440266; 27595833; 27667153; 27672107; 27695127; 27761872; 28027300; 28053021; 28057727; 28176360; 28189796; 28260094; 28264810; 28303855; 28314306; 28336906; 28337881; 28412361; 28428708; 28460011; 28498425; 28731684; 28735627; 28751450; 28760910; 28765120; 28859336; 29111717; 29154462; 29167421; 29240291; 29278387; 29372535; 29520442; 29531094; 29848687; 29897749; 29945890; 29998979	2109605; 2326172; 1449503; 14702039; 16421571; 15489334; 1907934; 14502282; 16574111; 17671174; 18026683; 18418598; 25394548; 25950090; 26155395; 23103127; 25157255; 25691885; 25970480; 16477023; 25313323
880	PRODH2 HSPOX1 HYPDH	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=200 mM for trans-4-L-hydroxyproline {ECO:0000269|PubMed:25697095}; KM=28 mM for oxygen {ECO:0000269|PubMed:25697095}; KM=143 uM for duroquinone {ECO:0000269|PubMed:25697095}; KM=25 uM for menadione {ECO:0000269|PubMed:25697095}; KM=124 uM for ubiquinone-1 {ECO:0000269|PubMed:25697095}; Note=kcat with trans-4-L-hydroxyproline (Hyp) and ubiquinone-1 is 0.19 sec(-1). Proline is unable to saturate PRODH2 at least up to 750mM. kcat/KM with proline and ubiquinone-10: 0.075 M(-1)/sec. kcat with oxygen, duroquinone, menadione and CoQ1 and with trans-4-L-hydroxyproline are 0.002 sec(-1), 0.27 sec(-1), 0.28 sec(-1) and 0.19 sec(-1), respectively. {ECO:0000269|PubMed:25697095};	1.5.5.3; 1.5.5.2	CATALYTIC ACTIVITY: Trans-4-hydroxy-L-proline + a quinone = (3R,5S)-3-hydroxy-1-pyrroline-5-carboxylate + a quinol. {ECO:0000269|PubMed:25697095}.; CATALYTIC ACTIVITY: L-proline + a quinone = (S)-1-pyrroline-5-carboxylate + a quinol. {ECO:0000269|PubMed:25697095}.		ACTIVITY REGULATION: Hydroproxyproline dehydrogenase activity is inhibited by THFA,(1R,3R)3-OH-cyclopentane-COOH and 5-OH-1H-pyrazole-3-COOH. {ECO:0000269|PubMed:25697095}.	COFACTOR: Name=FAD; Xref=ChEBI:CHEBI:57692; Evidence={ECO:0000269|PubMed:25697095}; 						glyoxylate metabolic process [GO:0046487]; proline catabolic process [GO:0006562]; proline catabolic process to glutamate [GO:0010133]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-NH group of donors [GO:0016645]; proline dehydrogenase activity [GO:0004657]; glyoxylate metabolic process [GO:0046487]; proline catabolic process [GO:0006562]; proline catabolic process to glutamate [GO:0010133]	FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-NH group of donors [GO:0016645]; proline dehydrogenase activity [GO:0004657]	GO:0004657; GO:0005739; GO:0005743; GO:0006562; GO:0010133; GO:0016645; GO:0046487; GO:0071949			MOD_RES 386 386 N6-acetyllysine. {ECO:0000250|UniProtKB:Q8VCZ9}.	25697095; 12865426; 13681368; 18287100; 20877624; 23861960; 6250440	25697095
941	EPHX2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=21 uM for threo-9,10-phosphonooxy-hydroxy-octadecanoic acid {ECO:0000269|PubMed:12574508, ECO:0000269|PubMed:12574510, ECO:0000269|PubMed:15196990}; KM=1.7 uM for 8,9-EET {ECO:0000269|PubMed:22798687}; KM=3.4 uM for 11,12-EET {ECO:0000269|PubMed:22798687}; KM=15 uM for 14,15-EET {ECO:0000269|PubMed:22798687}; KM=1.5 uM for leukotoxin {ECO:0000269|PubMed:22798687}; KM=1.1 mM for p-nitrophenyl phosphate {ECO:0000269|PubMed:12574508, ECO:0000269|PubMed:12574510, ECO:0000269|PubMed:15196990}; Vmax=338 nmol/min/mg enzyme with threo-9,10-phosphonooxy-hydroxy-octadecanoic acid {ECO:0000269|PubMed:12574508, ECO:0000269|PubMed:12574510, ECO:0000269|PubMed:15196990}; Vmax=0.9 umol/min/mg enzyme with 8,9-EET as substrate {ECO:0000269|PubMed:22798687}; Vmax=4.5 umol/min/mg enzyme with 11,12-EET as substrate {ECO:0000269|PubMed:22798687}; Vmax=7 umol/min/mg enzyme with 14,15-EET as substrate {ECO:0000269|PubMed:22798687}; Vmax=0.55 umol/min/mg enzyme with leukotoxin as substrate {ECO:0000269|PubMed:22798687}; Vmax=5.8 nmol/min/mg enzyme with p-nitrophenyl phosphate {ECO:0000269|PubMed:12574508, ECO:0000269|PubMed:12574510, ECO:0000269|PubMed:15196990}; 	3.3.2.10; 3.1.3.76	CATALYTIC ACTIVITY: An epoxide + H(2)O = a glycol. {ECO:0000269|PubMed:12574510, ECO:0000269|PubMed:12869654, ECO:0000269|PubMed:22798687}.; CATALYTIC ACTIVITY: (9S,10S)-10-hydroxy-9-(phosphonooxy)octadecanoate + H(2)O = (9S,10S)-9,10-dihydroxyoctadecanoate + phosphate. {ECO:0000269|PubMed:12574508, ECO:0000269|PubMed:12574510, ECO:0000269|PubMed:15196990}.	BINDING 383 383 Substrate. {ECO:0000269|PubMed:15096040, ECO:0000269|PubMed:16322563, ECO:0000269|PubMed:19746975, ECO:0000269|PubMed:19969453, ECO:0000269|PubMed:20934334}.	ACTIVITY REGULATION: Inhibited by 1-(1-acetylpiperidin-4-yl)-3-(4-(trifl uoromethoxy)phenyl)urea (TPAU), 1-cyclohexyl-3-dodecylurea (CDU), 12-(3-adamantan-1-yl-ureido)-dodecanoic acid (AUDA), 1-((3S, 5S, 7S)-adamantan-1-yl)-3-(5-(2-(2-ethoxyethoxy) ethoxy)pentyl)urea (AEPU), N-adamantyl-N[']-cyclohexyl urea (ACU), 4-(((1S, 4S)-4-(3-((3S, 5S, 7S)-adamantan-1-yl) ureido)cyclohexyl)oxy)benzoic acid (c-AUCB), 4-(((1R, 4R)-4-(3-((3S, 5S, 7S)-adamantan-1-yl)ureido)cyclohexyl)oxy)benzoic acid (t-AUCB), 4-(((1R, 4R)-4-(3-(4(trifluoromethoxy)phenyl)ureido)cyclohexyl)oxy)benzoic acid (t-TAUCB) and to a lesser extent by 8-(3-((3S, 5S, 7S)-adamantan-1-yl)ureido) octanoic acid (AUOA). {ECO:0000269|PubMed:22798687}.	COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:12574510, ECO:0000269|PubMed:15096040, ECO:0000269|PubMed:16322563}; 						cellular calcium ion homeostasis [GO:0006874]; cholesterol homeostasis [GO:0042632]; dephosphorylation [GO:0016311]; drug metabolic process [GO:0017144]; epoxide metabolic process [GO:0097176]; epoxygenase P450 pathway [GO:0019373]; inflammatory response [GO:0006954]; long-chain fatty acid biosynthetic process [GO:0042759]; phospholipid dephosphorylation [GO:0046839]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of gene expression [GO:0010628]; protein targeting to peroxisome [GO:0006625]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of cholesterol metabolic process [GO:0090181]; response to toxic substance [GO:0009636]; stilbene catabolic process [GO:0046272]; xenobiotic metabolic process [GO:0006805]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; 10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity [GO:0033885]; epoxide hydrolase activity [GO:0004301]; lipid phosphatase activity [GO:0042577]; magnesium ion binding [GO:0000287]; phosphatase activity [GO:0016791]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxic substance binding [GO:0015643]; cellular calcium ion homeostasis [GO:0006874]; cholesterol homeostasis [GO:0042632]; dephosphorylation [GO:0016311]; drug metabolic process [GO:0017144]; epoxide metabolic process [GO:0097176]; epoxygenase P450 pathway [GO:0019373]; inflammatory response [GO:0006954]; long-chain fatty acid biosynthetic process [GO:0042759]; phospholipid dephosphorylation [GO:0046839]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of gene expression [GO:0010628]; protein targeting to peroxisome [GO:0006625]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of cholesterol metabolic process [GO:0090181]; response to toxic substance [GO:0009636]; stilbene catabolic process [GO:0046272]; xenobiotic metabolic process [GO:0006805]	10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity [GO:0033885]; epoxide hydrolase activity [GO:0004301]; lipid phosphatase activity [GO:0042577]; magnesium ion binding [GO:0000287]; phosphatase activity [GO:0016791]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxic substance binding [GO:0015643]	GO:0000287; GO:0004301; GO:0005102; GO:0005777; GO:0005782; GO:0005829; GO:0006625; GO:0006805; GO:0006874; GO:0006954; GO:0008217; GO:0009636; GO:0010628; GO:0015643; GO:0016311; GO:0016791; GO:0017144; GO:0019373; GO:0033885; GO:0042577; GO:0042632; GO:0042759; GO:0042803; GO:0046272; GO:0046839; GO:0070062; GO:0072593; GO:0090181; GO:0097176; GO:0097755	SUBCELLULAR LOCATION: Cytoplasm. Peroxisome.	PTM: The N-terminus is blocked.; PTM: The covalent modification of cysteine by 15-deoxy-Delta12,14-prostaglandin-J2 is autocatalytic and reversible. It may occur as an alternative to other cysteine modifications, such as S-nitrosylation and S-palmitoylation (Probable). {ECO:0000305}.	MOD_RES 43 43 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 55 55 N6-succinyllysine. {ECO:0000250|UniProtKB:P34914}.; MOD_RES 191 191 N6-acetyllysine. {ECO:0000250|UniProtKB:P34914}.; MOD_RES 215 215 N6-acetyllysine. {ECO:0000250|UniProtKB:P34914}.; MOD_RES 370 370 Phosphoserine. {ECO:0000250|UniProtKB:P34914}.; MOD_RES 421 421 N6-succinyllysine. {ECO:0000250|UniProtKB:P34914}.; MOD_RES 455 455 N6-succinyllysine. {ECO:0000250|UniProtKB:P34914}.; MOD_RES 554 554 N6-succinyllysine. {ECO:0000250|UniProtKB:P34914}.	8342951; 8619856; 10862610; 14702039; 16421571; 15489334; 12869654; 12574508; 12574510; 15196990; 19608861; 21269460; 21164107; 22798687; 24275569; 15096040; 16322563; 19746975; 19969453; 20934334; 10830912; 11692079; 12468260; 14634838; 14732757; 15845398; 16115816; 16169070; 16202848; 16414022; 16545818; 16595607; 16957870; 17460077; 17495027; 17498780; 17919073; 18078836; 18216721; 18319271; 18323494; 18510611; 18537101; 18589104; 18632753; 18636124; 18676680; 18784359; 18818748; 19019335; 19074885; 19170196; 19343046; 19420105; 19527514; 19575027; 19578796; 19625176; 19692168; 19704161; 19814804; 19913121; 19940276; 20065888; 20140262; 20237496; 20379614; 20485444; 20628086; 20711500; 20819778; 20888937; 21044950; 21098312; 21192659; 21281786; 21302953; 21429967; 21642892; 21704394; 21988832; 22354938; 22387545; 22739108; 22986331; 23011468; 23152298; 23160182; 23237835; 23362272; 23576437; 23664879; 23684894; 23711456; 23999524; 24656800; 24771868; 25079952; 25173047; 25216066; 25388680; 25659109; 25800114; 25824304; 25839935; 25862210; 25877959; 25931264; 25947240; 25966114; 26230946; 26453326; 26845235; 26976569; 27009944; 27087514; 27266621; 27381900; 28409162; 28552948; 28835580; 28973302; 29058492; 29193961; 29295935; 29366648; 29665449	8342951; 8619856; 10862610; 14702039; 16421571; 15489334; 12869654; 12574508; 12574510; 15196990; 19608861; 21269460; 21164107; 22798687; 24275569; 15096040; 16322563; 19746975; 19969453; 20934334
1078	KCND2 KIAA1044	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: Note=Homotetrameric channels activate rapidly, i.e within a few msec. After that, they inactivate rapidly, i.e within about 50-100 msec. The voltage-dependence of activation and inactivation and other channel characteristics vary depending on the experimental conditions, the expression system and the presence or absence of ancillary subunits. Homotetrameric channels have a unitary conductance of about 4 pS when expressed in a heterologous system. For the activation of homotetrameric channels expressed in xenopus oocytes, the voltage at half-maximal amplitude is about -10 mV. The time constant for inactivation is about 20 msec. For inactivation, the voltage at half-maximal amplitude is -62 mV. The time constant for recovery after inactivation is about 70 msec. {ECO:0000305|PubMed:11507158, ECO:0000305|PubMed:17917103};											action potential [GO:0001508]; cellular response to hypoxia [GO:0071456]; chemical synaptic transmission [GO:0007268]; locomotor rhythm [GO:0045475]; neuronal action potential [GO:0019228]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sensory perception of pain [GO:0019233]	cell junction [GO:0030054]; dendritic spine [GO:0043197]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; intrinsic component of plasma membrane [GO:0031226]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic membrane [GO:0045211]; voltage-gated potassium channel complex [GO:0008076]	cell junction [GO:0030054]; dendritic spine [GO:0043197]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; intrinsic component of plasma membrane [GO:0031226]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic membrane [GO:0045211]; voltage-gated potassium channel complex [GO:0008076]; A-type (transient outward) potassium channel activity [GO:0005250]; metal ion binding [GO:0046872]; voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1905030]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; cellular response to hypoxia [GO:0071456]; chemical synaptic transmission [GO:0007268]; locomotor rhythm [GO:0045475]; neuronal action potential [GO:0019228]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sensory perception of pain [GO:0019233]	A-type (transient outward) potassium channel activity [GO:0005250]; metal ion binding [GO:0046872]; voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1905030]; voltage-gated potassium channel activity [GO:0005249]	GO:0001508; GO:0005249; GO:0005250; GO:0005886; GO:0005887; GO:0007268; GO:0008076; GO:0019228; GO:0019233; GO:0030054; GO:0031226; GO:0032809; GO:0034765; GO:0043197; GO:0043204; GO:0044853; GO:0045211; GO:0045475; GO:0046872; GO:0051260; GO:0071456; GO:0071805; GO:0098978; GO:0098982; GO:0099060; GO:1905030	SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11102480, ECO:0000269|PubMed:11507158, ECO:0000269|PubMed:14623880, ECO:0000269|PubMed:14695263, ECO:0000269|PubMed:14980201, ECO:0000269|PubMed:15454437, ECO:0000269|PubMed:16934482, ECO:0000269|PubMed:19171772, ECO:0000269|PubMed:24501278, ECO:0000269|PubMed:24811166}; Multi-pass membrane protein {ECO:0000269|PubMed:11102480, ECO:0000269|PubMed:14980201, ECO:0000305}. Cell projection, dendrite {ECO:0000269|PubMed:11102480}. Cell junction, synapse {ECO:0000250|UniProtKB:Q63881}. Perikaryon {ECO:0000250|UniProtKB:Q63881}. Cell junction, synapse, postsynaptic cell membrane {ECO:0000250|UniProtKB:Q63881}. Cell projection, dendritic spine {ECO:0000250|UniProtKB:Q63881}. Cell junction {ECO:0000250|UniProtKB:Q63881}. Note=In neurons, primarily detected on dendrites, dendritic spines and on the neuron cell body, but not on axons. Localized preferentially at the dendrites of pyramidal cells in the hippocampus CA1 layer. Detected at GABAergic synapses. Detected at cell junctions that are distinct from synaptic cell contacts. Detected in lipid rafts. Detected primarily at the endoplasmic reticulum or Golgi when expressed by itself (PubMed:15454437). Interaction with KCNIP1, KCNIP2, KCNIP3 or KCNIP4 promotes expression at the cell membrane (PubMed:15454437, PubMed:24811166). Interaction with DPP6 or DPP10 promotes expression at the cell membrane (By similarity). Internalized from the cell membrane by clathrin-dependent endocytosis in response to activation of AMPA-selective glutamate receptors and PKA-mediated phosphorylation at Ser-552. Redistributed from dendritic spines to the main dendritic shaft in response to activation of AMPA-selective glutamate receptors and activation of PKA (By similarity). {ECO:0000250|UniProtKB:Q63881, ECO:0000250|UniProtKB:Q9Z0V2, ECO:0000269|PubMed:15454437, ECO:0000269|PubMed:24811166}.	PTM: Phosphorylation at Ser-438 in response to MAPK activation is increased in stimulated dendrites. Interaction with KCNIP2 and DPP6 propomtes phosphorylation by PKA at Ser-552. Phosphorylation at Ser-552 has no effect on interaction with KCNIP3, but is required for the regulation of channel activity by KCNIP3. Phosphorylation at Ser-552 leads to KCND2 internalization (By similarity). Phosphorylated by MAPK in response to signaling via the metabotropic glutamate receptor GRM5 (By similarity). Phosphorylation at Ser-616 is required for the down-regulation of neuronal A-type currents in response to signaling via GRM5 (By similarity). {ECO:0000250|UniProtKB:Q63881, ECO:0000250|UniProtKB:Q9Z0V2}.	MOD_RES 38 38 Phosphothreonine. {ECO:0000250|UniProtKB:Q63881}.; MOD_RES 438 438 Phosphoserine. {ECO:0000250|UniProtKB:Q63881}.; MOD_RES 548 548 Phosphoserine. {ECO:0000250|UniProtKB:Q63881}.; MOD_RES 552 552 Phosphoserine. {ECO:0000250|UniProtKB:Q9Z0V2}.; MOD_RES 572 572 Phosphoserine. {ECO:0000250|UniProtKB:Q9Z0V2}.; MOD_RES 575 575 Phosphoserine. {ECO:0000250|UniProtKB:Q9Z0V2}.; MOD_RES 602 602 Phosphothreonine. {ECO:0000250|UniProtKB:Q63881}.; MOD_RES 607 607 Phosphothreonine. {ECO:0000250|UniProtKB:Q63881}.; MOD_RES 616 616 Phosphoserine. {ECO:0000250|UniProtKB:Q9Z0V2}.	9843794; 10470851; 10551270; 10729221; 12853948; 15489334; 11102480; 10676964; 11287421; 11507158; 12395204; 11847232; 12451113; 14695263; 15454437; 15358149; 16934482; 17917103; 18357523; 19171772; 24811166; 14980201; 14623880; 15991246; 14980207; 19213956; 24501278; 10681507; 11423117; 12829703; 14559911; 15563876; 16251476; 16260497; 16820361; 17057713; 17102134; 17187064; 17981906; 18364354; 18463498; 19401682; 19453640; 19596445; 20031566; 20045463; 20379614; 20393197; 20498229; 20709747; 21231794; 22122031; 23225603; 23692269; 24037343; 24225951; 24675763; 25003238; 25214526; 25599232; 25756524; 26209633; 26745419; 27307045; 29385176; 29581270	9843794; 10470851; 10551270; 10729221; 12853948; 15489334; 11102480; 10676964; 11287421; 11507158; 12395204; 11847232; 12451113; 14695263; 15454437; 15358149; 16934482; 17917103; 18357523; 19171772; 24811166; 14980201; 14623880; 15991246; 14980207; 19213956; 24501278
1087	LOXL2	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=1.01 mM for 1,5-diaminopentane {ECO:0000269|PubMed:20439985, ECO:0000269|PubMed:23319596}; KM=1.05 mM for spermine {ECO:0000269|PubMed:20439985, ECO:0000269|PubMed:23319596}; KM=0.59 uM for tropoelastin (without the first three SRCR domains) {ECO:0000269|PubMed:20439985, ECO:0000269|PubMed:23319596}; KM=0.62 uM for tropoelastin (without all four SRCR domains) {ECO:0000269|PubMed:20439985, ECO:0000269|PubMed:23319596}; Note=kcat is 2.04 min(-1) with tropoelastin as substrate (without the first three SRCR domains). kcat is 0.62 min(-1) with tropoelastin as substrate (without all four SRCR domains).;	1.4.3.13	CATALYTIC ACTIVITY: [Protein]-L-lysine + O(2) + H(2)O = [protein]-(S)-2-amino-6-oxohexanoate + NH(3) + H(2)O(2). {ECO:0000269|PubMed:20306300, ECO:0000269|PubMed:20439985, ECO:0000269|PubMed:23319596, ECO:0000269|PubMed:29581294}.		ACTIVITY REGULATION: According to some reports, it is inhibited by beta-aminopropionitrile (BAPN) (PubMed:20439985 and PubMed:23319596). According to another report, it is not inhibited by beta-aminopropionitrile (BAPN) (PubMed:20306300). Specifically inhibited by a mouse monoclonal antibody AB0023, inhibition occurs in a non-competitive manner. {ECO:0000269|PubMed:20306300, ECO:0000269|PubMed:20439985, ECO:0000269|PubMed:20818376, ECO:0000269|PubMed:23319596}.	COFACTOR: Name=Cu cation; Xref=ChEBI:CHEBI:23378; Evidence={ECO:0000269|PubMed:29581294}; ; COFACTOR: Name=lysine tyrosylquinone residue; Xref=ChEBI:CHEBI:20489; Evidence={ECO:0000269|PubMed:29581294}; ;  Note=Contains 1 lysine tyrosylquinone. {ECO:0000250|UniProtKB:P33072};						aging [GO:0007568]; cell adhesion [GO:0007155]; cellular protein modification process [GO:0006464]; collagen fibril organization [GO:0030199]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epithelial to mesenchymal transition [GO:0001837]; heterochromatin organization [GO:0070828]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]; transcription, DNA-templated [GO:0006351]	basement membrane [GO:0005604]; chromatin [GO:0000785]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	basement membrane [GO:0005604]; chromatin [GO:0000785]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; electron transfer activity [GO:0009055]; oligosaccharide binding [GO:0070492]; protein-lysine 6-oxidase activity [GO:0004720]; scavenger receptor activity [GO:0005044]; aging [GO:0007568]; cell adhesion [GO:0007155]; cellular protein modification process [GO:0006464]; collagen fibril organization [GO:0030199]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epithelial to mesenchymal transition [GO:0001837]; heterochromatin organization [GO:0070828]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]; transcription, DNA-templated [GO:0006351]	calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; electron transfer activity [GO:0009055]; oligosaccharide binding [GO:0070492]; protein-lysine 6-oxidase activity [GO:0004720]; scavenger receptor activity [GO:0005044]	GO:0000122; GO:0000785; GO:0001666; GO:0001837; GO:0001935; GO:0002040; GO:0004720; GO:0005044; GO:0005507; GO:0005509; GO:0005604; GO:0005615; GO:0005634; GO:0005654; GO:0005783; GO:0006351; GO:0006464; GO:0007155; GO:0007568; GO:0009055; GO:0010718; GO:0016020; GO:0018057; GO:0030199; GO:0032332; GO:0043542; GO:0045892; GO:0046688; GO:0062023; GO:0070492; GO:0070828; GO:1902455	SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix, basement membrane {ECO:0000269|PubMed:23319596}. Nucleus {ECO:0000269|PubMed:22204712, ECO:0000269|PubMed:24414204}. Chromosome {ECO:0000269|PubMed:27735137}. Endoplasmic reticulum {ECO:0000269|PubMed:28332555}. Note=Associated with chromatin (PubMed:27735137). It is unclear how LOXL2 is nuclear as it contains a signal sequence and has been shown to be secreted (PubMed:23319596). However, a number of reports confirm its intracellular location and its key role in transcription regulation (PubMed:22204712, PubMed:22483618). {ECO:0000269|PubMed:22204712, ECO:0000269|PubMed:23319596, ECO:0000269|PubMed:24414204, ECO:0000269|PubMed:27735137}.	PTM: The lysine tyrosylquinone cross-link (LTQ) is generated by condensation of the epsilon-amino group of a lysine with a topaquinone produced by oxidation of tyrosine. {ECO:0000269|PubMed:23319596, ECO:0000269|PubMed:29581294}.; PTM: N-glycosylated. N-glycosylation on Asn-455 and Asn-644 may be essential for proper folding and secretion; may be composed of a fucosylated carbohydrates attached to a trimannose N-linked glycan core. {ECO:0000269|PubMed:23319596}.	MOD_RES 689 689 2',4',5'-topaquinone. {ECO:0000269|PubMed:29581294}.	9079631; 14702039; 16421571; 15489334; 10212285; 16096638; 20026874; 20439985; 20818376; 21835952; 21233336; 21732535; 20306300; 22204712; 22157764; 22483618; 27392148; 23319596; 24239292; 24414204; 25959397; 27735137; 28332555; 29581294; 11313359; 12670920; 12820424; 16023247; 16906757; 17170699; 17287949; 18497746; 18559498; 18590575; 19015874; 19383344; 19394199; 19625348; 19724858; 20012301; 20043065; 20802105; 21519871; 21740577; 22739041; 23030485; 23357697; 23494965; 23640157; 23677379; 23933800; 23971878; 24008674; 24014025; 24177001; 24716982; 24863880; 25048396; 25092917; 25128648; 25146937; 25254241; 25275797; 25759215; 26096783; 26329904; 26490187; 26612622; 26676674; 26980013; 26983694; 27063404; 27278788; 27285767; 27363654; 27430160; 27488440; 27655685; 27694892; 27770022; 27784228; 28005267; 28246206; 28449718; 28480218; 28556501; 28677767; 28764769; 28864775; 28965583; 29052023; 29089463; 29107163; 29125826; 41816; 5246001; 6123066; 8636146	9079631; 14702039; 16421571; 15489334; 10212285; 16096638; 20026874; 20439985; 20818376; 21835952; 21233336; 21732535; 20306300; 22204712; 22157764; 22483618; 27392148; 23319596; 24239292; 24414204; 25959397; 27735137; 28332555; 29581294
1162	METAP1D MAP1D	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=573 uM for Met-pro-p-nitroanilide (at pH 8) {ECO:0000269|PubMed:17929833}; 	3.4.11.18	CATALYTIC ACTIVITY: Release of N-terminal amino acids, preferentially methionine, from peptides and arylamides. {ECO:0000255|HAMAP-Rule:MF_03174}.	BINDING 161 161 Substrate. {ECO:0000255|HAMAP-Rule:MF_03174}.; BINDING 259 259 Substrate. {ECO:0000255|HAMAP-Rule:MF_03174}.		COFACTOR: Name=Co(2+); Xref=ChEBI:CHEBI:48828; Evidence={ECO:0000255|HAMAP-Rule:MF_03174}; Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000255|HAMAP-Rule:MF_03174}; Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000255|HAMAP-Rule:MF_03174}; Name=Fe(2+); Xref=ChEBI:CHEBI:29033; Evidence={ECO:0000255|HAMAP-Rule:MF_03174}; ;  Note=Binds 2 divalent metal cations per subunit. Has a high-affinity and a low affinity metal-binding site. The true nature of the physiological cofactor is under debate. The enzyme is active with cobalt, zinc, manganese or divalent iron ions. Most likely, methionine aminopeptidases function as mononuclear Fe(2+)-metalloproteases under physiological conditions, and the catalytically relevant metal-binding site has been assigned to the histidine-containing high-affinity site. {ECO:0000255|HAMAP-Rule:MF_03174};	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 7.5-8.0. {ECO:0000269|PubMed:17929833};					N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; protein initiator methionine removal [GO:0070084]	intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]	intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; protein initiator methionine removal [GO:0070084]	aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]	GO:0004177; GO:0005739; GO:0008235; GO:0018206; GO:0031365; GO:0043231; GO:0046872; GO:0070006; GO:0070084	SUBCELLULAR LOCATION: Mitochondrion {ECO:0000255|HAMAP-Rule:MF_03174, ECO:0000269|PubMed:14532271}.			14532271; 16568094; 15489334; 17929833; 25944712; 19913121; 20379614; 20628086; 20877624; 26496610	14532271; 16568094; 15489334; 17929833; 25944712
1163	MARC1 MOSC1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=180 uM for benzamidoxime {ECO:0000269|PubMed:21029045}; KM=86 uM for NOHA {ECO:0000269|PubMed:21029045}; KM=272 uM for NHAM {ECO:0000269|PubMed:21029045}; Vmax=34 nmol/min/mg enzyme toward benzamidoxime {ECO:0000269|PubMed:21029045}; Vmax=105 nmol/min/mg enzyme toward benzamidoxime (at pH 6.0 and 37 degrees Celsius) {ECO:0000269|PubMed:24423752}; Vmax=55 nmol/min/mg enzyme toward NOHA {ECO:0000269|PubMed:21029045}; Vmax=43 nmol/min/mg enzyme toward NHAM {ECO:0000269|PubMed:21029045}; 	1.-.-.-				COFACTOR: Name=Mo-molybdopterin; Xref=ChEBI:CHEBI:71302; Evidence={ECO:0000269|PubMed:19053771, ECO:0000269|PubMed:24423752}; ;  Note=Binds 1 Mo-molybdopterin (Mo-MPT) cofactor per subunit. {ECO:0000269|PubMed:19053771, ECO:0000269|PubMed:24423752};						detoxification of nitrogen compound [GO:0051410]; nitrate metabolic process [GO:0042126]; oxidation-reduction process [GO:0055114]	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrate reductase activity [GO:0008940]; pyridoxal phosphate binding [GO:0030170]; detoxification of nitrogen compound [GO:0051410]; nitrate metabolic process [GO:0042126]; oxidation-reduction process [GO:0055114]	molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrate reductase activity [GO:0008940]; pyridoxal phosphate binding [GO:0030170]	GO:0005739; GO:0005741; GO:0008940; GO:0016021; GO:0030151; GO:0030170; GO:0042126; GO:0043546; GO:0051410; GO:0055114	SUBCELLULAR LOCATION: Mitochondrion outer membrane {ECO:0000269|PubMed:23086957}; Single-pass type II membrane protein {ECO:0000269|PubMed:23086957}. Membrane {ECO:0000305}; Lipid-anchor {ECO:0000305}. Note=Mitochondrial import is mediated by AA 1-40 and requires ATP.			14702039; 16710414; 15489334; 19053771; 21269460; 21029045; 23086957; 25255805; 25807930; 24423752; 20861021; 20877624; 21803866; 23703616; 24500710; 25144769; 25425164	14702039; 16710414; 15489334; 19053771; 21269460; 21029045; 23086957; 25255805; 25807930; 24423752
1173	MASP1 CRARF CRARF1 PRSS5	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.10 mM for Ac-Gly-Lys-OMe (at 30 degrees Celsius) {ECO:0000269|PubMed:11527969, ECO:0000269|PubMed:12538697}; KM=310 uM for Bz-Arg-OEt (at 30 degrees Celsius) {ECO:0000269|PubMed:11527969, ECO:0000269|PubMed:12538697}; KM=4.8 uM for C2 (at 37 degrees Celsius) {ECO:0000269|PubMed:11527969, ECO:0000269|PubMed:12538697}; 	3.4.21.-			ACTIVITY REGULATION: Inhibited by SERPING1 and A2M. {ECO:0000269|PubMed:11527969, ECO:0000269|PubMed:12538697}.				SITE 448 449 Cleavage; by autolysis. {ECO:0000269|PubMed:11290788}.			complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; negative regulation of complement activation [GO:0045916]; receptor-mediated endocytosis [GO:0006898]	cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]; complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; negative regulation of complement activation [GO:0045916]; receptor-mediated endocytosis [GO:0006898]	calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]	GO:0001867; GO:0004252; GO:0005509; GO:0005576; GO:0005615; GO:0005654; GO:0005829; GO:0006898; GO:0006956; GO:0008233; GO:0042803; GO:0045916; GO:0048306	SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:11485744}.	PTM: The iron and 2-oxoglutarate dependent 3-hydroxylation of aspartate and asparagine is (R) stereospecific within EGF domains. {ECO:0000250}.; PTM: N-glycosylated. Some N-linked glycan are of the complex-type (By similarity). {ECO:0000250}.; PTM: Autoproteolytic processing of the proenzyme produces the active enzyme composed on the heavy and the light chain held together by a disulfide bond. Isoform 1 but not isoform 2 is activated through autoproteolytic processing. {ECO:0000269|PubMed:11290788}.	MOD_RES 159 159 (3R)-3-hydroxyasparagine. {ECO:0000255}.	8240317; 8018603; 8921412; 10475605; 11485744; 14702039; 17974005; 16641997; 15489334; 11290788; 9367419; 9087411; 10679061; 10878362; 10946292; 11527969; 11907111; 12421953; 12538697; 15034049; 16335952; 16554018; 17182967; 19139490; 20956340; 18596036; 21258343; 26419238; 28301481; 10639434; 10925294; 11012776; 11532276; 12367778; 12370377; 12396008; 12601245; 14280442; 14707097; 15078867; 15199963; 15728497; 15804047; 16102832; 16112196; 16116205; 17179669; 17215869; 17444953; 17897951; 17938215; 18343499; 18456010; 18676680; 18842294; 19170196; 19423540; 19564340; 19607727; 19625176; 19667088; 19692168; 19917686; 19939495; 20032467; 20053996; 20375619; 20375634; 20400674; 20406964; 20438785; 20673767; 21035106; 21054788; 21625439; 21730084; 21900206; 22238349; 22511776; 22536427; 22607836; 22670777; 22691502; 22854970; 22966085; 23220946; 23386610; 23402018; 23602568; 23785123; 23792966; 23841802; 23861840; 23911397; 24023860; 24189400; 24424083; 24472859; 24683193; 25533914; 25745807; 25862418; 26173080; 26260032; 26371246; 26536449; 26614707; 26645987; 26789649; 27055907; 27057739; 27219453; 27344311; 27404661; 27405496; 27535802; 27605007; 28318015; 28720568; 6019133; 70787; 9153228	8240317; 8018603; 8921412; 10475605; 11485744; 14702039; 17974005; 16641997; 15489334; 11290788; 9367419; 9087411; 10679061; 10878362; 10946292; 11527969; 11907111; 12421953; 12538697; 15034049; 16335952; 16554018; 17182967; 19139490; 20956340; 18596036; 21258343; 26419238; 28301481
1208	LOXL3 LOXL	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=6.72 uM for STAT3 acetylated at 'Lys-685' (for deacetylation activity) {ECO:0000269|PubMed:28065600}; KM=1.59 uM for STAT3 acetylated at 'Lys-685' (for lysine 6-oxidase activity) {ECO:0000269|PubMed:28065600}; Note=kcat is 0.058 sec(-1) with STAT3 acetylated at 'Lys-685' (for deacetylation activity). kcat is 0.022 sec(-1) with STAT3 acetylated at 'Lys-685' (for lysine 6-oxidase activity). {ECO:0000269|PubMed:28065600};	1.4.3.-; 1.4.3.13	CATALYTIC ACTIVITY: [Protein]-L-lysine + O(2) + H(2)O = [protein]-(S)-2-amino-6-oxohexanoate + NH(3) + H(2)O(2). {ECO:0000269|PubMed:28065600}.; CATALYTIC ACTIVITY: [protein]-N(6)-acetyl-L-lysine + O(2) + H(2)O = [protein]-(S)-2-amino-6-oxohexanoate + acetamide + H(2)O(2). {ECO:0000269|PubMed:28065600}.			COFACTOR: Name=Cu cation; Xref=ChEBI:CHEBI:23378; Evidence={ECO:0000250|UniProtKB:P16636}; ; COFACTOR: Name=lysine tyrosylquinone residue; Xref=ChEBI:CHEBI:20489; Evidence={ECO:0000250|UniProtKB:P33072}; ;  Note=Contains 1 lysine tyrosylquinone. {ECO:0000250|UniProtKB:P33072};						epithelial to mesenchymal transition [GO:0001837]; fibronectin fibril organization [GO:1905590]; inflammatory response [GO:0006954]; lung development [GO:0030324]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; roof of mouth development [GO:0060021]; somite development [GO:0061053]; spinal cord development [GO:0021510]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; fibronectin binding [GO:0001968]; protein-lysine 6-oxidase activity [GO:0004720]; scavenger receptor activity [GO:0005044]; epithelial to mesenchymal transition [GO:0001837]; fibronectin fibril organization [GO:1905590]; inflammatory response [GO:0006954]; lung development [GO:0030324]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; roof of mouth development [GO:0060021]; somite development [GO:0061053]; spinal cord development [GO:0021510]	copper ion binding [GO:0005507]; fibronectin binding [GO:0001968]; protein-lysine 6-oxidase activity [GO:0004720]; scavenger receptor activity [GO:0005044]	GO:0001837; GO:0001968; GO:0004720; GO:0005044; GO:0005507; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0006954; GO:0016020; GO:0018057; GO:0021510; GO:0030324; GO:0045892; GO:0060021; GO:0061053; GO:1905590; GO:2000329; GO:2001046	SUBCELLULAR LOCATION: Secreted, extracellular space {ECO:0000250|UniProtKB:Q9Z175}. Cytoplasm {ECO:0000269|PubMed:28065600}. Nucleus {ECO:0000269|PubMed:28065600}. Note=It is unclear how LOXL3 is both intracellular (cytoplasmic and nuclear) and extracellular: it contains a clear signal sequence and is predicted to localize in the extracellular medium. However, the intracellular location is clearly reported and at least another protein of the family (LOXL2) also has intracellular and extracellular localization despite the presence of a signal sequence (PubMed:28065600). {ECO:0000269|PubMed:28065600}.; SUBCELLULAR LOCATION: Isoform 1: Secreted, extracellular space {ECO:0000305}.; SUBCELLULAR LOCATION: Isoform 2: Cytoplasm {ECO:0000269|PubMed:17018530}. Secreted, extracellular space {ECO:0000269|PubMed:17018530}.	PTM: The lysine tyrosylquinone cross-link (LTQ) is generated by condensation of the epsilon-amino group of a lysine with a topaquinone produced by oxidation of tyrosine. {ECO:0000250|UniProtKB:P33072}.	MOD_RES 670 670 2',4',5'-topaquinone. {ECO:0000250|UniProtKB:P33072}.	11284725; 11386757; 11334717; 17018530; 15815621; 15489334; 25663169; 26218558; 26957899; 28065600; 11313359; 16096638; 16169070; 16906757; 17287949; 19015874; 19724858; 21740577; 23357697; 25118846; 41816; 5246001; 6123066; 8636146	11284725; 11386757; 11334717; 17018530; 15815621; 15489334; 25663169; 26218558; 26957899; 28065600
1210	LPCAT4 AGPAT7 AYTL3 LPEAT2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=80 uM for lysophosphatidylethanolamine {ECO:0000269|PubMed:18458083}; KM=20 uM for oleoyl-CoA {ECO:0000269|PubMed:18458083}; Vmax=270 pmol/min/mg enzyme with lysophosphatidylethanolamine and oleoyl-CoA as substrates {ECO:0000269|PubMed:18458083}; 	2.3.1.23; 2.3.1.n6; 2.3.1.121; 2.3.1.67; 2.3.1.n7	CATALYTIC ACTIVITY: Acyl-CoA + 1-acyl-sn-glycero-3-phosphoethanolamine = CoA + 1,2-diacyl-sn-glycero-3-phosphoethanolamine. {ECO:0000269|PubMed:18458083}.; CATALYTIC ACTIVITY: Acyl-CoA + 1-alkenylglycerophosphoethanolamine = CoA + 1-alkenyl-2-acylglycerophosphoethanolamine. {ECO:0000269|PubMed:18458083}.; CATALYTIC ACTIVITY: Acyl-CoA + 1-acyl-sn-glycero-3-phosphocholine = CoA + 1,2-diacyl-sn-glycero-3-phosphocholine. {ECO:0000269|PubMed:18458083}.; CATALYTIC ACTIVITY: Acetyl-CoA + 1-alkyl-sn-glycero-3-phosphocholine = CoA + 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine. {ECO:0000269|PubMed:18458083}.; CATALYTIC ACTIVITY: Acyl-CoA + 1-acyl-sn-glycero-3-phosphatidylserine = CoA + 1,2-diacyl-sn-glycero-3-phosphatidylserine. {ECO:0000269|PubMed:18458083}.					PATHWAY: Lipid metabolism; phospholipid metabolism.				phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid metabolic process [GO:0006644]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-alkenylglycerophosphoethanolamine O-acyltransferase activity [GO:0047166]; 1-alkylglycerophosphocholine O-acetyltransferase activity [GO:0047192]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; lysophospholipid acyltransferase activity [GO:0071617]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid metabolic process [GO:0006644]	1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-alkenylglycerophosphoethanolamine O-acyltransferase activity [GO:0047166]; 1-alkylglycerophosphocholine O-acetyltransferase activity [GO:0047192]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; lysophospholipid acyltransferase activity [GO:0071617]	GO:0003841; GO:0005783; GO:0005789; GO:0006644; GO:0006654; GO:0016020; GO:0016021; GO:0036148; GO:0036150; GO:0036151; GO:0036152; GO:0047144; GO:0047166; GO:0047184; GO:0047192; GO:0071617	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:16243729, ECO:0000269|PubMed:18458083}; Multi-pass membrane protein {ECO:0000269|PubMed:16243729, ECO:0000269|PubMed:18458083}.			16243729; 14702039; 15489334; 18458083; 18691976; 21269460; 15367102; 15485873; 16495223; 16620771; 16704971; 16864775; 17182612; 17707131; 18195019; 18287005; 18718904; 18772128; 18781350; 19336658; 19351971; 22777291; 23815430; 9212163; 9461603	16243729; 14702039; 15489334; 18458083; 18691976; 21269460
1211	LPIN1 KIAA0188	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.35 mM for phosphatidate (isoform 1); KM=0.24 mM for phosphatidate (isoform 3); KM=0.11 mM for phosphatidate (isoform 4); 	3.1.3.4	CATALYTIC ACTIVITY: A 1,2-diacylglycerol 3-phosphate + H(2)O = a 1,2-diacyl-sn-glycerol + phosphate.		ACTIVITY REGULATION: Potently inhibited by sphingolipids, in particular, the sphingoid bases sphinganine and sphingosine and ceramide-1-phosphate. Inhibited by concentrations of Mg(2+) and Mn(2+) above their optimums and by Ca(2+), Zn(2+), N-ethylmaleimide and propranolol. {ECO:0000269|PubMed:20231281}.	COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:20231281}; Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000269|PubMed:20231281}; ;  Note=Mg(2+) and, at a lesser extent, Mn(2+). {ECO:0000269|PubMed:20231281};					BIOPHYSICOCHEMICAL PROPERTIES: ;  Temperature dependence: Optimum temperature is 40 degrees Celsius. Thermolabile above 40 degrees Celsius and essentially inactive at 60 degrees Celsius.;	animal organ regeneration [GO:0031100]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; mitotic nuclear envelope disassembly [GO:0007077]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription, DNA-templated [GO:0006351]; triglyceride biosynthetic process [GO:0019432]; triglyceride mobilization [GO:0006642]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]; animal organ regeneration [GO:0031100]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; mitotic nuclear envelope disassembly [GO:0007077]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription, DNA-templated [GO:0006351]; triglyceride biosynthetic process [GO:0019432]; triglyceride mobilization [GO:0006642]	phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]	GO:0003713; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005741; GO:0005789; GO:0005829; GO:0006351; GO:0006642; GO:0006646; GO:0006656; GO:0007077; GO:0008195; GO:0009062; GO:0019432; GO:0031100; GO:0031965; GO:0032869; GO:0045944; GO:0120162	SUBCELLULAR LOCATION: Nucleus membrane {ECO:0000250}. Cytoplasm, cytosol {ECO:0000250}. Endoplasmic reticulum membrane {ECO:0000250}.	PTM: Phosphorylated at multiple sites in response to insulin. Phosphorylation is controlled by the mTOR signaling pathway. Phosphorylation is decreased by epinephrine. Phosphorylation may not directly affect the catalytic activity but may regulate the localization. Dephosphorylated by the CTDNEP1-CNEP1R1 complex (By similarity). {ECO:0000250}.; PTM: Sumoylated. {ECO:0000250}.	MOD_RES 106 106 Phosphoserine. {ECO:0000250|UniProtKB:Q91ZP3}.; MOD_RES 150 150 Phosphoserine. {ECO:0000250|UniProtKB:Q91ZP3}.; MOD_RES 252 252 Phosphoserine. {ECO:0000250|UniProtKB:Q91ZP3}.; MOD_RES 254 254 Phosphoserine. {ECO:0000250|UniProtKB:Q91ZP3}.; MOD_RES 260 260 Phosphoserine. {ECO:0000250|UniProtKB:Q91ZP3}.; MOD_RES 264 264 Phosphothreonine. {ECO:0000250|UniProtKB:Q91ZP3}.; MOD_RES 294 294 Phosphoserine. {ECO:0000250|UniProtKB:Q91ZP3}.; MOD_RES 434 434 Phosphoserine. {ECO:0000250|UniProtKB:Q91ZP3}.; MOD_RES 438 438 Phosphoserine. {ECO:0000250|UniProtKB:Q91ZP3}.; MOD_RES 449 449 Phosphoserine. {ECO:0000250|UniProtKB:Q91ZP3}.; MOD_RES 600 600 Phosphoserine. {ECO:0000250|UniProtKB:Q91ZP3}.; MOD_RES 601 601 Phosphoserine. {ECO:0000250|UniProtKB:Q91ZP3}.; MOD_RES 887 887 Phosphoserine. {ECO:0000250|UniProtKB:Q91ZP3}.; MOD_RES 889 889 Phosphoserine. {ECO:0000250|UniProtKB:Q91ZP3}.	8724849; 14702039; 15815621; 15489334; 17158099; 18669648; 19690332; 20231281; 12111372; 16959974; 18817903; 22134922; 15889145; 17420445; 18693052; 18694939; 19494125; 19494126; 20876142; 21081492; 21413788; 22094256; 22986494; 26496610	8724849; 14702039; 15815621; 15489334; 17158099; 18669648; 19690332; 20231281; 12111372; 16959974; 18817903; 22134922
1253	ALOX15B	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1100 uM for arachidonate (isoform D at pH 7.4 and 20 degrees Celsius) {ECO:0000269|PubMed:10542053}; KM=10 uM for linoleate (isoform A at pH 7.4 and 20 degrees Celsius) {ECO:0000269|PubMed:10542053}; KM=25 uM for arachidonate (isoform A at pH 7.4 and 20 degrees Celsius) {ECO:0000269|PubMed:10542053}; Vmax=4 umol/min/mg enzyme with arachidonate as substrate (isoform A at pH 7.4 and 20 degrees Celsius) {ECO:0000269|PubMed:10542053}; Vmax=2 umol/min/mg enzyme with arachidonate as substrate (isoform D at pH 7.4 and 20 degrees Celsius) {ECO:0000269|PubMed:10542053}; Vmax=4 umol/min/mg enzyme with linoleate as substrate (isoform A at pH 7.4 and 20 degrees Celsius) {ECO:0000269|PubMed:10542053}; 	1.13.11.33; 1.13.11.-	CATALYTIC ACTIVITY: Arachidonate + O(2) = (5Z,8Z,11Z,13E)-(15S)-15-hydroperoxyicosa-5,8,11,13-tetraenoate.; CATALYTIC ACTIVITY: Linoleate + O(2) = (9Z,11E)-13-hydroxyoctadeca-9,11-dienoate.			COFACTOR: Name=Fe cation; Xref=ChEBI:CHEBI:24875; Evidence={ECO:0000255|PROSITE-ProRule:PRU00726, ECO:0000269|PubMed:24497644}; ;  Note=Binds 1 Fe cation per subunit. {ECO:0000255|PROSITE-ProRule:PRU00726, ECO:0000269|PubMed:24497644};		PATHWAY: Lipid metabolism; hydroperoxy eicosatetraenoic acid biosynthesis. {ECO:0000269|PubMed:10542053}.				apoptotic process [GO:0006915]; arachidonic acid metabolic process [GO:0019369]; hepoxilin biosynthetic process [GO:0051122]; linoleic acid metabolic process [GO:0043651]; lipid metabolic process [GO:0006629]; lipoxygenase pathway [GO:0019372]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; positive regulation of chemokine secretion [GO:0090197]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; prostate gland development [GO:0030850]; regulation of epithelial cell differentiation [GO:0030856]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; intracellular [GO:0005622]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; intracellular [GO:0005622]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; arachidonate 15-lipoxygenase activity [GO:0050473]; arachidonate 8(S)-lipoxygenase activity [GO:0036403]; calcium ion binding [GO:0005509]; iron ion binding [GO:0005506]; linoleate 13S-lipoxygenase activity [GO:0016165]; lipid binding [GO:0008289]; apoptotic process [GO:0006915]; arachidonic acid metabolic process [GO:0019369]; hepoxilin biosynthetic process [GO:0051122]; linoleic acid metabolic process [GO:0043651]; lipid metabolic process [GO:0006629]; lipoxygenase pathway [GO:0019372]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; positive regulation of chemokine secretion [GO:0090197]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; prostate gland development [GO:0030850]; regulation of epithelial cell differentiation [GO:0030856]	arachidonate 15-lipoxygenase activity [GO:0050473]; arachidonate 8(S)-lipoxygenase activity [GO:0036403]; calcium ion binding [GO:0005509]; iron ion binding [GO:0005506]; linoleate 13S-lipoxygenase activity [GO:0016165]; lipid binding [GO:0008289]	GO:0005506; GO:0005509; GO:0005622; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0006629; GO:0006915; GO:0008285; GO:0008289; GO:0010744; GO:0016020; GO:0016165; GO:0019369; GO:0019372; GO:0019898; GO:0030336; GO:0030850; GO:0030856; GO:0035360; GO:0036403; GO:0043651; GO:0045618; GO:0045786; GO:0045926; GO:0050473; GO:0051122; GO:0070062; GO:0090197	SUBCELLULAR LOCATION: Isoform A: Nucleus. Note=Other isoforms are excluded from the nucleus.; SUBCELLULAR LOCATION: Cytoplasm, cytosol. Cell membrane. Cytoplasm, cytoskeleton. Membrane; Peripheral membrane protein. Note=Predominantly cytosolic; becomes enriched at membranes upon calcium binding.			9177185; 11350124; 11839751; 16625196; 15489334; 10542053; 10625675; 12704195; 16112079; 18067895; 18755188; 22912809; 24497644; 12659684; 15247906; 15797645; 15799828; 16556493; 1662607; 16682954; 17662651; 18156936; 18570379; 19064572; 19423540; 19645454; 19661680; 20406964; 20428779; 20438785; 20668019; 20677014; 21316676; 21900394; 21951814; 22078795; 22980500; 24373925; 24376652; 24533104; 24975552; 25895668; 26918937; 27145229; 27435673; 28809482; 8334154	9177185; 11350124; 11839751; 16625196; 15489334; 10542053; 10625675; 12704195; 16112079; 18067895; 18755188; 22912809; 24497644
1302	ALOX12 12LO LOG12	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=8 uM for arachidonate (at pH 7.0 and 37 degrees Celsius) {ECO:0000269|PubMed:1851637}; KM=10 uM for arachidonate (at pH 8.0 and 25 degrees Celsius) {ECO:0000269|PubMed:8319693}; KM=6.2 uM for arachidonate (at pH 7.4) {ECO:0000269|PubMed:8250832}; KM=9 uM for linoleate (at pH 8.0 and 25 degrees Celsius) {ECO:0000269|PubMed:8319693}; KM=7.9 uM for leukotriene A4 (at pH 7.4) {ECO:0000269|PubMed:8250832}; KM=3 uM for eicosa-5,8,11,14,17-pentaenoate (at pH 7.0 and 37 degrees Celsius) {ECO:0000269|PubMed:1851637}; KM=35 uM for eicosa-8,11,14-trienoate (at pH 7.0 and 37 degrees Celsius) {ECO:0000269|PubMed:1851637}; KM=14.3 uM for 5,6-epoxy-8,11,14-eicosatrienoate (at pH 7.4) {ECO:0000269|PubMed:8250832}; Vmax=3 umol/min/mg enzyme with arachidonate as substrate (at pH 8.0 and 25 degrees Celsius) {ECO:0000269|PubMed:8319693}; Vmax=1.057 umol/min/mg enzyme with arachidonate as substrate (at pH 7.4) {ECO:0000269|PubMed:8250832}; Vmax=0.0375 umol/min/mg enzyme with linoleate as substrate (at pH 8.0 and 25 degrees Celsius) {ECO:0000269|PubMed:8319693}; Vmax=0.025 umol/min/mg enzyme with leukotriene A4 as substrate (at pH 7.4) {ECO:0000269|PubMed:8250832}; Vmax=0.985 umol/min/mg enzyme with 5,6-epoxy-8,11,14-eicosatrienoate as substrate (at pH 7.4) {ECO:0000269|PubMed:8250832}; 	1.13.11.31; 3.3.2.-	CATALYTIC ACTIVITY: Arachidonate + O(2) = (5Z,8Z,10E,14Z)-(12S)-12-hydroperoxyicosa-5,8,10,14-tetraenoate.; CATALYTIC ACTIVITY: (7E,9E,11Z,14Z)-(5S,6S)-5,6-epoxyicosa-7,9,11,14-tetraenoate + H(2)O = (5S,6R,15S)-trihydroxy-(7E,9E,11Z,13E)-eicosatetraenoate.; CATALYTIC ACTIVITY: (7E,9E,11Z,14Z)-(5S,6S)-5,6-epoxyicosa-7,9,11,14-tetraenoate + H(2)O = (5S,14R,15S)-trihydroxy-(6E,8Z,10E,12E)-eicosatetraenoate.		ACTIVITY REGULATION: Activated by EGF. {ECO:0000269|PubMed:8912711}.	COFACTOR: Name=Fe cation; Xref=ChEBI:CHEBI:24875; ;  Note=Binds 1 Fe cation per subunit.;	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 7.5-8.0 (for arachidonate 12-lipoxygenase activity). {ECO:0000269|PubMed:8250832, ECO:0000269|PubMed:8319693};	PATHWAY: Lipid metabolism; hydroperoxy eicosatetraenoic acid biosynthesis. {ECO:0000269|PubMed:1851637}.				arachidonic acid metabolic process [GO:0019369]; establishment of skin barrier [GO:0061436]; fatty acid oxidation [GO:0019395]; hepoxilin biosynthetic process [GO:0051122]; hepoxilin metabolic process [GO:0051121]; leukotriene A4 metabolic process [GO:1901751]; linoleic acid metabolic process [GO:0043651]; lipoxin A4 biosynthetic process [GO:2001303]; lipoxin B4 biosynthetic process [GO:2001306]; lipoxin biosynthetic process [GO:2001301]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of platelet aggregation [GO:0090331]; superoxide anion generation [GO:0042554]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; sarcolemma [GO:0042383]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; sarcolemma [GO:0042383]; arachidonate 12-lipoxygenase activity [GO:0004052]; hepoxilin A3 synthase activity [GO:0051120]; hepoxilin-epoxide hydrolase activity [GO:0047977]; iron ion binding [GO:0005506]; linoleate 13S-lipoxygenase activity [GO:0016165]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; arachidonic acid metabolic process [GO:0019369]; establishment of skin barrier [GO:0061436]; fatty acid oxidation [GO:0019395]; hepoxilin biosynthetic process [GO:0051122]; hepoxilin metabolic process [GO:0051121]; leukotriene A4 metabolic process [GO:1901751]; linoleic acid metabolic process [GO:0043651]; lipoxin A4 biosynthetic process [GO:2001303]; lipoxin B4 biosynthetic process [GO:2001306]; lipoxin biosynthetic process [GO:2001301]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of platelet aggregation [GO:0090331]; superoxide anion generation [GO:0042554]	arachidonate 12-lipoxygenase activity [GO:0004052]; hepoxilin A3 synthase activity [GO:0051120]; hepoxilin-epoxide hydrolase activity [GO:0047977]; iron ion binding [GO:0005506]; linoleate 13S-lipoxygenase activity [GO:0016165]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]	GO:0004052; GO:0005506; GO:0005737; GO:0005829; GO:0010656; GO:0016020; GO:0016165; GO:0016702; GO:0019369; GO:0019372; GO:0019395; GO:0042383; GO:0042554; GO:0042759; GO:0043651; GO:0047977; GO:0051120; GO:0051121; GO:0051122; GO:0061436; GO:0070062; GO:0090331; GO:1901751; GO:2001301; GO:2001303; GO:2001306	SUBCELLULAR LOCATION: Cytoplasm, cytosol. Membrane. Note=Membrane association is stimulated by EGF.		MOD_RES 246 246 Phosphoserine. {ECO:0000250|UniProtKB:F1LQ70}.	2244907; 2377602; 2217179; 16625196; 15489334; 1447217; 1570320; 8304420; 1851637; 8250832; 8319693; 8500694; 8912711; 9751607; 16638750; 18755188; 22237009; 23578768; 15308583; 17151091; 17460548; 10692117; 10727209; 11115402; 11914583; 12538614; 12664313; 12664573; 12664578; 12907138; 14532840; 14669797; 14767568; 15010818; 15111312; 15123652; 15142951; 15305153; 15474031; 15729574; 15797645; 16118214; 16482570; 16514435; 16598376; 16788089; 17045234; 17236225; 17379189; 17520163; 17893696; 18086569; 18187376; 18504448; 18547056; 18640486; 18676680; 18992148; 19046748; 19170196; 19328558; 19423540; 19469483; 19625176; 19663136; 19692168; 19885615; 19913121; 20061896; 20089617; 20181616; 20382140; 20406964; 20431935; 20438785; 20453000; 20570249; 20592751; 20626912; 20628086; 20653566; 20697415; 21085606; 21094135; 21104233; 21127289; 21225230; 2155925; 21945939; 22089472; 22275252; 22323304; 22384268; 22668814; 22864639; 22895552; 22924777; 22980500; 22991985; 23079635; 2318885; 23526143; 23528921; 23715757; 23784669; 23828562; 23832258; 24686056; 24783193; 24975552; 25260086; 25339205; 25532042; 25549319; 25598081; 25708815; 26037302; 26106157; 26372769; 26672987; 27470510; 29196930; 3770188; 8334154	2244907; 2377602; 2217179; 16625196; 15489334; 1447217; 1570320; 8304420; 1851637; 8250832; 8319693; 8500694; 8912711; 9751607; 16638750; 18755188; 22237009; 23578768; 15308583; 17151091; 17460548
1430	MTRR	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=2.89 uM for NADPH {ECO:0000269|PubMed:17892308}; KM=3540 uM for NADH {ECO:0000269|PubMed:17892308}; 	1.16.1.8	CATALYTIC ACTIVITY: 2 [methionine synthase]-methylcob(III)alamin + 2 S-adenosylhomocysteine + NADP(+) = 2 [methionine synthase]-cob(II)alamin + NADPH + 2 S-adenosyl-L-methionine. {ECO:0000269|PubMed:17892308}.	BINDING 318 318 NADP. {ECO:0000269|PubMed:17892308}.; BINDING 686 686 NADP. {ECO:0000269|PubMed:17892308}.; BINDING 724 724 FAD. {ECO:0000269|PubMed:17892308}.		COFACTOR: Name=FAD; Xref=ChEBI:CHEBI:57692; Evidence={ECO:0000269|PubMed:17892308}; ; COFACTOR: Name=FMN; Xref=ChEBI:CHEBI:58210; Evidence={ECO:0000269|PubMed:17892308}; 						cobalamin metabolic process [GO:0009235]; DNA methylation [GO:0006306]; folic acid metabolic process [GO:0046655]; homocysteine catabolic process [GO:0043418]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; negative regulation of cystathionine beta-synthase activity [GO:1904042]; oxidation-reduction process [GO:0055114]; S-adenosylmethionine cycle [GO:0033353]	cytosol [GO:0005829]	cytosol [GO:0005829]; [methionine synthase] reductase activity [GO:0030586]; aquacobalamin reductase (NADPH) activity [GO:0050444]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH binding [GO:0070402]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor [GO:0016723]; cobalamin metabolic process [GO:0009235]; DNA methylation [GO:0006306]; folic acid metabolic process [GO:0046655]; homocysteine catabolic process [GO:0043418]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; negative regulation of cystathionine beta-synthase activity [GO:1904042]; oxidation-reduction process [GO:0055114]; S-adenosylmethionine cycle [GO:0033353]	[methionine synthase] reductase activity [GO:0030586]; aquacobalamin reductase (NADPH) activity [GO:0050444]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH binding [GO:0070402]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor [GO:0016723]	GO:0003958; GO:0005829; GO:0006306; GO:0006555; GO:0009086; GO:0009235; GO:0010181; GO:0016723; GO:0030586; GO:0033353; GO:0043418; GO:0046655; GO:0050444; GO:0050660; GO:0050661; GO:0055114; GO:0070402; GO:0071949; GO:1904042	SUBCELLULAR LOCATION: Isoform B: Cytoplasm.; SUBCELLULAR LOCATION: Isoform C: Cytoplasm.; SUBCELLULAR LOCATION: Isoform A: Cytoplasm {ECO:0000269|PubMed:18221906}.		MOD_RES 198 198 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 216 216 Phosphoserine. {ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.	10564814; 9501215; 15372022; 15489334; 18221906; 20068231; 21269460; 23186163; 24275569; 17892308; 10484769; 10444342; 12375236; 15979034; 10791559; 11472746; 11592436; 11807890; 12020105; 12068375; 12091127; 12416982; 12482550; 12555939; 12590188; 12642343; 12649067; 12716294; 12801615; 12807760; 12810988; 12855226; 12876480; 12923861; 12939653; 14632302; 14652285; 14716779; 14967039; 14977639; 15059614; 15060097; 15135249; 15159311; 15216546; 15347655; 15514263; 15514969; 15612980; 15714522; 15797993; 15866085; 15889417; 15894670; 16006998; 16013960; 16115349; 16268464; 16316363; 16351505; 16470748; 16485733; 16575899; 16580699; 16769880; 16820193; 16861746; 16894458; 16947783; 16985020; 17009228; 17024475; 17035141; 17074544; 17079868; 17087642; 17101561; 17113603; 17119116; 17136115; 17152488; 17220339; 17311259; 17311260; 17376725; 17417062; 17436311; 17454638; 17461517; 17477549; 17522601; 17533396; 17546637; 17553479; 17554763; 17581676; 17596206; 17636160; 17655928; 17822659; 17853476; 17904392; 17925002; 17934692; 17967524; 17993766; 18004208; 18023275; 18034637; 18061941; 18174236; 18199722; 18204969; 18222012; 18226574; 18249021; 18257130; 18378576; 18427977; 18435414; 18483342; 18485163; 18510611; 18515090; 18590621; 18607581; 18610829; 18614746; 18635682; 18676680; 18682255; 18700049; 18771981; 18774170; 18774994; 18785313; 18792976; 18830263; 18836720; 18842997; 18843018; 18936436; 18978678; 18983896; 18988749; 18992148; 19020309; 19035314; 19048631; 19064571; 19064578; 19074885; 19112534; 19161160; 19170196; 19243433; 19254790; 19263808; 19336370; 19336437; 19339913; 19348062; 19353223; 19394322; 19427504; 19461557; 19493349; 19533788; 19625176; 19657388; 19692168; 19706844; 19729796; 19737740; 19760026; 19774638; 19776634; 19777601; 19812220; 19837268; 19843671; 19852428; 19858780; 19913121; 19936946; 19948975; 20031554; 20047525; 20056620; 20082058; 20085490; 20099281; 20120036; 20140262; 20180013; 20209990; 20373852; 20378615; 20386493; 20411324; 20437058; 20447924; 20453000; 20458436; 20466634; 20544798; 20549016; 20615890; 20628086; 20634891; 20647221; 20718043; 20726305; 20737570; 20852008; 20883119; 20888556; 20948192; 20955826; 20960050; 20962453; 21041608; 21045269; 21055808; 21070756; 21092627; 21204909; 21211571; 21349258; 21438757; 21472912; 21547363; 21774403; 21775772; 21780915; 21947961; 21987236; 22005284; 22057956; 22097960; 22179537; 22236648; 22339686; 22373582; 22475273; 22479380; 22665368; 22706675; 22719222; 22796266; 22813657; 22925068; 23039890; 23094987; 23188888; 23225055; 23266814; 23372658; 23425389; 23430981; 23459165; 23959833; 23986219; 24130171; 24261678; 24334125; 24589657; 24595101; 24815481; 24913415; 24965145; 25105440; 25140779; 25337902; 25416956; 25429430; 25518505; 25544792; 25754229; 25801727; 25809864; 25815774; 25888933; 25966116; 25978498; 26016497; 26037359; 26045171; 26063524; 26090795; 26154858; 26196053; 26214647; 26252105; 26266420; 26316272; 26334892; 26337056; 26345779; 26874989; 26989453; 27806663; 27983710; 28094822; 28118645; 28375104; 28436330; 28537809; 28691890; 28712006; 28758112; 28778621; 28876333; 28994615; 29321350; 29348398; 8968736; 8968737	10564814; 9501215; 15372022; 15489334; 18221906; 20068231; 21269460; 23186163; 24275569; 17892308; 10484769; 10444342; 12375236; 15979034
1477	KDM5D HY HYA JARID1D KIAA0234 SMCY	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=10 uM for 2-oxoglutarate {ECO:0000269|PubMed:27427228}; KM=6.2 uM for histone H3K4me3 {ECO:0000269|PubMed:27427228}; Note=Kcat are 2.6 min(-1) and 3.0 min(-1) for 2-oxoglutarate and histone H3K4me3, respectively. {ECO:0000269|PubMed:27427228};	1.14.11.-		BINDING 430 430 2-oxoglutarate. {ECO:0000250|UniProtKB:P29375}.; BINDING 512 512 2-oxoglutarate. {ECO:0000250|UniProtKB:P29375}.; BINDING 514 514 2-oxoglutarate. {ECO:0000250|UniProtKB:P29375}.; BINDING 522 522 2-oxoglutarate. {ECO:0000250|UniProtKB:P29375}.		COFACTOR: Name=L-ascorbate; Xref=ChEBI:CHEBI:38290; Evidence={ECO:0000269|PubMed:17320162}; ; COFACTOR: Name=Fe(2+); Xref=ChEBI:CHEBI:29033; Evidence={ECO:0000269|PubMed:17320162}; ;  Note=Binds 1 Fe(2+) ion per subunit. {ECO:0000269|PubMed:17320162};						histone H3-K4 demethylation [GO:0034720]; regulation of androgen receptor signaling pathway [GO:0060765]; T cell antigen processing and presentation [GO:0002457]; transcription, DNA-templated [GO:0006351]	fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]	fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; androgen receptor binding [GO:0050681]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K4 specific) [GO:0032453]; metal ion binding [GO:0046872]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; histone H3-K4 demethylation [GO:0034720]; regulation of androgen receptor signaling pathway [GO:0060765]; T cell antigen processing and presentation [GO:0002457]; transcription, DNA-templated [GO:0006351]	androgen receptor binding [GO:0050681]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K4 specific) [GO:0032453]; metal ion binding [GO:0046872]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]	GO:0000981; GO:0001650; GO:0002457; GO:0003677; GO:0005654; GO:0006351; GO:0032452; GO:0032453; GO:0034720; GO:0046872; GO:0050681; GO:0051213; GO:0060765	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:27185910, ECO:0000269|PubMed:27477906, ECO:0000305}.		MOD_RES 291 291 Phosphoserine. {ECO:0000250|UniProtKB:P41229}.; MOD_RES 307 307 Phosphoserine. {ECO:0000250|UniProtKB:P41229}.; MOD_RES 884 884 Phosphoserine. {ECO:0000250|UniProtKB:P41229}.; MOD_RES 1346 1346 Phosphoserine. {ECO:0000250|UniProtKB:P41229}.	8841177; 9039502; 10861003; 12815422; 15489334; 9060413; 17320162; 17320160; 17351630; 18459961; 26747897; 27427228; 27477906; 27185910; 11325850; 12438965; 15613541; 16988213; 17310255; 17320163; 17351631; 19223392; 19541808; 26215926; 26728332	8841177; 9039502; 10861003; 12815422; 15489334; 9060413; 17320162; 17320160; 17351630; 18459961; 26747897; 27427228; 27477906; 27185910; 
1478	KDM7A JHDM1D KDM7 KIAA1718	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.2 uM for histone H3 H3K9Me2 {ECO:0000269|PubMed:20023638}; 	1.14.11.-		BINDING 279 279 Substrate. {ECO:0000250}.; BINDING 299 299 Substrate. {ECO:0000250}.		COFACTOR: Name=Fe(2+); Xref=ChEBI:CHEBI:29033; Evidence={ECO:0000269|PubMed:20023638, ECO:0000269|PubMed:20194436}; ;  Note=Binds 1 Fe(2+) ion per subunit. {ECO:0000269|PubMed:20023638, ECO:0000269|PubMed:20194436};						histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; midbrain development [GO:0030901]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription, DNA-templated [GO:0006351]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K27 specific) [GO:0071558]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; histone demethylase activity (H4-K20 specific) [GO:0035575]; iron ion binding [GO:0005506]; methylated histone binding [GO:0035064]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors [GO:0016706]; zinc ion binding [GO:0008270]; histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; midbrain development [GO:0030901]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription, DNA-templated [GO:0006351]	histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K27 specific) [GO:0071558]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; histone demethylase activity (H4-K20 specific) [GO:0035575]; iron ion binding [GO:0005506]; methylated histone binding [GO:0035064]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors [GO:0016706]; zinc ion binding [GO:0008270]	GO:0005506; GO:0005634; GO:0005654; GO:0005730; GO:0006351; GO:0008270; GO:0016706; GO:0030901; GO:0032452; GO:0032454; GO:0033169; GO:0035064; GO:0035574; GO:0035575; GO:0045893; GO:0051864; GO:0070544; GO:0071557; GO:0071558	SUBCELLULAR LOCATION: Nucleus.		MOD_RES 604 604 Phosphoserine. {ECO:0000244|PubMed:23186163}.	14702039; 12853948; 12690205; 11214970; 17974005; 20194436; 20622853; 23186163; 20023638; 15630448; 16603237; 17713478; 18974108; 19843542; 20084082; 20129925; 20208542; 20526349; 20711500; 21424530; 21532585; 22143793; 22227394; 22615488; 22745804; 23583981; 24135138; 24345920; 25204415; 25907612; 26608785; 26688070; 27565733	14702039; 12853948; 12690205; 11214970; 17974005; 20194436; 20622853; 23186163; 20023638
1490	KHK	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=0.8 mM for D-fructose (at 25 degrees Celsius) {ECO:0000269|PubMed:12941785}; KM=0.15 mM for Mg-ATP (at 25 degrees Celsius) {ECO:0000269|PubMed:12941785}; Note=kcat is 7.6 sec(-1). {ECO:0000269|PubMed:12941785};	2.7.1.3	CATALYTIC ACTIVITY: ATP + D-fructose = ADP + D-fructose 1-phosphate. {ECO:0000269|PubMed:12941785}.	BINDING 15 15 D-fructose.; BINDING 41 41 D-fructose; via amide nitrogen.; BINDING 42 42 D-fructose.; BINDING 45 45 D-fructose.; BINDING 108 108 ATP.; BINDING 258 258 D-fructose.	ACTIVITY REGULATION: Requires potassium. Inhibition by ADP.			PATHWAY: Carbohydrate metabolism; fructose metabolism.				fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate [GO:0061624]; response to fructose [GO:0009750]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; response to sucrose [GO:0009744]; response to zinc ion [GO:0010043]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; ketohexokinase activity [GO:0004454]; fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate [GO:0061624]; response to fructose [GO:0009750]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; response to sucrose [GO:0009744]; response to zinc ion [GO:0010043]	ATP binding [GO:0005524]; ketohexokinase activity [GO:0004454]	GO:0004454; GO:0005524; GO:0005737; GO:0005829; GO:0009744; GO:0009749; GO:0009750; GO:0010043; GO:0032868; GO:0061624; GO:0070062				7833921; 15815621; 15489334; 9799106; 24275569; 19237742; 12941785; 16266770; 16372272; 17353931; 19158351; 19913121; 20628086; 20841500; 21033679; 21767952; 22371574; 23112875; 23341889; 24876114; 24900346; 25416956; 26083752; 27088854; 27322374; 28853885; 28954733	7833921; 15815621; 15489334; 9799106; 24275569; 19237742; 12941785
1522	KCNK1 HOHO1 KCNO1 TWIK1	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: Note=Has a unit conductance of 34 pS. Both activation and channel closure are very rapid. Is not voltage-gated. The relationship between voltage and current is nearly linear. Has a mean open time of 0.3 msec at a membrane potential of -80 mV, and 1.9 msec at +80 mV (PubMed:8605869). {ECO:0000269|PubMed:19959478, ECO:0000269|PubMed:8605869};				ACTIVITY REGULATION: Inhibited by Ba(2+) ions and quinidine (PubMed:8605869). Inhibited by quinine (PubMed:8605869, PubMed:21653227). Is slightly inhibited by 10 mM tetraethylammonium (TEA), and only marginally inhibited by 4-aminopyridine, charybdotoxin and dendrotoxin (PubMed:8605869). Lowering the extracellular pH to below 6.5 transiently activates the channel, and then inhibits channel activity (PubMed:15820677, PubMed:22431633). Inhibited when the intracellular pH is decreased down to pH 6.0, but this may be due to indirect effects (PubMed:8605869). {ECO:0000269|PubMed:15820677, ECO:0000269|PubMed:21653227, ECO:0000269|PubMed:22431633, ECO:0000269|PubMed:8605869}.				SITE 118 118 Important for increased permeability to Na(+) when K(+) levels are subphysiological. {ECO:0000269|PubMed:21653227}.; SITE 146 146 Part of a hydrophobic barrier that is stochastically dewetted and limits ion permeability. {ECO:0000269|PubMed:22431633, ECO:0000269|PubMed:25001086}.; SITE 261 261 Part of a hydrophobic barrier that is stochastically dewetted and limits ion permeability. {ECO:0000269|PubMed:25001086}.			cardiac conduction [GO:0061337]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of resting membrane potential [GO:0060075]; response to nicotine [GO:0035094]; sodium ion transmembrane transport [GO:0035725]; stabilization of membrane potential [GO:0030322]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell junction [GO:0030054]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; inward rectifier potassium channel complex [GO:1902937]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; recycling endosome [GO:0055037]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell junction [GO:0030054]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; inward rectifier potassium channel complex [GO:1902937]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; recycling endosome [GO:0055037]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076]; identical protein binding [GO:0042802]; inward rectifier potassium channel activity [GO:0005242]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; sodium channel activity [GO:0005272]; cardiac conduction [GO:0061337]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of resting membrane potential [GO:0060075]; response to nicotine [GO:0035094]; sodium ion transmembrane transport [GO:0035725]; stabilization of membrane potential [GO:0030322]	identical protein binding [GO:0042802]; inward rectifier potassium channel activity [GO:0005242]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; sodium channel activity [GO:0005272]	GO:0005242; GO:0005267; GO:0005272; GO:0005886; GO:0005887; GO:0006813; GO:0008076; GO:0016021; GO:0016324; GO:0022841; GO:0030054; GO:0030322; GO:0030425; GO:0031526; GO:0034705; GO:0035094; GO:0035725; GO:0042802; GO:0043204; GO:0043231; GO:0045202; GO:0055037; GO:0060075; GO:0061337; GO:0071805; GO:1902937	SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15820677, ECO:0000269|PubMed:17693262, ECO:0000269|PubMed:20498050, ECO:0000269|PubMed:21653227, ECO:0000269|PubMed:22282804, ECO:0000269|PubMed:22431633, ECO:0000269|PubMed:23169818, ECO:0000269|PubMed:25001086, ECO:0000269|PubMed:8605869, ECO:0000269|PubMed:8978667}; Multi-pass membrane protein {ECO:0000269|PubMed:22282804, ECO:0000269|PubMed:8978667, ECO:0000305}. Recycling endosome {ECO:0000269|PubMed:19959478}. Cell junction, synapse {ECO:0000250|UniProtKB:Q9Z2T2}. Cytoplasmic vesicle {ECO:0000250|UniProtKB:O08581}. Perikaryon {ECO:0000250|UniProtKB:O08581}. Cell projection, dendrite {ECO:0000250|UniProtKB:O08581}. Cell projection {ECO:0000250|UniProtKB:O08581}. Apical cell membrane {ECO:0000269|PubMed:21964404}; Multi-pass membrane protein {ECO:0000305}. Note=The heterodimer with KCNK2 is detected at the astrocyte cell membrane. Not detected at the astrocyte cell membrane when KCNK2 is absent. Detected on neuronal cell bodies, and to a lesser degree on neuronal cell projections. Detected on hippocampus dentate gyrus granule cell bodies and to a lesser degree on proximal dendrites. Detected in synaptic membranes. Detected at the apical cell membrane in stria vascularis in the cochlea. Detected at the apical cell membrane of vestibular dark cells situated between the crista and the utricle in the inner ear. Detected at the apical cell membrane in kidney proximal tubule segment S1 and in subapical compartments in segments S1, S2 and S3. Predominantly in cytoplasmic structures in kidney distal convoluted tubules and collecting ducts (By similarity). Detected at the apical cell membrane of bronchial epithelial cells (PubMed:21964404). {ECO:0000250|UniProtKB:O08581, ECO:0000250|UniProtKB:Q9Z2T2, ECO:0000269|PubMed:21964404}.	PTM: Sumoylation is controversial. Sumoylated by UBE2I (PubMed:15820677). Not sumoylated when expressed in xenopus oocytes or mammalian cells (PubMed:17693262). Sumoylation inactivates the channel, but does not interfere with expression at the cell membrane (PubMed:15820677). Sumoylation of a single subunit is sufficient to silence the dimeric channel (PubMed:20498050, PubMed:23169818). Sumoylation of KCNK1 is sufficient to silence heterodimeric channels formed by KCNK1 and KCNK3 or KCNK9 (PubMed:23169818). Desumoylated by SENP1; this activates the channel (PubMed:15820677, PubMed:20498050, PubMed:23169818). Desumoylated by SENP1; this strongly increases halothane-mediated activation of heterodimeric channels formed with KCNK9 (PubMed:23169818). SENP1 treatment has no effect (PubMed:17693262). {ECO:0000269|PubMed:15820677, ECO:0000269|PubMed:17693262, ECO:0000269|PubMed:20498050, ECO:0000269|PubMed:23169818}.	MOD_RES 326 326 Phosphoserine. {ECO:0000250|UniProtKB:Q9Z2T2}.	8605869; 9462864; 9362344; 16710414; 15489334; 8978667; 11165377; 15820677; 17693262; 17478540; 19959478; 20498050; 21653227; 21964404; 22814378; 22431633; 23169818; 25530075; 25001086; 25339226; 22282804; 16382106; 17652773; 19571146; 19948975; 20393194; 21988832; 25416956; 27103460; 27558721	8605869; 9462864; 9362344; 16710414; 15489334; 8978667; 11165377; 15820677; 17693262; 17478540; 19959478; 20498050; 21653227; 21964404; 22814378; 22431633; 23169818; 25530075; 25001086; 25339226; 22282804
1527	KDM5C DXS1272E JARID1C SMCX XE169	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=6 uM for 2-oxoglutarate {ECO:0000269|PubMed:26645689}; KM=3.3 uM for histone H3K4me3 {ECO:0000269|PubMed:26645689}; Note=Kcat are 1.92 min(-1) and 2.71 min(-1) for 2-oxoglutarate and histone H3K4me3, respectively. {ECO:0000269|PubMed:26645689};	1.14.11.-		BINDING 440 440 2-oxoglutarate. {ECO:0000250|UniProtKB:P29375}.; BINDING 522 522 2-oxoglutarate. {ECO:0000250|UniProtKB:P29375}.; BINDING 524 524 2-oxoglutarate. {ECO:0000250|UniProtKB:P29375}.; BINDING 532 532 2-oxoglutarate. {ECO:0000250|UniProtKB:P29375}.	ACTIVITY REGULATION: The inhibitor KDOAM-25 and others inhibit its demethylase activity, resulting to cell cycle arrest in myeloma cells. {ECO:0000269|PubMed:28262558}.	COFACTOR: Name=Fe(2+); Xref=ChEBI:CHEBI:29033; Evidence={ECO:0000269|PubMed:17320160}; ;  Note=Binds 1 Fe(2+) ion per subunit. {ECO:0000269|PubMed:17320160};						histone H3-K4 demethylation [GO:0034720]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K4 specific) [GO:0032453]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; zinc ion binding [GO:0008270]; histone H3-K4 demethylation [GO:0034720]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]	dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K4 specific) [GO:0032453]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; zinc ion binding [GO:0008270]	GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006351; GO:0008270; GO:0032452; GO:0032453; GO:0034720; GO:0045892; GO:0048511; GO:0051213	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00355, ECO:0000255|PROSITE-ProRule:PRU00537, ECO:0000269|PubMed:17468742}.		MOD_RES 287 287 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 301 301 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 317 317 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 893 893 Phosphoserine. {ECO:0000250|UniProtKB:P41230}.; MOD_RES 897 897 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1359 1359 Phosphoserine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.	8162017; 14702039; 15772651; 15489334; 7951230; 16964243; 17320161; 17320160; 17468742; 18669648; 19690332; 20068231; 21269460; 21406692; 23186163; 26645689; 28262558; 28112733; 19636912; 27214403; 15586325; 16538222; 16541399; 21076407; 23356856; 25666439; 17310255; 17320163; 17351631; 18078810; 18697827; 19346402; 19826449; 20054297; 20538609; 20711500; 21575681; 21725364; 22326837; 22611640; 23246292; 24029645; 24583395; 25016185; 25222147; 25609649; 25712104; 26059843; 26182878; 26496610; 26551685; 26580603; 26621457; 26858085; 26919706; 27058665; 27211531; 27696497; 27869828; 27896428; 28408295	8162017; 14702039; 15772651; 15489334; 7951230; 16964243; 17320161; 17320160; 17468742; 18669648; 19690332; 20068231; 21269460; 21406692; 23186163; 26645689; 28262558; 28112733; 19636912; 27214403; 15586325; 16538222; 16541399; 21076407; 23356856; 25666439
1540	MOCS3 UBA4	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.25 mM for thiosulfate {ECO:0000269|PubMed:15073332}; KM=0.28 mM for cyanide {ECO:0000269|PubMed:15073332}; 	2.7.7.80; 2.8.1.11	CATALYTIC ACTIVITY: ATP + [molybdopterin-synthase sulfur-carrier protein]-Gly-Gly = diphosphate + [molybdopterin-synthase sulfur-carrier protein]-Gly-Gly-AMP. {ECO:0000255|HAMAP-Rule:MF_03049, ECO:0000269|PubMed:15073332, ECO:0000269|PubMed:17459099, ECO:0000269|PubMed:18650437}.; CATALYTIC ACTIVITY: [Molybdopterin-synthase sulfur-carrier protein]-Gly-Gly-AMP + [cysteine desulfurase]-S-sulfanyl-L-cysteine + reduced acceptor = AMP + [molybdopterin-synthase sulfur-carrier protein]-Gly-NH-CH(2)-C(O)SH + [cysteine desulfurase] + oxidized acceptor. {ECO:0000255|HAMAP-Rule:MF_03049, ECO:0000269|PubMed:15073332, ECO:0000269|PubMed:17459099, ECO:0000269|PubMed:18650437}.	BINDING 92 92 ATP; via amide nitrogen. {ECO:0000255|HAMAP-Rule:MF_03049}.; BINDING 113 113 ATP. {ECO:0000255|HAMAP-Rule:MF_03049}.; BINDING 137 137 ATP. {ECO:0000255|HAMAP-Rule:MF_03049}.		COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000255|HAMAP-Rule:MF_03049}; ;  Note=Binds 1 zinc ion per subunit. {ECO:0000255|HAMAP-Rule:MF_03049};		PATHWAY: tRNA modification; 5-methoxycarbonylmethyl-2-thiouridine-tRNA biosynthesis. {ECO:0000255|HAMAP-Rule:MF_03049}.; PATHWAY: Cofactor biosynthesis; molybdopterin biosynthesis. {ECO:0000255|HAMAP-Rule:MF_03049}.				enzyme active site formation via cysteine modification to L-cysteine persulfide [GO:0018192]; molybdopterin cofactor biosynthetic process [GO:0032324]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098]	cytosol [GO:0005829]	cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molybdopterin-synthase adenylyltransferase activity [GO:0061605]; molybdopterin-synthase sulfurtransferase activity [GO:0061604]; nucleotidyltransferase activity [GO:0016779]; sulfurtransferase activity [GO:0016783]; thiosulfate sulfurtransferase activity [GO:0004792]; URM1 activating enzyme activity [GO:0042292]; enzyme active site formation via cysteine modification to L-cysteine persulfide [GO:0018192]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molybdopterin-synthase adenylyltransferase activity [GO:0061605]; molybdopterin-synthase sulfurtransferase activity [GO:0061604]; nucleotidyltransferase activity [GO:0016779]; sulfurtransferase activity [GO:0016783]; thiosulfate sulfurtransferase activity [GO:0004792]; URM1 activating enzyme activity [GO:0042292]	GO:0002098; GO:0002143; GO:0004792; GO:0005524; GO:0005829; GO:0006777; GO:0016779; GO:0016783; GO:0018192; GO:0032324; GO:0032447; GO:0034227; GO:0042292; GO:0046872; GO:0061604; GO:0061605	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_03049, ECO:0000269|PubMed:15073332}.			15073332; 11780052; 15489334; 15910006; 17459099; 18650437; 19017811; 21269460; 15231747; 18491921; 22453920; 25747390; 26917578; 28544736	15073332; 11780052; 15489334; 15910006; 17459099; 18650437; 19017811; 21269460; 
1586	MMAA	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=42 uM for GTP {ECO:0000269|PubMed:28497574}; KM=330 uM for GTP {ECO:0000269|PubMed:20876572}; KM=74 uM for GTP (in presence of MUT) {ECO:0000269|PubMed:20876572}; Note=kcat is 0.201 min(-1) for GTP hydrolysis (PubMed:28497574). kcat is 0.03 min(-1) for GTP hydrolysis (PubMed:20876572). {ECO:0000269|PubMed:20876572, ECO:0000269|PubMed:28497574};	3.6.-.-	CATALYTIC ACTIVITY: GTP + H(2)O = GDP + phosphate. {ECO:0000269|PubMed:20876572, ECO:0000269|PubMed:28497574}.	BINDING 292 292 GTP.	ACTIVITY REGULATION: GTPase activity is stimulated by MUT. {ECO:0000269|PubMed:20876572, ECO:0000269|PubMed:28497574}.			PATHWAY: Cofactor biosynthesis; adenosylcobalamin biosynthesis. {ECO:0000305|PubMed:20876572, ECO:0000305|PubMed:28497574}.				cobalamin biosynthetic process [GO:0009236]; cobalamin metabolic process [GO:0009235]	mitochondrial matrix [GO:0005759]	mitochondrial matrix [GO:0005759]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; cobalamin biosynthetic process [GO:0009236]; cobalamin metabolic process [GO:0009235]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]	GO:0003924; GO:0005525; GO:0005759; GO:0009235; GO:0009236; GO:0042802; GO:0042803	SUBCELLULAR LOCATION: Mitochondrion {ECO:0000305}.			12438653; 14702039; 15489334; 24275569; 25944712; 20876572; 15523652; 15308131; 17957493; 23026888; 28497574; 11350191; 11528502; 15643616; 16281286; 16451139; 1670635; 16866376; 17597648; 19371216; 1970180; 1977311; 21138732; 25525879; 2567699; 28536607; 28943303; 7909321; 8990001	12438653; 14702039; 15489334; 24275569; 25944712; 20876572; 15523652; 15308131; 17957493; 23026888; 28497574
1589	MMACHC	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=27.7 uM for glutathione {ECO:0000269|PubMed:19801555}; 	1.16.1.-		BINDING 104 104 Substrate. {ECO:0000244|PDB:3SC0, ECO:0000244|PDB:3SOM, ECO:0000269|PubMed:21697092, ECO:0000269|PubMed:22642810}.; BINDING 149 149 Substrate; via amide nitrogen. {ECO:0000244|PDB:3SC0, ECO:0000244|PDB:3SOM, ECO:0000269|PubMed:21697092, ECO:0000269|PubMed:22642810}.; BINDING 160 160 Substrate; via amide nitrogen and carbonyl oxygen. {ECO:0000244|PDB:3SC0, ECO:0000244|PDB:3SOM, ECO:0000269|PubMed:21697092, ECO:0000269|PubMed:22642810}.		COFACTOR: Name=FAD; Xref=ChEBI:CHEBI:57692; Evidence={ECO:0000269|PubMed:19700356, ECO:0000269|PubMed:21697092}; Name=FMN; Xref=ChEBI:CHEBI:58210; Evidence={ECO:0000269|PubMed:19700356, ECO:0000269|PubMed:21697092}; ;  Note=Can utilize both FAD and FMN. {ECO:0000269|PubMed:19700356, ECO:0000269|PubMed:21697092};		PATHWAY: Cofactor biosynthesis; adenosylcobalamin biosynthesis. {ECO:0000269|PubMed:19700356, ECO:0000269|PubMed:22642810, ECO:0000269|PubMed:25809485}.				cobalamin biosynthetic process [GO:0009236]; cobalamin metabolic process [GO:0009235]; demethylation [GO:0070988]; glutathione metabolic process [GO:0006749]; oxidation-reduction process [GO:0055114]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cobalamin binding [GO:0031419]; cyanocobalamin reductase (cyanide-eliminating) activity [GO:0033787]; demethylase activity [GO:0032451]; FAD binding [GO:0071949]; glutathione binding [GO:0043295]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; cobalamin biosynthetic process [GO:0009236]; cobalamin metabolic process [GO:0009235]; demethylation [GO:0070988]; glutathione metabolic process [GO:0006749]; oxidation-reduction process [GO:0055114]	cobalamin binding [GO:0031419]; cyanocobalamin reductase (cyanide-eliminating) activity [GO:0033787]; demethylase activity [GO:0032451]; FAD binding [GO:0071949]; glutathione binding [GO:0043295]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]	GO:0005737; GO:0005829; GO:0006749; GO:0009235; GO:0009236; GO:0016491; GO:0031419; GO:0032451; GO:0033787; GO:0042803; GO:0043295; GO:0055114; GO:0070988; GO:0071949	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:23270877}.		MOD_RES 245 245 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 247 247 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 275 275 Phosphoserine. {ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 279 279 Phosphoserine. {ECO:0000244|PubMed:20068231}.	17974005; 16710414; 15489334; 18669648; 19413330; 19801555; 19700356; 19690332; 20068231; 21269460; 21071249; 23415655; 23186163; 23270877; 24275569; 26483544; 21697092; 22642810; 16311595; 20219402; 25809485; 15292234; 16714133; 17431913; 18164228; 18245139; 18385497; 18779575; 19199254; 19200761; 19370762; 19447654; 19760748; 19767224; 20237496; 20631720; 20657474; 20877624; 22156578; 22832074; 23825108; 24577983; 24853097; 25535791; 25687216; 25982642; 26149271; 26253414; 26283149; 26563984; 27383490; 28442570; 28544088; 29068997; 29302025	17974005; 16710414; 15489334; 18669648; 19413330; 19801555; 19700356; 19690332; 20068231; 21269460; 21071249; 23415655; 23186163; 23270877; 24275569; 26483544; 21697092; 22642810; 16311595; 20219402; 25809485
1626	KDM1A AOF2 KDM1 KIAA0601 LSD1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=3.0 uM for H3 monomethyl-K4 {ECO:0000269|PubMed:16223729}; KM=4.2 uM for H3 dimethyl-K4 {ECO:0000269|PubMed:16223729}; KM=3.9 uM for H3 monomethyl-K4-monomethyl-K9 {ECO:0000269|PubMed:16223729}; KM=17.5 uM for monomethyl-K4-acetyl-K9 {ECO:0000269|PubMed:16223729}; 	1.-.-.-		BINDING 289 289 FAD. {ECO:0000269|PubMed:16885027, ECO:0000269|PubMed:16956976}.; BINDING 308 308 FAD. {ECO:0000269|PubMed:16885027, ECO:0000269|PubMed:16956976}.; BINDING 310 310 FAD. {ECO:0000269|PubMed:16885027, ECO:0000269|PubMed:16956976}.; BINDING 316 316 FAD. {ECO:0000269|PubMed:16885027, ECO:0000269|PubMed:16956976}.; BINDING 801 801 FAD. {ECO:0000269|PubMed:16885027, ECO:0000269|PubMed:16956976}.		COFACTOR: Name=FAD; Xref=ChEBI:CHEBI:57692; Evidence={ECO:0000269|PubMed:15620353, ECO:0000269|PubMed:15811342}; 						alternative mRNA splicing, via spliceosome [GO:0000380]; blood coagulation [GO:0007596]; cellular response to cAMP [GO:0071320]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; cerebral cortex development [GO:0021987]; guanine metabolic process [GO:0046098]; histone H3-K4 demethylation [GO:0034720]; histone H3-K9 demethylation [GO:0033169]; muscle cell development [GO:0055001]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron maturation [GO:0042551]; positive regulation of cell size [GO:0045793]; positive regulation of chromatin binding [GO:0035563]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of histone ubiquitination [GO:0033184]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein demethylation [GO:0006482]; regulation of cellular protein localization [GO:1903827]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of transcription by RNA polymerase II [GO:0006357]; response to fungicide [GO:0060992]; transcription, DNA-templated [GO:0006351]	DNA repair complex [GO:1990391]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor complex [GO:0005667]	DNA repair complex [GO:1990391]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor complex [GO:0005667]; androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; histone deacetylase activity [GO:0004407]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-K9 specific) [GO:0032454]; MRF binding [GO:0043426]; nuclear receptor transcription coactivator activity [GO:0030374]; oxidoreductase activity [GO:0016491]; p53 binding [GO:0002039]; telomeric DNA binding [GO:0042162]; telomeric repeat-containing RNA binding [GO:0061752]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; alternative mRNA splicing, via spliceosome [GO:0000380]; blood coagulation [GO:0007596]; cellular response to cAMP [GO:0071320]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; cerebral cortex development [GO:0021987]; guanine metabolic process [GO:0046098]; histone H3-K4 demethylation [GO:0034720]; histone H3-K9 demethylation [GO:0033169]; muscle cell development [GO:0055001]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron maturation [GO:0042551]; positive regulation of cell size [GO:0045793]; positive regulation of chromatin binding [GO:0035563]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of histone ubiquitination [GO:0033184]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein demethylation [GO:0006482]; regulation of cellular protein localization [GO:1903827]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of transcription by RNA polymerase II [GO:0006357]; response to fungicide [GO:0060992]; transcription, DNA-templated [GO:0006351]	androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; histone deacetylase activity [GO:0004407]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-K9 specific) [GO:0032454]; MRF binding [GO:0043426]; nuclear receptor transcription coactivator activity [GO:0030374]; oxidoreductase activity [GO:0016491]; p53 binding [GO:0002039]; telomeric DNA binding [GO:0042162]; telomeric repeat-containing RNA binding [GO:0061752]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]	GO:0000122; GO:0000380; GO:0000784; GO:0000790; GO:0002039; GO:0002052; GO:0003682; GO:0004407; GO:0005634; GO:0005654; GO:0005667; GO:0006351; GO:0006357; GO:0006482; GO:0007596; GO:0008134; GO:0010569; GO:0010976; GO:0016491; GO:0019899; GO:0021987; GO:0030374; GO:0032091; GO:0032451; GO:0032452; GO:0032453; GO:0032454; GO:0032991; GO:0033169; GO:0033184; GO:0034644; GO:0034648; GO:0034720; GO:0035563; GO:0042162; GO:0042551; GO:0043392; GO:0043426; GO:0043433; GO:0043518; GO:0044212; GO:0045793; GO:0045892; GO:0045944; GO:0046098; GO:0050660; GO:0050681; GO:0051091; GO:0055001; GO:0060992; GO:0061752; GO:0071320; GO:0071480; GO:0120162; GO:1902166; GO:1903827; GO:1990391	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11102443, ECO:0000269|PubMed:16079795}.	PTM: Polyubiquitinated by JADE2; which leads to its proteasomal degradation. {ECO:0000269|PubMed:25018020}.	MOD_RES 59 59 Phosphothreonine. {ECO:0000244|PubMed:18669648}.; MOD_RES 104 104 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332}.; MOD_RES 126 126 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:24275569}.; MOD_RES 131 131 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 135 135 Phosphotyrosine. {ECO:0000244|PubMed:24275569}.; MOD_RES 137 137 Phosphoserine. {ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 166 166 Phosphoserine. {ECO:0000244|PubMed:18220336, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 611 611 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 849 849 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231}.	9628581; 16710414; 15489334; 17974005; 12032298; 11102443; 12493763; 15620353; 15811342; 16140033; 16079794; 16079795; 16223729; 17081983; 17805299; 18220336; 18691976; 18669648; 19413330; 19369195; 19690332; 19880879; 20228790; 20562920; 20068231; 21269460; 21406692; 23186163; 24275569; 25018020; 28112733; 16885027; 16956976; 16531230; 23020937; 24838796; 26656649; 10444591; 10449787; 10904264; 11378386; 11545734; 11781575; 11909966; 11959846; 12724404; 16169070; 16418168; 16676006; 16702404; 16799558; 16914725; 16987819; 17043677; 17145880; 17277772; 17367163; 17409384; 17504018; 17511474; 17529991; 17537733; 17569509; 17687328; 17707228; 17873065; 17974977; 18039463; 18066052; 18172008; 18197256; 18216119; 18391013; 18487508; 18806873; 19052240; 19124609; 19223552; 19440552; 19497860; 19522008; 19703393; 19727073; 19884659; 19896696; 19934284; 20042638; 20127736; 20164337; 20189264; 20331966; 20333681; 20360068; 20389281; 20415477; 20448663; 20467437; 20568732; 20616235; 21098664; 21258344; 21289308; 21300290; 21400613; 21510664; 21516116; 21531005; 21602794; 21903422; 21937684; 21975933; 22128185; 22157815; 22169281; 22245111; 22310283; 22399799; 22447389; 22464800; 22493729; 22534796; 22542627; 22653443; 22802671; 22810585; 23015317; 23054398; 23072722; 23178685; 23236241; 23248157; 23287862; 23354309; 23384557; 23400681; 23455153; 23455924; 23528269; 23592333; 23592795; 23626788; 23721412; 23747727; 23752268; 23755305; 23795291; 23806369; 23900215; 23922913; 23928305; 24068396; 24075993; 24111946; 24139802; 24190971; 24217620; 24252778; 24316513; 24388204; 24486797; 24529708; 24658378; 24675890; 24715612; 24718924; 24726434; 24732800; 24744315; 24794925; 24820421; 24886859; 24912735; 24963049; 24986870; 24993879; 25036127; 25040359; 25043185; 25060070; 25173853; 25190802; 25482560; 25519973; 25605246; 25609649; 25649769; 25674267; 25679396; 25684206; 25728608; 25728837; 25730864; 25904247; 25916846; 25956476; 25990136; 25999347; 26028330; 26159421; 26166558; 26183527; 26225839; 26226427; 26240060; 26364657; 26460616; 26489763; 26496610; 26534764; 26638075; 26673564; 26719542; 26748182; 26751641; 26833707; 26840083; 26910647; 26970896; 27018646; 27094131; 27109588; 27112428; 27174370; 27195672; 27212032; 27277658; 27292636; 27325688; 27349498; 27384990; 27449289; 27470390; 27480105; 27501329; 27572339; 27626075; 27632941; 27651312; 27894074; 27894088; 28069602; 28098854; 28121627; 28186755; 28186757; 28209170; 28223039; 28277979; 28336409; 28348226; 28377178; 28381185; 28452984; 28534506; 28601046; 28617441; 28627608; 28667074; 28720390; 28783174; 28784588; 28800922; 28811844; 28832116; 28993646; 29030483; 29207083; 29281729; 29581250; 29949906; 9150135; 9651585; 9790534	9628581; 16710414; 15489334; 17974005; 12032298; 11102443; 12493763; 15620353; 15811342; 16140033; 16079794; 16079795; 16223729; 17081983; 17805299; 18220336; 18691976; 18669648; 19413330; 19369195; 19690332; 19880879; 20228790; 20562920; 20068231; 21269460; 21406692; 23186163; 24275569; 25018020; 28112733; 16885027; 16956976; 16531230; 23020937; 24838796; 26656649
1633	KDM5A JARID1A RBBP2 RBP2	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=9 uM for 2-oxoglutarate {ECO:0000269|PubMed:27427228}; KM=2.9 uM for histone H3K4me3 {ECO:0000269|PubMed:27427228}; Note=Kcat are 2.1 min(-1) and 1.9 min(-1) for 2-oxoglutarate and histone H3K4me3, respectively. {ECO:0000269|PubMed:27427228};	1.14.11.-		BINDING 409 409 2-oxoglutarate. {ECO:0000269|PubMed:26645689, ECO:0000269|PubMed:27427228}.; BINDING 491 491 2-oxoglutarate. {ECO:0000269|PubMed:26645689, ECO:0000269|PubMed:27427228}.; BINDING 493 493 2-oxoglutarate. {ECO:0000269|PubMed:26645689, ECO:0000269|PubMed:27427228}.; BINDING 501 501 2-oxoglutarate. {ECO:0000269|PubMed:26645689, ECO:0000269|PubMed:27427228}.	ACTIVITY REGULATION: The inhibitors KDOAM-25, CPI-455 and others inhibits its demethylase activity, resulting to cell growth arrest in cancer cells. {ECO:0000269|PubMed:27214401, ECO:0000269|PubMed:27427228}.	COFACTOR: Name=Fe(2+); Xref=ChEBI:CHEBI:29033; Evidence={ECO:0000250}; ;  Note=Binds 1 Fe(2+) ion per subunit. {ECO:0000250};						circadian regulation of gene expression [GO:0032922]; histone H3-K4 demethylation [GO:0034720]; histone H3-K9 demethylation [GO:0033169]; male gonad development [GO:0008584]; negative regulation of histone deacetylase activity [GO:1901726]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-binding transcription factor activity [GO:0051090]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; chromatin DNA binding [GO:0031490]; core promoter sequence-specific DNA binding [GO:0001046]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; methylated histone binding [GO:0035064]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 demethylation [GO:0034720]; histone H3-K9 demethylation [GO:0033169]; male gonad development [GO:0008584]; negative regulation of histone deacetylase activity [GO:1901726]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-binding transcription factor activity [GO:0051090]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366]	chromatin DNA binding [GO:0031490]; core promoter sequence-specific DNA binding [GO:0001046]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; methylated histone binding [GO:0035064]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]	GO:0000122; GO:0000981; GO:0001046; GO:0003677; GO:0003700; GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0006366; GO:0007283; GO:0008270; GO:0008584; GO:0031490; GO:0032452; GO:0032922; GO:0032993; GO:0033169; GO:0034647; GO:0034648; GO:0034720; GO:0035064; GO:0042393; GO:0045893; GO:0051090; GO:0051213; GO:1901726	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:15949438, ECO:0000269|PubMed:7935440}. Nucleus {ECO:0000250|UniProtKB:Q3UXZ9}. Note=Occupies promoters of genes involved in RNA metabolism and mitochondrial function. {ECO:0000250|UniProtKB:Q3UXZ9}.		MOD_RES 204 204 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1111 1111 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:24275569}.; MOD_RES 1330 1330 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1331 1331 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 1343 1343 Phosphothreonine. {ECO:0000250|UniProtKB:Q3UXZ9}.; MOD_RES 1345 1345 Phosphoserine. {ECO:0000250|UniProtKB:Q3UXZ9}.; MOD_RES 1438 1438 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1488 1488 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1595 1595 Phosphotyrosine. {ECO:0000250|UniProtKB:Q3UXZ9}.; MOD_RES 1598 1598 Phosphoserine. {ECO:0000244|PubMed:17081983}.; MOD_RES 1603 1603 Phosphoserine. {ECO:0000244|PubMed:17081983}.; MOD_RES 1666 1666 Phosphoserine. {ECO:0000244|PubMed:23186163}.	8414517; 16541075; 15489334; 1857421; 7935440; 9129143; 11358960; 15949438; 17081983; 17320163; 17320161; 17320160; 17311883; 18669648; 19690332; 20068231; 21960634; 23186163; 24275569; 28112733; 18270511; 19430464; 27499454; 27427228; 26645689; 27214401; 17310255; 17351631; 17884155; 23414517; 23752268; 25609649; 26496610; 28512031; 29537847	8414517; 16541075; 15489334; 1857421; 7935440; 9129143; 11358960; 15949438; 17081983; 17320163; 17320161; 17320160; 17311883; 18669648; 19690332; 20068231; 21960634; 23186163; 24275569; 28112733; 18270511; 19430464; 27499454; 27427228; 26645689; 27214401
1634	KDM5B JARID1B PLU1 RBBP2H1	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=9 uM for 2-oxoglutarate {ECO:0000269|PubMed:26645689}; KM=4 uM for histone H3K4me3 {ECO:0000269|PubMed:26645689}; Note=Kcat are 1.9 min(-1) and 2.0 min(-1) for 2-oxoglutarate and histone H3K4me3, respectively. {ECO:0000269|PubMed:26645689};	1.14.11.-		BINDING 425 425 2-oxoglutarate. {ECO:0000250|UniProtKB:P29375}.; BINDING 507 507 2-oxoglutarate. {ECO:0000250|UniProtKB:P29375}.; BINDING 509 509 2-oxoglutarate. {ECO:0000250|UniProtKB:P29375}.; BINDING 517 517 2-oxoglutarate. {ECO:0000250|UniProtKB:P29375}.	ACTIVITY REGULATION: Several specific inhibitors are being developed and tested (PubMed:27214403, PubMed:26741168). The inhibitor KDOAM-25 inhibits its demethylase activity, resulting to cell cycle arrest in myeloma cells (PubMed:28262558). {ECO:0000269|PubMed:26741168, ECO:0000269|PubMed:27214403, ECO:0000269|PubMed:28262558}.	COFACTOR: Name=Fe(2+); Xref=ChEBI:CHEBI:29033; Evidence={ECO:0000250}; ;  Note=Binds 1 Fe(2+) ion per subunit. {ECO:0000250};						branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to leukemia inhibitory factor [GO:1990830]; histone H3-K4 demethylation [GO:0034720]; lens fiber cell differentiation [GO:0070306]; mammary duct terminal end bud growth [GO:0060763]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; post-embryonic development [GO:0009791]; regulation of estradiol secretion [GO:2000864]; regulation of transcription by RNA polymerase II [GO:0006357]; response to fungicide [GO:0060992]; rhythmic process [GO:0048511]; single fertilization [GO:0007338]; transcription, DNA-templated [GO:0006351]; uterus morphogenesis [GO:0061038]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to leukemia inhibitory factor [GO:1990830]; histone H3-K4 demethylation [GO:0034720]; lens fiber cell differentiation [GO:0070306]; mammary duct terminal end bud growth [GO:0060763]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; post-embryonic development [GO:0009791]; regulation of estradiol secretion [GO:2000864]; regulation of transcription by RNA polymerase II [GO:0006357]; response to fungicide [GO:0060992]; rhythmic process [GO:0048511]; single fertilization [GO:0007338]; transcription, DNA-templated [GO:0006351]; uterus morphogenesis [GO:0061038]	dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]	GO:0000981; GO:0003677; GO:0003700; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006351; GO:0006357; GO:0007338; GO:0008270; GO:0009791; GO:0010628; GO:0032452; GO:0032453; GO:0033601; GO:0034647; GO:0034648; GO:0034720; GO:0042393; GO:0044344; GO:0045892; GO:0048511; GO:0051213; GO:0060444; GO:0060763; GO:0060992; GO:0061038; GO:0070306; GO:1990830; GO:1990837; GO:2000864	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00355, ECO:0000255|PROSITE-ProRule:PRU00537, ECO:0000269|PubMed:10336460, ECO:0000269|PubMed:12237901}.		MOD_RES 832 832 N6-acetyllysine. {ECO:0000250|UniProtKB:Q80Y84}.; MOD_RES 986 986 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1328 1328 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1456 1456 Phosphoserine. {ECO:0000244|PubMed:23186163}.	10336460; 10616211; 10878660; 16710414; 12237901; 12657635; 15803180; 16645588; 17320161; 17311883; 17373667; 17363312; 18669648; 23186163; 25218447; 25755297; 26645689; 28112733; 24952722; 26741168; 27214403; 28262558; 17310255; 17320163; 17351631; 17709396; 17973255; 18048344; 19336002; 19389623; 19536175; 19615732; 19798054; 20226085; 20403335; 20478252; 20832725; 20863814; 21084835; 21105039; 21369698; 21821892; 21937684; 21969366; 22152480; 22371483; 22534467; 22615382; 22669717; 23262439; 23408432; 23579952; 23759590; 23970103; 24412361; 24481781; 24495580; 24619877; 24778210; 24937458; 25450384; 25663457; 25755704; 25777981; 25789538; 25877751; 25909289; 25951238; 26125737; 26184998; 26621457; 26911146; 26917489; 27246838; 27480251; 27488530; 27584795; 27635108; 28082020; 28138513; 28344757; 28566884; 29246117; 8988173	10336460; 10616211; 10878660; 16710414; 12237901; 12657635; 15803180; 16645588; 17320161; 17311883; 17373667; 17363312; 18669648; 23186163; 25218447; 25755297; 26645689; 28112733; 24952722; 26741168; 27214403; 28262558
1642	MOCOS	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=15 uM for benzamidoxime {ECO:0000269|PubMed:16973608}; Vmax=0.24 nmol/min/mg enzyme {ECO:0000269|PubMed:16973608}; 	2.8.1.9	CATALYTIC ACTIVITY: Molybdenum cofactor + L-cysteine + reduced acceptor + 2 H(+) = thio-molybdenum cofactor + L-alanine + H(2)O + oxidized acceptor. {ECO:0000255|HAMAP-Rule:MF_03050}.			COFACTOR: Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326; Evidence={ECO:0000255|HAMAP-Rule:MF_03050}; 						molybdopterin cofactor biosynthetic process [GO:0032324]; molybdopterin cofactor metabolic process [GO:0043545]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]	cytosol [GO:0005829]	cytosol [GO:0005829]; lyase activity [GO:0016829]; Mo-molybdopterin cofactor sulfurase activity [GO:0008265]; molybdenum cofactor sulfurtransferase activity [GO:0102867]; molybdenum ion binding [GO:0030151]; pyridoxal phosphate binding [GO:0030170]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324]; molybdopterin cofactor metabolic process [GO:0043545]	lyase activity [GO:0016829]; molybdenum cofactor sulfurtransferase activity [GO:0102867]; molybdenum ion binding [GO:0030151]; Mo-molybdopterin cofactor sulfurase activity [GO:0008265]; pyridoxal phosphate binding [GO:0030170]	GO:0005829; GO:0006777; GO:0008265; GO:0016829; GO:0030151; GO:0030170; GO:0032324; GO:0043545; GO:0102867			MOD_RES 34 34 Phosphoserine. {ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 264 264 N6-(pyridoxal phosphate)lysine. {ECO:0000255|HAMAP-Rule:MF_03050}.; MOD_RES 528 528 Phosphoserine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 530 530 Phosphoserine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.	11302742; 14702039; 16177791; 15489334; 17974005; 16973608; 16964243; 18669648; 20068231; 23186163; 24275569; 14624414; 17368066; 15174051; 19500084; 21516116; 22495427; 25416956; 26496610	11302742; 14702039; 16177791; 15489334; 17974005; 16973608; 16964243; 18669648; 20068231; 23186163; 24275569; 14624414; 17368066
1737	LCAT	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=0.97 mM for LDL {ECO:0000269|PubMed:10329423}; KM=0.4 mM for HDL(2) {ECO:0000269|PubMed:10329423}; KM=0.10 mM for HDL(3) {ECO:0000269|PubMed:10329423}; Vmax=8.3 mmol/min/mg enzyme with LDL as substrate {ECO:0000269|PubMed:10329423}; Vmax=0.58 mmol/min/mg enzyme with HDL(2) as substrate {ECO:0000269|PubMed:10329423}; Vmax=2.0 mmol/min/mg enzyme with HDL(3) as substrate {ECO:0000269|PubMed:10329423}; Note=Affinity for LDL is 2.3 to 4-fold lower than for HDL. Relative reactivities are 16% for HDL(3), 1.3% for HDL(2) and 6.5% for LDL.;	2.3.1.43	CATALYTIC ACTIVITY: Phosphatidylcholine + a sterol = 1-acylglycerophosphocholine + a sterol ester. {ECO:0000255|PROSITE-ProRule:PRU10037, ECO:0000269|PubMed:10222237, ECO:0000269|PubMed:10329423, ECO:0000269|PubMed:14636062, ECO:0000269|PubMed:19065001, ECO:0000269|PubMed:25727495, ECO:0000269|PubMed:26195816, ECO:0000269|PubMed:3458198, ECO:0000269|PubMed:8820107}.		ACTIVITY REGULATION: APOA1 is the most potent activator in plasma. Also activated by APOE, APOC1 and APOA4. {ECO:0000269|PubMed:19065001}.				SITE 173 173 Determinant for substrate specificity. {ECO:0000305|PubMed:14636062}.			cholesterol esterification [GO:0034435]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; high-density lipoprotein particle remodeling [GO:0034375]; lipoprotein biosynthetic process [GO:0042158]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylcholine metabolic process [GO:0046470]; phospholipid metabolic process [GO:0006644]; regulation of high-density lipoprotein particle assembly [GO:0090107]; reverse cholesterol transport [GO:0043691]; very-low-density lipoprotein particle remodeling [GO:0034372]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; apolipoprotein A-I binding [GO:0034186]; phosphatidylcholine-sterol O-acyltransferase activity [GO:0004607]; cholesterol esterification [GO:0034435]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; high-density lipoprotein particle remodeling [GO:0034375]; lipoprotein biosynthetic process [GO:0042158]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylcholine metabolic process [GO:0046470]; phospholipid metabolic process [GO:0006644]; regulation of high-density lipoprotein particle assembly [GO:0090107]; reverse cholesterol transport [GO:0043691]; very-low-density lipoprotein particle remodeling [GO:0034372]	apolipoprotein A-I binding [GO:0034186]; phosphatidylcholine-sterol O-acyltransferase activity [GO:0004607]	GO:0004607; GO:0005576; GO:0005615; GO:0006644; GO:0006656; GO:0008203; GO:0030301; GO:0034186; GO:0034364; GO:0034372; GO:0034375; GO:0034435; GO:0042158; GO:0042632; GO:0043691; GO:0046470; GO:0070062; GO:0090107	SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:10222237, ECO:0000269|PubMed:19065001, ECO:0000269|PubMed:3458198, ECO:0000269|PubMed:8820107}. Note=Secreted into blood plasma (PubMed:3458198, PubMed:8820107, PubMed:10222237). Produced in astrocytes and secreted into cerebral spinal fluid (CSF). {ECO:0000269|PubMed:10222237, ECO:0000269|PubMed:3458198, ECO:0000269|PubMed:8820107}.	PTM: O- and N-glycosylated. O-glycosylation on Thr-431 and Ser-433 consists of sialylated galactose beta 1-->3N-acetylgalactosamine structures. N-glycosylated sites contain sialylated triantennary and/or biantennary complex structures. {ECO:0000269|PubMed:16335952, ECO:0000269|PubMed:7613477}.		3797244; 3458198; 15616553; 15489334; 2823898; 2823801; 2880847; 7613477; 8820107; 10222237; 10329423; 10722751; 14636062; 16335952; 17950106; 19065001; 26195816; 25727495; 1571050; 1737840; 2370048; 1681161; 1516702; 1859405; 8432868; 8318557; 7607641; 7711728; 8620346; 8807342; 9007616; 9261271; 9741700; 11423760; 12957688; 12966036; 15994445; 16051254; 16216249; 16874701; 21901787; 11369005; 11882335; 11966470; 12032172; 12048121; 12051518; 12139471; 12174215; 12573451; 12673583; 15102891; 15110745; 15115696; 15297675; 15472210; 15544352; 1587806; 15936482; 16061733; 16115486; 16542392; 16543491; 16770077; 16780378; 16883530; 17113061; 17206937; 17216278; 17272829; 17357073; 17526537; 17711302; 17855807; 18178167; 18193043; 18397721; 18485513; 18676680; 18719109; 18782872; 18823627; 18922527; 18996102; 19060906; 19060910; 19170196; 19306528; 19336370; 19515369; 19625176; 19671930; 19687369; 19692168; 19800416; 19878569; 19913121; 19948975; 20031551; 20160193; 20167577; 20571754; 20628086; 20634891; 20679960; 20714348; 20855565; 20884842; 20890173; 20972250; 21315357; 21597230; 21600519; 21798542; 21822774; 21875686; 22090275; 22133847; 22189200; 22326749; 22418575; 23023370; 23132909; 23142243; 23152129; 24140107; 24383078; 24423117; 24620755; 24789697; 24842300; 25110219; 25589508; 25894629; 25948084; 25964513; 26073399; 26117245; 26232163; 26644477; 29030428; 29758034; 4335615; 4340992; 8820100; 9829992	3797244; 3458198; 15616553; 15489334; 2823898; 2823801; 2880847; 7613477; 8820107; 10222237; 10329423; 10722751; 14636062; 16335952; 17950106; 19065001; 26195816; 25727495; 1571050; 1737840; 2370048; 1681161; 1516702; 1859405; 8432868; 8318557; 7607641; 7711728; 8620346; 8807342; 9007616; 9261271; 9741700; 11423760; 12957688; 12966036; 15994445; 16051254; 16216249; 16874701; 21901787
1770	LCMT1 LCMT CGI-68	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.1 uM for PP2AD {ECO:0000269|PubMed:10600115}; KM=1.3 uM for AdoMet {ECO:0000269|PubMed:10600115}; 	2.1.1.233	CATALYTIC ACTIVITY: S-adenosyl-L-methionine + [phosphatase 2A protein]-leucine = S-adenosyl-L-homocysteine + [phosphatase 2A protein]-leucine methyl ester. {ECO:0000269|PubMed:10600115, ECO:0000269|PubMed:21206058}.	BINDING 37 37 S-adenosyl-L-methionine. {ECO:0000244|PDB:3O7W, ECO:0000269|PubMed:21206058}.; BINDING 73 73 S-adenosyl-L-methionine. {ECO:0000244|PDB:3O7W, ECO:0000269|PubMed:21206058}.; BINDING 98 98 S-adenosyl-L-methionine; via carbonyl oxygen. {ECO:0000244|PDB:3O7W, ECO:0000269|PubMed:21206058}.; BINDING 122 122 S-adenosyl-L-methionine. {ECO:0000244|PDB:3O7W, ECO:0000269|PubMed:21206058}.; BINDING 198 198 S-adenosyl-L-methionine; via carbonyl oxygen. {ECO:0000244|PDB:3O7W, ECO:0000269|PubMed:21206058}.						CGI-68		cellular protein modification process [GO:0006464]; C-terminal protein methylation [GO:0006481]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of protein complex assembly [GO:0031333]; protein methylation [GO:0006479]; regulation of apoptotic process [GO:0042981]; regulation of glucose metabolic process [GO:0010906]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein C-terminal carboxyl O-methyltransferase activity [GO:0003880]; protein C-terminal leucine carboxyl O-methyltransferase activity [GO:0018423]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; C-terminal protein methylation [GO:0006481]; cellular protein modification process [GO:0006464]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of protein complex assembly [GO:0031333]; protein methylation [GO:0006479]; regulation of apoptotic process [GO:0042981]; regulation of glucose metabolic process [GO:0010906]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]	protein C-terminal carboxyl O-methyltransferase activity [GO:0003880]; protein C-terminal leucine carboxyl O-methyltransferase activity [GO:0018423]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]	GO:0000086; GO:0003880; GO:0005654; GO:0005829; GO:0006464; GO:0006479; GO:0006481; GO:0008757; GO:0010906; GO:0018423; GO:0031333; GO:0042981; GO:0090266				10600115; 10810093; 14702039; 15616553; 15489334; 17974005; 21269460; 21206058; 21292165; 16189514; 17724024; 20711500; 21900206; 22443683; 22732552; 23943618; 25839665; 27810903	10600115; 10810093; 14702039; 15616553; 15489334; 17974005; 21269460; 21206058; 21292165
1801	SLC7A8 LAT2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=221 uM for L-leucine {ECO:0000269|PubMed:10391915, ECO:0000269|PubMed:12117417, ECO:0000269|PubMed:15081149, ECO:0000269|PubMed:15918515}; KM=64 uM for MeHg-L-cysteine {ECO:0000269|PubMed:10391915, ECO:0000269|PubMed:12117417, ECO:0000269|PubMed:15081149, ECO:0000269|PubMed:15918515}; KM=161 uM for methionine {ECO:0000269|PubMed:10391915, ECO:0000269|PubMed:12117417, ECO:0000269|PubMed:15081149, ECO:0000269|PubMed:15918515}; KM=978 uM for L-alanine {ECO:0000269|PubMed:10391915, ECO:0000269|PubMed:12117417, ECO:0000269|PubMed:15081149, ECO:0000269|PubMed:15918515}; KM=89.35 uM for L-phenylalanine {ECO:0000269|PubMed:10391915, ECO:0000269|PubMed:12117417, ECO:0000269|PubMed:15081149, ECO:0000269|PubMed:15918515}; KM=57.3 uM for L-tryptophan {ECO:0000269|PubMed:10391915, ECO:0000269|PubMed:12117417, ECO:0000269|PubMed:15081149, ECO:0000269|PubMed:15918515}; KM=48.8 uM for L-tyrosine {ECO:0000269|PubMed:10391915, ECO:0000269|PubMed:12117417, ECO:0000269|PubMed:15081149, ECO:0000269|PubMed:15918515}; 											amino acid transport [GO:0006865]; cellular amino acid metabolic process [GO:0006520]; leukocyte migration [GO:0050900]; metal ion homeostasis [GO:0055065]; neutral amino acid transport [GO:0015804]; response to toxic substance [GO:0009636]	basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]; organic cation transmembrane transporter activity [GO:0015101]; peptide antigen binding [GO:0042605]; toxin transmembrane transporter activity [GO:0019534]; amino acid transport [GO:0006865]; cellular amino acid metabolic process [GO:0006520]; leukocyte migration [GO:0050900]; metal ion homeostasis [GO:0055065]; neutral amino acid transport [GO:0015804]; response to toxic substance [GO:0009636]	amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]; organic cation transmembrane transporter activity [GO:0015101]; peptide antigen binding [GO:0042605]; toxin transmembrane transporter activity [GO:0019534]	GO:0005737; GO:0005886; GO:0005887; GO:0006520; GO:0006865; GO:0009636; GO:0015101; GO:0015171; GO:0015175; GO:0015179; GO:0015297; GO:0015804; GO:0016323; GO:0019534; GO:0042605; GO:0050900; GO:0055065	SUBCELLULAR LOCATION: Cytoplasm. Basolateral cell membrane; Multi-pass membrane protein. Note=Localized to the cytoplasm when expressed alone but when coexpressed with SLC3A2/4F2hc, is localized to the plasma membrane. Colocalized with SLC3A2/4F2hc at the basolateral membrane of kidney cortex proximal tubules and small intestine epithelia of the villi.		MOD_RES 29 29 Phosphoserine. {ECO:0000250|UniProtKB:Q9QXW9}.	10391915; 10574970; 10080183; 15918515; 14702039; 12508121; 15489334; 11311135; 12117417; 12716892; 15081149; 16027961; 15769744; 10610726; 15901826; 17558306; 19808856; 19851296; 19913121; 20198315; 20379614; 20628086; 21486766; 25299125; 26050671; 27224648	10391915; 10574970; 10080183; 15918515; 14702039; 12508121; 15489334; 11311135; 12117417; 12716892; 15081149; 16027961; 15769744
1808	SLC7A5 CD98LC LAT1 MPE16	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=7.9 uM for T4 (in the presence of choline chloride) {ECO:0000269|PubMed:10574970, ECO:0000269|PubMed:11564694, ECO:0000269|PubMed:12117417, ECO:0000269|PubMed:12225859, ECO:0000269|PubMed:18262359}; KM=0.8 uM for T3 (in the presence of choline chloride) {ECO:0000269|PubMed:10574970, ECO:0000269|PubMed:11564694, ECO:0000269|PubMed:12117417, ECO:0000269|PubMed:12225859, ECO:0000269|PubMed:18262359}; KM=12.5 uM for reverse triiodothyronine (rT3) (in the presence of choline chloride) {ECO:0000269|PubMed:10574970, ECO:0000269|PubMed:11564694, ECO:0000269|PubMed:12117417, ECO:0000269|PubMed:12225859, ECO:0000269|PubMed:18262359}; KM=7.9 uM for 3,3'-diiodothyronine (in the presence of choline chloride) {ECO:0000269|PubMed:10574970, ECO:0000269|PubMed:11564694, ECO:0000269|PubMed:12117417, ECO:0000269|PubMed:12225859, ECO:0000269|PubMed:18262359}; KM=46 uM for leucine (in the presence of choline chloride) {ECO:0000269|PubMed:10574970, ECO:0000269|PubMed:11564694, ECO:0000269|PubMed:12117417, ECO:0000269|PubMed:12225859, ECO:0000269|PubMed:18262359}; KM=19 uM for tryptophan (in the presence of choline chloride) {ECO:0000269|PubMed:10574970, ECO:0000269|PubMed:11564694, ECO:0000269|PubMed:12117417, ECO:0000269|PubMed:12225859, ECO:0000269|PubMed:18262359}; KM=32 uM for L-leucine {ECO:0000269|PubMed:10574970, ECO:0000269|PubMed:11564694, ECO:0000269|PubMed:12117417, ECO:0000269|PubMed:12225859, ECO:0000269|PubMed:18262359}; KM=10 mM for L-alanine {ECO:0000269|PubMed:10574970, ECO:0000269|PubMed:11564694, ECO:0000269|PubMed:12117417, ECO:0000269|PubMed:12225859, ECO:0000269|PubMed:18262359}; KM=2.2 mM for L-glutamine {ECO:0000269|PubMed:10574970, ECO:0000269|PubMed:11564694, ECO:0000269|PubMed:12117417, ECO:0000269|PubMed:12225859, ECO:0000269|PubMed:18262359}; KM=35 uM for L-histidine {ECO:0000269|PubMed:10574970, ECO:0000269|PubMed:11564694, ECO:0000269|PubMed:12117417, ECO:0000269|PubMed:12225859, ECO:0000269|PubMed:18262359}; KM=740 uM for L-phenylalanine {ECO:0000269|PubMed:10574970, ECO:0000269|PubMed:11564694, ECO:0000269|PubMed:12117417, ECO:0000269|PubMed:12225859, ECO:0000269|PubMed:18262359}; KM=98 uM for MeHg-L-cysteine {ECO:0000269|PubMed:10574970, ECO:0000269|PubMed:11564694, ECO:0000269|PubMed:12117417, ECO:0000269|PubMed:12225859, ECO:0000269|PubMed:18262359}; KM=99 uM for methionine {ECO:0000269|PubMed:10574970, ECO:0000269|PubMed:11564694, ECO:0000269|PubMed:12117417, ECO:0000269|PubMed:12225859, ECO:0000269|PubMed:18262359}; KM=55.2 uM for phenylalanine (in T24 human bladder carcinoma cells) {ECO:0000269|PubMed:10574970, ECO:0000269|PubMed:11564694, ECO:0000269|PubMed:12117417, ECO:0000269|PubMed:12225859, ECO:0000269|PubMed:18262359}; KM=60.4 uM for tyrosine (in T24 human bladder carcinoma cells) {ECO:0000269|PubMed:10574970, ECO:0000269|PubMed:11564694, ECO:0000269|PubMed:12117417, ECO:0000269|PubMed:12225859, ECO:0000269|PubMed:18262359}; KM=16.4 uM for tyrosine (in human fibroblasts) {ECO:0000269|PubMed:10574970, ECO:0000269|PubMed:11564694, ECO:0000269|PubMed:12117417, ECO:0000269|PubMed:12225859, ECO:0000269|PubMed:18262359}; KM=138 uM for Dopa (in T24 human bladder carcinoma cells) {ECO:0000269|PubMed:10574970, ECO:0000269|PubMed:11564694, ECO:0000269|PubMed:12117417, ECO:0000269|PubMed:12225859, ECO:0000269|PubMed:18262359}; KM=96.5 uM for 3-O-methyldopa (in T24 human bladder carcinoma cells) {ECO:0000269|PubMed:10574970, ECO:0000269|PubMed:11564694, ECO:0000269|PubMed:12117417, ECO:0000269|PubMed:12225859, ECO:0000269|PubMed:18262359}; KM=153 uM for alpha-methyltyrosine (in T24 human bladder carcinoma cells) {ECO:0000269|PubMed:10574970, ECO:0000269|PubMed:11564694, ECO:0000269|PubMed:12117417, ECO:0000269|PubMed:12225859, ECO:0000269|PubMed:18262359}; KM=216 uM for alpha-methyldopa (in T24 human bladder carcinoma cells) {ECO:0000269|PubMed:10574970, ECO:0000269|PubMed:11564694, ECO:0000269|PubMed:12117417, ECO:0000269|PubMed:12225859, ECO:0000269|PubMed:18262359}; KM=191 uM for gabapentin (in T24 human bladder carcinoma cells) {ECO:0000269|PubMed:10574970, ECO:0000269|PubMed:11564694, ECO:0000269|PubMed:12117417, ECO:0000269|PubMed:12225859, ECO:0000269|PubMed:18262359}; KM=7.3 uM for triiodothyronine (in T24 human bladder carcinoma cells) {ECO:0000269|PubMed:10574970, ECO:0000269|PubMed:11564694, ECO:0000269|PubMed:12117417, ECO:0000269|PubMed:12225859, ECO:0000269|PubMed:18262359}; KM=162 uM for thyroxine (in T24 human bladder carcinoma cells) {ECO:0000269|PubMed:10574970, ECO:0000269|PubMed:11564694, ECO:0000269|PubMed:12117417, ECO:0000269|PubMed:12225859, ECO:0000269|PubMed:18262359}; KM=75.3 uM for melphanan (in T24 human bladder carcinoma cells) {ECO:0000269|PubMed:10574970, ECO:0000269|PubMed:11564694, ECO:0000269|PubMed:12117417, ECO:0000269|PubMed:12225859, ECO:0000269|PubMed:18262359}; KM=156 uM for BCH (in T24 human bladder carcinoma cells) {ECO:0000269|PubMed:10574970, ECO:0000269|PubMed:11564694, ECO:0000269|PubMed:12117417, ECO:0000269|PubMed:12225859, ECO:0000269|PubMed:18262359}; 											cell differentiation [GO:0030154]; cellular amino acid metabolic process [GO:0006520]; leukocyte migration [GO:0050900]; nervous system development [GO:0007399]; neutral amino acid transport [GO:0015804]	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; cell differentiation [GO:0030154]; cellular amino acid metabolic process [GO:0006520]; leukocyte migration [GO:0050900]; nervous system development [GO:0007399]; neutral amino acid transport [GO:0015804]	amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]	GO:0005829; GO:0005886; GO:0005887; GO:0006520; GO:0007399; GO:0015171; GO:0015175; GO:0015179; GO:0015297; GO:0015804; GO:0016020; GO:0016324; GO:0030154; GO:0042605; GO:0043231; GO:0050900; GO:0070062	SUBCELLULAR LOCATION: Cytoplasm, cytosol. Apical cell membrane; Multi-pass membrane protein. Note=Located to the plasma membrane by SLC3A2/4F2hc. Localized to the apical membrane of placental syncytiophoblastic cells. Expressed in both luminal and abluminal membranes of brain capillary endothelial cells (By similarity). {ECO:0000250}.		MOD_RES 31 31 Phosphoserine. {ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 35 35 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 45 45 Phosphothreonine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.	9751058; 10049700; 10072483; 11557028; 15489334; 1597461; 10391915; 10574970; 11311135; 11389679; 11564694; 11742812; 12117417; 12225859; 12824232; 16027961; 15769744; 16496379; 18691976; 18262359; 18669648; 19369195; 20068231; 21269460; 21406692; 23186163; 25998567; 25944712; 12925876; 15178563; 15200428; 15589117; 15900591; 15901826; 16175382; 17558306; 17622555; 18095110; 18253116; 18294274; 18382329; 18440724; 18813831; 19018776; 19068093; 19121087; 19171406; 19184136; 19347882; 19430419; 19559497; 19635099; 20091333; 20374249; 20375792; 20510678; 20601542; 20680301; 21055621; 21371427; 21439283; 21486766; 21501294; 21530999; 21798283; 21911578; 22007000; 22077314; 22110199; 22199264; 22593156; 22736142; 22813728; 23103253; 23221699; 23270998; 23516127; 23606334; 23696029; 23809372; 23824658; 24131658; 24168110; 24189400; 24606907; 24694899; 24704384; 24726839; 24890221; 25089027; 25220100; 25385314; 25561175; 25597310; 25701737; 25835180; 25852190; 25908107; 25979827; 26050671; 26054677; 26237765; 26256001; 26437640; 26496610; 26608079; 26621329; 26638075; 26657287; 26850337; 26944194; 27224648; 27276226; 27550420; 27566573; 27567475; 27834933; 27846244; 27912058; 28190014; 28320871; 28347255; 28739699; 28784848; 28937983; 29277611; 29278358; 7829099	9751058; 10049700; 10072483; 11557028; 15489334; 1597461; 10391915; 10574970; 11311135; 11389679; 11564694; 11742812; 12117417; 12225859; 12824232; 16027961; 15769744; 16496379; 18691976; 18262359; 18669648; 19369195; 20068231; 21269460; 21406692; 23186163; 25998567; 25944712
1831	GLO1	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=1.3 mM for methylglyoxal/glutathione (native form) {ECO:0000269|PubMed:20454679}; KM=0.7 mM for methylglyoxal/glutathione (reduced form) {ECO:0000269|PubMed:20454679}; Vmax=0.335 umol/min/mg enzyme with methylglyoxal/glutathione as substrate (native form) {ECO:0000269|PubMed:20454679}; Vmax=0.7 umol/min/mg enzyme with methylglyoxal/glutathione as substrate (reduced form) {ECO:0000269|PubMed:20454679}; Note=Reduction of GLO1 was carried out by incubation with 20 mM betamercaptoethanol prior to kinetic analysis.;	4.4.1.5	CATALYTIC ACTIVITY: (R)-S-lactoylglutathione = glutathione + methylglyoxal. {ECO:0000269|PubMed:23122816, ECO:0000269|PubMed:9705294}.	BINDING 34 34 Substrate; shared with dimeric partner.; BINDING 38 38 Substrate; shared with dimeric partner.; BINDING 104 104 Substrate; shared with dimeric partner.; BINDING 123 123 Substrate.; BINDING 127 127 Substrate.	ACTIVITY REGULATION: Regulated by oxidation of Cys-139 in response to the redox state of the cell. Results in the alternative formation of cystine or glutathione-bound cysteine, the latter modification leading to reduced enzyme activity. {ECO:0000269|PubMed:20454679}.	COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000269|PubMed:23122816, ECO:0000269|PubMed:9705294}; ;  Note=Binds 1 zinc ion per subunit. In the homodimer, two zinc ions are bound between subunits. {ECO:0000269|PubMed:23122816, ECO:0000269|PubMed:9705294};		PATHWAY: Secondary metabolite metabolism; methylglyoxal degradation; (R)-lactate from methylglyoxal: step 1/2.				carbohydrate metabolic process [GO:0005975]; glutathione metabolic process [GO:0006749]; methylglyoxal metabolic process [GO:0009438]; negative regulation of apoptotic process [GO:0043066]; osteoclast differentiation [GO:0030316]; pyruvate metabolic process [GO:0006090]; regulation of transcription by RNA polymerase II [GO:0006357]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; lactoylglutathione lyase activity [GO:0004462]; zinc ion binding [GO:0008270]; carbohydrate metabolic process [GO:0005975]; glutathione metabolic process [GO:0006749]; methylglyoxal metabolic process [GO:0009438]; negative regulation of apoptotic process [GO:0043066]; osteoclast differentiation [GO:0030316]; pyruvate metabolic process [GO:0006090]; regulation of transcription by RNA polymerase II [GO:0006357]	lactoylglutathione lyase activity [GO:0004462]; zinc ion binding [GO:0008270]	GO:0004462; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005975; GO:0006090; GO:0006357; GO:0006749; GO:0008270; GO:0009438; GO:0030316; GO:0043066; GO:0070062		PTM: Glutathionylation at Cys-139 inhibits enzyme activity. {ECO:0000269|PubMed:20454679}.; PTM: Phosphorylated at Thr-107 in the presence of CaMK2. However, this is a consensus site for phosphorylation by CK2 so phosphorylation may be mediated by CK2 rather than CaMK2. Phosphorylation is induced by TNF and suppresses the TNF-induced transcriptional activity of NF-kappa-B. {ECO:0000269|PubMed:17576200, ECO:0000269|PubMed:19199007}.; PTM: Exists in a nitric oxide (NO)-modified form. The exact nature of the modification is unknown, but it suppresses the TNF-induced transcriptional activity of NF-kappa-B.	MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:25944712, ECO:0000269|PubMed:20454679}.; MOD_RES 88 88 N6-succinyllysine. {ECO:0000250|UniProtKB:Q9CPU0}.; MOD_RES 107 107 Phosphothreonine. {ECO:0000269|PubMed:19199007}.; MOD_RES 139 139 S-glutathionyl cysteine; alternate. {ECO:0000269|PubMed:20454679}.; MOD_RES 148 148 N6-acetyllysine; alternate. {ECO:0000244|PubMed:19608861}.; MOD_RES 148 148 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q9CPU0}.	7684374; 8449929; 8670058; 10564821; 14702039; 14574404; 15489334; 20454679; 17576200; 19413330; 19199007; 19608861; 21269460; 24275569; 25944712; 9218781; 9705294; 10521255; 23122816; 11436564; 11785295; 11963573; 12942785; 15950319; 16305054; 16352396; 16555297; 16803681; 17346350; 17353931; 17463067; 17722011; 18079478; 18344682; 18413187; 18448827; 18455873; 18721844; 19211689; 19238574; 19379515; 19412133; 19452310; 20093988; 20180986; 20185929; 20379614; 20398646; 20398908; 20542521; 20544845; 20554694; 20562859; 20712647; 21029593; 21056979; 21253391; 21370249; 21386123; 21491613; 21738003; 21988832; 22188542; 22479608; 22614840; 22653787; 22771726; 23201419; 23351995; 23775136; 23982595; 24002659; 24040147; 24105621; 24158671; 24259499; 24494193; 24612481; 24662817; 24671236; 24767709; 24908234; 24966916; 24995521; 25139743; 25184957; 25201284; 25342507; 25407489; 25557363; 25609649; 25841781; 26122242; 26552067; 26618552; 26711908; 26784015; 26914966; 27000251; 27270765; 27406712; 27478003; 27696457; 27898103; 27999356; 28106734; 28549423; 28695773; 29156655; 29225125; 29385039; 29385725	7684374; 8449929; 8670058; 10564821; 14702039; 14574404; 15489334; 20454679; 17576200; 19413330; 19199007; 19608861; 21269460; 24275569; 25944712; 9218781; 9705294; 10521255; 23122816
1865	PKM OIP3 PK2 PK3 PKM2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=2.7 mM for phosphoenolpyruvate (at 32 degrees Celsius, pH 8.0) {ECO:0000269|PubMed:15996096, ECO:0000269|PubMed:1854723}; KM=0.17 mM for phosphoenolpyruvate (in the presence of 2 mM D-fructose 1,6-bisphosphate (FBP), at 32 degrees Celsius, pH 8.0) {ECO:0000269|PubMed:15996096, ECO:0000269|PubMed:1854723}; KM=0.34 mM for ADP (at 32 degrees Celsius, pH 8.0) {ECO:0000269|PubMed:15996096, ECO:0000269|PubMed:1854723}; KM=0.24 mM for ADP (in the presence of 2 mM FBP, at 32 degrees Celsius, pH 8.0) {ECO:0000269|PubMed:15996096, ECO:0000269|PubMed:1854723}; KM=0.13 mM for phosphoenolpyruvate (in the presence of 2 mM FBP, at 25 degrees Celsius) {ECO:0000269|PubMed:15996096, ECO:0000269|PubMed:1854723}; KM=0.63 mM for ADP (in the presence of 2 mM FBP, at 25 degrees Celsius) {ECO:0000269|PubMed:15996096, ECO:0000269|PubMed:1854723}; 	2.7.1.40	CATALYTIC ACTIVITY: ATP + pyruvate = ADP + phosphoenolpyruvate. {ECO:0000269|PubMed:15996096, ECO:0000269|PubMed:1854723}.	BINDING 70 70 Serine.; BINDING 73 73 Substrate. {ECO:0000250|UniProtKB:P30613}.; BINDING 106 106 Serine.; BINDING 120 120 ATP. {ECO:0000244|PDB:4FXF, ECO:0000269|PubMed:23530218}.; BINDING 207 207 ATP. {ECO:0000244|PDB:4FXF, ECO:0000269|PubMed:23530218}.; BINDING 270 270 Substrate; via amide nitrogen. {ECO:0000250|UniProtKB:P30613}.; BINDING 295 295 Substrate; via amide nitrogen. {ECO:0000250|UniProtKB:P30613}.; BINDING 296 296 Substrate; via amide nitrogen. {ECO:0000250|UniProtKB:P30613}.; BINDING 328 328 Substrate. {ECO:0000250|UniProtKB:P30613}.; BINDING 464 464 Serine.; BINDING 482 482 D-fructose 1,6-bisphosphate; part of allosteric site. {ECO:0000244|PDB:1T5A, ECO:0000244|PDB:4FXF, ECO:0000269|PubMed:15996096, ECO:0000269|PubMed:23530218}.; BINDING 489 489 D-fructose 1,6-bisphosphate; part of allosteric site. {ECO:0000244|PDB:1T5A, ECO:0000244|PDB:4FXF, ECO:0000269|PubMed:15996096, ECO:0000269|PubMed:23530218}.	ACTIVITY REGULATION: Isoform M2 is allosterically activated by D-fructose 1,6-bisphosphate (FBP). Inhibited by oxalate and 3,3',5-triiodo-L-thyronine (T3). The activity of the tetrameric form is inhibited by PML. Selective binding to tyrosine-phosphorylated peptides releases the allosteric activator FBP, leading to inhibition of PKM enzymatic activity, this diverts glucose metabolites from energy production to anabolic processes when cells are stimulated by certain growth factors. Glycolytic flux are highly dependent on de novo biosynthesis of serine and glycine, and serine is a natural ligand and allosteric activator of isoform M2. {ECO:0000269|PubMed:15996096, ECO:0000269|PubMed:18298799, ECO:0000269|PubMed:18337815, ECO:0000269|PubMed:1854723, ECO:0000269|PubMed:23064226, ECO:0000269|PubMed:2813362}.	COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000305|PubMed:23530218}; ; COFACTOR: Name=K(+); Xref=ChEBI:CHEBI:29103; Evidence={ECO:0000305|PubMed:23530218}; 	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH for T3 binding is 6.0-6.5. Increase in pH causes T3 binding to drop, does not bind T3 above pH 9.0 or below pH 5.0. {ECO:0000269|PubMed:15996096, ECO:0000269|PubMed:1854723};	PATHWAY: Carbohydrate degradation; glycolysis; pyruvate from D-glyceraldehyde 3-phosphate: step 5/5.	SITE 270 270 Transition state stabilizer. {ECO:0000250|UniProtKB:P00549}.; SITE 433 433 Crucial for phosphotyrosine binding.			animal organ regeneration [GO:0031100]; canonical glycolysis [GO:0061621]; cellular response to insulin stimulus [GO:0032869]; liver development [GO:0001889]; neutrophil degranulation [GO:0043312]; programmed cell death [GO:0012501]; protein homotetramerization [GO:0051289]; response to gravity [GO:0009629]; response to hypoxia [GO:0001666]; response to muscle inactivity [GO:0014870]; response to nutrient [GO:0007584]; skeletal muscle tissue regeneration [GO:0043403]	cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; pyruvate kinase complex [GO:1902912]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]	cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; pyruvate kinase complex [GO:1902912]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MHC class II protein complex binding [GO:0023026]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; RNA binding [GO:0003723]; thyroid hormone binding [GO:0070324]; animal organ regeneration [GO:0031100]; canonical glycolysis [GO:0061621]; cellular response to insulin stimulus [GO:0032869]; liver development [GO:0001889]; neutrophil degranulation [GO:0043312]; programmed cell death [GO:0012501]; protein homotetramerization [GO:0051289]; response to gravity [GO:0009629]; response to hypoxia [GO:0001666]; response to muscle inactivity [GO:0014870]; response to nutrient [GO:0007584]; skeletal muscle tissue regeneration [GO:0043403]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MHC class II protein complex binding [GO:0023026]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; RNA binding [GO:0003723]; thyroid hormone binding [GO:0070324]	GO:0000287; GO:0001666; GO:0001889; GO:0001917; GO:0003723; GO:0004743; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005929; GO:0007584; GO:0009629; GO:0012501; GO:0014870; GO:0016301; GO:0023026; GO:0030955; GO:0031012; GO:0031100; GO:0031982; GO:0032869; GO:0034774; GO:0042802; GO:0043209; GO:0043312; GO:0043403; GO:0043531; GO:0045296; GO:0051289; GO:0061621; GO:0070062; GO:0070324; GO:1902912; GO:1903561; GO:1904813	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:25263439}. Nucleus. Note=Translocates to the nucleus in response to different apoptotic stimuli. Nuclear translocation is sufficient to induce cell death that is caspase independent, isoform-specific and independent of its enzymatic activity.	PTM: ISGylated. {ECO:0000269|PubMed:16139798}.; PTM: Under hypoxia, hydroxylated by EGLN3. {ECO:0000269|PubMed:21620138}.; PTM: Acetylation at Lys-305 is stimulated by high glucose concentration, it decreases enzyme activity and promotes its lysosomal-dependent degradation via chaperone-mediated autophagy. {ECO:0000269|PubMed:21700219, ECO:0000269|Ref.11}.; PTM: FGFR1-dependent tyrosine phosphorylation is reduced by interaction with TRIM35. {ECO:0000269|PubMed:25263439}.	MOD_RES 2 2 N-acetylserine. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:25944712, ECO:0000269|Ref.11}.; MOD_RES 3 3 N6,N6,N6-trimethyllysine. {ECO:0000244|PubMed:24129315}.; MOD_RES 37 37 Phosphoserine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18088087, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 41 41 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 62 62 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 66 66 N6-succinyllysine. {ECO:0000250|UniProtKB:P52480}.; MOD_RES 89 89 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 97 97 Phosphoserine. {ECO:0000250|UniProtKB:P11980}.; MOD_RES 100 100 Phosphoserine. {ECO:0000250|UniProtKB:P11980}.; MOD_RES 105 105 Phosphotyrosine. {ECO:0000244|PubMed:15592455, ECO:0000244|PubMed:23186163}.; MOD_RES 127 127 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 148 148 Phosphotyrosine. {ECO:0000250|UniProtKB:P52480}.; MOD_RES 166 166 N6-acetyllysine; alternate. {ECO:0000244|PubMed:19608861}.; MOD_RES 166 166 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:P52480}.; MOD_RES 175 175 Phosphotyrosine. {ECO:0000244|PubMed:19690332}.; MOD_RES 195 195 Phosphothreonine. {ECO:0000244|PubMed:19690332}.; MOD_RES 266 266 N6-acetyllysine; alternate. {ECO:0000244|PubMed:19608861}.; MOD_RES 270 270 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:P52480}.; MOD_RES 305 305 N6-acetyllysine. {ECO:0000269|PubMed:21700219}.; MOD_RES 322 322 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:P52480}.; MOD_RES 322 322 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:P52480}.; MOD_RES 403 403 4-hydroxyproline. {ECO:0000269|PubMed:21620138}.; MOD_RES 408 408 4-hydroxyproline. {ECO:0000269|PubMed:21620138}.; MOD_RES 433 433 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 475 475 N6-acetyllysine. {ECO:0000250|UniProtKB:P52480}.; MOD_RES 498 498 N6-succinyllysine. {ECO:0000250|UniProtKB:P52480}.	2854097; 2813362; 2040271; 14702039; 16572171; 15489334; 1854723; 12665801; 25263439; 9466265; 12650930; 16139798; 15592455; 17081983; 16964243; 17308100; 18298799; 18191611; 18088087; 18691976; 18669648; 19413330; 19690332; 19608861; 20068231; 21269460; 21620138; 21483450; 21700219; 21406692; 23186163; 24275569; 24129315; 25114211; 25944712; 27199445; 28112733; 15996096; 18337815; 23064226; 23530218; 11960989; 12577067; 12620389; 12820312; 12820320; 12820337; 15161933; 15231747; 15982340; 16132722; 16169070; 16263121; 17011640; 17220478; 17406361; 17414054; 17446270; 17500595; 17620599; 18394773; 18464261; 18519040; 18789002; 1896471; 18985028; 18996102; 19097497; 19119138; 19135240; 19265196; 19367725; 19401544; 19463016; 19734428; 19738201; 19754967; 19805454; 19820423; 19920249; 19920251; 20000738; 20010808; 20082317; 20195357; 20304929; 20332442; 20360068; 20391533; 20562859; 20592362; 20602615; 20667897; 20711500; 20721957; 20847263; 20857498; 20962042; 20977946; 21044950; 21150319; 21325052; 21725354; 21900206; 21988832; 22044881; 22052977; 22056988; 22140559; 22231432; 22236875; 22271574; 22304920; 22306293; 22334075; 22465421; 22509023; 22623428; 22627140; 22736014; 22807066; 22864959; 22889453; 22901803; 22922757; 22999886; 23071357; 23086999; 23123196; 23130662; 23155487; 23178880; 23212076; 23267074; 23317289; 23386615; 23414517; 23423437; 23451252; 23515579; 23576436; 23602568; 23622982; 23640882; 23650620; 23663784; 23752568; 23793810; 23794342; 23814019; 23837608; 23840737; 23846818; 24077665; 24100037; 24120138; 24120661; 24142698; 24189400; 24284321; 24316223; 24344305; 24412244; 24466275; 24471565; 24481450; 24492614; 24508027; 24606918; 24619225; 24626155; 24649481; 24658033; 24686087; 24699725; 24716919; 24725412; 24747424; 24759699; 24762230; 24795025; 24817408; 24884829; 24898807; 24982407; 25041845; 25070887; 25233397; 25241761; 25260566; 25313085; 25344422; 25411978; 25412762; 25444918; 25446258; 25514599; 25541689; 25576919; 25609649; 25644089; 25645022; 25649613; 25661370; 25703326; 25708858; 25732087; 25735978; 25768091; 25773278; 25788265; 25808097; 25818238; 25840825; 25852190; 25880801; 25893434; 25912843; 25936600; 25955657; 25964202; 25970228; 26059508; 26082202; 26092770; 26140362; 26158845; 26172294; 26183399; 26234680; 26252254; 26252736; 26258887; 26290635; 26339369; 26385349; 26404132; 26405201; 26410533; 26453405; 26464675; 26493215; 26493994; 26496610; 26500058; 26500118; 26506517; 26542452; 26576639; 26607846; 26617865; 26639784; 26702927; 26715276; 26739387; 26752685; 26759242; 26780311; 26787900; 26874904; 26876154; 26926077; 26959741; 26975375; 26981025; 26989901; 26992222; 27012213; 27014756; 27040384; 27045080; 27080861; 27163637; 27167190; 27197174; 27249540; 27283076; 27323830; 27340866; 27384996; 27385486; 27413251; 27431728; 27467582; 27485204; 27573352; 27602585; 27606486; 27644251; 27801666; 27810895; 27821480; 27883057; 27894667; 27911861; 27989750; 28025580; 28035139; 28036303; 28086949; 28092997; 28183315; 28235245; 28259998; 28281967; 28346425; 28347237; 28380434; 28393220; 28394882; 28414323; 28415668; 28436957; 28446743; 28489603; 28498807; 28511909; 28543190; 28569774; 28583828; 28630053; 28641694; 28656802; 28726775; 28746922; 28778925; 28802581; 28858851; 28869444; 28994148; 29032577; 29058718; 29094170; 29155364; 29182273; 29225125; 29262861; 29277786; 29356574; 29393401; 29394289; 29540198; 29607934; 29619774; 29636835; 29748232; 3126495; 9990017	2854097; 2813362; 2040271; 14702039; 16572171; 15489334; 1854723; 12665801; 25263439; 9466265; 12650930; 16139798; 15592455; 17081983; 16964243; 17308100; 18298799; 18191611; 18088087; 18691976; 18669648; 19413330; 19690332; 19608861; 20068231; 21269460; 21620138; 21483450; 21700219; 21406692; 23186163; 24275569; 24129315; 25114211; 25944712; 27199445; 28112733; 15996096; 18337815; 23064226; 23530218
1903	ABCC10 MRP7 SIMRP7	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=57.8 uM for 17-beta-estradiol 17-(beta-D-glucuronide) (at 37 degrees Celsius) {ECO:0000269|PubMed:12527806}; Vmax=20 pmol/min/mg enzyme toward 17-beta-estradiol 17-(beta-D-glucuronide) (at 37 degrees Celsius) {ECO:0000269|PubMed:12527806}; 											transmembrane transport [GO:0055085]	integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity, coupled to transmembrane movement of substances [GO:0042626]; ATPase-coupled anion transmembrane transporter activity [GO:0043225]; transmembrane transport [GO:0055085]	ATPase activity, coupled to transmembrane movement of substances [GO:0042626]; ATPase-coupled anion transmembrane transporter activity [GO:0043225]; ATP binding [GO:0005524]	GO:0005524; GO:0005765; GO:0005886; GO:0005887; GO:0042626; GO:0043225; GO:0055085	SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:12566991, ECO:0000269|PubMed:15256465}; Multi-pass membrane protein {ECO:0000255|PROSITE-ProRule:PRU00441, ECO:0000269|PubMed:12566991, ECO:0000269|PubMed:15256465}.		MOD_RES 463 463 Phosphothreonine. {ECO:0000244|PubMed:18220336}.; MOD_RES 467 467 Phosphoserine. {ECO:0000244|PubMed:18220336}.	12566991; 11214971; 14574404; 17974005; 12527806; 15256465; 18220336; 11146224; 16034073; 16816140; 17203221; 19082471; 19118001; 19343046; 19841739; 21576088; 21628669; 22082652; 22739155; 23087055; 24431074; 24937672; 26655271; 27468921; 28051999; 28612064	12566991; 11214971; 14574404; 17974005; 12527806; 15256465; 18220336
1922	LCLAT1 AGPAT8 ALCAT1 LYCAT UNQ1849/PRO3579	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=39 uM for arachidonoyl-CoA (20:4) for LPIAT activity {ECO:0000269|PubMed:19075029}; KM=289 uM for oleoyl-CoA (18:1) for LPIAT activity {ECO:0000269|PubMed:19075029}; KM=134 uM for linoleoyl-CoA (18:2) for LPIAT activity {ECO:0000269|PubMed:19075029}; KM=34 uM for stearoyl-CoA (18:0) for LPIAT activity {ECO:0000269|PubMed:19075029}; KM=53 uM for palmitoyl-CoA (16:0) for LPIAT activity {ECO:0000269|PubMed:19075029}; KM=54 uM for oleoyl-CoA (18:1) for LPGAT activity {ECO:0000269|PubMed:19075029}; KM=36 uM for linoleoyl-CoA (18:2) for LPGAT activity {ECO:0000269|PubMed:19075029}; KM=70 uM for stearoyl-CoA (18:0) for LPGAT activity {ECO:0000269|PubMed:19075029}; KM=34 uM for palmitoyl-CoA (16:0) for LPGAT activity {ECO:0000269|PubMed:19075029}; Vmax=3230 nmol/min/mg enzyme toward arachidonoyl-CoA (20:4) for LPIAT activity {ECO:0000269|PubMed:19075029}; Vmax=7489 nmol/min/mg enzyme toward oleoyl-CoA (18:1) for LPIAT activity {ECO:0000269|PubMed:19075029}; Vmax=4696 nmol/min/mg enzyme toward linoleoyl-CoA (18:2) for LPIAT activity {ECO:0000269|PubMed:19075029}; Vmax=1078 nmol/min/mg enzyme toward stearoyl-CoA (18:0) for LPIAT activity {ECO:0000269|PubMed:19075029}; Vmax=11203 nmol/min/mg enzyme toward palmitoyl-CoA (16:0) for LPIAT activity {ECO:0000269|PubMed:19075029}; Vmax=5514 nmol/min/mg enzyme toward oleoyl-CoA (18:1) for LPGAT activity {ECO:0000269|PubMed:19075029}; Vmax=1358 nmol/min/mg enzyme toward linoleoyl-CoA (18:2) for LPGAT activity {ECO:0000269|PubMed:19075029}; Vmax=3530 nmol/min/mg enzyme toward stearoyl-CoA (18:0) for LPGAT activity {ECO:0000269|PubMed:19075029}; Vmax=1673 nmol/min/mg enzyme toward palmitoyl-CoA (16:0) for LPGAT activity {ECO:0000269|PubMed:19075029}; 	2.3.1.-; 2.3.1.51	CATALYTIC ACTIVITY: Acyl-CoA + 1-acyl-sn-glycerol 3-phosphate = CoA + 1,2-diacyl-sn-glycerol 3-phosphate.					PATHWAY: Phospholipid metabolism; CDP-diacylglycerol biosynthesis; CDP-diacylglycerol from sn-glycerol 3-phosphate: step 2/3.		UNQ1849/PRO3579		cardiolipin acyl-chain remodeling [GO:0035965]; CDP-diacylglycerol biosynthetic process [GO:0016024]; multicellular organism development [GO:0007275]; phosphatidic acid biosynthetic process [GO:0006654]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; O-acyltransferase activity [GO:0008374]; cardiolipin acyl-chain remodeling [GO:0035965]; CDP-diacylglycerol biosynthetic process [GO:0016024]; multicellular organism development [GO:0007275]; phosphatidic acid biosynthetic process [GO:0006654]	1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; O-acyltransferase activity [GO:0008374]	GO:0003841; GO:0005783; GO:0005789; GO:0005829; GO:0006654; GO:0007275; GO:0008374; GO:0016020; GO:0016021; GO:0016024; GO:0035965	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:19075029}; Multi-pass membrane protein {ECO:0000269|PubMed:19075029}.		MOD_RES 221 221 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.	12975309; 14702039; 15815621; 15489334; 16620771; 19075029; 19608861; 21406692; 15152008; 15367102; 16495223; 16704971; 16864775; 17707131; 18718904; 19336658; 22777291; 24779708; 25416956; 26638075; 28751023; 9212163; 9461603	12975309; 14702039; 15815621; 15489334; 16620771; 19075029; 19608861; 21406692
1978	KAT2A GCN5 GCN5L2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.83 uM for acetyl-CoA {ECO:0000269|PubMed:29211711}; KM=0.36 uM for succinyl-CoA {ECO:0000269|PubMed:29211711}; 	2.3.1.48; 2.3.1.-	CATALYTIC ACTIVITY: Acetyl-CoA + [protein]-L-lysine = CoA + [protein]-N(6)-acetyl-L-lysine. {ECO:0000269|PubMed:29211711}.; CATALYTIC ACTIVITY: Succinyl-CoA + [protein]-L-lysine = CoA + [protein]-N(6)-succinyl-L-lysine. {ECO:0000269|PubMed:29211711}.	BINDING 645 645 Succinyl-CoA. {ECO:0000244|PDB:5TRL, ECO:0000269|PubMed:29211711}.								alpha-tubulin acetylation [GO:0071929]; cardiac muscle cell differentiation [GO:0055007]; cell proliferation [GO:0008283]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; chromatin remodeling [GO:0006338]; cytokine production [GO:0001816]; heart development [GO:0007507]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone succinylation [GO:0106077]; internal peptidyl-lysine acetylation [GO:0018393]; intracellular distribution of mitochondria [GO:0048312]; in utero embryonic development [GO:0001701]; limb development [GO:0060173]; long-term memory [GO:0007616]; metencephalon development [GO:0022037]; midbrain development [GO:0030901]; multicellular organism growth [GO:0035264]; negative regulation of centriole replication [GO:0046600]; neural tube closure [GO:0001843]; positive regulation of cell projection organization [GO:0031346]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter [GO:0035948]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein deubiquitination [GO:0016579]; regulation of protein stability [GO:0031647]; regulation of regulatory T cell differentiation [GO:0045589]; regulation of synaptic plasticity [GO:0048167]; regulation of T cell activation [GO:0050863]; regulation of transcription by RNA polymerase II [GO:0006357]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; somitogenesis [GO:0001756]; telencephalon development [GO:0021537]; transcription by RNA polymerase II [GO:0006366]; viral process [GO:0016032]	Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; mitotic spindle [GO:0072686]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; STAGA complex [GO:0030914]; transcription factor TFTC complex [GO:0033276]	Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; mitotic spindle [GO:0072686]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; STAGA complex [GO:0030914]; transcription factor TFTC complex [GO:0033276]; chromatin binding [GO:0003682]; H3 histone acetyltransferase activity [GO:0010484]; histone acetyltransferase activity [GO:0004402]; histone acetyltransferase activity (H4-K12 specific) [GO:0043997]; histone deacetylase binding [GO:0042826]; histone succinyltransferase activity [GO:0106078]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; protein phosphatase binding [GO:0019903]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; alpha-tubulin acetylation [GO:0071929]; cardiac muscle cell differentiation [GO:0055007]; cell proliferation [GO:0008283]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; chromatin remodeling [GO:0006338]; cytokine production [GO:0001816]; heart development [GO:0007507]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone succinylation [GO:0106077]; in utero embryonic development [GO:0001701]; internal peptidyl-lysine acetylation [GO:0018393]; intracellular distribution of mitochondria [GO:0048312]; limb development [GO:0060173]; long-term memory [GO:0007616]; metencephalon development [GO:0022037]; midbrain development [GO:0030901]; multicellular organism growth [GO:0035264]; negative regulation of centriole replication [GO:0046600]; neural tube closure [GO:0001843]; positive regulation of cell projection organization [GO:0031346]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter [GO:0035948]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein deubiquitination [GO:0016579]; regulation of protein stability [GO:0031647]; regulation of regulatory T cell differentiation [GO:0045589]; regulation of synaptic plasticity [GO:0048167]; regulation of T cell activation [GO:0050863]; regulation of transcription by RNA polymerase II [GO:0006357]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; somitogenesis [GO:0001756]; telencephalon development [GO:0021537]; transcription by RNA polymerase II [GO:0006366]; viral process [GO:0016032]	chromatin binding [GO:0003682]; H3 histone acetyltransferase activity [GO:0010484]; histone acetyltransferase activity [GO:0004402]; histone acetyltransferase activity (H4-K12 specific) [GO:0043997]; histone deacetylase binding [GO:0042826]; histone succinyltransferase activity [GO:0106078]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; protein phosphatase binding [GO:0019903]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]	GO:0000790; GO:0001701; GO:0001756; GO:0001816; GO:0001843; GO:0003682; GO:0003713; GO:0004402; GO:0005615; GO:0005634; GO:0005654; GO:0005671; GO:0005737; GO:0005813; GO:0006338; GO:0006357; GO:0006366; GO:0007507; GO:0007616; GO:0008134; GO:0008283; GO:0010484; GO:0014070; GO:0016032; GO:0016578; GO:0016579; GO:0018393; GO:0019903; GO:0021537; GO:0022037; GO:0030901; GO:0030914; GO:0031346; GO:0031647; GO:0031667; GO:0033276; GO:0035066; GO:0035264; GO:0035948; GO:0036459; GO:0042826; GO:0043966; GO:0043997; GO:0044154; GO:0045589; GO:0045815; GO:0045944; GO:0046600; GO:0048167; GO:0048312; GO:0050863; GO:0055007; GO:0060173; GO:0061733; GO:0071356; GO:0071929; GO:0072686; GO:0106077; GO:0106078; GO:1990090; GO:2000679	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11564863, ECO:0000269|PubMed:27796307, ECO:0000269|PubMed:29211711}. Chromosome {ECO:0000269|PubMed:29211711}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000269|PubMed:27796307}. Note=Mainly localizes to the nucleus. Also localizes to centrosomes in late G1 and around the G1/S transition, coinciding with the onset of centriole formation. {ECO:0000269|PubMed:27796307}.		MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:22814378}.	8552087; 9611240; 15489334; 8684459; 11564863; 10373431; 10611234; 11384967; 11438666; 14767476; 15592455; 17301242; 18206972; 19103755; 22814378; 29174768; 28112733; 11090279; 17410582; 22464331; 27796307; 29211711; 10964718; 11044625; 11112321; 11250901; 12050117; 12391150; 12391296; 12482983; 12660246; 12743606; 14991602; 15107403; 15115762; 15472075; 15546612; 15715965; 15879553; 16260778; 16530044; 16612405; 17114293; 17157496; 17344417; 17353931; 17685488; 17967894; 17980597; 18250157; 1831692; 18418385; 18593473; 18838386; 18842595; 18936164; 19124466; 19150886; 19339690; 19343071; 19491097; 19615732; 19683498; 19800882; 20090754; 20224553; 20226045; 20442293; 20442780; 20508642; 20562830; 20801121; 20937768; 20972443; 21131905; 21280156; 21367571; 21402699; 21559432; 21725360; 21779003; 21875955; 21988832; 22055187; 22086303; 22110129; 22157815; 22465951; 22623781; 23033487; 23437046; 23543735; 23555303; 23661605; 23667505; 23913178; 24302725; 24480624; 24502362; 24705139; 24825348; 25111486; 25269644; 25426559; 25686500; 25707573; 25770212; 26256950; 26378521; 26420353; 26468280; 26496610; 26546801; 26637399; 26644179; 26977885; 27005833; 27147598; 27216891; 27377381; 27525514; 27749937; 28002667; 28412741; 28678170; 7566092; 8878478	8552087; 9611240; 15489334; 8684459; 11564863; 10373431; 10611234; 11384967; 11438666; 14767476; 15592455; 17301242; 18206972; 19103755; 22814378; 29174768; 28112733; 11090279; 17410582; 22464331; 27796307; 29211711
1982	CSNK1D HCKID	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=36.5 uM for alpha-casein {ECO:0000269|PubMed:23636092}; KM=635.8 uM for PER2 peptide {ECO:0000269|PubMed:23636092}; KM=180.6 uM for ATP {ECO:0000269|PubMed:23636092}; Note=Maximal velocity nearly identical for the reactions with alpha-casein and PER2 peptide.;	2.7.11.1; 2.7.11.26	CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.; CATALYTIC ACTIVITY: ATP + [tau protein] = ADP + [tau protein] phosphate.	BINDING 38 38 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.	ACTIVITY REGULATION: Exhibits substrate-dependent heparin activation. Drug-mediated inhibition leads to a delay of the oscillations with the magnitude of this effect dependent upon the timing of drug administration. Inhibited by phosphorylation. Repressed by 3-[(2,4,6-trimethoxyphenyl)methylidenyl]-indolin-2-one (IC261), N-(2-aminoethyl)-5-chloroisoquinoline-8-sulfonamide (CKI-7), 4-[4-(2,3-dihydro-benzo[1,4]dioxin-6-yl)-5-pyridin-2-yl-1H-imidazol-2-yl]benzamide (D4476), 3,4-diaryl-isoxazoles and -imidazoles, and 4-(3-cyclohexyl-5-(4-fluoro-phenyl)-3H-imidazol-4-yl) pyrimidin-2-ylamine (PF670462, PF670). {ECO:0000269|PubMed:14761950, ECO:0000269|PubMed:16027726, ECO:0000269|PubMed:19043076, ECO:0000269|PubMed:19591487, ECO:0000269|PubMed:20407760, ECO:0000269|PubMed:20696890, ECO:0000269|PubMed:21084295, ECO:0000269|PubMed:21258417, ECO:0000269|PubMed:21422228, ECO:0000269|PubMed:9632646}.							cellular response to nerve growth factor stimulus [GO:1990090]; ciliary basal body-plasma membrane docking [GO:0097711]; circadian regulation of gene expression [GO:0032922]; COPII vesicle coating [GO:0048208]; endocytosis [GO:0006897]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi organization [GO:0007030]; microtubule nucleation [GO:0007020]; non-motile cilium assembly [GO:1905515]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation [GO:1905426]; protein localization to centrosome [GO:0071539]; protein localization to cilium [GO:0061512]; protein localization to Golgi apparatus [GO:0034067]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of circadian rhythm [GO:0042752]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]	centrosome [GO:0005813]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle [GO:0005819]; spindle microtubule [GO:0005876]	centrosome [GO:0005813]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; peptide binding [GO:0042277]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; cellular response to nerve growth factor stimulus [GO:1990090]; ciliary basal body-plasma membrane docking [GO:0097711]; circadian regulation of gene expression [GO:0032922]; COPII vesicle coating [GO:0048208]; endocytosis [GO:0006897]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi organization [GO:0007030]; microtubule nucleation [GO:0007020]; non-motile cilium assembly [GO:1905515]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation [GO:1905426]; protein localization to centrosome [GO:0071539]; protein localization to cilium [GO:0061512]; protein localization to Golgi apparatus [GO:0034067]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of circadian rhythm [GO:0042752]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; peptide binding [GO:0042277]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]	GO:0000086; GO:0000139; GO:0001934; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005794; GO:0005813; GO:0005819; GO:0005829; GO:0005876; GO:0005886; GO:0006468; GO:0006897; GO:0007020; GO:0007030; GO:0008360; GO:0010389; GO:0016055; GO:0018105; GO:0032436; GO:0032922; GO:0033116; GO:0034067; GO:0042277; GO:0042752; GO:0043005; GO:0045296; GO:0048208; GO:0048471; GO:0050321; GO:0051225; GO:0061512; GO:0071539; GO:0090263; GO:0097711; GO:1905426; GO:1905515; GO:1990090; GO:2000052	SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Cytoplasm, perinuclear region. Cell membrane. Cytoplasm, cytoskeleton, spindle. Golgi apparatus. Note=Localized at mitotic spindle microtubules, and at the centrosomes and interphase in interphase cells. Recruited to the spindle apparatus and the centrosomes in response to DNA-damage. Correct subcellular localization requires kinase activity.	PTM: Autophosphorylated on serine and threonine residues; this autophosphorylation represses activity. Reactivated by phosphatase-mediated dephosphorylation. May be dephosphorylated by PP1.	MOD_RES 328 328 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 331 331 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 370 370 Phosphoserine. {ECO:0000250|UniProtKB:Q06486}.; MOD_RES 375 375 Omega-N-methylarginine. {ECO:0000250|UniProtKB:Q9DC28}.; MOD_RES 382 382 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 383 383 Phosphoserine. {ECO:0000244|PubMed:19690332}.; MOD_RES 384 384 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 407 407 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 411 411 Phosphoserine. {ECO:0000244|PubMed:19369195}.	8786104; 15070676; 14702039; 15489334; 9632646; 10606744; 10826492; 11161704; 11165242; 12270943; 12270714; 14761950; 16027726; 16618118; 17962809; 17562708; 18220336; 18691976; 18669648; 19591487; 19369195; 19043076; 19339517; 19690332; 20637175; 20041275; 20048001; 20699359; 20696890; 20407760; 20068231; 21269460; 21084295; 21422228; 21258417; 21145983; 23186163; 24275569; 9761932; 22168824; 23106386; 15800623; 16959974; 17344846; 23636092; 10428031; 10531061; 10719897; 10790862; 10807566; 10848614; 11076968; 11218372; 11232563; 11591712; 11779462; 11865049; 11875063; 11889036; 11956313; 12207013; 12221128; 12381662; 12782655; 12852856; 13678582; 14580337; 14701732; 14750904; 15498487; 15705883; 15767683; 15817302; 15917222; 16037817; 16189514; 16357211; 16462731; 16474406; 16507766; 16628007; 16777965; 16890155; 16983144; 16987893; 17115977; 17131344; 17218255; 17353931; 17574030; 17601350; 17646400; 17719545; 17721511; 18037885; 18228528; 18400165; 18419299; 18430226; 18566290; 18615013; 18694559; 18708403; 18786386; 18977241; 19004860; 19274088; 19564402; 19801658; 19805222; 19839995; 19940019; 19948962; 20149345; 20230748; 20399632; 20508983; 20558667; 20562859; 20708156; 20711500; 20805244; 21097556; 21273506; 21347367; 21422230; 21532587; 21548880; 21565611; 21620453; 21725307; 21792235; 21900206; 22052997; 22072790; 22094468; 22123863; 22179047; 22252131; 22331384; 22384121; 22575643; 22609948; 22653444; 22981886; 23141531; 23141541; 23253480; 23348840; 23400999; 23416715; 23455922; 23482395; 23527964; 23530209; 23747070; 23769972; 23789104; 23919824; 23921553; 24053599; 24089205; 24231678; 24424021; 24469809; 24817118; 24900428; 24982133; 25047611; 25191940; 25241761; 25313408; 25404202; 25416956; 25525153; 25532896; 25609649; 25665722; 25724478; 25744540; 26464264; 26496610; 26638075; 26676609; 26769969; 26803658; 27049670; 28338621; 28545154; 28581525; 28609096; 28886336; 29630366; 30146162; 7769006; 7790358; 8838651	8786104; 15070676; 14702039; 15489334; 9632646; 10606744; 10826492; 11161704; 11165242; 12270943; 12270714; 14761950; 16027726; 16618118; 17962809; 17562708; 18220336; 18691976; 18669648; 19591487; 19369195; 19043076; 19339517; 19690332; 20637175; 20041275; 20048001; 20699359; 20696890; 20407760; 20068231; 21269460; 21084295; 21422228; 21258417; 21145983; 23186163; 24275569; 9761932; 22168824; 23106386; 15800623; 16959974; 17344846; 23636092
1997	KCNB1	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: Note=Homotetrameric channels expressed in xenopus oocytes or in mammalian non-neuronal cells display delayed-rectifier voltage-dependent potassium currents which are activated during membrane depolarization, i.e within a risetime of about 20 msec (PubMed:8081723, PubMed:1283219). After that, inactivate very slowly, i.e within more than 5 sec (PubMed:8081723, PubMed:1283219). Their activation requires low threshold potentials of about -20 to -30 mV, with a midpoint activation at about 10 mV. For inactivation, the voltage at half-maximal amplitude is about -20 mV (PubMed:11852086). The time constant for recovery after inactivation is about 1.6 sec. Channels have an unitary conductance of about 8 pS (PubMed:10484328). The voltage-dependence of activation and inactivation and other channel characteristics vary depending on the experimental conditions, the expression system, the presence or absence of ancillary subunits and post-translational modifications. {ECO:0000269|PubMed:10484328, ECO:0000269|PubMed:11852086, ECO:0000269|PubMed:1283219, ECO:0000269|PubMed:8081723, ECO:0000305|PubMed:10414301, ECO:0000305|PubMed:15858231};				ACTIVITY REGULATION: Inhibited by 12.7 nM stromatoxin 1 (ScTx1), a spider venom toxin of the tarantula S.calceata (PubMed:14565763). Inhibited by 42 nM hanatoxin 1 (HaTx1), a spider venom toxin of the tarantula G.spatulata (PubMed:14565763). Modestly sensitive to millimolar levels of tetraethylammonium (TEA) (PubMed:8081723, PubMed:1283219). Modestly sensitive to millimolar levels of 4-aminopyridine (4-AP). Completely insensitive to toxins such as dendrotoxin (DTX) and charybdotoxin (CTX) (By similarity). {ECO:0000250|UniProtKB:P15387, ECO:0000269|PubMed:1283219, ECO:0000269|PubMed:14565763, ECO:0000269|PubMed:8081723, ECO:0000305|PubMed:10414301, ECO:0000305|PubMed:15858231}.							action potential [GO:0001508]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; glucose homeostasis [GO:0042593]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of insulin secretion [GO:0046676]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of long term synaptic depression [GO:1900454]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of protein targeting to membrane [GO:0090314]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of action potential [GO:0098900]; regulation of insulin secretion [GO:0050796]; regulation of ion transmembrane transport [GO:0034765]; regulation of motor neuron apoptotic process [GO:2000671]; vesicle docking involved in exocytosis [GO:0006904]	axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; lateral plasma membrane [GO:0016328]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]	axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; lateral plasma membrane [GO:0016328]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; protein heterodimerization activity [GO:0046982]; action potential [GO:0001508]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; glucose homeostasis [GO:0042593]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of insulin secretion [GO:0046676]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of long term synaptic depression [GO:1900454]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of protein targeting to membrane [GO:0090314]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of action potential [GO:0098900]; regulation of insulin secretion [GO:0050796]; regulation of ion transmembrane transport [GO:0034765]; regulation of motor neuron apoptotic process [GO:2000671]; vesicle docking involved in exocytosis [GO:0006904]	delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; protein heterodimerization activity [GO:0046982]	GO:0001508; GO:0005251; GO:0005886; GO:0006904; GO:0007215; GO:0008076; GO:0010701; GO:0016328; GO:0030054; GO:0030424; GO:0030425; GO:0031669; GO:0032809; GO:0033605; GO:0034765; GO:0042383; GO:0042593; GO:0043204; GO:0044325; GO:0045211; GO:0045956; GO:0046676; GO:0046982; GO:0050796; GO:0051260; GO:0071333; GO:0071805; GO:0072659; GO:0090314; GO:0098900; GO:1900454; GO:2000671	SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10484328, ECO:0000269|PubMed:11852086, ECO:0000269|PubMed:12060745, ECO:0000269|PubMed:12560340, ECO:0000269|PubMed:1283219, ECO:0000269|PubMed:19074135, ECO:0000269|PubMed:19223394, ECO:0000269|PubMed:19717558, ECO:0000269|PubMed:24477962, ECO:0000269|PubMed:24901643, ECO:0000269|PubMed:26503721, ECO:0000269|PubMed:8081723}. Perikaryon {ECO:0000269|PubMed:24477962}. Cell projection, axon {ECO:0000269|PubMed:24477962}. Cell projection, dendrite {ECO:0000269|PubMed:24477962}. Membrane; Multi-pass membrane protein. Cell junction, synapse, postsynaptic cell membrane {ECO:0000250|UniProtKB:P15387}. Cell junction, synapse {ECO:0000250|UniProtKB:P15387}. Cell junction, synapse, synaptosome {ECO:0000250|UniProtKB:P15387}. Lateral cell membrane {ECO:0000250|UniProtKB:P15387}. Cell membrane, sarcolemma {ECO:0000250|UniProtKB:P15387}. Note=Localizes to high-density somatodendritic clusters and non-clustered sites on the surface of neocortical and hippocampal pyramidal neurons in a cortical actin cytoskeleton-dependent manner (PubMed:24477962). Localizes also to high-density clusters in the axon initial segment (AIS), at ankyrin-G-deficient sites, on the surface of neocortical and hippocampal pyramidal neurons (PubMed:24477962). KCNB1-containing AIS clusters localize either in close apposition to smooth endoplasmic reticulum cisternal organelles or with GABA-A receptor-containing synapses of hippocampal and cortical pyramidal neurons, respectively (PubMed:24477962). Localizes to high-density clusters on the cell surface of atrial and ventricular myocytes and at the lateral plasma membrane in epithelial cells. Localizes both to the axial and transverse tubules (T tubule) and sarcolemma in ventricular myocytes. Associated with lipid raft domains. In cortical neurons, apoptotic injuries induce de novo plasma membrane insertion in a SNARE-dependent manner causing an apoptotic potassium current surge. {ECO:0000250|UniProtKB:P15387, ECO:0000250|UniProtKB:Q03717, ECO:0000269|PubMed:12060745, ECO:0000269|PubMed:19074135, ECO:0000269|PubMed:24477962, ECO:0000269|PubMed:24901643}.	PTM: Phosphorylated. Differential C-terminal phosphorylation on a subset of serines allows graded activity-dependent regulation of channel gating in hippocampal neurons. Ser-607 and Tyr-128 are significant sites of voltage-gated regulation through phosphorylation/dephosphorylation activities. Tyr-128 can be phosphorylated by Src and dephosphorylated by cytoplasmic form of the phosphatase PTPRE. CDK5-induced Ser-607 phosphorylation increases in response to acute blockade of neuronal activity. Phosphorylated on Tyr-128 by Src and on Ser-805 by MAPK14/P38MAPK; phosphorylations are necessary and sufficient for an increase in plasma membrane insertion, apoptotic potassium current surge and completion of the neuronal cell death program. Phosphorylated on Ser-520, Ser-607, Ser-656 and Ser-805 by CDK5; phosphorylation is necessary for KCNB1 channel clustering formation. The Ser-607 phosphorylation state differs between KCNB1-containing clusters on the proximal and distal portions of the axon initial segment (AIS). Highly phosphorylated on serine residues in the C-terminal cytoplasmic tail in resting neurons. Phosphorylated in pancreatic beta cells in response to incretin hormones stimulation in a PKA- and RPS6KA5/MSK1-dependent signaling pathway, promoting beta cell survival. Phosphorylation on Ser-567 is reduced during postnatal development with low levels at P2 and P5; levels then increase to reach adult levels by P14. Phosphorylation on Ser-457, Ser-541, Ser-567, Ser-607, Ser-656 and Ser-720 as well as the N-terminal Ser-15 are sensitive to calcineurin-mediated dephosphorylation contributing to the modulation of the voltage-dependent gating properties. Dephosphorylation by phosphatase PTPRE confers neuroprotection by its inhibitory influence on the neuronal apoptotic potassium current surge in a Zn(2+)-dependent manner. Dephosphorylated at Ser-607 by protein phosphatase PPP1CA. Hypoxia-, seizure- or glutamate-induced neuronal activity promote calcium/calcineurin-dependent dephosphorylation resulting in a loss of KCNB1-containing clustering and enhanced channel activity. In response to brain ischemia, Ser-567 and Ser-607 are strongly dephosphorylated while Ser-457 and Ser-720 are less dephosphorylated. In response to brain seizures, phosphorylation levels on Ser-567 and Ser-607 are greatly reduced. Phosphorylated/dephosphorylated by Src or FYN tyrosine-protein kinases and tyrosine phosphatase PTPRE in primary Schwann cells and sciatic nerve tissue (By similarity). {ECO:0000250|UniProtKB:P15387, ECO:0000250|UniProtKB:Q03717}.; PTM: Acetylated. Acetylation occurs in pancreatic beta cells in response to stimulation by incretin hormones in a histone acetyltransferase (HAT)/histone deacetylase (HDAC)-dependent signaling pathway, promoting beta cell survival. {ECO:0000250|UniProtKB:P15387}.; PTM: Sumoylated on Lys-474, preferentially with SUMO1; sumoylation induces a positive shift in the voltage-dependence of activation and inhibits channel activity (PubMed:19223394). Sumoylation increases the frequency of repetitive action potential firing at the cell surface of hippocampal neurons and decreases its frequency in pancreatic beta cells (PubMed:19223394). Desumoylated by SENP1 (PubMed:19223394). {ECO:0000269|PubMed:19223394}.	MOD_RES 15 15 Phosphoserine. {ECO:0000250|UniProtKB:P15387}.; MOD_RES 128 128 Phosphotyrosine; by Src. {ECO:0000250|UniProtKB:P15387}.; MOD_RES 444 444 Phosphoserine. {ECO:0000250|UniProtKB:Q03717}.; MOD_RES 457 457 Phosphoserine. {ECO:0000250|UniProtKB:Q03717}.; MOD_RES 484 484 Phosphoserine. {ECO:0000250|UniProtKB:P15387}.; MOD_RES 496 496 Phosphoserine. {ECO:0000250|UniProtKB:P15387}.; MOD_RES 503 503 Phosphoserine. {ECO:0000250|UniProtKB:P15387}.; MOD_RES 519 519 Phosphoserine. {ECO:0000250|UniProtKB:P15387}.; MOD_RES 520 520 Phosphoserine; by CDK5; in vitro. {ECO:0000250|UniProtKB:P15387}.; MOD_RES 541 541 Phosphoserine. {ECO:0000250|UniProtKB:P15387}.; MOD_RES 567 567 Phosphoserine. {ECO:0000250|UniProtKB:P15387}.; MOD_RES 590 590 Phosphoserine. {ECO:0000250|UniProtKB:P15387}.; MOD_RES 607 607 Phosphoserine; by CDK5. {ECO:0000250|UniProtKB:P15387}.; MOD_RES 656 656 Phosphoserine; by CDK5; in vitro. {ECO:0000250|UniProtKB:P15387}.; MOD_RES 720 720 Phosphoserine. {ECO:0000250|UniProtKB:P15387}.; MOD_RES 772 772 Phosphoserine. {ECO:0000250|UniProtKB:P15387}.; MOD_RES 800 800 Phosphoserine. {ECO:0000250|UniProtKB:P15387}.; MOD_RES 805 805 Phosphoserine; by CDK5, MAPK14; in vitro. {ECO:0000250|UniProtKB:P15387}.	8081723; 1283219; 11780052; 10484328; 10414301; 11852086; 12403834; 12060745; 14565763; 12560340; 14988243; 15858231; 19357235; 19074135; 19717558; 19223394; 23161216; 24477962; 24901643; 25164438; 26503721; 26477325; 12021261; 12475787; 15024041; 15051809; 15353504; 15569269; 15827117; 15955806; 16008572; 16880266; 17306374; 18212012; 18690023; 19265782; 19454037; 19622611; 19717445; 20379614; 20393197; 20547671; 20566856; 20709754; 21095721; 21231794; 21455829; 22106938; 22411134; 22560931; 22745487; 23223293; 23431371; 23857585; 24597762; 25908859; 26240432; 26242757; 26303499; 26377690; 26487174; 26505474; 26922553; 28373283; 28607108; 28768770; 28806457; 8698327	8081723; 1283219; 11780052; 10484328; 10414301; 11852086; 12403834; 12060745; 14565763; 12560340; 14988243; 15858231; 19357235; 19074135; 19717558; 19223394; 23161216; 24477962; 24901643; 25164438; 26503721; 26477325
2000	KCNA2	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: Note=Homotetrameric channels activate rapidly, i.e within a few msec, but inactivation is very slow, with only a marginal decrease in conductance over several seconds. The voltage-dependence of activation and inactivation and other channel characteristics vary depending on the experimental conditions, the expression system, post-translational modifications and the presence or absence of ancillary subunits. For the activation of homotetrameric channels expressed in xenopus oocytes, the threshold is at about -30 mV and the midpoint at about -5 mV. {ECO:0000269|PubMed:19912772};				ACTIVITY REGULATION: Inhibited by 4-aminopyridine (4-AP) and charybdotoxin (CTX), but not by tetraethylammonium (TEA) (PubMed:19912772). Inhibited by dendrotoxin (DTX) (By similarity). Inhibited by tityustoxin-K alpha (TsTX-Kalpha), a toxin that is highly specific for KCNA2 (By similarity). Inhibited by maurotoxin (By similarity). Inhibited by kappaM conotoxins kappaM-RIIIJ and kappaM-RIIIK; kappaM-RIIIJ has much higher affinity for channels containing KCNA2 than kappaM-RIIIK, with the exception of heterodimers formed by KCNA2 and KCNA7 where the opposite is true (PubMed:20220134). {ECO:0000250|UniProtKB:P63141, ECO:0000250|UniProtKB:P63142, ECO:0000269|PubMed:19912772, ECO:0000269|PubMed:20220134}.				SITE 252 252 Important for normal, slow channel gating. {ECO:0000250|UniProtKB:P63142}.; SITE 381 381 Important for binding with the scorpion mesomartoxin; when the scorpion mesomartoxin-rKv1.2/KCNA2 interaction is modeled, this residue is close to the 'Y-57' residue of the toxin. {ECO:0000250|UniProtKB:P63142}.			neuronal action potential [GO:0019228]; optic nerve structural organization [GO:0021633]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of circadian sleep/wake cycle, non-REM sleep [GO:0045188]; regulation of dopamine secretion [GO:0014059]; regulation of ion transmembrane transport [GO:0034765]; sensory perception of pain [GO:0019233]	axon [GO:0030424]; axon terminus [GO:0043679]; calyx of Held [GO:0044305]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; juxtaparanode region of axon [GO:0044224]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; neuronal cell body membrane [GO:0032809]; paranodal junction [GO:0033010]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]	axon [GO:0030424]; axon terminus [GO:0043679]; calyx of Held [GO:0044305]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; juxtaparanode region of axon [GO:0044224]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; neuronal cell body membrane [GO:0032809]; paranodal junction [GO:0033010]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; kinesin binding [GO:0019894]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; voltage-gated potassium channel activity [GO:0005249]; neuronal action potential [GO:0019228]; optic nerve structural organization [GO:0021633]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of circadian sleep/wake cycle, non-REM sleep [GO:0045188]; regulation of dopamine secretion [GO:0014059]; regulation of ion transmembrane transport [GO:0034765]; sensory perception of pain [GO:0019233]	delayed rectifier potassium channel activity [GO:0005251]; kinesin binding [GO:0019894]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; voltage-gated potassium channel activity [GO:0005249]	GO:0005249; GO:0005251; GO:0005267; GO:0005789; GO:0005886; GO:0005887; GO:0006813; GO:0008076; GO:0014059; GO:0015271; GO:0019228; GO:0019233; GO:0019894; GO:0021633; GO:0030027; GO:0030424; GO:0030425; GO:0031258; GO:0032809; GO:0033010; GO:0034765; GO:0043204; GO:0043679; GO:0044224; GO:0044305; GO:0045188; GO:0051260; GO:0071805; GO:0099056	SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11211111, ECO:0000269|PubMed:19912772, ECO:0000269|PubMed:20220134, ECO:0000269|PubMed:23769686, ECO:0000269|PubMed:8495559}; Multi-pass membrane protein {ECO:0000250|UniProtKB:P63142, ECO:0000305}. Membrane {ECO:0000250|UniProtKB:P63142}. Cell projection, axon {ECO:0000269|PubMed:16473933}. Cell junction, synapse {ECO:0000250|UniProtKB:P63142}. Endoplasmic reticulum membrane {ECO:0000250|UniProtKB:P63142}. Cell projection, lamellipodium membrane {ECO:0000250|UniProtKB:P63142}. Cell junction, synapse, synaptosome {ECO:0000250|UniProtKB:P63141}. Cell junction, synapse, presynaptic cell membrane {ECO:0000250|UniProtKB:P63141}. Cell projection, dendrite {ECO:0000250|UniProtKB:P63141}. Cell junction, paranodal septate junction {ECO:0000250|UniProtKB:P63141}. Note=KCNA2 by itself is detected both at the endoplasmic reticulum and at the cell membrane. Coexpression with KCNA4 or with beta subunits promotes expression at the cell membrane. Coexpression with KCNA1 inhibits cell surface expression. In myelinated peripheral axons, clustered in the juxtaparadonal region and at an internodal line located along the mesaxon and below the Schmidt-Lanterman incisures (By similarity). {ECO:0000250|UniProtKB:P63141, ECO:0000250|UniProtKB:P63142}.	PTM: Phosphorylated on tyrosine residues; phosphorylation increases in response to ischemia (By similarity). Phosphorylated on tyrosine residues by activated PTK2B/PYK2 (By similarity). Phosphorylation on tyrosine residues suppresses ion channel activity (By similarity). Phosphorylated on tyrosine residues in response to CHRM1 activation; this abolishes interaction with CTTN. This is probably due to endocytosis of the phosphorylated channel subunits (By similarity). Phosphorylated on serine residues in response to increased cAMP levels; phosphorylation is apparently not catalyzed by PKA (By similarity). {ECO:0000250|UniProtKB:P63142}.; PTM: N-glycosylated, with complex, sialylated N-glycans. {ECO:0000250|UniProtKB:P63142}.	MOD_RES 429 429 Phosphotyrosine. {ECO:0000250|UniProtKB:P63141}.; MOD_RES 434 434 Phosphoserine. {ECO:0000250|UniProtKB:P63141}.; MOD_RES 440 440 Phosphoserine. {ECO:0000250|UniProtKB:P63141}.; MOD_RES 441 441 Phosphoserine. {ECO:0000250|UniProtKB:Q09081}.; MOD_RES 449 449 Phosphoserine. {ECO:0000250|UniProtKB:Q09081}.; MOD_RES 458 458 Phosphotyrosine. {ECO:0000250|UniProtKB:P63142}.; MOD_RES 468 468 Phosphoserine. {ECO:0000250|UniProtKB:P63141}.	19912772; 14702039; 16710414; 15489334; 8495559; 10624965; 11211111; 11086297; 16473933; 17917103; 19713757; 20220134; 22649228; 23769686; 25477152; 25751627; 27864847; 15215309; 17234891; 17576778; 17959782; 18003609; 18042681; 18053989; 18056633; 18474843; 19389710; 19403695; 19435843; 19883299; 20393197; 20584892; 20842544; 21044565; 21231794; 21906595; 24682423; 24782544; 25300013; 25416956; 27062609; 27543892; 27733563; 28658141; 28806589; 29050392	19912772; 14702039; 16710414; 15489334; 8495559; 10624965; 11211111; 11086297; 16473933; 17917103; 19713757; 20220134; 22649228; 23769686; 25477152; 25751627; 27864847
2078	MOCS1 MIG11	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=0.79 uM for (8S)-3',8-cyclo-7,8-dihydroguanosine 5'-triphosphate {ECO:0000269|PubMed:23627491}; Note=kcat is 0.092 min(-1) for (8S)-3',8-cyclo-7,8-dihydroguanosine 5'-triphosphate. {ECO:0000269|PubMed:23627491};	4.1.99.22; 4.6.1.17	CATALYTIC ACTIVITY: GTP + S-adenosyl-L-methionine + reduced electron acceptor = (8S)-3',8-cyclo-7,8-dihydroguanosine 5'-triphosphate + 5'-deoxyadenosine + L-methionine + oxidized electron acceptor. {ECO:0000250|UniProtKB:P69848}.; CATALYTIC ACTIVITY: (8S)-3',8-cyclo-7,8-dihydroguanosine 5'-triphosphate = cyclic pyranopterin phosphate + diphosphate. {ECO:0000269|PubMed:23627491}.	BINDING 73 73 GTP. {ECO:0000250}.; BINDING 86 86 S-adenosyl-L-methionine. {ECO:0000250}.; BINDING 123 123 GTP. {ECO:0000250}.; BINDING 127 127 S-adenosyl-L-methionine; via carbonyl oxygen. {ECO:0000250}.; BINDING 154 154 GTP. {ECO:0000250}.; BINDING 178 178 S-adenosyl-L-methionine. {ECO:0000250}.; BINDING 215 215 GTP. {ECO:0000250}.; BINDING 249 249 S-adenosyl-L-methionine; via amide nitrogen and carbonyl oxygen. {ECO:0000250}.		COFACTOR: Name=[4Fe-4S] cluster; Xref=ChEBI:CHEBI:49883; Evidence={ECO:0000269|PubMed:15180982}; ;  Note=Binds 2 [4Fe-4S] clusters. Binds 1 [4Fe-4S] cluster coordinated with 3 cysteines and an exchangeable S-adenosyl-L-methionine and 1 [4Fe-4S] cluster coordinated with 3 cysteines and the GTP-derived substrate. {ECO:0000269|PubMed:15180982};		PATHWAY: Cofactor biosynthesis; molybdopterin biosynthesis.		MIG11		molybdopterin cofactor biosynthetic process [GO:0032324]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]	cytosol [GO:0005829]; molybdopterin synthase complex [GO:0019008]; nucleus [GO:0005634]	cytosol [GO:0005829]; molybdopterin synthase complex [GO:0019008]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; cyclic pyranopterin monophosphate synthase activity [GO:0061799]; GTP 3',8'-cyclase activity [GO:0061798]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324]	4 iron, 4 sulfur cluster binding [GO:0051539]; cyclic pyranopterin monophosphate synthase activity [GO:0061799]; GTP 3',8'-cyclase activity [GO:0061798]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]	GO:0005525; GO:0005634; GO:0005829; GO:0006777; GO:0019008; GO:0032324; GO:0046872; GO:0051539; GO:0061798; GO:0061799			MOD_RES 64 64 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 198 198 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 528 528 N6-acetyllysine. {ECO:0000250|UniProtKB:Q5RKZ7}.	9731530; 14702039; 14574404; 15489334; 10917590; 11891227; 12208140; 15180982; 19608861; 23627491; 23186163; 25697423; 9921896; 12754701; 16021469; 21988832	9731530; 14702039; 14574404; 15489334; 10917590; 11891227; 12208140; 15180982; 19608861; 23627491; 23186163; 25697423; 9921896; 12754701; 16021469
2248	KLK6 PRSS18 PRSS9	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1562 uM for Tosyl-Gly-Pro-Arg-AMC {ECO:0000269|PubMed:11983703, ECO:0000269|PubMed:12878203}; KM=777 uM for Tosyl-Gly-Pro-Lys-AMC {ECO:0000269|PubMed:11983703, ECO:0000269|PubMed:12878203}; KM=0.410 mM for Phe-Ser-Arg-AMC {ECO:0000269|PubMed:11983703, ECO:0000269|PubMed:12878203}; KM=0.455 mM for Gly-Gly-Arg-AMC {ECO:0000269|PubMed:11983703, ECO:0000269|PubMed:12878203}; KM=0.335 mM for Asp-Pro-Arg-AMC {ECO:0000269|PubMed:11983703, ECO:0000269|PubMed:12878203}; KM=0.758 mM for Gln-Gly-Arg-AMC {ECO:0000269|PubMed:11983703, ECO:0000269|PubMed:12878203}; KM=0.625 mM for Pro-Phe-Arg-AMC {ECO:0000269|PubMed:11983703, ECO:0000269|PubMed:12878203}; KM=0.271 mM for Val-Pro-Arg-AMC {ECO:0000269|PubMed:11983703, ECO:0000269|PubMed:12878203}; KM=1.72 mM for Val-Leu-Lys-AMC {ECO:0000269|PubMed:11983703, ECO:0000269|PubMed:12878203}; 	3.4.21.-			ACTIVITY REGULATION: Inhibited by a range of serine protease inhibitors including soybean trypsin inhibitor, benzamidine and serpins. Activated by a range of glycosaminoglycans including chondroitin sulfate, dermatan sulfate, heparan sulfate and heparin. {ECO:0000269|PubMed:12878203, ECO:0000269|PubMed:16321973}.				SITE 80 81 Cleavage; by autolysis.			amyloid precursor protein metabolic process [GO:0042982]; central nervous system development [GO:0007417]; collagen catabolic process [GO:0030574]; hormone metabolic process [GO:0042445]; myelination [GO:0042552]; neuron death [GO:0070997]; positive regulation of G-protein coupled receptor protein signaling pathway [GO:0045745]; protein autoprocessing [GO:0016540]; regulation of cell differentiation [GO:0045595]; regulation of neuron projection development [GO:0010975]; response to wounding [GO:0009611]; tissue regeneration [GO:0042246]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; secretory granule [GO:0030141]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; secretory granule [GO:0030141]; serine-type endopeptidase activity [GO:0004252]; amyloid precursor protein metabolic process [GO:0042982]; central nervous system development [GO:0007417]; collagen catabolic process [GO:0030574]; hormone metabolic process [GO:0042445]; myelination [GO:0042552]; neuron death [GO:0070997]; positive regulation of G-protein coupled receptor protein signaling pathway [GO:0045745]; protein autoprocessing [GO:0016540]; regulation of cell differentiation [GO:0045595]; regulation of neuron projection development [GO:0010975]; response to wounding [GO:0009611]; tissue regeneration [GO:0042246]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0005615; GO:0005730; GO:0005737; GO:0005739; GO:0005783; GO:0007417; GO:0009611; GO:0010975; GO:0016540; GO:0030141; GO:0030574; GO:0042246; GO:0042445; GO:0042552; GO:0042982; GO:0045595; GO:0045745; GO:0070997	SUBCELLULAR LOCATION: Secreted. Nucleus, nucleolus. Cytoplasm. Mitochondrion. Microsome. Note=In brain, detected in the nucleus of glial cells and in the nucleus and cytoplasm of neurons. Detected in the mitochondrial and microsomal fractions of HEK-293 cells and released into the cytoplasm following cell stress.	PTM: Inactivated by autolytic cleavage after Arg-80.		8898378; 9003450; 9312124; 10610719; 11054574; 15207701; 16800739; 14702039; 15057824; 15489334; 11018688; 10997858; 11668196; 12878203; 12928483; 15557757; 16987227; 16321973; 17417874; 12016211; 11983703; 12023317; 12074831; 12232761; 12480753; 14696124; 15255184; 15584920; 15837738; 15867230; 16203767; 17158887; 18359858; 18627290; 18854834; 18957059; 18992199; 19088065; 19383923; 19426157; 19558318; 19560453; 19707197; 19950700; 20403393; 20406964; 20424135; 20438785; 20680316; 20836755; 20846516; 21193224; 21464892; 21656738; 21741862; 21753781; 22102857; 22285222; 22373580; 22386244; 22477710; 22505518; 22505521; 22508489; 22699826; 22874102; 23049835; 23136250; 24430362; 24643912; 24669031; 24979321; 25153389; 25153391; 25476568; 25477184; 25640309; 25649006; 25990935; 26172508; 26231762; 27093921; 27168011; 27283773; 27483364; 27844409; 27863404; 28254587; 28376164; 28431272; 29224812; 29435805	8898378; 9003450; 9312124; 10610719; 11054574; 15207701; 16800739; 14702039; 15057824; 15489334; 11018688; 10997858; 11668196; 12878203; 12928483; 15557757; 16987227; 16321973; 17417874; 12016211; 11983703
2249	KLK8 NRPN PRSS19 TADG14 UNQ283/PRO322	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.07 mM for Pro-Phe-Arg-MCA {ECO:0000269|PubMed:16337200}; KM=0.07 mM for Z-Val-Val-Arg-MCA {ECO:0000269|PubMed:16337200}; KM=0.07 mM for Boc-Val-Pro-Arg-MCA {ECO:0000269|PubMed:16337200}; KM=0.10 mM for Boc-Leu-Lys-Arg-MCA {ECO:0000269|PubMed:16337200}; KM=0.10 mM for Boc-Val-Leu-Lys-MCA {ECO:0000269|PubMed:16337200}; KM=0.07 mM for Boc-Phe-Ser-Arg-MCA {ECO:0000269|PubMed:16337200}; Vmax=7.1 umol/min/mg enzyme toward Pro-Phe-Arg-MCA {ECO:0000269|PubMed:16337200}; Vmax=5.4 umol/min/mg enzyme toward Z-Val-Val-Arg-MCA {ECO:0000269|PubMed:16337200}; Vmax=3.9 umol/min/mg enzyme toward Boc-Val-Pro-Arg-MCA {ECO:0000269|PubMed:16337200}; Vmax=2.6 umol/min/mg enzyme toward Boc-Leu-Lys-Arg-MCA {ECO:0000269|PubMed:16337200}; Vmax=1.9 umol/min/mg enzyme toward Boc-Val-Leu-Lys-MCA {ECO:0000269|PubMed:16337200}; Vmax=1.6 umol/min/mg enzyme toward Boc-Phe-Ser-Arg-MCA {ECO:0000269|PubMed:16337200}; 	3.4.21.118	CATALYTIC ACTIVITY: Cleavage of amide substrates following the basic amino acids Arg or Lys at the P1 position, with a preference for Arg over Lys. {ECO:0000269|PubMed:16337200}.		ACTIVITY REGULATION: Inhibited by a range of serine protease inhibitors including antipain, aprotinin, leupeptin, benzamidine and soybean trypsin inhibitor. {ECO:0000269|PubMed:16337200}.		BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 8.5. Active from pH 7-10. {ECO:0000269|PubMed:16337200};			UNQ283/PRO322		cell death [GO:0008219]; keratinocyte proliferation [GO:0043616]; memory [GO:0007613]; negative regulation of axon regeneration [GO:0048681]; negative regulation of myelination [GO:0031642]; neuron projection morphogenesis [GO:0048812]; regulation of synapse organization [GO:0050807]; response to wounding [GO:0009611]; synapse organization [GO:0050808]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine protease inhibitor complex [GO:0097180]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine protease inhibitor complex [GO:0097180]; serine-type endopeptidase activity [GO:0004252]; cell death [GO:0008219]; keratinocyte proliferation [GO:0043616]; memory [GO:0007613]; negative regulation of axon regeneration [GO:0048681]; negative regulation of myelination [GO:0031642]; neuron projection morphogenesis [GO:0048812]; regulation of synapse organization [GO:0050807]; response to wounding [GO:0009611]; synapse organization [GO:0050808]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0005615; GO:0005737; GO:0007613; GO:0008219; GO:0009611; GO:0031642; GO:0043616; GO:0048681; GO:0048812; GO:0050807; GO:0050808; GO:0097180	SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:17761692}. Cytoplasm {ECO:0000269|PubMed:17761692}. Note=Shows a cytoplasmic distribution in the keratinocytes.			9714609; 10485494; 10102990; 11054574; 11309326; 12975309; 15057824; 15489334; 15282331; 11522960; 12147714; 12782581; 16337200; 17487847; 17761692; 19194479; 14749636; 15138549; 16800733; 17178872; 18354391; 19085836; 19125171; 19558318; 20360129; 20424135; 20614312; 20940292; 21988832; 22505524; 24614639; 24705354; 25416956; 25926655; 26099606; 27483364; 28142115; 30013126	9714609; 10485494; 10102990; 11054574; 11309326; 12975309; 15057824; 15489334; 15282331; 11522960; 12147714; 12782581; 16337200; 17487847; 17761692; 19194479
2281	KYNU	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=493 uM for L-kynurenine (at pH 7.0) {ECO:0000269|PubMed:11985583, ECO:0000269|PubMed:17300176, ECO:0000269|PubMed:8706755, ECO:0000269|PubMed:9180257}; KM=28.3 uM for DL-3-hydroxykynurenine (at pH 7.0) {ECO:0000269|PubMed:11985583, ECO:0000269|PubMed:17300176, ECO:0000269|PubMed:8706755, ECO:0000269|PubMed:9180257}; KM=3.0 uM for DL-3-hydroxykynurenine (at pH 7.9) {ECO:0000269|PubMed:11985583, ECO:0000269|PubMed:17300176, ECO:0000269|PubMed:8706755, ECO:0000269|PubMed:9180257}; 	3.7.1.3	CATALYTIC ACTIVITY: L-kynurenine + H(2)O = anthranilate + L-alanine. {ECO:0000255|HAMAP-Rule:MF_03017, ECO:0000269|PubMed:11985583, ECO:0000269|PubMed:17300176, ECO:0000269|PubMed:8706755, ECO:0000269|PubMed:9180257}.; CATALYTIC ACTIVITY: L-3-hydroxykynurenine + H(2)O = 3-hydroxyanthranilate + L-alanine. {ECO:0000255|HAMAP-Rule:MF_03017, ECO:0000269|PubMed:11985583, ECO:0000269|PubMed:17300176, ECO:0000269|PubMed:28792876, ECO:0000269|PubMed:8706755, ECO:0000269|PubMed:9180257}.	BINDING 137 137 Pyridoxal phosphate; via amide nitrogen. {ECO:0000255|HAMAP-Rule:MF_03017}.; BINDING 138 138 Pyridoxal phosphate. {ECO:0000255|HAMAP-Rule:MF_03017, ECO:0000269|PubMed:17300176}.; BINDING 221 221 Pyridoxal phosphate. {ECO:0000255|HAMAP-Rule:MF_03017}.; BINDING 250 250 Pyridoxal phosphate. {ECO:0000255|HAMAP-Rule:MF_03017, ECO:0000269|PubMed:17300176}.; BINDING 253 253 Pyridoxal phosphate. {ECO:0000255|HAMAP-Rule:MF_03017, ECO:0000269|PubMed:17300176}.; BINDING 275 275 Pyridoxal phosphate. {ECO:0000255|HAMAP-Rule:MF_03017, ECO:0000269|PubMed:17300176}.; BINDING 305 305 Pyridoxal phosphate. {ECO:0000255|HAMAP-Rule:MF_03017, ECO:0000269|PubMed:17300176}.; BINDING 333 333 Pyridoxal phosphate. {ECO:0000255|HAMAP-Rule:MF_03017, ECO:0000269|PubMed:17300176}.	ACTIVITY REGULATION: Inhibited by o-methoxybenzoylalanine (OMBA). {ECO:0000269|PubMed:8706755, ECO:0000269|PubMed:9180257}.	COFACTOR: Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326; Evidence={ECO:0000269|PubMed:17300176}; 	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 8.25 with DL-3-hydroxykynurenine as substrate. {ECO:0000269|PubMed:11985583, ECO:0000269|PubMed:17300176, ECO:0000269|PubMed:8706755, ECO:0000269|PubMed:9180257};	PATHWAY: Amino-acid degradation; L-kynurenine degradation; L-alanine and anthranilate from L-kynurenine: step 1/1. {ECO:0000255|HAMAP-Rule:MF_03017}.; PATHWAY: Cofactor biosynthesis; NAD(+) biosynthesis; quinolinate from L-kynurenine: step 2/3. {ECO:0000255|HAMAP-Rule:MF_03017, ECO:0000269|PubMed:28792876}.				'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; L-kynurenine catabolic process [GO:0097053]; NAD biosynthetic process [GO:0009435]; quinolinate biosynthetic process [GO:0019805]; response to interferon-gamma [GO:0034341]; response to vitamin B6 [GO:0034516]; tryptophan catabolic process [GO:0006569]; tryptophan catabolic process to acetyl-CoA [GO:0019442]; tryptophan catabolic process to kynurenine [GO:0019441]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 3-hydroxykynureninase activity [GO:0061981]; kynureninase activity [GO:0030429]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; L-kynurenine catabolic process [GO:0097053]; NAD biosynthetic process [GO:0009435]; quinolinate biosynthetic process [GO:0019805]; response to interferon-gamma [GO:0034341]; response to vitamin B6 [GO:0034516]; tryptophan catabolic process [GO:0006569]; tryptophan catabolic process to acetyl-CoA [GO:0019442]; tryptophan catabolic process to kynurenine [GO:0019441]	3-hydroxykynureninase activity [GO:0061981]; kynureninase activity [GO:0030429]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]	GO:0005654; GO:0005739; GO:0005829; GO:0006569; GO:0009435; GO:0019441; GO:0019442; GO:0019805; GO:0030170; GO:0030429; GO:0034341; GO:0034354; GO:0034516; GO:0042803; GO:0043420; GO:0061981; GO:0097053	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000255|HAMAP-Rule:MF_03017, ECO:0000269|PubMed:8706755}.		MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:22814378}.; MOD_RES 276 276 N6-(pyridoxal phosphate)lysine.	8706755; 9180257; 14702039; 15815621; 15489334; 11985583; 21269460; 22814378; 24275569; 17300176; 17334708; 28792876; 16080802; 19143568; 19805454; 20379614; 20711500; 20877624; 22012986; 26496610; 26725996	8706755; 9180257; 14702039; 15815621; 15489334; 11985583; 21269460; 22814378; 24275569; 17300176; 17334708; 28792876
2296	IMPDH1 IMPD1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=18 uM for Inosine 5'-phosphate {ECO:0000269|PubMed:7763314, ECO:0000269|PubMed:7903306}; KM=46 uM for NAD(+) {ECO:0000269|PubMed:7763314, ECO:0000269|PubMed:7903306}; 	1.1.1.205	CATALYTIC ACTIVITY: Inosine 5'-phosphate + NAD(+) + H(2)O = xanthosine 5'-phosphate + NADH. {ECO:0000255|HAMAP-Rule:MF_03156}.	BINDING 329 329 IMP.; BINDING 441 441 IMP. {ECO:0000255|HAMAP-Rule:MF_03156}.	ACTIVITY REGULATION: Mycophenolic acid (MPA) is a non-competitive inhibitor that prevents formation of the closed enzyme conformation by binding to the same site as the amobile flap. In contrast, mizoribine monophosphate (MZP) is a competitive inhibitor that induces the closed conformation. MPA is a potent inhibitor of mammalian IMPDHs but a poor inhibitor of the bacterial enzymes. MZP is a more potent inhibitor of bacterial IMPDH. Subject to product inhibition by XMP and NADH. Also inhibited by ADP. {ECO:0000255|HAMAP-Rule:MF_03156, ECO:0000269|PubMed:7903306}.	COFACTOR: Name=K(+); Xref=ChEBI:CHEBI:29103; Evidence={ECO:0000255|HAMAP-Rule:MF_03156}; 		PATHWAY: Purine metabolism; XMP biosynthesis via de novo pathway; XMP from IMP: step 1/1. {ECO:0000255|HAMAP-Rule:MF_03156}.				GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183]; lymphocyte proliferation [GO:0046651]; neutrophil degranulation [GO:0043312]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]	azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; DNA binding [GO:0003677]; IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183]; lymphocyte proliferation [GO:0046651]; neutrophil degranulation [GO:0043312]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]	DNA binding [GO:0003677]; IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]	GO:0000166; GO:0003676; GO:0003677; GO:0003723; GO:0003938; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0006177; GO:0006183; GO:0009168; GO:0034774; GO:0035578; GO:0043312; GO:0046651; GO:0046872; GO:1904813	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_03156, ECO:0000269|PubMed:14766016}. Nucleus {ECO:0000255|HAMAP-Rule:MF_03156, ECO:0000269|PubMed:14766016}.		MOD_RES 160 160 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 341 341 Omega-N-methylarginine. {ECO:0000250|UniProtKB:P50096}.; MOD_RES 355 355 Omega-N-methylarginine. {ECO:0000250|UniProtKB:P50096}.	1969416; 14702039; 12853948; 12690205; 15489334; 7903306; 15028279; 7763314; 14766016; 21269460; 23186163; 11875049; 11875050; 16384941; 15465556; 15851576; 16038673; 16214101; 16272056; 16936083; 17001353; 17713475; 17851563; 18295591; 18552984; 18974094; 20045992; 20061166; 20136638; 20238028; 20649757; 20679962; 20711500; 20718729; 20801516; 21791244; 21988832; 22183375; 22301190; 23534816; 23650620; 25105143; 25439607; 26496610; 8692836	1969416; 14702039; 12853948; 12690205; 15489334; 7903306; 15028279; 7763314; 14766016; 21269460; 23186163; 11875049; 11875050; 16384941
2300	DIO3 ITDI3 TXDI3	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=4.3 nM for L-thyroxine {ECO:0000269|PubMed:12746313}; Vmax=1.4 pmol/min/mg enzyme {ECO:0000269|PubMed:12746313}; 	1.21.99.3	CATALYTIC ACTIVITY: 3,3',5'-triiodo-L-thyronine + iodide + acceptor + H(+) = L-thyroxine + reduced acceptor. {ECO:0000269|PubMed:12746313}.									hormone biosynthetic process [GO:0042446]; negative regulation of eye photoreceptor cell development [GO:0042480]; positive regulation of multicellular organism growth [GO:0040018]; retinal cone cell apoptotic process [GO:0097474]; retinal cone cell development [GO:0046549]; thyroid hormone catabolic process [GO:0042404]; thyroid hormone generation [GO:0006590]	endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; thyroxine 5'-deiodinase activity [GO:0004800]; thyroxine 5-deiodinase activity [GO:0033798]; hormone biosynthetic process [GO:0042446]; negative regulation of eye photoreceptor cell development [GO:0042480]; positive regulation of multicellular organism growth [GO:0040018]; retinal cone cell apoptotic process [GO:0097474]; retinal cone cell development [GO:0046549]; thyroid hormone catabolic process [GO:0042404]; thyroid hormone generation [GO:0006590]	thyroxine 5'-deiodinase activity [GO:0004800]; thyroxine 5-deiodinase activity [GO:0033798]	GO:0004800; GO:0005886; GO:0006590; GO:0010008; GO:0016021; GO:0033798; GO:0040018; GO:0042404; GO:0042446; GO:0042480; GO:0046549; GO:0097474	SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:12419801}; Single-pass type II membrane protein {ECO:0000269|PubMed:12419801}. Endosome membrane {ECO:0000269|PubMed:12419801}; Single-pass type II membrane protein {ECO:0000269|PubMed:12419801}.			7593630; 12508121; 15489334; 12746313; 12419801; 18356288; 12586771; 12847093; 12943987; 15240580; 16037131; 16131329; 16131330; 18492748; 19190113; 19548001; 19819956; 19966805; 20566590; 20724312; 21398344; 21737452; 21828183; 22823995; 22825660; 23235188; 23271316; 24123616; 24317514; 24816254; 24878678; 25304215; 26727108; 26825960; 27329732; 27355490; 27829231; 29182613; 29186449	7593630; 12508121; 15489334; 12746313; 12419801; 18356288
2317	ITPK1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.3 uM for Ins(1,3,4)P3 {ECO:0000269|PubMed:11042108}; KM=0.1 uM for Ins(3,4,5,6)P4 {ECO:0000269|PubMed:11042108}; Vmax=320 pmol/min/ug enzyme with Ins(1,3,4)P3 as substrate {ECO:0000269|PubMed:11042108}; Vmax=780 pmol/min/ug enzyme enzyme with Ins(3,4,5,6)P4 as substrate {ECO:0000269|PubMed:11042108}; 	2.7.1.134; 2.7.1.159	CATALYTIC ACTIVITY: ATP + 1D-myo-inositol 3,4,5,6-tetrakisphosphate = ADP + 1D-myo-inositol 1,3,4,5,6-pentakisphosphate.; CATALYTIC ACTIVITY: ATP + 1D-myo-inositol 1,3,4-trisphosphate = ADP + 1D-myo-inositol 1,3,4,5-tetrakisphosphate.; CATALYTIC ACTIVITY: ATP + 1D-myo-inositol 1,3,4-trisphosphate = ADP + 1D-myo-inositol 1,3,4,6-tetrakisphosphate.	BINDING 18 18 1D-myo-inositol 1,3,4-trisphosphate. {ECO:0000250}.; BINDING 106 106 ATP.; BINDING 157 157 ATP.; BINDING 167 167 1D-myo-inositol 1,3,4-trisphosphate. {ECO:0000250}.; BINDING 199 199 1D-myo-inositol 1,3,4-trisphosphate. {ECO:0000250}.; BINDING 214 214 ATP.; BINDING 232 232 ATP.; BINDING 236 236 ATP.; BINDING 297 297 1D-myo-inositol 1,3,4-trisphosphate. {ECO:0000250}.		COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:8662638}; ;  Note=Binds 2 magnesium ions per subunit. {ECO:0000269|PubMed:8662638};						blood coagulation [GO:0007596]; inositol phosphate metabolic process [GO:0043647]; inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266]; neural tube development [GO:0021915]; signal transduction [GO:0007165]	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]	apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; ATP binding [GO:0005524]; catalytic activity [GO:0003824]; inositol tetrakisphosphate 1-kinase activity [GO:0047325]; inositol tetrakisphosphate 6-kinase activity [GO:0000825]; inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity [GO:0052825]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity [GO:0052831]; inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity [GO:0052830]; inositol-1,3,4-trisphosphate 5-kinase activity [GO:0052726]; inositol-1,3,4-trisphosphate 6-kinase activity [GO:0052725]; inositol-3,4,6-trisphosphate 1-kinase activity [GO:0052835]; isomerase activity [GO:0016853]; magnesium ion binding [GO:0000287]; blood coagulation [GO:0007596]; inositol phosphate metabolic process [GO:0043647]; inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266]; neural tube development [GO:0021915]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; catalytic activity [GO:0003824]; inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity [GO:0052825]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity [GO:0052831]; inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity [GO:0052830]; inositol-1,3,4-trisphosphate 5-kinase activity [GO:0052726]; inositol-1,3,4-trisphosphate 6-kinase activity [GO:0052725]; inositol-3,4,6-trisphosphate 1-kinase activity [GO:0052835]; inositol tetrakisphosphate 1-kinase activity [GO:0047325]; inositol tetrakisphosphate 6-kinase activity [GO:0000825]; isomerase activity [GO:0016853]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0000825; GO:0003824; GO:0005524; GO:0005829; GO:0007165; GO:0007596; GO:0016324; GO:0016853; GO:0021915; GO:0032957; GO:0043647; GO:0047325; GO:0052659; GO:0052725; GO:0052726; GO:0052825; GO:0052830; GO:0052831; GO:0052835; GO:0070266		PTM: Acetylation by EP300 and CREBBP destabilizes ITPK1, and down-regulates enzymatic activity. Deacetylated by SIRT1. {ECO:0000269|PubMed:22308441}.	MOD_RES 340 340 N6-acetyllysine; by EP300 and CREBBP. {ECO:0000269|PubMed:22308441}.; MOD_RES 383 383 N6-acetyllysine; by EP300 and CREBBP. {ECO:0000269|PubMed:22308441}.; MOD_RES 396 396 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 410 410 N6-acetyllysine; by EP300 and CREBBP. {ECO:0000269|PubMed:22308441}.	8662638; 11042108; 15489334; 11533064; 11909533; 12324474; 12925536; 15762844; 15837423; 21269460; 22814378; 22308441; 23186163; 29883610; 17616525; 10593988; 12223481; 15316017; 15474001; 16189514; 19724895; 19851296; 20198315; 20379614; 20467437; 22928859; 23416715; 24465924; 7761412; 8723348; 8769125; 9430698	8662638; 11042108; 15489334; 11533064; 11909533; 12324474; 12925536; 15762844; 15837423; 21269460; 22814378; 22308441; 23186163; 29883610; 17616525; 
2351	IRAK4	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=650 uM for ATP (at pH 7.5) {ECO:0000269|PubMed:17312103}; KM=1100 uM for substrate (at pH 7.5) {ECO:0000269|PubMed:17312103}; 	2.7.11.1	CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.	BINDING 213 213 ATP.; BINDING 329 329 ATP.		COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; 						cytokine production [GO:0001816]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; JNK cascade [GO:0007254]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of smooth muscle cell proliferation [GO:0048661]; toll-like receptor 9 signaling pathway [GO:0034162]; toll-like receptor signaling pathway [GO:0002224]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; interleukin-1 receptor binding [GO:0005149]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cytokine production [GO:0001816]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; JNK cascade [GO:0007254]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of smooth muscle cell proliferation [GO:0048661]; toll-like receptor 9 signaling pathway [GO:0034162]; toll-like receptor signaling pathway [GO:0002224]	ATP binding [GO:0005524]; interleukin-1 receptor binding [GO:0005149]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0001816; GO:0002224; GO:0002446; GO:0002755; GO:0004672; GO:0004674; GO:0005149; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007254; GO:0010008; GO:0034162; GO:0043123; GO:0045087; GO:0048661; GO:0051092; GO:0070498; GO:1990266	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:21325272}.	PTM: Phosphorylated. {ECO:0000250}.	MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:22814378}.; MOD_RES 34 34 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 342 342 Phosphothreonine. {ECO:0000269|PubMed:17312103, ECO:0000269|Ref.31}.; MOD_RES 345 345 Phosphothreonine. {ECO:0000269|PubMed:17161373, ECO:0000269|PubMed:17312103, ECO:0000269|Ref.31}.; MOD_RES 346 346 Phosphoserine. {ECO:0000269|PubMed:17161373, ECO:0000269|PubMed:17312103}.	11960013; 10508479; 14702039; 16541075; 15489334; 12496252; 12538665; 12925671; 15084582; 12637671; 16286016; 16951688; 17217339; 17337443; 16950813; 17997719; 18691976; 18669648; 19690332; 19608861; 20400509; 20068231; 21269460; 21325272; 21269878; 22814378; 23186163; 17161373; 17312103; 20485341; 17878374; 17344846; 19663824; 21057262; 24316379; 10854325; 11073981; 12138165; 12140561; 12297423; 12860405; 14625308; 15292196; 15361868; 15492225; 15767370; 15825022; 15905496; 15917247; 16024789; 16169070; 16286015; 16537705; 16907704; 17046325; 17141195; 17485511; 17507369; 17548806; 17675297; 17703412; 17878161; 17890055; 17893200; 17917042; 18070982; 18079163; 18174872; 18438411; 18503546; 18669862; 18710948; 18794297; 18829464; 18987746; 19006693; 19074885; 19120481; 19181383; 19224918; 19254290; 19258923; 19264966; 19423540; 19498957; 19505919; 19592493; 19703016; 19805105; 19898481; 19913121; 20056178; 20104875; 20105294; 20406964; 20438785; 20448286; 20588308; 20621347; 20628086; 20676093; 20966070; 21160042; 21166654; 21205819; 21220427; 21576904; 21606490; 21738793; 21827948; 21903422; 21988832; 22059479; 22606974; 22932140; 23002119; 23027530; 23041547; 23100432; 23255009; 23264652; 23376919; 23519847; 23591012; 23595970; 24194738; 24567333; 24690905; 25034608; 25201411; 25320238; 25344726; 25479567; 25707370; 25870132; 25886387; 25922567; 26075815; 26101573; 26101574; 26288698; 26472314; 26496610; 26698383; 27062898; 27476420; 27702822; 27840174; 27869651; 27876844; 27888910; 28498658; 28501511; 28512203; 28924041; 28947151; 29088270; 29172502; 29398441; 8599092; 8837778; 9430229	11960013; 10508479; 14702039; 16541075; 15489334; 12496252; 12538665; 12925671; 15084582; 12637671; 16286016; 16951688; 17217339; 17337443; 16950813; 17997719; 18691976; 18669648; 19690332; 19608861; 20400509; 20068231; 21269460; 21325272; 21269878; 22814378; 23186163; 17161373; 17312103; 20485341; 17878374; 17344846; 19663824; 21057262; 24316379
2375	KLK14 KLKL6	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=0.3 mM for S-2288 {ECO:0000269|PubMed:15654974, ECO:0000269|PubMed:17110383}; KM=0.2 mM for S-2222 {ECO:0000269|PubMed:15654974, ECO:0000269|PubMed:17110383}; KM=0.2 mM for S-2302 {ECO:0000269|PubMed:15654974, ECO:0000269|PubMed:17110383}; KM=0.7 mM for S-2586 {ECO:0000269|PubMed:15654974, ECO:0000269|PubMed:17110383}; KM=0.045 mM for Gln-Ala-Arg synthetic peptide {ECO:0000269|PubMed:15654974, ECO:0000269|PubMed:17110383}; KM=0.043 mM for Val-Pro-Arg synthetic peptide {ECO:0000269|PubMed:15654974, ECO:0000269|PubMed:17110383}; KM=0.09 mM for Pro-Phe-Arg synthetic peptide {ECO:0000269|PubMed:15654974, ECO:0000269|PubMed:17110383}; KM=0.278 mM for Phe-Ser-Arg synthetic peptide {ECO:0000269|PubMed:15654974, ECO:0000269|PubMed:17110383}; KM=0.0577 mM for Leu-Gly-Arg synthetic peptide {ECO:0000269|PubMed:15654974, ECO:0000269|PubMed:17110383}; KM=0.139 mM for Gln-Gly-Arg synthetic peptide {ECO:0000269|PubMed:15654974, ECO:0000269|PubMed:17110383}; KM=0.173 mM for Gly-Pro-Arg synthetic peptide {ECO:0000269|PubMed:15654974, ECO:0000269|PubMed:17110383}; KM=0.0268 mM for Gln-Arg-Arg synthetic peptide {ECO:0000269|PubMed:15654974, ECO:0000269|PubMed:17110383}; KM=0.130 mM for Gly-Gly-Arg synthetic peptide {ECO:0000269|PubMed:15654974, ECO:0000269|PubMed:17110383}; KM=0.578 mM for Val-Leu-Lys synthetic peptide {ECO:0000269|PubMed:15654974, ECO:0000269|PubMed:17110383}; Note=Has a higher catalytic efficiency for the trypsin-like enzyme substrates S-2288, S-2222 and S-2302 compared to S-2586 a chymotrypsin-like enzyme substrate. Has a lower catalytic activity compared to trypsin towards S-2288, S-2222 and S-2302. Cleaves preferentially after Arg residues.;	3.4.21.-			ACTIVITY REGULATION: Inhibited by SERPINA1, SERPINC1, SERPINE1, SERPINF2, aprotinin, soybean, trypsin inhibitor and leupeptin. Inhibited by serine protease inhibitor SPINK5. Has an autoproteolytic activity which may have a regulatory effect. Activated by citrate and inhibited by zinc and to a lower extent by manganese. {ECO:0000269|PubMed:15654974, ECO:0000269|PubMed:17110383, ECO:0000269|PubMed:17158887}.		BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 8.0. {ECO:0000269|PubMed:15654974, ECO:0000269|PubMed:17110383};					cornification [GO:0070268]; epidermis morphogenesis [GO:0048730]; fertilization [GO:0009566]; negative regulation of G-protein coupled receptor protein signaling pathway [GO:0045744]; positive regulation of G-protein coupled receptor protein signaling pathway [GO:0045745]; proteolysis [GO:0006508]; seminal clot liquefaction [GO:0070684]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; cornification [GO:0070268]; epidermis morphogenesis [GO:0048730]; fertilization [GO:0009566]; negative regulation of G-protein coupled receptor protein signaling pathway [GO:0045744]; positive regulation of G-protein coupled receptor protein signaling pathway [GO:0045745]; proteolysis [GO:0006508]; seminal clot liquefaction [GO:0070684]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005576; GO:0005615; GO:0006508; GO:0009566; GO:0045744; GO:0045745; GO:0048730; GO:0070268; GO:0070684	SUBCELLULAR LOCATION: Secreted, extracellular space {ECO:0000269|PubMed:15654974, ECO:0000269|PubMed:16456535, ECO:0000269|PubMed:17110383}.	PTM: Proteolytic cleavage of the activation peptide produces the active enzyme. {ECO:0000269|PubMed:17110383}.		11309303; 11352573; 17922479; 15057824; 15489334; 10969073; 12645335; 15843175; 15654974; 16800737; 16885167; 16456535; 17110383; 17158887; 18056261; 18482984; 17625593; 12439719; 12858357; 16434994; 18497543; 18627302; 19147544; 19383315; 19558318; 20155713; 20424135; 20667819; 21057706; 22505522; 22505523; 22505524; 23224034; 27533117; 29546479	11309303; 11352573; 17922479; 15057824; 15489334; 10969073; 12645335; 15843175; 15654974; 16800737; 16885167; 16456535; 17110383; 17158887; 18056261; 18482984; 17625593
2426	KCNC2	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: Note=Homotetrameric channels expressed in xenopus oocytes or in mammalian non-neuronal cells display delayed-rectifier voltage-dependent potassium currents, that are rapidly activated during membrane depolarization, i.e within a risetime of a few msec. After that, inactivates very slowly, i.e within about >800 msec. Their activation requires a threshold potential at about -10 mV, with a midpoint activation at about 12.1 mV and a steepness parameter of about 8.4 mV. The voltage-dependence of activation and inactivation and other channel characteristics vary depending on the experimental conditions, the expression system, the presence or absence of ancillary subunits and post-translational modifications. {ECO:0000269|PubMed:15709110, ECO:0000305|PubMed:10414303};				ACTIVITY REGULATION: Inhibited by Stichodactyla helianthus peptide ShK (PubMed:15709110). Inhibited by millimolar levels of tetraethylammonium (TEA). Contrary to other channels, inhibited only by millimolar levels of 4-aminopyridine (4-AP) (By similarity). {ECO:0000250|UniProtKB:P22462, ECO:0000269|PubMed:15709110, ECO:0000305|PubMed:10414303}.							cellular response to ammonium ion [GO:0071242]; cellular response to nitric oxide [GO:0071732]; cellular response to toxic substance [GO:0097237]; globus pallidus development [GO:0021759]; nitric oxide-cGMP-mediated signaling pathway [GO:0038060]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; regulation of insulin secretion [GO:0050796]; response to amine [GO:0014075]; response to ethanol [GO:0045471]; response to light intensity [GO:0009642]; response to magnesium ion [GO:0032026]; response to nerve growth factor [GO:1990089]; response to organic cyclic compound [GO:0014070]	apical plasma membrane [GO:0016324]; axolemma [GO:0030673]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular [GO:0005622]; membrane [GO:0016020]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; terminal bouton [GO:0043195]; vesicle [GO:0031982]; voltage-gated potassium channel complex [GO:0008076]	apical plasma membrane [GO:0016324]; axolemma [GO:0030673]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular [GO:0005622]; membrane [GO:0016020]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; terminal bouton [GO:0043195]; vesicle [GO:0031982]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; voltage-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099508]; voltage-gated potassium channel activity [GO:0005249]; cellular response to ammonium ion [GO:0071242]; cellular response to nitric oxide [GO:0071732]; cellular response to toxic substance [GO:0097237]; globus pallidus development [GO:0021759]; nitric oxide-cGMP-mediated signaling pathway [GO:0038060]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; regulation of insulin secretion [GO:0050796]; response to amine [GO:0014075]; response to ethanol [GO:0045471]; response to light intensity [GO:0009642]; response to magnesium ion [GO:0032026]; response to nerve growth factor [GO:1990089]; response to organic cyclic compound [GO:0014070]	delayed rectifier potassium channel activity [GO:0005251]; ion channel binding [GO:0044325]; voltage-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099508]; voltage-gated potassium channel activity [GO:0005249]	GO:0005249; GO:0005251; GO:0005622; GO:0005886; GO:0005887; GO:0008076; GO:0009642; GO:0014070; GO:0014075; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0021759; GO:0030054; GO:0030424; GO:0030425; GO:0030673; GO:0031982; GO:0032026; GO:0032809; GO:0038060; GO:0042734; GO:0043195; GO:0043204; GO:0044325; GO:0045202; GO:0045211; GO:0045471; GO:0050796; GO:0051260; GO:0051291; GO:0071242; GO:0071732; GO:0071805; GO:0097237; GO:0099508; GO:1903818; GO:1990089	SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15709110}; Multi-pass membrane protein {ECO:0000255}. Membrane {ECO:0000250|UniProtKB:Q14B80}; Multi-pass membrane protein {ECO:0000255}. Perikaryon {ECO:0000250|UniProtKB:Q14B80}. Cell projection, axon {ECO:0000250|UniProtKB:Q14B80}. Cell projection, dendrite {ECO:0000250|UniProtKB:Q14B80}. Cell junction, synapse, postsynaptic cell membrane {ECO:0000250|UniProtKB:Q14B80}. Cell junction, synapse, presynaptic cell membrane {ECO:0000250|UniProtKB:Q14B80}. Cell junction, synapse, synaptosome {ECO:0000250|UniProtKB:P22462}. Cell junction, synapse {ECO:0000250|UniProtKB:P22462}. Apical cell membrane {ECO:0000250|UniProtKB:P22462}. Basolateral cell membrane {ECO:0000250|UniProtKB:P22462}. Note=Colocalizes with parvalbumin in globus pallidus neurons. Localizes in thalamocortical axons and synapses. Localizes on the surface of cell somata, proximal dendrites and axonal membranes. Also detected throughout the neuropil. Localized in starburst cell somata and proximal dendrite processes. Colocalized with GABA in presynaptic terminals. Clustered in patches in somatic and proximal dendritic membrane as well as in axons and presnypatic terminals of GABAergic interneurons; some of these patches are found near postsynaptic sites. {ECO:0000250|UniProtKB:P22462, ECO:0000250|UniProtKB:Q14B80}.	PTM: Phosphorylated by PKA in cortical synaptosomes. cAMP-dependent phosphorylation inhibits channel activity (By similarity). Histamine H2 receptor- and PKA-induced phosphorylation extends action potential spike duration, reduces action potential spike amplitude, sustains maximum firing frequency in hippocampal interneurons; also reduces the incidence of high-frequency oscillations in hippocampal CA3 pyramidal cell layers. {ECO:0000250|UniProtKB:P22462, ECO:0000250|UniProtKB:Q14B80}.	MOD_RES 600 600 Phosphoserine. {ECO:0000250|UniProtKB:Q14B80}.	8111118; 14702039; 16541075; 15489334; 10414303; 11506885; 15709110; 23475819; 12475787; 14988243; 15569269; 15955806; 17306374; 19332619; 20393197; 21231794; 21912965; 23628987; 27623749	8111118; 14702039; 16541075; 15489334; 10414303; 11506885; 15709110; 23475819
2437	MVK	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=74 uM for ATP {ECO:0000269|PubMed:9325256}; KM=178 uM for ATP {ECO:0000269|PubMed:18302342}; KM=24 uM for (R)-mevalonate {ECO:0000269|PubMed:9325256}; KM=40 uM for (R)-mevalonate {ECO:0000269|PubMed:18302342}; Vmax=37 umol/min/mg enzyme with (R)-mevalonate as substrate {ECO:0000269|PubMed:9325256}; Vmax=28 umol/min/mg enzyme with (R)-mevalonate as substrate {ECO:0000269|PubMed:18302342}; 	2.7.1.36	CATALYTIC ACTIVITY: ATP + (R)-mevalonate = ADP + (R)-5-phosphomevalonate. {ECO:0000269|PubMed:18302342, ECO:0000269|PubMed:9325256}.	BINDING 13 13 ATP. {ECO:0000250|UniProtKB:P17256}.; BINDING 55 55 ATP. {ECO:0000250|UniProtKB:P17256}.; BINDING 135 135 ATP. {ECO:0000250|UniProtKB:P17256}.	ACTIVITY REGULATION: Farnesyl pyrophosphate is a competitive inhibitor. {ECO:0000269|PubMed:18302342}.	COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250|UniProtKB:P17256}; 		PATHWAY: Isoprenoid biosynthesis; isopentenyl diphosphate biosynthesis via mevalonate pathway; isopentenyl diphosphate from (R)-mevalonate: step 1/3.				cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; isoprenoid biosynthetic process [GO:0008299]; negative regulation of inflammatory response [GO:0050728]; regulation of cholesterol biosynthetic process [GO:0045540]	cytosol [GO:0005829]; peroxisome [GO:0005777]	cytosol [GO:0005829]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; mevalonate kinase activity [GO:0004496]; cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; isoprenoid biosynthetic process [GO:0008299]; negative regulation of inflammatory response [GO:0050728]; regulation of cholesterol biosynthetic process [GO:0045540]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; mevalonate kinase activity [GO:0004496]	GO:0000287; GO:0004496; GO:0005524; GO:0005777; GO:0005829; GO:0006695; GO:0008299; GO:0019287; GO:0042802; GO:0045540; GO:0050728	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:14730012}. Peroxisome {ECO:0000250|UniProtKB:P17256}.			1377680; 8302606; 9325256; 11313768; 15489334; 14730012; 21269460; 22983302; 24781643; 18302342; 10417275; 10401001; 10369261; 10369262; 11313769; 15536479; 12444096; 12477733; 12634869; 14749336; 15037710; 15188372; 16189514; 16234278; 17213252; 18193043; 18494797; 18512793; 18660489; 18941711; 19060906; 19148283; 19487539; 19605566; 20159775; 20160193; 20194276; 20430392; 20677014; 20714348; 20814828; 20972250; 21044950; 21124859; 21430599; 21548022; 22038276; 22159817; 22271696; 23834120; 24008101; 24064360; 24084495; 24411001; 24551296; 24708999; 25053464; 25059119; 25982894; 26420133; 26794421; 27213830; 27716295; 28095071	1377680; 8302606; 9325256; 11313768; 15489334; 14730012; 21269460; 22983302; 24781643; 18302342; 10417275; 10401001; 10369261; 10369262; 11313769; 15536479
2464	KMO	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=24.1 uM for L-kynurenine {ECO:0000269|PubMed:10672018, ECO:0000269|PubMed:23575632, ECO:0000269|PubMed:9237672}; KM=2 uM for L-kynurenine {ECO:0000269|PubMed:26752518}; KM=78 uM for L-kynurenine {ECO:0000269|PubMed:26752518}; Vmax=8.5 umol/min/mg enzyme {ECO:0000269|PubMed:10672018, ECO:0000269|PubMed:9237672}; Note=Kcat is 0.24 sec(-1) for L-kynurenine. {ECO:0000269|PubMed:28604669};	1.14.13.9	CATALYTIC ACTIVITY: L-kynurenine + NADPH + O(2) = 3-hydroxy-L-kynurenine + NADP(+) + H(2)O. {ECO:0000255|HAMAP-Rule:MF_03018, ECO:0000269|PubMed:10672018, ECO:0000269|PubMed:29429898, ECO:0000269|PubMed:9237672}.	BINDING 19 19 FAD; via amide nitrogen. {ECO:0000244|PDB:5X68, ECO:0000269|PubMed:29429898}.; BINDING 57 57 FAD; via amide nitrogen and carbonyl oxygen. {ECO:0000244|PDB:5X68, ECO:0000269|PubMed:29429898}.; BINDING 85 85 L-kynurenine. {ECO:0000250|UniProtKB:Q84HF5}.; BINDING 99 99 L-kynurenine. {ECO:0000250|UniProtKB:Q84HF5}.; BINDING 111 111 FAD. {ECO:0000244|PDB:5X68, ECO:0000269|PubMed:29429898}.; BINDING 136 136 FAD; via amide nitrogen and carbonyl oxygen. {ECO:0000244|PDB:5X68, ECO:0000269|PubMed:29429898}.; BINDING 172 172 FAD. {ECO:0000244|PDB:5X68, ECO:0000269|PubMed:29429898}.; BINDING 304 304 FAD; via amide nitrogen. {ECO:0000244|PDB:5X68, ECO:0000269|PubMed:29429898}.; BINDING 363 363 L-kynurenine. {ECO:0000250|UniProtKB:Q84HF5}.; BINDING 398 398 L-kynurenine. {ECO:0000250|UniProtKB:Q84HF5}.		COFACTOR: Name=FAD; Xref=ChEBI:CHEBI:57692; Evidence={ECO:0000255|HAMAP-Rule:MF_03018, ECO:0000269|PubMed:10672018, ECO:0000269|PubMed:29429898}; 	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 7.5. {ECO:0000269|PubMed:10672018, ECO:0000269|PubMed:9237672};	PATHWAY: Cofactor biosynthesis; NAD(+) biosynthesis; quinolinate from L-kynurenine: step 1/3. {ECO:0000255|HAMAP-Rule:MF_03018}.				'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; cellular response to interleukin-1 [GO:0071347]; kynurenine metabolic process [GO:0070189]; L-kynurenine metabolic process [GO:0097052]; NAD metabolic process [GO:0019674]; positive regulation of glutamate secretion, neurotransmission [GO:1903296]; positive regulation of neuron death [GO:1901216]; quinolinate biosynthetic process [GO:0019805]; response to lipopolysaccharide [GO:0032496]; response to salt stress [GO:0009651]; secondary metabolite biosynthetic process [GO:0044550]; tryptophan catabolic process [GO:0006569]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; kynurenine 3-monooxygenase activity [GO:0004502]; NAD(P)H oxidase activity [GO:0016174]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; cellular response to interleukin-1 [GO:0071347]; kynurenine metabolic process [GO:0070189]; L-kynurenine metabolic process [GO:0097052]; NAD metabolic process [GO:0019674]; positive regulation of glutamate secretion, neurotransmission [GO:1903296]; positive regulation of neuron death [GO:1901216]; quinolinate biosynthetic process [GO:0019805]; response to lipopolysaccharide [GO:0032496]; response to salt stress [GO:0009651]; secondary metabolite biosynthetic process [GO:0044550]; tryptophan catabolic process [GO:0006569]	FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; kynurenine 3-monooxygenase activity [GO:0004502]; NAD(P)H oxidase activity [GO:0016174]	GO:0004502; GO:0005741; GO:0005829; GO:0006569; GO:0009651; GO:0016021; GO:0016174; GO:0019674; GO:0019805; GO:0032496; GO:0034354; GO:0043420; GO:0044550; GO:0050660; GO:0070189; GO:0071347; GO:0071949; GO:0097052; GO:1901216; GO:1903296	SUBCELLULAR LOCATION: Mitochondrion outer membrane {ECO:0000255|HAMAP-Rule:MF_03018, ECO:0000269|PubMed:9237672}; Multi-pass membrane protein {ECO:0000255|HAMAP-Rule:MF_03018, ECO:0000269|PubMed:9237672}.			9237672; 10672018; 16710414; 12402501; 23575632; 26752518; 28604669; 29208702; 29429898; 15950064; 16716206; 19626040; 21030213; 21693093; 21727251; 23459468; 24316190; 25464917; 25715464; 26099564; 26589832; 27020856; 27077813; 28139632; 28319697	9237672; 10672018; 16710414; 12402501; 23575632; 26752518; 28604669; 29208702; 29429898
2468	PRKCI DXS1179E	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=13.5 uM for ATP (for recombinant purified PRKCI) {ECO:0000269|PubMed:10906326}; Vmax=7.4 pmol/min/mg enzyme {ECO:0000269|PubMed:10906326}; 	2.7.11.13	CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.	BINDING 283 283 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.	ACTIVITY REGULATION: Atypical PKCs (PRKCI and PRKCZ) exhibit an elevated basal enzymatic activity (that may be due to the interaction with SMG1 or SQSTM1) and are not regulated by diacylglycerol, phosphatidylserine, phorbol esters or calcium ions. Two specific sites, Thr-412 (activation loop of the kinase domain) and Thr-564 (turn motif), need to be phosphorylated for its full activation (By similarity). Might also be a target for novel lipid activators that are elevated during nutrient-stimulated insulin secretion. {ECO:0000250, ECO:0000269|PubMed:8524286}.							actin filament organization [GO:0007015]; bicellular tight junction assembly [GO:0070830]; cell-cell junction organization [GO:0045216]; cell migration [GO:0016477]; cellular response to insulin stimulus [GO:0032869]; cytoskeleton organization [GO:0007010]; establishment of apical/basal cell polarity [GO:0035089]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; eye photoreceptor cell development [GO:0042462]; Golgi vesicle budding [GO:0048194]; intracellular signal transduction [GO:0035556]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of neuron apoptotic process [GO:0043524]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of glucose import [GO:0046326]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein phosphorylation [GO:0006468]; protein targeting to membrane [GO:0006612]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to interleukin-1 [GO:0070555]; secretion [GO:0046903]; vesicle-mediated transport [GO:0016192]	apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; Schmidt-Lanterman incisure [GO:0043220]	apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; Schmidt-Lanterman incisure [GO:0043220]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; actin filament organization [GO:0007015]; bicellular tight junction assembly [GO:0070830]; cell migration [GO:0016477]; cell-cell junction organization [GO:0045216]; cellular response to insulin stimulus [GO:0032869]; cytoskeleton organization [GO:0007010]; establishment of apical/basal cell polarity [GO:0035089]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; eye photoreceptor cell development [GO:0042462]; Golgi vesicle budding [GO:0048194]; intracellular signal transduction [GO:0035556]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of neuron apoptotic process [GO:0043524]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of glucose import [GO:0046326]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein phosphorylation [GO:0006468]; protein targeting to membrane [GO:0006612]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to interleukin-1 [GO:0070555]; secretion [GO:0046903]; vesicle-mediated transport [GO:0016192]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]	GO:0000139; GO:0004672; GO:0004674; GO:0004697; GO:0005524; GO:0005543; GO:0005634; GO:0005654; GO:0005768; GO:0005829; GO:0005886; GO:0005923; GO:0006468; GO:0006612; GO:0007010; GO:0007015; GO:0010976; GO:0015630; GO:0016192; GO:0016324; GO:0016477; GO:0018105; GO:0019904; GO:0031252; GO:0032869; GO:0032991; GO:0034351; GO:0035089; GO:0035556; GO:0042462; GO:0043066; GO:0043220; GO:0043524; GO:0045171; GO:0045197; GO:0045216; GO:0045747; GO:0046326; GO:0046872; GO:0046903; GO:0048194; GO:0051092; GO:0060252; GO:0061024; GO:0070062; GO:0070555; GO:0070830; GO:0098685; GO:0098978; GO:0099072; GO:1903078; GO:2000353	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11891849, ECO:0000269|PubMed:15695176, ECO:0000269|PubMed:9566925}. Membrane {ECO:0000269|PubMed:16452474}. Endosome {ECO:0000269|PubMed:9566925}. Nucleus {ECO:0000269|PubMed:11891849, ECO:0000269|PubMed:15695176}. Note=Transported into the endosome through interaction with SQSTM1/p62. After phosphorylation by SRC, transported into the nucleus through interaction with KPNB1. Colocalizes with CDK7 in the cytoplasm and nucleus. Transported to vesicular tubular clusters (VTCs) through interaction with RAB2A. {ECO:0000269|PubMed:15695176, ECO:0000269|PubMed:9566925}.	PTM: Phosphorylation at Thr-412 in the activation loop is not mandatory for activation (By similarity). Upon neuronal growth factor (NGF) stimulation, phosphorylated by SRC at Tyr-265, Tyr-280 and Tyr-334. Phosphorylation at Tyr-265 facilitates binding to KPNB1/importin-beta regulating entry of PRKCI into the nucleus. Phosphorylation on Tyr-334 is important for NF-kappa-B stimulation. {ECO:0000250, ECO:0000269|PubMed:11713277, ECO:0000269|PubMed:11891849, ECO:0000269|PubMed:16125198, ECO:0000269|PubMed:16452474}.	MOD_RES 2 2 N-acetylproline. {ECO:0000244|PubMed:20068231}.; MOD_RES 3 3 Phosphothreonine. {ECO:0000244|PubMed:20068231}.; MOD_RES 7 7 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 8 8 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 9 9 Phosphothreonine. {ECO:0000244|PubMed:20068231}.; MOD_RES 265 265 Phosphotyrosine; by SRC. {ECO:0000269|PubMed:11713277, ECO:0000269|PubMed:11891849}.; MOD_RES 280 280 Phosphotyrosine; by SRC. {ECO:0000269|PubMed:11713277}.; MOD_RES 334 334 Phosphotyrosine; by SRC. {ECO:0000269|PubMed:11713277}.; MOD_RES 412 412 Phosphothreonine; by PDPK1. {ECO:0000305|PubMed:16125198}.; MOD_RES 564 564 Phosphothreonine. {ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:24275569, ECO:0000269|PubMed:16125198}.	8226978; 7607695; 15489334; 8524286; 9346882; 9566925; 10467349; 10356400; 10906326; 11042363; 11260256; 11257119; 11724794; 11713277; 11891849; 12893243; 12725730; 12871960; 14570876; 14684752; 15994303; 15695176; 16792529; 16452474; 17313651; 18270268; 18220336; 18691976; 18669648; 19327373; 19617897; 19690332; 20068231; 21269460; 21419810; 21189248; 21406692; 23186163; 24275569; 15143057; 15590654; 16125198; 17344846; 11244088; 11447115; 11978974; 12140376; 12721299; 12791393; 12815264; 12953056; 14670960; 14676191; 15024028; 15192100; 15302858; 15705582; 15887250; 16116079; 16189514; 16361262; 16644736; 16820593; 17057644; 17133348; 17570678; 17588663; 17626746; 17979178; 17990328; 18212741; 18234642; 18427549; 18538170; 18562307; 18571841; 18632643; 19060919; 19101699; 19243387; 19290490; 19549684; 19596235; 19615732; 19774416; 19805306; 20360068; 20445233; 20463008; 20562859; 20686607; 20808283; 20815904; 20945390; 21300793; 21373201; 21497093; 21516116; 21535317; 21667320; 21685893; 21775625; 21900206; 21988832; 22021906; 22120720; 22252131; 22349825; 22522453; 22939624; 23224638; 23359356; 23396968; 23418854; 23439680; 23446420; 23902751; 24045153; 24174471; 24255178; 24318287; 24366813; 24375676; 24525231; 24603690; 24636699; 24651432; 24753582; 24876225; 24887021; 25118327; 25501807; 25694446; 25852190; 26279297; 26475383; 26496610; 26535980; 26638075; 26792725; 26977885; 27312576; 27409422; 27481515; 27554601; 27554858; 27760826; 28432079; 28574228; 28698296; 28739484; 29048609	8226978; 7607695; 15489334; 8524286; 9346882; 9566925; 10467349; 10356400; 10906326; 11042363; 11260256; 11257119; 11724794; 11713277; 11891849; 12893243; 12725730; 12871960; 14570876; 14684752; 15994303; 15695176; 16792529; 16452474; 17313651; 18270268; 18220336; 18691976; 18669648; 19327373; 19617897; 19690332; 20068231; 21269460; 21419810; 21189248; 21406692; 23186163; 24275569; 15143057; 15590654; 16125198; 17344846
2553	MAN1B1 UNQ747/PRO1477	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.4 mM for Man9GlcNAc2 {ECO:0000269|PubMed:10521544}; 	3.2.1.113	CATALYTIC ACTIVITY: Hydrolysis of the terminal (1->2)-linked alpha-D-mannose residues in the oligo-mannose oligosaccharide Man(9)(GlcNAc)(2). {ECO:0000269|PubMed:10409699, ECO:0000269|PubMed:12090241, ECO:0000269|PubMed:15713668}.		ACTIVITY REGULATION: Inhibited by both 1-deoxymannojirimycin (dMNJ) and kifunensine. {ECO:0000269|PubMed:10409699}.	COFACTOR: Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000250|UniProtKB:P45700}; 	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is between 6.5 and 6.9. {ECO:0000269|PubMed:10521544};	PATHWAY: Protein modification; protein glycosylation. {ECO:0000250|UniProtKB:P32906}.		UNQ747/PRO1477		endoplasmic reticulum mannose trimming [GO:1904380]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; protein alpha-1,2-demannosylation [GO:0036508]; protein glycosylation [GO:0006486]; trimming of first mannose on A branch [GO:0036511]; trimming of second mannose on A branch [GO:0036512]; trimming of terminal mannose on B branch [GO:0036509]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent ERAD pathway [GO:0030433]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; endoplasmic reticulum mannose trimming [GO:1904380]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; protein alpha-1,2-demannosylation [GO:0036508]; protein glycosylation [GO:0006486]; trimming of first mannose on A branch [GO:0036511]; trimming of second mannose on A branch [GO:0036512]; trimming of terminal mannose on B branch [GO:0036509]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent ERAD pathway [GO:0030433]	calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]	GO:0000139; GO:0004571; GO:0005509; GO:0005783; GO:0005789; GO:0005794; GO:0006486; GO:0006491; GO:0009311; GO:0016020; GO:0016021; GO:0030433; GO:0036508; GO:0036509; GO:0036510; GO:0036511; GO:0036512; GO:0044322; GO:1903561; GO:1904380; GO:1904382	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:10409699}; Single-pass type II membrane protein {ECO:0000269|PubMed:10409699}.			10521544; 10409699; 12975309; 15164053; 15489334; 12090241; 18003979; 25944712; 10995765; 15713668; 21763484; 12736254; 12815101; 15785934; 17727818; 18619586; 19444872; 19739260; 21697506; 21900206; 22810585; 23427261; 23940818; 24348268; 24519966; 24566669; 25092655; 25411339; 26205822; 26496610; 26577042; 27856750; 28887821	10521544; 10409699; 12975309; 15164053; 15489334; 12090241; 18003979; 25944712; 10995765; 15713668; 21763484
2621	CYB5R4 NCB5OR	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=25 mM for O(2); 	1.6.2.2	CATALYTIC ACTIVITY: NADH + 2 ferricytochrome b5 = NAD(+) + H(+) + 2 ferrocytochrome b5.			COFACTOR: Name=FAD; Xref=ChEBI:CHEBI:57692; Evidence={ECO:0000269|PubMed:10611283}; 						bicarbonate transport [GO:0015701]; cell development [GO:0048468]; detection of oxygen [GO:0003032]; generation of precursor metabolites and energy [GO:0006091]; glucose homeostasis [GO:0042593]; insulin secretion [GO:0030073]; oxidation-reduction process [GO:0055114]; response to antibiotic [GO:0046677]; superoxide metabolic process [GO:0006801]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; perinuclear region of cytoplasm [GO:0048471]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; perinuclear region of cytoplasm [GO:0048471]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NAD(P)H oxidase activity [GO:0016174]; oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor [GO:0016653]; bicarbonate transport [GO:0015701]; cell development [GO:0048468]; detection of oxygen [GO:0003032]; generation of precursor metabolites and energy [GO:0006091]; glucose homeostasis [GO:0042593]; insulin secretion [GO:0030073]; oxidation-reduction process [GO:0055114]; response to antibiotic [GO:0046677]; superoxide metabolic process [GO:0006801]	cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NAD(P)H oxidase activity [GO:0016174]; oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor [GO:0016653]	GO:0003032; GO:0004128; GO:0005783; GO:0005789; GO:0006091; GO:0006801; GO:0015701; GO:0016174; GO:0016653; GO:0020037; GO:0030073; GO:0042593; GO:0046677; GO:0046872; GO:0048468; GO:0048471; GO:0055114	SUBCELLULAR LOCATION: Endoplasmic reticulum {ECO:0000269|PubMed:10611283, ECO:0000269|PubMed:15131110}. Note=Soluble protein.		MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:22814378}.	14574404; 15489334; 10611283; 22814378; 20630863; 15504981; 15131110; 16959974; 15858218; 19913121; 20628086; 22627575; 22810585; 23523930; 26878259	14574404; 15489334; 10611283; 22814378; 20630863; 15504981; 15131110; 16959974
2642	NAA50 MAK3 NAT13 NAT5	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=132.6 uM for M-A-A-A peptide {ECO:0000269|PubMed:27484799}; KM=126.1 uM for L-A-A-A peptide {ECO:0000269|PubMed:27484799}; KM=5 uM for Acetyl-CoA {ECO:0000269|PubMed:22311970}; KM=79 uM for M-L-G-P-E peptide {ECO:0000269|PubMed:19744929}; KM=91 uM for M-L-D-P-E peptide {ECO:0000269|PubMed:19744929}; KM=185 uM for M-I-G-P-E peptide {ECO:0000269|PubMed:19744929}; KM=190 uM for M-L-A-L-I peptide {ECO:0000269|PubMed:19744929}; KM=320 uM for M-L-G-T-G peptide {ECO:0000269|PubMed:19744929}; KM=416 uM for M-L-G-T-E peptide {ECO:0000269|PubMed:19744929}; KM=460 uM for M-L-R-P-E peptide {ECO:0000269|PubMed:19744929}; KM=478 uM for M-L-L-P-E peptide {ECO:0000269|PubMed:19744929}; KM=3734 uM for M-F-G-P-E peptide {ECO:0000269|PubMed:19744929}; Note=kcat is 7.2 min(-1) with M-L-G-P-E peptide. kcat is 7.2 min(-1) with M-L-D-P-E peptide. kcat is 10.9 min(-1) with M-I-G-P-E peptide. kcat is 6.8 min(-1) with M-L-A-L-I peptide. kcat is 2.3 min(-1) with M-L-G-T-G peptide. kcat is 5.6 min(-1) with M-L-G-T-E peptide. {ECO:0000269|PubMed:19744929};	2.3.1.258; 2.3.1.-	CATALYTIC ACTIVITY: Acetyl-CoA + an N-terminal-L-methionyl-L-alanyl-[protein] = an N-terminal-N(alpha)-acetyl-L-methionyl-L-alanyl-[protein] + CoA. {ECO:0000269|PubMed:19744929, ECO:0000269|PubMed:21900231, ECO:0000269|PubMed:22311970, ECO:0000269|PubMed:27484799}.; CATALYTIC ACTIVITY: Acetyl-CoA + an N-terminal-L-methionyl-L-seryl-[protein] = an N-terminal-N(alpha)-acetyl-L-methionyl-L-seryl-[protein] + CoA. {ECO:0000269|PubMed:19744929, ECO:0000269|PubMed:21900231, ECO:0000269|PubMed:22311970, ECO:0000269|PubMed:27484799}.; CATALYTIC ACTIVITY: Acetyl-CoA + an N-terminal-L-methionyl-L-valyl-[protein] = an N-terminal-N(alpha)-acetyl-L-methionyl-L-valyl-[protein] + CoA. {ECO:0000269|PubMed:19744929, ECO:0000269|PubMed:21900231, ECO:0000269|PubMed:22311970, ECO:0000269|PubMed:27484799}.; CATALYTIC ACTIVITY: Acetyl-CoA + an N-terminal-L-methionyl-L-threonyl-[protein] = an N-terminal-N(alpha)-acetyl-L-methionyl-L-threonyl-[protein] + CoA. {ECO:0000269|PubMed:19744929, ECO:0000269|PubMed:21900231, ECO:0000269|PubMed:22311970, ECO:0000269|PubMed:27484799}.; CATALYTIC ACTIVITY: Acetyl-CoA + an N-terminal-L-methionyl-L-lysyl-[protein] = an N-terminal-N(alpha)-acetyl-L-methionyl-L-lysyl-[protein] + CoA. {ECO:0000269|PubMed:19744929, ECO:0000269|PubMed:21900231, ECO:0000269|PubMed:22311970, ECO:0000269|PubMed:27484799}.; CATALYTIC ACTIVITY: Acetyl-CoA + an N-terminal-L-methionyl-L-leucyl-[protein] = an N-terminal-N(alpha)-acetyl-L-methionyl-L-leucyl-[protein] + CoA. {ECO:0000269|PubMed:19744929, ECO:0000269|PubMed:21900231, ECO:0000269|PubMed:22311970, ECO:0000269|PubMed:27484799}.; CATALYTIC ACTIVITY: Acetyl-CoA + an N-terminal-L-methionyl-L-phenylalanyl-[protein] = an N-terminal-N(alpha)-acetyl-L-methionyl-L-phenylalanyl-[protein] + CoA. {ECO:0000269|PubMed:19744929, ECO:0000269|PubMed:21900231, ECO:0000269|PubMed:22311970, ECO:0000269|PubMed:27484799}.; CATALYTIC ACTIVITY: Acetyl-CoA + an N-terminal-L-methionyl-L-tyrosyl-[protein] = an N-terminal-N(alpha)-acetyl-L-methionyl-L-tyrosyl-[protein] + CoA. {ECO:0000269|PubMed:19744929, ECO:0000269|PubMed:21900231, ECO:0000269|PubMed:22311970, ECO:0000269|PubMed:27484799}.	BINDING 31 31 Substrate. {ECO:0000244|PDB:3TFY, ECO:0000244|PDB:4X5K, ECO:0000269|PubMed:21900231, ECO:0000269|PubMed:27484799}.; BINDING 75 75 Substrate. {ECO:0000244|PDB:3TFY, ECO:0000244|PDB:4X5K, ECO:0000269|PubMed:21900231, ECO:0000269|PubMed:27484799}.			BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 7.5-8.0. {ECO:0000269|PubMed:21900231};					establishment of mitotic sister chromatid cohesion [GO:0034087]; mitotic sister chromatid cohesion, centromeric [GO:0071962]; N-terminal protein amino acid acetylation [GO:0006474]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; H4 histone acetyltransferase activity [GO:0010485]; peptide alpha-N-acetyltransferase activity [GO:0004596]; peptidyl-lysine acetyltransferase activity [GO:0052858]; establishment of mitotic sister chromatid cohesion [GO:0034087]; mitotic sister chromatid cohesion, centromeric [GO:0071962]; N-terminal protein amino acid acetylation [GO:0006474]	H4 histone acetyltransferase activity [GO:0010485]; peptide alpha-N-acetyltransferase activity [GO:0004596]; peptidyl-lysine acetyltransferase activity [GO:0052858]	GO:0004596; GO:0005634; GO:0005737; GO:0005829; GO:0006474; GO:0010485; GO:0034087; GO:0052858; GO:0070062; GO:0071962	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16507339, ECO:0000269|PubMed:17502424, ECO:0000269|PubMed:25732826, ECO:0000269|PubMed:27422821}. Nucleus {ECO:0000269|PubMed:25732826}. Note=Localizes to the cytoplasm in interphase cells (PubMed:17502424). {ECO:0000269|PubMed:17502424}.		MOD_RES 12 12 Phosphothreonine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 34 34 N6-acetyllysine; by autocatalysis. {ECO:0000244|PubMed:19608861, ECO:0000269|PubMed:19744929}.; MOD_RES 37 37 N6-acetyllysine; by autocatalysis. {ECO:0000244|PubMed:19608861, ECO:0000269|PubMed:19744929}.; MOD_RES 110 110 Phosphotyrosine. {ECO:0000244|PubMed:15592455}.; MOD_RES 140 140 N6-acetyllysine; by autocatalysis. {ECO:0000269|PubMed:19744929}.	14702039; 17974005; 15489334; 15592455; 16507339; 17502424; 18669648; 19660095; 19744929; 19608861; 20068231; 21269460; 22311970; 23186163; 25732826; 27422821; 21900231; 27484799; 17353931; 19398576; 20360068; 23557624; 25416956; 25609649; 25886145; 26496610	14702039; 17974005; 15489334; 15592455; 16507339; 17502424; 18669648; 19660095; 19744929; 19608861; 20068231; 21269460; 22311970; 23186163; 25732826; 27422821; 21900231; 27484799
2755	NADSYN1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.49 mM for deamido-NAD(+) {ECO:0000269|PubMed:12547821}; KM=0.089 mM for ATP {ECO:0000269|PubMed:12547821}; KM=1.44 mM for glutamine {ECO:0000269|PubMed:12547821}; KM=13.1 mM for ammonium {ECO:0000269|PubMed:12547821}; Vmax=0.99 nmol/min/ug enzyme deamido-NAD(+) {ECO:0000269|PubMed:12547821}; Vmax=0.61 nmol/min/ug enzyme ATP {ECO:0000269|PubMed:12547821}; Vmax=0.70 nmol/min/ug enzyme glutamine {ECO:0000269|PubMed:12547821}; Vmax=1.04 nmol/min/ug enzyme ammonium {ECO:0000269|PubMed:12547821}; 	6.3.5.1	CATALYTIC ACTIVITY: ATP + deamido-NAD(+) + L-glutamine + H(2)O = AMP + diphosphate + NAD(+) + L-glutamate.					PATHWAY: Cofactor biosynthesis; NAD(+) biosynthesis; NAD(+) from deamido-NAD(+) (L-Gln route): step 1/1.				NAD biosynthetic process [GO:0009435]; NAD metabolic process [GO:0019674]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; glutaminase activity [GO:0004359]; NAD+ synthase (glutamine-hydrolyzing) activity [GO:0003952]; NAD biosynthetic process [GO:0009435]; NAD metabolic process [GO:0019674]	ATP binding [GO:0005524]; glutaminase activity [GO:0004359]; NAD+ synthase (glutamine-hydrolyzing) activity [GO:0003952]	GO:0003952; GO:0004359; GO:0005524; GO:0005737; GO:0005829; GO:0009435; GO:0019674				12547821; 14702039; 16554811; 15489334; 21269460; 15231747; 16189514; 19367725; 19724895; 19851296; 19913121; 20198315; 20418485; 20628086; 22390397; 22785457; 23636220; 24642724; 25036637; 25416956; 26149120	12547821; 14702039; 16554811; 15489334; 21269460
2757	NADK	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=3.3 mM for ATP {ECO:0000269|PubMed:11594753}; KM=0.54 mM for NAD {ECO:0000269|PubMed:11594753}; Vmax=6.7 umol/min/mg enzyme {ECO:0000269|PubMed:11594753}; 	2.7.1.23	CATALYTIC ACTIVITY: ATP + NAD(+) = ADP + NADP(+). {ECO:0000269|PubMed:11594753}.			COFACTOR: Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240; Evidence={ECO:0000269|PubMed:11594753}; 	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 7.5. {ECO:0000269|PubMed:11594753};				BIOPHYSICOCHEMICAL PROPERTIES: ;  Temperature dependence: Optimum temperature is 55 degrees Celsius. {ECO:0000269|PubMed:11594753};	ATP metabolic process [GO:0046034]; NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741]; phosphorylation [GO:0016310]	cytosol [GO:0005829]	cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; ATP metabolic process [GO:0046034]; NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741]; phosphorylation [GO:0016310]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]	GO:0003951; GO:0005524; GO:0005829; GO:0006741; GO:0016310; GO:0019674; GO:0046034; GO:0046872			MOD_RES 46 46 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163}.; MOD_RES 48 48 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163}.; MOD_RES 50 50 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 55 55 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 64 64 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.	11594753; 14702039; 16710414; 15489334; 18669648; 19690332; 21406692; 23186163; 24275569; 15161933; 15324660; 16189514; 17353931; 17855339; 17979178; 18624398; 20379614; 20711500; 21526340; 24255178; 25416956; 26577408; 26806015; 28954733	11594753; 14702039; 16710414; 15489334; 18669648; 19690332; 21406692; 23186163; 24275569; 
2763	NLRP10 NALP10 NOD8 PYNOD	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=169.3 uM for ATP {ECO:0000269|PubMed:23861819}; KM=295.6 uM for GTP {ECO:0000269|PubMed:23861819}; 											adaptive immune response [GO:0002250]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 alpha secretion [GO:0050717]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 secretion [GO:2000484]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of T-helper 1 type immune response [GO:0002827]	cytoplasm [GO:0005737]; extrinsic component of plasma membrane [GO:0019897]	cytoplasm [GO:0005737]; extrinsic component of plasma membrane [GO:0019897]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; GTPase activity [GO:0003924]; adaptive immune response [GO:0002250]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 alpha secretion [GO:0050717]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 secretion [GO:2000484]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of T-helper 17 type immune response [GO:2000318]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; GTPase activity [GO:0003924]	GO:0002250; GO:0002827; GO:0003924; GO:0005524; GO:0005737; GO:0006954; GO:0016887; GO:0019897; GO:0045087; GO:0050717; GO:0050729; GO:0050829; GO:0050832; GO:1900426; GO:2000318; GO:2000484; GO:2000778	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:22672233}. Cell membrane {ECO:0000269|PubMed:22672233}; Peripheral membrane protein {ECO:0000305}. Note=Cytoplasmic protein which is recruited to the cell membrane by NOD1 following invasive bacterial infection. {ECO:0000269|PubMed:22672233}.			12563287; 15096476; 12766759; 15489334; 20393137; 22672233; 28766990; 22618865; 23861819; 15817483; 19544093; 20403135; 22365966; 23562614	12563287; 15096476; 12766759; 15489334; 20393137; 22672233; 28766990; 22618865; 23861819
2766	NANP C20orf147 HDHD4	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.09 mM for N-acetylneuraminate 9-P {ECO:0000269|PubMed:16237198}; KM=19.2 mM for fructose 1,6-P2 {ECO:0000269|PubMed:16237198}; KM=2.7 mM for 6-P-gluconate {ECO:0000269|PubMed:16237198}; KM=5.9 mM for N-acetylglucosamine 6-P {ECO:0000269|PubMed:16237198}; Vmax=112 umol/min/mg enzyme with N-acetylneuraminate 9-P as substrate {ECO:0000269|PubMed:16237198}; Vmax=6.10 umol/min/mg enzyme with fructose 1,6-P2 as substrate {ECO:0000269|PubMed:16237198}; Vmax=2.79 umol/min/mg enzyme with 6-P-gluconate as substrate {ECO:0000269|PubMed:16237198}; Vmax=2.46 umol/min/mg enzyme with N-acetylglucosamine 6-P as substrate {ECO:0000269|PubMed:16237198}; Vmax=0.149 umol/min/mg enzyme with sorbitol 6-P as substrate {ECO:0000269|PubMed:16237198}; Vmax=0.140 umol/min/mg enzyme with 3-P glycerate as substrate {ECO:0000269|PubMed:16237198}; Vmax=0.095 umol/min/mg enzyme with P-serine as substrate {ECO:0000269|PubMed:16237198}; Vmax=0.094 umol/min/mg enzyme with glycerol 3-P as substrate {ECO:0000269|PubMed:16237198}; Vmax=0.090 umol/min/mg enzyme with ribulose 5-P as substrate {ECO:0000269|PubMed:16237198}; Vmax=0.072 umol/min/mg enzyme with N-acetylmannosamine 6-P as substrate {ECO:0000269|PubMed:16237198}; Vmax=0.063 umol/min/mg enzyme with arabinose 6-P as substrate {ECO:0000269|PubMed:16237198}; Vmax=0.042 umol/min/mg enzyme with ribose 6-P as substrate {ECO:0000269|PubMed:16237198}; Vmax=0.023 umol/min/mg enzyme with glucosamine 6-P as substrate {ECO:0000269|PubMed:16237198}; Vmax=0.019 umol/min/mg enzyme with phosphoglycolate as substrate {ECO:0000269|PubMed:16237198}; Vmax=0.019 umol/min/mg enzyme with fructose 6-P as substrate {ECO:0000269|PubMed:16237198}; Vmax=0.017 umol/min/mg enzyme with glycerol 2-P as substrate {ECO:0000269|PubMed:16237198}; Vmax=0.016 umol/min/mg enzyme with glucose 6-P as substrate {ECO:0000269|PubMed:16237198}; Vmax=0.015 umol/min/mg enzyme with mannose 6-P as substrate {ECO:0000269|PubMed:16237198}; Vmax=0.004 umol/min/mg enzyme with glucose 1-P as substrate {ECO:0000269|PubMed:16237198}; Vmax=0.002 umol/min/mg enzyme with P-enolpyruvate as substrate {ECO:0000269|PubMed:16237198}; Vmax=0.001 umol/min/mg enzyme with ATP as substrate {ECO:0000269|PubMed:16237198}; 	3.1.3.29	CATALYTIC ACTIVITY: N-acylneuraminate 9-phosphate + H(2)O = N-acylneuraminate + phosphate. {ECO:0000269|PubMed:16237198}.	BINDING 164 164 Substrate.	ACTIVITY REGULATION: Inhibited by vanadate and calcium. {ECO:0000269|PubMed:16237198}.	COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:16237198}; 		PATHWAY: Amino-sugar metabolism; N-acetylneuraminate biosynthesis.				carbohydrate metabolic process [GO:0005975]; N-acetylglucosamine biosynthetic process [GO:0006045]; N-acetylneuraminate biosynthetic process [GO:0046380]	cytosol [GO:0005829]	cytosol [GO:0005829]; N-acylneuraminate-9-phosphatase activity [GO:0050124]; carbohydrate metabolic process [GO:0005975]; N-acetylglucosamine biosynthetic process [GO:0006045]; N-acetylneuraminate biosynthetic process [GO:0046380]	N-acylneuraminate-9-phosphatase activity [GO:0050124]	GO:0005829; GO:0005975; GO:0006045; GO:0046380; GO:0050124				14702039; 11780052; 15489334; 16237198; 20711500; 23747226; 26496610	14702039; 11780052; 15489334; 16237198; 
2798	NDOR1 NR1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=21 uM for cytochrome c {ECO:0000269|PubMed:10625700}; Vmax=1.2 umol/min/ug enzyme for cytochrome c reduction {ECO:0000269|PubMed:10625700}; 	1.18.1.-		BINDING 132 132 FMN. {ECO:0000255|HAMAP-Rule:MF_03178, ECO:0000269|PubMed:23596212}.; BINDING 350 350 FAD. {ECO:0000255|HAMAP-Rule:MF_03178}.; BINDING 460 460 NADP. {ECO:0000255|HAMAP-Rule:MF_03178}.; BINDING 558 558 NADP. {ECO:0000255|HAMAP-Rule:MF_03178}.; BINDING 596 596 FAD. {ECO:0000255|HAMAP-Rule:MF_03178}.		COFACTOR: Name=FAD; Xref=ChEBI:CHEBI:57692; Evidence={ECO:0000255|HAMAP-Rule:MF_03178, ECO:0000269|PubMed:10625700}; ; COFACTOR: Name=FMN; Xref=ChEBI:CHEBI:58210; Evidence={ECO:0000255|HAMAP-Rule:MF_03178, ECO:0000269|PubMed:10625700, ECO:0000269|PubMed:23596212}; 	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is about 8.0. {ECO:0000269|PubMed:10625700};					cell death [GO:0008219]; cellular response to menadione [GO:0036245]; iron-sulfur cluster assembly [GO:0016226]; oxidation-reduction process [GO:0055114]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity [GO:0016491]; cell death [GO:0008219]; cellular response to menadione [GO:0036245]; iron-sulfur cluster assembly [GO:0016226]; oxidation-reduction process [GO:0055114]	flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity [GO:0016491]	GO:0003958; GO:0005634; GO:0005737; GO:0005829; GO:0008219; GO:0010181; GO:0016226; GO:0016491; GO:0036245; GO:0045111; GO:0048471; GO:0050660; GO:0050661; GO:0055114	SUBCELLULAR LOCATION: Cytoplasm, perinuclear region {ECO:0000255|HAMAP-Rule:MF_03178, ECO:0000269|PubMed:10625700, ECO:0000269|PubMed:12871939}. Note=Concentrated in perinuclear structure. {ECO:0000255|HAMAP-Rule:MF_03178, ECO:0000269|PubMed:12871939}.			10625700; 12871939; 14702039; 15164053; 15489334; 16140270; 20802492; 21269460; 23596212; 15900210; 11371558; 12631275; 12871938; 12970194; 15728363; 15966732; 17401378; 18573874; 18625724; 19171935; 19194512; 19385603; 21152063; 22362766; 25416956	10625700; 12871939; 14702039; 15164053; 15489334; 16140270; 20802492; 21269460; 23596212; 15900210
2821	NDST2 HSST2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=4.7 uM for K5 polysaccharide {ECO:0000269|PubMed:12634318}; KM=0.76 uM for N-acetylated HS-II {ECO:0000269|PubMed:12634318}; 	2.8.2.8; 3.-.-.-; 2.8.2.-	CATALYTIC ACTIVITY: 3'-phosphoadenylyl sulfate + [heparan sulfate]-glucosamine = adenosine 3',5'-bisphosphate + [heparan sulfate]-N-sulfoglucosamine.	BINDING 711 711 PAPS. {ECO:0000250}.				PATHWAY: Glycan metabolism; heparan sulfate biosynthesis.; PATHWAY: Glycan metabolism; heparin biosynthesis.				glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin biosynthetic process [GO:0030210]; regulation of angiotensin levels in blood [GO:0002002]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; [heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; N-acetylglucosamine deacetylase activity [GO:0050119]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin biosynthetic process [GO:0030210]; regulation of angiotensin levels in blood [GO:0002002]	[heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; N-acetylglucosamine deacetylase activity [GO:0050119]	GO:0000139; GO:0002002; GO:0006024; GO:0015012; GO:0015016; GO:0016021; GO:0030210; GO:0050119	SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000250}; Single-pass type II membrane protein {ECO:0000250}.			9601056; 15489334; 10758005; 12634318; 16343444; 22660413; 11087757; 16385451; 7601448; 9915799	9601056; 15489334; 10758005; 12634318; 16343444; 22660413
2833	NFS1 NIFS HUSSY-08	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=434.75 uM for L-cysteine {ECO:0000269|PubMed:18650437}; Note=Kinetic parameter was determined for the protein lacking the 55 N-terminal amino acids and in a complex with LYRM4.;	2.8.1.7	CATALYTIC ACTIVITY: L-cysteine + acceptor = L-alanine + S-sulfanyl-acceptor.	BINDING 207 207 Pyridoxal phosphate. {ECO:0000250|UniProtKB:O29689}.; BINDING 235 235 Pyridoxal phosphate. {ECO:0000250|UniProtKB:P0A6B9}.; BINDING 295 295 Pyridoxal phosphate. {ECO:0000250|UniProtKB:P0A6B9}.		COFACTOR: Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326; Evidence={ECO:0000250|UniProtKB:O29689}; 				HUSSY-08		[2Fe-2S] cluster assembly [GO:0044571]; iron incorporation into metallo-sulfur cluster [GO:0018283]; molybdopterin cofactor biosynthetic process [GO:0032324]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; protein-containing complex assembly [GO:0065003]; small molecule metabolic process [GO:0044281]; sulfur amino acid metabolic process [GO:0000096]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine desulfurase activity [GO:0031071]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; [2Fe-2S] cluster assembly [GO:0044571]; iron incorporation into metallo-sulfur cluster [GO:0018283]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324]; protein-containing complex assembly [GO:0065003]; small molecule metabolic process [GO:0044281]; sulfur amino acid metabolic process [GO:0000096]	cysteine desulfurase activity [GO:0031071]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]	GO:0000096; GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006777; GO:0018283; GO:0030170; GO:0031071; GO:0032324; GO:0042803; GO:0044281; GO:0044571; GO:0046872; GO:0051536; GO:0065003	SUBCELLULAR LOCATION: Isoform Mitochondrial: Mitochondrion {ECO:0000269|PubMed:19454487, ECO:0000269|PubMed:26702583, ECO:0000269|PubMed:9885568}.; SUBCELLULAR LOCATION: Isoform Cytoplasmic: Cytoplasm {ECO:0000269|PubMed:9885568}. Nucleus {ECO:0000269|PubMed:19454487, ECO:0000269|PubMed:9885568}.		MOD_RES 258 258 N6-(pyridoxal phosphate)lysine. {ECO:0000250|UniProtKB:P0A6B9}.	9885568; 14702039; 11780052; 15489334; 11124703; 11060020; 18650437; 19454487; 21269460; 25944712; 26702583; 10639125; 11823441; 12785837; 12886008; 12947415; 12970193; 15509595; 15952888; 16847322; 17331979; 17474147; 18319250; 18339629; 18425540; 20522547; 20562859; 20873749; 21298097; 21776984; 21944046; 22077971; 22101253; 22306468; 22352884; 22511353; 26016389; 26016518; 26058080; 27519411; 28634302; 29097656	9885568; 14702039; 11780052; 15489334; 11124703; 11060020; 18650437; 19454487; 21269460; 25944712; 26702583
2906	MARC2 MOSC2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=830 uM for benzamidoxime {ECO:0000269|PubMed:21029045, ECO:0000269|PubMed:24423752}; KM=400 uM for benzamidoxime (at pH 6.0 and 37 degrees Celsius) {ECO:0000269|PubMed:24423752}; KM=3 mM for NOHA {ECO:0000269|PubMed:21029045, ECO:0000269|PubMed:24423752}; KM=3.7 mM for NHAM {ECO:0000269|PubMed:21029045, ECO:0000269|PubMed:24423752}; Vmax=307 nmol/min/mg enzyme toward benzamidoxime {ECO:0000269|PubMed:21029045, ECO:0000269|PubMed:24423752}; Vmax=119 nmol/min/mg enzyme toward benzamidoxime (at pH 6.0 and 37 degrees Celsius) {ECO:0000269|PubMed:24423752}; Vmax=373 nmol/min/mg enzyme toward NOHA {ECO:0000269|PubMed:21029045, ECO:0000269|PubMed:24423752}; Vmax=36.5 nmol/min/mg enzyme toward NHAM {ECO:0000269|PubMed:21029045, ECO:0000269|PubMed:24423752}; 	1.-.-.-				COFACTOR: Name=Mo-molybdopterin; Xref=ChEBI:CHEBI:71302; Evidence={ECO:0000269|PubMed:24423752}; ;  Note=Binds 1 Mo-molybdopterin (Mo-MPT) cofactor per subunit. {ECO:0000269|PubMed:24423752};						detoxification of nitrogen compound [GO:0051410]; nitrate metabolic process [GO:0042126]; oxidation-reduction process [GO:0055114]	mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]	mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrate reductase activity [GO:0008940]; pyridoxal phosphate binding [GO:0030170]; detoxification of nitrogen compound [GO:0051410]; nitrate metabolic process [GO:0042126]; oxidation-reduction process [GO:0055114]	molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrate reductase activity [GO:0008940]; pyridoxal phosphate binding [GO:0030170]	GO:0005739; GO:0005741; GO:0005777; GO:0008940; GO:0030151; GO:0030170; GO:0042126; GO:0043546; GO:0051410; GO:0055114	SUBCELLULAR LOCATION: Mitochondrion outer membrane; Peripheral membrane protein. Peroxisome {ECO:0000250}.	PTM: Ubiquitinated by PRKN during mitophagy, leading to its degradation and enhancement of mitophagy. Deubiquitinated by USP30. {ECO:0000269|PubMed:25621951}.	MOD_RES 156 156 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q922Q1}.	11230166; 17974005; 16710414; 15489334; 14702039; 21269460; 21029045; 24275569; 25621951; 24423752; 19053771; 19875103; 20379614; 20808825; 20861021; 20877624; 21803866; 21916412; 23703616; 24500710; 25144769; 25425164; 25713076	11230166; 17974005; 16710414; 15489334; 14702039; 21269460; 21029045; 24275569; 25621951; 24423752
2916	LPCAT3 MBOAT5 OACT5	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=41.29 uM for palmitoyl-CoA {ECO:0000269|PubMed:18195019}; KM=36.65 uM for stearoyl-CoA {ECO:0000269|PubMed:18195019}; KM=72.68 uM for oleoyl-CoA {ECO:0000269|PubMed:18195019}; KM=201.4 uM for linoleoyl-CoA {ECO:0000269|PubMed:18195019}; KM=71.56 uM for arachidonoyl-CoA {ECO:0000269|PubMed:18195019}; KM=72.19 uM for 1-palmitoyl-lysophosphatidylcholine {ECO:0000269|PubMed:18195019}; Vmax=1782 nmol/min/mg enzyme with palmitoyl-CoA and 1-palmitoyl-lysophosphatidylcholine as substrates {ECO:0000269|PubMed:18195019}; Vmax=996 nmol/min/mg enzyme with stearoyl-CoA and 1-palmitoyl-lysophosphatidylcholine as substrates {ECO:0000269|PubMed:18195019}; Vmax=4698 nmol/min/mg enzyme with oleoyl-CoA and 1-palmitoyl-lysophosphatidylcholine as substrates {ECO:0000269|PubMed:18195019}; Vmax=18148 nmol/min/mg enzyme with linoleoyl-CoA and 1-palmitoyl-lysophosphatidylcholine as substrates {ECO:0000269|PubMed:18195019}; Vmax=6247 nmol/min/mg enzyme with arachidonoyl-CoA and 1-palmitoyl-lysophosphatidylcholine as substrates {ECO:0000269|PubMed:18195019}; 	2.3.1.-; 2.3.1.23; 2.3.1.n6	CATALYTIC ACTIVITY: Acyl-CoA + 1-acyl-sn-glycero-3-phosphocholine = CoA + 1,2-diacyl-sn-glycero-3-phosphocholine.; CATALYTIC ACTIVITY: Acyl-CoA + 1-acyl-sn-glycero-3-phosphatidylserine = CoA + 1,2-diacyl-sn-glycero-3-phosphatidylserine.		ACTIVITY REGULATION: Activity is inhibited by thimerosal.			PATHWAY: Lipid metabolism; phospholipid metabolism.				phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid biosynthetic process [GO:0008654]; regulation of plasma lipoprotein particle levels [GO:0097006]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid biosynthetic process [GO:0008654]; regulation of plasma lipoprotein particle levels [GO:0097006]	1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]	GO:0003841; GO:0005789; GO:0008654; GO:0016020; GO:0016021; GO:0036150; GO:0036151; GO:0036152; GO:0047144; GO:0047184; GO:0097006	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:18195019}; Multi-pass membrane protein {ECO:0000269|PubMed:18195019}.		MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:25944712}.	17974005; 14702039; 16541075; 15489334; 9074930; 18195019; 18772128; 25944712; 16243729; 16704971; 16864775; 17182612; 18287005; 18458083; 18781350; 18782225; 19351971; 20018618; 20837115; 23580142; 25994902; 26638075; 27913621; 28683445; 7318338; 9051331	17974005; 14702039; 16541075; 15489334; 9074930; 18195019; 18772128; 25944712
2921	MECR NBRF1 CGI-63	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=37 uM for trans-2-hexenoyl-CoA {ECO:0000269|PubMed:12654921, ECO:0000269|PubMed:18479707}; KM=7.1 uM for trans-2-decenoyl-CoA {ECO:0000269|PubMed:12654921, ECO:0000269|PubMed:18479707}; KM=3.6 uM for trans-dodec-2-enoyl-CoA {ECO:0000269|PubMed:12654921, ECO:0000269|PubMed:18479707}; KM=10.4 uM for trans-dec-2-enoyl-CoA {ECO:0000269|PubMed:12654921, ECO:0000269|PubMed:18479707}; KM=10.2 uM for trans-oct-2-enoyl-CoA {ECO:0000269|PubMed:12654921, ECO:0000269|PubMed:18479707}; KM=4.3 uM for trans-tetradec-2-enoyl-CoA {ECO:0000269|PubMed:12654921, ECO:0000269|PubMed:18479707}; KM=6.6 uM for trans-hexadec-2-enoyl-CoA {ECO:0000269|PubMed:12654921, ECO:0000269|PubMed:18479707}; KM=63.5 uM for trans-hex-2-enoyl-CoA {ECO:0000269|PubMed:12654921, ECO:0000269|PubMed:18479707}; 	1.3.1.104	CATALYTIC ACTIVITY: An acyl-[acyl-carrier protein] + NADP(+) = a trans-2,3-dehydroacyl-[acyl-carrier protein] + NADPH. {ECO:0000305|PubMed:12654921, ECO:0000305|PubMed:18479707}.	BINDING 167 167 NADP. {ECO:0000250|UniProtKB:Q8WZM3}.; BINDING 368 368 NADP. {ECO:0000250|UniProtKB:Q8WZM3}.						CGI-63		fatty acid beta-oxidation [GO:0006635]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; trans-2-enoyl-CoA reductase (NADPH) activity [GO:0019166]; fatty acid beta-oxidation [GO:0006635]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]	trans-2-enoyl-CoA reductase (NADPH) activity [GO:0019166]	GO:0005634; GO:0005739; GO:0005759; GO:0006631; GO:0006633; GO:0006635; GO:0019166	SUBCELLULAR LOCATION: Isoform 1: Mitochondrion {ECO:0000269|PubMed:12654921}.; SUBCELLULAR LOCATION: Isoform 2: Cytoplasm {ECO:0000269|PubMed:25031892}. Nucleus {ECO:0000269|PubMed:25031892}.		MOD_RES 61 61 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q9DCS3}.; MOD_RES 61 61 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q9DCS3}.; MOD_RES 252 252 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q9DCS3}.; MOD_RES 252 252 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q9DCS3}.; MOD_RES 267 267 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q9DCS3}.; MOD_RES 267 267 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q9DCS3}.; MOD_RES 316 316 N6-succinyllysine. {ECO:0000250|UniProtKB:Q9DCS3}.	10810093; 14702039; 16710414; 15489334; 12654921; 21269460; 25031892; 24275569; 25944712; 18479707; 27817865; 20877624; 24161390; 26496610; 27845578	10810093; 14702039; 16710414; 15489334; 12654921; 21269460; 25031892; 24275569; 25944712; 18479707; 27817865
2966	MOGAT2 DC5 DGAT2L5	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=45 uM for sn-1-monooleoylglycerol {ECO:0000269|PubMed:12621063}; 	2.3.1.22	CATALYTIC ACTIVITY: Acyl-CoA + 2-acylglycerol = CoA + diacylglycerol.		ACTIVITY REGULATION: Inhibited by oleic acid and sphingosine, while it is stimulated by phosphatidylcholine, phosphatidylserine and phosphatidic acid. {ECO:0000250}.			PATHWAY: Glycerolipid metabolism; triacylglycerol biosynthesis.				diacylglycerol biosynthetic process [GO:0006651]; glycerol metabolic process [GO:0006071]; intestinal absorption [GO:0050892]; triglyceride biosynthetic process [GO:0019432]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 2-acylglycerol O-acyltransferase activity [GO:0003846]; acetyltransferase activity [GO:0016407]; diacylglycerol biosynthetic process [GO:0006651]; glycerol metabolic process [GO:0006071]; intestinal absorption [GO:0050892]; triglyceride biosynthetic process [GO:0019432]	2-acylglycerol O-acyltransferase activity [GO:0003846]; acetyltransferase activity [GO:0016407]	GO:0003846; GO:0005783; GO:0005789; GO:0006071; GO:0006651; GO:0016021; GO:0016407; GO:0019432; GO:0050892	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:12621063}; Multi-pass membrane protein {ECO:0000269|PubMed:12621063}.			12621063; 14702039; 15489334; 12824082; 12576479; 12618427; 14970677; 23536640; 24573674; 24784138; 25598079; 25838202; 27531967; 27665677	12621063; 14702039; 15489334; 12824082
2967	MOGAT3 DC7 DGAT2L7 UNQ9383/PRO34208	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: Vmax=9.3 nmol/min/mg enzyme with diacylglycerol as substrate {ECO:0000269|PubMed:12618427}; Vmax=22.8 nmol/min/mg enzyme with 2-monoacylglycerol as substrate {ECO:0000269|PubMed:12618427}; 	2.3.1.20; 2.3.1.22	CATALYTIC ACTIVITY: Acyl-CoA + 2-acylglycerol = CoA + diacylglycerol. {ECO:0000269|PubMed:12618427}.; CATALYTIC ACTIVITY: Acyl-CoA + 1,2-diacylglycerol = CoA + triacylglycerol. {ECO:0000269|PubMed:12618427}.					PATHWAY: Glycerolipid metabolism; triacylglycerol biosynthesis.		UNQ9383/PRO34208		glycerol metabolic process [GO:0006071]; triglyceride biosynthetic process [GO:0019432]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 2-acylglycerol O-acyltransferase activity [GO:0003846]; diacylglycerol O-acyltransferase activity [GO:0004144]; glycerol metabolic process [GO:0006071]; triglyceride biosynthetic process [GO:0019432]	2-acylglycerol O-acyltransferase activity [GO:0003846]; diacylglycerol O-acyltransferase activity [GO:0004144]	GO:0003846; GO:0004144; GO:0005789; GO:0006071; GO:0016021; GO:0019432	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}.			12618427; 12975309; 12853948; 15489334; 12824082; 14970677; 25838202	12618427; 12975309; 12853948; 15489334
3006	MGAT4A	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.118 mM for UDP-GlcNAc {ECO:0000269|PubMed:17006639}; 	2.4.1.145	CATALYTIC ACTIVITY: UDP-N-acetyl-alpha-D-glucosamine + beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-(beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6))-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc-N-Asn-[protein] = UDP + beta-D-GlcNAc-(1->2)-(beta-D-GlcNAc-(1->4))-alpha-D-Man-(1->3)-(beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6))-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc-N-Asn-[protein].			COFACTOR: Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240; Evidence={ECO:0000250}; 		PATHWAY: Protein modification; protein glycosylation.				cellular protein metabolic process [GO:0044267]; N-glycan processing [GO:0006491]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation [GO:0006487]	endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0008454]; metal ion binding [GO:0046872]; cellular protein metabolic process [GO:0044267]; N-glycan processing [GO:0006491]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation [GO:0006487]	alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0008454]; metal ion binding [GO:0046872]	GO:0000139; GO:0005788; GO:0006487; GO:0006491; GO:0008454; GO:0016021; GO:0043687; GO:0044267; GO:0046872; GO:0070062	SUBCELLULAR LOCATION: Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A: Golgi apparatus membrane {ECO:0000250}; Single-pass type II membrane protein {ECO:0000250}.; SUBCELLULAR LOCATION: Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A soluble form: Secreted {ECO:0000250}.		MOD_RES 474 474 Phosphoserine; by FAM20C. {ECO:0000269|PubMed:26091039}.	10024668; 14702039; 15815621; 15489334; 10463590; 16434023; 17006639; 26091039; 10570912; 15688387; 17488527; 17953760; 19751437; 23169300; 26589799; 28534963	10024668; 14702039; 15815621; 15489334; 10463590; 16434023; 17006639; 26091039
3039	MICAL1 MICAL NICAL	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=4.7 uM for F-actin (at saturing NADPH concentration) {ECO:0000269|PubMed:21864500}; KM=375 uM for NADPH (for the NADPH oxidase reaction) {ECO:0000269|PubMed:26845023}; Note=kcat is 0.28 sec(-1) for NADPH for the NADPH oxidase reaction. {ECO:0000269|PubMed:26845023};	1.14.13.225	CATALYTIC ACTIVITY: [F-actin]-L-methionine + NADPH + O(2) + H(+) = [F-actin]-L-methionine-(R)-S-oxide + NADP(+) + H(2)O. {ECO:0000250|UniProtKB:Q8VDP3}.	BINDING 95 95 FAD. {ECO:0000250|UniProtKB:Q8VDP3}.; BINDING 181 181 FAD; via amide nitrogen and carbonyl oxygen. {ECO:0000250|UniProtKB:Q8VDP3}.; BINDING 293 293 FAD. {ECO:0000250|UniProtKB:Q8VDP3}.; BINDING 393 393 FAD. {ECO:0000250|UniProtKB:Q8VDP3}.		COFACTOR: Name=FAD; Xref=ChEBI:CHEBI:57692; Evidence={ECO:0000269|PubMed:21864500}; 						actin filament depolymerization [GO:0030042]; blood coagulation [GO:0007596]; cytoskeleton organization [GO:0007010]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of protein phosphorylation [GO:0001933]; oxidation-reduction process [GO:0055114]; regulation of regulated secretory pathway [GO:1903305]; signal transduction [GO:0007165]; sulfur oxidation [GO:0019417]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; hippocampal mossy fiber expansion [GO:1990026]; intermediate filament [GO:0005882]; midbody [GO:0030496]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; hippocampal mossy fiber expansion [GO:1990026]; intermediate filament [GO:0005882]; midbody [GO:0030496]; actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; protein kinase binding [GO:0019901]; Rab GTPase binding [GO:0017137]; SH3 domain binding [GO:0017124]; actin filament depolymerization [GO:0030042]; blood coagulation [GO:0007596]; cytoskeleton organization [GO:0007010]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of protein phosphorylation [GO:0001933]; oxidation-reduction process [GO:0055114]; regulation of regulated secretory pathway [GO:1903305]; signal transduction [GO:0007165]; sulfur oxidation [GO:0019417]	actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; protein kinase binding [GO:0019901]; Rab GTPase binding [GO:0017137]; SH3 domain binding [GO:0017124]	GO:0001933; GO:0003779; GO:0004497; GO:0005737; GO:0005829; GO:0005882; GO:0007010; GO:0007165; GO:0007596; GO:0016709; GO:0017124; GO:0017137; GO:0019417; GO:0019901; GO:0030042; GO:0030496; GO:0043154; GO:0046872; GO:0055114; GO:0071949; GO:1903305; GO:1990026	SUBCELLULAR LOCATION: Cytoplasm. Cytoplasm, cytoskeleton. Midbody {ECO:0000269|PubMed:28230050}. Note=Accumulates transiently at the abscission site before abscission occurs. {ECO:0000269|PubMed:28230050}.		MOD_RES 475 475 Phosphothreonine. {ECO:0000250|UniProtKB:D3ZBP4}.; MOD_RES 617 617 Phosphoserine. {ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163}.; MOD_RES 872 872 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:21406692}.; MOD_RES 875 875 Phosphoserine. {ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:21406692}.; MOD_RES 876 876 Phosphoserine. {ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:21406692}.; MOD_RES 1057 1057 Phosphoserine. {ECO:0000244|PubMed:23186163}.	11827972; 11214971; 14702039; 14574404; 15489334; 17974005; 12110185; 12788069; 15694364; 17081983; 18305261; 19690332; 21864500; 21269460; 21406692; 23186163; 24440334; 26845023; 17043746; 17662518; 27552051; 28230050; 16959974; 15796781; 19913121; 20628086; 21638339; 21730291; 21900206; 22331357; 23834433; 25576923; 27430308; 27787846; 28229915	11827972; 11214971; 14702039; 14574404; 15489334; 17974005; 12110185; 12788069; 15694364; 17081983; 18305261; 19690332; 21864500; 21269460; 21406692; 23186163; 24440334; 26845023; 17043746; 17662518; 27552051; 28230050; 16959974
3049	MAPK12 ERK6 SAPK3	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=37 uM for ATP {ECO:0000269|PubMed:10212242}; KM=313 uM for EGFR substrate peptide {ECO:0000269|PubMed:10212242}; KM=254 uM for GST-ATF2 {ECO:0000269|PubMed:10212242}; 	2.7.11.24	CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein. {ECO:0000269|PubMed:10212242}.	BINDING 56 56 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.	ACTIVITY REGULATION: Activated by phosphorylation on threonine and tyrosine. MAP2K3/MKK3 and MAP2K6/MKK6 are both essential for the activation of MAPK12 induced by environmental stress, whereas MAP2K6/MKK6 is the major MAPK12 activator in response to TNF-alpha. {ECO:0000269|PubMed:10212242, ECO:0000269|PubMed:9430721}.	COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:10508788}; ;  Note=Binds 2 magnesium ions. {ECO:0000269|PubMed:10508788};						cell cycle arrest [GO:0007050]; DNA damage induced protein phosphorylation [GO:0006975]; muscle organ development [GO:0007517]; myoblast differentiation [GO:0045445]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of peptidase activity [GO:0010952]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; transcription, DNA-templated [GO:0006351]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; protein serine/threonine kinase activity [GO:0004674]; cell cycle arrest [GO:0007050]; DNA damage induced protein phosphorylation [GO:0006975]; muscle organ development [GO:0007517]; myoblast differentiation [GO:0045445]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of peptidase activity [GO:0010952]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; transcription, DNA-templated [GO:0006351]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006351; GO:0006355; GO:0006975; GO:0007050; GO:0007165; GO:0007517; GO:0010468; GO:0010952; GO:0018105; GO:0045445; GO:0051149	SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Mitochondrion. Note=Mitochondrial when associated with SH3BP5. In skeletal muscle colocalizes with SNTA1 at the neuromuscular junction and throughout the sarcolemma (By similarity). {ECO:0000250}.	PTM: Dually phosphorylated on Thr-183 and Tyr-185 by MAP2K3/MKK3 and MAP2K6/MKK6, which activates the enzyme. {ECO:0000269|PubMed:11010976, ECO:0000269|PubMed:17724032}.; PTM: Ubiquitinated. Ubiquitination leads to degradation by the proteasome pathway. {ECO:0000269|PubMed:17724032}.	MOD_RES 183 183 Phosphothreonine; by MAP2K3 and MAP2K6. {ECO:0000250|UniProtKB:Q63538}.; MOD_RES 185 185 Phosphotyrosine. {ECO:0000244|PubMed:23186163}.	8633070; 9169156; 8920915; 15461802; 10591208; 15489334; 9430721; 10212242; 11010976; 10848581; 11991731; 12167088; 14592936; 15284239; 17724032; 20605917; 21269460; 21172807; 21532888; 20626350; 23186163; 10508788; 17344846; 10330143; 10567720; 10585422; 10601328; 10744763; 10805738; 11481440; 11741533; 11741894; 12536241; 12761180; 12915405; 15158451; 15169762; 15342622; 15572127; 15719023; 17074887; 17088247; 17099248; 18559936; 19112161; 19251701; 19564926; 19913121; 20332238; 20628086; 20804750; 21044950; 21451146; 21862636; 21878638; 21988832; 22399296; 22522454; 22730326; 22730327; 23602568; 24412244; 24606918; 25158884; 25241761; 25314968; 25416956; 26588708; 26666822; 26708186; 26843485; 27246854; 27307780; 27353957; 28079973; 9069290; 9374491; 9393975; 9858528; 9988769	8633070; 9169156; 8920915; 15461802; 10591208; 15489334; 9430721; 10212242; 11010976; 10848581; 11991731; 12167088; 14592936; 15284239; 17724032; 20605917; 21269460; 21172807; 21532888; 20626350; 23186163; 10508788; 17344846
3086	MEP1A	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=110 uM for GRP {ECO:0000269|PubMed:17976009}; KM=18.0 uM for PTH 12-34 {ECO:0000269|PubMed:17976009}; KM=33.9 uM for secretin {ECO:0000269|PubMed:17976009}; KM=41.3 uM for substance P {ECO:0000269|PubMed:17976009}; KM=56.5 uM for LHRH {ECO:0000269|PubMed:17976009}; KM=73.2 uM for orcokinin {ECO:0000269|PubMed:17976009}; KM=292 uM for alpha-MSH {ECO:0000269|PubMed:17976009}; KM=125 uM for bradykinin {ECO:0000269|PubMed:17976009}; KM=200 uM for gastrin {ECO:0000269|PubMed:17976009}; 	3.4.24.18	CATALYTIC ACTIVITY: Hydrolysis of protein and peptide substrates preferentially on carboxyl side of hydrophobic residues.		ACTIVITY REGULATION: Inhibited by several hydroxamate compounds, the most potent inhibitor is actinonin. {ECO:0000269|PubMed:17976009}.	COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000255|PROSITE-ProRule:PRU01211}; ;  Note=Binds 1 zinc ion per subunit. {ECO:0000255|PROSITE-ProRule:PRU01211};							extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; meprin A complex [GO:0017090]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; meprin A complex [GO:0017090]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	GO:0004222; GO:0005615; GO:0005887; GO:0008270; GO:0017090; GO:0070062	SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.	PTM: N-glycosylated; contains GlcNAc, galactose, mannose and a small amount of fucose. {ECO:0000250}.		14702039; 14574404; 15489334; 8262185; 17976009; 12189145; 16378686; 17195012; 19262505; 20631730; 20806899; 22096485; 22326557; 22923609; 23123160; 24388959; 24474695; 27378469; 27999200; 28502593	14702039; 14574404; 15489334; 8262185; 17976009
3127	MINPP1 MIPP UNQ900/PRO1917	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.61 mM for 2,3-bisphosphoglycerate {ECO:0000269|PubMed:18413611}; KM=90 uM for inositol hexakisphosphate {ECO:0000269|PubMed:16759730}; Vmax=15.8 nmol/min/mg enzyme with 2,3-bisphospho-D-glycerate as substrate {ECO:0000269|PubMed:18413611}; Vmax=6.2 nmol/min/mg enzyme with inositol hexakisphosphate as substrate {ECO:0000269|PubMed:16759730}; 	3.1.3.62; 3.1.3.80	CATALYTIC ACTIVITY: Myo-inositol hexakisphosphate + H(2)O = myo-inositol pentakisphosphate (mixed isomers) + phosphate. {ECO:0000269|PubMed:18413611}.; CATALYTIC ACTIVITY: 2,3-bisphospho-D-glycerate + H(2)O = 2-phospho-D-glycerate + phosphate. {ECO:0000269|PubMed:18413611}.							UNQ900/PRO1917		bone mineralization [GO:0030282]; inositol phosphate metabolic process [GO:0043647]; ossification [GO:0001503]; polyphosphate metabolic process [GO:0006797]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; acid phosphatase activity [GO:0003993]; bisphosphoglycerate 3-phosphatase activity [GO:0034417]; inositol hexakisphosphate 2-phosphatase activity [GO:0052826]; inositol phosphate phosphatase activity [GO:0052745]; inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity [GO:0030351]; inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity [GO:0051717]; protein histidine phosphatase activity [GO:0101006]; bone mineralization [GO:0030282]; inositol phosphate metabolic process [GO:0043647]; ossification [GO:0001503]; polyphosphate metabolic process [GO:0006797]	acid phosphatase activity [GO:0003993]; bisphosphoglycerate 3-phosphatase activity [GO:0034417]; inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity [GO:0030351]; inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity [GO:0051717]; inositol hexakisphosphate 2-phosphatase activity [GO:0052826]; inositol phosphate phosphatase activity [GO:0052745]; protein histidine phosphatase activity [GO:0101006]	GO:0001503; GO:0003993; GO:0005783; GO:0005788; GO:0006797; GO:0030282; GO:0030351; GO:0034417; GO:0043647; GO:0051717; GO:0052745; GO:0052826; GO:0070062; GO:0101006	SUBCELLULAR LOCATION: Endoplasmic reticulum lumen {ECO:0000250|UniProtKB:O35217}.			9923613; 10087200; 11230166; 12975309; 14702039; 15164054; 15489334; 11297621; 16335952; 16759730; 18413611; 21269460; 25944712; 15979280; 16385451; 1653239; 19367725; 20304771; 21071540; 23186306; 26638075; 27038811	9923613; 10087200; 11230166; 12975309; 14702039; 15164054; 15489334; 11297621; 16335952; 16759730; 18413611; 21269460; 25944712
3184	NQO2 NMOR2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=28 uM for NRH {ECO:0000269|PubMed:15078100, ECO:0000269|PubMed:9367528}; KM=11.6 uM for menadione {ECO:0000269|PubMed:15078100, ECO:0000269|PubMed:9367528}; KM=252 uM for NADH {ECO:0000269|PubMed:15078100, ECO:0000269|PubMed:9367528}; 	1.10.5.1	CATALYTIC ACTIVITY: 1-(beta-D-ribofuranosyl)-1,4-dihydronicotinamide + a quinone = 1-(beta-D-ribofuranosyl)nicotinamide + a quinol. {ECO:0000269|PubMed:18579530}.	BINDING 12 12 FAD. {ECO:0000269|PubMed:18254726, ECO:0000269|PubMed:19236722}.; BINDING 156 156 FAD. {ECO:0000269|PubMed:18254726, ECO:0000269|PubMed:19236722}.; BINDING 194 194 FAD. {ECO:0000269|PubMed:18254726, ECO:0000269|PubMed:19236722}.; BINDING 201 201 FAD. {ECO:0000269|PubMed:18254726, ECO:0000269|PubMed:19236722}.	ACTIVITY REGULATION: Inhibited by melatonin, resveratrol and 5-hydroxytryptamine. {ECO:0000269|PubMed:18254726}.	COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; ;  Note=Binds 1 zinc ion per subunit.;; COFACTOR: Name=FAD; Xref=ChEBI:CHEBI:57692; 						oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; chloride ion binding [GO:0031404]; dihydronicotinamide riboside quinone reductase activity [GO:0001512]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; melatonin binding [GO:1904408]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on other nitrogenous compounds as donors [GO:0016661]; protein homodimerization activity [GO:0042803]; resveratrol binding [GO:1905594]; zinc ion binding [GO:0008270]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]	chloride ion binding [GO:0031404]; dihydronicotinamide riboside quinone reductase activity [GO:0001512]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; melatonin binding [GO:1904408]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on other nitrogenous compounds as donors [GO:0016661]; protein homodimerization activity [GO:0042803]; resveratrol binding [GO:1905594]; zinc ion binding [GO:0008270]	GO:0001512; GO:0005654; GO:0005829; GO:0006805; GO:0008270; GO:0009055; GO:0016491; GO:0016661; GO:0031404; GO:0042803; GO:0055114; GO:0070062; GO:0071949; GO:1904408; GO:1905594	SUBCELLULAR LOCATION: Cytoplasm.		MOD_RES 80 80 Phosphoserine. {ECO:0000244|PubMed:19369195}.; MOD_RES 197 197 Phosphoserine. {ECO:0000244|PubMed:19369195}.	1691923; 8182056; 14702039; 14574404; 15489334; 9367528; 9050836; 15078100; 19369195; 21269460; 24275569; 10433694; 15350128; 16129418; 18254726; 18579530; 19236722; 10945627; 11051261; 11688992; 12960511; 1351198; 14617031; 14639047; 14743216; 15451063; 15492766; 15694256; 15993843; 16025450; 16189514; 16191666; 16302811; 16545679; 16765324; 17332305; 17721511; 18314446; 18336668; 18502195; 18538895; 18826489; 19265439; 19343046; 19351655; 19495956; 19637314; 19671875; 20050988; 20379614; 20711500; 20966810; 21294640; 21351093; 21506232; 21538647; 21555518; 21718050; 21803122; 21859103; 21946896; 21994455; 22090421; 22206487; 22266466; 22770696; 23054000; 23131339; 23455153; 23471972; 23953689; 24189400; 24631540; 24695225; 25379648; 25416956; 26609153; 26636353; 28146103; 28346733; 29191878; 8985016	1691923; 8182056; 14702039; 14574404; 15489334; 9367528; 9050836; 15078100; 19369195; 21269460; 24275569; 10433694; 15350128; 16129418; 18254726; 18579530; 19236722
3191	MTHFD2 NMDMC	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=202 uM for NAD {ECO:0000269|PubMed:16100107}; KM=352 uM for NADP {ECO:0000269|PubMed:16100107}; 	1.5.1.15; 3.5.4.9	CATALYTIC ACTIVITY: 5,10-methylenetetrahydrofolate + NAD(+) = 5,10-methenyltetrahydrofolate + NADH. {ECO:0000269|PubMed:16100107}.; CATALYTIC ACTIVITY: 5,10-methenyltetrahydrofolate + H(2)O = 10-formyltetrahydrofolate.	BINDING 233 233 NAD. {ECO:0000269|PubMed:16100107, ECO:0000269|PubMed:27899380}.		COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; 						folic acid metabolic process [GO:0046655]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate metabolic process [GO:0046653]	extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; magnesium ion binding [GO:0000287]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; phosphate ion binding [GO:0042301]; folic acid metabolic process [GO:0046655]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate metabolic process [GO:0046653]	magnesium ion binding [GO:0000287]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; phosphate ion binding [GO:0042301]	GO:0000287; GO:0004477; GO:0004487; GO:0004488; GO:0005615; GO:0005739; GO:0005759; GO:0006730; GO:0042301; GO:0046653; GO:0046655	SUBCELLULAR LOCATION: Mitochondrion.		MOD_RES 50 50 N6-acetyllysine; alternate. {ECO:0000244|PubMed:19608861}.	2587219; 14702039; 15815621; 15489334; 19608861; 21269460; 22814378; 25944712; 28112733; 16100107; 27899380; 17353931; 21163947; 21516116; 21911578; 22190034; 24725412; 24733394; 26496610; 8218174	2587219; 14702039; 15815621; 15489334; 19608861; 21269460; 22814378; 25944712; 28112733; 16100107; 27899380
3206	NUS1 C6orf68 NGBR	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=11.1 uM for isopentenyl diphosphate {ECO:0000269|PubMed:28842490}; KM=0.68 uM for (2E,6E)-farnesyl diphosphate {ECO:0000269|PubMed:28842490}; Note=Values were measured with the heterodimer. kcat is 0.58 sec(-1) with (2E,6E)-farnesyl diphosphate and isopentenyl diphosphate as substrates. {ECO:0000269|PubMed:28842490};	2.5.1.87	CATALYTIC ACTIVITY: (2E,6E)-farnesyl diphosphate + n isopentenyl diphosphate = n diphosphate + ditrans,polycis-polyprenyl diphosphate (n = 10-55). {ECO:0000269|PubMed:25066056, ECO:0000269|PubMed:28842490}.		ACTIVITY REGULATION: Activated by phospholipids including cardiolipin, phosphatidylcholine, phosphatidylethanolamine, phosphatidylinositol and phosphatidylserine. {ECO:0000269|PubMed:28842490}.	COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:28842490}; 	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 8-9. Active from pH 5.5 to 9.3. {ECO:0000269|PubMed:28842490};	PATHWAY: Protein modification; protein glycosylation. {ECO:0000269|PubMed:25066056}.; PATHWAY: Lipid metabolism. {ECO:0000269|PubMed:25066056, ECO:0000269|PubMed:28842490}.				angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; dolichol biosynthetic process [GO:0019408]; dolichyl diphosphate biosynthetic process [GO:0006489]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of nitric-oxide synthase activity [GO:0051000]; protein mannosylation [GO:0035268]; regulation of intracellular cholesterol transport [GO:0032383]; vascular endothelial growth factor signaling pathway [GO:0038084]	dehydrodolichyl diphosphate synthase complex [GO:1904423]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	dehydrodolichyl diphosphate synthase complex [GO:1904423]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dehydrodolichyl diphosphate synthase activity [GO:0045547]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; dolichol biosynthetic process [GO:0019408]; dolichyl diphosphate biosynthetic process [GO:0006489]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of nitric-oxide synthase activity [GO:0051000]; protein mannosylation [GO:0035268]; regulation of intracellular cholesterol transport [GO:0032383]; vascular endothelial growth factor signaling pathway [GO:0038084]	dehydrodolichyl diphosphate synthase activity [GO:0045547]	GO:0001525; GO:0005789; GO:0006489; GO:0016021; GO:0019408; GO:0030154; GO:0032383; GO:0035268; GO:0038084; GO:0042632; GO:0043536; GO:0045547; GO:0051000; GO:1904423	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:19723497, ECO:0000269|PubMed:21572394}; Multi-pass membrane protein {ECO:0000303|PubMed:21572394}. Note=Colocalizes with Nogo-B during VEGF and wound healing angiogenesis. {ECO:0000269|PubMed:19723497}.			14574404; 15489334; 9294218; 16835300; 19723497; 21572394; 25066056; 28842490; 29100083; 14652022; 17764014; 21295283; 24223763; 24568601; 25075030; 25173099; 25202063; 26638075; 26840457; 28602162; 29346419; 7374371	14574404; 15489334; 9294218; 16835300; 19723497; 21572394; 25066056; 28842490; 29100083
3241	QPRT	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=21 uM for QA (at 0.1 mM PRPP) {ECO:0000269|PubMed:17868694}; KM=23 uM for QA (at 0.3 mM PRPP) {ECO:0000269|PubMed:17868694}; Vmax=1.2 uM/min/mg enzyme (at 0.3 mM QA and 0.1 mM PRPP) {ECO:0000269|PubMed:17868694}; Vmax=0.93 uM/min/mg enzyme (at 0.3 mM QA and 0.3 mM PRPP) {ECO:0000269|PubMed:17868694}; 	2.4.2.19	CATALYTIC ACTIVITY: Beta-nicotinate D-ribonucleotide + diphosphate + CO(2) = pyridine-2,3-dicarboxylate + 5-phospho-alpha-D-ribose 1-diphosphate.	BINDING 102 102 Substrate.; BINDING 161 161 Substrate.; BINDING 171 171 Substrate.; BINDING 201 201 Substrate. {ECO:0000250}.; BINDING 222 222 Substrate. {ECO:0000250}.	ACTIVITY REGULATION: Activity toward QA is slightly repressed by phosphoribosylpyrophosphate (PRPP) in both a competitive and a non-competitive manner. {ECO:0000269|PubMed:17868694}.			PATHWAY: Cofactor biosynthesis; NAD(+) biosynthesis; nicotinate D-ribonucleotide from quinolinate: step 1/1.				NAD biosynthetic process [GO:0009435]; NAD metabolic process [GO:0019674]; protein complex oligomerization [GO:0051259]; quinolinate catabolic process [GO:0034213]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; protein homodimerization activity [GO:0042803]; NAD biosynthetic process [GO:0009435]; NAD metabolic process [GO:0019674]; protein complex oligomerization [GO:0051259]; quinolinate catabolic process [GO:0034213]	nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; protein homodimerization activity [GO:0042803]	GO:0004514; GO:0005737; GO:0005829; GO:0009435; GO:0019674; GO:0034213; GO:0042803; GO:0051259; GO:0070062				9473669; 15489334; 24275569; 17868694; 21269460; 16189514; 19321014; 21988832; 24038671; 26805589; 27889611	9473669; 15489334; 24275569; 17868694; 21269460
3268	MTM1 CG2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=39 uM for PI3P {ECO:0000269|PubMed:14722070}; KM=17 uM for PI(3,5)P2 {ECO:0000269|PubMed:14722070}; 	3.1.3.95; 3.1.3.64	CATALYTIC ACTIVITY: 1-phosphatidyl-1D-myo-inositol 3-phosphate + H(2)O = 1-phosphatidyl-1D-myo-inositol + phosphate. {ECO:0000269|PubMed:10900271, ECO:0000269|PubMed:11001925, ECO:0000269|PubMed:12646134, ECO:0000269|PubMed:12847286}.; CATALYTIC ACTIVITY: 1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate + H(2)O = 1-phosphatidyl-1D-myo-inositol 5-phosphate + phosphate. {ECO:0000269|PubMed:12646134}.		ACTIVITY REGULATION: Allosterically activated by phosphatidylinositol 5-phosphate (PI5P). {ECO:0000269|PubMed:12646134}.							endosome to lysosome transport [GO:0008333]; intermediate filament organization [GO:0045109]; mitochondrion distribution [GO:0048311]; mitochondrion morphogenesis [GO:0070584]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of skeletal muscle tissue growth [GO:0048633]; protein dephosphorylation [GO:0006470]; protein transport [GO:0015031]; regulation of vacuole organization [GO:0044088]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; I band [GO:0031674]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; ruffle [GO:0001726]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; I band [GO:0031674]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; intermediate filament binding [GO:0019215]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; endosome to lysosome transport [GO:0008333]; intermediate filament organization [GO:0045109]; mitochondrion distribution [GO:0048311]; mitochondrion morphogenesis [GO:0070584]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of skeletal muscle tissue growth [GO:0048633]; protein dephosphorylation [GO:0006470]; protein transport [GO:0015031]; regulation of vacuole organization [GO:0044088]	intermediate filament binding [GO:0019215]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol binding [GO:0035091]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]	GO:0001726; GO:0004438; GO:0004721; GO:0004725; GO:0005737; GO:0005770; GO:0005829; GO:0005886; GO:0006470; GO:0006661; GO:0008333; GO:0015031; GO:0019215; GO:0030175; GO:0031674; GO:0032007; GO:0032435; GO:0035091; GO:0044088; GO:0045109; GO:0046716; GO:0046856; GO:0048311; GO:0048633; GO:0051898; GO:0052629; GO:0070584; GO:1902902	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10900271, ECO:0000269|PubMed:11001925}. Cell membrane; Peripheral membrane protein {ECO:0000269|PubMed:11001925}. Cell projection, filopodium {ECO:0000269|PubMed:12118066}. Cell projection, ruffle {ECO:0000269|PubMed:12118066}. Late endosome {ECO:0000269|PubMed:14722070}. Note=Localizes as a dense cytoplasmic network. Also localizes to the plasma membrane, including plasma membrane extensions such as filopodia and ruffles. Predominantly located in the cytoplasm following interaction with MTMR12. Recruited to the late endosome following EGF stimulation. {ECO:0000269|PubMed:11001925, ECO:0000269|PubMed:12118066}.		MOD_RES 13 13 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 18 18 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 495 495 Phosphothreonine. {ECO:0000244|PubMed:16964243}.; MOD_RES 588 588 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231}.	8640223; 9781038; 14702039; 15772651; 15489334; 9537414; 10790201; 11001925; 10900271; 12118066; 12646134; 12847286; 14722070; 16964243; 18669648; 20068231; 21269460; 21135508; 23186163; 25087613; 9285787; 9305655; 9829274; 10466421; 10502779; 10063835; 11793470; 12031625; 12859411; 12522554; 17005396; 19129059; 10215413; 10224048; 11302699; 11456308; 11552027; 11676921; 11733541; 11846405; 12391329; 12495846; 12890864; 12925573; 14500759; 14660569; 15725586; 15840652; 15883335; 1655747; 16787938; 16914545; 17008356; 17537630; 17621527; 17651088; 18429927; 18524850; 18774718; 19084976; 19846786; 20140253; 20358311; 20434914; 20477815; 20500434; 20562859; 20711500; 21478156; 21488203; 22068590; 22101172; 22403079; 22968136; 23818870; 23917616; 25957634; 27017278; 27155155; 28007904	8640223; 9781038; 14702039; 15772651; 15489334; 9537414; 10790201; 11001925; 10900271; 12118066; 12646134; 12847286; 14722070; 16964243; 18669648; 20068231; 21269460; 21135508; 23186163; 25087613; 9285787; 9305655; 9829274; 10466421; 10502779; 10063835; 11793470; 12031625; 12859411; 12522554; 17005396; 19129059
3303	NAAA ASAHL PLT	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=97 uM for N-palmitoylethanolamine {ECO:0000269|PubMed:15655246}; 	3.5.1.-			ACTIVITY REGULATION: Stimulated by DTT and Nonidet P-40. {ECO:0000269|PubMed:15655246}.		BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 4.5 with N-palmitoylethanolamine as substrate. {ECO:0000269|PubMed:15655246};					lipid metabolic process [GO:0006629]; neurotransmitter secretion [GO:0007269]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; presynapse [GO:0098793]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; presynapse [GO:0098793]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; transcription factor binding [GO:0008134]; lipid metabolic process [GO:0006629]; neurotransmitter secretion [GO:0007269]	hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; transcription factor binding [GO:0008134]	GO:0005737; GO:0006629; GO:0007269; GO:0008134; GO:0016810; GO:0043202; GO:0070062; GO:0098793	SUBCELLULAR LOCATION: Lysosome {ECO:0000305|PubMed:10610717, ECO:0000305|PubMed:15655246}.	PTM: N-glycosylated. Tunicamycin treatment causes a reduction in specific activity against N-palmitoylethanolamine. {ECO:0000269|PubMed:15655246, ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:22040171}.; PTM: Autoproteolytic cleavage in the acidic lumen of the lysosome activates the enzyme. {ECO:0000269|PubMed:22040171}.		10610717; 15655246; 15489334; 1446826; 22040171; 19159218; 15610181; 17980170; 18020949; 18806270; 19014633; 24741114; 27693242	10610717; 15655246; 15489334; 1446826; 22040171; 19159218
3313	NADK2 C5orf33 MNADK NADKD1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.022 mM for NAD(+) {ECO:0000269|PubMed:23212377}; KM=1.7 mM for ATP {ECO:0000269|PubMed:23212377}; KM=1.2 mM for tetrapolyphosphate {ECO:0000269|PubMed:23212377}; Vmax=0.091 umol/min/mg enzyme {ECO:0000269|PubMed:23212377}; 	2.7.1.23	CATALYTIC ACTIVITY: ATP + NAD(+) = ADP + NADP(+). {ECO:0000269|PubMed:23212377}.		ACTIVITY REGULATION: Inhibited by NADH, NADPH and NADP(+). {ECO:0000269|PubMed:23212377}.							NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; NAD+ kinase activity [GO:0003951]; protein homodimerization activity [GO:0042803]; NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741]	ATP binding [GO:0005524]; NAD+ kinase activity [GO:0003951]; protein homodimerization activity [GO:0042803]	GO:0003951; GO:0005524; GO:0005739; GO:0005759; GO:0006741; GO:0019674; GO:0042803	SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:23212377}.		MOD_RES 76 76 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C5H8}.; MOD_RES 76 76 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8C5H8}.; MOD_RES 188 188 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 302 302 N6-succinyllysine. {ECO:0000250|UniProtKB:Q8C5H8}.; MOD_RES 317 317 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C5H8}.; MOD_RES 317 317 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8C5H8}.; MOD_RES 367 367 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 397 397 N6-acetyllysine. {ECO:0000250|UniProtKB:Q8C5H8}.	14702039; 15372022; 15489334; 21269460; 23212377; 24847004; 24275569; 25944712; 23616928; 25525879; 27940755	14702039; 15372022; 15489334; 21269460; 23212377; 24847004; 24275569; 25944712
3359	MVD MPD	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=7.4 uM for (R)-5-diphosphomevalonate {ECO:0000269|PubMed:9392419}; KM=0.32 mM for ATP {ECO:0000269|PubMed:9392419}; 	4.1.1.33	CATALYTIC ACTIVITY: ATP + (R)-5-diphosphomevalonate = ADP + phosphate + isopentenyl diphosphate + CO(2). {ECO:0000269|PubMed:8626466}.					PATHWAY: Steroid biosynthesis; cholesterol biosynthesis.				cholesterol biosynthetic process [GO:0006695]; dolichyl diphosphate biosynthetic process [GO:0006489]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; isoprenoid biosynthetic process [GO:0008299]; positive regulation of cell proliferation [GO:0008284]; regulation of cholesterol biosynthetic process [GO:0045540]	cytosol [GO:0005829]	cytosol [GO:0005829]; ATP binding [GO:0005524]; diphosphomevalonate decarboxylase activity [GO:0004163]; Hsp70 protein binding [GO:0030544]; protein homodimerization activity [GO:0042803]; cholesterol biosynthetic process [GO:0006695]; dolichyl diphosphate biosynthetic process [GO:0006489]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; isoprenoid biosynthetic process [GO:0008299]; positive regulation of cell proliferation [GO:0008284]; regulation of cholesterol biosynthetic process [GO:0045540]	ATP binding [GO:0005524]; diphosphomevalonate decarboxylase activity [GO:0004163]; Hsp70 protein binding [GO:0030544]; protein homodimerization activity [GO:0042803]	GO:0004163; GO:0005524; GO:0005829; GO:0006489; GO:0006695; GO:0008284; GO:0008299; GO:0019287; GO:0030544; GO:0042803; GO:0045540			MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22223895}.; MOD_RES 96 96 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.	8626466; 15489334; 9392419; 18669648; 19413330; 21269460; 22223895; 23186163; 24275569; 26202976; 18823933; 16169070; 18660489; 19913121; 20628086; 26496610	8626466; 15489334; 9392419; 18669648; 19413330; 21269460; 22223895; 23186163; 24275569; 26202976; 18823933
3364	APIP CGI-29	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=9.3 uM for S-methyl-5-thio-D-ribulose 1-phosphate; Vmax=1.39 umol/min/mg enzyme; 	4.2.1.109	CATALYTIC ACTIVITY: S-methyl-5-thio-D-ribulose 1-phosphate = 5-(methylthio)-2,3-dioxopentyl phosphate + H(2)O. {ECO:0000255|HAMAP-Rule:MF_03116, ECO:0000269|PubMed:24367089}.	BINDING 97 97 Substrate. {ECO:0000255|HAMAP-Rule:MF_03116, ECO:0000305|PubMed:24367089}.		COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000255|HAMAP-Rule:MF_03116, ECO:0000269|PubMed:24367089}; ;  Note=Binds 1 zinc ion per subunit. {ECO:0000255|HAMAP-Rule:MF_03116, ECO:0000269|PubMed:24367089};		PATHWAY: Amino-acid biosynthesis; L-methionine biosynthesis via salvage pathway; L-methionine from S-methyl-5-thio-alpha-D-ribose 1-phosphate: step 2/6. {ECO:0000255|HAMAP-Rule:MF_03116, ECO:0000269|PubMed:23285211, ECO:0000269|PubMed:24367089}.		CGI-29		apoptotic process [GO:0006915]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]; negative regulation of apoptotic process [GO:0043066]; protein homotetramerization [GO:0051289]; pyroptosis [GO:0070269]; regulation of ERK1 and ERK2 cascade [GO:0070372]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; methylthioribulose 1-phosphate dehydratase activity [GO:0046570]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]; negative regulation of apoptotic process [GO:0043066]; protein homotetramerization [GO:0051289]; pyroptosis [GO:0070269]; regulation of ERK1 and ERK2 cascade [GO:0070372]	identical protein binding [GO:0042802]; methylthioribulose 1-phosphate dehydratase activity [GO:0046570]; zinc ion binding [GO:0008270]	GO:0005737; GO:0006915; GO:0008270; GO:0019284; GO:0019509; GO:0042802; GO:0043066; GO:0046570; GO:0051289; GO:0070269; GO:0070372	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_03116, ECO:0000269|PubMed:15262985, ECO:0000269|PubMed:23285211}.		MOD_RES 87 87 Phosphoserine. {ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.	10810093; 14702039; 16554811; 15489334; 15262985; 21269460; 21406692; 23285211; 22837397; 23186163; 24367089; 14743216; 16189514; 18625006; 19060904; 20711500; 20800603; 21382349; 22407486; 23192037; 25416956; 26496610; 26942872	10810093; 14702039; 16554811; 15489334; 15262985; 21269460; 21406692; 23285211; 22837397; 23186163; 24367089
3368	MUT	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=4.7 nM for adenosylcob(III)alamin {ECO:0000269|PubMed:25125334}; 	5.4.99.2	CATALYTIC ACTIVITY: (R)-methylmalonyl-CoA = succinyl-CoA. {ECO:0000269|PubMed:25125334, ECO:0000269|PubMed:28101778}.	BINDING 50 50 malonyl-CoA. {ECO:0000269|PubMed:20876572}.; BINDING 228 228 malonyl-CoA. {ECO:0000269|PubMed:20876572}.; BINDING 255 255 malonyl-CoA. {ECO:0000269|PubMed:20876572}.; BINDING 265 265 malonyl-CoA. {ECO:0000269|PubMed:20876572}.	ACTIVITY REGULATION: Inhibited by itaconyl-CoA, a metabolite that inactivates the coenzyme B12 cofactor (PubMed:29056341).	COFACTOR: Name=adenosylcob(III)alamin; Xref=ChEBI:CHEBI:18408; Evidence={ECO:0000269|PubMed:29056341}; 						cobalamin metabolic process [GO:0009235]; homocysteine metabolic process [GO:0050667]; positive regulation of GTPase activity [GO:0043547]; post-embryonic development [GO:0009791]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; cobalamin binding [GO:0031419]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methylmalonyl-CoA mutase activity [GO:0004494]; modified amino acid binding [GO:0072341]; protein homodimerization activity [GO:0042803]; cobalamin metabolic process [GO:0009235]; homocysteine metabolic process [GO:0050667]; positive regulation of GTPase activity [GO:0043547]; post-embryonic development [GO:0009791]	cobalamin binding [GO:0031419]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methylmalonyl-CoA mutase activity [GO:0004494]; modified amino acid binding [GO:0072341]; protein homodimerization activity [GO:0042803]	GO:0003924; GO:0004494; GO:0005739; GO:0005759; GO:0009235; GO:0009791; GO:0031419; GO:0042802; GO:0042803; GO:0043547; GO:0046872; GO:0050667; GO:0072341	SUBCELLULAR LOCATION: Mitochondrion matrix.		MOD_RES 89 89 N6-acetyllysine. {ECO:0000250|UniProtKB:P16332}.; MOD_RES 212 212 N6-acetyllysine. {ECO:0000250|UniProtKB:P16332}.; MOD_RES 335 335 N6-acetyllysine. {ECO:0000250|UniProtKB:P16332}.; MOD_RES 343 343 N6-succinyllysine. {ECO:0000250|UniProtKB:P16332}.; MOD_RES 481 481 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 595 595 N6-succinyllysine. {ECO:0000250|UniProtKB:P16332}.; MOD_RES 602 602 N6-acetyllysine. {ECO:0000250|UniProtKB:P16332}.	2567699; 1980486; 14702039; 14574404; 15489334; 24275569; 25944712; 29056341; 20876572; 1977311; 1670635; 1351030; 1346616; 7912889; 7909321; 9285782; 8990001; 9452100; 9554742; 10923046; 11350191; 15643616; 15781192; 16281286; 17113806; 17957493; 19588269; 21269460; 22727635; 25125334; 27167370; 26615597; 28101778; 11528502; 12438653; 14654360; 15523652; 16451139; 16866376; 17401587; 17410422; 17445044; 17597648; 17728257; 17966092; 18940555; 19088183; 1970180; 19806564; 20031578; 20186120; 20195357; 20800603; 20852008; 20877624; 21138732; 21604717; 23045948; 23311430; 23873214; 24330302; 24406457; 26370686; 26449400; 26454439; 26496610; 26830710; 27060300; 27233228; 28943303	2567699; 1980486; 14702039; 14574404; 15489334; 24275569; 25944712; 29056341; 20876572; 1977311; 1670635; 1351030; 1346616; 7912889; 7909321; 9285782; 8990001; 9452100; 9554742; 10923046; 11350191; 15643616; 15781192; 16281286; 17113806; 17957493; 19588269; 21269460; 22727635; 25125334; 27167370; 26615597; 28101778
3396	MYLK MLCK MLCK1 MYLK1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=6.5 uM for MLC (isoform 1 at 22 degrees Celsius) {ECO:0000269|PubMed:11113114}; KM=7.2 uM for MLC (isoform 2 at 22 degrees Celsius) {ECO:0000269|PubMed:11113114}; Vmax=11.9 umol/min/mg enzyme (isoform 1 at 22 degrees Celsius) {ECO:0000269|PubMed:11113114}; Vmax=10.9 umol/min/mg enzyme (isoform 1 at 22 degrees Celsius) {ECO:0000269|PubMed:11113114}; 	2.7.11.18	CATALYTIC ACTIVITY: ATP + [myosin light-chain] = ADP + [myosin light-chain] phosphate.	BINDING 1493 1493 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.	ACTIVITY REGULATION: Isoform 1 is activated by phosphorylation on Tyr-464 and Tyr-471. Isoforms which lack these tyrosine residues are not regulated in this way. All catalytically active isoforms require binding to calcium and calmodulin for activation. Repressed by organometallic pyridylnaphthalimide complexes, wortmannin, ML-7 (a synthetic naphthalenesulphonyl derivative that inhibits the binding of ATP to MLCK) and ML-9. {ECO:0000269|PubMed:11113114, ECO:0000269|PubMed:11976941, ECO:0000269|PubMed:14741352, ECO:0000269|PubMed:16284075, ECO:0000269|PubMed:16723733, ECO:0000269|PubMed:21918590}.	COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; ; COFACTOR: Name=Ca(2+); Xref=ChEBI:CHEBI:29108; 						aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; muscle contraction [GO:0006936]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]	actin cytoskeleton [GO:0015629]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]	actin cytoskeleton [GO:0015629]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]; aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; muscle contraction [GO:0006936]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]	actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]	GO:0001725; GO:0003779; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006936; GO:0006939; GO:0014820; GO:0015629; GO:0030027; GO:0030335; GO:0032060; GO:0032154; GO:0046872; GO:0051928; GO:0060414; GO:0071476; GO:0090303	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:20053363}. Cell projection, lamellipodium {ECO:0000269|PubMed:20053363}. Cleavage furrow {ECO:0000269|PubMed:15020676}. Cytoplasm, cytoskeleton, stress fiber {ECO:0000269|PubMed:15020676}. Note=Localized to stress fibers during interphase and to the cleavage furrow during mitosis. {ECO:0000269|PubMed:15020676}.	PTM: Can probably be down-regulated by phosphorylation. Tyrosine phosphorylation by ABL1 increases kinase activity, reverses MLCK-mediated inhibition of Arp2/3-mediated actin polymerization, and enhances CTTN-binding. Phosphorylation by SRC at Tyr-464 and Tyr-471 promotes CTTN binding. {ECO:0000269|PubMed:11113114, ECO:0000269|PubMed:12408982, ECO:0000269|PubMed:20861316}.; PTM: The C-terminus is deglutamylated by AGTPBP1/CCP1, AGBL1/CCP4 and AGBL4/CCP6, leading to the formation of Myosin light chain kinase, smooth muscle, deglutamylated form. The consequences of C-terminal deglutamylation are unknown (By similarity). {ECO:0000250}.; PTM: Acetylated at Lys-608 by NAA10/ARD1 via a calcium-dependent signaling; this acetylation represses kinase activity and reduces tumor cell migration. {ECO:0000269|PubMed:19826488}.	MOD_RES 231 231 Phosphotyrosine; by ABL1. {ECO:0000269|PubMed:20861316}.; MOD_RES 305 305 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 343 343 Phosphoserine. {ECO:0000250|UniProtKB:Q6PDN3}.; MOD_RES 365 365 Phosphoserine. {ECO:0000250|UniProtKB:Q6PDN3}.; MOD_RES 464 464 Phosphotyrosine; by ABL1 and SRC. {ECO:0000269|PubMed:11113114, ECO:0000269|PubMed:12408982, ECO:0000269|PubMed:20861316}.; MOD_RES 471 471 Phosphotyrosine; by SRC. {ECO:0000269|PubMed:11113114, ECO:0000269|PubMed:12408982}.; MOD_RES 556 556 Phosphotyrosine; by ABL1. {ECO:0000269|PubMed:20861316}.; MOD_RES 608 608 N6-acetyllysine. {ECO:0000269|PubMed:19826488}.; MOD_RES 611 611 Phosphotyrosine; by ABL1. {ECO:0000269|PubMed:20861316}.; MOD_RES 792 792 Phosphotyrosine; by ABL1. {ECO:0000269|PubMed:20861316}.; MOD_RES 846 846 Phosphotyrosine; by ABL1. {ECO:0000269|PubMed:20861316}.; MOD_RES 947 947 Phosphoserine. {ECO:0000250|UniProtKB:Q6PDN3}.; MOD_RES 1438 1438 Phosphoserine. {ECO:0000244|PubMed:18088087, ECO:0000244|PubMed:18318008, ECO:0000244|PubMed:24275569}.; MOD_RES 1449 1449 Phosphotyrosine; by ABL1. {ECO:0000269|PubMed:20861316}.; MOD_RES 1575 1575 Phosphotyrosine; by ABL1. {ECO:0000269|PubMed:20861316}.; MOD_RES 1635 1635 Phosphotyrosine; by ABL1. {ECO:0000269|PubMed:20861316}.; MOD_RES 1759 1759 Phosphoserine. {ECO:0000250|UniProtKB:Q6PDN3}.; MOD_RES 1760 1760 Phosphoserine. {ECO:0000250|UniProtKB:Q6PDN3}.; MOD_RES 1772 1772 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 1773 1773 Phosphoserine. {ECO:0000250|UniProtKB:Q6PDN3}.; MOD_RES 1776 1776 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 1778 1778 Phosphothreonine. {ECO:0000250|UniProtKB:Q6PDN3}.; MOD_RES 1779 1779 Phosphoserine. {ECO:0000244|PubMed:24275569}.	8575746; 9160829; 10198165; 11113114; 10536370; 15507455; 15020676; 14702039; 16641997; 15489334; 12408982; 11976941; 14741352; 15825080; 16835238; 16723733; 16284075; 18710790; 18088087; 18587400; 18318008; 19413330; 19429448; 19826488; 20453870; 20375339; 20053363; 20861316; 20181817; 20139351; 21918590; 19011151; 22015949; 22814378; 24275569; 18462678; 17344846; 21055718; 10092231; 10748018; 11346659; 11964068; 14627618; 14968112; 15310280; 156362; 15750850; 16399953; 17266121; 17472811; 17474147; 20711500; 21457715; 24116218; 25241761; 2526655; 25277244; 25416956; 25609649; 2764880; 3079756; 3780718; 3839510	8575746; 9160829; 10198165; 11113114; 10536370; 15507455; 15020676; 14702039; 16641997; 15489334; 12408982; 11976941; 14741352; 15825080; 16835238; 16723733; 16284075; 18710790; 18088087; 18587400; 18318008; 19413330; 19429448; 19826488; 20453870; 20375339; 20053363; 20861316; 20181817; 20139351; 21918590; 19011151; 22015949; 22814378; 24275569; 18462678; 17344846; 21055718
3414	ALOXE3	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=46 uM for (12R)-HPETE {ECO:0000269|PubMed:12881489, ECO:0000269|PubMed:17045234, ECO:0000269|PubMed:20921226}; KM=28 uM for (12S)-HPETE {ECO:0000269|PubMed:12881489, ECO:0000269|PubMed:17045234, ECO:0000269|PubMed:20921226}; KM=32 uM for (15S)-HPETE {ECO:0000269|PubMed:12881489, ECO:0000269|PubMed:17045234, ECO:0000269|PubMed:20921226}; KM=50 uM for synthetic fatty acid 9E,11Z,14Z-20:3omega6 (at pH 7.5) {ECO:0000269|PubMed:12881489, ECO:0000269|PubMed:17045234, ECO:0000269|PubMed:20921226}; Vmax=3.256 umol/min/mg enzyme for (12R)-HPETE (at pH 7.5) {ECO:0000269|PubMed:12881489, ECO:0000269|PubMed:17045234, ECO:0000269|PubMed:20921226}; Vmax=0.858 umol/min/mg enzyme for (12S)-HPETE (at pH 7.5) {ECO:0000269|PubMed:12881489, ECO:0000269|PubMed:17045234, ECO:0000269|PubMed:20921226}; Vmax=0.484 umol/min/mg enzyme for (15S)-HPETE (at pH 7.5) {ECO:0000269|PubMed:12881489, ECO:0000269|PubMed:17045234, ECO:0000269|PubMed:20921226}; Note=Has a 5 to 10 fold higher activity toward (12R)-HPETE (hydroperoxyeicosatetraenoic acid) compared to (12S)-HPETE and (15S)-HPETE. From (12R)-HPETE produces a stereoisomer of hepoxilin A3. More active on hydroperoxides with an R configuration than an S one.;	5.4.4.7; 4.2.1.152	CATALYTIC ACTIVITY: A hydroperoxy icosatetraenoate = a hydroxy epoxy icosatrienoate. {ECO:0000269|PubMed:12881489, ECO:0000269|PubMed:17045234, ECO:0000269|PubMed:20921226, ECO:0000269|PubMed:20923767, ECO:0000269|PubMed:21558561}.; CATALYTIC ACTIVITY: A hydroperoxy icosatetraenoate = an oxoicosatetraenoate + H(2)O. {ECO:0000269|PubMed:12881489, ECO:0000269|PubMed:17045234, ECO:0000269|PubMed:20921226, ECO:0000269|PubMed:20923767, ECO:0000269|PubMed:21558561}.			COFACTOR: Name=Fe cation; Xref=ChEBI:CHEBI:24875; Evidence={ECO:0000255|PROSITE-ProRule:PRU00726}; ;  Note=Binds 1 Fe cation per subunit. {ECO:0000255|PROSITE-ProRule:PRU00726};		PATHWAY: Lipid metabolism; hydroperoxy eicosatetraenoic acid biosynthesis.; PATHWAY: Lipid metabolism; sphingolipid metabolism.				arachidonic acid metabolic process [GO:0019369]; ceramide biosynthetic process [GO:0046513]; establishment of skin barrier [GO:0061436]; fat cell differentiation [GO:0045444]; hepoxilin biosynthetic process [GO:0051122]; linoleic acid metabolic process [GO:0043651]; lipoxygenase pathway [GO:0019372]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; sensory perception of pain [GO:0019233]; sphingolipid metabolic process [GO:0006665]	cytosol [GO:0005829]	cytosol [GO:0005829]; hepoxilin A3 synthase activity [GO:0051120]; iron ion binding [GO:0005506]; lyase activity [GO:0016829]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; arachidonic acid metabolic process [GO:0019369]; ceramide biosynthetic process [GO:0046513]; establishment of skin barrier [GO:0061436]; fat cell differentiation [GO:0045444]; hepoxilin biosynthetic process [GO:0051122]; linoleic acid metabolic process [GO:0043651]; lipoxygenase pathway [GO:0019372]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; sensory perception of pain [GO:0019233]; sphingolipid metabolic process [GO:0006665]	hepoxilin A3 synthase activity [GO:0051120]; iron ion binding [GO:0005506]; lyase activity [GO:0016829]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]	GO:0005506; GO:0005829; GO:0006665; GO:0016702; GO:0016829; GO:0019233; GO:0019369; GO:0019372; GO:0035357; GO:0043651; GO:0045444; GO:0046513; GO:0051120; GO:0051122; GO:0061436	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|PROSITE-ProRule:PRU00726}.			11350124; 12881489; 14702039; 15489334; 17045234; 20921226; 20923767; 21558561; 11773004; 15629692; 16116617; 19131948; 19890349; 17436029; 19064572; 19423540; 20406964; 20438785; 22622417; 23954555; 24021977; 25423909; 26370990; 26578203; 27868147	11350124; 12881489; 14702039; 15489334; 17045234; 20921226; 20923767; 21558561; 11773004; 15629692; 16116617; 19131948; 19890349
3452	MACROD1 LRP16	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=373 uM for O-acetyl-ADP-ribose {ECO:0000269|PubMed:21257746}; 	3.2.2.-; 3.5.1.-		BINDING 306 306 Substrate. {ECO:0000250}.	ACTIVITY REGULATION: Subject to competitive inhibition by the product ADP-ribose. {ECO:0000269|PubMed:21257746}.				SITE 100 100 Breakpoint for translocation to form RUNX1-MACROD1. {ECO:0000269|PubMed:17532767}.			cellular response to DNA damage stimulus [GO:0006974]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; deacetylase activity [GO:0019213]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; cellular response to DNA damage stimulus [GO:0006974]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278]	deacetylase activity [GO:0019213]; hydrolase activity, acting on glycosyl bonds [GO:0016798]	GO:0005634; GO:0005654; GO:0006974; GO:0016798; GO:0019213; GO:0042278; GO:0051725	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:23474712}. Note=Recruited to DNA lesions, probably via mono-APD-ribosylated proteins.		MOD_RES 96 96 N6-succinyllysine. {ECO:0000250|UniProtKB:Q922B1}.; MOD_RES 103 103 N6-succinyllysine. {ECO:0000250|UniProtKB:Q922B1}.; MOD_RES 129 129 N6-succinyllysine. {ECO:0000250|UniProtKB:Q922B1}.; MOD_RES 163 163 N6-acetyllysine. {ECO:0000250|UniProtKB:Q922B1}.	12578638; 15489334; 12790785; 17893710; 17914104; 17532767; 19022849; 19403568; 21269460; 23474712; 25944712; 28112733; 21257746; 15691879; 16831279; 19698216; 19824120; 19840441; 19958623; 20035625; 20355243; 21483817; 22623428; 25735744; 26261536; 28820388	12578638; 15489334; 12790785; 17893710; 17914104; 17532767; 19022849; 19403568; 21269460; 23474712; 25944712; 28112733; 21257746
3528	DMGDH	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=1.4 mM for N,N-dimethylglycine {ECO:0000269|PubMed:27486859}; Vmax=22.1 umol/min/mg enzyme; Note=kcat is 213 min(-1) for N,N-dimethylglycine. {ECO:0000269|PubMed:27486859};	1.5.8.4	CATALYTIC ACTIVITY: N,N-dimethylglycine + 5,6,7,8-tetrahydrofolate + electron-transfer flavoprotein = sarcosine + 5,10-methylenetetrahydrofolate + reduced electron-transfer flavoprotein. {ECO:0000269|PubMed:27486859}.	BINDING 219 219 FAD; via amide nitrogen and carbonyl oxygen. {ECO:0000244|PDB:5L46, ECO:0000269|PubMed:27486859}.; BINDING 251 251 FAD. {ECO:0000250|UniProtKB:Q63342}.; BINDING 676 676 Tetrahydrofolate. {ECO:0000250|UniProtKB:Q63342}.; BINDING 744 744 Tetrahydrofolate. {ECO:0000250|UniProtKB:Q63342}.		COFACTOR: Name=FAD; Xref=ChEBI:CHEBI:57692; Evidence={ECO:0000269|PubMed:27486859}; ;  Note=Binds 1 FAD covalently per monomer. {ECO:0000269|PubMed:27486859};		PATHWAY: Amine and polyamine degradation; betaine degradation; sarcosine from betaine: step 2/2.				amino-acid betaine catabolic process [GO:0006579]; choline catabolic process [GO:0042426]; choline metabolic process [GO:0019695]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; dimethylglycine dehydrogenase activity [GO:0047865]; electron transfer activity [GO:0009055]; RNA binding [GO:0003723]; amino-acid betaine catabolic process [GO:0006579]; choline catabolic process [GO:0042426]; choline metabolic process [GO:0019695]	dimethylglycine dehydrogenase activity [GO:0047865]; electron transfer activity [GO:0009055]; RNA binding [GO:0003723]	GO:0003723; GO:0005739; GO:0005759; GO:0006579; GO:0009055; GO:0019695; GO:0042426; GO:0047865	SUBCELLULAR LOCATION: Mitochondrion.		MOD_RES 91 91 Tele-8alpha-FAD histidine. {ECO:0000244|PDB:5L46, ECO:0000269|PubMed:27486859}.; MOD_RES 114 114 N6-acetyllysine. {ECO:0000250|UniProtKB:Q9DBT9}.; MOD_RES 148 148 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q9DBT9}.; MOD_RES 148 148 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q9DBT9}.; MOD_RES 168 168 N6-acetyllysine. {ECO:0000250|UniProtKB:Q9DBT9}.; MOD_RES 223 223 N6-acetyllysine. {ECO:0000250|UniProtKB:Q9DBT9}.; MOD_RES 317 317 N6-succinyllysine. {ECO:0000250|UniProtKB:Q9DBT9}.; MOD_RES 319 319 N6-succinyllysine. {ECO:0000250|UniProtKB:Q9DBT9}.; MOD_RES 335 335 N6-acetyllysine. {ECO:0000250|UniProtKB:Q9DBT9}.; MOD_RES 360 360 N6-acetyllysine. {ECO:0000250|UniProtKB:Q9DBT9}.; MOD_RES 434 434 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q9DBT9}.; MOD_RES 434 434 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q9DBT9}.; MOD_RES 523 523 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q9DBT9}.; MOD_RES 523 523 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q9DBT9}.; MOD_RES 655 655 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q9DBT9}.; MOD_RES 655 655 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q9DBT9}.; MOD_RES 764 764 N6-acetyllysine. {ECO:0000250|UniProtKB:Q9DBT9}.; MOD_RES 795 795 N6-succinyllysine. {ECO:0000250|UniProtKB:Q9DBT9}.	10767172; 11231903; 14702039; 15372022; 10102904; 27486859; 24275569; 18937046; 19048631; 19913121; 20628086; 20634891; 20662904; 20877624; 25795213; 26675765; 27614103	10767172; 11231903; 14702039; 15372022; 10102904; 27486859; 24275569
3529	MACROD2 C20orf133	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=107 uM for O-acetyl-ADP-ribose {ECO:0000269|PubMed:21257746}; 	3.2.2.-; 3.5.1.-		BINDING 224 224 Substrate.	ACTIVITY REGULATION: Subject to product inhibition by ADP-ribose. {ECO:0000269|PubMed:23474712}.							brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278]	centrosome [GO:0005813]; nucleolus [GO:0005730]; nucleus [GO:0005634]	centrosome [GO:0005813]; nucleolus [GO:0005730]; nucleus [GO:0005634]; deacetylase activity [GO:0019213]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278]	deacetylase activity [GO:0019213]; hydrolase activity, acting on glycosyl bonds [GO:0016798]	GO:0005634; GO:0005730; GO:0005813; GO:0006974; GO:0007420; GO:0016798; GO:0019213; GO:0042278; GO:0051725	SUBCELLULAR LOCATION: Nucleus. Note=Recruited to DNA lesions, probably via mono-APD-ribosylated proteins.			14702039; 11780052; 15489334; 18655026; 21257746; 23474712; 17586838; 18593871; 18987618; 19240061; 19847924; 20044523; 20379614; 20663923; 21656903; 25360606; 25422431; 27304844; 28069995	14702039; 11780052; 15489334; 18655026; 21257746; 23474712
3538	MAP3K9 MLK1 PRKE1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=62 uM for ATP {ECO:0000269|PubMed:11325962}; KM=7 uM for myelin basic protein (MBP) as substrate {ECO:0000269|PubMed:11325962}; 	2.7.11.25	CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.	BINDING 171 171 ATP.	ACTIVITY REGULATION: Homodimerization via the leucine zipper domains is required for autophosphorylation of multiple sites in the activation loop and subsequent activation. Autophosphorylation at Thr-312 is the key step in activation of MAP3K9/MLK1 and is required for full phosphorylation. Autophosphorylation at Thr-304 and Ser-308 have been shown to be of secondary importance in the activation of MAP3K9/MLK1. CEP-1347 and many indolocarbazole analogs have been shown to act as inhibitors of MAP3K9/MLK1 activity. {ECO:0000269|PubMed:11325962, ECO:0000269|PubMed:11755341, ECO:0000269|PubMed:15610029}.	COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; 						activation of JUN kinase activity [GO:0007257]; apoptotic process [GO:0006915]; positive regulation of apoptotic process [GO:0043065]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; ATP binding [GO:0005524]; JUN kinase kinase kinase activity [GO:0004706]; MAP kinase kinase activity [GO:0004708]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; activation of JUN kinase activity [GO:0007257]; apoptotic process [GO:0006915]; positive regulation of apoptotic process [GO:0043065]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]	ATP binding [GO:0005524]; JUN kinase kinase kinase activity [GO:0004706]; MAP kinase kinase activity [GO:0004708]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0004706; GO:0004708; GO:0005524; GO:0005737; GO:0006351; GO:0006355; GO:0006468; GO:0006915; GO:0007257; GO:0042803; GO:0043065; GO:0046777		PTM: Autophosphorylation on serine and threonine residues within the activation loop plays a role in enzyme activation. Thr-312 is likely to be the main autophosphorylation site. Autophosphorylation also occurs on Thr-304 and Ser-308. {ECO:0000269|PubMed:11325962, ECO:0000269|PubMed:15610029}.	MOD_RES 304 304 Phosphothreonine; by autocatalysis. {ECO:0000269|PubMed:15610029}.; MOD_RES 305 305 Phosphothreonine; by autocatalysis. {ECO:0000269|PubMed:15610029}.; MOD_RES 308 308 Phosphoserine; by autocatalysis. {ECO:0000269|PubMed:15610029}.; MOD_RES 312 312 Phosphothreonine; by autocatalysis. {ECO:0000269|PubMed:15610029}.; MOD_RES 533 533 Phosphoserine. {ECO:0000244|PubMed:23186163}.	15610029; 15489334; 8477742; 11325962; 11416147; 11755341; 18241037; 19369195; 23186163; 18714982; 17344846; 19826002; 20379614; 21481795; 22197930; 22939624; 23836671; 26573018; 26637668; 28081468; 28298643	15610029; 15489334; 8477742; 11325962; 11416147; 11755341; 18241037; 19369195; 23186163; 18714982; 17344846
3582	MTAP MSAP	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=5 uM for S-methyl-5'-thioadenosine {ECO:0000269|PubMed:3091600, ECO:0000269|PubMed:8687427}; KM=580 uM for phosphate {ECO:0000269|PubMed:3091600, ECO:0000269|PubMed:8687427}; KM=23 uM for adenine {ECO:0000269|PubMed:3091600, ECO:0000269|PubMed:8687427}; KM=8 uM for S-methyl-5-thio-alpha-D-ribose 1-phosphate {ECO:0000269|PubMed:3091600, ECO:0000269|PubMed:8687427}; 	2.4.2.28	CATALYTIC ACTIVITY: S-methyl-5'-thioadenosine + phosphate = adenine + S-methyl-5-thio-alpha-D-ribose 1-phosphate. {ECO:0000255|HAMAP-Rule:MF_03155}.	BINDING 18 18 Phosphate.; BINDING 196 196 Substrate; via amide nitrogen.; BINDING 197 197 Phosphate.	ACTIVITY REGULATION: Inhibited by 5'-methylthiotubercin and 5'-chloroformycin.		BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 7.2-7.6. {ECO:0000269|PubMed:3091600, ECO:0000269|PubMed:8687427};	PATHWAY: Amino-acid biosynthesis; L-methionine biosynthesis via salvage pathway; S-methyl-5-thio-alpha-D-ribose 1-phosphate from S-methyl-5'-thioadenosine (phosphorylase route): step 1/1. {ECO:0000255|HAMAP-Rule:MF_03155}.	SITE 178 178 Important for substrate specificity.; SITE 233 233 Important for substrate specificity.			interleukin-12-mediated signaling pathway [GO:0035722]; L-methionine salvage from methylthioadenosine [GO:0019509]; nucleobase-containing compound metabolic process [GO:0006139]; purine ribonucleoside salvage [GO:0006166]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; phosphorylase activity [GO:0004645]; S-methyl-5-thioadenosine phosphorylase activity [GO:0017061]; interleukin-12-mediated signaling pathway [GO:0035722]; L-methionine salvage from methylthioadenosine [GO:0019509]; nucleobase-containing compound metabolic process [GO:0006139]; purine ribonucleoside salvage [GO:0006166]	phosphorylase activity [GO:0004645]; S-methyl-5-thioadenosine phosphorylase activity [GO:0017061]	GO:0004645; GO:0005634; GO:0005829; GO:0006139; GO:0006166; GO:0017061; GO:0019509; GO:0035722; GO:0070062	SUBCELLULAR LOCATION: Cytoplasm. Nucleus {ECO:0000255|HAMAP-Rule:MF_03155}.		MOD_RES 51 51 N6-acetyllysine. {ECO:0000250|UniProtKB:Q9CQ65}.	7604019; 8650244; 22464254; 15164053; 15489334; 3091600; 8687427; 11895909; 17912432; 19097084; 21269460; 21412930; 10404592; 15122881; 14705926; 20934997; 11985785; 12438261; 12875987; 14506228; 15492751; 15511635; 15534104; 15662124; 15832197; 16038020; 16081515; 16618910; 16631464; 16778103; 18237276; 18555557; 19272367; 19427650; 19578365; 19622299; 19665068; 19887491; 20064372; 20081810; 20302706; 20562859; 20574843; 20637465; 20647408; 21135097; 21342647; 21356366; 21962134; 21985704; 21988832; 22685558; 23000879; 23040436; 23462334; 23508829; 24324622; 24969958; 25416956; 25426549; 25609649; 26088413; 26638075; 26656376; 26751376; 26819315; 26909863; 26910893; 27479139; 27761950; 28477716; 6425836; 6785752	7604019; 8650244; 22464254; 15164053; 15489334; 3091600; 8687427; 11895909; 17912432; 19097084; 21269460; 21412930; 10404592; 15122881; 14705926; 20934997
3587	L2HGDH C14orf160	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=800 uM for L-2-hydroxyglutarate {ECO:0000269|PubMed:16005139}; 	1.1.99.2	CATALYTIC ACTIVITY: (S)-2-hydroxyglutarate + acceptor = 2-oxoglutarate + reduced acceptor. {ECO:0000269|PubMed:16005139}.			COFACTOR: Name=FAD; Xref=ChEBI:CHEBI:57692; Evidence={ECO:0000269|PubMed:16005139}; 						2-oxoglutarate metabolic process [GO:0006103]; cellular protein metabolic process [GO:0044267]	integral component of membrane [GO:0016021]; integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	integral component of membrane [GO:0016021]; integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; 2-hydroxyglutarate dehydrogenase activity [GO:0047545]; 2-oxoglutarate metabolic process [GO:0006103]; cellular protein metabolic process [GO:0044267]	2-hydroxyglutarate dehydrogenase activity [GO:0047545]	GO:0005739; GO:0005743; GO:0006103; GO:0016021; GO:0031305; GO:0044267; GO:0047545	SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:16005139}.		MOD_RES 104 104 N6-acetyllysine. {ECO:0000250|UniProtKB:Q91YP0}.; MOD_RES 155 155 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 173 173 N6-acetyllysine. {ECO:0000250|UniProtKB:Q91YP0}.	15548604; 14702039; 12508121; 15489334; 16005139; 19608861; 21269460; 24275569; 25944712; 15385440; 16134148; 17876720; 18362286; 18415700; 18671189; 18780161; 19911013; 20020533; 20052767; 20727073; 20852250; 20877624; 21625441; 24573090; 24606602; 26496610; 26829733	15548604; 14702039; 12508121; 15489334; 16005139; 19608861; 21269460; 24275569; 25944712; 15385440; 16134148
3625	MIF GLIF MMIF	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=249 uM for phenylpyruvate {ECO:0000269|PubMed:11439086}; KM=168 uM for p-hydroxyphenylpyruvate {ECO:0000269|PubMed:11439086}; Vmax=2113 umol/min/mg enzyme toward phenylpyruvate {ECO:0000269|PubMed:11439086}; Vmax=524 umol/min/mg enzyme toward p-hydroxyphenylpyruvate {ECO:0000269|PubMed:11439086}; 	5.3.2.1; 5.3.3.12	CATALYTIC ACTIVITY: Keto-phenylpyruvate = enol-phenylpyruvate.; CATALYTIC ACTIVITY: L-dopachrome = 5,6-dihydroxyindole-2-carboxylate.	BINDING 33 33 Substrate.; BINDING 65 65 Substrate; via amide nitrogen.; BINDING 98 98 Substrate.								carboxylic acid metabolic process [GO:0019752]; cell aging [GO:0007569]; cell proliferation [GO:0008283]; cell surface receptor signaling pathway [GO:0007166]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-12-mediated signaling pathway [GO:0035722]; leukocyte migration [GO:0050900]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell aging [GO:0090344]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of cellular protein metabolic process [GO:0032269]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of macrophage chemotaxis [GO:0010760]; negative regulation of mature B cell apoptotic process [GO:0002906]; negative regulation of myeloid cell apoptotic process [GO:0033033]; neutrophil degranulation [GO:0043312]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of myeloid leukocyte cytokine production involved in immune response [GO:0061081]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphorylation [GO:0042327]; positive regulation of prostaglandin secretion involved in immune response [GO:0061078]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of tumor necrosis factor production [GO:0032760]; prostaglandin biosynthetic process [GO:0001516]; protein homotrimerization [GO:0070207]; regulation of macrophage activation [GO:0043030]	cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]	cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]; chemoattractant activity [GO:0042056]; cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; dopachrome isomerase activity [GO:0004167]; identical protein binding [GO:0042802]; phenylpyruvate tautomerase activity [GO:0050178]; protease binding [GO:0002020]; signaling receptor binding [GO:0005102]; carboxylic acid metabolic process [GO:0019752]; cell aging [GO:0007569]; cell proliferation [GO:0008283]; cell surface receptor signaling pathway [GO:0007166]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-12-mediated signaling pathway [GO:0035722]; leukocyte migration [GO:0050900]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell aging [GO:0090344]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of cellular protein metabolic process [GO:0032269]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of macrophage chemotaxis [GO:0010760]; negative regulation of mature B cell apoptotic process [GO:0002906]; negative regulation of myeloid cell apoptotic process [GO:0033033]; neutrophil degranulation [GO:0043312]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of myeloid leukocyte cytokine production involved in immune response [GO:0061081]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphorylation [GO:0042327]; positive regulation of prostaglandin secretion involved in immune response [GO:0061078]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of tumor necrosis factor production [GO:0032760]; prostaglandin biosynthetic process [GO:0001516]; protein homotrimerization [GO:0070207]; regulation of macrophage activation [GO:0043030]	chemoattractant activity [GO:0042056]; cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; dopachrome isomerase activity [GO:0004167]; identical protein binding [GO:0042802]; phenylpyruvate tautomerase activity [GO:0050178]; protease binding [GO:0002020]; signaling receptor binding [GO:0005102]	GO:0001516; GO:0002020; GO:0002906; GO:0004167; GO:0005102; GO:0005125; GO:0005126; GO:0005576; GO:0005615; GO:0005654; GO:0005829; GO:0006954; GO:0007166; GO:0007569; GO:0008283; GO:0009986; GO:0010629; GO:0010739; GO:0010760; GO:0019752; GO:0030330; GO:0030890; GO:0031666; GO:0031982; GO:0032269; GO:0032760; GO:0033033; GO:0033138; GO:0034774; GO:0035722; GO:0042056; GO:0042327; GO:0042802; GO:0043030; GO:0043066; GO:0043209; GO:0043312; GO:0043406; GO:0043518; GO:0045087; GO:0048146; GO:0050178; GO:0050715; GO:0050731; GO:0050900; GO:0061078; GO:0061081; GO:0070062; GO:0070207; GO:0070374; GO:0071157; GO:0090238; GO:0090344; GO:1902166; GO:1904813; GO:2000343	SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:15908412, ECO:0000269|PubMed:19454686, ECO:0000269|PubMed:2552447, ECO:0000269|PubMed:8234256}. Cytoplasm {ECO:0000269|PubMed:11089976, ECO:0000269|PubMed:19454686}. Note=Does not have a cleavable signal sequence and is secreted via a specialized, non-classical pathway. Secreted by macrophages upon stimulation by bacterial lipopolysaccharide (LPS), or by M.tuberculosis antigens. {ECO:0000269|PubMed:15908412}.		MOD_RES 78 78 N6-acetyllysine; alternate. {ECO:0000244|PubMed:19608861}.; MOD_RES 78 78 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:P34884}.	2552447; 8234256; 7947826; 8188240; 15461802; 14702039; 15489334; 12665801; 1286669; 7683862; 7679497; 11089976; 11508429; 11439086; 12681488; 12782713; 15908412; 17443469; 19454686; 19608861; 21269460; 22223895; 22814378; 24275569; 25944712; 8766818; 8610159; 8643551; 10353846; 11170644; 17526494; 19090677; 23776208; 11920501; 11978887; 11985788; 11997397; 12009356; 12070782; 12109441; 12126556; 12180727; 12186913; 12218292; 12218308; 12235522; 12355488; 12402212; 12445161; 12480958; 12507885; 12576459; 12607777; 12612911; 12615835; 12626594; 12631237; 12667094; 12738641; 12740374; 12746913; 12796500; 12847682; 12965208; 14502271; 14551601; 14581488; 14607690; 14736878; 14760795; 14962818; 15018649; 15065001; 15146413; 15146431; 15170913; 15216464; 15231747; 15286457; 15292349; 15304087; 15308783; 15545061; 15545824; 15576462; 15585204; 15585220; 15612021; 15630728; 15659324; 15757663; 15800984; 15815686; 15820792; 15838879; 15910495; 15910597; 16000172; 16038020; 16051683; 16085663; 16115023; 16133063; 16169070; 16179637; 16189514; 16200611; 16205314; 16220288; 16224818; 16247506; 16285950; 16314470; 16314559; 16317091; 16369812; 16385258; 16388506; 16488392; 16527487; 16538639; 16677407; 16709839; 16724072; 16767681; 16780713; 16807115; 16820919; 16839849; 16854377; 16861224; 16872482; 16893895; 16929348; 17005573; 17029206; 17075815; 17108334; 17142775; 17166737; 17172590; 17181929; 17206642; 17215861; 17224449; 17353931; 17435771; 17438452; 17438455; 17495357; 17541237; 17559578; 17591062; 17592555; 17620429; 17658526; 17706208; 17709373; 17712545; 17728788; 17763209; 17786285; 17854804; 17854909; 17869648; 17906677; 17912466; 18034423; 18037272; 18054247; 18060744; 18074864; 18078632; 18081874; 18097599; 18165264; 18171527; 18171602; 18177450; 18228042; 18239193; 18242614; 18261992; 18270460; 18356846; 18362243; 18426738; 18466513; 18469521; 18474653; 18490733; 18493321; 18502749; 18618071; 18676531; 18677096; 18680514; 18684922; 18710704; 18720262; 18794110; 18795803; 18815136; 18832726; 18852457; 18853133; 18930766; 19009023; 19038405; 19062717; 19081768; 19109179; 19155217; 19157791; 19167373; 19170716; 19188484; 19196797; 19260777; 19299454; 19317738; 19346297; 19376177; 19394321; 19417556; 19423540; 19428548; 19463016; 19464392; 19475570; 19591577; 19601712; 19602265; 19644855; 19665027; 19720544; 19723024; 19724898; 19726058; 19737008; 19747950; 19759012; 19762145; 19773451; 19776019; 19776337; 19829123; 19836948; 19913121; 19938192; 19941661; 19950249; 20038293; 20085845; 20127054; 20149326; 20178462; 20185308; 20193596; 20200619; 20203087; 20233515; 20237496; 20303284; 20346241; 20360068; 20369477; 20380014; 20382217; 20383199; 20406964; 20438785; 20439102; 20447688; 20448056; 20452482; 20460119; 20467327; 20471506; 20499270; 20534506; 20546256; 20562859; 20573157; 20598902; 20621719; 20628086; 20646540; 20673868; 20805296; 20807568; 20811626; 20829434; 20847814; 20861157; 20863520; 20872800; 20878093; 20980171; 21030269; 21045753; 21071513; 21087445; 21106938; 21162929; 21168764; 21169549; 21208809; 21209875; 21269946; 21281800; 21283538; 21283592; 21360573; 21401926; 21417823; 21512965; 21515791; 21553324; 21575460; 21607559; 21623990; 21641401; 21684012; 21725855; 21750916; 21773885; 21792010; 21817065; 21823060; 21848392; 21852299; 21875883; 21890178; 21988832; 21990375; 22007254; 22079264; 22099602; 22127710; 22166284; 22174124; 22206839; 22271573; 22302395; 22327470; 22415145; 22449335; 22451332; 22461895; 22543583; 22609310; 22611320; 22623428; 22649515; 22676646; 22693633; 22742858; 22759564; 22782901; 22810585; 22813781; 22820623; 22821831; 22883521; 22892326; 22893706; 22898393; 22909194; 22927777; 22931430; 22939113; 22949182; 22952837; 23023114; 23028743; 23043599; 23050964; 23060578; 23064787; 23068083; 23125447; 23179933; 23207293; 23246423; 23272137; 23315862; 23354841; 23383040; 23402792; 23403077; 23410506; 23411097; 23451183; 23497377; 23523092; 23526214; 23537651; 23552723; 23566229; 23650620; 23707797; 23721694; 23759989; 23770720; 23794947; 23846621; 23882081; 23895962; 23913513; 23978362; 23985752; 24003215; 24039418; 24066864; 24091309; 24098445; 24138931; 24151396; 24158957; 24167613; 24194192; 24274936; 24356968; 24366206; 24379579; 24384723; 24396292; 24424397; 24429801; 24441872; 24490973; 24527464; 24530749; 24569872; 24644543; 24667663; 24683185; 24687413; 24826917; 24840392; 24850900; 24862346; 24879618; 24932684; 24939415; 25022961; 25050663; 25056219; 25105152; 25108206; 25168062; 25172501; 25329590; 25458401; 25460285; 25463068; 25487600; 25503271; 25530499; 25561410; 25593081; 25600533; 25697265; 25712213; 25712805; 25716200; 25730019; 25743213; 25762421; 25821795; 25861163; 25930990; 25966103; 25972622; 25998484; 26005773; 26020638; 26039541; 26087187; 26107210; 26138061; 26139098; 26161389; 26209628; 26234719; 26272322; 26280537; 26281331; 26345783; 26348853; 26352431; 26364929; 26403072; 26412712; 26426302; 26453918; 26485680; 26496610; 26530123; 26535701; 26541175; 26542751; 26549761; 26603621; 26638028; 26638075; 26656832; 26719579; 26741693; 26750167; 26752645; 26783235; 26825917; 26829742; 26851955; 26852939; 26858459; 26866879; 26872252; 26883190; 26911630; 26933127; 26935642; 26952810; 26976591; 26980763; 26985869; 27049098; 27079941; 27101443; 27105877; 27145382; 27156768; 27157615; 27163877; 27190066; 27197190; 27207917; 27226569; 27270225; 27298517; 27299179; 27337548; 27364992; 27381622; 27402018; 27426952; 27434219; 27453287; 27509135; 27544048; 27573366; 27598332; 27612504; 27619729; 27696094; 27721403; 27793992; 27811451; 27844180; 27872288; 28086136; 28160516; 28331211; 28338494; 28366792; 28370484; 28407372; 28429502; 28513076; 28574571; 28578664; 28624489; 28642171; 28657145; 28668810; 28703031; 28704499; 28726057; 28729134; 28768722; 28801314; 28823650; 28965181; 29079416; 29096759; 29120365; 29207023; 29239244; 29257298; 29259749; 29289260; 29412660; 29575754; 29669180	2552447; 8234256; 7947826; 8188240; 15461802; 14702039; 15489334; 12665801; 1286669; 7683862; 7679497; 11089976; 11508429; 11439086; 12681488; 12782713; 15908412; 17443469; 19454686; 19608861; 21269460; 22223895; 22814378; 24275569; 25944712; 8766818; 8610159; 8643551; 10353846; 11170644; 17526494; 19090677; 23776208
3642	MGLL	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=110 uM for 2-arachidonoyglycerol {ECO:0000269|PubMed:22969151}; Vmax=120 nmol/min/mg enzyme toward 2-arachidonoyglycerol {ECO:0000269|PubMed:22969151}; 	3.1.1.23	CATALYTIC ACTIVITY: Hydrolyzes glycerol monoesters of long-chain fatty acids. {ECO:0000250|UniProtKB:O35678}.					PATHWAY: Glycerolipid metabolism; triacylglycerol degradation. {ECO:0000250|UniProtKB:O35678}.				acylglycerol acyl-chain remodeling [GO:0036155]; acylglycerol catabolic process [GO:0046464]; arachidonic acid metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; regulation of endocannabinoid signaling pathway [GO:2000124]; regulation of inflammatory response [GO:0050727]; regulation of sensory perception of pain [GO:0051930]; regulation of signal transduction [GO:0009966]; triglyceride catabolic process [GO:0019433]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; protein homodimerization activity [GO:0042803]; acylglycerol acyl-chain remodeling [GO:0036155]; acylglycerol catabolic process [GO:0046464]; arachidonic acid metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; regulation of endocannabinoid signaling pathway [GO:2000124]; regulation of inflammatory response [GO:0050727]; regulation of sensory perception of pain [GO:0051930]; regulation of signal transduction [GO:0009966]; triglyceride catabolic process [GO:0019433]	acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; protein homodimerization activity [GO:0042803]	GO:0004622; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0006629; GO:0006633; GO:0006954; GO:0009966; GO:0016020; GO:0019369; GO:0019433; GO:0019898; GO:0036155; GO:0042803; GO:0046464; GO:0047372; GO:0050727; GO:0051930; GO:2000124	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250|UniProtKB:O35678}. Membrane {ECO:0000250|UniProtKB:O35678}; Peripheral membrane protein {ECO:0000250|UniProtKB:O35678}.		MOD_RES 10 10 Phosphothreonine. {ECO:0000250|UniProtKB:O35678}.; MOD_RES 58 58 Nitrated tyrosine. {ECO:0000250|UniProtKB:O35678}.	9495531; 11470505; 14702039; 16641997; 15489334; 17974005; 20079333; 22969151; 22814378; 24275569; 19957260; 19962385; 1249056; 15272052; 16169070; 17621164; 18096503; 18452279; 18721756; 19014633; 19233690; 19913121; 20464001; 20628086; 20711500; 20855465; 20976246; 21118518; 21308848; 21543155; 21802006; 22349814; 22664939; 22827915; 23455058; 23553709; 24368842; 24593280; 24633487; 25078047; 25120746; 25560837; 25636199; 26000748; 26555264; 26595473; 26948343; 26997225; 27366945; 27767105; 27884159; 28088576; 28213089; 29148769; 29498843; 3955067; 7295321	9495531; 11470505; 14702039; 16641997; 15489334; 17974005; 20079333; 22969151; 22814378; 24275569; 19957260; 19962385
3646	MGAT4B UNQ906/PRO1927	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.242 mM for UDP-GlcNAc {ECO:0000269|PubMed:17006639}; 	2.4.1.145	CATALYTIC ACTIVITY: UDP-N-acetyl-alpha-D-glucosamine + beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-(beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6))-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc-N-Asn-[protein] = UDP + beta-D-GlcNAc-(1->2)-(beta-D-GlcNAc-(1->4))-alpha-D-Man-(1->3)-(beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6))-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc-N-Asn-[protein].			COFACTOR: Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240; Evidence={ECO:0000250}; 		PATHWAY: Protein modification; protein glycosylation.		UNQ906/PRO1927		N-glycan processing [GO:0006491]; protein N-linked glycosylation [GO:0006487]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0008454]; metal ion binding [GO:0046872]; N-glycan processing [GO:0006491]; protein N-linked glycosylation [GO:0006487]	alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0008454]; metal ion binding [GO:0046872]	GO:0000139; GO:0006487; GO:0006491; GO:0008454; GO:0016021; GO:0046872	SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000250}; Single-pass type II membrane protein {ECO:0000250}.			10372966; 12975309; 14702039; 15372022; 15489334; 17974005; 16434023; 17006639; 10570912; 16169070; 17488527; 19913121; 20628086; 20711500; 25944901	10372966; 12975309; 14702039; 15372022; 15489334; 17974005; 16434023; 17006639
3703	MME EPN	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=55.1 uM for angiotensin-1 {ECO:0000269|PubMed:15283675}; KM=179 uM for angiotensin-2 {ECO:0000269|PubMed:15283675}; KM=111.4 uM for angiotensin 1-9 {ECO:0000269|PubMed:15283675}; 	3.4.24.11	CATALYTIC ACTIVITY: Preferential cleavage of polypeptides between hydrophobic residues, particularly with Phe or Tyr at P1'. {ECO:0000269|PubMed:15283675, ECO:0000269|PubMed:27588448, ECO:0000269|PubMed:8168535}.	BINDING 103 103 Substrate carboxyl. {ECO:0000250}.	ACTIVITY REGULATION: Inhibited in a dose dependent manner by opiorphin. {ECO:0000269|PubMed:17101991}.	COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000269|PubMed:14747736, ECO:0000269|PubMed:17704566}; ;  Note=Binds 1 zinc ion per subunit. {ECO:0000269|PubMed:14747736, ECO:0000269|PubMed:17704566};						amyloid-beta clearance [GO:0097242]; amyloid-beta metabolic process [GO:0050435]; angiotensin maturation [GO:0002003]; cellular response to cytokine stimulus [GO:0071345]; cellular response to UV-A [GO:0071492]; cellular response to UV-B [GO:0071493]; creatinine metabolic process [GO:0046449]; kidney development [GO:0001822]; neutrophil degranulation [GO:0043312]; peptide metabolic process [GO:0006518]; proteolysis [GO:0006508]; replicative senescence [GO:0090399]; sensory perception of pain [GO:0019233]	axon [GO:0030424]; brush border [GO:0005903]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection terminus [GO:0044306]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]	axon [GO:0030424]; brush border [GO:0005903]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection terminus [GO:0044306]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; amyloid-beta clearance [GO:0097242]; amyloid-beta metabolic process [GO:0050435]; angiotensin maturation [GO:0002003]; cellular response to cytokine stimulus [GO:0071345]; cellular response to UV-A [GO:0071492]; cellular response to UV-B [GO:0071493]; creatinine metabolic process [GO:0046449]; kidney development [GO:0001822]; neutrophil degranulation [GO:0043312]; peptide metabolic process [GO:0006518]; proteolysis [GO:0006508]; replicative senescence [GO:0090399]; sensory perception of pain [GO:0019233]	endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]	GO:0001822; GO:0002003; GO:0004175; GO:0004222; GO:0005737; GO:0005886; GO:0005887; GO:0005903; GO:0005925; GO:0006508; GO:0006518; GO:0008021; GO:0008237; GO:0008238; GO:0008270; GO:0016021; GO:0019233; GO:0030424; GO:0030425; GO:0030667; GO:0042277; GO:0043312; GO:0044306; GO:0045202; GO:0046449; GO:0050435; GO:0070062; GO:0071345; GO:0071492; GO:0071493; GO:0090399; GO:0097242	SUBCELLULAR LOCATION: Cell membrane; Single-pass type II membrane protein.	PTM: Myristoylation is a determinant of membrane targeting. {ECO:0000269|PubMed:19756956}.; PTM: Glycosylation at Asn-628 is necessary both for surface expression and neutral endopeptidase activity. {ECO:0000269|PubMed:10669592, ECO:0000269|PubMed:12754519, ECO:0000269|PubMed:14747736, ECO:0000269|PubMed:17704566, ECO:0000269|PubMed:22766194}.	MOD_RES 4 4 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 6 6 Phosphoserine. {ECO:0000244|PubMed:24275569}.	2971756; 2968607; 2528730; 14702039; 15489334; 3162217; 2972276; 2531377; 8168535; 12754519; 15283675; 17101991; 20876573; 19756956; 22766194; 24275569; 27588448; 26991897; 27583304; 10669592; 14747736; 17704566; 10439449; 10994648; 11140838; 11849775; 11906289; 12070597; 12087466; 12102663; 12105192; 12140380; 12150966; 12203213; 12387451; 12393702; 12447961; 12485446; 12527400; 12657655; 12754344; 12785004; 14550292; 14673956; 14739539; 14749444; 14767532; 14968440; 15047060; 15205682; 15217945; 15286660; 15294904; 15464186; 15469471; 15502805; 15548496; 15578072; 15720419; 15785408; 15860464; 15870909; 15945081; 16123216; 16226260; 16400325; 16652149; 16700740; 16722930; 16857799; 16877296; 16900210; 16900384; 16940054; 16943769; 16948517; 17207277; 17220478; 17294442; 17296585; 17335564; 17342744; 17363457; 17591969; 17662271; 17712175; 17845760; 17876294; 17885484; 17906676; 17928142; 17953966; 18042078; 18092952; 18182043; 18292286; 18370954; 18393807; 18518902; 18539150; 18602473; 18605079; 18619643; 18806483; 19019493; 19047112; 19057576; 19127446; 19152193; 19196432; 19250583; 19287335; 19326964; 19437324; 19448593; 19515046; 19575892; 19606063; 19656156; 19661328; 19752720; 19787248; 19816087; 19817893; 19864659; 19897485; 19925052; 19948975; 19961253; 20014550; 20051779; 20051780; 20061637; 20079015; 20105452; 20175824; 20184665; 20204382; 20376800; 20390424; 20459800; 20468064; 20506111; 20546336; 20574156; 20663017; 20685603; 20711432; 20716621; 20856894; 20886092; 20947507; 20957047; 21052031; 21076839; 21225496; 21315759; 21365649; 21425402; 21499231; 21515054; 21585282; 21609487; 21651905; 21677537; 21681600; 21775056; 21804528; 21835428; 21877416; 21883368; 21988858; 21989348; 22006372; 22014058; 2201681; 22183801; 22257901; 22272689; 22286396; 22300665; 22371247; 22384224; 22410801; 22417750; 22464152; 22492182; 22572771; 22767595; 22880404; 22898766; 22994707; 23063927; 23065018; 23138928; 23219141; 23289620; 23339695; 23348903; 23356903; 23360525; 23509938; 23566254; 23650620; 23653392; 23686701; 23752268; 23827863; 23838604; 23857215; 23863409; 24040464; 24099862; 24460801; 24603459; 24754336; 24825898; 24848988; 24874475; 24895167; 24972738; 25089527; 25125048; 25279712; 25282623; 25308002; 25452160; 25608772; 25713420; 25733581; 25759539; 25921112; 26124315; 26362309; 26414904; 26562027; 26573127; 26609034; 26830028; 26846903; 26881775; 27039776; 27096746; 27302413; 2736261; 27513891; 27616053; 27641335; 28294061; 28553432; 28628241; 29056123; 29196110; 29306324; 29330223; 29906506; 8687431; 9232196; 9857225	2971756; 2968607; 2528730; 14702039; 15489334; 3162217; 2972276; 2531377; 8168535; 12754519; 15283675; 17101991; 20876573; 19756956; 22766194; 24275569; 27588448; 26991897; 27583304; 10669592; 14747736; 17704566
3726	PMVK PMKI	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=25 uM for (R)-5-phosphomevalonate {ECO:0000269|PubMed:16519518, ECO:0000269|PubMed:9392419}; KM=0.26 mM for ATP {ECO:0000269|PubMed:16519518, ECO:0000269|PubMed:9392419}; Vmax=46.4 umol/min/mg enzyme with (R)-5-phosphomevalonate as substrate {ECO:0000269|PubMed:16519518, ECO:0000269|PubMed:9392419}; Vmax=52 umol/min/mg enzyme with ATP as substrate {ECO:0000269|PubMed:16519518, ECO:0000269|PubMed:9392419}; 	2.7.4.2	CATALYTIC ACTIVITY: ATP + (R)-5-phosphomevalonate = ADP + (R)-5-diphosphomevalonate. {ECO:0000269|PubMed:8663599}.	BINDING 141 141 ATP. {ECO:0000305|PubMed:17902708, ECO:0000305|PubMed:18618710}.; BINDING 170 170 Substrate. {ECO:0000269|PubMed:18618710}.; BINDING 171 171 ATP. {ECO:0000305|PubMed:18618710}.; BINDING 176 176 ATP. {ECO:0000305|PubMed:18618710}.; BINDING 180 180 ATP. {ECO:0000305|PubMed:18618710}.				PATHWAY: Isoprenoid biosynthesis; isopentenyl diphosphate biosynthesis via mevalonate pathway; isopentenyl diphosphate from (R)-mevalonate: step 2/3.				cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; regulation of cholesterol biosynthetic process [GO:0045540]; response to cholesterol [GO:0070723]; sterol biosynthetic process [GO:0016126]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; peroxisome [GO:0005777]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; phosphomevalonate kinase activity [GO:0004631]; cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; regulation of cholesterol biosynthetic process [GO:0045540]; response to cholesterol [GO:0070723]; sterol biosynthetic process [GO:0016126]	ATP binding [GO:0005524]; phosphomevalonate kinase activity [GO:0004631]	GO:0004631; GO:0005524; GO:0005777; GO:0005829; GO:0006695; GO:0016020; GO:0016126; GO:0019287; GO:0045540; GO:0070062; GO:0070723	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:10191291, ECO:0000269|PubMed:27052676}.			8663599; 15489334; 10191291; 9392419; 14729858; 16519518; 17902708; 21269460; 22814378; 24275569; 25944712; 18618710; 26202976; 27052676; 17353931; 18660489; 18798562; 18985028; 19913121; 20628086; 22623428	8663599; 15489334; 10191291; 9392419; 14729858; 16519518; 17902708; 21269460; 22814378; 24275569; 25944712; 18618710; 26202976; 27052676
3728	NMRK2 ITGB1BP3 NRK2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.19 mM for nicotinamide riboside (with ATP as cosubstrate) {ECO:0000269|PubMed:17914902}; KM=30 mM for nicotinamide riboside (with GTP as cosubstrate) {ECO:0000269|PubMed:17914902}; KM=0.11 mM for tiazofurin (with ATP as cosubstrate) {ECO:0000269|PubMed:17914902}; KM=0.063 mM for nicotinic acid riboside (with ATP as cosubstrate) {ECO:0000269|PubMed:17914902}; KM=1.3 mM for uridine (with ATP as cosubstrate) {ECO:0000269|PubMed:17914902}; 	2.7.1.22; 2.7.1.173	CATALYTIC ACTIVITY: ATP + 1-(beta-D-ribofuranosyl)-nicotinamide = ADP + beta-nicotinamide D-ribonucleotide. {ECO:0000269|PubMed:17914902}.; CATALYTIC ACTIVITY: ATP + beta-D-ribosylnicotinate = ADP + nicotinate beta-D-ribonucleotide. {ECO:0000269|PubMed:17914902}.	BINDING 130 130 ATP. {ECO:0000250|UniProtKB:Q9NWW6}.; BINDING 131 131 Substrate. {ECO:0000250|UniProtKB:Q9NWW6}.				PATHWAY: Cofactor biosynthesis; NAD(+) biosynthesis. {ECO:0000305|PubMed:17914902}.				NAD biosynthetic process [GO:0009435]; NAD metabolic process [GO:0019674]; negative regulation of myoblast differentiation [GO:0045662]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; ribosylnicotinamide kinase activity [GO:0050262]; ribosylnicotinate kinase activity [GO:0061769]; NAD biosynthetic process [GO:0009435]; NAD metabolic process [GO:0019674]; negative regulation of myoblast differentiation [GO:0045662]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; ribosylnicotinamide kinase activity [GO:0050262]; ribosylnicotinate kinase activity [GO:0061769]	GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0009435; GO:0019674; GO:0043231; GO:0045662; GO:0046872; GO:0050262; GO:0061769				10613898; 15137942; 14702039; 15057824; 15489334; 12941630; 17914902; 12809483; 16169070; 19531469; 21504897; 21900206	10613898; 15137942; 14702039; 15057824; 15489334; 12941630; 17914902
3849	NAT8 CML1 GLA TSC501	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=64 uM for S-benzyl-L-cysteine (at 37 degrees Celsius) {ECO:0000269|PubMed:20392701}; KM=23 uM for acetyl-CoA (at 37 degrees Celsius) {ECO:0000269|PubMed:20392701}; Note=A Vmax of 4.4 nmol/min/mg enzyme toward S-benzyl-L-cysteine was estimated using crude cell extracts. A Vmax of 3.1 nmol/min/mg enzyme toward acetyl-CoA was estimated using crude cell extracts.;	2.3.1.-; 2.3.1.80	CATALYTIC ACTIVITY: Acetyl-CoA + an L-cysteine-S-conjugate = CoA + an N-acetyl L-cysteine-S-conjugate. {ECO:0000269|PubMed:20392701}.					PATHWAY: Sulfur metabolism; glutathione metabolism. {ECO:0000269|PubMed:20392701}.				amyloid-beta metabolic process [GO:0050435]; cellular protein metabolic process [GO:0044267]; glutathione metabolic process [GO:0006749]; negative regulation of apoptotic process [GO:0043066]; peptidyl-lysine N6-acetylation [GO:0018003]; positive regulation of gene expression [GO:0010628]; response to drug [GO:0042493]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; cysteine-S-conjugate N-acetyltransferase activity [GO:0047198]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; amyloid-beta metabolic process [GO:0050435]; cellular protein metabolic process [GO:0044267]; glutathione metabolic process [GO:0006749]; negative regulation of apoptotic process [GO:0043066]; peptidyl-lysine N6-acetylation [GO:0018003]; positive regulation of gene expression [GO:0010628]; response to drug [GO:0042493]	cysteine-S-conjugate N-acetyltransferase activity [GO:0047198]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]	GO:0004468; GO:0005783; GO:0005789; GO:0005793; GO:0006749; GO:0010628; GO:0016021; GO:0018003; GO:0033116; GO:0042493; GO:0043066; GO:0044267; GO:0047198; GO:0050435	SUBCELLULAR LOCATION: Endoplasmic reticulum-Golgi intermediate compartment membrane; Single-pass type II membrane protein. Endoplasmic reticulum membrane; Single-pass type II membrane protein.			9852678; 11397015; 15489334; 19011241; 20392701; 22267734; 24556617; 17425515; 18402670; 20383145; 20385109; 20711500; 25301944; 26819345	9852678; 11397015; 15489334; 19011241; 20392701; 22267734; 24556617
3869	NIT2 CUA002	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=0.009 mM for alpha-ketoglutaramate (open-chain form) {ECO:0000269|PubMed:19595734}; Vmax=5.9 umol/min/mg enzyme with alpha-ketoglutaramate as substrate {ECO:0000269|PubMed:19595734}; Note=In solution, alpha-ketoglutaramate is in equilibrium with a cyclic form (2-hydroxy-5-oxoproline), and at pH 8.0 or above, the rate of ring opening is no longer limiting for the omega-amidase reaction.;	3.5.1.3	CATALYTIC ACTIVITY: A monoamide of a dicarboxylate + H(2)O = a dicarboxylate + NH(3).							CUA002		asparagine metabolic process [GO:0006528]; glutamine metabolic process [GO:0006541]; neutrophil degranulation [GO:0043312]; oxaloacetate metabolic process [GO:0006107]	centrosome [GO:0005813]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]	centrosome [GO:0005813]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; omega-amidase activity [GO:0050152]; asparagine metabolic process [GO:0006528]; glutamine metabolic process [GO:0006541]; neutrophil degranulation [GO:0043312]; oxaloacetate metabolic process [GO:0006107]	omega-amidase activity [GO:0050152]	GO:0005576; GO:0005813; GO:0005829; GO:0006107; GO:0006528; GO:0006541; GO:0035580; GO:0043312; GO:0050152; GO:0070062; GO:1904724	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17488281}.		MOD_RES 26 26 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 68 68 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q9JHW2}.; MOD_RES 68 68 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q9JHW2}.; MOD_RES 123 123 N6-succinyllysine. {ECO:0000250|UniProtKB:Q9JHW2}.; MOD_RES 130 130 N6-succinyllysine. {ECO:0000250|UniProtKB:Q9JHW2}.	10959838; 14702039; 15489334; 14528910; 15592455; 17488281; 19595734; 21269460; 24275569; 25944712; 20711500; 22674578; 23650620; 25008847; 25609649; 25738796	10959838; 14702039; 15489334; 14528910; 15592455; 17488281; 19595734; 21269460; 24275569; 25944712
3879	NOX5	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.06 uM for calcium {ECO:0000269|PubMed:14982937}; 	1.6.3.-			ACTIVITY REGULATION: Activated by calcium which induces conformational changes and interaction between the N-terminal regulatory region and the C-terminal catalytic region. Inhibited by diphenylene iodonium. {ECO:0000269|PubMed:14982937}.	COFACTOR: Name=FAD; Xref=ChEBI:CHEBI:57692; Evidence={ECO:0000269|PubMed:14982937}; ; COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:14982937}; 						angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell proliferation [GO:0008283]; cellular response to oxidative stress [GO:0034599]; cytokine secretion [GO:0050663]; cytoskeleton-dependent cytokinesis [GO:0061640]; endothelial cell proliferation [GO:0001935]; oxidation-reduction process [GO:0055114]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of fusion of sperm to egg plasma membrane [GO:0043012]; regulation of proton transport [GO:0010155]; superoxide anion generation [GO:0042554]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; NADP binding [GO:0050661]; proton channel activity [GO:0015252]; superoxide-generating NADPH oxidase activity [GO:0016175]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell proliferation [GO:0008283]; cellular response to oxidative stress [GO:0034599]; cytokine secretion [GO:0050663]; cytoskeleton-dependent cytokinesis [GO:0061640]; endothelial cell proliferation [GO:0001935]; oxidation-reduction process [GO:0055114]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of fusion of sperm to egg plasma membrane [GO:0043012]; regulation of proton transport [GO:0010155]; superoxide anion generation [GO:0042554]	calcium ion binding [GO:0005509]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; NADP binding [GO:0050661]; proton channel activity [GO:0015252]; superoxide-generating NADPH oxidase activity [GO:0016175]	GO:0001525; GO:0001935; GO:0005509; GO:0005783; GO:0005789; GO:0006915; GO:0008283; GO:0010155; GO:0015252; GO:0016021; GO:0016175; GO:0020037; GO:0034599; GO:0042554; GO:0043012; GO:0050660; GO:0050661; GO:0050663; GO:0055114; GO:0061640; GO:2000379	SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.; SUBCELLULAR LOCATION: Isoform v2: Endoplasmic reticulum.; SUBCELLULAR LOCATION: Isoform v5: Endoplasmic reticulum.			11483596; 14702039; 16572171; 15489334; 15994299; 11376945; 12686516; 14982937; 16179589; 16339585; 17275676; 12121572; 12186557; 15927447; 16177112; 16707484; 16873416; 17089090; 17122966; 17164239; 17214994; 17346712; 17587483; 17603936; 17947454; 18466778; 18468509; 18614798; 18672905; 20056178; 20086178; 20339118; 20576920; 21297032; 21319793; 21525435; 21901141; 22182486; 22291013; 22387196; 22427510; 22503554; 23030296; 23439561; 23851018; 24262797; 24505490; 24688893; 25415612; 25559363; 25706776; 25722086; 25797883; 25871798; 26510438; 26901778; 26963053; 27391469; 27511066; 27614387; 28034671; 28473473; 28762556; 28830888; 29048637	11483596; 14702039; 16572171; 15489334; 15994299; 11376945; 12686516; 14982937; 16179589; 16339585; 17275676
3885	NDST1 HSST HSST1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=13.3 uM for K5 polysaccharide {ECO:0000269|PubMed:12634318}; KM=0.35 uM for N-acetylated HS-II {ECO:0000269|PubMed:12634318}; 	2.8.2.8; 3.-.-.-; 2.8.2.-	CATALYTIC ACTIVITY: 3'-phosphoadenylyl sulfate + [heparan sulfate]-glucosamine = adenosine 3',5'-bisphosphate + [heparan sulfate]-N-sulfoglucosamine.	BINDING 712 712 PAPS. {ECO:0000269|PubMed:10196134}.				PATHWAY: Glycan metabolism; heparan sulfate biosynthesis.; PATHWAY: Glycan metabolism; heparin biosynthesis.				aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; fibroblast growth factor receptor signaling pathway [GO:0008543]; forebrain development [GO:0030900]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; inflammatory response [GO:0006954]; midbrain development [GO:0030901]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of smoothened signaling pathway [GO:0045880]; protein sulfation [GO:0006477]; respiratory gaseous exchange [GO:0007585]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; [heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; heparan sulfate N-acetylglucosaminyltransferase activity [GO:0042328]; N-acetylglucosamine deacetylase activity [GO:0050119]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; fibroblast growth factor receptor signaling pathway [GO:0008543]; forebrain development [GO:0030900]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; inflammatory response [GO:0006954]; midbrain development [GO:0030901]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of smoothened signaling pathway [GO:0045880]; protein sulfation [GO:0006477]; respiratory gaseous exchange [GO:0007585]	[heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; heparan sulfate N-acetylglucosaminyltransferase activity [GO:0042328]; N-acetylglucosamine deacetylase activity [GO:0050119]	GO:0000139; GO:0003279; GO:0006024; GO:0006477; GO:0006954; GO:0007585; GO:0008543; GO:0015012; GO:0015014; GO:0015016; GO:0016021; GO:0030210; GO:0030900; GO:0030901; GO:0035904; GO:0042328; GO:0043410; GO:0045880; GO:0048702; GO:0048703; GO:0050119; GO:0060976	SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000269|PubMed:9230113}; Single-pass type II membrane protein {ECO:0000269|PubMed:9230113}.			7601448; 9230113; 15489334; 9744796; 10758005; 12634318; 22660413; 18337501; 10196134; 25125150; 11087757; 14966466; 16343444; 19336475; 19710461; 19851296; 19915053; 20129923; 20198315; 21947487; 23884416; 25156775; 26109066; 28211985; 28404855; 9915799	7601448; 9230113; 15489334; 9744796; 10758005; 12634318; 22660413; 18337501; 10196134; 25125150
3900	NMNAT2 C1orf15 KIAA0479	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=32 uM for NMN {ECO:0000269|PubMed:16118205, ECO:0000269|PubMed:17402747}; KM=70 uM for NAD(+) {ECO:0000269|PubMed:16118205, ECO:0000269|PubMed:17402747}; KM=204 uM for ATP {ECO:0000269|PubMed:16118205, ECO:0000269|PubMed:17402747}; KM=1119 uM for PPi {ECO:0000269|PubMed:16118205, ECO:0000269|PubMed:17402747}; KM=14.5 uM for NaMN {ECO:0000269|PubMed:16118205, ECO:0000269|PubMed:17402747}; KM=304 uM for NMNH {ECO:0000269|PubMed:16118205, ECO:0000269|PubMed:17402747}; Vmax=1.1 umol/min/mg enzyme for NAD synthesis {ECO:0000269|PubMed:16118205, ECO:0000269|PubMed:17402747}; Vmax=3 umol/min/mg enzyme for pyrophosphorolytic NAD(+) cleavage {ECO:0000269|PubMed:16118205, ECO:0000269|PubMed:17402747}; Vmax=7 umol/min/mg enzyme for pyrophosphorolytic NADH cleavage {ECO:0000269|PubMed:16118205, ECO:0000269|PubMed:17402747}; Note=KM is >100 uM for triazofurin monophosphate.;	2.7.7.1; 2.7.7.18	CATALYTIC ACTIVITY: ATP + nicotinamide ribonucleotide = diphosphate + NAD(+). {ECO:0000269|PubMed:16118205, ECO:0000269|PubMed:17402747}.; CATALYTIC ACTIVITY: ATP + beta-nicotinate-D-ribonucleotide = diphosphate + deamido-NAD(+). {ECO:0000269|PubMed:16118205, ECO:0000269|PubMed:17402747}.	BINDING 24 24 ATP. {ECO:0000250|UniProtKB:Q96T66}.	ACTIVITY REGULATION: Inhibited by P1-(adenosine-5')-P3-(nicotinamide-riboside-5')-triphosphate (Np3AD) and P1-(adenosine-5')-P4-(nicotinamide-riboside-5')-tetraphosphate (Np4AD). {ECO:0000269|PubMed:17402747}.	COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:12359228, ECO:0000269|PubMed:14516279, ECO:0000269|PubMed:17402747}; ;  Note=Divalent metal cations. Mg(2+) confers the highest activity. {ECO:0000269|PubMed:12359228, ECO:0000269|PubMed:14516279, ECO:0000269|PubMed:17402747};	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 6.0-9.0. {ECO:0000269|PubMed:12359228, ECO:0000269|PubMed:16118205, ECO:0000269|PubMed:17402747};	PATHWAY: Cofactor biosynthesis; NAD(+) biosynthesis; NAD(+) from nicotinamide D-ribonucleotide: step 1/1. {ECO:0000269|PubMed:16118205, ECO:0000269|PubMed:17402747}.; PATHWAY: Cofactor biosynthesis; NAD(+) biosynthesis; deamido-NAD(+) from nicotinate D-ribonucleotide: step 1/1. {ECO:0000269|PubMed:16118205, ECO:0000269|PubMed:17402747}.				'de novo' NAD biosynthetic process from aspartate [GO:0034628]; NAD biosynthetic process [GO:0009435]; NAD metabolic process [GO:0019674]	axon [GO:0030424]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]	axon [GO:0030424]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; nicotinamide-nucleotide adenylyltransferase activity [GO:0000309]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]; 'de novo' NAD biosynthetic process from aspartate [GO:0034628]; NAD biosynthetic process [GO:0009435]; NAD metabolic process [GO:0019674]	ATP binding [GO:0005524]; nicotinamide-nucleotide adenylyltransferase activity [GO:0000309]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]	GO:0000139; GO:0000309; GO:0004515; GO:0005524; GO:0005770; GO:0005794; GO:0005802; GO:0009435; GO:0019674; GO:0030424; GO:0030659; GO:0034628; GO:0045202	SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000269|PubMed:16118205}; Lipid-anchor {ECO:0000250|UniProtKB:Q8BNJ3}. Cytoplasmic vesicle membrane {ECO:0000250|UniProtKB:Q8BNJ3}; Lipid-anchor {ECO:0000250|UniProtKB:Q8BNJ3}. Cytoplasm {ECO:0000269|PubMed:16118205}. Cell projection, axon {ECO:0000250|UniProtKB:Q8BNJ3}. Note=Delivered to axons with Golgi-derived cytoplasmic vesicles. {ECO:0000250|UniProtKB:Q8BNJ3}.	PTM: Degraded in response to injured neurite. Degradation is probably caused by ubiquitination by MYCBP2 (By similarity). Ubiquitinated on threonine and/or serine residues by MYCBP2; consequences of threonine and/or serine ubiquitination are however unclear (PubMed:29643511). {ECO:0000250|UniProtKB:Q8BNJ3, ECO:0000269|PubMed:29643511}.; PTM: Palmitoylated; palmitoylation is required for membrane association. {ECO:0000250|UniProtKB:Q8BNJ3}.		11318611; 9455484; 16710414; 15489334; 12359228; 14516279; 16118205; 17402747; 29643511; 20379614; 20388704; 20857515; 20943658; 20962850; 22027994; 23579329; 23764899; 24552824; 24840802; 26783109; 27218101; 27254664; 28544218; 28855716	11318611; 9455484; 16710414; 15489334; 12359228; 14516279; 16118205; 17402747; 29643511
4277	PUDP DXF68S1E FAM16AX GS1 HDHD1 HDHD1A	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.38 uM for 5'-PsiMP {ECO:0000269|PubMed:20722631}; KM=1.5 mM for 3'-AMP {ECO:0000269|PubMed:20722631}; KM=5.9 mM for Fructose-6-P {ECO:0000269|PubMed:20722631}; KM=9.4 mM for 5'-UMP {ECO:0000269|PubMed:20722631}; 	3.1.3.96	CATALYTIC ACTIVITY: Pseudouridine 5'-phosphate + H(2)O = pseudouridine + phosphate. {ECO:0000269|PubMed:20722631}.			COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:20722631}; 						nucleotide metabolic process [GO:0009117]; pyrimidine nucleoside salvage [GO:0043097]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; pseudouridine 5'-phosphatase activity [GO:1990738]; nucleotide metabolic process [GO:0009117]; pyrimidine nucleoside salvage [GO:0043097]	hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; pseudouridine 5'-phosphatase activity [GO:1990738]	GO:0005737; GO:0005829; GO:0009117; GO:0016787; GO:0016791; GO:0043097; GO:0046872; GO:1990738					14702039; 15772651; 15489334; 1284467; 20722631; 21269460; 
4299	HAO1 GOX1 HAOX1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=141 uM for glycolate {ECO:0000269|PubMed:18215067}; KM=40 uM for 2-hydroxy octanoate {ECO:0000269|PubMed:18215067}; KM=2200 uM for glyoxylate {ECO:0000269|PubMed:18215067}; 	1.1.3.15	CATALYTIC ACTIVITY: (S)-2-hydroxy acid + O(2) = 2-oxo acid + H(2)O(2). {ECO:0000269|PubMed:18215067}.	BINDING 26 26 Substrate.; BINDING 108 108 FMN. {ECO:0000255|PROSITE-ProRule:PRU00683, ECO:0000269|PubMed:18215067, ECO:0000269|PubMed:20054120, ECO:0000269|Ref.10}.; BINDING 130 130 FMN. {ECO:0000255|PROSITE-ProRule:PRU00683, ECO:0000269|PubMed:18215067, ECO:0000269|PubMed:20054120, ECO:0000269|Ref.10}.; BINDING 132 132 FMN. {ECO:0000255|PROSITE-ProRule:PRU00683, ECO:0000269|PubMed:18215067, ECO:0000269|PubMed:20054120, ECO:0000269|Ref.10}.; BINDING 132 132 Substrate.; BINDING 158 158 FMN. {ECO:0000255|PROSITE-ProRule:PRU00683, ECO:0000269|PubMed:18215067, ECO:0000269|PubMed:20054120, ECO:0000269|Ref.10}.; BINDING 167 167 Substrate.; BINDING 236 236 FMN. {ECO:0000255|PROSITE-ProRule:PRU00683, ECO:0000269|PubMed:18215067, ECO:0000269|PubMed:20054120, ECO:0000269|Ref.10}.; BINDING 258 258 FMN. {ECO:0000255|PROSITE-ProRule:PRU00683, ECO:0000269|PubMed:18215067, ECO:0000269|PubMed:20054120, ECO:0000269|Ref.10}.; BINDING 263 263 Substrate.; BINDING 315 315 FMN. {ECO:0000255|PROSITE-ProRule:PRU00683, ECO:0000269|PubMed:18215067, ECO:0000269|PubMed:20054120, ECO:0000269|Ref.10}.		COFACTOR: Name=FMN; Xref=ChEBI:CHEBI:58210; Evidence={ECO:0000255|PROSITE-ProRule:PRU00683, ECO:0000269|PubMed:18215067}; 		PATHWAY: Organic acid metabolism; glycolate degradation; 3-phospho-D-glycerate from glycolate: step 1/4.				cellular nitrogen compound metabolic process [GO:0034641]; fatty acid alpha-oxidation [GO:0001561]; glycolate catabolic process [GO:0046296]; protein targeting to peroxisome [GO:0006625]; response to oxidative stress [GO:0006979]	cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; (S)-2-hydroxy-acid oxidase activity [GO:0003973]; FMN binding [GO:0010181]; glycolate oxidase activity [GO:0008891]; glyoxylate oxidase activity [GO:0047969]; long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity [GO:0052853]; medium-chain-(S)-2-hydroxy-acid oxidase activity [GO:0052854]; signaling receptor binding [GO:0005102]; very-long-chain-(S)-2-hydroxy-acid oxidase activity [GO:0052852]; cellular nitrogen compound metabolic process [GO:0034641]; fatty acid alpha-oxidation [GO:0001561]; glycolate catabolic process [GO:0046296]; protein targeting to peroxisome [GO:0006625]; response to oxidative stress [GO:0006979]	(S)-2-hydroxy-acid oxidase activity [GO:0003973]; FMN binding [GO:0010181]; glycolate oxidase activity [GO:0008891]; glyoxylate oxidase activity [GO:0047969]; long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity [GO:0052853]; medium-chain-(S)-2-hydroxy-acid oxidase activity [GO:0052854]; signaling receptor binding [GO:0005102]; very-long-chain-(S)-2-hydroxy-acid oxidase activity [GO:0052852]	GO:0001561; GO:0003973; GO:0005102; GO:0005777; GO:0005782; GO:0005829; GO:0006625; GO:0006979; GO:0008891; GO:0010181; GO:0034641; GO:0046296; GO:0047969; GO:0052852; GO:0052853; GO:0052854	SUBCELLULAR LOCATION: Peroxisome.		MOD_RES 184 184 N6-succinyllysine. {ECO:0000250|UniProtKB:Q9WU19}.; MOD_RES 194 194 Phosphoserine. {ECO:0000250|UniProtKB:Q9WU19}.; MOD_RES 230 230 Phosphoserine. {ECO:0000244|PubMed:24275569}.	10978532; 10777549; 11780052; 15489334; 24275569; 18215067; 20054120; 14623081; 17669354; 20189245; 21141873	10978532; 10777549; 11780052; 15489334; 24275569; 18215067; 20054120; 
4326	FPGS	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=201 uM for L-glutamate (isoform 2 at 37 degrees Celsius in the presence of 1 mM ATP and 2 mM L-glutamate) {ECO:0000269|PubMed:17875718, ECO:0000269|PubMed:8662720}; KM=200 uM for MgATP (isoform 2 at 37 degrees Celsius in the presence of 1 mM ATP and 2 mM L-glutamate) {ECO:0000269|PubMed:17875718, ECO:0000269|PubMed:8662720}; KM=59 uM for pteroylglutamic acid (PteGlu) (isoform 2 at 37 degrees Celsius in the presence of 1 mM ATP and 2 mM L-glutamate) {ECO:0000269|PubMed:17875718, ECO:0000269|PubMed:8662720}; KM=16 uM for PteGlu(2) (isoform 2 at 37 degrees Celsius in the presence of 1 mM ATP and 2 mM L-glutamate) {ECO:0000269|PubMed:17875718, ECO:0000269|PubMed:8662720}; KM=20 uM for PteGlu(3) (isoform 2 at 37 degrees Celsius in the presence of 1 mM ATP and 2 mM L-glutamate) {ECO:0000269|PubMed:17875718, ECO:0000269|PubMed:8662720}; KM=12 uM for PteGlu(4) (isoform 2 at 37 degrees Celsius in the presence of 1 mM ATP and 2 mM L-glutamate) {ECO:0000269|PubMed:17875718, ECO:0000269|PubMed:8662720}; KM=64 uM for PteGlu(5) (isoform 2 at 37 degrees Celsius in the presence of 1 mM ATP and 2 mM L-glutamate) {ECO:0000269|PubMed:17875718, ECO:0000269|PubMed:8662720}; KM=0.81 uM for H(2)PteGlu (isoform 2 at 37 degrees Celsius in the presence of 1 mM ATP and 2 mM L-glutamate) {ECO:0000269|PubMed:17875718, ECO:0000269|PubMed:8662720}; KM=47 uM for H(2)PteGlu(2) (isoform 2 at 37 degrees Celsius in the presence of 1 mM ATP and 2 mM L-glutamate) {ECO:0000269|PubMed:17875718, ECO:0000269|PubMed:8662720}; KM=1.6 uM for (6ambo)-tetrahydropteroylpoly-gamma-glutamate (H(4)PteGlu) (isoform 2 at 37 degrees Celsius in the presence of 1 mM ATP and 2 mM L-glutamate) {ECO:0000269|PubMed:17875718, ECO:0000269|PubMed:8662720}; KM=4.4 uM for (6S)-H(4)PteGlu (isoform 2 at 37 degrees Celsius in the presence of 1 mM ATP and 2 mM L-glutamate) {ECO:0000269|PubMed:17875718, ECO:0000269|PubMed:8662720}; KM=3.3 uM for (6S)-H(4)PteGlu(2) (isoform 2 at 37 degrees Celsius in the presence of 1 mM ATP and 2 mM L-glutamate) {ECO:0000269|PubMed:17875718, ECO:0000269|PubMed:8662720}; KM=1.4 uM for (6S)-H(4)PteGlu(3) (isoform 2 at 37 degrees Celsius in the presence of 1 mM ATP and 2 mM L-glutamate) {ECO:0000269|PubMed:17875718, ECO:0000269|PubMed:8662720}; KM=1.6 uM for (6S)-H(4)PteGlu(4) (isoform 2 at 37 degrees Celsius in the presence of 1 mM ATP and 2 mM L-glutamate) {ECO:0000269|PubMed:17875718, ECO:0000269|PubMed:8662720}; KM=1.4 uM for (6S)-H(4)PteGlu(5) (isoform 2 at 37 degrees Celsius in the presence of 1 mM ATP and 2 mM L-glutamate) {ECO:0000269|PubMed:17875718, ECO:0000269|PubMed:8662720}; KM=3.7 uM for (6R)-10-formyl-H(4)PteGlu (isoform 2 at 37 degrees Celsius in the presence of 1 mM ATP and 2 mM L-glutamate) {ECO:0000269|PubMed:17875718, ECO:0000269|PubMed:8662720}; KM=2.7 uM for (6R)-10-formyl-H(4)PteGlu(2) (isoform 2 at 37 degrees Celsius in the presence of 1 mM ATP and 2 mM L-glutamate) {ECO:0000269|PubMed:17875718, ECO:0000269|PubMed:8662720}; KM=105 uM for (6S)-5-formyl-H(4)PteGlu (isoform 2 at 37 degrees Celsius in the presence of 1 mM ATP and 2 mM L-glutamate) {ECO:0000269|PubMed:17875718, ECO:0000269|PubMed:8662720}; KM=13 uM for (6S)-5-formyl-H(4)PteGlu(2) (isoform 2 at 37 degrees Celsius in the presence of 1 mM ATP and 2 mM L-glutamate) {ECO:0000269|PubMed:17875718, ECO:0000269|PubMed:8662720}; KM=48 uM for (6S)-5-methyl-H(4)PteGlu (isoform 2 at 37 degrees Celsius in the presence of 1 mM ATP and 2 mM L-glutamate) {ECO:0000269|PubMed:17875718, ECO:0000269|PubMed:8662720}; KM=4.4 uM for aminopterin (isoform 2 at 37 degrees Celsius in the presence of 1 mM ATP and 2 mM L-glutamate) {ECO:0000269|PubMed:17875718, ECO:0000269|PubMed:8662720}; KM=55.5 uM for methotrexate (isoform 2, at 37 degrees Celsius in the presence of 10 mM ATP and pH 8.5) {ECO:0000269|PubMed:17875718}; KM=52.6 uM for methotrexate (isoform 1, at 37 degrees Celsius in the presence of 10 mM ATP and pH 8.5) {ECO:0000269|PubMed:17875718}; KM=71 uM for methotrexate (Glu-1) (isoform 2, at 37 degrees Celsius in the presence of 1 mM ATP and 2 mM L-glutamate) {ECO:0000269|PubMed:8662720}; KM=50 uM for methotrexate (Glu-2) (isoform 2, at 37 degrees Celsius in the presence of 1 mM ATP and 2 mM L-glutamate) {ECO:0000269|PubMed:8662720}; KM=148 uM for methotrexate (Glu-3) (isoform 2, at 37 degrees Celsius in the presence of 1 mM ATP and 2 mM L-glutamate) {ECO:0000269|PubMed:8662720}; KM=5.3 uM for 5-deazaacyclotetrahydrofolate (isoform 2, at 37 degrees Celsius in the presence of 1 mM ATP and 2 mM L-glutamate) {ECO:0000269|PubMed:8662720}; KM=2.8 uM for 2-methyl-5,8-dideazaisofolate (isoform 2, at 37 degrees Celsius in the presence of 1 mM ATP and 2 mM L-glutamate) {ECO:0000269|PubMed:8662720}; KM=1702 uM for glutamic acid (isoform 2, at 37 degrees Celsius in the presence of 10 mM ATP and pH 8.5) {ECO:0000269|PubMed:17875718}; KM=2068 uM for glutamic acid (isoform 1, at 37 degrees Celsius in the presence of 10 mM ATP and pH 8.5) {ECO:0000269|PubMed:17875718}; Vmax=0.34 umol/h/mg enzyme with methotrexate as substrate (isoform 2, at 37 degrees Celsius in the presence of 10 mM ATP and pH 8.5) {ECO:0000269|PubMed:17875718}; Vmax=0.05 umol/h/mg enzyme with methotrexate as substrate (isoform 1, at 37 degrees Celsius in the presence of 10 mM ATP and pH 8.5) {ECO:0000269|PubMed:17875718}; Vmax=1.26 umol/h/mg enzyme with glutamic acid as substrate (isoform 2, at 37 degrees Celsius in the presence of 10 mM ATP and pH 8.5) {ECO:0000269|PubMed:17875718}; Vmax=0.25 umol/h/mg enzyme with glutamic acid as substrate (isoform 1, at 37 degrees Celsius in the presence of 10 mM ATP and pH 8.5) {ECO:0000269|PubMed:17875718}; 	6.3.2.17	CATALYTIC ACTIVITY: ATP + tetrahydropteroyl-(gamma-Glu)(n) + L-glutamate = ADP + phosphate + tetrahydropteroyl-(gamma-Glu)(n+1). {ECO:0000269|PubMed:1409616, ECO:0000269|PubMed:17875718, ECO:0000269|PubMed:18672898, ECO:0000269|PubMed:8408018, ECO:0000269|PubMed:8408020, ECO:0000269|PubMed:8662720}.	BINDING 363 363 ATP. {ECO:0000250|UniProtKB:P08192}.; BINDING 377 377 ATP. {ECO:0000250|UniProtKB:P08192}.	ACTIVITY REGULATION: Activated by 10 mM sodium bicarbonate. {ECO:0000269|PubMed:8662720}.	COFACTOR: Name=K(+); Xref=ChEBI:CHEBI:29103; Evidence={ECO:0000269|PubMed:8662720}; Name=NH4(+); Xref=ChEBI:CHEBI:28938; Evidence={ECO:0000269|PubMed:8662720}; ;  Note=A monovalent cation. K(+) is most effective, followed by NH4(+) and Rb(+). Na(+), Li(+) and Cs(+) are ineffective. {ECO:0000269|PubMed:8662720};	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 9.6 (isoform 2). {ECO:0000269|PubMed:17875718, ECO:0000269|PubMed:8662720};	PATHWAY: Cofactor biosynthesis; tetrahydrofolylpolyglutamate biosynthesis.				animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell proliferation [GO:0008283]; dihydrofolate biosynthetic process [GO:0006761]; folic acid-containing compound metabolic process [GO:0006760]; folic acid metabolic process [GO:0046655]; glutamate metabolic process [GO:0006536]; liver development [GO:0001889]; nucleobase-containing compound metabolic process [GO:0006139]; one-carbon metabolic process [GO:0006730]; tetrahydrofolylpolyglutamate biosynthetic process [GO:0046901]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tetrahydrofolylpolyglutamate synthase activity [GO:0004326]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell proliferation [GO:0008283]; dihydrofolate biosynthetic process [GO:0006761]; folic acid metabolic process [GO:0046655]; folic acid-containing compound metabolic process [GO:0006760]; glutamate metabolic process [GO:0006536]; liver development [GO:0001889]; nucleobase-containing compound metabolic process [GO:0006139]; one-carbon metabolic process [GO:0006730]; tetrahydrofolylpolyglutamate biosynthetic process [GO:0046901]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tetrahydrofolylpolyglutamate synthase activity [GO:0004326]	GO:0001889; GO:0004326; GO:0005524; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006139; GO:0006536; GO:0006730; GO:0006760; GO:0006761; GO:0007420; GO:0008283; GO:0031100; GO:0046655; GO:0046872; GO:0046901	SUBCELLULAR LOCATION: Isoform 1: Mitochondrion inner membrane {ECO:0000269|PubMed:16169100}. Mitochondrion matrix {ECO:0000269|PubMed:16169100, ECO:0000269|PubMed:8408020, ECO:0000269|PubMed:8662720}.; SUBCELLULAR LOCATION: Isoform 2: Cytoplasm {ECO:0000269|PubMed:8662720}.		MOD_RES 43 43 N-acetylmethionine. {ECO:0000244|PubMed:22814378}.; MOD_RES 539 539 Phosphoserine. {ECO:0000244|PubMed:23186163}.	14702039; 15164053; 15489334; 8662720; 7721888; 1409616; 8521387; 8408018; 8408019; 8408020; 8408021; 16169100; 17875718; 18672898; 22814378; 23186163; 14676127; 16122883; 16707018; 17119116; 17286537; 17891500; 18381794; 18830263; 18842806; 19016697; 19093297; 19131550; 19161160; 19636555; 19841321; 20037791; 20453000; 20651609; 20877624; 21093159; 21380490; 21418912; 22018726; 22698741; 22809608; 22895141; 24583629; 24908438; 25164808; 25229333; 25765001; 26107232; 26652611; 26676887; 26751406; 26895662; 27036162; 27064343; 27387303; 27987364	14702039; 15164053; 15489334; 8662720; 7721888; 1409616; 8521387; 8408018; 8408019; 8408020; 8408021; 16169100; 17875718; 18672898; 22814378; 23186163
4380	FMO3	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=21 uM for trimethylamine (at pH 8.5) {ECO:0000269|PubMed:17050781, ECO:0000269|PubMed:17531949}; KM=31 uM for trimethylamine (at pH 7.4 and 37 degrees Celsius) {ECO:0000269|PubMed:17050781, ECO:0000269|PubMed:17531949}; KM=43 uM for benzydamine (at pH 7.4 and 37 degrees Celsius) {ECO:0000269|PubMed:17050781, ECO:0000269|PubMed:17531949}; KM=55.7 uM for ethylenethiourea (at pH 8.5) {ECO:0000269|PubMed:17050781, ECO:0000269|PubMed:17531949}; KM=71.8 uM for methimazole (at pH 8.5) {ECO:0000269|PubMed:17050781, ECO:0000269|PubMed:17531949}; KM=150.1 uM for sulindac (at pH 8.5) {ECO:0000269|PubMed:17050781, ECO:0000269|PubMed:17531949}; KM=248 uM for methyl p-tolyl sulfide (at pH 7.4 and 37 degrees Celsius) {ECO:0000269|PubMed:17050781, ECO:0000269|PubMed:17531949}; 	1.14.13.8; 1.14.13.148	CATALYTIC ACTIVITY: N,N-dimethylaniline + NADPH + O(2) = N,N-dimethylaniline N-oxide + NADP(+) + H(2)O. {ECO:0000269|PubMed:9536088}.; CATALYTIC ACTIVITY: N,N,N-trimethylamine + NADPH + O(2) = N,N,N-trimethylamine N-oxide + NADP(+) + H(2)O. {ECO:0000269|PubMed:9536088}.	BINDING 32 32 FAD. {ECO:0000250|UniProtKB:Q9HFE4}.		COFACTOR: Name=FAD; Xref=ChEBI:CHEBI:57692; 						oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; organelle membrane [GO:0031090]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; organelle membrane [GO:0031090]; flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; trimethylamine monooxygenase activity [GO:0034899]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]	flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; trimethylamine monooxygenase activity [GO:0034899]	GO:0004497; GO:0004499; GO:0005789; GO:0006805; GO:0016021; GO:0031090; GO:0034899; GO:0043231; GO:0050660; GO:0050661; GO:0055114	SUBCELLULAR LOCATION: Microsome membrane {ECO:0000250|UniProtKB:P32417}; Single-pass membrane protein {ECO:0000255}. Endoplasmic reticulum membrane {ECO:0000250|UniProtKB:P32417}; Single-pass membrane protein {ECO:0000255}.		MOD_RES 401 401 Phosphoserine. {ECO:0000250|UniProtKB:P97501}.	1542660; 8654418; 9417913; 14702039; 16710414; 15489334; 9224773; 9536088; 17531949; 24275569; 10338091; 10479479; 11191884; 12527699; 15618753; 12893987; 17050781; 11717182; 11809920; 12814961; 12903042; 15203093; 15623613; 16183778; 16214918; 16324215; 16481213; 16598836; 16600650; 16800822; 16858129; 16863467; 16996766; 17096187; 17142560; 17257434; 17559352; 17584019; 17786630; 17881660; 17885620; 18180394; 18305374; 18443301; 19321370; 19336370; 19356079; 19571433; 19577495; 19761368; 19898482; 20056567; 20173083; 20182906; 20198379; 20529763; 20679960; 20734064; 21075259; 22409263; 22819296; 23147717; 23211429; 23266626; 23510775; 23563705; 23567996; 23791655; 23855261; 24028545; 24173915; 24448396; 25224784; 25288227; 25760532; 25849138; 26218418; 26519273; 26616280; 26839369; 26856397; 27513517; 27523475; 28331852; 28413702; 28819071; 29121650; 4195988; 5048998	1542660; 8654418; 9417913; 14702039; 16710414; 15489334; 9224773; 9536088; 17531949; 24275569; 10338091; 10479479; 11191884; 12527699; 15618753; 12893987; 17050781
4412	HAT1 KAT1	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=6.68 uM for acetyl-CoA {ECO:0000269|PubMed:22615379}; Note=kcat is 4.14 (sec-1) for acetyl-CoA. {ECO:0000269|PubMed:22615379};	2.3.1.48	CATALYTIC ACTIVITY: Acetyl-CoA + [protein]-L-lysine = CoA + [protein]-N(6)-acetyl-L-lysine. {ECO:0000269|PubMed:11585814, ECO:0000269|PubMed:22615379, ECO:0000269|PubMed:9427644}.						SITE 199 199 Interaction with histone H4 N-terminus. {ECO:0000269|PubMed:22615379}.			chromatin silencing at telomere [GO:0006348]; DNA packaging [GO:0006323]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; histone H4 acetylation [GO:0043967]; internal protein amino acid acetylation [GO:0006475]; response to nutrient [GO:0007584]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; chromatin silencing at telomere [GO:0006348]; DNA packaging [GO:0006323]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; histone H4 acetylation [GO:0043967]; internal protein amino acid acetylation [GO:0006475]; response to nutrient [GO:0007584]	H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]	GO:0000784; GO:0000790; GO:0004402; GO:0005634; GO:0005654; GO:0005737; GO:0006323; GO:0006335; GO:0006336; GO:0006348; GO:0006475; GO:0007584; GO:0010485; GO:0016363; GO:0032991; GO:0042393; GO:0043231; GO:0043967	SUBCELLULAR LOCATION: Isoform A: Nucleus matrix.; SUBCELLULAR LOCATION: Isoform B: Cytoplasm. Nucleus. Nucleus matrix. Nucleus, nucleoplasm. Note=Localization is predominantly nuclear in normal cells. Treatment with hydrogen peroxide or ionizing radiation enhances nuclear localization through redistribution of existing protein.		MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22223895}.; MOD_RES 9 9 N6-acetyllysine. {ECO:0000250|UniProtKB:Q8BY71}.; MOD_RES 15 15 N6-acetyllysine. {ECO:0000250|UniProtKB:Q8BY71}.; MOD_RES 343 343 Phosphoserine. {ECO:0000244|PubMed:23186163}.	9427644; 15815621; 15489334; 11585814; 12841681; 19413330; 20148353; 20953179; 21269460; 22223895; 23186163; 22615379; 16959974; 15161933; 18617639; 19410544; 19498464; 19549727; 19615732; 19862764; 20224553; 20562859; 20711500; 22190034; 23606334; 25416956; 25609649; 25665578; 26496610	9427644; 15815621; 15489334; 11585814; 12841681; 19413330; 20148353; 20953179; 21269460; 22223895; 23186163; 22615379; 16959974
4446	DBH	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.8 mM for tyramine {ECO:0000269|PubMed:8546710}; 	1.14.17.1	CATALYTIC ACTIVITY: 3,4-dihydroxyphenethylamine + ascorbate + O(2) = noradrenaline + dehydroascorbate + H(2)O. {ECO:0000269|PubMed:3443096, ECO:0000269|PubMed:7961964, ECO:0000269|PubMed:8546710}.			COFACTOR: Name=Cu(2+); Xref=ChEBI:CHEBI:29036; Evidence={ECO:0000269|PubMed:8546710, ECO:0000305|PubMed:27152332}; ;  Note=Binds 2 copper ions per subunit. {ECO:0000305|PubMed:27152332};	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 5.2. {ECO:0000269|PubMed:8546710};	PATHWAY: Catecholamine biosynthesis; (R)-noradrenaline biosynthesis; (R)-noradrenaline from dopamine: step 1/1. {ECO:0000269|PubMed:27148966, ECO:0000269|PubMed:3443096, ECO:0000269|PubMed:8546710}.	SITE 39 40 Cleavage. {ECO:0000250|UniProtKB:P15101}.			behavioral response to ethanol [GO:0048149]; blood vessel remodeling [GO:0001974]; catecholamine biosynthetic process [GO:0042423]; chemical synaptic transmission [GO:0007268]; cytokine production [GO:0001816]; dopamine catabolic process [GO:0042420]; fear response [GO:0042596]; glucose homeostasis [GO:0042593]; homoiothermy [GO:0042309]; leukocyte mediated immunity [GO:0002443]; leukocyte migration [GO:0050900]; locomotory behavior [GO:0007626]; maternal behavior [GO:0042711]; memory [GO:0007613]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of vasoconstriction [GO:0045907]; regulation of cell proliferation [GO:0042127]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; response to amphetamine [GO:0001975]; response to pain [GO:0048265]; visual learning [GO:0008542]	chromaffin granule lumen [GO:0034466]; chromaffin granule membrane [GO:0042584]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; secretory granule lumen [GO:0034774]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658]	chromaffin granule lumen [GO:0034466]; chromaffin granule membrane [GO:0042584]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; secretory granule lumen [GO:0034774]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658]; catalytic activity [GO:0003824]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; L-ascorbic acid binding [GO:0031418]; behavioral response to ethanol [GO:0048149]; blood vessel remodeling [GO:0001974]; catecholamine biosynthetic process [GO:0042423]; chemical synaptic transmission [GO:0007268]; cytokine production [GO:0001816]; dopamine catabolic process [GO:0042420]; fear response [GO:0042596]; glucose homeostasis [GO:0042593]; homoiothermy [GO:0042309]; leukocyte mediated immunity [GO:0002443]; leukocyte migration [GO:0050900]; locomotory behavior [GO:0007626]; maternal behavior [GO:0042711]; memory [GO:0007613]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of vasoconstriction [GO:0045907]; regulation of cell proliferation [GO:0042127]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; response to amphetamine [GO:0001975]; response to pain [GO:0048265]; visual learning [GO:0008542]	catalytic activity [GO:0003824]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; L-ascorbic acid binding [GO:0031418]	GO:0001816; GO:0001974; GO:0001975; GO:0002443; GO:0003824; GO:0004500; GO:0005507; GO:0005576; GO:0005615; GO:0005737; GO:0005783; GO:0005815; GO:0006589; GO:0007268; GO:0007613; GO:0007626; GO:0008542; GO:0016020; GO:0016021; GO:0030658; GO:0030667; GO:0031418; GO:0034466; GO:0034774; GO:0042127; GO:0042309; GO:0042420; GO:0042421; GO:0042423; GO:0042584; GO:0042593; GO:0042596; GO:0042711; GO:0043231; GO:0045907; GO:0048149; GO:0048265; GO:0050900; GO:0120162; GO:2001236	SUBCELLULAR LOCATION: Soluble dopamine beta-hydroxylase: Cytoplasmic vesicle, secretory vesicle lumen {ECO:0000269|PubMed:7961964}. Cytoplasmic vesicle, secretory vesicle, chromaffin granule lumen {ECO:0000269|PubMed:7961964}. Secreted {ECO:0000269|PubMed:7961964, ECO:0000269|PubMed:8546710}.; SUBCELLULAR LOCATION: Cytoplasmic vesicle, secretory vesicle membrane {ECO:0000269|PubMed:7961964}; Single-pass type II membrane protein {ECO:0000305}. Cytoplasmic vesicle, secretory vesicle, chromaffin granule membrane {ECO:0000269|PubMed:7961964}; Single-pass type II membrane protein {ECO:0000305}.	PTM: N-glycosylated. {ECO:0000269|PubMed:27152332, ECO:0000269|PubMed:8546710}.; PTM: Proteolytic cleavage after the membrane-anchor leads to the release of the soluble form. {ECO:0000250|UniProtKB:P15101}.		15164053; 3443096; 15489334; 2922261; 8546710; 7961964; 16335952; 19139490; 27148966; 27152332; 10490716; 10391209; 10391210; 11857564; 11085595; 11140838; 11857576; 11904129; 11904130; 11943777; 12360111; 12488060; 12555232; 12624717; 12660802; 12707943; 12730829; 12778453; 12833405; 12960750; 14991826; 15077009; 15102340; 15167700; 15205702; 15505174; 15767706; 15796803; 16032443; 16097364; 16133787; 16152569; 16252068; 16272956; 16389711; 16616730; 16616989; 16741944; 16831359; 16874303; 16876143; 17095019; 17131588; 17157269; 17171650; 17187001; 17200925; 17457369; 17503472; 17503507; 17625104; 17853400; 18030083; 18032384; 18081028; 18172755; 18173840; 18207134; 18270970; 18275850; 18330705; 18338249; 18404133; 18486967; 1857555; 18722802; 18821565; 18821566; 18973765; 18982239; 19016604; 19058789; 19086053; 19107190; 19152006; 19156168; 19219470; 19360691; 19415821; 19506906; 19560519; 19604093; 19673036; 19757024; 19772578; 19851296; 19874574; 19913121; 19944766; 20006992; 20009769; 20035263; 20127808; 20129829; 20198315; 20350135; 20418890; 20430042; 20464528; 20468064; 20498626; 20505554; 20602615; 20621148; 20628086; 20732903; 20734064; 20814407; 20931244; 21070631; 21126477; 21209083; 21471955; 21509519; 21538940; 21668745; 21685187; 21688126; 21761554; 22028891; 22408582; 22445279; 22513716; 22760354; 22761865; 22765285; 22871345; 22875483; 22895683; 22906516; 23054588; 23261162; 23384717; 23416088; 23458673; 23510745; 23559427; 23692268; 23707643; 23906995; 23951054; 23962674; 23988761; 24201835; 24210742; 24391727; 24521142; 24809448; 24888991; 24986918; 24990418; 25326128; 25336319; 25450229; 25975715; 26356164; 26400296; 26616837; 26632697; 26667034; 26762739; 26868704; 26891013; 26986136; 27177268; 27194378; 27239844; 27447243; 27776953; 27778639; 28139629; 28707163; 9084894; 9564683	15164053; 3443096; 15489334; 2922261; 8546710; 7961964; 16335952; 19139490; 27148966; 27152332; 10490716; 10391209; 10391210; 11857564
4461	GALNT16 GALNTL1 KIAA1130	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=251 uM for Muc5AC {ECO:0000269|PubMed:22186971}; KM=310 uM for Muc5AC-3 {ECO:0000269|PubMed:22186971}; KM=390 uM for Muc5AC-13 {ECO:0000269|PubMed:22186971}; KM=332 uM for EA2 {ECO:0000269|PubMed:22186971}; 	2.4.1.41	CATALYTIC ACTIVITY: UDP-N-acetyl-alpha-D-galactosamine + polypeptide = UDP + N-acetyl-alpha-D-galactosaminyl-polypeptide. {ECO:0000269|PubMed:22186971}.	BINDING 163 163 Substrate. {ECO:0000250}.; BINDING 188 188 Substrate. {ECO:0000250}.; BINDING 212 212 Substrate. {ECO:0000250}.; BINDING 317 317 Substrate. {ECO:0000250}.; BINDING 348 348 Substrate. {ECO:0000250}.; BINDING 351 351 Substrate. {ECO:0000250}.; BINDING 353 353 Substrate. {ECO:0000250}.		COFACTOR: Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250}; 		PATHWAY: Protein modification; protein glycosylation.				protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]	GO:0000139; GO:0004653; GO:0016021; GO:0018242; GO:0018243; GO:0030246; GO:0046872	SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000250}; Single-pass type II membrane protein {ECO:0000250}.			10574461; 14702039; 15489334; 22186971; 20379614; 22183981; 9295285; 9394011	10574461; 14702039; 15489334; 22186971
4520	HACD4 PTPLAD2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=6.8 uM for 3-hydroxypalmitoyl-CoA (at 37 degrees Celsius) {ECO:0000269|PubMed:18554506}; 	4.2.1.134	CATALYTIC ACTIVITY: A very-long-chain (3R)-3-hydroxyacyl-CoA = a very-long-chain trans-2,3-dehydroacyl-CoA + H(2)O. {ECO:0000269|PubMed:18554506}.					PATHWAY: Lipid metabolism; fatty acid biosynthesis. {ECO:0000269|PubMed:18554506}.				fatty acid elongation [GO:0030497]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761]	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; 3-hydroxy-arachidoyl-CoA dehydratase activity [GO:0102343]; 3-hydroxy-behenoyl-CoA dehydratase activity [GO:0102344]; 3-hydroxy-lignoceroyl-CoA dehydratase activity [GO:0102345]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; enzyme binding [GO:0019899]; very-long-chain 3-hydroxyacyl-CoA dehydratase activity [GO:0102158]; fatty acid elongation [GO:0030497]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761]	3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; 3-hydroxy-arachidoyl-CoA dehydratase activity [GO:0102343]; 3-hydroxy-behenoyl-CoA dehydratase activity [GO:0102344]; 3-hydroxy-lignoceroyl-CoA dehydratase activity [GO:0102345]; enzyme binding [GO:0019899]; very-long-chain 3-hydroxyacyl-CoA dehydratase activity [GO:0102158]	GO:0005783; GO:0018812; GO:0019899; GO:0030148; GO:0030176; GO:0030497; GO:0042761; GO:0102158; GO:0102343; GO:0102344; GO:0102345	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:18554506}; Multi-pass membrane protein {ECO:0000269|PubMed:18554506}.			15164053; 15489334; 17974005; 18554506; 24530685; 29031776	15164053; 15489334; 17974005; 18554506
4527	SHMT2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=278 uM for L-serine {ECO:0000269|PubMed:25619277}; KM=23 uM for tetrahydrofolate {ECO:0000269|PubMed:25619277}; 	2.1.2.1	CATALYTIC ACTIVITY: 5,10-methylenetetrahydrofolate + glycine + H(2)O = tetrahydrofolate + L-serine. {ECO:0000269|PubMed:24075985, ECO:0000269|PubMed:25619277, ECO:0000269|PubMed:29364879}.		ACTIVITY REGULATION: Hydroxymethyltransferase is inhibited by succinylation at Lys-280. {ECO:0000269|PubMed:29180469}.	COFACTOR: Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326; Evidence={ECO:0000269|PubMed:25619277, ECO:0000305|PubMed:29364879}; 		PATHWAY: One-carbon metabolism; tetrahydrofolate interconversion. {ECO:0000305|PubMed:25619277}.				folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]; one-carbon metabolic process [GO:0006730]; positive regulation of cell proliferation [GO:0008284]; protein homotetramerization [GO:0051289]; protein K63-linked deubiquitination [GO:0070536]; protein tetramerization [GO:0051262]; regulation of aerobic respiration [GO:1903715]; regulation of mitochondrial translation [GO:0070129]; regulation of oxidative phosphorylation [GO:0002082]; response to type I interferon [GO:0034340]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]	BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; amino acid binding [GO:0016597]; chromatin binding [GO:0003682]; glycine hydroxymethyltransferase activity [GO:0004372]; identical protein binding [GO:0042802]; L-allo-threonine aldolase activity [GO:0008732]; pyridoxal phosphate binding [GO:0030170]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]; one-carbon metabolic process [GO:0006730]; positive regulation of cell proliferation [GO:0008284]; protein homotetramerization [GO:0051289]; protein K63-linked deubiquitination [GO:0070536]; protein tetramerization [GO:0051262]; regulation of aerobic respiration [GO:1903715]; regulation of mitochondrial translation [GO:0070129]; regulation of oxidative phosphorylation [GO:0002082]; response to type I interferon [GO:0034340]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]	amino acid binding [GO:0016597]; chromatin binding [GO:0003682]; glycine hydroxymethyltransferase activity [GO:0004372]; identical protein binding [GO:0042802]; L-allo-threonine aldolase activity [GO:0008732]; pyridoxal phosphate binding [GO:0030170]	GO:0002082; GO:0003682; GO:0004372; GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0006544; GO:0006563; GO:0006564; GO:0006730; GO:0008284; GO:0008732; GO:0015630; GO:0016597; GO:0019264; GO:0030170; GO:0034340; GO:0035999; GO:0042645; GO:0042802; GO:0046653; GO:0046655; GO:0051262; GO:0051289; GO:0070062; GO:0070129; GO:0070536; GO:0070552; GO:1903715	SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:21876188, ECO:0000269|PubMed:24075985}. Mitochondrion matrix, mitochondrion nucleoid {ECO:0000269|PubMed:18063578}. Mitochondrion inner membrane {ECO:0000269|PubMed:21876188}. Cytoplasm {ECO:0000269|PubMed:24075985}. Nucleus {ECO:0000269|PubMed:24075985}. Note=Mainly localizes in the mitochondrion. Also found in the cytoplasm and nucleus as part of the BRISC complex (PubMed:24075985). {ECO:0000269|PubMed:24075985}.	PTM: Succinylation at Lys-280 inhibits the hydroxymethyltransferase activity. Desuccinylation by SIRT5 restores the activity, leading to promote cell proliferation. {ECO:0000269|PubMed:29180469}.	MOD_RES 103 103 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 181 181 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 196 196 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 280 280 N6-(pyridoxal phosphate)lysine; alternate. {ECO:0000305|PubMed:29364879}.; MOD_RES 280 280 N6-succinyllysine; alternate. {ECO:0000269|PubMed:29180469}.; MOD_RES 297 297 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 356 356 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 464 464 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 469 469 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 470 470 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 474 474 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.	14702039; 16541075; 15489334; 10828359; 8999870; 8505317; 18063578; 19608861; 21269460; 21876188; 24075985; 23186163; 24275569; 25902260; 25944712; 29180469; 29452640; 29364879; 25619277; 11386852; 12577067; 17220478; 17353931; 18636124; 18984158; 18988749; 19048631; 19086053; 19513116; 19615732; 19805454; 19913121; 20186120; 20562859; 20628086; 20711500; 20808282; 20869947; 20877624; 21516116; 22220685; 22304920; 23902751; 25416956; 25525879; 25609649; 25855294; 26103880; 26662310; 26752685; 26975021; 27391339; 27530298; 27666119; 27836973; 29020998; 29073064; 9573390	14702039; 16541075; 15489334; 10828359; 8999870; 8505317; 18063578; 19608861; 21269460; 21876188; 24075985; 23186163; 24275569; 25902260; 25944712; 29180469; 29452640; 29364879; 25619277
4549	HACD2 PTPLB	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=121.7 uM for 3-hydroxypalmitoyl-CoA (at 37 degrees Celsius) {ECO:0000269|PubMed:18554506}; 	4.2.1.134	CATALYTIC ACTIVITY: A very-long-chain (3R)-3-hydroxyacyl-CoA = a very-long-chain trans-2,3-dehydroacyl-CoA + H(2)O. {ECO:0000269|PubMed:18554506}.					PATHWAY: Lipid metabolism; fatty acid biosynthesis. {ECO:0000269|PubMed:18554506}.				fatty acid elongation [GO:0030497]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; peptidyl-tyrosine dephosphorylation [GO:0035335]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; 3-hydroxy-arachidoyl-CoA dehydratase activity [GO:0102343]; 3-hydroxy-behenoyl-CoA dehydratase activity [GO:0102344]; 3-hydroxy-lignoceroyl-CoA dehydratase activity [GO:0102345]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; 3R-hydroxyacyl-CoA dehydratase activity [GO:0080023]; enzyme binding [GO:0019899]; very-long-chain 3-hydroxyacyl-CoA dehydratase activity [GO:0102158]; fatty acid elongation [GO:0030497]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; peptidyl-tyrosine dephosphorylation [GO:0035335]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761]	3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; 3-hydroxy-arachidoyl-CoA dehydratase activity [GO:0102343]; 3-hydroxy-behenoyl-CoA dehydratase activity [GO:0102344]; 3-hydroxy-lignoceroyl-CoA dehydratase activity [GO:0102345]; 3R-hydroxyacyl-CoA dehydratase activity [GO:0080023]; enzyme binding [GO:0019899]; very-long-chain 3-hydroxyacyl-CoA dehydratase activity [GO:0102158]	GO:0005783; GO:0005789; GO:0018812; GO:0019899; GO:0030148; GO:0030176; GO:0030497; GO:0035335; GO:0035338; GO:0042761; GO:0080023; GO:0102158; GO:0102343; GO:0102344; GO:0102345	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:15024066, ECO:0000269|PubMed:18554506}; Multi-pass membrane protein {ECO:0000269|PubMed:15024066, ECO:0000269|PubMed:18554506}.		MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19413330, ECO:0000269|PubMed:25732826}.	15024066; 14702039; 16641997; 15489334; 18554506; 19413330; 21269460; 22814378; 24275569; 25732826; 20379614; 20677014; 25416956; 26496610; 26638075; 28784662	15024066; 14702039; 16641997; 15489334; 18554506; 19413330; 21269460; 22814378; 24275569; 25732826
4581	HINT3	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=1.5 uM for indolepropinoic acyl-adenylate {ECO:0000269|PubMed:17870088}; KM=22 uM for adenine {ECO:0000269|PubMed:17870088}; KM=29 uM for guanine {ECO:0000269|PubMed:17870088}; KM=32 uM for hypoxanthine {ECO:0000269|PubMed:17870088}; KM=121 uM for uracil {ECO:0000269|PubMed:17870088}; KM=181 uM for cytosine {ECO:0000269|PubMed:17870088}; Note=HINT3 prefers purine over pyrimidine-based substrates.;	3.-.-.-											cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]	hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]	GO:0000166; GO:0005634; GO:0005737; GO:0016787	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17870088}. Nucleus {ECO:0000269|PubMed:17870088}. Note=Localized as aggregates in the cytoplasm and the nucleus.		MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22814378}.		14702039; 14574404; 15489334; 12119013; 17870088; 18669648; 19413330; 21269460; 22814378
4583	GLYATL2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=4.4 uM for oleoyl-CoA {ECO:0000269|PubMed:20305126}; Vmax=933 nmol/min/mg enzyme with oleoyl-CoA as substrate {ECO:0000269|PubMed:20305126}; 	2.3.1.13	CATALYTIC ACTIVITY: Acyl-CoA + glycine = CoA + N-acylglycine.									long-chain fatty acid catabolic process [GO:0042758]; medium-chain fatty acid catabolic process [GO:0051793]; monounsaturated fatty acid catabolic process [GO:1903965]	endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]	endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; glycine N-acyltransferase activity [GO:0047961]; long-chain fatty acid catabolic process [GO:0042758]; medium-chain fatty acid catabolic process [GO:0051793]; monounsaturated fatty acid catabolic process [GO:1903965]	glycine N-acyltransferase activity [GO:0047961]	GO:0005739; GO:0005783; GO:0042758; GO:0047961; GO:0051793; GO:1903965	SUBCELLULAR LOCATION: Endoplasmic reticulum {ECO:0000269|PubMed:20305126}.	PTM: Acetylation at Lys-19 drastically decreases the production of N-oleoyl and N-arachidonoyl glycines. {ECO:0000269|PubMed:22408254}.	MOD_RES 19 19 N6-acetyllysine. {ECO:0000269|PubMed:22408254}.	22475485; 15489334; 20305126; 22408254; 7802672; 931988	22475485; 15489334; 20305126; 22408254
4644	GLRA1	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: Note=A concentration of about 0.02 mM glycine results in half-maximal channel conductance for homopentamers. A concentration of 0.018 mM glycine results in half-maximal channel conductance for homopentamers upon heterologous expression in cultured human embryonic kidney cells (PubMed:9009272). A concentration of 0.027 mM glycine results in half-maximal channel conductance for homopentamers upon heterologous expression in cultured human embryonic kidney cells (PubMed:7920629). {ECO:0000269|PubMed:7920629, ECO:0000269|PubMed:9009272};				ACTIVITY REGULATION: Channel activity is potentiated by nanomolar concentrations of Zn(2+); half-maximal activation is observed with 37 nM Zn(2+) (PubMed:16144831). Inhibited by higher Zn(2+) levels; haf-maximal inhibition occurs at 20 uM Zn(2+) (PubMed:16144831). Inhibited by strychnine (PubMed:2155780, PubMed:16144831, PubMed:25445488). Inhibited by lindane (PubMed:25445488). Inhibited by picrotoxin (PubMed:22715885, PubMed:23994010, PubMed:25730860). Strychnine binding locks the channel in a closed conformation and prevents channel opening in response to extracellular glycine (By similarity). {ECO:0000250|UniProtKB:O93430, ECO:0000269|PubMed:16144831, ECO:0000269|PubMed:2155780, ECO:0000269|PubMed:22715885, ECO:0000269|PubMed:23994010, ECO:0000269|PubMed:25445488, ECO:0000269|PubMed:25730860}.				SITE 289 289 Important for obstruction of the ion pore in the closed conformation. {ECO:0000269|PubMed:25730860}.			acrosome reaction [GO:0007340]; action potential [GO:0001508]; adult walking behavior [GO:0007628]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; inhibitory postsynaptic potential [GO:0060080]; ion transport [GO:0006811]; muscle contraction [GO:0006936]; negative regulation of transmission of nerve impulse [GO:0051970]; neuromuscular process controlling posture [GO:0050884]; neuropeptide signaling pathway [GO:0007218]; positive regulation of acrosome reaction [GO:2000344]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of respiratory gaseous exchange by neurological system process [GO:0002087]; response to alcohol [GO:0097305]; righting reflex [GO:0060013]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]; visual perception [GO:0007601]	calyx of Held [GO:0044305]; cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic membrane [GO:0099056]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202]	calyx of Held [GO:0044305]; cell junction [GO:0030054]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic membrane [GO:0099056]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; identical protein binding [GO:0042802]; taurine binding [GO:0030977]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity [GO:0022824]; zinc ion binding [GO:0008270]; acrosome reaction [GO:0007340]; action potential [GO:0001508]; adult walking behavior [GO:0007628]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; inhibitory postsynaptic potential [GO:0060080]; ion transport [GO:0006811]; muscle contraction [GO:0006936]; negative regulation of transmission of nerve impulse [GO:0051970]; neuromuscular process controlling posture [GO:0050884]; neuropeptide signaling pathway [GO:0007218]; positive regulation of acrosome reaction [GO:2000344]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of respiratory gaseous exchange by neurological system process [GO:0002087]; response to alcohol [GO:0097305]; righting reflex [GO:0060013]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]; visual perception [GO:0007601]	extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; identical protein binding [GO:0042802]; taurine binding [GO:0030977]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity [GO:0022824]; zinc ion binding [GO:0008270]	GO:0001508; GO:0001964; GO:0002087; GO:0004888; GO:0005783; GO:0005886; GO:0005887; GO:0006811; GO:0006821; GO:0006936; GO:0007218; GO:0007340; GO:0007601; GO:0007628; GO:0008270; GO:0009897; GO:0016021; GO:0016594; GO:0016934; GO:0022824; GO:0030054; GO:0030425; GO:0030977; GO:0034707; GO:0042391; GO:0042802; GO:0043005; GO:0043025; GO:0043204; GO:0043231; GO:0044305; GO:0045202; GO:0050884; GO:0051260; GO:0051291; GO:0051970; GO:0060012; GO:0060013; GO:0060077; GO:0060080; GO:0071230; GO:0071294; GO:0071361; GO:0097305; GO:0098690; GO:0099056; GO:0099060; GO:1902476; GO:2000344	SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell membrane {ECO:0000250|UniProtKB:Q64018}; Multi-pass membrane protein {ECO:0000250|UniProtKB:Q64018}. Cell junction, synapse {ECO:0000250|UniProtKB:Q64018}. Perikaryon {ECO:0000250|UniProtKB:Q64018}. Cell projection, dendrite {ECO:0000250|UniProtKB:Q64018}. Cell membrane {ECO:0000269|PubMed:14551753, ECO:0000269|PubMed:16144831, ECO:0000269|PubMed:2155780, ECO:0000269|PubMed:22715885, ECO:0000269|PubMed:22973015, ECO:0000269|PubMed:24108130, ECO:0000269|PubMed:25445488, ECO:0000269|PubMed:25730860, ECO:0000269|PubMed:25973519, ECO:0000269|PubMed:7920629, ECO:0000269|PubMed:7925268, ECO:0000269|PubMed:9009272}; Multi-pass membrane protein {ECO:0000269|PubMed:23994010, ECO:0000269|PubMed:25730860, ECO:0000305|PubMed:2155780}.			2155780; 14702039; 15489334; 7920629; 14551753; 16144831; 19861413; 22715885; 22973015; 25973519; 25445488; 12667090; 15952785; 23994010; 25730860; 8298642; 7925268; 7981700; 7881416; 7611730; 8571969; 8733061; 9009272; 9067762; 10514101; 9920650; 24108130; 11580237; 11781706; 11973623; 11981020; 11981021; 11994009; 12080117; 12237328; 12239220; 12356883; 12661758; 12679369; 12740384; 12746425; 12766618; 12826676; 12954867; 14525990; 14563849; 14593111; 14698963; 14981077; 15287733; 15365143; 15489161; 15771552; 15951389; 16078201; 16109711; 16361257; 16832093; 16941485; 17040914; 17181559; 17433503; 17434460; 17469203; 17534957; 17655760; 17655979; 17887775; 18036150; 18043720; 18292428; 18690053; 18710260; 18806798; 19049967; 19073849; 19086053; 19286654; 19626554; 19705103; 19732286; 19874574; 19959465; 20198385; 20631190; 20959090; 20959630; 21414903; 21463577; 21917927; 21955162; 22037201; 22264702; 22279218; 22816018; 22995908; 23035114; 23090334; 23834509; 24097980; 24970905; 25079583; 25356525; 25568133; 25572390; 26079326; 26845851; 27226610; 27923639; 8717357; 9677400	2155780; 14702039; 15489334; 7920629; 14551753; 16144831; 19861413; 22715885; 22973015; 25973519; 25445488; 12667090; 15952785; 23994010; 25730860; 8298642; 7925268; 7981700; 7881416; 7611730; 8571969; 8733061; 9009272; 9067762; 10514101; 9920650; 24108130
4724	IFI30 GILT IP30	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=1200 uM for F(ab')2 fragment when denatured {ECO:0000269|PubMed:10639150}; KM=10 uM for F(ab')2 fragment {ECO:0000269|PubMed:10639150}; Note=Kinetic parameters shown are for mature enzyme.;	1.8.-.-					BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 4-5. {ECO:0000269|PubMed:10639150};					antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; interferon-gamma-mediated signaling pathway [GO:0060333]	cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]	cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; oxidoreductase activity, acting on a sulfur group of donors [GO:0016667]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; interferon-gamma-mediated signaling pathway [GO:0060333]	oxidoreductase activity, acting on a sulfur group of donors [GO:0016667]	GO:0005576; GO:0005764; GO:0005829; GO:0016667; GO:0019886; GO:0030054; GO:0042590; GO:0043202; GO:0043231; GO:0060333	SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:10639150, ECO:0000269|PubMed:3136170}. Lysosome {ECO:0000269|PubMed:10639150, ECO:0000269|PubMed:3136170}.	PTM: N-glycosylated. Sugar chains contain mannose-6-phosphate. {ECO:0000269|PubMed:10639150, ECO:0000269|PubMed:10852914}.; PTM: Synthesized as a 35 kDa precursor which is then processed into the mature 30 kDa form via cleavage of N-terminal and C-terminal propeptides. Processing of the precursor is mediated by multiple lysosomal proteases.		3136170; 10639150; 14702039; 15057824; 15489334; 10852914; 21269460; 24275569; 25944712; 12021307; 12198183; 1508672; 17142755; 18343923; 18362138; 18410276; 19240061; 20668223; 20711500; 21701784; 23246037; 25416956; 25852190; 26116226; 26496610; 26930048; 27655726; 7530745; 8176225; 8483949; 8530158; 9143706	3136170; 10639150; 14702039; 15057824; 15489334; 10852914; 21269460; 24275569; 25944712
4731	SHMT1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.18 mM for L-serine {ECO:0000269|PubMed:24698160}; KM=5.2 uM for tetrahydrofolate {ECO:0000269|PubMed:24698160}; 	2.1.2.1	CATALYTIC ACTIVITY: 5,10-methylenetetrahydrofolate + glycine + H(2)O = tetrahydrofolate + L-serine. {ECO:0000269|PubMed:24698160, ECO:0000269|PubMed:8505317}.		ACTIVITY REGULATION: Inhibited by tetrahydrofolate concentrations above 40 uM. {ECO:0000269|PubMed:24698160}.	COFACTOR: Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326; Evidence={ECO:0000269|PubMed:24698160, ECO:0000269|PubMed:25619277, ECO:0000269|PubMed:9753690}; 		PATHWAY: One-carbon metabolism; tetrahydrofolate interconversion. {ECO:0000305|PubMed:24698160}.				carnitine biosynthetic process [GO:0045329]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to tetrahydrofolate [GO:1904482]; dTMP biosynthetic process [GO:0006231]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; negative regulation of translation [GO:0017148]; protein homotetramerization [GO:0051289]; protein tetramerization [GO:0051262]; purine nucleobase biosynthetic process [GO:0009113]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; glycine hydroxymethyltransferase activity [GO:0004372]; identical protein binding [GO:0042802]; L-allo-threonine aldolase activity [GO:0008732]; mRNA 5'-UTR binding [GO:0048027]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; carnitine biosynthetic process [GO:0045329]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to tetrahydrofolate [GO:1904482]; dTMP biosynthetic process [GO:0006231]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; negative regulation of translation [GO:0017148]; protein homotetramerization [GO:0051289]; protein tetramerization [GO:0051262]; purine nucleobase biosynthetic process [GO:0009113]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]	glycine hydroxymethyltransferase activity [GO:0004372]; identical protein binding [GO:0042802]; L-allo-threonine aldolase activity [GO:0008732]; mRNA 5'-UTR binding [GO:0048027]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; translation repressor activity, mRNA regulatory element binding [GO:0000900]	GO:0000900; GO:0004372; GO:0005634; GO:0005829; GO:0006231; GO:0006544; GO:0006563; GO:0006565; GO:0008732; GO:0009113; GO:0017148; GO:0019264; GO:0030170; GO:0035999; GO:0042802; GO:0042803; GO:0045329; GO:0046653; GO:0046655; GO:0048027; GO:0051262; GO:0051289; GO:0070062; GO:0070905; GO:1904482; GO:1990830	SUBCELLULAR LOCATION: Cytoplasm.		MOD_RES 257 257 N6-(pyridoxal phosphate)lysine. {ECO:0000244|PDB:1BJ4, ECO:0000269|PubMed:9753690}.	8505317; 9056951; 14702039; 16625196; 15489334; 19608861; 21269460; 24075985; 24698160; 24275569; 25619277; 9753690; 11386852; 12161434; 12604405; 12615003; 14656021; 15059614; 15060097; 15122597; 15198953; 15531579; 15598699; 15797993; 16006999; 16046727; 16049973; 16169070; 16365025; 16447238; 16536979; 17035141; 17074544; 17113224; 17119116; 17206530; 17311259; 17311260; 17420066; 17446168; 17595805; 17891500; 17896178; 17904392; 18378616; 18381459; 18427977; 18635682; 18830263; 18996879; 19020309; 19048631; 19064578; 19086053; 19159907; 19161160; 19223009; 19336370; 19513116; 19619240; 19692168; 19706844; 19707223; 19734143; 19751277; 19774638; 19776626; 19777601; 19858780; 20101025; 20140262; 20386493; 20398908; 20453000; 20458436; 20511665; 20544798; 20562859; 20615890; 20634891; 20670920; 20737570; 20842733; 20852008; 20877624; 20920350; 20977478; 21055808; 21090237; 21178087; 21687976; 21987236; 21988832; 22044939; 22194612; 22220685; 22803112; 23322534; 23421317; 23474074; 24641398; 24716966; 24789272; 25194438; 25412303; 25416956; 25609649; 26125758; 26316272; 26553359; 26666829; 26950450; 27530298; 28288142; 28760597; 28762673; 29073064; 29321350; 627563; 6361812	8505317; 9056951; 14702039; 16625196; 15489334; 19608861; 21269460; 24075985; 24698160; 24275569; 25619277; 9753690
4759	ESCO1 EFO1 KIAA1911	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=77 uM for acetyl-CoA {ECO:0000269|PubMed:27803161}; 	2.3.1.-										peptidyl-lysine acetylation [GO:0018394]; post-translational protein acetylation [GO:0034421]; regulation of DNA replication [GO:0006275]; sister chromatid cohesion [GO:0007062]	chromatin [GO:0000785]; chromosome [GO:0005694]; nucleoplasm [GO:0005654]	chromatin [GO:0000785]; chromosome [GO:0005694]; nucleoplasm [GO:0005654]; acetyltransferase activity [GO:0016407]; identical protein binding [GO:0042802]; N-acetyltransferase activity [GO:0008080]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; zinc ion binding [GO:0008270]; peptidyl-lysine acetylation [GO:0018394]; post-translational protein acetylation [GO:0034421]; regulation of DNA replication [GO:0006275]; sister chromatid cohesion [GO:0007062]	acetyltransferase activity [GO:0016407]; identical protein binding [GO:0042802]; N-acetyltransferase activity [GO:0008080]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; zinc ion binding [GO:0008270]	GO:0000785; GO:0005654; GO:0005694; GO:0006275; GO:0007062; GO:0008080; GO:0008270; GO:0016407; GO:0018394; GO:0034421; GO:0042802; GO:0061733	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:14576321, ECO:0000269|PubMed:15958495}. Chromosome {ECO:0000269|PubMed:15958495}. Note=Nuclear at interphase, associated with chromosomes during mitosis. {ECO:0000269|PubMed:15958495}.	PTM: Phosphorylated during mitosis. {ECO:0000269|PubMed:15958495}.	MOD_RES 200 200 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 412 412 Phosphoserine. {ECO:0000244|PubMed:20068231}.	11572484; 17974005; 15489334; 14702039; 14576321; 15958495; 18614053; 18669648; 19907496; 20068231; 23186163; 25772364; 27803161; 27112597; 15821733; 18411254; 19074885; 19861517; 20331966; 20360068; 21111234; 22101327; 22885700; 23755103; 26051894; 26305936; 26547586; 28847955; 8291532	11572484; 17974005; 15489334; 14702039; 14576321; 15958495; 18614053; 18669648; 19907496; 20068231; 23186163; 25772364; 27803161; 27112597
4776	EYA3	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.8 uM for H2AXY142ph {ECO:0000269|PubMed:19351884}; KM=72 uM for H2AXS139ph {ECO:0000269|PubMed:19351884}; 	3.1.3.48	CATALYTIC ACTIVITY: Protein tyrosine phosphate + H(2)O = protein tyrosine + phosphate. {ECO:0000269|PubMed:19234442, ECO:0000269|PubMed:19351884}.			COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250|UniProtKB:O00167}; ;  Note=Binds 1 Mg(2+) ion per subunit. {ECO:0000250|UniProtKB:O00167};						anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; double-strand break repair [GO:0006302]; histone dephosphorylation [GO:0016576]; multicellular organism development [GO:0007275]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; positive regulation of DNA repair [GO:0045739]; regulation of transcription, DNA-templated [GO:0006355]; response to ionizing radiation [GO:0010212]; transcription, DNA-templated [GO:0006351]; visual perception [GO:0007601]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; metal ion binding [GO:0046872]; protein tyrosine phosphatase activity [GO:0004725]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; double-strand break repair [GO:0006302]; histone dephosphorylation [GO:0016576]; multicellular organism development [GO:0007275]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; positive regulation of DNA repair [GO:0045739]; regulation of transcription, DNA-templated [GO:0006355]; response to ionizing radiation [GO:0010212]; transcription, DNA-templated [GO:0006351]; visual perception [GO:0007601]	metal ion binding [GO:0046872]; protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005813; GO:0006302; GO:0006351; GO:0006355; GO:0007275; GO:0007601; GO:0009653; GO:0010212; GO:0016576; GO:0030154; GO:0045739; GO:0046872; GO:2001240	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P97480}. Nucleus {ECO:0000269|PubMed:19234442}. Note=Localizes at sites of DNA damage at double-strand breaks (DSBs) (PubMed:19234442). With decreasing efficiency, translocalized to the nucleus by SIX2 and SIX5, and SIX4, respectively (By similarity). {ECO:0000250|UniProtKB:P97480, ECO:0000269|PubMed:19234442}.	PTM: Ser-266 phosphorylation is required for localization at sites of DNA damage and directing interaction with H2AX. {ECO:0000269|PubMed:19234442}.	MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:19413330}.; MOD_RES 262 262 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 266 266 Phosphoserine. {ECO:0000269|PubMed:19234442}.; MOD_RES 438 438 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 472 472 Phosphoserine. {ECO:0000244|PubMed:21406692}.	9020840; 9049631; 14702039; 16710414; 15489334; 9887327; 17525332; 19413330; 19351884; 19234442; 21269460; 21406692; 23186163; 18847512; 22908299; 24705354; 25814554	9020840; 9049631; 14702039; 16710414; 15489334; 9887327; 17525332; 19413330; 19351884; 19234442; 21269460; 21406692; 23186163
4788	FBP2	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=1.3 uM for fructose 1,6-bisphosphate {ECO:0000269|PubMed:16213487, ECO:0000269|PubMed:17350621}; KM=2.6 uM for fructose 1,6-bisphosphate {ECO:0000269|PubMed:16213487, ECO:0000269|PubMed:17350621}; Note=The kinetic constants are determined for the recombinant enzyme expressed in E.coli.;	3.1.3.11	CATALYTIC ACTIVITY: D-fructose 1,6-bisphosphate + H(2)O = D-fructose 6-phosphate + phosphate. {ECO:0000269|PubMed:17350621, ECO:0000269|PubMed:18214967}.	BINDING 18 18 AMP; via carbonyl oxygen. {ECO:0000269|PubMed:22120740}.; BINDING 122 122 Substrate.; BINDING 141 141 AMP. {ECO:0000269|PubMed:22120740}.; BINDING 265 265 Substrate.; BINDING 275 275 Substrate.	ACTIVITY REGULATION: Subject to complex allosteric regulation. The enzyme can assume an active R-state, or an inactive T-state. Intermediate conformations may exist. AMP acts as allosteric inhibitor. Fructose 2,6-bisphosphate acts as competitive inhibitor. Strongly inhibited by Ca(2+). {ECO:0000269|PubMed:16213487, ECO:0000269|PubMed:17350621, ECO:0000269|PubMed:18214967}.	COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:16213487, ECO:0000269|PubMed:24086250}; ;  Note=Binds 3 Mg(2+) ions per subunit. {ECO:0000269|PubMed:16213487, ECO:0000269|PubMed:24086250};		PATHWAY: Carbohydrate biosynthesis; gluconeogenesis.	SITE 33 33 Important for the conversion from active R-state to inactive T-state in the presence of AMP.			fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; sucrose biosynthetic process [GO:0005986]	cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; Z disc [GO:0030018]	cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; sucrose biosynthetic process [GO:0005986]	fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]	GO:0005654; GO:0005829; GO:0005886; GO:0005986; GO:0006000; GO:0006002; GO:0006094; GO:0030018; GO:0030054; GO:0030388; GO:0042132; GO:0042802; GO:0046872; GO:0070062	SUBCELLULAR LOCATION: Cell junction {ECO:0000250}. Cytoplasm. Nucleus. Cytoplasm, myofibril, sarcomere, Z line. Note=In neonatal cardiomyocytes, distributed throughout the cytosol, accumulating in the intercalated disks which occur at the Z line of cardiomyocytes and connect adjacent cells, and also located in the nucleus; dissociates from the Z line following an increase in cytosolic Ca(2+) concentration (By similarity). In muscle precursor cells, localizes predominantly to the nucleus and to a lesser extent to the cytoplasm at the proliferative phase, while mainly localizing to the cytoplasm at the differentiation phase (By similarity). Colocalizes with ALDOA and alpha-actinin on both sides of the Z line of skeletal muscle; dissociates rapidly from the Z line following an increase in cytosolic Ca(2+) concentration. {ECO:0000250}.		MOD_RES 216 216 Phosphotyrosine. {ECO:0000250|UniProtKB:Q9Z1N1}.; MOD_RES 219 219 Phosphotyrosine. {ECO:0000250|UniProtKB:Q9Z1N1}.	9678974; 15164053; 15489334; 12507293; 16213487; 17350621; 18214967; 19626708; 22120740; 24086250; 16169070; 19893584; 20800603; 24063558; 24412244; 24412565; 25416956; 27050133; 9382095	9678974; 15164053; 15489334; 12507293; 16213487; 17350621; 18214967; 19626708; 22120740; 24086250
4884	GSTM3 GST5	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.1 mM for 1-chloro-2,4-dinitrobenzene {ECO:0000269|PubMed:10587441}; KM=0.084 mM for glutathione {ECO:0000269|PubMed:10587441}; 	2.5.1.18	CATALYTIC ACTIVITY: RX + glutathione = HX + R-S-glutathione. {ECO:0000269|PubMed:10587441}.	BINDING 120 120 Substrate. {ECO:0000250}.								cellular detoxification of nitrogen compound [GO:0070458]; establishment of blood-nerve barrier [GO:0008065]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; nitrobenzene metabolic process [GO:0018916]; response to estrogen [GO:0043627]; xenobiotic catabolic process [GO:0042178]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; nucleus [GO:0005634]; sperm fibrous sheath [GO:0035686]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; nucleus [GO:0005634]; sperm fibrous sheath [GO:0035686]; enzyme binding [GO:0019899]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; cellular detoxification of nitrogen compound [GO:0070458]; establishment of blood-nerve barrier [GO:0008065]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; nitrobenzene metabolic process [GO:0018916]; response to estrogen [GO:0043627]; xenobiotic catabolic process [GO:0042178]	enzyme binding [GO:0019899]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]	GO:0004364; GO:0005634; GO:0005737; GO:0005829; GO:0006749; GO:0008065; GO:0018916; GO:0019899; GO:0035686; GO:0042178; GO:0042802; GO:0042803; GO:0043295; GO:0043627; GO:0045171; GO:0070062; GO:0070458; GO:1901687	SUBCELLULAR LOCATION: Cytoplasm.	PTM: The N-terminus is blocked.		2345169; 9882431; 15489334; 8373352; 8218382; 21269460; 28112733; 10587441; 10329152; 10783391; 11040079; 11081456; 11173863; 11289100; 11303592; 11327815; 11408349; 11511301; 11535247; 11692073; 11740339; 11927838; 12016153; 12042665; 12063626; 12211029; 12359356; 12548461; 12577067; 12627223; 14634838; 14735473; 14968442; 15069685; 15115915; 15338373; 15459020; 15525789; 15621212; 15654505; 15665284; 15829318; 15914277; 16006997; 16081649; 16112301; 16172217; 16189514; 16298388; 16328000; 16488179; 16509765; 16548513; 16598069; 16760134; 16765145; 16886896; 16985026; 17034008; 17083362; 17220350; 17259654; 17290392; 17353931; 17372252; 17449559; 17531812; 17565746; 17601350; 17617661; 17716224; 17904251; 17922434; 18065725; 18177825; 18204928; 18258609; 18423940; 18447907; 18510611; 18551009; 18569590; 18668224; 18676680; 18850183; 18977241; 18990750; 18992148; 19060904; 19062541; 19074885; 19151192; 19170196; 19336475; 19339270; 19343046; 19407363; 19424794; 19486347; 19521675; 19692168; 19696791; 19751749; 19786980; 19789190; 19822571; 19856098; 19860743; 19898482; 19913121; 19922706; 20029944; 20032816; 20083122; 20085333; 20136364; 20200426; 20237496; 20391138; 20391338; 20437850; 20461808; 20485444; 20549140; 20577141; 20628086; 20634891; 20661821; 20819778; 20847076; 20970553; 21072184; 21106529; 21513434; 21516116; 21668448; 21900206; 22360420; 22430872; 22522127; 22976281; 23036584; 23167362; 24157827; 24689813; 25040976; 25193115; 26125851; 27021019; 27607418; 27993795; 8182750; 8203914; 8331657; 8431482; 9551553; 9839448	2345169; 9882431; 15489334; 8373352; 8218382; 21269460; 28112733; 10587441
4886	ENPP2 ATX PDNP2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.5 mM for 16:0-LPC (at pH 8.5) {ECO:0000269|PubMed:12176993, ECO:0000269|PubMed:18175805}; KM=5.5 mM for pNP-TMP (at pH 8.5) {ECO:0000269|PubMed:12176993, ECO:0000269|PubMed:18175805}; KM=11.3 mM for pNppp (isoform 1) {ECO:0000269|PubMed:12176993, ECO:0000269|PubMed:18175805}; KM=5.7 mM for pNppp (isoform 2) {ECO:0000269|PubMed:12176993, ECO:0000269|PubMed:18175805}; KM=19.8 mM for pNppp (isoform 3) {ECO:0000269|PubMed:12176993, ECO:0000269|PubMed:18175805}; Vmax=1.9 nmol/min/ug enzyme with pNppp as substrate (isoform 1) {ECO:0000269|PubMed:12176993, ECO:0000269|PubMed:18175805}; Vmax=0.67 nmol/min/ug enzyme with pNppp as substrate (isoform 2) {ECO:0000269|PubMed:12176993, ECO:0000269|PubMed:18175805}; Vmax=1.6 nmol/min/ug enzyme with pNppp as substrate (isoform 3) {ECO:0000269|PubMed:12176993, ECO:0000269|PubMed:18175805}; 	3.1.4.39	CATALYTIC ACTIVITY: 1-alkyl-sn-glycero-3-phosphoethanolamine + H(2)O = 1-alkyl-sn-glycerol 3-phosphate + ethanolamine. {ECO:0000269|PubMed:12176993, ECO:0000269|PubMed:15769751, ECO:0000269|PubMed:18175805, ECO:0000269|PubMed:21240271, ECO:0000269|PubMed:26371182, ECO:0000269|PubMed:27754931}.	BINDING 231 231 Substrate. {ECO:0000244|PDB:4ZG7, ECO:0000305|PubMed:26371182}.; BINDING 307 307 Substrate. {ECO:0000250|UniProtKB:Q9R1E6}.	ACTIVITY REGULATION: Inhibited by lysophosphatidic acid (LPA) and sphingosine-1-phosphate (S1P). Inhibited by EDTA and EGTA (Probable). {ECO:0000305|PubMed:15769751, ECO:0000305|PubMed:18175805, ECO:0000305|PubMed:21240271}.	COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000269|PubMed:26371182, ECO:0000269|PubMed:27754931, ECO:0000269|PubMed:28414242}; ;  Note=Binds 2 Zn(2+) ions per subunit. {ECO:0000269|PubMed:26371182, ECO:0000269|PubMed:27754931, ECO:0000269|PubMed:28414242};; COFACTOR: Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000269|PubMed:26371182, ECO:0000269|PubMed:27754931, ECO:0000269|PubMed:28414242}; ;  Note=Binds 1 Ca(2+) ion per subunit. {ECO:0000269|PubMed:26371182, ECO:0000269|PubMed:27754931, ECO:0000269|PubMed:28414242};	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 9.0 (isoform 1), 8.0 (isoform 3). Isoform 1 is less sensitive to pH. Isoform 1, isoform 2 and isoform 3 all retain some activity at pH 9.5. {ECO:0000269|PubMed:12176993, ECO:0000269|PubMed:18175805};		SITE 853 853 Essential for catalytic activity. {ECO:0000250|UniProtKB:Q9R1E6}.		BIOPHYSICOCHEMICAL PROPERTIES: ;  Temperature dependence: Isoform 1 and isoform 3 are active from 45 to 60 degrees Celsius. {ECO:0000269|PubMed:12176993, ECO:0000269|PubMed:18175805};	cell motility [GO:0048870]; chemotaxis [GO:0006935]; immune response [GO:0006955]; phosphatidylcholine catabolic process [GO:0034638]; phospholipid catabolic process [GO:0009395]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of angiogenesis [GO:0045765]; regulation of cell migration [GO:0030334]	extracellular space [GO:0005615]; plasma membrane [GO:0005886]	extracellular space [GO:0005615]; plasma membrane [GO:0005886]; alkylglycerophosphoethanolamine phosphodiesterase activity [GO:0047391]; calcium ion binding [GO:0005509]; hydrolase activity [GO:0016787]; lysophospholipase activity [GO:0004622]; nucleic acid binding [GO:0003676]; nucleotide diphosphatase activity [GO:0004551]; phosphodiesterase I activity [GO:0004528]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; cell motility [GO:0048870]; chemotaxis [GO:0006935]; immune response [GO:0006955]; phosphatidylcholine catabolic process [GO:0034638]; phospholipid catabolic process [GO:0009395]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of angiogenesis [GO:0045765]; regulation of cell migration [GO:0030334]	alkylglycerophosphoethanolamine phosphodiesterase activity [GO:0047391]; calcium ion binding [GO:0005509]; hydrolase activity [GO:0016787]; lysophospholipase activity [GO:0004622]; nucleic acid binding [GO:0003676]; nucleotide diphosphatase activity [GO:0004551]; phosphodiesterase I activity [GO:0004528]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]	GO:0003676; GO:0004528; GO:0004551; GO:0004622; GO:0005044; GO:0005509; GO:0005615; GO:0005886; GO:0006935; GO:0006955; GO:0008134; GO:0008270; GO:0009395; GO:0010634; GO:0016787; GO:0030247; GO:0030334; GO:0034638; GO:0045765; GO:0047391; GO:0048870; GO:0050731; GO:2000394	SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:12176993, ECO:0000269|PubMed:15769751, ECO:0000269|PubMed:1733949, ECO:0000269|PubMed:26371182, ECO:0000269|PubMed:27754931}.	PTM: N-glycosylation, but not furin-cleavage, plays a critical role on secretion and on lysoPLD activity. {ECO:0000250}.		7982964; 8586446; 8579579; 15769751; 18175805; 16421571; 15489334; 12176993; 1733949; 11559573; 15700135; 21240271; 26371182; 28414242; 27754931; 12498389; 12757929; 15027116; 15897878; 15933052; 16117781; 16356477; 16529861; 16627485; 16782887; 16837466; 17013094; 17577119; 17804602; 17902023; 18054784; 18249559; 18327261; 18337445; 18497954; 19027716; 19204739; 19212832; 19222837; 19297419; 19477432; 19506801; 19521548; 19522250; 19549252; 19614625; 20197381; 20231358; 20356387; 20379614; 20467438; 20495010; 20623382; 20888793; 21246658; 21419756; 21439952; 21505238; 21696367; 21719699; 21765444; 21777571; 21971049; 22002750; 22140473; 22155714; 22314276; 22474126; 22644624; 22700442; 22744859; 22820036; 22864860; 22922883; 22952646; 22975311; 23150666; 23258351; 23377000; 23478591; 23558934; 23639740; 23866971; 24050723; 24122794; 24443508; 24548887; 24582488; 24641902; 24642343; 24852265; 24935929; 24969110; 24984830; 25195735; 25277122; 25277244; 25450205; 25536867; 25896349; 25977291; 26037280; 26071407; 26072274; 26111716; 26224810; 26313906; 26391552; 26628447; 26727116; 26800320; 27268273; 27390295; 27506882; 27540113; 27583415; 27757783; 27784781; 27911319; 28052132; 28298439; 28347252; 28539367; 28731719; 28968864; 29058512; 29305605; 29328374; 29414802; 29568204	7982964; 8586446; 8579579; 15769751; 18175805; 16421571; 15489334; 12176993; 1733949; 11559573; 15700135; 21240271; 26371182; 28414242; 27754931
4894	CES3 UNQ869/PRO1887	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=137 uM for 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothecin {ECO:0000269|PubMed:15100172}; KM=460 uM for 7-ethyl-10-[4-(1-piperidino)-1-amino]-carbonyloxycamptothecin {ECO:0000269|PubMed:15100172}; 	3.1.1.1	CATALYTIC ACTIVITY: A carboxylic ester + H(2)O = an alcohol + a carboxylate. {ECO:0000255|PROSITE-ProRule:PRU10039}.							UNQ869/PRO1887		low-density lipoprotein particle clearance [GO:0034383]; xenobiotic metabolic process [GO:0006805]	cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]	cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; carboxylic ester hydrolase activity [GO:0052689]; low-density lipoprotein particle clearance [GO:0034383]; xenobiotic metabolic process [GO:0006805]	carboxylic ester hydrolase activity [GO:0052689]	GO:0005788; GO:0005829; GO:0006805; GO:0034383; GO:0052689; GO:0070062	SUBCELLULAR LOCATION: Endoplasmic reticulum lumen {ECO:0000250}.	PTM: N-glycosylated. {ECO:0000269|PubMed:15100172, ECO:0000269|PubMed:19159218}.		15100172; 12975309; 14702039; 15616553; 15489334; 14581373; 15687373; 19159218; 20422440; 20711500; 22700792	15100172; 12975309; 14702039; 15616553; 15489334; 14581373; 15687373; 19159218
4895	ETHE1 HSCO	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.34 mM for glutathione persulfide (GSSH) {ECO:0000269|PubMed:23144459}; Vmax=113 umol/min/mg enzyme (in the presence of equimolar amounts of GSSH and GSH and at 22 degrees Celsius) {ECO:0000269|PubMed:23144459}; 	1.13.11.18	CATALYTIC ACTIVITY: S-sulfanylglutathione + O(2) + H(2)O = glutathione + sulfite + 2 H(+). {ECO:0000269|PubMed:19136963, ECO:0000269|PubMed:23144459, ECO:0000269|PubMed:25596185}.		ACTIVITY REGULATION: Glutathione increases enzyme activity. {ECO:0000269|PubMed:23144459}.	COFACTOR: Name=Fe(2+); Xref=ChEBI:CHEBI:29033; Evidence={ECO:0000269|PubMed:19136963, ECO:0000269|PubMed:23144459, ECO:0000269|PubMed:25596185}; ;  Note=Binds 1 Fe(2+) ion per subunit. {ECO:0000269|PubMed:19136963, ECO:0000269|PubMed:23144459, ECO:0000269|PubMed:25596185};						glutathione metabolic process [GO:0006749]; hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; iron ion binding [GO:0005506]; sulfur dioxygenase activity [GO:0050313]; glutathione metabolic process [GO:0006749]; hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]	iron ion binding [GO:0005506]; sulfur dioxygenase activity [GO:0050313]	GO:0005506; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0006749; GO:0050313; GO:0070221; GO:0070813	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12398897}. Nucleus {ECO:0000269|PubMed:12398897}. Mitochondrion matrix {ECO:0000269|PubMed:14732903}.		MOD_RES 14 14 Phosphoserine. {ECO:0000250|UniProtKB:Q9DCM0}.; MOD_RES 19 19 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 66 66 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 172 172 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q9DCM0}.; MOD_RES 172 172 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q9DCM0}.	12398897; 14732903; 15057824; 15489334; 19136963; 19608861; 21269460; 23144459; 24275569; 25944712; 25596185; 18593870; 16169070; 16183799; 16929096; 19463016; 20711500; 20877624; 20978941; 24344204; 25198162; 25525879; 27074420; 27742479	12398897; 14732903; 15057824; 15489334; 19136963; 19608861; 21269460; 23144459; 24275569; 25944712; 25596185; 18593870
4941	FAM20C DMP4	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.8 uM for manganese/ATP {ECO:0000269|PubMed:23754375}; 	2.7.11.1	CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein. {ECO:0000269|PubMed:22582013, ECO:0000269|PubMed:23754375, ECO:0000269|PubMed:25789606}.	BINDING 269 269 ATP; via amide nitrogen. {ECO:0000250|UniProtKB:Q9XTW2}.; BINDING 285 285 ATP. {ECO:0000250|UniProtKB:Q9XTW2}.; BINDING 306 306 ATP. {ECO:0000250|UniProtKB:Q9XTW2}.; BINDING 463 463 ATP. {ECO:0000250|UniProtKB:Q9XTW2}.; BINDING 478 478 ATP. {ECO:0000250|UniProtKB:Q9XTW2}.	ACTIVITY REGULATION: Serine/threonine protein kinase activity is increased upon interaction with FAM20A. {ECO:0000269|PubMed:25789606}.	COFACTOR: Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000269|PubMed:23754375, ECO:0000305|PubMed:22582013}; 						ATP metabolic process [GO:0046034]; biomineral tissue development [GO:0031214]; cellular protein metabolic process [GO:0044267]; dentinogenesis [GO:0097187]; enamel mineralization [GO:0070166]; odontoblast differentiation [GO:0071895]; osteoclast maturation [GO:0036179]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; post-translational protein modification [GO:0043687]; protein phosphorylation [GO:0006468]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036]; regulation of phosphorus metabolic process [GO:0051174]	endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]	endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]; ATP metabolic process [GO:0046034]; biomineral tissue development [GO:0031214]; cellular protein metabolic process [GO:0044267]; dentinogenesis [GO:0097187]; enamel mineralization [GO:0070166]; odontoblast differentiation [GO:0071895]; osteoclast maturation [GO:0036179]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; post-translational protein modification [GO:0043687]; protein phosphorylation [GO:0006468]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036]; regulation of phosphorus metabolic process [GO:0051174]	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]	GO:0004674; GO:0005509; GO:0005524; GO:0005615; GO:0005788; GO:0005794; GO:0006468; GO:0030145; GO:0030501; GO:0031214; GO:0036179; GO:0040036; GO:0043687; GO:0044267; GO:0045669; GO:0046034; GO:0051174; GO:0070062; GO:0070166; GO:0071895; GO:0097187	SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:26091039}. Golgi apparatus {ECO:0000250|UniProtKB:Q5MJS3}.	PTM: N-glycosylation is required for folding. {ECO:0000305|PubMed:26091039}.; PTM: Autophosphorylated. {ECO:0000269|PubMed:26091039}.		12853948; 12690205; 15489334; 17974005; 26091039; 15676076; 19159218; 22582013; 23754375; 25789606; 17924334; 19250384; 20643727; 20825432; 21900206; 22900076; 23325605; 23732115; 24039075; 24706917; 24982027; 25026495; 25862977; 25928877; 25936777; 27667191; 27862258; 28236661; 28784772; 29277934; 29572475	12853948; 12690205; 15489334; 17974005; 26091039; 15676076; 19159218; 22582013; 23754375; 25789606; 17924334
4971	FAHD1 C16orf36 YISKL	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=4.6 uM for acetylpyruvate {ECO:0000269|PubMed:21878618}; KM=32 uM for oxaloacetate {ECO:0000269|PubMed:25575590}; Vmax=0.135 umol/min/mg enzyme toward acetylpyruvate {ECO:0000269|PubMed:21878618}; Vmax=0.21 umol/min/mg enzyme with oxaloacetate as substrate {ECO:0000269|PubMed:25575590}; 	3.7.1.5; 4.1.1.3	CATALYTIC ACTIVITY: A 3-acylpyruvate + H(2)O = a carboxylate + pyruvate. {ECO:0000269|PubMed:21878618}.; CATALYTIC ACTIVITY: Oxaloacetate = pyruvate + CO(2). {ECO:0000269|PubMed:25575590}.			COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000305|PubMed:15551868, ECO:0000305|PubMed:21878618}; Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000305|PubMed:15551868, ECO:0000305|PubMed:21878618}; 						tricarboxylic acid cycle [GO:0006099]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; acetylpyruvate hydrolase activity [GO:0018773]; acylpyruvate hydrolase activity [GO:0047621]; fumarylpyruvate hydrolase activity [GO:0034545]; metal ion binding [GO:0046872]; oxaloacetate decarboxylase activity [GO:0008948]; tricarboxylic acid cycle [GO:0006099]	acetylpyruvate hydrolase activity [GO:0018773]; acylpyruvate hydrolase activity [GO:0047621]; fumarylpyruvate hydrolase activity [GO:0034545]; metal ion binding [GO:0046872]; oxaloacetate decarboxylase activity [GO:0008948]	GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006099; GO:0008948; GO:0018773; GO:0034545; GO:0046872; GO:0047621	SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:21878618}. Cytoplasm, cytosol {ECO:0000269|PubMed:21878618}.		MOD_RES 40 40 Phosphoserine. {ECO:0000250|UniProtKB:Q6AYQ8}.; MOD_RES 113 113 N6-acetyllysine. {ECO:0000250|UniProtKB:Q8R0F8}.; MOD_RES 115 115 N6-succinyllysine. {ECO:0000250|UniProtKB:Q8R0F8}.	11157797; 11230166; 14702039; 15616553; 15489334; 21269460; 21878618; 24275569; 25575590; 25944712; 15551868; 15231747; 17342744; 20237496; 20877624; 21988832; 25609649; 26266933; 28286170	11157797; 11230166; 14702039; 15616553; 15489334; 21269460; 21878618; 24275569; 25575590; 25944712; 15551868
5006	FBP1 FBP	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=2.7 uM for fructose 1,6-biphosphate {ECO:0000269|PubMed:17350621}; Note=The kinetic constants are determined for the recombinant enzyme expressed in E.coli.;	3.1.3.11	CATALYTIC ACTIVITY: D-fructose 1,6-bisphosphate + H(2)O = D-fructose 6-phosphate + phosphate. {ECO:0000269|PubMed:17350621, ECO:0000269|PubMed:8387495}.	BINDING 141 141 AMP. {ECO:0000244|PDB:1FTA, ECO:0000269|PubMed:7809062}.; BINDING 265 265 Substrate. {ECO:0000250|UniProtKB:P00636}.	ACTIVITY REGULATION: Subject to complex allosteric regulation. The enzyme can assume an active R-state, or an inactive T-state. Intermediate conformations may exist. AMP acts as allosteric inhibitor. AMP binding affects the turnover of bound substrate and not the affinity for substrate. Fructose 2,6-bisphosphate acts as competitive inhibitor. Fructose 2,6-bisphosphate and AMP have synergistic effects. {ECO:0000269|PubMed:16442285, ECO:0000269|PubMed:16446092, ECO:0000269|PubMed:17350621, ECO:0000269|PubMed:18650089, ECO:0000269|PubMed:7809062}.	COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:7809062}; ;  Note=Binds 3 Mg(2+) ions per subunit. {ECO:0000250|UniProtKB:P00636};		PATHWAY: Carbohydrate biosynthesis; gluconeogenesis.				cellular response to drug [GO:0035690]; cellular response to magnesium ion [GO:0071286]; dephosphorylation [GO:0016311]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein homotetramerization [GO:0051289]; regulation of gluconeogenesis [GO:0006111]; sucrose biosynthetic process [GO:0005986]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; transcriptional repressor activity, RNA polymerase II transcription factor binding [GO:0001191]; cellular response to drug [GO:0035690]; cellular response to magnesium ion [GO:0071286]; dephosphorylation [GO:0016311]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein homotetramerization [GO:0051289]; regulation of gluconeogenesis [GO:0006111]; sucrose biosynthetic process [GO:0005986]	AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; transcriptional repressor activity, RNA polymerase II transcription factor binding [GO:0001191]	GO:0000122; GO:0001191; GO:0005634; GO:0005737; GO:0005829; GO:0005986; GO:0006000; GO:0006002; GO:0006094; GO:0006111; GO:0016208; GO:0016311; GO:0030308; GO:0030388; GO:0035690; GO:0042132; GO:0042802; GO:0045820; GO:0046580; GO:0046872; GO:0048029; GO:0051289; GO:0070062; GO:0071286			MOD_RES 2 2 N-acetylalanine. {ECO:0000250|UniProtKB:P00637}.; MOD_RES 151 151 N6-succinyllysine. {ECO:0000250|UniProtKB:Q9QXD6}.; MOD_RES 216 216 Phosphotyrosine. {ECO:0000250|UniProtKB:Q9QXD6}.; MOD_RES 245 245 Phosphotyrosine. {ECO:0000250|UniProtKB:Q9QXD6}.; MOD_RES 265 265 Phosphotyrosine. {ECO:0000244|PubMed:24275569}.	2842796; 8387495; 8135811; 7558035; 10222032; 15164053; 15489334; 7589895; 16497803; 17350621; 18375435; 22517657; 24275569; 8382525; 7809062; 16446092; 16442285; 18650089; 9382095; 12126934; 25601412; 12507293; 15965961; 16169070; 16189514; 16275660; 18460190; 18660489; 18780768; 18978678; 19259699; 19505453; 19626708; 19762234; 19881551; 19969452; 20045638; 20096900; 20151204; 20711500; 21044950; 21516116; 21550236; 21900206; 21988832; 22039417; 22057438; 22120740; 23453623; 23755305; 23881342; 24007283; 24128068; 24146906; 24412244; 25043030; 25416956; 25844935; 26068981; 26546081; 27079415; 27197151; 27742690; 27780144; 27780225; 27841754; 27978536; 28336726; 28387640; 28599390; 28653874; 28990097; 29016355; 29566023; 29678579; 7961695; 9678974	2842796; 8387495; 8135811; 7558035; 10222032; 15164053; 15489334; 7589895; 16497803; 17350621; 18375435; 22517657; 24275569; 8382525; 7809062; 16446092; 16442285; 18650089; 9382095; 12126934; 25601412
5039	FLAD1 PP591	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.5 uM for FMN {ECO:0000269|PubMed:16643857, ECO:0000269|PubMed:17049878}; KM=0.36 uM for FMN (isoform 2) {ECO:0000269|PubMed:16643857, ECO:0000269|PubMed:17049878}; Vmax=6.1 nmol/min/mg enzyme {ECO:0000269|PubMed:16643857, ECO:0000269|PubMed:17049878}; Vmax=3.9 nmol/min/mg enzyme (isoform 2) {ECO:0000269|PubMed:16643857, ECO:0000269|PubMed:17049878}; 	2.7.7.2	CATALYTIC ACTIVITY: ATP + FMN = diphosphate + FAD. {ECO:0000269|PubMed:16643857}.			COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:16643857, ECO:0000269|PubMed:17049878}; 		PATHWAY: Cofactor biosynthesis; FAD biosynthesis; FAD from FMN: step 1/1.		PP591		FAD biosynthetic process [GO:0006747]; oxidation-reduction process [GO:0055114]; riboflavin metabolic process [GO:0006771]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; FMN adenylyltransferase activity [GO:0003919]; FAD biosynthetic process [GO:0006747]; oxidation-reduction process [GO:0055114]; riboflavin metabolic process [GO:0006771]	ATP binding [GO:0005524]; FMN adenylyltransferase activity [GO:0003919]	GO:0003919; GO:0005524; GO:0005737; GO:0005759; GO:0005829; GO:0005886; GO:0006747; GO:0006771; GO:0055114	SUBCELLULAR LOCATION: Isoform 1: Mitochondrion matrix {ECO:0000269|PubMed:20060505}.; SUBCELLULAR LOCATION: Isoform 2: Cytoplasm.		MOD_RES 106 106 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976}.; MOD_RES 378 378 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8R123}.; MOD_RES 378 378 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8R123}.; MOD_RES 563 563 Phosphoserine. {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:23186163}.	16643857; 15498874; 16710414; 15489334; 9110174; 17049878; 18691976; 18669648; 19369195; 20060505; 21269460; 23186163; 24275569; 27259049; 16189514; 18985028; 19240958; 20186120; 21900206; 21988832; 22190034; 25416956; 25525879	16643857; 15498874; 16710414; 15489334; 9110174; 17049878; 18691976; 18669648; 19369195; 20060505; 21269460; 23186163; 24275569; 27259049
5143	SLC1A1 EAAC1 EAAT3	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=268 uM for L-glutamate {ECO:0000269|PubMed:26690923}; 			BINDING 370 370 Aspartate. {ECO:0000250|UniProtKB:P43003}.; BINDING 444 444 Aspartate. {ECO:0000250|UniProtKB:P43003}.; BINDING 451 451 Aspartate. {ECO:0000250|UniProtKB:P43003}.								chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; cysteine transport [GO:0042883]; D-aspartate import across plasma membrane [GO:0070779]; glutamate secretion [GO:0014047]; ion transport [GO:0006811]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamate import [GO:0051938]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; positive regulation of heart rate [GO:0010460]; protein homooligomerization [GO:0051260]	apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; chloride transmembrane transporter activity [GO:0015108]; cysteine transmembrane transporter activity [GO:0033229]; glutamate binding [GO:0016595]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; cysteine transport [GO:0042883]; D-aspartate import across plasma membrane [GO:0070779]; glutamate secretion [GO:0014047]; ion transport [GO:0006811]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamate import [GO:0051938]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; positive regulation of heart rate [GO:0010460]; protein homooligomerization [GO:0051260]	amino acid transmembrane transporter activity [GO:0015171]; chloride transmembrane transporter activity [GO:0015108]; cysteine transmembrane transporter activity [GO:0033229]; glutamate:sodium symporter activity [GO:0015501]; glutamate binding [GO:0016595]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]	GO:0005313; GO:0005314; GO:0005886; GO:0005887; GO:0006811; GO:0007268; GO:0010460; GO:0014047; GO:0015108; GO:0015171; GO:0015501; GO:0015813; GO:0016020; GO:0016324; GO:0016595; GO:0033229; GO:0042883; GO:0046872; GO:0051260; GO:0051938; GO:0070062; GO:0070779; GO:0098712; GO:0140009; GO:1902476	SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:21123949, ECO:0000269|PubMed:26690923, ECO:0000269|PubMed:7521911, ECO:0000269|PubMed:7914198, ECO:0000269|PubMed:8857541}; Multi-pass membrane protein {ECO:0000250|UniProtKB:P43003}. Apical cell membrane {ECO:0000269|PubMed:21123949}; Multi-pass membrane protein {ECO:0000250|UniProtKB:P43003}.	PTM: Glycosylated.	MOD_RES 517 517 Phosphoserine. {ECO:0000250|UniProtKB:P51906}.; MOD_RES 522 522 Phosphoserine. {ECO:0000250|UniProtKB:P51906}.	7859077; 7914198; 7521911; 11317217; 15164053; 15489334; 8857541; 26690923; 21982423; 23341099; 21123949; 11242046; 11823462; 15135231; 15716409; 16061389; 16116111; 16189514; 16198020; 16478724; 16566829; 16800850; 16818866; 16818867; 16858406; 17221839; 17360916; 17360917; 17588938; 17630698; 17646425; 17894418; 17991780; 18096700; 18167356; 18286588; 18846501; 19086053; 19152386; 19156168; 19349310; 19360657; 19569082; 19644675; 19884611; 20155310; 20235792; 20378543; 20398908; 20410850; 20424168; 20468064; 20634426; 21084597; 21445956; 21990008; 22095641; 22424243; 22479505; 22483750; 22532568; 22617815; 22707712; 22776887; 23411042; 23564280; 23606572; 23660601; 23695234; 23850643; 23931931; 24162932; 24163246; 24214974; 24578174; 24768158; 25033183; 25275463; 25416956; 25445080; 25515313; 26007177; 26112741; 26771863; 27153812; 27233497; 27358480; 27978527; 28324217; 28962897; 29304071; 7791878; 9108121	7859077; 7914198; 7521911; 11317217; 15164053; 15489334; 8857541; 26690923; 21982423; 23341099; 21123949
5154	EEF2K	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.2 uM for EEF2 {ECO:0000269|PubMed:11015200}; Vmax=4 nmol/min/mg enzyme {ECO:0000269|PubMed:11015200}; 	2.7.11.20	CATALYTIC ACTIVITY: ATP + [elongation factor 2] = ADP + [elongation factor 2] phosphate. {ECO:0000269|PubMed:11015200, ECO:0000269|PubMed:9144159}.		ACTIVITY REGULATION: Undergoes calcium/calmodulin-dependent intramolecular autophosphorylation, and this results in it becoming partially calcium/calmodulin-independent. {ECO:0000250}.							cellular response to anoxia [GO:0071454]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to insulin stimulus [GO:0032869]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of endocytosis [GO:0045807]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of protein autophosphorylation [GO:0031952]; response to ischemia [GO:0002931]; response to prolactin [GO:1990637]; translational elongation [GO:0006414]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; postsynaptic density [GO:0014069]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; elongation factor-2 kinase activity [GO:0004686]; protein kinase activity [GO:0004672]; translation factor activity, RNA binding [GO:0008135]; cellular response to anoxia [GO:0071454]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to insulin stimulus [GO:0032869]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of endocytosis [GO:0045807]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of protein autophosphorylation [GO:0031952]; response to ischemia [GO:0002931]; response to prolactin [GO:1990637]; translational elongation [GO:0006414]	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; elongation factor-2 kinase activity [GO:0004686]; protein kinase activity [GO:0004672]; translation factor activity, RNA binding [GO:0008135]	GO:0002931; GO:0004672; GO:0004686; GO:0005509; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006414; GO:0008135; GO:0014069; GO:0031952; GO:0032869; GO:0043066; GO:0043197; GO:0045807; GO:0046777; GO:0051965; GO:0061003; GO:0071277; GO:0071320; GO:0071454; GO:1990416; GO:1990637		PTM: Autophosphorylated at multiple residues, Thr-348 being the major site. Phosphorylated by AMP-activated protein kinase AMPK at Ser-398 leading to EEF2K activation and protein synthesis inhibition. Phosphorylated by TRPM7 at Ser-78 resulting in improved protein stability, higher EE2F phosphorylated and subsequently reduced rate of protein synthesis. Phosphorylation by other kinases such as CDK1 and MAPK13 at Ser-359 or RPS6KA1 and RPS6KB1 at Ser-366 instead decrease EEF2K activity and promote protein synthesis. {ECO:0000269|PubMed:11015200, ECO:0000269|PubMed:11500363, ECO:0000269|PubMed:11500364, ECO:0000269|PubMed:14709557, ECO:0000269|PubMed:18337751, ECO:0000269|PubMed:21112387, ECO:0000269|PubMed:22216903}.	MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:22223895}.; MOD_RES 18 18 Phosphoserine. {ECO:0000244|PubMed:15144186, ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 27 27 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 61 61 Phosphoserine; by autocatalysis. {ECO:0000269|PubMed:22216903}.; MOD_RES 66 66 Phosphoserine; by autocatalysis. {ECO:0000269|PubMed:22216903}.; MOD_RES 70 70 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 71 71 Phosphoserine. {ECO:0000250|UniProtKB:O08796}.; MOD_RES 72 72 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 74 74 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 78 78 Phosphoserine; by autocatalysis and TRPM7. {ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:21112387, ECO:0000269|PubMed:22216903}.; MOD_RES 243 243 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 348 348 Phosphothreonine; by autocatalysis. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569, ECO:0000269|PubMed:22216903}.; MOD_RES 353 353 Phosphothreonine; by autocatalysis. {ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:22216903}.; MOD_RES 359 359 Phosphoserine; by MAPK13 and CDK1. {ECO:0000269|PubMed:11500363, ECO:0000269|PubMed:18337751}.; MOD_RES 366 366 Phosphoserine; by autocatalysis, RPS6KA1 and RPS6KB1. {ECO:0000269|PubMed:11500364, ECO:0000269|PubMed:22216903}.; MOD_RES 392 392 Phosphoserine. {ECO:0000250|UniProtKB:O08796}.; MOD_RES 398 398 Phosphoserine; by AMPK. {ECO:0000269|PubMed:14709557}.; MOD_RES 435 435 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 445 445 Phosphoserine; by autocatalysis. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569, ECO:0000269|PubMed:22216903}.; MOD_RES 470 470 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 474 474 Phosphoserine; by autocatalysis. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569, ECO:0000269|PubMed:22216903}.; MOD_RES 477 477 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 491 491 Phosphoserine; by autocatalysis. {ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:22216903}.; MOD_RES 500 500 Phosphoserine; by PKA. {ECO:0000250|UniProtKB:P70531}.	9144159; 15616553; 15489334; 11015200; 11500363; 11500364; 15144186; 14709557; 17081983; 16964243; 18337751; 18669648; 19413330; 19690332; 20068231; 21269460; 21112387; 21406692; 22216903; 22223895; 23186163; 24275569; 17344846; 12171600; 14684180; 15024086; 15809305; 16098202; 16171514; 16921268; 19636416; 20300520; 20379614; 21278783; 21659604; 22115317; 22269896; 22329831; 22669845; 22749997; 22911754; 22932089; 23182879; 23184662; 23455922; 23706743; 23812389; 24193916; 24732796; 24955726; 25012662; 25182533; 25330770; 25353634; 25609649; 25670349; 25755286; 25776553; 26009171; 26806303; 26918606; 27181208; 27499441; 27571275; 27752775; 27760376; 27956550; 28502587; 29024627; 29094413	9144159; 15616553; 15489334; 11015200; 11500363; 11500364; 15144186; 14709557; 17081983; 16964243; 18337751; 18669648; 19413330; 19690332; 20068231; 21269460; 21112387; 21406692; 22216903; 22223895; 23186163; 24275569; 17344846
5182	SLC1A3 EAAT1 GLAST GLAST1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=525 uM for L-glutamate {ECO:0000269|PubMed:26690923}; 			BINDING 402 402 Aspartate. {ECO:0000244|PDB:5LM4, ECO:0000269|PubMed:28424515}.; BINDING 476 476 Aspartate. {ECO:0000244|PDB:5LM4, ECO:0000269|PubMed:28424515}.; BINDING 483 483 Aspartate. {ECO:0000244|PDB:5LM4, ECO:0000269|PubMed:28424515}.								auditory behavior [GO:0031223]; cell morphogenesis involved in neuron differentiation [GO:0048667]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; cranial nerve development [GO:0021545]; D-aspartate import across plasma membrane [GO:0070779]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; glutamate biosynthetic process [GO:0006537]; glutamate secretion [GO:0014047]; ion transport [GO:0006811]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamate import [GO:0051938]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; neuromuscular process controlling balance [GO:0050885]; neurotransmitter uptake [GO:0001504]; positive regulation of synaptic transmission [GO:0050806]; potassium ion transmembrane transport [GO:0071805]; response to antibiotic [GO:0046677]; response to light stimulus [GO:0009416]; response to wounding [GO:0009611]; sensory perception of sound [GO:0007605]	cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; glutamate binding [GO:0016595]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; auditory behavior [GO:0031223]; cell morphogenesis involved in neuron differentiation [GO:0048667]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; cranial nerve development [GO:0021545]; D-aspartate import across plasma membrane [GO:0070779]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; glutamate biosynthetic process [GO:0006537]; glutamate secretion [GO:0014047]; ion transport [GO:0006811]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamate import [GO:0051938]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; neuromuscular process controlling balance [GO:0050885]; neurotransmitter uptake [GO:0001504]; positive regulation of synaptic transmission [GO:0050806]; potassium ion transmembrane transport [GO:0071805]; response to antibiotic [GO:0046677]; response to light stimulus [GO:0009416]; response to wounding [GO:0009611]; sensory perception of sound [GO:0007605]	amino acid transmembrane transporter activity [GO:0015171]; glutamate:sodium symporter activity [GO:0015501]; glutamate binding [GO:0016595]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]	GO:0001504; GO:0005313; GO:0005314; GO:0005886; GO:0005887; GO:0006537; GO:0006811; GO:0007268; GO:0007605; GO:0009416; GO:0009449; GO:0009611; GO:0009986; GO:0014047; GO:0015171; GO:0015501; GO:0015813; GO:0016020; GO:0016595; GO:0021545; GO:0031223; GO:0043005; GO:0043025; GO:0046677; GO:0046872; GO:0048667; GO:0050806; GO:0050885; GO:0051938; GO:0070779; GO:0071805; GO:0098712; GO:0140009; GO:1902476	SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:20477940, ECO:0000269|PubMed:26690923, ECO:0000269|PubMed:28032905, ECO:0000269|PubMed:7521911, ECO:0000269|PubMed:8123008}; Multi-pass membrane protein {ECO:0000269|PubMed:28424515}.	PTM: Glycosylated. {ECO:0000250|UniProtKB:P24942}.	MOD_RES 512 512 Phosphoserine. {ECO:0000244|PubMed:23186163}.	8218410; 7521911; 8123008; 8647279; 16042756; 14702039; 15372022; 18669648; 20477940; 22814378; 23186163; 26690923; 28032905; 28424515; 16116111; 11242046; 11792462; 11826152; 12769187; 12911626; 14713304; 14730707; 14743216; 14749132; 15135231; 15535133; 15718040; 15950021; 16061389; 16516348; 16877378; 17221839; 17316900; 17581948; 17627080; 17676873; 18446307; 18454440; 18657127; 18678877; 19086053; 19139306; 19156168; 19283393; 19338517; 19352218; 19736351; 19913121; 20628086; 21233784; 21528001; 21707071; 21711518; 21732909; 21876140; 22252783; 22292083; 22424243; 22569537; 22706862; 23107647; 23356950; 23706640; 23902751; 23913256; 24332449; 24578174; 24705354; 25036385; 25064059; 25391854; 25660734; 25789968; 26057049; 26203187; 26233565; 26358886; 26638075; 26683197; 27196320; 27296938; 27445142; 27476799; 27829685; 27889915; 29208948; 7791878; 7859077; 9108121	8218410; 7521911; 8123008; 8647279; 16042756; 14702039; 15372022; 18669648; 20477940; 22814378; 23186163; 26690923; 28032905; 28424515; 16116111
5274	FUT1 H HSC	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=2.4 mM for phenyl beta-D-galactoside {ECO:0000269|PubMed:2118655}; 	2.4.1.344	CATALYTIC ACTIVITY: GDP-beta-L-fucose + beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-R = GDP + alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-R. {ECO:0000269|PubMed:2118655}.					PATHWAY: Protein modification; protein glycosylation.				carbohydrate metabolic process [GO:0005975]; L-fucose catabolic process [GO:0042355]; protein glycosylation [GO:0006486]	Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]	Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; fucosyltransferase activity [GO:0008417]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; L-fucose catabolic process [GO:0042355]; protein glycosylation [GO:0006486]	fucosyltransferase activity [GO:0008417]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]	GO:0005794; GO:0005887; GO:0005975; GO:0006486; GO:0008107; GO:0008417; GO:0016020; GO:0032580; GO:0042355	SUBCELLULAR LOCATION: Golgi apparatus, Golgi stack membrane; Single-pass type II membrane protein. Note=Membrane-bound form in trans cisternae of Golgi.			2118655; 9122901; 9226185; 15489334; 7912436; 9299444; 12652076; 12697902; 15476160; 15487706; 15847661; 16331565; 17459061; 17922418; 18023290; 18155296; 18205178; 18374127; 18686606; 19137814; 19572973; 20506485; 21839020; 21983725; 22053055; 22161108; 23063462; 23533340; 24467809; 24527852; 24665114; 25101798; 25239830; 25297588; 25761312; 26908442; 26986216; 27240592; 27560716; 27834485; 28026021; 28103512; 28940895; 29130097	2118655; 9122901; 9226185; 15489334; 7912436; 9299444
5275	FUT2 SEC2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=11.5 mM for phenyl-beta-D-galactoside {ECO:0000269|PubMed:7876235}; KM=3.6 mM for lacto-N-biose {ECO:0000269|PubMed:7876235}; KM=3.8 mM for N-acetyllactosamine {ECO:0000269|PubMed:7876235}; KM=197 uM for GDP-fucose {ECO:0000269|PubMed:7876235}; 	2.4.1.344; 2.4.1.69	CATALYTIC ACTIVITY: GDP-beta-L-fucose + beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-R = GDP + alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-R. {ECO:0000269|PubMed:7876235}.; CATALYTIC ACTIVITY: GDP-beta-L-fucose + beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-R = GDP + alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-R. {ECO:0000269|PubMed:7876235}.					PATHWAY: Protein modification; protein glycosylation. {ECO:0000269|PubMed:7876235}.				carbohydrate metabolic process [GO:0005975]; L-fucose catabolic process [GO:0042355]; protein glycosylation [GO:0006486]	extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]	extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; fucosyltransferase activity [GO:0008417]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; L-fucose catabolic process [GO:0042355]; protein glycosylation [GO:0006486]	fucosyltransferase activity [GO:0008417]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]	GO:0005794; GO:0005975; GO:0006486; GO:0008107; GO:0008417; GO:0016021; GO:0032580; GO:0042355; GO:0070062	SUBCELLULAR LOCATION: Golgi apparatus, Golgi stack membrane; Single-pass type II membrane protein. Note=Membrane-bound form in trans cisternae of Golgi.			7876235; 9219535; 15489334; 8621666; 8755920; 8018146; 12692541; 21625510; 22068912; 24733310; 9760207; 18776911; 11535550; 11606829; 11806852; 11916003; 12164325; 12645255; 12673421; 15250822; 15338364; 15476160; 15487706; 15757249; 15809881; 16008680; 16168124; 16306606; 16514298; 17054072; 17537929; 17655580; 17760744; 17805536; 17922418; 18067503; 18422843; 18803289; 18997004; 19169360; 19303062; 19487333; 19572973; 19625176; 19692168; 19757028; 20000042; 20172014; 20197723; 20506485; 20514537; 20533259; 20565774; 20570966; 20800603; 20852008; 20880207; 20971884; 21040203; 21056528; 21256510; 21725903; 22025362; 22025780; 22053055; 22188519; 22237057; 22471454; 22521342; 22664149; 22672431; 23002346; 23065099; 23075394; 23201895; 23402911; 23958938; 24122375; 24277741; 24326010; 24527852; 24612312; 24705354; 24720527; 24828903; 25037042; 25505295; 25642664; 25744498; 25761312; 26061595; 26231005; 26389824; 26454189; 26646561; 27503233; 27559109; 27834485; 27859559; 28742214; 28824326; 29040465	7876235; 9219535; 15489334; 8621666; 8755920; 8018146; 12692541; 21625510; 22068912; 24733310; 9760207; 18776911
5342	GGPS1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=3 uM for isopentenyl diphosphate {ECO:0000269|PubMed:16698791}; KM=4.2 uM for farnesyl diphosphate {ECO:0000269|PubMed:16698791}; 	2.5.1.-; 2.5.1.1; 2.5.1.29; 2.5.1.10	CATALYTIC ACTIVITY: Dimethylallyl diphosphate + isopentenyl diphosphate = diphosphate + geranyl diphosphate. {ECO:0000269|PubMed:16698791}.; CATALYTIC ACTIVITY: Geranyl diphosphate + isopentenyl diphosphate = diphosphate + (2E,6E)-farnesyl diphosphate. {ECO:0000269|PubMed:16698791}.; CATALYTIC ACTIVITY: (2E,6E)-farnesyl diphosphate + isopentenyl diphosphate = diphosphate + geranylgeranyl diphosphate. {ECO:0000269|PubMed:16698791}.	BINDING 25 25 Isopentenyl diphosphate. {ECO:0000250}.; BINDING 28 28 Isopentenyl diphosphate. {ECO:0000250}.; BINDING 57 57 Isopentenyl diphosphate. {ECO:0000250}.; BINDING 73 73 Dimethylallyl diphosphate.; BINDING 74 74 Isopentenyl diphosphate. {ECO:0000250}.; BINDING 151 151 Dimethylallyl diphosphate.; BINDING 152 152 Dimethylallyl diphosphate.; BINDING 185 185 Dimethylallyl diphosphate.; BINDING 202 202 Dimethylallyl diphosphate.; BINDING 212 212 Dimethylallyl diphosphate. {ECO:0000250}.	ACTIVITY REGULATION: Subject to product inhibition by geranylgeranyl diphosphate. {ECO:0000269|PubMed:16698791}.	COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000305}; ;  Note=Binds 3 Mg(2+) ions. {ECO:0000305};		PATHWAY: Isoprenoid biosynthesis; farnesyl diphosphate biosynthesis; farnesyl diphosphate from geranyl diphosphate and isopentenyl diphosphate: step 1/1.; PATHWAY: Isoprenoid biosynthesis; geranyl diphosphate biosynthesis; geranyl diphosphate from dimethylallyl diphosphate and isopentenyl diphosphate: step 1/1.; PATHWAY: Isoprenoid biosynthesis; geranylgeranyl diphosphate biosynthesis; geranylgeranyl diphosphate from farnesyl diphosphate and isopentenyl diphosphate: step 1/1.				cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384]; geranylgeranyl diphosphate biosynthetic process [GO:0033386]; isoprenoid metabolic process [GO:0006720]; regulation of cholesterol biosynthetic process [GO:0045540]	cytosol [GO:0005829]	cytosol [GO:0005829]; dimethylallyltranstransferase activity [GO:0004161]; farnesyltranstransferase activity [GO:0004311]; geranyltranstransferase activity [GO:0004337]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384]; geranylgeranyl diphosphate biosynthetic process [GO:0033386]; isoprenoid metabolic process [GO:0006720]; regulation of cholesterol biosynthetic process [GO:0045540]	dimethylallyltranstransferase activity [GO:0004161]; farnesyltranstransferase activity [GO:0004311]; geranyltranstransferase activity [GO:0004337]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]	GO:0004161; GO:0004311; GO:0004337; GO:0005829; GO:0006695; GO:0006720; GO:0033384; GO:0033386; GO:0042802; GO:0045337; GO:0045540; GO:0046872	SUBCELLULAR LOCATION: Cytoplasm.		MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:22814378}.	9741684; 10026212; 10931946; 10101267; 14702039; 16710414; 15489334; 21269460; 22814378; 16698791; 16684881; 18726356; 25416956	9741684; 10026212; 10931946; 10101267; 14702039; 16710414; 15489334; 21269460; 22814378; 16698791
5371	GGCT C7orf24 CRF21	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=2.0 mM for gamma-glutamyl-L-alanine; Vmax=50.3 umol/min/mg enzyme; 	4.3.2.9	CATALYTIC ACTIVITY: Alpha-(gamma-L-glutamyl)-L-amino acid = alpha-L-amino acid + 5-oxo-L-proline.	BINDING 139 139 Substrate. {ECO:0000305|PubMed:18515354}.								glutathione biosynthetic process [GO:0006750]; release of cytochrome c from mitochondria [GO:0001836]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; gamma-glutamylcyclotransferase activity [GO:0003839]; protein homodimerization activity [GO:0042803]; glutathione biosynthetic process [GO:0006750]; release of cytochrome c from mitochondria [GO:0001836]	gamma-glutamylcyclotransferase activity [GO:0003839]; protein homodimerization activity [GO:0042803]	GO:0001836; GO:0003839; GO:0005829; GO:0006750; GO:0042803; GO:0070062			MOD_RES 173 173 Phosphoserine. {ECO:0000250|UniProtKB:Q9D7X8}.	14702039; 12853948; 15489334; 16765912; 21269460; 18515354; 17932939; 17850744; 19423540; 20406964; 20438785; 20527979; 22205682; 23386615; 23513927; 23853312; 24189400; 24342434; 24366813; 25609649; 25818003; 25941902; 26339607; 26496610; 26828272; 29307834; 29429592	14702039; 12853948; 15489334; 16765912; 21269460; 18515354; 17932939
5383	GLRA2	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: Note=For isoform Alpha-2* homopentamers, a concentration of about 66 uM glycine results in half-maximal channel conductance. For isoform Alpha-2B homopentamers, a concentration of about 34 uM glycine results in half-maximal channel conductance.;				ACTIVITY REGULATION: Inhibited by strychnine (PubMed:2155780, PubMed:15302677). Inhibited by picrotoxin (PubMed:15302677). Channel activity is potentiated by 10-100 uM Zn(2+) (PubMed:15302677, PubMed:16144831, PubMed:23895467). Channel activity is marginally increased by 50 mM ethanol; it is strongly increased by a combination of 0.5 uM Zn(2+) and 50 mM ethanol (PubMed:23895467). Channel activity is inhibited by 100-1000 uM Zn(2+) (PubMed:15302677). {ECO:0000269|PubMed:15302677, ECO:0000269|PubMed:16144831, ECO:0000269|PubMed:2155780, ECO:0000269|PubMed:23895467}.				SITE 295 295 Important for obstruction of the ion pore in the closed conformation. {ECO:0000250|UniProtKB:P23415}.			cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; neuropeptide signaling pathway [GO:0007218]; synaptic transmission, glycinergic [GO:0060012]	cell junction [GO:0030054]; cell projection [GO:0042995]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]	cell junction [GO:0030054]; cell projection [GO:0042995]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; neuropeptide signaling pathway [GO:0007218]; synaptic transmission, glycinergic [GO:0060012]	extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]	GO:0004888; GO:0005886; GO:0005887; GO:0007218; GO:0016594; GO:0016934; GO:0022852; GO:0030054; GO:0034220; GO:0034707; GO:0042995; GO:0045211; GO:0046872; GO:0060012; GO:0071230; GO:0071294; GO:0071361; GO:1902476	SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell membrane {ECO:0000250|UniProtKB:Q7TNC8}; Multi-pass membrane protein {ECO:0000250|UniProtKB:P23415}. Cell junction, synapse {ECO:0000250|UniProtKB:Q7TNC8}. Cell membrane {ECO:0000269|PubMed:15302677, ECO:0000269|PubMed:16144831, ECO:0000269|PubMed:2155780, ECO:0000269|PubMed:23895467, ECO:0000269|PubMed:25445488}; Multi-pass membrane protein {ECO:0000250|UniProtKB:P23415}. Cell projection {ECO:0000250|UniProtKB:Q7TNC8}.			2155780; 9674912; 15302677; 14702039; 15772651; 15489334; 8973915; 16144831; 23895467; 25445488; 15147510; 16169070; 19086053; 19874574; 20237295; 21988832; 22606311; 27382060; 8717357; 9677400	2155780; 9674912; 15302677; 14702039; 15772651; 15489334; 8973915; 16144831; 23895467; 25445488
5388	GLYAT ACGNAT CAT GAT	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=57.9 mM for benzoyl-CoA {ECO:0000269|PubMed:7802672}; KM=83.7 mM for salicyl-CoA {ECO:0000269|PubMed:7802672}; KM=124 mM for isovaleryl-CoA {ECO:0000269|PubMed:7802672}; KM=198 mM for octanoyl-CoA {ECO:0000269|PubMed:7802672}; Vmax=17.1 umol/min/mg enzyme with benzoyl-CoA as substrate {ECO:0000269|PubMed:7802672}; Vmax=10.1 umol/min/mg enzyme with salicyl-CoA as substrate {ECO:0000269|PubMed:7802672}; Vmax=7.64 umol/min/mg enzyme with isovaleryl-CoA as substrate {ECO:0000269|PubMed:7802672}; Vmax=3.3 umol/min/mg enzyme with octanoyl-CoA as substrate {ECO:0000269|PubMed:7802672}; 	2.3.1.13; 2.3.1.71	CATALYTIC ACTIVITY: Acyl-CoA + glycine = CoA + N-acylglycine. {ECO:0000303|PubMed:22475485, ECO:0000303|PubMed:7802672}.; CATALYTIC ACTIVITY: Benzoyl-CoA + glycine = CoA + hippurate. {ECO:0000303|PubMed:22475485, ECO:0000303|PubMed:7802672}.									acyl-CoA metabolic process [GO:0006637]; benzoyl-CoA metabolic process [GO:1901787]; glycine metabolic process [GO:0006544]; monocarboxylic acid metabolic process [GO:0032787]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; glycine N-acyltransferase activity [GO:0047961]; glycine N-benzoyltransferase activity [GO:0047962]; transferase activity, transferring acyl groups [GO:0016746]; acyl-CoA metabolic process [GO:0006637]; benzoyl-CoA metabolic process [GO:1901787]; glycine metabolic process [GO:0006544]; monocarboxylic acid metabolic process [GO:0032787]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805]	glycine N-acyltransferase activity [GO:0047961]; glycine N-benzoyltransferase activity [GO:0047962]; transferase activity, transferring acyl groups [GO:0016746]	GO:0005739; GO:0005759; GO:0006544; GO:0006637; GO:0006805; GO:0009636; GO:0016746; GO:0032787; GO:0047961; GO:0047962; GO:1901787	SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:22475485}.		MOD_RES 16 16 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q91XE0}.; MOD_RES 16 16 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q91XE0}.; MOD_RES 127 127 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q91XE0}.; MOD_RES 127 127 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q91XE0}.; MOD_RES 141 141 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q91XE0}.; MOD_RES 141 141 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q91XE0}.; MOD_RES 159 159 N6-acetyllysine. {ECO:0000250|UniProtKB:Q91XE0}.; MOD_RES 169 169 N6-succinyllysine. {ECO:0000250|UniProtKB:Q91XE0}.; MOD_RES 183 183 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q91XE0}.; MOD_RES 183 183 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q91XE0}.; MOD_RES 256 256 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q91XE0}.; MOD_RES 256 256 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q91XE0}.	10630424; 22475485; 16554811; 15489334; 7802672; 24275569; 16169070; 19252341; 20064372; 20877624; 20925583; 23108985; 23237781; 25416956; 26149650; 28759163; 931988	10630424; 22475485; 16554811; 15489334; 7802672; 24275569
5396	GLRX2 GRX2 CGI-133	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=5.9 mM for GSH {ECO:0000269|PubMed:14676218}; KM=0.77 mM for glutathionylated ribonuclease A {ECO:0000269|PubMed:14676218}; KM=4.3 mM for glutathionylated BSA {ECO:0000269|PubMed:14676218}; KM=0.11 mM for glutathionylated beta-mercaptoethanol {ECO:0000269|PubMed:14676218}; 			BINDING 74 74 Glutathione. {ECO:0000269|PubMed:17121859}.; BINDING 109 109 Glutathione. {ECO:0000269|PubMed:17121859}.; BINDING 121 121 Glutathione; via amide nitrogen and carbonyl oxygen. {ECO:0000269|PubMed:17121859}.	ACTIVITY REGULATION: The 2Fe-2S present in the homodimer leads to inactivation of the enzyme. The 2Fe-2S may serve as a redox sensor: the presence of one-electron oxidants or reductants leading to the loss of the 2Fe-2S cluster, subsequent monomerization and activation of the enzyme. Unlike other glutaredoxins, it is not inhibited by oxidation of structural Cys residues. {ECO:0000269|PubMed:15917333}.					CGI-133		aging [GO:0007568]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; cellular response to superoxide [GO:0071451]; DNA protection [GO:0042262]; glutathione metabolic process [GO:0006749]; regulation of signal transduction [GO:0009966]; regulation of transcription, DNA-templated [GO:0006355]; response to hydrogen peroxide [GO:0042542]; response to organic substance [GO:0010033]; response to redox state [GO:0051775]; response to temperature stimulus [GO:0009266]	dendrite [GO:0030425]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	dendrite [GO:0030425]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 2 iron, 2 sulfur cluster binding [GO:0051537]; arsenate reductase (glutaredoxin) activity [GO:0008794]; electron transfer activity [GO:0009055]; glutathione disulfide oxidoreductase activity [GO:0015038]; metal ion binding [GO:0046872]; protein disulfide isomerase activity [GO:0003756]; protein disulfide oxidoreductase activity [GO:0015035]; aging [GO:0007568]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; cellular response to superoxide [GO:0071451]; DNA protection [GO:0042262]; glutathione metabolic process [GO:0006749]; regulation of signal transduction [GO:0009966]; regulation of transcription, DNA-templated [GO:0006355]; response to hydrogen peroxide [GO:0042542]; response to organic substance [GO:0010033]; response to redox state [GO:0051775]; response to temperature stimulus [GO:0009266]	2 iron, 2 sulfur cluster binding [GO:0051537]; arsenate reductase (glutaredoxin) activity [GO:0008794]; electron transfer activity [GO:0009055]; glutathione disulfide oxidoreductase activity [GO:0015038]; metal ion binding [GO:0046872]; protein disulfide isomerase activity [GO:0003756]; protein disulfide oxidoreductase activity [GO:0015035]	GO:0003756; GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0006355; GO:0006749; GO:0006915; GO:0007568; GO:0008794; GO:0009055; GO:0009266; GO:0009966; GO:0010033; GO:0015035; GO:0015038; GO:0030154; GO:0030425; GO:0042262; GO:0042542; GO:0043025; GO:0043231; GO:0045454; GO:0046872; GO:0051537; GO:0051775; GO:0071451	SUBCELLULAR LOCATION: Isoform 1: Mitochondrion.; SUBCELLULAR LOCATION: Isoform 2: Nucleus.		MOD_RES 20 20 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 77 77 S-glutathionyl cysteine; alternate. {ECO:0000269|PubMed:17121859}.	11297543; 11397793; 16710414; 10810093; 15489334; 15184054; 15297967; 14676218; 15328416; 15649413; 15917333; 23186163; 17121859; 17065220; 17115894; 17546662; 17961515; 18816065; 19292455; 20547138; 20877624; 20929858; 21437321; 21735102; 22139372; 24295294; 25735211; 28618115; 29101900	11297543; 11397793; 16710414; 10810093; 15489334; 15184054; 15297967; 14676218; 15328416; 15649413; 15917333; 23186163; 17121859
5397	GLS GLS1 KIAA0838	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.9 mM for glutamine (isoform 1) {ECO:0000269|PubMed:22049910}; KM=1.4 mM for glutamine (isoform 3) {ECO:0000269|PubMed:22049910}; 	3.5.1.2	CATALYTIC ACTIVITY: L-glutamine + H(2)O = L-glutamate + NH(3). {ECO:0000269|PubMed:22049910}.	BINDING 286 286 Substrate.; BINDING 335 335 Substrate.; BINDING 381 381 Substrate.; BINDING 388 388 Substrate.; BINDING 414 414 Substrate.; BINDING 466 466 Substrate.; BINDING 484 484 Substrate; via amide nitrogen.	ACTIVITY REGULATION: Isoform 1 and isoform 3 are activated by phosphate. Inhibited by BPTES. BPTES binds between subunits and favors dissociation of the tetramer into dimers. {ECO:0000269|PubMed:22049910}.							cellular amino acid biosynthetic process [GO:0008652]; chemical synaptic transmission [GO:0007268]; glutamate biosynthetic process [GO:0006537]; glutamate secretion [GO:0014047]; glutamine catabolic process [GO:0006543]; protein homotetramerization [GO:0051289]; regulation of respiratory gaseous exchange by neurological system process [GO:0002087]; suckling behavior [GO:0001967]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; glutaminase activity [GO:0004359]; cellular amino acid biosynthetic process [GO:0008652]; chemical synaptic transmission [GO:0007268]; glutamate biosynthetic process [GO:0006537]; glutamate secretion [GO:0014047]; glutamine catabolic process [GO:0006543]; protein homotetramerization [GO:0051289]; regulation of respiratory gaseous exchange by neurological system process [GO:0002087]; suckling behavior [GO:0001967]	glutaminase activity [GO:0004359]	GO:0001967; GO:0002087; GO:0004359; GO:0005739; GO:0005759; GO:0005829; GO:0006537; GO:0006543; GO:0007268; GO:0008652; GO:0014047; GO:0051289	SUBCELLULAR LOCATION: Isoform 1: Cytoplasm, cytosol.; SUBCELLULAR LOCATION: Isoform 3: Mitochondrion.		MOD_RES 130 130 N6-succinyllysine. {ECO:0000250|UniProtKB:D3Z7P3}.; MOD_RES 164 164 N6-succinyllysine. {ECO:0000250|UniProtKB:D3Z7P3}.; MOD_RES 311 311 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 652 652 Phosphoserine. {ECO:0000250|UniProtKB:P13264}.	11015561; 10048485; 10719215; 15489334; 14759258; 16899818; 17940881; 19139490; 19608861; 21269460; 22228304; 24275569; 25944712; 22049910; 10620514; 12579526; 14722097; 15246207; 15496140; 15642443; 17353931; 17669570; 19156168; 19219026; 19222703; 19423540; 19428808; 19428809; 19428810; 19500843; 20406964; 20438785; 20659789; 20711500; 20820037; 20869947; 20877624; 21045145; 21234284; 21457947; 21852960; 22106309; 22304920; 22326218; 22360420; 22538822; 22892846; 23507704; 23578284; 23636801; 23722553; 23935106; 24086752; 24122876; 24276018; 24333121; 24451979; 24696726; 24755074; 25297978; 25482439; 25880019; 25915584; 26134042; 26575584; 26710269; 26771232; 26988803; 27089238; 27338638; 27501743; 27542409; 28185053; 28218035; 28498807; 28526749; 28800318; 29032577; 29097210; 29317493; 29367649; 29441491; 3214421	11015561; 10048485; 10719215; 15489334; 14759258; 16899818; 17940881; 19139490; 19608861; 21269460; 22228304; 24275569; 25944712; 22049910; 
5407	GCDH	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=4.7 uM for glutaryl-CoA (at pH 6.5) {ECO:0000269|PubMed:17176108, ECO:0000269|PubMed:6423663}; KM=5.5 uM for glutaryl-CoA (at pH 7.5) {ECO:0000269|PubMed:17176108, ECO:0000269|PubMed:6423663}; KM=8.1 uM for glutaryl-CoA (at pH 7.6) {ECO:0000269|PubMed:17176108, ECO:0000269|PubMed:6423663}; KM=34.0 uM for glutaryl-CoA (at pH 8.5) {ECO:0000269|PubMed:17176108, ECO:0000269|PubMed:6423663}; Note=Release of crotonyl-CoA product from the enzyme is the rate-determining step in its steady-state turnover.;	1.3.8.6	CATALYTIC ACTIVITY: Glutaryl-CoA + electron-transfer flavoprotein = crotonyl-CoA + CO(2) + reduced electron-transfer flavoprotein. {ECO:0000269|PubMed:8541831}.	BINDING 186 186 Substrate; via carbonyl oxygen.; BINDING 319 319 FAD. {ECO:0000250}.; BINDING 330 330 FAD. {ECO:0000250}.; BINDING 415 415 Substrate; via amide nitrogen.; BINDING 434 434 FAD; via carbonyl oxygen.	ACTIVITY REGULATION: Strongly inhibited by MCPA-CoA, a metabolite of hypoglycin which is present in unripened fruit of the ackee tree. {ECO:0000269|PubMed:6423663}.	COFACTOR: Name=FAD; Xref=ChEBI:CHEBI:57692; 		PATHWAY: Amino-acid metabolism; lysine degradation.; PATHWAY: Amino-acid metabolism; tryptophan metabolism.				fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; lysine catabolic process [GO:0006554]; tryptophan metabolic process [GO:0006568]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; lysine catabolic process [GO:0006554]; tryptophan metabolic process [GO:0006568]	fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]	GO:0000062; GO:0004361; GO:0005739; GO:0005759; GO:0006554; GO:0006568; GO:0033539; GO:0046949; GO:0050660	SUBCELLULAR LOCATION: Mitochondrion matrix.		MOD_RES 240 240 N6-acetyllysine. {ECO:0000250|UniProtKB:Q60759}.	1438360; 8541831; 9600243; 14702039; 15057824; 15489334; 6423663; 9711871; 17176108; 21269460; 24275569; 25944712; 15274622; 18020372; 8900227; 8900228; 14707522; 18775954; 24973495; 11705404; 15985591; 16368216; 17314511; 17474147; 17661081; 19119138; 19862010; 19913121; 20032085; 20514322; 20628086; 20732827; 20877624; 21163940; 21811973; 21911578; 21912879; 21968293; 22231382; 23225040; 24332224; 25297592; 25525879; 25863083; 26058080; 26071121; 26496610; 27397597; 28389991; 29419857; 9266361	1438360; 8541831; 9600243; 14702039; 15057824; 15489334; 6423663; 9711871; 17176108; 21269460; 24275569; 25944712; 15274622; 18020372; 8900227; 8900228; 14707522; 18775954; 24973495
5447	GDPGP1 C15orf58	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=2 uM for GDP-D-glucose (at 31 degrees Celsius) {ECO:0000269|PubMed:21507950}; KM=12 uM for GDP-L-galactose (at 31 degrees Celsius) {ECO:0000269|PubMed:21507950}; KM=42 uM for GDP-D-mannose (at 31 degrees Celsius) {ECO:0000269|PubMed:21507950}; KM=2.9 mM for inorganic phosphate (at 31 degrees Celsius) {ECO:0000269|PubMed:21507950}; Note=kcat is 26 s(-1) at 31 degrees Celsius. The catalytic efficiency for GDP-D-glucose is 35-fold higher than for GDP-L-galactose.;	2.7.7.78	CATALYTIC ACTIVITY: GDP-alpha-D-glucose + phosphate = alpha-D-glucose 1-phosphate + GDP. {ECO:0000269|PubMed:21507950}.									glucose metabolic process [GO:0006006]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; GDP-D-glucose phosphorylase activity [GO:0080048]; guanyl-nucleotide exchange factor activity [GO:0005085]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; nucleotidyltransferase activity [GO:0016779]; glucose metabolic process [GO:0006006]	GDP-D-glucose phosphorylase activity [GO:0080048]; guanyl-nucleotide exchange factor activity [GO:0005085]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; nucleotidyltransferase activity [GO:0016779]	GO:0000166; GO:0005085; GO:0005737; GO:0006006; GO:0016779; GO:0016787; GO:0080048	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.				14702039; 16572171; 21507950
5459	GLYCTK HBEBP4 LP5910	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.1 mM for D-glycerate {ECO:0000269|PubMed:20949620}; 	2.7.1.31	CATALYTIC ACTIVITY: ATP + D-glycerate = ADP + 3-phospho-D-glycerate. {ECO:0000269|PubMed:16753811, ECO:0000269|PubMed:20949620}.							LP5910		fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate [GO:0061624]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glycerate kinase activity [GO:0008887]; fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate [GO:0061624]; protein phosphorylation [GO:0006468]	ATP binding [GO:0005524]; glycerate kinase activity [GO:0008887]	GO:0005524; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0006468; GO:0008887; GO:0061624	SUBCELLULAR LOCATION: Isoform 1: Cytoplasm {ECO:0000269|PubMed:16753811}.; SUBCELLULAR LOCATION: Isoform 2: Cytoplasm. Mitochondrion {ECO:0000269|PubMed:16753811}.		MOD_RES 60 60 Phosphoserine. {ECO:0000244|PubMed:24275569}.	16753811; 15498874; 14702039; 15489334; 20949620; 24275569; 16189514; 19060904; 20800603; 21988832; 2537226; 25416956	16753811; 15498874; 14702039; 15489334; 20949620; 24275569
5499	RARRES3 RIG1 TIG3	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=400 uM for dipalmitoyl-PC {ECO:0000269|PubMed:19615464}; Vmax=530 nmol/min/mg enzyme with dipalmitoyl-PC as substrate {ECO:0000269|PubMed:19615464}; Vmax=240 nmol/min/mg enzyme with dipalmitoyl-PE as substrate {ECO:0000269|PubMed:19615464}; 	3.1.1.-					BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 8. {ECO:0000269|PubMed:19615464};					lipid catabolic process [GO:0016042]; negative regulation of cell proliferation [GO:0008285]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phospholipid metabolic process [GO:0006644]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; phospholipase A2 activity [GO:0004623]; transferase activity, transferring acyl groups [GO:0016746]; lipid catabolic process [GO:0016042]; negative regulation of cell proliferation [GO:0008285]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phospholipid metabolic process [GO:0006644]	phospholipase A2 activity [GO:0004623]; transferase activity, transferring acyl groups [GO:0016746]	GO:0004623; GO:0005829; GO:0006644; GO:0008285; GO:0016021; GO:0016042; GO:0016746; GO:0036152	SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Single-pass membrane protein {ECO:0000250}.			9843971; 10687848; 19615464; 14702039; 16554811; 15489334; 12879006; 12928434; 15742394; 15850806; 15856468; 17196792; 17762858; 19245694; 19913121; 20588308; 20628086; 21858038; 22009441; 22290676; 22605381; 22616991; 22825852; 22960220; 24401997; 24599174; 24800889; 24867881; 25315416; 25361079; 25416956; 25752576; 25871522; 26223644; 26299329; 26355912; 26503625; 26535695; 26910120; 26951515; 26992218; 27265729; 27318973; 27404108; 27707918; 28057020; 28273895; 28468914; 28532996; 28560754; 28639915; 28738907; 28892164; 29669840	9843971; 10687848; 19615464; 14702039; 16554811; 15489334
5500	HSP90AB1 HSP90B HSPC2 HSPCB	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=300 uM for ATP {ECO:0000269|PubMed:18400751}; 			BINDING 46 46 ATP. {ECO:0000250}.; BINDING 88 88 ATP.; BINDING 107 107 ATP. {ECO:0000250}.; BINDING 133 133 ATP; via amide nitrogen. {ECO:0000250}.; BINDING 392 392 ATP. {ECO:0000250}.	ACTIVITY REGULATION: In the resting state, through the dimerization of its C-terminal domain, HSP90 forms a homodimer which is defined as the open conformation. Upon ATP-binding, the N-terminal domain undergoes significant conformational changes and comes in contact to form an active closed conformation. After HSP90 finishes its chaperoning tasks of assisting the proper folding, stabilization and activation of client proteins under the active state, ATP molecule is hydrolyzed to ADP which then dissociates from HSP90 and directs the protein back to the resting state. {ECO:0000269|PubMed:18400751}.				SITE 126 127 Cleaved under oxidative stress. {ECO:0000269|PubMed:22848402}.			axon extension [GO:0048675]; cellular response to drug [GO:0035690]; cellular response to interleukin-4 [GO:0071353]; cellular response to organic cyclic compound [GO:0071407]; central nervous system neuron axonogenesis [GO:0021955]; chaperone-mediated protein complex assembly [GO:0051131]; establishment of cell polarity [GO:0030010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of complement-dependent cytotoxicity [GO:1903660]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of transforming growth factor beta activation [GO:1901389]; neutrophil degranulation [GO:0043312]; placenta development [GO:0001890]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell size [GO:0045793]; positive regulation of cyclin-dependent protein kinase activity [GO:1904031]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein binding [GO:0032092]; positive regulation of protein import into nucleus, translocation [GO:0033160]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of telomerase activity [GO:0051973]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of cellular protein localization [GO:1903827]; regulation of cellular response to heat [GO:1900034]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; regulation of protein ubiquitination [GO:0031396]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; response to cocaine [GO:0042220]; response to salt stress [GO:0009651]; response to unfolded protein [GO:0006986]; supramolecular fiber organization [GO:0097435]; telomerase holoenzyme complex assembly [GO:1905323]; telomere maintenance via telomerase [GO:0007004]; virion attachment to host cell [GO:0019062]; xenobiotic metabolic process [GO:0006805]	apical plasma membrane [GO:0016324]; aryl hydrocarbon receptor complex [GO:0034751]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; inclusion body [GO:0016234]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ooplasm [GO:1990917]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; sperm head plasma membrane [GO:1990913]	apical plasma membrane [GO:0016324]; aryl hydrocarbon receptor complex [GO:0034751]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; inclusion body [GO:0016234]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ooplasm [GO:1990917]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; sperm head plasma membrane [GO:1990913]; ATP binding [GO:0005524]; ATP-dependent protein binding [GO:0043008]; ATPase activity, coupled [GO:0042623]; cadherin binding [GO:0045296]; CTP binding [GO:0002135]; dATP binding [GO:0032564]; disordered domain specific binding [GO:0097718]; DNA polymerase binding [GO:0070182]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; histone methyltransferase binding [GO:1990226]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; MHC class II protein complex binding [GO:0023026]; nitric-oxide synthase regulator activity [GO:0030235]; peptide binding [GO:0042277]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; RNA binding [GO:0003723]; sulfonylurea receptor binding [GO:0017098]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; UTP binding [GO:0002134]; axon extension [GO:0048675]; cellular response to drug [GO:0035690]; cellular response to interleukin-4 [GO:0071353]; cellular response to organic cyclic compound [GO:0071407]; central nervous system neuron axonogenesis [GO:0021955]; chaperone-mediated protein complex assembly [GO:0051131]; establishment of cell polarity [GO:0030010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of complement-dependent cytotoxicity [GO:1903660]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of transforming growth factor beta activation [GO:1901389]; neutrophil degranulation [GO:0043312]; placenta development [GO:0001890]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell size [GO:0045793]; positive regulation of cyclin-dependent protein kinase activity [GO:1904031]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein binding [GO:0032092]; positive regulation of protein import into nucleus, translocation [GO:0033160]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of telomerase activity [GO:0051973]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of cellular protein localization [GO:1903827]; regulation of cellular response to heat [GO:1900034]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; regulation of protein ubiquitination [GO:0031396]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; response to cocaine [GO:0042220]; response to salt stress [GO:0009651]; response to unfolded protein [GO:0006986]; supramolecular fiber organization [GO:0097435]; telomerase holoenzyme complex assembly [GO:1905323]; telomere maintenance via telomerase [GO:0007004]; virion attachment to host cell [GO:0019062]; xenobiotic metabolic process [GO:0006805]	ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; ATP-dependent protein binding [GO:0043008]; cadherin binding [GO:0045296]; CTP binding [GO:0002135]; dATP binding [GO:0032564]; disordered domain specific binding [GO:0097718]; DNA polymerase binding [GO:0070182]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; histone methyltransferase binding [GO:1990226]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; MHC class II protein complex binding [GO:0023026]; nitric-oxide synthase regulator activity [GO:0030235]; peptide binding [GO:0042277]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; RNA binding [GO:0003723]; sulfonylurea receptor binding [GO:0017098]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; UTP binding [GO:0002134]	GO:0001890; GO:0002134; GO:0002135; GO:0003723; GO:0003725; GO:0005524; GO:0005525; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005765; GO:0005829; GO:0006457; GO:0006805; GO:0006986; GO:0007004; GO:0009651; GO:0009986; GO:0016020; GO:0016234; GO:0016323; GO:0016324; GO:0017098; GO:0019062; GO:0019887; GO:0019900; GO:0019901; GO:0021955; GO:0023026; GO:0030010; GO:0030235; GO:0030511; GO:0030911; GO:0031072; GO:0031396; GO:0031526; GO:0031625; GO:0032092; GO:0032435; GO:0032516; GO:0032564; GO:0032991; GO:0033138; GO:0033160; GO:0034751; GO:0034774; GO:0035690; GO:0038096; GO:0042220; GO:0042277; GO:0042470; GO:0042623; GO:0042802; GO:0042803; GO:0042826; GO:0043008; GO:0043025; GO:0043312; GO:0043524; GO:0044294; GO:0044295; GO:0044325; GO:0045296; GO:0045429; GO:0045597; GO:0045793; GO:0046983; GO:0048156; GO:0048471; GO:0048675; GO:0050821; GO:0051082; GO:0051131; GO:0051248; GO:0051897; GO:0051973; GO:0060334; GO:0060338; GO:0070062; GO:0070182; GO:0071157; GO:0071353; GO:0071407; GO:0071902; GO:0097435; GO:0097718; GO:1900034; GO:1901389; GO:1901799; GO:1902949; GO:1903660; GO:1903827; GO:1904031; GO:1904813; GO:1905323; GO:1990226; GO:1990913; GO:1990917; GO:2000010	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16580629, ECO:0000269|PubMed:18239673, ECO:0000269|PubMed:24880080, ECO:0000269|PubMed:9482106}. Melanosome {ECO:0000269|PubMed:17081065}. Nucleus {ECO:0000269|PubMed:18239673}. Secreted {ECO:0000269|PubMed:20599762}. Cell membrane {ECO:0000269|PubMed:20599762}. Note=Identified by mass spectrometry in melanosome fractions from stage I to stage IV (PubMed:17081065). Translocates with BIRC2 from the nucleus to the cytoplasm during differentiation (PubMed:18239673). Secreted when associated with TGFB1 processed form (LAP) (PubMed:20599762). {ECO:0000269|PubMed:17081065, ECO:0000269|PubMed:18239673, ECO:0000269|PubMed:20599762}.	PTM: Ubiquitinated in the presence of STUB1-UBE2D1 complex (in vitro). {ECO:0000269|PubMed:18042044}.; PTM: ISGylated. {ECO:0000269|PubMed:16139798}.; PTM: S-nitrosylated; negatively regulates the ATPase activity. {ECO:0000305|PubMed:19696785}.; PTM: Phosphorylation at Tyr-301 by SRC is induced by lipopolysaccharide (PubMed:23585225). Phosphorylation at Ser-226 and Ser-255 inhibits AHR interaction (PubMed:15581363). {ECO:0000269|PubMed:15581363, ECO:0000269|PubMed:23585225}.; PTM: Methylated by SMYD2; facilitates dimerization and chaperone complex formation; promotes cancer cell proliferation. {ECO:0000269|PubMed:24880080}.; PTM: Cleaved following oxidative stress resulting in HSP90AB1 protein radicals formation; disrupts the chaperoning function and the degradation of its client proteins. {ECO:0000269|PubMed:22848402}.	MOD_RES 219 219 N6-succinyllysine. {ECO:0000250|UniProtKB:P11499}.; MOD_RES 226 226 Phosphoserine. {ECO:0000244|PubMed:18088087, ECO:0000244|PubMed:18318008, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 255 255 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:23186163, ECO:0000269|Ref.12}.; MOD_RES 261 261 Phosphoserine. {ECO:0000250|UniProtKB:P11499}.; MOD_RES 297 297 Phosphothreonine. {ECO:0000244|PubMed:17525332, ECO:0000244|PubMed:23186163}.; MOD_RES 301 301 Phosphotyrosine; by SRC. {ECO:0000269|PubMed:23585225}.; MOD_RES 305 305 Phosphotyrosine. {ECO:0000250|UniProtKB:P11499}.; MOD_RES 307 307 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 399 399 N6-malonyllysine. {ECO:0000269|PubMed:21908771}.; MOD_RES 435 435 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 445 445 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 479 479 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 481 481 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 484 484 Phosphotyrosine. {ECO:0000250|UniProtKB:P11499}.; MOD_RES 531 531 N6-methylated lysine; alternate. {ECO:0000269|PubMed:24880080}.; MOD_RES 531 531 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:P11499}.; MOD_RES 574 574 N6-methylated lysine. {ECO:0000269|PubMed:24880080}.; MOD_RES 577 577 N6-succinyllysine. {ECO:0000250|UniProtKB:P11499}.; MOD_RES 590 590 S-nitrosocysteine. {ECO:0000305|PubMed:19696785}.; MOD_RES 624 624 N6-acetyllysine. {ECO:0000250|UniProtKB:P11499}.; MOD_RES 669 669 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 718 718 Phosphoserine; by PLK2 and PLK3. {ECO:0000269|PubMed:22828320}.	3301534; 2768249; 2469626; 11230166; 14702039; 14574404; 15489334; 2492519; 8180474; 9150948; 7588731; 9482106; 15581363; 15358771; 16139798; 15592455; 16580629; 17081983; 17081065; 16478993; 17525332; 18042044; 18620420; 18239673; 18400751; 18088087; 18669648; 18318008; 19696785; 19608861; 20599762; 20353823; 20068231; 21269460; 21908771; 22022502; 21406692; 22828320; 22843495; 22848402; 23585225; 23186163; 23428871; 23431407; 24613385; 24880080; 24275569; 24681825; 25486457; 25973397; 26517842; 25944712; 27295069; 26991466; 15217611; 15159550; 10409742; 10409767; 11036079; 11259606; 11274138; 11583998; 11751894; 11786556; 11967258; 12191486; 12573486; 12577067; 12615073; 12668662; 14697242; 14743216; 14761955; 15047060; 15161933; 15270074; 15324660; 15381148; 15591061; 15657067; 15664193; 15870294; 16169070; 16263121; 16293251; 16330544; 16403413; 16641196; 16650407; 16698020; 16797541; 17110338; 17188549; 17216044; 17349957; 17400507; 17435760; 17620599; 17703304; 17721511; 17785525; 17855507; 17932509; 17955473; 17979178; 18538669; 18540824; 18635947; 18654987; 18818696; 18850735; 19150985; 19167051; 19309728; 19375531; 19486527; 19773279; 19805454; 19875381; 20006655; 20018861; 20029029; 20038533; 20085233; 20195357; 20303873; 20391533; 20467437; 20562859; 20618441; 20642453; 20801936; 20936779; 21044950; 21131419; 21146485; 21183720; 21210654; 21281639; 21325639; 21360678; 21642987; 21700222; 21900206; 21911578; 21988832; 22011577; 22014111; 22069710; 22085931; 22113938; 22179618; 22227520; 22267324; 22304920; 22318716; 22433123; 22579285; 22613557; 22623428; 22759865; 22810585; 22939624; 23075850; 23414517; 23455922; 23606334; 23650620; 23764002; 23823123; 24189400; 24267889; 24502978; 24581495; 24618592; 24658140; 24694367; 24947832; 25036637; 25241761; 25277244; 25416956; 25608045; 25609649; 25995454; 26496610; 26638075; 27339980; 27462449; 29382832; 7848918; 7961644; 8455624; 9222609; 9447995; 9727490; 9844631	3301534; 2768249; 2469626; 11230166; 14702039; 14574404; 15489334; 2492519; 8180474; 9150948; 7588731; 9482106; 15581363; 15358771; 16139798; 15592455; 16580629; 17081983; 17081065; 16478993; 17525332; 18042044; 18620420; 18239673; 18400751; 18088087; 18669648; 18318008; 19696785; 19608861; 20599762; 20353823; 20068231; 21269460; 21908771; 22022502; 21406692; 22828320; 22843495; 22848402; 23585225; 23186163; 23428871; 23431407; 24613385; 24880080; 24275569; 24681825; 25486457; 25973397; 26517842; 25944712; 27295069; 26991466; 15217611; 15159550; 
5509	MCCC2 MCCB	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=45 uM for ATP {ECO:0000269|PubMed:17360195}; KM=74 uM for 3-methylcrotonyl-CoA {ECO:0000269|PubMed:17360195}; Note=kcat is 4.0 sec(-1).;	6.4.1.4	CATALYTIC ACTIVITY: ATP + 3-methylcrotonoyl-CoA + HCO(3)(-) = ADP + phosphate + 3-methylglutaconyl-CoA. {ECO:0000269|PubMed:17360195}.					PATHWAY: Amino-acid degradation; L-leucine degradation; (S)-3-hydroxy-3-methylglutaryl-CoA from 3-isovaleryl-CoA: step 2/3.				biotin metabolic process [GO:0006768]; coenzyme A metabolic process [GO:0015936]; leucine catabolic process [GO:0006552]; protein heterooligomerization [GO:0051291]	3-methylcrotonyl-CoA carboxylase complex, mitochondrial [GO:0002169]; cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	3-methylcrotonyl-CoA carboxylase complex, mitochondrial [GO:0002169]; cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; biotin metabolic process [GO:0006768]; coenzyme A metabolic process [GO:0015936]; leucine catabolic process [GO:0006552]; protein heterooligomerization [GO:0051291]	ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]	GO:0002169; GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006552; GO:0006768; GO:0015936; GO:0051291; GO:1905202	SUBCELLULAR LOCATION: Mitochondrion matrix {ECO:0000269|PubMed:11170888, ECO:0000269|PubMed:16023992}.		MOD_RES 70 70 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q3ULD5}.; MOD_RES 70 70 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q3ULD5}.; MOD_RES 141 141 N6-succinyllysine. {ECO:0000250|UniProtKB:Q3ULD5}.; MOD_RES 495 495 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q3ULD5}.; MOD_RES 495 495 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q3ULD5}.; MOD_RES 511 511 N6-acetyllysine. {ECO:0000250|UniProtKB:Q3ULD5}.	11170888; 11181649; 11406611; 15372022; 15489334; 16023992; 17360195; 21269460; 24275569; 25944712; 17968484; 16010683; 21071250; 22150417; 22264772; 22642865; 25382614; 27601257; 10064314; 10190325; 11185745; 11735028; 12124727; 16134170; 17876819; 19380743; 19851296; 20153287; 20186120; 20198315; 20562859; 20869947; 20877624; 21642987; 22123817; 22810585; 23386615; 23752268; 24344204; 25525879; 25609649; 26752685; 2868710; 7356336; 7842009; 8817339; 8930409; 9630604	11170888; 11181649; 11406611; 15372022; 15489334; 16023992; 17360195; 21269460; 24275569; 25944712; 17968484; 16010683; 21071250; 22150417; 22264772; 22642865; 25382614; 27601257
5539	HSD17B6 RODH SDR9C6	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=0.19 uM for NAD {ECO:0000269|PubMed:10896656, ECO:0000269|PubMed:11360992}; KM=0.18 uM for NADH {ECO:0000269|PubMed:10896656, ECO:0000269|PubMed:11360992}; KM=54 uM for NADPH {ECO:0000269|PubMed:10896656, ECO:0000269|PubMed:11360992}; KM=940 uM for NADP {ECO:0000269|PubMed:10896656, ECO:0000269|PubMed:11360992}; KM=3.2 uM for all-trans-retinol {ECO:0000269|PubMed:10896656, ECO:0000269|PubMed:11360992}; KM=0.24 uM for allopregnanolone {ECO:0000269|PubMed:10896656, ECO:0000269|PubMed:11360992}; KM=0.13 uM for 3-alpha-androstanediol {ECO:0000269|PubMed:10896656, ECO:0000269|PubMed:11360992}; KM=0.23 uM for androsterone {ECO:0000269|PubMed:10896656, ECO:0000269|PubMed:11360992}; KM=0.13 uM for dehydroepiandrosterone {ECO:0000269|PubMed:10896656, ECO:0000269|PubMed:11360992}; Vmax=1.2 nmol/min/mg enzyme with all-trans-retinol {ECO:0000269|PubMed:10896656, ECO:0000269|PubMed:11360992}; Vmax=14.7 nmol/min/mg enzyme with allopregnanolone {ECO:0000269|PubMed:10896656, ECO:0000269|PubMed:11360992}; Vmax=16.5 nmol/min/mg enzyme with 3-alpha-androstanediol {ECO:0000269|PubMed:10896656, ECO:0000269|PubMed:11360992}; Vmax=35 nmol/min/mg enzyme with androsterone {ECO:0000269|PubMed:10896656, ECO:0000269|PubMed:11360992}; Vmax=0.90 nmol/min/mg enzyme with dehydroepiandrosterone {ECO:0000269|PubMed:10896656, ECO:0000269|PubMed:11360992}; Note=The kinetic parameters were determined using microsomes from transfected cells.;	1.1.1.105; 1.1.1.239; 1.1.1.62	CATALYTIC ACTIVITY: 17-beta-estradiol + NAD(P)(+) = estrone + NAD(P)H.; CATALYTIC ACTIVITY: Testosterone + NAD(+) = androstenedione + NADH.; CATALYTIC ACTIVITY: All-trans-retinol-[cellular-retinol-binding-protein] + NAD(+) = all-trans-retinal-[cellular-retinol-binding-protein] + NADH.	BINDING 164 164 Substrate. {ECO:0000255}.								androgen biosynthetic process [GO:0006702]; androgen catabolic process [GO:0006710]	early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; intracellular [GO:0005622]	early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; intracellular [GO:0005622]; catalytic activity [GO:0003824]; electron transfer activity [GO:0009055]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; oxidoreductase activity [GO:0016491]; retinol dehydrogenase activity [GO:0004745]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; androgen biosynthetic process [GO:0006702]; androgen catabolic process [GO:0006710]	catalytic activity [GO:0003824]; electron transfer activity [GO:0009055]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; oxidoreductase activity [GO:0016491]; retinol dehydrogenase activity [GO:0004745]; testosterone dehydrogenase (NAD+) activity [GO:0047035]	GO:0003824; GO:0004303; GO:0004745; GO:0005622; GO:0005783; GO:0006702; GO:0006710; GO:0009055; GO:0016491; GO:0031901; GO:0047035	SUBCELLULAR LOCATION: Microsome membrane {ECO:0000269|PubMed:11360992}; Peripheral membrane protein {ECO:0000269|PubMed:11360992}; Lumenal side {ECO:0000269|PubMed:11360992}. Early endosome membrane {ECO:0000305}; Peripheral membrane protein {ECO:0000305}; Lumenal side {ECO:0000305}.			9188497; 10896656; 15489334; 11360992; 11513953; 24275569; 10617778; 17070195; 17289849; 19837928; 20200332; 21039282; 22114194; 24244276; 25422294; 8884265	9188497; 10896656; 15489334; 11360992; 11513953; 24275569
5547	HIF1AN FIH1	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=100 uM for HIF1A (788-822) peptide {ECO:0000269|PubMed:14701857}; KM=160 uM for HIF2A (832-866) peptide {ECO:0000269|PubMed:14701857}; KM=0.5 uM for Fe(2+) {ECO:0000269|PubMed:14701857}; KM=25 uM for 2-oxoglutarate {ECO:0000269|PubMed:14701857}; KM=260 uM for ascorbate {ECO:0000269|PubMed:14701857}; KM=90 uM for O(2) {ECO:0000269|PubMed:14701857}; Note=The kinetic constants are determined for the recombinant FLAG-His-tagged protein.;	1.14.11.30; 1.14.11.n4	CATALYTIC ACTIVITY: Hypoxia-inducible factor-L-asparagine + 2-oxoglutarate + O(2) = hypoxia-inducible factor-(3S)-3-hydroxy-L-asparagine + succinate + CO(2). {ECO:0000269|PubMed:12042299, ECO:0000269|PubMed:12080085, ECO:0000269|PubMed:14701857, ECO:0000269|PubMed:17573339}.; CATALYTIC ACTIVITY: [Ankyrin-repeat domain protein]-L-histidine + 2-oxoglutarate + O(2) = [ankyrin-repeat domain protein]-(3S)-3-hydroxy-L-histidine + succinate + CO(2). {ECO:0000269|PubMed:21251231}.; CATALYTIC ACTIVITY: [Ankyrin-repeat domain protein]-L-asparagine + 2-oxoglutarate + O(2) = [ankyrin-repeat domain protein]-(3S)-3-hydroxy-L-asparagine + succinate + CO(2). {ECO:0000269|PubMed:17003112, ECO:0000269|PubMed:17573339, ECO:0000269|PubMed:18299578, ECO:0000269|PubMed:19245366, ECO:0000269|PubMed:21177872}.; CATALYTIC ACTIVITY: [Ankyrin-repeat domain protein]-L-aspartate + 2-oxoglutarate + O(2) = [ankyrin-repeat domain protein]-(3S)-3-hydroxy-L-aspartate + succinate + CO(2). {ECO:0000269|PubMed:21177872}.	BINDING 145 145 2-oxoglutarate. {ECO:0000269|PubMed:12432100, ECO:0000269|PubMed:12446723, ECO:0000269|PubMed:21251231}.; BINDING 152 152 Substrate. {ECO:0000269|PubMed:21177872}.; BINDING 196 196 2-oxoglutarate. {ECO:0000269|PubMed:12432100, ECO:0000269|PubMed:12446723, ECO:0000269|PubMed:21251231}.; BINDING 205 205 2-oxoglutarate. {ECO:0000269|PubMed:12432100, ECO:0000269|PubMed:12446723, ECO:0000269|PubMed:21251231}.; BINDING 214 214 2-oxoglutarate. {ECO:0000269|PubMed:12432100, ECO:0000269|PubMed:12446723, ECO:0000269|PubMed:21251231}.; BINDING 294 294 2-oxoglutarate. {ECO:0000269|PubMed:12432100, ECO:0000269|PubMed:12446723, ECO:0000269|PubMed:21251231}.; BINDING 300 300 Substrate; via amide nitrogen. {ECO:0000269|PubMed:21177872}.; BINDING 321 321 Substrate. {ECO:0000269|PubMed:21177872}.		COFACTOR: Name=Fe(2+); Xref=ChEBI:CHEBI:29033; Evidence={ECO:0000269|PubMed:12432100, ECO:0000269|PubMed:12446723, ECO:0000269|PubMed:15913349, ECO:0000269|PubMed:17135241, ECO:0000269|PubMed:20396966, ECO:0000269|PubMed:20822901, ECO:0000269|PubMed:21251231, ECO:0000269|PubMed:21460794}; 			SITE 340 340 Important for dimer formation.			negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; oxidation-reduction process [GO:0055114]; peptidyl-asparagine hydroxylation [GO:0042265]; peptidyl-aspartic acid hydroxylation [GO:0042264]; peptidyl-histidine hydroxylation [GO:0036138]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of vasculogenesis [GO:2001214]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; transcription, DNA-templated [GO:0006351]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; ankyrin repeat binding [GO:0071532]; carboxylic acid binding [GO:0031406]; cofactor binding [GO:0048037]; hypoxia-inducible factor-asparagine oxygenase activity [GO:0102113]; iron ion binding [GO:0005506]; NF-kappaB binding [GO:0051059]; Notch binding [GO:0005112]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors [GO:0016706]; oxygen sensor activity [GO:0019826]; peptidyl-asparagine 3-dioxygenase activity [GO:0036140]; peptidyl-histidine dioxygenase activity [GO:0036139]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; oxidation-reduction process [GO:0055114]; peptidyl-asparagine hydroxylation [GO:0042265]; peptidyl-aspartic acid hydroxylation [GO:0042264]; peptidyl-histidine hydroxylation [GO:0036138]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of vasculogenesis [GO:2001214]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; transcription, DNA-templated [GO:0006351]	ankyrin repeat binding [GO:0071532]; carboxylic acid binding [GO:0031406]; cofactor binding [GO:0048037]; hypoxia-inducible factor-asparagine oxygenase activity [GO:0102113]; iron ion binding [GO:0005506]; NF-kappaB binding [GO:0051059]; Notch binding [GO:0005112]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors [GO:0016706]; oxygen sensor activity [GO:0019826]; peptidyl-asparagine 3-dioxygenase activity [GO:0036140]; peptidyl-histidine dioxygenase activity [GO:0036139]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]	GO:0005112; GO:0005506; GO:0005654; GO:0005737; GO:0005829; GO:0006351; GO:0008270; GO:0016706; GO:0019826; GO:0031406; GO:0036138; GO:0036139; GO:0036140; GO:0042264; GO:0042265; GO:0042803; GO:0045663; GO:0045746; GO:0048037; GO:0048471; GO:0051059; GO:0055114; GO:0061418; GO:0061428; GO:0071532; GO:0102113; GO:2001214	SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Cytoplasm, perinuclear region. Note=Mainly cytoplasmic localization, but interaction with NOTCH1 results in nuclear localization and interaction with ABPA3 results in perinuclear localization in macrophages.		MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378}.	11641274; 14702039; 15164054; 15489334; 17974005; 12080085; 12042299; 15239670; 14701857; 14734545; 17003112; 18299578; 19413330; 19245366; 19726677; 21269460; 22645313; 22223895; 22814378; 26948053; 12432100; 12446723; 12482756; 15913349; 17135241; 17573339; 18611856; 20822901; 20396966; 21460794; 21251231; 21177872; 11959990; 12615973; 16189514; 16385451; 17682059; 18096060; 18280659; 18398039; 18676680; 18927305; 18936059; 19060904; 19071119; 19074848; 19134330; 19170196; 19401150; 19615732; 19692168; 19696166; 20145132; 20453000; 20720525; 20727020; 21069436; 21443853; 21732131; 21808058; 22002313; 22532441; 22724510; 22891326; 23296631; 23351038; 23606740; 24100311; 24388053; 24465898; 24521875; 24867948; 25320245; 25351569; 25413349; 25431923; 25609649; 25687434; 25728779; 25837583; 25907805; 26112411; 26205124; 26682036; 26727884; 26749281; 26752685; 27815979; 28061479; 29047187; 29056521; 29435217	11641274; 14702039; 15164054; 15489334; 17974005; 12080085; 12042299; 15239670; 14701857; 14734545; 17003112; 18299578; 19413330; 19245366; 19726677; 21269460; 22645313; 22223895; 22814378; 26948053; 12432100; 12446723; 12482756; 15913349; 17135241; 17573339; 18611856; 20822901; 20396966; 21460794; 21251231; 21177872
5560	HNMT	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=5.47 uM for histamine (at pH 8.0 and 25 degrees Celsius) {ECO:0000269|PubMed:26206890}; 	2.1.1.8	CATALYTIC ACTIVITY: S-adenosyl-L-methionine + histamine = S-adenosyl-L-homocysteine + N(tau)-methylhistamine. {ECO:0000255|PROSITE-ProRule:PRU00929, ECO:0000269|PubMed:26206890}.	BINDING 28 28 Substrate.; BINDING 60 60 S-adenosyl-L-methionine; via carbonyl oxygen.; BINDING 89 89 S-adenosyl-L-methionine.; BINDING 94 94 S-adenosyl-L-methionine.; BINDING 120 120 S-adenosyl-L-methionine; via amide nitrogen.; BINDING 142 142 S-adenosyl-L-methionine; via carbonyl oxygen.; BINDING 283 283 Substrate.								brain development [GO:0007420]; histamine catabolic process [GO:0001695]; histidine catabolic process [GO:0006548]; methylation [GO:0032259]; respiratory gaseous exchange [GO:0007585]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; neuron projection [GO:0043005]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; neuron projection [GO:0043005]; histamine N-methyltransferase activity [GO:0046539]; brain development [GO:0007420]; histamine catabolic process [GO:0001695]; histidine catabolic process [GO:0006548]; methylation [GO:0032259]; respiratory gaseous exchange [GO:0007585]	histamine N-methyltransferase activity [GO:0046539]	GO:0001695; GO:0005737; GO:0005829; GO:0006548; GO:0007420; GO:0007585; GO:0032259; GO:0043005; GO:0046539; GO:0070062	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:26206890}.			7943261; 8145732; 8605025; 14667820; 14702039; 15815621; 15489334; 21269460; 24275569; 11566133; 9547362; 10803682; 26206890; 10752634; 12167489; 12417108; 12755416; 12835614; 12867290; 15551002; 15693910; 15770103; 15953854; 16168438; 16205835; 16489678; 16554448; 16669609; 16950574; 1711890; 17651147; 17703412; 17985251; 18086566; 18154359; 18254975; 18266724; 18543121; 19025430; 19156168; 19178400; 19247692; 19258923; 19343046; 19538200; 19773194; 19898482; 20237496; 20379614; 20503287; 20551163; 20602615; 21040557; 21044950; 21138759; 21794955; 21988832; 23932992; 24835231; 25768024; 25909280; 26496610; 26989676; 27130307; 27255477; 27399132; 28400155; 29506638	7943261; 8145732; 8605025; 14667820; 14702039; 15815621; 15489334; 21269460; 24275569; 11566133; 9547362; 10803682; 26206890
5568	HRASLS2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=300 uM for dipalmitoyl-PC {ECO:0000269|PubMed:19615464}; Vmax=670 nmol/min/mg enzyme with dipalmitoyl-PC as substrate {ECO:0000269|PubMed:19615464}; Vmax=122 nmol/min/mg enzyme with dipalmitoyl-PE as substrate {ECO:0000269|PubMed:19615464}; Vmax=103 nmol/min/mg enzyme using dipalmitoyl-PC as an acyl donor and PE as an acyl acceptor {ECO:0000269|PubMed:19615464}; 	2.3.1.-; 3.1.1.-	CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-acylglycerophosphocholine + a carboxylate. {ECO:0000269|PubMed:22605381}.; CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 2-acylglycerophosphocholine + a carboxylate. {ECO:0000269|PubMed:22605381}.; CATALYTIC ACTIVITY: A 1,2-diacyl-sn-glycero-3-phosphocholine + a 1,2-diacyl-sn-glycero-3-phosphoethanolamine = a 1-acyl-sn-glycero-3-phosphocholine + H(+) + N-acyl-1,2-diacyl-sn-glycero-3-phosphoethanolamine. {ECO:0000269|PubMed:19615464}.; CATALYTIC ACTIVITY: A 1,2-diacyl-sn-glycero-3-phosphocholine + a 1,2-diacyl-sn-glycero-3-phosphoethanolamine = a 2-acyl-sn-glycero-3-phosphocholine + H(+) + N-acyl-1,2-diacyl-sn-glycero-3-phosphoethanolamine. {ECO:0000269|PubMed:19615464}.				BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 8. {ECO:0000269|PubMed:19615464};					lipid catabolic process [GO:0016042]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]; transferase activity, transferring acyl groups [GO:0016746]; lipid catabolic process [GO:0016042]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]	hydrolase activity [GO:0016787]; transferase activity, transferring acyl groups [GO:0016746]	GO:0005829; GO:0016021; GO:0016042; GO:0016746; GO:0016787; GO:0036152	SUBCELLULAR LOCATION: Cytoplasm. Membrane; Single-pass membrane protein. Note=Exhibits a granular pattern in the cytoplasm with preferential perinuclear localization.			19615464; 14702039; 18163183; 22605381; 19913121; 20628086; 22825852; 26503625	19615464; 14702039; 18163183; 22605381
5638	HMGCLL1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=40 uM for (S)-3-hydroxy-3-methylglutaryl-CoA (at pH 9) {ECO:0000269|PubMed:22847177, ECO:0000269|PubMed:22865860}; KM=75 uM for (S)-3-hydroxy-3-methylglutaryl-CoA (at pH 8) {ECO:0000269|PubMed:22847177, ECO:0000269|PubMed:22865860}; KM=28 uM for (S)-3-hydroxy-3-methylglutaryl-CoA {ECO:0000269|PubMed:22847177, ECO:0000269|PubMed:22865860}; KM=49 uM for (S)-3-hydroxy-3-methylglutaryl-CoA (in presence of magnesium) {ECO:0000269|PubMed:22847177, ECO:0000269|PubMed:22865860}; KM=0.18 uM for (S)-3-hydroxy-3-methylglutaryl-CoA (in presence of manganese) {ECO:0000269|PubMed:22847177, ECO:0000269|PubMed:22865860}; Vmax=12 nmol/min/mg enzyme with (S)-3-hydroxy-3-methylglutaryl-CoA as substrate at pH 9 {ECO:0000269|PubMed:22847177, ECO:0000269|PubMed:22865860}; Vmax=25 nmol/min/mg enzyme with (S)-3-hydroxy-3-methylglutaryl-CoA as substrate at pH 8 {ECO:0000269|PubMed:22847177, ECO:0000269|PubMed:22865860}; 	4.1.3.4	CATALYTIC ACTIVITY: (S)-3-hydroxy-3-methylglutaryl-CoA = acetyl-CoA + acetoacetate. {ECO:0000269|PubMed:22847177, ECO:0000269|PubMed:22865860}.	BINDING 86 86 Substrate. {ECO:0000250}.		COFACTOR: Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240; Evidence={ECO:0000305|PubMed:22865860}; 		PATHWAY: Metabolic intermediate metabolism; (S)-3-hydroxy-3-methylglutaryl-CoA degradation; acetoacetate from (S)-3-hydroxy-3-methylglutaryl-CoA: step 1/1.				ketone body biosynthetic process [GO:0046951]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; hydroxymethylglutaryl-CoA lyase activity [GO:0004419]; metal ion binding [GO:0046872]; ketone body biosynthetic process [GO:0046951]	hydroxymethylglutaryl-CoA lyase activity [GO:0004419]; metal ion binding [GO:0046872]	GO:0004419; GO:0005783; GO:0005789; GO:0005829; GO:0016020; GO:0046872; GO:0046951; GO:0048471	SUBCELLULAR LOCATION: Cytoplasm, cytosol. Endoplasmic reticulum membrane; Peripheral membrane protein.			14702039; 14574404; 15489334; 22865860; 22847177; 20379614	14702039; 14574404; 15489334; 22865860; 22847177
5652	HSP90AA1 HSP90A HSPC1 HSPCA	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=300 uM for ATP {ECO:0000269|PubMed:18400751}; 			BINDING 51 51 ATP.; BINDING 93 93 ATP.; BINDING 112 112 ATP. {ECO:0000250}.; BINDING 138 138 ATP; via amide nitrogen.; BINDING 400 400 ATP. {ECO:0000250}.	ACTIVITY REGULATION: In the resting state, through the dimerization of its C-terminal domain, HSP90 forms a homodimer which is defined as the open conformation (PubMed:18400751). Upon ATP-binding, the N-terminal domain undergoes significant conformational changes and comes in contact to form an active closed conformation (PubMed:18400751). After HSP90 finishes its chaperoning tasks of assisting the proper folding, stabilization and activation of client proteins under the active state, ATP molecule is hydrolyzed to ADP which then dissociates from HSP90 and directs the protein back to the resting state (PubMed:18400751). Co-chaperone TSC1 promotes ATP binding and inhibits HSP90AA1 ATPase activity (PubMed:29127155). Binding to phosphorylated AHSA1 promotes HSP90AA1 ATPase activity (PubMed:29127155). Inhibited by Ganetespib (STA-9090) and SNX-2112 (PubMed:29127155). {ECO:0000269|PubMed:18400751, ECO:0000269|PubMed:29127155}.							axon extension [GO:0048675]; central nervous system neuron axonogenesis [GO:0021955]; chaperone-mediated autophagy [GO:0061684]; chaperone-mediated protein complex assembly [GO:0051131]; ciliary basal body-plasma membrane docking [GO:0097711]; cofactor metabolic process [GO:0051186]; cytokine-mediated signaling pathway [GO:0019221]; ERBB2 signaling pathway [GO:0038128]; establishment of cell polarity [GO:0030010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; G2/M transition of mitotic cell cycle [GO:0000086]; mitochondrial transport [GO:0006839]; neutrophil degranulation [GO:0043312]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein polymerization [GO:0032273]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of telomerase activity [GO:0051973]; protein import into mitochondrial outer membrane [GO:0045040]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; protein unfolding [GO:0043335]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular protein localization [GO:1903827]; regulation of cellular response to heat [GO:1900034]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of protein complex assembly [GO:0043254]; regulation of protein ubiquitination [GO:0031396]; response to antibiotic [GO:0046677]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; signal transduction [GO:0007165]; telomerase holoenzyme complex assembly [GO:1905323]; telomere maintenance via telomerase [GO:0007004]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; melanosome [GO:0042470]; membrane [GO:0016020]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; secretory granule lumen [GO:0034774]	axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; melanosome [GO:0042470]; membrane [GO:0016020]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; secretory granule lumen [GO:0034774]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; disordered domain specific binding [GO:0097718]; DNA polymerase binding [GO:0070182]; GTPase binding [GO:0051020]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; MHC class II protein complex binding [GO:0023026]; nitric-oxide synthase regulator activity [GO:0030235]; nucleotide binding [GO:0000166]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; protein tyrosine kinase binding [GO:1990782]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; axon extension [GO:0048675]; central nervous system neuron axonogenesis [GO:0021955]; chaperone-mediated autophagy [GO:0061684]; chaperone-mediated protein complex assembly [GO:0051131]; ciliary basal body-plasma membrane docking [GO:0097711]; cofactor metabolic process [GO:0051186]; cytokine-mediated signaling pathway [GO:0019221]; ERBB2 signaling pathway [GO:0038128]; establishment of cell polarity [GO:0030010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; G2/M transition of mitotic cell cycle [GO:0000086]; mitochondrial transport [GO:0006839]; neutrophil degranulation [GO:0043312]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein polymerization [GO:0032273]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of telomerase activity [GO:0051973]; protein import into mitochondrial outer membrane [GO:0045040]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; protein unfolding [GO:0043335]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular protein localization [GO:1903827]; regulation of cellular response to heat [GO:1900034]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of protein complex assembly [GO:0043254]; regulation of protein ubiquitination [GO:0031396]; response to antibiotic [GO:0046677]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; signal transduction [GO:0007165]; telomerase holoenzyme complex assembly [GO:1905323]; telomere maintenance via telomerase [GO:0007004]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	ATPase activity [GO:0016887]; ATPase activity, coupled [GO:0042623]; ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; DNA polymerase binding [GO:0070182]; GTPase binding [GO:0051020]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; MHC class II protein complex binding [GO:0023026]; nitric-oxide synthase regulator activity [GO:0030235]; nucleotide binding [GO:0000166]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; protein tyrosine kinase binding [GO:1990782]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	GO:0000086; GO:0000166; GO:0001934; GO:0003723; GO:0004713; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006839; GO:0006898; GO:0006986; GO:0007004; GO:0007165; GO:0009408; GO:0009409; GO:0010389; GO:0016020; GO:0016887; GO:0019221; GO:0021955; GO:0023026; GO:0030010; GO:0030235; GO:0030911; GO:0031396; GO:0031625; GO:0032273; GO:0032587; GO:0032991; GO:0033138; GO:0034774; GO:0038096; GO:0038128; GO:0042026; GO:0042470; GO:0042623; GO:0042802; GO:0042803; GO:0042826; GO:0043025; GO:0043202; GO:0043209; GO:0043254; GO:0043312; GO:0043335; GO:0044294; GO:0044295; GO:0045040; GO:0045429; GO:0046677; GO:0048010; GO:0048156; GO:0048471; GO:0048675; GO:0050821; GO:0050999; GO:0051020; GO:0051082; GO:0051131; GO:0051186; GO:0051897; GO:0051973; GO:0061684; GO:0070062; GO:0070182; GO:0071682; GO:0097110; GO:0097711; GO:0097718; GO:1900034; GO:1902949; GO:1903364; GO:1903827; GO:1904813; GO:1905323; GO:1990782	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P07901}. Cytoplasm {ECO:0000250|UniProtKB:P07901}. Melanosome {ECO:0000269|PubMed:17081065}. Cell membrane {ECO:0000269|PubMed:11276205}. Note=Identified by mass spectrometry in melanosome fractions from stage I to stage IV.	PTM: ISGylated. {ECO:0000269|PubMed:16139798}.; PTM: S-nitrosylated; negatively regulates the ATPase activity and the activation of eNOS by HSP90AA1. {ECO:0000269|PubMed:15937123}.; PTM: Ubiquitinated via 'Lys-63'-linked polyubiquitination by HECTD1. Ubiquitination promotes translocation into the cytoplasm away from the membrane and secretory pathways. {ECO:0000250|UniProtKB:P07901}.	MOD_RES 5 5 Phosphothreonine; by PRKDC. {ECO:0000269|PubMed:2507541}.; MOD_RES 7 7 Phosphothreonine; by PRKDC. {ECO:0000269|PubMed:2507541}.; MOD_RES 58 58 N6-acetyllysine. {ECO:0000250|UniProtKB:P07901}.; MOD_RES 84 84 N6-acetyllysine. {ECO:0000250|UniProtKB:P07901}.; MOD_RES 231 231 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18318008, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569, ECO:0000269|PubMed:2492519}.; MOD_RES 252 252 Phosphoserine. {ECO:0000244|PubMed:18088087, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 263 263 Phosphoserine. {ECO:0000244|PubMed:16807684, ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18088087, ECO:0000244|PubMed:18318008, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19367720, ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:2492519}.; MOD_RES 313 313 Phosphotyrosine. {ECO:0000250|UniProtKB:P07901}.; MOD_RES 443 443 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 453 453 Phosphoserine. {ECO:0000250|UniProtKB:P82995}.; MOD_RES 458 458 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 476 476 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 489 489 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 492 492 Phosphotyrosine. {ECO:0000250|UniProtKB:P07901}.; MOD_RES 585 585 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 598 598 S-nitrosocysteine. {ECO:0000269|PubMed:15937123}.; MOD_RES 641 641 Phosphoserine. {ECO:0000244|PubMed:23186163}.	2780322; 1368637; 2527334; 16269234; 14702039; 12508121; 2469626; 2591742; 15489334; 2492519; 10409742; 15937123; 2507541; 8289821; 7588731; 9195923; 9660753; 10508479; 11274138; 11583998; 11276205; 12853476; 12604615; 15235609; 15708368; 15383005; 15577939; 17081983; 16807684; 16531226; 18400751; 19367720; 18088087; 18691976; 18669648; 18318008; 19413330; 19690332; 19608861; 19875381; 16139798; 17081065; 17028174; 18256191; 19696785; 20353823; 20068231; 21269460; 21406692; 23569206; 23186163; 24613385; 24275569; 24681825; 25973397; 25738358; 26517842; 25944712; 27295069; 26991466; 27353360; 26754925; 29127155; 29743370; 9108479; 9817749; 16307917; 10376602; 10376603; 10469573; 10579907; 10648629; 10781589; 10878805; 10913161; 11071886; 11076968; 11087732; 11483758; 11604500; 11695992; 11751878; 11751892; 11751894; 11779851; 11805120; 11809754; 11879202; 11956313; 11988487; 12134158; 12176997; 12207013; 12221128; 12239347; 12471035; 12526792; 12668662; 12725864; 12799359; 12852856; 12855682; 12871950; 12944901; 13678582; 14557268; 14570880; 14580337; 14614132; 14638689; 14668798; 14676191; 14712222; 14718169; 14724288; 14743216; 14749716; 15001580; 15009113; 15046863; 15047060; 15062560; 15077177; 15118073; 15118125; 15146192; 15159550; 15161933; 15182205; 15217611; 15231747; 15247219; 15247284; 15270074; 15284455; 15308668; 15329413; 15358769; 15358771; 15371419; 15381148; 15467163; 15476407; 15498487; 15526284; 15529360; 15568014; 15591061; 15613472; 15643424; 15647277; 15664193; 15705883; 15713410; 15777846; 15791211; 15950906; 15972449; 15974572; 16007214; 16024644; 16038408; 16049054; 16049941; 16083881; 16118214; 16132836; 16169070; 16171778; 16187797; 16202589; 16212417; 16213716; 16263121; 16275660; 16278218; 16280321; 16300468; 16306228; 16330544; 16357211; 16394098; 16403413; 16462731; 16478993; 16480864; 16495214; 16565516; 16641196; 16644868; 16682002; 16698020; 16741950; 16760434; 16774932; 16777603; 16844778; 16849543; 16884307; 16888650; 16890155; 1689311; 16919237; 16938294; 16949366; 16953218; 16969069; 16978839; 17024179; 17030621; 17083915; 17088927; 17148781; 17177598; 17188549; 17211576; 17216044; 17218278; 17220478; 17222799; 17299090; 17304350; 17324930; 17327415; 17336451; 17349580; 17372273; 17400507; 17427945; 17431102; 17548610; 17569659; 17574030; 17615582; 17620599; 17630989; 17646400; 17646646; 17698952; 17699773; 17707089; 17712310; 17719545; 17728246; 17785525; 17826744; 17908693; 17915561; 17955473; 17957250; 17975158; 17977914; 17978573; 18020435; 18037622; 18037885; 18078691; 18197612; 18211808; 18229454; 18245548; 18270269; 18285346; 18320023; 18343820; 18347946; 18373550; 18386162; 18412542; 18457385; 18485364; 18485875; 18497978; 18511277; 18511558; 18538669; 18566290; 18591668; 18615013; 18617639; 18635947; 18638579; 18694559; 18695913; 18800240; 18820127; 18836734; 18922470; 18929486; 18950863; 18957107; 18988734; 19004860; 19026643; 19028451; 19047110; 19061638; 19073599; 19090995; 19110265; 19119138; 19136058; 19138996; 19142186; 19147678; 19150985; 19156129; 19159681; 19167051; 19193894; 19237602; 19245816; 19254810; 19293389; 19301319; 19329795; 19350847; 19397496; 19458189; 19486527; 19519743; 19560417; 19560753; 19576239; 19583220; 19598015; 19610616; 19635199; 19656872; 19682504; 19696406; 1973074; 19738418; 19740745; 19758187; 19759002; 19764559; 19805454; 19840459; 19855434; 19856365; 19908836; 19913121; 19913553; 19933325; 19940019; 19952119; 19952121; 19965370; 20000738; 20006655; 20007907; 20011505; 20018861; 20029029; 20033049; 20038533; 20048054; 20089831; 20129057; 20159553; 20188096; 20195357; 20210521; 20226014; 20230748; 20237157; 20308323; 20309963; 20360068; 20373063; 20391533; 20399632; 20416171; 20439430; 20451233; 20467437; 20493732; 20508983; 20546334; 20553606; 20558667; 20558745; 20562859; 20585984; 20602789; 20628086; 20634891; 20642453; 20651072; 20659681; 20662534; 20663926; 20668552; 20686127; 20688913; 20691061; 20694452; 20718493; 20731692; 20806039; 20864038; 20924358; 20936779; 20937817; 20966921; 20981255; 21103899; 21106457; 21126747; 21129190; 21146485; 21177334; 21183720; 21251717; 21273506; 21325639; 21347367; 21360678; 21369706; 21372220; 21408136; 21419342; 21420297; 21422230; 21438541; 21439943; 21445309; 21478269; 21501532; 21515049; 21548880; 21561141; 21565611; 21605975; 21612924; 21620453; 21642987; 21647436; 21658391; 21700222; 21709012; 21715165; 21725307; 21781956; 21787283; 21792235; 21855341; 21871133; 21875325; 21875461; 21875802; 21911578; 21919888; 21937440; 21972823; 21988832; 21998300; 22011577; 22016036; 22020280; 22022502; 22028380; 22069710; 22085931; 22094468; 22120110; 22144665; 22179047; 22192591; 22194440; 22199355; 22246440; 22268041; 22270370; 22304920; 22315411; 22318716; 22351691; 22360420; 22409343; 22433123; 22490666; 22504172; 22510516; 22543833; 22554505; 22573733; 22575643; 22592212; 22632933; 22653444; 22653663; 22674575; 22689214; 22693070; 22727666; 22810585; 22824801; 22841823; 22843495; 22843619; 22848402; 22849407; 22869732; 22877636; 22898980; 22902560; 22912728; 22935698; 22938030; 22939624; 22952420; 22975376; 22984537; 22989880; 23018093; 23023377; 23047954; 23065205; 23065523; 23075850; 23114515; 23135731; 23139789; 23141531; 23141541; 23190580; 23190606; 23201460; 23228483; 23253480; 23272037; 23285036; 23300914; 23348840; 23359685; 23362263; 23386606; 23386615; 23400999; 23414517; 23418523; 23428871; 23455323; 23455922; 23456764; 23530209; 23552409; 23554224; 23589305; 23606334; 23638161; 23650620; 23674492; 23747070; 23764002; 23769972; 23789104; 23823123; 23844194; 23873112; 23874879; 23921553; 23936217; 23951259; 23965991; 23990450; 23995768; 24053599; 24089205; 24100158; 24109220; 24117238; 24126057; 24138221; 24189400; 24206096; 24231678; 24267889; 24292678; 24332488; 24338924; 24355684; 24369839; 24379398; 24384723; 24388965; 24389346; 24398428; 24451373; 24463348; 24469809; 24511009; 24521827; 24567332; 24608665; 24658140; 24673104; 24680776; 24682747; 24689038; 24694367; 24706778; 24715760; 24718854; 2472219; 24733395; 24743777; 24751441; 24782094; 24794838; 24849514; 24901434; 24922078; 24927996; 24947832; 24949977; 24952482; 24962213; 24980703; 24982133; 25024377; 25036637; 25047611; 25075042; 25111496; 25188333; 25202009; 25205430; 25205676; 25262350; 25277244; 25290150; 25297628; 25313408; 25313505; 25316816; 25368984; 25416956; 25423885; 25486457; 25490978; 25532896; 25609649; 25640309; 25677667; 25682284; 25713068; 25714412; 25739426; 25852146; 25945584; 25955495; 25957766; 26010604; 26028330; 26071189; 26141945; 26151834; 26205540; 26271675; 26286954; 26330616; 26334999; 26427407; 26432328; 26496610; 26500058; 26556859; 26556860; 26565746; 26592496; 26595521; 26616658; 26638075; 26704341; 26752685; 26782567; 26804907; 26808260; 26874923; 26884463; 26982469; 27107422; 27226232; 27233944; 27254664; 27279135; 27301716; 27302312; 27448590; 27462449; 27738310; 27771574; 27870927; 27933959; 28032595; 28038472; 28038712; 28049024; 28053100; 28064214; 28143869; 28157708; 28199108; 28218749; 28221352; 28631426; 28723223; 28751373; 28765916; 28816574; 28855508; 28870917; 28878208; 28914785; 29178343; 29262861; 29267381; 29273709; 29491085; 29528635; 29701469; 29768913; 30033218; 3023071; 3783823; 7479864; 7526779; 7535773; 7769006; 7790358; 7848918; 8036006; 8455624; 8493579; 8530489; 8617201; 8617235; 8665853; 8782602; 8838651; 8948635; 9173876; 9182576; 9222609; 9395444; 9472046; 9580552; 9727490; 9844631	2780322; 1368637; 2527334; 16269234; 14702039; 12508121; 2469626; 2591742; 15489334; 2492519; 10409742; 15937123; 2507541; 8289821; 7588731; 9195923; 9660753; 10508479; 11274138; 11583998; 11276205; 12853476; 12604615; 15235609; 15708368; 15383005; 15577939; 17081983; 16807684; 16531226; 18400751; 19367720; 18088087; 18691976; 18669648; 18318008; 19413330; 19690332; 19608861; 19875381; 16139798; 17081065; 17028174; 18256191; 19696785; 20353823; 20068231; 21269460; 21406692; 23569206; 23186163; 24613385; 24275569; 24681825; 25973397; 25738358; 26517842; 25944712; 27295069; 26991466; 27353360; 26754925; 29127155; 29743370; 9108479; 9817749; 16307917
5656	HACD1 PTPLA	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=33.6 uM for 3-hydroxypalmitoyl-CoA (at 37 degrees Celsius) {ECO:0000269|PubMed:18554506}; 	4.2.1.134	CATALYTIC ACTIVITY: A very-long-chain (3R)-3-hydroxyacyl-CoA = a very-long-chain trans-2,3-dehydroacyl-CoA + H(2)O. {ECO:0000269|PubMed:18554506, ECO:0000269|PubMed:23933735}.					PATHWAY: Lipid metabolism; fatty acid biosynthesis. {ECO:0000269|PubMed:18554506}.				cellular protein-containing complex assembly [GO:0034622]; cementum mineralization [GO:0071529]; fatty acid elongation [GO:0030497]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; multicellular organism development [GO:0007275]; positive regulation of cell-substrate adhesion [GO:0010811]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; 3-hydroxy-arachidoyl-CoA dehydratase activity [GO:0102343]; 3-hydroxy-behenoyl-CoA dehydratase activity [GO:0102344]; 3-hydroxy-lignoceroyl-CoA dehydratase activity [GO:0102345]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; 3R-hydroxyacyl-CoA dehydratase activity [GO:0080023]; enzyme binding [GO:0019899]; hydroxyapatite binding [GO:0046848]; very-long-chain 3-hydroxyacyl-CoA dehydratase activity [GO:0102158]; cellular protein-containing complex assembly [GO:0034622]; cementum mineralization [GO:0071529]; fatty acid elongation [GO:0030497]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; multicellular organism development [GO:0007275]; positive regulation of cell-substrate adhesion [GO:0010811]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761]	3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; 3-hydroxy-arachidoyl-CoA dehydratase activity [GO:0102343]; 3-hydroxy-behenoyl-CoA dehydratase activity [GO:0102344]; 3-hydroxy-lignoceroyl-CoA dehydratase activity [GO:0102345]; 3R-hydroxyacyl-CoA dehydratase activity [GO:0080023]; enzyme binding [GO:0019899]; hydroxyapatite binding [GO:0046848]; very-long-chain 3-hydroxyacyl-CoA dehydratase activity [GO:0102158]	GO:0005783; GO:0005789; GO:0007275; GO:0010811; GO:0018812; GO:0019899; GO:0030148; GO:0030176; GO:0030497; GO:0034622; GO:0035338; GO:0042761; GO:0046848; GO:0071529; GO:0080023; GO:0102158; GO:0102343; GO:0102344; GO:0102345	SUBCELLULAR LOCATION: Isoform 1: Endoplasmic reticulum membrane {ECO:0000269|PubMed:18554506}; Multi-pass membrane protein {ECO:0000269|PubMed:18554506}.	PTM: N-glycosylated. {ECO:0000269|PubMed:23933735}.	MOD_RES 22 22 Phosphoserine. {ECO:0000244|PubMed:18669648}.	11054553; 10644438; 22067203; 15164054; 15489334; 18554506; 18669648; 23933735; 25263524; 15829503; 16385451; 19241460; 19913121; 20628086; 20724468; 23071563; 27939133; 28784662	11054553; 10644438; 22067203; 15164054; 15489334; 18554506; 18669648; 23933735; 25263524
5657	HACD3 BIND1 PTPLAD1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=49.5 uM for 3-hydroxypalmitoyl-CoA (at 37 degrees Celsius) {ECO:0000269|PubMed:18554506}; 	4.2.1.134	CATALYTIC ACTIVITY: A very-long-chain (3R)-3-hydroxyacyl-CoA = a very-long-chain trans-2,3-dehydroacyl-CoA + H(2)O. {ECO:0000269|PubMed:18554506}.					PATHWAY: Lipid metabolism; fatty acid biosynthesis. {ECO:0000269|PubMed:18554506}.				activation of JUN kinase activity [GO:0007257]; fatty acid elongation [GO:0030497]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of viral genome replication [GO:0045070]; Rac protein signal transduction [GO:0016601]; Rho protein signal transduction [GO:0007266]; small GTPase mediated signal transduction [GO:0007264]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; integral component of endoplasmic reticulum membrane [GO:0030176]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; integral component of endoplasmic reticulum membrane [GO:0030176]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; 3-hydroxy-arachidoyl-CoA dehydratase activity [GO:0102343]; 3-hydroxy-behenoyl-CoA dehydratase activity [GO:0102344]; 3-hydroxy-lignoceroyl-CoA dehydratase activity [GO:0102345]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; very-long-chain 3-hydroxyacyl-CoA dehydratase activity [GO:0102158]; activation of JUN kinase activity [GO:0007257]; fatty acid elongation [GO:0030497]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of viral genome replication [GO:0045070]; Rac protein signal transduction [GO:0016601]; Rho protein signal transduction [GO:0007266]; small GTPase mediated signal transduction [GO:0007264]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761]	3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; 3-hydroxy-arachidoyl-CoA dehydratase activity [GO:0102343]; 3-hydroxy-behenoyl-CoA dehydratase activity [GO:0102344]; 3-hydroxy-lignoceroyl-CoA dehydratase activity [GO:0102345]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; very-long-chain 3-hydroxyacyl-CoA dehydratase activity [GO:0102158]	GO:0005096; GO:0005739; GO:0005783; GO:0005829; GO:0005925; GO:0007249; GO:0007257; GO:0007264; GO:0007266; GO:0016601; GO:0018812; GO:0019899; GO:0030148; GO:0030176; GO:0030497; GO:0031965; GO:0042761; GO:0045070; GO:0046726; GO:0102158; GO:0102343; GO:0102344; GO:0102345	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:18554506}; Multi-pass membrane protein {ECO:0000269|PubMed:18554506}.		MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:25944712}.; MOD_RES 7 7 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 114 114 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18220336, ECO:0000244|PubMed:18318008, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 135 135 Phosphoserine. {ECO:0000244|PubMed:23186163}.	10747961; 11042152; 14702039; 16572171; 15489334; 16516406; 16638134; 17081983; 18554506; 18220336; 18691976; 18669648; 18318008; 19369195; 19690332; 20068231; 21269460; 21406692; 23186163; 24275569; 25687571; 25944712; 14743216; 17353931; 18160438; 19656872; 20562859; 21182205; 21706016; 21911578; 22190034; 22560525; 22593156; 23764002; 23902751; 23935497; 24189400; 24725412; 25561175; 25609649; 26496610; 26638075	10747961; 11042152; 14702039; 16572171; 15489334; 16516406; 16638134; 17081983; 18554506; 18220336; 18691976; 18669648; 18318008; 19369195; 19690332; 20068231; 21269460; 21406692; 23186163; 24275569; 25687571; 25944712
5676	HINT2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=128 uM for adenosine 5'-O-p-nitrophenylphosphoramidate {ECO:0000269|PubMed:16762638}; 	3.-.-.-		BINDING 63 63 Purine nucleotide phosphoramidate. {ECO:0000244|PDB:4INI, ECO:0000269|PubMed:23659632}.; BINDING 80 80 Purine nucleotide phosphoramidate. {ECO:0000244|PDB:4INI, ECO:0000269|PubMed:23659632}.; BINDING 136 136 Purine nucleotide phosphoramidate. {ECO:0000244|PDB:4INI, ECO:0000269|PubMed:23659632}.								apoptotic process [GO:0006915]; lipid catabolic process [GO:0016042]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; steroid biosynthetic process [GO:0006694]	mitochondrion [GO:0005739]; nucleolus [GO:0005730]	mitochondrion [GO:0005739]; nucleolus [GO:0005730]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; apoptotic process [GO:0006915]; lipid catabolic process [GO:0016042]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; steroid biosynthetic process [GO:0006694]	hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]	GO:0000166; GO:0005730; GO:0005739; GO:0006694; GO:0006915; GO:0016042; GO:0016787; GO:2000757	SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:16762638, ECO:0000269|PubMed:18653718}.		MOD_RES 119 119 N6-acetyllysine. {ECO:0000250|UniProtKB:Q9D0S9}.; MOD_RES 139 139 N6-acetyllysine. {ECO:0000250|UniProtKB:Q9D0S9}.	15164053; 15489334; 16762638; 18653718; 21269460; 24275569; 25944712; 23659632; 28968488; 20877624; 23682076; 28088787; 28947137	15164053; 15489334; 16762638; 18653718; 21269460; 24275569; 25944712; 23659632; 28968488
5689	HPRT1 HPRT	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=5.4 uM for IMP {ECO:0000269|PubMed:10338013}; KM=0.45 uM for hypoxanthine {ECO:0000269|PubMed:10338013}; KM=25 uM for pyrophosphate {ECO:0000269|PubMed:10338013}; KM=31 uM for phosphoribosylpyrophosphate {ECO:0000269|PubMed:10338013}; 	2.4.2.8	CATALYTIC ACTIVITY: IMP + diphosphate = hypoxanthine + 5-phospho-alpha-D-ribose 1-diphosphate.; CATALYTIC ACTIVITY: GMP + diphosphate = guanine + 5-phospho-alpha-D-ribose 1-diphosphate.	BINDING 69 69 GMP. {ECO:0000269|PubMed:8044844}.; BINDING 166 166 GMP. {ECO:0000269|PubMed:8044844}.; BINDING 194 194 GMP; via carbonyl oxygen. {ECO:0000269|PubMed:8044844}.		COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; ;  Note=Binds 2 magnesium ions per subunit. The magnesium ions are essentially bound to the substrate and have few direct interactions with the protein.;		PATHWAY: Purine metabolism; IMP biosynthesis via salvage pathway; IMP from hypoxanthine: step 1/1.				adenine salvage [GO:0006168]; central nervous system neuron development [GO:0021954]; cerebral cortex neuron differentiation [GO:0021895]; dendrite morphogenesis [GO:0048813]; dopamine metabolic process [GO:0042417]; GMP catabolic process [GO:0046038]; grooming behavior [GO:0007625]; guanine salvage [GO:0006178]; hypoxanthine metabolic process [GO:0046100]; hypoxanthine salvage [GO:0043103]; IMP metabolic process [GO:0046040]; IMP salvage [GO:0032264]; locomotory behavior [GO:0007626]; lymphocyte proliferation [GO:0046651]; positive regulation of dopamine metabolic process [GO:0045964]; protein homotetramerization [GO:0051289]; purine-containing compound salvage [GO:0043101]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside salvage [GO:0006166]; response to amphetamine [GO:0001975]; striatum development [GO:0021756]; T cell mediated cytotoxicity [GO:0001913]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; guanine phosphoribosyltransferase activity [GO:0052657]; hypoxanthine phosphoribosyltransferase activity [GO:0004422]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; protein homodimerization activity [GO:0042803]; adenine salvage [GO:0006168]; central nervous system neuron development [GO:0021954]; cerebral cortex neuron differentiation [GO:0021895]; dendrite morphogenesis [GO:0048813]; dopamine metabolic process [GO:0042417]; GMP catabolic process [GO:0046038]; grooming behavior [GO:0007625]; guanine salvage [GO:0006178]; hypoxanthine metabolic process [GO:0046100]; hypoxanthine salvage [GO:0043103]; IMP metabolic process [GO:0046040]; IMP salvage [GO:0032264]; locomotory behavior [GO:0007626]; lymphocyte proliferation [GO:0046651]; positive regulation of dopamine metabolic process [GO:0045964]; protein homotetramerization [GO:0051289]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside salvage [GO:0006166]; purine-containing compound salvage [GO:0043101]; response to amphetamine [GO:0001975]; striatum development [GO:0021756]; T cell mediated cytotoxicity [GO:0001913]	guanine phosphoribosyltransferase activity [GO:0052657]; hypoxanthine phosphoribosyltransferase activity [GO:0004422]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; protein homodimerization activity [GO:0042803]	GO:0000166; GO:0000287; GO:0001913; GO:0001975; GO:0004422; GO:0005737; GO:0005829; GO:0006164; GO:0006166; GO:0006168; GO:0006178; GO:0007625; GO:0007626; GO:0021756; GO:0021895; GO:0021954; GO:0032264; GO:0042417; GO:0042802; GO:0042803; GO:0043101; GO:0043103; GO:0045964; GO:0046038; GO:0046040; GO:0046100; GO:0046651; GO:0048813; GO:0051289; GO:0052657; GO:0070062	SUBCELLULAR LOCATION: Cytoplasm.		MOD_RES 2 2 N-acetylalanine. {ECO:0000269|PubMed:7107641}.; MOD_RES 103 103 N6-acetyllysine. {ECO:0000250|UniProtKB:P00493}.; MOD_RES 142 142 Phosphothreonine. {ECO:0000250|UniProtKB:P27605}.	6300847; 2341149; 14702039; 15772651; 15489334; 7107641; 3023844; 21269460; 24275569; 25114211; 25944712; 28112733; 8044844; 10360366; 10338013; 1487231; 15990111; 19527031; 6853490; 6853716; 6572373; 6706936; 3358423; 3384338; 3265398; 2896620; 3198771; 3148064; 2572141; 2909537; 2910902; 2738157; 2928313; 2347587; 2358296; 2246854; 2018042; 2071157; 1937471; 1840476; 1551676; 1301916; 7987318; 7627191; 9003484; 9452051; 15571223; 17027311; 20544509; 24940672; 11219770; 11434773; 11668636; 11714443; 11891689; 12175903; 12376523; 12616531; 12874812; 14767555; 15146465; 15178494; 15204312; 15277709; 15491638; 15571220; 15571222; 15571224; 15601998; 15779006; 15862283; 15862284; 15987524; 16189514; 16216473; 16240158; 16458330; 16951156; 17353931; 17454734; 17628775; 17697207; 17700363; 17934765; 18288319; 18316217; 18407966; 18409516; 18494542; 18536021; 18600506; 18600559; 18779430; 18835879; 19016344; 19060904; 19342420; 19672249; 19706768; 19995283; 20038437; 20045992; 20536392; 20562859; 20981450; 21305049; 21486037; 21780909; 22042773; 22132982; 22132984; 22132986; 22183764; 22331909; 22360420; 23348497; 23448281; 23473102; 23907213; 24075303; 25136576; 25416956; 25494538; 25609649; 25612837; 25914368; 25965333; 26050630; 26204901; 26368337; 26752685; 27379977; 27404508; 27420966; 27754763; 28524722; 28712454; 28813147; 28904386; 29161011; 29185864	6300847; 2341149; 14702039; 15772651; 15489334; 7107641; 3023844; 21269460; 24275569; 25114211; 25944712; 28112733; 8044844; 10360366; 10338013; 1487231; 15990111; 19527031; 6853490; 6853716; 6572373; 6706936; 3358423; 3384338; 3265398; 2896620; 3198771; 3148064; 2572141; 2909537; 2910902; 2738157; 2928313; 2347587; 2358296; 2246854; 2018042; 2071157; 1937471; 1840476; 1551676; 1301916; 7987318; 7627191; 9003484; 9452051; 15571223; 17027311; 20544509; 24940672
5690	HPSE HEP HPA HPA1 HPR1 HPSE1 HSE1	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=7.7 uM for M09 S05a, an heparin sulfate analog with a nonasaccharide with N-sulfation and a single GlcNS(6S) toward the reducing end {ECO:0000269|PubMed:28581485}; Note=Kcat is 0.53 sec(-1) for M09 S05a. {ECO:0000269|PubMed:28581485};	3.2.1.166	CATALYTIC ACTIVITY: Endohydrolysis of (1->4)-beta-D-glycosidic bonds of heparan sulfate chains in heparan sulfate proteoglycan. {ECO:0000269|PubMed:11973358, ECO:0000269|PubMed:12213822, ECO:0000269|PubMed:12927802, ECO:0000269|PubMed:20181948, ECO:0000269|PubMed:20561914, ECO:0000269|PubMed:20634491}.	BINDING 97 97 Heparan sulfate; via amide nitrogen. {ECO:0000244|PDB:5E97, ECO:0000244|PDB:5E98, ECO:0000244|PDB:5E9B, ECO:0000269|PubMed:28581485}.; BINDING 296 296 Heparan sulfate. {ECO:0000244|PDB:5E9C, ECO:0000269|PubMed:28581485}.; BINDING 303 303 Heparan sulfate. {ECO:0000244|PDB:5E9C, ECO:0000269|PubMed:28581485}.	ACTIVITY REGULATION: Inhibited by EDTA, laminarin sulfate and, to a lower extent, by heparin and sulfamin and activated by calcium and magnesium. {ECO:0000250}.		BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 4-6. {ECO:0000269|PubMed:10446189, ECO:0000269|PubMed:10764835, ECO:0000269|PubMed:12713442, ECO:0000269|PubMed:15848168};					angiogenesis involved in wound healing [GO:0060055]; cell-matrix adhesion [GO:0007160]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200]; neutrophil degranulation [GO:0043312]; positive regulation of blood coagulation [GO:0030194]; positive regulation of hair follicle development [GO:0051798]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of vascular endothelial growth factor production [GO:0010575]; proteoglycan metabolic process [GO:0006029]; regulation of hair follicle development [GO:0051797]; vascular wound healing [GO:0061042]	extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]	extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]; beta-glucuronidase activity [GO:0004566]; heparanase activity [GO:0030305]; protein dimerization activity [GO:0046983]; syndecan binding [GO:0045545]; angiogenesis involved in wound healing [GO:0060055]; cell-matrix adhesion [GO:0007160]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200]; neutrophil degranulation [GO:0043312]; positive regulation of blood coagulation [GO:0030194]; positive regulation of hair follicle development [GO:0051798]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of vascular endothelial growth factor production [GO:0010575]; proteoglycan metabolic process [GO:0006029]; regulation of hair follicle development [GO:0051797]; vascular wound healing [GO:0061042]	beta-glucuronidase activity [GO:0004566]; heparanase activity [GO:0030305]; protein dimerization activity [GO:0046983]; syndecan binding [GO:0045545]	GO:0004566; GO:0005576; GO:0005634; GO:0005654; GO:0005764; GO:0005765; GO:0006027; GO:0006029; GO:0007160; GO:0010575; GO:0030194; GO:0030200; GO:0030305; GO:0033690; GO:0035580; GO:0043202; GO:0043231; GO:0043312; GO:0045121; GO:0045545; GO:0046983; GO:0051797; GO:0051798; GO:0051897; GO:0060055; GO:0061042	SUBCELLULAR LOCATION: Lysosome membrane; Peripheral membrane protein. Secreted. Nucleus. Note=Proheparanase is secreted via vesicles of the Golgi. Interacts with cell membrane heparan sulfate proteoglycans (HSPGs). Endocytosed and accumulates in endosomes. Transferred to lysosomes where it is proteolytically cleaved to produce the active enzyme. Under certain stimuli, transferred to the cell surface. Associates with lipid rafts. Colocalizes with SDC1 in endosomal/lysosomal vesicles. Accumulates in perinuclear lysosomal vesicles. Heparin retains proheparanase in the extracellular medium (By similarity). {ECO:0000250}.	PTM: Proteolytically processed. The cleavage of the 65 kDa form leads to the generation of a linker peptide, and 8 kDa and 50 kDa products. The active form, the 8/50 kDa heterodimer, is resistant to degradation. Complete removal of the linker peptide appears to be a prerequisite to the complete activation of the enzyme. {ECO:0000269|PubMed:10395325, ECO:0000269|PubMed:11973358, ECO:0000269|PubMed:12441129, ECO:0000269|PubMed:15126626, ECO:0000269|PubMed:15659389, ECO:0000269|PubMed:15848168}.; PTM: N-glycosylated. Glycosylation of the 50 kDa subunit appears to be essential for its solubility. {ECO:0000269|PubMed:10395325, ECO:0000269|PubMed:12713442, ECO:0000269|PubMed:14573609, ECO:0000269|PubMed:16263699, ECO:0000269|PubMed:19159218}.		10405343; 10446189; 10395325; 10395326; 10764835; 11547900; 12713442; 17208203; 15815621; 15489334; 11123890; 12441129; 12213822; 11973358; 12927802; 12773484; 14573609; 15044433; 15292202; 15126626; 15848168; 15659389; 15760902; 16452201; 16263699; 18557927; 18798279; 19244131; 19159218; 20097882; 20634491; 20561914; 20181948; 20576607; 20309870; 21131364; 26575439; 28581485; 15334672; 10940554; 11759110; 11779847; 11798780; 12027584; 12029075; 12065771; 12097647; 12219030; 12509917; 12679316; 12824922; 12837765; 12904690; 14522979; 14558943; 14633698; 14676122; 14769819; 14967027; 14989983; 15034597; 15040016; 15100255; 15144715; 15368349; 15471949; 15610235; 15625607; 15645118; 15682491; 15728796; 15737842; 15983219; 16007175; 16093249; 16097072; 16112651; 16217746; 16288472; 16391819; 16429446; 16514606; 16759020; 16790442; 16826429; 16855356; 16867222; 16890383; 16982797; 17051139; 17095861; 17141400; 17217623; 17261577; 17284253; 17339423; 17419711; 17437011; 17467664; 17481627; 17519955; 17524042; 17611567; 17634531; 17989358; 18064313; 18167611; 18212251; 18217145; 18246800; 18288398; 18305555; 18329709; 18357711; 18390199; 18450756; 18487013; 18512775; 18545691; 18609704; 18618498; 18646256; 18647407; 18662687; 18704599; 18773863; 18809970; 18812315; 19096032; 19157148; 19180921; 19305494; 19401035; 19406828; 19437318; 19452723; 19715595; 19749739; 19802384; 19835469; 19916174; 19955948; 19956890; 20007507; 20075159; 20164500; 20193112; 20339231; 20403028; 20434010; 20578081; 20619346; 20653782; 20660327; 20798248; 21029368; 21076620; 21153652; 21257720; 21364956; 21385059; 21415391; 21424539; 21461610; 21464728; 21483695; 21490396; 21505182; 21671176; 21706269; 21757697; 21780097; 21965756; 22001963; 22005029; 22009724; 22020734; 22102278; 22133010; 22194600; 22227299; 22260074; 22276173; 22331282; 22363633; 22488243; 22575501; 22682139; 22692572; 22719918; 22952874; 23028487; 23048032; 23162016; 23241438; 23251556; 23288725; 23313782; 23370684; 23415719; 23430739; 23467544; 23499526; 23499527; 23499528; 23499529; 23499530; 23504321; 23504323; 23511033; 23649655; 23650620; 23704979; 23771368; 23794232; 23902751; 23907942; 23982701; 24169805; 24189015; 24286246; 24291708; 24319286; 24465803; 24632672; 24699306; 24740543; 24747732; 24753252; 24766948; 24861922; 24862152; 24887057; 24922641; 24937189; 24954766; 25065557; 25149140; 25185798; 25189635; 25337202; 25370734; 25423319; 25503134; 25548284; 25586097; 25616966; 25682080; 25727320; 25732677; 25743687; 25745999; 25849134; 25912399; 25944690; 26039697; 26200836; 26249176; 26489695; 26552066; 26624982; 26689987; 26713365; 26720478; 26849235; 26916313; 26972718; 27019315; 27067977; 27091112; 27129145; 27166252; 27322195; 27565180; 27595937; 27685626; 27758044; 28038446; 28351285; 28386074; 28387673; 28388549; 28581441; 28794202; 28994624; 29153700	10405343; 10446189; 10395325; 10395326; 10764835; 11547900; 12713442; 17208203; 15815621; 15489334; 11123890; 12441129; 12213822; 11973358; 12927802; 12773484; 14573609; 15044433; 15292202; 15126626; 15848168; 15659389; 15760902; 16452201; 16263699; 18557927; 18798279; 19244131; 19159218; 20097882; 20634491; 20561914; 20181948; 20576607; 20309870; 21131364; 26575439; 28581485; 15334672
5693	HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=25.7 uM for acetoacetyl-CoA (in the presence of 0.2 mM NADH, at pH 7.0 and 25 degrees Celsius) {ECO:0000269|PubMed:12917011}; KM=85.2 uM for beta-hydroxybutyryl-CoA (in the presence of 1 mM NAD, at pH 9.3 and 25 degrees Celsius) {ECO:0000269|PubMed:12917011}; KM=41 uM for androsterone (in the presence of 1 mM NAD, at pH 9.3 and 25 degrees Celsius) {ECO:0000269|PubMed:12917011}; KM=5 uM for 5-alpha-pregnan-20-beta-ol-3-one (in the presence of 1 mM NAD, at pH 9.3 and 25 degrees Celsius) {ECO:0000269|PubMed:12917011}; KM=219 uM for isoursodeoxycholic acid (in the presence of 1 mM NAD, at pH 9.3 and 25 degrees Celsius) {ECO:0000269|PubMed:12917011}; KM=36.4 uM for chenodeoxycholic acid (in the presence of 1 mM NAD, at pH 9.3 and 25 degrees Celsius) {ECO:0000269|PubMed:12917011}; KM=1.7 uM for dehydrocorticosterone (in the presence of 1 mM NAD, at pH 9.3 and 25 degrees Celsius) {ECO:0000269|PubMed:12917011}; KM=30.6 uM for NADH (in the presence of acetoacetyl-CoA, at pH 7.0 and 25 degrees Celsius) {ECO:0000269|PubMed:12917011}; KM=42.3 uM for NAD (in the presence of beta-hydroxybutyryl-CoA, at pH 9.3 and 25 degrees Celsius) {ECO:0000269|PubMed:12917011}; KM=69 uM for for DL-3-hydroxybutyryl-CoA {ECO:0000269|PubMed:28888424}; KM=7.7 uM for for allopregnanolone {ECO:0000269|PubMed:28888424}; Note=Kcat is 458 min(-1) for DL-3-hydroxybutyryl-CoA (PubMed:28888424). Kcat is 706 min(-1) for allopregnanolone (PubMed:28888424). {ECO:0000269|PubMed:28888424};	1.1.1.35; 1.1.1.51; 1.1.1.178	CATALYTIC ACTIVITY: (2S,3S)-3-hydroxy-2-methylbutanoyl-CoA + NAD(+) = 2-methylacetoacetyl-CoA + NADH. {ECO:0000269|PubMed:12917011}.; CATALYTIC ACTIVITY: Testosterone + NAD(P)(+) = androst-4-ene-3,17-dione + NAD(P)H. {ECO:0000269|PubMed:12917011, ECO:0000269|PubMed:28888424}.; CATALYTIC ACTIVITY: (S)-3-hydroxyacyl-CoA + NAD(+) = 3-oxoacyl-CoA + NADH. {ECO:0000269|PubMed:12917011, ECO:0000269|PubMed:18996107, ECO:0000269|PubMed:25925575, ECO:0000269|PubMed:28888424, ECO:0000269|PubMed:9553139}.	BINDING 155 155 Substrate. {ECO:0000269|PubMed:15087549}.; BINDING 172 172 NAD. {ECO:0000269|PubMed:15342248}.			BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 9.3 for the dehydrogenase reaction at 25 degrees Celsius, and 7.0 for the reductase reaction at 25 degrees Celsius. {ECO:0000269|PubMed:12917011};					branched-chain amino acid catabolic process [GO:0009083]; lipid metabolic process [GO:0006629]; mitochondrial tRNA 3'-end processing [GO:1990180]; mitochondrial tRNA 5'-end processing [GO:0097745]; mitochondrial tRNA methylation [GO:0070901]; mitochondrial tRNA processing [GO:0090646]; mitochondrion organization [GO:0007005]; protein homotetramerization [GO:0051289]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity [GO:0047015]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; cholate 7-alpha-dehydrogenase activity [GO:0008709]; RNA binding [GO:0003723]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283]; tRNA binding [GO:0000049]; branched-chain amino acid catabolic process [GO:0009083]; lipid metabolic process [GO:0006629]; mitochondrial tRNA 3'-end processing [GO:1990180]; mitochondrial tRNA 5'-end processing [GO:0097745]; mitochondrial tRNA methylation [GO:0070901]; mitochondrial tRNA processing [GO:0090646]; mitochondrion organization [GO:0007005]; protein homotetramerization [GO:0051289]	3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity [GO:0047015]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; cholate 7-alpha-dehydrogenase activity [GO:0008709]; RNA binding [GO:0003723]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283]; tRNA binding [GO:0000049]	GO:0000049; GO:0003723; GO:0003857; GO:0005737; GO:0005739; GO:0005759; GO:0005886; GO:0006629; GO:0007005; GO:0008709; GO:0009083; GO:0030283; GO:0030678; GO:0047015; GO:0051289; GO:0070901; GO:0090646; GO:0097745; GO:1990180	SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:12917011, ECO:0000269|PubMed:18984158}.		MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:25944712}.; MOD_RES 53 53 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:O08756}.; MOD_RES 53 53 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:O08756}.; MOD_RES 69 69 N6-acetyllysine. {ECO:0000250|UniProtKB:O08756}.; MOD_RES 99 99 N6-acetyllysine. {ECO:0000250|UniProtKB:O08756}.; MOD_RES 105 105 N6-acetyllysine. {ECO:0000250|UniProtKB:O08756}.; MOD_RES 212 212 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:O08756}.; MOD_RES 212 212 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:O08756}.	9338779; 9671743; 9553139; 15772651; 15489334; 12917011; 17236142; 18252223; 18984158; 21269460; 23042678; 24275569; 25575635; 25944712; 29040705; 15342248; 15087549; 20077426; 12696021; 16148061; 18996107; 19706438; 22132097; 24549042; 25925575; 26950678; 28888424; 11559359; 15665036; 15804423; 17266347; 17500595; 17707551; 17917077; 18765932; 19343046; 19422801; 19449377; 19601895; 19756307; 20000738; 20186120; 20562859; 20638476; 20664630; 20711500; 20869947; 21382475; 21559454; 21593607; 21857155; 21900206; 22174920; 22336717; 22623428; 22810585; 22991464; 23266819; 23755257; 23834306; 23849775; 24244276; 25007702; 25375021; 25525879; 25609649; 25879199; 25928769; 25953853; 26016801; 26338420; 26496610; 26752685; 26884257; 27291402; 28188816; 9512533	9338779; 9671743; 9553139; 15772651; 15489334; 12917011; 17236142; 18252223; 18984158; 21269460; 23042678; 24275569; 25575635; 25944712; 29040705; 15342248; 15087549; 20077426; 12696021; 16148061; 18996107; 19706438; 22132097; 24549042; 25925575; 26950678; 28888424
5726	ABHD12 C20orf22	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=117 uM for 2-arachidonoyglycerol {ECO:0000269|PubMed:22969151}; Vmax=42 nmol/min/mg enzyme toward 2-arachidonoyglycerol {ECO:0000269|PubMed:22969151}; 	3.1.1.23	CATALYTIC ACTIVITY: Hydrolyzes glycerol monoesters of long-chain fatty acids. {ECO:0000269|PubMed:22969151}.				BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 7.2-9 with 2-arachidonoyglycerol as substrate. {ECO:0000269|PubMed:22969151};					acylglycerol catabolic process [GO:0046464]; adult walking behavior [GO:0007628]; glycerophospholipid catabolic process [GO:0046475]; monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]; protein depalmitoylation [GO:0002084]; response to auditory stimulus [GO:0010996]	AMPA glutamate receptor complex [GO:0032281]; dendrite cytoplasm [GO:0032839]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	AMPA glutamate receptor complex [GO:0032281]; dendrite cytoplasm [GO:0032839]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; acylglycerol catabolic process [GO:0046464]; adult walking behavior [GO:0007628]; glycerophospholipid catabolic process [GO:0046475]; monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]; protein depalmitoylation [GO:0002084]; response to auditory stimulus [GO:0010996]	acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]	GO:0002084; GO:0004622; GO:0005886; GO:0006660; GO:0007628; GO:0008474; GO:0010996; GO:0016021; GO:0032281; GO:0032839; GO:0046464; GO:0046475; GO:0047372; GO:0052651	SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:Q99LR1}; Single-pass membrane protein {ECO:0000250|UniProtKB:Q99LR1}.	PTM: Glycosylated. {ECO:0000250|UniProtKB:Q99LR1}.		14702039; 11780052; 15489334; 17974005; 20797687; 21269460; 22969151; 22938382; 24027063; 25944712; 21418147; 21911578; 23490117; 24697911; 25743180; 26638075; 27890673; 28448692	14702039; 11780052; 15489334; 17974005; 20797687; 21269460; 22969151; 22938382; 24027063; 25944712
5756	DUSP23 LDP3 VHZ	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.498 mM for p-nitrophenylphosphate {ECO:0000269|PubMed:15201283}; 	3.1.3.16; 3.1.3.48	CATALYTIC ACTIVITY: Protein tyrosine phosphate + H(2)O = protein tyrosine + phosphate. {ECO:0000255|PROSITE-ProRule:PRU10044}.; CATALYTIC ACTIVITY: [a protein]-serine/threonine phosphate + H(2)O = [a protein]-serine/threonine + phosphate.									dephosphorylation [GO:0016311]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phosphatase activity [GO:0016791]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; dephosphorylation [GO:0016311]	phosphatase activity [GO:0016791]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]	GO:0004722; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008138; GO:0016311; GO:0016791	SUBCELLULAR LOCATION: Cytoplasm, cytosol. Nucleus. Note=Mainly cytosolic. Also nuclear.			15281913; 14702039; 16710414; 15489334; 15201283; 15147733; 21269460; 25944712; 18245086; 16169070; 19463016; 19913121; 20453000; 20509867; 20628086; 21900206; 23145819; 25416956; 27737517	15281913; 14702039; 16710414; 15489334; 15201283; 15147733; 21269460; 25944712; 18245086
5772	DECR1 DECR SDR18C1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=7.7 uM for NADPH {ECO:0000269|PubMed:15531764}; KM=14.3 uM for trans-2,trans-4-hexadienoyl-CoA {ECO:0000269|PubMed:15531764}; Vmax=30.3 umol/min/mg enzyme {ECO:0000269|PubMed:15531764}; 	1.3.1.34	CATALYTIC ACTIVITY: Trans-2,3-didehydroacyl-CoA + NADP(+) = trans,trans-2,3,4,5-tetradehydroacyl-CoA + NADPH. {ECO:0000269|PubMed:15531764}.	BINDING 91 91 NADP. {ECO:0000269|PubMed:15531764}.; BINDING 91 91 Substrate. {ECO:0000250}.; BINDING 117 117 NADP. {ECO:0000269|PubMed:15531764}.; BINDING 119 119 Substrate. {ECO:0000269|PubMed:15531764}.; BINDING 149 149 Substrate. {ECO:0000269|PubMed:15531764}.; BINDING 157 157 Substrate. {ECO:0000269|PubMed:15531764}.; BINDING 214 214 NADP. {ECO:0000269|PubMed:15531764}.; BINDING 251 251 Substrate. {ECO:0000250}.								fatty acid beta-oxidation [GO:0006635]; positive regulation of cold-induced thermogenesis [GO:0120162]; protein homotetramerization [GO:0051289]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 2,4-dienoyl-CoA reductase (NADPH) activity [GO:0008670]; NADPH binding [GO:0070402]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]; fatty acid beta-oxidation [GO:0006635]; positive regulation of cold-induced thermogenesis [GO:0120162]; protein homotetramerization [GO:0051289]	2,4-dienoyl-CoA reductase (NADPH) activity [GO:0008670]; NADPH binding [GO:0070402]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]	GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006635; GO:0008670; GO:0016651; GO:0051289; GO:0070402; GO:0120162	SUBCELLULAR LOCATION: Mitochondrion.		MOD_RES 42 42 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q9CQ62}.; MOD_RES 42 42 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q9CQ62}.; MOD_RES 49 49 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q9CQ62}.; MOD_RES 49 49 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q9CQ62}.; MOD_RES 69 69 Phosphothreonine. {ECO:0000244|PubMed:24275569}.; MOD_RES 73 73 N6-succinyllysine. {ECO:0000250|UniProtKB:Q9CQ62}.; MOD_RES 97 97 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q9CQ62}.; MOD_RES 97 97 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q9CQ62}.; MOD_RES 230 230 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 244 244 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q9CQ62}.; MOD_RES 244 244 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q9CQ62}.; MOD_RES 260 260 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q9CQ62}.; MOD_RES 260 260 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q9CQ62}.; MOD_RES 319 319 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q9CQ62}.; MOD_RES 319 319 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q9CQ62}.	7818482; 9403065; 14702039; 16421571; 15489334; 19608861; 21269460; 24847004; 24275569; 25944712; 15531764; 15629123; 18193341; 18472006; 18568448; 19049547; 19773279; 20360068; 20379614; 20711500; 20877624; 21182205; 22360420; 22623428; 22810585; 23902751; 24326071; 26496610	7818482; 9403065; 14702039; 16421571; 15489334; 19608861; 21269460; 24847004; 24275569; 25944712; 15531764
5796	DNPH1 C6orf108 RCL	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=57 uM for dGMP {ECO:0000269|PubMed:24260472}; KM=97 uM for dAMP {ECO:0000269|PubMed:24260472}; KM=104 uM for dIMP {ECO:0000269|PubMed:24260472}; KM=2500 uM for dCMP {ECO:0000269|PubMed:24260472}; KM=7800 uM for dUMP {ECO:0000269|PubMed:24260472}; KM=25000 uM for dTMP {ECO:0000269|PubMed:24260472}; Note=kcat is 0.002 sec(-1) with dGMP as substrate. kcat is 0.0025 sec(-1) with dAMP as substrate. kcat is 0.0016 sec(-1) with dIMP as substrate. kcat is 0.2 sec(-1) with dUMP as substrate. kcat is 0.0083 sec(-1) with dCMP as substrate. kcat is 0.025 sec(-1) with dTMP as substrate. {ECO:0000269|PubMed:24260472};	3.2.2.-	CATALYTIC ACTIVITY: A deoxyribonucleoside 5'-monophosphate + H(2)0 = deoxyribose 5-monophosphate + a purine or pyrimidine base. {ECO:0000255|HAMAP-Rule:MF_03036, ECO:0000269|PubMed:24260472, ECO:0000269|PubMed:25108359}.	BINDING 39 39 Substrate. {ECO:0000255|HAMAP-Rule:MF_03036}.; BINDING 56 56 Substrate. {ECO:0000269|PubMed:25108359}.; BINDING 104 104 Substrate. {ECO:0000255|HAMAP-Rule:MF_03036, ECO:0000269|PubMed:25108359}.								cell proliferation [GO:0008283]; deoxyribonucleoside monophosphate catabolic process [GO:0009159]; epithelial cell differentiation [GO:0030855]; nucleoside metabolic process [GO:0009116]; positive regulation of cell growth [GO:0030307]; purine nucleotide catabolic process [GO:0006195]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; deoxyribonucleoside 5'-monophosphate N-glycosidase activity [GO:0070694]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; cell proliferation [GO:0008283]; deoxyribonucleoside monophosphate catabolic process [GO:0009159]; epithelial cell differentiation [GO:0030855]; nucleoside metabolic process [GO:0009116]; positive regulation of cell growth [GO:0030307]; purine nucleotide catabolic process [GO:0006195]	deoxyribonucleoside 5'-monophosphate N-glycosidase activity [GO:0070694]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]	GO:0005634; GO:0005829; GO:0006195; GO:0008283; GO:0009116; GO:0009159; GO:0030307; GO:0030855; GO:0042802; GO:0042803; GO:0070062; GO:0070694	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_03036, ECO:0000269|PubMed:18726892}. Nucleus {ECO:0000255|HAMAP-Rule:MF_03036}.		MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378}.; MOD_RES 28 28 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 98 98 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 123 123 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 128 128 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 138 138 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 169 169 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.	9271375; 18726892; 14574404; 15489334; 17081983; 18669648; 19413330; 19690332; 20068231; 21269460; 21406692; 22223895; 22814378; 23186163; 24260472; 24275569; 25944712; 25108359; 16189514; 17234634; 17353931; 20962348; 21044950; 21988832; 23385460; 25416956; 26496610	9271375; 18726892; 14574404; 15489334; 17081983; 18669648; 19413330; 19690332; 20068231; 21269460; 21406692; 22223895; 22814378; 23186163; 24260472; 24275569; 25944712; 25108359
5822	DDX39B BAT1 UAP56	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=3.3 uM for ATP {ECO:0000269|PubMed:17562711}; Vmax=0.126 uM/min/mg enzyme with ATP as substrate {ECO:0000269|PubMed:17562711}; 	3.6.4.13	CATALYTIC ACTIVITY: ATP + H(2)O = ADP + phosphate. {ECO:0000269|PubMed:17984224}.									liver development [GO:0001889]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of translation [GO:0045727]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; RNA export from nucleus [GO:0006405]; RNA secondary structure unwinding [GO:0010501]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]; viral mRNA export from host cell nucleus [GO:0046784]	cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; transcription export complex [GO:0000346]	cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; transcription export complex [GO:0000346]; ATP binding [GO:0005524]; ATP-dependent protein binding [GO:0043008]; ATP-dependent RNA helicase activity [GO:0004004]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]; liver development [GO:0001889]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of translation [GO:0045727]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; RNA export from nucleus [GO:0006405]; RNA secondary structure unwinding [GO:0010501]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]; viral mRNA export from host cell nucleus [GO:0046784]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent protein binding [GO:0043008]; ATP-dependent RNA helicase activity [GO:0004004]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]	GO:0000245; GO:0000346; GO:0000398; GO:0001889; GO:0003723; GO:0004004; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005730; GO:0005737; GO:0006405; GO:0006406; GO:0008186; GO:0008380; GO:0010501; GO:0016363; GO:0016607; GO:0016887; GO:0017070; GO:0030621; GO:0031124; GO:0032786; GO:0042802; GO:0043008; GO:0044877; GO:0045727; GO:0046784; GO:0061051; GO:1904707; GO:2000002; GO:2000573	SUBCELLULAR LOCATION: Nucleus. Nucleus speckle. Cytoplasm. Note=Can translocate to the cytoplasm in the presence of MX1. TREX complex assembly seems to occur in regions surrounding nuclear speckles known as perispeckles.		MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22223895}.; MOD_RES 36 36 N6-acetyllysine; alternate. {ECO:0000244|PubMed:19608861}.; MOD_RES 38 38 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 41 41 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 172 172 Phosphothreonine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.	7601445; 16702430; 14574404; 15489334; 9242493; 11675789; 12944400; 14667819; 15833825; 15998806; 15870275; 17190602; 16478985; 17562711; 17984224; 18974867; 18669648; 19413330; 19836239; 19608861; 20844015; 20068231; 21269460; 21859714; 22144908; 22223895; 22928037; 23299939; 23186163; 23222130; 24275569; 25755297; 25662211; 28112733; 15585580; 15296731; 10228171; 10323864; 10357856; 10371034; 10489353; 11073998; 11739738; 11979277; 12577067; 12871933; 14559993; 15028669; 15175163; 15324660; 15843211; 15969671; 16101831; 16169070; 16949217; 17000901; 17517687; 18240960; 18364396; 18381799; 18411249; 18593880; 18715507; 18834321; 18957205; 18987644; 19115949; 19262567; 19264631; 19403039; 19505873; 19851445; 19913121; 20116367; 20129943; 20360068; 20379614; 20453000; 20467437; 20573985; 20610707; 20628086; 20711500; 20854863; 20933106; 21147923; 21507964; 21680511; 21799930; 21947206; 22071774; 22207203; 22304920; 22446327; 22623428; 22810585; 22893130; 23084401; 23602568; 23826332; 23902751; 2408761; 24244187; 24811749; 25038626; 25836925; 25920683; 26265379; 26496610; 28025139; 28212935; 28340352; 9660949	7601445; 16702430; 14574404; 15489334; 9242493; 11675789; 12944400; 14667819; 15833825; 15998806; 15870275; 17190602; 16478985; 17562711; 17984224; 18974867; 18669648; 19413330; 19836239; 19608861; 20844015; 20068231; 21269460; 21859714; 22144908; 22223895; 22928037; 23299939; 23186163; 23222130; 24275569; 25755297; 25662211; 28112733; 15585580; 15296731
5833	DUSP13 BEDP DUSP13A MDSP	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=7.5 mM for p-nitrophenol phosphate (at pH 6.0) {ECO:0000269|PubMed:15252030}; 	3.1.3.16; 3.1.3.48	CATALYTIC ACTIVITY: Protein tyrosine phosphate + H(2)O = protein tyrosine + phosphate. {ECO:0000255|PROSITE-ProRule:PRU10044, ECO:0000305|PubMed:15252030, ECO:0000305|PubMed:29106959}.; CATALYTIC ACTIVITY: [a protein]-serine/threonine phosphate + H(2)O = [a protein]-serine/threonine + phosphate.		ACTIVITY REGULATION: Inhibited by vanadate. {ECO:0000269|PubMed:15252030}.							dephosphorylation [GO:0016311]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; dephosphorylation [GO:0016311]	phosphatase activity [GO:0016791]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine phosphatase activity [GO:0004725]	GO:0004725; GO:0005737; GO:0008138; GO:0016311; GO:0016791	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15252030}.			15252030; 14702039; 15489334; 20358250; 29106959; 16385451	15252030; 14702039; 15489334; 20358250; 29106959
5851	HSD17B12 SDR12C1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=3.5 uM for estrone {ECO:0000269|PubMed:16166196}; 	1.1.1.330; 1.1.1.62	CATALYTIC ACTIVITY: A very-long-chain (3R)-3-hydroxyacyl-CoA + NADP(+) = a very-long-chain 3-oxoacyl-CoA + NADPH. {ECO:0000269|PubMed:12482854}.; CATALYTIC ACTIVITY: 17-beta-estradiol + NAD(P)(+) = estrone + NAD(P)H. {ECO:0000269|PubMed:16166196}.	BINDING 189 189 Substrate. {ECO:0000250}.				PATHWAY: Lipid metabolism; fatty acid biosynthesis. {ECO:0000269|PubMed:12482854}.; PATHWAY: Steroid biosynthesis; estrogen biosynthesis. {ECO:0000269|PubMed:16166196}.				estrogen biosynthetic process [GO:0006703]; extracellular matrix organization [GO:0030198]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of cell-substrate adhesion [GO:0010811]	endoplasmic reticulum membrane [GO:0005789]; extracellular matrix [GO:0031012]; integral component of membrane [GO:0016021]	endoplasmic reticulum membrane [GO:0005789]; extracellular matrix [GO:0031012]; integral component of membrane [GO:0016021]; 3-oxo-arachidoyl-CoA reductase activity [GO:0102339]; 3-oxo-behenoyl-CoA reductase activity [GO:0102340]; 3-oxo-cerotoyl-CoA reductase activity [GO:0102342]; 3-oxo-lignoceroyl-CoA reductase activity [GO:0102341]; collagen binding [GO:0005518]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; estrogen biosynthetic process [GO:0006703]; extracellular matrix organization [GO:0030198]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of cell-substrate adhesion [GO:0010811]	3-oxo-arachidoyl-CoA reductase activity [GO:0102339]; 3-oxo-behenoyl-CoA reductase activity [GO:0102340]; 3-oxo-cerotoyl-CoA reductase activity [GO:0102342]; 3-oxo-lignoceroyl-CoA reductase activity [GO:0102341]; collagen binding [GO:0005518]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]	GO:0001968; GO:0004303; GO:0005518; GO:0005789; GO:0006633; GO:0006703; GO:0008201; GO:0010811; GO:0016021; GO:0016509; GO:0030198; GO:0031012; GO:0035338; GO:0102339; GO:0102340; GO:0102341; GO:0102342	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:12482854}; Multi-pass membrane protein {ECO:0000269|PubMed:12482854}.			14702039; 16554811; 15489334; 12482854; 16113833; 16166196; 20937905; 21269460; 24275569; 25944712; 16621523; 19190350; 19429442; 19460435; 19533843; 20562859; 20677014; 21409596; 21911578; 2197970; 22190034; 22593156; 22903146; 23435447; 23752268; 24058506; 25416956; 25561175; 26638075; 26752685; 29324448; 8075637; 8547185; 9536209	14702039; 16554811; 15489334; 12482854; 16113833; 16166196; 20937905; 21269460; 24275569; 25944712
5854	HSD17B2 EDH17B2 SDR9C2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.21 uM for estradiol {ECO:0000269|PubMed:8099587}; KM=0.39 uM for testosterone {ECO:0000269|PubMed:8099587}; KM=0.31 uM for dihydrotestosterone {ECO:0000269|PubMed:8099587}; KM=0.71 uM for 20-alpha-dihydroprogesterone {ECO:0000269|PubMed:8099587}; KM=0.78 uM for estrone {ECO:0000269|PubMed:8099587}; KM=2.63 uM for androstenedione {ECO:0000269|PubMed:8099587}; Vmax=38 nmol/min/mg enzyme with estradiol as substrate {ECO:0000269|PubMed:8099587}; Vmax=45 nmol/min/mg enzyme with testosterone as substrate {ECO:0000269|PubMed:8099587}; Vmax=38 nmol/min/mg enzyme with dihydrotestosterone as substrate {ECO:0000269|PubMed:8099587}; Vmax=5.6 nmol/min/mg enzyme with 20-alpha-dihydroprogesterone as substrate {ECO:0000269|PubMed:8099587}; Vmax=6.6 nmol/min/mg enzyme with estrone as substrate {ECO:0000269|PubMed:8099587}; Vmax=11.5 nmol/min/mg enzyme with androstenedione as substrate {ECO:0000269|PubMed:8099587}; 	1.1.1.62; 1.1.1.239	CATALYTIC ACTIVITY: 17-beta-estradiol + NAD(P)(+) = estrone + NAD(P)H.; CATALYTIC ACTIVITY: Testosterone + NAD(+) = androstenedione + NADH.	BINDING 219 219 Substrate. {ECO:0000250}.								estrogen biosynthetic process [GO:0006703]; in utero embryonic development [GO:0001701]; placenta development [GO:0001890]; response to retinoic acid [GO:0032526]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity [GO:0047006]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; estrogen biosynthetic process [GO:0006703]; in utero embryonic development [GO:0001701]; placenta development [GO:0001890]; response to retinoic acid [GO:0032526]	17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity [GO:0047006]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; testosterone dehydrogenase (NAD+) activity [GO:0047035]	GO:0001701; GO:0001890; GO:0004303; GO:0005789; GO:0006703; GO:0016021; GO:0032526; GO:0047006; GO:0047035	SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type II membrane protein {ECO:0000305}.			8099587; 7546291; 14702039; 15489334; 21269460; 24275569; 11940569; 12161528; 12957669; 14634838; 14666693; 15199113; 16595205; 16807381; 16954436; 17260097; 17505937; 17507624; 17510238; 17953976; 17993718; 18348690; 18372405; 18510611; 18636124; 18676680; 18794456; 18980759; 18984855; 18996480; 19401349; 19415745; 19453261; 19556422; 19574343; 19598235; 19625176; 19692168; 19729830; 19797119; 20148360; 20200332; 20214802; 20379614; 20453000; 20634197; 20734064; 21365123; 21877158; 21900597; 22546946; 24560990; 24563232; 24682418; 24938708; 25776474; 25929810; 26123590; 26228249; 26230928; 26323233; 9783542	8099587; 7546291; 14702039; 15489334; 21269460; 24275569
5855	DHRS11 SDR24C1 UNQ836/PRO1774	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.1 uM for NADPH {ECO:0000269|PubMed:26920053}; KM=0.7 uM for estrone (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; KM=1.3 uM for 5-alpha-androstan-3-alpha-ol-17-one (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; KM=2.2 uM for 5-alpha-androstan-3-beta-ol-17-one (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; KM=11 uM for dehydroepiandrosterone (DHEA) (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; KM=12 uM for DHEA sulfate (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; KM=19 uM for 4-androsten-3-alpha-ol-17-one (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; KM=0.7 uM for 5-beta-pregnan-20-beta-ol-3-one (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; KM=1.1 uM for dehydrolithocholic acid (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; KM=5.2 uM for 5-beta-cholanic acid-3,7-dione (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; KM=5.1 uM for 20-alpha-hydroxyprogesterone (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; KM=44 uM for taurodehydrocholic acid (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; KM=29 uM for dehydrocholic acid (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; KM=102 uM for 5-beta-dihydrotestosterone (DHT) (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; KM=5.2 uM for 5-beta-androstane-3,17-dione (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; KM=4.6 uM for 4-androstene-3,17-dione (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; KM=12 uM for 5-alpha-androstane-3,17-dione (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; KM=2.1 uM for 5-beta-pregnane-21-ol-3,20-dione (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; KM=3.4 uM for progesterone (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; KM=15 uM for 5-beta-pregnane-3,20-dione (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; KM=16 uM for 17-beta-estradiol (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; KM=30 uM for testosterone (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; KM=23 uM for 4-androstene-3-alpha,17-beta-diol (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; KM=11 uM for 5-androstene-3-alpha,17-beta-diol (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; KM=26 uM for 5-alpha-dihydrotestosterone (DHT) (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; KM=9.2 uM for 5-alpha-androstane-3-alpha,17-beta-diol (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; KM=1.1 uM for 5-alpha-androstane-3-beta,17-beta-diol (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; KM=36 uM for 5-beta-androstan-3-beta-ol-17-one (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; KM=12 uM for 5-beta-androstane-3-beta,17-beta-diol (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; KM=22 uM for 3-beta-hydroxyprogesterone (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; KM=36 uM for 5-beta-pregnan-3-beta-ol-20-one (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; KM=14 uM for 5-beta-pregnane-3-beta,20-beta-diol (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; KM=4.7 uM for 5-beta-pregnane-3-beta,21-diol-20-one (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; KM=0.4 uM for isolithocholic acid (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; KM=60 uM for 1-phenyl-1,2-propanedione (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; KM=620 uM for 2,3-hexanedione (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; KM=201 uM for 2,3-heptanedione (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; KM=420 uM for 3,4-hexanedione (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; KM=178 uM for alpha-tetralone (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; KM=740 uM for loxoprofen (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; Vmax=43 nmol/min/mg enzyme with estrone as substrate (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; Vmax=42 nmol/min/mg enzyme with 5-alpha-androstan-3-alpha-ol-17-one as substrate (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; Vmax=49 nmol/min/mg enzyme with 5-alpha-androstan-3-beta-ol-17-one as substrate (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; Vmax=118 nmol/min/mg enzyme with dehydroepiandrosterone (DHEA) as substrate (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; Vmax=60 nmol/min/mg enzyme with DHEA sulfate as substrate (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; Vmax=43 nmol/min/mg enzyme with 4-androsten-3-alpha-ol-17-one as substrate (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; Vmax=44 nmol/min/mg enzyme with 5-beta-pregnan-20-beta-ol-3-one as substrate (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; Vmax=44 nmol/min/mg enzyme with dehydrolithocholic acid as substrate (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; Vmax=85 nmol/min/mg enzyme with 5-beta-cholanic acid-3,7-dione as substrate (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; Vmax=40 nmol/min/mg enzyme with 20-alpha-hydroxyprogesterone as substrate (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; Vmax=200 nmol/min/mg enzyme with taurodehydrocholic acid as substrate (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; Vmax=119 nmol/min/mg enzyme with dehydrocholic acid as substrate (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; Vmax=389 nmol/min/mg enzyme with 5-beta-dihydrotestosterone (DTH) as substrate (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; Vmax=62 nmol/min/mg enzyme with 5-beta-androstane-3,17-dione as substrate (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; Vmax=52 nmol/min/mg enzyme with 4-androstene-3,17-dione as substrate (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; Vmax=57 nmol/min/mg enzyme with 5-alpha-androstane-3,17-dione as substrate (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; Vmax=49 nmol/min/mg enzyme with 5-beta-pregnane-21-ol-3,20-dione as substrate (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; Vmax=36 nmol/min/mg enzyme with progesterone as substrate (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; Vmax=123 nmol/min/mg enzyme with 5-beta-pregnane-3,20-dione as substrate (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; Vmax=246 nmol/min/mg enzyme with 17-beta-estradiol as substrate (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; Vmax=238 nmol/min/mg enzyme with testosterone as substrate (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; Vmax=33 nmol/min/mg enzyme with 4-androstene-3-alpha,17-beta-diol as substrate (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; Vmax=366 nmol/min/mg enzyme with 5-androstene-3-alpha,17-beta-diol as substrate (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; Vmax=117 nmol/min/mg enzyme with 5-alpha-dihydrotestosterone (DHT) as substrate (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; Vmax=40 nmol/min/mg enzyme with 5-alpha-androstane-3-alpha,17-beta-diol as substrate (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; Vmax=96 nmol/min/mg enzyme with 5-alpha-androstane-3-beta,17-beta-diol as substrate (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; Vmax=137 nmol/min/mg enzyme with 5-beta-androstan-3-beta-ol-17-one as substrate (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; Vmax=511 nmol/min/mg enzyme with 5-beta-androstane-3-beta,17-beta-diol as substrate (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; Vmax=364 nmol/min/mg enzyme with 3-beta-hydroxyprogesterone as substrate (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; Vmax=268 nmol/min/mg enzyme with 5-beta-pregnan-3-beta-ol-20-one as substrate (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; Vmax=220 nmol/min/mg enzyme with 5-beta-pregnane-3-beta,20-beta-diol as substrate (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; Vmax=96 nmol/min/mg enzyme with 5-beta-pregnane-3-beta,21-diol-20-one as substrate (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; Vmax=28 nmol/min/mg enzyme with isolithocholic acid as substrate (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; Vmax=69 nmol/min/mg enzyme with 1-phenyl-1,2-propanedione as substrate (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; Vmax=331 nmol/min/mg enzyme with 2,3-hexanedione as substrate (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; Vmax=86 nmol/min/mg enzyme with 2,3-heptanedione as substrate (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; Vmax=166 nmol/min/mg enzyme with 3,4-hexanedione as substrate (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; Vmax=67 nmol/min/mg enzyme with alpha-tetralone as substrate (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; Vmax=51 nmol/min/mg enzyme with loxoprofen as substrate (at 37 degrees Celsius) {ECO:0000269|PubMed:26920053}; 	1.1.1.270; 1.1.1.62	CATALYTIC ACTIVITY: A 3-beta-hydroxysteroid + NADP(+) = a 3-oxosteroid + NADPH. {ECO:0000269|PubMed:26920053}.; CATALYTIC ACTIVITY: 17-beta-estradiol + NAD(P)(+) = estrone + NAD(P)H. {ECO:0000269|PubMed:26920053}.	BINDING 49 49 NADP. {ECO:0000244|PDB:1XG5}.; BINDING 97 97 NADP; via carbonyl oxygen. {ECO:0000244|PDB:1XG5}.; BINDING 151 151 Substrate. {ECO:0000244|PDB:1XG5}.; BINDING 166 166 NADP. {ECO:0000244|PDB:1XG5}.; BINDING 166 166 Substrate. {ECO:0000244|PDB:1XG5}.; BINDING 170 170 NADP. {ECO:0000244|PDB:1XG5}.; BINDING 208 208 NADP. {ECO:0000244|PDB:1XG5}.	ACTIVITY REGULATION: Inhibited by flavonoids including apigenin, luteolin, genistein, kaempferol and quercetin and also by carbenoxolone, zearalenone, glycyrrhetinic, curcumin and flufenamic acid. {ECO:0000269|PubMed:26920053}.			PATHWAY: Steroid biosynthesis; estrogen biosynthesis. {ECO:0000305|PubMed:26920053}.		UNQ836/PRO1774		estrogen biosynthetic process [GO:0006703]; steroid biosynthetic process [GO:0006694]	extracellular region [GO:0005576]	extracellular region [GO:0005576]; 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; 17-beta-ketosteroid reductase activity [GO:0072555]; 3-keto sterol reductase activity [GO:0000253]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; nucleotide binding [GO:0000166]; estrogen biosynthetic process [GO:0006703]; steroid biosynthetic process [GO:0006694]	17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; 17-beta-ketosteroid reductase activity [GO:0072555]; 3-keto sterol reductase activity [GO:0000253]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; nucleotide binding [GO:0000166]	GO:0000166; GO:0000253; GO:0004303; GO:0005576; GO:0006694; GO:0006703; GO:0072555; GO:0072582	SUBCELLULAR LOCATION: Secreted {ECO:0000305}.				26920053; 12975309; 14702039; 15489334; 21269460; 19027726
5875	HSD17B4 EDH17B4 SDR8C1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=10 uM for D-3-hydroxy-octanoyl-CoA {ECO:0000269|PubMed:9089413}; KM=13 uM for NAD {ECO:0000269|PubMed:9089413}; KM=2.7 uM for 3-ketooctanoyl-CoA {ECO:0000269|PubMed:9089413}; KM=5.4 uM for NADH {ECO:0000269|PubMed:9089413}; Vmax=8.8 umol/min/mg enzyme {ECO:0000269|PubMed:9089413}; 	1.1.1.n12; 4.2.1.107; 4.2.1.119	CATALYTIC ACTIVITY: (R)-3-hydroxyacyl-CoA + NAD(+) = 3-oxoacyl-CoA + NADH. {ECO:0000269|PubMed:9089413}.; CATALYTIC ACTIVITY: (24R,25R)-3-alpha,7-alpha,12-alpha,24-tetrahydroxy-5-beta-cholestanoyl-CoA = (24E)-3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA + H(2)O. {ECO:0000269|PubMed:9089413}.; CATALYTIC ACTIVITY: (3R)-3-hydroxyacyl-CoA = (2E)-2-enoyl-CoA + H(2)O. {ECO:0000269|PubMed:9089413}.	BINDING 21 21 NAD; via amide nitrogen.; BINDING 40 40 NAD.; BINDING 99 99 NAD; via carbonyl oxygen.; BINDING 151 151 Substrate. {ECO:0000250}.; BINDING 435 435 (3R)-3-hydroxydecanoyl-CoA. {ECO:0000250}.; BINDING 533 533 (3R)-3-hydroxydecanoyl-CoA; via amide nitrogen. {ECO:0000250}.; BINDING 563 563 (3R)-3-hydroxydecanoyl-CoA; via carbonyl oxygen. {ECO:0000250}.; BINDING 706 706 Substrate.; BINDING 724 724 Substrate.				PATHWAY: Lipid metabolism; fatty acid beta-oxidation.				alpha-linolenic acid metabolic process [GO:0036109]; androgen metabolic process [GO:0008209]; bile acid biosynthetic process [GO:0006699]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; medium-chain fatty-acyl-CoA metabolic process [GO:0036112]; osteoblast differentiation [GO:0001649]; protein targeting to peroxisome [GO:0006625]; very long-chain fatty-acyl-CoA metabolic process [GO:0036111]	cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity [GO:0033989]; isomerase activity [GO:0016853]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; alpha-linolenic acid metabolic process [GO:0036109]; androgen metabolic process [GO:0008209]; bile acid biosynthetic process [GO:0006699]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; medium-chain fatty-acyl-CoA metabolic process [GO:0036112]; osteoblast differentiation [GO:0001649]; protein targeting to peroxisome [GO:0006625]; very long-chain fatty-acyl-CoA metabolic process [GO:0036111]	17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity [GO:0033989]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; isomerase activity [GO:0016853]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]	GO:0001649; GO:0003857; GO:0005102; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006625; GO:0006635; GO:0006699; GO:0008209; GO:0008210; GO:0016020; GO:0016508; GO:0016853; GO:0033540; GO:0033989; GO:0036109; GO:0036111; GO:0036112; GO:0042803; GO:0044594	SUBCELLULAR LOCATION: Peroxisome.		MOD_RES 46 46 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:P51660}.; MOD_RES 46 46 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:P51660}.; MOD_RES 52 52 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 57 57 N6-succinyllysine. {ECO:0000250|UniProtKB:P51660}.; MOD_RES 68 68 N6-succinyllysine. {ECO:0000250|UniProtKB:P51660}.; MOD_RES 84 84 N6-succinyllysine. {ECO:0000250|UniProtKB:P51660}.; MOD_RES 265 265 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 275 275 N6-succinyllysine. {ECO:0000250|UniProtKB:P51660}.; MOD_RES 304 304 Phosphoserine. {ECO:0000244|PubMed:19369195}.; MOD_RES 309 309 Phosphoserine. {ECO:0000244|PubMed:19369195}.; MOD_RES 356 356 N6-succinyllysine. {ECO:0000250|UniProtKB:P51660}.; MOD_RES 424 424 N6-succinyllysine. {ECO:0000250|UniProtKB:P51660}.; MOD_RES 565 565 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 579 579 N6-succinyllysine. {ECO:0000250|UniProtKB:P51660}.; MOD_RES 663 663 N6-succinyllysine. {ECO:0000250|UniProtKB:P51660}.; MOD_RES 669 669 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 707 707 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 725 725 N6-succinyllysine. {ECO:0000250|UniProtKB:P51660}.	7487879; 9089413; 9880674; 14702039; 15372022; 15489334; 8902629; 10671535; 19369195; 19690332; 19608861; 21269460; 23186163; 24275569; 25944712; 11700068; 15644212; 9482850; 10400999; 11743515; 20673864; 25956234; 11500517; 11734571; 14743216; 16385454; 16766224; 17220478; 17353931; 18086758; 18281655; 18415690; 18676680; 18794456; 19100308; 19170196; 19453261; 19463016; 19574343; 19598235; 19625176; 19627379; 19692168; 19722192; 19776291; 19913121; 20214802; 20453000; 20562859; 20566640; 20628086; 20634197; 20711500; 20734064; 20877624; 20949532; 21150319; 21525035; 21988832; 22002062; 22265031; 22575643; 23181892; 23308274; 23313254; 23663784; 23902751; 24189400; 25448063; 25609649; 26058080; 26496610; 26638075; 26970254; 28186977; 28296597; 28830375; 8656081	7487879; 9089413; 9880674; 14702039; 15372022; 15489334; 8902629; 10671535; 19369195; 19690332; 19608861; 21269460; 23186163; 24275569; 25944712; 11700068; 15644212; 9482850; 10400999; 11743515; 20673864; 25956234
5959	DUT	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=2.5 uM for dUTP {ECO:0000269|PubMed:8631816}; Note=for both isoform 2 and isoform 3.;	3.6.1.23	CATALYTIC ACTIVITY: dUTP + H(2)O = dUMP + diphosphate. {ECO:0000269|PubMed:8805593}.	BINDING 198 198 Substrate; via amide nitrogen and carbonyl oxygen. {ECO:0000269|PubMed:8805593}.; BINDING 241 241 Substrate. {ECO:0000250}.	ACTIVITY REGULATION: Phosphorylation is necessary for activity.	COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:8805593}; 		PATHWAY: Pyrimidine metabolism; dUMP biosynthesis; dUMP from dCTP (dUTP route): step 2/2.				DNA replication [GO:0006260]; dUMP biosynthetic process [GO:0006226]; dUTP catabolic process [GO:0046081]; nucleobase-containing compound metabolic process [GO:0006139]; nucleobase-containing small molecule interconversion [GO:0015949]	extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; dUTP diphosphatase activity [GO:0004170]; magnesium ion binding [GO:0000287]; RNA binding [GO:0003723]; DNA replication [GO:0006260]; dUMP biosynthetic process [GO:0006226]; dUTP catabolic process [GO:0046081]; nucleobase-containing compound metabolic process [GO:0006139]; nucleobase-containing small molecule interconversion [GO:0015949]	dUTP diphosphatase activity [GO:0004170]; magnesium ion binding [GO:0000287]; RNA binding [GO:0003723]	GO:0000287; GO:0003723; GO:0004170; GO:0005634; GO:0005654; GO:0005739; GO:0006139; GO:0006226; GO:0006260; GO:0015949; GO:0046081; GO:0070062	SUBCELLULAR LOCATION: Isoform 2: Nucleus {ECO:0000269|PubMed:8631816, ECO:0000269|PubMed:9070952}.; SUBCELLULAR LOCATION: Isoform 3: Mitochondrion {ECO:0000269|PubMed:8631816, ECO:0000269|PubMed:9070952}.	PTM: Nuclear isoform 2 is phosphorylated in vivo on Ser-11, a reaction that can be catalyzed in vitro by CDC2. Phosphorylation in mature T-cells occurs in a cell cycle-dependent manner. Isoform 3 is not phosphorylated. {ECO:0000269|PubMed:8389461}.	MOD_RES 88 88 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 99 99 Phosphoserine. {ECO:0000244|PubMed:23186163}.	8631816; 9070952; 9228092; 14702039; 15489334; 1325640; 8389461; 8631817; 17081983; 16964243; 18669648; 20068231; 21269460; 21406692; 23186163; 24275569; 25944712; 8805593; 17880943; 12096336; 12577067; 12799180; 16189514; 16325515; 17353931; 17848562; 18234856; 18464913; 19015155; 19060904; 19302784; 19403629; 19637314; 19879316; 19968781; 20560137; 20562859; 20711500; 20877624; 21780905; 22172489; 22339362; 22404301; 23871696; 23894549; 24311590; 28073829; 29748212	8631816; 9070952; 9228092; 14702039; 15489334; 1325640; 8389461; 8631817; 17081983; 16964243; 18669648; 20068231; 21269460; 21406692; 23186163; 24275569; 25944712; 8805593; 17880943
6025	IMPDH2 IMPD2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=9.3 uM for Inosine 5'-phosphate {ECO:0000269|PubMed:7763314, ECO:0000269|PubMed:7903306}; KM=32 uM for NAD(+) {ECO:0000269|PubMed:7763314, ECO:0000269|PubMed:7903306}; 	1.1.1.205	CATALYTIC ACTIVITY: Inosine 5'-phosphate + NAD(+) + H(2)O = xanthosine 5'-phosphate + NADH. {ECO:0000255|HAMAP-Rule:MF_03156}.	BINDING 329 329 IMP. {ECO:0000255|HAMAP-Rule:MF_03156}.; BINDING 441 441 IMP. {ECO:0000255|HAMAP-Rule:MF_03156}.	ACTIVITY REGULATION: Mycophenolic acid (MPA) is a non-competitive inhibitor that prevents formation of the closed enzyme conformation by binding to the same site as the amobile flap. In contrast, mizoribine monophosphate (MZP) is a competitive inhibitor that induces the closed conformation. MPA is a potent inhibitor of mammalian IMPDHs but a poor inhibitor of the bacterial enzymes. MZP is a more potent inhibitor of bacterial IMPDH. Subject to product inhibition by XMP and NADH. Also inhibited by ADP. {ECO:0000255|HAMAP-Rule:MF_03156, ECO:0000269|PubMed:7903306}.	COFACTOR: Name=K(+); Xref=ChEBI:CHEBI:29103; 		PATHWAY: Purine metabolism; XMP biosynthesis via de novo pathway; XMP from IMP: step 1/1. {ECO:0000255|HAMAP-Rule:MF_03156}.				cellular response to interleukin-4 [GO:0071353]; circadian rhythm [GO:0007623]; GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183]; lymphocyte proliferation [GO:0046651]; neutrophil degranulation [GO:0043312]; protein homotetramerization [GO:0051289]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; retina development in camera-type eye [GO:0060041]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; secretory granule lumen [GO:0034774]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; secretory granule lumen [GO:0034774]; DNA binding [GO:0003677]; IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; cellular response to interleukin-4 [GO:0071353]; circadian rhythm [GO:0007623]; GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183]; lymphocyte proliferation [GO:0046651]; neutrophil degranulation [GO:0043312]; protein homotetramerization [GO:0051289]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; retina development in camera-type eye [GO:0060041]	DNA binding [GO:0003677]; IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]	GO:0000166; GO:0003677; GO:0003723; GO:0003938; GO:0005576; GO:0005634; GO:0005737; GO:0005778; GO:0005829; GO:0006177; GO:0006183; GO:0007623; GO:0009168; GO:0016020; GO:0034774; GO:0043312; GO:0046651; GO:0046872; GO:0051289; GO:0060041; GO:0070062; GO:0071353; GO:1904813	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_03156, ECO:0000269|PubMed:14766016}. Nucleus {ECO:0000255|HAMAP-Rule:MF_03156, ECO:0000269|PubMed:14766016}.	PTM: The N-terminus is blocked.; PTM: Acetylated by CLOCK in a circadian manner (PubMed:28985504). {ECO:0000269|PubMed:28985504}.	MOD_RES 122 122 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 160 160 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 400 400 Phosphotyrosine. {ECO:0000244|PubMed:15592455}.; MOD_RES 416 416 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 511 511 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.	2902093; 1969416; 7999076; 7896827; 15489334; 8098009; 7903306; 7763314; 14766016; 15592455; 17081983; 17496727; 18669648; 19413330; 19608861; 20068231; 21269460; 23186163; 24275569; 25944712; 28985504; 28112733; 10097070; 12577067; 15140983; 15383276; 15621150; 16713569; 17342744; 17353931; 17660802; 17713475; 18043470; 18444945; 18583139; 18677108; 18847512; 18976158; 19367581; 19597826; 19617864; 19738201; 19770842; 19810816; 20045992; 20061166; 20135634; 20562859; 20679962; 20718729; 20808934; 21181270; 21460227; 21525035; 21911578; 21996196; 22066532; 22928911; 23602568; 23606334; 23650620; 23902751; 24477477; 24659377; 24980853; 25105143; 25392102; 25416956; 25465060; 25604459; 25609649; 26496610; 26638075; 27343244; 27378425; 28076787; 28389646	2902093; 1969416; 7999076; 7896827; 15489334; 8098009; 7903306; 7763314; 14766016; 15592455; 17081983; 17496727; 18669648; 19413330; 19608861; 20068231; 21269460; 23186163; 24275569; 25944712; 28985504; 28112733; 10097070; 
6111	INMT	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=2.9 mM for tryptamine {ECO:0000269|PubMed:10552930}; 	2.1.1.49; 2.1.1.96	CATALYTIC ACTIVITY: S-adenosyl-L-methionine + an amine = S-adenosyl-L-homocysteine + a methylated amine. {ECO:0000269|PubMed:10552930}.; CATALYTIC ACTIVITY: S-adenosyl-L-methionine + dimethyl sulfide = S-adenosyl-L-homocysteine + trimethylsulfonium. {ECO:0000269|PubMed:10552930}.	BINDING 20 20 S-adenosyl-L-methionine.; BINDING 25 25 S-adenosyl-L-methionine.; BINDING 63 63 S-adenosyl-L-methionine; via carbonyl oxygen.; BINDING 69 69 S-adenosyl-L-methionine.; BINDING 90 90 S-adenosyl-L-methionine.; BINDING 163 163 S-adenosyl-L-methionine; via carbonyl oxygen.								amine metabolic process [GO:0009308]; methylation [GO:0032259]; response to toxic substance [GO:0009636]	cytosol [GO:0005829]	cytosol [GO:0005829]; amine N-methyltransferase activity [GO:0030748]; S-adenosyl-L-methionine:beta-alanine N-methyltransferase activity [GO:0102707]; thioether S-methyltransferase activity [GO:0004790]; amine metabolic process [GO:0009308]; methylation [GO:0032259]; response to toxic substance [GO:0009636]	amine N-methyltransferase activity [GO:0030748]; S-adenosyl-L-methionine:beta-alanine N-methyltransferase activity [GO:0102707]; thioether S-methyltransferase activity [GO:0004790]	GO:0004790; GO:0005829; GO:0009308; GO:0009636; GO:0030748; GO:0032259; GO:0102707	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.		MOD_RES 13 13 N6-succinyllysine. {ECO:0000250|UniProtKB:P40936}.; MOD_RES 96 96 N6-succinyllysine. {ECO:0000250|UniProtKB:P40936}.	10552930; 14702039; 12853948; 15489334; 15014171; 19913121; 20628086; 25416956; 26183064; 26537946; 3350800	10552930; 14702039; 12853948; 15489334; 15014171; 
6112	INO80 INO80A INOC1 KIAA1259	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=167 uM for ATP {ECO:0000269|PubMed:16298340}; 	3.6.4.-	CATALYTIC ACTIVITY: ATP + H(2)O = ADP + phosphate. {ECO:0000269|PubMed:16298340, ECO:0000269|PubMed:21303910}.		ACTIVITY REGULATION: Activated upon binding to double stranded DNA or nucleosomes. {ECO:0000269|PubMed:16298340, ECO:0000269|PubMed:21303910}.		BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 7. {ECO:0000269|PubMed:16298340};				BIOPHYSICOCHEMICAL PROPERTIES: ;  Temperature dependence: Optimum temperature is 37 degrees Celsius. {ECO:0000269|PubMed:16298340};	cell division [GO:0051301]; cellular response to ionizing radiation [GO:0071479]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; mitotic sister chromatid segregation [GO:0000070]; positive regulation of cell growth [GO:0030307]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; spindle assembly [GO:0051225]; transcription, DNA-templated [GO:0006351]; UV-damage excision repair [GO:0070914]	cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; intermediate filament cytoskeleton [GO:0045111]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]	cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; intermediate filament cytoskeleton [GO:0045111]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; cell division [GO:0051301]; cellular response to ionizing radiation [GO:0071479]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; mitotic sister chromatid segregation [GO:0000070]; positive regulation of cell growth [GO:0030307]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; spindle assembly [GO:0051225]; transcription, DNA-templated [GO:0006351]; UV-damage excision repair [GO:0070914]	actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]	GO:0000070; GO:0000724; GO:0003677; GO:0003779; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0005874; GO:0005886; GO:0006302; GO:0006338; GO:0006351; GO:0008094; GO:0010571; GO:0016579; GO:0016604; GO:0030307; GO:0031011; GO:0034644; GO:0043014; GO:0045111; GO:0045944; GO:0051225; GO:0051301; GO:0070914; GO:0071479; GO:2000045	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:20237820}. Nucleus {ECO:0000255|PROSITE-ProRule:PRU00746, ECO:0000269|PubMed:16298340, ECO:0000269|PubMed:18026119, ECO:0000269|PubMed:20237820, ECO:0000269|PubMed:20971067}. Cytoplasm, cytoskeleton, spindle {ECO:0000269|PubMed:20237820}. Chromosome {ECO:0000269|PubMed:20237820}. Note=Localizes to the cytoplasm in quiescent cell (PubMed:20237820). Associates with spindle microtubules during mitosis (PubMed:20237820). Colocalizes with PCNA at replication forks during S-phase (PubMed:20237820). Recruited to DNA damage sites in a ACTR8-dependent manner (PubMed:20971067). {ECO:0000269|PubMed:20237820, ECO:0000269|PubMed:20971067}.		MOD_RES 118 118 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 1512 1512 Phosphoserine. {ECO:0000244|PubMed:18669648}.	10574462; 15489334; 17974005; 16230350; 16298340; 17721549; 18026119; 18922472; 18669648; 19690332; 19608861; 20971067; 20687897; 20237820; 20855601; 21303910; 27939641; 10391953; 12732143; 12944386; 14742321; 15811629; 15882621; 16223728; 16906146; 17882165; 19014934; 19109893; 19609301; 21135142; 21388382; 24145797; 26496610; 29643506	10574462; 15489334; 17974005; 16230350; 16298340; 17721549; 18026119; 18922472; 18669648; 19690332; 19608861; 20971067; 20687897; 20237820; 20855601; 21303910; 27939641
6113	ISYNA1 INO1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.57 mM for 6-phosphate {ECO:0000269|PubMed:15024000}; KM=8 uM for NAD {ECO:0000269|PubMed:15024000}; 	5.5.1.4	CATALYTIC ACTIVITY: D-glucose 6-phosphate = 1D-myo-inositol 3-phosphate. {ECO:0000269|PubMed:15024000}.		ACTIVITY REGULATION: Inhibited by mood-stabilizing drugs such as valproate (VPA) and lithium. {ECO:0000269|PubMed:17901568, ECO:0000269|PubMed:17988368}.	COFACTOR: Name=NAD(+); Xref=ChEBI:CHEBI:57540; Evidence={ECO:0000269|PubMed:15024000}; 	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 8.0. {ECO:0000269|PubMed:15024000};	PATHWAY: Polyol metabolism; myo-inositol biosynthesis; myo-inositol from D-glucose 6-phosphate: step 1/2.				inositol biosynthetic process [GO:0006021]; inositol phosphate metabolic process [GO:0043647]; phospholipid biosynthetic process [GO:0008654]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; inositol-3-phosphate synthase activity [GO:0004512]; inositol biosynthetic process [GO:0006021]; inositol phosphate metabolic process [GO:0043647]; phospholipid biosynthetic process [GO:0008654]	inositol-3-phosphate synthase activity [GO:0004512]	GO:0004512; GO:0005737; GO:0005829; GO:0006021; GO:0008654; GO:0043647	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.			12941308; 17121280; 14702039; 17974005; 15057824; 15489334; 15464731; 15024000; 17988368; 17901568; 21269460; 16169070; 17353931; 19369418; 20711500; 21044950; 21988832; 22810585; 25416956	12941308; 17121280; 14702039; 17974005; 15057824; 15489334; 15464731; 15024000; 17988368; 17901568; 21269460
6127	IMPA2 IMP.18P	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=5 mM for myo-inositol 1-monophosphate {ECO:0000269|PubMed:17068342}; 	3.1.3.25	CATALYTIC ACTIVITY: Myo-inositol phosphate + H(2)O = myo-inositol + phosphate.	BINDING 81 81 Substrate. {ECO:0000269|PubMed:17340635}.; BINDING 224 224 Substrate. {ECO:0000269|PubMed:17340635}.; BINDING 231 231 Substrate. {ECO:0000250}.	ACTIVITY REGULATION: Inhibited by high Li(+) and restricted Mg(2+) concentrations. {ECO:0000269|PubMed:15504365, ECO:0000269|PubMed:17068342}.	COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:17068342}; 	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 7.5-8.0. {ECO:0000269|PubMed:17068342};	PATHWAY: Polyol metabolism; myo-inositol biosynthesis; myo-inositol from D-glucose 6-phosphate: step 2/2.				inositol biosynthetic process [GO:0006021]; inositol metabolic process [GO:0006020]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; phosphate-containing compound metabolic process [GO:0006796]; phosphatidylinositol phosphorylation [GO:0046854]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; inositol biosynthetic process [GO:0006021]; inositol metabolic process [GO:0006020]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; phosphate-containing compound metabolic process [GO:0006796]; phosphatidylinositol phosphorylation [GO:0046854]; signal transduction [GO:0007165]	inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]	GO:0005737; GO:0005829; GO:0006020; GO:0006021; GO:0006796; GO:0007165; GO:0008934; GO:0042803; GO:0043647; GO:0046854; GO:0046855; GO:0046872; GO:0052832; GO:0052833				9322233; 10822345; 15489334; 15504365; 17068342; 21269460; 17340635; 11317223; 1377913; 14624008; 14699425; 15505643; 15557493; 16169070; 17251911; 17388992; 17434096; 19066393; 19910543; 20153384; 20398908; 20711500; 20800640; 21213002; 21900206; 23414517; 23453640; 25416956; 27661109; 27748550; 29499505	9322233; 10822345; 15489334; 15504365; 17068342; 21269460; 17340635; 
6142	IDH3A	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: Vmax=20.0 umol/min/mg enzyme with isocitrate as substrate (heterotetramer) {ECO:0000269|PubMed:28139779}; Vmax=10.9 umol/min/mg enzyme with isocitrate as substrate (heterodimer composed of IDH3A and IDH3B subunits) {ECO:0000269|PubMed:28139779}; Vmax=7.29 umol/min/mg enzyme with isocitrate as substrate (heterodimer composed of IDH3A and IDH3G subunits) {ECO:0000269|PubMed:28139779}; Vmax=20.7 umol/min/mg enzyme with isocitrate as substrate in the presence of citrate (heterotetramer) {ECO:0000269|PubMed:28139779}; Vmax=11.2 umol/min/mg enzyme with isocitrate as substrate in the presence of citrate (heterodimer composed of IDH3A and IDH3B subunits) {ECO:0000269|PubMed:28139779}; Vmax=10.0 umol/min/mg enzyme with isocitrate as substrate in the presence of citrate (heterodimer composed of IDH3A and IDH3G subunits) {ECO:0000269|PubMed:28139779}; Vmax=22.1 umol/min/mg enzyme with isocitrate as substrate in the presence of ADP (heterotetramer) {ECO:0000269|PubMed:28139779}; Vmax=11.2 umol/min/mg enzyme with isocitrate as substrate in the presence of ADP (heterodimer composed of IDH3A and IDH3B subunits) {ECO:0000269|PubMed:28139779}; Vmax=9.42 umol/min/mg enzyme with isocitrate as substrate in the presence of ADP (heterodimer composed of IDH3A and IDH3G subunits) {ECO:0000269|PubMed:28139779}; Vmax=21.3 umol/min/mg enzyme with isocitrate as substrate in the presence of citrate and ADP (heterotetramer) {ECO:0000269|PubMed:28139779}; Vmax=11.9 umol/min/mg enzyme with isocitrate as substrate in the presence of citrate and ADP (heterodimer composed of IDH3A and IDH3B subunits) {ECO:0000269|PubMed:28139779}; Vmax=13.1 umol/min/mg enzyme with isocitrate as substrate in the presence of citrate and ADP (heterodimer composed of IDH3A and IDH3G subunits) {ECO:0000269|PubMed:28139779}; Vmax=17.7 umol/min/mg enzyme with isocitrate as substrate in the presence of ATP (heterotetramer) {ECO:0000269|PubMed:28139779}; Vmax=6.62 umol/min/mg enzyme with isocitrate as substrate in the presence ATP (heterodimer composed of IDH3A and IDH3G subunits) {ECO:0000269|PubMed:28139779}; Vmax=17.6 umol/min/mg enzyme with isocitrate as substrate in the presence of citrate and ATP (heterotetramer) {ECO:0000269|PubMed:28139779}; Vmax=8.94 umol/min/mg enzyme with isocitrate as substrate in the presence of citrate and ATP (heterodimer composed of IDH3A and IDH3G subunits) {ECO:0000269|PubMed:28139779}; Note=kcat is 26.7 sec(-1) for the heterotetramer with isocitrate as substrate. kcat is 14.6 sec(-1) for the heterodimer composed of IDH3A and IDH3B subunits with isocitrate as substrate. kcat is 9.72 sec(-1) for the heterodimer composed of IDH3A and IDH3G subunits with isocitrate as substrate. kcat is 23.4 sec(-1) for the heterotetramer with isocitrate as substrate in the presence of citrate and ATP. kcat is 11.9 sec(-1) for the heterodimer composed of IDH3A and IDH3G subunits with isocitrate as substrate in the presence of citrate and ATP. kcat is 28.4 sec(-1) for the heterotetramer with isocitrate as substrate in the presence of citrate and ADP. kcat is 15.8 sec(-1) for the heterodimer composed of IDH3A and IDH3B subunits with isocitrate as substrate in the presence of citrate and ADP. kcat is 17.6 sec(-1) for the heterodimer composed of IDH3A and IDH3G subunits with isocitrate as substrate in the presence of citrate and ADP. {ECO:0000269|PubMed:28139779};	1.1.1.41	CATALYTIC ACTIVITY: Isocitrate + NAD(+) = 2-oxoglutarate + CO(2) + NADH. {ECO:0000269|PubMed:28098230, ECO:0000269|PubMed:28139779}.	BINDING 115 115 Substrate. {ECO:0000269|PubMed:28098230}.; BINDING 125 125 Substrate. {ECO:0000269|PubMed:28098230}.; BINDING 146 146 Substrate. {ECO:0000269|PubMed:28098230}.	ACTIVITY REGULATION: The heterotetramer and the heterodimer composed of IDH3A and IDH3G subunits can be allosterically activated by citrate (CIT) or/and ADP, and the two activators can act independently or synergistically. The heterodimer composed of IDH3A and IDH3B subunits cannot be allosterically regulated and the allosteric regulation of the heterotetramer is through the IDH3G subunit and not the IDH3B subunit. The IDH3G subunit contains the allosteric site which consists of a CIT-binding site and an ADP-binding site, and the binding of CIT and ADP causes conformational changes at the allosteric site which are transmitted to the active site in the catalytic subunit (IDH3A) through a cascade of conformational changes at the heterodimer interface, leading to stabilization of the isocitrate-binding at the active site and thus activation of the enzyme. ATP can activate the heterotetramer and the heterodimer composed of IDH3A and IDH3G subunits at low concentrations but inhibits their activities at high concentrations, whereas ATP exhibits only inhibitory effect on the heterodimer composed of IDH3A and IDH3B subunits. {ECO:0000269|PubMed:28098230, ECO:0000269|PubMed:28139779}.	COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:28098230, ECO:0000269|PubMed:28139779}; Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000269|PubMed:28139779}; ;  Note=Divalent metal cations; Mn(2+) or Mg(2+). Activity higher in presence of Mn(2+) than of Mg(2+). Binds 1 Mg(2+) or Mn(2+) ion per subunit. {ECO:0000269|PubMed:28139779};			SITE 153 153 Critical for catalysis. {ECO:0000269|PubMed:28098230, ECO:0000269|PubMed:28139779}.; SITE 200 200 Critical for catalysis. {ECO:0000269|PubMed:28098230}.			carbohydrate metabolic process [GO:0005975]; tricarboxylic acid cycle [GO:0006099]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; carbohydrate metabolic process [GO:0005975]; tricarboxylic acid cycle [GO:0006099]	isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]	GO:0000287; GO:0004449; GO:0005634; GO:0005739; GO:0005759; GO:0005975; GO:0006099; GO:0043209; GO:0051287	SUBCELLULAR LOCATION: Mitochondrion.		MOD_RES 77 77 N6-succinyllysine. {ECO:0000250|UniProtKB:Q9D6R2}.; MOD_RES 101 101 Phosphothreonine. {ECO:0000250|UniProtKB:Q9D6R2}.; MOD_RES 223 223 N6-acetyllysine. {ECO:0000250|UniProtKB:Q9D6R2}.; MOD_RES 343 343 N6-acetyllysine; alternate. {ECO:0000244|PubMed:19608861}.; MOD_RES 343 343 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q9D6R2}.; MOD_RES 350 350 N6-succinyllysine. {ECO:0000250|UniProtKB:Q9D6R2}.	7755589; 17974005; 15489334; 19608861; 21269460; 25944712; 28139779; 28098230; 14555658; 14743216; 16737955; 17314511; 17432878; 19615732; 20306291; 20435888; 20562859; 20711500; 20869947; 20877624; 21988832; 22190034; 25531325; 29453450	7755589; 17974005; 15489334; 19608861; 21269460; 25944712; 28139779; 28098230
6190	IMPA1 IMPA	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=42 uM for D-myo-inositol 1-phosphate {ECO:0000269|PubMed:8068620}; KM=62 uM for L-myo-inositol 1-phosphate {ECO:0000269|PubMed:8068620}; 	3.1.3.25; 3.1.3.94	CATALYTIC ACTIVITY: Myo-inositol phosphate + H(2)O = myo-inositol + phosphate. {ECO:0000269|PubMed:1377913, ECO:0000269|PubMed:8068620, ECO:0000269|PubMed:8718889, ECO:0000269|PubMed:9462881}.; CATALYTIC ACTIVITY: Alpha-D-galactose 1-phosphate + H(2)O = D-galactose + phosphate. {ECO:0000269|PubMed:9462881}.	BINDING 70 70 Substrate. {ECO:0000269|PubMed:8068620, ECO:0000303|PubMed:8068621}.; BINDING 213 213 Substrate. {ECO:0000269|PubMed:8068620, ECO:0000303|PubMed:8068621}.; BINDING 220 220 Substrate. {ECO:0000269|PubMed:8068620}.	ACTIVITY REGULATION: Activity with myo-inositol monophosphate and D-galactose 1-phosphate is inhibited by Li(+), Ca(2+) and Mn(2+), but also by Mg(2+) at concentrations above 3 mM. {ECO:0000269|PubMed:17068342, ECO:0000269|PubMed:8718889, ECO:0000269|PubMed:9462881}.	COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:17068342, ECO:0000269|PubMed:8718889, ECO:0000269|PubMed:9462881, ECO:0000303|PubMed:23027737, ECO:0000303|PubMed:8068621}; 	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 7.0-7.5. {ECO:0000269|PubMed:17068342};	PATHWAY: Polyol metabolism; myo-inositol biosynthesis; myo-inositol from D-glucose 6-phosphate: step 2/2.				inositol biosynthetic process [GO:0006021]; inositol metabolic process [GO:0006020]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; phosphate-containing compound metabolic process [GO:0006796]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; identical protein binding [GO:0042802]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; inositol monophosphate phosphatase activity [GO:0052834]; lithium ion binding [GO:0031403]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; inositol biosynthetic process [GO:0006021]; inositol metabolic process [GO:0006020]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; phosphate-containing compound metabolic process [GO:0006796]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]; signal transduction [GO:0007165]	identical protein binding [GO:0042802]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; inositol monophosphate phosphatase activity [GO:0052834]; lithium ion binding [GO:0031403]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]	GO:0000287; GO:0005737; GO:0005829; GO:0006020; GO:0006021; GO:0006661; GO:0006796; GO:0007165; GO:0008934; GO:0030145; GO:0031403; GO:0042802; GO:0042803; GO:0043647; GO:0046854; GO:0046855; GO:0052832; GO:0052833; GO:0052834	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17068342}.		MOD_RES 168 168 Phosphothreonine. {ECO:0000244|PubMed:23186163}.	1377913; 9339367; 14702039; 16421571; 15489334; 9462881; 17068342; 18669648; 19690332; 21269460; 23186163; 26416544; 1332026; 8068620; 8068621; 8718889; 23027737; 14699425; 16189514; 19447967; 20153384; 21516116; 22157815; 25416956; 27440438	1377913; 9339367; 14702039; 16421571; 15489334; 9462881; 17068342; 18669648; 19690332; 21269460; 23186163; 26416544; 1332026; 8068620; 8068621; 8718889; 23027737
6240	ACOT2 PTE2 PTE2A	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=40.3 uM for C10-acyl-CoA {ECO:0000269|PubMed:16940157}; KM=8.9 uM for C12-acyl-CoA {ECO:0000269|PubMed:16940157}; KM=1.6 uM for C14-acyl-CoA {ECO:0000269|PubMed:16940157}; KM=2.0 uM for C16-acyl-CoA {ECO:0000269|PubMed:16940157}; KM=2.8 uM for C18-acyl-CoA {ECO:0000269|PubMed:16940157}; KM=4.8 uM for C20-acyl-CoA {ECO:0000269|PubMed:16940157}; KM=4.5 uM for C16:1-acyl-CoA {ECO:0000269|PubMed:16940157}; KM=6.1 uM for C18:1-acyl-CoA {ECO:0000269|PubMed:16940157}; KM=4.3 uM for C18:1-trans-acyl-CoA {ECO:0000269|PubMed:16940157}; Vmax=212 nmol/min/mg enzyme toward C10-acyl-CoA {ECO:0000269|PubMed:16940157}; Vmax=681 nmol/min/mg enzyme toward C12-acyl-CoA {ECO:0000269|PubMed:16940157}; Vmax=766 nmol/min/mg enzyme toward C14-acyl-CoA {ECO:0000269|PubMed:16940157}; Vmax=656 nmol/min/mg enzyme toward C16-acyl-CoA {ECO:0000269|PubMed:16940157}; Vmax=488 nmol/min/mg enzyme toward C18-acyl-CoA {ECO:0000269|PubMed:16940157}; Vmax=408 nmol/min/mg enzyme toward C20-acyl-CoA {ECO:0000269|PubMed:16940157}; Vmax=661 nmol/min/mg enzyme toward C16:1-acyl-CoA {ECO:0000269|PubMed:16940157}; Vmax=304 nmol/min/mg enzyme toward C18:1-acyl-CoA {ECO:0000269|PubMed:16940157}; Vmax=418 nmol/min/mg enzyme toward C18:1-trans-acyl-CoA {ECO:0000269|PubMed:16940157}; 	3.1.2.2	CATALYTIC ACTIVITY: Palmitoyl-CoA + H(2)O = CoA + palmitate. {ECO:0000269|PubMed:16940157}.									acyl-CoA metabolic process [GO:0006637]; long-chain fatty acid metabolic process [GO:0001676]; protein targeting to peroxisome [GO:0006625]; very long-chain fatty acid metabolic process [GO:0000038]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; signaling receptor binding [GO:0005102]; acyl-CoA metabolic process [GO:0006637]; long-chain fatty acid metabolic process [GO:0001676]; protein targeting to peroxisome [GO:0006625]; very long-chain fatty acid metabolic process [GO:0000038]	acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; signaling receptor binding [GO:0005102]	GO:0000038; GO:0001676; GO:0005102; GO:0005739; GO:0005759; GO:0005782; GO:0005829; GO:0006625; GO:0006637; GO:0016290; GO:0047617; GO:0052689; GO:0102991	SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:16940157}.		MOD_RES 104 104 N6-acetyllysine. {ECO:0000250|UniProtKB:Q9QYR9}.; MOD_RES 470 470 N6-succinyllysine. {ECO:0000250|UniProtKB:Q9QYR9}.	7596406; 16940157; 14702039; 15489334; 10944470; 19497300; 20379614; 20470824; 20877624; 22465940; 22586271; 22871024; 23700546	7596406; 16940157; 14702039; 15489334; 10944470; 19497300
6241	ACOT4 PTE2B PTEIB	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=14 uM for succinyl-CoA {ECO:0000269|PubMed:16940157}; KM=147 uM for glutaryl-CoA {ECO:0000269|PubMed:16940157}; KM=3.4 uM for C14-acyl-CoA {ECO:0000269|PubMed:16940157}; Vmax=581 nmol/min/mg enzyme toward succinyl-CoA {ECO:0000269|PubMed:16940157}; Vmax=132 nmol/min/mg enzyme toward glutaryl-CoA {ECO:0000269|PubMed:16940157}; Vmax=137 nmol/min/mg enzyme toward C14-acyl-CoA {ECO:0000269|PubMed:16940157}; 	3.1.2.2	CATALYTIC ACTIVITY: Palmitoyl-CoA + H(2)O = CoA + palmitate. {ECO:0000269|PubMed:16940157}.									acyl-CoA metabolic process [GO:0006637]; dicarboxylic acid catabolic process [GO:0043649]; dicarboxylic acid metabolic process [GO:0043648]; long-chain fatty acid metabolic process [GO:0001676]; protein targeting to peroxisome [GO:0006625]; saturated monocarboxylic acid metabolic process [GO:0032788]; short-chain fatty acid metabolic process [GO:0046459]; succinyl-CoA metabolic process [GO:0006104]; unsaturated monocarboxylic acid metabolic process [GO:0032789]; very long-chain fatty acid metabolic process [GO:0000038]	cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; signaling receptor binding [GO:0005102]; succinyl-CoA hydrolase activity [GO:0004778]; acyl-CoA metabolic process [GO:0006637]; dicarboxylic acid catabolic process [GO:0043649]; dicarboxylic acid metabolic process [GO:0043648]; long-chain fatty acid metabolic process [GO:0001676]; protein targeting to peroxisome [GO:0006625]; saturated monocarboxylic acid metabolic process [GO:0032788]; short-chain fatty acid metabolic process [GO:0046459]; succinyl-CoA metabolic process [GO:0006104]; unsaturated monocarboxylic acid metabolic process [GO:0032789]; very long-chain fatty acid metabolic process [GO:0000038]	acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; signaling receptor binding [GO:0005102]; succinyl-CoA hydrolase activity [GO:0004778]	GO:0000038; GO:0001676; GO:0004778; GO:0005102; GO:0005777; GO:0005782; GO:0005829; GO:0006104; GO:0006625; GO:0006637; GO:0016290; GO:0032788; GO:0032789; GO:0043648; GO:0043649; GO:0046459; GO:0047617; GO:0052689; GO:0102991	SUBCELLULAR LOCATION: Peroxisome {ECO:0000269|PubMed:16940157}.		MOD_RES 313 313 N6-succinyllysine. {ECO:0000250|UniProtKB:Q8BWN8}.	14702039; 15489334; 16940157; 24275569; 11673457; 16141203; 25961151	14702039; 15489334; 16940157; 24275569; 
6262	AKR1E2 AKR1CL2 AKRDC1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=6.1 uM for 9,10-phenanthrenequinone with NADPH as cofactor {ECO:0000269|PubMed:12604216}; KM=44.3 uM for 9,10-phenanthrenequinone (at 25 degrees Celsius) {ECO:0000269|PubMed:15118078}; KM=166 uM for NADPH (at 25 degrees Celsius) {ECO:0000269|PubMed:15118078}; KM=2.3 mM for NADH (at 25 degrees Celsius) {ECO:0000269|PubMed:15118078}; Vmax=0.42 nmol/min/mg enzyme towards 9,10-phenanthrenequinone with NADPH as cofactor {ECO:0000269|PubMed:12604216}; 	1.1.1.263	CATALYTIC ACTIVITY: 1,5-anhydro-D-glucitol + NADP(+) = 1,5-anhydro-D-fructose + NADPH. {ECO:0000250|UniProtKB:Q9DCT1}.	BINDING 35 35 NADP. {ECO:0000250|UniProtKB:O60218}.; BINDING 102 102 Substrate. {ECO:0000250|UniProtKB:O60218}.; BINDING 194 194 NADP. {ECO:0000250|UniProtKB:O60218}.	ACTIVITY REGULATION: Inhibited by p-chloromercuribenzoic acid and alkyliodines. {ECO:0000250|UniProtKB:P82125}.				SITE 69 69 Lowers pKa of active site Tyr. {ECO:0000250|UniProtKB:P14550}.			oxidation-reduction process [GO:0055114]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; 1,5-anhydro-D-fructose reductase activity [GO:0050571]; oxidoreductase activity [GO:0016491]; oxidation-reduction process [GO:0055114]	1,5-anhydro-D-fructose reductase activity [GO:0050571]; oxidoreductase activity [GO:0016491]	GO:0005654; GO:0005794; GO:0005829; GO:0016491; GO:0050571; GO:0055114	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.			12604216; 15164054; 15489334; 15118078; 16385451	12604216; 15164054; 15489334; 15118078
6267	ALDH4A1 ALDH4 P5CDH	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=100 uM for NAD {ECO:0000269|PubMed:22516612}; KM=32 uM for L-pyrroline-5-carboxylate {ECO:0000269|PubMed:22516612}; 	1.2.1.88	CATALYTIC ACTIVITY: L-glutamate 5-semialdehyde + NAD(+) + H(2)O = L-glutamate + NADH. {ECO:0000269|PubMed:22516612}.	BINDING 208 208 NAD. {ECO:0000250}.; BINDING 233 233 NAD. {ECO:0000250}.; BINDING 447 447 NAD. {ECO:0000250}.; BINDING 513 513 Substrate. {ECO:0000250}.				PATHWAY: Amino-acid degradation; L-proline degradation into L-glutamate; L-glutamate from L-proline: step 2/2. {ECO:0000269|PubMed:22516612}.	SITE 211 211 Transition state stabilizer. {ECO:0000250}.			4-hydroxyproline catabolic process [GO:0019470]; glyoxylate metabolic process [GO:0046487]; proline catabolic process [GO:0006562]; proline catabolic process to glutamate [GO:0010133]; proline metabolic process [GO:0006560]	mitochondrial matrix [GO:0005759]	mitochondrial matrix [GO:0005759]; 1-pyrroline-5-carboxylate dehydrogenase activity [GO:0003842]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; electron transfer activity [GO:0009055]; identical protein binding [GO:0042802]; 4-hydroxyproline catabolic process [GO:0019470]; glyoxylate metabolic process [GO:0046487]; proline catabolic process [GO:0006562]; proline catabolic process to glutamate [GO:0010133]; proline metabolic process [GO:0006560]	1-pyrroline-5-carboxylate dehydrogenase activity [GO:0003842]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; electron transfer activity [GO:0009055]; identical protein binding [GO:0042802]	GO:0003842; GO:0004029; GO:0005759; GO:0006560; GO:0006562; GO:0009055; GO:0010133; GO:0019470; GO:0042802; GO:0046487	SUBCELLULAR LOCATION: Mitochondrion matrix.		MOD_RES 31 31 N6-succinyllysine. {ECO:0000250|UniProtKB:Q8CHT0}.; MOD_RES 44 44 Phosphoserine. {ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 52 52 N6-acetyllysine. {ECO:0000250|UniProtKB:Q8CHT0}.; MOD_RES 93 93 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8CHT0}.; MOD_RES 93 93 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8CHT0}.; MOD_RES 99 99 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8CHT0}.; MOD_RES 99 99 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8CHT0}.; MOD_RES 114 114 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8CHT0}.; MOD_RES 114 114 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8CHT0}.; MOD_RES 130 130 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8CHT0}.; MOD_RES 130 130 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8CHT0}.; MOD_RES 175 175 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8CHT0}.; MOD_RES 175 175 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8CHT0}.; MOD_RES 318 318 N6-acetyllysine. {ECO:0000250|UniProtKB:Q8CHT0}.; MOD_RES 347 347 N6-succinyllysine. {ECO:0000250|UniProtKB:Q8CHT0}.; MOD_RES 365 365 N6-acetyllysine. {ECO:0000250|UniProtKB:Q8CHT0}.; MOD_RES 376 376 N6-acetyllysine. {ECO:0000250|UniProtKB:Q8CHT0}.; MOD_RES 395 395 N6-succinyllysine. {ECO:0000250|UniProtKB:Q8CHT0}.; MOD_RES 462 462 N6-acetyllysine. {ECO:0000250|UniProtKB:Q8CHT0}.; MOD_RES 509 509 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8CHT0}.; MOD_RES 509 509 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8CHT0}.; MOD_RES 531 531 N6-acetyllysine. {ECO:0000250|UniProtKB:Q8CHT0}.; MOD_RES 552 552 N6-acetyllysine. {ECO:0000250|UniProtKB:Q8CHT0}.	8621661; 14702039; 16710414; 15489334; 1395511; 1286669; 8493898; 21269460; 23186163; 24275569; 25944712; 22516612; 9700195; 13681370; 14986171; 19898482; 20453000; 20877624; 21988832; 24502590; 26058080; 3944130; 500817	8621661; 14702039; 16710414; 15489334; 1395511; 1286669; 8493898; 21269460; 23186163; 24275569; 25944712; 22516612; 9700195
6268	AKT2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=358.4 uM for ATP (for purified and in vitro activated AKT2) {ECO:0000269|PubMed:16540465}; KM=3.4 uM for peptide substrate (for purified and in vitro activated AKT2) {ECO:0000269|PubMed:16540465}; KM=564 uM for ATP (for recombinant myristoylated AKT2 expressed and immunoprecipitated from Rat-1 cells) {ECO:0000269|PubMed:16540465}; KM=2.3 uM for peptide substrate (for recombinant myristoylated AKT2 expressed and immunoprecipitated from Rat-1 cells) {ECO:0000269|PubMed:16540465}; 	2.7.11.1	CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.	BINDING 181 181 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.; BINDING 181 181 Inhibitor.; BINDING 200 200 Inhibitor.; BINDING 232 232 Inhibitor; via amide nitrogen.; BINDING 236 236 Inhibitor.; BINDING 279 279 Inhibitor; via carbonyl oxygen.; BINDING 293 293 Inhibitor.; BINDING 294 294 Inhibitor; via amide nitrogen.	ACTIVITY REGULATION: Two specific sites, one in the kinase domain (Thr-309) and the other in the C-terminal regulatory region (Ser-474), need to be phosphorylated for its full activation. Aminofurazans are potent AKT2 inhibitors. {ECO:0000269|PubMed:18800763, ECO:0000269|PubMed:19179070}.							activation of GTPase activity [GO:0090630]; carbohydrate transport [GO:0008643]; cellular protein modification process [GO:0006464]; cellular response to high light intensity [GO:0071486]; cellular response to insulin stimulus [GO:0032869]; fat cell differentiation [GO:0045444]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; insulin receptor signaling pathway [GO:0008286]; intracellular protein transmembrane transport [GO:0065002]; intracellular signal transduction [GO:0035556]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of apoptotic process [GO:0043066]; negative regulation of plasma membrane long-chain fatty acid transport [GO:0010748]; peptidyl-serine phosphorylation [GO:0018105]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of cell migration [GO:0030335]; positive regulation of cell motility [GO:2000147]; positive regulation of cell proliferation [GO:0008284]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose import in response to insulin stimulus [GO:2001275]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of vesicle fusion [GO:0031340]; protein kinase B signaling [GO:0043491]; protein localization to plasma membrane [GO:0072659]; regulation of cell cycle arrest [GO:0071156]; regulation of cell migration [GO:0030334]; regulation of translation [GO:0006417]; retinal rod cell apoptotic process [GO:0097473]; signal transduction [GO:0007165]	cell cortex [GO:0005938]; cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]	cell cortex [GO:0005938]; cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; activation of GTPase activity [GO:0090630]; carbohydrate transport [GO:0008643]; cellular protein modification process [GO:0006464]; cellular response to high light intensity [GO:0071486]; cellular response to insulin stimulus [GO:0032869]; fat cell differentiation [GO:0045444]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; insulin receptor signaling pathway [GO:0008286]; intracellular protein transmembrane transport [GO:0065002]; intracellular signal transduction [GO:0035556]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of apoptotic process [GO:0043066]; negative regulation of plasma membrane long-chain fatty acid transport [GO:0010748]; peptidyl-serine phosphorylation [GO:0018105]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of cell migration [GO:0030335]; positive regulation of cell motility [GO:2000147]; positive regulation of cell proliferation [GO:0008284]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose import in response to insulin stimulus [GO:2001275]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of vesicle fusion [GO:0031340]; protein kinase B signaling [GO:0043491]; protein localization to plasma membrane [GO:0072659]; regulation of cell cycle arrest [GO:0071156]; regulation of cell migration [GO:0030334]; regulation of translation [GO:0006417]; retinal rod cell apoptotic process [GO:0097473]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]	GO:0001934; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005769; GO:0005829; GO:0005886; GO:0005938; GO:0005978; GO:0006006; GO:0006417; GO:0006464; GO:0007165; GO:0008284; GO:0008286; GO:0008643; GO:0010748; GO:0010907; GO:0010918; GO:0018105; GO:0030334; GO:0030335; GO:0031340; GO:0032000; GO:0032287; GO:0032587; GO:0032869; GO:0032991; GO:0035556; GO:0043066; GO:0043231; GO:0043491; GO:0045444; GO:0045725; GO:0046326; GO:0046872; GO:0060644; GO:0065002; GO:0071156; GO:0071486; GO:0072659; GO:0090314; GO:0090630; GO:0097473; GO:2000147; GO:2001275	SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Cell membrane; Peripheral membrane protein. Early endosome {ECO:0000250|UniProtKB:Q60823}. Note=Localizes within both nucleus and cytoplasm of proliferative primary myoblasts and mostly within the nucleus of differentiated primary myoblasts. By virtue of the N-terminal PH domain, is recruited to sites of the plasma membrane containing increased PI(3,4,5)P3 or PI(3,4)P2, cell membrane targeting is also facilitared by interaction with CLIP3. Colocalizes with WDFY2 in early endosomes (By similarity). {ECO:0000250|UniProtKB:Q60823}.	PTM: Phosphorylation on Thr-309 and Ser-474 is required for full activity. {ECO:0000269|PubMed:12434148, ECO:0000269|PubMed:15890450, ECO:0000269|PubMed:20059950, ECO:0000269|PubMed:9512493}.; PTM: Ubiquitinated; undergoes both 'Lys-48'- and 'Lys-63'-linked polyubiquitination. TRAF6-induced 'Lys-63'-linked AKT2 ubiquitination. When fully phosphorylated and translocated into the nucleus, undergoes 'Lys-48'-polyubiquitination catalyzed by TTC3, leading to its degradation by the proteasome. {ECO:0000269|PubMed:19713527, ECO:0000269|PubMed:20059950}.; PTM: O-GlcNAcylation at Thr-306 and Thr-313 inhibits activating phosphorylation at Thr-309 via disrupting the interaction between AKT and PDK1. {ECO:0000250}.	MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:22223895}.; MOD_RES 34 34 Phosphoserine. {ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 126 126 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 309 309 Phosphothreonine; by PDPK1. {ECO:0000269|PubMed:12434148, ECO:0000269|PubMed:15890450, ECO:0000269|PubMed:20059950, ECO:0000269|PubMed:9512493}.; MOD_RES 447 447 Phosphoserine. {ECO:0000244|PubMed:19690332}.; MOD_RES 451 451 Phosphothreonine. {ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:24275569}.; MOD_RES 474 474 Phosphoserine. {ECO:0000244|PubMed:19690332, ECO:0000269|PubMed:15890450, ECO:0000269|PubMed:20059950}.; MOD_RES 478 478 Phosphoserine. {ECO:0000244|PubMed:19690332}.	1801921; 1409633; 14702039; 15057824; 15489334; 9512493; 10983986; 15890450; 16792529; 16540465; 17565718; 18669648; 20059950; 19139280; 19690332; 19713527; 20167810; 21269460; 21620960; 21432781; 21737686; 22223895; 23186163; 24275569; 12086620; 12434148; 12517337; 14755158; 17275837; 18800763; 19179070; 15166380; 17344846; 19164855; 21979934; 10082674; 10102273; 10358075; 10454575; 10485710; 10490848; 10523666; 10779773; 11274386; 11504915; 11598301; 11715018; 11994271; 12114024; 12114503; 12138205; 12150915; 12167717; 12172553; 12176997; 12228231; 12244303; 12480711; 12482965; 12517798; 12524439; 12545160; 12663464; 12733712; 12734182; 12767043; 12791994; 12808085; 12808134; 12869586; 14504284; 14522993; 14612499; 14617782; 14637151; 14654898; 14699494; 14735903; 15010337; 15102693; 15111130; 15169778; 15183529; 15191648; 15314020; 15527798; 15531580; 15557754; 15718470; 15808505; 15919790; 15987444; 16272144; 16365168; 16982699; 17012749; 17210635; 17276404; 17327441; 17332325; 17369524; 17372934; 17386267; 17451234; 17482291; 17515613; 17535800; 17544405; 17576055; 17577629; 17804734; 17825284; 17895832; 17908691; 17914025; 18048359; 18281467; 18316591; 18353613; 18396141; 18573912; 18660489; 18669636; 18768676; 18794358; 18842333; 18996102; 19064572; 19074768; 19075230; 19079138; 19164214; 19197940; 19261608; 19372382; 19405949; 19435822; 19453261; 19644473; 19771908; 19797172; 19825827; 19843246; 19897488; 19913121; 19933843; 20018949; 20056178; 20056908; 20102399; 20109457; 20116920; 20133737; 20151677; 20186503; 20354455; 20398329; 20447721; 20489726; 20514445; 20602615; 20628086; 20687898; 20688159; 20691427; 20848774; 20856200; 21048031; 21050850; 21092549; 21148297; 21179235; 21182834; 21297943; 21507933; 21518566; 21590431; 21618512; 21636708; 21680733; 21722267; 21907143; 21932427; 21979951; 21988832; 22025163; 22031698; 22107784; 22261254; 22334668; 22480544; 22556379; 22657251; 22748472; 22762500; 22778840; 22809628; 22939624; 22975685; 23018889; 23092922; 23250987; 23305873; 23321478; 23389849; 23431171; 23444369; 23464484; 23468863; 23478189; 23567263; 23684622; 23777806; 23823123; 23900341; 23912456; 23929892; 24030155; 24039187; 24056770; 24123662; 24150286; 24169049; 24244431; 24321521; 24337067; 24565443; 24642468; 24656454; 24699302; 24769357; 24819169; 24835590; 24838891; 24946858; 24947832; 24970808; 25025572; 25059120; 25134663; 25162660; 25173755; 25233414; 25246356; 25253241; 25263462; 25285168; 25288334; 25304263; 25733895; 25771729; 25856297; 25894377; 25936945; 25951903; 26055712; 26102366; 26158514; 26183061; 26229955; 26234648; 26254095; 26265781; 26318486; 26475619; 26496610; 26500117; 26512921; 26638075; 26701849; 26711268; 26803515; 26828791; 26855332; 26953242; 26971877; 27067543; 27105349; 27189341; 27545875; 27663592; 27878243; 27878305; 27906180; 28026019; 28036396; 28068324; 28129626; 28271235; 28341696; 28404925; 28440469; 28455433; 28456993; 28534950; 28541532; 28557977; 28586057; 28689659; 28837154; 28931550; 29025710; 29075783; 29141982; 29207197; 29235817; 29484395; 29494643; 7637810; 8524413; 8645147; 9094314; 9228007; 9346240; 9381178; 9445477; 9679957; 9736715; 9768361; 9812896; 9829964	1801921; 1409633; 14702039; 15057824; 15489334; 9512493; 10983986; 15890450; 16792529; 16540465; 17565718; 18669648; 20059950; 19139280; 19690332; 19713527; 20167810; 21269460; 21620960; 21432781; 21737686; 22223895; 23186163; 24275569; 12086620; 12434148; 12517337; 14755158; 17275837; 18800763; 19179070; 15166380; 17344846; 19164855; 21979934
6314	ACSL5 ACS5 FACL5 UNQ633/PRO1250	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.11 uM for palmitic acid (isoform 1 at pH 7.5) {ECO:0000269|PubMed:17681178}; KM=0.38 uM for palmitic acid (isoform 1 at pH 9.5) {ECO:0000269|PubMed:17681178}; KM=0.04 uM for palmitic acid (isoform 3 at pH 7.5) {ECO:0000269|PubMed:17681178}; KM=0.15 uM for palmitic acid (isoform 3 at pH 8.5) {ECO:0000269|PubMed:17681178}; 	6.2.1.3	CATALYTIC ACTIVITY: ATP + a long-chain fatty acid + CoA = AMP + diphosphate + an acyl-CoA.			COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250}; 	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 9.5 (isoform 1), 7.5-8.5 (isoform 3). {ECO:0000269|PubMed:17681178};			UNQ633/PRO1250		long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]	ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]	GO:0001676; GO:0004467; GO:0005524; GO:0005634; GO:0005730; GO:0005739; GO:0005741; GO:0005783; GO:0005789; GO:0016020; GO:0016021; GO:0035338; GO:0102391; GO:2001236	SUBCELLULAR LOCATION: Mitochondrion. Endoplasmic reticulum. Mitochondrion outer membrane {ECO:0000250}; Single-pass type III membrane protein {ECO:0000250}. Endoplasmic reticulum membrane {ECO:0000250}; Single-pass type III membrane protein {ECO:0000250}.		MOD_RES 361 361 N6-acetyllysine. {ECO:0000250|UniProtKB:Q8JZR0}.	17681178; 12975309; 14702039; 15164054; 15489334; 18691976; 19459852; 18806831; 21269460; 24275569; 16959974; 10548543; 11127823; 11707336; 15736044; 15809837; 16198472; 16385451; 17379924; 17495181; 17761945; 18228202; 19218499; 19463016; 20379614; 20470896; 20711500; 20877624; 21516116; 22163040; 22171129; 23348389; 24222123; 24725412; 24770931; 25356045; 27189022; 28153554; 28498416; 28808653	17681178; 12975309; 14702039; 15164054; 15489334; 18691976; 19459852; 18806831; 21269460; 24275569; 16959974
6321	ADCY10 SAC	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.8 mM for ATP-Mn(2+) {ECO:0000269|PubMed:12609998}; KM=2.41 mM for Mg(2+) {ECO:0000269|PubMed:12609998}; 	4.6.1.1	CATALYTIC ACTIVITY: ATP = 3',5'-cyclic AMP + diphosphate. {ECO:0000269|PubMed:12609998, ECO:0000269|PubMed:15659711, ECO:0000269|PubMed:24567411, ECO:0000269|PubMed:24616449, ECO:0000269|PubMed:25040695}.	BINDING 95 95 Bicarbonate. {ECO:0000244|PDB:4CLL, ECO:0000244|PDB:4OYZ, ECO:0000269|PubMed:24567411, ECO:0000269|PubMed:24616449}.; BINDING 99 99 ATP. {ECO:0000244|PDB:4USW, ECO:0000269|PubMed:25040695, ECO:0000305|PubMed:24567411, ECO:0000305|PubMed:24616449}.; BINDING 144 144 ATP. {ECO:0000244|PDB:4USW, ECO:0000269|PubMed:25040695, ECO:0000305|PubMed:24567411, ECO:0000305|PubMed:24616449}.; BINDING 167 167 Bicarbonate; via amide nitrogen and carbonyl oxygen. {ECO:0000244|PDB:4CLL, ECO:0000244|PDB:4OYZ, ECO:0000269|PubMed:24567411, ECO:0000269|PubMed:24616449}.; BINDING 176 176 Bicarbonate. {ECO:0000244|PDB:4CLL, ECO:0000244|PDB:4OYZ, ECO:0000269|PubMed:24567411, ECO:0000269|PubMed:24616449}.; BINDING 337 337 Bicarbonate; via amide nitrogen. {ECO:0000244|PDB:4CLL, ECO:0000244|PDB:4OYZ, ECO:0000269|PubMed:24567411, ECO:0000269|PubMed:24616449}.; BINDING 406 406 ATP; via carbonyl oxygen. {ECO:0000244|PDB:4USW, ECO:0000269|PubMed:25040695, ECO:0000305|PubMed:24567411, ECO:0000305|PubMed:24616449}.	ACTIVITY REGULATION: Activated by manganese or magnesium ions (PubMed:12609998, PubMed:24616449). In the presence of magnesium ions, the enzyme is activated by bicarbonate (PubMed:12609998, PubMed:15659711, PubMed:24567411). In the presence of manganese ions, the enzyme is inhibited by bicarbonate (PubMed:15659711). In the absence of magnesium and bicarbonate, the enzyme is weakly activated by calcium (PubMed:15659711). Calcium mildly increases the enzyme activity, also in the presence of magnesium ions (PubMed:15659711, PubMed:25040695). {ECO:0000269|PubMed:12609998, ECO:0000269|PubMed:15659711, ECO:0000269|PubMed:24567411, ECO:0000269|PubMed:24616449, ECO:0000269|PubMed:25040695}.	COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:12609998, ECO:0000269|PubMed:15659711, ECO:0000269|PubMed:24567411, ECO:0000269|PubMed:25040695, ECO:0000305|PubMed:24616449}; Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000269|PubMed:12609998, ECO:0000269|PubMed:15659711, ECO:0000269|PubMed:24616449}; ;  Note=Binds 2 magnesium ions per subunit (PubMed:25040695). Is also active with manganese (in vitro) (PubMed:12609998, PubMed:15659711, PubMed:24616449). {ECO:0000269|PubMed:12609998, ECO:0000269|PubMed:15659711, ECO:0000269|PubMed:24616449, ECO:0000305|PubMed:25040695};						cAMP biosynthetic process [GO:0006171]; cellular response to inorganic substance [GO:0071241]; epithelial cilium movement [GO:0003351]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; spermatogenesis [GO:0007283]	apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; growth cone [GO:0030426]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; growth cone [GO:0030426]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; bicarbonate binding [GO:0071890]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; cAMP biosynthetic process [GO:0006171]; cellular response to inorganic substance [GO:0071241]; epithelial cilium movement [GO:0003351]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; spermatogenesis [GO:0007283]	adenylate cyclase activity [GO:0004016]; ATPase binding [GO:0051117]; ATP binding [GO:0005524]; bicarbonate binding [GO:0071890]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]	GO:0000287; GO:0003351; GO:0004016; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005856; GO:0005886; GO:0005929; GO:0006171; GO:0007283; GO:0030145; GO:0030425; GO:0030426; GO:0035556; GO:0043025; GO:0043065; GO:0045177; GO:0045178; GO:0048471; GO:0051117; GO:0071241; GO:0071890	SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15659711}; Peripheral membrane protein {ECO:0000269|PubMed:15659711}; Cytoplasmic side {ECO:0000269|PubMed:15659711}. Cytoplasm, cytoskeleton {ECO:0000269|PubMed:12475901, ECO:0000269|PubMed:15659711}. Cytoplasm, perinuclear region {ECO:0000269|PubMed:12475901, ECO:0000269|PubMed:15659711}. Nucleus {ECO:0000269|PubMed:12475901, ECO:0000269|PubMed:15659711}. Cell projection, cilium {ECO:0000269|PubMed:17591988}. Cytoplasm {ECO:0000269|PubMed:12475901}. Mitochondrion {ECO:0000269|PubMed:12475901}. Note=Distributed to subcellular compartments containing cAMP targets. Found as a plasma membrane-associated protein, protein concentrated in the perinuclear region and protein colocalized with actin or tubulin. {ECO:0000269|PubMed:12475901, ECO:0000269|PubMed:15659711}.	PTM: Cleavage may occur to generate the active 48 kDa form. {ECO:0000305}.		11423534; 11932268; 12609998; 14702039; 16710414; 15489334; 12475901; 15659711; 17591988; 24616449; 25040695; 24567411; 18209474; 19064610; 19093065; 19536175; 20130594; 20379614; 21994938; 22775536; 23209152; 23255611; 23332756; 24100033; 24420537; 24698940; 24699740; 24792377; 24845016; 25409931; 26857816; 26961873; 27547922	11423534; 11932268; 12609998; 14702039; 16710414; 15489334; 12475901; 15659711; 17591988; 24616449; 25040695; 24567411
6372	ALDH1A1 ALDC ALDH1 PUMB1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=59.4 uM for NAD (at pH 8.0) {ECO:0000269|PubMed:19296407}; KM=238.2 uM for acetaldehyde (at pH 8.0) {ECO:0000269|PubMed:19296407}; KM=142.2 uM for benzaldehyde (at pH 8.0) {ECO:0000269|PubMed:19296407}; KM=4.8 uM for 4-hydroxynonenal (at pH 8.0) {ECO:0000269|PubMed:19296407}; KM=121.4 uM for propionaldehyde (at pH 8.0) {ECO:0000269|PubMed:19296407}; KM=15 uM for propionaldehyde (at pH 7.5) {ECO:0000269|PubMed:25450233}; KM=3.5 uM for malonaldehyde (at pH 8.0) {ECO:0000269|PubMed:19296407}; KM=177.1 uM for trans-2-heptenal (at pH 8.0) {ECO:0000269|PubMed:19296407}; Vmax=149.7 nmol/min/mg enzyme with NAD (at pH 8.0) {ECO:0000269|PubMed:19296407}; Vmax=631.4 nmol/min/mg enzyme with acetaldehyde (at pH 8.0) {ECO:0000269|PubMed:19296407}; Vmax=750.3 nmol/min/mg enzyme with benzaldehyde (at pH 8.0) {ECO:0000269|PubMed:19296407}; Vmax=135 nmol/min/mg enzyme with 4-hydroxynonenal (at pH 8.0) {ECO:0000269|PubMed:19296407}; Vmax=445.3 nmol/min/mg enzyme with propionaldehyde (at pH 8.0) {ECO:0000269|PubMed:19296407}; Vmax=381.6 nmol/min/mg enzyme with malonaldehyde (at pH 8.0) {ECO:0000269|PubMed:19296407}; Vmax=155.8 nmol/min/mg enzyme with trans-2-heptenal (at pH 8.0) {ECO:0000269|PubMed:19296407}; 	1.2.1.-; 1.2.1.36	CATALYTIC ACTIVITY: Retinal + NAD(+) + H(2)O = retinoate + NADH. {ECO:0000250|UniProtKB:P51647}.		ACTIVITY REGULATION: Inhibited by citral, disulfiram, and cyanamide. Activated by diethylstilbestrol (PubMed:19296407). Inhibited by duocarmycin analogs (PubMed:26373694). {ECO:0000269|PubMed:19296407, ECO:0000269|PubMed:26373694}.			PATHWAY: Cofactor metabolism; retinol metabolism. {ECO:0000250|UniProtKB:P51647}.	SITE 170 170 Transition state stabilizer. {ECO:0000250|UniProtKB:P20000}.			cellular aldehyde metabolic process [GO:0006081]; ethanol oxidation [GO:0006069]; fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate [GO:0061624]; negative regulation of cold-induced thermogenesis [GO:0120163]; oxidation-reduction process [GO:0055114]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; androgen binding [GO:0005497]; benzaldehyde dehydrogenase (NAD+) activity [GO:0018479]; GTPase activator activity [GO:0005096]; NAD binding [GO:0051287]; retinal dehydrogenase activity [GO:0001758]; cellular aldehyde metabolic process [GO:0006081]; ethanol oxidation [GO:0006069]; fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate [GO:0061624]; negative regulation of cold-induced thermogenesis [GO:0120163]; oxidation-reduction process [GO:0055114]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]	aldehyde dehydrogenase (NAD) activity [GO:0004029]; androgen binding [GO:0005497]; benzaldehyde dehydrogenase (NAD+) activity [GO:0018479]; GTPase activator activity [GO:0005096]; NAD binding [GO:0051287]; retinal dehydrogenase activity [GO:0001758]	GO:0001523; GO:0001758; GO:0004029; GO:0005096; GO:0005497; GO:0005737; GO:0005829; GO:0006069; GO:0006081; GO:0018479; GO:0042572; GO:0051287; GO:0055114; GO:0061624; GO:0070062; GO:0120163	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250|UniProtKB:P48644}.	PTM: The N-terminus is blocked most probably by acetylation. {ECO:0000250|UniProtKB:P15437}.	MOD_RES 2 2 N-acetylserine. {ECO:0000244|PubMed:22223895, ECO:0000269|PubMed:6723659}.; MOD_RES 91 91 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 128 128 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 252 252 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 337 337 Phosphothreonine. {ECO:0000244|PubMed:24275569}.; MOD_RES 353 353 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 367 367 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 410 410 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 413 413 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 419 419 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 435 435 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 495 495 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.	2591967; 8214422; 19296407; 15164053; 15489334; 8493914; 6723659; 4015823; 2987944; 3676276; 2776714; 19608861; 21269460; 22223895; 24275569; 26373694; 25450233; 25634381; 10631996; 12174908; 14506398; 14678778; 15597079; 16189514; 16857736; 16878979; 17175089; 17222227; 17286337; 17502835; 17628022; 18082256; 18331377; 18343808; 18371393; 18450747; 18496131; 18644979; 18805086; 18848913; 18854779; 19018242; 19025616; 19129088; 19329942; 19343046; 19385968; 19447584; 19450560; 19478994; 19696793; 19703508; 19706361; 19774675; 19808966; 19874574; 19911270; 20010854; 20019840; 20142235; 20228222; 20379614; 20422001; 20516116; 20585849; 20596639; 20606680; 20634891; 20711500; 20959018; 20959469; 21045151; 21098716; 21118965; 21231983; 21282737; 21336637; 21371077; 21399615; 21441790; 21482329; 21695188; 21708005; 21804471; 21827011; 21907803; 21988832; 22005464; 22012766; 22014057; 22080062; 22098156; 22101256; 22115706; 22123295; 22195027; 22260461; 22380773; 22407396; 22417385; 22430847; 224930; 22544210; 22581680; 22591209; 22608744; 22617249; 22649953; 22710732; 22725270; 22782852; 22877687; 22878609; 22887839; 22899292; 22928012; 22930220; 22938492; 23005595; 23084350; 23112116; 23220285; 23220587; 23236537; 23252868; 23267077; 23295229; 23332924; 23434145; 23444097; 23454351; 23465277; 23483187; 23585015; 23707659; 23759596; 23762304; 23787917; 23799031; 23805041; 23845466; 23916993; 23969936; 24008128; 24043631; 24080087; 24120944; 24197864; 24210755; 24266898; 24285422; 24285572; 24289252; 24327017; 24374552; 24422956; 24450601; 24464599; 24485040; 24511023; 24519209; 24596390; 24599561; 24670249; 24671051; 24716927; 24770634; 24786601; 24827824; 24865427; 24887554; 24938375; 24954508; 25120797; 25148045; 25181420; 25182808; 25216223; 25216266; 25230277; 25253129; 25270363; 25344211; 25384215; 25416956; 25451256; 25502770; 25582316; 25585687; 25599843; 25643237; 25670168; 25710579; 25793304; 25843691; 25864109; 25881507; 25921687; 25999351; 26046383; 26063415; 26070788; 26080709; 26130650; 26148881; 26160842; 26175266; 26230297; 26254374; 26298632; 26305673; 26358078; 26391478; 26398662; 26399460; 26449187; 26456957; 26462023; 26517640; 26617768; 26625750; 26676482; 26682730; 26894647; 26896768; 26907783; 26934553; 26975188; 27000059; 27035162; 27152521; 27239845; 27272809; 27290698; 27368476; 27380877; 27461829; 27542268; 27620279; 27696244; 27768764; 27789528; 27813328; 27832750; 27891591; 28106104; 28122543; 28129349; 28184944; 28193222; 28219011; 28244015; 28280079; 28295901; 28383433; 28415606; 28418868; 28449663; 28476825; 28604744; 28640095; 28737489; 28756208; 28870918; 28888039; 28939082; 29103772; 29170132; 29353288; 29399699; 29516013; 29753392	2591967; 8214422; 19296407; 15164053; 15489334; 8493914; 6723659; 4015823; 2987944; 3676276; 2776714; 19608861; 21269460; 22223895; 24275569; 26373694; 25450233; 25634381
6374	ALDH9A1 ALDH4 ALDH7 ALDH9	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=11 uM for 4-aminobutyraldehyde; 	1.2.1.47; 1.2.1.3; 1.2.1.19	CATALYTIC ACTIVITY: 4-trimethylammoniobutanal + NAD(+) + H(2)O = 4-trimethylammoniobutanoate + NADH.; CATALYTIC ACTIVITY: An aldehyde + NAD(+) + H(2)O = a carboxylate + NADH.; CATALYTIC ACTIVITY: 4-aminobutanal + NAD(+) + H(2)O = 4-aminobutanoate + NADH.				BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is about 9.4 with propionaldehyde as substrate, and 7.5 with 4-aminobutyraldehyde as substrate.;	PATHWAY: Amine and polyamine biosynthesis; carnitine biosynthesis.	SITE 157 157 Transition state stabilizer. {ECO:0000250}.			carnitine biosynthetic process [GO:0045329]; cellular aldehyde metabolic process [GO:0006081]; hormone metabolic process [GO:0042445]; neurotransmitter biosynthetic process [GO:0042136]; oxidation-reduction process [GO:0055114]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 1-pyrroline dehydrogenase activity [GO:0033737]; 3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; 4-trimethylammoniobutyraldehyde dehydrogenase activity [GO:0047105]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; aminobutyraldehyde dehydrogenase activity [GO:0019145]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; carnitine biosynthetic process [GO:0045329]; cellular aldehyde metabolic process [GO:0006081]; hormone metabolic process [GO:0042445]; neurotransmitter biosynthetic process [GO:0042136]; oxidation-reduction process [GO:0055114]	1-pyrroline dehydrogenase activity [GO:0033737]; 3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; 4-trimethylammoniobutyraldehyde dehydrogenase activity [GO:0047105]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; aminobutyraldehyde dehydrogenase activity [GO:0019145]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]	GO:0004028; GO:0004029; GO:0005737; GO:0005829; GO:0006081; GO:0019145; GO:0033737; GO:0042136; GO:0042445; GO:0043878; GO:0045329; GO:0047105; GO:0055114; GO:0070062	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.		MOD_RES 2 2 N-acetylserine; in 4-trimethylaminobutyraldehyde dehydrogenase, N-terminally processed. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378, ECO:0000269|Ref.5}.; MOD_RES 30 30 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q9JLJ2}.; MOD_RES 30 30 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q9JLJ2}.; MOD_RES 59 59 N6-succinyllysine. {ECO:0000250|UniProtKB:Q9JLJ2}.; MOD_RES 298 298 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 303 303 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q9JLJ2}.; MOD_RES 303 303 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q9JLJ2}.; MOD_RES 344 344 N6-acetyllysine. {ECO:0000250|UniProtKB:Q9JLJ2}.	8786138; 10702312; 14702039; 16710414; 8645224; 8269919; 2925663; 19413330; 19608861; 21269460; 22223895; 22814378; 24275569; 25944712; 17353931; 18334916; 19064610; 19343046; 19536175; 19615732; 20379614; 20562859; 20711500; 20877624; 26010099	8786138; 10702312; 14702039; 16710414; 8645224; 8269919; 2925663; 19413330; 19608861; 21269460; 22223895; 22814378; 24275569; 25944712
6375	AKR1C1 DDH DDH1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=5 uM for (s)-tetralol {ECO:0000269|PubMed:11013348, ECO:0000269|PubMed:8573067}; KM=38 uM for (s)-indan-1-ol {ECO:0000269|PubMed:11013348, ECO:0000269|PubMed:8573067}; KM=580 uM for benzene dihydrodiol {ECO:0000269|PubMed:11013348, ECO:0000269|PubMed:8573067}; KM=3 uM for 5-beta-pregnane-3-alpha,20-alpha-diol {ECO:0000269|PubMed:11013348, ECO:0000269|PubMed:8573067}; KM=3 uM for 5-beta-pregnan-20-alpha-ol-3-one {ECO:0000269|PubMed:11013348, ECO:0000269|PubMed:8573067}; KM=12 uM for 4-pregnen-20-alpha-ol-3-one {ECO:0000269|PubMed:11013348, ECO:0000269|PubMed:8573067}; KM=133 uM for 9-alpha,11-beta-prostaglandin F(2) {ECO:0000269|PubMed:11013348, ECO:0000269|PubMed:8573067}; KM=2 uM for 5-beta-pregnan-3-alpha-ol-20-one {ECO:0000269|PubMed:11013348, ECO:0000269|PubMed:8573067}; KM=1 uM for 5-beta-androstane-3,17-dione {ECO:0000269|PubMed:11013348, ECO:0000269|PubMed:8573067}; KM=12 uM for prostaglandin D(2) {ECO:0000269|PubMed:11013348, ECO:0000269|PubMed:8573067}; KM=0.6 uM for 20-alpha-hydroxyprogesterone (with NADH) {ECO:0000269|PubMed:11013348, ECO:0000269|PubMed:8573067}; 	1.1.1.-; 1.1.1.149; 1.1.1.112; 1.3.1.20	CATALYTIC ACTIVITY: 17-alpha,20-alpha-dihydroxypregn-4-en-3-one + NAD(P)(+) = 17-alpha-hydroxyprogesterone + NAD(P)H. {ECO:0000269|PubMed:11013348, ECO:0000269|PubMed:8573067}.; CATALYTIC ACTIVITY: Trans-1,2-dihydrobenzene-1,2-diol + NADP(+) = catechol + NADPH. {ECO:0000269|PubMed:11013348, ECO:0000269|PubMed:8573067}.; CATALYTIC ACTIVITY: Indan-1-ol + NAD(P)(+) = indanone + NAD(P)H. {ECO:0000269|PubMed:8573067}.	BINDING 24 24 Substrate.; BINDING 50 50 NADP. {ECO:0000269|PubMed:12899831, ECO:0000269|PubMed:21414777}.; BINDING 117 117 Substrate. {ECO:0000250}.; BINDING 190 190 NADP. {ECO:0000269|PubMed:12899831, ECO:0000269|PubMed:21414777}.; BINDING 222 222 Substrate.; BINDING 227 227 Substrate.	ACTIVITY REGULATION: Inhibited by hexestrol with an IC(50) of 9.5 uM, 1,10-phenanthroline with an IC(50) of 55 uM, 1,7-phenanthroline with an IC(50) of 72 uM, flufenamic acid with an IC(50) of 6.0 uM, indomethacin with an IC(50) of 140 uM, ibuprofen with an IC(50) of 950 uM, lithocholic acid with an IC(50) of 25 uM, ursodeoxycholic acid with an IC(50) of 340 uM and chenodeoxycholic acid with an IC(50) of 570 uM. {ECO:0000269|PubMed:8573067}.				SITE 54 54 Important for substrate specificity. {ECO:0000250}.; SITE 84 84 Lowers pKa of active site Tyr. {ECO:0000250}.; SITE 222 222 May be involved in the mediating step between the transformation of progesterone and the release of the cofactor.			bile acid and bile salt transport [GO:0015721]; bile acid metabolic process [GO:0008206]; cellular response to jasmonic acid stimulus [GO:0071395]; cholesterol homeostasis [GO:0042632]; daunorubicin metabolic process [GO:0044597]; digestion [GO:0007586]; doxorubicin metabolic process [GO:0044598]; epithelial cell differentiation [GO:0030855]; intestinal cholesterol absorption [GO:0030299]; oxidation-reduction process [GO:0055114]; progesterone metabolic process [GO:0042448]; protein homooligomerization [GO:0051260]; response to organophosphorus [GO:0046683]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; xenobiotic metabolic process [GO:0006805]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity [GO:0047006]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; androsterone dehydrogenase (B-specific) activity [GO:0047042]; bile acid binding [GO:0032052]; carboxylic acid binding [GO:0031406]; indanol dehydrogenase activity [GO:0047718]; ketosteroid monooxygenase activity [GO:0047086]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; phenanthrene 9,10-monooxygenase activity [GO:0018636]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]; bile acid and bile salt transport [GO:0015721]; bile acid metabolic process [GO:0008206]; cellular response to jasmonic acid stimulus [GO:0071395]; cholesterol homeostasis [GO:0042632]; daunorubicin metabolic process [GO:0044597]; digestion [GO:0007586]; doxorubicin metabolic process [GO:0044598]; epithelial cell differentiation [GO:0030855]; intestinal cholesterol absorption [GO:0030299]; oxidation-reduction process [GO:0055114]; progesterone metabolic process [GO:0042448]; protein homooligomerization [GO:0051260]; response to organophosphorus [GO:0046683]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; xenobiotic metabolic process [GO:0006805]	17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity [GO:0047006]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; androsterone dehydrogenase (B-specific) activity [GO:0047042]; bile acid binding [GO:0032052]; carboxylic acid binding [GO:0031406]; indanol dehydrogenase activity [GO:0047718]; ketosteroid monooxygenase activity [GO:0047086]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; phenanthrene 9,10-monooxygenase activity [GO:0018636]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]	GO:0001523; GO:0004032; GO:0004033; GO:0005829; GO:0006805; GO:0007586; GO:0008206; GO:0015721; GO:0016655; GO:0018636; GO:0030299; GO:0030855; GO:0031406; GO:0032052; GO:0042448; GO:0042574; GO:0042632; GO:0044597; GO:0044598; GO:0046683; GO:0047006; GO:0047042; GO:0047086; GO:0047115; GO:0047718; GO:0051260; GO:0055114; GO:0070062; GO:0071395	SUBCELLULAR LOCATION: Cytoplasm.			8486699; 8132567; 7515059; 7626489; 10672042; 11013348; 15164054; 15489334; 8274401; 8573067; 8172617; 12899831; 21414777; 11158055; 11956619; 12579257; 12733716; 13678667; 15212687; 15492289; 15494612; 16338060; 16361083; 16385451; 16543247; 17149600; 17618725; 17697149; 17945194; 18087047; 18620380; 18624398; 18654764; 18984031; 19014918; 19218247; 19320734; 19423521; 19487289; 19696165; 19738201; 19846565; 20673851; 20689807; 20727920; 21217827; 21232532; 21521174; 21851338; 21900206; 22064385; 22278827; 23165153; 23183084; 23933386; 24189185; 24390875; 25416956; 25816367; 26362498; 26934124; 27698389; 28259989	8486699; 8132567; 7515059; 7626489; 10672042; 11013348; 15164054; 15489334; 8274401; 8573067; 8172617; 12899831; 21414777
6376	AKR1C3 DDH1 HSD17B5 KIAA0119 PGFS	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=142.1 uM for progesterone {ECO:0000269|PubMed:10557352}; KM=2.37 uM for 5-alpha-dihydrotestosterone {ECO:0000269|PubMed:10557352}; KM=1.0 uM for androstanediol {ECO:0000269|PubMed:10557352}; Vmax=20.1 nmol/min/mg enzyme with progesterone as substrate {ECO:0000269|PubMed:10557352}; Vmax=1.8 nmol/min/mg enzyme with 5-alpha-dihydrotestosterone as substrate {ECO:0000269|PubMed:10557352}; Vmax=4.4 nmol/min/mg enzyme with androstanediol as substrate {ECO:0000269|PubMed:10557352}; 	1.-.-.-; 1.1.1.357; 1.1.1.112; 1.1.1.188; 1.1.1.239; 1.1.1.64; 1.3.1.20	CATALYTIC ACTIVITY: Trans-1,2-dihydrobenzene-1,2-diol + NADP(+) = catechol + NADPH.; CATALYTIC ACTIVITY: A 3-alpha-hydroxysteroid + NAD(P)(+) = a 3-oxosteroid + NAD(P)H. {ECO:0000269|PubMed:10622721, ECO:0000269|PubMed:11165022, ECO:0000269|PubMed:7650035, ECO:0000269|PubMed:9415401, ECO:0000269|PubMed:9927279}.; CATALYTIC ACTIVITY: (5Z,13E)-(15S)-9-alpha,11-alpha,15-trihydroxyprosta-5,13-dienoate + NADP(+) = (5Z,13E)-(15S)-9-alpha,15-dihydroxy-11-oxoprosta-5,13-dienoate + NADPH. {ECO:0000269|PubMed:10622721, ECO:0000269|PubMed:11165022, ECO:0000269|PubMed:7650035, ECO:0000269|PubMed:9415401, ECO:0000269|PubMed:9927279}.; CATALYTIC ACTIVITY: Testosterone + NAD(+) = androstenedione + NADH. {ECO:0000269|PubMed:10622721, ECO:0000269|PubMed:11165022, ECO:0000269|PubMed:7650035, ECO:0000269|PubMed:9415401, ECO:0000269|PubMed:9927279}.; CATALYTIC ACTIVITY: Testosterone + NADP(+) = androst-4-ene-3,17-dione + NADPH. {ECO:0000269|PubMed:10622721, ECO:0000269|PubMed:11165022, ECO:0000269|PubMed:7650035, ECO:0000269|PubMed:9415401, ECO:0000269|PubMed:9927279}.; CATALYTIC ACTIVITY: Indan-1-ol + NAD(P)(+) = indanone + NAD(P)H.	BINDING 117 117 Substrate. {ECO:0000250}.	ACTIVITY REGULATION: Strongly inhibited by nonsteroidal anti-inflammatory drugs (NSAID) including flufenamic acid and indomethacin. Also inhibited by the flavinoid, rutin, and by selective serotonin inhibitors (SSRIs).				SITE 54 54 Important for substrate specificity. {ECO:0000250}.; SITE 84 84 Lowers pKa of active site Tyr. {ECO:0000250}.; SITE 227 227 Involved in ligand recognition and product release.; SITE 306 306 Involved in ligand recognition and product release.			cellular response to cadmium ion [GO:0071276]; cellular response to calcium ion [GO:0071277]; cellular response to corticosteroid stimulus [GO:0071384]; cellular response to jasmonic acid stimulus [GO:0071395]; cellular response to prostaglandin D stimulus [GO:0071799]; cellular response to prostaglandin stimulus [GO:0071379]; cellular response to reactive oxygen species [GO:0034614]; cellular response to starvation [GO:0009267]; cyclooxygenase pathway [GO:0019371]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; farnesol catabolic process [GO:0016488]; G-protein coupled receptor signaling pathway [GO:0007186]; keratinocyte differentiation [GO:0030216]; macromolecule metabolic process [GO:0043170]; male gonad development [GO:0008584]; negative regulation of retinoic acid biosynthetic process [GO:1900053]; oxidation-reduction process [GO:0055114]; positive regulation of cell death [GO:0010942]; positive regulation of cell proliferation [GO:0008284]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; progesterone metabolic process [GO:0042448]; prostaglandin metabolic process [GO:0006693]; protein import into nucleus, translocation [GO:0000060]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; regulation of testosterone biosynthetic process [GO:2000224]; renal absorption [GO:0070293]; response to nutrient [GO:0007584]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; steroid metabolic process [GO:0008202]; testosterone biosynthetic process [GO:0061370]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular [GO:0005622]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular [GO:0005622]; nucleus [GO:0005634]; 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; androsterone dehydrogenase activity [GO:0047023]; delta4-3-oxosteroid 5beta-reductase activity [GO:0047787]; dihydrotestosterone 17-beta-dehydrogenase activity [GO:0035410]; geranylgeranyl reductase activity [GO:0045550]; indanol dehydrogenase activity [GO:0047718]; ketoreductase activity [GO:0045703]; ketosteroid monooxygenase activity [GO:0047086]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; phenanthrene 9,10-monooxygenase activity [GO:0018636]; prostaglandin D2 11-ketoreductase activity [GO:0036131]; prostaglandin H2 endoperoxidase reductase activity [GO:0036130]; prostaglandin-F synthase activity [GO:0047017]; retinal dehydrogenase activity [GO:0001758]; retinol dehydrogenase activity [GO:0004745]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]; cellular response to cadmium ion [GO:0071276]; cellular response to calcium ion [GO:0071277]; cellular response to corticosteroid stimulus [GO:0071384]; cellular response to jasmonic acid stimulus [GO:0071395]; cellular response to prostaglandin D stimulus [GO:0071799]; cellular response to prostaglandin stimulus [GO:0071379]; cellular response to reactive oxygen species [GO:0034614]; cellular response to starvation [GO:0009267]; cyclooxygenase pathway [GO:0019371]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; farnesol catabolic process [GO:0016488]; G-protein coupled receptor signaling pathway [GO:0007186]; keratinocyte differentiation [GO:0030216]; macromolecule metabolic process [GO:0043170]; male gonad development [GO:0008584]; negative regulation of retinoic acid biosynthetic process [GO:1900053]; oxidation-reduction process [GO:0055114]; positive regulation of cell death [GO:0010942]; positive regulation of cell proliferation [GO:0008284]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; progesterone metabolic process [GO:0042448]; prostaglandin metabolic process [GO:0006693]; protein import into nucleus, translocation [GO:0000060]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; regulation of testosterone biosynthetic process [GO:2000224]; renal absorption [GO:0070293]; response to nutrient [GO:0007584]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; steroid metabolic process [GO:0008202]; testosterone biosynthetic process [GO:0061370]	15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; androsterone dehydrogenase activity [GO:0047023]; delta4-3-oxosteroid 5beta-reductase activity [GO:0047787]; dihydrotestosterone 17-beta-dehydrogenase activity [GO:0035410]; geranylgeranyl reductase activity [GO:0045550]; indanol dehydrogenase activity [GO:0047718]; ketoreductase activity [GO:0045703]; ketosteroid monooxygenase activity [GO:0047086]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; phenanthrene 9,10-monooxygenase activity [GO:0018636]; prostaglandin D2 11-ketoreductase activity [GO:0036131]; prostaglandin-F synthase activity [GO:0047017]; prostaglandin H2 endoperoxidase reductase activity [GO:0036130]; retinal dehydrogenase activity [GO:0001758]; retinol dehydrogenase activity [GO:0004745]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]	GO:0000060; GO:0001523; GO:0001758; GO:0004032; GO:0004033; GO:0004745; GO:0005622; GO:0005634; GO:0005737; GO:0005829; GO:0006693; GO:0007186; GO:0007584; GO:0008202; GO:0008284; GO:0008584; GO:0009267; GO:0010942; GO:0016488; GO:0016655; GO:0018636; GO:0019371; GO:0030216; GO:0034614; GO:0035410; GO:0036130; GO:0036131; GO:0042448; GO:0042574; GO:0043170; GO:0044597; GO:0044598; GO:0045550; GO:0045703; GO:0047017; GO:0047020; GO:0047023; GO:0047035; GO:0047045; GO:0047086; GO:0047115; GO:0047718; GO:0047787; GO:0048385; GO:0051897; GO:0052650; GO:0055114; GO:0061370; GO:0070062; GO:0070293; GO:0071276; GO:0071277; GO:0071379; GO:0071384; GO:0071395; GO:0071799; GO:1900053; GO:2000224; GO:2000353; GO:2000379	SUBCELLULAR LOCATION: Cytoplasm.			8274401; 7650035; 7626489; 9415401; 10622721; 10557352; 10672042; 11165022; 7788527; 14702039; 15164054; 15489334; 9927279; 21269460; 24275569; 14979715; 14996743; 15087468; 11158055; 12037313; 13678667; 14671194; 14997212; 15047184; 15212687; 15284179; 15582534; 15781210; 15814298; 16169070; 16189514; 16263811; 16302261; 16337083; 16338060; 16475787; 16480815; 16601286; 16983398; 17071532; 17149600; 17166832; 17220347; 17507624; 17583494; 17697149; 17940109; 18087047; 18306354; 18339682; 18552976; 18574251; 18632753; 18641923; 18676680; 18692800; 18984855; 18996480; 19014918; 19162045; 19170196; 19273550; 19320734; 19336370; 19336506; 19423521; 19460435; 19487289; 19574343; 19625176; 19692168; 19846565; 19942269; 20036328; 20086173; 20126582; 20145130; 20201926; 20379614; 20453000; 20634197; 20661409; 20689807; 20734064; 21039282; 21151387; 21232532; 21323680; 21365123; 21444150; 21521174; 21851338; 22170488; 22505408; 22507964; 22670171; 22877157; 22937138; 23024260; 23116553; 23183084; 23196782; 23432095; 23454516; 23519145; 23748150; 24012099; 24228104; 24244276; 24316309; 24411201; 24571686; 24832494; 24838369; 24917395; 25419901; 25446850; 25514466; 25522430; 25649766; 25661377; 25754347; 25849402; 26160177; 26170067; 26308156; 26362498; 26429394; 27019068; 27055738; 27085562; 27111237; 27385003; 27485119; 28025170; 28259989; 28359237; 28457968; 29602039; 29777907; 3862115	8274401; 7650035; 7626489; 9415401; 10622721; 10557352; 10672042; 11165022; 7788527; 14702039; 15164054; 15489334; 9927279; 21269460; 24275569; 14979715; 14996743; 15087468
6378	ACER2 ASAH3L PP11646	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=81 uM for D-erythro-C(24:1)-ceramide (at 37 degrees Celsius and pH 9.0) {ECO:0000269|PubMed:20089856}; Vmax=27 pmol/min/mg enzyme with D-erythro-C(24:1)-ceramide as substrate {ECO:0000269|PubMed:20089856}; 	3.5.1.23	CATALYTIC ACTIVITY: N-acylsphingosine + H(2)O = a carboxylate + sphingosine.		ACTIVITY REGULATION: Specifically activated by lumenal, but not cytosolic Ca(2+). Inhibited by Zn(2+) or Cu(2+). Mg(2+) or Mn(2+) have no effect on ceramidase activity. {ECO:0000269|PubMed:20089856}.		BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 7.5-9.0. {ECO:0000269|PubMed:20089856};			PP11646		activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cellular response to drug [GO:0035690]; ceramide metabolic process [GO:0006672]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of protein glycosylation in Golgi [GO:0090285]; positive regulation of cell death [GO:0010942]; positive regulation of cell proliferation [GO:0008284]; response to retinoic acid [GO:0032526]; sphingolipid biosynthetic process [GO:0030148]; sphingosine biosynthetic process [GO:0046512]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; ceramidase activity [GO:0102121]; dihydroceramidase activity [GO:0071633]; N-acylsphingosine amidohydrolase activity [GO:0017040]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cellular response to drug [GO:0035690]; ceramide metabolic process [GO:0006672]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of protein glycosylation in Golgi [GO:0090285]; positive regulation of cell death [GO:0010942]; positive regulation of cell proliferation [GO:0008284]; response to retinoic acid [GO:0032526]; sphingolipid biosynthetic process [GO:0030148]; sphingosine biosynthetic process [GO:0046512]	ceramidase activity [GO:0102121]; dihydroceramidase activity [GO:0071633]; N-acylsphingosine amidohydrolase activity [GO:0017040]	GO:0000139; GO:0001953; GO:0005794; GO:0006672; GO:0006919; GO:0008284; GO:0010942; GO:0017040; GO:0030148; GO:0030173; GO:0032526; GO:0033629; GO:0035690; GO:0046512; GO:0071633; GO:0090285; GO:0102121	SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000269|PubMed:16940153, ECO:0000269|PubMed:20089856}; Multi-pass membrane protein {ECO:0000269|PubMed:16940153, ECO:0000269|PubMed:20089856}.			16940153; 15498874; 15164053; 15489334; 18945876; 20089856; 20379614; 20628055; 24708996; 26943039	16940153; 15498874; 15164053; 15489334; 18945876; 20089856
6395	AASDHPPT CGI-80 HAH-P HSPC223 x0005	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.44 mM for magnesium {ECO:0000269|PubMed:18022563}; KM=0.025 mM for coenzyme A {ECO:0000269|PubMed:18022563}; 	2.7.8.-	CATALYTIC ACTIVITY: CoA-[4'-phosphopantetheine] + apo-[acyl-carrier-protein] = adenosine 3',5'-bisphosphate + holo-[acyl-carrier-protein].	BINDING 47 47 Coenzyme A.		COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:12815048, ECO:0000269|PubMed:18022563}; ;  Note=Binds 1 Mg(2+) ion. {ECO:0000269|PubMed:12815048, ECO:0000269|PubMed:18022563};				CGI-80 HAH-P HSPC223 x0005		lysine biosynthetic process via aminoadipic acid [GO:0019878]; pantothenate metabolic process [GO:0015939]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; holo-[acyl-carrier-protein] synthase activity [GO:0008897]; magnesium ion binding [GO:0000287]; lysine biosynthetic process via aminoadipic acid [GO:0019878]; pantothenate metabolic process [GO:0015939]	holo-[acyl-carrier-protein] synthase activity [GO:0008897]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005829; GO:0008897; GO:0015939; GO:0019878; GO:0070062	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12815048}.		MOD_RES 258 258 Phosphoserine. {ECO:0000244|PubMed:17525332, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.	11286508; 10810093; 11042152; 10931946; 14702039; 16554811; 15489334; 17974005; 12815048; 17525332; 18669648; 20068231; 21269460; 23186163; 24275569; 18022563; 16189514; 17353931; 19596235; 19615732; 19933275; 20562859; 25416956; 25609649; 26638075	11286508; 10810093; 11042152; 10931946; 14702039; 16554811; 15489334; 17974005; 12815048; 17525332; 18669648; 20068231; 21269460; 23186163; 24275569; 18022563
6402	ACOX1 ACOX	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=73 uM for palmitoyl-CoA (isoform 1) {ECO:0000269|PubMed:17603022}; KM=90 uM for palmitoyl-CoA (isoform 2) {ECO:0000269|PubMed:17603022}; 	1.3.3.6	CATALYTIC ACTIVITY: Acyl-CoA + O(2) = trans-2,3-dehydroacyl-CoA + H(2)O(2). {ECO:0000250|UniProtKB:P07872}.	BINDING 139 139 FAD. {ECO:0000250|UniProtKB:P07872}.; BINDING 178 178 FAD; via amide nitrogen. {ECO:0000250|UniProtKB:P07872}.		COFACTOR: Name=FAD; Xref=ChEBI:CHEBI:57692; Evidence={ECO:0000269|PubMed:17603022}; 	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 8.5 for isoform 1 and 7.5-8.5 for isoform 2. {ECO:0000269|PubMed:17603022};	PATHWAY: Lipid metabolism; peroxisomal fatty acid beta-oxidation.			BIOPHYSICOCHEMICAL PROPERTIES: ;  Temperature dependence: Optimum temperature for isoform 1 at pH 7.5 is 40 degrees Celsius with no activity at 50 degrees Celsius. Optimum temperature for isoform 2 at pH 7.5 is 47.5 degrees Celsius with 57% activity retained at 50 degrees Celsius. {ECO:0000269|PubMed:17603022};	alpha-linolenic acid metabolic process [GO:0036109]; cholesterol homeostasis [GO:0042632]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; peroxisome fission [GO:0016559]; prostaglandin metabolic process [GO:0006693]; protein targeting to peroxisome [GO:0006625]; regulation of lipid metabolic process [GO:0019216]; spermatogenesis [GO:0007283]; very long-chain fatty acid metabolic process [GO:0000038]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; acyl-CoA dehydrogenase activity [GO:0003995]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; palmitoyl-CoA oxidase activity [GO:0016401]; PDZ domain binding [GO:0030165]; protein N-terminus binding [GO:0047485]; signaling receptor binding [GO:0005102]; alpha-linolenic acid metabolic process [GO:0036109]; cholesterol homeostasis [GO:0042632]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; peroxisome fission [GO:0016559]; prostaglandin metabolic process [GO:0006693]; protein targeting to peroxisome [GO:0006625]; regulation of lipid metabolic process [GO:0019216]; spermatogenesis [GO:0007283]; very long-chain fatty acid metabolic process [GO:0000038]	acyl-CoA dehydrogenase activity [GO:0003995]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; palmitoyl-CoA oxidase activity [GO:0016401]; PDZ domain binding [GO:0030165]; protein N-terminus binding [GO:0047485]; signaling receptor binding [GO:0005102]	GO:0000038; GO:0003995; GO:0003997; GO:0005102; GO:0005634; GO:0005654; GO:0005730; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0005886; GO:0006091; GO:0006625; GO:0006629; GO:0006693; GO:0007283; GO:0016020; GO:0016401; GO:0016559; GO:0019216; GO:0019395; GO:0030165; GO:0033539; GO:0033540; GO:0036109; GO:0042632; GO:0043231; GO:0047485; GO:0050660; GO:0055088; GO:0071949	SUBCELLULAR LOCATION: Peroxisome {ECO:0000250|UniProtKB:P07872}.		MOD_RES 26 26 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 89 89 N6-succinyllysine. {ECO:0000250|UniProtKB:Q9R0H0}.; MOD_RES 90 90 N6-succinyllysine. {ECO:0000250|UniProtKB:Q9R0H0}.; MOD_RES 216 216 N6-acetyllysine. {ECO:0000250|UniProtKB:Q9R0H0}.; MOD_RES 241 241 N6-succinyllysine. {ECO:0000250|UniProtKB:Q9R0H0}.; MOD_RES 255 255 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 267 267 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 272 272 N6-acetyllysine. {ECO:0000250|UniProtKB:Q9R0H0}.; MOD_RES 349 349 N6-succinyllysine. {ECO:0000250|UniProtKB:Q9R0H0}.; MOD_RES 437 437 N6-acetyllysine; alternate. {ECO:0000244|PubMed:19608861}.; MOD_RES 437 437 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q9R0H0}.; MOD_RES 446 446 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q9R0H0}.; MOD_RES 446 446 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q9R0H0}.; MOD_RES 500 500 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 504 504 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 512 512 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q9R0H0}.; MOD_RES 512 512 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q9R0H0}.; MOD_RES 542 542 N6-succinyllysine. {ECO:0000250|UniProtKB:Q9R0H0}.; MOD_RES 637 637 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q9R0H0}.; MOD_RES 637 637 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q9R0H0}.; MOD_RES 643 643 N6-succinyllysine. {ECO:0000250|UniProtKB:Q9R0H0}.; MOD_RES 649 649 Phosphoserine. {ECO:0000250|UniProtKB:Q9R0H0}.; MOD_RES 651 651 N6-acetyllysine. {ECO:0000250|UniProtKB:Q9R0H0}.; MOD_RES 654 654 N6-succinyllysine. {ECO:0000250|UniProtKB:Q9R0H0}.	8159712; 7876265; 8040306; 8117268; 14702039; 17974005; 16625196; 15489334; 17081983; 17603022; 18281296; 18669648; 19608861; 20195242; 21269460; 23186163; 24275569; 25944712; 11815777; 17458872; 11500517; 11734571; 18536048; 18660489; 19710929; 20110263; 20562859; 22002062; 23933200; 24189400; 24418004; 25260751; 8656081	8159712; 7876265; 8040306; 8117268; 14702039; 17974005; 16625196; 15489334; 17081983; 17603022; 18281296; 18669648; 19608861; 20195242; 21269460; 23186163; 24275569; 25944712; 11815777; 17458872
6403	ACOT13 THEM2 HT012 PNAS-27	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=4.9 uM for n-decanoyl-CoA {ECO:0000269|PubMed:19170545}; KM=26 uM for n-octanoyl-CoA {ECO:0000269|PubMed:19170545}; KM=5 uM for myristoyl-CoA {ECO:0000269|PubMed:19170545}; KM=9 uM for palmitoyl-CoA {ECO:0000269|PubMed:19170545}; KM=9 uM for oleoyl-CoA {ECO:0000269|PubMed:19170545}; KM=10 uM for 3,4-dihydroxyphenylacetyl-CoA {ECO:0000269|PubMed:19170545}; KM=40 uM for 3-hydroxyphenylacetyl-CoA {ECO:0000269|PubMed:19170545}; 	3.1.2.-		BINDING 50 50 Substrate.						HT012 PNAS-27		acyl-CoA metabolic process [GO:0006637]; negative regulation of cold-induced thermogenesis [GO:0120163]; protein homotetramerization [GO:0051289]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; spindle [GO:0005819]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; spindle [GO:0005819]; acyl-CoA hydrolase activity [GO:0047617]; acyl-CoA metabolic process [GO:0006637]; negative regulation of cold-induced thermogenesis [GO:0120163]; protein homotetramerization [GO:0051289]	acyl-CoA hydrolase activity [GO:0047617]	GO:0005634; GO:0005737; GO:0005739; GO:0005819; GO:0005829; GO:0006637; GO:0047617; GO:0051289; GO:0120163	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250|UniProtKB:Q9CQR4}. Mitochondrion {ECO:0000250|UniProtKB:Q9CQR4}. Nucleus {ECO:0000250|UniProtKB:Q9CQR4}. Cytoplasm, cytoskeleton, spindle {ECO:0000250|UniProtKB:Q9CQR4}. Note=During interphase, found both in the nucleus and in the cytoplasm. At mitosis, localizes to the spindle. Colocalizes with tubulin. {ECO:0000250|UniProtKB:Q9CQR4}.		MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378, ECO:0000244|PubMed:25944712}.; MOD_RES 2 2 N-acetylthreonine; in Acyl-coenzyme A thioesterase 13, N-terminally processed. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378, ECO:0000244|PubMed:25944712}.; MOD_RES 27 27 N6-acetyllysine. {ECO:0000250|UniProtKB:Q9CQR4}.; MOD_RES 37 37 N6-acetyllysine. {ECO:0000250|UniProtKB:Q9CQR4}.; MOD_RES 43 43 N6-acetyllysine. {ECO:0000250|UniProtKB:Q9CQR4}.; MOD_RES 108 108 N6-acetyllysine. {ECO:0000250|UniProtKB:Q9CQR4}.; MOD_RES 127 127 N6-acetyllysine. {ECO:0000250|UniProtKB:Q9CQR4}.	10931946; 14702039; 14574404; 15489334; 19413330; 21269460; 22223895; 22814378; 24275569; 25944712; 16934754; 19170545; 11696000; 15638818; 16423998; 16940157; 17045243; 17353931; 17704541; 18095154; 18624398; 19738201; 20338778; 20470824; 20711500; 20877624; 22262880; 22465940; 23700546; 23901139; 23954868; 24732803; 24894958; 25002576; 25953057	10931946; 14702039; 14574404; 15489334; 19413330; 21269460; 22223895; 22814378; 24275569; 25944712; 16934754; 19170545; 
6431	ACOT1 CTE1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=35.8 uM for C10-acyl-CoA {ECO:0000269|PubMed:16940157}; KM=3.6 uM for C12-acyl-CoA {ECO:0000269|PubMed:16940157}; KM=2.8 uM for C14-acyl-CoA {ECO:0000269|PubMed:16940157}; KM=3.6 uM for C16-acyl-CoA {ECO:0000269|PubMed:16940157}; KM=2.4 uM for C18-acyl-CoA {ECO:0000269|PubMed:16940157}; KM=2 uM for C20-acyl-CoA {ECO:0000269|PubMed:16940157}; KM=2.4 uM for C16:1-acyl-CoA {ECO:0000269|PubMed:16940157}; KM=4.1 uM for C18:1-acyl-CoA {ECO:0000269|PubMed:16940157}; KM=2.1 uM for C18:1-trans-acyl-CoA {ECO:0000269|PubMed:16940157}; Vmax=224 nmol/min/mg enzyme toward C10-acyl-CoA {ECO:0000269|PubMed:16940157}; Vmax=700 nmol/min/mg enzyme toward C12-acyl-CoA {ECO:0000269|PubMed:16940157}; Vmax=912 nmol/min/mg enzyme toward C14-acyl-CoA {ECO:0000269|PubMed:16940157}; Vmax=691 nmol/min/mg enzyme toward C16-acyl-CoA {ECO:0000269|PubMed:16940157}; Vmax=597 nmol/min/mg enzyme toward C18-acyl-CoA {ECO:0000269|PubMed:16940157}; Vmax=520 nmol/min/mg enzyme toward C20-acyl-CoA {ECO:0000269|PubMed:16940157}; Vmax=577 nmol/min/mg enzyme toward C16:1-acyl-CoA {ECO:0000269|PubMed:16940157}; Vmax=258 nmol/min/mg enzyme toward C18:1-acyl-CoA {ECO:0000269|PubMed:16940157}; Vmax=309 nmol/min/mg enzyme toward C18:1-trans-acyl-CoA {ECO:0000269|PubMed:16940157}; 	3.1.2.2	CATALYTIC ACTIVITY: Palmitoyl-CoA + H(2)O = CoA + palmitate.									acyl-CoA metabolic process [GO:0006637]; long-chain fatty acid metabolic process [GO:0001676]; very long-chain fatty acid metabolic process [GO:0000038]	cytosol [GO:0005829]	cytosol [GO:0005829]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; acyl-CoA metabolic process [GO:0006637]; long-chain fatty acid metabolic process [GO:0001676]; very long-chain fatty acid metabolic process [GO:0000038]	acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]	GO:0000038; GO:0001676; GO:0005829; GO:0006637; GO:0016290; GO:0047617; GO:0052689; GO:0102991	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16940157}.			16940157; 15489334; 11696000; 15638818; 16423998; 16934754; 19170545; 20338778; 20470824; 22465940; 23700546; 23901139; 24732803; 25002576; 26496610	16940157; 15489334; 
6437	ADA ADA1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=37 uM for adenosine (at 25 degrees Celsius and pH 5.5) {ECO:0000269|PubMed:8452534}; Vmax=41 umol/min/mg enzyme {ECO:0000269|PubMed:23193172}; 	3.5.4.4	CATALYTIC ACTIVITY: Adenosine + H(2)O = inosine + NH(3). {ECO:0000269|PubMed:16670267, ECO:0000269|PubMed:23193172, ECO:0000269|PubMed:8452534}.	BINDING 17 17 Substrate. {ECO:0000244|PDB:3IAR, ECO:0000269|Ref.24}.; BINDING 19 19 Substrate. {ECO:0000244|PDB:3IAR, ECO:0000269|Ref.24}.; BINDING 184 184 Substrate; via amide nitrogen. {ECO:0000244|PDB:3IAR, ECO:0000269|Ref.24}.; BINDING 296 296 Substrate. {ECO:0000244|PDB:3IAR, ECO:0000269|Ref.24}.	ACTIVITY REGULATION: Inhibited by Cu(2+) and Hg(2+), coformycin, deoxycoformycin (dCF), 2-deoxyadenosine, 6-methylaminopurine riboside, 2-3-iso-propylidene-adenosine and erythro-9-(2-hydroxy-3-nonyl)adenine. {ECO:0000269|PubMed:16670267, ECO:0000269|PubMed:8452534}.	COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000305|Ref.24}; ;  Note=Binds 1 zinc ion per subunit. {ECO:0000305|Ref.24};			SITE 58 58 Important for interaction with adenosine receptors and increasing their affinity for agonists. {ECO:0000269|PubMed:23193172}.; SITE 62 62 Important for interaction with adenosine receptors and increasing their affinity for agonists. {ECO:0000269|PubMed:23193172}.; SITE 238 238 Important for catalytic activity. {ECO:0000250|UniProtKB:P03958}.			adenosine catabolic process [GO:0006154]; aging [GO:0007568]; cell adhesion [GO:0007155]; dATP catabolic process [GO:0046061]; deoxyadenosine catabolic process [GO:0006157]; embryonic digestive tract development [GO:0048566]; germinal center B cell differentiation [GO:0002314]; histamine secretion [GO:0001821]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; negative regulation of adenosine receptor signaling pathway [GO:0060169]; negative regulation of circadian sleep/wake cycle, non-REM sleep [GO:0042323]; negative regulation of inflammatory response [GO:0050728]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of mature B cell apoptotic process [GO:0002906]; negative regulation of mucus secretion [GO:0070256]; negative regulation of penile erection [GO:0060407]; negative regulation of thymocyte apoptotic process [GO:0070244]; Peyer's patch development [GO:0048541]; placenta development [GO:0001890]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of germinal center formation [GO:0002636]; positive regulation of heart rate [GO:0010460]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of T cell receptor signaling pathway [GO:0050862]; purine-containing compound salvage [GO:0043101]; purine nucleotide salvage [GO:0032261]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; regulation of cell-cell adhesion mediated by integrin [GO:0033632]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to morphine [GO:0043278]; response to vitamin E [GO:0033197]; T cell activation [GO:0042110]; trophectodermal cell differentiation [GO:0001829]; xanthine biosynthetic process [GO:0046111]	cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; lysosome [GO:0005764]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]	cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; lysosome [GO:0005764]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; adenosine deaminase activity [GO:0004000]; purine nucleoside binding [GO:0001883]; zinc ion binding [GO:0008270]; adenosine catabolic process [GO:0006154]; aging [GO:0007568]; cell adhesion [GO:0007155]; dATP catabolic process [GO:0046061]; deoxyadenosine catabolic process [GO:0006157]; embryonic digestive tract development [GO:0048566]; germinal center B cell differentiation [GO:0002314]; histamine secretion [GO:0001821]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; negative regulation of adenosine receptor signaling pathway [GO:0060169]; negative regulation of circadian sleep/wake cycle, non-REM sleep [GO:0042323]; negative regulation of inflammatory response [GO:0050728]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of mature B cell apoptotic process [GO:0002906]; negative regulation of mucus secretion [GO:0070256]; negative regulation of penile erection [GO:0060407]; negative regulation of thymocyte apoptotic process [GO:0070244]; Peyer's patch development [GO:0048541]; placenta development [GO:0001890]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of germinal center formation [GO:0002636]; positive regulation of heart rate [GO:0010460]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of T cell receptor signaling pathway [GO:0050862]; purine nucleotide salvage [GO:0032261]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; purine-containing compound salvage [GO:0043101]; regulation of cell-cell adhesion mediated by integrin [GO:0033632]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to morphine [GO:0043278]; response to vitamin E [GO:0033197]; T cell activation [GO:0042110]; trophectodermal cell differentiation [GO:0001829]; xanthine biosynthetic process [GO:0046111]	adenosine deaminase activity [GO:0004000]; purine nucleoside binding [GO:0001883]; zinc ion binding [GO:0008270]	GO:0001666; GO:0001821; GO:0001829; GO:0001883; GO:0001889; GO:0001890; GO:0002314; GO:0002636; GO:0002686; GO:0002906; GO:0004000; GO:0005615; GO:0005764; GO:0005829; GO:0005886; GO:0006154; GO:0006157; GO:0007155; GO:0007568; GO:0008270; GO:0009168; GO:0009897; GO:0009986; GO:0010460; GO:0016020; GO:0030054; GO:0030890; GO:0032261; GO:0032839; GO:0033089; GO:0033197; GO:0033632; GO:0042110; GO:0042323; GO:0042542; GO:0043025; GO:0043101; GO:0043103; GO:0043278; GO:0045987; GO:0046061; GO:0046103; GO:0046111; GO:0046638; GO:0048286; GO:0048541; GO:0048566; GO:0050728; GO:0050850; GO:0050862; GO:0060169; GO:0060205; GO:0060407; GO:0070244; GO:0070256	SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11772392, ECO:0000269|PubMed:8101391}; Peripheral membrane protein; Extracellular side. Cell junction {ECO:0000269|PubMed:11772392}. Cytoplasmic vesicle lumen {ECO:0000250|UniProtKB:P03958}. Cytoplasm {ECO:0000250}. Lysosome {ECO:0000269|PubMed:8452534}. Note=Colocalized with DPP4 at the cell surface. {ECO:0000269|PubMed:11772392}.		MOD_RES 2 2 N-acetylalanine. {ECO:0000269|Ref.8}.; MOD_RES 54 54 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 232 232 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.	6090454; 6546794; 3839456; 3028473; 11780052; 15489334; 6688808; 8452534; 8101391; 7907293; 10951221; 11772392; 15016824; 14691230; 16670267; 19690332; 19608861; 21269460; 20959412; 21919946; 23193172; 2166947; 8031011; 6208479; 3839802; 3182793; 2783588; 1284479; 8227344; 8299233; 8589684; 7599635; 9225964; 9361033; 10200056; 16221767; 18772397; 21734253; 26166670; 11121182; 11354825; 11534018; 11901152; 12104097; 12113294; 12381379; 12712614; 12774669; 12809673; 12935677; 14726805; 15063762; 15257174; 15281007; 15632314; 15761857; 15983379; 16133068; 16224193; 16410722; 16724628; 16754522; 16886895; 16970880; 17181544; 17243920; 17287605; 17340203; 17397971; 17536804; 17696452; 18218852; 18222177; 18302529; 18357489; 18560234; 18562134; 18597230; 18673094; 18680557; 18768081; 18794722; 19019667; 19026999; 19086053; 19172437; 19237091; 19470168; 19521708; 19633200; 19668260; 19703146; 19789510; 19845893; 19901882; 19913121; 20147632; 20174870; 20180986; 20306731; 20347569; 20392501; 20412337; 20414589; 20453107; 20480728; 20522203; 20548128; 20554694; 20581655; 20590444; 20615890; 20628086; 20651391; 20836741; 20872567; 20943049; 21044950; 21198750; 21269755; 21350874; 21359089; 21365880; 21461854; 21496384; 21593678; 21640091; 21725047; 21856036; 21860532; 21865054; 21988832; 22062893; 22086524; 22104430; 22184407; 22614344; 22719194; 22942500; 22952909; 23066321; 23096558; 23160984; 23240012; 23433854; 23768730; 23897810; 23959645; 24257613; 24305782; 24453844; 24640520; 24682206; 24762755; 24896148; 24965595; 24997584; 25125338; 25170811; 25293959; 25437848; 25527815; 25647479; 25689690; 25764155; 25963491; 26216523; 26261621; 26310829; 26329539; 26376800; 26659614; 26707067; 26794633; 26918693; 26980102; 26994767; 27017482; 27044834; 27186641; 27273565; 27557561; 27663683; 28748310; 29061410; 29194839; 30017738	6090454; 6546794; 3839456; 3028473; 11780052; 15489334; 6688808; 8452534; 8101391; 7907293; 10951221; 11772392; 15016824; 14691230; 16670267; 19690332; 19608861; 21269460; 20959412; 21919946; 23193172; 2166947; 8031011; 6208479; 3839802; 3182793; 2783588; 1284479; 8227344; 8299233; 8589684; 7599635; 9225964; 9361033; 10200056; 16221767; 18772397; 21734253; 26166670
6463	ACE2 UNQ868/PRO1885	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=6.9 uM for angiotensin I {ECO:0000269|PubMed:11815627}; KM=2 uM for angiotensin II {ECO:0000269|PubMed:11815627}; KM=6.8 uM for apelin-13 {ECO:0000269|PubMed:11815627}; KM=5.5 uM for dynorphin-13 {ECO:0000269|PubMed:11815627}; 	3.4.17.23	CATALYTIC ACTIVITY: Angiotensin II + H(2)O = angiotensin-(1-7) + L-phenylalanine.	BINDING 169 169 Chloride.; BINDING 273 273 Substrate.; BINDING 345 345 Substrate.; BINDING 346 346 Substrate; via carbonyl oxygen.; BINDING 371 371 Substrate.; BINDING 477 477 Chloride.; BINDING 481 481 Chloride.; BINDING 515 515 Substrate.	ACTIVITY REGULATION: Activated by chloride and fluoride, but not bromide. Inhibited by MLN-4760, cFP_Leu, and EDTA, but not by the ACE inhibitors linosipril, captopril and enalaprilat. {ECO:0000269|PubMed:10924499, ECO:0000269|PubMed:10969042, ECO:0000269|PubMed:11815627, ECO:0000269|PubMed:15231706}.	COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000269|PubMed:11815627}; ;  Note=Binds 1 zinc ion per subunit. {ECO:0000269|PubMed:11815627};; COFACTOR: Name=chloride; Xref=ChEBI:CHEBI:17996; Evidence={ECO:0000269|PubMed:11815627}; ;  Note=Binds 1 Cl(-) ion per subunit. {ECO:0000269|PubMed:11815627};	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 6.5 in the presence of 1 M NaCl. Active from pH 6 to 9. {ECO:0000269|PubMed:11815627};			UNQ868/PRO1885		angiotensin maturation [GO:0002003]; angiotensin-mediated drinking behavior [GO:0003051]; positive regulation of amino acid transport [GO:0051957]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of gap junction assembly [GO:1903598]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; receptor biosynthetic process [GO:0032800]; receptor-mediated virion attachment to host cell [GO:0046813]; regulation of blood vessel diameter [GO:0097746]; regulation of cardiac conduction [GO:1903779]; regulation of cell proliferation [GO:0042127]; regulation of cytokine production [GO:0001817]; regulation of inflammatory response [GO:0050727]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; regulation of vasoconstriction [GO:0019229]; tryptophan transport [GO:0015827]; viral entry into host cell [GO:0046718]	brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; endopeptidase activity [GO:0004175]; metallocarboxypeptidase activity [GO:0004181]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; angiotensin maturation [GO:0002003]; angiotensin-mediated drinking behavior [GO:0003051]; positive regulation of amino acid transport [GO:0051957]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of gap junction assembly [GO:1903598]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; receptor biosynthetic process [GO:0032800]; receptor-mediated virion attachment to host cell [GO:0046813]; regulation of blood vessel diameter [GO:0097746]; regulation of cardiac conduction [GO:1903779]; regulation of cell proliferation [GO:0042127]; regulation of cytokine production [GO:0001817]; regulation of inflammatory response [GO:0050727]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; regulation of vasoconstriction [GO:0019229]; tryptophan transport [GO:0015827]; viral entry into host cell [GO:0046718]	carboxypeptidase activity [GO:0004180]; endopeptidase activity [GO:0004175]; metallocarboxypeptidase activity [GO:0004181]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]	GO:0001618; GO:0001817; GO:0002003; GO:0003051; GO:0003081; GO:0004175; GO:0004180; GO:0004181; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0008270; GO:0009986; GO:0015827; GO:0016021; GO:0019229; GO:0031526; GO:0032800; GO:0042127; GO:0045121; GO:0046718; GO:0046813; GO:0050727; GO:0051957; GO:0060452; GO:0070062; GO:0097746; GO:1903598; GO:1903779; GO:2000379	SUBCELLULAR LOCATION: Processed angiotensin-converting enzyme 2: Secreted.; SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane protein. Cytoplasm {ECO:0000250}. Note=Detected in both cell membrane and cytoplasm in neurons. {ECO:0000250}.	PTM: N-glycosylation on Asn-90 may limit SARS infectivity. {ECO:0000269|PubMed:10924499, ECO:0000269|PubMed:14647384, ECO:0000269|PubMed:14754895, ECO:0000269|PubMed:15084671, ECO:0000269|PubMed:19159218}.; PTM: Proteolytic cleavage by ADAM17 generates a secreted form. Also cleaved by serine proteases: TMPRSS2, TMPRSS11D and HPN/TMPRSS1. {ECO:0000269|PubMed:15983030, ECO:0000269|PubMed:21068237, ECO:0000269|PubMed:21563828, ECO:0000269|PubMed:24227843}.		10969042; 10924499; 15231706; 15937940; 12975309; 15489334; 17974005; 15276642; 12459472; 11815627; 14647384; 15151696; 15141377; 15452268; 15084671; 15671045; 15791205; 15983030; 15897467; 19159218; 21563828; 21068237; 24227843; 14754895; 12967627; 14670965; 15165741; 15233982; 15283675; 15361769; 15380922; 15640278; 15769906; 15979045; 16001071; 16006956; 16055515; 16088128; 16166094; 16166518; 16211375; 16215952; 16283142; 16315782; 16338465; 16459167; 16510163; 16574921; 16647014; 16690935; 16866021; 16912312; 16962475; 17037534; 17037543; 17037544; 17037581; 17079315; 17303661; 17473847; 17504232; 17703127; 17897017; 17906677; 18022600; 18070603; 18208662; 18223023; 18223027; 18223028; 18258853; 18310257; 18389211; 18441099; 18448527; 18490652; 18496132; 18502721; 18554741; 18560893; 18660448; 18753062; 18814896; 18926157; 18931070; 19020433; 19021774; 19034303; 19051693; 19067252; 19077694; 19136547; 19141296; 19164471; 19164480; 19212105; 19286756; 19286757; 19289653; 19297479; 19411314; 19461648; 19684612; 19700132; 19716087; 19864379; 19901337; 19913121; 19924243; 19926873; 19934006; 20060185; 20117248; 20117991; 20142028; 20160196; 20204277; 20224560; 20349406; 20484496; 20541774; 20559404; 20592051; 20628086; 20660625; 20674894; 20679547; 20692300; 20703229; 20798044; 20813695; 20831027; 20854388; 21052031; 21072744; 21189404; 21265092; 21316680; 21346373; 21411533; 21457402; 21490025; 21670585; 21814048; 21864606; 21880865; 21946695; 21952934; 21963832; 21993363; 22025374; 22033511; 22048948; 22179088; 22291007; 22297693; 22475818; 22523556; 22647782; 22718567; 22749485; 22750422; 23077079; 23091417; 23144053; 23230080; 23328447; 23488800; 23545945; 23630610; 23816468; 23893738; 23921915; 24014829; 24054336; 24100303; 24112034; 24134599; 24142614; 24147777; 24158104; 24172901; 24191856; 24342297; 24564768; 24662240; 24691269; 24728465; 24838502; 24842388; 24920267; 25200929; 25237166; 25237167; 25359286; 25519733; 25534429; 25663464; 25665060; 25701390; 25721616; 25791940; 25813276; 25815490; 25869724; 26067610; 26995300; 27063099; 27093376; 27121444; 27310975; 27460845; 27488276; 27500554; 27615597; 27738071; 27884212; 27889958; 27965422; 27983983; 28186543; 28223093; 28440441; 28605813; 28744816; 29128354; 29441892; 30102747	10969042; 10924499; 15231706; 15937940; 12975309; 15489334; 17974005; 15276642; 12459472; 11815627; 14647384; 15151696; 15141377; 15452268; 15084671; 15671045; 15791205; 15983030; 15897467; 19159218; 21563828; 21068237; 24227843; 14754895
6484	ASAH2 HNAC1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=71.4 uM for octanoyl-sphingosine {ECO:0000269|PubMed:10781606, ECO:0000269|PubMed:16229686}; KM=66 uM for palmitoyl-sphingosine {ECO:0000269|PubMed:10781606, ECO:0000269|PubMed:16229686}; KM=60.1 uM for D-erythro-C12-NBD-ceramide {ECO:0000269|PubMed:10781606, ECO:0000269|PubMed:16229686}; Vmax=160 umol/min/mg enzyme with octanoyl-sphingosine as substrate {ECO:0000269|PubMed:10781606, ECO:0000269|PubMed:16229686}; Vmax=16 umol/min/mg enzyme with palmitoyl-sphingosine as substrate {ECO:0000269|PubMed:10781606, ECO:0000269|PubMed:16229686}; Vmax=0.68 nmol/min/mg enzyme with D-erythro-C12-NBD-ceramide as substrate {ECO:0000269|PubMed:10781606, ECO:0000269|PubMed:16229686}; 	3.5.1.23	CATALYTIC ACTIVITY: N-acylsphingosine + H(2)O = a carboxylate + sphingosine. {ECO:0000269|PubMed:10781606, ECO:0000269|PubMed:16229686, ECO:0000269|PubMed:26190575}.		ACTIVITY REGULATION: Inhibited by dithiothreitol (DTT). Activity is mildly stimulated by Ca(2+) and Mg(2+), but is not inhibited by EDTA (PubMed:10781606, PubMed:16229686). Activity is inhibited by mM levels of Fe(2+), Zn(2+) and Cu(2+) (PubMed:16229686). {ECO:0000269|PubMed:10781606, ECO:0000269|PubMed:16229686}.	COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000269|PubMed:26190575}; ;  Note=Binds 1 zinc ion per subunit. {ECO:0000269|PubMed:26190575};	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 7.5-9.5. {ECO:0000269|PubMed:10781606, ECO:0000269|PubMed:16229686};					apoptotic process [GO:0006915]; ceramide metabolic process [GO:0006672]; sphingosine metabolic process [GO:0006670]	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; ceramidase activity [GO:0102121]; N-acylsphingosine amidohydrolase activity [GO:0017040]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; ceramide metabolic process [GO:0006672]; sphingosine metabolic process [GO:0006670]	calcium ion binding [GO:0005509]; ceramidase activity [GO:0102121]; N-acylsphingosine amidohydrolase activity [GO:0017040]; zinc ion binding [GO:0008270]	GO:0005509; GO:0005739; GO:0005886; GO:0006670; GO:0006672; GO:0006915; GO:0008270; GO:0016021; GO:0017040; GO:0102121	SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15845354}; Single-pass type II membrane protein {ECO:0000269|PubMed:15845354}. Note=The neutral ceramidase soluble form is a secreted protein. According to PubMed:10781606, it is mitochondrial. However, they used a shorter form in its N-terminus, which may explain this localization which probably does not exist in vivo.	PTM: N-glycosylated. Required for enzyme activity. {ECO:0000250|UniProtKB:Q9JHE3}.; PTM: O-glycosylated. Required to retain it as a type II membrane protein at the cell surface. {ECO:0000269|PubMed:15845354}.; PTM: Phosphorylated. May prevent ubiquitination and subsequent degradation. {ECO:0000250|UniProtKB:Q91XT9}.; PTM: Ubiquitinated, leading to its degradation by the proteasome. Ubiquitination is triggered by nitric oxid. {ECO:0000250|UniProtKB:Q91XT9}.		14557071; 15946935; 15164054; 10781606; 15489334; 15845354; 16061940; 16229686; 17334805; 26190575; 15210766; 16385451; 16940153; 17475390; 17982236; 20520628; 20877624; 21530485; 21531200; 24397980	14557071; 15946935; 15164054; 10781606; 15489334; 15845354; 16061940; 16229686; 17334805; 26190575
6493	PHYKPL AGXT2L2 PP9286	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=16 uM for 5-phosphohydroxy-L-lysine (at 30 degrees Celsius) {ECO:0000269|PubMed:22241472}; Vmax=256 nmol/min/mg enzyme {ECO:0000269|PubMed:22241472}; 	4.2.3.134	CATALYTIC ACTIVITY: (5R)-5-phosphonooxy-L-lysine + H(2)O = (S)-2-amino-6-oxohexanoate + NH(3) + phosphate.			COFACTOR: Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326; Evidence={ECO:0000269|PubMed:22241472}; 				PP9286		collagen catabolic process [GO:0030574]; lysine catabolic process [GO:0006554]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; alanine-glyoxylate transaminase activity [GO:0008453]; identical protein binding [GO:0042802]; lyase activity [GO:0016829]; pyridoxal phosphate binding [GO:0030170]; collagen catabolic process [GO:0030574]; lysine catabolic process [GO:0006554]	alanine-glyoxylate transaminase activity [GO:0008453]; identical protein binding [GO:0042802]; lyase activity [GO:0016829]; pyridoxal phosphate binding [GO:0030170]	GO:0005739; GO:0005759; GO:0006554; GO:0008453; GO:0016829; GO:0030170; GO:0030574; GO:0042802	SUBCELLULAR LOCATION: Mitochondrion {ECO:0000305}.		MOD_RES 278 278 N6-(pyridoxal phosphate)lysine. {ECO:0000250}.	15498874; 14702039; 15372022; 15489334; 22241472; 24275569; 23242558; 16189514; 20711500; 20877624; 21044950; 25416956; 26496610	15498874; 14702039; 15372022; 15489334; 22241472; 24275569; 23242558
6495	ATG4C APG4C AUTL1 AUTL3	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=47.5 uM for MAP1LC3B {ECO:0000269|PubMed:21177865}; KM=12.4 uM for GABARAPL2 {ECO:0000269|PubMed:21177865}; 	3.4.22.-			ACTIVITY REGULATION: Inhibited by N-ethylmaleimide.							autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; C-terminal protein lipidation [GO:0006501]; protein delipidation [GO:0051697]; protein targeting to membrane [GO:0006612]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; cysteine-type endopeptidase activity [GO:0004197]; peptidase activity [GO:0008233]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; C-terminal protein lipidation [GO:0006501]; protein delipidation [GO:0051697]; protein targeting to membrane [GO:0006612]; proteolysis [GO:0006508]	cysteine-type endopeptidase activity [GO:0004197]; peptidase activity [GO:0008233]	GO:0000045; GO:0000422; GO:0004197; GO:0005576; GO:0005737; GO:0005829; GO:0006501; GO:0006508; GO:0006612; GO:0006914; GO:0008233; GO:0044804; GO:0051697	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.		MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:19413330}.; MOD_RES 451 451 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 452 452 Phosphothreonine. {ECO:0000244|PubMed:23186163}.	12446702; 14702039; 16710414; 15489334; 19413330; 21177865; 23186163; 15187094; 18193044; 19322194; 20562859; 22248718; 27742532; 28423511	12446702; 14702039; 16710414; 15489334; 19413330; 21177865; 23186163
6524	ATG4D APG4D AUTL4	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=13.1 uM for MAP1LC3B {ECO:0000269|PubMed:21177865}; KM=7.2 uM for GABARAPL2 {ECO:0000269|PubMed:21177865}; 	3.4.22.-			ACTIVITY REGULATION: Inhibited by N-ethylmaleimide.				SITE 63 64 Cleavage; by CASP3.			apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; C-terminal protein lipidation [GO:0006501]; protein delipidation [GO:0051697]; protein targeting to membrane [GO:0006612]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; cysteine-type endopeptidase activity [GO:0004197]; apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; C-terminal protein lipidation [GO:0006501]; protein delipidation [GO:0051697]; protein targeting to membrane [GO:0006612]	cysteine-type endopeptidase activity [GO:0004197]	GO:0000045; GO:0000422; GO:0004197; GO:0005737; GO:0005759; GO:0005829; GO:0006501; GO:0006612; GO:0006915; GO:0044804; GO:0051697	SUBCELLULAR LOCATION: Cysteine protease ATG4D: Cytoplasm {ECO:0000269|PubMed:19549685}.; SUBCELLULAR LOCATION: Cysteine protease ATG4D, mitochondrial: Cytoplasm {ECO:0000269|PubMed:19549685}. Mitochondrion matrix {ECO:0000269|PubMed:19549685, ECO:0000269|PubMed:22441018}. Note=Imported into mitochondrial matrix after cleavage by CASP3 during oxidative stress and cell death. {ECO:0000269|PubMed:22441018}.	PTM: Cleaved by CASP3 during apoptosis which leads to increased activity. The cleavage by CASP3 reveals a cryptic mitochondrial targeting sequence immediately downstream of their canonical caspase cleavage sites which leads to mitochondrial import of the protein. {ECO:0000269|PubMed:19549685, ECO:0000269|PubMed:22441018}.	MOD_RES 467 467 Phosphoserine. {ECO:0000244|PubMed:23186163}.	12446702; 15057824; 15489334; 19549685; 21177865; 22441018; 23186163; 15187094; 19322194; 23508006; 27265029; 28834690	12446702; 15057824; 15489334; 19549685; 21177865; 22441018; 23186163
6573	ATG4A APG4A AUTL2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=33.9 uM for MAP1LC3B {ECO:0000269|PubMed:21177865, ECO:0000269|PubMed:22302004}; KM=20.8 uM for GABARAP {ECO:0000269|PubMed:21177865, ECO:0000269|PubMed:22302004}; KM=36.7 uM for GABARAPL1 {ECO:0000269|PubMed:21177865, ECO:0000269|PubMed:22302004}; KM=15.7 uM for GABARAPL2 {ECO:0000269|PubMed:21177865, ECO:0000269|PubMed:22302004}; 	3.4.22.-			ACTIVITY REGULATION: Inhibited by N-ethylmaleimide. Redox-regulated during autophagy since reducing conditions activate ATG4A whereas an oxidizing environment such as the presence of H(2)O(2) inhibits its activity. {ECO:0000269|PubMed:12473658, ECO:0000269|PubMed:17347651}.							autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; C-terminal protein lipidation [GO:0006501]; protein delipidation [GO:0051697]; protein targeting to membrane [GO:0006612]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; C-terminal protein lipidation [GO:0006501]; protein delipidation [GO:0051697]; protein targeting to membrane [GO:0006612]; proteolysis [GO:0006508]	cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]	GO:0000045; GO:0000422; GO:0004197; GO:0005737; GO:0005829; GO:0006501; GO:0006508; GO:0006612; GO:0008234; GO:0044804; GO:0051697	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.			12446702; 15169837; 14702039; 15772651; 15489334; 12473658; 17347651; 21177865; 21245471; 22302004; 15187094; 19322194; 20010802; 20562859; 20819778; 21122541; 21297227; 23508006; 24229464; 24256813; 25416956; 25426560; 26061994; 26496610; 27276686; 28253956	12446702; 15169837; 14702039; 15772651; 15489334; 12473658; 17347651; 21177865; 21245471; 22302004; 
6588	ARSG KIAA1001 UNQ839/PRO1777	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=4.2 mM for p-nitrocatechol sulfate {ECO:0000269|PubMed:18283100}; Vmax=63.5 umol/min/mg enzyme toward p-nitrocatechol sulfate {ECO:0000269|PubMed:18283100}; 	3.1.6.-		BINDING 137 137 Substrate. {ECO:0000250}.; BINDING 162 162 Substrate. {ECO:0000250}.; BINDING 251 251 Substrate. {ECO:0000250}.	ACTIVITY REGULATION: Inhibited by phosphate. The phosphate forms a covalent bond with the active site 3-oxoalanine.	COFACTOR: Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000250}; ;  Note=Binds 1 Ca(2+) ion per subunit. {ECO:0000250};	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 5.4. {ECO:0000269|PubMed:18283100};			UNQ839/PRO1777	BIOPHYSICOCHEMICAL PROPERTIES: ;  Temperature dependence: Most efficient at 45-50 degrees Celsius. {ECO:0000269|PubMed:18283100};	sulfur compound metabolic process [GO:0006790]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; lysosome [GO:0005764]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; lysosome [GO:0005764]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; sulfur compound metabolic process [GO:0006790]	arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]	GO:0004065; GO:0005615; GO:0005764; GO:0005783; GO:0005788; GO:0006790; GO:0046872	SUBCELLULAR LOCATION: Lysosome {ECO:0000269|PubMed:12461688, ECO:0000269|PubMed:18283100}. Note=Previously observed endoplasmic reticulum localization is most likely due to folding/maturation problems for overexpressed proteins.	PTM: N-glycosylated.; PTM: The conversion to 3-oxoalanine (also known as C-formylglycine, FGly), of a serine or cysteine residue in prokaryotes and of a cysteine residue in eukaryotes, is critical for catalytic activity. {ECO:0000250}.; PTM: Glycosylated.	MOD_RES 84 84 3-oxoalanine (Cys). {ECO:0000269|PubMed:18283100}.	10231032; 12975309; 15489334; 12461688; 18283100; 25825126; 12757705; 12757706; 14563551; 15657036; 16368756; 19960030; 20379614; 24375517; 25135642; 8681943; 9699462	10231032; 12975309; 15489334; 12461688; 18283100; 25825126
6610	ATG4B APG4B AUTL1 KIAA0943	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=5.1 uM for MAP1LC3B {ECO:0000269|PubMed:21177865, ECO:0000269|PubMed:22302004}; KM=5.8 uM for GABARAP {ECO:0000269|PubMed:21177865, ECO:0000269|PubMed:22302004}; KM=4.4 uM for GABARAPL1 {ECO:0000269|PubMed:21177865, ECO:0000269|PubMed:22302004}; KM=6.1 uM for GABARAPL2 {ECO:0000269|PubMed:21177865, ECO:0000269|PubMed:22302004}; 	3.4.22.-			ACTIVITY REGULATION: Inhibited by N-ethylmaleimide. Redox-regulated during autophagy since reducing conditions activate ATG4A whereas an oxidizing environment such as the presence of H(2)O(2) inhibits its activity. {ECO:0000269|PubMed:17347651}.							autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; C-terminal protein lipidation [GO:0006501]; macroautophagy [GO:0016236]; positive regulation of protein catabolic process [GO:0045732]; protein delipidation [GO:0051697]; protein targeting to membrane [GO:0006612]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; endopeptidase activity [GO:0004175]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; C-terminal protein lipidation [GO:0006501]; macroautophagy [GO:0016236]; positive regulation of protein catabolic process [GO:0045732]; protein delipidation [GO:0051697]; protein targeting to membrane [GO:0006612]; proteolysis [GO:0006508]	cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; endopeptidase activity [GO:0004175]	GO:0000045; GO:0000422; GO:0004175; GO:0004197; GO:0005737; GO:0005829; GO:0006501; GO:0006508; GO:0006612; GO:0006914; GO:0008234; GO:0016236; GO:0044804; GO:0045732; GO:0051697	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.		MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378, ECO:0000269|Ref.9}.; MOD_RES 383 383 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:24275569}.	12446702; 15169837; 10231032; 14702039; 17974005; 15815621; 15489334; 15187094; 17081983; 17347651; 19413330; 19369195; 19690332; 20068231; 21269460; 21177865; 21406692; 22302004; 22223895; 22814378; 24275569; 16183633; 16325851; 19322194; 15355958; 16169070; 16704426; 17353931; 18083104; 19596235; 20010802; 20562859; 21900206; 23508006; 24755409; 24991826; 25652856; 26378241; 26499184; 26662804; 27527864; 27556700; 27770612; 28253956; 28287329; 28821708; 28835545; 28889000; 28902354; 29169176; 29232556	12446702; 15169837; 10231032; 14702039; 17974005; 15815621; 15489334; 15187094; 17081983; 17347651; 19413330; 19369195; 19690332; 20068231; 21269460; 21177865; 21406692; 22302004; 22223895; 22814378; 24275569; 16183633; 16325851; 19322194
6618	ASAH1 ASAH HSD-33 HSD33	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=149 uM for N-lauroylsphingosine {ECO:0000269|PubMed:7744740}; Vmax=136 nmol/h/mg enzyme with N-lauroylsphingosine as substrate {ECO:0000269|PubMed:7744740}; 	3.5.1.23	CATALYTIC ACTIVITY: N-acylsphingosine + H(2)O = a carboxylate + sphingosine. {ECO:0000269|PubMed:7744740}.				BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 3.8-4.3 with N-lauroylsphingosine as substrate. {ECO:0000269|PubMed:7744740};			HSD-33 HSD33		ceramide metabolic process [GO:0006672]; glycosphingolipid metabolic process [GO:0006687]; neutrophil degranulation [GO:0043312]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; tertiary granule lumen [GO:1904724]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; tertiary granule lumen [GO:1904724]; catalytic activity [GO:0003824]; ceramidase activity [GO:0102121]; N-acylsphingosine amidohydrolase activity [GO:0017040]; ceramide metabolic process [GO:0006672]; glycosphingolipid metabolic process [GO:0006687]; neutrophil degranulation [GO:0043312]	catalytic activity [GO:0003824]; ceramidase activity [GO:0102121]; N-acylsphingosine amidohydrolase activity [GO:0017040]	GO:0003824; GO:0005576; GO:0005615; GO:0006672; GO:0006687; GO:0017040; GO:0043202; GO:0043312; GO:0070062; GO:0102121; GO:1904724; GO:1904813	SUBCELLULAR LOCATION: Lysosome.			8955159; 10993717; 10610716; 16421571; 15489334; 7744740; 12754519; 16335952; 16263699; 19159218; 21269460; 24275569; 25944712; 11241842; 12638942; 16951918; 20609603; 22703880; 21893389; 21982811; 24164096; 12764132; 12815059; 15088070; 16169070; 16500425; 17174955; 17713573; 17881906; 18245333; 18477771; 19298866; 19367725; 19905902; 19913121; 20217867; 20360068; 20379614; 20520628; 20628086; 20871013; 21335555; 21375364; 21493710; 21504271; 21700700; 21846728; 21988832; 22261821; 22322590; 22515519; 23416715; 23423838; 23518908; 23602568; 23650620; 23707712; 23777806; 24091326; 24098536; 24189400; 24355074; 25131496; 25888580; 26553872; 26687835; 26945816; 27026573; 27411168; 27650050; 27825124; 28251733; 28905881; 29278706	8955159; 10993717; 10610716; 16421571; 15489334; 7744740; 12754519; 16335952; 16263699; 19159218; 21269460; 24275569; 25944712; 11241842; 12638942; 16951918; 20609603; 22703880; 21893389; 21982811; 24164096
6621	SMPDL3A ASML3A	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=326 uM for ATP {ECO:0000269|PubMed:26783088}; KM=306 uM for ADP {ECO:0000269|PubMed:26783088}; KM=348 uM for ADP-ribose {ECO:0000269|PubMed:26783088}; KM=390 uM for CDP-ethanolamine {ECO:0000269|PubMed:26783088}; KM=262 uM for CDP-choline {ECO:0000269|PubMed:26783088}; 	3.1.4.-		BINDING 114 114 Substrate. {ECO:0000269|PubMed:26783088}.; BINDING 151 151 Substrate. {ECO:0000269|PubMed:26783088}.; BINDING 152 152 Substrate. {ECO:0000269|PubMed:26783088}.	ACTIVITY REGULATION: Requires micromolar levels of Zn(2+) for activity (PubMed:26783088). Inhibited by millimolar levels of Zn(2+) (PubMed:25288789, PubMed:26783088). {ECO:0000269|PubMed:25288789, ECO:0000269|PubMed:26783088}.	COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000269|PubMed:26783088}; ;  Note=Binds 2 Zn(2+) per subunit. {ECO:0000269|PubMed:26783088};	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 4-6. {ECO:0000269|PubMed:25288789};					nucleoside triphosphate catabolic process [GO:0009143]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; phosphoric diester hydrolase activity [GO:0008081]; zinc ion binding [GO:0008270]; nucleoside triphosphate catabolic process [GO:0009143]	phosphoric diester hydrolase activity [GO:0008081]; zinc ion binding [GO:0008270]	GO:0005615; GO:0008081; GO:0008270; GO:0009143; GO:0070062	SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:25288789}.	PTM: N-glycosylated. {ECO:0000269|PubMed:25288789}.		14702039; 14574404; 15489334; 19159218; 25288789; 26783088; 12442002; 15174051; 20195357; 22810003; 28104755; 28414139	14702039; 14574404; 15489334; 19159218; 25288789; 26783088
6626	ASS1 ASS	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=112 uM for citrulline (at pH 7.0 and 37 degrees Celsius) {ECO:0000269|PubMed:18473344}; KM=68 uM for aspartate (at pH 7.0 and 37 degrees Celsius) {ECO:0000269|PubMed:18473344}; Vmax=143 nmol/min/mg enzyme toward citrulline (at pH 7.0 and 37 degrees Celsius) {ECO:0000269|PubMed:18473344}; Vmax=116 nmol/min/mg enzyme toward aspartate (at pH 7.0 and 37 degrees {ECO:0000269|PubMed:18473344}; 	6.3.4.5	CATALYTIC ACTIVITY: ATP + L-citrulline + L-aspartate = AMP + diphosphate + N(omega)-(L-arginino)succinate. {ECO:0000269|PubMed:18473344, ECO:0000269|PubMed:27287393, ECO:0000269|PubMed:8792870}.	BINDING 36 36 ATP; via amide nitrogen and carbonyl oxygen. {ECO:0000250}.; BINDING 87 87 Citrulline. {ECO:0000269|PubMed:18323623}.; BINDING 92 92 Citrulline. {ECO:0000269|PubMed:18323623}.; BINDING 119 119 Aspartate. {ECO:0000269|PubMed:18323623}.; BINDING 123 123 Aspartate. {ECO:0000269|PubMed:18323623}.; BINDING 123 123 Citrulline. {ECO:0000269|PubMed:18323623}.; BINDING 124 124 Aspartate. {ECO:0000269|PubMed:18323623}.; BINDING 127 127 Citrulline. {ECO:0000269|PubMed:18323623}.; BINDING 180 180 Citrulline. {ECO:0000269|PubMed:18323623}.; BINDING 189 189 Citrulline. {ECO:0000269|PubMed:18323623}.; BINDING 270 270 Citrulline. {ECO:0000269|PubMed:18323623}.; BINDING 282 282 Citrulline. {ECO:0000269|PubMed:18323623}.				PATHWAY: Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. {ECO:0000305|PubMed:18473344, ECO:0000305|PubMed:27287393, ECO:0000305|PubMed:8792870}.; PATHWAY: Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. {ECO:0000305|PubMed:18473344, ECO:0000305|PubMed:27287393, ECO:0000305|PubMed:8792870}.				acute-phase response [GO:0006953]; aging [GO:0007568]; arginine biosynthetic process [GO:0006526]; argininosuccinate metabolic process [GO:0000053]; aspartate metabolic process [GO:0006531]; cellular response to amine stimulus [GO:0071418]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ammonium ion [GO:0071242]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucagon stimulus [GO:0071377]; cellular response to interferon-gamma [GO:0071346]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oleic acid [GO:0071400]; cellular response to tumor necrosis factor [GO:0071356]; circadian rhythm [GO:0007623]; citrulline metabolic process [GO:0000052]; diaphragm development [GO:0060539]; kidney development [GO:0001822]; liver development [GO:0001889]; midgut development [GO:0007494]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; response to estradiol [GO:0032355]; response to growth hormone [GO:0060416]; response to mycotoxin [GO:0010046]; response to nutrient [GO:0007584]; response to zinc ion [GO:0010043]; urea cycle [GO:0000050]	cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; lysosome [GO:0005764]; mitochondrial outer membrane [GO:0005741]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; perikaryon [GO:0043204]	cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; lysosome [GO:0005764]; mitochondrial outer membrane [GO:0005741]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; perikaryon [GO:0043204]; amino acid binding [GO:0016597]; argininosuccinate synthase activity [GO:0004055]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; toxic substance binding [GO:0015643]; acute-phase response [GO:0006953]; aging [GO:0007568]; arginine biosynthetic process [GO:0006526]; argininosuccinate metabolic process [GO:0000053]; aspartate metabolic process [GO:0006531]; cellular response to amine stimulus [GO:0071418]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ammonium ion [GO:0071242]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucagon stimulus [GO:0071377]; cellular response to interferon-gamma [GO:0071346]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oleic acid [GO:0071400]; cellular response to tumor necrosis factor [GO:0071356]; circadian rhythm [GO:0007623]; citrulline metabolic process [GO:0000052]; diaphragm development [GO:0060539]; kidney development [GO:0001822]; liver development [GO:0001889]; midgut development [GO:0007494]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; response to estradiol [GO:0032355]; response to growth hormone [GO:0060416]; response to mycotoxin [GO:0010046]; response to nutrient [GO:0007584]; response to zinc ion [GO:0010043]; urea cycle [GO:0000050]	amino acid binding [GO:0016597]; argininosuccinate synthase activity [GO:0004055]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; toxic substance binding [GO:0015643]	GO:0000050; GO:0000052; GO:0000053; GO:0001822; GO:0001889; GO:0003723; GO:0004055; GO:0005524; GO:0005634; GO:0005737; GO:0005741; GO:0005764; GO:0005783; GO:0005829; GO:0006526; GO:0006531; GO:0006953; GO:0007494; GO:0007568; GO:0007584; GO:0007623; GO:0010043; GO:0010046; GO:0015643; GO:0016597; GO:0032355; GO:0042802; GO:0043204; GO:0043209; GO:0045429; GO:0060416; GO:0060539; GO:0070062; GO:0070852; GO:0071222; GO:0071230; GO:0071242; GO:0071320; GO:0071346; GO:0071356; GO:0071377; GO:0071400; GO:0071418; GO:0071499; GO:0071549; GO:1903038	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:28985504, ECO:0000305|PubMed:27287393}.	PTM: Acetylated by CLOCK in a circadian manner which negatively regulates its enzyme activity. Deacetylated by histone deacetylases. {ECO:0000269|PubMed:28985504}.	MOD_RES 87 87 Phosphotyrosine. {ECO:0000250|UniProtKB:P09034}.; MOD_RES 112 112 N6-acetyllysine. {ECO:0000250|UniProtKB:P16460}.; MOD_RES 113 113 Phosphotyrosine. {ECO:0000244|PubMed:24275569}.; MOD_RES 165 165 N6-acetyllysine; by CLOCK. {ECO:0000269|PubMed:28985504}.; MOD_RES 176 176 N6-acetyllysine; by CLOCK. {ECO:0000269|PubMed:28985504}.; MOD_RES 180 180 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 219 219 Phosphothreonine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.	6194510; 6321498; 11941481; 14702039; 15489334; 3027451; 2788888; 9150948; 1708740; 20068231; 21269460; 23186163; 24275569; 28985504; 8792870; 17496144; 18323623; 2358466; 1943692; 7977368; 11708871; 12815590; 14680976; 15863597; 16475226; 18473344; 19006241; 23611581; 24889030; 25179242; 27287393; 28111830; 11988016; 12620389; 14570901; 15161933; 15192091; 16124451; 16169070; 16189514; 16380201; 16703398; 17096330; 17314511; 17354225; 18263583; 18840401; 19000307; 19358837; 19409979; 19533750; 19913121; 19934275; 20159990; 20360068; 20628086; 20706999; 20711500; 20739017; 21044950; 21106532; 21481813; 21988832; 22430140; 23339388; 23549872; 23897555; 24192130; 24255178; 24297925; 24508627; 24692592; 24927999; 25333458; 25416956; 25548129; 26496610; 26560030; 26638075; 26895070; 26972697; 26982031; 27431689; 27584578; 27683125; 27765932; 28132756; 28587924; 28646562; 28981931; 518841	6194510; 6321498; 11941481; 14702039; 15489334; 3027451; 2788888; 9150948; 1708740; 20068231; 21269460; 23186163; 24275569; 28985504; 8792870; 17496144; 18323623; 2358466; 1943692; 7977368; 11708871; 12815590; 14680976; 15863597; 16475226; 18473344; 19006241; 23611581; 24889030; 25179242; 27287393; 28111830
6627	ATAT1 C6orf134 MEC17 Nbla00487	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=2.0 uM for free alpha-tubulin {ECO:0000269|PubMed:21068373, ECO:0000269|PubMed:23071314}; KM=1.6 uM for polymerized tubulin (microtubules) {ECO:0000269|PubMed:21068373, ECO:0000269|PubMed:23071314}; KM=2.2 uM for acetyl-CoA {ECO:0000269|PubMed:21068373, ECO:0000269|PubMed:23071314}; Note=kcat is 2.2 h(-1) for the acetylation of polymerized tubulin (microtubules), 0.35 h(-1) for the acetylation of free tubulin, and 1.47 h(-1)with acetyl-CoA as substrate.;	2.3.1.108	CATALYTIC ACTIVITY: Acetyl-CoA + [alpha-tubulin]-L-lysine = CoA + [alpha-tubulin]-N(6)-acetyl-L-lysine. {ECO:0000255|HAMAP-Rule:MF_03130, ECO:0000269|PubMed:20829795, ECO:0000269|PubMed:23071314, ECO:0000269|PubMed:23110214, ECO:0000269|PubMed:24906155}.						SITE 58 58 Crucial for catalytic activity. {ECO:0000255|HAMAP-Rule:MF_03130, ECO:0000269|PubMed:23071318}.	Nbla00487		alpha-tubulin acetylation [GO:0071929]; cilium assembly [GO:0060271]; dentate gyrus development [GO:0021542]; neuron development [GO:0048666]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; regulation of fat cell differentiation [GO:0045598]; regulation of microtubule cytoskeleton organization [GO:0070507]; spermatogenesis [GO:0007283]	axon [GO:0030424]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule bundle [GO:0097427]; mitotic spindle [GO:0072686]	axon [GO:0030424]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule bundle [GO:0097427]; mitotic spindle [GO:0072686]; coenzyme binding [GO:0050662]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; tubulin N-acetyltransferase activity [GO:0019799]; alpha-tubulin acetylation [GO:0071929]; cilium assembly [GO:0060271]; dentate gyrus development [GO:0021542]; neuron development [GO:0048666]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; regulation of fat cell differentiation [GO:0045598]; regulation of microtubule cytoskeleton organization [GO:0070507]; spermatogenesis [GO:0007283]	coenzyme binding [GO:0050662]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; tubulin N-acetyltransferase activity [GO:0019799]	GO:0004468; GO:0005794; GO:0005829; GO:0005874; GO:0005905; GO:0005925; GO:0007283; GO:0019799; GO:0021542; GO:0030424; GO:0045598; GO:0048666; GO:0050662; GO:0060271; GO:0070507; GO:0071929; GO:0072686; GO:0097427; GO:1900227	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_03130, ECO:0000269|PubMed:24097348}. Membrane, clathrin-coated pit {ECO:0000255|HAMAP-Rule:MF_03130, ECO:0000269|PubMed:24097348}. Cell junction, focal adhesion {ECO:0000255|HAMAP-Rule:MF_03130, ECO:0000269|PubMed:24097348}. Cell projection, axon {ECO:0000255|HAMAP-Rule:MF_03130}. Cytoplasm, cytoskeleton {ECO:0000255|HAMAP-Rule:MF_03130}. Cytoplasm, cytoskeleton, spindle {ECO:0000255|HAMAP-Rule:MF_03130}.	PTM: Autoacetylation strongly increases tubulin acetylation. {ECO:0000255|HAMAP-Rule:MF_03130}.	MOD_RES 56 56 N6-acetyllysine; by autocatalysis. {ECO:0000250|UniProtKB:Q8K341, ECO:0000255|HAMAP-Rule:MF_03130}.; MOD_RES 146 146 N6-acetyllysine; by autocatalysis. {ECO:0000250|UniProtKB:Q8K341, ECO:0000255|HAMAP-Rule:MF_03130}.; MOD_RES 233 233 N6-acetyllysine; by autocatalysis. {ECO:0000250|UniProtKB:Q8K341, ECO:0000255|HAMAP-Rule:MF_03130}.; MOD_RES 244 244 N6-acetyllysine; by autocatalysis. {ECO:0000250|UniProtKB:Q8K341, ECO:0000255|HAMAP-Rule:MF_03130}.; MOD_RES 272 272 Phosphoserine. {ECO:0000250|UniProtKB:Q6MG11}.; MOD_RES 276 276 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 305 305 Asymmetric dimethylarginine. {ECO:0000250|UniProtKB:Q8K341}.; MOD_RES 315 315 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 323 323 Omega-N-methylarginine. {ECO:0000244|PubMed:24129315}.	12880961; 14702039; 14574404; 15489334; 17974005; 20829795; 21068373; 23110214; 23186163; 24097348; 24129315; 23071318; 23071314; 24906155; 17084703; 19081074; 19823565; 19851445; 20603001; 23602568; 24760594; 24846647; 25494100; 25602620; 26227334; 27752143; 27836544; 28428427; 9427680	12880961; 14702039; 14574404; 15489334; 17974005; 20829795; 21068373; 23110214; 23186163; 24097348; 24129315; 23071318; 23071314; 24906155
6643	AKR7A2 AFAR AFAR1 AKR7	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=20 uM for succinic semialdehyde {ECO:0000269|PubMed:10510318}; KM=17 uM for 2-carboxybenzaldehyde {ECO:0000269|PubMed:10510318}; KM=8 uM for 9,10-phenanthrenequinone {ECO:0000269|PubMed:10510318}; KM=102 uM for 1,2-naphthoquinone {ECO:0000269|PubMed:10510318}; 	1.1.1.n11	CATALYTIC ACTIVITY: 4-hydroxybutanoate + NADP(+) = succinate semialdehyde + NADPH. {ECO:0000269|PubMed:10510318}.	BINDING 72 72 NADP. {ECO:0000269|Ref.14}.; BINDING 141 141 Substrate. {ECO:0000250}.; BINDING 197 197 NADP. {ECO:0000269|Ref.14}.; BINDING 250 250 NADP. {ECO:0000269|Ref.14}.; BINDING 260 260 Substrate. {ECO:0000250}.; BINDING 263 263 Substrate. {ECO:0000250}.; BINDING 359 359 Substrate. {ECO:0000250}.					SITE 105 105 Lowers pKa of active site Tyr. {ECO:0000250}.			carbohydrate metabolic process [GO:0005975]; cellular aldehyde metabolic process [GO:0006081]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; xenobiotic metabolic process [GO:0006805]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; electron transfer activity [GO:0009055]; phenanthrene-9,10-epoxide hydrolase activity [GO:0019119]; carbohydrate metabolic process [GO:0005975]; cellular aldehyde metabolic process [GO:0006081]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; xenobiotic metabolic process [GO:0006805]	alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; electron transfer activity [GO:0009055]; phenanthrene-9,10-epoxide hydrolase activity [GO:0019119]	GO:0004032; GO:0004033; GO:0005794; GO:0005829; GO:0005975; GO:0006081; GO:0006805; GO:0009055; GO:0019119; GO:0044597; GO:0044598; GO:0070062	SUBCELLULAR LOCATION: Golgi apparatus {ECO:0000250}. Cytoplasm {ECO:0000269|PubMed:9576847}.		MOD_RES 40 40 Phosphoserine. {ECO:0000250|UniProtKB:Q8CG76}.; MOD_RES 128 128 N6-acetyllysine. {ECO:0000250|UniProtKB:Q8CG76}.; MOD_RES 236 236 N6-succinyllysine. {ECO:0000250|UniProtKB:Q8CG76}.; MOD_RES 255 255 Phosphoserine. {ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.	16710414; 15489334; 9576847; 9823300; 10510318; 12071861; 17591773; 21269460; 23186163; 24275569; 25944712; 18752886; 11409944; 12727802; 12879023; 16189514; 16970545; 17353931; 18416522; 19077459; 19367725; 20877624; 21044367; 22623428; 25027672; 25416956; 25451587; 26496610; 28536627	16710414; 15489334; 9576847; 9823300; 10510318; 12071861; 17591773; 21269460; 23186163; 24275569; 25944712; 18752886
6665	AS3MT CYT19	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=4.6 uM for sodium arsenite {ECO:0000269|PubMed:16407288}; KM=11.8 uM for AdoMet {ECO:0000269|PubMed:16407288}; 	2.1.1.137	CATALYTIC ACTIVITY: S-adenosyl-L-methionine + arsenite = S-adenosyl-L-homocysteine + methylarsonate. {ECO:0000269|PubMed:16407288, ECO:0000269|PubMed:25997655}.; CATALYTIC ACTIVITY: S-adenosyl-L-methionine + methylarsonite = S-adenosyl-L-homocysteine + dimethylarsinate. {ECO:0000269|PubMed:16407288, ECO:0000269|PubMed:25997655}.									arsonoacetate metabolic process [GO:0018872]; methylation [GO:0032259]; toxin metabolic process [GO:0009404]	cytosol [GO:0005829]	cytosol [GO:0005829]; arsenite methyltransferase activity [GO:0030791]; methylarsonite methyltransferase activity [GO:0030792]; arsonoacetate metabolic process [GO:0018872]; methylation [GO:0032259]; toxin metabolic process [GO:0009404]	arsenite methyltransferase activity [GO:0030791]; methylarsonite methyltransferase activity [GO:0030792]	GO:0005829; GO:0009404; GO:0018872; GO:0030791; GO:0030792; GO:0032259	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250|UniProtKB:Q8VHT6}.		MOD_RES 335 335 Phosphoserine. {ECO:0000244|PubMed:24275569}.	16407288; 15164054; 15489334; 21269460; 22005461; 24275569; 25997655; 18334919; 15808521; 15929903; 16385451; 17306849; 17450230; 17637926; 17850829; 17889916; 18414634; 18588996; 18682255; 18976679; 19152805; 19159958; 19167370; 19371612; 19411561; 19430483; 19538983; 19896490; 19932709; 20014157; 20129672; 20532380; 20547570; 20571777; 20621156; 20711500; 20877624; 20971157; 21247820; 21537954; 21731446; 22339537; 22341486; 22547080; 22712827; 22747749; 22955273; 23070617; 23093101; 23665909; 23742935; 24154821; 24239724; 24361376; 24536095; 24621105; 24792412; 24845704; 25156000; 25349987; 25447140; 25461954; 25491248; 26209557; 26366667; 26411936; 26928318; 27004590; 27158905; 27401531; 27922604; 28235556; 28640505	16407288; 15164054; 15489334; 21269460; 22005461; 24275569; 25997655; 18334919
6683	ABCB9 KIAA1520	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=6.8 uM for peptide RRYQNSTCL {ECO:0000269|PubMed:15863492}; 						BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 7.0. {ECO:0000269|PubMed:15863492};				BIOPHYSICOCHEMICAL PROPERTIES: ;  Temperature dependence: Optimum temperature is 37 degrees Celsius. {ECO:0000269|PubMed:15863492};	peptide transport [GO:0015833]; protein transport [GO:0015031]; transmembrane transport [GO:0055085]	integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]	integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; ATP binding [GO:0005524]; oligopeptide-transporting ATPase activity [GO:0015421]; peptide-transporting ATPase activity [GO:0015440]; protein homodimerization activity [GO:0042803]; transmembrane transporter activity [GO:0022857]; peptide transport [GO:0015833]; protein transport [GO:0015031]; transmembrane transport [GO:0055085]	ATP binding [GO:0005524]; oligopeptide-transporting ATPase activity [GO:0015421]; peptide-transporting ATPase activity [GO:0015440]; protein homodimerization activity [GO:0042803]; transmembrane transporter activity [GO:0022857]	GO:0005524; GO:0005764; GO:0005765; GO:0015031; GO:0015421; GO:0015440; GO:0015833; GO:0016021; GO:0022857; GO:0030176; GO:0042803; GO:0043231; GO:0055085	SUBCELLULAR LOCATION: Lysosome membrane {ECO:0000269|PubMed:10748049, ECO:0000269|PubMed:15577206, ECO:0000269|PubMed:17897319, ECO:0000269|PubMed:17977821, ECO:0000269|PubMed:18175933, ECO:0000269|PubMed:18952056, ECO:0000269|PubMed:20377823, ECO:0000269|PubMed:21212514}; Multi-pass membrane protein {ECO:0000255|PROSITE-ProRule:PRU00441, ECO:0000269|PubMed:10748049, ECO:0000269|PubMed:15577206, ECO:0000269|PubMed:17897319, ECO:0000269|PubMed:17977821, ECO:0000269|PubMed:18175933, ECO:0000269|PubMed:18952056, ECO:0000269|PubMed:20377823, ECO:0000269|PubMed:21212514}. Note=May be located in membrane rafts.				11011155; 10748049; 13679046; 15491607; 10819331; 14702039; 16541075; 15489334; 15577206; 15863492; 17977821; 17897319; 18952056; 18175933; 18434309; 20377823; 21212514; 11829140
6690	ACOT8 ACTEIII PTE1 PTE2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=10.1 uM for decanoyl-CoA {ECO:0000269|PubMed:9153233}; Vmax=7.1 umol/min/mg enzyme {ECO:0000269|PubMed:9153233}; 	3.1.2.27	CATALYTIC ACTIVITY: Choloyl-CoA + H(2)O = cholate + CoA. {ECO:0000269|PubMed:15194431, ECO:0000269|PubMed:9299485}.		ACTIVITY REGULATION: Inhibited by CoASH (IC(50)=10-15 uM). Also inhibited by cysteine-reactive agents. {ECO:0000250|UniProtKB:P58137}.							acyl-CoA metabolic process [GO:0006637]; alpha-linolenic acid metabolic process [GO:0036109]; bile acid biosynthetic process [GO:0006699]; dicarboxylic acid catabolic process [GO:0043649]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid catabolic process [GO:0009062]; negative regulation of CD4 biosynthetic process [GO:0045225]; peroxisome fission [GO:0016559]; protein targeting to peroxisome [GO:0006625]; viral process [GO:0016032]	cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]	cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; choloyl-CoA hydrolase activity [GO:0033882]; CoA hydrolase activity [GO:0016289]; medium-chain acyl-CoA hydrolase activity [GO:0052815]; palmitoyl-CoA hydrolase activity [GO:0016290]; signaling receptor binding [GO:0005102]; acyl-CoA metabolic process [GO:0006637]; alpha-linolenic acid metabolic process [GO:0036109]; bile acid biosynthetic process [GO:0006699]; dicarboxylic acid catabolic process [GO:0043649]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid catabolic process [GO:0009062]; negative regulation of CD4 biosynthetic process [GO:0045225]; peroxisome fission [GO:0016559]; protein targeting to peroxisome [GO:0006625]; viral process [GO:0016032]	acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; choloyl-CoA hydrolase activity [GO:0033882]; CoA hydrolase activity [GO:0016289]; medium-chain acyl-CoA hydrolase activity [GO:0052815]; palmitoyl-CoA hydrolase activity [GO:0016290]; signaling receptor binding [GO:0005102]	GO:0003986; GO:0005102; GO:0005782; GO:0005829; GO:0006625; GO:0006637; GO:0006699; GO:0009062; GO:0016032; GO:0016289; GO:0016290; GO:0016559; GO:0033540; GO:0033882; GO:0036109; GO:0043649; GO:0045225; GO:0047617; GO:0052689; GO:0052815	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10092594}. Peroxisome matrix {ECO:0000269|PubMed:10092594, ECO:0000269|PubMed:15194431}. Note=Predominantly localized in the peroxisome (PubMed:10092594, PubMed:15194431). {ECO:0000269|PubMed:10092594, ECO:0000269|PubMed:15194431}.			9299485; 9153233; 10092594; 11780052; 15489334; 15194431; 11755680; 21269460; 25944712; 11673457; 16756494; 16940157; 17314511; 18538142; 21911578; 22002062; 22190034; 22810585; 23606334; 24189400; 25416956; 26496610	9299485; 9153233; 10092594; 11780052; 15489334; 15194431; 11755680; 21269460; 25944712
6726	ABHD6	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=159 uM for 2-arachidonoyglycerol {ECO:0000269|PubMed:22969151}; Vmax=45 nmol/min/mg enzyme toward 2-arachidonoyglycerol {ECO:0000269|PubMed:22969151}; 	3.1.1.23	CATALYTIC ACTIVITY: Hydrolyzes glycerol monoesters of long-chain fatty acids. {ECO:0000269|PubMed:22969151}.				BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 7.2-9 with 2-arachidonoyglycerol as substrate. {ECO:0000269|PubMed:22969151};					acylglycerol catabolic process [GO:0046464]; long term synaptic depression [GO:0060292]; negative regulation of cell migration [GO:0030336]; negative regulation of cold-induced thermogenesis [GO:0120163]; phospholipid catabolic process [GO:0009395]; positive regulation of lipid biosynthetic process [GO:0046889]; regulation of endocannabinoid signaling pathway [GO:2000124]	AMPA glutamate receptor complex [GO:0032281]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of postsynaptic membrane [GO:0099055]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	AMPA glutamate receptor complex [GO:0032281]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of postsynaptic membrane [GO:0099055]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; acylglycerol lipase activity [GO:0047372]; phospholipase activity [GO:0004620]; acylglycerol catabolic process [GO:0046464]; long term synaptic depression [GO:0060292]; negative regulation of cell migration [GO:0030336]; negative regulation of cold-induced thermogenesis [GO:0120163]; phospholipid catabolic process [GO:0009395]; positive regulation of lipid biosynthetic process [GO:0046889]; regulation of endocannabinoid signaling pathway [GO:2000124]	acylglycerol lipase activity [GO:0047372]; phospholipase activity [GO:0004620]	GO:0004620; GO:0005739; GO:0005886; GO:0009395; GO:0016021; GO:0030336; GO:0032281; GO:0046464; GO:0046889; GO:0047372; GO:0060292; GO:0098978; GO:0098982; GO:0099055; GO:0120163; GO:2000124	SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:Q8R2Y0}; Single-pass type II membrane protein {ECO:0000255}. Mitochondrion {ECO:0000250|UniProtKB:Q8R2Y0}.			14702039; 16641997; 15489334; 22969151; 18360779; 19793082; 21418147; 21988832; 22827915; 24534757; 26491015; 26496610; 27114538; 28880480	14702039; 16641997; 15489334; 22969151
6731	THEM5 ACOT15	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=2.4 uM for palmitoyl-CoA (C16:0) {ECO:0000269|PubMed:22586271}; KM=4.2 uM for stearoyl-CoA (C18:0) {ECO:0000269|PubMed:22586271}; KM=2.9 uM for oleoyl-CoA (C18:1) {ECO:0000269|PubMed:22586271}; KM=4.2 uM for linoleoyl-CoA (C18:2) {ECO:0000269|PubMed:22586271}; 	3.1.2.2	CATALYTIC ACTIVITY: Palmitoyl-CoA + H(2)O = CoA + palmitate. {ECO:0000269|PubMed:22586271}.									acyl-CoA metabolic process [GO:0006637]; cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid metabolic process [GO:0006631]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]	mitochondrial matrix [GO:0005759]	mitochondrial matrix [GO:0005759]; acyl-CoA hydrolase activity [GO:0047617]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; acyl-CoA metabolic process [GO:0006637]; cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid metabolic process [GO:0006631]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]	acyl-CoA hydrolase activity [GO:0047617]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]	GO:0005759; GO:0006631; GO:0006637; GO:0016290; GO:0035336; GO:0035965; GO:0047617; GO:0102991	SUBCELLULAR LOCATION: Mitochondrion matrix {ECO:0000269|PubMed:22586271}.			14702039; 16710414; 15489334; 22586271; 16940157; 20237496; 20470824; 20877624; 22465940; 22871024; 23700546; 25416956	14702039; 16710414; 15489334; 22586271
6772	ABCA8 KIAA0822	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=30.4 uM for estradiol-beta-glucuronide {ECO:0000269|PubMed:12379217}; KM=0.1 uM for LTC4 {ECO:0000269|PubMed:12379217}; KM=10.3 uM for taurochlorate {ECO:0000269|PubMed:12379217}; KM=5.0 uM for PAH {ECO:0000269|PubMed:12379217}; KM=0.5 uM for estrone sulfate {ECO:0000269|PubMed:12379217}; KM=0.4 uM for ochratoxin A {ECO:0000269|PubMed:12379217}; 											lipid transport [GO:0006869]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity, coupled to transmembrane movement of substances [GO:0042626]; xenobiotic transmembrane transporting ATPase activity [GO:0008559]; lipid transport [GO:0006869]; transmembrane transport [GO:0055085]	ATPase activity, coupled to transmembrane movement of substances [GO:0042626]; ATP binding [GO:0005524]; xenobiotic transmembrane transporting ATPase activity [GO:0008559]	GO:0005524; GO:0005743; GO:0005886; GO:0006869; GO:0008559; GO:0016021; GO:0042626; GO:0055085	SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.			10048485; 16625196; 15489334; 12379217; 19159218; 24275569; 12111378; 15899824; 19343046; 21707071; 23560799; 23948991; 28468577; 28882873; 3457471	10048485; 16625196; 15489334; 12379217; 19159218; 24275569; 12111378
6782	ACE DCP DCP1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=2.51 mM for Hip-His-Leu {ECO:0000269|PubMed:11076943, ECO:0000269|PubMed:12542396}; 	3.2.1.-; 3.4.15.1	CATALYTIC ACTIVITY: Release of a C-terminal dipeptide, oligopeptide-|-Xaa-Yaa, when Xaa is not Pro, and Yaa is neither Asp nor Glu. Thus, conversion of angiotensin I to angiotensin II, with increase in vasoconstrictor activity, but no action on angiotensin II.	BINDING 231 231 Chloride 1.; BINDING 529 529 Chloride 1.; BINDING 791 791 Chloride 2.; BINDING 829 829 Chloride 3.; BINDING 1090 1090 Chloride 2.; BINDING 1094 1094 Chloride 2.; BINDING 1127 1127 Chloride 3.	ACTIVITY REGULATION: Strongly activated by chloride. Specifically inhibited by lisinopril, captopril and enalaprilat.	COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; ;  Note=Binds 2 Zn(2+) ions per subunit.;; COFACTOR: Isoform Testis-specific: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; ;  Note=Isoform Testis-specific only binds 1 Zn(2+) ion per subunit.;; COFACTOR: Name=chloride; Xref=ChEBI:CHEBI:17996; ;  Note=Binds 3 chloride ions per subunit.;			SITE 1225 1225 Not glycosylated. {ECO:0000269|PubMed:9013598}.			amyloid-beta metabolic process [GO:0050435]; angiotensin maturation [GO:0002003]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; arachidonic acid secretion [GO:0050482]; blood vessel remodeling [GO:0001974]; cell proliferation in bone marrow [GO:0071838]; heart contraction [GO:0060047]; hematopoietic stem cell differentiation [GO:0060218]; hormone catabolic process [GO:0042447]; kidney development [GO:0001822]; mononuclear cell proliferation [GO:0032943]; negative regulation of gap junction assembly [GO:1903597]; neutrophil mediated immunity [GO:0002446]; peptide catabolic process [GO:0043171]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein tyrosine kinase activity [GO:0061098]; proteolysis [GO:0006508]; regulation of angiotensin metabolic process [GO:0060177]; regulation of blood pressure [GO:0008217]; regulation of blood vessel diameter [GO:0097746]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of renal output by angiotensin [GO:0002019]; regulation of smooth muscle cell migration [GO:0014910]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; regulation of vasoconstriction [GO:0019229]; spermatogenesis [GO:0007283]	endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]	endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; bradykinin receptor binding [GO:0031711]; carboxypeptidase activity [GO:0004180]; chloride ion binding [GO:0031404]; drug binding [GO:0008144]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; metallodipeptidase activity [GO:0070573]; metallopeptidase activity [GO:0008237]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; peptidyl-dipeptidase activity [GO:0008241]; tripeptidyl-peptidase activity [GO:0008240]; zinc ion binding [GO:0008270]; amyloid-beta metabolic process [GO:0050435]; angiotensin maturation [GO:0002003]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; arachidonic acid secretion [GO:0050482]; blood vessel remodeling [GO:0001974]; cell proliferation in bone marrow [GO:0071838]; heart contraction [GO:0060047]; hematopoietic stem cell differentiation [GO:0060218]; hormone catabolic process [GO:0042447]; kidney development [GO:0001822]; mononuclear cell proliferation [GO:0032943]; negative regulation of gap junction assembly [GO:1903597]; neutrophil mediated immunity [GO:0002446]; peptide catabolic process [GO:0043171]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein tyrosine kinase activity [GO:0061098]; proteolysis [GO:0006508]; regulation of angiotensin metabolic process [GO:0060177]; regulation of blood pressure [GO:0008217]; regulation of blood vessel diameter [GO:0097746]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of renal output by angiotensin [GO:0002019]; regulation of smooth muscle cell migration [GO:0014910]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; regulation of vasoconstriction [GO:0019229]; spermatogenesis [GO:0007283]	actin binding [GO:0003779]; bradykinin receptor binding [GO:0031711]; carboxypeptidase activity [GO:0004180]; chloride ion binding [GO:0031404]; drug binding [GO:0008144]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; metallodipeptidase activity [GO:0070573]; metallopeptidase activity [GO:0008237]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; peptidyl-dipeptidase activity [GO:0008241]; tripeptidyl-peptidase activity [GO:0008240]; zinc ion binding [GO:0008270]	GO:0001822; GO:0001974; GO:0002003; GO:0002019; GO:0002446; GO:0002474; GO:0003081; GO:0003779; GO:0004175; GO:0004180; GO:0005576; GO:0005615; GO:0005764; GO:0005768; GO:0005886; GO:0006508; GO:0007283; GO:0008144; GO:0008217; GO:0008237; GO:0008238; GO:0008240; GO:0008241; GO:0008270; GO:0009897; GO:0014910; GO:0016021; GO:0019229; GO:0031404; GO:0031434; GO:0031711; GO:0032943; GO:0042447; GO:0043171; GO:0050435; GO:0050482; GO:0051019; GO:0060047; GO:0060177; GO:0060218; GO:0061098; GO:0070062; GO:0070573; GO:0071838; GO:0097746; GO:1900086; GO:1902033; GO:1903597; GO:2000170	SUBCELLULAR LOCATION: Angiotensin-converting enzyme, soluble form: Secreted.; SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane protein. Cytoplasm {ECO:0000250}. Note=Detected in both cell membrane and cytoplasm in neurons. {ECO:0000250}.	PTM: Phosphorylated by CK2 on Ser-1299; which allows membrane retention. {ECO:0000269|PubMed:12386153}.	MOD_RES 1299 1299 Phosphoserine. {ECO:0000269|PubMed:12386153}.	2849100; 2547653; 2554286; 10319862; 14702039; 16625196; 2558109; 9642152; 1649623; 8755737; 9013598; 10769174; 10969042; 10924499; 11076943; 12386153; 12459472; 12542396; 15151696; 15671045; 16335952; 19159218; 21269460; 12540854; 15236580; 16476442; 10099885; 10391210; 11551873; 14694062; 15534175; 15277638; 16116425; 25787250; 10023114; 10080429; 10099886; 10197222; 10221352; 10227270; 10334805; 10335726; 10351920; 10352194; 10362030; 10371375; 10376201; 10404693; 10474023; 10483967; 10536878; 10544843; 10546020; 10575803; 10608470; 10636255; 10643899; 10657713; 10673731; 10675799; 10681079; 10759003; 10770265; 10793025; 10794598; 10821127; 10821348; 10854008; 10874368; 10874503; 10882751; 10889131; 10899077; 10904024; 10923445; 10937809; 10963892; 10971153; 10983692; 10997795; 11001581; 11018310; 11027844; 11029323; 11030378; 11043512; 11054622; 11071385; 11071585; 11078932; 11106322; 11116113; 11121171; 11124487; 11145009; 11153913; 11155741; 11204304; 11208365; 11213892; 11234416; 11328206; 11345362; 11354635; 11361058; 11367719; 11367888; 11401115; 11422735; 11427204; 11428725; 11484170; 11485372; 11518842; 11522714; 11522715; 11527624; 11550114; 11568114; 11568784; 11593574; 11688760; 11696688; 11699055; 11707217; 11707686; 11711521; 11711524; 11714857; 11718065; 11728946; 11755945; 11756350; 11761617; 11773214; 11774217; 11776100; 11781714; 11803189; 11836444; 11840772; 11861692; 11867868; 11870238; 11888948; 11918988; 11923700; 12015245; 12031704; 12031990; 12032106; 12043886; 12084438; 12113906; 12114366; 12126783; 12147786; 12196500; 12204015; 12204859; 12205735; 12215901; 12297007; 12359135; 12360613; 12362316; 12372063; 12388790; 12394950; 12419932; 12453999; 12459519; 12468767; 12471298; 12514670; 12522467; 12556231; 12574792; 12575194; 12605101; 12611423; 12624945; 12627873; 12660488; 12669270; 12687832; 12695469; 12697976; 12728665; 12736093; 12832734; 12875914; 12885793; 12906984; 1314601; 14563588; 14585904; 14607851; 14671555; 14675596; 14759632; 15013333; 15076187; 15083369; 15106838; 15112434; 15283675; 15300633; 15332573; 15338496; 15385810; 15387996; 15470205; 15481848; 15498534; 15526842; 15532370; 15555355; 15563875; 15595935; 15614025; 15651670; 15699938; 15732660; 15788353; 15793788; 15804059; 15892865; 15978554; 16037885; 16080804; 16420563; 16485730; 16538877; 16544732; 16603315; 16612256; 16621107; 1668266; 16736244; 16741188; 16741369; 16818212; 16866021; 16915032; 16926677; 17003099; 17042482; 17083073; 17163998; 17223428; 17274465; 17300045; 17326392; 17367703; 17383306; 17452507; 17519002; 17531119; 17570179; 18457420; 1848554; 1851160; 18568123; 18647135; 18660489; 18706898; 18986708; 18996102; 19081678; 19203483; 19420105; 19475602; 19497121; 19502259; 19506579; 19525331; 19559392; 19655271; 19847428; 19851296; 19865794; 19889475; 19943553; 20022223; 20066004; 20233165; 20826823; 21352096; 21810173; 23056909; 24015848; 24289879; 24297181; 24502978; 24900839; 2558510; 26403559; 26748546; 2846041; 29206036; 29476645; 3017438; 6269175; 6270633; 7485124; 7555560; 7556981; 7586243; 7589881; 7677086; 7697839; 7759715; 7759716; 7772074; 7783416; 7807498; 7807499; 7840807; 7955173; 7993479; 8045571; 8096947; 8177269; 8538349; 8541160; 8558760; 8566943; 8587251; 8596758; 8644625; 8644984; 8677872; 8704045; 8749698; 8752809; 8772691; 8772692; 8773433; 8781765; 8895041; 8903617; 8906516; 8931914; 8946109; 8983828; 8989733; 9037328; 9109842; 9137889; 9140789; 9147898; 9180106; 9180368; 9197423; 9201110; 9227291; 9247728; 9258202; 9258285; 9264477; 9270088; 9291178; 9358012; 9377825; 9409318; 9443774; 9462412; 9498629; 9535412; 9561998; 9588764; 9594210; 9611729; 9660089; 9693941; 9694588; 9713438; 9713444; 9733227; 9740630; 9781631; 9788731; 9825196; 9863550; 9863894; 9916793	2849100; 2547653; 2554286; 10319862; 14702039; 16625196; 2558109; 9642152; 1649623; 8755737; 9013598; 10769174; 10969042; 10924499; 11076943; 12386153; 12459472; 12542396; 15151696; 15671045; 16335952; 19159218; 21269460; 12540854; 15236580; 16476442; 10099885; 10391210; 11551873; 14694062; 15534175; 15277638; 16116425; 25787250
6791	AADAT KAT2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.9 mM for aminoadipate {ECO:0000269|PubMed:18620547}; KM=4.7 mM for kynurenine {ECO:0000269|PubMed:18620547}; KM=1.7 mM for methionine {ECO:0000269|PubMed:18620547}; KM=1.6 mM for glutamate {ECO:0000269|PubMed:18620547}; KM=1.8 mM for tyrosine {ECO:0000269|PubMed:18620547}; KM=1.2 mM for 2-oxoglutarate {ECO:0000269|PubMed:18620547}; KM=1.5 mM for 2-oxocaproic acid {ECO:0000269|PubMed:18620547}; KM=1.8 mM for phenylpyruvate {ECO:0000269|PubMed:18620547}; KM=1.4 mM for ino-3-pyruvate {ECO:0000269|PubMed:18620547}; 	2.6.1.39; 2.6.1.7	CATALYTIC ACTIVITY: L-kynurenine + 2-oxoglutarate = 4-(2-aminophenyl)-2,4-dioxobutanoate + L-glutamate.; CATALYTIC ACTIVITY: L-2-aminoadipate + 2-oxoglutarate = 2-oxoadipate + L-glutamate.	BINDING 20 20 Substrate.; BINDING 74 74 Substrate.; BINDING 142 142 Substrate.; BINDING 202 202 Substrate.; BINDING 399 399 Substrate.	ACTIVITY REGULATION: Kynurenine transaminase activity is competitively inhibited by aminoadipate, asparagine, glutamate, histidine, cysteine, lysine, 3-hydroxy-kynurenine and phenylalanine. {ECO:0000269|PubMed:18620547}.	COFACTOR: Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326; Evidence={ECO:0000269|PubMed:12126930, ECO:0000269|PubMed:18056995, ECO:0000269|PubMed:18056996}; 	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 7-9. {ECO:0000269|PubMed:18620547};	PATHWAY: Amino-acid degradation; L-lysine degradation via saccharopine pathway; glutaryl-CoA from L-lysine: step 4/6.			BIOPHYSICOCHEMICAL PROPERTIES: ;  Temperature dependence: Optimum temperature is 50 degrees Celsius. {ECO:0000269|PubMed:18620547};	2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; glutamate metabolic process [GO:0006536]; kynurenine metabolic process [GO:0070189]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; lysine catabolic process [GO:0006554]; tryptophan catabolic process [GO:0006569]	mitochondrial matrix [GO:0005759]	mitochondrial matrix [GO:0005759]; 2-aminoadipate transaminase activity [GO:0047536]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; glutamate metabolic process [GO:0006536]; kynurenine metabolic process [GO:0070189]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; lysine catabolic process [GO:0006554]; tryptophan catabolic process [GO:0006569]	2-aminoadipate transaminase activity [GO:0047536]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]	GO:0005759; GO:0006103; GO:0006536; GO:0006554; GO:0006569; GO:0009058; GO:0016212; GO:0030170; GO:0033512; GO:0042803; GO:0047536; GO:0070189	SUBCELLULAR LOCATION: Mitochondrion {ECO:0000305}.		MOD_RES 69 69 N6-acetyllysine. {ECO:0000250|UniProtKB:Q9WVM8}.; MOD_RES 179 179 N6-acetyllysine. {ECO:0000250|UniProtKB:Q9WVM8}.; MOD_RES 263 263 N6-(pyridoxal phosphate)lysine; alternate.; MOD_RES 263 263 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q9WVM8}.; MOD_RES 263 263 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q9WVM8}.; MOD_RES 339 339 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q9WVM8}.; MOD_RES 339 339 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q9WVM8}.; MOD_RES 367 367 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q9WVM8}.; MOD_RES 367 367 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q9WVM8}.; MOD_RES 422 422 N6-acetyllysine. {ECO:0000250|UniProtKB:Q9WVM8}.	12126930; 14702039; 15489334; 24275569; 18620547; 18056995; 18056996; 13069505; 20684605; 20877624; 21473761; 21712776; 23466229; 24140252; 24900455; 24900560; 26773745; 27023527; 28706436	12126930; 14702039; 15489334; 24275569; 18620547; 18056995; 18056996
6792	ABCB11 BSEP	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=30.4 uM for taurocholate {ECO:0000269|PubMed:17264802}; Vmax=232 pmol/min/mg enzyme for taurocholate transport {ECO:0000269|PubMed:17264802}; 											bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; canalicular bile acid transport [GO:0015722]	apical part of cell [GO:0045177]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; plasma membrane [GO:0005886]	apical part of cell [GO:0045177]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; bile acid-exporting ATPase activity [GO:0015432]; canalicular bile acid transmembrane transporter activity [GO:0015126]; sodium-exporting ATPase activity, phosphorylative mechanism [GO:0008554]; transporter activity [GO:0005215]; bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; canalicular bile acid transport [GO:0015722]	ATP binding [GO:0005524]; bile acid-exporting ATPase activity [GO:0015432]; canalicular bile acid transmembrane transporter activity [GO:0015126]; sodium-exporting ATPase activity, phosphorylative mechanism [GO:0008554]; transporter activity [GO:0005215]	GO:0005215; GO:0005524; GO:0005886; GO:0005887; GO:0006699; GO:0008554; GO:0015126; GO:0015432; GO:0015721; GO:0015722; GO:0016020; GO:0045177; GO:0046581; GO:0070062	SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.		MOD_RES 586 586 Phosphothreonine. {ECO:0000244|PubMed:24275569}.; MOD_RES 587 587 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 690 690 Phosphoserine. {ECO:0000250|UniProtKB:Q9QY30}.; MOD_RES 701 701 Phosphoserine. {ECO:0000250|UniProtKB:O70127}.; MOD_RES 704 704 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 1214 1214 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 1321 1321 Phosphoserine. {ECO:0000250|UniProtKB:O70127}.	9806540; 15815621; 17082223; 24275569; 10579978; 11829140; 11815775; 15300568; 15077010; 16039748; 16763017; 16799996; 17264802; 24969679; 11495894; 11600213; 11745042; 11783115; 12404239; 12404240; 12825874; 14762791; 14999697; 15159385; 15471871; 15791618; 16290310; 16749857; 16871584; 16890614; 16941683; 17622941; 18176959; 18270374; 18395098; 18521185; 18660489; 18668439; 18676680; 18692205; 18987030; 19060910; 19101985; 19170196; 19343046; 19408031; 19571440; 19625176; 19669124; 19692168; 19821532; 19833092; 19845854; 19888660; 19898482; 19913121; 19937311; 20010382; 20028269; 20147439; 20163776; 20232290; 20379614; 20414253; 20447715; 20453000; 20628086; 20683201; 20702406; 20723035; 20855565; 20857261; 20858683; 20883210; 21490445; 21691112; 21766090; 21811948; 21988832; 22098322; 22161577; 22673116; 22681771; 23022423; 23279303; 23750872; 23758865; 23876151; 23929842; 24002920; 24335466; 24366234; 24378332; 24711118; 24729004; 25085279; 25104267; 25332267; 25378077; 25392597; 25661339; 25713208; 25735837; 25771912; 26019035; 26735860; 26845599; 26910619; 27050426; 27293027; 27472061; 27493120; 28073941; 28292275; 28425419; 28733223; 28839429; 28860020	9806540; 15815621; 17082223; 24275569; 10579978; 11829140; 11815775; 15300568; 15077010; 16039748; 16763017; 16799996; 17264802; 24969679
6833	ACACB ACC2 ACCB	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=120 uM for ATP {ECO:0000269|PubMed:16854592}; KM=110 uM for ATP (isoform 2) {ECO:0000269|PubMed:19190759}; KM=58 uM for acetyl-CoA {ECO:0000269|PubMed:16854592}; KM=94 uM for acetyl-CoA (isoform 3) {ECO:0000269|PubMed:19190759}; KM=6.5 mM for NaHCO3 (isoform 3) {ECO:0000269|PubMed:19190759}; KM=3.0 mM for NaHCO(3) {ECO:0000269|PubMed:16854592}; 	6.4.1.2; 6.3.4.14	CATALYTIC ACTIVITY: ATP + acetyl-CoA + HCO(3)(-) = ADP + phosphate + malonyl-CoA. {ECO:0000269|PubMed:16854592, ECO:0000269|PubMed:20952656}.; CATALYTIC ACTIVITY: ATP + [biotin carboxyl-carrier protein]-biotin-N(6)-L-lysine + hydrogencarbonate- = ADP + phosphate + [biotin carboxyl-carrier protein]-carboxybiotin-N(6)-L-lysine. {ECO:0000250|UniProtKB:Q13085}.	BINDING 1934 1934 Coenzyme A. {ECO:0000250}.; BINDING 2238 2238 Coenzyme A. {ECO:0000250}.; BINDING 2240 2240 Coenzyme A. {ECO:0000250}.	ACTIVITY REGULATION: Activity is increased by oligomerization. Activated by citrate. Citrate and MID1IP1 promote oligomerization. Inhibited by malonyl-CoA. {ECO:0000269|PubMed:16854592, ECO:0000269|PubMed:20952656}.	COFACTOR: Name=biotin; Xref=ChEBI:CHEBI:57586; Evidence={ECO:0000269|PubMed:16854592}; ; COFACTOR: Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250}; ;  Note=Binds 2 manganese ions per subunit. {ECO:0000250};		PATHWAY: Lipid metabolism; malonyl-CoA biosynthesis; malonyl-CoA from acetyl-CoA: step 1/1.				acetyl-CoA metabolic process [GO:0006084]; carnitine shuttle [GO:0006853]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]; negative regulation of catalytic activity [GO:0043086]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of gene expression [GO:0010629]; positive regulation of cellular metabolic process [GO:0031325]; positive regulation of heart growth [GO:0060421]; positive regulation of lipid storage [GO:0010884]; protein homotetramerization [GO:0051289]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of glucose metabolic process [GO:0010906]; response to drug [GO:0042493]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]	cytosol [GO:0005829]; endomembrane system [GO:0012505]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	cytosol [GO:0005829]; endomembrane system [GO:0012505]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; acetyl-CoA metabolic process [GO:0006084]; carnitine shuttle [GO:0006853]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]; negative regulation of catalytic activity [GO:0043086]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of gene expression [GO:0010629]; positive regulation of cellular metabolic process [GO:0031325]; positive regulation of heart growth [GO:0060421]; positive regulation of lipid storage [GO:0010884]; protein homotetramerization [GO:0051289]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of glucose metabolic process [GO:0010906]; response to drug [GO:0042493]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]	acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]	GO:0003989; GO:0004075; GO:0005524; GO:0005634; GO:0005739; GO:0005741; GO:0005829; GO:0006084; GO:0006633; GO:0006853; GO:0009374; GO:0010629; GO:0010884; GO:0010906; GO:0012505; GO:0014070; GO:0031325; GO:0031667; GO:0031999; GO:0042493; GO:0042802; GO:0043086; GO:0045540; GO:0046872; GO:0051289; GO:0060421; GO:0097009; GO:2001295	SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:10677481}. Nucleus {ECO:0000269|PubMed:10677481}. Endomembrane system. Note=May associate with membranes.	PTM: Phosphorylated by AMPK, leading to inactivation of the enzyme. Required for the maintenance of skeletal muscle lipid and glucose homeostasis (By similarity). {ECO:0000250|UniProtKB:E9Q4Z2, ECO:0000269|PubMed:12488245}.	MOD_RES 35 35 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 70 70 Phosphothreonine. {ECO:0000244|PubMed:24275569}.; MOD_RES 91 91 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 95 95 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 169 169 Phosphoserine. {ECO:0000250|UniProtKB:Q13085}.; MOD_RES 175 175 Phosphoserine. {ECO:0000250|UniProtKB:Q13085}.; MOD_RES 192 192 Phosphoserine. {ECO:0000250|UniProtKB:Q13085}.; MOD_RES 195 195 Phosphoserine. {ECO:0000250|UniProtKB:Q13085}.; MOD_RES 200 200 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 207 207 Phosphothreonine. {ECO:0000250|UniProtKB:E9Q4Z2}.; MOD_RES 220 220 Phosphoserine. {ECO:0000250|UniProtKB:P11497}.; MOD_RES 222 222 Phosphoserine; by AMPK. {ECO:0000269|PubMed:12488245}.; MOD_RES 469 469 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 753 753 Phosphothreonine. {ECO:0000250|UniProtKB:Q13085}.; MOD_RES 929 929 N6-biotinyllysine. {ECO:0000250, ECO:0000255|PROSITE-ProRule:PRU01066}.; MOD_RES 1340 1340 Phosphoserine. {ECO:0000250|UniProtKB:E9Q4Z2}.; MOD_RES 1342 1342 Phosphothreonine. {ECO:0000244|PubMed:24275569}.; MOD_RES 1360 1360 Phosphoserine. {ECO:0000250|UniProtKB:E9Q4Z2}.; MOD_RES 1405 1405 Phosphoserine. {ECO:0000250|UniProtKB:Q13085}.	9099716; 16854592; 16541075; 8670171; 10677481; 12488245; 18669648; 19190759; 20952656; 24275569; 17876819; 18772397; 10064314; 12086953; 12413941; 14627750; 14766011; 15060529; 15590647; 16134170; 16885160; 17223360; 17276402; 17521700; 18031993; 18247344; 18455495; 18556348; 18614941; 18996102; 19034549; 19359168; 19390150; 19618481; 19846279; 19900410; 20085763; 20139635; 20153287; 20168990; 20233797; 20379614; 20457939; 20468064; 20514549; 20519229; 20599696; 20602615; 20799892; 20855566; 20877624; 20965718; 21150319; 21278420; 21553357; 21908218; 21944854; 21953464; 22123817; 23081748; 23156397; 23460794; 24255178; 24277613; 24502978; 24740690; 25262148; 26022126; 26030797; 26976583; 27635760; 27693630; 28081256; 2868710; 28768177; 7732023; 8930409; 9630604	9099716; 16854592; 16541075; 8670171; 10677481; 12488245; 18669648; 19190759; 20952656; 24275569; 17876819; 18772397
6850	NUDT1 MTH1	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=8.3 uM for 2-hydroxy-dATP (at 30 degrees Celsius and pH 8.0) {ECO:0000269|PubMed:11139615}; KM=5.7 uM for 2-hydroxy-dATP (at 30 degrees Celsius and pH 7.2) {ECO:0000269|PubMed:11139615}; KM=4.3 uM for 2-hydroxy-rATP (at 30 degrees Celsius and pH 8.0) {ECO:0000269|PubMed:11139615}; KM=13.9 uM for 8-hydroxy-dATP (at 30 degrees Celsius and pH 8.0) {ECO:0000269|PubMed:11139615}; KM=51.0 uM for 8-hydroxy-rATP (at 30 degrees Celsius and pH 8.0) {ECO:0000269|PubMed:11139615}; KM=15.2 uM for 8-hydroxy-dGTP (at 30 degrees Celsius and pH 8.0) {ECO:0000269|PubMed:11139615}; KM=12.8 uM for 8-hydroxy-dGTP (at 30 degrees Celsius and pH 7.2) {ECO:0000269|PubMed:11139615}; KM=13.2 uM for 8-hydroxy-dGTP (at 22 degrees Celsius and pH 7.5) {ECO:0000269|PubMed:21787772}; KM=55.0 uM for 8-hydroxy-rGTP (at 30 degrees Celsius and pH 8.0) {ECO:0000269|PubMed:11139615}; KM=258 uM for dGTP (at 30 degrees Celsius and pH 8.0) {ECO:0000269|PubMed:11139615}; Note=The kinetic constants are determined for the recombinant enzyme expressed in E.coli. 2-hydroxy-rATP shows the best catalytic efficiency.;	3.6.1.55; 3.6.1.56	CATALYTIC ACTIVITY: 8-oxo-dGTP + H(2)O = 8-oxo-dGMP + diphosphate. {ECO:0000269|PubMed:10373420, ECO:0000269|PubMed:10608900, ECO:0000269|PubMed:11139615, ECO:0000269|PubMed:11756418, ECO:0000269|PubMed:12857738, ECO:0000269|PubMed:16607562, ECO:0000269|PubMed:21787772, ECO:0000269|PubMed:22556419, ECO:0000269|PubMed:24695224, ECO:0000269|PubMed:24695225, ECO:0000269|PubMed:26999531, ECO:0000269|PubMed:28035004, ECO:0000269|PubMed:7782328, ECO:0000269|PubMed:8226881}.; CATALYTIC ACTIVITY: 2-hydroxy-dATP + H(2)O = 2-hydroxy-dAMP + diphosphate. {ECO:0000269|PubMed:10373420, ECO:0000269|PubMed:11139615, ECO:0000269|PubMed:11756418, ECO:0000269|PubMed:12857738, ECO:0000269|PubMed:16607562, ECO:0000269|PubMed:24695224, ECO:0000269|PubMed:24695225, ECO:0000269|PubMed:26999531, ECO:0000269|PubMed:28035004}.	BINDING 49 49 Substrate; via carbonyl oxygen. {ECO:0000244|PDB:3ZR0, ECO:0000244|PDB:5FSI, ECO:0000244|PDB:5GHI, ECO:0000269|PubMed:21787772, ECO:0000269|PubMed:26999531}.; BINDING 64 64 Substrate. {ECO:0000244|PDB:3ZR0, ECO:0000244|PDB:5GHI, ECO:0000269|PubMed:21787772, ECO:0000269|PubMed:26999531}.; BINDING 74 74 Substrate. {ECO:0000244|PDB:3ZR0, ECO:0000244|PDB:5FSI, ECO:0000244|PDB:5GHI, ECO:0000244|PDB:5GHM, ECO:0000244|PDB:5GHO, ECO:0000269|PubMed:21787772, ECO:0000269|PubMed:26999531}.	ACTIVITY REGULATION: 2-hydroxy-dATPase activity is inhibited by 2-OH-dADP, 8-OH-dGDP and 8-OH-dGTP. 8-OH-dGTPase activity is inhibited by 8-OH-dGDP, 2-OH-dADP and 2-OH-dATP. {ECO:0000269|PubMed:10373420}.	COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000305|PubMed:15133035}; ;  Note=Binds 1 Mg(2+) ion per subunit. {ECO:0000305|PubMed:15133035};	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 7.8-8.2 with 8-hydroxy-dGTP as substrate, and 8.0-8.5 with 2-hydroxy-dATP as substrate. {ECO:0000269|PubMed:10373420, ECO:0000269|PubMed:11139615, ECO:0000269|PubMed:21787772};		SITE 68 68 Important for 2-OH-dATPase and 8-oxo-dGTPase activities. {ECO:0000269|PubMed:11756418}.; SITE 158 158 Essential for 2-OH-dATPase and 8-oxo-dGTPase activities. {ECO:0000269|PubMed:11756418}.; SITE 160 160 Essential for 2-OH-dATPase activity and important for 8-oxo-dGTPase activity. {ECO:0000269|PubMed:11756418}.			aging [GO:0007568]; dATP catabolic process [GO:0046061]; dGTP catabolic process [GO:0006203]; DNA protection [GO:0042262]; DNA repair [GO:0006281]; male gonad development [GO:0008584]; nucleobase-containing small molecule catabolic process [GO:0034656]; purine nucleotide catabolic process [GO:0006195]; response to cadmium ion [GO:0046686]; response to oxidative stress [GO:0006979]	acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity [GO:0044714]; 2-hydroxy-adenosine triphosphate pyrophosphatase activity [GO:0044713]; 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity [GO:0035539]; 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity [GO:0008413]; ATP diphosphatase activity [GO:0047693]; GTP diphosphatase activity [GO:0036219]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; snoRNA binding [GO:0030515]; aging [GO:0007568]; dATP catabolic process [GO:0046061]; dGTP catabolic process [GO:0006203]; DNA protection [GO:0042262]; DNA repair [GO:0006281]; male gonad development [GO:0008584]; nucleobase-containing small molecule catabolic process [GO:0034656]; purine nucleotide catabolic process [GO:0006195]; response to cadmium ion [GO:0046686]; response to oxidative stress [GO:0006979]	2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity [GO:0044714]; 2-hydroxy-adenosine triphosphate pyrophosphatase activity [GO:0044713]; 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity [GO:0035539]; 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity [GO:0008413]; ATP diphosphatase activity [GO:0047693]; GTPase activity [GO:0003924]; GTP diphosphatase activity [GO:0036219]; metal ion binding [GO:0046872]; snoRNA binding [GO:0030515]	GO:0001669; GO:0003924; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0005886; GO:0006195; GO:0006203; GO:0006281; GO:0006979; GO:0007568; GO:0008413; GO:0008584; GO:0030515; GO:0031965; GO:0034656; GO:0035539; GO:0036219; GO:0042262; GO:0044713; GO:0044714; GO:0046061; GO:0046686; GO:0046872; GO:0047693	SUBCELLULAR LOCATION: Isoform p18: Cytoplasm, cytosol {ECO:0000269|PubMed:12857738, ECO:0000269|PubMed:16607562, ECO:0000269|PubMed:7782328}. Mitochondrion matrix {ECO:0000269|PubMed:7782328, ECO:0000305|PubMed:12857738, ECO:0000305|PubMed:16607562}. Nucleus {ECO:0000269|PubMed:12857738, ECO:0000269|PubMed:7782328}. Note=Mostly present in cytosol (PubMed:7782328). A minor proportion is mitochondrial (PubMed:7782328). A very small amount of the protein is associated with nuclei (PubMed:7782328). Variant Met-124 has decreased efficiency in translocation to mitochondria (PubMed:16607562). {ECO:0000269|PubMed:16607562, ECO:0000269|PubMed:7782328}.; SUBCELLULAR LOCATION: Isoform p26: Mitochondrion matrix {ECO:0000269|PubMed:16607562}.	PTM: The N-terminus is blocked.		8226881; 7713500; 9211940; 10536140; 12690205; 12853948; 15489334; 7782328; 10373420; 10608900; 11139615; 11756418; 12857738; 16607562; 21269460; 22556419; 15133035; 17142918; 21787772; 24695224; 24695225; 26999531; 28679043; 28035004; 15516784; 16774934; 11136354; 11852070; 12051680; 12051941; 12619034; 12717453; 12757855; 12957652; 14634838; 15095864; 15449173; 15654505; 15730954; 15931596; 16600130; 17207658; 17252231; 17353931; 17417778; 17917452; 18091433; 18270339; 18510611; 18515411; 18776649; 18848840; 20144704; 20453000; 20562859; 21289483; 21355073; 21421019; 21538080; 21784087; 22790201; 22841817; 22974734; 23295485; 23396182; 24144844; 24258965; 24928220; 25023700; 25127756; 25416956; 25893378; 26202347; 26238318; 26730155; 26755138; 26862114; 26878898; 26980051; 27210421; 27350386; 27714533; 27827301; 27917618; 28340109; 28577950; 28882182; 28929756; 28947420; 29442275; 29485874; 29773556; 7713494	8226881; 7713500; 9211940; 10536140; 12690205; 12853948; 15489334; 7782328; 10373420; 10608900; 11139615; 11756418; 12857738; 16607562; 21269460; 22556419; 15133035; 17142918; 21787772; 24695224; 24695225; 26999531; 28679043; 28035004; 15516784; 16774934
6876	SLC3A2 MDU1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=295 uM for glutamine (in the presence of NaCl) {ECO:0000269|PubMed:10903140}; KM=236 uM for leucine (in the presence of NaCl) {ECO:0000269|PubMed:10903140}; KM=120 uM for arginine (in the presence of NaCl) {ECO:0000269|PubMed:10903140}; KM=138 uM for arginine (in the absence of NaCl) {ECO:0000269|PubMed:10903140}; 											amino acid transport [GO:0006865]; calcium ion transport [GO:0006816]; carbohydrate metabolic process [GO:0005975]; leukocyte migration [GO:0050900]; L-leucine import across plasma membrane [GO:1903801]; response to exogenous dsRNA [GO:0043330]; tryptophan transport [GO:0015827]	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium:sodium antiporter activity [GO:0005432]; catalytic activity [GO:0003824]; double-stranded RNA binding [GO:0003725]; neutral amino acid transmembrane transporter activity [GO:0015175]; RNA binding [GO:0003723]; amino acid transport [GO:0006865]; calcium ion transport [GO:0006816]; carbohydrate metabolic process [GO:0005975]; L-leucine import across plasma membrane [GO:1903801]; leukocyte migration [GO:0050900]; response to exogenous dsRNA [GO:0043330]; tryptophan transport [GO:0015827]	cadherin binding [GO:0045296]; calcium:sodium antiporter activity [GO:0005432]; catalytic activity [GO:0003824]; double-stranded RNA binding [GO:0003725]; neutral amino acid transmembrane transporter activity [GO:0015175]; RNA binding [GO:0003723]	GO:0003723; GO:0003725; GO:0003824; GO:0005432; GO:0005634; GO:0005829; GO:0005886; GO:0005975; GO:0006816; GO:0006865; GO:0009986; GO:0015175; GO:0015827; GO:0016020; GO:0016021; GO:0016324; GO:0042470; GO:0043330; GO:0045296; GO:0050900; GO:0070062; GO:1903801	SUBCELLULAR LOCATION: Apical cell membrane; Single-pass type II membrane protein. Melanosome. Note=Identified by mass spectrometry in melanosome fractions from stage I to stage IV. Localized to the plasma membrane when associated with SLC7A5 or SLC7A8. Localized to the placental apical membrane. Located selectively at cell-cell adhesion sites (By similarity). Colocalized with SLC7A8/LAT2 at the basolateral membrane of kidney proximal tubules and small intestine epithelia. Expressed in both luminal and abluminal membranes of brain capillary endothelial cells (By similarity). {ECO:0000250}.	PTM: Phosphorylation on Ser-406; Ser-408 or Ser-410 and on Ser-527 or Ser-531 by ecto-protein kinases favors heterotypic cell-cell interactions. {ECO:0000269|PubMed:19065266}.	MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:22814378, ECO:0000269|Ref.9}.; MOD_RES 103 103 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 106 106 Phosphothreonine. {ECO:0000250|UniProtKB:Q794F9}.; MOD_RES 134 134 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 165 165 Phosphoserine. {ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163}.; MOD_RES 406 406 Phosphoserine. {ECO:0000305|PubMed:19065266}.; MOD_RES 408 408 Phosphoserine. {ECO:0000305|PubMed:19065266}.; MOD_RES 410 410 Phosphoserine. {ECO:0000305|PubMed:19065266}.; MOD_RES 527 527 Phosphoserine. {ECO:0000305|PubMed:19065266}.; MOD_RES 531 531 Phosphoserine. {ECO:0000305|PubMed:19065266}.	3476959; 3036867; 3480538; 3265470; 11557028; 16554811; 15489334; 9829974; 9751058; 9878049; 10903140; 11311135; 11389679; 11696247; 11564694; 11742812; 12270127; 12117417; 12225859; 11840567; 14603368; 12716892; 12754519; 15980244; 15769744; 16335952; 17081983; 16496379; 17081065; 19065266; 19413330; 19159218; 19139490; 19349973; 19690332; 21269460; 21406692; 22223895; 22814378; 23186163; 24275569; 25114211; 25998567; 25944712; 17724034; 10049700; 10391915; 10863037; 11417227; 15151999; 15657067; 15901826; 15918515; 16799092; 17353931; 19738201; 19805454; 20217867; 21252943; 21397861; 21656680; 21911578; 22304920; 22593156; 23289620; 23606334; 23902751; 24189400; 25609649; 26514267; 26638075; 26752685	3476959; 3036867; 3480538; 3265470; 11557028; 16554811; 15489334; 9829974; 9751058; 9878049; 10903140; 11311135; 11389679; 11696247; 11564694; 11742812; 12270127; 12117417; 12225859; 11840567; 14603368; 12716892; 12754519; 15980244; 15769744; 16335952; 17081983; 16496379; 17081065; 19065266; 19413330; 19159218; 19139490; 19349973; 19690332; 21269460; 21406692; 22223895; 22814378; 23186163; 24275569; 25114211; 25998567; 25944712; 17724034
6877	NT5C3A NT5C3 P5N1 UMPH1 HSPC233	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=15 uM for m(7)GMP (at 37 degrees Celsius) {ECO:0000269|PubMed:24603684}; KM=66 uM for CMP {ECO:0000269|PubMed:15968458}; KM=80 uM for CMP (at 37 degrees Celsius) {ECO:0000269|PubMed:24603684}; 	3.1.3.5; 3.1.3.91	CATALYTIC ACTIVITY: N(7)-methyl-GMP + H(2)O = N(7)-methyl-guanosine + phosphate. {ECO:0000269|PubMed:24603684}.; CATALYTIC ACTIVITY: CMP + H(2)O = cytidine + phosphate. {ECO:0000269|PubMed:15968458}.; CATALYTIC ACTIVITY: A 5'-ribonucleotide + H(2)O = a ribonucleoside + phosphate. {ECO:0000269|PubMed:15968458}.	BINDING 135 135 CMP. {ECO:0000250|UniProtKB:Q9W197}.; BINDING 135 135 N(7)-methyl-GMP. {ECO:0000250|UniProtKB:Q9W197}.; BINDING 156 156 N(7)-methyl-GMP. {ECO:0000250|UniProtKB:Q9W197}.; BINDING 252 252 Substrate. {ECO:0000250|UniProtKB:Q9D020}.						HSPC233		adenosine metabolic process [GO:0046085]; defense response to virus [GO:0051607]; nucleotide metabolic process [GO:0009117]; pyrimidine nucleoside catabolic process [GO:0046135]; pyrimidine nucleoside metabolic process [GO:0006213]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; 5'-nucleotidase activity [GO:0008253]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; tRNA 2'-phosphotransferase activity [GO:0000215]; adenosine metabolic process [GO:0046085]; defense response to virus [GO:0051607]; nucleotide metabolic process [GO:0009117]; pyrimidine nucleoside catabolic process [GO:0046135]; pyrimidine nucleoside metabolic process [GO:0006213]	5'-nucleotidase activity [GO:0008253]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; tRNA 2'-phosphotransferase activity [GO:0000215]	GO:0000166; GO:0000215; GO:0000287; GO:0005737; GO:0005783; GO:0005829; GO:0006213; GO:0008253; GO:0009117; GO:0046085; GO:0046135; GO:0051607	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.; SUBCELLULAR LOCATION: Isoform 2: Endoplasmic reticulum.		MOD_RES 278 278 Phosphoserine. {ECO:0000250|UniProtKB:Q9D020}.	10942414; 11369620; 11230166; 14702039; 12853948; 15489334; 11042152; 8557639; 15604219; 15968458; 21269460; 22814378; 24603684; 17405878; 12930399; 15238149; 16461318; 18499901; 25153905; 11795870; 12418222; 12580951; 17349762; 18775979; 19623099; 20877624; 21988832; 23139015; 23223233; 25000516; 26288249; 27381654; 9428647	10942414; 11369620; 11230166; 14702039; 12853948; 15489334; 11042152; 8557639; 15604219; 15968458; 21269460; 22814378; 24603684; 17405878; 12930399; 15238149; 16461318; 18499901; 25153905
6913	AADAC DAC	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.8 mM for flutamide {ECO:0000269|PubMed:19339378, ECO:0000269|PubMed:22207054, ECO:0000269|PubMed:22415931, ECO:0000269|PubMed:24125761}; KM=0.6 mM for flutamide {ECO:0000269|PubMed:19339378, ECO:0000269|PubMed:22207054, ECO:0000269|PubMed:22415931, ECO:0000269|PubMed:24125761}; KM=0.472 mM for flutamide {ECO:0000269|PubMed:19339378, ECO:0000269|PubMed:22207054, ECO:0000269|PubMed:22415931, ECO:0000269|PubMed:24125761}; KM=3.05 mM for phenacetin {ECO:0000269|PubMed:19339378, ECO:0000269|PubMed:22207054, ECO:0000269|PubMed:22415931, ECO:0000269|PubMed:24125761}; KM=1.8 mM for phenacetin {ECO:0000269|PubMed:19339378, ECO:0000269|PubMed:22207054, ECO:0000269|PubMed:22415931, ECO:0000269|PubMed:24125761}; KM=1.42 mM for phenacetin {ECO:0000269|PubMed:19339378, ECO:0000269|PubMed:22207054, ECO:0000269|PubMed:22415931, ECO:0000269|PubMed:24125761}; KM=0.2 mM for rifampicin {ECO:0000269|PubMed:19339378, ECO:0000269|PubMed:22207054, ECO:0000269|PubMed:22415931, ECO:0000269|PubMed:24125761}; KM=0.154 mM for rifampicin {ECO:0000269|PubMed:19339378, ECO:0000269|PubMed:22207054, ECO:0000269|PubMed:22415931, ECO:0000269|PubMed:24125761}; Vmax=1.1 nmol/min/mg enzyme toward flutamide {ECO:0000269|PubMed:19339378, ECO:0000269|PubMed:22207054, ECO:0000269|PubMed:22415931, ECO:0000269|PubMed:24125761}; Vmax=0.617 nmol/min/mg enzyme toward flutamide {ECO:0000269|PubMed:19339378, ECO:0000269|PubMed:22207054, ECO:0000269|PubMed:22415931, ECO:0000269|PubMed:24125761}; Vmax=1.34 nmol/min/mg enzyme toward phenacetin {ECO:0000269|PubMed:19339378, ECO:0000269|PubMed:22207054, ECO:0000269|PubMed:22415931, ECO:0000269|PubMed:24125761}; Vmax=6.4 nmol/min/mg enzyme toward phenacetin {ECO:0000269|PubMed:19339378, ECO:0000269|PubMed:22207054, ECO:0000269|PubMed:22415931, ECO:0000269|PubMed:24125761}; Vmax=1.42 nmol/min/mg enzyme toward phenacetin {ECO:0000269|PubMed:19339378, ECO:0000269|PubMed:22207054, ECO:0000269|PubMed:22415931, ECO:0000269|PubMed:24125761}; Vmax=0.149 nmol/min/mg enzyme toward rifampicin {ECO:0000269|PubMed:19339378, ECO:0000269|PubMed:22207054, ECO:0000269|PubMed:22415931, ECO:0000269|PubMed:24125761}; Vmax=0.060 nmol/min/mg enzyme toward rifampicin {ECO:0000269|PubMed:19339378, ECO:0000269|PubMed:22207054, ECO:0000269|PubMed:22415931, ECO:0000269|PubMed:24125761}; 	3.1.1.3	CATALYTIC ACTIVITY: Triacylglycerol + H(2)O = diacylglycerol + a carboxylate.									catabolic process [GO:0009056]; positive regulation of triglyceride catabolic process [GO:0010898]; xenobiotic metabolic process [GO:0006805]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]; catalytic activity [GO:0003824]; deacetylase activity [GO:0019213]; lipase activity [GO:0016298]; serine hydrolase activity [GO:0017171]; triglyceride lipase activity [GO:0004806]; catabolic process [GO:0009056]; positive regulation of triglyceride catabolic process [GO:0010898]; xenobiotic metabolic process [GO:0006805]	catalytic activity [GO:0003824]; deacetylase activity [GO:0019213]; lipase activity [GO:0016298]; serine hydrolase activity [GO:0017171]; triglyceride lipase activity [GO:0004806]	GO:0003824; GO:0004806; GO:0005789; GO:0006805; GO:0009056; GO:0010898; GO:0016021; GO:0016298; GO:0017171; GO:0019213; GO:0031090	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Single-pass type II membrane protein. Microsome membrane; Single-pass type II membrane protein.	PTM: Glycosylation is required for enzyme activity. {ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:24125761}.		8063807; 14702039; 16641997; 15489334; 2043131; 17936933; 19339378; 19159218; 22207054; 22415931; 24125761; 23542347; 24275569; 12721789; 10318829; 19343046; 20379614; 20542992; 21856291; 22813719; 26444075; 27422753; 28606603	8063807; 14702039; 16641997; 15489334; 2043131; 17936933; 19339378; 19159218; 22207054; 22415931; 24125761; 23542347; 24275569; 12721789
6982	PPT2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=67 uM for S-palmitoyl-CoA {ECO:0000269|PubMed:12855696}; KM=37 uM for S-palmitoyl-N-acetylcysteamine {ECO:0000269|PubMed:12855696}; KM=117 uM for 4-methylumbelliferyl-6-S-palmitoyl-beta-D-glucopyranoside {ECO:0000269|PubMed:12855696}; Vmax=1.7 umol/min/mg enzyme toward S-palmitoyl-CoA {ECO:0000269|PubMed:12855696}; Vmax=3.3 umol/min/mg enzyme toward S-palmitoyl-N-acetylcysteamine {ECO:0000269|PubMed:12855696}; Vmax=0.43 umol/min/mg enzyme toward 4-methylumbelliferyl-6-S-palmitoyl-beta-D-glucopyranoside {ECO:0000269|PubMed:12855696}; 	3.1.2.-					BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 7.0. {ECO:0000269|PubMed:9341199};					fatty-acyl-CoA biosynthetic process [GO:0046949]	extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]	extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; palmitoyl hydrolase activity [GO:0098599]; palmitoyl-(protein) hydrolase activity [GO:0008474]; thiolester hydrolase activity [GO:0016790]; fatty-acyl-CoA biosynthetic process [GO:0046949]	palmitoyl-(protein) hydrolase activity [GO:0008474]; palmitoyl hydrolase activity [GO:0098599]; thiolester hydrolase activity [GO:0016790]	GO:0005764; GO:0008474; GO:0016790; GO:0043202; GO:0043231; GO:0046949; GO:0070062; GO:0098599	SUBCELLULAR LOCATION: Lysosome {ECO:0000269|PubMed:9341199}.			9341199; 10417332; 11230166; 14702039; 14656967; 14574404; 15489334; 14759258; 21269460; 25944712; 12855696; 10051407; 20010835; 20470824; 22465940; 23700546	9341199; 10417332; 11230166; 14702039; 14656967; 14574404; 15489334; 14759258; 21269460; 25944712; 12855696; 10051407
7006	NPEPPS PSA	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=2.20 mM for Lys-p-NA {ECO:0000269|PubMed:10978616, ECO:0000269|PubMed:17154549}; KM=0.25 mM for Leu-p-NA {ECO:0000269|PubMed:10978616, ECO:0000269|PubMed:17154549}; KM=0.27 mM for Ala-p-NA {ECO:0000269|PubMed:10978616, ECO:0000269|PubMed:17154549}; KM=0.80 mM for Met-p-NA {ECO:0000269|PubMed:10978616, ECO:0000269|PubMed:17154549}; KM=0.47 mM for Pro-p-NA {ECO:0000269|PubMed:10978616, ECO:0000269|PubMed:17154549}; KM=0.21 mM for Val-p-NA {ECO:0000269|PubMed:10978616, ECO:0000269|PubMed:17154549}; KM=182 uM for Ala-MCA {ECO:0000269|PubMed:10978616, ECO:0000269|PubMed:17154549}; KM=189 uM for Met-MCA {ECO:0000269|PubMed:10978616, ECO:0000269|PubMed:17154549}; KM=220 uM for Lys-MCA {ECO:0000269|PubMed:10978616, ECO:0000269|PubMed:17154549}; KM=91 uM for Leu-MCA {ECO:0000269|PubMed:10978616, ECO:0000269|PubMed:17154549}; KM=167 uM for Phe-MCA {ECO:0000269|PubMed:10978616, ECO:0000269|PubMed:17154549}; 	3.4.11.14	CATALYTIC ACTIVITY: Release of an N-terminal amino acid, preferentially alanine, from a wide range of peptides, amides and arylamides.	BINDING 180 180 Substrate. {ECO:0000250}.	ACTIVITY REGULATION: Strongly inhibited by bestatin, leuhistin, actinonin, amastatin, 1,10-phenanthroline, DFP, PCMBS, Zn(2+), Cd(2+), Co(2+), Cu(2+), Hg(2+), EDTA and puromycin. Not inhibited by PMSF, and only slightly inhibited by leupeptin and aprotinin. Activity is increased by Mg(2+) and Ca(2+). {ECO:0000269|PubMed:10978616, ECO:0000269|PubMed:17154549, ECO:0000269|PubMed:17318184}.	COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250}; ;  Note=Binds 1 zinc ion per subunit. {ECO:0000250};	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 7.5. Stable from pH 5.0 to 8.0. {ECO:0000269|PubMed:10978616, ECO:0000269|PubMed:17154549};		SITE 438 438 Transition state stabilizer. {ECO:0000250}.		BIOPHYSICOCHEMICAL PROPERTIES: ;  Temperature dependence: Stable up to 40 degrees Celsius. {ECO:0000269|PubMed:10978616, ECO:0000269|PubMed:17154549};	cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]	aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]	GO:0000209; GO:0004177; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0042277; GO:0043171; GO:0070006; GO:0070062; GO:0071456; GO:1903955	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:10978616}. Nucleus {ECO:0000305}.		MOD_RES 464 464 Nitrated tyrosine. {ECO:0000250|UniProtKB:Q11011}.	9048733; 14702039; 16625196; 15489334; 11435692; 10329370; 10978616; 11062501; 12729622; 17154549; 17318184; 19917696; 21269460; 24275569; 14706550; 15224091; 15224092; 16849449; 17353931; 19494703; 19615732; 19805454; 20377816; 20562859; 20711500; 20829225; 21320871; 23455922; 25142031; 25342037; 25609649; 26078706; 9668046	9048733; 14702039; 16625196; 15489334; 11435692; 10329370; 10978616; 11062501; 12729622; 17154549; 17318184; 19917696; 21269460; 24275569
7032	PRKX PKX1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=127 uM for ATP (in the presence of 10 mM magnesium chloride) {ECO:0000269|PubMed:10026146, ECO:0000269|PubMed:12082174}; KM=58 uM for kemptide (in the presence of 10 mM magnesium chloride) {ECO:0000269|PubMed:10026146, ECO:0000269|PubMed:12082174}; KM=6.7 uM for kemptide (in the presence of 1 uM Br-cAMP at 30 degrees Celsius) {ECO:0000269|PubMed:10026146, ECO:0000269|PubMed:12082174}; 	2.7.11.1	CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein. {ECO:0000269|PubMed:10026146, ECO:0000269|PubMed:12082174}.	BINDING 78 78 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.	ACTIVITY REGULATION: Binding of cAMP to the PRKAR1A or PRKAR1B regulatory subunits induces dissociation of the holoenzyme heterotetramer. The released monomeric PRKX is then active and able to phosphorylate its substrates. {ECO:0000269|PubMed:10026146, ECO:0000269|PubMed:12082174, ECO:0000269|PubMed:20819953}.							angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epithelial tube morphogenesis [GO:0060562]; kidney morphogenesis [GO:0060993]; myeloid cell differentiation [GO:0030099]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of epithelial cell differentiation involved in kidney development [GO:2000696]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epithelial tube morphogenesis [GO:0060562]; kidney morphogenesis [GO:0060993]; myeloid cell differentiation [GO:0030099]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of epithelial cell differentiation involved in kidney development [GO:2000696]	ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]	GO:0001525; GO:0001935; GO:0004691; GO:0005524; GO:0005634; GO:0005737; GO:0007155; GO:0018105; GO:0030099; GO:0030155; GO:0030334; GO:0031589; GO:0043542; GO:0046777; GO:0060562; GO:0060993; GO:2000696	SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=cAMP induces nuclear translocation.	PTM: Phosphorylated; autophosphorylates in vitro.	MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:22814378}.; MOD_RES 203 203 Phosphothreonine. {ECO:0000250|UniProtKB:Q922R0}.	7633447; 15489334; 9302280; 9860982; 10026146; 12082174; 16236808; 15879576; 16491121; 17980165; 19367327; 20819953; 21684272; 22814378; 21971312; 22020623; 22939624; 26252946; 26496610; 27630294	7633447; 15489334; 9302280; 9860982; 10026146; 12082174; 16236808; 15879576; 16491121; 17980165; 19367327; 20819953; 21684272; 22814378
7088	REN	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1 uM for angiotensinogen (in absence of ATP6AP2); KM=0.15 uM for angiotensinogen (in presence of membrane-bound ATP6AP2); 	3.4.23.15	CATALYTIC ACTIVITY: Cleavage of Leu-|-Xaa bond in angiotensinogen to generate angiotensin I.		ACTIVITY REGULATION: Interaction with ATP6AP2 results in a 5-fold increased efficiency in angiotensinogen processing.							amyloid-beta metabolic process [GO:0050435]; angiotensin maturation [GO:0002003]; cell maturation [GO:0048469]; cellular response to drug [GO:0035690]; drinking behavior [GO:0042756]; hormone-mediated signaling pathway [GO:0009755]; kidney development [GO:0001822]; male gonad development [GO:0008584]; mesonephros development [GO:0001823]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of MAPK cascade [GO:0043408]; renin-angiotensin regulation of aldosterone production [GO:0002018]; response to cAMP [GO:0051591]; response to cGMP [GO:0070305]; response to immobilization stress [GO:0035902]; response to lipopolysaccharide [GO:0032496]	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; aspartic-type endopeptidase activity [GO:0004190]; insulin-like growth factor receptor binding [GO:0005159]; peptidase activity [GO:0008233]; signaling receptor binding [GO:0005102]; amyloid-beta metabolic process [GO:0050435]; angiotensin maturation [GO:0002003]; cell maturation [GO:0048469]; cellular response to drug [GO:0035690]; drinking behavior [GO:0042756]; hormone-mediated signaling pathway [GO:0009755]; kidney development [GO:0001822]; male gonad development [GO:0008584]; mesonephros development [GO:0001823]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of MAPK cascade [GO:0043408]; renin-angiotensin regulation of aldosterone production [GO:0002018]; response to cAMP [GO:0051591]; response to cGMP [GO:0070305]; response to immobilization stress [GO:0035902]; response to lipopolysaccharide [GO:0032496]	aspartic-type endopeptidase activity [GO:0004190]; insulin-like growth factor receptor binding [GO:0005159]; peptidase activity [GO:0008233]; signaling receptor binding [GO:0005102]	GO:0001822; GO:0001823; GO:0002003; GO:0002018; GO:0004190; GO:0005102; GO:0005159; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0006508; GO:0008217; GO:0008233; GO:0008584; GO:0009755; GO:0032496; GO:0035690; GO:0035902; GO:0042756; GO:0043408; GO:0045177; GO:0048469; GO:0050435; GO:0051591; GO:0070305	SUBCELLULAR LOCATION: Secreted. Membrane. Note=Associated to membranes via binding to ATP6AP2.			6324167; 3530608; 6391881; 16710414; 15489334; 6138751; 3032746; 2540188; 3516796; 2016271; 12045255; 2493678; 1608447; 20927107; 16116425; 19664745; 10665661; 10903938; 11224002; 11409653; 11776100; 11800056; 11803527; 11903315; 12186695; 12394950; 12431442; 12431445; 12473863; 12544508; 12556231; 12569263; 12613527; 12684512; 12695419; 12736712; 12854169; 12862204; 12927775; 12933794; 14530292; 15075192; 15368359; 15662219; 15739123; 15837327; 15914769; 16036389; 16138564; 16169070; 16189286; 16375820; 16396763; 16446393; 16480874; 16615274; 16672053; 16790508; 16933186; 16940215; 16990260; 17113558; 17158202; 17416596; 17455195; 17476284; 17485830; 17546276; 17562974; 17574423; 17660193; 17693975; 17703434; 17785633; 1807356; 18077515; 18091737; 18175911; 18188989; 18192836; 18202178; 18205094; 18212269; 18259612; 18260994; 18325076; 18483152; 18486430; 18508487; 18519826; 18632798; 18698213; 18718746; 18722896; 18794727; 18856058; 18922597; 18953568; 19023100; 19073901; 19126660; 19144755; 19243623; 19358611; 19369955; 19457666; 19473121; 19509012; 19513539; 19536175; 19673942; 19716087; 19733264; 19759335; 19761684; 19853442; 19891555; 19913121; 19959358; 20160196; 20201926; 20223792; 20379614; 20380117; 20429690; 20452482; 20486282; 20502328; 20529973; 20537141; 20577119; 20628086; 20662730; 20673868; 20702505; 20826507; 20843686; 20850300; 20861226; 20884641; 20925572; 21036942; 21084044; 21111986; 21112780; 21163863; 21330419; 21330422; 21340620; 21424086; 21443456; 21490026; 21521263; 21576655; 21659414; 21697610; 21712789; 21741239; 21742440; 21840218; 21881521; 21941204; 21941205; 22022827; 22042811; 22136493; 22193701; 22396488; 22453004; 22459392; 22575890; 22676457; 22695510; 22721990; 22726934; 23077077; 23108193; 23111329; 23122821; 23292178; 23358739; 23360239; 23425156; 23461768; 24154707; 24164175; 24218434; 24284398; 24436325; 24900262; 24965793; 25050166; 25143328; 25237165; 25279703; 25333683; 25491485; 25510769; 25534858; 25660845; 25728416; 25754490; 25767135; 25782742; 25849646; 26076559; 26102248; 26163660; 26300226; 26366736; 26489635; 26753721; 27271344; 27428770; 27534428; 27687967; 27720325; 27774132; 27927648; 28019132; 28395289; 28640140; 28641212; 28747358; 28875746; 2892488; 28985999; 29233044; 29548814; 4289389; 4322712; 4330891; 4360430; 7493993; 7608971; 7902711; 7915644; 9172787; 9237498	6324167; 3530608; 6391881; 16710414; 15489334; 6138751; 3032746; 2540188; 3516796; 2016271; 12045255; 2493678; 1608447; 20927107; 16116425; 19664745
7132	PPP3CA CALNA CNA	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=2.04 uM for NFATC1 {ECO:0000269|PubMed:19154138}; KM=2.22 uM for DARPP32 {ECO:0000269|PubMed:19154138}; 	3.1.3.16	CATALYTIC ACTIVITY: [a protein]-serine/threonine phosphate + H(2)O = [a protein]-serine/threonine + phosphate. {ECO:0000269|PubMed:15671020, ECO:0000269|PubMed:18838687, ECO:0000269|PubMed:19154138, ECO:0000269|PubMed:23468591, ECO:0000305|PubMed:26248042}.		ACTIVITY REGULATION: Activated by Ca(2+)-bound calmodulin following an increase in intracellular Ca(2+). At low Ca(2+) concentrations, the catalytic subunit (also known as calcineurin A) is inactive and is bound to the regulatory subunit (also known as calcineurin B) in which only two high-affinity binding sites are occupied by Ca(2+). In response to elevated calcium levels, the occupancy of the low-affinity sites on calcineurin B by Ca(2+) causes a conformational change of the C-terminal regulatory domain of calcineurin A, resulting in the exposure of the calmodulin-binding domain and in the partial activation of calcineurin A. The subsequent binding of Ca(2+)-bound calmodulin leads to the displacement of the autoinhibitory domain from the active site and possibly of the autoinhibitory segment from the substrate binding site which fully activates calcineurin A. Inhibited by immunosuppressant drug FK506 (tacrolimus) in complex with FKBP12 and also by immunosuppressant drug cyclosporin A (CsA) in complex with PPIA/cyclophilin A; the inhibition is Ca(2+)-dependent (PubMed:26248042). {ECO:0000250|UniProtKB:P16298, ECO:0000269|PubMed:26248042}.	COFACTOR: Name=Fe(3+); Xref=ChEBI:CHEBI:29034; Evidence={ECO:0000269|PubMed:12218175, ECO:0000269|PubMed:17498738, ECO:0000269|PubMed:22343722, ECO:0000269|PubMed:26248042, ECO:0000269|PubMed:27974827, ECO:0000269|PubMed:8524402}; ;  Note=Binds 1 Fe(3+) ion per subunit. {ECO:0000269|PubMed:12218175, ECO:0000269|PubMed:17498738, ECO:0000269|PubMed:22343722, ECO:0000269|PubMed:26248042, ECO:0000269|PubMed:27974827, ECO:0000269|PubMed:8524402};; COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000269|PubMed:12218175, ECO:0000269|PubMed:17498738, ECO:0000269|PubMed:22343722, ECO:0000269|PubMed:26248042, ECO:0000269|PubMed:27974827, ECO:0000269|PubMed:8524402}; ;  Note=Binds 1 zinc ion per subunit. {ECO:0000269|PubMed:12218175, ECO:0000269|PubMed:17498738, ECO:0000269|PubMed:22343722, ECO:0000269|PubMed:26248042, ECO:0000269|PubMed:27974827, ECO:0000269|PubMed:8524402};			SITE 352 352 Interaction with PxVP motif in substrate. {ECO:0000269|PubMed:23468591, ECO:0000269|PubMed:27974827}.			brain development [GO:0007420]; calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; dephosphorylation [GO:0016311]; excitatory postsynaptic potential [GO:0060079]; Fc-epsilon receptor signaling pathway [GO:0038095]; G1/S transition of mitotic cell cycle [GO:0000082]; multicellular organismal response to stress [GO:0033555]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endocytosis [GO:0045807]; positive regulation of transcription by RNA polymerase II [GO:0045944]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; T cell activation [GO:0042110]; transition between fast and slow fiber [GO:0014883]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]	calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; sarcolemma [GO:0042383]; Schaffer collateral - CA1 synapse [GO:0098685]; slit diaphragm [GO:0036057]; Z disc [GO:0030018]	calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; sarcolemma [GO:0042383]; Schaffer collateral - CA1 synapse [GO:0098685]; slit diaphragm [GO:0036057]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; cyclosporin A binding [GO:0016018]; drug binding [GO:0008144]; enzyme binding [GO:0019899]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein serine/threonine phosphatase activity [GO:0004722]; brain development [GO:0007420]; calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; dephosphorylation [GO:0016311]; excitatory postsynaptic potential [GO:0060079]; Fc-epsilon receptor signaling pathway [GO:0038095]; G1/S transition of mitotic cell cycle [GO:0000082]; multicellular organismal response to stress [GO:0033555]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endocytosis [GO:0045807]; positive regulation of transcription by RNA polymerase II [GO:0045944]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; T cell activation [GO:0042110]; transition between fast and slow fiber [GO:0014883]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]	calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; cyclosporin A binding [GO:0016018]; drug binding [GO:0008144]; enzyme binding [GO:0019899]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0000082; GO:0001975; GO:0004722; GO:0005509; GO:0005516; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0007223; GO:0007420; GO:0008144; GO:0014883; GO:0014898; GO:0016018; GO:0016311; GO:0019899; GO:0030018; GO:0030335; GO:0033173; GO:0033192; GO:0033555; GO:0035562; GO:0035690; GO:0036057; GO:0038095; GO:0042110; GO:0042383; GO:0043197; GO:0045785; GO:0045807; GO:0045944; GO:0046676; GO:0046982; GO:0046983; GO:0048741; GO:0050774; GO:0051091; GO:0051592; GO:0060079; GO:0070886; GO:0071333; GO:0098685; GO:0098978; GO:0099170; GO:1903244; GO:1903799; GO:1905205	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19154138, ECO:0000269|PubMed:22343722}. Cell membrane {ECO:0000269|PubMed:22343722}; Peripheral membrane protein {ECO:0000269|PubMed:22343722}. Cell membrane, sarcolemma {ECO:0000250|UniProtKB:P63329}. Cytoplasm, myofibril, sarcomere, Z line {ECO:0000250|UniProtKB:P63329}. Cell projection, dendritic spine {ECO:0000269|PubMed:22343722}. Note=Colocalizes with ACTN1 and MYOZ2 at the Z line in heart and skeletal muscle (By similarity). Recruited to the cell membrane by scaffold protein AKAP5 following L-type Ca(2+)-channel activation (PubMed:22343722). {ECO:0000250|UniProtKB:P63329, ECO:0000269|PubMed:22343722}.		MOD_RES 2 2 N-acetylserine. {ECO:0000244|PubMed:22814378}.; MOD_RES 224 224 Nitrated tyrosine. {ECO:0000250|UniProtKB:P63328}.; MOD_RES 469 469 Phosphoserine. {ECO:0000250|UniProtKB:P63329}.; MOD_RES 492 492 Phosphoserine. {ECO:0000244|PubMed:23186163}.	8392375; 20590401; 21647268; 14702039; 17974005; 19054851; 15815621; 15489334; 11114196; 11842093; 12809556; 15454081; 15671020; 17923693; 18838687; 19154138; 21269460; 22814378; 23186163; 28942967; 8524402; 12218175; 12357034; 17498738; 17502104; 18384083; 19404396; 22343722; 23468591; 25144868; 26248042; 27974827; 10860980; 11015619; 11030334; 11231878; 12015605; 12135494; 12577067; 12586544; 12975316; 14704270; 15671033; 16150694; 16189514; 16880514; 16920709; 17320203; 17474147; 17478429; 18296442; 18628988; 18660489; 18815128; 19034380; 19285944; 193860; 19422382; 19458075; 19492085; 19851316; 19879877; 19896943; 19913121; 20107831; 20195357; 20379146; 20379614; 20413672; 20422345; 20501444; 20514436; 20628086; 20700529; 20711500; 21047202; 21070662; 21233773; 21674474; 21785830; 21900206; 21903422; 22100452; 22164265; 22270398; 22285318; 22360420; 22506312; 22665060; 22688515; 22691791; 22739212; 23317196; 23744075; 23824189; 23888774; 24191726; 24298017; 24418105; 24672054; 24954618; 25286016; 25416956; 25609649; 25637383; 25720963; 26812016; 27009276; 27307045; 27911714; 28842480; 28967377; 6330098; 7479966; 7545680; 7657645; 7708705; 7889407; 8397339; 8576111; 8631904; 8684469; 8799126; 9106655; 9312192; 9660947; 9727000	8392375; 20590401; 21647268; 14702039; 17974005; 19054851; 15815621; 15489334; 11114196; 11842093; 12809556; 15454081; 15671020; 17923693; 18838687; 19154138; 21269460; 22814378; 23186163; 28942967; 8524402; 12218175; 12357034; 17498738; 17502104; 18384083; 19404396; 22343722; 23468591; 25144868; 26248042; 27974827
7133	PPP3CC CALNA3 CNA3	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.27 uM for NFATC1 {ECO:0000269|PubMed:19154138}; KM=0.94 uM for DARPP32 {ECO:0000269|PubMed:19154138}; 	3.1.3.16	CATALYTIC ACTIVITY: [a protein]-serine/threonine phosphate + H(2)O = [a protein]-serine/threonine + phosphate. {ECO:0000269|PubMed:19154138}.		ACTIVITY REGULATION: Activated by Ca(2+)-bound calmodulin following an increase in intracellular Ca(2+). At low Ca(2+) concentrations, the catalytic subunit (also known as calcineurin A) is inactive and is bound to the regulatory subunit (also known as calcineurin B) in which only two high-affinity binding sites are occupied by Ca(2+). In response to elevated calcium levels, the occupancy of the low-affinity sites on calcineurin B by Ca(2+) causes a conformational change of the C-terminal regulatory domain of calcineurin A, resulting in the exposure of the calmodulin-binding domain and in the partial activation of calcineurin A. The subsequent binding of Ca(2+)-bound calmodulin leads to the displacement of the autoinhibitory domain from the active site and possibly of the autoinhibitory segment from the substrate binding site which fully activates calcineurin A. {ECO:0000250|UniProtKB:P16298}.	COFACTOR: Name=Fe(3+); Xref=ChEBI:CHEBI:29034; Evidence={ECO:0000250|UniProtKB:P16298}; ;  Note=Binds 1 Fe(3+) ion per subunit. {ECO:0000250|UniProtKB:P16298};; COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250|UniProtKB:P16298}; ;  Note=Binds 1 zinc ion per subunit. {ECO:0000250|UniProtKB:P16298};						brain development [GO:0007420]; calcineurin-NFAT signaling cascade [GO:0033173]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; protein dephosphorylation [GO:0006470]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; presynaptic cytosol [GO:0099523]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; presynaptic cytosol [GO:0099523]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]; brain development [GO:0007420]; calcineurin-NFAT signaling cascade [GO:0033173]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; protein dephosphorylation [GO:0006470]	calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]	GO:0005516; GO:0005737; GO:0005829; GO:0006470; GO:0007420; GO:0033173; GO:0033192; GO:0046872; GO:0098978; GO:0099523; GO:1900244			MOD_RES 483 483 Phosphoserine. {ECO:0000244|PubMed:23186163}.	1339277; 14702039; 16421571; 15489334; 19154138; 23186163; 10195903; 12851458; 15820226; 15843870; 17339875; 17895921; 18198266; 18201382; 18343007; 18460741; 18715757; 18991849; 19367581; 193860; 20107831; 20379146; 20398908; 20537399; 20593291; 20711500; 21047202; 21988832; 22360420; 23497497; 23747857; 24709691; 25416956; 26627835; 27225880; 29275364; 29294030; 6330098; 7708705	1339277; 14702039; 16421571; 15489334; 19154138; 23186163
7176	PPM1K PP2CM	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=10.7 mM for p-nitrophenylphosphate {ECO:0000269|PubMed:17336929}; Vmax=3.6 umol/min/mg enzyme toward p-nitrophenylphosphate (at 30 degrees Celsius) {ECO:0000269|PubMed:17336929}; Vmax=4 nmol/min/mg enzyme toward branched-chain alpha-ketoacid dehydrogenase complex (at 37 degrees Celsius) {ECO:0000269|PubMed:17336929}; Note=Half maximal activity toward p-nitrophenylphosphate achieved with 3.7 mM of manganese ions.;	3.1.3.16	CATALYTIC ACTIVITY: [a protein]-serine/threonine phosphate + H(2)O = [a protein]-serine/threonine + phosphate.			COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Name=Mn(2+); Xref=ChEBI:CHEBI:29035; ;  Note=Binds 1 Mg(2+) or Mn(2+) ion per subunit.;						branched-chain amino acid catabolic process [GO:0009083]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; branched-chain amino acid catabolic process [GO:0009083]	metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0005739; GO:0005759; GO:0009083; GO:0046872	SUBCELLULAR LOCATION: Mitochondrion matrix {ECO:0000269|PubMed:17336929, ECO:0000269|PubMed:17374715}.		MOD_RES 248 248 Phosphoserine. {ECO:0000250|UniProtKB:Q8BXN7}.	17374715; 17336929; 14702039; 17974005; 15815621; 15489334; 23086801; 18058037; 23200863; 16685424; 18846501; 18987618; 20877624; 21988832; 22291014; 23446828; 25416956; 26592513; 28768654	17374715; 17336929; 14702039; 17974005; 15815621; 15489334; 23086801; 18058037; 23200863
7181	PPP5C PPP5	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.847 uM for CSNK1E (at 30 degrees Celsius) {ECO:0000269|PubMed:15546861, ECO:0000269|PubMed:16790549}; KM=13.2 uM for MAPT/TAU (at pH 7.4 and 30 degrees Celsius) {ECO:0000269|PubMed:15546861, ECO:0000269|PubMed:16790549}; 	3.1.3.16	CATALYTIC ACTIVITY: [a protein]-serine/threonine phosphate + H(2)O = [a protein]-serine/threonine + phosphate.	BINDING 244 244 Substrate. {ECO:0000269|PubMed:15155720}.; BINDING 275 275 Substrate. {ECO:0000269|PubMed:15155720}.; BINDING 400 400 Substrate. {ECO:0000269|PubMed:15155720}.; BINDING 427 427 Substrate. {ECO:0000269|PubMed:15155720}.	ACTIVITY REGULATION: Autoinhibited. In the autoinhibited state, the TPR domain interacts with the catalytic region and prevents substrate access to the catalytic pocket. Allosterically activated by various polyunsaturated fatty acids, free long-chain fatty-acids and long-chain fatty acyl-CoA esters, arachidonic acid being the most effective activator. HSP90A and probably RAC1, GNA12 and GNA13 can also release the autoinhibition by the TPR repeat. Activation by RAC1, GNA12 and GNA13 is synergistic with the one produced by fatty acids binding. Inhibited by okadaic acid. {ECO:0000269|PubMed:15383005, ECO:0000269|PubMed:15577939, ECO:0000269|PubMed:19601647, ECO:0000269|PubMed:19948726, ECO:0000269|PubMed:22399290, ECO:0000269|PubMed:9000529}.	COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Name=Mn(2+); Xref=ChEBI:CHEBI:29035; ;  Note=Binds 2 Mg(2+) or Mn(2+) cations per subunit.;						cellular response to cadmium ion [GO:0071276]; cellular response to hydrogen peroxide [GO:0070301]; DNA repair [GO:0006281]; histone dephosphorylation [GO:0016576]; MAPK cascade [GO:0000165]; mitotic cell cycle [GO:0000278]; negative regulation of neuron death [GO:1901215]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of glucocorticoid receptor signaling pathway [GO:2000324]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein dephosphorylation [GO:0006470]; protein heterooligomerization [GO:0051291]; response to arachidonic acid [GO:1904550]; response to lead ion [GO:0010288]; response to morphine [GO:0043278]; transcription, DNA-templated [GO:0006351]	chaperone complex [GO:0101031]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; proximal dendrite [GO:1990635]	chaperone complex [GO:0101031]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; proximal dendrite [GO:1990635]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; G-protein alpha-subunit binding [GO:0001965]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; RNA binding [GO:0003723]; cellular response to cadmium ion [GO:0071276]; cellular response to hydrogen peroxide [GO:0070301]; DNA repair [GO:0006281]; histone dephosphorylation [GO:0016576]; MAPK cascade [GO:0000165]; mitotic cell cycle [GO:0000278]; negative regulation of neuron death [GO:1901215]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of glucocorticoid receptor signaling pathway [GO:2000324]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein dephosphorylation [GO:0006470]; protein heterooligomerization [GO:0051291]; response to arachidonic acid [GO:1904550]; response to lead ion [GO:0010288]; response to morphine [GO:0043278]; transcription, DNA-templated [GO:0006351]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; G-protein alpha-subunit binding [GO:0001965]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; RNA binding [GO:0003723]	GO:0000165; GO:0000278; GO:0001933; GO:0001965; GO:0003723; GO:0004721; GO:0004722; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006281; GO:0006351; GO:0006470; GO:0008017; GO:0008289; GO:0010288; GO:0016576; GO:0016791; GO:0032991; GO:0035970; GO:0042802; GO:0043123; GO:0043204; GO:0043231; GO:0043278; GO:0043531; GO:0046872; GO:0051291; GO:0051879; GO:0070262; GO:0070301; GO:0071276; GO:0101031; GO:1901215; GO:1904550; GO:1990635; GO:2000324	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15383005}. Cytoplasm {ECO:0000269|PubMed:15383005, ECO:0000269|PubMed:19948726}. Cell membrane {ECO:0000269|PubMed:19948726}. Note=Predominantly nuclear (PubMed:15383005). But also present in the cytoplasm (PubMed:15383005). Translocates from the cytoplasm to the plasma membrane in a RAC1-dependent manner (PubMed:19948726). {ECO:0000269|PubMed:15383005, ECO:0000269|PubMed:19948726}.	PTM: Activated by at least two different proteolytic cleavages producing a 56 kDa and a 50 kDa form. {ECO:0000269|PubMed:15383005, ECO:0000269|PubMed:23102700}.	MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19413330}.	7925273; 8666404; 15057824; 15489334; 8561788; 9000529; 9405394; 14871926; 14764652; 14734805; 15383005; 15546861; 16260606; 16892053; 16790549; 19413330; 19176521; 19608861; 19948726; 21269460; 21144835; 22781750; 22399290; 23102700; 27353360; 29127155; 9482716; 15155720; 15577939; 16531226; 19601647; 11504734; 12519780; 15218033; 15328343; 16169070; 17043677; 17084641; 18280813; 18547097; 19367725; 19586900; 19615732; 19875381; 20029029; 20562859; 20711500; 20875921; 21360678; 21706016; 21779496; 21900206; 21921034; 22592921; 23184943; 23352616; 23414517; 23416715; 23602568; 24327656; 25036637; 25269953; 25326185; 25796168; 26157124; 26496610; 27002182; 27466404; 27501780; 27742828; 28534961	7925273; 8666404; 15057824; 15489334; 8561788; 9000529; 9405394; 14871926; 14764652; 14734805; 15383005; 15546861; 16260606; 16892053; 16790549; 19413330; 19176521; 19608861; 19948726; 21269460; 21144835; 22781750; 22399290; 23102700; 27353360; 29127155; 9482716; 15155720; 15577939; 16531226; 19601647
7199	PMM2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=16 uM for alpha-D-mannose 1-phosphate {ECO:0000269|PubMed:16540464}; KM=13.5 uM for alpha-D-glucose 1-phosphate {ECO:0000269|PubMed:16540464}; 	5.4.2.8	CATALYTIC ACTIVITY: Alpha-D-mannose 1-phosphate = D-mannose 6-phosphate.	BINDING 21 21 Substrate. {ECO:0000250}.; BINDING 123 123 Substrate. {ECO:0000250}.; BINDING 134 134 Substrate. {ECO:0000250}.; BINDING 141 141 Substrate. {ECO:0000250}.; BINDING 179 179 Substrate. {ECO:0000250}.; BINDING 181 181 Substrate. {ECO:0000250}.				PATHWAY: Nucleotide-sugar biosynthesis; GDP-alpha-D-mannose biosynthesis; alpha-D-mannose 1-phosphate from D-fructose 6-phosphate: step 2/2.				GDP-mannose biosynthetic process [GO:0009298]; mannose metabolic process [GO:0006013]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein targeting to ER [GO:0045047]	cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]	cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; phosphomannomutase activity [GO:0004615]; GDP-mannose biosynthetic process [GO:0009298]; mannose metabolic process [GO:0006013]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein targeting to ER [GO:0045047]	phosphomannomutase activity [GO:0004615]	GO:0004615; GO:0005634; GO:0005829; GO:0006013; GO:0006486; GO:0006487; GO:0009298; GO:0043025; GO:0045047	SUBCELLULAR LOCATION: Cytoplasm.		MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378}.; MOD_RES 149 149 N6-acetyllysine. {ECO:0000250|UniProtKB:Q9Z2M7}.	9140401; 9425221; 14702039; 15616553; 15489334; 16540464; 21269460; 22223895; 22814378; 24275569; 17850744; 10527672; 9497260; 9781039; 10066032; 10602363; 10571956; 11058895; 11058896; 10801058; 11350185; 12357336; 15844218; 17307006; 11891694; 11935250; 13129599; 15342340; 17166182; 17451957; 17694350; 18203160; 19235233; 20638314; 20800603; 21541725; 22374380; 23430200; 23988505; 25173107; 25324542; 25355454; 25416956; 26014514; 27053713; 28373276; 28425223; 28954837; 29470411; 9070917; 9119384	9140401; 9425221; 14702039; 15616553; 15489334; 16540464; 21269460; 22223895; 22814378; 24275569; 17850744; 10527672; 9497260; 9781039; 10066032; 10602363; 10571956; 11058895; 11058896; 10801058; 11350185; 12357336; 15844218; 17307006
7228	PPIL1 CYPL1 CGI-124 UNQ2425/PRO4984	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=230 uM for N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide {ECO:0000269|PubMed:16595688}; 	5.2.1.8	CATALYTIC ACTIVITY: Peptidylproline (omega=180) = peptidylproline (omega=0). {ECO:0000269|PubMed:16595688}.	BINDING 119 119 Cyclosporin A. {ECO:0000305|PubMed:16595688}.; BINDING 125 125 Cyclosporin A. {ECO:0000305|PubMed:16595688}.	ACTIVITY REGULATION: Inhibited by Cyclosporin A. {ECO:0000269|PubMed:16595688}.					CGI-124 UNQ2425/PRO4984		mRNA splicing, via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]	catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]	catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; cyclosporin A binding [GO:0016018]; disordered domain specific binding [GO:0097718]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA splicing, via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]	cyclosporin A binding [GO:0016018]; disordered domain specific binding [GO:0097718]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	GO:0000398; GO:0000413; GO:0003755; GO:0005634; GO:0005654; GO:0006457; GO:0016018; GO:0071007; GO:0071013; GO:0097718	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11991638, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770}.		MOD_RES 149 149 Phosphoserine. {ECO:0000244|PubMed:23186163}.	8978786; 10810093; 12975309; 14574404; 15489334; 16595688; 11991638; 21269460; 23186163; 20368803; 28502770; 28076346; 11118221; 11532962; 12176931; 12411573; 12414731; 12477934; 14625303; 15024032; 15166247; 15772761; 16809785; 18322460; 19103666; 20007319; 20360068; 20423332; 20980672; 21526149; 22365833; 22419818; 22575643; 22623428; 22959432; 23345524; 23602568; 25416956; 26496610; 29301961; 29361316; 2963332; 6088074; 6206566	8978786; 10810093; 12975309; 14574404; 15489334; 16595688; 11991638; 21269460; 23186163; 20368803; 28502770; 28076346
7246	AGPAT5	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=5.52 uM for LPA sn-1 C18:1; KM=16.30 uM for C18:1-CoA; Vmax=2.42 nmol/min/mg enzyme toward LPA sn-1 C18:1; Vmax=1.22 nmol/min/mg enzyme toward C18:1-CoA; 	2.3.1.51	CATALYTIC ACTIVITY: Acyl-CoA + 1-acyl-sn-glycerol 3-phosphate = CoA + 1,2-diacyl-sn-glycerol 3-phosphate.					PATHWAY: Phospholipid metabolism; CDP-diacylglycerol biosynthesis; CDP-diacylglycerol from sn-glycerol 3-phosphate: step 2/3.				acylglycerol metabolic process [GO:0006639]; CDP-diacylglycerol biosynthetic process [GO:0016024]; hematopoietic progenitor cell differentiation [GO:0002244]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; acylglycerol metabolic process [GO:0006639]; CDP-diacylglycerol biosynthetic process [GO:0016024]; hematopoietic progenitor cell differentiation [GO:0002244]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654]	1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]	GO:0002244; GO:0003841; GO:0005635; GO:0005739; GO:0005741; GO:0005789; GO:0006639; GO:0006654; GO:0008654; GO:0016021; GO:0016024	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:21173190}; Multi-pass membrane protein {ECO:0000269|PubMed:21173190}. Nucleus envelope {ECO:0000269|PubMed:21173190}. Mitochondrion {ECO:0000269|PubMed:21173190}.			11230166; 15489334; 14702039; 16620771; 21269460; 21173190; 25944712; 15367102; 16495223; 16704971; 16864775; 17707131; 18718904; 19336658; 20235792; 20379614; 20877624; 22157815; 22777291; 23606334; 25416956; 9212163; 9461603	11230166; 15489334; 14702039; 16620771; 21269460; 21173190; 25944712
7259	PLPP5 DPPL1 HTPAP PPAPDC1B	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=41 uM for diacylglycerol pyrophosphate {ECO:0000269|PubMed:17590538}; KM=277 uM for phosphatidate {ECO:0000269|PubMed:17590538}; KM=295 uM for lysophosphatidate {ECO:0000269|PubMed:17590538}; 	3.1.3.4	CATALYTIC ACTIVITY: A 1,2-diacylglycerol 3-phosphate + H(2)O = a 1,2-diacyl-sn-glycerol + phosphate. {ECO:0000269|PubMed:17590538}.		ACTIVITY REGULATION: Inhibited by N-ethylmaleimide. {ECO:0000269|PubMed:17590538}.							phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; phosphatidate phosphatase activity [GO:0008195]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; signal transduction [GO:0007165]	phosphatidate phosphatase activity [GO:0008195]	GO:0005737; GO:0005886; GO:0005887; GO:0006644; GO:0007165; GO:0008195; GO:0046839	SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.			17590538; 16421571; 15489334; 16261160; 10224668; 18757432; 20711500; 21219541; 21531764; 24051013; 24603412	17590538; 16421571; 15489334; 16261160
7417	PARK7	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=173.4 uM for casein {ECO:0000269|PubMed:20304780}; KM=0.44 mM for glycated N-acetylarginine (at pH 7.0 and 22 degrees Celsius) {ECO:0000269|PubMed:25416785}; KM=0.35 mM for glycated N-acetyllysine (at pH 7.0 and 22 degrees Celsius) {ECO:0000269|PubMed:25416785}; KM=0.32 mM for glycated N-acetylcysteine (at pH 7.0 and 22 degrees Celsius) {ECO:0000269|PubMed:25416785}; Note=kcat is 0.27 sec(-1) for the deglycation of glycated N-acetylarginine. kcat is 0.28 sec(-1) for the deglycation of glycated N-acetyllysine. kcat is 0.42 sec(-1) for the deglycation of glycated N-acetylcysteine. {ECO:0000269|PubMed:25416785};	3.1.2.-; 3.5.1.-; 3.5.1.124	CATALYTIC ACTIVITY: An N(omega)-(1-hydroxy-2-oxopropyl)-[protein]-L-arginine + H(2)O = a [protein]-L-arginine + lactate. {ECO:0000269|PubMed:25416785}.; CATALYTIC ACTIVITY: An N(6)-(1-hydroxy-2-oxopropyl)-[protein]-L-lysine + H(2)O = a [protein]-L-lysine + lactate. {ECO:0000269|PubMed:25416785}.; CATALYTIC ACTIVITY: An S-(1-hydroxy-2-oxopropyl)-[protein]-L-cysteine + H(2)O = a [protein]-L-cysteine + lactate. {ECO:0000269|PubMed:25416785}.; CATALYTIC ACTIVITY: An N(omega)-(1-hydroxy-2-oxoethyl)-[protein]-L-arginine + H(2)O = a [protein]-L-arginine + glycolate. {ECO:0000269|PubMed:25416785}.; CATALYTIC ACTIVITY: An N(6)-(1-hydroxy-2-oxoethyl)-[protein]-L-lysine + H(2)O = a [protein]-L-lysine + glycolate. {ECO:0000269|PubMed:25416785}.; CATALYTIC ACTIVITY: An S-(1-hydroxy-2-oxoethyl)-[protein]-L-cysteine + H(2)O = a [protein]-L-cysteine + glycolate. {ECO:0000269|PubMed:25416785}.; CATALYTIC ACTIVITY: N(2)-(1-hydroxy-2-oxopropyl)-dGTP + H(2)O = dGTP + lactate. {ECO:0000269|PubMed:28596309}.; CATALYTIC ACTIVITY: N(2)-(1-hydroxy-2-oxopropyl)-GTP + H(2)O = GTP + lactate. {ECO:0000269|PubMed:28596309}.; CATALYTIC ACTIVITY: N(2)-(1-hydroxy-2-oxopropyl)-GDP + H(2)O = GDP + lactate. {ECO:0000269|PubMed:28596309}.; CATALYTIC ACTIVITY: N(2)-(1-hydroxy-2-oxopropyl)-GMP + H(2)O = GMP + lactate. {ECO:0000269|PubMed:28596309}.; CATALYTIC ACTIVITY: N(2)-(1-hydroxy-2-oxoethyl)-dGTP + H(2)O = dGTP + glycolate. {ECO:0000305|PubMed:28596309}.; CATALYTIC ACTIVITY: N(2)-(1-hydroxy-2-oxoethyl)-GTP + H(2)O = GTP + glycolate. {ECO:0000269|PubMed:28596309}.; CATALYTIC ACTIVITY: N(2)-(1-hydroxy-2-oxoethyl)-GDP + H(2)O = GDP + glycolate. {ECO:0000305|PubMed:28596309}.; CATALYTIC ACTIVITY: N(2)-(1-hydroxy-2-oxoethyl)-GMP + H(2)O = GMP + glycolate. {ECO:0000305|PubMed:28596309}.; CATALYTIC ACTIVITY: An N(2)-(1-hydroxy-2-oxopropyl)-guanosine in RNA + H(2)O = a guanosine in RNA + lactate. {ECO:0000269|PubMed:28596309}.; CATALYTIC ACTIVITY: An N(2)-(1-hydroxy-2-oxopropyl)-2'-deoxyguanosine in DNA + H(2)O = a 2'-deoxyguanosine in RNA + lactate. {ECO:0000269|PubMed:28596309}.; CATALYTIC ACTIVITY: An N(2)-(1-hydroxy-2-oxoethyl)-guanosine in RNA + H(2)O = a guanosine in RNA + glycolate. {ECO:0000305|PubMed:28596309}.; CATALYTIC ACTIVITY: An N(2)-(1-hydroxy-2-oxoethyl)-2'-deoxyguanosine in DNA + H(2)O = a 2'-deoxyguanosine in RNA + glycolate. {ECO:0000305|PubMed:28596309}.			COFACTOR: ;  Note=Deglycase activity does not require glutathione as a cofactor, however, glycated glutathione constitutes a PARK7 substrate. {ECO:0000269|PubMed:25416785};						activation of protein kinase B activity [GO:0032148]; adult locomotory behavior [GO:0008344]; autophagy [GO:0006914]; cellular response to glyoxal [GO:0036471]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; detoxification of copper ion [GO:0010273]; detoxification of mercury ion [GO:0050787]; DNA repair [GO:0006281]; dopamine uptake involved in synaptic transmission [GO:0051583]; enzyme active site formation via L-cysteine sulfinic acid [GO:0018323]; glucose homeostasis [GO:0042593]; glutathione deglycation [GO:0036531]; glycolate biosynthetic process [GO:0046295]; glyoxal metabolic process [GO:1903189]; guanine deglycation [GO:0106044]; guanine deglycation, glyoxal removal [GO:0106046]; guanine deglycation, methylglyoxal removal [GO:0106045]; hydrogen peroxide metabolic process [GO:0042743]; inflammatory response [GO:0006954]; insulin secretion [GO:0030073]; lactate biosynthetic process [GO:0019249]; membrane depolarization [GO:0051899]; membrane hyperpolarization [GO:0060081]; methylglyoxal metabolic process [GO:0009438]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of death-inducing signaling complex assembly [GO:1903073]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of hydrogen peroxide-induced neuron death [GO:1903208]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein binding [GO:0032091]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein K48-linked deubiquitination [GO:1903094]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of TRAIL-activated apoptotic signaling pathway [GO:1903122]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; negative regulation of ubiquitin-specific protease activity [GO:2000157]; peptidyl-arginine deglycation [GO:0036527]; peptidyl-cysteine deglycation [GO:0036526]; peptidyl-lysine deglycation [GO:0036528]; positive regulation of acute inflammatory response to antigenic stimulus [GO:0002866]; positive regulation of androgen receptor activity [GO:2000825]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of L-dopa biosynthetic process [GO:1903197]; positive regulation of L-dopa decarboxylase activity [GO:1903200]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of oxidative phosphorylation uncoupler activity [GO:2000277]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of pyrroline-5-carboxylate reductase activity [GO:1903168]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of superoxide dismutase activity [GO:1901671]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of tyrosine 3-monooxygenase activity [GO:1903178]; protein deglycation, glyoxal removal [GO:0036529]; protein deglycation, methylglyoxal removal [GO:0036530]; protein deglycosylation [GO:0006517]; protein stabilization [GO:0050821]; Ras protein signal transduction [GO:0007265]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of inflammatory response [GO:0050727]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of neuron apoptotic process [GO:0043523]; regulation of supramolecular fiber organization [GO:1902903]; single fertilization [GO:0007338]	axon [GO:0030424]; cell body [GO:0044297]; cell-cell adherens junction [GO:0005913]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; PML body [GO:0016605]; presynapse [GO:0098793]	axon [GO:0030424]; cell body [GO:0044297]; cell-cell adherens junction [GO:0005913]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; PML body [GO:0016605]; presynapse [GO:0098793]; androgen receptor binding [GO:0050681]; cadherin binding [GO:0045296]; copper ion binding [GO:0005507]; cupric ion binding [GO:1903135]; cuprous ion binding [GO:1903136]; cytokine binding [GO:0019955]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; L-dopa decarboxylase activator activity [GO:0036478]; mercury ion binding [GO:0045340]; mRNA binding [GO:0003729]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peptidase activity [GO:0008233]; peroxiredoxin activity [GO:0051920]; protein deglycase activity [GO:0036524]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; scaffold protein binding [GO:0097110]; signaling receptor binding [GO:0005102]; small protein activating enzyme binding [GO:0044388]; superoxide dismutase copper chaperone activity [GO:0016532]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; tyrosine 3-monooxygenase activator activity [GO:0036470]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-specific protease binding [GO:1990381]; activation of protein kinase B activity [GO:0032148]; adult locomotory behavior [GO:0008344]; autophagy [GO:0006914]; cellular response to glyoxal [GO:0036471]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; detoxification of copper ion [GO:0010273]; detoxification of mercury ion [GO:0050787]; DNA repair [GO:0006281]; dopamine uptake involved in synaptic transmission [GO:0051583]; enzyme active site formation via L-cysteine sulfinic acid [GO:0018323]; glucose homeostasis [GO:0042593]; glutathione deglycation [GO:0036531]; glycolate biosynthetic process [GO:0046295]; glyoxal metabolic process [GO:1903189]; guanine deglycation [GO:0106044]; guanine deglycation, glyoxal removal [GO:0106046]; guanine deglycation, methylglyoxal removal [GO:0106045]; hydrogen peroxide metabolic process [GO:0042743]; inflammatory response [GO:0006954]; insulin secretion [GO:0030073]; lactate biosynthetic process [GO:0019249]; membrane depolarization [GO:0051899]; membrane hyperpolarization [GO:0060081]; methylglyoxal metabolic process [GO:0009438]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of death-inducing signaling complex assembly [GO:1903073]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of hydrogen peroxide-induced neuron death [GO:1903208]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein binding [GO:0032091]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein K48-linked deubiquitination [GO:1903094]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of TRAIL-activated apoptotic signaling pathway [GO:1903122]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; negative regulation of ubiquitin-specific protease activity [GO:2000157]; peptidyl-arginine deglycation [GO:0036527]; peptidyl-cysteine deglycation [GO:0036526]; peptidyl-lysine deglycation [GO:0036528]; positive regulation of acute inflammatory response to antigenic stimulus [GO:0002866]; positive regulation of androgen receptor activity [GO:2000825]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of L-dopa biosynthetic process [GO:1903197]; positive regulation of L-dopa decarboxylase activity [GO:1903200]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of oxidative phosphorylation uncoupler activity [GO:2000277]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of pyrroline-5-carboxylate reductase activity [GO:1903168]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of superoxide dismutase activity [GO:1901671]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of tyrosine 3-monooxygenase activity [GO:1903178]; protein deglycation, glyoxal removal [GO:0036529]; protein deglycation, methylglyoxal removal [GO:0036530]; protein deglycosylation [GO:0006517]; protein stabilization [GO:0050821]; Ras protein signal transduction [GO:0007265]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of inflammatory response [GO:0050727]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of neuron apoptotic process [GO:0043523]; regulation of supramolecular fiber organization [GO:1902903]; single fertilization [GO:0007338]	androgen receptor binding [GO:0050681]; cadherin binding [GO:0045296]; copper ion binding [GO:0005507]; cupric ion binding [GO:1903135]; cuprous ion binding [GO:1903136]; cytokine binding [GO:0019955]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; L-dopa decarboxylase activator activity [GO:0036478]; mercury ion binding [GO:0045340]; mRNA binding [GO:0003729]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peptidase activity [GO:0008233]; peroxiredoxin activity [GO:0051920]; protein deglycase activity [GO:0036524]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; scaffold protein binding [GO:0097110]; signaling receptor binding [GO:0005102]; small protein activating enzyme binding [GO:0044388]; superoxide dismutase copper chaperone activity [GO:0016532]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; tyrosine 3-monooxygenase activator activity [GO:0036470]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-specific protease binding [GO:1990381]	GO:0000785; GO:0001933; GO:0002866; GO:0003713; GO:0003729; GO:0005102; GO:0005507; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005783; GO:0005829; GO:0005886; GO:0005913; GO:0006281; GO:0006469; GO:0006517; GO:0006914; GO:0006954; GO:0007005; GO:0007265; GO:0007338; GO:0008134; GO:0008233; GO:0008344; GO:0009438; GO:0010273; GO:0010628; GO:0010629; GO:0016532; GO:0016605; GO:0016684; GO:0018323; GO:0019249; GO:0019899; GO:0019900; GO:0019955; GO:0030073; GO:0030424; GO:0031397; GO:0032091; GO:0032148; GO:0032435; GO:0032757; GO:0033138; GO:0033234; GO:0033864; GO:0034599; GO:0036470; GO:0036471; GO:0036478; GO:0036524; GO:0036526; GO:0036527; GO:0036528; GO:0036529; GO:0036530; GO:0036531; GO:0042593; GO:0042743; GO:0042802; GO:0042803; GO:0043066; GO:0043523; GO:0043524; GO:0044297; GO:0044388; GO:0044390; GO:0045121; GO:0045296; GO:0045340; GO:0045944; GO:0046295; GO:0046826; GO:0048471; GO:0050681; GO:0050727; GO:0050787; GO:0050821; GO:0051091; GO:0051444; GO:0051583; GO:0051881; GO:0051897; GO:0051899; GO:0051920; GO:0060081; GO:0060548; GO:0060765; GO:0070062; GO:0070301; GO:0070491; GO:0090073; GO:0097110; GO:0098793; GO:0106044; GO:0106045; GO:0106046; GO:1900182; GO:1901215; GO:1901671; GO:1901984; GO:1902177; GO:1902236; GO:1902903; GO:1902958; GO:1903073; GO:1903094; GO:1903122; GO:1903135; GO:1903136; GO:1903168; GO:1903178; GO:1903181; GO:1903189; GO:1903197; GO:1903200; GO:1903202; GO:1903206; GO:1903208; GO:1903377; GO:1903384; GO:1903427; GO:1903428; GO:1903599; GO:1905259; GO:1990381; GO:2000157; GO:2000277; GO:2000679; GO:2000825; GO:2001237; GO:2001268	SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q99LX0}; Lipid-anchor {ECO:0000250|UniProtKB:Q99LX0}. Cytoplasm {ECO:0000269|PubMed:12851414, ECO:0000269|PubMed:14579415, ECO:0000269|PubMed:15976810, ECO:0000269|PubMed:19229105, ECO:0000269|PubMed:28596309}. Nucleus {ECO:0000269|PubMed:12851414, ECO:0000269|PubMed:14579415, ECO:0000269|PubMed:15976810, ECO:0000269|PubMed:16390825, ECO:0000269|PubMed:28596309}. Membrane raft {ECO:0000250|UniProtKB:O88767}. Mitochondrion {ECO:0000269|PubMed:15181200, ECO:0000269|PubMed:18711745, ECO:0000269|PubMed:19229105}. Note=Under normal conditions, located predominantly in the cytoplasm and, to a lesser extent, in the nucleus and mitochondrion. Translocates to the mitochondrion and subsequently to the nucleus in response to oxidative stress and exerts an increased cytoprotective effect against oxidative damage (PubMed:18711745). Detected in tau inclusions in brains from neurodegenerative disease patients (PubMed:14705119). Membrane raft localization in astrocytes and neuronal cells requires palmitoylation. {ECO:0000269|PubMed:14705119, ECO:0000269|PubMed:18711745}.	PTM: Sumoylated on Lys-130 by PIAS2 or PIAS4; which is enhanced after ultraviolet irradiation and essential for cell-growth promoting activity and transforming activity. {ECO:0000269|PubMed:15976810}.; PTM: Cys-106 is easily oxidized to sulfinic acid. {ECO:0000269|PubMed:12939276, ECO:0000269|PubMed:15976810}.; PTM: Undergoes cleavage of a C-terminal peptide and subsequent activation of protease activity in response to oxidative stress. {ECO:0000269|PubMed:20304780}.	MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:25944712}.; MOD_RES 67 67 Phosphotyrosine. {ECO:0000244|PubMed:15592455}.; MOD_RES 106 106 Cysteine sulfinic acid (-SO2H); alternate. {ECO:0000269|PubMed:12939276}.; MOD_RES 148 148 N6-acetyllysine. {ECO:0000250|UniProtKB:Q99LX0}.; MOD_RES 182 182 N6-succinyllysine. {ECO:0000250|UniProtKB:Q99LX0}.	9070310; 14702039; 16710414; 15489334; 11223268; 11477070; 12851414; 14713311; 12612053; 14579415; 14705119; 14662519; 14749723; 15502874; 15592455; 15976810; 16390825; 17015834; 18626009; 19229105; 18711745; 20304780; 21269460; 21097510; 22523093; 22611253; 23847046; 23792957; 24275569; 25416785; 25944712; 27903648; 28013050; 26995087; 28596309; 12914946; 12761214; 12796482; 12939276; 12855764; 15181200; 12953260; 12446870; 14705128; 15365989; 14607841; 15254937; 14872018; 16240358; 16632486; 17846173; 20186336; 12548343; 12815653; 14504966; 14557580; 14598065; 14625045; 14638971; 14652021; 14712351; 14985393; 15018843; 15108293; 15219840; 15304593; 15308309; 15372597; 15503154; 15542239; 15703819; 15717024; 15766664; 15790595; 15935068; 15944198; 15970950; 15983381; 16157901; 16227205; 16316629; 16331561; 16403519; 16517609; 16570276; 16731528; 16781058; 17017532; 17034344; 17085780; 17120294; 17451229; 17487420; 17504761; 17510388; 17531812; 17540176; 17599367; 17671684; 17882163; 17949781; 18000879; 18045143; 18162323; 18181649; 18331584; 18382667; 18430896; 18436956; 18570440; 18586035; 18632777; 18647263; 18689799; 18704525; 18706098; 18707128; 18717316; 18722352; 18722801; 18785233; 18817430; 18822273; 18841573; 18922803; 18973254; 18974921; 19006224; 19014922; 19023331; 19064576; 19124468; 19224617; 19335984; 19371728; 19384955; 19405094; 19425177; 19429112; 19596235; 19615732; 19680261; 19686841; 19692353; 19703902; 19716892; 19733211; 19822128; 19825160; 19968671; 20014998; 20061558; 20127688; 20146068; 20150646; 20156966; 20190752; 20213747; 20300974; 20395301; 20497343; 20506312; 20510502; 20540987; 20543466; 20634198; 20639397; 20673799; 20708612; 20730377; 20736773; 20806408; 20842103; 20877624; 20938049; 20940149; 21055329; 21160133; 21322020; 21410067; 21445310; 21535932; 21556124; 21575935; 21645620; 21670963; 21785459; 21796667; 21819105; 21852238; 21893204; 21943684; 22024154; 22066264; 22132160; 22157000; 22173095; 22223849; 22233331; 22272336; 22321799; 22404125; 22445250; 22492997; 22508282; 22511790; 22515803; 22526154; 22532838; 22554508; 22555455; 22571429; 22664331; 22666465; 22836768; 22892098; 22956510; 22960331; 22968650; 22985211; 23015639; 23076395; 23149933; 23151319; 23182168; 23241025; 23250426; 23347603; 23418303; 23447676; 23530187; 23592371; 23593018; 23714193; 23727824; 23743200; 23831022; 23844142; 23902708; 23986421; 24052110; 24070869; 24128678; 24144264; 24155657; 24176883; 24207095; 24242043; 24280570; 24398929; 24504364; 24567322; 24614826; 24664754; 24681255; 24697266; 24832775; 24899725; 24918637; 24920663; 24947010; 24969178; 25037998; 25058424; 25129821; 25210784; 25283443; 25378175; 25383140; 25384406; 25416956; 25475127; 25677538; 25721338; 25822630; 25833141; 25892179; 26022125; 26048984; 26125099; 26234586; 26245297; 26254420; 26261582; 26305376; 26334622; 26390688; 26496610; 26624998; 26739068; 26752685; 26780326; 26913805; 26965687; 26972524; 27093578; 27097320; 27105916; 27112662; 27171370; 27270837; 27455133; 27460976; 27470541; 27544688; 27582551; 27592010; 27611333; 27664330; 27703196; 27734217; 27989121; 28245986; 28330770; 28374920; 28458339; 28580701; 28600848; 28618925; 28705587; 28844983; 28873462; 28932933; 28954246; 29016861; 29100048; 29115508; 29147901; 29147902; 29147903; 29147908; 29147909; 29147911; 29175327; 29177768; 29559831; 30063823	9070310; 14702039; 16710414; 15489334; 11223268; 11477070; 12851414; 14713311; 12612053; 14579415; 14705119; 14662519; 14749723; 15502874; 15592455; 15976810; 16390825; 17015834; 18626009; 19229105; 18711745; 20304780; 21269460; 21097510; 22523093; 22611253; 23847046; 23792957; 24275569; 25416785; 25944712; 27903648; 28013050; 26995087; 28596309; 12914946; 12761214; 12796482; 12939276; 12855764; 15181200; 12953260; 12446870; 14705128; 15365989; 14607841; 15254937; 14872018; 16240358; 16632486; 17846173; 20186336
7450	PAH	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=150 uM for L-phenylalanine {ECO:0000269|PubMed:18835579}; KM=154 uM for L-phenylalanine (at 25 degrees Celsius) {ECO:0000269|PubMed:18460651}; KM=30 uM for tetrahydrobiopterin (BH(4)) {ECO:0000269|PubMed:18835579}; KM=36 uM for tetrahydrobiopterin (BH(4)) (at 25 degrees Celsius) {ECO:0000269|PubMed:18460651}; Vmax=3500 nmol/min/mg enzyme towards L-phenylalanine (at 25 degrees Celsius) {ECO:0000269|PubMed:18460651}; Vmax=3600 nmol/min/mg enzyme towards tetrahydrobiopterin (BH(4)) (at 25 degrees Celsius) {ECO:0000269|PubMed:18460651}; Vmax=3640 nmol/min/mg enzyme towards L-phenylalanine (preincubated with L-Phe) {ECO:0000269|PubMed:18835579}; Vmax=1230 nmol/min/mg enzyme towards L-phenylalanine (preincubated with BH(4)) {ECO:0000269|PubMed:18835579}; 	1.14.16.1	CATALYTIC ACTIVITY: L-phenylalanine + tetrahydrobiopterin + O(2) = L-tyrosine + 4a-hydroxytetrahydrobiopterin. {ECO:0000269|PubMed:18460651, ECO:0000269|PubMed:18835579}.		"ACTIVITY REGULATION: N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an ""inhibitory"" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule. {ECO:0000269|PubMed:18460651, ECO:0000269|PubMed:18835579}."	COFACTOR: Name=Fe(2+); Xref=ChEBI:CHEBI:29033; Evidence={ECO:0000250|UniProtKB:P04176}; 		PATHWAY: Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine: step 1/6.			BIOPHYSICOCHEMICAL PROPERTIES: ;  Temperature dependence: Optimum temperature is 50 degrees Celsius. {ECO:0000269|PubMed:18835579};	catecholamine biosynthetic process [GO:0042423]; cellular amino acid biosynthetic process [GO:0008652]; L-phenylalanine catabolic process [GO:0006559]; neurotransmitter biosynthetic process [GO:0042136]	cytosol [GO:0005829]	cytosol [GO:0005829]; iron ion binding [GO:0005506]; phenylalanine 4-monooxygenase activity [GO:0004505]; catecholamine biosynthetic process [GO:0042423]; cellular amino acid biosynthetic process [GO:0008652]; L-phenylalanine catabolic process [GO:0006559]; neurotransmitter biosynthetic process [GO:0042136]	iron ion binding [GO:0005506]; phenylalanine 4-monooxygenase activity [GO:0004505]	GO:0004505; GO:0005506; GO:0005829; GO:0006559; GO:0008652; GO:0042136; GO:0042423		PTM: Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine. {ECO:0000269|PubMed:12185072}.	MOD_RES 16 16 Phosphoserine; by PKA. {ECO:0000244|PubMed:24275569, ECO:0000269|PubMed:12185072}.	2986678; 15489334; 2461704; 12185072; 18460651; 18835579; 21269460; 24275569; 9406548; 9843368; 9642259; 10694386; 11718561; 1679029; 2246858; 1301187; 8594560; 2840952; 2564729; 2615649; 1975559; 1671810; 2014802; 1672294; 1672290; 1679030; 1709636; 1358789; 1355066; 1363837; 1363838; 8406445; 8098245; 8364546; 8068076; 8088845; 7833954; 8889583; 8889590; 9048935; 9101291; 9450897; 9521426; 9600453; 10200057; 9452061; 9452062; 9792407; 9792411; 9852673; 9950317; 10679941; 11326337; 11180595; 11385716; 11461196; 11935335; 12501224; 18538294; 23792259; 22526846; 22513348; 11172645; 11524738; 11678552; 11708866; 11855940; 12056888; 12096915; 12126628; 12173030; 12200907; 12210276; 12379147; 12554741; 12603326; 12603331; 12640344; 12649065; 12653545; 12655545; 12655546; 12655552; 12765842; 12777691; 12782966; 14568534; 14654659; 15060071; 15135070; 15192831; 15300621; 15313177; 15459954; 15464430; 15556637; 15557004; 15730960; 15793771; 15917086; 16086286; 16256386; 16402341; 16545551; 16755493; 16765994; 16917891; 16935936; 17096675; 17502162; 17557229; 17627389; 17630668; 17633563; 17924342; 18184144; 18247293; 18294361; 18299955; 18346471; 18374504; 18387838; 18447256; 18769885; 18798839; 18937047; 18937293; 18956252; 18985011; 19036622; 19062537; 19062542; 19086053; 19099685; 19147918; 19161120; 19199246; 19292873; 19360691; 19394257; 19444284; 19485247; 19629656; 19674121; 19786003; 19915519; 19938643; 20017307; 20082265; 20140859; 20187763; 20188615; 20457534; 20468064; 20667834; 20711500; 20937381; 21154324; 21811977; 21890392; 21988832; 22005392; 22028648; 22333022; 22549968; 22698810; 22763404; 22808937; 23074961; 23220018; 23296088; 23537590; 23856132; 23898865; 23932990; 24048906; 24078561; 24130151; 24350308; 24401910; 24510552; 24510568; 24606907; 24607329; 24825084; 24941924; 25449068; 25596310; 2563633; 25750018; 25863075; 25863076; 25990862; 26025954; 26542770; 26575882; 26600521; 26759449; 26803807; 26919687; 27049649; 27173423; 27264808; 27308838; 27447460; 27620137; 28389235; 28604955; 28653649; 28676969; 29032371; 29413232; 29653233; 29684050; 8573072	2986678; 15489334; 2461704; 12185072; 18460651; 18835579; 21269460; 24275569; 9406548; 9843368; 9642259; 10694386; 11718561; 1679029; 2246858; 1301187; 8594560; 2840952; 2564729; 2615649; 1975559; 1671810; 2014802; 1672294; 1672290; 1679030; 1709636; 1358789; 1355066; 1363837; 1363838; 8406445; 8098245; 8364546; 8068076; 8088845; 7833954; 8889583; 8889590; 9048935; 9101291; 9450897; 9521426; 9600453; 10200057; 9452061; 9452062; 9792407; 9792411; 9852673; 9950317; 10679941; 11326337; 11180595; 11385716; 11461196; 11935335; 12501224; 18538294; 23792259; 22526846; 22513348
7576	SLC46A1 HCP1 PCFT	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.3 uM for folic acid (at pH 5.5) {ECO:0000269|PubMed:17129779, ECO:0000269|PubMed:17475902}; KM=1.5 uM for folic acid (at pH 6.0) {ECO:0000269|PubMed:17129779, ECO:0000269|PubMed:17475902}; KM=2.7 uM for folic acid (at pH 6.5) {ECO:0000269|PubMed:17129779, ECO:0000269|PubMed:17475902}; KM=6.0 uM for folic acid (at pH 7.0) {ECO:0000269|PubMed:17129779, ECO:0000269|PubMed:17475902}; KM=56.2 uM for folic acid (at pH 7.5) {ECO:0000269|PubMed:17129779, ECO:0000269|PubMed:17475902}; 						BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 4.0-5.5. Activity decreases above pH 5.5 and reaches negligible levels at neutral pH and above. {ECO:0000269|PubMed:17129779, ECO:0000269|PubMed:17475902};					cellular iron ion homeostasis [GO:0006879]; folate import across plasma membrane [GO:1904447]; folic acid metabolic process [GO:0046655]; folic acid transport [GO:0015884]; intestinal folate absorption [GO:0098829]; methotrexate transport [GO:0051958]; proton transmembrane transport [GO:1902600]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; folic acid binding [GO:0005542]; folic acid transmembrane transporter activity [GO:0008517]; heme transporter activity [GO:0015232]; methotrexate transmembrane transporter activity [GO:0015350]; proton transmembrane transporter activity [GO:0015078]; cellular iron ion homeostasis [GO:0006879]; folate import across plasma membrane [GO:1904447]; folic acid metabolic process [GO:0046655]; folic acid transport [GO:0015884]; intestinal folate absorption [GO:0098829]; methotrexate transport [GO:0051958]; proton transmembrane transport [GO:1902600]	folic acid binding [GO:0005542]; folic acid transmembrane transporter activity [GO:0008517]; heme transporter activity [GO:0015232]; methotrexate transmembrane transporter activity [GO:0015350]; proton transmembrane transporter activity [GO:0015078]	GO:0005542; GO:0005737; GO:0005886; GO:0006879; GO:0008517; GO:0009986; GO:0015078; GO:0015232; GO:0015350; GO:0015884; GO:0016021; GO:0016324; GO:0031526; GO:0046655; GO:0051958; GO:0098829; GO:1902600; GO:1904447	SUBCELLULAR LOCATION: Apical cell membrane; Multi-pass membrane protein. Cytoplasm {ECO:0000250}. Note=Localizes to the apical membrane of intestinal cells in iron-deficient cells, while it resides in the cytoplasm in iron-replete cells. {ECO:0000250}.		MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:22814378}.; MOD_RES 6 6 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 458 458 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.	14702039; 15489334; 17974005; 16143108; 17129779; 17156779; 17446347; 17335806; 17475902; 18691976; 18669648; 19159218; 20068231; 22814378; 23601781; 23186163; 25053408; 18559978; 20686069; 20805364; 21333572; 17947394; 18003745; 18650265; 18718264; 18817749; 18842806; 19074442; 19176287; 19403800; 19508863; 19643086; 19762432; 19913121; 20005757; 20036773; 20225891; 20628086; 20724482; 20795774; 21256110; 21338559; 21489556; 21602279; 21656680; 22179615; 22345511; 22496243; 22785121; 22843796; 22954694; 23313509; 23552283; 23609145; 23656756; 24396145; 24597986; 25124723; 25608532; 25801697; 25877470; 26193446; 26789141; 26884338; 27251438; 28138029; 28802835; 28945836; 29208467; 8662720	14702039; 15489334; 17974005; 16143108; 17129779; 17156779; 17446347; 17335806; 17475902; 18691976; 18669648; 19159218; 20068231; 22814378; 23601781; 23186163; 25053408; 18559978; 20686069; 20805364; 21333572
7587	PDE10A	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=56 nM for cAMP {ECO:0000269|PubMed:17389385}; KM=4.4 uM for cGMP {ECO:0000269|PubMed:17389385}; Vmax=507 nmol/min/mg enzyme for cAMP {ECO:0000269|PubMed:17389385}; Vmax=1860 nmol/min/mg enzyme for cGMP {ECO:0000269|PubMed:17389385}; 	3.1.4.17; 3.1.4.35	CATALYTIC ACTIVITY: Nucleoside 3',5'-cyclic phosphate + H(2)O = nucleoside 5'-phosphate.; CATALYTIC ACTIVITY: Guanosine 3',5'-cyclic phosphate + H(2)O = guanosine 5'-phosphate.	BINDING 364 364 Allosteric effector.; BINDING 383 383 Allosteric effector.; BINDING 515 515 Substrate.; BINDING 716 716 Substrate.	ACTIVITY REGULATION: Inhibited by dipyridamole and moderately by IBMX. cAMP acts as an allosteric activator. {ECO:0000269|PubMed:16330539}.	COFACTOR: Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240; Evidence={ECO:0000269|PubMed:17389385}; ;  Note=Binds 2 divalent metal cations per subunit. Site 1 may preferentially bind zinc ions, while site 2 has a preference for magnesium and/or manganese ions. {ECO:0000269|PubMed:17389385};		PATHWAY: Purine metabolism; 3',5'-cyclic AMP degradation; AMP from 3',5'-cyclic AMP: step 1/1.; PATHWAY: Purine metabolism; 3',5'-cyclic GMP degradation; GMP from 3',5'-cyclic GMP: step 1/1.				cAMP catabolic process [GO:0006198]; cGMP catabolic process [GO:0046069]; G-protein coupled receptor signaling pathway [GO:0007186]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cGMP-mediated signaling [GO:0010754]; regulation of protein kinase A signaling [GO:0010738]	cytosol [GO:0005829]; membrane [GO:0016020]; perikaryon [GO:0043204]	cytosol [GO:0005829]; membrane [GO:0016020]; perikaryon [GO:0043204]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; metal ion binding [GO:0046872]; cAMP catabolic process [GO:0006198]; cGMP catabolic process [GO:0046069]; G-protein coupled receptor signaling pathway [GO:0007186]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cGMP-mediated signaling [GO:0010754]; regulation of protein kinase A signaling [GO:0010738]	3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; metal ion binding [GO:0046872]	GO:0004114; GO:0004115; GO:0004118; GO:0005829; GO:0006198; GO:0007186; GO:0010738; GO:0010754; GO:0016020; GO:0030552; GO:0030553; GO:0043204; GO:0043951; GO:0046069; GO:0046872; GO:0047555	SUBCELLULAR LOCATION: Cytoplasm. Note=Located mostly to soluble cellular fractions.	PTM: Isoform PDE10A2: Phosphorylated on Thr-16. {ECO:0000269|PubMed:10441464}.		10441464; 10373451; 10393245; 14574404; 15489334; 10998054; 16330539; 18691976; 19369195; 27058446; 27058447; 17389385; 18477562; 15769620; 16169070; 19622871; 21602043; 21988093; 22142545; 22222034; 22321214; 22365755; 22377514; 22902656; 23149228; 24102193; 24238902; 24375910; 24758746; 24837154; 24944747; 25062128; 25456383; 25515954; 25863433; 25960322; 26077491; 26378882; 26494583; 26602277; 26878596; 27301679; 27491708; 28406621; 29491261; 8557689	10441464; 10373451; 10393245; 14574404; 15489334; 10998054; 16330539; 18691976; 19369195; 27058446; 27058447; 17389385; 18477562
7616	PDE4A DPDE2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=4.0 uM for cAMP (isoform 2) {ECO:0000269|PubMed:11306681, ECO:0000269|PubMed:15738310}; KM=3 uM for cAMP (isoform 6) {ECO:0000269|PubMed:11306681, ECO:0000269|PubMed:15738310}; 	3.1.4.53	CATALYTIC ACTIVITY: Adenosine 3',5'-cyclic phosphate + H(2)O = adenosine 5'-phosphate.	BINDING 474 474 cAMP. {ECO:0000250}.; BINDING 591 591 cAMP. {ECO:0000250}.; BINDING 642 642 cAMP. {ECO:0000250}.	ACTIVITY REGULATION: Isoform 1, isoform 2, isoform 6 and isoform 7 are inhibited by rolipram and cilomilast. Isoform 1, isoform 2 and isoform 6 are inhibited by 4-[(3-butoxy-4-methoxyphenyl)-methyl]-2-imidazolidinone (Ro 20-1724), roflumilast and denbufylline. {ECO:0000269|PubMed:11306681, ECO:0000269|PubMed:15738310, ECO:0000269|PubMed:18095939}.	COFACTOR: Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240; Evidence={ECO:0000269|PubMed:17727341}; ;  Note=Binds 2 divalent metal cations per subunit. Site 1 may preferentially bind zinc ions, while site 2 has a preference for magnesium and/or manganese ions. {ECO:0000269|PubMed:17727341};		PATHWAY: Purine metabolism; 3',5'-cyclic AMP degradation; AMP from 3',5'-cyclic AMP: step 1/1.	SITE 69 70 Cleavage; by caspase-3.; SITE 594 594 Binds AMP, but not cAMP. {ECO:0000250}.			cAMP catabolic process [GO:0006198]; cellular response to drug [GO:0035690]; G-protein coupled receptor signaling pathway [GO:0007186]; regulation of cAMP-mediated signaling [GO:0043949]; regulation of protein kinase A signaling [GO:0010738]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; cAMP binding [GO:0030552]; metal ion binding [GO:0046872]; cAMP catabolic process [GO:0006198]; cellular response to drug [GO:0035690]; G-protein coupled receptor signaling pathway [GO:0007186]; regulation of cAMP-mediated signaling [GO:0043949]; regulation of protein kinase A signaling [GO:0010738]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165]	3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; cAMP binding [GO:0030552]; metal ion binding [GO:0046872]	GO:0004115; GO:0005654; GO:0005829; GO:0005886; GO:0006198; GO:0007165; GO:0007186; GO:0007608; GO:0010738; GO:0016020; GO:0030552; GO:0032587; GO:0035690; GO:0043949; GO:0046872; GO:0048471	SUBCELLULAR LOCATION: Isoform 1: Cytoplasm, perinuclear region.; SUBCELLULAR LOCATION: Isoform 2: Cytoplasm, perinuclear region. Cell projection, ruffle membrane.; SUBCELLULAR LOCATION: Isoform 4: Membrane; Peripheral membrane protein. Note=Isoform 4 has propensity for association with membranes.; SUBCELLULAR LOCATION: Isoform 6: Cytoplasm, perinuclear region.; SUBCELLULAR LOCATION: Isoform 7: Cytoplasm. Membrane. Note=Predominantly cytoplasmic.	PTM: Phosphorylation by MAPKAPK2 its activation through PKA phosphorylation (By similarity). Phosphorylated at Ser-686 and Ser-688 when expressed in S.frugiperda cells. Isoform 2 and isoform 7 are activated by phosphorylation at Ser-119 and Ser-123 respectively by PKA. {ECO:0000250, ECO:0000269|PubMed:11566027}.; PTM: Proteolytically cleaved by caspase-3.	MOD_RES 13 13 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 152 152 Phosphoserine; by MAPKAPK2. {ECO:0000250|UniProtKB:P54748}.; MOD_RES 157 157 Phosphoserine. {ECO:0000250|UniProtKB:P54748}.; MOD_RES 165 165 Phosphoserine. {ECO:0000244|PubMed:19690332}.; MOD_RES 209 209 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 346 346 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 686 686 Phosphoserine. {ECO:0000305|PubMed:11566027}.; MOD_RES 688 688 Phosphoserine. {ECO:0000305|PubMed:11566027}.	8413254; 7888306; 7772058; 9677330; 11306681; 15738310; 18095939; 15057824; 15489334; 2160582; 11566027; 14759258; 18669648; 19690332; 20196770; 23186163; 17727341; 11839681; 11852080; 11994273; 12023945; 12764607; 12810716; 15047569; 15769620; 16257373; 16300476; 16856845; 16940352; 17576803; 17721511; 19018233; 19047098; 19642024; 19759179; 19913121; 20082309; 20086095; 20467438; 20554760; 20628086; 20813835; 21161247; 21652625; 21732365; 21898905; 22223051; 22484154; 23008439; 23043089; 24227907; 24616094; 24813785; 25230992; 25576684; 26496610; 27267386; 27542768; 27993970; 28356347; 28427099; 28701494; 28867658; 9371714	8413254; 7888306; 7772058; 9677330; 11306681; 15738310; 18095939; 15057824; 15489334; 2160582; 11566027; 14759258; 18669648; 19690332; 20196770; 23186163; 17727341; 
7619	PDE9A	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=0.113 uM for cGMP {ECO:0000269|PubMed:21483814}; KM=501 uM for cAMP {ECO:0000269|PubMed:21483814}; Vmax=0.285 umol/min/mg enzyme with cGMP as substrate {ECO:0000269|PubMed:21483814}; Vmax=3.7 umol/min/mg enzyme with cAMP as substrate {ECO:0000269|PubMed:21483814}; Note=kcat is 0.18 sec(-1) for cGMP. kcat is 2.37 sec(-1) for cAMP. {ECO:0000269|PubMed:21483814};	3.1.4.35	CATALYTIC ACTIVITY: Guanosine 3',5'-cyclic phosphate + H(2)O = guanosine 5'-phosphate. {ECO:0000269|PubMed:18757755, ECO:0000269|PubMed:21483814, ECO:0000269|PubMed:9624146}.	BINDING 353 353 cGMP. {ECO:0000269|PubMed:18757755}.; BINDING 462 462 cGMP. {ECO:0000269|PubMed:18757755}.; BINDING 484 484 cGMP. {ECO:0000269|PubMed:18757755}.; BINDING 484 484 Inhibitor specific to PDE9A. {ECO:0000269|PubMed:21483814, ECO:0000269|PubMed:22985069, ECO:0000269|PubMed:23025719}.; BINDING 513 513 Inhibitor. {ECO:0000269|PubMed:19919087, ECO:0000269|PubMed:20121115, ECO:0000269|PubMed:21483814, ECO:0000269|PubMed:22985069, ECO:0000269|PubMed:23025719}.	ACTIVITY REGULATION: Inhibited by zaprinast; inhibitor is however not specific to PDE9A (PubMed:9624146). Specifically inhibited by BAY-73-6691 (1-(2-chlorophenyl)-6-((2R)-3,3,3- trifluoro-2-methylpropyl)-1,5-dihydro-4H-pyrazolo(3,4-d)pyrimidine-4-one) (PubMed:16150925). BAY-73-9961 has two enantiomers, (R) and (S), due to the presence of a chiral center, and both forms vary in their pattern of interaction (PubMed:20121115, PubMed:21483814). Specifically inhibited by PF-4181366 (4H-Pyrazolo[3,4-d]pyrimidin-4-one, 1- cyclopentyl-1,5-dihydro-6-[(3S,4S)-4-methyl- 1-(6-quinoxalinylmethyl)-3-pyrrolidinyl]-one) (PubMed:19919087). Specifically inhibited by PF-4449613 ((R)-6-(1-(3-phenoxyazetidin-1-yl)ethyl)-1-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-d]pyrimidin- 4(5H)-one) (PubMed:25799991). Specifically inhibited by inhibitor 28 (2-((1-(2-Chlorophenyl)-4-hydroxy-1Hpyrazolo[ 3,4-d]pyrimidin-6-yl)amino)-N-(4- methoxyphenyl)propanamide): inhibitor forms a hydrogen bond with Tyr-484 and Gln-513 (PubMed:22985069). Specifically inhibited by 1-Cyclopentyl-6-[(1r)-1-(3-phenoxyazetidin- 1-Yl)ethyl]-1,5-dihydro-4h-pyrazolo[3,4-D] pyrimidin-4-one: inhibitor forms a hydrogen bond with Tyr-484 and Gln-513 (PubMed:23025719). {ECO:0000269|PubMed:16150925, ECO:0000269|PubMed:19919087, ECO:0000269|PubMed:20121115, ECO:0000269|PubMed:21483814, ECO:0000269|PubMed:22985069, ECO:0000269|PubMed:23025719, ECO:0000269|PubMed:25799991, ECO:0000269|PubMed:9624146, ECO:0000303|PubMed:24746902}.	COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000269|PubMed:19919087, ECO:0000269|PubMed:20121115, ECO:0000269|PubMed:21483814, ECO:0000269|PubMed:22985069, ECO:0000269|PubMed:23025719, ECO:0000305|PubMed:18757755}; ;  Note=Binds 1 Zn(2+) ion per subunit. Binds 2 divalent metal cations per subunit: site 1 preferentially binds zinc, while site 2 has a preference for magnesium. Tightly binds zinc. {ECO:0000269|PubMed:19919087, ECO:0000269|PubMed:20121115, ECO:0000269|PubMed:21483814, ECO:0000269|PubMed:22985069, ECO:0000269|PubMed:23025719, ECO:0000305|PubMed:18757755};; COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:19919087, ECO:0000269|PubMed:20121115, ECO:0000269|PubMed:21483814, ECO:0000269|PubMed:22985069, ECO:0000269|PubMed:23025719, ECO:0000305|PubMed:18757755}; ;  Note=Binds 1 Mg(2+) ions per subunit. Binds 2 divalent metal cations per subunit: site 1 preferentially binds zinc, while site 2 has a preference for magnesium. Binds magnesium less tightly than zinc. {ECO:0000269|PubMed:19919087, ECO:0000269|PubMed:20121115, ECO:0000269|PubMed:21483814, ECO:0000269|PubMed:22985069, ECO:0000269|PubMed:23025719, ECO:0000305|PubMed:18757755};		PATHWAY: Purine metabolism; 3',5'-cyclic GMP degradation; GMP from 3',5'-cyclic GMP: step 1/1.				cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; cGMP metabolic process [GO:0046068]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; signal transduction [GO:0007165]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; cGMP catabolic process [GO:0046069]; cGMP metabolic process [GO:0046068]; cGMP-mediated signaling [GO:0019934]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; signal transduction [GO:0007165]	3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]	GO:0004114; GO:0005783; GO:0005794; GO:0005829; GO:0007165; GO:0010613; GO:0019934; GO:0032587; GO:0042383; GO:0042802; GO:0043204; GO:0046068; GO:0046069; GO:0046872; GO:0047555; GO:0048471	SUBCELLULAR LOCATION: Isoform PDE9A1: Cell projection, ruffle membrane {ECO:0000269|PubMed:17090334}. Cytoplasm, perinuclear region {ECO:0000269|PubMed:17090334}. Golgi apparatus {ECO:0000269|PubMed:17090334}. Endoplasmic reticulum {ECO:0000269|PubMed:17090334}. Cell membrane, sarcolemma {ECO:0000269|PubMed:25799991}.; SUBCELLULAR LOCATION: Isoform PDE9A2: Cell projection, ruffle membrane {ECO:0000269|PubMed:17090334}. Cytoplasm, perinuclear region {ECO:0000269|PubMed:17090334}.; SUBCELLULAR LOCATION: Isoform PDE9A3: Cytoplasm {ECO:0000269|PubMed:17090334}. Endoplasmic reticulum {ECO:0000269|PubMed:17090334}.; SUBCELLULAR LOCATION: Isoform PDE9A17: Cytoplasm {ECO:0000269|PubMed:17090334}. Endoplasmic reticulum {ECO:0000269|PubMed:17090334}.		MOD_RES 379 379 Phosphoserine. {ECO:0000250|UniProtKB:Q8QZV1}.	9624146; 9856478; 12565835; 14527714; 17090334; 14702039; 10830953; 15489334; 16150925; 22328573; 24746902; 25799991; 15210993; 18757755; 19919087; 20121115; 21483814; 22985069; 23025719; 16189514; 17008408; 19060904; 19214142; 20351714; 20379614; 21336703; 21736695; 22960860; 25416956; 26316540; 8557689	9624146; 9856478; 12565835; 14527714; 17090334; 14702039; 10830953; 15489334; 16150925; 22328573; 24746902; 25799991; 15210993; 18757755; 19919087; 20121115; 21483814; 22985069; 23025719
7623	PDE11A	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=3.0 uM for cAMP (isoform 1) {ECO:0000269|PubMed:10725373, ECO:0000269|PubMed:10906126, ECO:0000269|PubMed:11050148}; KM=1.4 uM for cGMP (isoform 1) {ECO:0000269|PubMed:10725373, ECO:0000269|PubMed:10906126, ECO:0000269|PubMed:11050148}; KM=3.0 uM for cAMP (isoform 2) {ECO:0000269|PubMed:10725373, ECO:0000269|PubMed:10906126, ECO:0000269|PubMed:11050148}; KM=1.5 uM for cGMP (isoform 2) {ECO:0000269|PubMed:10725373, ECO:0000269|PubMed:10906126, ECO:0000269|PubMed:11050148}; KM=3.3 uM for cAMP (isoform 3) {ECO:0000269|PubMed:10725373, ECO:0000269|PubMed:10906126, ECO:0000269|PubMed:11050148}; KM=3.7 uM for cGMP (isoform 3) {ECO:0000269|PubMed:10725373, ECO:0000269|PubMed:10906126, ECO:0000269|PubMed:11050148}; KM=1.04 uM for cAMP (isoform 4) {ECO:0000269|PubMed:10725373, ECO:0000269|PubMed:10906126, ECO:0000269|PubMed:11050148}; KM=0.52 uM for cGMP (isoform 4) {ECO:0000269|PubMed:10725373, ECO:0000269|PubMed:10906126, ECO:0000269|PubMed:11050148}; Vmax=3.6 pmol/min/ug enzyme with cAMP as substrate (isoform 4) {ECO:0000269|PubMed:10725373, ECO:0000269|PubMed:10906126, ECO:0000269|PubMed:11050148}; Vmax=3.9 pmol/min/ug enzyme with cGMP as substrate (isoform 4) {ECO:0000269|PubMed:10725373, ECO:0000269|PubMed:10906126, ECO:0000269|PubMed:11050148}; Vmax=270 pmol/min/ug enzyme with cAMP as substrate (isoform 1) {ECO:0000269|PubMed:10725373, ECO:0000269|PubMed:10906126, ECO:0000269|PubMed:11050148}; Vmax=120 pmol/min/ug enzyme with cGMP as substrate (isoform 1) {ECO:0000269|PubMed:10725373, ECO:0000269|PubMed:10906126, ECO:0000269|PubMed:11050148}; 	3.1.4.35; 3.1.4.53	CATALYTIC ACTIVITY: Guanosine 3',5'-cyclic phosphate + H(2)O = guanosine 5'-phosphate.; CATALYTIC ACTIVITY: Adenosine 3',5'-cyclic phosphate + H(2)O = adenosine 5'-phosphate.	BINDING 869 869 cAMP or cGMP. {ECO:0000250}.	ACTIVITY REGULATION: Inhibited by 3-isobutyl-1-methylxanthine (IBMX), zaprinast and dipyridamole. cGMP acts as an allosteric activator. Weakly inhibited by Sildenafil (Viagra) and Tadalafil (Cialis); however, the fact that the protein is probably absent from testis, suggests that it is not biologically relevant and is not related with erectile dysfunction. {ECO:0000269|PubMed:10725373, ECO:0000269|PubMed:11050148, ECO:0000269|PubMed:16079899, ECO:0000269|PubMed:16330539}.	COFACTOR: Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240; Evidence={ECO:0000250}; ;  Note=Binds 2 divalent metal cations per subunit. Site 1 may preferentially bind zinc ions, while site 2 has a preference for magnesium and/or manganese ions. {ECO:0000250};						G-protein coupled receptor signaling pathway [GO:0007186]; metabolic process [GO:0008152]; signal transduction [GO:0007165]	cytosol [GO:0005829]	cytosol [GO:0005829]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; cyclic-nucleotide phosphodiesterase activity [GO:0004112]; metal ion binding [GO:0046872]; G-protein coupled receptor signaling pathway [GO:0007186]; metabolic process [GO:0008152]; signal transduction [GO:0007165]	3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; cyclic-nucleotide phosphodiesterase activity [GO:0004112]; metal ion binding [GO:0046872]	GO:0004112; GO:0004114; GO:0004115; GO:0004118; GO:0005829; GO:0007165; GO:0007186; GO:0008152; GO:0030553; GO:0046872; GO:0047555	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:10906126}.		MOD_RES 162 162 Phosphoserine. {ECO:0000250|UniProtKB:P0C1Q2}.; MOD_RES 163 163 Phosphoserine. {ECO:0000250|UniProtKB:P0C1Q2}.; MOD_RES 239 239 Phosphoserine. {ECO:0000244|PubMed:19690332}.	10906126; 10725373; 11050148; 11121118; 15815621; 15489334; 15800651; 16079899; 16330539; 16767104; 19690332; 15769620; 17008408; 17178847; 18043711; 18312413; 18491255; 18559625; 19214142; 19429701; 19549888; 19557111; 19671705; 19689430; 19913121; 20110084; 20351714; 20379614; 20628086; 20881257; 20920776; 21047926; 21697861; 22996146; 26459559; 8557689	10906126; 10725373; 11050148; 11121118; 15815621; 15489334; 15800651; 16079899; 16330539; 16767104; 19690332
7702	OAS2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=2.1 mM for ATP {ECO:0000269|PubMed:10464285, ECO:0000269|PubMed:11986302, ECO:0000269|PubMed:9880569}; 	2.7.7.84	CATALYTIC ACTIVITY: 3 ATP = pppA2'p5'A2'p5'A + 2 diphosphate. {ECO:0000269|PubMed:10464285, ECO:0000269|PubMed:11682059, ECO:0000269|PubMed:11986302, ECO:0000269|PubMed:9880569}.	BINDING 396 396 ATP. {ECO:0000250|UniProtKB:P00973}.; BINDING 544 544 ATP. {ECO:0000305|PubMed:11986302}.; BINDING 547 547 ATP. {ECO:0000305|PubMed:11986302}.	ACTIVITY REGULATION: Produced as a latent enzyme which is activated by double stranded RNA (dsRNA) generated during the course of viral infection(PubMed:9880569). The dsRNA activator must be at least 15 nucleotides long, and no modification of the 2'-hydroxyl group is tolerated (PubMed:9880569). ssRNA or dsDNA do not act as activators (PubMed:9880569). Strongly inhibited by copper, iron and zinc ions (PubMed:11682059). Partially inhibited by cobalt and nickel ions (PubMed:11682059). {ECO:0000269|PubMed:11682059, ECO:0000269|PubMed:9880569}.	COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:11682059}; 						defense response to virus [GO:0051607]; interferon-gamma-mediated signaling pathway [GO:0060333]; nucleobase-containing compound metabolic process [GO:0006139]; regulation of lactation [GO:1903487]; response to bacterium [GO:0009617]; response to virus [GO:0009615]; RNA catabolic process [GO:0006401]; type I interferon signaling pathway [GO:0060337]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; 2'-5'-oligoadenylate synthetase activity [GO:0001730]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; defense response to virus [GO:0051607]; interferon-gamma-mediated signaling pathway [GO:0060333]; nucleobase-containing compound metabolic process [GO:0006139]; regulation of lactation [GO:1903487]; response to bacterium [GO:0009617]; response to virus [GO:0009615]; RNA catabolic process [GO:0006401]; type I interferon signaling pathway [GO:0060337]	2'-5'-oligoadenylate synthetase activity [GO:0001730]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]	GO:0001730; GO:0003725; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006139; GO:0006401; GO:0009615; GO:0009617; GO:0016020; GO:0043231; GO:0046872; GO:0048471; GO:0051607; GO:0060333; GO:0060337; GO:1903487	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19923450}. Cytoplasm, perinuclear region {ECO:0000269|PubMed:19923450}.	PTM: Myristoylation is not essential for its activity. {ECO:0000269|PubMed:2211721, ECO:0000269|PubMed:9880569}.; PTM: Glycosylated. Glycosylation is essential for its activity. {ECO:0000269|PubMed:9880569}.	MOD_RES 378 378 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.	1577824; 14702039; 16541075; 15489334; 11986302; 2211721; 9880569; 10464285; 11682059; 17408844; 19923450; 19904482; 19608861; 21269460; 21142819; 24275569; 11092454; 11337497; 11404376; 12029096; 12447867; 14769151; 15047845; 1508672; 16009940; 16014697; 1730654; 18362138; 19559055; 19853919; 20588308; 21050126; 23337612; 24328427; 24594345; 25416956; 26595239; 27572959; 27899133; 6162102; 6548414; 7530745; 8176225; 8483949; 8530158; 9096384; 9143706; 9861020	1577824; 14702039; 16541075; 15489334; 11986302; 2211721; 9880569; 10464285; 11682059; 17408844; 19923450; 19904482; 19608861; 21269460; 21142819; 24275569
7705	OGT	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.8 uM for UDP-N-acetyl-D-glucosamine {ECO:0000269|PubMed:21240259}; 	2.4.1.255	CATALYTIC ACTIVITY: UDP-N-acetyl-alpha-D-glucosamine + [protein]-L-serine = UDP + [protein]-3-O-(N-acetyl-beta-D-glucosaminyl)-L-serine. {ECO:0000269|PubMed:15361863, ECO:0000269|PubMed:21240259, ECO:0000269|PubMed:21285374, ECO:0000269|PubMed:23103939, ECO:0000305|PubMed:26678539}.; CATALYTIC ACTIVITY: UDP-N-acetyl-alpha-D-glucosamine + [protein]-L-threonine = UDP + [protein]-3-O-(N-acetyl-beta-D-glucosaminyl)-L-threonine. {ECO:0000269|PubMed:15361863, ECO:0000269|PubMed:21240259, ECO:0000269|PubMed:21285374, ECO:0000305|PubMed:26678539}.	BINDING 849 849 UDP. {ECO:0000244|PDB:4GYW, ECO:0000269|PubMed:23103939}.; BINDING 852 852 UDP. {ECO:0000244|PDB:4GYW, ECO:0000269|PubMed:23103939}.; BINDING 935 935 UDP. {ECO:0000244|PDB:4GYW, ECO:0000269|PubMed:23103939}.	ACTIVITY REGULATION: Subject to product inhibition by UDP. {ECO:0000269|PubMed:21240259}.			PATHWAY: Protein modification; protein glycosylation. {ECO:0000269|PubMed:15361863, ECO:0000269|PubMed:21240259, ECO:0000269|PubMed:21285374, ECO:0000269|PubMed:23103939, ECO:0000269|PubMed:26678539}.				apoptotic process [GO:0006915]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; signal transduction [GO:0007165]	cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; acetylglucosaminyltransferase activity [GO:0008375]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; apoptotic process [GO:0006915]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; signal transduction [GO:0007165]	acetylglucosaminyltransferase activity [GO:0008375]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]	GO:0000123; GO:0005547; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0005886; GO:0006110; GO:0006111; GO:0006357; GO:0006493; GO:0006915; GO:0007165; GO:0007584; GO:0008375; GO:0016262; GO:0016485; GO:0016579; GO:0031397; GO:0032435; GO:0032868; GO:0032922; GO:0032991; GO:0035020; GO:0043981; GO:0043982; GO:0043984; GO:0045862; GO:0045944; GO:0046626; GO:0048015; GO:0061087; GO:0080182; GO:0097363; GO:0120162	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:26678539}. Cytoplasm {ECO:0000269|PubMed:26678539}. Note=Predominantly localizes to the nucleus. {ECO:0000269|PubMed:26678539}.; SUBCELLULAR LOCATION: Isoform 2: Mitochondrion {ECO:0000269|PubMed:20824293}. Membrane {ECO:0000269|PubMed:20824293}. Note=Associates with the mitochondrial inner membrane. {ECO:0000269|PubMed:20824293}.; SUBCELLULAR LOCATION: Isoform 3: Cytoplasm {ECO:0000269|PubMed:21285374}. Nucleus {ECO:0000269|PubMed:20018852, ECO:0000269|PubMed:21285374}. Cell membrane {ECO:0000250|UniProtKB:P56558}. Mitochondrion membrane {ECO:0000250|UniProtKB:P56558}. Cell projection {ECO:0000250|UniProtKB:P56558}. Note=Mostly in the nucleus. Retained in the nucleus via interaction with HCFC1 (PubMed:21285374). After insulin induction, translocated from the nucleus to the cell membrane via phophatidylinositide binding. Colocalizes with AKT1 at the plasma membrane. TRAK1 recruits this protein to mitochondria. In the absence of TRAK1, localizes in cytosol and nucleus (By similarity). {ECO:0000250|UniProtKB:P56558, ECO:0000269|PubMed:21285374}.; SUBCELLULAR LOCATION: Isoform 4: Cytoplasm. Nucleus.	PTM: Ubiquitinated, leading to its proteasomal degradation. {ECO:0000269|PubMed:21285374}.; PTM: Phosphorylation on Ser-3 or Ser-4 by GSK3-beta positively regulates its activity. {ECO:0000250}.	MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22814378, ECO:0000269|Ref.5}.; MOD_RES 3 3 Phosphoserine; by GSK3-beta; alternate. {ECO:0000250|UniProtKB:Q8CGY8}.; MOD_RES 4 4 Phosphoserine; by GSK3-beta; alternate. {ECO:0000250|UniProtKB:Q8CGY8}.; MOD_RES 20 20 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 989 989 Phosphotyrosine. {ECO:0000250|UniProtKB:P56558}.	9083068; 11773972; 17974005; 15489334; 12150998; 12670868; 18669648; 19413330; 19451179; 19073609; 19377461; 24336203; 20018852; 20018868; 20200153; 20824293; 21269460; 22121020; 21285374; 22814378; 22923583; 23353889; 23629655; 23186163; 23222540; 24995978; 24474760; 26678539; 28742148; 15361863; 21240259; 23103939; 26273451; 28302723; 28584052; 16189514; 16449650; 17000644; 17353931; 17882263; 19615732; 19932102; 20360068; 20711500; 20805357; 21295698; 21516116; 21851590; 22082911; 22575643; 23088713; 23103942; 23395175; 24256146; 24311690; 25416956; 25609649; 26237509; 26496610; 26638075; 27618188; 28659383; 29058723; 29606577; 29723473	9083068; 11773972; 17974005; 15489334; 12150998; 12670868; 18669648; 19413330; 19451179; 19073609; 19377461; 24336203; 20018852; 20018868; 20200153; 20824293; 21269460; 22121020; 21285374; 22814378; 22923583; 23353889; 23629655; 23186163; 23222540; 24995978; 24474760; 26678539; 28742148; 15361863; 21240259; 23103939; 26273451; 28302723; 28584052
7744	NUDT3 DIPP DIPP1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=5.9 uM for Ap6A {ECO:0000269|PubMed:10419486, ECO:0000269|PubMed:12370170, ECO:0000269|PubMed:9822604}; KM=7.7 uM for Ap5A {ECO:0000269|PubMed:10419486, ECO:0000269|PubMed:12370170, ECO:0000269|PubMed:9822604}; KM=38 mM for 5-phosphoribose 1-diphosphate {ECO:0000269|PubMed:10419486, ECO:0000269|PubMed:12370170, ECO:0000269|PubMed:9822604}; KM=4.2 nM for PP-InsP5 {ECO:0000269|PubMed:10419486, ECO:0000269|PubMed:12370170, ECO:0000269|PubMed:9822604}; 	3.6.1.52; 3.6.1.-	CATALYTIC ACTIVITY: Diphospho-myo-inositol polyphosphate + H(2)O = myo-inositol polyphosphate + phosphate. {ECO:0000269|PubMed:10419486, ECO:0000269|PubMed:12370170, ECO:0000269|PubMed:9822604}.	BINDING 10 10 Substrate. {ECO:0000244|PDB:2FVV, ECO:0000244|PDB:2Q9P, ECO:0000269|PubMed:19585659}.; BINDING 115 115 Substrate. {ECO:0000244|PDB:2Q9P, ECO:0000269|PubMed:19585659}.; BINDING 133 133 Substrate. {ECO:0000244|PDB:2FVV, ECO:0000244|PDB:2Q9P, ECO:0000269|PubMed:19585659}.	ACTIVITY REGULATION: Inhibited by fluoride and InsP6. {ECO:0000269|PubMed:19585659}.	COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:19585659}; ;  Note=Binds 3 Mg(2+) ions per subunit. {ECO:0000269|PubMed:19585659};	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 7-7.5. {ECO:0000269|PubMed:10419486, ECO:0000269|PubMed:12370170, ECO:0000269|PubMed:9822604};					adenosine 5'-(hexahydrogen pentaphosphate) catabolic process [GO:1901911]; cell-cell signaling [GO:0007267]; diadenosine hexaphosphate catabolic process [GO:1901909]; diadenosine pentaphosphate catabolic process [GO:1901907]; diadenosine polyphosphate catabolic process [GO:0015961]; diphosphoinositol polyphosphate catabolic process [GO:0071544]; inositol phosphate metabolic process [GO:0043647]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; bis(5'-adenosyl)-hexaphosphatase activity [GO:0034431]; bis(5'-adenosyl)-pentaphosphatase activity [GO:0034432]; diphosphoinositol-polyphosphate diphosphatase activity [GO:0008486]; endopolyphosphatase activity [GO:0000298]; inositol bisdiphosphate tetrakisphosphate diphosphatase activity [GO:0052841]; inositol diphosphate pentakisphosphate diphosphatase activity [GO:0052842]; inositol diphosphate tetrakisphosphate diphosphatase activity [GO:0052840]; inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity [GO:0052846]; inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity [GO:0052847]; inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity [GO:0052843]; inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity [GO:0052848]; inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity [GO:0052844]; inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity [GO:0052845]; m7G(5')pppN diphosphatase activity [GO:0050072]; magnesium ion binding [GO:0000287]; adenosine 5'-(hexahydrogen pentaphosphate) catabolic process [GO:1901911]; cell-cell signaling [GO:0007267]; diadenosine hexaphosphate catabolic process [GO:1901909]; diadenosine pentaphosphate catabolic process [GO:1901907]; diadenosine polyphosphate catabolic process [GO:0015961]; diphosphoinositol polyphosphate catabolic process [GO:0071544]; inositol phosphate metabolic process [GO:0043647]	bis(5'-adenosyl)-hexaphosphatase activity [GO:0034431]; bis(5'-adenosyl)-pentaphosphatase activity [GO:0034432]; diphosphoinositol-polyphosphate diphosphatase activity [GO:0008486]; endopolyphosphatase activity [GO:0000298]; inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity [GO:0052846]; inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity [GO:0052847]; inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity [GO:0052843]; inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity [GO:0052848]; inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity [GO:0052844]; inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity [GO:0052845]; inositol bisdiphosphate tetrakisphosphate diphosphatase activity [GO:0052841]; inositol diphosphate pentakisphosphate diphosphatase activity [GO:0052842]; inositol diphosphate tetrakisphosphate diphosphatase activity [GO:0052840]; m7G(5')pppN diphosphatase activity [GO:0050072]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0000298; GO:0005634; GO:0005737; GO:0005829; GO:0007267; GO:0008486; GO:0015961; GO:0034431; GO:0034432; GO:0043647; GO:0050072; GO:0052840; GO:0052841; GO:0052842; GO:0052843; GO:0052844; GO:0052845; GO:0052846; GO:0052847; GO:0052848; GO:0071544; GO:1901907; GO:1901909; GO:1901911	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.		MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:22814378}.	9822604; 14702039; 14574404; 15489334; 10419486; 10585413; 12370170; 21269460; 22814378; 19585659; 10777568; 12105228; 12121577; 16169070; 16189514; 19893584; 20711500; 21565611; 21900206; 23708086; 26496610; 26932476	9822604; 14702039; 14574404; 15489334; 10419486; 10585413; 12370170; 21269460; 22814378; 19585659
7778	OSCP1 C1orf102 NOR1	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=35.0 uM for p-aminohippurate (PAH) {ECO:0000269|PubMed:16006562}; KM=62.3 uM for tetraethylammonium {ECO:0000269|PubMed:16006562}; Note=In Xenopus laevis oocytes, in a sodium-independent manner.;												basal plasma membrane [GO:0009925]	basal plasma membrane [GO:0009925]		GO:0009925	SUBCELLULAR LOCATION: Basal cell membrane. Note=Syncytiotrophoblast in placenta.			12819961; 16006562; 14702039; 16710414; 15489334; 18237537; 19727524; 20379614; 21803736; 23831407; 26781989	12819961; 16006562; 14702039; 16710414; 15489334
7785	NUDT22 PP11246	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=16.5 uM for UDP-glucose {ECO:0000269|PubMed:29413322}; KM=51.4 uM for UDP-galactose {ECO:0000269|PubMed:29413322}; Note=kcat is 0.69 sec(-1) for UDP-glucose. kcat is 0.55 sec(-1) for UDP-galactose. {ECO:0000269|PubMed:29413322};	3.6.1.45	CATALYTIC ACTIVITY: UDP-sugar + H(2)O = UMP + alpha-D-aldose 1-phosphate. {ECO:0000269|PubMed:29413322}.	BINDING 56 56 Substrate; via amide nitrogen and carbonyl oxygen. {ECO:0000244|PDB:5LOR}.; BINDING 87 87 Substrate. {ECO:0000244|PDB:5LOR}.; BINDING 139 139 Substrate. {ECO:0000244|PDB:5LOR}.; BINDING 144 144 Substrate; via amide nitrogen. {ECO:0000244|PDB:5LOR}.; BINDING 151 151 Substrate. {ECO:0000244|PDB:5LOR}.; BINDING 156 156 Substrate. {ECO:0000244|PDB:5LOR}.; BINDING 158 158 Substrate. {ECO:0000244|PDB:5LOR}.; BINDING 274 274 Substrate. {ECO:0000244|PDB:5LOR}.		COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:29413322}; 				PP11246			nucleoplasm [GO:0005654]	nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; UDP-sugar diphosphatase activity [GO:0008768]	metal ion binding [GO:0046872]; UDP-sugar diphosphatase activity [GO:0008768]	GO:0005654; GO:0008768; GO:0046872				15498874; 16554811; 15489334; 29413322; 19913121; 20237496; 20628086; 25416956	15498874; 16554811; 15489334; 29413322
7787	NUDT15 MTH2	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=42 uM for dGTP (at pH 7.5) {ECO:0000269|PubMed:26238318}; KM=110 uM for 8-oxo-dGTP (at pH 7.5) {ECO:0000269|PubMed:26238318}; Note=Has a 10-fold higher catalytic efficiency toward dGTP compared to 8-oxo-dGTP. {ECO:0000269|PubMed:26238318};	3.6.1.9	CATALYTIC ACTIVITY: A nucleoside triphosphate + H(2)O = a nucleotide + diphosphate. {ECO:0000269|PubMed:26238318}.			COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250|UniProtKB:Q8BG93}; Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250|UniProtKB:Q8BG93}; ;  Note=Magnesium may be the real cofactor in vivo. {ECO:0000250|UniProtKB:Q8BG93};						dGTP catabolic process [GO:0006203]; DNA protection [GO:0042262]; exogenous drug catabolic process [GO:0042738]; mitotic cell cycle [GO:0000278]; nucleobase-containing small molecule catabolic process [GO:0034656]; nucleoside phosphate catabolic process [GO:1901292]; purine nucleotide catabolic process [GO:0006195]; regulation of proteasomal protein catabolic process [GO:0061136]	cytosol [GO:0005829]	cytosol [GO:0005829]; 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity [GO:0035539]; 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity [GO:0008413]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; nucleoside-diphosphatase activity [GO:0017110]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; dGTP catabolic process [GO:0006203]; DNA protection [GO:0042262]; exogenous drug catabolic process [GO:0042738]; mitotic cell cycle [GO:0000278]; nucleobase-containing small molecule catabolic process [GO:0034656]; nucleoside phosphate catabolic process [GO:1901292]; purine nucleotide catabolic process [GO:0006195]; regulation of proteasomal protein catabolic process [GO:0061136]	8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity [GO:0035539]; 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity [GO:0008413]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; nucleoside-diphosphatase activity [GO:0017110]; nucleoside-triphosphate diphosphatase activity [GO:0047429]	GO:0000278; GO:0005829; GO:0006195; GO:0006203; GO:0008413; GO:0017110; GO:0034656; GO:0035529; GO:0035539; GO:0042262; GO:0042738; GO:0046872; GO:0047429; GO:0061136; GO:1901292				14702039; 15057823; 15489334; 8810257; 19419956; 21269460; 22556419; 25108385; 26878724; 26238318; 12767940; 20144704; 21988832; 25624441; 26033531; 26076924; 26405151; 26503813; 26590936; 26735160; 27095468; 27193222; 27308664; 27381176; 27416873; 27530327; 27577869; 28470355; 28566182; 28570428; 28883280; 28963908; 29206869; 29210335; 29398872; 29491687	14702039; 15057823; 15489334; 8810257; 19419956; 21269460; 22556419; 25108385; 26878724; 26238318
7829	PRUNE1 PRUNE	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.91 uM for cAMP {ECO:0000269|PubMed:14998490, ECO:0000269|PubMed:17655525}; KM=2.3 uM for cGMP {ECO:0000269|PubMed:14998490, ECO:0000269|PubMed:17655525}; Vmax=12.8 pmol/min/ug enzyme with cAMP as substrate {ECO:0000269|PubMed:14998490, ECO:0000269|PubMed:17655525}; Vmax=0.8 pmol/min/ug enzyme with cGMP as substrate {ECO:0000269|PubMed:14998490, ECO:0000269|PubMed:17655525}; 	3.6.1.1	CATALYTIC ACTIVITY: Diphosphate + H(2)O = 2 phosphate.		ACTIVITY REGULATION: Activated by magnesium ions and inhibited by manganese ions. Inhibited by dipyridamole, moderately sensitive to IBMX and inhibited by vinpocetine. {ECO:0000269|PubMed:14998490}.	COFACTOR: Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250}; ;  Note=Binds 2 manganese ions per subunit. {ECO:0000250};						regulation of microtubule polymerization [GO:0031113]; regulation of neurogenesis [GO:0050767]	cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]	cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; inorganic diphosphatase activity [GO:0004427]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; tubulin binding [GO:0015631]; regulation of microtubule polymerization [GO:0031113]; regulation of neurogenesis [GO:0050767]	inorganic diphosphatase activity [GO:0004427]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; tubulin binding [GO:0015631]	GO:0004427; GO:0005634; GO:0005829; GO:0005925; GO:0015631; GO:0016791; GO:0031113; GO:0046872; GO:0050767	SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Cell junction, focal adhesion. Note=In some transfected cells a nuclear staining is also observed.		MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:22814378}.; MOD_RES 399 399 Phosphoserine. {ECO:0000250|UniProtKB:Q8BIW1}.; MOD_RES 410 410 Phosphothreonine. {ECO:0000250|UniProtKB:Q8BIW1}.; MOD_RES 414 414 Phosphoserine. {ECO:0000250|UniProtKB:Q8BIW1}.	10602478; 14702039; 16710414; 15489334; 10524757; 17974005; 11687967; 14998490; 15671547; 16428445; 17655525; 17906697; 21269460; 22814378; 28211990; 28334956; 26539891; 18978678; 20735841; 23448979; 23455922; 25026278; 27037526; 27109060	10602478; 14702039; 16710414; 15489334; 10524757; 17974005; 11687967; 14998490; 15671547; 16428445; 17655525; 17906697; 21269460; 22814378; 28211990; 28334956; 26539891
7847	RNASE6 RNS6	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=5.0 uM for tRNA {ECO:0000269|PubMed:8836175}; KM=2.63 mM for UpA dinucleotide {ECO:0000269|PubMed:27013146}; KM=1.22 mM for CpA dinucleotide {ECO:0000269|PubMed:27013146}; KM=2.06 mM for cytidine 2,3-cyclic phosphate {ECO:0000269|PubMed:27013146}; 	3.1.27.-		BINDING 86 86 Substrate. {ECO:0000250}.; BINDING 105 105 Substrate. {ECO:0000250}.					SITE 24 24 Important for bactericidal activity, bacterial agglutination activity and binding to bacterial lipopolysaccharide (LPS). {ECO:0000269|PubMed:27089320}.; SITE 36 36 Important for bactericidal activity, bacterial agglutination activity and binding to bacterial lipopolysaccharide (LPS). {ECO:0000269|PubMed:27089320}.; SITE 59 59 Facilitates cleavage of polynucleotide substrates. {ECO:0000269|PubMed:27013146}.; SITE 61 61 Critical for catalytic activity. {ECO:0000250|UniProtKB:Q9H1E1}.			antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; antimicrobial humoral response [GO:0019730]; defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; RNA catabolic process [GO:0006401]; RNA phosphodiester bond hydrolysis [GO:0090501]	cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; lysosome [GO:0005764]	cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; lysosome [GO:0005764]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; ribonuclease activity [GO:0004540]; antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; antimicrobial humoral response [GO:0019730]; defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; RNA catabolic process [GO:0006401]; RNA phosphodiester bond hydrolysis [GO:0090501]	endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; ribonuclease activity [GO:0004540]	GO:0003676; GO:0004519; GO:0004540; GO:0005576; GO:0005615; GO:0005622; GO:0005764; GO:0006401; GO:0006952; GO:0019730; GO:0019731; GO:0031410; GO:0045087; GO:0050829; GO:0050830; GO:0051607; GO:0061844; GO:0090501	SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:25075772}. Lysosome {ECO:0000305|PubMed:25075772}. Cytoplasmic granule {ECO:0000269|PubMed:25075772}.			8836175; 15489334; 25075772; 27089320; 27013146; 16169070; 16940129; 17150966; 18673279; 20180804; 20235792; 22327069; 23302724	8836175; 15489334; 25075772; 27089320; 27013146
7858	RGN SMP30	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=2.7 mM for gluconolactone (with Zn(2+) as cofactor) {ECO:0000269|PubMed:20329768}; KM=0.6 mM for gluconolactone (with Mn(2+) as cofactor) {ECO:0000269|PubMed:20329768}; KM=1.3 mM for gluconolactone (with Mg(2+) as cofactor) {ECO:0000269|PubMed:20329768}; KM=3.7 mM for gluconolactone (with Ca(2+) as cofactor) {ECO:0000269|PubMed:20329768}; 	3.1.1.17	CATALYTIC ACTIVITY: D-glucono-1,5-lactone + H(2)O = D-gluconate. {ECO:0000269|PubMed:20329768, ECO:0000269|PubMed:23349732}.	BINDING 101 101 Substrate.; BINDING 103 103 Substrate.; BINDING 121 121 Substrate. {ECO:0000250}.		COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000269|PubMed:20329768, ECO:0000269|PubMed:23349732}; Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000269|PubMed:20329768, ECO:0000269|PubMed:23349732}; Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000269|PubMed:20329768, ECO:0000269|PubMed:23349732}; Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:20329768, ECO:0000269|PubMed:23349732}; ;  Note=Binds 1 divalent metal cation per subunit. Most active with Zn(2+) and Mn(2+) ions. The physiological cofactor is most likely Ca(2+) or Mg(2+). {ECO:0000269|PubMed:20329768, ECO:0000269|PubMed:23349732};						aging [GO:0007568]; cellular calcium ion homeostasis [GO:0006874]; kidney development [GO:0001822]; L-ascorbic acid biosynthetic process [GO:0019853]; liver regeneration [GO:0097421]; negative regulation of apoptotic process [GO:0043066]; negative regulation of bone development [GO:1903011]; negative regulation of calcium-dependent ATPase activity [GO:1903611]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of DNA catabolic process [GO:1903625]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of flagellated sperm motility [GO:1901318]; negative regulation of GTPase activity [GO:0034260]; negative regulation of leucine-tRNA ligase activity [GO:1903634]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of RNA biosynthetic process [GO:1902679]; positive regulation of ATPase activity [GO:0032781]; positive regulation of calcium-transporting ATPase activity [GO:1901896]; positive regulation of dUTP diphosphatase activity [GO:1903629]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phosphatase activity [GO:0010922]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; positive regulation of superoxide dismutase activity [GO:1901671]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of calcium-mediated signaling [GO:0050848]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270]; aging [GO:0007568]; cellular calcium ion homeostasis [GO:0006874]; kidney development [GO:0001822]; L-ascorbic acid biosynthetic process [GO:0019853]; liver regeneration [GO:0097421]; negative regulation of apoptotic process [GO:0043066]; negative regulation of bone development [GO:1903011]; negative regulation of calcium-dependent ATPase activity [GO:1903611]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of DNA catabolic process [GO:1903625]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of flagellated sperm motility [GO:1901318]; negative regulation of GTPase activity [GO:0034260]; negative regulation of leucine-tRNA ligase activity [GO:1903634]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of RNA biosynthetic process [GO:1902679]; positive regulation of ATPase activity [GO:0032781]; positive regulation of calcium-transporting ATPase activity [GO:1901896]; positive regulation of dUTP diphosphatase activity [GO:1903629]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phosphatase activity [GO:0010922]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; positive regulation of superoxide dismutase activity [GO:1901671]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of calcium-mediated signaling [GO:0050848]; spermatogenesis [GO:0007283]	calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270]	GO:0001822; GO:0004341; GO:0005509; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0006469; GO:0006874; GO:0007283; GO:0007568; GO:0008270; GO:0010867; GO:0010907; GO:0010922; GO:0019853; GO:0030234; GO:0032515; GO:0032781; GO:0034260; GO:0043066; GO:0043547; GO:0045019; GO:0045723; GO:0050680; GO:0050848; GO:0051344; GO:0097421; GO:1901318; GO:1901671; GO:1901896; GO:1902679; GO:1903011; GO:1903052; GO:1903611; GO:1903625; GO:1903629; GO:1903634; GO:2000279	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.		MOD_RES 144 144 N6-succinyllysine. {ECO:0000250|UniProtKB:Q64374}.; MOD_RES 244 244 N6-succinyllysine. {ECO:0000250|UniProtKB:Q64374}.; MOD_RES 253 253 N6-succinyllysine. {ECO:0000250|UniProtKB:Q64374}.	7548213; 10677570; 14702039; 15772651; 15489334; 24275569; 20329768; 23349732; 12619687; 15358188; 15502314; 15714273; 15962315; 18507831; 19347872; 19690176; 19801822; 19946731; 21047503; 21347421; 21431902; 21680783; 21684279; 22121208; 22652898; 23453039; 24606440; 24975685; 25050833; 25128811; 25230901; 25847529; 26072307; 26619319; 26935290; 27221776; 27411833; 27633001; 27991558; 28028056; 28181135	7548213; 10677570; 14702039; 15772651; 15489334; 24275569; 20329768; 23349732
7868	RDH11 ARSDR1 PSDR1 SDR7C1 CGI-82	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=0.23 uM for NADPH {ECO:0000269|PubMed:12036956}; KM=0.8 uM for NADP {ECO:0000269|PubMed:12036956}; KM=0.5 uM for all-trans-retinal {ECO:0000269|PubMed:12036956}; KM=0.62 uM for 13-cis-retinal {ECO:0000269|PubMed:12036956}; KM=0.19 uM for 9-cis-retinal {ECO:0000269|PubMed:12036956}; KM=1.3 uM for all-trans-retinol {ECO:0000269|PubMed:12036956}; Vmax=18 nmol/min/mg enzyme with all-trans-retinal as substrate {ECO:0000269|PubMed:12036956}; Vmax=7 nmol/min/mg enzyme with 13-cis-retinal as substrate {ECO:0000269|PubMed:12036956}; Vmax=1.6 nmol/min/mg enzyme with 9-cis-retinal as substrate {ECO:0000269|PubMed:12036956}; Vmax=0.95 nmol/min/mg enzyme with all-trans-retinol as substrate {ECO:0000269|PubMed:12036956}; Note=Vmax is measured per mg microsomal protein.;	1.1.1.300	CATALYTIC ACTIVITY: All-trans-retinol + NADP(+) = all-trans-retinal + NADPH. {ECO:0000269|PubMed:12036956}.	BINDING 177 177 Substrate. {ECO:0000250}.						CGI-82		adaptation of rhodopsin mediated signaling [GO:0016062]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular [GO:0005622]; photoreceptor inner segment [GO:0001917]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular [GO:0005622]; photoreceptor inner segment [GO:0001917]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; retinol dehydrogenase activity [GO:0004745]; adaptation of rhodopsin mediated signaling [GO:0016062]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]	NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; retinol dehydrogenase activity [GO:0004745]	GO:0001523; GO:0001917; GO:0004745; GO:0005622; GO:0005789; GO:0016021; GO:0016062; GO:0016616; GO:0042572; GO:0042574; GO:0052650	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:12036956}; Single-pass type II membrane protein {ECO:0000269|PubMed:12036956}.	PTM: Not glycosylated.	MOD_RES 112 112 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.	11245473; 10810093; 14702039; 16303743; 12508121; 15489334; 17286855; 12036956; 19608861; 21269460; 24916380; 24275569; 25944712; 10369264; 12226107; 12407145; 12532453; 12680773; 14674758; 17249616; 18039331; 18295589; 20711500; 20801113; 21900206; 22593156; 25542782; 25829192; 9705317	11245473; 10810093; 14702039; 16303743; 12508121; 15489334; 17286855; 12036956; 19608861; 21269460; 24916380; 24275569; 25944712
7869	RDH16 RODH4 SDR9C8	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.14 uM for androsterone {ECO:0000269|PubMed:9677409}; KM=0.22 uM for androstanediol {ECO:0000269|PubMed:9677409}; KM=0.80 uM for dihydrotestosterone {ECO:0000269|PubMed:9677409}; KM=0.13 uM for NAD {ECO:0000269|PubMed:9677409}; KM=190 uM for NADP {ECO:0000269|PubMed:9677409}; 	1.1.-.-		BINDING 164 164 Substrate. {ECO:0000250}.	ACTIVITY REGULATION: Inhibited by citral, perillyl alcohol, geraniol, farnesol and geranyl geraniol. {ECO:0000269|PubMed:9677409}.							lipid metabolic process [GO:0006629]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; organelle membrane [GO:0031090]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; organelle membrane [GO:0031090]; electron transfer activity [GO:0009055]; retinol dehydrogenase activity [GO:0004745]; lipid metabolic process [GO:0006629]	electron transfer activity [GO:0009055]; retinol dehydrogenase activity [GO:0004745]	GO:0004745; GO:0005789; GO:0006629; GO:0009055; GO:0016021; GO:0031090; GO:0043231	SUBCELLULAR LOCATION: Microsome membrane; Single-pass type IV membrane protein. Endoplasmic reticulum membrane {ECO:0000305}; Single-pass type IV membrane protein {ECO:0000305}.	PTM: Not N-glycosylated.		9677409; 10329026; 11967490; 12534290; 24275569; 10617778; 14596915; 21621639; 28394339; 8884265	9677409; 10329026; 11967490; 12534290; 24275569
7901	REV3L POLZ REV3	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=5.71 uM for dATP (for Pol-zeta2); KM=1.17 uM for dATP (for Pol-zeta4); Note=kcat is 0.31 min(-1) for DNA synthesis by Pol-zeta4. kcat is 0.05 min(-1) for DNA synthesis by Pol-zeta2. {ECO:0000269|PubMed:24449906};	2.7.7.7	CATALYTIC ACTIVITY: Deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1).			COFACTOR: Name=[4Fe-4S] cluster; Xref=ChEBI:CHEBI:49883; Evidence={ECO:0000250}; ;  Note=Binds 1 [4Fe-4S] cluster. {ECO:0000250};						DNA-dependent DNA replication [GO:0006261]; error-prone translesion synthesis [GO:0042276]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; zeta DNA polymerase complex [GO:0016035]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; zeta DNA polymerase complex [GO:0016035]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; DNA-dependent DNA replication [GO:0006261]; error-prone translesion synthesis [GO:0042276]	4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]	GO:0000166; GO:0003677; GO:0003887; GO:0005634; GO:0005654; GO:0005730; GO:0006261; GO:0016035; GO:0042276; GO:0046872; GO:0051539	SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.		MOD_RES 1030 1030 Phosphoserine. {ECO:0000244|PubMed:19690332}.; MOD_RES 1041 1041 Phosphothreonine. {ECO:0000244|PubMed:19690332}.; MOD_RES 1724 1724 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1967 1967 Phosphoserine. {ECO:0000244|PubMed:23186163}.	9618506; 10102035; 9925914; 14574404; 10660610; 19690332; 23186163; 24449906; 20164194; 10887153; 10984059; 11006276; 11058110; 11485998; 11784855; 12145297; 12444249; 12459444; 12584190; 12717825; 12952891; 14657033; 15189446; 15199127; 15254543; 15475561; 15657443; 16357261; 16611994; 16819516; 17043239; 18242152; 18622427; 18779149; 19074885; 19153606; 19170759; 19237606; 19289490; 19492058; 19564618; 19661089; 20028736; 20054135; 20159559; 20453000; 20466635; 20660785; 20711500; 20952260; 21143968; 21455670; 21926160; 22028621; 22303021; 22349819; 22547703; 22700975; 22721435; 22772988; 22828282; 22859295; 22859296; 22869133; 23143872; 23303771; 23456618; 24648516; 24956248; 25113059; 25609649; 25781640; 26068067; 26165320; 26462070; 26752104; 26790612; 27095204; 27338670; 27849610; 28075014; 29254481; 29307819; 30111544; 3941892; 8658138; 8751446	9618506; 10102035; 9925914; 14574404; 10660610; 19690332; 23186163; 24449906; 20164194
7954	PITRM1 KIAA1104 MP1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.07 uM for leumorphin ARG-ARG-GLN-PHE-LYS-VAL-VAL-THR-ARG-SER-GLN peptide (at pH 7.5) {ECO:0000269|PubMed:19196155}; KM=0.5 uM for TYR-GLY-GLY-LEU-ARG-ARG-GLY-GLN peptide (at pH 7.5) {ECO:0000269|PubMed:19196155}; 	3.4.24.-			ACTIVITY REGULATION: Mainly exists in a closed and catalytically competent conformation but a closed-to-open switch allows substrate entry into the catalytic chamber (PubMed:24931469). Substrate binding induces closure and dimerization (PubMed:24931469). A disulfide bond may lock the enzyme in a closed conformation preventing substrate entry into the catalytic chamber, participating in redox regulation of the enzyme (Probable). Inhibited by metal-chelating agents (PubMed:10360838). Inhibited by nickel and zinc excess, and slightly activated by manganese (PubMed:19196155). {ECO:0000269|PubMed:10360838, ECO:0000269|PubMed:19196155, ECO:0000269|PubMed:24931469, ECO:0000305|PubMed:16849325, ECO:0000305|PubMed:24931469}.	COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000269|PubMed:24931469}; ;  Note=Binds 1 zinc ion per subunit. {ECO:0000269|PubMed:24931469};	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 7.7. {ECO:0000269|PubMed:10360838};					protein targeting to mitochondrion [GO:0006626]; proteolysis [GO:0006508]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; enzyme activator activity [GO:0008047]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; protein targeting to mitochondrion [GO:0006626]; proteolysis [GO:0006508]	enzyme activator activity [GO:0008047]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]	GO:0004222; GO:0005739; GO:0005759; GO:0006508; GO:0006626; GO:0008047; GO:0008237; GO:0008270	SUBCELLULAR LOCATION: Mitochondrion matrix {ECO:0000269|PubMed:16849325, ECO:0000269|PubMed:19196155}.	PTM: A disulfide bond locks the enzyme in the closed conformation preventing substrate entry into the catalytic chamber. {ECO:0000305|PubMed:16849325, ECO:0000305|PubMed:24931469}.	MOD_RES 759 759 N6-acetyllysine. {ECO:0000250|UniProtKB:Q8K411}.; MOD_RES 770 770 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8K411}.; MOD_RES 770 770 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8K411}.; MOD_RES 849 849 N6-succinyllysine. {ECO:0000250|UniProtKB:Q8K411}.; MOD_RES 884 884 N6-acetyllysine. {ECO:0000250|UniProtKB:Q8K411}.; MOD_RES 946 946 N6-succinyllysine. {ECO:0000250|UniProtKB:Q8K411}.	10360838; 14702039; 15164054; 15489334; 10470851; 16849325; 19196155; 21269460; 24275569; 24931469; 25944712; 16385451; 18951430; 19851296; 19962426; 21750375; 23041349; 25525879; 26697887	10360838; 14702039; 15164054; 15489334; 10470851; 16849325; 19196155; 21269460; 24275569; 24931469; 25944712
8040	RNASE7 UNQ2516/PRO6006	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=2.2 uM for tRNA {ECO:0000269|PubMed:12244054}; 	3.1.27.-		BINDING 91 91 Substrate. {ECO:0000250}.					SITE 66 66 Critical for catalytic activity. {ECO:0000269|PubMed:17150966}.	UNQ2516/PRO6006		antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; antimicrobial humoral response [GO:0019730]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; membrane disruption in other organism [GO:0051673]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; endonuclease activity [GO:0004519]; lipopolysaccharide binding [GO:0001530]; nucleic acid binding [GO:0003676]; peptidoglycan binding [GO:0042834]; ribonuclease activity [GO:0004540]; antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; antimicrobial humoral response [GO:0019730]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; membrane disruption in other organism [GO:0051673]	endonuclease activity [GO:0004519]; lipopolysaccharide binding [GO:0001530]; nucleic acid binding [GO:0003676]; peptidoglycan binding [GO:0042834]; ribonuclease activity [GO:0004540]	GO:0001530; GO:0003676; GO:0004519; GO:0004540; GO:0005576; GO:0005615; GO:0005737; GO:0019730; GO:0019731; GO:0042834; GO:0045087; GO:0050829; GO:0050830; GO:0050832; GO:0051673; GO:0061844	SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:12244054, ECO:0000269|PubMed:25075772}. Note=Detected in urine. {ECO:0000269|PubMed:25075772}.			12244054; 12527768; 12975309; 12508121; 15489334; 25075772; 17150966; 16940129; 18673279; 19262607; 19366593; 19641608; 19919305; 20180804; 20668470; 22327069; 23302724; 23469087; 23545750; 23555696; 23614747; 24107847; 24747887; 27089320; 27089327; 27401534; 27513608; 28378334	12244054; 12527768; 12975309; 12508121; 15489334; 25075772; 17150966
8055	RNPEPL1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.37 mM for Met-AMC {ECO:0000269|PubMed:19508204}; KM=0.17 mM for Citrulline-AMC {ECO:0000269|PubMed:19508204}; KM=1.72 mM for Ala-AMC {ECO:0000269|PubMed:19508204}; KM=0.91 mM for Arg-AMC {ECO:0000269|PubMed:19508204}; KM=0.89 mM for Asn-AMC {ECO:0000269|PubMed:19508204}; KM=0.41 mM for Gln-AMC {ECO:0000269|PubMed:19508204}; KM=0.18 mM for His-AMC {ECO:0000269|PubMed:19508204}; KM=1.05 mM for Ile-AMC {ECO:0000269|PubMed:19508204}; KM=0.34 mM for Leu-AMC {ECO:0000269|PubMed:19508204}; KM=1.72 mM for Lys-AMC {ECO:0000269|PubMed:19508204}; KM=0.65 mM for Phe-AMC {ECO:0000269|PubMed:19508204}; KM=1.76 mM for Ser-AMC {ECO:0000269|PubMed:19508204}; KM=0.12 mM for Trp-AMC {ECO:0000269|PubMed:19508204}; KM=0.12 mM for Tyr-AMC {ECO:0000269|PubMed:19508204}; 	3.4.11.-; 3.4.11.18	CATALYTIC ACTIVITY: Release of N-terminal amino acids, preferentially methionine, from peptides and arylamides. {ECO:0000269|PubMed:19508204}.		ACTIVITY REGULATION: Inhibited by calcium but not affected by chloride ions. Inhibited by amastatin and to a lower extent by bestatin. Weakly inhibited by puromycin. {ECO:0000269|PubMed:19508204}.	COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250|UniProtKB:P15144}; ;  Note=Binds 1 zinc ion per subunit. {ECO:0000250|UniProtKB:P15144};	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 6.6-8.0. {ECO:0000269|PubMed:19508204};		SITE 442 442 Transition state stabilizer. {ECO:0000250|UniProtKB:P15144}.			peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]	metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]	GO:0005737; GO:0006508; GO:0008270; GO:0042277; GO:0043171; GO:0070006				15815621; 15489334; 11017071; 14702039; 17974005; 19508204; 16959974; 20414141; 20549515; 20711500	15815621; 15489334; 11017071; 14702039; 17974005; 19508204; 16959974
8141	PPP3CB CALNA2 CALNB CNA2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.69 uM for NFATC1 {ECO:0000269|PubMed:19154138}; KM=0.7 uM for DARPP32 {ECO:0000269|PubMed:19154138}; 	3.1.3.16	CATALYTIC ACTIVITY: [a protein]-serine/threonine phosphate + H(2)O = [a protein]-serine/threonine + phosphate. {ECO:0000269|PubMed:19154138, ECO:0000269|PubMed:26794871}.		ACTIVITY REGULATION: Activated by Ca(2+)-bound calmodulin following an increase in intracellular Ca(2+). At low Ca(2+) concentrations, the catalytic subunit (also known as calcineurin A) is inactive and is bound to the regulatory subunit (also known as calcineurin B) in which only two high-affinity binding sites are occupied by Ca(2+). In response to elevated calcium levels, the occupancy of the low-affinity sites on calcineurin B by Ca(2+) causes a conformational change of the C-terminal regulatory domain of calcineurin A, resulting in the exposure of the calmodulin-binding domain and in the partial activation of calcineurin A. The subsequent binding of Ca(2+)-bound calmodulin leads to the displacement of the autoinhibitory domain from the active site and possibly of the autoinhibitory segment from the substrate binding site which fully activates calcineurin A. {ECO:0000269|PubMed:19154138, ECO:0000269|PubMed:26794871}.	COFACTOR: Name=Fe(3+); Xref=ChEBI:CHEBI:29034; Evidence={ECO:0000269|PubMed:26794871}; ;  Note=Binds 1 Fe(3+) ion per subunit. {ECO:0000269|PubMed:26794871};; COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000269|PubMed:26794871}; ;  Note=Binds 1 zinc ion per subunit. {ECO:0000269|PubMed:26794871};						axon extension [GO:0048675]; calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion regulated exocytosis [GO:0017156]; cellular response to drug [GO:0035690]; dephosphorylation [GO:0016311]; Fc-epsilon receptor signaling pathway [GO:0038095]; heart development [GO:0007507]; learning [GO:0007612]; locomotion involved in locomotory behavior [GO:0031987]; lymphangiogenesis [GO:0001946]; memory [GO:0007613]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; regulation of insulin secretion [GO:0050796]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle endocytosis [GO:1900242]; response to cytokine [GO:0034097]; signal transduction [GO:0007165]; social behavior [GO:0035176]; T cell activation [GO:0042110]; T cell differentiation [GO:0030217]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]	calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; Z disc [GO:0030018]	calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; drug binding [GO:0008144]; enzyme binding [GO:0019899]; protein dimerization activity [GO:0046983]; protein phosphatase 2B binding [GO:0030346]; protein serine/threonine phosphatase activity [GO:0004722]; axon extension [GO:0048675]; calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion regulated exocytosis [GO:0017156]; cellular response to drug [GO:0035690]; dephosphorylation [GO:0016311]; Fc-epsilon receptor signaling pathway [GO:0038095]; heart development [GO:0007507]; learning [GO:0007612]; locomotion involved in locomotory behavior [GO:0031987]; lymphangiogenesis [GO:0001946]; memory [GO:0007613]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; regulation of insulin secretion [GO:0050796]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle endocytosis [GO:1900242]; response to cytokine [GO:0034097]; signal transduction [GO:0007165]; social behavior [GO:0035176]; T cell activation [GO:0042110]; T cell differentiation [GO:0030217]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]	calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; drug binding [GO:0008144]; enzyme binding [GO:0019899]; protein dimerization activity [GO:0046983]; protein phosphatase 2B binding [GO:0030346]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0001915; GO:0001946; GO:0004722; GO:0005509; GO:0005516; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005955; GO:0006468; GO:0006470; GO:0007165; GO:0007223; GO:0007507; GO:0007612; GO:0007613; GO:0008144; GO:0016311; GO:0017156; GO:0019899; GO:0030018; GO:0030217; GO:0030315; GO:0030346; GO:0031987; GO:0033173; GO:0033192; GO:0034097; GO:0035176; GO:0035690; GO:0035774; GO:0038095; GO:0042098; GO:0042110; GO:0043029; GO:0045893; GO:0045944; GO:0046983; GO:0048167; GO:0048675; GO:0050796; GO:0098978; GO:1900242	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19154138}.		MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19413330}.; MOD_RES 478 478 Phosphoserine. {ECO:0000250|UniProtKB:P48453}.	2556704; 1848109; 15164054; 15489334; 19413330; 19154138; 26794871; 10860980; 11015619; 11030334; 11231878; 12015605; 12975316; 15514034; 15557343; 16024800; 16880514; 16920709; 17474147; 17502104; 18034994; 18296442; 18458866; 19136967; 19287956; 193860; 19659461; 19851316; 19913121; 19925438; 20107831; 20379146; 20562859; 20593291; 20628086; 20700529; 21047202; 21233773; 21423799; 21531385; 21664352; 21903422; 22739212; 23669360; 24366813; 25286016; 25882844; 26496610; 27907007; 6330098; 7479966; 7545680; 7657645; 7708705; 7889407; 8397339; 8576111; 8631904; 8684469; 8799126; 9106655; 9312192; 9727000	2556704; 1848109; 15164054; 15489334; 19413330; 19154138; 26794871
8169	PKN1 PAK1 PKN PRK1 PRKCL1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=20.6 uM for HDAC5 {ECO:0000269|PubMed:20188095}; 	2.7.11.13	CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein. {ECO:0000269|PubMed:18066052}.	BINDING 644 644 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.	ACTIVITY REGULATION: Kinase activity is activated upon binding to Rho proteins (RHOA, RHOB and RAC1). Activated by lipids, particularly cardiolipin and to a lesser extent by other acidic phospholipids. Activated by caspase-3 (CASP3) cleavage during apoptosis. Two specific sites, Thr-774 (activation loop of the kinase domain) and Ser-916 (turn motif), need to be phosphorylated for its full activation. {ECO:0000269|PubMed:8571126, ECO:0000269|PubMed:9751706}.				SITE 108 109 Cleavage; by caspase-3.; SITE 454 455 Cleavage; by caspase-3.; SITE 558 559 Cleavage; by caspase-3.			activation of JUN kinase activity [GO:0007257]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; epithelial cell migration [GO:0010631]; histone H3-T11 phosphorylation [GO:0035407]; hyperosmotic response [GO:0006972]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; regulation of germinal center formation [GO:0002634]; regulation of immunoglobulin production [GO:0002637]; regulation of transcription by RNA polymerase II [GO:0006357]; renal system process [GO:0003014]; signal transduction [GO:0007165]; spleen development [GO:0048536]; transcription, DNA-templated [GO:0006351]	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; GTP-Rho binding [GO:0017049]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; histone kinase activity (H3-T11 specific) [GO:0035402]; nuclear receptor transcription coactivator activity [GO:0030374]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activity [GO:0004674]; Rac GTPase binding [GO:0048365]; activation of JUN kinase activity [GO:0007257]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; epithelial cell migration [GO:0010631]; histone H3-T11 phosphorylation [GO:0035407]; hyperosmotic response [GO:0006972]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; regulation of germinal center formation [GO:0002634]; regulation of immunoglobulin production [GO:0002637]; regulation of transcription by RNA polymerase II [GO:0006357]; renal system process [GO:0003014]; signal transduction [GO:0007165]; spleen development [GO:0048536]; transcription, DNA-templated [GO:0006351]	androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; GTP-Rho binding [GO:0017049]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; histone kinase activity (H3-T11 specific) [GO:0035402]; nuclear receptor transcription coactivator activity [GO:0030374]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activity [GO:0004674]; Rac GTPase binding [GO:0048365]	GO:0001782; GO:0001783; GO:0002634; GO:0002637; GO:0003014; GO:0003682; GO:0004672; GO:0004674; GO:0004697; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005829; GO:0006351; GO:0006357; GO:0006468; GO:0006469; GO:0006972; GO:0007165; GO:0007257; GO:0010631; GO:0017049; GO:0018105; GO:0030374; GO:0030496; GO:0030889; GO:0032154; GO:0032991; GO:0035402; GO:0035407; GO:0042393; GO:0042826; GO:0048365; GO:0048536; GO:0050681; GO:2000145	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17332740, ECO:0000269|PubMed:9478917}. Nucleus {ECO:0000269|PubMed:12514133}. Endosome {ECO:0000269|PubMed:9478917}. Cell membrane {ECO:0000250|UniProtKB:Q63433}; Peripheral membrane protein {ECO:0000250|UniProtKB:Q63433}. Cleavage furrow {ECO:0000269|PubMed:17332740}. Midbody {ECO:0000269|PubMed:17332740}. Note=Associates with chromatin in a ligand-dependent manner. Localization to endosomes is mediated via its interaction with RHOB. Association to the cell membrane is dependent on Ser-377 phosphorylation. Accumulates during telophase at the cleavage furrow and finally concentrates around the midbody in cytokinesis. {ECO:0000250|UniProtKB:Q63433, ECO:0000269|PubMed:17332740}.	PTM: Autophosphorylated; preferably on serine. Phosphorylated during mitosis. {ECO:0000269|PubMed:10792047, ECO:0000269|PubMed:17332740}.; PTM: Activated by limited proteolysis with trypsin. {ECO:0000250}.; PTM: (Microbial infection) In case of infection, polyubiquitinated by the bacterial E3 ubiquitin-protein ligase SspH1, leading to its proteasomal degradation. {ECO:0000269|PubMed:24248594}.	MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22814378}.; MOD_RES 69 69 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 205 205 Phosphoserine. {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19690332}.; MOD_RES 374 374 Phosphoserine. {ECO:0000250|UniProtKB:Q63433}.; MOD_RES 448 448 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 533 533 Phosphoserine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 537 537 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 540 540 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 559 559 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332}.; MOD_RES 562 562 Phosphoserine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 608 608 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 774 774 Phosphothreonine; by PDPK1. {ECO:0000269|PubMed:10792047}.; MOD_RES 778 778 Phosphothreonine. {ECO:0000244|PubMed:18220336}.; MOD_RES 914 914 Phosphothreonine. {ECO:0000244|PubMed:19690332}.; MOD_RES 916 916 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.	8135837; 7851406; 14702039; 15057824; 15489334; 7988719; 8557118; 8621664; 8571126; 9175763; 9478917; 9751706; 10792047; 11104762; 12514133; 16611232; 16331689; 16964243; 17332740; 18220336; 18691976; 18066052; 18669648; 19413330; 19690332; 19608861; 20188095; 20228790; 20068231; 21269460; 21224381; 21754995; 21406692; 22814378; 23186163; 24275569; 10619026; 10388627; 14514689; 18006505; 24248594; 17344846; 10467162; 10753910; 10924361; 11134534; 12761180; 12783890; 15003508; 15123640; 15791647; 16079795; 16189514; 16603238; 17301291; 17721511; 18429822; 18519042; 18713748; 19427017; 19723632; 19913121; 20237496; 20628086; 20711500; 21351730; 21516116; 21749319; 21900206; 21988832; 22893700; 22939624; 24114839; 24128008; 24189400; 25111382; 25416956; 25504435; 26296974; 27919031; 28875501; 9988689	8135837; 7851406; 14702039; 15057824; 15489334; 7988719; 8557118; 8621664; 8571126; 9175763; 9478917; 9751706; 10792047; 11104762; 12514133; 16611232; 16331689; 16964243; 17332740; 18220336; 18691976; 18066052; 18669648; 19413330; 19690332; 19608861; 20188095; 20228790; 20068231; 21269460; 21224381; 21754995; 21406692; 22814378; 23186163; 24275569; 10619026; 10388627; 14514689; 18006505; 24248594; 17344846
8170	PKN2 PRK2 PRKCL2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=15.83 uM for HDAC5 {ECO:0000269|PubMed:20188095}; 	2.7.11.13	CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.	BINDING 686 686 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.	ACTIVITY REGULATION: Kinase activity is activated upon binding to GTP-bound Rhoa/Rac1 GTPases. Activated by caspase-3 (CASP3) cleavage during apoptosis. Activated by lipids, particularly cardiolipin and to a lesser extent by other acidic phospholipids and unsaturated fatty acids. Two specific sites, Thr-816 (activation loop of the kinase domain) and Thr-958 (turn motif), need to be phosphorylated for its full activation. {ECO:0000269|PubMed:10926925, ECO:0000269|PubMed:18835241, ECO:0000269|PubMed:9368003}.				SITE 117 118 Cleavage; by caspase-3.; SITE 700 701 Cleavage; by caspase-3.			apical junction assembly [GO:0043297]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell projection organization [GO:0030030]; epithelial cell migration [GO:0010631]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; transcription, DNA-templated [GO:0006351]	apical junction complex [GO:0043296]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	apical junction complex [GO:0043296]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; GTP-Rho binding [GO:0017049]; histone deacetylase binding [GO:0042826]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; apical junction assembly [GO:0043297]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell projection organization [GO:0030030]; epithelial cell migration [GO:0010631]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; transcription, DNA-templated [GO:0006351]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; GTP-Rho binding [GO:0017049]; histone deacetylase binding [GO:0042826]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]	GO:0003723; GO:0004672; GO:0004674; GO:0004697; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006351; GO:0006355; GO:0006468; GO:0006915; GO:0007049; GO:0007155; GO:0007165; GO:0010631; GO:0016301; GO:0016604; GO:0017049; GO:0018105; GO:0030027; GO:0030030; GO:0030496; GO:0032154; GO:0032467; GO:0032991; GO:0035556; GO:0042826; GO:0043296; GO:0043297; GO:0045070; GO:0045111; GO:0045296; GO:0045931; GO:0048471; GO:0051301; GO:0070063; GO:2000145	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11356191, ECO:0000269|PubMed:17332740}. Nucleus {ECO:0000269|PubMed:11356191}. Membrane {ECO:0000250|UniProtKB:Q8BWW9}. Cell projection, lamellipodium {ECO:0000269|PubMed:11356191}. Cytoplasm, cytoskeleton {ECO:0000269|PubMed:11356191}. Cleavage furrow {ECO:0000269|PubMed:17332740}. Midbody {ECO:0000269|PubMed:17332740}. Cell junction {ECO:0000269|PubMed:20974804}. Note=Colocalizes with PTPN13 in lamellipodia-like structures, regions of large actin turnover. Accumulates during telophase at the cleavage furrow and concentrates finally around the midbody in cytokinesis. Recruited to nascent cell-cell contacts at the apical surface of cells. In the course of viral infection, colocalizes with HCV NS5B at perinuclear region in the cytoplasm. {ECO:0000269|PubMed:11356191, ECO:0000269|PubMed:17332740}.	PTM: Autophosphorylated. Phosphorylated during mitosis. Phosphorylated by CDK10 (PubMed:27104747). {ECO:0000269|PubMed:10792047, ECO:0000269|PubMed:17332740, ECO:0000269|PubMed:27104747}.; PTM: Activated by limited proteolysis with trypsin (By similarity). Proteolytically cleaved by caspase-3 during the induction of apoptotic cell death. {ECO:0000250, ECO:0000269|PubMed:9368003}.	MOD_RES 21 21 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 77 77 N6-acetyllysine. {ECO:0000250|UniProtKB:Q8BWW9}.; MOD_RES 110 110 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 121 121 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000269|PubMed:27104747}.; MOD_RES 124 124 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000269|PubMed:27104747}.; MOD_RES 302 302 Phosphoserine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231}.; MOD_RES 306 306 Phosphoserine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231}.; MOD_RES 360 360 Phosphoserine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 362 362 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 535 535 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 583 583 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 620 620 Phosphoserine. {ECO:0000250|UniProtKB:Q8BWW9}.; MOD_RES 628 628 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 631 631 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 816 816 Phosphothreonine; by PDPK1. {ECO:0000269|PubMed:10792047}.; MOD_RES 952 952 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 958 958 Phosphothreonine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.	7988719; 7851406; 14702039; 16710414; 15489334; 9368003; 9121475; 10226025; 10026169; 10818102; 10926925; 10792047; 11356191; 11781095; 11777936; 15364941; 17081983; 16964243; 17332740; 17924679; 18835241; 18220336; 18691976; 18669648; 19413330; 19369195; 19690332; 20188095; 20068231; 21269460; 20974804; 21754995; 23186163; 24275569; 27104747; 10619026; 10753910; 12783890; 14514689; 16752908; 17110931; 17632197; 18006505; 18234856; 18437351; 18443202; 18978678; 19380854; 19463016; 19615732; 19723632; 19892838; 19913121; 20379614; 20467437; 20628086; 21351730; 21900206; 22490666; 22511787; 22939624; 23416715; 24128008; 24189400; 25036637; 25513777; 25518860; 26041307; 26296974; 26496610; 26638075; 27919031; 28720584; 29655979; 9988689	7988719; 7851406; 14702039; 16710414; 15489334; 9368003; 9121475; 10226025; 10026169; 10818102; 10926925; 10792047; 11356191; 11781095; 11777936; 15364941; 17081983; 16964243; 17332740; 17924679; 18835241; 18220336; 18691976; 18669648; 19413330; 19369195; 19690332; 20188095; 20068231; 21269460; 20974804; 21754995; 23186163; 24275569; 27104747
8190	RAB3GAP1 KIAA0066 RAB3GAP	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=75 uM for GTP-loaded RAB3A {ECO:0000269|PubMed:10859313}; 											brain development [GO:0007420]; camera-type eye development [GO:0043010]; establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; excitatory postsynaptic potential [GO:0060079]; face morphogenesis [GO:0060325]; hypothalamus development [GO:0021854]; lipid droplet organization [GO:0034389]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization [GO:0061646]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein lipidation [GO:1903061]; regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903233]; regulation of GTPase activity [GO:0043087]; regulation of short-term neuronal synaptic plasticity [GO:0048172]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rab GTPase binding [GO:0017137]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; excitatory postsynaptic potential [GO:0060079]; face morphogenesis [GO:0060325]; hypothalamus development [GO:0021854]; lipid droplet organization [GO:0034389]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization [GO:0061646]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein lipidation [GO:1903061]; regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903233]; regulation of GTPase activity [GO:0043087]; regulation of short-term neuronal synaptic plasticity [GO:0048172]	GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rab GTPase binding [GO:0017137]	GO:0005085; GO:0005096; GO:0005789; GO:0005794; GO:0005811; GO:0005829; GO:0007420; GO:0010628; GO:0017137; GO:0021854; GO:0032991; GO:0034389; GO:0043010; GO:0043087; GO:0043547; GO:0048172; GO:0060079; GO:0060325; GO:0061646; GO:0070062; GO:0071782; GO:0097051; GO:0098794; GO:1903061; GO:1903233; GO:1903373; GO:2000786	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:9852129}. Note=In neurons, it is enriched in the synaptic soluble fraction.		MOD_RES 83 83 Phosphoserine. {ECO:0000250|UniProtKB:Q80UJ7}.; MOD_RES 379 379 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 537 537 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 579 579 Phosphoserine. {ECO:0000250|UniProtKB:Q80UJ7}.; MOD_RES 581 581 Phosphoserine. {ECO:0000250|UniProtKB:Q80UJ7}.; MOD_RES 590 590 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 664 664 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 908 908 Phosphothreonine. {ECO:0000244|PubMed:23186163}.	7584044; 15815621; 15489334; 17974005; 9030515; 9852129; 10859313; 15696165; 17081983; 18669648; 19690332; 20068231; 21269460; 22337587; 23186163; 24275569; 10559986; 10562278; 15914536; 16207721; 17353931; 17488286; 18286824; 18664496; 20195357; 20512159; 20562859; 22768674; 22876574; 23176487; 23333653; 23416715; 23420520; 23593153; 23833071; 24891604; 25159528; 25233431; 25332050; 25453831; 25495476; 25612670; 26063829; 26138576; 26421802; 26638075; 27256633; 28342870; 28575017; 9733780	7584044; 15815621; 15489334; 17974005; 9030515; 9852129; 10859313; 15696165; 17081983; 18669648; 19690332; 20068231; 21269460; 22337587; 23186163; 24275569
8236	PMM1 PMMH22	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=54 uM for alpha-D-mannose 1-phosphate {ECO:0000269|PubMed:16540464}; KM=7.5 uM for alpha-D-glucose 1-phosphate {ECO:0000269|PubMed:16540464}; 	5.4.2.8	CATALYTIC ACTIVITY: Alpha-D-mannose 1-phosphate = D-mannose 6-phosphate.	BINDING 28 28 Substrate.; BINDING 132 132 Substrate.; BINDING 143 143 Substrate.; BINDING 150 150 Substrate.; BINDING 186 186 Substrate; via amide nitrogen.; BINDING 188 188 Substrate.; BINDING 190 190 Substrate.	ACTIVITY REGULATION: IMP, a metabolite whose concentration is elevated in anoxia, inhibits phosphomannomutase and phosphoglucomutase activities and strongly enhances glucose-1,6-bisphosphatase activity. {ECO:0000250}.	COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:16540464}; 		PATHWAY: Nucleotide-sugar biosynthesis; GDP-alpha-D-mannose biosynthesis; alpha-D-mannose 1-phosphate from D-fructose 6-phosphate: step 2/2.				cellular response to leukemia inhibitory factor [GO:1990830]; GDP-mannose biosynthetic process [GO:0009298]; mannose metabolic process [GO:0006013]; protein N-linked glycosylation [GO:0006487]; protein targeting to ER [GO:0045047]	cytosol [GO:0005829]; neuronal cell body [GO:0043025]	cytosol [GO:0005829]; neuronal cell body [GO:0043025]; metal ion binding [GO:0046872]; phosphomannomutase activity [GO:0004615]; cellular response to leukemia inhibitory factor [GO:1990830]; GDP-mannose biosynthetic process [GO:0009298]; mannose metabolic process [GO:0006013]; protein N-linked glycosylation [GO:0006487]; protein targeting to ER [GO:0045047]	metal ion binding [GO:0046872]; phosphomannomutase activity [GO:0004615]	GO:0004615; GO:0005829; GO:0006013; GO:0006487; GO:0009298; GO:0043025; GO:0045047; GO:0046872; GO:1990830	SUBCELLULAR LOCATION: Cytoplasm.		MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:22814378}.; MOD_RES 242 242 Phosphoserine. {ECO:0000250|UniProtKB:O35621}.	9070917; 9119384; 15461802; 14702039; 10591208; 15489334; 22814378; 16540464; 12789572; 16189514; 17186415; 18591914; 18927083; 21078624; 21988832; 22157815; 25416956; 26496610; 29261720; 29695157; 9140401	9070917; 9119384; 15461802; 14702039; 10591208; 15489334; 22814378; 16540464
8237	NAPRT FHIP NAPRT1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=44.3 uM for nicotinic acid (in the presence of 3 mM ATP) {ECO:0000269|PubMed:21742010}; KM=22.1 uM for 5-phosphoribosyl-1-pyrophosphate (in the presence of 3 mM ATP) {ECO:0000269|PubMed:21742010}; KM=27.3 uM for nicotinic acid (in the presence of inorganic phosphate) {ECO:0000269|PubMed:21742010}; KM=38.2 uM for 5-phosphoribosyl-1-pyrophosphate (in the presence of inorganic phosphate) {ECO:0000269|PubMed:21742010}; 	6.3.4.21	CATALYTIC ACTIVITY: Nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H(2)O = beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate. {ECO:0000269|PubMed:17604275, ECO:0000269|PubMed:21742010, ECO:0000269|PubMed:26042198}.	BINDING 21 21 Nicotinate. {ECO:0000250|UniProtKB:Q9HJ28}.; BINDING 210 210 Nicotinate. {ECO:0000250|UniProtKB:Q9HJ28}.; BINDING 318 318 Nicotinate. {ECO:0000250|UniProtKB:Q9HJ28}.; BINDING 380 380 Phosphoribosylpyrophosphate. {ECO:0000250|UniProtKB:Q9HJ28}.		COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:21742010}; Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000269|PubMed:21742010}; ;  Note=Activity is highest with Mn(2+). {ECO:0000269|PubMed:21742010};		PATHWAY: Cofactor biosynthesis; NAD(+) biosynthesis; nicotinate D-ribonucleotide from nicotinate: step 1/1. {ECO:0000269|PubMed:17604275, ECO:0000269|PubMed:21742010, ECO:0000269|PubMed:26042198}.				NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; neutrophil degranulation [GO:0043312]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]	azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nicotinate phosphoribosyltransferase activity [GO:0004516]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; neutrophil degranulation [GO:0043312]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979]	nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; nicotinate phosphoribosyltransferase activity [GO:0004516]	GO:0004514; GO:0004516; GO:0005576; GO:0005829; GO:0006979; GO:0019358; GO:0034356; GO:0035578; GO:0043312; GO:0070062	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:17604275}.	PTM: Transiently phosphorylated on a His residue during the reaction cycle. Phosphorylation strongly increases the affinity for substrates and increases the rate of nicotinate D-ribonucleotide production. Dephosphorylation regenerates the low-affinity form of the enzyme, leading to product release. {ECO:0000250|UniProtKB:P22253}.	MOD_RES 213 213 Phosphohistidine. {ECO:0000250|UniProtKB:P22253}.; MOD_RES 537 537 Phosphoserine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:24275569}.	17604275; 15489334; 17081983; 16964243; 18669648; 20068231; 21269460; 21406692; 21742010; 24275569; 26042198; 13563527; 21492230; 22570471; 24097869; 25416956; 26496610; 26675378; 28416276; 28860121; 4349867; 8692836	17604275; 15489334; 17081983; 16964243; 18669648; 20068231; 21269460; 21406692; 21742010; 24275569; 26042198
8239	PGM1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=80 uM for alpha-D-glucose 1-phosphate {ECO:0000269|PubMed:25288802}; 	5.4.2.2	CATALYTIC ACTIVITY: Alpha-D-glucose 1-phosphate = alpha-D-glucose 6-phosphate. {ECO:0000269|PubMed:15378030, ECO:0000269|PubMed:25288802}.	BINDING 19 19 Substrate. {ECO:0000250|UniProtKB:P00949}.; BINDING 23 23 Substrate. {ECO:0000250|UniProtKB:P00949}.; BINDING 130 130 Substrate. {ECO:0000250|UniProtKB:P00949}.; BINDING 357 357 Substrate. {ECO:0000250|UniProtKB:P00949}.; BINDING 389 389 Substrate. {ECO:0000250|UniProtKB:P00949}.; BINDING 515 515 Substrate. {ECO:0000250|UniProtKB:P00949}.	ACTIVITY REGULATION: Glucose-1,6-bisphosphate enhances phosphorylation of the active site Ser-117, and thereby increases enzyme activity. {ECO:0000269|PubMed:25288802}.	COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:26972339}; ;  Note=Binds 1 Mg(2+) ion per subunit. {ECO:0000269|PubMed:26972339};						galactose catabolic process [GO:0019388]; gluconeogenesis [GO:0006094]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; glycolytic process [GO:0006096]; neutrophil degranulation [GO:0043312]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; tertiary granule lumen [GO:1904724]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; tertiary granule lumen [GO:1904724]; magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; galactose catabolic process [GO:0019388]; gluconeogenesis [GO:0006094]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; glycolytic process [GO:0006096]; neutrophil degranulation [GO:0043312]	magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]	GO:0000287; GO:0004614; GO:0005576; GO:0005737; GO:0005829; GO:0005978; GO:0005980; GO:0006006; GO:0006094; GO:0006096; GO:0015629; GO:0019388; GO:0043312; GO:0070062; GO:1904724; GO:1904813	SUBCELLULAR LOCATION: Isoform 1: Cytoplasm.	PTM: Phosphorylation at Thr-467 by PAK1 significantly enhances enzymatic activity. {ECO:0000269|PubMed:15378030}.	MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:22814378}.; MOD_RES 16 16 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 115 115 Phosphothreonine. {ECO:0000250|UniProtKB:Q9D0F9}.; MOD_RES 117 117 Phosphoserine. {ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000269|PubMed:25288802}.; MOD_RES 134 134 Phosphoserine. {ECO:0000250|UniProtKB:P38652}.; MOD_RES 185 185 Phosphothreonine. {ECO:0000244|PubMed:24275569}.; MOD_RES 201 201 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 206 206 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 213 213 Phosphoserine. {ECO:0000250|UniProtKB:P38652}.; MOD_RES 349 349 N6-acetyllysine. {ECO:0000250|UniProtKB:Q9D0F9}.; MOD_RES 353 353 Phosphotyrosine. {ECO:0000250|UniProtKB:Q9D0F9}.; MOD_RES 369 369 Phosphoserine. {ECO:0000250|UniProtKB:P38652}.; MOD_RES 378 378 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 419 419 N6-succinyllysine. {ECO:0000250|UniProtKB:Q9D0F9}.; MOD_RES 467 467 Phosphothreonine; by PAK1. {ECO:0000269|PubMed:15378030}.; MOD_RES 477 477 Phosphoserine. {ECO:0000250|UniProtKB:P38652}.; MOD_RES 485 485 Phosphoserine. {ECO:0000250|UniProtKB:P38652}.; MOD_RES 505 505 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 507 507 Phosphothreonine. {ECO:0000250|UniProtKB:Q9D0F9}.; MOD_RES 509 509 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 541 541 Phosphoserine. {ECO:0000250|UniProtKB:P38652}.	1530890; 14702039; 16710414; 15489334; 8257433; 15378030; 17081983; 17924679; 18669648; 19690332; 19608861; 20068231; 21269460; 21406692; 22814378; 23186163; 24275569; 26972339; 7902567; 7902568; 19625727; 22492991; 22976764; 24499211; 25288802; 11785295; 11963573; 12608294; 12942785; 15522220; 17804405; 18091362; 1840235; 18495743; 18927083; 19377068; 19430480; 20378605; 20379614; 20562859; 20711500; 20800603; 21044950; 23414517; 23650620; 24952355; 26768186; 28117557; 30122451	1530890; 14702039; 16710414; 15489334; 8257433; 15378030; 17081983; 17924679; 18669648; 19690332; 19608861; 20068231; 21269460; 21406692; 22814378; 23186163; 24275569; 26972339; 7902567; 7902568; 19625727; 22492991; 22976764; 24499211; 25288802
8248	PIP4K2A PIP5K2 PIP5K2A	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=50 uM for phosphatidylinositol-5- phosphate {ECO:0000269|PubMed:20583997}; Vmax=466 pmol/min/ug enzyme {ECO:0000269|PubMed:20583997}; 	2.7.1.149	CATALYTIC ACTIVITY: ATP + 1-phosphatidyl-1D-myo-inositol 5-phosphate = ADP + 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate. {ECO:0000269|PubMed:9367159}.									megakaryocyte development [GO:0035855]; phosphatidylinositol biosynthetic process [GO:0006661]; phospholipid metabolic process [GO:0006644]; positive regulation of autophagosome assembly [GO:2000786]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]	autophagosome [GO:0005776]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	autophagosome [GO:0005776]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-phosphate 4-kinase activity [GO:0052811]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-phosphate 4-kinase activity [GO:0016309]; ATP binding [GO:0005524]; megakaryocyte development [GO:0035855]; phosphatidylinositol biosynthetic process [GO:0006661]; phospholipid metabolic process [GO:0006644]; positive regulation of autophagosome assembly [GO:2000786]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]	1-phosphatidylinositol-3-phosphate 4-kinase activity [GO:0052811]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-phosphate 4-kinase activity [GO:0016309]; ATP binding [GO:0005524]	GO:0005524; GO:0005654; GO:0005776; GO:0005829; GO:0005886; GO:0006644; GO:0006661; GO:0010506; GO:0014066; GO:0016308; GO:0016309; GO:0035855; GO:0052811; GO:2000786	SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}. Nucleus {ECO:0000269|PubMed:20583997}. Cytoplasm {ECO:0000269|PubMed:20583997}. Note=May translocate from the cytosol to the cell membrane upon activation of tyrosine phosphorylation. May translocate from the inner to the outer segments of the rod photoreceptor cells in response to light (By similarity). Localization to the nucleus is modulated by the interaction with PIP4K2B. {ECO:0000250}.		MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:22223895}.; MOD_RES 3 3 Phosphothreonine. {ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:23186163}.; MOD_RES 14 14 Phosphoserine. {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 89 89 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 145 145 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.	7852364; 7639683; 14702039; 15164054; 15489334; 9367159; 18364242; 18691976; 19413330; 19369195; 19608861; 20583997; 19896968; 20068231; 21269460; 22223895; 23186163; 10508590; 10698683; 11604140; 12422219; 12509423; 14582145; 16094259; 16385451; 16563698; 16801950; 16823801; 16949365; 17410640; 17555944; 18314871; 18545987; 18753295; 19328558; 19475563; 19644675; 19656170; 19937977; 20379614; 21041608; 21124964; 21377334; 21988832; 22190034; 23193159; 23455922; 23739505; 23758345; 23902751; 23996088; 24081551; 24086693; 24366813; 24681948; 24788727; 25025909; 25495341; 25548108; 25609649; 26496610; 27149463; 28476190; 29518392; 7629060; 9211928; 9660759	7852364; 7639683; 14702039; 15164054; 15489334; 9367159; 18364242; 18691976; 19413330; 19369195; 19608861; 20583997; 19896968; 20068231; 21269460; 22223895; 23186163
8327	AGPAT3 LPAAT3 UNQ759/PRO1490	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=4.78 uM for LPA sn-1 C18:1 {ECO:0000269|PubMed:21173190}; KM=21.53 uM for C18:1-CoA {ECO:0000269|PubMed:21173190}; Vmax=6.35 nmol/min/mg enzyme toward LPA sn-1 C18:1 {ECO:0000269|PubMed:21173190}; Vmax=0.74 nmol/min/mg enzyme toward C18:1-CoA {ECO:0000269|PubMed:21173190}; 	2.3.1.51	CATALYTIC ACTIVITY: Acyl-CoA + 1-acyl-sn-glycerol 3-phosphate = CoA + 1,2-diacyl-sn-glycerol 3-phosphate.					PATHWAY: Phospholipid metabolism; CDP-diacylglycerol biosynthesis; CDP-diacylglycerol from sn-glycerol 3-phosphate: step 2/3.		UNQ759/PRO1490		CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654]	1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]	GO:0000139; GO:0003841; GO:0005635; GO:0005783; GO:0005789; GO:0005886; GO:0006654; GO:0008654; GO:0016020; GO:0016021; GO:0016024	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:20537980, ECO:0000269|PubMed:21173190}; Multi-pass membrane protein {ECO:0000269|PubMed:20537980}. Nucleus envelope.			11487472; 12975309; 10830953; 15489334; 14702039; 17974005; 20537980; 21173190; 12925777; 15367102; 16495223; 16620771; 16704971; 16864775; 17707131; 18718904; 19336658; 19635840; 20379614; 20711500; 21516116; 22562055; 22777291; 25233431; 9212163; 9461603	11487472; 12975309; 10830953; 15489334; 14702039; 17974005; 20537980; 21173190
8353	PLCD3 KIAA1964	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=105.3 uM for PIP2 {ECO:0000269|PubMed:10336610}; Vmax=28.5 umol/min/mg enzyme {ECO:0000269|PubMed:10336610}; 	3.1.4.11	CATALYTIC ACTIVITY: 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + H(2)O = 1D-myo-inositol 1,4,5-trisphosphate + diacylglycerol. {ECO:0000269|PubMed:10336610}.	BINDING 480 480 Substrate. {ECO:0000250}.; BINDING 482 482 Substrate. {ECO:0000250}.; BINDING 557 557 Substrate. {ECO:0000250}.; BINDING 584 584 Substrate. {ECO:0000250}.	ACTIVITY REGULATION: Strongly activated by phosphatidic acid. Inhibited by phosphatidylethanolamine (PtdEtn), phosphatidylcholine (PtdCho), sphingomyelin and phosphatidylserine (PtdSer). {ECO:0000269|PubMed:10336610, ECO:0000269|PubMed:9799116}.	COFACTOR: Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000305|PubMed:9799116}; ;  Note=Binds 3 Ca(2+) ions per subunit. Two of the Ca(2+) ions are bound to the C2 domain. {ECO:0000305|PubMed:9799116};						angiogenesis [GO:0001525]; inositol phosphate metabolic process [GO:0043647]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipid catabolic process [GO:0016042]; regulation of cell proliferation [GO:0042127]	cleavage furrow [GO:0032154]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	cleavage furrow [GO:0032154]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; phosphatidylinositol phospholipase C activity [GO:0004435]; angiogenesis [GO:0001525]; inositol phosphate metabolic process [GO:0043647]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipid catabolic process [GO:0016042]; regulation of cell proliferation [GO:0042127]	metal ion binding [GO:0046872]; phosphatidylinositol phospholipase C activity [GO:0004435]	GO:0001525; GO:0004435; GO:0005829; GO:0005886; GO:0016042; GO:0032154; GO:0035556; GO:0042127; GO:0043647; GO:0046872; GO:0060716	SUBCELLULAR LOCATION: Membrane; Peripheral membrane protein. Cytoplasm. Cleavage furrow. Note=Localizes at the cleavage furrow during cytokinesis.		MOD_RES 105 105 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 496 496 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 573 573 Phosphoserine. {ECO:0000244|PubMed:23186163}.	14702039; 15489334; 17974005; 11853319; 9360711; 9056492; 9799116; 10702670; 10336610; 11500033; 11706040; 15505048; 17041247; 18669648; 20068231; 23186163; 11022047; 11022048; 15231748; 15702972; 16107206; 19179337; 19329342; 19344632; 19367725; 19430483; 19913121; 20056178; 20628086; 20852445; 22723964; 23902751; 23948486; 2550068; 26496610; 2841328; 29115528; 7890667	14702039; 15489334; 17974005; 11853319; 9360711; 9056492; 9799116; 10702670; 10336610; 11500033; 11706040; 15505048; 17041247; 18669648; 20068231; 23186163
8354	PLPP4 DPPL2 PPAPDC1 PPAPDC1A	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=104 uM for diacylglycerol pyrophosphate {ECO:0000269|PubMed:17590538}; KM=506 uM for phosphatidate {ECO:0000269|PubMed:17590538}; KM=580 uM for lysophosphatidate {ECO:0000269|PubMed:17590538}; 	3.1.3.4	CATALYTIC ACTIVITY: A 1,2-diacylglycerol 3-phosphate + H(2)O = a 1,2-diacyl-sn-glycerol + phosphate. {ECO:0000269|PubMed:17590538}.		ACTIVITY REGULATION: Inhibited by N-ethylmaleimide. {ECO:0000269|PubMed:17590538}.							Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; signal transduction [GO:0007165]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; phosphatidate phosphatase activity [GO:0008195]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; signal transduction [GO:0007165]	identical protein binding [GO:0042802]; phosphatidate phosphatase activity [GO:0008195]	GO:0005886; GO:0005887; GO:0006644; GO:0007165; GO:0008195; GO:0038096; GO:0042802; GO:0046839	SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.			17590538; 15164054; 15489334; 10224668; 20235792; 20379614; 28851360	17590538; 15164054; 15489334
8365	POMGNT1 MGAT1.2 UNQ746/PRO1475	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.85 mM for mannosylpeptide {ECO:0000269|PubMed:11709191, ECO:0000269|PubMed:11742540}; KM=0.73 mM for UDP-GlcNAc {ECO:0000269|PubMed:11709191, ECO:0000269|PubMed:11742540}; KM=30 mM for Man(alpha1-)O-benzyl {ECO:0000269|PubMed:11709191, ECO:0000269|PubMed:11742540}; KM=12 mM for CYA[Man(alpha1-)O-T]AV {ECO:0000269|PubMed:11709191, ECO:0000269|PubMed:11742540}; 	2.4.1.-	CATALYTIC ACTIVITY: UDP-N-acetyl-alpha-D-glucosamine + O-alpha-D-mannosylprotein = UDP + N-acetyl-beta-D-glucosaminyl-(1->2)-O-alpha-D-mannosylprotein. {ECO:0000269|PubMed:11709191, ECO:0000269|PubMed:11742540, ECO:0000269|PubMed:12788071, ECO:0000269|PubMed:26908613, ECO:0000269|PubMed:27391550, ECO:0000269|PubMed:27493216}.	BINDING 129 129 Carbohydrate. {ECO:0000269|PubMed:27493216}.; BINDING 179 179 Carbohydrate. {ECO:0000269|PubMed:27493216}.; BINDING 207 207 Carbohydrate. {ECO:0000269|PubMed:27493216}.; BINDING 338 338 UDP-GlcNAc. {ECO:0000244|PDB:5GGI, ECO:0000305|PubMed:27493216}.; BINDING 371 371 UDP-GlcNAc. {ECO:0000244|PDB:5GGI, ECO:0000305|PubMed:27493216}.		COFACTOR: Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000269|PubMed:27493216, ECO:0000305|PubMed:12788071}; ;  Note=The manganese ion interacts primarily with the substrate UDP-N-acetylglucosamine. {ECO:0000269|PubMed:27493216};	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 6.0. {ECO:0000269|PubMed:11709191, ECO:0000269|PubMed:11742540};	PATHWAY: Protein modification; protein glycosylation. {ECO:0000269|PubMed:11709191, ECO:0000269|PubMed:11742540, ECO:0000269|PubMed:26908613, ECO:0000269|PubMed:27391550, ECO:0000269|PubMed:27493216}.		UNQ746/PRO1475		O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]	Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]	Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]; manganese ion binding [GO:0030145]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]	acetylglucosaminyltransferase activity [GO:0008375]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]; manganese ion binding [GO:0030145]	GO:0000139; GO:0006493; GO:0008375; GO:0016021; GO:0016266; GO:0030145; GO:0030173; GO:0047223	SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000269|PubMed:17034757, ECO:0000303|PubMed:11709191}; Single-pass type II membrane protein {ECO:0000305|PubMed:11709191}.		MOD_RES 7 7 Phosphoserine. {ECO:0000244|PubMed:23186163}.	11709191; 12588800; 12975309; 14702039; 16710414; 15489334; 11742540; 17034757; 23186163; 24275569; 12788071; 15207699; 27493216; 15236414; 15466003; 17030669; 19067344; 18195152; 19299310; 26908613; 27391550; 12467726; 16857188; 17869517; 17878207; 17881266; 17906881; 20816175; 21361872; 21684258; 21727005; 21988832; 22419172; 22554691; 23689641; 24731844; 24733390; 25416956; 25561175; 26328495; 26783077; 28989719; 29048655	11709191; 12588800; 12975309; 14702039; 16710414; 15489334; 11742540; 17034757; 23186163; 24275569; 12788071; 15207699; 27493216; 15236414; 15466003; 17030669; 19067344; 18195152; 19299310; 26908613; 27391550
8373	PNMT PENT	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=99 uM for phenylethanolamine {ECO:0000269|PubMed:16363801}; KM=3.4 uM for S-adenosyl-L-methionine {ECO:0000269|PubMed:16363801}; 	2.1.1.28	CATALYTIC ACTIVITY: S-adenosyl-L-methionine + phenylethanolamine = S-adenosyl-L-homocysteine + N-methylphenylethanolamine.	BINDING 35 35 S-adenosyl-L-methionine.; BINDING 40 40 S-adenosyl-L-methionine.; BINDING 85 85 S-adenosyl-L-methionine.; BINDING 101 101 S-adenosyl-L-methionine.; BINDING 106 106 S-adenosyl-L-methionine.; BINDING 181 181 S-adenosyl-L-methionine; via carbonyl oxygen.; BINDING 219 219 Substrate.				PATHWAY: Catecholamine biosynthesis; (R)-adrenaline biosynthesis; (R)-adrenaline from (R)-noradrenaline: step 1/1.				catecholamine biosynthetic process [GO:0042423]; epinephrine biosynthetic process [GO:0042418]	cytosol [GO:0005829]	cytosol [GO:0005829]; phenylethanolamine N-methyltransferase activity [GO:0004603]; catecholamine biosynthetic process [GO:0042423]; epinephrine biosynthetic process [GO:0042418]	phenylethanolamine N-methyltransferase activity [GO:0004603]	GO:0004603; GO:0005829; GO:0042418; GO:0042423			MOD_RES 7 7 Phosphoserine. {ECO:0000244|PubMed:23186163}.	3372503; 2835776; 15489334; 23186163; 11591352; 16363801; 16942016; 17845018; 16277617; 11140838; 11378842; 11807261; 11900856; 11958827; 12634439; 14553966; 14695818; 15010812; 15848714; 15893506; 15968085; 16279783; 16894395; 17117180; 17544870; 17645789; 18349382; 18702937; 18715275; 18937842; 19086053; 19343046; 19570037; 19913121; 19952402; 20090367; 20204374; 20468064; 20628086; 20642456; 21044950; 21866188; 24018397; 24900472; 27007161	3372503; 2835776; 15489334; 23186163; 11591352; 16363801; 16942016; 17845018; 16277617
8382	PIP4K2B PIP5K2B	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=30 uM for phosphatidylinositol-5- phosphate {ECO:0000269|PubMed:20583997}; Vmax=0.2 pmol/min/ug enzyme {ECO:0000269|PubMed:20583997}; 	2.7.1.149	CATALYTIC ACTIVITY: ATP + 1-phosphatidyl-1D-myo-inositol 5-phosphate = ADP + 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate.									cell surface receptor signaling pathway [GO:0007166]; phosphatidylinositol biosynthetic process [GO:0006661]; phospholipid metabolic process [GO:0006644]; positive regulation of autophagosome assembly [GO:2000786]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]	autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-phosphate 4-kinase activity [GO:0052811]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-phosphate 4-kinase activity [GO:0016309]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; cell surface receptor signaling pathway [GO:0007166]; phosphatidylinositol biosynthetic process [GO:0006661]; phospholipid metabolic process [GO:0006644]; positive regulation of autophagosome assembly [GO:2000786]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]	1-phosphatidylinositol-3-phosphate 4-kinase activity [GO:0052811]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-phosphate 4-kinase activity [GO:0016309]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]	GO:0005524; GO:0005654; GO:0005776; GO:0005789; GO:0005829; GO:0005886; GO:0006644; GO:0006661; GO:0007166; GO:0010506; GO:0014066; GO:0016308; GO:0016309; GO:0042803; GO:0052811; GO:2000786	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Cell membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Nucleus {ECO:0000269|PubMed:20583997}. Cytoplasm {ECO:0000269|PubMed:20583997}. Note=Associated with the plasma membrane and the endoplasmic reticulum. {ECO:0000250}.	PTM: Ubiquitinated by the SPOP/CUL3 complex. Ubiquitination is stimulated by PtdIns5P levels. {ECO:0000269|PubMed:20583997}.	MOD_RES 2 2 N-acetylserine. {ECO:0000244|PubMed:22223895}.; MOD_RES 8 8 Phosphothreonine. {ECO:0000250|UniProtKB:P48426}.; MOD_RES 19 19 Phosphoserine. {ECO:0000250|UniProtKB:P48426}.; MOD_RES 94 94 N6-acetyllysine. {ECO:0000250|UniProtKB:P48426}.; MOD_RES 150 150 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 322 322 Phosphothreonine. {ECO:0000250|UniProtKB:Q80XI4}.; MOD_RES 326 326 Phosphoserine. {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195}.	9038203; 15489334; 18691976; 18669648; 19369195; 19608861; 20583997; 21269460; 22223895; 9753329; 10698683; 11604140; 12422219; 16713569; 16949365; 17353931; 18753295; 19896968; 23193159; 23455922; 23758345; 24366813; 25416956; 25495341; 26496610; 26638075; 26774281; 9211928; 9367159; 9660759	9038203; 15489334; 18691976; 18669648; 19369195; 19608861; 20583997; 21269460; 22223895; 9753329
8386	PIF1 C15orf20	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.17 mM for ATP {ECO:0000269|PubMed:18835853}; 	3.6.4.12	CATALYTIC ACTIVITY: ATP + H(2)O = ADP + phosphate. {ECO:0000255|HAMAP-Rule:MF_03176, ECO:0000269|PubMed:17827721}.			COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000255|HAMAP-Rule:MF_03176, ECO:0000269|PubMed:16522649}; 						DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; G-quadruplex DNA unwinding [GO:0044806]; mitochondrial genome maintenance [GO:0000002]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; regulation of telomere maintenance [GO:0032204]; telomere maintenance [GO:0000723]	mitochondrion [GO:0005739]; nuclear chromosome, telomeric region [GO:0000784]; replication fork [GO:0005657]	mitochondrion [GO:0005739]; nuclear chromosome, telomeric region [GO:0000784]; replication fork [GO:0005657]; ATP binding [GO:0005524]; ATP-dependent 5'-3' DNA helicase activity [GO:0043141]; ATP-dependent 5'-3' DNA/RNA helicase activity [GO:0033682]; G-quadruplex DNA binding [GO:0051880]; magnesium ion binding [GO:0000287]; single-stranded DNA-dependent ATP-dependent DNA helicase activity [GO:0017116]; telomerase inhibitor activity [GO:0010521]; telomeric DNA binding [GO:0042162]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; G-quadruplex DNA unwinding [GO:0044806]; mitochondrial genome maintenance [GO:0000002]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; regulation of telomere maintenance [GO:0032204]; telomere maintenance [GO:0000723]	ATP binding [GO:0005524]; ATP-dependent 5'-3' DNA/RNA helicase activity [GO:0033682]; ATP-dependent 5'-3' DNA helicase activity [GO:0043141]; G-quadruplex DNA binding [GO:0051880]; magnesium ion binding [GO:0000287]; single-stranded DNA-dependent ATP-dependent DNA helicase activity [GO:0017116]; telomerase inhibitor activity [GO:0010521]; telomeric DNA binding [GO:0042162]	GO:0000002; GO:0000287; GO:0000723; GO:0000784; GO:0005524; GO:0005657; GO:0005739; GO:0006260; GO:0006281; GO:0006310; GO:0010521; GO:0017116; GO:0032204; GO:0032211; GO:0033682; GO:0042162; GO:0043141; GO:0044806; GO:0051880; GO:0051974	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|HAMAP-Rule:MF_03176, ECO:0000269|PubMed:16522649, ECO:0000269|PubMed:17172855, ECO:0000269|PubMed:17827721}.; SUBCELLULAR LOCATION: Isoform 4: Mitochondrion {ECO:0000255|HAMAP-Rule:MF_03176, ECO:0000269|PubMed:23275553}.		MOD_RES 27 27 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 151 151 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.	16522649; 18835853; 14702039; 15489334; 17172855; 17827721; 18669648; 19700773; 20524933; 20068231; 21406692; 23186163; 23657261; 23275553; 21616935; 22347400; 23596008; 23924759; 25036637; 25359767; 25589786; 26904952	16522649; 18835853; 14702039; 15489334; 17172855; 17827721; 18669648; 19700773; 20524933; 20068231; 21406692; 23186163; 23657261; 23275553
8439	SLC34A3 NPT2C NPTIIC	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=79 uM for phosphate {ECO:0000269|PubMed:11880379}; 											cellular phosphate ion homeostasis [GO:0030643]; phosphate ion transport [GO:0006817]; sodium ion transport [GO:0006814]	apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; sodium-dependent phosphate transmembrane transporter activity [GO:0015321]; sodium:phosphate symporter activity [GO:0005436]; cellular phosphate ion homeostasis [GO:0030643]; phosphate ion transport [GO:0006817]; sodium ion transport [GO:0006814]	sodium:phosphate symporter activity [GO:0005436]; sodium-dependent phosphate transmembrane transporter activity [GO:0015321]	GO:0005436; GO:0005737; GO:0005886; GO:0005903; GO:0006814; GO:0006817; GO:0015321; GO:0016021; GO:0016324; GO:0030643; GO:0031526; GO:0031982	SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.		MOD_RES 4 4 Phosphoserine. {ECO:0000250|UniProtKB:Q8K4R8}.	11880379; 14702039; 15164053; 16358214; 16358215; 15504899; 16955105; 17968493; 18480181; 19820004; 22159077; 22387237; 22672866; 22806288; 23246670; 24700880; 24924704; 29505567	11880379; 14702039; 15164053; 16358214; 16358215
8447	NTHL1 NTH1 OCTS3	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=371 nM for 5-hydroxy-6-hydrothymine containing duplex oligonucleotides (N-glycosylase activity) {ECO:0000269|PubMed:11380260, ECO:0000269|PubMed:9890904}; KM=1093 nM for 5-hydroxyuracil containing duplex oligonucleotides (N-glycosylase activity) {ECO:0000269|PubMed:11380260, ECO:0000269|PubMed:9890904}; KM=548 nM for 5-hydroxycytosine containing duplex oligonucleotides (N-glycosylase activity) {ECO:0000269|PubMed:11380260, ECO:0000269|PubMed:9890904}; KM=1101 nM for thymine glycol containing duplex oligonucleotides (N-glycosylase activity) {ECO:0000269|PubMed:11380260, ECO:0000269|PubMed:9890904}; KM=718 nM for 5,6-dihydroxycytosine containing duplex oligonucleotides (N-glycosylase activity) {ECO:0000269|PubMed:11380260, ECO:0000269|PubMed:9890904}; KM=0.05 nM for 5-hydroxycytosine-G containing duplex oligonucleotides (N-glycosylase activity) {ECO:0000269|PubMed:11380260, ECO:0000269|PubMed:9890904}; KM=0.2 nM for 5-hydroxycytosine-A containing duplex oligonucleotides (N-glycosylase activity) {ECO:0000269|PubMed:11380260, ECO:0000269|PubMed:9890904}; 	3.2.2.-; 4.2.99.18	CATALYTIC ACTIVITY: The C-O-P bond 3' to the apurinic or apyrimidinic site in DNA is broken by a beta-elimination reaction, leaving a 3'-terminal unsaturated sugar and a product with a terminal 5'-phosphate. {ECO:0000250|UniProtKB:P20625, ECO:0000255|HAMAP-Rule:MF_03183, ECO:0000269|PubMed:11287425, ECO:0000269|PubMed:12140329, ECO:0000269|PubMed:12144783}.		ACTIVITY REGULATION: APE1 displaces NTHL1 from the N-glycosylase-generated AP site in DNA, thereby increasing the turnover of the DNA N-glycosylase activity. AP lyase activity is stimulated by YBX1. {ECO:0000269|PubMed:11287425, ECO:0000269|PubMed:12519758}.	COFACTOR: Name=[4Fe-4S] cluster; Xref=ChEBI:CHEBI:49883; Evidence={ECO:0000255|HAMAP-Rule:MF_03183}; ;  Note=Binds 1 [4Fe-4S] cluster. The cluster does not appear to play a role in catalysis, but is probably involved in the proper positioning of the enzyme along the DNA strand. {ECO:0000255|HAMAP-Rule:MF_03183};			SITE 239 239 Important for catalytic activity.			base-excision repair, AP site formation [GO:0006285]; depyrimidination [GO:0045008]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]	mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA N-glycosylase activity [GO:0019104]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity [GO:0000703]; base-excision repair, AP site formation [GO:0006285]; depyrimidination [GO:0045008]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]	4 iron, 4 sulfur cluster binding [GO:0051539]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; DNA N-glycosylase activity [GO:0019104]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity [GO:0000703]	GO:0000703; GO:0003690; GO:0003906; GO:0004519; GO:0005634; GO:0005654; GO:0005739; GO:0006285; GO:0006296; GO:0008534; GO:0019104; GO:0045008; GO:0046872; GO:0051539; GO:0140078	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|HAMAP-Rule:MF_03183, ECO:0000269|PubMed:10882850, ECO:0000269|PubMed:12531031, ECO:0000269|PubMed:9611236}. Mitochondrion {ECO:0000255|HAMAP-Rule:MF_03183, ECO:0000269|PubMed:9611236}.		MOD_RES 71 71 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 73 73 Phosphoserine. {ECO:0000244|PubMed:21406692}.	8990169; 9831664; 15616553; 9705289; 9045706; 15489334; 10882850; 12144783; 9611236; 9890904; 11380260; 11695910; 11287425; 11328882; 12531031; 12140329; 12519758; 14734554; 15533839; 17923696; 18669648; 20005182; 20110254; 20068231; 21930793; 21406692; 23186163; 24275569; 25938944; 14522981; 15341901; 15358233; 16111924; 16221681; 16446124; 17150535; 17353931; 18307537; 18515411; 19414504; 20226869; 20522537; 20574454; 20877624; 21048031; 22465744; 26400813; 26496610; 26559593; 27713038; 27839712; 28292631; 28709015; 8218289	8990169; 9831664; 15616553; 9705289; 9045706; 15489334; 10882850; 12144783; 9611236; 9890904; 11380260; 11695910; 11287425; 11328882; 12531031; 12140329; 12519758; 14734554; 15533839; 17923696; 18669648; 20005182; 20110254; 20068231; 21930793; 21406692; 23186163; 24275569; 25938944
8477	OARD1 C6orf130	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=182 uM for O-acetyl-ADP-ribose {ECO:0000269|PubMed:21849506}; 	3.5.1.-		BINDING 21 21 Substrate; via amide nitrogen.; BINDING 152 152 Substrate; via carboxylate.	ACTIVITY REGULATION: Subject to competitive inhibition by the product ADP-ribose. {ECO:0000269|PubMed:21849506}.							purine nucleoside metabolic process [GO:0042278]		deacetylase activity [GO:0019213]; purine nucleoside binding [GO:0001883]; purine nucleoside metabolic process [GO:0042278]	deacetylase activity [GO:0019213]; purine nucleoside binding [GO:0001883]	GO:0001883; GO:0019213; GO:0042278			MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378}.; MOD_RES 4 4 Phosphoserine. {ECO:0000244|PubMed:21406692}.	14702039; 14574404; 15489334; 21269460; 21406692; 22223895; 22814378; 23186163; 21849506; 23481255; 26091342	14702039; 14574404; 15489334; 21269460; 21406692; 22223895; 22814378; 23186163; 21849506
8611	SMOX C20orf16 SMO UNQ3039/PRO9854	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=0.6 uM for spermine (isoform 1) {ECO:0000269|PubMed:12141946, ECO:0000269|PubMed:12398765, ECO:0000269|PubMed:18422650}; KM=0.5 uM for spermine (isoform 6) {ECO:0000269|PubMed:12141946, ECO:0000269|PubMed:12398765, ECO:0000269|PubMed:18422650}; KM=3.0 uM for N1-acetylspermine (Isoform 1 and isoform 6) {ECO:0000269|PubMed:12141946, ECO:0000269|PubMed:12398765, ECO:0000269|PubMed:18422650}; Note=Kcat is 27-fold higher with spermine than N1-acetylspermine as substrate for isoform 1 and isoform 6.;	1.5.3.16	CATALYTIC ACTIVITY: Spermine + O(2) + H(2)O = spermidine + 3-aminopropanal + H(2)O(2).		ACTIVITY REGULATION: Inhibited at more than 90% by SL-11144, SL-11150 and SL-11158, at concentrations less than 1 uM.	COFACTOR: Name=FAD; Xref=ChEBI:CHEBI:57692; Evidence={ECO:0000250}; ;  Note=Binds 1 FAD per subunit. {ECO:0000250};	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 9.5 with spermine as substrate. {ECO:0000269|PubMed:12141946, ECO:0000269|PubMed:12398765, ECO:0000269|PubMed:18422650};	PATHWAY: Amine and polyamine degradation; spermine degradation.		UNQ3039/PRO9854		polyamine biosynthetic process [GO:0006596]; polyamine catabolic process [GO:0006598]; spermine catabolic process [GO:0046208]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity [GO:0052895]; norspermine:oxygen oxidoreductase activity [GO:0052894]; polyamine oxidase activity [GO:0046592]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]; polyamine biosynthetic process [GO:0006596]; polyamine catabolic process [GO:0006598]; spermine catabolic process [GO:0046208]	N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity [GO:0052895]; norspermine:oxygen oxidoreductase activity [GO:0052894]; polyamine oxidase activity [GO:0046592]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]	GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006596; GO:0006598; GO:0031965; GO:0043231; GO:0046208; GO:0046592; GO:0052894; GO:0052895; GO:0052901	SUBCELLULAR LOCATION: Isoform 1: Cytoplasm. Nucleus.; SUBCELLULAR LOCATION: Isoform 4: Cytoplasm. Nucleus.; SUBCELLULAR LOCATION: Isoform 6: Cytoplasm. Nucleus.			11454677; 12398765; 18422650; 12975309; 14702039; 11780052; 15489334; 17974005; 12727196; 12141946; 15221502; 16959974; 16207710; 18302221; 19165232; 19727732; 20000632; 20059804; 20127992; 20379614; 20946629; 21152090; 21839041; 23665428; 24025154; 25174398; 26895301; 27041578; 29138259	11454677; 12398765; 18422650; 12975309; 14702039; 11780052; 15489334; 17974005; 12727196; 12141946; 15221502; 16959974
8689	RBKS RBSK	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=2.17 mM for ribose (in the presence of 10 mM inorganic phosphate) {ECO:0000269|PubMed:17585908}; KM=3.39 mM for ribose (in the presence of 5 mM inorganic phosphate) {ECO:0000269|PubMed:17585908}; KM=6.62 mM for ribose (in the presence of 2 mM inorganic phosphate) {ECO:0000269|PubMed:17585908}; KM=30.43 mM for ribose (in the presence of 1 mM inorganic phosphate) {ECO:0000269|PubMed:17585908}; KM=0.07 mM for ATP (in the presence of 5 mM inorganic phosphate) {ECO:0000269|PubMed:17585908}; KM=0.08 mM for ATP (in the presence of 2 mM inorganic phosphate) {ECO:0000269|PubMed:17585908}; KM=0.10 mM for ATP (in the presence of 1 mM inorganic phosphate) {ECO:0000269|PubMed:17585908}; 	2.7.1.15	CATALYTIC ACTIVITY: ATP + D-ribose = ADP + D-ribose 5-phosphate. {ECO:0000255|HAMAP-Rule:MF_03215, ECO:0000269|PubMed:17585908}.	BINDING 154 154 Substrate. {ECO:0000250|UniProtKB:P0A9J6, ECO:0000255|HAMAP-Rule:MF_03215}.; BINDING 199 199 ATP. {ECO:0000255|HAMAP-Rule:MF_03215, ECO:0000269|Ref.7}.; BINDING 256 256 ATP. {ECO:0000255|HAMAP-Rule:MF_03215, ECO:0000269|Ref.7}.; BINDING 269 269 Substrate. {ECO:0000250|UniProtKB:P0A9J6, ECO:0000255|HAMAP-Rule:MF_03215}.; BINDING 295 295 ATP. {ECO:0000255|HAMAP-Rule:MF_03215, ECO:0000269|Ref.7}.	ACTIVITY REGULATION: Activated by a monovalent cation that binds near, but not in, the active site. The most likely occupant of the site in vivo is potassium. Ion binding induces a conformational change that may alter substrate affinity (By similarity). Competitively inhibited by phosphonoacetic acid, etidronate, 2-carboxethylphosphonic acid, N-(phosphonomethyl)glycine, N-(phosphonomethyl)iminodiacetic acid and clodronate (PubMed:17585908). {ECO:0000255|HAMAP-Rule:MF_03215, ECO:0000269|PubMed:17585908}.	COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000255|HAMAP-Rule:MF_03215}; ;  Note=Requires a divalent cation, most likely magnesium in vivo, as an electrophilic catalyst to aid phosphoryl group transfer. It is the chelate of the metal and the nucleotide that is the actual substrate. {ECO:0000255|HAMAP-Rule:MF_03215};		PATHWAY: Carbohydrate metabolism; D-ribose degradation; D-ribose 5-phosphate from beta-D-ribopyranose: step 2/2. {ECO:0000255|HAMAP-Rule:MF_03215}.				carbohydrate phosphorylation [GO:0046835]; D-ribose catabolic process [GO:0019303]; pentose-phosphate shunt [GO:0006098]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; carbohydrate kinase activity [GO:0019200]; metal ion binding [GO:0046872]; ribokinase activity [GO:0004747]; carbohydrate phosphorylation [GO:0046835]; D-ribose catabolic process [GO:0019303]; pentose-phosphate shunt [GO:0006098]	ATP binding [GO:0005524]; carbohydrate kinase activity [GO:0019200]; metal ion binding [GO:0046872]; ribokinase activity [GO:0004747]	GO:0004747; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006098; GO:0019200; GO:0019303; GO:0046835; GO:0046872	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P25332, ECO:0000255|HAMAP-Rule:MF_03215}. Nucleus {ECO:0000250|UniProtKB:P25332, ECO:0000255|HAMAP-Rule:MF_03215}.			14702039; 15815621; 15489334; 17585908; 18560757; 20379614; 21044950; 25749547; 26496610	14702039; 15815621; 15489334; 17585908; 
8720	GRK1 RHOK	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=3.5 uM for rhodopsin {ECO:0000269|PubMed:15946941}; KM=10.6 uM for ATP {ECO:0000269|PubMed:15946941}; Vmax=1132 nmol/min/mg enzyme {ECO:0000269|PubMed:15946941}; 	2.7.11.14	CATALYTIC ACTIVITY: ATP + [rhodopsin] = ADP + [rhodopsin] phosphate. {ECO:0000269|PubMed:15946941}.	BINDING 219 219 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.	ACTIVITY REGULATION: Inhibited by phosphorylation of Ser-21. {ECO:0000269|PubMed:15946941}.							protein autophosphorylation [GO:0046777]; regulation of G-protein coupled receptor protein signaling pathway [GO:0008277]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; rhodopsin mediated signaling pathway [GO:0016056]; visual perception [GO:0007601]	photoreceptor disc membrane [GO:0097381]	photoreceptor disc membrane [GO:0097381]; ATP binding [GO:0005524]; G-protein coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672]; rhodopsin kinase activity [GO:0050254]; protein autophosphorylation [GO:0046777]; regulation of G-protein coupled receptor protein signaling pathway [GO:0008277]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; rhodopsin mediated signaling pathway [GO:0016056]; visual perception [GO:0007601]	ATP binding [GO:0005524]; G-protein coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672]; rhodopsin kinase activity [GO:0050254]	GO:0004672; GO:0004703; GO:0005524; GO:0007601; GO:0008277; GO:0016056; GO:0022400; GO:0046777; GO:0050254; GO:0097381	SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:P28327}; Lipid-anchor {ECO:0000250|UniProtKB:P28327}.	PTM: Autophosphorylated, Ser-21 is a minor site of autophosphorylation compared to Ser-491 and Thr-492 (By similarity). Phosphorylation at Ser-21 is regulated by light and activated by cAMP. {ECO:0000250, ECO:0000269|PubMed:15946941}.; PTM: Farnesylation is required for full activity. {ECO:0000250|UniProtKB:P28327}.	MOD_RES 5 5 Phosphoserine. {ECO:0000250|UniProtKB:P28327}.; MOD_RES 8 8 Phosphothreonine. {ECO:0000250|UniProtKB:P28327}.; MOD_RES 21 21 Phosphoserine; by PKA and autocatalysis. {ECO:0000269|PubMed:15946941}.; MOD_RES 491 491 Phosphoserine; by autocatalysis. {ECO:0000250|UniProtKB:P28327}.; MOD_RES 492 492 Phosphothreonine; by autocatalysis. {ECO:0000250|UniProtKB:P28327}.; MOD_RES 560 560 Cysteine methyl ester. {ECO:0000250|UniProtKB:P28327}.	9147475; 8812493; 14702039; 15057823; 11717351; 15946941; 9268593; 9020843; 17070587; 11754336; 1387789; 16319817; 16407241; 16478881; 1672047; 17524610; 17765441; 18266817; 18803695; 19753316; 1999465; 20430952; 21922265; 22183412; 22658984; 22959359; 24670923; 25852190; 25979333; 26349155; 26350504; 27511724; 28511019; 3164688; 7629115; 7926045; 8626439	9147475; 8812493; 14702039; 15057823; 11717351; 15946941; 9268593; 9020843; 17070587
8751	RHOBTB3 KIAA0878	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=48 uM for ATP {ECO:0000269|PubMed:19490898}; 	3.6.1.-										male gonad development [GO:0008584]; retrograde transport, endosome to Golgi [GO:0042147]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; trans-Golgi network membrane [GO:0032588]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; trans-Golgi network membrane [GO:0032588]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; GTPase activity [GO:0003924]; Rab GTPase binding [GO:0017137]; male gonad development [GO:0008584]; retrograde transport, endosome to Golgi [GO:0042147]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; GTPase activity [GO:0003924]; Rab GTPase binding [GO:0017137]	GO:0003924; GO:0005524; GO:0005829; GO:0008584; GO:0016887; GO:0017137; GO:0032588; GO:0042147; GO:0070062	SUBCELLULAR LOCATION: Golgi apparatus {ECO:0000269|PubMed:19490898}.			12426103; 10048485; 14702039; 15489334; 19490898; 11359012; 11827983; 16885419; 18195106; 19834535; 21421921; 22245496; 24145166; 25416956; 26215701; 7909812; 8440258; 9230071; 9590177	12426103; 10048485; 14702039; 15489334; 19490898
8834	NUDT16	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=0.062 uM for IDP (at 37 degrees Celsius) {ECO:0000269|PubMed:20385596}; KM=0.088 uM for dIDP (at 37 degrees Celsius) {ECO:0000269|PubMed:20385596}; KM=0.330 uM for GDP (at 37 degrees Celsius) {ECO:0000269|PubMed:20385596}; KM=0.319 mM for dGDP (at 37 degrees Celsius) {ECO:0000269|PubMed:20385596}; KM=15.7 mM for XDP (at 37 degrees Celsius) {ECO:0000269|PubMed:20385596}; KM=22.1 mM for ITP (at 37 degrees Celsius) {ECO:0000269|PubMed:20385596}; KM=24.1 mM for dITP (at 37 degrees Celsius) {ECO:0000269|PubMed:20385596}; Note=kcat is 0.931 sec(-1) with IDP. kcat is 0.966 sec(-1) with dIDP. kcat is 0.518 sec(-1) with GDP. kcat is 0.492 sec(-1) with dGDP. kcat is 2.6 sec(-1) with XDP. kcat is 3.06 sec(-1) with ITP. kcat is 3.2 sec(-1) with dITP. The catalytic efficiency for IDP is at least 1.3-fold higher than for dIDP, 9.6-fold higher than for GDP and dGDP, 100-fold higher than for XDP, ITP and dITP. {ECO:0000269|PubMed:20385596};	3.6.1.62; 3.6.1.64	CATALYTIC ACTIVITY: 5'-(N(7)-methylguanosine 5'-triphospho)-[mRNA] + H(2)O = N(7)-methylguanosine 5'-diphosphate + 5'-phospho-[mRNA]. {ECO:0000269|PubMed:15053875, ECO:0000269|PubMed:17567574, ECO:0000269|PubMed:18820299, ECO:0000269|PubMed:21070968, ECO:0000269|PubMed:21337011}.; CATALYTIC ACTIVITY: IDP + H(2)O = IMP + phosphate. {ECO:0000269|PubMed:20385596, ECO:0000269|PubMed:26121039}.; CATALYTIC ACTIVITY: dIDP + H(2)O = dIMP + phosphate. {ECO:0000269|PubMed:20385596, ECO:0000269|PubMed:26121039}.	BINDING 24 24 Substrate. {ECO:0000305|PubMed:26121039}.; BINDING 50 50 Substrate. {ECO:0000305|PubMed:26121039}.; BINDING 57 57 Substrate; via amide nitrogen. {ECO:0000305|PubMed:26121039}.; BINDING 170 170 Substrate. {ECO:0000305|PubMed:26121039}.	ACTIVITY REGULATION: The phosphatase activity is inhibited by the product IMP. {ECO:0000269|PubMed:26121039}.	COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:17567574, ECO:0000269|PubMed:21337011, ECO:0000269|PubMed:26121039}; Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000269|PubMed:17567574, ECO:0000269|PubMed:21337011}; Name=Co(2+); Xref=ChEBI:CHEBI:48828; Evidence={ECO:0000269|PubMed:17567574, ECO:0000269|PubMed:21337011}; ;  Note=Binds 3 or 4 divalent metal cations. Acts specifically on U8 snoRNA with magnesium as cofactor. Has broad substrate specificity with bound manganese or cobalt (in vitro). {ECO:0000269|PubMed:17567574, ECO:0000269|PubMed:21337011};	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Gradually increased from pH 6.5 to 8.5 in its IDP hydrolyzing activity. {ECO:0000269|PubMed:20385596};				BIOPHYSICOCHEMICAL PROPERTIES: ;  Temperature dependence: Exhibited a temperature-dependent increase in its IDP hydrolyzing activity up to 60 degrees Celsius. {ECO:0000269|PubMed:20385596};	adenosine to inosine editing [GO:0006382]; dITP catabolic process [GO:0035863]; IDP catabolic process [GO:0046709]; mRNA catabolic process [GO:0006402]; negative regulation of rRNA processing [GO:2000233]; nucleobase-containing small molecule catabolic process [GO:0034656]; positive regulation of cell cycle process [GO:0090068]; positive regulation of cell proliferation [GO:0008284]; positive regulation of double-strand break repair [GO:2000781]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; snoRNA catabolic process [GO:0016077]; XDP catabolic process [GO:1901639]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chloride ion binding [GO:0031404]; cobalt ion binding [GO:0050897]; dIDP diphosphatase activity [GO:0097383]; dITP diphosphatase activity [GO:0035870]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; IDP phosphatase activity [GO:1990003]; ITP binding [GO:1901641]; m7G(5')pppN diphosphatase activity [GO:0050072]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; metalloexopeptidase activity [GO:0008235]; mRNA binding [GO:0003729]; nucleotide phosphatase activity, acting on free nucleotides [GO:0098519]; phosphodiesterase decapping endonuclease activity [GO:1990174]; protein homodimerization activity [GO:0042803]; snoRNA binding [GO:0030515]; XTP binding [GO:1901640]; adenosine to inosine editing [GO:0006382]; dITP catabolic process [GO:0035863]; IDP catabolic process [GO:0046709]; mRNA catabolic process [GO:0006402]; negative regulation of rRNA processing [GO:2000233]; nucleobase-containing small molecule catabolic process [GO:0034656]; positive regulation of cell cycle process [GO:0090068]; positive regulation of cell proliferation [GO:0008284]; positive regulation of double-strand break repair [GO:2000781]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; snoRNA catabolic process [GO:0016077]; XDP catabolic process [GO:1901639]	chloride ion binding [GO:0031404]; cobalt ion binding [GO:0050897]; dIDP diphosphatase activity [GO:0097383]; dITP diphosphatase activity [GO:0035870]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; IDP phosphatase activity [GO:1990003]; ITP binding [GO:1901641]; m7G(5')pppN diphosphatase activity [GO:0050072]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; metalloexopeptidase activity [GO:0008235]; mRNA binding [GO:0003729]; nucleotide phosphatase activity, acting on free nucleotides [GO:0098519]; phosphodiesterase decapping endonuclease activity [GO:1990174]; protein homodimerization activity [GO:0042803]; snoRNA binding [GO:0030515]; XTP binding [GO:1901640]	GO:0000287; GO:0003729; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006382; GO:0006402; GO:0008235; GO:0008284; GO:0016077; GO:0030145; GO:0030515; GO:0031404; GO:0034656; GO:0035863; GO:0035870; GO:0042802; GO:0042803; GO:0046709; GO:0050072; GO:0050897; GO:0090068; GO:0090502; GO:0097383; GO:0098519; GO:1901639; GO:1901640; GO:1901641; GO:1990003; GO:1990174; GO:2000233; GO:2000781	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20385596, ECO:0000269|PubMed:21337011}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:Q6TEC1}. Nucleus, nucleolus {ECO:0000250|UniProtKB:Q6TEC1}. Cytoplasm {ECO:0000269|PubMed:21070968, ECO:0000269|PubMed:21337011}. Note=Localized predominantly in the cytoplasm (PubMed:21070968). Localized in nucleolus, and in a minor proportion in distinct foci in the nucleoplasm (By similarity). {ECO:0000250|UniProtKB:Q6TEC1, ECO:0000269|PubMed:21070968}.			14702039; 16344560; 16641997; 15489334; 15053875; 17567574; 18820299; 21070968; 20385596; 21269460; 21337011; 24275569; 18607096; 26121039; 23902751; 25609649; 26038567; 28344317; 29483298; 29967538	14702039; 16344560; 16641997; 15489334; 15053875; 17567574; 18820299; 21070968; 20385596; 21269460; 21337011; 24275569; 18607096; 26121039
8952	NUDT10 APS2 DIPP3A	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.088 uM for PP-InsP5 {ECO:0000269|PubMed:12105228, ECO:0000269|PubMed:12121577}; KM=19 uM for Ap6A {ECO:0000269|PubMed:12105228, ECO:0000269|PubMed:12121577}; KM=50 uM for Ap5A {ECO:0000269|PubMed:12105228, ECO:0000269|PubMed:12121577}; 	3.6.1.52; 3.6.1.60	CATALYTIC ACTIVITY: Diphospho-myo-inositol polyphosphate + H(2)O = myo-inositol polyphosphate + phosphate. {ECO:0000269|PubMed:12105228, ECO:0000269|PubMed:12121577, ECO:0000269|PubMed:12370170}.; CATALYTIC ACTIVITY: P(1),P(6)-bis(5'-adenosyl)hexaphosphate + H(2)O = adenosine 5'-pentaphosphate + AMP. {ECO:0000269|PubMed:12105228, ECO:0000269|PubMed:12121577, ECO:0000269|PubMed:12370170}.; CATALYTIC ACTIVITY: P(1),P(5)-bis(5'-adenosyl)pentaphosphate + H(2)O = adenosine 5'-tetraphosphate + AMP. {ECO:0000269|PubMed:12105228, ECO:0000269|PubMed:12121577, ECO:0000269|PubMed:12370170}.	BINDING 9 9 Substrate. {ECO:0000250|UniProtKB:O95989}.; BINDING 115 115 Substrate. {ECO:0000250|UniProtKB:O95989}.; BINDING 133 133 Substrate. {ECO:0000250|UniProtKB:O95989}.		COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250, ECO:0000269|PubMed:12121577}; Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250, ECO:0000269|PubMed:12121577}; ;  Note=Binds 3 Mg(2+) or Mn(2+) ions per subunit. Mn(2+) may be the true cofactor in vivo. {ECO:0000250, ECO:0000269|PubMed:12121577};	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 8.5. {ECO:0000269|PubMed:12105228, ECO:0000269|PubMed:12121577};					adenosine 5'-(hexahydrogen pentaphosphate) catabolic process [GO:1901911]; diadenosine hexaphosphate catabolic process [GO:1901909]; diadenosine pentaphosphate catabolic process [GO:1901907]; diphosphoinositol polyphosphate metabolic process [GO:0071543]; inositol phosphate metabolic process [GO:0043647]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; bis(5'-adenosyl)-hexaphosphatase activity [GO:0034431]; bis(5'-adenosyl)-pentaphosphatase activity [GO:0034432]; diphosphoinositol-polyphosphate diphosphatase activity [GO:0008486]; endopolyphosphatase activity [GO:0000298]; inositol bisdiphosphate tetrakisphosphate diphosphatase activity [GO:0052841]; inositol diphosphate pentakisphosphate diphosphatase activity [GO:0052842]; inositol diphosphate tetrakisphosphate diphosphatase activity [GO:0052840]; inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity [GO:0052846]; inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity [GO:0052847]; inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity [GO:0052843]; inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity [GO:0052848]; inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity [GO:0052844]; inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity [GO:0052845]; m7G(5')pppN diphosphatase activity [GO:0050072]; metal ion binding [GO:0046872]; adenosine 5'-(hexahydrogen pentaphosphate) catabolic process [GO:1901911]; diadenosine hexaphosphate catabolic process [GO:1901909]; diadenosine pentaphosphate catabolic process [GO:1901907]; diphosphoinositol polyphosphate metabolic process [GO:0071543]; inositol phosphate metabolic process [GO:0043647]	bis(5'-adenosyl)-hexaphosphatase activity [GO:0034431]; bis(5'-adenosyl)-pentaphosphatase activity [GO:0034432]; diphosphoinositol-polyphosphate diphosphatase activity [GO:0008486]; endopolyphosphatase activity [GO:0000298]; inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity [GO:0052846]; inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity [GO:0052847]; inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity [GO:0052843]; inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity [GO:0052848]; inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity [GO:0052844]; inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity [GO:0052845]; inositol bisdiphosphate tetrakisphosphate diphosphatase activity [GO:0052841]; inositol diphosphate pentakisphosphate diphosphatase activity [GO:0052842]; inositol diphosphate tetrakisphosphate diphosphatase activity [GO:0052840]; m7G(5')pppN diphosphatase activity [GO:0050072]; metal ion binding [GO:0046872]	GO:0000298; GO:0005634; GO:0005737; GO:0005829; GO:0008486; GO:0034431; GO:0034432; GO:0043647; GO:0046872; GO:0050072; GO:0052840; GO:0052841; GO:0052842; GO:0052843; GO:0052844; GO:0052845; GO:0052846; GO:0052847; GO:0052848; GO:0071543; GO:1901907; GO:1901909; GO:1901911	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305|PubMed:12121577}.			12105228; 14702039; 15772651; 15489334; 12121577; 12370170; 21269460; 10419486; 10585413; 10777568; 16169070; 18264097; 18264098; 20564319; 20711500; 21071540; 25416956; 9822604	12105228; 14702039; 15772651; 15489334; 12121577; 12370170; 21269460; 
8960	NUDT18 MTH3	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=10.7 uM for 8-Oxo-dGDP {ECO:0000269|PubMed:22556419}; KM=11.7 uM for 8-Oxo-GDP {ECO:0000269|PubMed:22556419}; Vmax=212 pmol/min/ug enzyme toward 8-Oxo-dGDP (at 30 degrees Celsius) {ECO:0000269|PubMed:22556419}; Vmax=246 pmol/min/ug enzyme toward 8-Oxo-GDP (at 30 degrees Celsius) {ECO:0000269|PubMed:22556419}; 	3.6.1.58	CATALYTIC ACTIVITY: 8-oxo-dGDP + H(2)O = 8-oxo-dGMP + phosphate. {ECO:0000269|PubMed:22556419}.			COFACTOR: Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250, ECO:0000269|PubMed:22556419}; Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250, ECO:0000269|PubMed:22556419}; 	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 8.5. {ECO:0000269|PubMed:22556419};					dADP catabolic process [GO:0046057]; dGDP catabolic process [GO:0046067]; GDP catabolic process [GO:0046712]; nucleobase-containing small molecule catabolic process [GO:0034656]	cytosol [GO:0005829]	cytosol [GO:0005829]; 8-hydroxy-dADP phosphatase activity [GO:0044717]; 8-oxo-dGDP phosphatase activity [GO:0044715]; 8-oxo-GDP phosphatase activity [GO:0044716]; magnesium ion binding [GO:0000287]; dADP catabolic process [GO:0046057]; dGDP catabolic process [GO:0046067]; GDP catabolic process [GO:0046712]; nucleobase-containing small molecule catabolic process [GO:0034656]	8-hydroxy-dADP phosphatase activity [GO:0044717]; 8-oxo-dGDP phosphatase activity [GO:0044715]; 8-oxo-GDP phosphatase activity [GO:0044716]; magnesium ion binding [GO:0000287]	GO:0000287; GO:0005829; GO:0034656; GO:0044715; GO:0044716; GO:0044717; GO:0046057; GO:0046067; GO:0046712				14702039; 16421571; 15489334; 22556419; 16189514; 16713569; 19060904; 21044950; 22458338; 24352381; 26496610	14702039; 16421571; 15489334; 22556419; 
8970	POFUT2 C21orf80 FUT13 KIAA0958	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=9.8 uM for GDP-fucose {ECO:0000269|PubMed:22588082}; 	2.4.1.221	CATALYTIC ACTIVITY: Transfers an alpha-L-fucosyl residue from GDP-beta-L-fucose to the serine hydroxy group of a protein acceptor. {ECO:0000269|PubMed:22588082}.	BINDING 371 371 Substrate. {ECO:0000244|PDB:4AP6}.	ACTIVITY REGULATION: Inhibited by EDTA and by Zn(2+). {ECO:0000269|PubMed:22588082}.			PATHWAY: Protein modification; protein glycosylation.	SITE 396 396 Essential for catalytic activity.			fucose metabolic process [GO:0006004]; mesoderm formation [GO:0001707]; protein O-linked fucosylation [GO:0036066]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of secretion [GO:0051046]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]	endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; peptide-O-fucosyltransferase activity [GO:0046922]; fucose metabolic process [GO:0006004]; mesoderm formation [GO:0001707]; protein O-linked fucosylation [GO:0036066]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of secretion [GO:0051046]	peptide-O-fucosyltransferase activity [GO:0046922]	GO:0001707; GO:0005789; GO:0005794; GO:0006004; GO:0010468; GO:0010717; GO:0036066; GO:0046922; GO:0051046	SUBCELLULAR LOCATION: Endoplasmic reticulum {ECO:0000269|PubMed:15233996}. Golgi apparatus {ECO:0000269|PubMed:15233996}. Note=Mainly located in the endoplasmic reticulum.			15233996; 12966037; 10231032; 17974005; 10830953; 15489334; 11067851; 16464858; 17395589; 17395588; 25944712; 22588082; 19615732; 20549515; 20562859; 25544610; 27773385	15233996; 12966037; 10231032; 17974005; 10830953; 15489334; 11067851; 16464858; 17395589; 17395588; 25944712; 22588082
8996	POFUT1 FUT12 KIAA0180	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=6 uM for F7 EGF domain {ECO:0000269|PubMed:11524432}; KM=4 uM for GDP-fucose {ECO:0000269|PubMed:11524432}; Vmax=3 umol/min/mg enzyme {ECO:0000269|PubMed:11524432}; 	2.4.1.221	CATALYTIC ACTIVITY: Transfers an alpha-L-fucosyl residue from GDP-beta-L-fucose to the serine hydroxy group of a protein acceptor. {ECO:0000269|PubMed:11524432}.	BINDING 340 340 Substrate. {ECO:0000244|PDB:5UXH, ECO:0000269|PubMed:28334865}.				PATHWAY: Protein modification; protein glycosylation. {ECO:0000269|PubMed:11524432}.				angiogenesis [GO:0001525]; fucose metabolic process [GO:0006004]; heart development [GO:0007507]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; O-glycan processing [GO:0016266]; protein O-linked fucosylation [GO:0036066]; protein O-linked glycosylation [GO:0006493]; regulation of Notch signaling pathway [GO:0008593]; regulation of transcription, DNA-templated [GO:0006355]; somitogenesis [GO:0001756]	endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]	endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; fucosyltransferase activity [GO:0008417]; peptide-O-fucosyltransferase activity [GO:0046922]; angiogenesis [GO:0001525]; fucose metabolic process [GO:0006004]; heart development [GO:0007507]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; O-glycan processing [GO:0016266]; protein O-linked fucosylation [GO:0036066]; protein O-linked glycosylation [GO:0006493]; regulation of Notch signaling pathway [GO:0008593]; regulation of transcription, DNA-templated [GO:0006355]; somitogenesis [GO:0001756]	fucosyltransferase activity [GO:0008417]; peptide-O-fucosyltransferase activity [GO:0046922]	GO:0001525; GO:0001756; GO:0005783; GO:0006004; GO:0006355; GO:0006493; GO:0007219; GO:0007399; GO:0007507; GO:0008417; GO:0008593; GO:0016020; GO:0016266; GO:0036066; GO:0046922	SUBCELLULAR LOCATION: Endoplasmic reticulum {ECO:0000250|UniProtKB:Q6EV70}.	PTM: N-glycosylated. {ECO:0000269|PubMed:19159218}.		11524432; 8724849; 12168954; 14702039; 11780052; 15489334; 8358148; 19159218; 21269460; 23684010; 25944712; 28334865; 12486116; 15653671; 15692013; 18347015; 20000738; 20379614; 21464368; 21988832; 24064921; 25107841; 25157627; 25165882; 25229252; 26486618; 26638075; 27003260; 28040433; 28709865	11524432; 8724849; 12168954; 14702039; 11780052; 15489334; 8358148; 19159218; 21269460; 23684010; 25944712; 28334865
9015	NTPCR C1orf57	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=5 uM for ATP {ECO:0000269|PubMed:17291528}; KM=46 uM for ADP {ECO:0000269|PubMed:17291528}; KM=4 uM for GTP {ECO:0000269|PubMed:17291528}; KM=6 uM for CTP {ECO:0000269|PubMed:17291528}; KM=7 uM for TTP {ECO:0000269|PubMed:17291528}; 	3.6.1.15	CATALYTIC ACTIVITY: NTP + H(2)O = NDP + phosphate.										membrane [GO:0016020]	membrane [GO:0016020]; ATP binding [GO:0005524]; nucleoside-triphosphatase activity [GO:0017111]; nucleotide phosphatase activity, acting on free nucleotides [GO:0098519]; RNA binding [GO:0003723]	ATP binding [GO:0005524]; nucleoside-triphosphatase activity [GO:0017111]; nucleotide phosphatase activity, acting on free nucleotides [GO:0098519]; RNA binding [GO:0003723]	GO:0003723; GO:0005524; GO:0016020; GO:0017111; GO:0098519			MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19413330}.; MOD_RES 165 165 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.	15489334; 19413330; 19608861; 21269460; 25944712; 17291528; 19367725; 19463016; 20195357; 21988832; 22623428; 23602568; 24725412; 25561175; 26496610; 26638075; 26752685	15489334; 19413330; 19608861; 21269460; 25944712; 17291528
9021	NUDT11 APS1 DIPP3B	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.053 uM for PP-InsP5 {ECO:0000269|PubMed:12105228, ECO:0000269|PubMed:12121577}; KM=13 uM for Ap6A {ECO:0000269|PubMed:12105228, ECO:0000269|PubMed:12121577}; KM=37 uM for Ap5A {ECO:0000269|PubMed:12105228, ECO:0000269|PubMed:12121577}; 	3.6.1.52; 3.6.1.60	CATALYTIC ACTIVITY: Diphospho-myo-inositol polyphosphate + H(2)O = myo-inositol polyphosphate + phosphate. {ECO:0000269|PubMed:12105228, ECO:0000269|PubMed:12121577, ECO:0000269|PubMed:12370170}.; CATALYTIC ACTIVITY: P(1),P(6)-bis(5'-adenosyl)hexaphosphate + H(2)O = adenosine 5'-pentaphosphate + AMP. {ECO:0000269|PubMed:12105228, ECO:0000269|PubMed:12121577, ECO:0000269|PubMed:12370170}.; CATALYTIC ACTIVITY: P(1),P(5)-bis(5'-adenosyl)pentaphosphate + H(2)O = adenosine 5'-tetraphosphate + AMP. {ECO:0000269|PubMed:12105228, ECO:0000269|PubMed:12121577, ECO:0000269|PubMed:12370170}.	BINDING 9 9 Substrate. {ECO:0000250|UniProtKB:O95989}.; BINDING 115 115 Substrate. {ECO:0000250|UniProtKB:O95989}.; BINDING 133 133 Substrate. {ECO:0000250|UniProtKB:O95989}.		COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250, ECO:0000269|PubMed:12121577}; Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250, ECO:0000269|PubMed:12121577}; ;  Note=Binds 3 Mg(2+) or Mn(2+) ions per subunit. Mn(2+) may be the true cofactor in vivo. {ECO:0000250, ECO:0000269|PubMed:12121577};	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 8.5. {ECO:0000269|PubMed:12105228, ECO:0000269|PubMed:12121577};					adenosine 5'-(hexahydrogen pentaphosphate) catabolic process [GO:1901911]; diadenosine hexaphosphate catabolic process [GO:1901909]; diadenosine pentaphosphate catabolic process [GO:1901907]; diphosphoinositol polyphosphate metabolic process [GO:0071543]; inositol phosphate metabolic process [GO:0043647]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular [GO:0005622]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular [GO:0005622]; nucleus [GO:0005634]; bis(5'-adenosyl)-hexaphosphatase activity [GO:0034431]; bis(5'-adenosyl)-pentaphosphatase activity [GO:0034432]; diphosphoinositol-polyphosphate diphosphatase activity [GO:0008486]; endopolyphosphatase activity [GO:0000298]; inositol bisdiphosphate tetrakisphosphate diphosphatase activity [GO:0052841]; inositol diphosphate pentakisphosphate diphosphatase activity [GO:0052842]; inositol diphosphate tetrakisphosphate diphosphatase activity [GO:0052840]; inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity [GO:0052846]; inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity [GO:0052847]; inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity [GO:0052843]; inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity [GO:0052848]; inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity [GO:0052844]; inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity [GO:0052845]; m7G(5')pppN diphosphatase activity [GO:0050072]; metal ion binding [GO:0046872]; adenosine 5'-(hexahydrogen pentaphosphate) catabolic process [GO:1901911]; diadenosine hexaphosphate catabolic process [GO:1901909]; diadenosine pentaphosphate catabolic process [GO:1901907]; diphosphoinositol polyphosphate metabolic process [GO:0071543]; inositol phosphate metabolic process [GO:0043647]	bis(5'-adenosyl)-hexaphosphatase activity [GO:0034431]; bis(5'-adenosyl)-pentaphosphatase activity [GO:0034432]; diphosphoinositol-polyphosphate diphosphatase activity [GO:0008486]; endopolyphosphatase activity [GO:0000298]; inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity [GO:0052846]; inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity [GO:0052847]; inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity [GO:0052843]; inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity [GO:0052848]; inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity [GO:0052844]; inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity [GO:0052845]; inositol bisdiphosphate tetrakisphosphate diphosphatase activity [GO:0052841]; inositol diphosphate pentakisphosphate diphosphatase activity [GO:0052842]; inositol diphosphate tetrakisphosphate diphosphatase activity [GO:0052840]; m7G(5')pppN diphosphatase activity [GO:0050072]; metal ion binding [GO:0046872]	GO:0000298; GO:0005622; GO:0005634; GO:0005737; GO:0005829; GO:0008486; GO:0034431; GO:0034432; GO:0043647; GO:0046872; GO:0050072; GO:0052840; GO:0052841; GO:0052842; GO:0052843; GO:0052844; GO:0052845; GO:0052846; GO:0052847; GO:0052848; GO:0071543; GO:1901907; GO:1901909; GO:1901911	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12121577}.			12105228; 14702039; 15772651; 15489334; 12121577; 12370170; 21269460; 10419486; 10585413; 10777568; 18264097; 18264098; 19902474; 21071540; 22730461; 9822604	12105228; 14702039; 15772651; 15489334; 12121577; 12370170; 21269460
9023	NUDT12	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=11 uM for NADH {ECO:0000269|PubMed:12790796}; KM=16 uM for NADPH {ECO:0000269|PubMed:12790796}; KM=190 uM for NAD {ECO:0000269|PubMed:12790796}; 	3.6.1.22	CATALYTIC ACTIVITY: NAD(H) + H(2)O = AMP + NMN(H). {ECO:0000269|PubMed:12790796}.			COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250}; Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250}; 	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 8-9. {ECO:0000269|PubMed:12790796};					NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; NAD catabolic process [GO:0019677]; NADP catabolic process [GO:0006742]	nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; metal ion binding [GO:0046872]; NAD+ diphosphatase activity [GO:0000210]; NADH pyrophosphatase activity [GO:0035529]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; NAD catabolic process [GO:0019677]; NADP catabolic process [GO:0006742]	metal ion binding [GO:0046872]; NAD+ diphosphatase activity [GO:0000210]; NADH pyrophosphatase activity [GO:0035529]	GO:0000210; GO:0005634; GO:0005777; GO:0005782; GO:0006742; GO:0019677; GO:0034356; GO:0035529; GO:0046872	SUBCELLULAR LOCATION: Peroxisome {ECO:0000269|PubMed:12790796}.		MOD_RES 185 185 N6-succinyllysine. {ECO:0000250|UniProtKB:Q9DCN1}.; MOD_RES 292 292 N6-succinyllysine. {ECO:0000250|UniProtKB:Q9DCN1}.	11230166; 14702039; 15489334; 12790796; 20379614; 25416956	11230166; 14702039; 15489334; 12790796
9031	PRSS33	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=6.9 mM for H-DL-Val-Leu-Arg-pNA {ECO:0000269|PubMed:12795636}; 	3.4.21.-										protein kinase C signaling [GO:0070528]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; protein kinase C signaling [GO:0070528]; proteolysis [GO:0006508]	serine-type endopeptidase activity [GO:0004252]	GO:0004252; GO:0005615; GO:0005737; GO:0006508; GO:0070528	SUBCELLULAR LOCATION: Secreted {ECO:0000250}.			12795636; 15616553; 15489334; 28216055	12795636; 15616553; 15489334
9035	NUDT4 DIPP2 KIAA0487 HDCMB47P	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=4.2 nM for PP-InsP5 {ECO:0000269|PubMed:10777568}; 	3.6.1.52	CATALYTIC ACTIVITY: Diphospho-myo-inositol polyphosphate + H(2)O = myo-inositol polyphosphate + phosphate. {ECO:0000269|PubMed:10777568, ECO:0000269|PubMed:12370170}.	BINDING 10 10 Substrate. {ECO:0000250|UniProtKB:O95989}.; BINDING 115 115 Substrate. {ECO:0000250|UniProtKB:O95989}.; BINDING 133 133 Substrate. {ECO:0000250|UniProtKB:O95989}.		COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250|UniProtKB:Q96G61}; Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250|UniProtKB:Q96G61}; ;  Note=Binds 3 Mg(2+) or Mn(2+) ions per subunit. {ECO:0000250|UniProtKB:Q96G61};				HDCMB47P		adenosine 5'-(hexahydrogen pentaphosphate) catabolic process [GO:1901911]; calcium-mediated signaling [GO:0019722]; cyclic-nucleotide-mediated signaling [GO:0019935]; diadenosine hexaphosphate catabolic process [GO:1901909]; diadenosine pentaphosphate catabolic process [GO:1901907]; diphosphoinositol polyphosphate metabolic process [GO:0071543]; inositol phosphate metabolic process [GO:0043647]; intracellular signal transduction [GO:0035556]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular [GO:0005622]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular [GO:0005622]; nucleus [GO:0005634]; bis(5'-adenosyl)-hexaphosphatase activity [GO:0034431]; bis(5'-adenosyl)-pentaphosphatase activity [GO:0034432]; diphosphoinositol-polyphosphate diphosphatase activity [GO:0008486]; endopolyphosphatase activity [GO:0000298]; inositol bisdiphosphate tetrakisphosphate diphosphatase activity [GO:0052841]; inositol diphosphate pentakisphosphate diphosphatase activity [GO:0052842]; inositol diphosphate tetrakisphosphate diphosphatase activity [GO:0052840]; inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity [GO:0052846]; inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity [GO:0052847]; inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity [GO:0052843]; inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity [GO:0052848]; inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity [GO:0052844]; inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity [GO:0052845]; m7G(5')pppN diphosphatase activity [GO:0050072]; metal ion binding [GO:0046872]; snoRNA binding [GO:0030515]; adenosine 5'-(hexahydrogen pentaphosphate) catabolic process [GO:1901911]; calcium-mediated signaling [GO:0019722]; cyclic-nucleotide-mediated signaling [GO:0019935]; diadenosine hexaphosphate catabolic process [GO:1901909]; diadenosine pentaphosphate catabolic process [GO:1901907]; diphosphoinositol polyphosphate metabolic process [GO:0071543]; inositol phosphate metabolic process [GO:0043647]; intracellular signal transduction [GO:0035556]	bis(5'-adenosyl)-hexaphosphatase activity [GO:0034431]; bis(5'-adenosyl)-pentaphosphatase activity [GO:0034432]; diphosphoinositol-polyphosphate diphosphatase activity [GO:0008486]; endopolyphosphatase activity [GO:0000298]; inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity [GO:0052846]; inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity [GO:0052847]; inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity [GO:0052843]; inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity [GO:0052848]; inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity [GO:0052844]; inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity [GO:0052845]; inositol bisdiphosphate tetrakisphosphate diphosphatase activity [GO:0052841]; inositol diphosphate pentakisphosphate diphosphatase activity [GO:0052842]; inositol diphosphate tetrakisphosphate diphosphatase activity [GO:0052840]; m7G(5')pppN diphosphatase activity [GO:0050072]; metal ion binding [GO:0046872]; snoRNA binding [GO:0030515]	GO:0000298; GO:0005622; GO:0005634; GO:0005737; GO:0005829; GO:0008486; GO:0019722; GO:0019935; GO:0030515; GO:0034431; GO:0034432; GO:0035556; GO:0043647; GO:0046872; GO:0050072; GO:0052840; GO:0052841; GO:0052842; GO:0052843; GO:0052844; GO:0052845; GO:0052846; GO:0052847; GO:0052848; GO:0071543; GO:1901907; GO:1901909; GO:1901911	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12121577}.		MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:22814378}.	10777568; 9455484; 17974005; 14702039; 15489334; 12121577; 12370170; 21269460; 22814378; 10419486; 10585413; 10827188; 11502751; 12105228; 19463016; 25416956; 9822604	10777568; 9455484; 17974005; 14702039; 15489334; 12121577; 12370170; 21269460; 22814378; 
9084	OAS1 OIAS	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.31 mM for ATP {ECO:0000269|PubMed:12799444}; 	2.7.7.84	CATALYTIC ACTIVITY: 3 ATP = pppA2'p5'A2'p5'A + 2 diphosphate. {ECO:0000269|PubMed:10464285, ECO:0000269|PubMed:12799444, ECO:0000269|PubMed:23319625, ECO:0000269|PubMed:25775560, ECO:0000269|PubMed:3753689, ECO:0000269|PubMed:3754863, ECO:0000269|PubMed:9407111}.	BINDING 63 63 ATP. {ECO:0000269|PubMed:23319625}.; BINDING 210 210 ATP. {ECO:0000250|UniProtKB:P29728}.; BINDING 213 213 ATP. {ECO:0000269|PubMed:23319625}.; BINDING 229 229 ATP. {ECO:0000269|PubMed:23319625}.	ACTIVITY REGULATION: Produced as a latent enzyme which is activated by dsRNA generated during the course of viral infection. The dsRNA activator must be at least 15 nucleotides long, and no modification of the 2'-hydroxyl group is tolerated. ssRNA or dsDNA do not act as activators. {ECO:0000269|PubMed:12799444, ECO:0000269|PubMed:23319625}.	COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:23319625}; 			SITE 158 158 Interaction with dsRNA.			cellular response to interferon-alpha [GO:0035457]; defense response to virus [GO:0051607]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; interferon-gamma-mediated signaling pathway [GO:0060333]; negative regulation of viral genome replication [GO:0045071]; protein complex oligomerization [GO:0051259]; purine nucleotide biosynthetic process [GO:0006164]; regulation of ribonuclease activity [GO:0060700]; response to virus [GO:0009615]; type I interferon signaling pathway [GO:0060337]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; 2'-5'-oligoadenylate synthetase activity [GO:0001730]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; cellular response to interferon-alpha [GO:0035457]; defense response to virus [GO:0051607]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; interferon-gamma-mediated signaling pathway [GO:0060333]; negative regulation of viral genome replication [GO:0045071]; protein complex oligomerization [GO:0051259]; purine nucleotide biosynthetic process [GO:0006164]; regulation of ribonuclease activity [GO:0060700]; response to virus [GO:0009615]; type I interferon signaling pathway [GO:0060337]	2'-5'-oligoadenylate synthetase activity [GO:0001730]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]	GO:0001730; GO:0003725; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0006006; GO:0006164; GO:0009615; GO:0035457; GO:0042593; GO:0045071; GO:0046872; GO:0051259; GO:0051607; GO:0060333; GO:0060337; GO:0060700	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19923450, ECO:0000269|PubMed:3753689, ECO:0000269|PubMed:3754863}. Mitochondrion {ECO:0000269|PubMed:19923450}. Nucleus {ECO:0000269|PubMed:19923450, ECO:0000269|PubMed:3753689}. Microsome {ECO:0000269|PubMed:19923450}. Endoplasmic reticulum {ECO:0000269|PubMed:19923450}. Secreted {ECO:0000250}. Note=Associated with different subcellular fractions such as mitochondrial, nuclear, and rough/smooth microsomal fractions. {ECO:0000269|PubMed:19923450}.			2416561; 3753689; 3754863; 1651324; 17024523; 14702039; 16541075; 15489334; 3121313; 2830497; 2456211; 2411547; 6348777; 9407111; 10464285; 12799444; 17408844; 18931074; 19923450; 19203244; 19904482; 21269460; 21142819; 25775560; 23319625; 11092454; 11337497; 11404376; 11980899; 11986302; 12029096; 12082089; 12447867; 12944978; 14769151; 15039538; 15047845; 1508672; 15732009; 15766558; 15850793; 15855350; 15865429; 16009940; 16014697; 16235172; 16644715; 16824203; 17092260; 1730654; 17963609; 18362138; 19247438; 19434718; 19462904; 19515215; 19559055; 19665006; 19799013; 19956105; 20079393; 20309637; 20588308; 20628624; 20679634; 21050126; 21182542; 21450824; 21638280; 21735172; 21935451; 21988832; 2211721; 22709583; 22710942; 23011799; 23196181; 23220500; 23337612; 23455924; 23529855; 23575436; 24905202; 25059424; 25416956; 25477390; 25550087; 26063222; 26398832; 26412166; 26505957; 26516113; 26643049; 27422384; 27899133; 28640813; 28704535; 28744639; 6162102; 6548414; 7530745; 8176225; 8483949; 8530158; 9096384; 9143706; 9861020	2416561; 3753689; 3754863; 1651324; 17024523; 14702039; 16541075; 15489334; 3121313; 2830497; 2456211; 2411547; 6348777; 9407111; 10464285; 12799444; 17408844; 18931074; 19923450; 19203244; 19904482; 21269460; 21142819; 25775560; 23319625
9128	NMNAT1 NMNAT	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=34 uM for NMN {ECO:0000269|PubMed:16118205, ECO:0000269|PubMed:17402747}; KM=40 uM for ATP {ECO:0000269|PubMed:16118205, ECO:0000269|PubMed:17402747}; KM=937 uM for PPi {ECO:0000269|PubMed:16118205, ECO:0000269|PubMed:17402747}; KM=59 uM for NAD(+) {ECO:0000269|PubMed:16118205, ECO:0000269|PubMed:17402747}; Vmax=25 umol/min/mg enzyme for NAD synthesis {ECO:0000269|PubMed:16118205, ECO:0000269|PubMed:17402747}; Vmax=60.5 umol/min/ug enzyme for NAD(+) cleavage {ECO:0000269|PubMed:16118205, ECO:0000269|PubMed:17402747}; Vmax=8.5 umol/min/ug enzyme for NADH cleavage {ECO:0000269|PubMed:16118205, ECO:0000269|PubMed:17402747}; 	2.7.7.1; 2.7.7.18	CATALYTIC ACTIVITY: ATP + nicotinamide ribonucleotide = diphosphate + NAD(+). {ECO:0000269|PubMed:11027696}.; CATALYTIC ACTIVITY: ATP + beta-nicotinate-D-ribonucleotide = diphosphate + deamido-NAD(+).	BINDING 24 24 ATP. {ECO:0000250|UniProtKB:Q96T66}.; BINDING 58 58 ATP. {ECO:0000250|UniProtKB:Q96T66}.	ACTIVITY REGULATION: Activity is strongly inhibited by galotannin. Inhibited by P1-(adenosine-5')-P4-(nicotinic-acid-riboside-5')-tetraphosphate (Nap4AD). {ECO:0000269|PubMed:17402747}.	COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000269|PubMed:11027696, ECO:0000269|PubMed:17402747}; Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:11027696, ECO:0000269|PubMed:17402747}; ;  Note=Divalent metal cations. Zn(2+) confers higher activity as compared to Mg(2+). {ECO:0000269|PubMed:11027696, ECO:0000269|PubMed:17402747};		PATHWAY: Cofactor biosynthesis; NAD(+) biosynthesis; NAD(+) from nicotinamide D-ribonucleotide: step 1/1.; PATHWAY: Cofactor biosynthesis; NAD(+) biosynthesis; deamido-NAD(+) from nicotinate D-ribonucleotide: step 1/1.				'de novo' NAD biosynthetic process from aspartate [GO:0034628]; ATP generation from poly-ADP-D-ribose [GO:1990966]; NAD biosynthetic process [GO:0009435]; NAD metabolic process [GO:0019674]; response to wounding [GO:0009611]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nicotinamide-nucleotide adenylyltransferase activity [GO:0000309]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]; 'de novo' NAD biosynthetic process from aspartate [GO:0034628]; ATP generation from poly-ADP-D-ribose [GO:1990966]; NAD biosynthetic process [GO:0009435]; NAD metabolic process [GO:0019674]; response to wounding [GO:0009611]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nicotinamide-nucleotide adenylyltransferase activity [GO:0000309]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]	GO:0000309; GO:0004515; GO:0005524; GO:0005634; GO:0005654; GO:0009435; GO:0009611; GO:0016604; GO:0019674; GO:0034628; GO:0042802; GO:1990966	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11248244, ECO:0000269|PubMed:12574164, ECO:0000269|PubMed:16118205, ECO:0000269|PubMed:22842230}.		MOD_RES 117 117 Phosphoserine. {ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 119 119 Phosphothreonine. {ECO:0000244|PubMed:24275569}.	11248244; 11027696; 11891043; 14702039; 16710414; 15489334; 12574164; 16118205; 17402747; 19413330; 22842230; 23186163; 24275569; 27257257; 11959140; 11751893; 11788603; 22842231; 22842229; 22842227; 17360427; 19403820; 19458223; 19478080; 19913121; 20379614; 20388704; 20457531; 20628086; 20926655; 20954240; 21071441; 21516116; 21988832; 22334709; 23351689; 23737528; 23940504; 24830548; 25416956; 25988908; 26018082; 26316326; 26464178; 26496610; 28369829	11248244; 11027696; 11891043; 14702039; 16710414; 15489334; 12574164; 16118205; 17402747; 19413330; 22842230; 23186163; 24275569; 27257257; 11959140; 11751893; 11788603; 22842231; 22842229; 22842227
9130	NMNAT3 FKSG76	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=209 uM for NMN {ECO:0000269|PubMed:16118205, ECO:0000269|PubMed:17402747}; KM=130 uM for NAD(+) {ECO:0000269|PubMed:16118205, ECO:0000269|PubMed:17402747}; KM=29 uM for ATP {ECO:0000269|PubMed:16118205, ECO:0000269|PubMed:17402747}; KM=390 uM for PPi {ECO:0000269|PubMed:16118205, ECO:0000269|PubMed:17402747}; KM=276 uM for GTP {ECO:0000269|PubMed:16118205, ECO:0000269|PubMed:17402747}; KM=350 uM for ITP {ECO:0000269|PubMed:16118205, ECO:0000269|PubMed:17402747}; KM=111 uM for NaMN {ECO:0000269|PubMed:16118205, ECO:0000269|PubMed:17402747}; KM=130 uM for NMNH {ECO:0000269|PubMed:16118205, ECO:0000269|PubMed:17402747}; KM=2.01 uM for triazofurin monophosphate {ECO:0000269|PubMed:16118205, ECO:0000269|PubMed:17402747}; Vmax=3.6 umol/min/mg enzyme for NAD synthesis {ECO:0000269|PubMed:16118205, ECO:0000269|PubMed:17402747}; Vmax=12.8 umol/min/mg enzyme for pyrophosphorolytic NAD(+) cleavage {ECO:0000269|PubMed:16118205, ECO:0000269|PubMed:17402747}; Vmax=2.9 umol/min/mg enzyme for pyrophosphorolytic NADH cleavage {ECO:0000269|PubMed:16118205, ECO:0000269|PubMed:17402747}; 	2.7.7.18; 2.7.7.1	CATALYTIC ACTIVITY: ATP + nicotinamide ribonucleotide = diphosphate + NAD(+).; CATALYTIC ACTIVITY: ATP + beta-nicotinate-D-ribonucleotide = diphosphate + deamido-NAD(+).	BINDING 22 22 ATP. {ECO:0000269|PubMed:12574164}.; BINDING 56 56 ATP. {ECO:0000269|PubMed:12574164}.; BINDING 140 140 ATP; shared with dimeric partner. {ECO:0000269|PubMed:12574164}.	ACTIVITY REGULATION: Activity is strongly inhibited by galotannin. Inhibited by P1-(adenosine-5')-P4-(nicotinic-acid-riboside-5')-tetraphosphate (Nap4AD). {ECO:0000269|PubMed:17402747}.	COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:17402747}; ;  Note=Divalent metal cations. Mg(2+) confers the highest activity. {ECO:0000269|PubMed:17402747};		PATHWAY: Cofactor biosynthesis; NAD(+) biosynthesis; NAD(+) from nicotinamide D-ribonucleotide: step 1/1.; PATHWAY: Cofactor biosynthesis; NAD(+) biosynthesis; deamido-NAD(+) from nicotinate D-ribonucleotide: step 1/1.		FKSG76		'de novo' NAD biosynthetic process from aspartate [GO:0034628]; NAD biosynthetic process [GO:0009435]; NAD metabolic process [GO:0019674]; response to wounding [GO:0009611]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; nicotinamide-nucleotide adenylyltransferase activity [GO:0000309]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]; 'de novo' NAD biosynthetic process from aspartate [GO:0034628]; NAD biosynthetic process [GO:0009435]; NAD metabolic process [GO:0019674]; response to wounding [GO:0009611]	ATP binding [GO:0005524]; nicotinamide-nucleotide adenylyltransferase activity [GO:0000309]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]	GO:0000309; GO:0004515; GO:0005524; GO:0005739; GO:0005759; GO:0009435; GO:0009611; GO:0019674; GO:0034628	SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:12574164, ECO:0000269|PubMed:16118205}.			14702039; 16641997; 15489334; 16118205; 17402747; 25944712; 12574164; 20388704; 20457531; 24155910	14702039; 16641997; 15489334; 16118205; 17402747; 25944712; 12574164
9144	NMRK1 C9orf95 NRK1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.088 mM for nicotinamide riboside (with ATP as cosubstrate) {ECO:0000269|PubMed:17914902, ECO:0000269|PubMed:8809081}; KM=0.068 mM for nicotinamide riboside (with GTP as cosubstrate) {ECO:0000269|PubMed:17914902, ECO:0000269|PubMed:8809081}; KM=0.27 mM for tiazofurin (with ATP as cosubstrate) {ECO:0000269|PubMed:17914902, ECO:0000269|PubMed:8809081}; KM=0.051 mM for nicotinic acid riboside (with ATP as cosubstrate) {ECO:0000269|PubMed:17914902, ECO:0000269|PubMed:8809081}; KM=17 mM for uridine (with ATP as cosubstrate) {ECO:0000269|PubMed:17914902, ECO:0000269|PubMed:8809081}; 	2.7.1.22; 2.7.1.173	CATALYTIC ACTIVITY: ATP + 1-(beta-D-ribofuranosyl)-nicotinamide = ADP + beta-nicotinamide D-ribonucleotide. {ECO:0000269|PubMed:17914902, ECO:0000269|PubMed:8809081}.; CATALYTIC ACTIVITY: ATP + beta-D-ribosylnicotinate = ADP + nicotinate beta-D-ribonucleotide. {ECO:0000269|PubMed:17914902, ECO:0000269|PubMed:8809081}.	BINDING 128 128 ATP. {ECO:0000244|PDB:2P0E, ECO:0000269|PubMed:17914902}.; BINDING 129 129 Substrate. {ECO:0000244|PDB:2P0E, ECO:0000244|PDB:2QL6, ECO:0000244|PDB:2QT0, ECO:0000244|PDB:2QT1, ECO:0000269|PubMed:17914902}.			BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 6.5-9. {ECO:0000269|PubMed:17914902, ECO:0000269|PubMed:8809081};	PATHWAY: Cofactor biosynthesis; NAD(+) biosynthesis. {ECO:0000305|PubMed:17914902}.				NAD biosynthetic process [GO:0009435]; NAD metabolic process [GO:0019674]	cytosol [GO:0005829]	cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; ribosylnicotinamide kinase activity [GO:0050262]; ribosylnicotinate kinase activity [GO:0061769]; NAD biosynthetic process [GO:0009435]; NAD metabolic process [GO:0019674]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; ribosylnicotinamide kinase activity [GO:0050262]; ribosylnicotinate kinase activity [GO:0061769]	GO:0005524; GO:0005829; GO:0009435; GO:0019674; GO:0046872; GO:0050262; GO:0061769				15137942; 14702039; 15164053; 15489334; 8809081; 24275569; 17914902; 17698003; 19531469; 21504897; 25416956; 27725675	15137942; 14702039; 15164053; 15489334; 8809081; 24275569; 17914902; 17698003
9167	NUDT5 NUDIX5 HSPC115	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=2.1 uM for 8-oxo-dGDP {ECO:0000269|PubMed:19699693}; KM=2.9 uM for 8-oxo-dADP {ECO:0000269|PubMed:19699693}; KM=8.8 uM for 2-oxo-dADP {ECO:0000269|PubMed:19699693}; KM=4.0 uM for 5-CHO-dUDP {ECO:0000269|PubMed:19699693}; KM=7.6 uM for dGDP {ECO:0000269|PubMed:19699693}; KM=12.6 uM for dADP {ECO:0000269|PubMed:19699693}; KM=3.8 uM for 8-oxo-dGDP (at pH 8.0) {ECO:0000269|PubMed:21389046}; KM=3.5 uM for 8-oxo-dGDP (at pH 10.0) {ECO:0000269|PubMed:21389046}; KM=1.9 uM for ADP-D-ribose (at pH 8.0) {ECO:0000269|PubMed:21389046}; KM=36 uM for 8-oxo-dGTP (at pH 10.0) {ECO:0000269|PubMed:21389046}; KM=42.6 uM for ADP-D-ribose (in the presence of diphosphate) {ECO:0000269|PubMed:27257257}; Vmax=11 pmol/min/ug enzyme with 8-oxo-dGDP as substrate (at pH 8.0) {ECO:0000269|PubMed:21389046}; Vmax=2400 pmol/min/ug enzyme with ADP-D-ribose as substrate (at pH 8.0) {ECO:0000269|PubMed:21389046}; Vmax=46 pmol/min/ug enzyme with 8-oxo-dGDP as substrate (at pH 10.0) {ECO:0000269|PubMed:21389046}; Vmax=1.7 pmol/min/ug enzyme with 8-oxo-dGTP as substrate (at pH 10.0) {ECO:0000269|PubMed:21389046}; Note=kcat is 0.369 min(-1) for 8-OH-dGDP. kcat is 0.538 min(-1) for 8-OH-dADP. kcat is 0.226 min(-1) for 2-OH-dADP. kcat is 0.209 min(-1) for 5-CHO-dUDP. kcat is 0.929 min(-1) for dGDP. kcat is 0.365 min(-1) for dADP. {ECO:0000269|PubMed:19699693};	3.6.1.13; 3.6.1.58; 2.7.7.96	CATALYTIC ACTIVITY: ATP + D-ribose 5-phosphate = diphosphate + ADP-D-ribose. {ECO:0000269|PubMed:27257257}.; CATALYTIC ACTIVITY: ADP-D-ribose + H(2)O = AMP + D-ribose 5-phosphate. {ECO:0000269|PubMed:17052728, ECO:0000269|PubMed:21389046}.; CATALYTIC ACTIVITY: 8-oxo-dGDP + H(2)O = 8-oxo-dGMP + phosphate. {ECO:0000269|PubMed:17052728, ECO:0000269|PubMed:19699693, ECO:0000269|PubMed:21389046}.	BINDING 28 28 Substrate. {ECO:0000269|PubMed:17052728, ECO:0000269|PubMed:18462755, ECO:0000269|PubMed:21768126}.; BINDING 51 51 Substrate; shared with dimeric partner. {ECO:0000269|PubMed:17052728, ECO:0000269|PubMed:18462755, ECO:0000269|PubMed:21768126}.; BINDING 84 84 Substrate. {ECO:0000269|PubMed:17052728, ECO:0000269|PubMed:18462755, ECO:0000269|PubMed:21768126}.; BINDING 98 98 Substrate; via amide nitrogen. {ECO:0000269|PubMed:17052728}.; BINDING 133 133 Substrate. {ECO:0000269|PubMed:17052728}.		COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:17052728, ECO:0000269|PubMed:18462755, ECO:0000269|PubMed:21768126}; ;  Note=Binds 3 Mg(2+) ions per subunit. {ECO:0000269|PubMed:17052728, ECO:0000269|PubMed:18462755, ECO:0000269|PubMed:21768126};				HSPC115		ATP generation from poly-ADP-D-ribose [GO:1990966]; chromatin remodeling [GO:0006338]; D-ribose catabolic process [GO:0019303]; nucleobase-containing small molecule catabolic process [GO:0034656]; nucleotide metabolic process [GO:0009117]; ribonucleoside diphosphate catabolic process [GO:0009191]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular [GO:0005622]; nucleus [GO:0005634]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular [GO:0005622]; nucleus [GO:0005634]; 8-oxo-dGDP phosphatase activity [GO:0044715]; ADP-ribose diphosphatase activity [GO:0047631]; ADP-sugar diphosphatase activity [GO:0019144]; magnesium ion binding [GO:0000287]; nucleotidyltransferase activity [GO:0016779]; protein homodimerization activity [GO:0042803]; snoRNA binding [GO:0030515]; ATP generation from poly-ADP-D-ribose [GO:1990966]; chromatin remodeling [GO:0006338]; D-ribose catabolic process [GO:0019303]; nucleobase-containing small molecule catabolic process [GO:0034656]; nucleotide metabolic process [GO:0009117]; ribonucleoside diphosphate catabolic process [GO:0009191]	8-oxo-dGDP phosphatase activity [GO:0044715]; ADP-ribose diphosphatase activity [GO:0047631]; ADP-sugar diphosphatase activity [GO:0019144]; magnesium ion binding [GO:0000287]; nucleotidyltransferase activity [GO:0016779]; protein homodimerization activity [GO:0042803]; snoRNA binding [GO:0030515]	GO:0000287; GO:0005622; GO:0005634; GO:0005829; GO:0006338; GO:0009117; GO:0009191; GO:0016779; GO:0019144; GO:0019303; GO:0030515; GO:0034656; GO:0042803; GO:0044715; GO:0047631; GO:0070062; GO:1990966	SUBCELLULAR LOCATION: Nucleus {ECO:0000305|PubMed:27257257}.	PTM: Phosphorylation at Thr-45 is required for homodimer stability; dephosphorylation results in destabilization of the homodimer. Dephosphorylation at Thr-45 promotes the ATP-synthesis activity. {ECO:0000269|PubMed:27257257}.	MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:22223895}.; MOD_RES 3 3 Phosphoserine. {ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 10 10 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 45 45 Phosphothreonine. {ECO:0000269|PubMed:27257257}.; MOD_RES 74 74 Phosphotyrosine. {ECO:0000244|PubMed:15592455}.; MOD_RES 210 210 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 218 218 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.	10567213; 10722730; 11042152; 14702039; 15489334; 15592455; 19413330; 19699693; 19608861; 20068231; 21269460; 21389046; 21406692; 22905912; 22223895; 23186163; 27257257; 28112733; 17052728; 18462755; 21768126; 12717453; 15503857; 16169070; 17353931; 20144704; 20360068; 20711500; 21900206; 22200976; 23581889; 25665578; 26496610; 29343827	10567213; 10722730; 11042152; 14702039; 15489334; 15592455; 19413330; 19699693; 19608861; 20068231; 21269460; 21389046; 21406692; 22905912; 22223895; 23186163; 27257257; 28112733; 17052728; 18462755; 21768126
9219	P3H2 LEPREL1 MLAT4	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=80 uM for 2-oxoglutarate {ECO:0000269|PubMed:18487197}; KM=110 uM for ascorbate {ECO:0000269|PubMed:18487197}; KM=0.5 uM for Fe(2+) {ECO:0000269|PubMed:18487197}; 	1.14.11.7	CATALYTIC ACTIVITY: L-proline-[procollagen] + 2-oxoglutarate + O(2) = trans-3-hydroxy-L-proline-[procollagen] + succinate + CO(2). {ECO:0000269|PubMed:18487197}.		ACTIVITY REGULATION: Inhibited by pyridine 2,4-dicarboxylate, an analog of 2-oxoglutarate. {ECO:0000269|PubMed:18487197}.	COFACTOR: Name=Fe cation; Xref=ChEBI:CHEBI:24875; Evidence={ECO:0000305|PubMed:18487197}; ; COFACTOR: Name=L-ascorbate; Xref=ChEBI:CHEBI:38290; Evidence={ECO:0000305|PubMed:18487197}; 						collagen metabolic process [GO:0032963]; negative regulation of cell proliferation [GO:0008285]; peptidyl-proline hydroxylation [GO:0019511]	basement membrane [GO:0005604]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; Golgi apparatus [GO:0005794]; sarcoplasmic reticulum [GO:0016529]	basement membrane [GO:0005604]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; Golgi apparatus [GO:0005794]; sarcoplasmic reticulum [GO:0016529]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 3-dioxygenase activity [GO:0019797]; collagen metabolic process [GO:0032963]; negative regulation of cell proliferation [GO:0008285]; peptidyl-proline hydroxylation [GO:0019511]	iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 3-dioxygenase activity [GO:0019797]	GO:0005506; GO:0005604; GO:0005783; GO:0005788; GO:0005794; GO:0008285; GO:0016529; GO:0019511; GO:0019797; GO:0031418; GO:0032963	SUBCELLULAR LOCATION: Endoplasmic reticulum {ECO:0000255|PROSITE-ProRule:PRU10138, ECO:0000269|PubMed:15063763}. Sarcoplasmic reticulum {ECO:0000305|PubMed:15063763}. Golgi apparatus {ECO:0000269|PubMed:15063763}.			10449603; 15063763; 14702039; 16641997; 15489334; 18487197; 16959974; 21885030; 15044469; 18519826; 19436308; 20235792; 20379614; 20711500; 21757687; 24172257; 25469533; 25525168; 26496610	10449603; 15063763; 14702039; 16641997; 15489334; 18487197; 16959974; 21885030
9735	SLC7A7	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=31.7 uM for L-leucine (in the presence of 0.1 M NaCl) {ECO:0000269|PubMed:9878049}; KM=16.2 uM for L-leucine (in the presence of 0.1 M LiCl) {ECO:0000269|PubMed:9878049}; 				ACTIVITY REGULATION: Arginine transport is inhibited by protein kinase C (PKC) and treatment with phorbol-12-myristate-13-acetate (PMA).							cellular amino acid metabolic process [GO:0006520]; leukocyte migration [GO:0050900]; protein-containing complex assembly [GO:0065003]; regulation of arginine metabolic process [GO:0000821]	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; antiporter activity [GO:0015297]; basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]; cellular amino acid metabolic process [GO:0006520]; leukocyte migration [GO:0050900]; protein-containing complex assembly [GO:0065003]; regulation of arginine metabolic process [GO:0000821]	antiporter activity [GO:0015297]; basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]	GO:0000821; GO:0005886; GO:0005887; GO:0006520; GO:0015174; GO:0015179; GO:0015297; GO:0016323; GO:0050900; GO:0065003	SUBCELLULAR LOCATION: Basolateral cell membrane {ECO:0000269|PubMed:15756301}; Multi-pass membrane protein {ECO:0000269|PubMed:15756301}.		MOD_RES 18 18 Phosphoserine. {ECO:0000250|UniProtKB:Q9Z1K8}.; MOD_RES 25 25 Phosphoserine. {ECO:0000250|UniProtKB:Q9Z1K8}.	9829974; 9878049; 10080183; 10737982; 14702039; 15489334; 11078698; 11742806; 14603368; 15280038; 17329401; 17197568; 10080182; 10631139; 10655553; 12402335; 15756301; 15776427; 16959974; 17764084; 15901826; 20711500	9829974; 9878049; 10080183; 10737982; 14702039; 15489334; 11078698; 11742806; 14603368; 15280038; 17329401; 17197568; 10080182; 10631139; 10655553; 12402335; 15756301; 15776427; 16959974; 17764084
10087	ZUP1 C6orf113 ZUFSP	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=50.4 uM for Arg-Leu-Arg-Gly-Gly-AMC {ECO:0000269|PubMed:29476094}; KM=4.9 uM for Ub-Rhodamine {ECO:0000269|PubMed:29576528}; Note=kcat is 4.9 sec(-1) with Arg-Leu-Arg-Gly-Gly-AMC as substrate (PubMed:29476094). kcat is 0.084 sec(-1) with Ub-Rhodamine as substrate (PubMed:29576528). {ECO:0000269|PubMed:29476094, ECO:0000269|PubMed:29576528};	3.4.19.12	CATALYTIC ACTIVITY: Thiol-dependent hydrolysis of ester, thioester, amide, peptide and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76-residue protein attached to proteins as an intracellular targeting signal). {ECO:0000269|PubMed:29476094, ECO:0000269|PubMed:29576528}.						SITE 487 487 Involved in the stabilization of negative charge on the oxyanion by the formation of the oxyanion hole. {ECO:0000305|PubMed:29576527}.				cytoplasm [GO:0005737]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]	metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]	GO:0003676; GO:0005634; GO:0005737; GO:0036459; GO:0046872	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:29476094}. Nucleus {ECO:0000269|PubMed:29476094, ECO:0000269|PubMed:29576527, ECO:0000269|PubMed:29576528}. Note=Mostly present in the nuclear fraction. Localizes to DNA lesions. {ECO:0000269|PubMed:29576527, ECO:0000269|PubMed:29576528}.		MOD_RES 262 262 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.	14702039; 17974005; 14574404; 15489334; 19608861; 29563501; 29576527; 29576528; 29476094; 16189514; 23455924; 25416956	14702039; 17974005; 14574404; 15489334; 19608861; 29563501; 29576527; 29576528; 29476094
10135	XXYLT1 C3orf21 PSEC0251	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.28 mM for UDP-alpha-D-xylose {ECO:0000269|PubMed:8982869}; 	2.4.2.n3	CATALYTIC ACTIVITY: UDP-alpha-D-xylose + alpha-D-xylose-(1->3)-beta-D-glucosyl-R = UDP + alpha-D-xylose-(1->3)-alpha-D-xylose-(1->3)-beta-D-glucosyl-R. {ECO:0000269|PubMed:22117070, ECO:0000269|PubMed:8982869}.	BINDING 227 227 UDP-alpha-D-xylose; via amide nitrogen. {ECO:0000250|UniProtKB:Q3U4G3}.; BINDING 290 290 UDP-alpha-D-xylose. {ECO:0000250|UniProtKB:Q3U4G3}.; BINDING 328 328 UDP-alpha-D-xylose; via carbonyl oxygen. {ECO:0000250|UniProtKB:Q3U4G3}.; BINDING 331 331 Substrate glycopeptide. {ECO:0000250|UniProtKB:Q3U4G3}.; BINDING 331 331 UDP-alpha-D-xylose. {ECO:0000250|UniProtKB:Q3U4G3}.; BINDING 360 360 Substrate glycopeptide. {ECO:0000250|UniProtKB:Q3U4G3}.; BINDING 385 385 Substrate glycopeptide. {ECO:0000250|UniProtKB:Q3U4G3}.		COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:8982869}; Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000269|PubMed:8982869}; ;  Note=Has the highest in vitro activity with 20 mM Mn(2+), a concentration entirely out of the physiological range. Can also utilize Mg(2+), suggesting this may be the physiological cofactor. {ECO:0000269|PubMed:8982869};	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 7.2. {ECO:0000269|PubMed:8982869};			PSEC0251		O-glycan processing [GO:0016266]	integral component of endoplasmic reticulum membrane [GO:0030176]	integral component of endoplasmic reticulum membrane [GO:0030176]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]	magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]	GO:0000287; GO:0016266; GO:0030145; GO:0030176; GO:0035252	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:22117070}; Single-pass type II membrane protein {ECO:0000269|PubMed:22117070}.			22117070; 14702039; 16303743; 15489334; 8982869; 28422717	22117070; 14702039; 16303743; 15489334; 8982869
10176	XYLB	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=24 uM for D-xylulose {ECO:0000269|PubMed:23179721}; 	2.7.1.17	CATALYTIC ACTIVITY: ATP + D-xylulose = ADP + D-xylulose 5-phosphate. {ECO:0000269|PubMed:23179721}.	BINDING 99 99 Substrate.; BINDING 170 170 Substrate.; BINDING 280 280 Substrate.; BINDING 281 281 Substrate.; BINDING 355 355 ATP.; BINDING 445 445 ATP.								carbohydrate metabolic process [GO:0005975]; D-xylose metabolic process [GO:0042732]; generation of precursor metabolites and energy [GO:0006091]; glucuronate catabolic process to xylulose 5-phosphate [GO:0019640]; xylulose catabolic process [GO:0005998]; xylulose metabolic process [GO:0005997]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; xylulokinase activity [GO:0004856]; carbohydrate metabolic process [GO:0005975]; D-xylose metabolic process [GO:0042732]; generation of precursor metabolites and energy [GO:0006091]; glucuronate catabolic process to xylulose 5-phosphate [GO:0019640]; xylulose catabolic process [GO:0005998]; xylulose metabolic process [GO:0005997]	ATP binding [GO:0005524]; xylulokinase activity [GO:0004856]	GO:0004856; GO:0005524; GO:0005737; GO:0005829; GO:0005975; GO:0005997; GO:0005998; GO:0006091; GO:0019640; GO:0042732				14702039; 16641997; 15489334; 9763671; 21269460; 24275569; 23179721; 20379614; 23027762; 25855559	14702039; 16641997; 15489334; 9763671; 21269460; 24275569; 23179721
10211	YME1L1 FTSH1 YME1L UNQ1868/PRO4304	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.4 mM for ATP {ECO:0000269|PubMed:27786171}; 	3.4.24.-				COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000305|PubMed:26923599}; ;  Note=Binds 1 zinc ion per subunit. {ECO:0000305|PubMed:26923599};				UNQ1868/PRO4304		cell proliferation [GO:0008283]; mitochondrial protein catabolic process [GO:0035694]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; protein hexamerization [GO:0034214]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; cell proliferation [GO:0008283]; mitochondrial protein catabolic process [GO:0035694]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; protein hexamerization [GO:0034214]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]	ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]	GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0006515; GO:0007005; GO:0008237; GO:0008283; GO:0016020; GO:0016021; GO:0016604; GO:0034214; GO:0034982; GO:0035694; GO:0043066; GO:0046872	SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000269|PubMed:10843804, ECO:0000269|PubMed:22262461}. Mitochondrion {ECO:0000269|PubMed:26923599, ECO:0000269|PubMed:27495975}.	PTM: Proteolytically processed by mitochondrial processing peptidase (MPP) to generate the mature form. {ECO:0000269|PubMed:27495975}.		10843804; 12975309; 14702039; 15164054; 15489334; 18076378; 21269460; 22262461; 23186163; 25944712; 26759378; 26923599; 27786171; 27495975; 16385451; 20186120; 20562859; 20711500; 21988832; 22593156; 23455922; 23602568; 24267889; 24344204; 24725412; 25609649; 26496610; 27642048; 27737933	10843804; 12975309; 14702039; 15164054; 15489334; 18076378; 21269460; 22262461; 23186163; 25944712; 26759378; 26923599; 27786171; 27495975
10332	SLC7A6 KIAA0245	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=295 uM for glutamine (in the presence of NaCl) {ECO:0000269|PubMed:10903140}; KM=236 uM for leucine (in the presence of NaCl) {ECO:0000269|PubMed:10903140}; KM=120 uM for arginine (in the presence of NaCl) {ECO:0000269|PubMed:10903140}; KM=138 uM for arginine (in the absence of NaCl) {ECO:0000269|PubMed:10903140}; 				ACTIVITY REGULATION: Arginine transport is strongly inhibited by lysine, glutamate, leucine, glutamine, methionine and histidine, in the presence of Na(+). Also inhibited by protein kinase C (PKC) and treatment with phorbol-12-myristate-13-acetate (PMA). Mutual inhibition is observed when leucine or glutamine is used as substrate. Inhibition of arginine and leucine uptake also occurs when SLC3A2/4F2hc is either truncated at its C-terminus or mutated at critical residues within the terminal 15 amino acids.							cellular amino acid metabolic process [GO:0006520]; leukocyte migration [GO:0050900]; protein-containing complex assembly [GO:0065003]	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; L-amino acid transmembrane transporter activity [GO:0015179]; cellular amino acid metabolic process [GO:0006520]; leukocyte migration [GO:0050900]; protein-containing complex assembly [GO:0065003]	amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; L-amino acid transmembrane transporter activity [GO:0015179]	GO:0005886; GO:0005887; GO:0006520; GO:0015171; GO:0015179; GO:0015297; GO:0016323; GO:0043231; GO:0050900; GO:0065003	SUBCELLULAR LOCATION: Basolateral cell membrane {ECO:0000269|PubMed:15756301, ECO:0000269|PubMed:16785209}; Multi-pass membrane protein {ECO:0000269|PubMed:15756301, ECO:0000269|PubMed:16785209}.		MOD_RES 30 30 Phosphoserine. {ECO:0000250|UniProtKB:Q8BGK6}.	9829974; 9039502; 17974005; 15489334; 11078698; 10903140; 11311135; 11742806; 14603368; 15280038; 15756301; 16785209; 17329401; 17197568; 15901826; 19443642; 21182203; 22007000; 23221699; 24052624; 24142711	9829974; 9039502; 17974005; 15489334; 11078698; 10903140; 11311135; 11742806; 14603368; 15280038; 15756301; 16785209; 17329401; 17197568
10579	TSTD1 KAT	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.0 mM for glutathione {ECO:0000269|PubMed:24981631}; KM=14.0 mM for thiosulfate {ECO:0000269|PubMed:24981631}; KM=0.04 mM for glutathione (in the presence of sulfur dioxygenase) {ECO:0000269|PubMed:24981631}; KM=10.7 mM for thiosulfate (in the presence of sulfur dioxygenase) {ECO:0000269|PubMed:24981631}; KM=11.0 mM for thiosulfate (when glutathione is the acceptor) {ECO:0000269|PubMed:24981631}; KM=10.4 mM for thiosulfate (when cystein is the acceptor) {ECO:0000269|PubMed:24981631}; KM=36.0 mM for thiosulfate (when coenzyme A is the acceptor) {ECO:0000269|PubMed:24981631}; KM=14.01 mM for thiosulfate (when DTT is the acceptor) {ECO:0000269|PubMed:24981631}; KM=12.0 mM for thiosulfate (when cyanide is the acceptor) {ECO:0000269|PubMed:24981631}; KM=1.7 mM for glutathione (when thiosulfate is the acceptor) {ECO:0000269|PubMed:24981631}; KM=2.5 mM for cystein (when thiosulfate is the acceptor) {ECO:0000269|PubMed:24981631}; KM=0.09 mM for coenzyme A (when thiosulfate is the acceptor) {ECO:0000269|PubMed:24981631}; KM=0.12 mM for DTT (when thiosulfate is the acceptor) {ECO:0000269|PubMed:24981631}; KM=0.22 mM for cyanide (when thiosulfate is the acceptor) {ECO:0000269|PubMed:24981631}; 	2.8.1.-	CATALYTIC ACTIVITY: Thiosulfate + glutathione = sulfite + S-sulfanylglutathione + H(+). {ECO:0000269|PubMed:24981631}.		ACTIVITY REGULATION: GSS(-) is a potent inhibitor of TSTD1, since the presence of the sulfur dioxygenase (SDO) strongly increases the TSTD1 catalytic activity (PubMed:24981631). {ECO:0000269|PubMed:24981631}.							sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; thiosulfate-thiol sulfurtransferase activity [GO:0050337]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]	thiosulfate-thiol sulfurtransferase activity [GO:0050337]	GO:0005737; GO:0005829; GO:0036464; GO:0048471; GO:0050337; GO:0070221	SUBCELLULAR LOCATION: Cytoplasm, perinuclear region {ECO:0000269|PubMed:12817473}. Note=Localized around the nuclear membranes.			12817473; 16710414; 15489334; 12665801; 21269460; 22814378; 24981631; 19913121; 20628086; 21845542; 27030575; 29348167; 6361026	12817473; 16710414; 15489334; 12665801; 21269460; 22814378; 24981631
10582	TTBK2 KIAA0847	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=18 uM for RRKDLHDDEEDEAMSIYpA peptide {ECO:0000269|PubMed:21548880}; KM=141 uM for RRKDLHDDEEDEAMSIYA peptide {ECO:0000269|PubMed:21548880}; Vmax=76 umol/min/mg enzyme with RRKDLHDDEEDEAMSIYpA peptide as substrate {ECO:0000269|PubMed:21548880}; Vmax=66 umol/min/mg enzyme with RRKDLHDDEEDEAMSIYA peptide as substrate {ECO:0000269|PubMed:21548880}; 	2.7.11.1	CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein. {ECO:0000269|PubMed:21548880}.	BINDING 50 50 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.								cerebellar granular layer development [GO:0021681]; cerebellar granule cell precursor tangential migration [GO:0021935]; cerebellum development [GO:0021549]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule binding [GO:1904527]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of protein localization to microtubule [GO:1902817]; peptidyl-serine phosphorylation [GO:0018105]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; smoothened signaling pathway [GO:0007224]	centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]	centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinesin binding [GO:0019894]; microtubule plus-end binding [GO:0051010]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; cerebellar granular layer development [GO:0021681]; cerebellar granule cell precursor tangential migration [GO:0021935]; cerebellum development [GO:0021549]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule binding [GO:1904527]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of protein localization to microtubule [GO:1902817]; peptidyl-serine phosphorylation [GO:0018105]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; smoothened signaling pathway [GO:0007224]	ATP binding [GO:0005524]; kinesin binding [GO:0019894]; microtubule plus-end binding [GO:0051010]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]	GO:0000226; GO:0004672; GO:0004674; GO:0005524; GO:0005615; GO:0005634; GO:0005814; GO:0005829; GO:0007026; GO:0007224; GO:0008360; GO:0018105; GO:0019894; GO:0021549; GO:0021681; GO:0021935; GO:0030334; GO:0035869; GO:0036064; GO:0050321; GO:0051010; GO:0060271; GO:0097711; GO:1902817; GO:1904527	SUBCELLULAR LOCATION: Cell projection, cilium {ECO:0000250}. Cytoplasm, cytoskeleton, cilium basal body {ECO:0000250}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriole. Cytoplasm, cytosol. Nucleus. Note=Localizes to the transition zone in primary cilia in response to cell cycle signals that promote ciliogenesis (By similarity). May also be present in cytosol and, at lower level in the nucleus. {ECO:0000250}.		MOD_RES 445 445 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 786 786 Phosphoserine. {ECO:0000244|PubMed:21406692}.; MOD_RES 1103 1103 Phosphoserine. {ECO:0000244|PubMed:23186163}.	14702039; 16572171; 15489334; 10048485; 18037885; 21548880; 21406692; 22863007; 23141541; 23186163; 17344846; 19533200; 26063658; 15148151; 16357211; 17353931; 17574030; 17646400; 17719545; 18694559; 19380743; 19768375; 20379614; 20399632; 20558667; 20562859; 20667868; 21273506; 21422230; 21565611; 21620453; 21725307; 21792235; 22020623; 22179047; 22653444; 22814243; 23141531; 23253480; 23400999; 23747070; 24053599; 24469809; 24982133; 25297623; 25416956; 25473830; 25950000; 26323690; 27607061; 28219405	14702039; 16572171; 15489334; 10048485; 18037885; 21548880; 21406692; 22863007; 23141541; 23186163; 17344846; 19533200; 26063658
10856	SLC22A1 OCT1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.47 mM for metformin {ECO:0000269|PubMed:16272756, ECO:0000269|PubMed:9187257, ECO:0000269|PubMed:9655880}; KM=229 uM for TEA {ECO:0000269|PubMed:16272756, ECO:0000269|PubMed:9187257, ECO:0000269|PubMed:9655880}; KM=14.6 uM for MPP {ECO:0000269|PubMed:16272756, ECO:0000269|PubMed:9187257, ECO:0000269|PubMed:9655880}; Vmax=396 pmol/min/mg enzyme for metformin uptake {ECO:0000269|PubMed:16272756, ECO:0000269|PubMed:9187257, ECO:0000269|PubMed:9655880}; Vmax=2.89 nmol/min/mg enzyme for TEA uptake {ECO:0000269|PubMed:16272756, ECO:0000269|PubMed:9187257, ECO:0000269|PubMed:9655880}; 								SITE 450 450 Involved in affinity and selectivity of cations as well as in translocation. {ECO:0000250}.			dopamine transport [GO:0015872]; drug transmembrane transport [GO:0006855]; epinephrine transport [GO:0048241]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; neurotransmitter transport [GO:0006836]; norepinephrine transport [GO:0015874]; organic cation transport [GO:0015695]; protein homooligomerization [GO:0051260]	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; acetylcholine transmembrane transporter activity [GO:0005277]; monoamine transmembrane transporter activity [GO:0008504]; organic anion transmembrane transporter activity [GO:0008514]; organic cation transmembrane transporter activity [GO:0015101]; protein homodimerization activity [GO:0042803]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; secondary active organic cation transmembrane transporter activity [GO:0008513]; dopamine transport [GO:0015872]; drug transmembrane transport [GO:0006855]; epinephrine transport [GO:0048241]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; neurotransmitter transport [GO:0006836]; norepinephrine transport [GO:0015874]; organic cation transport [GO:0015695]; protein homooligomerization [GO:0051260]	acetylcholine transmembrane transporter activity [GO:0005277]; monoamine transmembrane transporter activity [GO:0008504]; organic anion transmembrane transporter activity [GO:0008514]; organic cation transmembrane transporter activity [GO:0015101]; protein homodimerization activity [GO:0042803]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; secondary active organic cation transmembrane transporter activity [GO:0008513]	GO:0005277; GO:0005886; GO:0005887; GO:0006836; GO:0006855; GO:0008504; GO:0008513; GO:0008514; GO:0010248; GO:0015101; GO:0015651; GO:0015695; GO:0015872; GO:0015874; GO:0016020; GO:0016323; GO:0042803; GO:0048241; GO:0051260	SUBCELLULAR LOCATION: Basolateral cell membrane {ECO:0000269|PubMed:16263091}; Multi-pass membrane protein {ECO:0000269|PubMed:16263091}.	PTM: Phosphorylated. {ECO:0000250}.	MOD_RES 333 333 Phosphoserine. {ECO:0000250|UniProtKB:O08966}.; MOD_RES 541 541 Phosphothreonine. {ECO:0000244|PubMed:24275569}.	9260930; 9187257; 11388889; 14702039; 14574404; 15489334; 9655880; 11408531; 15389554; 16263091; 16272756; 16436500; 16581093; 17635184; 24275569; 12439218; 12719534; 14697261; 15499200; 11543633; 12439217; 15135235; 15817714; 16141367; 16597591; 16788146; 17111267; 17220237; 17393420; 17476361; 17568400; 17609683; 17701831; 17934801; 17971819; 18483382; 18559609; 18669873; 19021069; 19141712; 19141860; 19336679; 19381165; 19536068; 19584153; 19591196; 19833842; 19898263; 19950608; 19954617; 20103563; 20143233; 20173083; 20363215; 20371711; 20379614; 20424473; 20429798; 20445576; 20660041; 20679960; 20680652; 20682687; 20720558; 20921968; 20960210; 21044367; 21104302; 21988832; 22202118; 22207690; 22483271; 22498645; 22508387; 22718759; 22735389; 22810231; 22875535; 22913740; 23144633; 23223357; 23272163; 23440379; 23532667; 23545524; 23612856; 23836662; 23859569; 23922447; 23929842; 24117365; 24352644; 24399729; 24469953; 24524306; 24530383; 24533710; 24688079; 24780098; 25155932; 25358338; 25582574; 25753371; 25883089; 26354214; 26546461; 26605869; 26657401; 26872727; 26920453; 27082504; 27207652; 27278216; 27407018; 27610747; 28154092; 28714373; 28942964; 29236753; 29949790	9260930; 9187257; 11388889; 14702039; 14574404; 15489334; 9655880; 11408531; 15389554; 16263091; 16272756; 16436500; 16581093; 17635184; 24275569; 12439218; 12719534; 14697261; 15499200
10869	SLC25A36	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=1.19 mM for UTP (at 25 degrees Celsius) {ECO:0000269|PubMed:25320081}; KM=0.21 mM for CTP (at 25 degrees Celsius) {ECO:0000269|PubMed:25320081}; KM=2.5 mM for TTP (at 25 degrees Celsius) {ECO:0000269|PubMed:25320081}; KM=0.23 mM for GTP (at 25 degrees Celsius) {ECO:0000269|PubMed:25320081}; Vmax=30.7 umol/min/g enzyme toward UTP (at 25 degrees Celsius) {ECO:0000269|PubMed:25320081}; Vmax=51.2 umol/min/g enzyme toward CTP (at 25 degrees Celsius) {ECO:0000269|PubMed:25320081}; Vmax=8 umol/min/g enzyme toward TTP (at 25 degrees Celsius) {ECO:0000269|PubMed:25320081}; Vmax=23.6 umol/min/g enzyme toward GTP (at 25 degrees Celsius) {ECO:0000269|PubMed:25320081}; Note=The inhibitory constants (Ki) of these compounds are 1.3 um (UTP), 224 um (CTP), 276 um (GTP), and 181 um (ITP). CTP is the best substrate. {ECO:0000269|PubMed:25320081};											mitochondrial genome maintenance [GO:0000002]; mitochondrial transport [GO:0006839]; mitochondrion organization [GO:0007005]; pyrimidine nucleotide import into mitochondrion [GO:1990519]; pyrimidine nucleotide transport [GO:0006864]; regulation of mitochondrial membrane potential [GO:0051881]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; pyrimidine nucleotide transmembrane transporter activity [GO:0015218]; mitochondrial genome maintenance [GO:0000002]; mitochondrial transport [GO:0006839]; mitochondrion organization [GO:0007005]; pyrimidine nucleotide import into mitochondrion [GO:1990519]; pyrimidine nucleotide transport [GO:0006864]; regulation of mitochondrial membrane potential [GO:0051881]	pyrimidine nucleotide transmembrane transporter activity [GO:0015218]	GO:0000002; GO:0005739; GO:0005743; GO:0006839; GO:0006864; GO:0007005; GO:0015218; GO:0016021; GO:0051881; GO:1990519	SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000305|PubMed:25320081}; Multi-pass membrane protein {ECO:0000255}.			14702039; 16641997; 15489334; 11230166; 17210862; 25320081; 16169070; 19010793; 20877624; 20944657; 23266187	14702039; 16641997; 15489334; 11230166; 17210862; 25320081
10883	SLC29A1 ENT1	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=0.62 mM for adenosine {ECO:0000269|PubMed:12527552}; Note=Vmax for adenosine uptake is about the same for SLC29A1 and SLC29A2.;											cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; excitatory postsynaptic potential [GO:0060079]; lactation [GO:0007595]; neurotransmitter reuptake [GO:0098810]; nucleobase-containing compound metabolic process [GO:0006139]; nucleoside transport [GO:0015858]; sleep [GO:0030431]; uridine transport [GO:0015862]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; nucleoside transmembrane transporter activity [GO:0005337]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; excitatory postsynaptic potential [GO:0060079]; lactation [GO:0007595]; neurotransmitter reuptake [GO:0098810]; nucleobase-containing compound metabolic process [GO:0006139]; nucleoside transport [GO:0015858]; sleep [GO:0030431]; uridine transport [GO:0015862]	nucleoside transmembrane transporter activity [GO:0005337]	GO:0005337; GO:0005886; GO:0005887; GO:0006139; GO:0007595; GO:0015858; GO:0015862; GO:0016020; GO:0016323; GO:0016324; GO:0030431; GO:0060079; GO:0071333; GO:0071456; GO:0098793; GO:0098794; GO:0098810	SUBCELLULAR LOCATION: Basolateral cell membrane; Multi-pass membrane protein. Apical cell membrane; Multi-pass membrane protein. Cell membrane; Multi-pass membrane protein. Note=Predominantly localized in the basolateral membrane in polarized MDCK cells.	PTM: Glycosylated. {ECO:0000269|PubMed:19349973}.	MOD_RES 254 254 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 269 269 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 273 273 Phosphoserine. {ECO:0000244|PubMed:23186163}.	8986748; 10755314; 12384580; 12527552; 14702039; 14574404; 15489334; 18669648; 19349973; 23219802; 23186163; 25944712; 16959974; 14667819; 19874574; 21516116; 21656680; 25725289; 26638075; 9478986	8986748; 10755314; 12384580; 12527552; 14702039; 14574404; 15489334; 18669648; 19349973; 23219802; 23186163; 25944712; 16959974
10886	SLC29A2 DER12 ENT2 HNP36	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=0.2 mM for uridine {ECO:0000269|PubMed:12527552, ECO:0000269|PubMed:9396714}; KM=0.75 mM for adenosine {ECO:0000269|PubMed:12527552, ECO:0000269|PubMed:9396714}; Note=Vmax for adenosine uptake is about the same for SLC29A1 and SLC29A2.;											cell proliferation [GO:0008283]; neurotransmitter reuptake [GO:0098810]; nucleobase-containing compound metabolic process [GO:0006139]; nucleoside transport [GO:0015858]	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; presynapse [GO:0098793]	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; nucleoside transmembrane transporter activity [GO:0005337]; cell proliferation [GO:0008283]; neurotransmitter reuptake [GO:0098810]; nucleobase-containing compound metabolic process [GO:0006139]; nucleoside transport [GO:0015858]	nucleoside transmembrane transporter activity [GO:0005337]	GO:0005337; GO:0005730; GO:0005886; GO:0005887; GO:0006139; GO:0008283; GO:0015858; GO:0016323; GO:0031965; GO:0098793; GO:0098810	SUBCELLULAR LOCATION: Basolateral cell membrane {ECO:0000269|PubMed:12527552}; Multi-pass membrane protein {ECO:0000269|PubMed:12527552}. Nucleus membrane {ECO:0000269|PubMed:12527552}; Multi-pass membrane protein {ECO:0000269|PubMed:12527552}. Note=Localized at the basolateral cell membrane in polarized MDCK cells.		MOD_RES 252 252 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692}.	7639753; 9396714; 9478986; 12527552; 14702039; 16554811; 15489334; 12590919; 19413330; 20068231; 21406692; 23186163; 16214850; 12006583; 12820662; 15386342; 15644498; 15649894; 16924660; 17921321; 17926640; 18635603; 18703227; 18945750; 19105964; 19297449; 20392501; 21156465; 21516116; 21822668; 23590299; 23639800; 27160886; 28218790; 8986748	7639753; 9396714; 9478986; 12527552; 14702039; 16554811; 15489334; 12590919; 19413330; 20068231; 21406692; 23186163; 16214850
10892	SLC36A4 PAT4	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=3.1 uM for L-proline {ECO:0000269|PubMed:21097500}; KM=1.7 uM for L-tryptophan {ECO:0000269|PubMed:21097500}; 						BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 7.4 (for proline transport). {ECO:0000269|PubMed:21097500};					L-alanine transport [GO:0015808]; L-proline import across plasma membrane [GO:1904271]; L-tryptophan transmembrane transport [GO:1904556]; proline transport [GO:0015824]; tryptophan transport [GO:0015827]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; L-alanine transmembrane transporter activity [GO:0015180]; L-proline transmembrane transporter activity [GO:0015193]; L-tryptophan transmembrane transporter activity [GO:0015196]; symporter activity [GO:0015293]; L-alanine transport [GO:0015808]; L-proline import across plasma membrane [GO:1904271]; L-tryptophan transmembrane transport [GO:1904556]; proline transport [GO:0015824]; tryptophan transport [GO:0015827]	L-alanine transmembrane transporter activity [GO:0015180]; L-proline transmembrane transporter activity [GO:0015193]; L-tryptophan transmembrane transporter activity [GO:0015196]; symporter activity [GO:0015293]	GO:0005774; GO:0005886; GO:0015180; GO:0015193; GO:0015196; GO:0015293; GO:0015808; GO:0015824; GO:0015827; GO:0016021; GO:1904271; GO:1904556	SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.		MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:22814378}.	14702039; 15489334; 21097500; 22814378; 20498635; 21656680; 26434594	14702039; 15489334; 21097500; 22814378
10895	SLC35B2 PAPST1 PSEC0149	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.8 uM for PAPS {ECO:0000269|PubMed:12716889}; 									PSEC0149		3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; 3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; 3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]	3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]	GO:0000139; GO:0005794; GO:0016020; GO:0016021; GO:0030173; GO:0030176; GO:0043123; GO:0046963; GO:0046964; GO:0050428	SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000269|PubMed:12716889}; Multi-pass membrane protein {ECO:0000269|PubMed:12716889}.		MOD_RES 427 427 Phosphoserine. {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.	12716889; 12761501; 14702039; 16303743; 14574404; 15489334; 18691976; 18669648; 19413330; 20068231; 21269460; 23186163; 25944712; 16492677; 17353931; 19773279; 20978009; 24576181; 25124574; 8619989	12716889; 12761501; 14702039; 16303743; 14574404; 15489334; 18691976; 18669648; 19413330; 20068231; 21269460; 23186163; 25944712
10908	SRD5A2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.9 uM for testosterone (at pH 6.0) {ECO:0000269|PubMed:10898110}; KM=8 uM for NADPH (at pH 6.0) {ECO:0000269|PubMed:10898110}; Vmax=1.9 nmol/min/mg enzyme with testosterone as substrate with NADPH as cofactor (at pH 6.0) {ECO:0000269|PubMed:10898110}; 	1.3.1.22	CATALYTIC ACTIVITY: A 3-oxo-5-alpha-steroid + NADP(+) = a 3-oxo-Delta(4)-steroid + NADPH. {ECO:0000269|PubMed:10898110}.				BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimally active at acidic pHs.;					androgen biosynthetic process [GO:0006702]; androgen metabolic process [GO:0008209]; biphenyl metabolic process [GO:0018879]; bone development [GO:0060348]; cell-cell signaling [GO:0007267]; cell differentiation [GO:0030154]; dibenzo-p-dioxin metabolic process [GO:0018894]; female genitalia development [GO:0030540]; hippocampus development [GO:0021766]; hypothalamus development [GO:0021854]; male genitalia development [GO:0030539]; male gonad development [GO:0008584]; phthalate metabolic process [GO:0018963]; progesterone metabolic process [GO:0042448]; response to drug [GO:0042493]; response to follicle-stimulating hormone [GO:0032354]; response to nutrient levels [GO:0031667]; response to peptide hormone [GO:0043434]; response to steroid hormone [GO:0048545]; response to testosterone [GO:0033574]; steroid catabolic process [GO:0006706]; testosterone biosynthetic process [GO:0061370]	cell body fiber [GO:0070852]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; organelle membrane [GO:0031090]	cell body fiber [GO:0070852]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; organelle membrane [GO:0031090]; 3-oxo-5-alpha-steroid 4-dehydrogenase activity [GO:0003865]; amide binding [GO:0033218]; cholestenone 5-alpha-reductase activity [GO:0047751]; sterol 5-alpha reductase activity [GO:0009917]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283]; androgen biosynthetic process [GO:0006702]; androgen metabolic process [GO:0008209]; biphenyl metabolic process [GO:0018879]; bone development [GO:0060348]; cell differentiation [GO:0030154]; cell-cell signaling [GO:0007267]; dibenzo-p-dioxin metabolic process [GO:0018894]; female genitalia development [GO:0030540]; hippocampus development [GO:0021766]; hypothalamus development [GO:0021854]; male genitalia development [GO:0030539]; male gonad development [GO:0008584]; phthalate metabolic process [GO:0018963]; progesterone metabolic process [GO:0042448]; response to drug [GO:0042493]; response to follicle-stimulating hormone [GO:0032354]; response to nutrient levels [GO:0031667]; response to peptide hormone [GO:0043434]; response to steroid hormone [GO:0048545]; response to testosterone [GO:0033574]; steroid catabolic process [GO:0006706]; testosterone biosynthetic process [GO:0061370]	3-oxo-5-alpha-steroid 4-dehydrogenase activity [GO:0003865]; amide binding [GO:0033218]; cholestenone 5-alpha-reductase activity [GO:0047751]; sterol 5-alpha reductase activity [GO:0009917]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283]	GO:0003865; GO:0005789; GO:0006702; GO:0006706; GO:0007267; GO:0008209; GO:0008584; GO:0009917; GO:0016021; GO:0018879; GO:0018894; GO:0018963; GO:0021766; GO:0021854; GO:0030154; GO:0030283; GO:0030539; GO:0030540; GO:0031090; GO:0031667; GO:0032354; GO:0033218; GO:0033574; GO:0042448; GO:0042493; GO:0043025; GO:0043434; GO:0047751; GO:0048545; GO:0060348; GO:0061370; GO:0070852	SUBCELLULAR LOCATION: Microsome membrane; Multi-pass membrane protein. Endoplasmic reticulum membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.			1944596; 1505484; 14702039; 15489334; 1522235; 7554313; 8626825; 8768837; 9208814; 9843052; 9745434; 10501358; 10718838; 10999800; 10898110; 11927504; 12843198; 14560315; 15528927; 15064320; 16181229; 15770495; 16098368; 11164181; 11303586; 11355945; 11381197; 11440959; 11547131; 11571725; 11588134; 11751447; 11845321; 11847524; 11869378; 11903314; 12042668; 12100746; 12111704; 12115497; 12137870; 12164325; 12210487; 12370109; 12446983; 12670724; 12712437; 12738739; 12746845; 12771801; 12815006; 12869400; 12949937; 12971967; 14594182; 14652280; 14693733; 14739525; 15061984; 15136785; 15201804; 15212687; 15241822; 15266301; 15326487; 15337247; 15389785; 15477877; 15538746; 15711606; 15733480; 16018939; 16029630; 16039774; 16174723; 16325991; 16487406; 16608396; 16716118; 16736621; 16818707; 16821341; 16849416; 16859836; 17108148; 17136762; 17220347; 17328668; 17376218; 17448593; 17507624; 17588204; 17609295; 17669147; 17785571; 17823934; 17986282; 18000232; 18086758; 18097518; 18163429; 18258185; 18268111; 18306354; 18314109; 18350250; 18391525; 18391540; 18431743; 18469342; 18483391; 18495332; 18501301; 18503826; 18566991; 18717241; 18722876; 18767927; 18780294; 18949357; 19064572; 19125422; 19215786; 19246976; 19267353; 19383266; 19443907; 19492581; 19505920; 19574343; 19760631; 19846565; 19913121; 19914946; 19926884; 19956849; 19962986; 20019388; 20056642; 20059664; 20132346; 20173016; 20179965; 20200332; 20214802; 20215396; 20381444; 20511729; 20628086; 20634197; 20734064; 20736251; 20800085; 20855474; 21037542; 21177315; 21218640; 21402750; 21511288; 21530059; 21540559; 21557268; 21627373; 21631525; 21676395; 21714467; 21715084; 22272144; 22362597; 22453073; 22486281; 22509838; 22707254; 22735779; 23044880; 23112260; 23277398; 23329752; 2339109; 23505265; 23664981; 23729601; 23867117; 23953348; 24012728; 24244276; 24277450; 24365257; 24412121; 24665940; 24737579; 24810473; 25310105; 25598933; 25700986; 25735326; 25974403; 26092425; 26169017; 26174685; 26332453; 26345832; 26751392; 26761946; 26855069; 26930261; 27051040; 27086719; 27224879; 27848231; 27849622; 28347315; 28397209; 28410957; 28489754; 28544750; 28663096; 28713005; 28940538; 28947209; 29080015; 29084161; 29187470; 9138662; 9536209	1944596; 1505484; 14702039; 15489334; 1522235; 7554313; 8626825; 8768837; 9208814; 9843052; 9745434; 10501358; 10718838; 10999800; 10898110; 11927504; 12843198; 14560315; 15528927; 15064320; 16181229; 15770495; 16098368
10911	SLC4A7 BT NBC2 NBC2B NBC3 NBCn1 SBC2 SLC4A6	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=24 mM for external sodium {ECO:0000269|PubMed:10347222}; 				ACTIVITY REGULATION: Transporter activity is regulated by CA2/carbonic anhydrase 2, cAMP and PKA. Insensitive to stilbene derivatives. PubMed:10347222 states it is inhibited by 5-(N-ethyl-N-isopropyl)-amiloride (EIPA).							auditory receptor cell development [GO:0060117]; bicarbonate transport [GO:0015701]; regulation of intracellular pH [GO:0051453]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; synapse [GO:0045202]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; synapse [GO:0045202]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; auditory receptor cell development [GO:0060117]; bicarbonate transport [GO:0015701]; regulation of intracellular pH [GO:0051453]	inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]	GO:0005452; GO:0005886; GO:0005887; GO:0008510; GO:0015701; GO:0016021; GO:0016323; GO:0016324; GO:0031410; GO:0032420; GO:0045202; GO:0051453; GO:0060117	SUBCELLULAR LOCATION: Basolateral cell membrane; Multi-pass membrane protein. Apical cell membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}. Cell projection, stereocilium {ECO:0000250}. Note=Also described at the apical cell membrane. Localizes to the stereocilia of cochlear outer hair cells and to the lateral membrane of cochlear inner hair cells (By similarity). {ECO:0000250}.		MOD_RES 52 52 Phosphoserine. {ECO:0000250|UniProtKB:Q8BTY2}.; MOD_RES 55 55 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 84 84 Phosphoserine. {ECO:0000250|UniProtKB:Q9R1N3}.; MOD_RES 150 150 Phosphoserine. {ECO:0000250|UniProtKB:Q9R1N3}.; MOD_RES 233 233 Phosphoserine. {ECO:0000250|UniProtKB:Q8BTY2}.; MOD_RES 242 242 Phosphoserine. {ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 382 382 Phosphoserine. {ECO:0000250|UniProtKB:Q8BTY2}.; MOD_RES 400 400 Phosphoserine. {ECO:0000250|UniProtKB:Q9R1N3}.; MOD_RES 403 403 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 407 407 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 556 556 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 557 557 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1167 1167 Phosphothreonine. {ECO:0000244|PubMed:18220336, ECO:0000244|PubMed:19690332}.; MOD_RES 1176 1176 Phosphoserine. {ECO:0000244|PubMed:18220336, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231}.; MOD_RES 1213 1213 Phosphoserine. {ECO:0000244|PubMed:18669648}.	9610397; 10347222; 17974005; 16641997; 12403779; 12444018; 14736710; 15144186; 16301216; 17081983; 18220336; 18669648; 19448079; 19349973; 19690332; 20068231; 21406692; 23186163; 25944712; 10362779; 10978526; 11305939; 11788353; 14578046; 15324660; 17353931; 17624982; 19330027; 20095854; 20145138; 20542029; 21224233; 22120673; 22383045; 22907202; 23117855; 24788003; 25241983; 25249183; 25609649; 26496610; 26638075; 27609814; 27784683; 28087731; 28087757	9610397; 10347222; 17974005; 16641997; 12403779; 12444018; 14736710; 15144186; 16301216; 17081983; 18220336; 18669648; 19448079; 19349973; 19690332; 20068231; 21406692; 23186163; 25944712
10933	SELENBP1 SBP	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=4.8 nM for methanethiol {ECO:0000269|PubMed:29255262}; 	1.8.3.4	CATALYTIC ACTIVITY: Methanethiol + O(2) + H(2)O = formaldehyde + H(2)S + H(2)O(2). {ECO:0000269|PubMed:29255262}.					PATHWAY: Organosulfur degradation. {ECO:0000269|PubMed:29255262}.				protein transport [GO:0015031]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; methanethiol oxidase activity [GO:0018549]; selenium binding [GO:0008430]; protein transport [GO:0015031]	methanethiol oxidase activity [GO:0018549]; selenium binding [GO:0008430]	GO:0001650; GO:0005615; GO:0005730; GO:0005829; GO:0008430; GO:0015031; GO:0016020; GO:0018549; GO:0070062	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:14991897}. Cytoplasm, cytosol {ECO:0000269|PubMed:14991897, ECO:0000269|PubMed:16223876}. Membrane {ECO:0000250|UniProtKB:Q8VIF7}; Peripheral membrane protein {ECO:0000250|UniProtKB:Q8VIF7}. Note=May associate with Golgi membrane (By similarity). May associate with the membrane of autophagosomes (By similarity). {ECO:0000250|UniProtKB:Q8VIF7}.	PTM: Phosphorylated. {ECO:0000305|PubMed:14991897}.; PTM: The N-terminus is blocked. {ECO:0000250}.	MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:22814378}.; MOD_RES 111 111 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 371 371 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 467 467 Phosphoserine. {ECO:0000250|UniProtKB:P17563}.	9027582; 14702039; 16710414; 15489334; 9679983; 14991897; 16223876; 16380993; 16645984; 19118533; 21269460; 22814378; 24275569; 29255262; 15108003; 16169070; 16189514; 18163446; 18435490; 19367725; 19596560; 19615732; 19896693; 19924303; 20332323; 20354826; 20480265; 20530237; 20615253; 20628624; 20706999; 21143902; 21338716; 21497372; 21900206; 22072582; 23416715; 23483240; 23704933; 23977169; 24737289; 25227434; 25974208; 25993660; 26241353; 26593911; 26956891; 27965399	9027582; 14702039; 16710414; 15489334; 9679983; 14991897; 16223876; 16380993; 16645984; 19118533; 21269460; 22814378; 24275569; 29255262
10958	SLC25A24 APC1 MCSC1 SCAMC1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.97 mM for AMP {ECO:0000269|PubMed:15123600}; KM=0.3 mM for ADP {ECO:0000269|PubMed:15123600}; KM=0.33 mM for ATP {ECO:0000269|PubMed:15123600}; KM=0.2 mM for ATP-Mg {ECO:0000269|PubMed:15123600}; KM=1.64 mM for Pi {ECO:0000269|PubMed:15123600}; Vmax=337 umol/min/g enzyme with AMP as substrate {ECO:0000269|PubMed:15123600}; Vmax=345 umol/min/g enzyme with ADP as substrate {ECO:0000269|PubMed:15123600}; Vmax=320 umol/min/g enzyme with ATP as substrate {ECO:0000269|PubMed:15123600}; Vmax=365 umol/min/g enzyme with ATP-Mg as substrate {ECO:0000269|PubMed:15123600}; Vmax=380 umol/min/g enzyme with Pi as substrate {ECO:0000269|PubMed:15123600}; 											ATP transport [GO:0015867]; cellular response to calcium ion [GO:0071277]; cellular response to oxidative stress [GO:0034599]; mitochondrial transport [GO:0006839]; regulation of cell death [GO:0010941]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ADP transmembrane transporter activity [GO:0015217]; ATP transmembrane transporter activity [GO:0005347]; calcium ion binding [GO:0005509]; ATP transport [GO:0015867]; cellular response to calcium ion [GO:0071277]; cellular response to oxidative stress [GO:0034599]; mitochondrial transport [GO:0006839]; regulation of cell death [GO:0010941]	ADP transmembrane transporter activity [GO:0015217]; ATP transmembrane transporter activity [GO:0005347]; calcium ion binding [GO:0005509]	GO:0005347; GO:0005509; GO:0005739; GO:0005743; GO:0006839; GO:0010941; GO:0015217; GO:0015867; GO:0016021; GO:0034599; GO:0071277	SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000269|PubMed:15054102, ECO:0000269|PubMed:15123600, ECO:0000269|PubMed:22015608}; Multi-pass membrane protein {ECO:0000269|PubMed:15054102, ECO:0000269|PubMed:15123600, ECO:0000269|PubMed:22015608}.		MOD_RES 320 320 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8BMD8}.; MOD_RES 320 320 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8BMD8}.; MOD_RES 336 336 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 437 437 N6-acetyllysine; alternate. {ECO:0000244|PubMed:19608861}.; MOD_RES 437 437 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8BMD8}.	15054102; 15123600; 14702039; 16710414; 15489334; 19608861; 21269460; 22015608; 25944712; 24332718; 29100093; 19463016; 20379614; 20877624; 23260140; 23266187; 23288039; 23606334; 25599384; 26164100; 26496610; 29100094	15054102; 15123600; 14702039; 16710414; 15489334; 19608861; 21269460; 22015608; 25944712; 24332718; 29100093
10960	SLC25A23 APC2 MCSC2 SCAMC3	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.3 mM for AMP {ECO:0000269|PubMed:15123600}; KM=0.54 mM for ADP {ECO:0000269|PubMed:15123600}; KM=0.31 mM for ATP {ECO:0000269|PubMed:15123600}; KM=0.22 mM for ATP-Mg {ECO:0000269|PubMed:15123600}; KM=1.4 mM for Pi {ECO:0000269|PubMed:15123600}; Vmax=68 umol/min/g enzyme with AMP as substrate {ECO:0000269|PubMed:15123600}; Vmax=73 umol/min/g enzyme with ADP as substrate {ECO:0000269|PubMed:15123600}; Vmax=65 umol/min/g enzyme with ATP as substrate {ECO:0000269|PubMed:15123600}; Vmax=79 umol/min/g enzyme with ATP-Mg as substrate {ECO:0000269|PubMed:15123600}; Vmax=70 umol/min/g enzyme with Pi as substrate {ECO:0000269|PubMed:15123600}; 											calcium import into the mitochondrion [GO:0036444]; cellular response to calcium ion [GO:0071277]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial transport [GO:0006839]; regulation of cellular respiration [GO:0043457]; regulation of oxidative phosphorylation [GO:0002082]; regulation of sequestering of calcium ion [GO:0051282]; urea homeostasis [GO:0097274]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ADP transmembrane transporter activity [GO:0015217]; ATP transmembrane transporter activity [GO:0005347]; calcium ion binding [GO:0005509]; calcium import into the mitochondrion [GO:0036444]; cellular response to calcium ion [GO:0071277]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial transport [GO:0006839]; regulation of cellular respiration [GO:0043457]; regulation of oxidative phosphorylation [GO:0002082]; regulation of sequestering of calcium ion [GO:0051282]; urea homeostasis [GO:0097274]	ADP transmembrane transporter activity [GO:0015217]; ATP transmembrane transporter activity [GO:0005347]; calcium ion binding [GO:0005509]	GO:0002082; GO:0005347; GO:0005509; GO:0005739; GO:0005743; GO:0006839; GO:0006851; GO:0015217; GO:0016021; GO:0036444; GO:0043457; GO:0051282; GO:0071277; GO:0097274	SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000269|PubMed:15054102, ECO:0000269|PubMed:15123600, ECO:0000269|PubMed:15716113}; Multi-pass membrane protein {ECO:0000269|PubMed:15054102, ECO:0000269|PubMed:15123600, ECO:0000269|PubMed:15716113}.			15054102; 15123600; 15716113; 14702039; 15489334; 15801905; 24430870; 20706999; 20877624; 23266187; 25416956; 27993893; 28695448	15054102; 15123600; 15716113; 14702039; 15489334; 15801905; 24430870
10991	XPNPEP1 XPNPEPL XPNPEPL1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=100.6 uM for bradykinin {ECO:0000269|PubMed:11106490, ECO:0000269|PubMed:18515364}; KM=308 uM for the tripeptide Arg-Pro-Pro {ECO:0000269|PubMed:11106490, ECO:0000269|PubMed:18515364}; 	3.4.11.9	CATALYTIC ACTIVITY: Release of any N-terminal amino acid, including proline, that is linked to proline, even from a dipeptide or tripeptide. {ECO:0000269|PubMed:11106490, ECO:0000269|PubMed:18515364}.	BINDING 77 77 Substrate. {ECO:0000250|UniProtKB:O44750}.; BINDING 395 395 Substrate; via tele nitrogen. {ECO:0000250|UniProtKB:O44750}.; BINDING 489 489 Substrate; via tele nitrogen. {ECO:0000250|UniProtKB:O44750}.; BINDING 498 498 Substrate; via tele nitrogen. {ECO:0000250|UniProtKB:O44750}.; BINDING 523 523 Substrate. {ECO:0000250|UniProtKB:O44750}.	ACTIVITY REGULATION: Inhibited by apstatin and the metal ion chelators EDTA and 1,10-phenanthroline. Partially inhibited by dithiothreitol. Not inhibited by enalaprilat or amastatin. {ECO:0000269|PubMed:11106490}.	COFACTOR: Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000269|PubMed:11106490, ECO:0000269|PubMed:18515364}; ;  Note=Binds 2 manganese ions per subunit. {ECO:0000269|PubMed:11106490, ECO:0000269|PubMed:18515364};	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 8.2. {ECO:0000269|PubMed:11106490, ECO:0000269|PubMed:18515364};					bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]; bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508]	aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]	GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0010815; GO:0030145; GO:0042803; GO:0070006; GO:0070062	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.		MOD_RES 304 304 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.	9465902; 10871044; 11106490; 14702039; 17974005; 15164054; 15489334; 12665801; 19608861; 21269460; 22814378; 24275569; 18515364; 16169070; 16385451; 17043677; 19126663; 20379614; 20460270; 21052031; 21900206; 29351301	9465902; 10871044; 11106490; 14702039; 17974005; 15164054; 15489334; 12665801; 19608861; 21269460; 22814378; 24275569; 18515364
10992	XPNPEP2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.837 mM for Arg-Pro-Pro {ECO:0000269|PubMed:15361070}; KM=75 uM for Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg (bradykinin) {ECO:0000269|PubMed:15361070}; KM=56 uM for Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe (bradykinin[1-8]) {ECO:0000269|PubMed:15361070}; KM=18 uM for synthetic fluorescent substrate Lys(Dnp)-Pro-Pro-Gly-Phe-Ser-Pro-Lys(Abz)NH(2) {ECO:0000269|PubMed:15361070}; KM=20 uM for synthetic fluorescent substrate Lys(Dnp)-Pro-Pro-Gly-Lys(Abz)NH(2) {ECO:0000269|PubMed:15361070}; KM=19 uM for synthetic fluorescent substrate Lys(Dnp)-Pro-Pro-Lys(Abz)NH(2) {ECO:0000269|PubMed:15361070}; 	3.4.11.9	CATALYTIC ACTIVITY: Release of any N-terminal amino acid, including proline, that is linked to proline, even from a dipeptide or tripeptide. {ECO:0000269|PubMed:15361070}.	BINDING 116 116 Substrate. {ECO:0000250|UniProtKB:O44750}.; BINDING 430 430 Substrate; via tele nitrogen. {ECO:0000250|UniProtKB:O44750}.; BINDING 524 524 Substrate; via tele nitrogen. {ECO:0000250|UniProtKB:O44750}.; BINDING 533 533 Substrate; via tele nitrogen. {ECO:0000250|UniProtKB:O44750}.; BINDING 555 555 Substrate. {ECO:0000250|UniProtKB:O44750}.	ACTIVITY REGULATION: Inhibited by apstatin and the chelating agent 1,10-phenanthroline. Also inhibited by high concentrations of Zn(2+). Not significantly inhibited by bestatin or phosphoramidon. {ECO:0000269|PubMed:15361070}.	COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250|UniProtKB:Q95333}; 	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 7.4. {ECO:0000269|PubMed:15361070};						anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]	anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]	aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]	GO:0004177; GO:0005576; GO:0005886; GO:0016020; GO:0031225; GO:0046872; GO:0070006; GO:0070062	SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q95333}; Lipid-anchor, GPI-anchor {ECO:0000250|UniProtKB:Q95333}.	PTM: N-glycosylated. {ECO:0000269|PubMed:15361070}.		9375790; 15772651; 15489334; 16175507; 15361070; 20625347; 21898657; 11072085; 17003818; 18158172; 18515364; 19178938; 21052031; 23276181; 2443973; 27788882; 28670957; 3422494	9375790; 15772651; 15489334; 16175507; 15361070; 20625347; 21898657
10993	XPNPEP3	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.62 mM for Met-Pro-Ala {ECO:0000269|PubMed:28476889}; KM=2.45 mM for Leu-Pro-Ala {ECO:0000269|PubMed:28476889}; KM=3.06 mM for Phe-Pro-Ala {ECO:0000269|PubMed:28476889}; KM=0.55 mM for Tyr-Pro-Ala {ECO:0000269|PubMed:28476889}; KM=4.91 mM for Tyr-Ser-Ser {ECO:0000269|PubMed:28476889}; KM=4.20 mM for Tyr-Ala-Ala {ECO:0000269|PubMed:28476889}; KM=3.74 mM for Tyr-Ser-Ser-Ala-Ala-Ala-Ala {ECO:0000269|PubMed:28476889}; 	3.4.11.9	CATALYTIC ACTIVITY: Release of any N-terminal amino acid, including proline, that is linked to proline, even from a dipeptide or tripeptide. {ECO:0000269|PubMed:25609706, ECO:0000269|PubMed:28476889}.	BINDING 300 300 Substrate. {ECO:0000244|PDB:5X49, ECO:0000269|PubMed:28476889}.; BINDING 331 331 Substrate. {ECO:0000244|PDB:5X49, ECO:0000269|PubMed:28476889}.; BINDING 342 342 Substrate. {ECO:0000244|PDB:5X49, ECO:0000269|PubMed:28476889, ECO:0000305|PubMed:25609706}.; BINDING 424 424 Substrate. {ECO:0000244|PDB:5X49, ECO:0000269|PubMed:28476889}.; BINDING 431 431 Substrate. {ECO:0000244|PDB:5X49, ECO:0000269|PubMed:28476889}.; BINDING 451 451 Substrate. {ECO:0000244|PDB:5X49, ECO:0000269|PubMed:28476889}.; BINDING 475 475 Substrate. {ECO:0000244|PDB:5X49, ECO:0000269|PubMed:28476889, ECO:0000305|PubMed:25609706}.		COFACTOR: Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000269|PubMed:28476889}; ;  Note=Binds 2 manganese ions per subunit. {ECO:0000269|PubMed:28476889};						glomerular filtration [GO:0003094]; protein processing [GO:0016485]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]; glomerular filtration [GO:0003094]; protein processing [GO:0016485]; proteolysis [GO:0006508]	aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]	GO:0003094; GO:0004177; GO:0005737; GO:0005739; GO:0006508; GO:0016485; GO:0030145; GO:0042803; GO:0070006	SUBCELLULAR LOCATION: Isoform 1: Mitochondrion {ECO:0000269|PubMed:20179356, ECO:0000269|PubMed:25609706}. Cytoplasm {ECO:0000269|PubMed:25609706}. Note=Mainly mitochondrial. Translocates to the cytoplasm following TNFRSF1B activation. {ECO:0000269|PubMed:25609706}.; SUBCELLULAR LOCATION: Isoform 2: Cytoplasm {ECO:0000269|PubMed:25609706}.			15461802; 14702039; 17974005; 10591208; 15489334; 15708373; 21269460; 25609706; 25944712; 28476889; 20179356; 14743216; 17110338; 20360068; 20562859; 21068128; 25609649	15461802; 14702039; 17974005; 10591208; 15489334; 15708373; 21269460; 25609706; 25944712; 28476889; 20179356
10997	XYLT1 XT1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.9 uM for recombinant bikunin {ECO:0000269|PubMed:15294915, ECO:0000269|PubMed:15461586}; Vmax=764 pmol/h/mg enzyme with recombinant bikunin as substrate {ECO:0000269|PubMed:15294915, ECO:0000269|PubMed:15461586}; 	2.4.2.26	CATALYTIC ACTIVITY: UDP-alpha-D-xylose + [protein]-L-serine = UDP + [protein]-3-O-(beta-D-xylosyl)-L-serine. {ECO:0000269|PubMed:11087729, ECO:0000269|PubMed:11099377, ECO:0000269|PubMed:15294915, ECO:0000269|PubMed:15461586, ECO:0000269|PubMed:23982343, ECO:0000269|PubMed:29681470}.	BINDING 333 333 UDP-xylose; via carbonyl oxygen. {ECO:0000244|PDB:6EJ7, ECO:0000269|PubMed:29681470}.; BINDING 361 361 UDP-xylose. {ECO:0000244|PDB:6EJ7, ECO:0000269|PubMed:29681470}.; BINDING 575 575 UDP-xylose. {ECO:0000244|PDB:6EJ7, ECO:0000269|PubMed:29681470}.		COFACTOR: Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240; Evidence={ECO:0000269|PubMed:15294915, ECO:0000269|PubMed:15461586}; 		PATHWAY: Glycan metabolism; chondroitin sulfate biosynthesis. {ECO:0000269|PubMed:17189265, ECO:0000269|PubMed:23982343}.; PATHWAY: Glycan metabolism; heparan sulfate biosynthesis. {ECO:0000269|PubMed:17189265}.				chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; embryonic skeletal system development [GO:0048706]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; ossification involved in bone maturation [GO:0043931]; proteoglycan biosynthetic process [GO:0030166]	extracellular space [GO:0005615]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	extracellular space [GO:0005615]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; metal ion binding [GO:0046872]; protein xylosyltransferase activity [GO:0030158]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; embryonic skeletal system development [GO:0048706]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; ossification involved in bone maturation [GO:0043931]; proteoglycan biosynthetic process [GO:0030166]	acetylglucosaminyltransferase activity [GO:0008375]; metal ion binding [GO:0046872]; protein xylosyltransferase activity [GO:0030158]	GO:0000137; GO:0000139; GO:0005615; GO:0006024; GO:0008375; GO:0015012; GO:0016021; GO:0030158; GO:0030166; GO:0030203; GO:0030206; GO:0043931; GO:0046872; GO:0048706; GO:0050650	SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000269|PubMed:23982343, ECO:0000269|PubMed:28462984}; Single-pass type II membrane protein {ECO:0000305}. Secreted {ECO:0000269|PubMed:11087729, ECO:0000269|PubMed:16571645}. Note=Detected predominantly in the Golgi apparatus. {ECO:0000269|PubMed:28462984}.	PTM: Contains 7 disulfide bonds. {ECO:0000305|PubMed:15461586}.; PTM: N-glycosylated. {ECO:0000269|PubMed:11087729}.		15461586; 11099377; 11087729; 11814476; 15294915; 17189265; 29681470; 16571645; 24581741; 23982343; 28462984; 16133423; 16164625; 16225459; 16569644; 16759312; 16778156; 17003309; 17194707; 17635914; 17980567; 18294457; 18763033; 19014925; 19197251; 19762916; 20379614; 21150319; 22479506; 23223231; 23747722; 25476526; 25609649; 26601923; 27030147; 27881841; 28085539	15461586; 11099377; 11087729; 11814476; 15294915; 17189265; 29681470; 16571645; 24581741; 23982343; 28462984
11026	G6PC2 IGRP	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.45 mM for glucose-6-phosphate (at pH 6.5); 	3.1.3.9	CATALYTIC ACTIVITY: D-glucose 6-phosphate + H(2)O = D-glucose + phosphate. {ECO:0000269|PubMed:14722102}.	BINDING 79 79 Substrate. {ECO:0000255}.; BINDING 168 168 Substrate. {ECO:0000255}.				PATHWAY: Carbohydrate biosynthesis; gluconeogenesis.				gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; regulation of insulin secretion [GO:0050796]	endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]	endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; glucose-6-phosphatase activity [GO:0004346]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; regulation of insulin secretion [GO:0050796]	glucose-6-phosphatase activity [GO:0004346]	GO:0004346; GO:0005789; GO:0006094; GO:0030176; GO:0042593; GO:0050796; GO:0051156	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:15044018}; Multi-pass membrane protein {ECO:0000269|PubMed:15044018}.	PTM: N-glycosylated; the non-glycosylated form is more unstable and is degraded through the proteasome. {ECO:0000269|PubMed:15044018}.		11297555; 17974005; 15815621; 15489334; 15044018; 14722102; 16520917; 18451265; 16012821; 16493034; 17376840; 17607665; 18521185; 18753309; 18984742; 19060907; 19060910; 19082990; 19096518; 19125775; 19238352; 19533084; 19651812; 19669124; 19741163; 19741166; 19937311; 20029179; 20081858; 20571754; 20622168; 20628598; 20668700; 20816152; 20826583; 20858683; 21036910; 21515849; 22438186; 22486180; 22983906; 23508304; 23840762; 24030068; 25078492; 26341315; 27611587; 28704540; 28783164	11297555; 17974005; 15815621; 15489334; 15044018; 14722102; 16520917; 18451265
11069	SLC2A10 GLUT10	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.28 mM for 2-deoxy-D-glucose; 											glucose import [GO:0046323]; glucose transmembrane transport [GO:1904659]; hexose transmembrane transport [GO:0008645]	endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; carbohydrate:proton symporter activity [GO:0005351]; D-glucose transmembrane transporter activity [GO:0055056]; glucose transmembrane transporter activity [GO:0005355]; glucose import [GO:0046323]; glucose transmembrane transport [GO:1904659]; hexose transmembrane transport [GO:0008645]	carbohydrate:proton symporter activity [GO:0005351]; D-glucose transmembrane transporter activity [GO:0055056]; glucose transmembrane transporter activity [GO:0005355]	GO:0005351; GO:0005355; GO:0005886; GO:0008645; GO:0012505; GO:0016021; GO:0046323; GO:0048471; GO:0055056; GO:1904659	SUBCELLULAR LOCATION: Endomembrane system {ECO:0000269|PubMed:16550171}; Multi-pass membrane protein {ECO:0000269|PubMed:16550171}. Cytoplasm, perinuclear region {ECO:0000269|PubMed:16550171}.			11247674; 11592815; 14702039; 11780052; 15489334; 12941788; 16550171; 17935213; 10821868; 10970791; 11832379; 12890477; 15936967; 15975113; 16051383; 16336637; 16586067; 18565096; 18774132; 18818946; 19913121; 20379614; 20628086; 20735855; 22001912; 25078964; 25373504; 26376865; 27153185; 28726533	11247674; 11592815; 14702039; 11780052; 15489334; 12941788; 16550171; 17935213
11094	EYA2 EAB1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.9 uM for H2AXY142ph {ECO:0000269|PubMed:19351884}; KM=80 uM for H2AXS139ph {ECO:0000269|PubMed:19351884}; 	3.1.3.48	CATALYTIC ACTIVITY: Protein tyrosine phosphate + H(2)O = protein tyrosine + phosphate. {ECO:0000269|PubMed:19351884}.			COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:19858093}; ;  Note=Binds 1 Mg(2+) ion per subunit. {ECO:0000269|PubMed:19858093};						DNA repair [GO:0006281]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; histone dephosphorylation [GO:0016576]; mesodermal cell fate specification [GO:0007501]; mitochondrial outer membrane permeabilization [GO:0097345]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; positive regulation of DNA repair [GO:0045739]; regulation of transcription, DNA-templated [GO:0006355]; striated muscle tissue development [GO:0014706]; transcription, DNA-templated [GO:0006351]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; magnesium ion binding [GO:0000287]; protein tyrosine phosphatase activity [GO:0004725]; transcription factor binding [GO:0008134]; DNA repair [GO:0006281]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; histone dephosphorylation [GO:0016576]; mesodermal cell fate specification [GO:0007501]; mitochondrial outer membrane permeabilization [GO:0097345]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; positive regulation of DNA repair [GO:0045739]; regulation of transcription, DNA-templated [GO:0006355]; striated muscle tissue development [GO:0014706]; transcription, DNA-templated [GO:0006351]	magnesium ion binding [GO:0000287]; protein tyrosine phosphatase activity [GO:0004725]; transcription factor binding [GO:0008134]	GO:0000287; GO:0004725; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006281; GO:0006351; GO:0006355; GO:0007501; GO:0008134; GO:0014706; GO:0016576; GO:0045739; GO:0097192; GO:0097345; GO:2001240	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10906137, ECO:0000269|PubMed:12500905}. Nucleus {ECO:0000269|PubMed:10906137, ECO:0000269|PubMed:12500905, ECO:0000269|PubMed:19497856}. Note=Retained in the cytoplasm via interaction with GNAZ and GNAI2 (PubMed:10906137). Interaction with SIX1, SIX2, SIX4 or SIX5 is required for translocation to the nucleus (PubMed:10906137, PubMed:12500905). {ECO:0000269|PubMed:10906137, ECO:0000269|PubMed:12500905}.			9195991; 9020840; 11780052; 15489334; 9049631; 9887327; 10906137; 12500905; 19497856; 21706047; 19351884; 19858093; 23435380; 16189514; 19234442; 21516116; 22908299; 24835590	9195991; 9020840; 11780052; 15489334; 9049631; 9887327; 10906137; 12500905; 19497856; 21706047; 19351884; 19858093; 23435380
11142	GATM AGAT	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=2.0 uM for arginine {ECO:0000269|PubMed:3800397, ECO:0000269|PubMed:9266688}; KM=3.0 uM for glycine {ECO:0000269|PubMed:3800397, ECO:0000269|PubMed:9266688}; Vmax=0.44 umol/min/mg enzyme {ECO:0000269|PubMed:3800397, ECO:0000269|PubMed:9266688}; 	2.1.4.1	CATALYTIC ACTIVITY: L-arginine + glycine = L-ornithine + guanidinoacetate. {ECO:0000269|PubMed:27233232, ECO:0000269|PubMed:3800397}.					PATHWAY: Amine and polyamine biosynthesis; creatine biosynthesis; creatine from L-arginine and glycine: step 1/2.				creatine biosynthetic process [GO:0006601]; creatine metabolic process [GO:0006600]; learning or memory [GO:0007611]; multicellular organism development [GO:0007275]; muscle atrophy [GO:0014889]; positive regulation of cold-induced thermogenesis [GO:0120162]	extracellular exosome [GO:0070062]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]	extracellular exosome [GO:0070062]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; glycine amidinotransferase activity [GO:0015068]; creatine biosynthetic process [GO:0006601]; creatine metabolic process [GO:0006600]; learning or memory [GO:0007611]; multicellular organism development [GO:0007275]; muscle atrophy [GO:0014889]; positive regulation of cold-induced thermogenesis [GO:0120162]	glycine amidinotransferase activity [GO:0015068]	GO:0005739; GO:0005743; GO:0005758; GO:0006600; GO:0006601; GO:0007275; GO:0007611; GO:0014889; GO:0015068; GO:0070062; GO:0120162	SUBCELLULAR LOCATION: Isoform 1: Mitochondrion inner membrane; Peripheral membrane protein; Intermembrane side. Note=Probably attached to the outer side of the inner membrane.; SUBCELLULAR LOCATION: Isoform 2: Cytoplasm.		MOD_RES 46 46 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 49 49 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 385 385 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.	8313955; 14702039; 16572171; 15489334; 3800397; 9148748; 9165070; 16820567; 16125225; 16614068; 19608861; 20682460; 22386973; 24275569; 25944712; 9218780; 9266688; 9915841; 11555793; 23660394; 23770102; 26490222; 27233232; 19430482; 20360068; 20711500; 20877624; 21988832; 23010440; 24004504; 24136289; 25863251; 26542286; 28055022	8313955; 14702039; 16572171; 15489334; 3800397; 9148748; 9165070; 16820567; 16125225; 16614068; 19608861; 20682460; 22386973; 24275569; 25944712; 9218780; 9266688; 9915841; 11555793; 23660394; 23770102; 26490222; 27233232
11148	GBA3 CBG CBGL1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=40 uM for 4-methylumbelliferyl-beta-D-glucopyranoside {ECO:0000269|PubMed:11389701, ECO:0000269|PubMed:11784319}; KM=50 uM for 4-methylumbelliferyl-beta-D-galactopyranoside {ECO:0000269|PubMed:11389701, ECO:0000269|PubMed:11784319}; KM=370 uM for 4-nitrophenyl-beta-D-fucopyranoside {ECO:0000269|PubMed:11389701, ECO:0000269|PubMed:11784319}; KM=570 uM for 4-nitrophenyl-alpha-D-arabinopyranoside {ECO:0000269|PubMed:11389701, ECO:0000269|PubMed:11784319}; KM=1.76 mM for 4-nitrophenyl-beta-D-glucopyranoside {ECO:0000269|PubMed:11389701, ECO:0000269|PubMed:11784319}; KM=3.14 mM for 4-nitrophenyl-beta-D-galactopyranoside {ECO:0000269|PubMed:11389701, ECO:0000269|PubMed:11784319}; KM=1.58 mM for 4-nitrophenyl-beta-D-xylopyranoside {ECO:0000269|PubMed:11389701, ECO:0000269|PubMed:11784319}; KM=52.6 mM for 4-nitrophenyl-beta-L-arabinopyranoside {ECO:0000269|PubMed:11389701, ECO:0000269|PubMed:11784319}; KM=35 uM for genistein-7-glucoside {ECO:0000269|PubMed:11389701, ECO:0000269|PubMed:11784319}; KM=118 uM for daidzein-7-glucoside {ECO:0000269|PubMed:11389701, ECO:0000269|PubMed:11784319}; KM=31.8 uM for quercetin-4'-glucoside {ECO:0000269|PubMed:11389701, ECO:0000269|PubMed:11784319}; KM=42.2 uM for quercetin-7-glucoside {ECO:0000269|PubMed:11389701, ECO:0000269|PubMed:11784319}; KM=21.5 uM for apigenin-7-glucoside {ECO:0000269|PubMed:11389701, ECO:0000269|PubMed:11784319}; KM=10 uM for luteolin-4'-glucoside {ECO:0000269|PubMed:11389701, ECO:0000269|PubMed:11784319}; KM=50 uM for luteolin-7-glucoside {ECO:0000269|PubMed:11389701, ECO:0000269|PubMed:11784319}; KM=432 uM for naringenin-7-glucoside {ECO:0000269|PubMed:11389701, ECO:0000269|PubMed:11784319}; KM=253 uM for eriodictyol-7-glucoside {ECO:0000269|PubMed:11389701, ECO:0000269|PubMed:11784319}; Vmax=10 umol/min/mg enzyme toward 4-nitrophenyl-beta-D-glucopyranoside {ECO:0000269|PubMed:11389701, ECO:0000269|PubMed:11784319}; Vmax=1.73 umol/min/mg enzyme toward genistein-7-glucoside {ECO:0000269|PubMed:11389701, ECO:0000269|PubMed:11784319}; Vmax=2.75 umol/min/mg enzyme toward daidzein-7-glucoside {ECO:0000269|PubMed:11389701, ECO:0000269|PubMed:11784319}; Vmax=1.19 umol/min/mg enzyme toward quercetin-4'-glucoside {ECO:0000269|PubMed:11389701, ECO:0000269|PubMed:11784319}; Vmax=0.77 umol/min/mg enzyme toward quercetin-7-glucoside {ECO:0000269|PubMed:11389701, ECO:0000269|PubMed:11784319}; Vmax=1.30 umol/min/mg enzyme toward apigenin-7-glucoside {ECO:0000269|PubMed:11389701, ECO:0000269|PubMed:11784319}; Vmax=1.30 umol/min/mg enzyme toward luteolin-4'-glucoside {ECO:0000269|PubMed:11389701, ECO:0000269|PubMed:11784319}; Vmax=2.85 umol/min/mg enzyme toward luteolin-7-glucoside {ECO:0000269|PubMed:11389701, ECO:0000269|PubMed:11784319}; Vmax=0.93 umol/min/mg enzyme toward naringenin-7-glucoside {ECO:0000269|PubMed:11389701, ECO:0000269|PubMed:11784319}; Vmax=0.90 umol/min/mg enzyme toward eriodictyol-7-glucoside {ECO:0000269|PubMed:11389701, ECO:0000269|PubMed:11784319}; 	3.2.1.21	CATALYTIC ACTIVITY: Hydrolysis of terminal, non-reducing beta-D-glucosyl residues with release of beta-D-glucose.	BINDING 17 17 Substrate.; BINDING 120 120 Substrate.; BINDING 164 164 Substrate.; BINDING 309 309 Substrate.; BINDING 417 417 Substrate.	ACTIVITY REGULATION: Inhibited by 2,4-dinitrophenyl-2-fluoro-2-deoxy-beta-D-glucopyranoside and sodium taurocholate. {ECO:0000269|PubMed:11389701, ECO:0000269|PubMed:11784319}.		BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 6.5. Active from pH 5 to 7.5. Activity decreases sharply with increasing acidity and is less than 4% at pH 4. {ECO:0000269|PubMed:11389701, ECO:0000269|PubMed:11784319};				BIOPHYSICOCHEMICAL PROPERTIES: ;  Temperature dependence: Optimum temperature is 50 degrees Celsius. Stable more than 24 hours at 37 degrees Celsius. Loses activity at 58 degrees Celsius. {ECO:0000269|PubMed:11389701, ECO:0000269|PubMed:11784319};	cellular oligosaccharide catabolic process [GO:0051692]; glycoside catabolic process [GO:0016139]; glycosphingolipid metabolic process [GO:0006687]; glycosylceramide catabolic process [GO:0046477]; positive regulation of exo-alpha-sialidase activity [GO:1903017]; protein stabilization [GO:0050821]	catalytic complex [GO:1902494]; cytosol [GO:0005829]	catalytic complex [GO:1902494]; cytosol [GO:0005829]; beta-galactosidase activity [GO:0004565]; beta-glucosidase activity [GO:0008422]; glucosylceramidase activity [GO:0004348]; glycosylceramidase activity [GO:0017042]; scopolin beta-glucosidase activity [GO:0102483]; cellular oligosaccharide catabolic process [GO:0051692]; glycoside catabolic process [GO:0016139]; glycosphingolipid metabolic process [GO:0006687]; glycosylceramide catabolic process [GO:0046477]; positive regulation of exo-alpha-sialidase activity [GO:1903017]; protein stabilization [GO:0050821]	beta-galactosidase activity [GO:0004565]; beta-glucosidase activity [GO:0008422]; glucosylceramidase activity [GO:0004348]; glycosylceramidase activity [GO:0017042]; scopolin beta-glucosidase activity [GO:0102483]	GO:0004348; GO:0004565; GO:0005829; GO:0006687; GO:0008422; GO:0016139; GO:0017042; GO:0046477; GO:0050821; GO:0051692; GO:0102483; GO:1902494; GO:1903017	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:12594539, ECO:0000269|PubMed:17595169}.	PTM: The N-terminus is blocked.		11043382; 11389701; 11784319; 15489334; 12667141; 12594539; 17595169; 17555766; 18662675; 15322500; 20728381; 21988832; 26193330	11043382; 11389701; 11784319; 15489334; 12667141; 12594539; 17595169; 17555766; 18662675; 15322500
11179	ELOVL7	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=2.6 uM for C18:3(n-3)-CoA {ECO:0000269|PubMed:21959040}; KM=11.7 uM for malonyl-CoA {ECO:0000269|PubMed:21959040}; Vmax=0.33 pmol/min/ug enzyme toward C18:3(n-3)-CoA {ECO:0000269|PubMed:21959040}; Vmax=0.31 pmol/min/ug enzyme toward malonyl-CoA {ECO:0000269|PubMed:21959040}; 	2.3.1.199	CATALYTIC ACTIVITY: A very-long-chain acyl-CoA + malonyl-CoA = CoA + a very-long-chain 3-oxoacyl-CoA + CO(2). {ECO:0000255|HAMAP-Rule:MF_03207, ECO:0000269|PubMed:20937905, ECO:0000269|PubMed:21959040}.					PATHWAY: Lipid metabolism; fatty acid biosynthesis. {ECO:0000255|HAMAP-Rule:MF_03207, ECO:0000269|PubMed:20937905, ECO:0000269|PubMed:21959040}.				fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]	3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]	GO:0005783; GO:0005789; GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0030176; GO:0034625; GO:0034626; GO:0035338; GO:0042761; GO:0102336; GO:0102337; GO:0102338; GO:0102756	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000255|HAMAP-Rule:MF_03207, ECO:0000269|PubMed:20937905}; Multi-pass membrane protein {ECO:0000255|HAMAP-Rule:MF_03207}.			15489334; 14702039; 17974005; 19826053; 20937905; 21959040; 19505953; 20379614; 25416956; 25732827; 27928700	15489334; 14702039; 17974005; 19826053; 20937905; 21959040
11200	ENPP6 UNQ1889/PRO4334	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=344 uM for GPC {ECO:0000269|PubMed:15788404}; KM=296 uM for 12:0-LPC {ECO:0000269|PubMed:15788404}; KM=440 uM for 14:0-LPC {ECO:0000269|PubMed:15788404}; KM=165 uM for 16:0-LPC {ECO:0000269|PubMed:15788404}; KM=434 uM for 18:2-LPC {ECO:0000269|PubMed:15788404}; KM=563 uM for 20:4-LPC {ECO:0000269|PubMed:15788404}; Vmax=484 nmol/min/mg enzyme with GPC as substrate {ECO:0000269|PubMed:15788404}; Vmax=463 nmol/min/mg enzyme with 12:0-LPC as substrate {ECO:0000269|PubMed:15788404}; Vmax=367 nmol/min/mg enzyme with 14:0-LPC as substrate {ECO:0000269|PubMed:15788404}; Vmax=89 nmol/min/mg enzyme with 16:0-LPC as substrate {ECO:0000269|PubMed:15788404}; Vmax=285 nmol/min/mg enzyme with 18:2-LPC as substrate {ECO:0000269|PubMed:15788404}; Vmax=470 nmol/min/mg enzyme with 20:4-LPC as substrate {ECO:0000269|PubMed:15788404}; 	3.1.4.-; 3.1.4.38	CATALYTIC ACTIVITY: A lysophosphatidylcholine + H(2)O = a monoacylglycerol + phosphocholine. {ECO:0000269|PubMed:15788404}.; CATALYTIC ACTIVITY: sn-glycero-3-phosphocholine + H(2)O = glycerol + phosphocholine. {ECO:0000269|PubMed:15788404}.		ACTIVITY REGULATION: Inhibited by EDTA and EGTA in vitro. {ECO:0000269|PubMed:15788404}.	COFACTOR: Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240; Evidence={ECO:0000269|PubMed:15788404}; 	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 8.5-7.5. {ECO:0000269|PubMed:15788404};			UNQ1889/PRO4334		choline metabolic process [GO:0019695]; glycerophospholipid catabolic process [GO:0046475]; lipid metabolic process [GO:0006629]	anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]	anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; glycerophosphocholine cholinephosphodiesterase activity [GO:0047390]; glycerophosphodiester phosphodiesterase activity [GO:0008889]; phosphoric diester hydrolase activity [GO:0008081]; choline metabolic process [GO:0019695]; glycerophospholipid catabolic process [GO:0046475]; lipid metabolic process [GO:0006629]	glycerophosphocholine cholinephosphodiesterase activity [GO:0047390]; glycerophosphodiester phosphodiesterase activity [GO:0008889]; phosphoric diester hydrolase activity [GO:0008081]	GO:0005576; GO:0005886; GO:0006629; GO:0008081; GO:0008889; GO:0019695; GO:0031225; GO:0046475; GO:0047390; GO:0070062	SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15788404}; Lipid-anchor, GPI-anchor {ECO:0000269|PubMed:15788404}. Note=A small amount of the protein may be found in the extracellular milieu.		MOD_RES 71 71 Phosphoserine. {ECO:0000250|UniProtKB:B0BND0}.		12975309; 14702039; 15815621; 15489334; 15788404; 23161088
11206	CES1 CES2 SES1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=106.6 uM for p-nitrophenyl acetate {ECO:0000269|PubMed:18485328, ECO:0000269|PubMed:7980644, ECO:0000269|PubMed:9169443, ECO:0000269|PubMed:9490062}; KM=775.7 uM for L-methylphenidate {ECO:0000269|PubMed:18485328, ECO:0000269|PubMed:7980644, ECO:0000269|PubMed:9169443, ECO:0000269|PubMed:9490062}; KM=663.5 uM for D-methylphenidate {ECO:0000269|PubMed:18485328, ECO:0000269|PubMed:7980644, ECO:0000269|PubMed:9169443, ECO:0000269|PubMed:9490062}; KM=116 uM for cocaine {ECO:0000269|PubMed:18485328, ECO:0000269|PubMed:7980644, ECO:0000269|PubMed:9169443, ECO:0000269|PubMed:9490062}; KM=43 mM for ethanol {ECO:0000269|PubMed:18485328, ECO:0000269|PubMed:7980644, ECO:0000269|PubMed:9169443, ECO:0000269|PubMed:9490062}; KM=0.8 mM for 4-methylumbelliferyl acetate {ECO:0000269|PubMed:18485328, ECO:0000269|PubMed:7980644, ECO:0000269|PubMed:9169443, ECO:0000269|PubMed:9490062}; KM=6.3 mM for heroin {ECO:0000269|PubMed:18485328, ECO:0000269|PubMed:7980644, ECO:0000269|PubMed:9169443, ECO:0000269|PubMed:9490062}; KM=8.3 mM for 6-monoacetylmorphine {ECO:0000269|PubMed:18485328, ECO:0000269|PubMed:7980644, ECO:0000269|PubMed:9169443, ECO:0000269|PubMed:9490062}; Vmax=493.9 nmol/min/mg enzyme with p-nitrophenyl acetate as substrate {ECO:0000269|PubMed:18485328, ECO:0000269|PubMed:7980644, ECO:0000269|PubMed:9169443, ECO:0000269|PubMed:9490062}; Vmax=1701.1 pmol/min/mg enzyme with L-methylphenidate as substrate {ECO:0000269|PubMed:18485328, ECO:0000269|PubMed:7980644, ECO:0000269|PubMed:9169443, ECO:0000269|PubMed:9490062}; Vmax=177.2 pmol/min/mg enzyme with D-methylphenidate as substrate {ECO:0000269|PubMed:18485328, ECO:0000269|PubMed:7980644, ECO:0000269|PubMed:9169443, ECO:0000269|PubMed:9490062}; 	3.1.1.1; 3.1.1.56	CATALYTIC ACTIVITY: A carboxylic ester + H(2)O = an alcohol + a carboxylate. {ECO:0000255|PROSITE-ProRule:PRU10039, ECO:0000269|PubMed:7980644, ECO:0000269|PubMed:9169443, ECO:0000269|PubMed:9490062}.; CATALYTIC ACTIVITY: 4-methylumbelliferyl acetate + H(2)O = 4-methylumbelliferone + acetate. {ECO:0000269|PubMed:9169443}.		ACTIVITY REGULATION: Activated by CHAPS. {ECO:0000269|PubMed:9490062}.		BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 6.5. {ECO:0000269|PubMed:18485328, ECO:0000269|PubMed:7980644, ECO:0000269|PubMed:9169443, ECO:0000269|PubMed:9490062};					cholesterol biosynthetic process [GO:0006695]; cholesterol ester hydrolysis involved in cholesterol transport [GO:0090122]; epithelial cell differentiation [GO:0030855]; medium-chain fatty acid metabolic process [GO:0051791]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; carboxylic ester hydrolase activity [GO:0052689]; methylumbelliferyl-acetate deacetylase activity [GO:0047374]; sterol esterase activity [GO:0004771]; cholesterol biosynthetic process [GO:0006695]; cholesterol ester hydrolysis involved in cholesterol transport [GO:0090122]; epithelial cell differentiation [GO:0030855]; medium-chain fatty acid metabolic process [GO:0051791]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805]	carboxylic ester hydrolase activity [GO:0052689]; methylumbelliferyl-acetate deacetylase activity [GO:0047374]; sterol esterase activity [GO:0004771]	GO:0004771; GO:0005783; GO:0005788; GO:0005829; GO:0006695; GO:0006805; GO:0009636; GO:0030855; GO:0047374; GO:0051791; GO:0052689; GO:0090122	SUBCELLULAR LOCATION: Endoplasmic reticulum lumen {ECO:0000269|PubMed:10562416}.	PTM: Contains sialic acid.; PTM: Cleavage of the signal sequence can occur at 2 positions, either between Trp-17 and Gly-18 or between Gly-18 and His-19.	MOD_RES 380 380 Phosphoserine. {ECO:0000244|PubMed:24275569}.	1918003; 8218228; 8406473; 8049197; 10562416; 11015575; 11812220; 14702039; 15616553; 15489334; 10518925; 7980644; 9490062; 8597091; 12022871; 1997784; 2070086; 1748313; 9169443; 18485328; 24275569; 25944712; 12725862; 12679808; 12773168; 12960109; 15475243; 15475733; 15931389; 16081098; 16282638; 16419644; 16962139; 16971496; 17407327; 17537833; 17764701; 18305377; 18328811; 18599737; 18794728; 18983829; 19185566; 19332024; 19343046; 19508181; 19658107; 19715681; 19733552; 19932971; 20051531; 20529763; 20530478; 20649590; 20975297; 21081832; 21516116; 21994455; 22237548; 22442219; 22525521; 22588607; 22688218; 22700792; 22943824; 23111421; 23275066; 23468884; 23658012; 23936796; 24141856; 24170778; 24212379; 24350812; 24563511; 25704243; 26076923; 26340669; 26587656; 26657071; 26825642; 26871237; 26915813; 27075303; 27130352; 27228223; 27450232; 27614009; 27638507; 28139840; 28473326; 28532270; 28639420; 28786738; 28838926; 28990360; 29321244	1918003; 8218228; 8406473; 8049197; 10562416; 11015575; 11812220; 14702039; 15616553; 15489334; 10518925; 7980644; 9490062; 8597091; 12022871; 1997784; 2070086; 1748313; 9169443; 18485328; 24275569; 25944712; 12725862; 12679808
11209	CES2 ICE	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.39 mM for cocaine {ECO:0000269|PubMed:9169443}; KM=0.15 mM for 4-methylumbelliferyl acetate {ECO:0000269|PubMed:9169443}; KM=6.8 mM for heroin {ECO:0000269|PubMed:9169443}; KM=0.13 mM for 6-monoacetylmorphine {ECO:0000269|PubMed:9169443}; 	3.1.1.84; 3.1.1.1; 3.1.1.56	CATALYTIC ACTIVITY: Cocaine + H(2)O = ecgonine methyl ester + benzoate. {ECO:0000269|PubMed:9169443}.; CATALYTIC ACTIVITY: A carboxylic ester + H(2)O = an alcohol + a carboxylate. {ECO:0000255|PROSITE-ProRule:PRU10039, ECO:0000269|PubMed:9169443}.; CATALYTIC ACTIVITY: 4-methylumbelliferyl acetate + H(2)O = 4-methylumbelliferone + acetate. {ECO:0000269|PubMed:9169443}.									catabolic process [GO:0009056]; prostaglandin metabolic process [GO:0006693]; xenobiotic metabolic process [GO:0006805]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; carboxylic ester hydrolase activity [GO:0052689]; hydrolase activity [GO:0016787]; methylumbelliferyl-acetate deacetylase activity [GO:0047374]; catabolic process [GO:0009056]; prostaglandin metabolic process [GO:0006693]; xenobiotic metabolic process [GO:0006805]	carboxylic ester hydrolase activity [GO:0052689]; hydrolase activity [GO:0016787]; methylumbelliferyl-acetate deacetylase activity [GO:0047374]	GO:0005783; GO:0005788; GO:0006693; GO:0006805; GO:0009056; GO:0016787; GO:0047374; GO:0052689	SUBCELLULAR LOCATION: Endoplasmic reticulum lumen {ECO:0000269|PubMed:22446793}.	PTM: Glycosylated. {ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:9169443}.	MOD_RES 27 27 Pyrrolidone carboxylic acid. {ECO:0000250|UniProtKB:P14943}.	9144407; 9169443; 14702039; 17974005; 15616553; 15489334; 19159218; 22446793; 28677105; 21269460; 24275569; 12721789; 15618752; 12725862; 12835618; 12960109; 15475243; 15475733; 15592324; 15967118; 16690525; 16963839; 17483951; 17537833; 17640957; 17764701; 18259949; 18305377; 18473752; 18794728; 18797458; 18983829; 19274604; 19343046; 19349540; 19367725; 19508181; 19856659; 19956635; 20195289; 20237496; 20379614; 20529763; 20628086; 20649590; 20711500; 22525521; 23471941; 23480903; 24195516; 24212379; 25724353; 26025324; 26806650; 26825642; 27149931; 28099843; 28285137; 28532270; 29651325; 7980644	9144407; 9169443; 14702039; 17974005; 15616553; 15489334; 19159218; 22446793; 28677105; 21269460; 24275569; 12721789; 15618752
11249	ALAD	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.09 mM for 5-aminolevulinate at pH 7 {ECO:0000269|PubMed:11032836}; Vmax=43 umol/h/mg enzyme at pH 7 {ECO:0000269|PubMed:11032836}; 	4.2.1.24	CATALYTIC ACTIVITY: 2 5-aminolevulinate = porphobilinogen + 2 H(2)O. {ECO:0000269|PubMed:11032836, ECO:0000269|PubMed:12897770, ECO:0000269|PubMed:19812033}.	BINDING 209 209 Substrate 1.; BINDING 221 221 Substrate 1.; BINDING 279 279 Substrate 2.; BINDING 318 318 Substrate 2.	ACTIVITY REGULATION: Can alternate between a fully active homooctamer and a low-activity homohexamer. A bound magnesium ion may promote the assembly of the fully active homooctamer. The magnesium-binding site is absent in the low-activity homohexamer. Inhibited by compounds that favor the hexameric state. Inhibited by divalent lead ions. The lead ions partially displace the zinc cofactor. {ECO:0000269|PubMed:11032836, ECO:0000269|PubMed:12897770, ECO:0000269|PubMed:19812033}.	COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000269|PubMed:11032836}; ;  Note=Binds 8 zinc ions per octamer. Requires four zinc ions per octamer for full catalytic activity. Can bind up to 2 zinc ions per subunit. {ECO:0000269|PubMed:11032836};	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 6.8-7.3. {ECO:0000269|PubMed:11032836};	PATHWAY: Porphyrin-containing compound metabolism; protoporphyrin-IX biosynthesis; coproporphyrinogen-III from 5-aminolevulinate: step 1/4.				cellular response to interleukin-4 [GO:0071353]; cellular response to lead ion [GO:0071284]; heme biosynthetic process [GO:0006783]; negative regulation of proteasomal protein catabolic process [GO:1901799]; neutrophil degranulation [GO:0043312]; protein homooligomerization [GO:0051260]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to activity [GO:0014823]; response to aluminum ion [GO:0010044]; response to amino acid [GO:0043200]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to cobalt ion [GO:0032025]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to glucocorticoid [GO:0051384]; response to herbicide [GO:0009635]; response to hypoxia [GO:0001666]; response to ionizing radiation [GO:0010212]; response to iron ion [GO:0010039]; response to lipopolysaccharide [GO:0032496]; response to mercury ion [GO:0046689]; response to methylmercury [GO:0051597]; response to oxidative stress [GO:0006979]; response to platinum ion [GO:0070541]; response to selenium ion [GO:0010269]; response to vitamin B1 [GO:0010266]; response to vitamin E [GO:0033197]; response to zinc ion [GO:0010043]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; catalytic activity [GO:0003824]; identical protein binding [GO:0042802]; porphobilinogen synthase activity [GO:0004655]; proteasome core complex binding [GO:1904854]; zinc ion binding [GO:0008270]; cellular response to interleukin-4 [GO:0071353]; cellular response to lead ion [GO:0071284]; heme biosynthetic process [GO:0006783]; negative regulation of proteasomal protein catabolic process [GO:1901799]; neutrophil degranulation [GO:0043312]; protein homooligomerization [GO:0051260]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to activity [GO:0014823]; response to aluminum ion [GO:0010044]; response to amino acid [GO:0043200]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to cobalt ion [GO:0032025]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to glucocorticoid [GO:0051384]; response to herbicide [GO:0009635]; response to hypoxia [GO:0001666]; response to ionizing radiation [GO:0010212]; response to iron ion [GO:0010039]; response to lipopolysaccharide [GO:0032496]; response to mercury ion [GO:0046689]; response to methylmercury [GO:0051597]; response to oxidative stress [GO:0006979]; response to platinum ion [GO:0070541]; response to selenium ion [GO:0010269]; response to vitamin B1 [GO:0010266]; response to vitamin E [GO:0033197]; response to zinc ion [GO:0010043]	catalytic activity [GO:0003824]; identical protein binding [GO:0042802]; porphobilinogen synthase activity [GO:0004655]; proteasome core complex binding [GO:1904854]; zinc ion binding [GO:0008270]	GO:0001666; GO:0003824; GO:0004655; GO:0005576; GO:0005634; GO:0005829; GO:0006782; GO:0006783; GO:0006979; GO:0008270; GO:0009635; GO:0010039; GO:0010043; GO:0010044; GO:0010212; GO:0010266; GO:0010269; GO:0014823; GO:0032025; GO:0032496; GO:0033197; GO:0034774; GO:0042802; GO:0043200; GO:0043312; GO:0045471; GO:0046685; GO:0046686; GO:0046689; GO:0051260; GO:0051384; GO:0051597; GO:0070062; GO:0070541; GO:0070542; GO:0071284; GO:0071353; GO:1901799; GO:1904813; GO:1904854			MOD_RES 199 199 N6-succinyllysine. {ECO:0000250|UniProtKB:P10518}.; MOD_RES 215 215 Phosphoserine. {ECO:0000250|UniProtKB:P10518}.; MOD_RES 252 252 N6-succinyllysine. {ECO:0000250|UniProtKB:P10518}.	3463993; 1678509; 1569184; 14702039; 15164053; 15489334; 12665801; 3092810; 1769358; 11032836; 17966070; 19812033; 21269460; 24275569; 12897770; 1716854; 2063868; 1309003; 10519994; 10706561; 16398658; 17236137; 11032841; 11335187; 11413692; 11427399; 11444968; 11459423; 11800328; 11860952; 11909869; 12469218; 12611663; 12896855; 12972060; 14527840; 14694653; 15064157; 15213514; 15258767; 15381398; 15386154; 15587989; 15915653; 15954127; 16140629; 16203232; 16263504; 16377642; 16445899; 16487505; 16497859; 16730797; 16757504; 17164378; 17291479; 17366816; 17383846; 17649958; 17823382; 18271513; 18282196; 18432999; 18569569; 18676680; 18784554; 18795909; 18936436; 19028776; 19170196; 19327888; 19440429; 19515364; 19548578; 19625176; 19686844; 19692168; 19723536; 19766174; 19789817; 20021040; 20021192; 20069172; 20123609; 20406759; 20510440; 20798009; 21293208; 21327641; 21396434; 21439310; 21762684; 21799727; 22101007; 22298357; 22851944; 23606334; 23650620; 24156693; 24500903; 24631795; 24855033; 25460652; 25514583; 25528913; 25820613; 25963508; 26275098; 26287972; 26701682; 27657831; 28045381; 28276576; 28403546; 28960093; 29028685; 29148924; 30025905; 8080400	3463993; 1678509; 1569184; 14702039; 15164053; 15489334; 12665801; 3092810; 1769358; 11032836; 17966070; 19812033; 21269460; 24275569; 12897770; 1716854; 2063868; 1309003; 10519994; 10706561; 16398658; 17236137
11308	GCH1 DYT5 GCH	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=116 uM for GTP {ECO:0000269|PubMed:2500984}; 	3.5.4.16	CATALYTIC ACTIVITY: GTP + H(2)O = formate + 2-amino-4-hydroxy-6-(erythro-1,2,3-trihydroxypropyl)-dihydropteridine triphosphate. {ECO:0000269|PubMed:16778797, ECO:0000269|PubMed:2463916, ECO:0000269|PubMed:3753653}.		ACTIVITY REGULATION: GTP shows a positive allosteric effect, and tetrahydrobiopterin inhibits the enzyme activity. Zinc is required for catalytic activity. Inhibited by Mg(2+). {ECO:0000269|PubMed:14717702, ECO:0000269|PubMed:16778797, ECO:0000269|PubMed:3753653}.		BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 7.7 in phosphate buffer. {ECO:0000269|PubMed:2500984};	PATHWAY: Cofactor biosynthesis; 7,8-dihydroneopterin triphosphate biosynthesis; 7,8-dihydroneopterin triphosphate from GTP: step 1/1. {ECO:0000305|PubMed:16778797, ECO:0000305|PubMed:2463916, ECO:0000305|PubMed:3753653}.			BIOPHYSICOCHEMICAL PROPERTIES: ;  Temperature dependence: Relatively stable at high temperatures. Retains 50% of its activity after incubation at 70 degrees Celsius for 15 minutes. {ECO:0000269|PubMed:2500984};	7,8-dihydroneopterin 3'-triphosphate biosynthetic process [GO:0035998]; cofactor metabolic process [GO:0051186]; dopamine biosynthetic process [GO:0042416]; negative regulation of blood pressure [GO:0045776]; neuromuscular process controlling posture [GO:0050884]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of heart rate [GO:0010460]; positive regulation of nitric-oxide synthase activity [GO:0051000]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; pteridine-containing compound biosynthetic process [GO:0042559]; regulation of blood pressure [GO:0008217]; regulation of lung blood pressure [GO:0014916]; regulation of removal of superoxide radicals [GO:2000121]; response to interferon-gamma [GO:0034341]; response to lipopolysaccharide [GO:0032496]; response to pain [GO:0048265]; response to tumor necrosis factor [GO:0034612]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]; vasodilation [GO:0042311]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; neuron projection terminus [GO:0044306]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; neuron projection terminus [GO:0044306]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; coenzyme binding [GO:0050662]; GTP binding [GO:0005525]; GTP cyclohydrolase I activity [GO:0003934]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; mitogen-activated protein kinase binding [GO:0051019]; protein homodimerization activity [GO:0042803]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270]; 7,8-dihydroneopterin 3'-triphosphate biosynthetic process [GO:0035998]; cofactor metabolic process [GO:0051186]; dopamine biosynthetic process [GO:0042416]; negative regulation of blood pressure [GO:0045776]; neuromuscular process controlling posture [GO:0050884]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of heart rate [GO:0010460]; positive regulation of nitric-oxide synthase activity [GO:0051000]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; pteridine-containing compound biosynthetic process [GO:0042559]; regulation of blood pressure [GO:0008217]; regulation of lung blood pressure [GO:0014916]; regulation of removal of superoxide radicals [GO:2000121]; response to interferon-gamma [GO:0034341]; response to lipopolysaccharide [GO:0032496]; response to pain [GO:0048265]; response to tumor necrosis factor [GO:0034612]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]; vasodilation [GO:0042311]	calcium ion binding [GO:0005509]; coenzyme binding [GO:0050662]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; GTP cyclohydrolase I activity [GO:0003934]; GTP-dependent protein binding [GO:0030742]; mitogen-activated protein kinase binding [GO:0051019]; protein homodimerization activity [GO:0042803]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270]	GO:0003924; GO:0003934; GO:0005509; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006729; GO:0006809; GO:0008217; GO:0008270; GO:0010460; GO:0014916; GO:0030742; GO:0031369; GO:0031410; GO:0031965; GO:0032496; GO:0032991; GO:0034341; GO:0034612; GO:0035998; GO:0042311; GO:0042416; GO:0042559; GO:0042803; GO:0044306; GO:0045776; GO:0046654; GO:0048265; GO:0050662; GO:0050884; GO:0051000; GO:0051019; GO:0051186; GO:0051260; GO:0051291; GO:2000121	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12176133, ECO:0000269|PubMed:16778797, ECO:0000269|PubMed:2463916}. Nucleus {ECO:0000269|PubMed:16778797}.	PTM: Phosphorylated by casein kinase II at Ser-81 in HAECs during oscillatory shear stress; phosphorylation at Ser-81 results in increased enzyme activity. {ECO:0000269|PubMed:17704208}.	MOD_RES 60 60 Phosphoserine. {ECO:0000244|PubMed:19690332}.; MOD_RES 81 81 Phosphoserine. {ECO:0000269|PubMed:17704208}.	1520321; 8068008; 8695054; 11284739; 15489334; 8666288; 1482676; 7730309; 3753653; 2500984; 2463916; 7678411; 9222755; 9445252; 12176133; 12002810; 12607127; 14646243; 14717702; 16338639; 15604419; 15649650; 16848765; 16778797; 16696853; 17057711; 17704208; 19690332; 11087827; 7874165; 7501255; 8957022; 8852666; 9120469; 9328244; 9667588; 9778264; 10987649; 10582612; 10208576; 10076897; 10825351; 11113234; 12391354; 17101830; 23762320; 10457396; 11580249; 12821132; 12925450; 14551046; 15679701; 15753436; 15852365; 15909293; 16149046; 16267845; 16643317; 17044972; 17111153; 17343757; 17363416; 17407085; 17410324; 17557242; 17655760; 17717598; 17804835; 17898029; 18202219; 18276179; 18358407; 18374612; 18410856; 18515178; 18554280; 18598896; 18752196; 18824773; 19011239; 19014702; 19081190; 19101819; 19104007; 19195260; 19292934; 19294699; 19332422; 19491146; 19515581; 19533203; 19566901; 19573577; 19615732; 19674121; 19735094; 19775452; 19851158; 19913121; 19926872; 19959292; 20108370; 20187889; 20418482; 20437540; 20491893; 20581851; 20628086; 20633294; 20838263; 20842020; 20937667; 21037510; 21181356; 21422102; 21674621; 21733738; 21834904; 21896313; 21900206; 21969008; 21988832; 22068827; 22172551; 22293547; 22373569; 22770721; 22798524; 22971341; 22976901; 22984419; 23059057; 23211702; 23314412; 23322459; 24018121; 24124602; 24136375; 24465804; 24561090; 24674769; 24993959; 25119902; 25192508; 25270546; 25369080; 25599448; 25634433; 25783971; 26215833; 26392364; 26400349; 26804608; 26814432; 27185167; 27269966; 27653855; 27666935; 27826622; 27871051; 28380328; 28397219; 28558098; 28585439; 28958832; 29405179; 7663943; 8502995	1520321; 8068008; 8695054; 11284739; 15489334; 8666288; 1482676; 7730309; 3753653; 2500984; 2463916; 7678411; 9222755; 9445252; 12176133; 12002810; 12607127; 14646243; 14717702; 16338639; 15604419; 15649650; 16848765; 16778797; 16696853; 17057711; 17704208; 19690332; 11087827; 7874165; 7501255; 8957022; 8852666; 9120469; 9328244; 9667588; 9778264; 10987649; 10582612; 10208576; 10076897; 10825351; 11113234; 12391354; 17101830; 23762320
11323	GADL1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=2.72 mM for L-aspartate {ECO:0000269|PubMed:23038267}; KM=1.14 mM for 3-sulfino-L-alanine (cysteine sulfinic acid) {ECO:0000269|PubMed:23038267}; Vmax=1.56 umol/min/mg enzyme toward L-aspartate {ECO:0000269|PubMed:23038267}; Vmax=2.31 umol/min/mg enzyme toward 3-sulfino-L-alanine (cysteine sulfinic acid) {ECO:0000269|PubMed:23038267}; 	4.1.1.11; 4.1.1.29	CATALYTIC ACTIVITY: L-aspartate = beta-alanine + CO(2). {ECO:0000269|PubMed:23038267}.; CATALYTIC ACTIVITY: 3-sulfino-L-alanine = hypotaurine + CO(2). {ECO:0000269|PubMed:23038267}.; CATALYTIC ACTIVITY: H(+) + L-cysteate = CO2 + taurine. {ECO:0000250|UniProtKB:Q80WP8}.			COFACTOR: Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326; Evidence={ECO:0000269|PubMed:23038267}; 						cellular amino acid biosynthetic process [GO:0008652]; sulfur amino acid catabolic process [GO:0000098]	cytosol [GO:0005829]	cytosol [GO:0005829]; aspartate 1-decarboxylase activity [GO:0004068]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; sulfinoalanine decarboxylase activity [GO:0004782]; cellular amino acid biosynthetic process [GO:0008652]; sulfur amino acid catabolic process [GO:0000098]	aspartate 1-decarboxylase activity [GO:0004068]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; sulfinoalanine decarboxylase activity [GO:0004782]	GO:0000098; GO:0004068; GO:0004782; GO:0005829; GO:0008652; GO:0016831; GO:0030170			MOD_RES 333 333 N6-(pyridoxal phosphate)lysine. {ECO:0000250|UniProtKB:Q80WP8}.	17974005; 16641997; 14702039; 15489334; 23038267; 26327310; 22718265; 24369049; 25415457; 28214779	17974005; 16641997; 14702039; 15489334; 23038267; 26327310
11330	GARS	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=1.3 uM for tRNA(Gly(GCC)) {ECO:0000269|PubMed:17544401}; KM=15 uM for glycine {ECO:0000269|PubMed:17544401}; KM=0.74 uM for tRNA(Gly) {ECO:0000269|PubMed:28675565}; Note=Kcat is 0.049 (sec-1) for aminoacylation for tRNA(Gly). {ECO:0000269|PubMed:28675565};	3.6.1.17; 6.1.1.14	CATALYTIC ACTIVITY: ATP + glycine + tRNA(Gly) = AMP + diphosphate + glycyl-tRNA(Gly). {ECO:0000269|PubMed:17544401, ECO:0000269|PubMed:28675565}.; CATALYTIC ACTIVITY: P(1),P(4)-bis(5'-guanosyl) tetraphosphate + H(2)O = GTP + GMP. {ECO:0000269|PubMed:19710017}.	BINDING 213 213 Substrate. {ECO:0000269|PubMed:19710017}.; BINDING 299 299 Substrate. {ECO:0000269|PubMed:19710017}.; BINDING 435 435 Substrate; via carbonyl oxygen. {ECO:0000269|PubMed:19710017}.								diadenosine tetraphosphate biosynthetic process [GO:0015966]; mitochondrial glycyl-tRNA aminoacylation [GO:0070150]; tRNA aminoacylation for protein translation [GO:0006418]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; secretory granule [GO:0030141]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; secretory granule [GO:0030141]; ATP binding [GO:0005524]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; glycine-tRNA ligase activity [GO:0004820]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; mitochondrial glycyl-tRNA aminoacylation [GO:0070150]; tRNA aminoacylation for protein translation [GO:0006418]	ATP binding [GO:0005524]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; glycine-tRNA ligase activity [GO:0004820]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]	GO:0004081; GO:0004820; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006418; GO:0015966; GO:0030141; GO:0030424; GO:0042802; GO:0046983; GO:0070062; GO:0070150	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17035524}. Cell projection, axon {ECO:0000269|PubMed:17035524, ECO:0000269|PubMed:25168514}. Secreted {ECO:0000250|UniProtKB:Q9CZD3}. Secreted, exosome {ECO:0000250|UniProtKB:Q9CZD3}. Note=Secreted by motor neuron, possibly through the exosome pathway (By similarity). In transfected COS7 cells, not detected in mitochondria, nor in Golgi apparatus (PubMed:17035524). {ECO:0000250|UniProtKB:Q9CZD3, ECO:0000269|PubMed:17035524}.		MOD_RES 35 35 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 204 204 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 453 453 Phosphotyrosine. {ECO:0000250|UniProtKB:Q9CZD3}.; MOD_RES 501 501 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 700 700 Phosphoserine. {ECO:0000250|UniProtKB:Q9CZD3}.; MOD_RES 736 736 Phosphothreonine. {ECO:0000244|PubMed:23186163}.	7962006; 7753621; 14702039; 12853948; 15489334; 7961834; 17035524; 19608861; 21269460; 23186163; 25168514; 24275569; 25944712; 17544401; 17545306; 19710017; 12690580; 17101916; 17663003; 20169446; 23279345; 24627108; 24604904; 26244500; 26503042; 28675565; 28594869; 15161933; 16169070; 16534118; 17142907; 17353931; 17595294; 18275849; 19329989; 19412816; 19805454; 20562859; 20877624; 21988832; 22144914; 22345558; 23606334; 24508626; 24807208; 24898252; 25218976; 25277244; 25497084; 25525879; 25609649; 25972375; 26000875; 26327585; 26638075; 26752685; 26797133; 27008886; 27261259; 27348078; 27862672	7962006; 7753621; 14702039; 12853948; 15489334; 7961834; 17035524; 19608861; 21269460; 23186163; 25168514; 24275569; 25944712; 17544401; 17545306; 19710017; 12690580; 17101916; 17663003; 20169446; 23279345; 24627108; 24604904; 26244500; 26503042; 28675565; 28594869
11402	GALE	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=69 uM for UDP-galactose (at 37 degrees Celsius and pH 8.8) {ECO:0000269|PubMed:11117433, ECO:0000269|PubMed:16302980}; Vmax=1.22 mmol/min/mg enzyme with UDP-galactose as substrate {ECO:0000269|PubMed:11117433, ECO:0000269|PubMed:16302980}; 	5.1.3.2; 5.1.3.7	CATALYTIC ACTIVITY: UDP-alpha-D-glucose = UDP-alpha-D-galactose. {ECO:0000269|PubMed:22654673}.; CATALYTIC ACTIVITY: UDP-N-acetyl-alpha-D-glucosamine = UDP-N-acetyl-alpha-D-galactosamine. {ECO:0000269|PubMed:22654673}.	BINDING 88 88 NAD; via carbonyl oxygen. {ECO:0000269|PubMed:10801319, ECO:0000269|PubMed:11279032, ECO:0000269|PubMed:11279193}.; BINDING 92 92 NAD. {ECO:0000269|PubMed:10801319, ECO:0000269|PubMed:11279032, ECO:0000269|PubMed:11279193}.; BINDING 161 161 NAD. {ECO:0000269|PubMed:10801319, ECO:0000269|PubMed:11279032, ECO:0000269|PubMed:11279193}.; BINDING 185 185 NAD. {ECO:0000269|PubMed:10801319}.; BINDING 239 239 Substrate. {ECO:0000269|PubMed:10801319, ECO:0000269|PubMed:11279032, ECO:0000269|PubMed:11279193}.		COFACTOR: Name=NAD(+); Xref=ChEBI:CHEBI:57540; Evidence={ECO:0000269|PubMed:10801319, ECO:0000269|PubMed:22654673, ECO:0000303|PubMed:11279032, ECO:0000303|PubMed:11279193}; 		PATHWAY: Carbohydrate metabolism; galactose metabolism.				galactose catabolic process [GO:0019388]	cytosol [GO:0005829]	cytosol [GO:0005829]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; UDP-glucose 4-epimerase activity [GO:0003978]; UDP-N-acetylglucosamine 4-epimerase activity [GO:0003974]; galactose catabolic process [GO:0019388]	identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; UDP-glucose 4-epimerase activity [GO:0003978]; UDP-N-acetylglucosamine 4-epimerase activity [GO:0003974]	GO:0003974; GO:0003978; GO:0005829; GO:0019388; GO:0042802; GO:0042803				8593531; 9538513; 16385452; 14702039; 16710414; 15489334; 21269460; 22654673; 23732289; 15175331; 24275569; 10801319; 11279032; 11279193; 9326324; 9973283; 11117433; 11903335; 16302980; 16301867; 15639193; 15701638; 16189514; 18188677; 19250319; 19738201; 20711500; 22613355; 23644136; 25150110; 25201731; 25416956; 26162744; 26565537	8593531; 9538513; 16385452; 14702039; 16710414; 15489334; 21269460; 22654673; 23732289; 15175331; 24275569; 10801319; 11279032; 11279193; 9326324; 9973283; 11117433; 11903335; 16302980; 16301867; 15639193
11421	GBA2 KIAA1605 AD035	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.7 uM for 3-beta-D-glucosido-lithocholic {ECO:0000269|PubMed:9111029}; KM=6.2 uM for 3-beta-D-glucosido-chenodeoxycholic {ECO:0000269|PubMed:9111029}; KM=210 uM for beta-D-glucoside {ECO:0000269|PubMed:9111029}; 	3.2.1.45	CATALYTIC ACTIVITY: D-glucosyl-N-acylsphingosine + H(2)O = D-glucose + N-acylsphingosine. {ECO:0000269|PubMed:11489889}.		ACTIVITY REGULATION: Enzymatic activity is dependent on membrane association and requires the presence of lipids. {ECO:0000250}.					AD035		bile acid metabolic process [GO:0008206]; central nervous system neuron development [GO:0021954]; glucosylceramide catabolic process [GO:0006680]; glycoside catabolic process [GO:0016139]; glycosphingolipid metabolic process [GO:0006687]	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]	endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; beta-glucosidase activity [GO:0008422]; glucosylceramidase activity [GO:0004348]; bile acid metabolic process [GO:0008206]; central nervous system neuron development [GO:0021954]; glucosylceramide catabolic process [GO:0006680]; glycoside catabolic process [GO:0016139]; glycosphingolipid metabolic process [GO:0006687]	beta-glucosidase activity [GO:0008422]; glucosylceramidase activity [GO:0004348]	GO:0000139; GO:0004348; GO:0005789; GO:0005790; GO:0005886; GO:0006680; GO:0006687; GO:0008206; GO:0008422; GO:0016021; GO:0016139; GO:0021954	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}; Cytoplasmic side {ECO:0000250}. Golgi apparatus membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}; Cytoplasmic side {ECO:0000250}. Note=Not localized to lipid rafts. {ECO:0000269|PubMed:17105727}.			11489889; 10997877; 14702039; 17974005; 15164053; 15489334; 9111029; 17105727; 23332916; 23332917; 18829375; 19933215; 20427274; 20593214; 20711500; 21724649; 21837367; 22659419; 23073830; 23250757; 23880767; 24070122; 24252062; 24275721; 24337409; 26220345; 26492578; 26496610; 26514267; 26638075; 27115290; 27255555; 27553021; 28052128; 28258214; 29333001	11489889; 10997877; 14702039; 17974005; 15164053; 15489334; 9111029; 17105727; 23332916; 23332917
11457	HMBS PBGD UPS	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=48 uM for porphobilinogen {ECO:0000269|PubMed:23815679}; Vmax=1261 nmol/h/mg enzyme (at 37 degrees Celsius) {ECO:0000269|PubMed:23815679}; 	2.5.1.61	CATALYTIC ACTIVITY: 4 porphobilinogen + H(2)O = hydroxymethylbilane + 4 NH(3).			COFACTOR: Name=dipyrromethane; Xref=ChEBI:CHEBI:60342; ;  Note=Binds 1 dipyrromethane group covalently.;		PATHWAY: Porphyrin-containing compound metabolism; protoporphyrin-IX biosynthesis; coproporphyrinogen-III from 5-aminolevulinate: step 2/4.			BIOPHYSICOCHEMICAL PROPERTIES: ;  Temperature dependence: Displays high thermal stability. The half-denaturation temperature (Tm) is about 74 degrees Celsius. {ECO:0000269|PubMed:23815679};	heme biosynthetic process [GO:0006783]; peptidyl-pyrromethane cofactor linkage [GO:0018160]; protoporphyrinogen IX biosynthetic process [GO:0006782]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; hydroxymethylbilane synthase activity [GO:0004418]; heme biosynthetic process [GO:0006783]; peptidyl-pyrromethane cofactor linkage [GO:0018160]; protoporphyrinogen IX biosynthetic process [GO:0006782]	hydroxymethylbilane synthase activity [GO:0004418]	GO:0004418; GO:0005737; GO:0005829; GO:0006782; GO:0006783; GO:0018160	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.		MOD_RES 2 2 N-acetylserine. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378}.; MOD_RES 15 15 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 69 69 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 74 74 N6-acetyllysine. {ECO:0000250|UniProtKB:P22907}.; MOD_RES 147 147 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 261 261 S-(dipyrrolylmethanemethyl)cysteine.	2875434; 3816774; 7916736; 14702039; 16554811; 15489334; 3422427; 2609111; 19413330; 21269460; 22223895; 22814378; 23186163; 24275569; 19207107; 18936296; 2243128; 1714233; 1496994; 1427766; 1301948; 8262523; 8401516; 8268934; 8270254; 8270256; 8081367; 7866402; 7962538; 7757070; 8825929; 9199558; 9225970; 9654202; 9463797; 10494093; 10453740; 10502788; 10657149; 10602775; 11399210; 11030413; 10782018; 11013452; 12406973; 12372055; 11857754; 12773194; 14757946; 14669009; 14970743; 15669678; 16211556; 18406650; 19138865; 19292878; 23815679; 25703257; 25870942; 11202057; 11831862; 11940707; 1358185; 1358782; 15003823; 15643298; 16390615; 16817012; 16935474; 17298216; 17298217; 17459418; 18070416; 18405488; 18554962; 18627369; 19656452; 19656453; 19913121; 20536026; 20580577; 20628086; 20978940; 21669542; 22748422; 23811755; 24705354; 25389600; 25445397; 25923088; 26062020; 26228342; 26287972; 27769855; 27849156; 7354069; 8094629	2875434; 3816774; 7916736; 14702039; 16554811; 15489334; 3422427; 2609111; 19413330; 21269460; 22223895; 22814378; 23186163; 24275569; 19207107; 18936296; 2243128; 1714233; 1496994; 1427766; 1301948; 8262523; 8401516; 8268934; 8270254; 8270256; 8081367; 7866402; 7962538; 7757070; 8825929; 9199558; 9225970; 9654202; 9463797; 10494093; 10453740; 10502788; 10657149; 10602775; 11399210; 11030413; 10782018; 11013452; 12406973; 12372055; 11857754; 12773194; 14757946; 14669009; 14970743; 15669678; 16211556; 18406650; 19138865; 19292878; 23815679; 25703257; 25870942
11467	G6PC3 UGRP	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=1.0 mM for glucose-6-phosphate (at pH 5.5) {ECO:0000269|PubMed:12965222, ECO:0000269|PubMed:13129915}; KM=2.0 mM for glucose-6-phosphate (at pH 6.5) {ECO:0000269|PubMed:12965222, ECO:0000269|PubMed:13129915}; Note=8 times less active compared to G6PC under the same experimental conditions.;	3.1.3.9	CATALYTIC ACTIVITY: D-glucose 6-phosphate + H(2)O = D-glucose + phosphate. {ECO:0000269|PubMed:12965222}.	BINDING 79 79 Substrate. {ECO:0000255}.; BINDING 161 161 Substrate. {ECO:0000255}.	ACTIVITY REGULATION: Inhibited by vanadate. {ECO:0000269|PubMed:13129915}.			PATHWAY: Carbohydrate biosynthesis; gluconeogenesis.				gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose-6-phosphate transport [GO:0015760]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; glucose-6-phosphatase activity [GO:0004346]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose-6-phosphate transport [GO:0015760]	glucose-6-phosphatase activity [GO:0004346]	GO:0004346; GO:0005783; GO:0005789; GO:0006094; GO:0015760; GO:0016020; GO:0030176; GO:0051156	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:13129915}; Multi-pass membrane protein {ECO:0000269|PubMed:13129915}.			15489334; 12370122; 12965222; 13129915; 14718531; 14765991; 19118303; 20799326; 20616219; 20220065; 22469094; 22050868; 24105461; 23298686; 23018568; 24750412; 25492228; 18337100; 20498302; 20717171; 21048031; 21206270; 21264919; 21385794; 21677667; 21891829; 23180359; 23454784; 23758768; 24322501; 24796372; 25284454; 25391451; 25491320; 26479985; 27571123; 27793029; 28713988	15489334; 12370122; 12965222; 13129915; 14718531; 14765991; 19118303; 20799326; 20616219; 20220065; 22469094; 22050868; 24105461; 23298686; 23018568; 24750412; 25492228
11504	PYCR1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.151 mM for NAD(+) {ECO:0000269|PubMed:16730026}; KM=3.06 mM for NADP(+) {ECO:0000269|PubMed:16730026}; 	1.5.1.2	CATALYTIC ACTIVITY: L-proline + NAD(P)(+) = 1-pyrroline-5-carboxylate + NAD(P)H. {ECO:0000269|PubMed:16730026}.	BINDING 34 34 NADP; via carbonyl oxygen. {ECO:0000269|Ref.18}.; BINDING 56 56 NADP. {ECO:0000269|Ref.18}.	ACTIVITY REGULATION: Subject to competitive inhibition by the reaction product proline. Subject to competitive inhibition by stearoyl coenzyme A. {ECO:0000269|PubMed:16730026}.			PATHWAY: Amino-acid biosynthesis; L-proline biosynthesis; L-proline from L-glutamate 5-semialdehyde: step 1/1.				cellular amino acid biosynthetic process [GO:0008652]; cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; proline biosynthetic process [GO:0006561]; regulation of mitochondrial membrane potential [GO:0051881]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; pyrroline-5-carboxylate reductase activity [GO:0004735]; cellular amino acid biosynthetic process [GO:0008652]; cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; proline biosynthetic process [GO:0006561]; regulation of mitochondrial membrane potential [GO:0051881]	identical protein binding [GO:0042802]; pyrroline-5-carboxylate reductase activity [GO:0004735]	GO:0004735; GO:0005739; GO:0005759; GO:0006561; GO:0008652; GO:0034599; GO:0042802; GO:0051881; GO:0055129; GO:1903206	SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:19648921}.		MOD_RES 2 2 N-acetylserine. {ECO:0000244|PubMed:19413330, ECO:0000269|Ref.8, ECO:0000269|Ref.9}.; MOD_RES 278 278 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 301 301 Phosphoserine. {ECO:0000244|PubMed:23186163}.	1730675; 14702039; 16625196; 15489334; 19413330; 19648921; 20068231; 21269460; 23186163; 24930674; 25944712; 16730026; 19576563; 22052856; 18847512; 20869947; 21204221; 21487760; 21567914; 21900206; 21988832; 22323290; 22623428; 23024808; 23531708; 23743200; 24035636; 24431009; 24725412; 25525879; 25609649; 26496610; 26638075; 26733354; 2722838; 27677826; 28078560; 28194412; 28258219; 28379297	1730675; 14702039; 16625196; 15489334; 19413330; 19648921; 20068231; 21269460; 23186163; 24930674; 25944712; 16730026; 19576563; 22052856
11505	PYCR2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.64 mM for NADH {ECO:0000269|PubMed:2722838}; KM=0.04 mM for NADPH {ECO:0000269|PubMed:2722838}; KM=1.49 mM for pyrroline-5-carboxylate (in the presence of NADH) {ECO:0000269|PubMed:2722838}; KM=0.23 mM for pyrroline-5-carboxylate (in the presence of NADPH) {ECO:0000269|PubMed:2722838}; Vmax=28.5 umol/min/ug enzyme (in the presence of NADH) {ECO:0000269|PubMed:2722838}; Vmax=3.7 umol/min/ug enzyme (in the presence of NADPH) {ECO:0000269|PubMed:2722838}; 	1.5.1.2	CATALYTIC ACTIVITY: L-proline + NAD(P)(+) = 1-pyrroline-5-carboxylate + NAD(P)H. {ECO:0000269|PubMed:2722838, ECO:0000269|PubMed:6894153}.	BINDING 34 34 NADP; via carbonyl oxygen. {ECO:0000250}.; BINDING 56 56 NADP. {ECO:0000250}.	ACTIVITY REGULATION: Subject to competitive inhibition by NADP. Not inhibited by proline. {ECO:0000269|PubMed:2722838, ECO:0000269|PubMed:6894153}.			PATHWAY: Amino-acid biosynthesis; L-proline biosynthesis; L-proline from L-glutamate 5-semialdehyde: step 1/1.				cellular amino acid biosynthetic process [GO:0008652]; cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; proline biosynthetic process [GO:0006561]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyrroline-5-carboxylate reductase activity [GO:0004735]; cellular amino acid biosynthetic process [GO:0008652]; cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; proline biosynthetic process [GO:0006561]	pyrroline-5-carboxylate reductase activity [GO:0004735]	GO:0004735; GO:0005739; GO:0005759; GO:0006561; GO:0008652; GO:0034599; GO:0055129	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:2722838}. Mitochondrion {ECO:0000269|PubMed:23024808, ECO:0000269|PubMed:25865492}.		MOD_RES 2 2 N-acetylserine. {ECO:0000269|Ref.6}.; MOD_RES 304 304 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.	14702039; 16710414; 15489334; 6894153; 2722838; 16964243; 18669648; 19413330; 20068231; 21269460; 21406692; 23024808; 23186163; 24930674; 25865492; 25944712; 14743216; 15231748; 16713569; 17353931; 18234856; 18847512; 19119138; 19738201; 20186120; 20869947; 22593156; 23663784; 25036637; 25525879; 26496610; 26634742; 26638075; 26733354; 27130255; 9514741	14702039; 16710414; 15489334; 6894153; 2722838; 16964243; 18669648; 19413330; 20068231; 21269460; 21406692; 23024808; 23186163; 24930674; 25865492; 25944712
11508	PLA2G4B	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: Vmax=7.9 pmol/min/mg enzyme (isoform 5) {ECO:0000269|PubMed:10085124}; Vmax=3.6 pmol/min/ug enzyme with cAMP as substrate (isoform 4) {ECO:0000269|PubMed:10085124}; Vmax=140 nmol/min/ug enzyme with 1-[14C]16:0-2-lyso-PC as substrate (isoform 5) {ECO:0000269|PubMed:10085124}; Vmax=1.6 nmol/min/ug enzyme with 1-[14C]16:0-2-lyso-PC as substrate (isoform 3) {ECO:0000269|PubMed:10085124}; Vmax=2.1 nmol/min/ug enzyme with 1-16:0-2-[14C]20:4-PC as substrate (isoform 5) {ECO:0000269|PubMed:10085124}; Vmax=0.6 nmol/min/ug enzyme with 1-16:0-2-[14C]20:4-PE as substrate (isoform 5) {ECO:0000269|PubMed:10085124}; Vmax=0.8 nmol/min/ug enzyme with 1-16:0-2-[14C]20:4-PE as substrate (isoform 3) {ECO:0000269|PubMed:10085124}; Vmax=0.3 nmol/min/ug enzyme with 1-16:0-2-[14C]18:2-PE as substrate (isoform 3) {ECO:0000269|PubMed:10085124}; 	3.1.1.4	CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-acylglycerophosphocholine + a carboxylate. {ECO:0000269|PubMed:10085124, ECO:0000269|PubMed:10358058, ECO:0000269|PubMed:16617059}.		ACTIVITY REGULATION: Stimulated by cytosolic Ca(2+). {ECO:0000269|PubMed:10085124, ECO:0000269|PubMed:10358058}.							arachidonic acid metabolic process [GO:0019369]; calcium-mediated signaling [GO:0019722]; glycerophospholipid catabolic process [GO:0046475]; inflammatory response [GO:0006954]; IRE1-mediated unfolded protein response [GO:0036498]; parturition [GO:0007567]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid metabolic process [GO:0006644]	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extracellular region [GO:0005576]; mitochondrial inner membrane [GO:0005743]	cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extracellular region [GO:0005576]; mitochondrial inner membrane [GO:0005743]; calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; calcium-dependent phospholipid binding [GO:0005544]; lysophospholipase activity [GO:0004622]; phosphatidylcholine 1-acylhydrolase activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; arachidonic acid metabolic process [GO:0019369]; calcium-mediated signaling [GO:0019722]; glycerophospholipid catabolic process [GO:0046475]; inflammatory response [GO:0006954]; IRE1-mediated unfolded protein response [GO:0036498]; parturition [GO:0007567]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid metabolic process [GO:0006644]	calcium-dependent phospholipase A2 activity [GO:0047498]; calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; lysophospholipase activity [GO:0004622]; phosphatidylcholine 1-acylhydrolase activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]	GO:0004622; GO:0004623; GO:0005509; GO:0005544; GO:0005576; GO:0005743; GO:0005829; GO:0006644; GO:0006654; GO:0006954; GO:0007567; GO:0008970; GO:0019369; GO:0019722; GO:0031901; GO:0036148; GO:0036150; GO:0036151; GO:0036152; GO:0036498; GO:0046475; GO:0047498; GO:0102567; GO:0102568	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:16617059}.; SUBCELLULAR LOCATION: Isoform 3: Mitochondrion membrane; Peripheral membrane protein. Early endosome membrane; Peripheral membrane protein. Note=Translocates to membrane vesicles in a calcium-dependent fashion.			10085124; 10358058; 16617059; 14702039; 16572171; 10092647; 10336645; 12359733; 14709560; 15944408; 16539657; 18614531; 19019078; 1904318; 19501189; 20705608; 20711500; 23416715; 24835590; 8083230; 9417066; 9705332	10085124; 10358058; 16617059; 14702039; 16572171
11518	PAFAH2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=42 uM for 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine (PAF) {ECO:0000269|PubMed:9494101}; KM=10 uM for 1-decanoyl-2-(4-nitrophenylglutaryl) phosphate (DNGP) {ECO:0000269|PubMed:9494101}; Vmax=35 umol/min/mg enzyme with 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine (PAF) as substrate {ECO:0000269|PubMed:9494101}; Vmax=1.7 umol/min/mg enzyme with 1-decanoyl-2-(4-nitrophenylglutaryl) phosphate (DNGP) as substrate {ECO:0000269|PubMed:9494101}; 	3.1.1.47	CATALYTIC ACTIVITY: 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine + H(2)O = 1-alkyl-sn-glycero-3-phosphocholine + acetate. {ECO:0000269|PubMed:9494101}.		ACTIVITY REGULATION: Inhibited by phenylmethanesulfonyl fluoride, 3,4,dichloroisocoumarin, diisopropyl fluorophosphate (DFP) and diethyl p-nitrophenyl phosphate (DENP). {ECO:0000269|PubMed:9494101}.							blood coagulation [GO:0007596]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]	endoplasmic reticulum membrane [GO:0005789]	endoplasmic reticulum membrane [GO:0005789]; 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; phospholipid binding [GO:0005543]; blood coagulation [GO:0007596]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]	1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; phospholipid binding [GO:0005543]	GO:0003847; GO:0005543; GO:0005789; GO:0006629; GO:0007596; GO:0016042; GO:0043066	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:9494101}. Membrane {ECO:0000250|UniProtKB:P79106}; Lipid-anchor {ECO:0000250|UniProtKB:P79106}. Endoplasmic reticulum membrane {ECO:0000250|UniProtKB:P79106}; Lipid-anchor {ECO:0000250|UniProtKB:P79106}. Note=In resting cells, localizes to intracellular membranes and cytoplasm. Translocates from the cytoplasm to intracellular membranes upon oxidative stress. {ECO:0000250|UniProtKB:P79106}.			8955149; 9494101; 16710414; 15489334; 9218411; 11294621; 12406338; 16650870; 17157859; 17272759; 21882811; 25707358; 26791393	8955149; 9494101; 16710414; 15489334; 9218411
11576	PADI4 PAD4 PADI5 PDI5	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.055 mM for fibrinogen {ECO:0000269|PubMed:15629448}; KM=0.064 mM for filaggrin {ECO:0000269|PubMed:15629448}; Vmax=33.2 umol/h/mg enzyme toward fibrinogen {ECO:0000269|PubMed:15629448}; Vmax=8.0 umol/h/mg enzyme toward filaggrin {ECO:0000269|PubMed:15629448}; 	3.5.3.15	CATALYTIC ACTIVITY: Protein L-arginine + H(2)O = protein L-citrulline + NH(3). {ECO:0000269|PubMed:16567635, ECO:0000269|PubMed:21245532}.	BINDING 346 346 TDFA Inhibitor. {ECO:0000269|PubMed:22004374}.; BINDING 369 369 TDFA Inhibitor. {ECO:0000269|PubMed:22004374}.; BINDING 374 374 Substrate.; BINDING 374 374 TDFA Inhibitor. {ECO:0000269|PubMed:22004374}.; BINDING 471 471 TDFA Inhibitor. {ECO:0000269|PubMed:22004374}.; BINDING 473 473 TDFA Inhibitor. {ECO:0000269|PubMed:22004374}.; BINDING 639 639 Substrate; via carbonyl oxygen.; BINDING 645 645 TDFA Inhibitor. {ECO:0000269|PubMed:22004374}.	ACTIVITY REGULATION: Strongly Inhibited by F-amidine and N-alpha-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide (Cl-amidine). These inhibitors are however not specific to PADI4 and also inhibit other members of the family (PubMed:17002273). Incorporation of a carboxylate ortho to the backbone amide of Cl-amidine results in inhibitors with increased specificity for PADI4: N-alpha-(2-carboxyl)benzoyl-N(5)-(2-fluoro-1-iminoethyl)-L-ornithine amide (o-F-amidine) and N-alpha-(2-carboxyl)benzoyl-N(5)-(2-chloro-1-iminoethyl)-L-ornithine amide (o-Cl-amidine) (PubMed:21882827). Strongly and specifically inhibited by Thr-Asp-F-amidine (TDFA); other members of the family are not inhibited (PubMed:22004374). {ECO:0000269|PubMed:17002273, ECO:0000269|PubMed:21882827, ECO:0000269|PubMed:22004374}.	COFACTOR: Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000269|PubMed:15629448, ECO:0000269|PubMed:16567635, ECO:0000269|PubMed:17002273}; ;  Note=Binds 5 Ca(2+) ions per subunit. {ECO:0000269|PubMed:15629448, ECO:0000269|PubMed:16567635, ECO:0000269|PubMed:17002273};	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 6.5-9.0. {ECO:0000269|PubMed:15629448};					arginine deiminase pathway [GO:0019546]; cellular protein modification process [GO:0006464]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; histone citrullination [GO:0036414]; histone H3-R26 citrullination [GO:0036413]; innate immune response [GO:0045087]; nucleosome assembly [GO:0006334]; protein citrullination [GO:0018101]; regulation of transcription, DNA-templated [GO:0006355]; stem cell population maintenance [GO:0019827]; transcription, DNA-templated [GO:0006351]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; arginine binding [GO:0034618]; arginine deiminase activity [GO:0016990]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; protein-arginine deiminase activity [GO:0004668]; arginine deiminase pathway [GO:0019546]; cellular protein modification process [GO:0006464]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; histone citrullination [GO:0036414]; histone H3-R26 citrullination [GO:0036413]; innate immune response [GO:0045087]; nucleosome assembly [GO:0006334]; protein citrullination [GO:0018101]; regulation of transcription, DNA-templated [GO:0006355]; stem cell population maintenance [GO:0019827]; transcription, DNA-templated [GO:0006351]	arginine binding [GO:0034618]; arginine deiminase activity [GO:0016990]; calcium ion binding [GO:0005509]; protein-arginine deiminase activity [GO:0004668]; protein homodimerization activity [GO:0042803]	GO:0004668; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006325; GO:0006334; GO:0006338; GO:0006351; GO:0006355; GO:0006464; GO:0016990; GO:0018101; GO:0019546; GO:0019827; GO:0032991; GO:0034618; GO:0036413; GO:0036414; GO:0042803; GO:0045087	SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Cytoplasmic granule. Note=Cytoplasmic granules of eosinophils and neutrophils.	PTM: Autocitrullination at Arg-372 and Arg-374 inactivates the enzyme.	MOD_RES 205 205 Citrulline. {ECO:0000269|PubMed:20201080}.; MOD_RES 212 212 Citrulline. {ECO:0000269|PubMed:20201080}.; MOD_RES 218 218 Citrulline. {ECO:0000269|PubMed:20201080}.; MOD_RES 372 372 Citrulline. {ECO:0000269|PubMed:20201080}.; MOD_RES 374 374 Citrulline. {ECO:0000269|PubMed:20201080}.; MOD_RES 383 383 Citrulline. {ECO:0000269|PubMed:20201080}.	10488123; 15087120; 14702039; 16710414; 15489334; 11435484; 12833157; 15339660; 15345777; 15629448; 15731352; 18209087; 20201080; 15247907; 16567635; 17002273; 21245532; 21882827; 22004374; 15338034; 11069618; 12392711; 12393868; 12416996; 15077293; 15731287; 15814578; 15883854; 15998632; 16060666; 16200584; 16355400; 16380915; 16385500; 16449362; 16469113; 16502257; 16519819; 16828881; 17216583; 17265154; 17303166; 17353931; 17469103; 17888206; 17911417; 17968929; 17980669; 18087673; 18292109; 18398945; 18462498; 18466472; 18466513; 18505818; 18576335; 18633125; 18668562; 18764812; 18849993; 19004619; 19158815; 19199100; 19199253; 19332633; 19470526; 19843866; 20039406; 20190809; 20233754; 20476860; 20496417; 20537173; 20563870; 20584675; 20630876; 20827398; 21039740; 21062850; 21267570; 21418828; 21454715; 21466234; 21584310; 21655091; 21698003; 21731701; 21981985; 22334079; 22459419; 22552437; 22614825; 22907585; 22944128; 22976394; 23028349; 23164236; 23214088; 23382808; 23450494; 23577190; 23698378; 23818587; 24140127; 24454473; 24510904; 24564960; 24594197; 24874575; 24901704; 25138370; 25205591; 25416956; 25562673; 25622091; 26019128; 26043831; 26082376; 26149185; 26245941; 26255191; 26415740; 26474773; 26546893; 26563365; 26673819; 27051025; 27176594; 27182695; 27372294; 27556695; 27700100; 27706751; 28182665; 28328217; 28551357; 28653215; 28832760; 29039504; 29148420; 29302826; 29393388; 29518108; 29734142	10488123; 15087120; 14702039; 16710414; 15489334; 11435484; 12833157; 15339660; 15345777; 15629448; 15731352; 18209087; 20201080; 15247907; 16567635; 17002273; 21245532; 21882827; 22004374; 15338034
11616	MFSD5 UNQ832/PRO1759	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=546 nM for molybdate (when expressed in yeast) {ECO:0000269|PubMed:21464289}; 									UNQ832/PRO1759			integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; molybdate ion transmembrane transporter activity [GO:0015098]	molybdate ion transmembrane transporter activity [GO:0015098]	GO:0005886; GO:0015098; GO:0016020; GO:0016021	SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.			12975309; 17974005; 14702039; 16303743; 16541075; 15489334; 21044875; 21464289; 20953506; 21516116; 21988832; 25416956	12975309; 17974005; 14702039; 16303743; 16541075; 15489334; 21044875; 21464289
11626	IPPK C9orf12	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.43 uM for Ins(1,3,4,5,6)P5 {ECO:0000269|PubMed:12084730}; KM=21 uM for ATP {ECO:0000269|PubMed:12084730}; Vmax=31 nmol/min/mg enzyme {ECO:0000269|PubMed:12084730}; 	2.7.1.158	CATALYTIC ACTIVITY: ATP + 1D-myo-inositol 1,3,4,5,6-pentakisphosphate = ADP + 1D-myo-inositol hexakisphosphate. {ECO:0000269|PubMed:12084730}.									inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; inositol phosphorylation [GO:0052746]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]	cytosol [GO:0005829]; intracellular [GO:0005622]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytosol [GO:0005829]; intracellular [GO:0005622]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; inositol pentakisphosphate 2-kinase activity [GO:0035299]; protein-containing complex scaffold activity [GO:0032947]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; inositol phosphorylation [GO:0052746]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]	ATP binding [GO:0005524]; inositol pentakisphosphate 2-kinase activity [GO:0035299]; protein-containing complex scaffold activity [GO:0032947]	GO:0005524; GO:0005622; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0032947; GO:0032958; GO:0035299; GO:0043647; GO:0052746; GO:1901838	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}.		MOD_RES 282 282 Phosphoserine. {ECO:0000244|PubMed:23186163}.	12084730; 14702039; 15164053; 15489334; 15967797; 23186163; 17702752; 17705785; 23487458; 24165122; 26976604; 29746542	12084730; 14702039; 15164053; 15489334; 15967797; 23186163
11646	IYD C6orf71 DEHAL1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=2.67 uM for L-DIT {ECO:0000269|PubMed:15289438}; KM=1.35 uM for L-MIT {ECO:0000269|PubMed:15289438}; 	1.21.1.1	CATALYTIC ACTIVITY: L-tyrosine + 2 NADP(+) + 2 iodide = 3,5-diiodo-L-tyrosine + 2 NADPH. {ECO:0000269|PubMed:15289438, ECO:0000269|PubMed:18434651, ECO:0000269|PubMed:25395621}.	BINDING 128 128 FMN; via amide nitrogen. {ECO:0000244|PDB:4TTC, ECO:0000269|PubMed:25395621}.; BINDING 130 130 Substrate; via amide nitrogen. {ECO:0000244|PDB:4TTC}.; BINDING 157 157 Substrate. {ECO:0000244|PDB:4TTC, ECO:0000269|PubMed:25395621}.; BINDING 161 161 Substrate. {ECO:0000244|PDB:4TTC, ECO:0000269|PubMed:25395621}.; BINDING 182 182 Substrate. {ECO:0000244|PDB:4TTC, ECO:0000269|PubMed:25395621}.; BINDING 279 279 FMN. {ECO:0000244|PDB:4TTB, ECO:0000244|PDB:4TTC, ECO:0000269|PubMed:25395621}.		COFACTOR: Name=FMN; Xref=ChEBI:CHEBI:58210; Evidence={ECO:0000269|PubMed:25395621}; 						oxidation-reduction process [GO:0055114]; thyroid hormone generation [GO:0006590]; thyroid hormone metabolic process [GO:0042403]; tyrosine metabolic process [GO:0006570]	cytoplasmic vesicle membrane [GO:0030659]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	cytoplasmic vesicle membrane [GO:0030659]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; FMN binding [GO:0010181]; iodide peroxidase activity [GO:0004447]; oxidoreductase activity [GO:0016491]; oxidation-reduction process [GO:0055114]; thyroid hormone generation [GO:0006590]; thyroid hormone metabolic process [GO:0042403]; tyrosine metabolic process [GO:0006570]	FMN binding [GO:0010181]; iodide peroxidase activity [GO:0004447]; oxidoreductase activity [GO:0016491]	GO:0004447; GO:0005654; GO:0005886; GO:0005887; GO:0006570; GO:0006590; GO:0010181; GO:0016491; GO:0030659; GO:0042403; GO:0055114	SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15289438}; Single-pass membrane protein {ECO:0000269|PubMed:15289438}. Cytoplasmic vesicle membrane {ECO:0000269|PubMed:15289438}.			14574404; 15489334; 14702039; 15289438; 24275569; 25395621; 18434651; 16910871; 17322488; 18765512; 20298747; 21870604; 22535972; 25416956; 26151430; 30052294	14574404; 15489334; 14702039; 15289438; 24275569; 25395621; 18434651
11658	JMJD6 KIAA0585 PTDSR	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=39 uM for 2-oxoglutarate {ECO:0000269|PubMed:20684070}; 	1.14.11.-		BINDING 184 184 Substrate. {ECO:0000250}.; BINDING 197 197 2-oxoglutarate. {ECO:0000269|PubMed:20679243}.; BINDING 204 204 Substrate. {ECO:0000250}.; BINDING 285 285 2-oxoglutarate. {ECO:0000269|PubMed:20679243}.		COFACTOR: Name=Fe(2+); Xref=ChEBI:CHEBI:29033; Evidence={ECO:0000269|PubMed:19574390}; ;  Note=Binds 1 Fe(2+) ion per subunit. {ECO:0000269|PubMed:19574390};						cell surface receptor signaling pathway [GO:0007166]; erythrocyte development [GO:0048821]; heart development [GO:0007507]; histone H3-R2 demethylation [GO:0070078]; histone H4-R3 demethylation [GO:0070079]; kidney development [GO:0001822]; lung development [GO:0030324]; macrophage activation [GO:0042116]; mRNA processing [GO:0006397]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]; positive regulation of transcription, DNA-templated [GO:0045893]; recognition of apoptotic cell [GO:0043654]; regulation of mRNA splicing, via spliceosome [GO:0048024]; retina development in camera-type eye [GO:0060041]; RNA splicing [GO:0008380]; sprouting angiogenesis [GO:0002040]; T cell differentiation in thymus [GO:0033077]; transcription, DNA-templated [GO:0006351]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-R2 specific) [GO:0033746]; histone demethylase activity (H4-R3 specific) [GO:0033749]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; signaling receptor activity [GO:0038023]; single-stranded RNA binding [GO:0003727]; transcription coactivator activity [GO:0003713]; cell surface receptor signaling pathway [GO:0007166]; erythrocyte development [GO:0048821]; heart development [GO:0007507]; histone H3-R2 demethylation [GO:0070078]; histone H4-R3 demethylation [GO:0070079]; kidney development [GO:0001822]; lung development [GO:0030324]; macrophage activation [GO:0042116]; mRNA processing [GO:0006397]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]; positive regulation of transcription, DNA-templated [GO:0045893]; recognition of apoptotic cell [GO:0043654]; regulation of mRNA splicing, via spliceosome [GO:0048024]; retina development in camera-type eye [GO:0060041]; RNA splicing [GO:0008380]; sprouting angiogenesis [GO:0002040]; T cell differentiation in thymus [GO:0033077]; transcription, DNA-templated [GO:0006351]	histone demethylase activity [GO:0032452]; histone demethylase activity (H3-R2 specific) [GO:0033746]; histone demethylase activity (H4-R3 specific) [GO:0033749]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; signaling receptor activity [GO:0038023]; single-stranded RNA binding [GO:0003727]; transcription coactivator activity [GO:0003713]	GO:0001822; GO:0002040; GO:0003713; GO:0003723; GO:0003727; GO:0005506; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0006351; GO:0006397; GO:0007166; GO:0007507; GO:0008380; GO:0018395; GO:0030324; GO:0032452; GO:0033077; GO:0033746; GO:0033749; GO:0038023; GO:0042116; GO:0042802; GO:0042803; GO:0043654; GO:0045893; GO:0048024; GO:0048821; GO:0060041; GO:0070078; GO:0070079; GO:0070815; GO:1990904	SUBCELLULAR LOCATION: Nucleus, nucleoplasm. Nucleus, nucleolus. Note=Mainly found throughout the nucleoplasm outside of regions containing heterochromatic DNA, with some localization in nucleolus. During mitosis, excluded from the nucleus and reappears in the telophase of the cell cycle.		MOD_RES 38 38 Phosphoserine. {ECO:0000244|PubMed:23186163}.	9628581; 14702039; 16625196; 15489334; 14729065; 15072554; 15622002; 17947579; 19574390; 21060799; 21269460; 21555454; 23186163; 20684070; 20679243; 11877474; 15345036; 17534701; 18564434; 19492415; 20685276; 21300889; 22189873; 22621393; 22701020; 23303181; 23455924; 23595221; 23688307; 24360279; 24667498; 25219359; 25416956; 25951181; 26037477; 26819475; 27081402; 27613418; 27899633; 28684529; 28882645; 29176719; 29187213; 29229759	9628581; 14702039; 16625196; 15489334; 14729065; 15072554; 15622002; 17947579; 19574390; 21060799; 21269460; 21555454; 23186163; 20684070; 20679243
11667	AK8 C9orf98	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=4.1 uM for AMP {ECO:0000269|PubMed:21080915}; KM=630 uM for dAMP {ECO:0000269|PubMed:21080915}; KM=1.4 uM for CMP {ECO:0000269|PubMed:21080915}; Vmax=2400 pmol/min/ug enzyme with AMP as substrate {ECO:0000269|PubMed:21080915}; Vmax=1360 pmol/min/ug enzyme with dAMP as substrate {ECO:0000269|PubMed:21080915}; Vmax=190 pmol/min/ug enzyme with CMP as substrate {ECO:0000269|PubMed:21080915}; 	2.7.4.3; 2.7.4.6	CATALYTIC ACTIVITY: ATP + AMP = 2 ADP. {ECO:0000269|PubMed:21080915}.; CATALYTIC ACTIVITY: ATP + nucleoside diphosphate = ADP + nucleoside triphosphate. {ECO:0000269|PubMed:21080915, ECO:0000269|PubMed:23416111}.	BINDING 147 147 AMP 1. {ECO:0000250|UniProtKB:P69441}.; BINDING 203 203 AMP 1. {ECO:0000250|UniProtKB:P69441}.; BINDING 361 361 AMP 2. {ECO:0000250|UniProtKB:P69441}.; BINDING 392 392 ATP 2. {ECO:0000250|UniProtKB:P69441}.								nucleobase-containing small molecule interconversion [GO:0015949]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; ventricular system development [GO:0021591]	axoneme [GO:0005930]; cytosol [GO:0005829]; sperm flagellum [GO:0036126]	axoneme [GO:0005930]; cytosol [GO:0005829]; sperm flagellum [GO:0036126]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside kinase activity [GO:0019206]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; ventricular system development [GO:0021591]	adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside kinase activity [GO:0019206]	GO:0004017; GO:0004127; GO:0004550; GO:0005524; GO:0005829; GO:0005930; GO:0006165; GO:0009142; GO:0015949; GO:0019206; GO:0021591; GO:0036126	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:21080915}.			14702039; 15164053; 15489334; 21080915; 23416111; 10215863; 19240061; 20379614; 23455924; 25416956	14702039; 15164053; 15489334; 21080915; 23416111
11688	ITPA C20orf37 My049 OK/SW-cl.9	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=0.51 mM for ITP {ECO:0000269|PubMed:11278832, ECO:0000269|PubMed:17090528}; KM=0.31 mM for dITP {ECO:0000269|PubMed:11278832, ECO:0000269|PubMed:17090528}; KM=0.57 mM for XTP {ECO:0000269|PubMed:11278832, ECO:0000269|PubMed:17090528}; KM=40.7 uM for dHAPTP {ECO:0000269|PubMed:11278832, ECO:0000269|PubMed:17090528}; KM=933 uM for dGTP {ECO:0000269|PubMed:11278832, ECO:0000269|PubMed:17090528}; Vmax=1520 umol/min/mg enzyme for ITP {ECO:0000269|PubMed:11278832, ECO:0000269|PubMed:17090528}; Vmax=940 umol/min/mg enzyme for dITP {ECO:0000269|PubMed:11278832, ECO:0000269|PubMed:17090528}; Vmax=1680 umol/min/mg enzyme for XTP {ECO:0000269|PubMed:11278832, ECO:0000269|PubMed:17090528}; Note=Vmax values are similar for dITP, dHAPTP and dGTP.;	3.6.1.9	CATALYTIC ACTIVITY: A nucleoside triphosphate + H(2)O = a nucleotide + diphosphate. {ECO:0000255|HAMAP-Rule:MF_03148, ECO:0000269|PubMed:17090528}.	BINDING 56 56 Substrate.; BINDING 172 172 Substrate.		COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:17138556}; ;  Note=Binds 1 Mg(2+) ion per subunit. {ECO:0000269|PubMed:17138556};	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 10. {ECO:0000269|PubMed:11278832, ECO:0000269|PubMed:17090528};			My049 OK/SW-cl.9		chromosome organization [GO:0051276]; deoxyribonucleoside triphosphate catabolic process [GO:0009204]; ITP catabolic process [GO:0006193]; nucleoside triphosphate catabolic process [GO:0009143]; purine nucleotide catabolic process [GO:0006195]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dITP diphosphatase activity [GO:0035870]; identical protein binding [GO:0042802]; ITP diphosphatase activity [GO:0036220]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; nucleotide binding [GO:0000166]; XTP diphosphatase activity [GO:0036222]; chromosome organization [GO:0051276]; deoxyribonucleoside triphosphate catabolic process [GO:0009204]; ITP catabolic process [GO:0006193]; nucleoside triphosphate catabolic process [GO:0009143]; purine nucleotide catabolic process [GO:0006195]	dITP diphosphatase activity [GO:0035870]; identical protein binding [GO:0042802]; ITP diphosphatase activity [GO:0036220]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; nucleotide binding [GO:0000166]; XTP diphosphatase activity [GO:0036222]	GO:0000166; GO:0005737; GO:0005829; GO:0006193; GO:0006195; GO:0009143; GO:0009204; GO:0035529; GO:0035870; GO:0036220; GO:0036222; GO:0042802; GO:0046872; GO:0047429; GO:0051276	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_03148, ECO:0000269|PubMed:11278832}.		MOD_RES 2 2 N-acetylalanine. {ECO:0000255|HAMAP-Rule:MF_03148, ECO:0000269|Ref.9}.	11278832; 11780052; 15489334; 17090528; 21269460; 26224535; 17077483; 17138556; 12384777; 12436200; 15167706; 15322947; 15564886; 15571265; 15571266; 15946879; 15973722; 16214825; 16431304; 16611274; 16947783; 17113761; 17304144; 17530705; 17697198; 18223458; 18240903; 18685564; 18823306; 19193698; 19214663; 19229528; 19579612; 19631656; 19682085; 19858780; 19914375; 19956635; 20045992; 20081199; 20173735; 20308917; 20393862; 20547162; 20637204; 20711500; 20930204; 20977565; 21246582; 21612542; 21817190; 22052220; 22060550; 22189977; 22225964; 22272297; 22384212; 22430973; 22460221; 22554247; 22584257; 22585729; 23126166; 23139603; 23195617; 23301546; 23528839; 23538996; 23547827; 23730840; 23770441; 23850877; 23933495; 23960450; 24449403; 24519039; 24659876; 24760000; 24774509; 25240429; 25287171; 25303517; 25340831; 25416956; 25713999; 25743001; 26030972; 26104535; 26110293; 26154744; 26223482; 26242828; 26279293; 26438033; 26670100; 26674571; 26880169; 27040635; 27618981; 27779101; 28109022; 28165327; 28198349; 28233743; 28480960; 28543275; 28723780	11278832; 11780052; 15489334; 17090528; 21269460; 26224535; 17077483; 17138556; 12384777; 12436200
11697	AK6 CINAP AD-004 CGI-137	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=192 uM for AMP {ECO:0000269|PubMed:15630091, ECO:0000269|PubMed:16079131, ECO:0000269|PubMed:22038794}; KM=45 uM for ATP (for adenylate kinase activity) {ECO:0000269|PubMed:15630091, ECO:0000269|PubMed:16079131, ECO:0000269|PubMed:22038794}; KM=332 uM for ATP (for ATPase activity) {ECO:0000269|PubMed:15630091, ECO:0000269|PubMed:16079131, ECO:0000269|PubMed:22038794}; Vmax=1.27 umol/min/mg enzyme for ATPase activity {ECO:0000269|PubMed:15630091, ECO:0000269|PubMed:16079131, ECO:0000269|PubMed:22038794}; Vmax=982 nmol/min/mg enzyme for the forward adenylate kinase reaction {ECO:0000269|PubMed:15630091, ECO:0000269|PubMed:16079131, ECO:0000269|PubMed:22038794}; Vmax=955 nmol/min/mg enzyme for the reverse adenylate kinase reaction {ECO:0000269|PubMed:15630091, ECO:0000269|PubMed:16079131, ECO:0000269|PubMed:22038794}; Note=kcat is 6.3 sec(-1) for adenylate kinase activity. kcat is 4.8 sec(-1) for ATPase activity.;	2.7.4.3	CATALYTIC ACTIVITY: ATP + AMP = 2 ADP. {ECO:0000255|HAMAP-Rule:MF_03173, ECO:0000269|PubMed:15630091}.	BINDING 39 39 AMP. {ECO:0000305}.; BINDING 79 79 ATP.; BINDING 105 105 ATP.; BINDING 109 109 ATP.						AD-004 CGI-137		nucleobase-containing small molecule interconversion [GO:0015949]	Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; nucleoside monophosphate kinase activity [GO:0050145]; nucleobase-containing small molecule interconversion [GO:0015949]	adenylate kinase activity [GO:0004017]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; nucleoside monophosphate kinase activity [GO:0050145]	GO:0004017; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0015030; GO:0015949; GO:0016020; GO:0016887; GO:0050145	SUBCELLULAR LOCATION: Nucleus, nucleoplasm. Nucleus, Cajal body. Note=Displays widespread diffuse nucleoplasmic distribution but not detected in nucleoli. Detected in Cajal bodies but not in all cells.			16079131; 10810093; 10931946; 15372022; 15489334; 15213396; 21269460; 15630091; 22038794; 20974138; 21988832; 25416956; 27477389	16079131; 10810093; 10931946; 15372022; 15489334; 15213396; 21269460; 15630091; 22038794
11721	KCNB2	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: Note=Homotetrameric channels expressed in xenopus oocytes or in mammalian non-neuronal cells display delayed-rectifier voltage-dependent potassium currents which are activated during membrane depolarization, i.e within a risetime of about 20 msec. After that, inactivate very slowly. Their activation requires low threshold potentials of about -20 to -30 mV, with a midpoint activation at about 10 mV. For inactivation, the voltage at half-maximal amplitude is about -30 mV. Channels have an unitary conductance of about 14 pS. The voltage-dependence of activation and inactivation and other channel characteristics vary depending on the experimental conditions, the expression system and post-translational modifications. {ECO:0000305|PubMed:10414301};				ACTIVITY REGULATION: Inhibited by quinine at micromolar levels. Modestly sensitive to millimolar levels of tetraethylammonium (TEA) and 4-aminopyridine (4-AP). {ECO:0000250|UniProtKB:Q63099, ECO:0000250|UniProtKB:Q95167, ECO:0000305|PubMed:10414301}.							potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]; regulation of smooth muscle contraction [GO:0006940]	dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]	dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]; regulation of smooth muscle contraction [GO:0006940]	delayed rectifier potassium channel activity [GO:0005251]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]	GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0006940; GO:0008076; GO:0016021; GO:0030425; GO:0032809; GO:0034765; GO:0043204; GO:0046982; GO:0051260; GO:0071805; GO:0072659	SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q63099}; Multi-pass membrane protein {ECO:0000250|UniProtKB:Q63099}. Perikaryon {ECO:0000250|UniProtKB:Q63099}. Cell projection, dendrite {ECO:0000250|UniProtKB:Q63099}. Note=Localized uniformly throughout cell bodies and dendrites. Colocalizes with KCNB1 to high-density somatodendritic clusters on cortical pyramidal neurons. {ECO:0000250|UniProtKB:Q63099}.	PTM: Phosphorylated. {ECO:0000250|UniProtKB:Q63099}.	MOD_RES 448 448 Phosphoserine. {ECO:0000250|UniProtKB:Q63099}.	9612272; 10414301; 16959974; 17474147; 17903301; 18676988; 19010793; 20125193; 20379614; 20393197; 21231794; 22422395; 23953852; 25339316; 28607108	9612272; 10414301; 16959974
11775	PARP16 ARTD15 C15orf30	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=290 uM for NAD (at 37 degrees Celsius) {ECO:0000269|PubMed:22701565}; Vmax=0.7 pmol/h/ug enzyme (at 37 degrees Celsius) {ECO:0000269|PubMed:22701565}; 	2.4.2.30	CATALYTIC ACTIVITY: NAD(+) + (ADP-D-ribosyl)(n)-acceptor = nicotinamide + (ADP-D-ribosyl)(n+1)-acceptor. {ECO:0000269|PubMed:22701565}.	BINDING 152 152 NAD. {ECO:0000269|PubMed:22661712}.; BINDING 182 182 NAD. {ECO:0000269|PubMed:22661712}.; BINDING 254 254 NAD; may stabilize a reaction intermediate. {ECO:0000269|PubMed:22661712}.					SITE 193 193 Nicotinamide-stacking aromate. {ECO:0000269|PubMed:22661712}.			cellular response to leukemia inhibitory factor [GO:1990830]; endoplasmic reticulum unfolded protein response [GO:0030968]; IRE1-mediated unfolded protein response [GO:0036498]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of cell death [GO:0060548]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; kinase binding [GO:0019900]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein serine/threonine kinase activator activity [GO:0043539]; cellular response to leukemia inhibitory factor [GO:1990830]; endoplasmic reticulum unfolded protein response [GO:0030968]; IRE1-mediated unfolded protein response [GO:0036498]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of cell death [GO:0060548]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]	kinase binding [GO:0019900]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein serine/threonine kinase activator activity [GO:0043539]	GO:0003950; GO:0005635; GO:0005783; GO:0005789; GO:0005829; GO:0006471; GO:0016020; GO:0016021; GO:0019900; GO:0030968; GO:0034356; GO:0036498; GO:0043539; GO:0060548; GO:0070213; GO:0071782; GO:0071902; GO:1990830	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Single-pass type IV membrane protein {ECO:0000269|PubMed:22701565}.	PTM: Auto-ADP-ribosylated. {ECO:0000269|PubMed:22661712, ECO:0000269|PubMed:22701565}.		14702039; 16572171; 15489334; 20106667; 23103912; 22701565; 25944712; 22661712; 15674325; 23230272; 25037261; 25416956; 26496610	14702039; 16572171; 15489334; 20106667; 23103912; 22701565; 25944712; 22661712
11815	OTULIN FAM105B	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=7.98 uM for linear diubiquitin {ECO:0000269|PubMed:23746843}; Note=Kcat is 6.3 sec(-1) with linear diubiquitin as substrate. {ECO:0000269|PubMed:23746843};	3.4.19.12	CATALYTIC ACTIVITY: Thiol-dependent hydrolysis of ester, thioester, amide, peptide and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76-residue protein attached to proteins as an intracellular targeting signal). {ECO:0000269|PubMed:23746843, ECO:0000269|PubMed:23827681, ECO:0000269|PubMed:27523608, ECO:0000269|PubMed:28919039}.	BINDING 314 314 Linear diubiquitin. {ECO:0000244|PDB:3ZNZ, ECO:0000244|PDB:4KSK, ECO:0000244|PDB:4KSL, ECO:0000269|PubMed:23708998, ECO:0000269|PubMed:23746843}.								innate immune response [GO:0045087]; negative regulation of inflammatory response [GO:0050728]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; protein linear deubiquitination [GO:1990108]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; sprouting angiogenesis [GO:0002040]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; LUBAC complex [GO:0071797]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; LUBAC complex [GO:0071797]; cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; innate immune response [GO:0045087]; negative regulation of inflammatory response [GO:0050728]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; protein linear deubiquitination [GO:1990108]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; sprouting angiogenesis [GO:0002040]; Wnt signaling pathway [GO:0016055]	cysteine-type peptidase activity [GO:0008234]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]	GO:0002040; GO:0004843; GO:0005737; GO:0005829; GO:0008234; GO:0010803; GO:0016055; GO:0032088; GO:0045087; GO:0050728; GO:0060828; GO:0070431; GO:0071797; GO:1990108	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:23746843}.	PTM: Ubiquitinated. {ECO:0000269|PubMed:23746843}.; PTM: Acetylated. {ECO:0000269|PubMed:23746843}.; PTM: Phosphorylated (PubMed:23746843, PubMed:24726323, PubMed:24726327). Phosphorylation at Tyr-56 prevents interaction with RNF31; dephosphorylation promotes interaction with RNF31 and the LUBAC complex (PubMed:24726323, PubMed:24726327). {ECO:0000269|PubMed:23746843, ECO:0000269|PubMed:24726323, ECO:0000269|PubMed:24726327}.	MOD_RES 56 56 Phosphotyrosine. {ECO:0000269|PubMed:24726323, ECO:0000269|PubMed:24726327}.	15372022; 15489334; 14702039; 21269460; 23827681; 23806334; 26670046; 26997266; 27523608; 27458237; 27559085; 23746843; 23708998; 24726323; 24726327; 28919039; 16189514; 20379614; 20467437; 24461064; 25416956; 26235645; 28481361; 7851534	15372022; 15489334; 14702039; 21269460; 23827681; 23806334; 26670046; 26997266; 27523608; 27458237; 27559085; 23746843; 23708998; 24726323; 24726327; 28919039
11816	DAO DAMOX	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=3.6 mM for D-serine {ECO:0000269|PubMed:17088322, ECO:0000269|PubMed:17303072}; KM=1.7 mM for D-proline {ECO:0000269|PubMed:17088322, ECO:0000269|PubMed:17303072}; KM=1.1 mM for D-tyrosine {ECO:0000269|PubMed:17088322, ECO:0000269|PubMed:17303072}; KM=1.5 mM for D-DOPA {ECO:0000269|PubMed:17088322, ECO:0000269|PubMed:17303072}; KM=1.2 mM for D-phenylalanine {ECO:0000269|PubMed:17088322, ECO:0000269|PubMed:17303072}; KM=0.9 mM for D-alanine {ECO:0000269|PubMed:17088322, ECO:0000269|PubMed:17303072}; 	1.4.3.3	CATALYTIC ACTIVITY: A D-amino acid + H(2)O + O(2) = a 2-oxo acid + NH(3) + H(2)O(2). {ECO:0000269|PubMed:17088322}.	BINDING 53 53 Substrate.; BINDING 164 164 FAD; via amide nitrogen and carbonyl oxygen. {ECO:0000269|PubMed:17088322, ECO:0000269|PubMed:18455394}.; BINDING 182 182 FAD. {ECO:0000269|PubMed:17088322, ECO:0000269|PubMed:18455394}.; BINDING 217 217 Substrate.; BINDING 228 228 Substrate.; BINDING 283 283 Substrate.; BINDING 313 313 Substrate; via carbonyl oxygen.		COFACTOR: Name=FAD; Xref=ChEBI:CHEBI:57692; 						cellular nitrogen compound metabolic process [GO:0034641]; D-alanine catabolic process [GO:0055130]; dopamine biosynthetic process [GO:0042416]; D-serine catabolic process [GO:0036088]; D-serine metabolic process [GO:0070178]; proline catabolic process [GO:0006562]; protein targeting to peroxisome [GO:0006625]	cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; cofactor binding [GO:0048037]; D-amino-acid oxidase activity [GO:0003884]; FAD binding [GO:0071949]; protein dimerization activity [GO:0046983]; signaling receptor binding [GO:0005102]; cellular nitrogen compound metabolic process [GO:0034641]; D-alanine catabolic process [GO:0055130]; D-serine catabolic process [GO:0036088]; D-serine metabolic process [GO:0070178]; dopamine biosynthetic process [GO:0042416]; proline catabolic process [GO:0006562]; protein targeting to peroxisome [GO:0006625]	cofactor binding [GO:0048037]; D-amino-acid oxidase activity [GO:0003884]; FAD binding [GO:0071949]; protein dimerization activity [GO:0046983]; signaling receptor binding [GO:0005102]	GO:0003884; GO:0005102; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006562; GO:0006625; GO:0034641; GO:0036088; GO:0042416; GO:0046983; GO:0048037; GO:0055130; GO:0070178; GO:0071949	SUBCELLULAR LOCATION: Peroxisome.			2901986; 14702039; 15489334; 1356107; 12364586; 24275569; 17088322; 17303072; 18455394; 12053066; 14966479; 15464270; 16380905; 16616139; 16828464; 17055463; 17179078; 17250995; 17336946; 17408693; 17492767; 17627036; 17629951; 17728673; 17890006; 18165970; 18544534; 18560437; 18583979; 18715757; 19156168; 19223009; 19309736; 19367581; 19438227; 19439994; 19586533; 19670078; 19685198; 19693267; 19729970; 19823762; 20178891; 20368421; 20483168; 20521334; 20602615; 20712760; 20855273; 21421061; 21471957; 21679769; 21700703; 21988832; 22239582; 22802136; 22865246; 23219954; 23497497; 23555897; 23566269; 23631755; 23859606; 24085347; 24237903; 24256253; 25001371; 25416956; 25982580; 26986737; 27130307; 27400736; 28285246; 28750137	2901986; 14702039; 15489334; 1356107; 12364586; 24275569; 17088322; 17303072; 18455394
11830	PLA2G16 HRASLS3 HREV107	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=300 uM for dipalmitoyl-PC {ECO:0000269|PubMed:19615464}; Vmax=2.57 umol/min/mg enzyme with dipalmitoyl-PC as substrate {ECO:0000269|PubMed:19615464}; Vmax=267 nmol/min/mg enzyme with dipalmitoyl-PE as substrate {ECO:0000269|PubMed:19615464}; 	3.1.1.32; 3.1.1.4	CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-acylglycerophosphocholine + a carboxylate. {ECO:0000269|PubMed:19047760, ECO:0000269|PubMed:19615464, ECO:0000269|PubMed:20837014, ECO:0000269|PubMed:22605381, ECO:0000269|PubMed:22923616}.; CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 2-acylglycerophosphocholine + a carboxylate. {ECO:0000269|PubMed:19047760, ECO:0000269|PubMed:19615464, ECO:0000269|PubMed:20837014, ECO:0000269|PubMed:22605381, ECO:0000269|PubMed:22923616}.				BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 9. {ECO:0000269|PubMed:19615464};					ether lipid metabolic process [GO:0046485]; lipid catabolic process [GO:0016042]; negative regulation of cell cycle [GO:0045786]; peroxisome organization [GO:0007031]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylinositol acyl-chain remodeling [GO:0036149]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid biosynthetic process [GO:0008654]; phospholipid metabolic process [GO:0006644]; regulation of adipose tissue development [GO:1904177]; triglyceride metabolic process [GO:0006641]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; 1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; phosphatidylcholine 1-acylhydrolase activity [GO:0008970]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; transferase activity, transferring acyl groups [GO:0016746]; ether lipid metabolic process [GO:0046485]; lipid catabolic process [GO:0016042]; negative regulation of cell cycle [GO:0045786]; peroxisome organization [GO:0007031]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylinositol acyl-chain remodeling [GO:0036149]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid biosynthetic process [GO:0008654]; phospholipid metabolic process [GO:0006644]; regulation of adipose tissue development [GO:1904177]; triglyceride metabolic process [GO:0006641]	1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; phosphatidylcholine 1-acylhydrolase activity [GO:0008970]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; transferase activity, transferring acyl groups [GO:0016746]	GO:0004623; GO:0005777; GO:0005778; GO:0005783; GO:0005829; GO:0006641; GO:0006644; GO:0007031; GO:0008654; GO:0008970; GO:0016021; GO:0016042; GO:0016746; GO:0036149; GO:0036150; GO:0036151; GO:0036152; GO:0045786; GO:0046485; GO:0048471; GO:0052739; GO:0052740; GO:0102567; GO:0102568; GO:1904177	SUBCELLULAR LOCATION: Membrane {ECO:0000305|PubMed:22605381}; Single-pass membrane protein {ECO:0000255}. Cytoplasm {ECO:0000269|PubMed:17374643}. Cytoplasm, perinuclear region {ECO:0000250|UniProtKB:Q8R3U1}. Peroxisome membrane {ECO:0000250|UniProtKB:Q8R3U1}.			9771974; 11526504; 19615464; 14702039; 15489334; 10508479; 11973642; 17374643; 19047760; 19136964; 28077878; 20837014; 22605381; 22923616; 25383759; 10085124; 10092647; 10336645; 10358058; 12054741; 14709560; 15944408; 16189514; 16617059; 16713569; 17003497; 18614531; 19019078; 1904318; 19501189; 20501645; 20705608; 22825852; 24884338; 25024203; 25416956; 25871522; 25993412; 26018079; 26381418; 26503625; 26933804; 8083230; 9417066; 9705332	9771974; 11526504; 19615464; 14702039; 15489334; 10508479; 11973642; 17374643; 19047760; 19136964; 28077878; 20837014; 22605381; 22923616; 25383759
11845	MTPAP PAPD1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.1 mM for ATP {ECO:0000269|PubMed:21292163}; KM=0.7 mM for UTP {ECO:0000269|PubMed:21292163}; 	2.7.7.19	CATALYTIC ACTIVITY: ATP + RNA(n) = diphosphate + RNA(n+1). {ECO:0000269|PubMed:20970105, ECO:0000269|PubMed:21292163}.			COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:21292163}; Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000269|PubMed:21292163}; 						histone mRNA catabolic process [GO:0071044]; mRNA polyadenylation [GO:0006378]; transcription, DNA-templated [GO:0006351]	intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]	intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; polynucleotide adenylyltransferase activity [GO:0004652]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; UTP binding [GO:0002134]; histone mRNA catabolic process [GO:0071044]; mRNA polyadenylation [GO:0006378]; transcription, DNA-templated [GO:0006351]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; polynucleotide adenylyltransferase activity [GO:0004652]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; UTP binding [GO:0002134]	GO:0000287; GO:0002134; GO:0003723; GO:0004652; GO:0005524; GO:0005739; GO:0006351; GO:0006378; GO:0030145; GO:0042802; GO:0042803; GO:0043231; GO:0071044	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:18172165}. Mitochondrion {ECO:0000269|PubMed:15547249, ECO:0000269|PubMed:15769737}.		MOD_RES 90 90 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.	15547249; 15769737; 16533400; 14702039; 17974005; 15164054; 15489334; 18172165; 19608861; 21269460; 21292163; 20970105; 16385451; 16810331; 17509149; 18984674; 19204726; 20186120; 20360068; 20379614; 20877624; 21903422; 24651433; 25008111; 25609649; 26354863; 26496610	15547249; 15769737; 16533400; 14702039; 17974005; 15164054; 15489334; 18172165; 19608861; 21269460; 21292163; 20970105
11849	PAPOLG PAP2 PAPG	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.051 uM for poly(A)(15) {ECO:0000269|PubMed:11431479}; 	2.7.7.19	CATALYTIC ACTIVITY: ATP + RNA(n) = diphosphate + RNA(n+1). {ECO:0000269|PubMed:11287430, ECO:0000269|PubMed:11431479, ECO:0000269|PubMed:11463842}.	BINDING 108 108 ATP. {ECO:0000250}.; BINDING 166 166 ATP. {ECO:0000250}.; BINDING 227 227 ATP. {ECO:0000269|PubMed:24076191}.; BINDING 236 236 ATP. {ECO:0000269|PubMed:24076191}.		COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250}; Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250}; ;  Note=Binds 2 magnesium ions. Also active with manganese. {ECO:0000250};			SITE 152 152 Interaction with RNA. {ECO:0000250}.; SITE 157 157 Interaction with RNA. {ECO:0000250}.; SITE 327 327 Interaction with RNA. {ECO:0000250}.; SITE 398 398 Interaction with RNA. {ECO:0000250}.; SITE 532 532 Interaction with RNA. {ECO:0000250}.			mRNA polyadenylation [GO:0006378]; RNA polyadenylation [GO:0043631]	cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; RNA polyadenylation [GO:0043631]	ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]	GO:0003723; GO:0004652; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006378; GO:0016020; GO:0016604; GO:0043631; GO:0046872	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11287430, ECO:0000269|PubMed:11431479, ECO:0000269|PubMed:11463842}.		MOD_RES 2 2 N6-acetyllysine. {ECO:0000244|PubMed:21406692}.; MOD_RES 23 23 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 29 29 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 525 525 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 599 599 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 648 648 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 654 654 Phosphothreonine. {ECO:0000244|PubMed:18669648}.; MOD_RES 684 684 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163}.; MOD_RES 708 708 Phosphoserine. {ECO:0000244|PubMed:23186163}.	11287430; 11463842; 11431479; 14702039; 15815621; 15489334; 18220336; 18669648; 19413330; 19690332; 21269460; 21406692; 22814378; 23186163; 24076191; 20513922; 26496610; 26638075	11287430; 11463842; 11431479; 14702039; 15815621; 15489334; 18220336; 18669648; 19413330; 19690332; 21269460; 21406692; 22814378; 23186163; 24076191
11854	PARP9 BAL BAL1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=196 uM for NAD(+) {ECO:0000269|PubMed:28525742}; 	2.4.2.30	CATALYTIC ACTIVITY: NAD(+) + (ADP-D-ribosyl)(n)-acceptor = nicotinamide + (ADP-D-ribosyl)(n+1)-acceptor. {ECO:0000255|PROSITE-ProRule:PRU00397, ECO:0000269|PubMed:28525742}.		ACTIVITY REGULATION: Binding to poly(ADP-ribose) does not affect its activity. {ECO:0000269|PubMed:28525742}.							cell migration [GO:0016477]; defense response to virus [GO:0051607]; double-strand break repair [GO:0006302]; innate immune response [GO:0045087]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of catalytic activity [GO:0043086]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of interferon-gamma-mediated signaling pathway [GO:0060335]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; posttranscriptional regulation of gene expression [GO:0010608]; protein ADP-ribosylation [GO:0006471]; regulation of response to interferon-gamma [GO:0060330]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of DNA damage [GO:0090734]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of DNA damage [GO:0090734]; ADP-D-ribose binding [GO:0072570]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; STAT family protein binding [GO:0097677]; transcription corepressor activity [GO:0003714]; ubiquitin-like protein ligase binding [GO:0044389]; cell migration [GO:0016477]; defense response to virus [GO:0051607]; double-strand break repair [GO:0006302]; innate immune response [GO:0045087]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of catalytic activity [GO:0043086]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of interferon-gamma-mediated signaling pathway [GO:0060335]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; posttranscriptional regulation of gene expression [GO:0010608]; protein ADP-ribosylation [GO:0006471]; regulation of response to interferon-gamma [GO:0060330]	ADP-D-ribose binding [GO:0072570]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; STAT family protein binding [GO:0097677]; transcription corepressor activity [GO:0003714]; ubiquitin-like protein ligase binding [GO:0044389]	GO:0000122; GO:0002230; GO:0003714; GO:0003950; GO:0004857; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006302; GO:0006471; GO:0010608; GO:0010629; GO:0016020; GO:0016477; GO:0019899; GO:0032991; GO:0034356; GO:0035563; GO:0042393; GO:0042531; GO:0043086; GO:0044389; GO:0045087; GO:0045893; GO:0051607; GO:0060330; GO:0060335; GO:0072570; GO:0090734; GO:0097677; GO:1900182; GO:2001034	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:16809771, ECO:0000269|PubMed:26479788, ECO:0000269|PubMed:27796300}. Nucleus {ECO:0000269|PubMed:11110709, ECO:0000269|PubMed:16809771, ECO:0000269|PubMed:23230272, ECO:0000269|PubMed:26479788, ECO:0000269|PubMed:28525742}. Note=Shuttles between the nucleus and the cytosol (PubMed:16809771). Translocates to the nucleus in response to IFNG or IFNB1 stimulation (PubMed:26479788). Export to the cytosol depends on the interaction with DTX3L (PubMed:16809771). Localizes at sites of DNA damage in a PARP1-dependent manner (PubMed:23230272, PubMed:28525742). {ECO:0000269|PubMed:16809771, ECO:0000269|PubMed:23230272, ECO:0000269|PubMed:26479788, ECO:0000269|PubMed:28525742}.	PTM: ADP-ribosylated by PARP14. {ECO:0000269|PubMed:27796300}.		11110709; 14702039; 16641997; 15489334; 17974005; 12670957; 16809771; 20106667; 23230272; 26479788; 27796300; 28525742; 15674325; 18339380; 22701565; 23487038; 24886089; 26496610	11110709; 14702039; 16641997; 15489334; 17974005; 12670957; 16809771; 20106667; 23230272; 26479788; 27796300; 28525742; 
11871	OGA HEXC KIAA0679 MEA5 MGEA5	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.1 mM for pNP-GlcNAc {ECO:0000269|PubMed:11788610}; Vmax=652 umol/min/mg enzyme with pNP-GLcNAc as substrate {ECO:0000269|PubMed:11788610}; 	3.2.1.169	CATALYTIC ACTIVITY: [Protein]-3-O-(N-acetyl-beta-D-glucosaminyl)-L-serine + H(2)O = [protein]-L-serine + N-acetyl-D-glucosamine. {ECO:0000269|PubMed:11148210, ECO:0000269|PubMed:11788610, ECO:0000269|PubMed:18586680, ECO:0000269|PubMed:20863279, ECO:0000269|PubMed:22365600, ECO:0000305|PubMed:20673219}.; CATALYTIC ACTIVITY: [Protein]-3-O-(N-acetyl-beta-D-glucosaminyl)-L-threonine + H(2)O = [protein]-L-threonine + N-acetyl-D-glucosamine. {ECO:0000269|PubMed:11148210, ECO:0000269|PubMed:11788610, ECO:0000269|PubMed:18586680, ECO:0000269|PubMed:20863279, ECO:0000269|PubMed:22365600, ECO:0000305|PubMed:20673219}.	BINDING 67 67 Substrate; via carbonyl oxygen. {ECO:0000250|UniProtKB:Q2CEE3}.; BINDING 98 98 Substrate. {ECO:0000250|UniProtKB:Q0TR53}.; BINDING 174 174 Substrate. {ECO:0000250|UniProtKB:Q0TR53}.; BINDING 219 219 Substrate. {ECO:0000250|UniProtKB:Q2CEE3}.; BINDING 285 285 Substrate. {ECO:0000250|UniProtKB:Q2CEE3}.; BINDING 313 313 Substrate. {ECO:0000250|UniProtKB:Q2CEE3}.	ACTIVITY REGULATION: Inhibited by N-acetylglucosamine and not N-acetylgalactosamine. {ECO:0000269|PubMed:11148210}.		BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 5.7-7. {ECO:0000269|PubMed:11148210};		SITE 413 414 Cleavage; by caspase-3. {ECO:0000269|PubMed:18586680}.			glycoprotein catabolic process [GO:0006516]; N-acetylglucosamine metabolic process [GO:0006044]; protein deglycosylation [GO:0006517]; protein O-linked glycosylation [GO:0006493]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102167]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102571]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102166]; beta-N-acetylglucosaminidase activity [GO:0016231]; hyalurononglucosaminidase activity [GO:0004415]; glycoprotein catabolic process [GO:0006516]; N-acetylglucosamine metabolic process [GO:0006044]; protein deglycosylation [GO:0006517]; protein O-linked glycosylation [GO:0006493]	[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102571]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102167]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102166]; beta-N-acetylglucosaminidase activity [GO:0016231]; hyalurononglucosaminidase activity [GO:0004415]	GO:0004415; GO:0005634; GO:0005829; GO:0006044; GO:0006493; GO:0006516; GO:0006517; GO:0016020; GO:0016231; GO:0102166; GO:0102167; GO:0102571	SUBCELLULAR LOCATION: Isoform 3: Nucleus {ECO:0000269|PubMed:11341771}.; SUBCELLULAR LOCATION: Isoform 1: Cytoplasm {ECO:0000269|PubMed:11148210, ECO:0000269|PubMed:11341771, ECO:0000269|PubMed:11788610}.	PTM: Proteolytically cleaved by caspase-3 during apoptosis. The fragments interact with each other; cleavage does not decrease enzyme activity. {ECO:0000269|PubMed:11788610, ECO:0000269|PubMed:18586680}.	MOD_RES 364 364 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.	9811929; 11341771; 11148210; 9734811; 12168954; 15164054; 15489334; 11788610; 16533067; 18586680; 18669648; 19413330; 19690332; 20863279; 20673219; 20068231; 21269460; 21406692; 22814378; 23186163; 24088714; 28742148; 22365600; 12359146; 16169070; 17546623; 18641620; 19423084; 19615732; 19715310; 19913121; 20195357; 20198314; 20628086; 20711500; 21163940; 21178104; 21282530; 21471514; 21567137; 21717526; 21900206; 22311971; 22730328; 22783592; 24365779; 24705316; 25036637; 25173736; 25183011; 26269457; 26527687; 26638075; 26980036; 27231347; 27601472; 28319083; 28346405; 28627871; 28939839	9811929; 11341771; 11148210; 9734811; 12168954; 15164054; 15489334; 11788610; 16533067; 18586680; 18669648; 19413330; 19690332; 20863279; 20673219; 20068231; 21269460; 21406692; 22814378; 23186163; 24088714; 28742148; 22365600
11918	TP53I3 PIG3	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=215 uM for 1,2-naphthoquinone {ECO:0000269|PubMed:19349281}; 	1.-.-.-		BINDING 41 41 NADP. {ECO:0000269|PubMed:19349281}.; BINDING 192 192 NADP. {ECO:0000269|PubMed:19349281}.; BINDING 322 322 NADP. {ECO:0000269|PubMed:19349281}.								NADP metabolic process [GO:0006739]; regulation of apoptotic process [GO:0042981]	cytosol [GO:0005829]	cytosol [GO:0005829]; NADPH binding [GO:0070402]; NADPH:quinone reductase activity [GO:0003960]; protein homodimerization activity [GO:0042803]; quinone binding [GO:0048038]; NADP metabolic process [GO:0006739]; regulation of apoptotic process [GO:0042981]	NADPH:quinone reductase activity [GO:0003960]; NADPH binding [GO:0070402]; protein homodimerization activity [GO:0042803]; quinone binding [GO:0048038]	GO:0003960; GO:0005829; GO:0006739; GO:0042803; GO:0042981; GO:0048038; GO:0070402			MOD_RES 1 1 N-acetylmethionine. {ECO:0000269|Ref.9}.	9305847; 15067011; 15815621; 15489334; 21269460; 19349281; 17224074; 11684014; 11919562; 14729977; 15192123; 15491642; 16169070; 18676680; 18801469; 19064572; 19170196; 19336552; 19343046; 19367725; 19573080; 19625176; 19692168; 19773279; 20023697; 20453000; 20603616; 22461624; 23241165; 24388982; 26133772; 26464464; 26472723; 27029070; 28259183; 28351326	9305847; 15067011; 15815621; 15489334; 21269460; 19349281; 17224074
11975	PIK3C2A	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=122 uM for PtdIns (in the absence of phosphatidylserine) {ECO:0000269|PubMed:9337861}; KM=64 uM for PtdIns (in the presence of phosphatidylserine) {ECO:0000269|PubMed:9337861}; KM=25 uM for PtdIns4P (in the presence of phosphatidylserine) {ECO:0000269|PubMed:9337861}; KM=15 uM for ATP (with PtdIns as substrate) (in the absence of phosphatidylserine) {ECO:0000269|PubMed:9337861}; KM=32 uM for ATP (with PtdIns as substrate) (in the presence of phosphatidylserine) {ECO:0000269|PubMed:9337861}; KM=54 uM for ATP (with PtdIns4P as substrate) (in the presence of phosphatidylserine) {ECO:0000269|PubMed:9337861}; Vmax=990 pmol/min/mg enzyme with PtdIns as substrate (in the absence of phosphatidylserine) {ECO:0000269|PubMed:9337861}; Vmax=200 pmol/min/mg enzyme with PtdIns as substrate (in the presence of phosphatidylserine) {ECO:0000269|PubMed:9337861}; Vmax=240 pmol/min/mg enzyme with PtdIns4P as substrate (in the presence of phosphatidylserine) {ECO:0000269|PubMed:9337861}; Vmax=6800 pmol/min/mg enzyme toward ATP with PtdIns as substrate (in the absence of phosphatidylserine) {ECO:0000269|PubMed:9337861}; Vmax=805 pmol/min/mg enzyme toward ATP with PtdIns as substrate (in the presence of phosphatidylserine) {ECO:0000269|PubMed:9337861}; Vmax=880 pmol/min/mg enzyme toward ATP with PtdIns4P as substrate (in the presence of phosphatidylserine) {ECO:0000269|PubMed:9337861}; Note=In the absence of the carrier phosphatidylserine, enzymatic kinetics toward PtdIns4P are non-linear.;	2.7.1.154	CATALYTIC ACTIVITY: ATP + 1-phosphatidyl-1D-myo-inositol 4-phosphate = ADP + 1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate.		ACTIVITY REGULATION: Activated by insulin (By similarity). Only slightly inhibited by wortmannin and LY294002. Activated by clathrin. {ECO:0000250, ECO:0000269|PubMed:10766823, ECO:0000269|PubMed:11239472, ECO:0000269|PubMed:9337861}.	COFACTOR: Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000269|PubMed:10805725, ECO:0000269|PubMed:9337861}; Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:10805725, ECO:0000269|PubMed:9337861}; ;  Note=Ca(2+) or Mg(2+). Mn(2+) cannot be used. {ECO:0000269|PubMed:10805725, ECO:0000269|PubMed:9337861};			SITE 244 244 Not phosphorylated. {ECO:0000269|PubMed:12719431}.; SITE 249 249 Not phosphorylated. {ECO:0000269|PubMed:12719431}.; SITE 251 251 Not phosphorylated. {ECO:0000269|PubMed:12719431}.; SITE 254 254 Not phosphorylated. {ECO:0000269|PubMed:12719431}.; SITE 262 262 Not phosphorylated. {ECO:0000269|PubMed:12719431}.; SITE 266 266 Not phosphorylated. {ECO:0000269|PubMed:12719431}.			cell migration [GO:0016477]; clathrin coat assembly [GO:0048268]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; exocytosis [GO:0006887]; insulin receptor signaling pathway [GO:0008286]; membrane organization [GO:0061024]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol biosynthetic process [GO:0006661]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; vascular smooth muscle contraction [GO:0014829]	clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol binding [GO:0035091]; cell migration [GO:0016477]; clathrin coat assembly [GO:0048268]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; exocytosis [GO:0006887]; insulin receptor signaling pathway [GO:0008286]; membrane organization [GO:0061024]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol biosynthetic process [GO:0006661]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; vascular smooth muscle contraction [GO:0014829]	1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol binding [GO:0035091]	GO:0005524; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0005942; GO:0006661; GO:0006887; GO:0006897; GO:0007173; GO:0008286; GO:0014065; GO:0014829; GO:0016020; GO:0016303; GO:0016477; GO:0030136; GO:0031982; GO:0035004; GO:0035005; GO:0035091; GO:0048008; GO:0048268; GO:0061024; GO:0070062; GO:0090050	SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10766823, ECO:0000269|PubMed:11239472, ECO:0000269|PubMed:17038310}. Golgi apparatus {ECO:0000269|PubMed:10766823, ECO:0000269|PubMed:11239472}. Cytoplasmic vesicle, clathrin-coated vesicle {ECO:0000269|PubMed:10766823, ECO:0000269|PubMed:11239472}. Nucleus {ECO:0000269|PubMed:11606566}. Cytoplasm {ECO:0000269|PubMed:11606566, ECO:0000269|PubMed:14563213}. Note=Inserts preferentially into membranes containing PtdIns(4,5)P2 (PubMed:17038310). Associated with RNA-containing structures (PubMed:11606566). {ECO:0000269|PubMed:11606566, ECO:0000269|PubMed:17038310}.	PTM: Phosphorylated upon insulin stimulation; which may lead to enzyme activation (By similarity). Phosphorylated on Ser-259 during mitosis and upon UV irradiation; which does not change enzymatic activity but leads to proteasomal degradation. Ser-259 phosphorylation may be mediated by CDK1 or JNK, depending on the physiological state of the cell. {ECO:0000250, ECO:0000269|PubMed:11606566, ECO:0000269|PubMed:12719431}.	MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19413330}.; MOD_RES 60 60 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 108 108 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 259 259 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569, ECO:0000269|PubMed:12719431}.; MOD_RES 327 327 Phosphoserine. {ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 338 338 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 630 630 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1281 1281 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1553 1553 Phosphoserine. {ECO:0000244|PubMed:23186163}.	9337861; 14702039; 16554811; 15489334; 10766823; 10805725; 11606566; 11239472; 14563213; 12719431; 16215232; 18691976; 18669648; 19413330; 19369195; 19690332; 21081650; 20068231; 21269460; 21127054; 17371240; 21406692; 23186163; 24275569; 17038310; 10394364; 11604418; 11694590; 11994746; 12057195; 12237112; 12952949; 14729612; 15135396; 15183893; 15252009; 15649145; 15703209; 15797027; 16155256; 16326391; 16903783; 17110375; 17116749; 17512409; 17540576; 17620599; 17644513; 17651088; 17721511; 18312637; 18388313; 18403640; 19261849; 19591801; 19615732; 20197460; 20379614; 20416519; 20448150; 20453000; 20467438; 20562859; 20711500; 20946875; 21445324; 21779028; 23192342; 23320105; 23414517; 23823722; 24255178; 24581490; 25233418; 25614622; 25667265; 25779105; 26175229; 26387957; 26496610; 26638075; 26950487; 27412598; 27779101; 28150169; 28195573; 28910396; 7624799; 7628435; 8374173; 8524399; 8670264; 8999962; 9113989; 9286278; 9514948; 9516481; 9830063; 9878262	9337861; 14702039; 16554811; 15489334; 10766823; 10805725; 11606566; 11239472; 14563213; 12719431; 16215232; 18691976; 18669648; 19413330; 19369195; 19690332; 21081650; 20068231; 21269460; 21127054; 17371240; 21406692; 23186163; 24275569; 17038310; 
11982	PLA2G4A CPLA2 PLA2G4	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: Vmax=2.7 umol/min/mg enzyme for the phospholipase A2 reaction {ECO:0000269|PubMed:8083230}; Vmax=4.6 umol/min/mg enzyme for the lysophosphatase reaction {ECO:0000269|PubMed:8083230}; 	3.1.1.4; 3.1.1.5	CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-acylglycerophosphocholine + a carboxylate.; CATALYTIC ACTIVITY: 2-lysophosphatidylcholine + H(2)O = glycerophosphocholine + a carboxylate.		ACTIVITY REGULATION: Stimulated by agonists such as ATP, EGF, thrombin and bradykinin as well as by cytosolic Ca(2+).							arachidonic acid metabolic process [GO:0019369]; arachidonic acid secretion [GO:0050482]; cardiolipin acyl-chain remodeling [GO:0035965]; cellular response to antibiotic [GO:0071236]; icosanoid biosynthetic process [GO:0046456]; icosanoid metabolic process [GO:0006690]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phosphatidylinositol acyl-chain remodeling [GO:0036149]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid catabolic process [GO:0009395]; phospholipid metabolic process [GO:0006644]; platelet activating factor biosynthetic process [GO:0006663]; regulation of cell proliferation [GO:0042127]	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; mitochondrial inner membrane [GO:0005743]	cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; mitochondrial inner membrane [GO:0005743]; calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; calcium-dependent phospholipid binding [GO:0005544]; lysophospholipase activity [GO:0004622]; phosphatidylcholine 1-acylhydrolase activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; arachidonic acid metabolic process [GO:0019369]; arachidonic acid secretion [GO:0050482]; cardiolipin acyl-chain remodeling [GO:0035965]; cellular response to antibiotic [GO:0071236]; icosanoid biosynthetic process [GO:0046456]; icosanoid metabolic process [GO:0006690]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phosphatidylinositol acyl-chain remodeling [GO:0036149]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid catabolic process [GO:0009395]; phospholipid metabolic process [GO:0006644]; platelet activating factor biosynthetic process [GO:0006663]; regulation of cell proliferation [GO:0042127]	calcium-dependent phospholipase A2 activity [GO:0047498]; calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; lysophospholipase activity [GO:0004622]; phosphatidylcholine 1-acylhydrolase activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]	GO:0004622; GO:0004623; GO:0005509; GO:0005544; GO:0005743; GO:0005789; GO:0005794; GO:0005811; GO:0005829; GO:0006644; GO:0006654; GO:0006663; GO:0006690; GO:0008970; GO:0009395; GO:0019369; GO:0031410; GO:0035965; GO:0036148; GO:0036149; GO:0036150; GO:0036151; GO:0036152; GO:0042127; GO:0046456; GO:0047498; GO:0050482; GO:0071236; GO:0102567; GO:0102568	SUBCELLULAR LOCATION: Cytoplasm. Cytoplasmic vesicle. Note=Translocates to membrane vesicles in a calcium-dependent fashion.	PTM: Activated by phosphorylation at both Ser-505 and Ser-727. {ECO:0000269|PubMed:8381049, ECO:0000269|PubMed:9468497}.	MOD_RES 2 2 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 268 268 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 434 434 Phosphoserine. {ECO:0000250|UniProtKB:P50393}.; MOD_RES 435 435 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 437 437 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 505 505 Phosphoserine; by MAPK. {ECO:0000269|PubMed:8381049, ECO:0000269|PubMed:9468497}.; MOD_RES 515 515 Phosphoserine. {ECO:0000250|UniProtKB:P50393}.; MOD_RES 727 727 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:9468497}.; MOD_RES 729 729 Phosphoserine. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.	1904318; 1869522; 16710414; 15489334; 8381049; 8083230; 8619991; 8702602; 9468497; 11416127; 17081983; 16964243; 18451993; 18088087; 18669648; 20068231; 21269460; 21406692; 23186163; 28112733; 9430701; 9665851; 10319815; 16959974; 10085124; 10092647; 10336645; 10358058; 10359595; 10366595; 10491174; 10978317; 11080672; 11353443; 11375391; 11479288; 11737068; 12048163; 12124392; 12414998; 12432908; 12444032; 12765847; 12885780; 14609334; 14686920; 14709560; 14726390; 14769798; 14963030; 15007070; 15041036; 15118355; 15259375; 15276701; 15318030; 15331599; 15358156; 15475363; 15789617; 15944408; 15975962; 16181776; 16221889; 16375935; 16407173; 16409471; 16585943; 16603549; 16617059; 16829784; 16963226; 17178883; 17344094; 17353931; 17417066; 17460547; 17629734; 17672871; 17685590; 17725579; 17728982; 17873281; 17901074; 17971499; 17976189; 18065419; 18280113; 18388244; 18471798; 18502815; 18562188; 18566601; 18583979; 18614531; 18632668; 18641641; 18665843; 18686860; 18818748; 19019078; 19019335; 19091957; 19176526; 19237603; 19280714; 19336370; 19367725; 19401382; 19450127; 19501189; 19527514; 19560328; 19625654; 19632995; 19675210; 19717620; 19718435; 19753100; 19778898; 19795129; 19843712; 19913121; 20034614; 20044029; 20056178; 20066429; 20069553; 20112044; 20138193; 20140262; 20203101; 20211985; 20227521; 20351714; 20379614; 20392485; 20420828; 20435073; 20464283; 20478385; 20628086; 20635443; 20643646; 20667012; 20705608; 20802406; 20808133; 21097525; 21127289; 21148506; 21150319; 21185392; 21198294; 21247147; 21268080; 21315000; 21478406; 21536681; 21746768; 21771656; 21862584; 21896865; 21994455; 22003202; 22130221; 22138395; 22274867; 22378731; 22398721; 22456504; 22648535; 22728329; 22895089; 22911431; 23043861; 23219238; 23268370; 23307260; 23416715; 23549331; 23801329; 23948114; 24349530; 24366870; 24693448; 24721622; 25102815; 25365190; 25609649; 25617738; 25761116; 25893499; 25904158; 25969996; 26162318; 26183771; 26303530; 26416244; 26496610; 26525102; 27133131; 27528014; 27554058; 27819025; 27977772; 28383549; 28649002; 28724385; 28887431; 29167338; 29307829; 29342349; 30071514; 7663164; 7766652; 8636128; 8706669; 8777586; 8910365; 9115999; 9323323; 9417066; 9487141; 9671731; 9705332; 9800222	1904318; 1869522; 16710414; 15489334; 8381049; 8083230; 8619991; 8702602; 9468497; 11416127; 17081983; 16964243; 18451993; 18088087; 18669648; 20068231; 21269460; 21406692; 23186163; 28112733; 9430701; 9665851; 10319815; 16959974
11983	PLA2G4C	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: Vmax=218 pmol/min/mg enzyme {ECO:0000269|PubMed:10085124}; 	3.1.1.4	CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-acylglycerophosphocholine + a carboxylate. {ECO:0000269|PubMed:10085124, ECO:0000269|PubMed:14529291, ECO:0000269|PubMed:9705332}.		ACTIVITY REGULATION: Inhibited by palmitoyl-CoA (PubMed:14529291). Not regulated by calcium (PubMed:9705332, PubMed:10085124). {ECO:0000269|PubMed:10085124, ECO:0000269|PubMed:14529291, ECO:0000269|PubMed:9705332}.							arachidonic acid metabolic process [GO:0019369]; glycerophospholipid catabolic process [GO:0046475]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; parturition [GO:0007567]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylinositol acyl-chain remodeling [GO:0036149]; phospholipid metabolic process [GO:0006644]	cell cortex [GO:0005938]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]	cell cortex [GO:0005938]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; phosphatidylcholine 1-acylhydrolase activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; phospholipid binding [GO:0005543]; arachidonic acid metabolic process [GO:0019369]; glycerophospholipid catabolic process [GO:0046475]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; parturition [GO:0007567]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylinositol acyl-chain remodeling [GO:0036149]; phospholipid metabolic process [GO:0006644]	calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; phosphatidylcholine 1-acylhydrolase activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) [GO:0102568]; phospholipid binding [GO:0005543]	GO:0004622; GO:0004623; GO:0005543; GO:0005635; GO:0005654; GO:0005789; GO:0005829; GO:0005938; GO:0006644; GO:0006954; GO:0007567; GO:0008970; GO:0016020; GO:0019369; GO:0035556; GO:0036149; GO:0036151; GO:0036152; GO:0046475; GO:0047499; GO:0102567; GO:0102568	SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:10085124, ECO:0000269|PubMed:14529291, ECO:0000269|PubMed:9705332}; Lipid-anchor {ECO:0000269|PubMed:10085124, ECO:0000269|PubMed:14529291, ECO:0000269|PubMed:9705332}.		MOD_RES 337 337 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 538 538 Cysteine methyl ester. {ECO:0000269|PubMed:14529291, ECO:0000305|PubMed:9705332}.	9705332; 10085124; 14702039; 15057824; 15489334; 17974005; 14529291; 18088087; 24275569; 11958371; 12039969; 12359733; 12396716; 15695510; 15788676; 15908428; 15944408; 16181776; 16882668; 17213206; 17417066; 17459165; 18686860; 19501189; 19913121; 20016400; 20056178; 20452986; 20628086; 20705608; 21184677; 21600875; 22108055; 22878031; 26160611; 26364726; 27611910; 28651698; 2925608	9705332; 10085124; 14702039; 15057824; 15489334; 17974005; 14529291; 18088087; 24275569
12066	OXSM	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=3.9 uM for C4-[acyl-carrier-protein] {ECO:0000269|PubMed:15668256}; KM=1.9 uM for C6-[acyl-carrier-protein] {ECO:0000269|PubMed:15668256}; KM=10.9 uM for C8-[acyl-carrier-protein] {ECO:0000269|PubMed:15668256}; KM=1.8 uM for C10-[acyl-carrier-protein] {ECO:0000269|PubMed:15668256}; KM=9.5 uM for C12-[acyl-carrier-protein] {ECO:0000269|PubMed:15668256}; KM=50.8 uM for C14-[acyl-carrier-protein] {ECO:0000269|PubMed:15668256}; Vmax=129 nmol/min/mg enzyme toward C4-[acyl-carrier-protein] {ECO:0000269|PubMed:15668256}; Vmax=241 nmol/min/mg enzyme toward C6-[acyl-carrier-protein] {ECO:0000269|PubMed:15668256}; Vmax=271 nmol/min/mg enzyme toward C8-[acyl-carrier-protein] {ECO:0000269|PubMed:15668256}; Vmax=364 nmol/min/mg enzyme toward C10-[acyl-carrier-protein] {ECO:0000269|PubMed:15668256}; Vmax=1045 nmol/min/mg enzyme toward C12-[acyl-carrier-protein] {ECO:0000269|PubMed:15668256}; Vmax=115 nmol/min/mg enzyme toward C14-[acyl-carrier-protein] {ECO:0000269|PubMed:15668256}; Note=The highest catalytic efficiency is observed for C10-[acyl-carrier-protein].;	2.3.1.41	CATALYTIC ACTIVITY: Acyl-[acyl-carrier-protein] + malonyl-[acyl-carrier-protein] = 3-oxoacyl-[acyl-carrier-protein] + CO(2) + [acyl-carrier-protein].		ACTIVITY REGULATION: Inhibited by cerulenin. {ECO:0000269|PubMed:15668256}.			PATHWAY: Lipid metabolism; fatty acid biosynthesis.				acyl-CoA metabolic process [GO:0006637]; medium-chain fatty acid biosynthetic process [GO:0051792]; short-chain fatty acid biosynthetic process [GO:0051790]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; acyl-CoA metabolic process [GO:0006637]; medium-chain fatty acid biosynthetic process [GO:0051792]; short-chain fatty acid biosynthetic process [GO:0051790]	3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]	GO:0004315; GO:0005739; GO:0005829; GO:0006637; GO:0051790; GO:0051792	SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:15668256}.		MOD_RES 109 109 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q9D404}.; MOD_RES 109 109 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q9D404}.; MOD_RES 113 113 N6-succinyllysine. {ECO:0000250|UniProtKB:Q9D404}.; MOD_RES 174 174 N6-acetyllysine; alternate. {ECO:0000244|PubMed:19608861}.; MOD_RES 174 174 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q9D404}.	14702039; 16641997; 15489334; 15668256; 19608861; 21269460; 17242430; 16959974; 20877624; 26496610	14702039; 16641997; 15489334; 15668256; 19608861; 21269460; 17242430; 16959974
12068	PYCR3 PYCRL	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=0.42 mM for NADH {ECO:0000269|PubMed:23024808}; KM=0.37 mM for NADPH {ECO:0000269|PubMed:23024808}; KM=4.64 mM for pyrroline-5-carboxylate (in the presence of NADH) {ECO:0000269|PubMed:23024808}; KM=0.38 mM for pyrroline-5-carboxylate (in the presence of NADPH) {ECO:0000269|PubMed:23024808}; Note=kcat is 197 sec(-1) for the NADH-dependent reduction reduction of pyrroline-5-carboxylate. kcat is 35 sec(-1) for the NADPH-dependent reduction of pyrroline-5-carboxylate. {ECO:0000269|PubMed:23024808};	1.5.1.2	CATALYTIC ACTIVITY: L-proline + NAD(P)(+) = 1-pyrroline-5-carboxylate + NAD(P)H. {ECO:0000269|PubMed:23024808}.		ACTIVITY REGULATION: Not inhibited by proline. {ECO:0000269|PubMed:23024808}.			PATHWAY: Amino-acid biosynthesis; L-proline biosynthesis; L-proline from L-glutamate 5-semialdehyde: step 1/1. {ECO:0000269|PubMed:23024808}.				cellular amino acid biosynthetic process [GO:0008652]; L-proline biosynthetic process [GO:0055129]	cytosol [GO:0005829]	cytosol [GO:0005829]; pyrroline-5-carboxylate reductase activity [GO:0004735]; cellular amino acid biosynthetic process [GO:0008652]; L-proline biosynthetic process [GO:0055129]	pyrroline-5-carboxylate reductase activity [GO:0004735]	GO:0004735; GO:0005829; GO:0008652; GO:0055129	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:23024808}.		MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:22814378}.	14702039; 16421571; 15489334; 17974005; 21269460; 23024808; 22814378; 20562859; 21988832; 22653443; 23455924; 23902751; 25416956; 26496610; 2722838	14702039; 16421571; 15489334; 17974005; 21269460; 23024808; 22814378
12117	HPGD PGDH1 SDR36C1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=3.4 uM for prostaglandin E2 {ECO:0000269|PubMed:16828555}; KM=38 uM for NAD {ECO:0000269|PubMed:16828555}; 	1.1.1.141	CATALYTIC ACTIVITY: (5Z,13E,15S)-11-alpha,15-dihydroxy-9-oxoprost-5,13-dienoate + NAD(+) = (5Z,13E)-11-alpha-hydroxy-9,15-dioxoprost-5,13-dienoate + NADH.	BINDING 91 91 NAD; via carbonyl oxygen. {ECO:0000269|PubMed:21072165}.; BINDING 138 138 Substrate. {ECO:0000305}.; BINDING 148 148 Substrate. {ECO:0000305}.								ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; lipoxin biosynthetic process [GO:2001301]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]	basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]	basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; protein homodimerization activity [GO:0042803]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; lipoxin biosynthetic process [GO:2001301]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]	15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD+ binding [GO:0070403]; NAD binding [GO:0051287]; prostaglandin E receptor activity [GO:0004957]; protein homodimerization activity [GO:0042803]	GO:0001822; GO:0003824; GO:0004957; GO:0005654; GO:0005829; GO:0006693; GO:0007179; GO:0007565; GO:0007567; GO:0016323; GO:0016404; GO:0019372; GO:0030728; GO:0032355; GO:0032496; GO:0042759; GO:0042803; GO:0043065; GO:0045471; GO:0045786; GO:0051287; GO:0070062; GO:0070403; GO:0070493; GO:0097070; GO:1904707; GO:2001301	SUBCELLULAR LOCATION: Cytoplasm.			2337593; 1697582; 7557451; 9099873; 14702039; 15815621; 15489334; 2025296; 10837478; 12788907; 15574495; 16828555; 8482380; 18500342; 21072165; 18805827; 12664592; 12679466; 12914529; 14718596; 15181076; 15581601; 15680906; 16632868; 16880406; 16997128; 17463062; 18174234; 18212353; 18328086; 18593902; 18632593; 18660489; 18987618; 19010907; 19034772; 19138967; 19306095; 19336370; 19494278; 19568269; 19584167; 19608733; 19667156; 19667157; 19820419; 19913121; 19917058; 20042636; 20086108; 20093479; 20299379; 20304053; 20452482; 20628086; 20635443; 20643784; 20673868; 20689807; 20699658; 21047993; 21426412; 21469975; 22072156; 22082586; 22197745; 22416177; 23430757; 23506845; 23625286; 23717544; 23954207; 24471568; 24533558; 24657469; 24694755; 24699315; 24760190; 24816859; 25003827; 25433169; 25586183; 25691459; 25735395; 25773924; 25863089; 26093984; 26135126; 26261578; 26287481; 27075590; 27522468; 27561985; 28320945; 29042428; 29101039; 29224225; 3954355	2337593; 1697582; 7557451; 9099873; 14702039; 15815621; 15489334; 2025296; 10837478; 12788907; 15574495; 16828555; 8482380; 18500342; 21072165; 18805827
12141	PHF8 KIAA1111 ZNF422	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=134 uM for histone H3 H3K9Me2 {ECO:0000269|PubMed:20023638}; KM=8 uM for histone H3 H3K4me3 and H3K9Me2 {ECO:0000269|PubMed:20023638}; 	1.14.11.27	CATALYTIC ACTIVITY: Protein N(6),N(6)-dimethyl-L-lysine + 2 2-oxoglutarate + 2 O(2) = protein L-lysine + 2 succinate + 2 formaldehyde + 2 CO(2). {ECO:0000269|PubMed:19843542, ECO:0000269|PubMed:20023638}.	BINDING 280 280 Substrate.; BINDING 300 300 Substrate.		COFACTOR: Name=Fe(2+); Xref=ChEBI:CHEBI:29033; Evidence={ECO:0000305|PubMed:19843542, ECO:0000305|PubMed:20023638}; ;  Note=Binds 1 Fe(2+) ion per subunit. {ECO:0000305|PubMed:19843542, ECO:0000305|PubMed:20023638};						brain development [GO:0007420]; G1/S transition of mitotic cell cycle [GO:0000082]; histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; negative regulation of chromatin silencing at rDNA [GO:0061188]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase I [GO:0045943]; transcription, DNA-templated [GO:0006351]	nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K27 specific) [GO:0071558]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; histone demethylase activity (H4-K20 specific) [GO:0035575]; iron ion binding [GO:0005506]; methylated histone binding [GO:0035064]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors [GO:0016706]; zinc ion binding [GO:0008270]; brain development [GO:0007420]; G1/S transition of mitotic cell cycle [GO:0000082]; histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; negative regulation of chromatin silencing at rDNA [GO:0061188]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription, DNA-templated [GO:0006351]	chromatin binding [GO:0003682]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K27 specific) [GO:0071558]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; histone demethylase activity (H4-K20 specific) [GO:0035575]; iron ion binding [GO:0005506]; methylated histone binding [GO:0035064]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors [GO:0016706]; zinc ion binding [GO:0008270]	GO:0000082; GO:0003682; GO:0005506; GO:0005634; GO:0005654; GO:0005730; GO:0006351; GO:0007420; GO:0008270; GO:0016706; GO:0031965; GO:0032452; GO:0032454; GO:0033169; GO:0035064; GO:0035574; GO:0035575; GO:0045893; GO:0045943; GO:0051864; GO:0061188; GO:0070544; GO:0071557; GO:0071558	SUBCELLULAR LOCATION: Nucleus. Nucleus, nucleolus. Note=Recruited to H3K4me3 sites on chromatin during interphase. Dissociates from chromatin when cells enter mitosis.	PTM: Phosphorylation at Ser-69 and Ser-120 are required for dissociation from chromatin and accumulation of H4K20Me1 levels during prophase. {ECO:0000269|PubMed:20622854}.	MOD_RES 69 69 Phosphoserine; by CDK1. {ECO:0000269|PubMed:20622854}.; MOD_RES 120 120 Phosphoserine; by CDK1. {ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:20622854}.; MOD_RES 651 651 Phosphoserine. {ECO:0000244|PubMed:19690332}.; MOD_RES 704 704 Phosphotyrosine. {ECO:0000250|UniProtKB:Q80TJ7}.; MOD_RES 705 705 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332}.; MOD_RES 706 706 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332}.; MOD_RES 722 722 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 804 804 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 826 826 Phosphoserine. {ECO:0000250|UniProtKB:Q80TJ7}.; MOD_RES 834 834 Phosphoserine. {ECO:0000250|UniProtKB:Q80TJ7}.; MOD_RES 854 854 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:21406692}.; MOD_RES 857 857 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 880 880 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.	10470851; 12168954; 14702039; 17974005; 15772651; 15489334; 16199551; 17081983; 18669648; 19413330; 19690332; 20531378; 20548336; 19843542; 20346720; 20421419; 20208542; 20622853; 20622854; 20068231; 21269460; 21406692; 23186163; 20101266; 20067792; 20023638; 17661819; 23092983; 12086618; 12208845; 16603237; 17884155; 18498374; 20084082; 20129925; 20467438; 20966048; 21532585; 21851590; 22120715; 22615488; 22850744; 23518351; 23979597; 24146981; 24656813; 25065740; 25204660; 26496610; 26751588; 27689328; 28734980; 28765946; 29246768; 29330049	10470851; 12168954; 14702039; 17974005; 15772651; 15489334; 16199551; 17081983; 18669648; 19413330; 19690332; 20531378; 20548336; 19843542; 20346720; 20421419; 20208542; 20622853; 20622854; 20068231; 21269460; 21406692; 23186163; 20101266; 20067792; 20023638; 17661819; 23092983
12146	PHLPP1 KIAA0606 PHLPP PLEKHE1 SCOP	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.5 mM for p-nitrophenyl phosphate {ECO:0000269|PubMed:24892992}; 	3.1.3.16	CATALYTIC ACTIVITY: [a protein]-serine/threonine phosphate + H(2)O = [a protein]-serine/threonine + phosphate. {ECO:0000269|PubMed:15808505, ECO:0000269|PubMed:24892992}.		ACTIVITY REGULATION: Insensitive to okadaic acid (PubMed:15808505). Deubiquitination by WDR48-USP12 complex positively regulates PHLPP1 stability (PubMed:24145035). {ECO:0000269|PubMed:15808505, ECO:0000269|PubMed:24145035}.	COFACTOR: Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250}; ;  Note=Binds 2 manganese ions per subunit (By similarity). Mn(2+) is inhibitory below pH 8 and activating above pH 8 (PubMed:24892992). {ECO:0000250, ECO:0000269|PubMed:24892992};						apoptotic process [GO:0006915]; entrainment of circadian clock [GO:0009649]; negative regulation of protein kinase B signaling [GO:0051898]; regulation of apoptotic process [GO:0042981]; regulation of JNK cascade [GO:0046328]; regulation of MAPK cascade [GO:0043408]; regulation of p38MAPK cascade [GO:1900744]; regulation of protein kinase C signaling [GO:0090036]; regulation of T cell anergy [GO:0002667]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; apoptotic process [GO:0006915]; entrainment of circadian clock [GO:0009649]; negative regulation of protein kinase B signaling [GO:0051898]; regulation of apoptotic process [GO:0042981]; regulation of JNK cascade [GO:0046328]; regulation of MAPK cascade [GO:0043408]; regulation of p38MAPK cascade [GO:1900744]; regulation of protein kinase C signaling [GO:0090036]; regulation of T cell anergy [GO:0002667]	metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0002667; GO:0004722; GO:0005737; GO:0005829; GO:0005886; GO:0006915; GO:0009649; GO:0031965; GO:0042981; GO:0043408; GO:0046328; GO:0046872; GO:0051898; GO:0090036; GO:1900744	SUBCELLULAR LOCATION: Cytoplasm. Membrane; Peripheral membrane protein. Nucleus. Note=In colorectal cancer tissue, expression is concentrated at the lateral membrane of epithelial cells.; SUBCELLULAR LOCATION: Isoform 2: Cell membrane {ECO:0000269|PubMed:21804599}.		MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:22814378}.; MOD_RES 317 317 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 412 412 Phosphoserine. {ECO:0000244|PubMed:23186163}.	16177791; 9628581; 12168954; 15489334; 14702039; 15808505; 17081983; 17386267; 18162466; 19732725; 19079341; 20513427; 21701506; 21986499; 21804599; 22814378; 24145035; 23186163; 24892992; 24530606; 25820252; 18511290; 19261608; 19615732; 19690890; 19745829; 19797085; 20379614; 20574456; 20677014; 20861921; 21177869; 21454620; 21461637; 21840483; 22044669; 22144674; 22183406; 22237780; 22340730; 22391563; 22931649; 23440515; 23455924; 23512990; 23846336; 24037758; 24061475; 24121273; 24393845; 24945731; 25776496; 25793736; 26245343; 26427440; 26463718; 26496610; 26760962; 26823799; 26971226; 27248326; 27760826; 27913677; 28139510; 28212545; 28263966; 28696259	16177791; 9628581; 12168954; 15489334; 14702039; 15808505; 17081983; 17386267; 18162466; 19732725; 19079341; 20513427; 21701506; 21986499; 21804599; 22814378; 24145035; 23186163; 24892992; 24530606; 25820252
12147	PHLPP2 KIAA0931 PHLPPL	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=4.13 mM for p-nitrophenyl phosphate; 	3.1.3.16	CATALYTIC ACTIVITY: [a protein]-serine/threonine phosphate + H(2)O = [a protein]-serine/threonine + phosphate. {ECO:0000269|PubMed:17386267, ECO:0000269|PubMed:24892992}.		ACTIVITY REGULATION: Inhibited by AKT1, AKT2 and AKT3. Activated by oleic acid and arachidonic acid (PubMed:24892992). {ECO:0000269|PubMed:24892992, ECO:0000305}.	COFACTOR: Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250}; ;  Note=Binds 2 manganese ions per subunit. Mn(2+) is inhibitory below pH 8 and activating above pH 8 (PubMed:24892992). {ECO:0000250, ECO:0000269|PubMed:24892992};						hippocampus development [GO:0021766]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment membrane [GO:0042622]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment membrane [GO:0042622]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; hippocampus development [GO:0021766]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]	metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]	GO:0001917; GO:0004722; GO:0005634; GO:0005737; GO:0005829; GO:0006470; GO:0007165; GO:0021766; GO:0042622; GO:0046872	SUBCELLULAR LOCATION: Cytoplasm. Membrane; Peripheral membrane protein. Nucleus. Note=In colorectal cancer tissue, expression is concentrated in the cytoplasm and nucleus.		MOD_RES 1210 1210 Phosphoserine. {ECO:0000244|PubMed:23186163}.	10231032; 17974005; 15616553; 15489334; 14702039; 17386267; 18162466; 19732725; 19079341; 20513427; 21986499; 21804599; 23186163; 24892992; 24530606; 15808505; 19261608; 19324870; 19615732; 20379614; 21701506; 22183406; 23184957; 23715723; 23846336; 23856247; 24553260; 24945731; 25160587; 25793736; 25888950; 25977341; 26245343; 26276160; 26427440; 27556506; 27760826; 27822662; 27913677; 28224609; 28327189; 28433657; 28972042; 30045018	10231032; 17974005; 15616553; 15489334; 14702039; 17386267; 18162466; 19732725; 19079341; 20513427; 21986499; 21804599; 23186163; 24892992; 24530606
12222	PTPN2 PTPT	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.48 mM for p-nitrophenyl phosphate (at pH 6.5 and 25 degrees Celsius) {ECO:0000269|PubMed:11907034}; 	3.1.3.48	CATALYTIC ACTIVITY: Protein tyrosine phosphate + H(2)O = protein tyrosine + phosphate. {ECO:0000255|PROSITE-ProRule:PRU10044}.	BINDING 182 182 Substrate. {ECO:0000250}.; BINDING 260 260 Substrate. {ECO:0000250}.								B cell differentiation [GO:0030183]; cellular response to cytokine stimulus [GO:0071345]; erythrocyte differentiation [GO:0030218]; glucose homeostasis [GO:0042593]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell proliferation [GO:0008285]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of interleukin-2-mediated signaling pathway [GO:1902206]; negative regulation of interleukin-4-mediated signaling pathway [GO:1902215]; negative regulation of interleukin-6-mediated signaling pathway [GO:0070104]; negative regulation of lipid storage [GO:0010888]; negative regulation of macrophage colony-stimulating factor signaling pathway [GO:1902227]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of positive thymic T cell selection [GO:1902233]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; T cell differentiation [GO:0030217]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; STAT family protein binding [GO:0097677]; syntaxin binding [GO:0019905]; B cell differentiation [GO:0030183]; cellular response to cytokine stimulus [GO:0071345]; erythrocyte differentiation [GO:0030218]; glucose homeostasis [GO:0042593]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell proliferation [GO:0008285]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of interleukin-2-mediated signaling pathway [GO:1902206]; negative regulation of interleukin-4-mediated signaling pathway [GO:1902215]; negative regulation of interleukin-6-mediated signaling pathway [GO:0070104]; negative regulation of lipid storage [GO:0010888]; negative regulation of macrophage colony-stimulating factor signaling pathway [GO:1902227]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of positive thymic T cell selection [GO:1902233]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; T cell differentiation [GO:0030217]	integrin binding [GO:0005178]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; STAT family protein binding [GO:0097677]; syntaxin binding [GO:0019905]	GO:0000122; GO:0004725; GO:0004726; GO:0005178; GO:0005634; GO:0005654; GO:0005783; GO:0005793; GO:0005829; GO:0005886; GO:0008285; GO:0008286; GO:0010804; GO:0010888; GO:0019901; GO:0019905; GO:0030183; GO:0030217; GO:0030218; GO:0030971; GO:0035335; GO:0042059; GO:0042532; GO:0042593; GO:0045650; GO:0045722; GO:0046627; GO:0050728; GO:0050860; GO:0050922; GO:0060334; GO:0060336; GO:0060339; GO:0061099; GO:0070104; GO:0070373; GO:0071345; GO:0097677; GO:1902202; GO:1902206; GO:1902215; GO:1902227; GO:1902233; GO:1902237; GO:1903899; GO:2000587	SUBCELLULAR LOCATION: Isoform 1: Endoplasmic reticulum {ECO:0000269|PubMed:7593185}. Endoplasmic reticulum-Golgi intermediate compartment {ECO:0000269|PubMed:7593185}. Note=Targeted to the endoplasmic reticulum by its C-terminal hydrophobic region. {ECO:0000269|PubMed:7593185}.; SUBCELLULAR LOCATION: Isoform 2: Nucleus. Cytoplasm. Cell membrane. Note=Predominantly localizes to chromatin (By similarity). Able to shuttle between the nucleus and the cytoplasm and to dephosphorylate plasma membrane receptors (PubMed:9488479). Recruited by activated ITGA1 at the plasma membrane. {ECO:0000250, ECO:0000269|PubMed:9488479}.	PTM: Isoform 2: Specifically phosphorylated in a cell cycle-dependent manner by cyclin-dependent kinases CDK1 and CDK2. Probably activated through phosphorylation by PKR. {ECO:0000269|PubMed:15030318, ECO:0000269|PubMed:16431927}.	MOD_RES 22 22 Phosphotyrosine. {ECO:0000250|UniProtKB:P18031}.; MOD_RES 52 52 Phosphoserine. {ECO:0000250|UniProtKB:P18031}.; MOD_RES 68 68 Phosphotyrosine. {ECO:0000250|UniProtKB:P18031}.; MOD_RES 216 216 S-nitrosocysteine. {ECO:0000250|UniProtKB:P18031}.; MOD_RES 293 293 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 298 298 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 304 304 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.	2546150; 14702039; 16177791; 15489334; 1731319; 7593185; 9361013; 9488479; 10734133; 12359225; 11909529; 12138178; 12612081; 15030318; 14966296; 15609043; 15592458; 15696169; 16431927; 16595549; 17210636; 18819921; 18669648; 20068231; 21269460; 22080863; 21406692; 23006999; 23186163; 24275569; 11907034; 12171910; 12459463; 12847239; 12907755; 14600148; 15192089; 15539083; 15778465; 16293614; 17554260; 17554261; 17554300; 18438405; 18519826; 18587394; 18593762; 18840653; 18936107; 18948751; 18978792; 19073967; 19174780; 19240061; 19264985; 19336676; 19422935; 19430480; 19565500; 19615732; 19755676; 19760754; 19818778; 19861958; 19898481; 19922411; 20059965; 20088380; 20190752; 20203524; 20222910; 20379614; 20403149; 20473312; 20689057; 20711500; 20886065; 20940300; 20962850; 21072187; 21115548; 21179116; 21220691; 21246196; 21551237; 21791476; 21876762; 21984578; 21987459; 22021207; 22105363; 22233524; 22294642; 22404968; 22426692; 22457781; 22671594; 22671596; 22960018; 23124138; 23166300; 23328081; 23454379; 23518806; 23579275; 23840476; 24022492; 24040033; 24127071; 24480412; 24608439; 24901824; 24936733; 25311528; 25460303; 25489960; 26026268; 26090670; 26139109; 26208487; 26344020; 26496610; 26638075; 26734582; 26817397; 26892021; 26928573; 27342690; 27746364; 28092676; 28107378; 28145159; 28342869; 28804910; 29456405	2546150; 14702039; 16177791; 15489334; 1731319; 7593185; 9361013; 9488479; 10734133; 12359225; 11909529; 12138178; 12612081; 15030318; 14966296; 15609043; 15592458; 15696169; 16431927; 16595549; 17210636; 18819921; 18669648; 20068231; 21269460; 22080863; 21406692; 23006999; 23186163; 24275569; 11907034
12260	PGP	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=1.4 mM for glycerol-3-phosphate {ECO:0000269|PubMed:26755581}; KM=1.5 mM for 2-phosphoglycolate {ECO:0000269|PubMed:26755581}; Vmax=100 nmol/min/mg enzyme with glycerol-3-phosphate as substrate {ECO:0000269|PubMed:26755581}; Vmax=500 nmol/min/mg enzyme with 2-phosphoglycolate as substrate {ECO:0000269|PubMed:26755581}; Note=Given the respective intracellular concentrations of glycerol-3-phosphate and 2-phosphoglycolate, glycerol-3-phosphate with a concentration of 2 to 10 mM is most probably the physiological substrate. {ECO:0000269|PubMed:26755581};	3.1.3.21; 3.1.3.48	CATALYTIC ACTIVITY: Protein tyrosine phosphate + H(2)O = protein tyrosine + phosphate. {ECO:0000250|UniProtKB:Q8CHP8}.; CATALYTIC ACTIVITY: Glycerol 1-phosphate + H(2)O = glycerol + phosphate. {ECO:0000269|PubMed:26755581}.			COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250|UniProtKB:Q8CHP8}; ;  Note=Binds 1 Mg(2+) ion per subunit. {ECO:0000250|UniProtKB:Q8CHP8};			SITE 204 204 Important for substrate specificity. {ECO:0000250|UniProtKB:Q8CHP8}.			dephosphorylation [GO:0016311]; glycerol biosynthetic process [GO:0006114]; glycerophospholipid metabolic process [GO:0006650]; negative regulation of gluconeogenesis [GO:0045721]; peptidyl-tyrosine dephosphorylation [GO:0035335]	cytosol [GO:0005829]	cytosol [GO:0005829]; glycerol-1-phosphatase activity [GO:0000121]; glycerol-3-phosphatase activity [GO:0043136]; magnesium ion binding [GO:0000287]; nucleotide phosphatase activity, acting on free nucleotides [GO:0098519]; phosphoglycolate phosphatase activity [GO:0008967]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; dephosphorylation [GO:0016311]; glycerol biosynthetic process [GO:0006114]; glycerophospholipid metabolic process [GO:0006650]; negative regulation of gluconeogenesis [GO:0045721]; peptidyl-tyrosine dephosphorylation [GO:0035335]	glycerol-1-phosphatase activity [GO:0000121]; glycerol-3-phosphatase activity [GO:0043136]; magnesium ion binding [GO:0000287]; nucleotide phosphatase activity, acting on free nucleotides [GO:0098519]; phosphoglycolate phosphatase activity [GO:0008967]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]	GO:0000121; GO:0000287; GO:0004721; GO:0004725; GO:0005829; GO:0006114; GO:0006650; GO:0008967; GO:0016311; GO:0035335; GO:0043136; GO:0045721; GO:0098519				15616553; 215071; 21269460; 26755581; 15260917; 15661399; 16160620; 17038883; 18640717; 20091410; 21861206; 25720491; 27544441; 29524543	15616553; 215071; 21269460; 26755581
12290	PHOSPHO1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=3 uM for PEA {ECO:0000269|PubMed:15175005}; KM=11.4 uM for PCho {ECO:0000269|PubMed:15175005}; 	3.1.3.75	CATALYTIC ACTIVITY: O-phosphoethanolamine + H(2)O = ethanolamine + phosphate. {ECO:0000269|PubMed:15175005}.; CATALYTIC ACTIVITY: Phosphocholine + H(2)O = choline + phosphate. {ECO:0000269|PubMed:15175005}.	BINDING 43 43 Substrate. {ECO:0000305}.; BINDING 123 123 Substrate. {ECO:0000305}.		COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:15175005}; 	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 6.7. {ECO:0000269|PubMed:15175005};					bone mineralization involved in bone maturation [GO:0035630]; endochondral ossification [GO:0001958]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; regulation of bone mineralization [GO:0030500]	cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular membrane-bounded organelle [GO:0065010]	cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular membrane-bounded organelle [GO:0065010]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; phosphocholine phosphatase activity [GO:0052731]; phosphoethanolamine phosphatase activity [GO:0052732]; pyrophosphatase activity [GO:0016462]; bone mineralization involved in bone maturation [GO:0035630]; endochondral ossification [GO:0001958]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; regulation of bone mineralization [GO:0030500]	metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; phosphocholine phosphatase activity [GO:0052731]; phosphoethanolamine phosphatase activity [GO:0052732]; pyrophosphatase activity [GO:0016462]	GO:0001958; GO:0005829; GO:0006646; GO:0006656; GO:0016462; GO:0016791; GO:0030500; GO:0031012; GO:0035630; GO:0046872; GO:0052731; GO:0052732; GO:0065010				12464021; 18471996; 16625196; 15489334; 15175005; 15050893; 14983068; 16054448; 19453261; 24533943; 27148772; 28173150	12464021; 18471996; 16625196; 15489334; 15175005; 15050893; 14983068; 16054448
12318	PGM2 MSTP006	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=45.7 uM for alpha-D-ribose 1-phosphate {ECO:0000269|PubMed:17804405}; KM=4.1 uM for 2-deoxy-alpha-D-ribose 1-phosphate {ECO:0000269|PubMed:17804405}; KM=114 uM for alpha-D-glucose 1-phosphate {ECO:0000269|PubMed:17804405}; Vmax=104.3 umol/min/mg enzyme with alpha-D-ribose 1-phosphate as substrate {ECO:0000269|PubMed:17804405}; Vmax=20.8 umol/min/mg enzyme with 2-deoxy-alpha-D-ribose 1-phosphate as substrate {ECO:0000269|PubMed:17804405}; Vmax=22.8 umol/min/mg enzyme with alpha-D-glucose 1-phosphate as substrate {ECO:0000269|PubMed:17804405}; 	5.4.2.2; 5.4.2.7	CATALYTIC ACTIVITY: Alpha-D-glucose 1-phosphate = alpha-D-glucose 6-phosphate.; CATALYTIC ACTIVITY: Alpha-D-ribose 1-phosphate = D-ribose 5-phosphate.; CATALYTIC ACTIVITY: 2-deoxy-alpha-D-ribose 1-phosphate = 2-deoxy-alpha-D-ribose 5-phosphate.	BINDING 59 59 Substrate. {ECO:0000250|UniProtKB:P00949}.; BINDING 63 63 Substrate. {ECO:0000250|UniProtKB:P00949}.; BINDING 400 400 Substrate. {ECO:0000250|UniProtKB:P00949}.; BINDING 438 438 Substrate. {ECO:0000250|UniProtKB:P00949}.		COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250}; ;  Note=Binds 1 Mg(2+) ion per subunit. {ECO:0000250};		PATHWAY: Carbohydrate degradation; 2-deoxy-D-ribose 1-phosphate degradation; D-glyceraldehyde 3-phosphate and acetaldehyde from 2-deoxy-alpha-D-ribose 1-phosphate: step 1/2.		MSTP006		deoxyribose phosphate catabolic process [GO:0046386]; galactose catabolic process [GO:0019388]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; neutrophil degranulation [GO:0043312]; pentose-phosphate shunt [GO:0006098]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; phosphopentomutase activity [GO:0008973]; deoxyribose phosphate catabolic process [GO:0046386]; galactose catabolic process [GO:0019388]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; neutrophil degranulation [GO:0043312]; pentose-phosphate shunt [GO:0006098]	magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; phosphopentomutase activity [GO:0008973]	GO:0000287; GO:0004614; GO:0005576; GO:0005829; GO:0005978; GO:0005980; GO:0006006; GO:0006098; GO:0008973; GO:0019388; GO:0034774; GO:0043312; GO:0046386; GO:0070062; GO:1904813	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.		MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378, ECO:0000269|PubMed:12665801}.; MOD_RES 165 165 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.	11230166; 14702039; 15815621; 15489334; 12665801; 17804405; 18669648; 19413330; 20068231; 21269460; 22223895; 22814378; 23186163; 24275569; 1840235; 18927083; 19805454; 21044950; 23650620; 25277244; 7902568; 8257433	11230166; 14702039; 15815621; 15489334; 12665801; 17804405; 18669648; 19413330; 20068231; 21269460; 22223895; 22814378; 23186163; 24275569
12339	PHOSPHO2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=45.5 uM for pyridoxal 5'-phosphate {ECO:0000269|PubMed:16054448}; Vmax=633 nmol/min/mg enzyme with pyridoxal 5'-phosphate as substrate {ECO:0000269|PubMed:16054448}; 	3.1.3.74	CATALYTIC ACTIVITY: Pyridoxal 5'-phosphate + H(2)O = pyridoxal + phosphate. {ECO:0000269|PubMed:16054448}.	BINDING 19 19 Substrate. {ECO:0000250}.; BINDING 99 99 Substrate. {ECO:0000250}.		COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250}; 								metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; pyridoxal phosphatase activity [GO:0033883]	metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; pyridoxal phosphatase activity [GO:0033883]	GO:0016791; GO:0033883; GO:0046872				14702039; 15815621; 15489334; 16054448; 20711500; 25416956	14702039; 15815621; 15489334; 16054448
12351	PI4KA PIK4 PIK4CA	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=300 uM for ATP {ECO:0000269|PubMed:10101268}; 	2.7.1.67	CATALYTIC ACTIVITY: ATP + 1-phosphatidyl-1D-myo-inositol = ADP + 1-phosphatidyl-1D-myo-inositol 4-phosphate. {ECO:0000269|PubMed:10101268}.		ACTIVITY REGULATION: Activated by Triton X-100, insensitive to inhibition by adenosine and inhibited by wortmannin (By similarity). Isoform 2 is activated by detergents such as Triton X-100 and inhibited by adenosine (PubMed:7961848). The PI4K complex acts as a regulator of phosphatidylinositol 4-phosphate (PtdIns(4)P) synthesis (PubMed:23229899, PubMed:26571211). Interaction with TMEM150A regulates PtdIns(4)P synthesis (PubMed:25608530). {ECO:0000250|UniProtKB:O08662, ECO:0000269|PubMed:23229899, ECO:0000269|PubMed:25608530, ECO:0000269|PubMed:26571211, ECO:0000269|PubMed:7961848}.							actin cytoskeleton organization [GO:0030036]; multi-organism membrane organization [GO:0044803]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol phosphorylation [GO:0046854]; phosphorylation [GO:0016310]; signal transduction [GO:0007165]; viral replication complex formation and maintenance [GO:0046786]; viral RNA genome replication [GO:0039694]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi-associated vesicle membrane [GO:0030660]; membrane [GO:0016020]; plasma membrane [GO:0005886]; viral replication complex [GO:0019034]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi-associated vesicle membrane [GO:0030660]; membrane [GO:0016020]; plasma membrane [GO:0005886]; viral replication complex [GO:0019034]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; kinase activity [GO:0016301]; actin cytoskeleton organization [GO:0030036]; multi-organism membrane organization [GO:0044803]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; signal transduction [GO:0007165]; viral replication complex formation and maintenance [GO:0046786]; viral RNA genome replication [GO:0039694]	1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; kinase activity [GO:0016301]	GO:0004430; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0006661; GO:0007165; GO:0016020; GO:0016301; GO:0016310; GO:0019034; GO:0030036; GO:0030660; GO:0039694; GO:0044803; GO:0045296; GO:0046786; GO:0046854; GO:0048015; GO:0070062	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:23229899, ECO:0000269|PubMed:24417819}. Cell membrane {ECO:0000269|PubMed:23229899, ECO:0000269|PubMed:24417819}. Note=Localization to the plasma membrane is mediated by the PI4K complex and association with EFR3 (EFR3A or EFR3B), TTC7 (TTC7A or TTC7B) and FAM126 (FAM126A or FAM126B) (PubMed:23229899). Localization to the plasma membrane is regulated by TMEM150A (PubMed:25608530). {ECO:0000269|PubMed:23229899, ECO:0000269|PubMed:25608530}.		MOD_RES 230 230 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 256 256 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 257 257 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 259 259 Phosphoserine. {ECO:0000250|UniProtKB:E9Q3L2}.; MOD_RES 260 260 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 262 262 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 265 265 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163}.; MOD_RES 429 429 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1154 1154 Phosphotyrosine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1436 1436 Phosphoserine. {ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.	7961848; 10591208; 10101268; 15489334; 18691976; 18669648; 19369195; 19690332; 21269460; 23229899; 23186163; 24417819; 24275569; 25855803; 25608530; 26571211; 10559940; 11279162; 11923287; 12324459; 15607035; 16169070; 17215244; 19738201; 20711500; 21238945; 21297162; 21900206; 21911578; 22252131; 22623428; 23675303; 23935497; 25604459; 25609649; 26496610; 26514267; 29229838; 9148941	7961848; 10591208; 10101268; 15489334; 18691976; 18669648; 19369195; 19690332; 21269460; 23229899; 23186163; 24417819; 24275569; 25855803; 25608530; 26571211
12363	PTGS2 COX2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=16.2 uM for arachidonate (in absence of sodium nitroprusside NO donor) {ECO:0000269|PubMed:16373578}; KM=12 uM for arachidonic acid {ECO:0000269|PubMed:26859324}; KM=17.0 uM for arachidonate (in presence of sodium nitroprusside NO donor) {ECO:0000269|PubMed:16373578}; Vmax=81.3 nmol/min/mg enzyme (in absence of sodium nitroprusside NO donor) {ECO:0000269|PubMed:16373578}; Vmax=132 nmol/min/mg enzyme (in absence of sodium nitroprusside NO donor) {ECO:0000269|PubMed:16373578}; 	1.14.99.1	CATALYTIC ACTIVITY: Arachidonate + AH(2) + 2 O(2) = prostaglandin H(2) + A + H(2)O. {ECO:0000269|PubMed:16373578, ECO:0000269|PubMed:26859324, ECO:0000269|PubMed:27226593}.	BINDING 106 106 Substrate. {ECO:0000250|UniProtKB:Q05769}.; BINDING 341 341 Substrate. {ECO:0000250|UniProtKB:Q05769}.	ACTIVITY REGULATION: Inhibited by nonsteroidal anti-inflammatory drugs (NSAIDs) including aspirin, ibuprofen, flurbiprofen and celecoxib (PubMed:26859324). Inhibited by flufenamic acid, mefenamic acid and tolfenamic acid (PubMed:27226593). {ECO:0000269|PubMed:26859324, ECO:0000269|PubMed:27226593}.	COFACTOR: Name=heme b; Xref=ChEBI:CHEBI:60344; Evidence={ECO:0000269|PubMed:26859324, ECO:0000269|PubMed:27226593, ECO:0000269|PubMed:27710942}; ;  Note=Binds 1 heme b (iron(II)-protoporphyrin IX) group per subunit. {ECO:0000269|PubMed:26859324, ECO:0000269|PubMed:27226593, ECO:0000269|PubMed:27710942};		PATHWAY: Lipid metabolism; prostaglandin biosynthesis. {ECO:0000269|PubMed:26859324, ECO:0000269|PubMed:27226593}.	SITE 516 516 Aspirin-acetylated serine. {ECO:0000269|PubMed:26859324}.			aging [GO:0007568]; angiogenesis [GO:0001525]; bone mineralization [GO:0030282]; brown fat cell differentiation [GO:0050873]; cellular response to ATP [GO:0071318]; cellular response to fluid shear stress [GO:0071498]; cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to lead ion [GO:0071284]; cellular response to mechanical stimulus [GO:0071260]; cellular response to non-ionic osmotic stress [GO:0071471]; cellular response to UV [GO:0034644]; cyclooxygenase pathway [GO:0019371]; cytokine-mediated signaling pathway [GO:0019221]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; hair cycle [GO:0042633]; inflammatory response [GO:0006954]; learning [GO:0007612]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; maintenance of permeability of blood-brain barrier [GO:0035633]; memory [GO:0007613]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902219]; negative regulation of smooth muscle contraction [GO:0045986]; negative regulation of synaptic transmission, dopaminergic [GO:0032227]; ovulation [GO:0030728]; positive regulation of apoptotic process [GO:0043065]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of fever generation [GO:0031622]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of platelet-derived growth factor production [GO:0090362]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transforming growth factor beta production [GO:0071636]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vasoconstriction [GO:0045907]; prostaglandin biosynthetic process [GO:0001516]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; response to angiotensin [GO:1990776]; response to estradiol [GO:0032355]; response to fatty acid [GO:0070542]; response to fructose [GO:0009750]; response to glucocorticoid [GO:0051384]; response to lipopolysaccharide [GO:0032496]; response to lithium ion [GO:0010226]; response to manganese ion [GO:0010042]; response to oxidative stress [GO:0006979]; response to tumor necrosis factor [GO:0034612]; response to vitamin D [GO:0033280]; sensory perception of pain [GO:0019233]	caveola [GO:0005901]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; neuron projection [GO:0043005]; organelle membrane [GO:0031090]; protein-containing complex [GO:0032991]	caveola [GO:0005901]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; neuron projection [GO:0043005]; organelle membrane [GO:0031090]; protein-containing complex [GO:0032991]; arachidonate 15-lipoxygenase activity [GO:0050473]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]; protein homodimerization activity [GO:0042803]; aging [GO:0007568]; angiogenesis [GO:0001525]; bone mineralization [GO:0030282]; brown fat cell differentiation [GO:0050873]; cellular response to ATP [GO:0071318]; cellular response to fluid shear stress [GO:0071498]; cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to lead ion [GO:0071284]; cellular response to mechanical stimulus [GO:0071260]; cellular response to non-ionic osmotic stress [GO:0071471]; cellular response to UV [GO:0034644]; cyclooxygenase pathway [GO:0019371]; cytokine-mediated signaling pathway [GO:0019221]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; hair cycle [GO:0042633]; inflammatory response [GO:0006954]; learning [GO:0007612]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; maintenance of permeability of blood-brain barrier [GO:0035633]; memory [GO:0007613]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902219]; negative regulation of smooth muscle contraction [GO:0045986]; negative regulation of synaptic transmission, dopaminergic [GO:0032227]; ovulation [GO:0030728]; positive regulation of apoptotic process [GO:0043065]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of fever generation [GO:0031622]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of platelet-derived growth factor production [GO:0090362]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transforming growth factor beta production [GO:0071636]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vasoconstriction [GO:0045907]; prostaglandin biosynthetic process [GO:0001516]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; response to angiotensin [GO:1990776]; response to estradiol [GO:0032355]; response to fatty acid [GO:0070542]; response to fructose [GO:0009750]; response to glucocorticoid [GO:0051384]; response to lipopolysaccharide [GO:0032496]; response to lithium ion [GO:0010226]; response to manganese ion [GO:0010042]; response to oxidative stress [GO:0006979]; response to tumor necrosis factor [GO:0034612]; response to vitamin D [GO:0033280]; sensory perception of pain [GO:0019233]	arachidonate 15-lipoxygenase activity [GO:0050473]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]; protein homodimerization activity [GO:0042803]	GO:0001516; GO:0001525; GO:0004601; GO:0004666; GO:0005737; GO:0005783; GO:0005788; GO:0005789; GO:0005901; GO:0006954; GO:0006979; GO:0007566; GO:0007568; GO:0007612; GO:0007613; GO:0008217; GO:0008285; GO:0009750; GO:0010042; GO:0010226; GO:0010575; GO:0016702; GO:0019221; GO:0019233; GO:0019371; GO:0019372; GO:0019899; GO:0020037; GO:0030282; GO:0030728; GO:0031090; GO:0031394; GO:0031622; GO:0031915; GO:0032227; GO:0032355; GO:0032496; GO:0032991; GO:0033138; GO:0033280; GO:0034356; GO:0034605; GO:0034612; GO:0034644; GO:0035633; GO:0042307; GO:0042633; GO:0042759; GO:0042803; GO:0043005; GO:0043065; GO:0043154; GO:0045429; GO:0045786; GO:0045907; GO:0045986; GO:0045987; GO:0046697; GO:0046872; GO:0048661; GO:0050473; GO:0050727; GO:0050873; GO:0051384; GO:0051926; GO:0051968; GO:0070542; GO:0071260; GO:0071284; GO:0071318; GO:0071456; GO:0071471; GO:0071498; GO:0071636; GO:0090050; GO:0090271; GO:0090336; GO:0090362; GO:0097756; GO:1902219; GO:1990776	SUBCELLULAR LOCATION: Microsome membrane; Peripheral membrane protein. Endoplasmic reticulum membrane; Peripheral membrane protein.	PTM: S-nitrosylation by NOS2 (iNOS) activates enzyme activity. S-nitrosylation may take place on different Cys residues in addition to Cys-526. {ECO:0000269|PubMed:16373578}.	MOD_RES 526 526 S-nitrosocysteine. {ECO:0000305|PubMed:16373578}.	8473346; 1380156; 8181472; 7945196; 14702039; 16710414; 15489334; 7947975; 16373578; 17113084; 10966456; 24605250; 27710942; 26859324; 27226593; 15308583; 10956391; 11309440; 11705852; 11712072; 11809691; 11809750; 11844819; 11847219; 11850206; 11867761; 11880271; 11891188; 11891209; 11897504; 11901151; 11906292; 11911965; 11913955; 11920472; 11920515; 11939728; 11948128; 11957147; 11959891; 11972392; 11981837; 11992399; 11994539; 12016158; 12021045; 12032335; 12050157; 12050227; 12051953; 12067908; 12070598; 12072439; 12086404; 12124799; 12131767; 12143054; 12145315; 12162677; 12164325; 12167656; 12174888; 12193665; 12195707; 12197220; 12205039; 12209724; 12209745; 12213900; 12218179; 12324457; 12349897; 12377741; 12378621; 12391278; 12393863; 12393872; 12397176; 12401798; 12405290; 12433707; 12444028; 12450219; 12452062; 12459168; 12462194; 12470703; 12480928; 12485854; 12485915; 12488433; 12493747; 12498388; 12505789; 12519124; 12519748; 12532440; 12532441; 12555215; 12578839; 12579269; 12591723; 12592372; 12598658; 12600292; 12626523; 12628757; 12636104; 12642362; 12654832; 12664576; 12664644; 12665651; 12667327; 12677571; 12679908; 12684668; 12692419; 12698187; 12701770; 12718655; 12720297; 12727794; 12743126; 12748469; 12751754; 12754192; 12759151; 12761889; 12763047; 12767510; 12767532; 12770691; 12771929; 12777984; 12782823; 12784332; 12789263; 12800228; 12800231; 12800245; 12813143; 12821125; 12821538; 12832284; 12835322; 12837757; 12838502; 12839690; 12839952; 12842195; 12860389; 12865795; 12871860; 12875991; 12881220; 12882963; 12883661; 12883688; 12885872; 12891667; 12907138; 12914528; 12920574; 12954496; 12956275; 12957358; 12970159; 12970891; 13680221; 14501677; 14505259; 14507922; 14514642; 14517215; 14530307; 14532848; 14532971; 14534699; 14535998; 14550281; 14555963; 14557269; 14558947; 14566822; 14582702; 14594816; 14596920; 14597555; 14604894; 14607721; 14616542; 14623265; 14623891; 14625295; 14630807; 14645117; 14654083; 14669280; 14675489; 14681319; 14702352; 14707264; 14712483; 14716842; 14719060; 14724276; 14726416; 14729623; 14735188; 14744769; 14747187; 14748725; 14749287; 14749922; 14754878; 14760075; 14769824; 14871981; 14966191; 14977838; 14984594; 14985703; 14988266; 14988445; 14989896; 15000150; 15010261; 15010822; 15013358; 15014019; 15022477; 15041036; 15050918; 15055524; 15063780; 15067173; 15069531; 15100359; 15102673; 15131052; 15138244; 15146435; 15150618; 15151617; 15151619; 15156159; 15162003; 15167446; 15173859; 15181076; 15190260; 15210717; 15220111; 15221958; 15222024; 15222037; 15228443; 15231484; 15234907; 15246970; 15248379; 15254709; 15259059; 15272284; 15274307; 15276698; 15285012; 15301234; 15319438; 15328200; 15328521; 15330183; 15331599; 15334675; 15355919; 15361550; 15374967; 15375804; 15375805; 15381252; 15383564; 15450303; 15456896; 15461587; 15471850; 15474472; 15478052; 15484698; 15485847; 15501771; 15504548; 15525653; 15533352; 15544595; 15550400; 15550453; 15569051; 15569819; 15569856; 15574495; 15591227; 15596291; 15599594; 15609300; 15628724; 15630188; 15632146; 15645119; 15645120; 15653566; 15654517; 15667946; 15673847; 15692221; 15695237; 15704107; 15707991; 15713675; 15720413; 15731178; 15754118; 15754411; 15756444; 15767259; 15767339; 15777967; 15778400; 15784717; 15789615; 15800927; 15809733; 15809909; 15812311; 15816645; 15817909; 15831295; 15833737; 15838264; 15841323; 15843495; 15844661; 15856454; 15856465; 15863442; 15864753; 15867220; 15869467; 15870511; 15870920; 15872218; 15878334; 15878911; 15878914; 15882925; 15896711; 15899904; 15919917; 15921850; 15929167; 15929174; 15930344; 15944924; 15949313; 15950779; 15950941; 15963597; 15968728; 15978332; 15979990; 15994313; 16005433; 16010419; 16024651; 16035618; 16044148; 16046401; 16046707; 16076963; 16083499; 16083713; 16087791; 16097070; 16097073; 16101131; 16110762; 16111807; 16115753; 16136507; 16150050; 16157291; 16164044; 16168133; 16169726; 16172382; 16174078; 16181776; 16186418; 16195339; 16203768; 16203985; 16205694; 16212965; 16215757; 16237757; 16256948; 16273614; 16278387; 16284883; 16309832; 16314473; 16323955; 16326073; 16338068; 16341840; 16343055; 16344721; 16352617; 16357062; 16361272; 16371352; 16391819; 16393343; 16399783; 16407418; 16414978; 16415009; 16419156; 16432453; 16442500; 16453284; 16458279; 16463667; 16473553; 16474375; 16474989; 16475165; 16479074; 16479190; 16481301; 16487513; 16489098; 16489533; 16494037; 16495511; 16497971; 16498361; 16505480; 16506214; 16515599; 16521222; 16531283; 16542464; 16550596; 16552798; 16563251; 16574063; 16574793; 16596190; 16598755; 16603435; 16606823; 16612568; 16632868; 16675095; 16678543; 16681759; 16681998; 16682957; 16687473; 16699180; 16699947; 16702043; 16702519; 16718274; 16723309; 16731743; 16733863; 16733888; 16760271; 16762620; 16775170; 16782382; 16786043; 16788380; 16807542; 16820089; 16820091; 16820791; 16820795; 16820889; 16821264; 16822500; 16823844; 16831230; 16840740; 16868662; 16870193; 16871410; 16875891; 16879213; 16884383; 16890383; 16905570; 16908593; 16912160; 16917094; 16921134; 16926398; 16930602; 16950767; 16952555; 16959787; 16972245; 16979925; 16979927; 16982623; 16984258; 16997132; 16998585; 17001073; 17003477; 17006983; 17011110; 17012241; 17012371; 17013098; 17016639; 17018629; 17046322; 17058024; 17062883; 17066444; 17071117; 17078003; 17092424; 17095859; 17097611; 17105783; 17128412; 17130490; 17133356; 17143555; 17151091; 17156191; 17156488; 17166941; 17171651; 17175104; 17177291; 17178263; 17178883; 17181859; 17192687; 17202846; 17214885; 17218407; 17222248; 17234302; 17244951; 17264103; 17265445; 17290397; 17295901; 17303142; 17307204; 17308999; 17322116; 17325901; 17328065; 17332916; 17337058; 17341442; 17342342; 17350020; 17354234; 17355643; 17356794; 17373929; 17392515; 17395887; 17404026; 17404027; 17405913; 17413988; 17418864; 17429393; 17429597; 17434257; 17437847; 17444036; 17455223; 17457030; 17459764; 17460548; 17460551; 17479405; 17495879; 17504375; 17507659; 17509026; 17510310; 17511025; 17515883; 17525067; 17525632; 17536311; 17536451; 17542993; 17544005; 17550984; 17553653; 17555580; 17560572; 17560944; 17562850; 17570496; 17572069; 17573729; 17578436; 17581270; 17581403; 17581404; 17581413; 17581812; 17588340; 17592301; 17592548; 17594159; 17599805; 17604853; 17609663; 17611676; 17614770; 17616393; 17616668; 17624083; 17624243; 17624339; 17624726; 17627037; 17631383; 17635918; 17640058; 17640750; 17643350; 17645803; 17650224; 17651852; 17657731; 17671679; 17671709; 17672932; 17673564; 17678966; 17680542; 17681165; 17683115; 17693978; 17697546; 17702421; 17702963; 17703412; 17707579; 17710160; 17724132; 17727817; 17823287; 17851225; 17851687; 17855346; 17868457; 17868881; 17876541; 17881124; 17889855; 17916073; 17916229; 17924829; 17927697; 17936921; 17952860; 17955050; 17956662; 17961495; 17962194; 17968676; 17970040; 17977913; 17982107; 17982644; 17991613; 17999989; 18000398; 18006811; 18006935; 18027256; 18032824; 18038187; 18039779; 18048499; 18053993; 18062281; 18064329; 18069633; 18069634; 18070438; 18079209; 18085997; 18093816; 18094075; 18097584; 18156149; 18159174; 18164040; 18165598; 18167131; 18171606; 18172254; 18173398; 18181047; 18181832; 18190720; 18192694; 18199541; 18201240; 18201523; 18202756; 18203712; 18204072; 18212353; 18214026; 18216296; 18224252; 18234542; 18237405; 18245266; 18250037; 18261751; 18262731; 18276112; 18280718; 18284542; 18285462; 18287876; 18288396; 18294142; 18295507; 18297687; 18307244; 18311113; 18314621; 18316157; 18319253; 18320325; 18326857; 18330256; 18330937; 18334709; 18344086; 18345509; 18349295; 18350611; 18356024; 18362501; 18367112; 18367179; 18367585; 18373164; 18378414; 18381795; 18381949; 18381966; 18385811; 18392637; 18393288; 18395088; 18398416; 18408893; 18449856; 18453539; 18459455; 18462368; 18462890; 18466392; 18469157; 18471798; 18478928; 18479189; 18489027; 18496814; 18498876; 18503750; 18512730; 18514098; 18524846; 18550243; 18555503; 18565510; 18565574; 18571838; 18572386; 18579107; 18592138; 18594470; 18601905; 18611916; 18617679; 18627789; 18632220; 18636124; 18645679; 18650379; 18657230; 18660489; 18663571; 18668543; 18671671; 18671849; 18676680; 18691269; 18691306; 18692035; 18695918; 18703629; 18705402; 18714022; 18718465; 18720000; 18727513; 18752906; 18753249; 18754318; 18758643; 18768181; 18771702; 18771989; 18773440; 18775915; 18790560; 18794809; 18795070; 18797196; 18798061; 18800677; 18802697; 18817855; 18818748; 18819034; 18823436; 18825488; 18831511; 18841789; 18842581; 18843292; 18854308; 18922923; 18930197; 18936204; 18950008; 18953425; 18974063; 18976937; 18985541; 18989535; 18991687; 18992148; 18997734; 18997828; 19004621; 19015962; 19016757; 19017360; 19017995; 19019335; 19029777; 19031967; 19033684; 19039588; 19040046; 19042116; 19046748; 19047118; 19047153; 19048457; 19056482; 19056642; 19056653; 19058305; 19058955; 19060633; 19062735; 19064572; 19074839; 19075598; 19082453; 19082758; 19084589; 19088039; 19102009; 19116446; 19118057; 19124115; 19124506; 19127598; 19132985; 19133256; 19138835; 19138978; 19140872; 19141058; 19161536; 19169273; 19170196; 19173907; 19188749; 19188819; 19197984; 19201881; 19203995; 19205707; 19218139; 19218340; 19219602; 19221469; 19223558; 19236532; 19236744; 19236750; 19236756; 19238444; 19241124; 19241157; 19244345; 19245590; 19247455; 19251796; 19258542; 19258923; 19260469; 19268443; 19268562; 19272160; 19276290; 19278989; 19280060; 19280666; 19282568; 19287974; 19289254; 19289707; 19299454; 19304526; 19318492; 19318593; 19319478; 19321801; 19327107; 19329856; 19336370; 19346994; 19347867; 19351509; 19375854; 19383355; 19422084; 19423183; 19423214; 19423863; 19428370; 19433337; 19437564; 19452719; 19452725; 19455278; 19462903; 19463183; 19465063; 19467701; 19468846; 19469866; 19484991; 19487460; 19488068; 19491270; 19494233; 19495976; 19497798; 19505919; 19505922; 19513556; 19527514; 19544971; 19549529; 19558494; 19560328; 19567186; 19568414; 19576320; 19578796; 19579928; 19584262; 19585117; 19591688; 19608016; 19616539; 19618291; 19621391; 19625176; 19625268; 19627000; 19630103; 19631939; 19632843; 19638428; 19639178; 19647233; 19655414; 19661089; 19667156; 19669667; 19671325; 19671676; 19675284; 19679653; 19680656; 19692168; 19706164; 19723044; 19723084; 19723090; 19723094; 19723101; 19723105; 19723114; 19741338; 19748095; 19748535; 19755647; 19756737; 19763374; 19769727; 19773451; 19776642; 19777615; 19781342; 19788502; 19789190; 19794144; 19797430; 19797925; 19802674; 19804834; 19816074; 19820421; 19825968; 19836060; 19836124; 19845533; 19846662; 19861248; 19862774; 19864304; 19885582; 19887674; 19889076; 19890662; 19895739; 19898482; 19900134; 19900843; 19913121; 19915048; 19917472; 19917608; 19920789; 19925030; 19925564; 19930591; 19933775; 19940361; 19940363; 19940973; 19946014; 19948975; 19949677; 19954066; 19960513; 19965896; 20011601; 20016751; 20019776; 20027603; 20028875; 20030038; 20032081; 20033767; 20034614; 20034753; 20042743; 20043083; 20050331; 20052522; 20068092; 20068324; 20069397; 20075740; 20086108; 20093363; 20099494; 20110601; 20117988; 20120857; 20120873; 20144201; 20144265; 20145033; 20145612; 20160714; 20167866; 20169190; 20177132; 20178602; 20193563; 20204301; 20204402; 20213098; 20220108; 20236942; 20299798; 20304053; 20308035; 20332326; 20346139; 20348947; 20354817; 20358279; 20364406; 20369487; 20372792; 20376700; 20378913; 20382140; 20388081; 20397266; 20399617; 20401641; 20403997; 20405237; 20409773; 20416077; 20429377; 20429385; 20431935; 20445548; 20446925; 20448286; 20452482; 20453000; 20472470; 20473875; 20489206; 20503287; 20514410; 20514441; 20519349; 20530427; 20536410; 20537326; 20538124; 20545118; 20558741; 20559705; 20563831; 20571967; 20582552; 20585313; 20588070; 20592629; 20592893; 20594217; 20599859; 20608938; 20620096; 20627335; 20628086; 20628624; 20631257; 20631636; 20635443; 20644176; 20644561; 20645029; 20649594; 20653782; 20656057; 20664981; 20673501; 20673868; 20676755; 20683050; 20686383; 20688044; 20688905; 20697803; 20702505; 20713430; 20717945; 20720307; 20724130; 20732417; 20733059; 20803508; 20808059; 20808133; 20809087; 20810665; 20811626; 20814068; 20819509; 20819530; 20824502; 20827102; 20830783; 20846124; 20854947; 20878073; 20878581; 20880066; 20887233; 20889146; 20934684; 20939988; 20944149; 20950588; 20953506; 20954072; 20957341; 20960565; 21031415; 21042835; 21044318; 21047437; 21059239; 21059296; 21061265; 21069452; 21071513; 21078168; 21081043; 21085606; 21086572; 21088406; 21091235; 21107726; 21112532; 21114363; 21124790; 21131835; 21138631; 21145050; 21153458; 21157974; 21160376; 21168919; 21179273; 21182498; 21187081; 21187340; 21198273; 21209362; 21215666; 21219643; 21236709; 21244365; 21251952; 21254648; 21266582; 21270615; 21275453; 21277633; 21277871; 21283657; 21299081; 21301321; 21309483; 21311042; 21319320; 21319594; 21343834; 21354125; 21356386; 21362301; 21371074; 21371829; 21385353; 21385935; 21388279; 21401943; 21412163; 21416732; 21417982; 21424030; 21424032; 21424698; 21426663; 21426847; 21437756; 21467029; 21478098; 21481131; 21481333; 21482803; 21494638; 21517752; 21533532; 21538574; 21559086; 21561892; 21572400; 21574137; 21600223; 21605700; 21625016; 21642596; 21655952; 21678409; 21681438; 21683347; 21699462; 21705955; 21710354; 21713707; 21728052; 21729542; 21734188; 21734230; 21737640; 21745389; 21762277; 21762900; 21779349; 21782872; 21790228; 21792076; 21798652; 21800055; 21809666; 21813027; 21822307; 21830391; 21840193; 21840784; 21842276; 21845875; 21848701; 21849808; 21854221; 21854542; 21856910; 21857970; 21858104; 21867538; 21868314; 21874258; 21900123; 21907277; 21912077; 21913191; 21915288; 21924077; 21924350; 21925143; 21957142; 21969813; 21972293; 21976141; 21979415; 21980345; 21984126; 21995456; 22000259; 22002749; 22014124; 22037828; 22038215; 22038216; 22039326; 22042094; 22049153; 22049790; 22050691; 22063737; 22072783; 22093778; 22100366; 22101739; 22133296; 22135046; 22147962; 22152242; 22159575; 22170686; 22173719; 22185734; 22199296; 22199301; 22200969; 22203921; 22206958; 22213326; 22224631; 22228276; 22228328; 22234093; 22235849; 22242948; 22247036; 22251572; 22286316; 22287745; 22294637; 22308510; 22330070; 22330859; 22331023; 22335196; 22337942; 22342541; 22347460; 22371637; 22376259; 22385256; 22389271; 22397921; 22406049; 22409848; 22416915; 22433003; 22435505; 22435969; 22441740; 22460097; 22460857; 22464751; 22474323; 22487732; 22504626; 22506937; 22521508; 22527932; 22534817; 22547578; 22551325; 22553404; 22556158; 22575501; 22577245; 22582975; 22587873; 22588264; 22593181; 22608095; 22622868; 22626465; 22627629; 22685558; 22686557; 22696230; 22698646; 22710400; 22718198; 22729746; 22735610; 22740037; 22748678; 22758658; 22761909; 22763881; 22763923; 22782583; 22805469; 22808264; 22819245; 22822059; 22824620; 22826171; 22859522; 22863264; 22870593; 22884582; 22885178; 22887904; 22901457; 22929917; 22936450; 22942274; 22944132; 22960430; 22971811; 22972377; 22982857; 22991985; 22993369; 22998445; 23028744; 23029430; 23052170; 23053989; 23059845; 23095338; 23105117; 23117931; 23124652; 23126361; 23144866; 23153564; 23177619; 23209664; 23219238; 23220503; 23221733; 23226427; 23232839; 23233037; 23239446; 23240010; 23250779; 23254909; 23261444; 23275522; 23301386; 23321929; 23326583; 23357220; 23360427; 23376640; 23393346; 23398566; 23398724; 23434145; 23435965; 23437263; 23444045; 23446663; 23449721; 23453006; 23462226; 23494177; 23495037; 23516071; 23520664; 23523690; 23527044; 23531863; 23536473; 23536693; 23548966; 23564449; 23579063; 23597562; 23601296; 23613363; 23617728; 23620771; 23629521; 23633486; 23635401; 23642086; 23645839; 23666959; 23668350; 23678036; 23680674; 23681850; 23715826; 23729350; 23729401; 23734008; 23755232; 23756256; 23762835; 23765972; 23771849; 23775011; 23776069; 23777936; 23786928; 23847198; 23851330; 23852948; 23857285; 23869759; 23873111; 23898071; 23900502; 23907768; 23922175; 23955344; 23973710; 23973990; 24022467; 24023834; 24037722; 24052986; 24056964; 24064301; 24083698; 24089527; 24100466; 24115825; 24127267; 24133193; 24142638; 24171795; 24178897; 24184161; 24186266; 24187465; 24204704; 24221358; 24243443; 24244288; 24254970; 24267395; 24289600; 24294363; 24337484; 24342014; 24344016; 24346019; 24349530; 24357184; 24358237; 24383454; 24387269; 24388097; 24393208; 24398550; 24402873; 24423291; 24434582; 24436266; 24446343; 24462562; 24469360; 24471989; 24513487; 24518566; 24551049; 24565956; 24569980; 24599585; 24614038; 24614081; 24616567; 24621265; 24637636; 24641411; 24652950; 24657343; 24670538; 24687028; 24694755; 24704993; 24720952; 24725412; 24733273; 24742714; 24743777; 24756243; 24758697; 24761915; 24779988; 24789723; 24791632; 24796340; 24816739; 24831259; 24836925; 24859418; 24867691; 24870748; 24899082; 24909729; 24922641; 24934485; 24935598; 24938358; 24950702; 24959005; 24964373; 24967690; 24969217; 24970799; 24981555; 24983372; 24998576; 25003256; 25011213; 25028647; 25034525; 25047043; 25060715; 25064845; 25080527; 25091480; 25095741; 25113252; 25130519; 25133426; 25137041; 25139833; 25166592; 25169526; 25172542; 25185658; 25199460; 25201048; 25214704; 25215902; 25217662; 25231214; 25231994; 25242379; 25281773; 25289898; 25301050; 25303727; 25305454; 25320180; 25323004; 25338411; 25338928; 25339021; 25355039; 25368279; 25370734; 25374215; 25381814; 25392182; 25400773; 25422106; 25422234; 25438689; 25449785; 25451254; 25483152; 25488950; 25520090; 25545478; 25548276; 25579548; 25595899; 25645360; 25658624; 25669978; 25681793; 25693081; 25701047; 25703332; 25710724; 25711229; 25711465; 25721048; 25722432; 25730260; 25735328; 25736926; 25743830; 25754990; 25760396; 25767384; 25771405; 25777747; 25812673; 25817787; 25863097; 25888998; 25890183; 25900875; 25906828; 25962348; 25963660; 25966079; 25973067; 25975224; 25977924; 25988363; 26011146; 26026674; 26034355; 26045835; 26047642; 26054111; 26064972; 26081267; 26097553; 26098693; 26111272; 26125280; 26125824; 26151770; 26153366; 26191267; 26220687; 26222488; 26261650; 26276091; 26280673; 26282205; 26359357; 26369479; 26381025; 26385185; 26423666; 26438136; 26440049; 26452035; 26476537; 26477987; 26497206; 26498465; 26498686; 26503024; 26505400; 26508788; 26518876; 26540629; 26546977; 26551717; 26554780; 26556718; 26560040; 26565028; 26568042; 26608958; 26648518; 26671095; 26674784; 26703471; 26707712; 26722563; 26743292; 26744410; 26774881; 26788504; 26791786; 26791964; 26822858; 26881519; 26920155; 26925639; 26945481; 26957558; 26959737; 26984380; 27016075; 27059979; 27060751; 27065336; 27072264; 27072265; 27079437; 27097228; 27101738; 27109475; 27115470; 27140699; 27145042; 27173352; 27177092; 27180879; 27215623; 27216189; 27232854; 27253400; 27253528; 27261878; 27265729; 27271770; 27287269; 27314294; 27317138; 27323060; 27342370; 27344083; 27362771; 27363623; 27401285; 27412115; 27443496; 27450326; 27451881; 27494851; 27539669; 27568096; 27577989; 27612965; 27628320; 27642067; 27647999; 27661110; 27695098; 27731497; 27756840; 27764771; 27818595; 27821648; 27824617; 27854106; 28032559; 28044053; 28068952; 28096231; 28108096; 28135203; 28139497; 28152501; 28157665; 28178650; 28188432; 28192229; 28194409; 28230039; 28231855; 28244682; 28323501; 28330776; 28393249; 28405152; 28409880; 28432463; 28523391; 28571770; 28586004; 28604419; 28624843; 28634076; 28642262; 28676625; 28677781; 28682162; 28704403; 28709031; 28718447; 28734688; 28739688; 28749959; 28765120; 28779848; 28934138; 28946145; 28958600; 29250535; 29254791; 29257846; 29297092; 29484424; 29524580; 29537212; 4514999; 4521806; 4776443; 7568157; 8175750; 8901870; 9139685	8473346; 1380156; 8181472; 7945196; 14702039; 16710414; 15489334; 7947975; 16373578; 17113084; 10966456; 24605250; 27710942; 26859324; 27226593; 15308583
12366	POGLUT1 C3orf9 CLP46 KTELC1 MDSRP MDS010 UNQ490/PRO1006	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=72 uM for UDP-Glc {ECO:0000269|PubMed:21081508}; Vmax=7.6 pmol/min/ug enzyme {ECO:0000269|PubMed:21081508}; 	2.4.1.-; 2.4.2.26	CATALYTIC ACTIVITY: UDP-alpha-D-xylose + [protein]-L-serine = UDP + [protein]-3-O-(beta-D-xylosyl)-L-serine. {ECO:0000269|PubMed:21081508, ECO:0000269|PubMed:28775322}.	BINDING 177 177 UDP-glucose. {ECO:0000244|PDB:5L0U, ECO:0000269|PubMed:28775322}.; BINDING 212 212 UDP-glucose. {ECO:0000244|PDB:5L0U, ECO:0000269|PubMed:28775322}.; BINDING 218 218 UDP-glucose. {ECO:0000244|PDB:5L0U, ECO:0000269|PubMed:28775322}.				PATHWAY: Protein modification; protein glycosylation. {ECO:0000269|PubMed:21081508, ECO:0000269|PubMed:21490058, ECO:0000269|PubMed:21949356, ECO:0000269|PubMed:28775322}.	SITE 132 132 Interaction with the consensus sequence C-X-S-X-[PA]-C in peptide substrates. {ECO:0000269|PubMed:28775322}.; SITE 240 240 Interaction with the consensus sequence C-X-S-X-[PA]-C in peptide substrates. {ECO:0000269|PubMed:28775322}.	MDS010 UNQ490/PRO1006		axial mesoderm development [GO:0048318]; cardiovascular system development [GO:0072358]; gastrulation [GO:0007369]; glycolipid metabolic process [GO:0006664]; muscle tissue development [GO:0060537]; paraxial mesoderm development [GO:0048339]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; regulation of gastrulation [GO:0010470]; somitogenesis [GO:0001756]	endoplasmic reticulum lumen [GO:0005788]	endoplasmic reticulum lumen [GO:0005788]; glucosyltransferase activity [GO:0046527]; protein xylosyltransferase activity [GO:0030158]; UDP-glucosyltransferase activity [GO:0035251]; UDP-xylosyltransferase activity [GO:0035252]; axial mesoderm development [GO:0048318]; cardiovascular system development [GO:0072358]; gastrulation [GO:0007369]; glycolipid metabolic process [GO:0006664]; muscle tissue development [GO:0060537]; paraxial mesoderm development [GO:0048339]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; regulation of gastrulation [GO:0010470]; somitogenesis [GO:0001756]	glucosyltransferase activity [GO:0046527]; protein xylosyltransferase activity [GO:0030158]; UDP-glucosyltransferase activity [GO:0035251]; UDP-xylosyltransferase activity [GO:0035252]	GO:0001756; GO:0005788; GO:0006493; GO:0006664; GO:0007369; GO:0010470; GO:0018242; GO:0030158; GO:0035251; GO:0035252; GO:0045747; GO:0046527; GO:0048318; GO:0048339; GO:0060537; GO:0072358	SUBCELLULAR LOCATION: Endoplasmic reticulum lumen {ECO:0000269|PubMed:16524674, ECO:0000269|PubMed:24387993, ECO:0000269|PubMed:27807076}.			16524674; 12975309; 14702039; 16303743; 16641997; 15489334; 15340161; 21490058; 21081508; 21949356; 24387993; 27807076; 28775322; 27479915; 18243100; 19822096; 20143914; 20190752; 21458412; 23692084; 25528443; 26058784; 28481732; 29034878	16524674; 12975309; 14702039; 16303743; 16641997; 15489334; 15340161; 21490058; 21081508; 21949356; 24387993; 27807076; 28775322; 27479915
12412	PTS	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=8.1 uM for 7,8-dihydroneopterin triphosphate {ECO:0000269|PubMed:10531334}; Vmax=120 nmol/min/mg enzyme {ECO:0000269|PubMed:10531334}; 	4.2.3.12	CATALYTIC ACTIVITY: 7,8-dihydroneopterin 3'-triphosphate = 6-pyruvoyl-5,6,7,8-tetrahydropterin + triphosphate. {ECO:0000269|PubMed:1282802}.			COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250}; ;  Note=Binds 1 zinc ion per subunit. {ECO:0000250};		PATHWAY: Cofactor biosynthesis; tetrahydrobiopterin biosynthesis; tetrahydrobiopterin from 7,8-dihydroneopterin triphosphate: step 1/3.				cellular amino acid metabolic process [GO:0006520]; central nervous system development [GO:0007417]; cofactor metabolic process [GO:0051186]; tetrahydrobiopterin biosynthetic process [GO:0006729]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; 6-pyruvoyltetrahydropterin synthase activity [GO:0003874]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; cellular amino acid metabolic process [GO:0006520]; central nervous system development [GO:0007417]; cofactor metabolic process [GO:0051186]; tetrahydrobiopterin biosynthetic process [GO:0006729]	6-pyruvoyltetrahydropterin synthase activity [GO:0003874]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]	GO:0003874; GO:0005737; GO:0005739; GO:0005829; GO:0006520; GO:0006729; GO:0007417; GO:0042802; GO:0042803; GO:0046872; GO:0051186		PTM: Phosphorylation of Ser-19 is required for maximal enzyme activity. {ECO:0000269|PubMed:10531334}.	MOD_RES 19 19 Phosphoserine; by PKG. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569, ECO:0000269|PubMed:10531334}.; MOD_RES 28 28 Phosphoserine. {ECO:0000250|UniProtKB:Q9R1Z7}.; MOD_RES 128 128 Phosphotyrosine. {ECO:0000244|PubMed:24275569}.	1282802; 8216273; 7698774; 8841415; 15489334; 18669648; 20068231; 23186163; 24275569; 10531334; 9222755; 8178819; 7493990; 8707300; 9222757; 9159737; 9450907; 10585341; 10220141; 10874306; 11388593; 11438997; 11916314; 14551150; 16086286; 16135092; 16169070; 16189514; 17270157; 17407085; 17590551; 18505119; 19060904; 19167051; 19350512; 19360691; 19491146; 19674121; 19830588; 20877624; 21516116; 22237589; 25416956; 3536512; 7563095; 8137809; 8307017	1282802; 8216273; 7698774; 8841415; 15489334; 18669648; 20068231; 23186163; 24275569; 10531334; 9222755; 8178819; 7493990; 8707300; 9222757; 9159737; 9450907; 10585341; 10220141; 10874306; 11388593
12414	PTDSS2 PSS2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=120 uM for serine (in the presence of 1 mM PE) {ECO:0000269|PubMed:19014349}; Vmax=0.57 mmol/h/mg enzyme {ECO:0000269|PubMed:19014349}; 	2.7.8.29	CATALYTIC ACTIVITY: L-1-phosphatidylethanolamine + L-serine = L-1-phosphatidylserine + ethanolamine.		ACTIVITY REGULATION: Inhibited in both the MAM and the ER per se by ethanolamine. Requires calcium ions. {ECO:0000269|PubMed:19014349}.		BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is around 7.5. {ECO:0000269|PubMed:19014349};	PATHWAY: Phospholipid metabolism; phosphatidylserine biosynthesis.				phosphatidylserine biosynthetic process [GO:0006659]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; CDP-diacylglycerol-serine O-phosphatidyltransferase activity [GO:0003882]; transferase activity [GO:0016740]; phosphatidylserine biosynthetic process [GO:0006659]	CDP-diacylglycerol-serine O-phosphatidyltransferase activity [GO:0003882]; transferase activity [GO:0016740]	GO:0003882; GO:0005789; GO:0006659; GO:0016020; GO:0016021; GO:0016740	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}. Note=Highly enriched in the mitochondria-associated membrane (MAM). {ECO:0000250}.		MOD_RES 16 16 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18088087, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 24 24 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 485 485 Phosphothreonine. {ECO:0000244|PubMed:18691976}.	17974005; 16421571; 15489334; 17081983; 18088087; 18691976; 18669648; 19014349; 19159218; 19369195; 20068231; 21406692; 23186163; 24275569; 26496610; 26638075; 9642289	17974005; 16421571; 15489334; 17081983; 18088087; 18691976; 18669648; 19014349; 19159218; 19369195; 20068231; 21406692; 23186163; 24275569
12433	PTGIS CYP8 CYP8A1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=9.55 uM for 6-keto-PGF1alpha {ECO:0000269|PubMed:25623425}; KM=13 uM for prostaglandin H2 (at 23 degrees Celsius) {ECO:0000269|PubMed:18032380}; Vmax=534 mmol/min/pg enzyme {ECO:0000269|PubMed:25623425}; Vmax=980 mol/min/mol enzyme {ECO:0000269|PubMed:18032380}; 	5.3.99.4	CATALYTIC ACTIVITY: (5Z,13E)-(15S)-9-alpha,11-alpha-epidioxy-15-hydroxyprosta-5,13-dienoate = (5Z,13E)-(15S)-6,9-alpha-epoxy-11-alpha,15-dihydroxyprosta-5,13-dienoate. {ECO:0000269|PubMed:18032380, ECO:0000269|PubMed:25623425}.	BINDING 106 106 Substrate. {ECO:0000250|UniProtKB:F1RE08}.; BINDING 112 112 Substrate; via amide nitrogen. {ECO:0000250|UniProtKB:F1RE08}.; BINDING 287 287 Substrate. {ECO:0000250|UniProtKB:F1RE08}.; BINDING 382 382 Substrate. {ECO:0000250|UniProtKB:F1RE08}.		COFACTOR: Name=heme; Xref=ChEBI:CHEBI:30413; Evidence={ECO:0000269|PubMed:17020766, ECO:0000269|PubMed:18032380}; 						apoptotic signaling pathway [GO:0097190]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cyclooxygenase pathway [GO:0019371]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; icosanoid metabolic process [GO:0006690]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of inflammatory response [GO:0050728]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of angiogenesis [GO:0045766]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; prostaglandin biosynthetic process [GO:0001516]	caveola [GO:0005901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]	caveola [GO:0005901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; prostaglandin-I synthase activity [GO:0008116]; apoptotic signaling pathway [GO:0097190]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cyclooxygenase pathway [GO:0019371]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; icosanoid metabolic process [GO:0006690]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of inflammatory response [GO:0050728]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of angiogenesis [GO:0045766]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; prostaglandin biosynthetic process [GO:0001516]	heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; prostaglandin-I synthase activity [GO:0008116]	GO:0001516; GO:0004497; GO:0005506; GO:0005615; GO:0005634; GO:0005783; GO:0005789; GO:0005901; GO:0006690; GO:0007566; GO:0008116; GO:0016021; GO:0016705; GO:0019371; GO:0020037; GO:0032088; GO:0034356; GO:0035360; GO:0045019; GO:0045766; GO:0046697; GO:0050728; GO:0071347; GO:0071354; GO:0071456; GO:0097190; GO:1900119	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250|UniProtKB:Q29626}; Single-pass membrane protein {ECO:0000255}.			8185632; 11281454; 11780052; 15489334; 12372404; 25623425; 17020766; 18032380; 10051404; 11130769; 11368458; 11924728; 12040339; 12193162; 12213900; 12414894; 12414902; 12428676; 12664597; 12741817; 12751759; 12924623; 1400444; 15115769; 15182267; 16007128; 16081819; 16406803; 16537708; 17070428; 17210107; 17221326; 17303142; 17374734; 17635855; 17641676; 18081314; 19040046; 19046748; 19056482; 19064572; 19065539; 19124506; 19147528; 19187034; 19265782; 19276290; 19327107; 19336370; 19534932; 19578796; 19719985; 19789190; 19913121; 20159982; 20346360; 20348234; 20357747; 20452033; 20453000; 20628086; 22072641; 22109564; 22219064; 23807031; 24225501; 24605778; 25256272; 26130461	8185632; 11281454; 11780052; 15489334; 12372404; 25623425; 17020766; 18032380
12437	PTK6 BRK	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=83 uM for ATP {ECO:0000269|PubMed:12121988}; Vmax=37 nmol/min/mg enzyme {ECO:0000269|PubMed:12121988}; 	2.7.10.2	CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate. {ECO:0000255|PROSITE-ProRule:PRU10028, ECO:0000269|PubMed:12121988, ECO:0000269|PubMed:27480927, ECO:0000269|PubMed:27993680}.	BINDING 219 219 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000305|PubMed:27480927, ECO:0000305|PubMed:27993680}.	ACTIVITY REGULATION: Activated by EGF, NRG1 and IGF1. Inhibited by SOCS3 to phosphorylate STAT3. Stabilized in the inactive form by an association between the SH3 domain and the SH2-TK linker region. Interaction between Trp-184 within SH2-TK linker region and the catalytic domain appears essential for positive regulation of kinase activity. {ECO:0000269|PubMed:12121988, ECO:0000269|PubMed:15870689, ECO:0000269|PubMed:15961400, ECO:0000269|PubMed:16568091, ECO:0000269|PubMed:17822667}.							cell migration [GO:0016477]; cellular response to retinoic acid [GO:0071300]; ERBB2 signaling pathway [GO:0038128]; innate immune response [GO:0045087]; intestinal epithelial cell differentiation [GO:0060575]; negative regulation of growth [GO:0045926]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of signal transduction [GO:0009968]; peptidyl-tyrosine autophosphorylation [GO:0038083]; positive regulation of cell cycle [GO:0045787]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of neuron projection development [GO:0010976]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell proliferation [GO:0042127]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; tyrosine phosphorylation of STAT protein [GO:0007260]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; cell migration [GO:0016477]; cellular response to retinoic acid [GO:0071300]; ERBB2 signaling pathway [GO:0038128]; innate immune response [GO:0045087]; intestinal epithelial cell differentiation [GO:0060575]; negative regulation of growth [GO:0045926]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of signal transduction [GO:0009968]; peptidyl-tyrosine autophosphorylation [GO:0038083]; positive regulation of cell cycle [GO:0045787]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of neuron projection development [GO:0010976]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell proliferation [GO:0042127]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; tyrosine phosphorylation of STAT protein [GO:0007260]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]	GO:0001726; GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007169; GO:0007260; GO:0009968; GO:0010976; GO:0016477; GO:0016604; GO:0031234; GO:0038083; GO:0038128; GO:0042127; GO:0042531; GO:0042802; GO:0045087; GO:0045742; GO:0045787; GO:0045926; GO:0046777; GO:0060575; GO:0061099; GO:0071300	SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Cell projection, ruffle. Membrane {ECO:0000250}. Note=Colocalizes with KHDRBS1, KHDRBS2 or KHDRBS3, within the nucleus. Nuclear localization in epithelial cells of normal prostate but cytoplasmic localization in cancer prostate.	PTM: Autophosphorylated. Autophosphorylation of Tyr-342 leads to an increase of kinase activity. Tyr-447 binds to the SH2 domain when phosphorylated and negatively regulates kinase activity. {ECO:0000269|PubMed:10913193, ECO:0000269|PubMed:12121988, ECO:0000269|PubMed:15471878, ECO:0000269|PubMed:20026641}.	MOD_RES 13 13 Phosphotyrosine; by autocatalysis. {ECO:0000269|PubMed:12121988}.; MOD_RES 61 61 Phosphotyrosine; by autocatalysis. {ECO:0000269|PubMed:12121988}.; MOD_RES 66 66 Phosphotyrosine; by autocatalysis. {ECO:0000269|PubMed:12121988}.; MOD_RES 114 114 Phosphotyrosine; by autocatalysis. {ECO:0000244|PubMed:18691976, ECO:0000269|PubMed:12121988}.; MOD_RES 342 342 Phosphotyrosine; by autocatalysis. {ECO:0000269|PubMed:12121988}.; MOD_RES 351 351 Phosphotyrosine; by autocatalysis. {ECO:0000269|PubMed:12121988}.; MOD_RES 447 447 Phosphotyrosine. {ECO:0000269|PubMed:10913193}.	8036022; 9333026; 9749526; 14702039; 11780052; 15489334; 8940083; 9185712; 10980601; 10913193; 12121988; 12833144; 15471878; 15572663; 15509496; 15539407; 15961400; 16179349; 15870689; 16651629; 16568091; 17822667; 17997837; 18829532; 18296648; 18691976; 18719096; 19439179; 20193745; 20026641; 21479203; 15056653; 27480927; 27993680; 17344846; 10831586; 12482964; 12540842; 12725532; 14597415; 14676834; 16273093; 16782892; 17254966; 17254967; 17500595; 17721511; 17908796; 18077133; 18414028; 18710949; 18781181; 19075005; 19304789; 19393627; 19401189; 19621240; 19661439; 20107323; 20162673; 20554524; 20606012; 20628086; 20687930; 20700126; 20929863; 20952511; 21240512; 21380407; 21423214; 21481795; 21603980; 21715330; 21923922; 22084245; 22231447; 22547065; 22705009; 22849407; 22939624; 22989419; 23007395; 23027128; 23291984; 23352614; 23497344; 23707532; 23758975; 23814047; 23856248; 23928995; 24523872; 24728074; 24788754; 25019382; 25153721; 25241146; 25377660; 25416956; 25733683; 25748447; 25770659; 25838168; 25852190; 25897081; 25938342; 25940761; 26013168; 26751287; 26825173; 26983689; 27311570; 28214294; 29879184; 9325318	8036022; 9333026; 9749526; 14702039; 11780052; 15489334; 8940083; 9185712; 10980601; 10913193; 12121988; 12833144; 15471878; 15572663; 15509496; 15539407; 15961400; 16179349; 15870689; 16651629; 16568091; 17822667; 17997837; 18829532; 18296648; 18691976; 18719096; 19439179; 20193745; 20026641; 21479203; 15056653; 27480927; 27993680; 17344846
12468	PTDSS1 KIAA0024 PSSA	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=67 uM for serine (in the presence of 2 mM PC) {ECO:0000269|PubMed:19014349}; KM=24 uM for serine (in the presence of 1 mM PE) {ECO:0000269|PubMed:19014349}; 	2.7.8.29	CATALYTIC ACTIVITY: L-1-phosphatidylethanolamine + L-serine = L-1-phosphatidylserine + ethanolamine.		ACTIVITY REGULATION: Requires calcium ions. Activated by exogenous phosphatidylethanolamine. {ECO:0000269|PubMed:19014349, ECO:0000269|PubMed:9539713}.		BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH for both PC and PE is between 7.0 and 7.5. {ECO:0000269|PubMed:19014349};	PATHWAY: Phospholipid metabolism; phosphatidylserine biosynthesis.				phosphatidylserine biosynthetic process [GO:0006659]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transferase activity [GO:0016740]; phosphatidylserine biosynthetic process [GO:0006659]	transferase activity [GO:0016740]	GO:0005789; GO:0006659; GO:0016020; GO:0016021; GO:0016740	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}. Note=Highly enriched in the mitochondria-associated membrane (MAM). {ECO:0000250}.		MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:25944712}.; MOD_RES 417 417 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 425 425 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 442 442 Phosphoserine. {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:20068231}.; MOD_RES 454 454 Phosphoserine. {ECO:0000244|PubMed:20068231}.	7584026; 14702039; 16421571; 15489334; 9539713; 17081983; 18220336; 18691976; 18669648; 19014349; 19369195; 20068231; 21406692; 23186163; 25944712; 24241535; 20379614; 21516116; 26496610; 26638075; 26742492; 27044099; 9642289	7584026; 14702039; 16421571; 15489334; 9539713; 17081983; 18220336; 18691976; 18669648; 19014349; 19369195; 20068231; 21406692; 23186163; 25944712; 24241535
12490	PTGR2 ZADH1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=11.21 uM for 15-keto-PGE2 {ECO:0000269|PubMed:19000823}; KM=15.87 uM for NADPH {ECO:0000269|PubMed:19000823}; Vmax=159 nmol/min/mg enzyme for 15-keto-PGE2 {ECO:0000269|PubMed:19000823}; Vmax=67 nmol/min/mg enzyme for NADPH {ECO:0000269|PubMed:19000823}; 	1.3.1.48	CATALYTIC ACTIVITY: 11-alpha-hydroxy-9,15-dioxoprost-5-enoate + NAD(P)(+) = (5Z)-(13E)-11-alpha-hydroxy-9,15-dioxoprosta-5,13-dienoate + NAD(P)H. {ECO:0000269|PubMed:19000823}.	BINDING 192 192 NADP.; BINDING 208 208 NADP.; BINDING 231 231 NADP.; BINDING 337 337 NADP.								prostaglandin metabolic process [GO:0006693]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; prostaglandin metabolic process [GO:0006693]	13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]	GO:0005737; GO:0006693; GO:0036132; GO:0047522	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.			15004468; 14702039; 17974005; 15489334; 21269460; 24275569; 19000823; 17449869; 20877624; 22998775; 26820738	15004468; 14702039; 17974005; 15489334; 21269460; 24275569; 19000823; 
12562	L3HYPDH C14orf149	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=7.23 mM for trans-3-hydroxy-L-proline {ECO:0000269|PubMed:22528483}; Vmax=39.5 umol/min/mg enzyme {ECO:0000269|PubMed:22528483}; 	4.2.1.77	CATALYTIC ACTIVITY: Trans-3-hydroxy-L-proline = 1-pyrroline 2-carboxylate + H(2)O. {ECO:0000269|PubMed:22528483, ECO:0000269|PubMed:24649405}.	BINDING 269 269 Substrate. {ECO:0000250}.			BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 8.0. {ECO:0000269|PubMed:22528483};							hydro-lyase activity [GO:0016836]; trans-L-3-hydroxyproline dehydratase activity [GO:0050346]	hydro-lyase activity [GO:0016836]; trans-L-3-hydroxyproline dehydratase activity [GO:0050346]	GO:0016836; GO:0050346				14702039; 12508121; 15489334; 21269460; 22528483; 24649405; 20379614	14702039; 12508121; 15489334; 21269460; 22528483; 24649405
12657	TARS2 TARSL1	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=2.5 mM for L-threonine {ECO:0000269|PubMed:26811336}; KM=1.1 uM for tRNA(Thr) {ECO:0000269|PubMed:26811336}; KM=180 mM for L-serine {ECO:0000269|PubMed:26811336}; Note=kcat is 5.8 sec(-1) for the activation reaction of L-threonine. kcat is 1.1 sec(-1) for the activation reaction of L-serine. kcat is 0.061 sec(-1) for the aminoacylation of tRNA(Thr) with L-threonine. {ECO:0000269|PubMed:26811336};	6.1.1.3	CATALYTIC ACTIVITY: ATP + L-threonine + tRNA(Thr) = AMP + diphosphate + L-threonyl-tRNA(Thr). {ECO:0000269|PubMed:26811336}.									mitochondrial threonyl-tRNA aminoacylation [GO:0070159]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; threonine-tRNA ligase activity [GO:0004829]; mitochondrial threonyl-tRNA aminoacylation [GO:0070159]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; threonine-tRNA ligase activity [GO:0004829]	GO:0002161; GO:0004829; GO:0005524; GO:0005739; GO:0005759; GO:0042803; GO:0070159	SUBCELLULAR LOCATION: Mitochondrion matrix {ECO:0000250}.		MOD_RES 52 52 Phosphoserine. {ECO:0000244|PubMed:21406692}.	14702039; 16710414; 15489334; 15779907; 21269460; 21406692; 24827421; 25944712; 26811336; 17353931; 17384640; 19209188; 20186120; 20869947; 20877624; 21911578; 23902751; 25036637; 25609649; 26496610	14702039; 16710414; 15489334; 15779907; 21269460; 21406692; 24827421; 25944712; 26811336
12714	RARS	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=3.9 uM for arginine (ATP-PPi exchange at 37 degrees Celsius) {ECO:0000269|PubMed:16055448}; KM=3.5 uM for arginine (arginylation at 37 degrees Celsius) {ECO:0000269|PubMed:16055448}; KM=1183 uM for ATP (ATP-PPi exchange at 37 Celsius) {ECO:0000269|PubMed:16055448}; KM=910 uM for ATP (arginylation at 37 Celsius) {ECO:0000269|PubMed:16055448}; KM=0.05 uM for calf liver tRNA-Arg (ATP-PPi exchange at 37 Celsius) {ECO:0000269|PubMed:16055448}; KM=0.41 uM for calf liver tRNA-Arg (arginylation at 37 Celsius) {ECO:0000269|PubMed:16055448}; 	6.1.1.19	CATALYTIC ACTIVITY: ATP + L-arginine + tRNA(Arg) = AMP + diphosphate + L-arginyl-tRNA(Arg). {ECO:0000269|PubMed:16055448, ECO:0000269|PubMed:25288775}.	BINDING 211 211 L-arginine. {ECO:0000244|PDB:4Q2T, ECO:0000269|PubMed:24859084}.; BINDING 384 384 L-arginine. {ECO:0000244|PDB:4Q2T, ECO:0000269|PubMed:24859084}.; BINDING 388 388 L-arginine. {ECO:0000244|PDB:4Q2T, ECO:0000269|PubMed:24859084}.; BINDING 412 412 L-arginine. {ECO:0000244|PDB:4Q2T, ECO:0000269|PubMed:24859084}.								arginyl-tRNA aminoacylation [GO:0006420]; tRNA aminoacylation for protein translation [GO:0006418]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; arginine binding [GO:0034618]; arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; tRNA binding [GO:0000049]; arginyl-tRNA aminoacylation [GO:0006420]; tRNA aminoacylation for protein translation [GO:0006418]	arginine binding [GO:0034618]; arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; tRNA binding [GO:0000049]	GO:0000049; GO:0004814; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006418; GO:0006420; GO:0016020; GO:0017101; GO:0034618; GO:0045296; GO:0070062	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16055448, ECO:0000269|PubMed:16430231}. Cytoplasm, cytosol {ECO:0000269|PubMed:19289464}.		MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378}.	7590355; 14702039; 15489334; 12665801; 10358004; 16055448; 16430231; 17443684; 19413330; 19131329; 19289464; 19608861; 21269460; 22223895; 22814378; 24656866; 24777941; 24275569; 24859084; 25288775; 11714285; 14743216; 16661668; 16661782; 17353931; 20195357; 20877624; 20923763; 21150319; 21911578; 22190034; 22623428; 23606334; 23902751; 24189400; 24898251; 25609649; 25724651; 26496610; 28905880; 8052601; 8078941; 8188258; 8449960; 9278442; 9556618	7590355; 14702039; 15489334; 12665801; 10358004; 16055448; 16430231; 17443684; 19413330; 19131329; 19289464; 19608861; 21269460; 22223895; 22814378; 24656866; 24777941; 24275569; 24859084; 25288775
12823	SLCO4C1 OATP4C1 OATPX SLC21A20	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=7.8 uM for digoxin {ECO:0000269|PubMed:14993604}; KM=0.38 uM for ouabain {ECO:0000269|PubMed:14993604}; KM=5.9 uM for thyroxine {ECO:0000269|PubMed:14993604}; 											cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; neutrophil degranulation [GO:0043312]; sodium-independent organic anion transport [GO:0043252]; spermatogenesis [GO:0007283]	azurophil granule membrane [GO:0035577]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]	azurophil granule membrane [GO:0035577]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; neutrophil degranulation [GO:0043312]; sodium-independent organic anion transport [GO:0043252]; spermatogenesis [GO:0007283]	sodium-independent organic anion transmembrane transporter activity [GO:0015347]	GO:0005886; GO:0005887; GO:0007275; GO:0007283; GO:0015347; GO:0016323; GO:0030154; GO:0035577; GO:0035579; GO:0043252; GO:0043312; GO:0070062	SUBCELLULAR LOCATION: Basolateral cell membrane {ECO:0000250|UniProtKB:Q71MB6}; Multi-pass membrane protein {ECO:0000250|UniProtKB:Q71MB6}. Note=Detected at the basolateral membrane of the proximal tubule cell in the kidney. {ECO:0000250|UniProtKB:Q71MB6}.		MOD_RES 15 15 Phosphoserine. {ECO:0000250|UniProtKB:Q71MB6}.; MOD_RES 16 16 Phosphoserine. {ECO:0000250|UniProtKB:Q8BGD4}.; MOD_RES 24 24 Phosphoserine. {ECO:0000250|UniProtKB:Q8BGD4}.; MOD_RES 26 26 Phosphoserine. {ECO:0000250|UniProtKB:Q8BGD4}.; MOD_RES 28 28 Phosphoserine. {ECO:0000250|UniProtKB:Q8BGD4}.	14993604; 14702039; 17314201; 19197249; 19875811; 19913121; 20610891; 20628086; 20691413; 23650620; 26638075; 8692836	14993604; 14702039; 17314201
12831	SRM SPS1 SRML1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=20 uM for putrescine {ECO:0000269|PubMed:17585781}; KM=0.9 uM for S-adenosylmethioninamine {ECO:0000269|PubMed:17585781}; 	2.5.1.16	CATALYTIC ACTIVITY: S-adenosyl 3-(methylthio)propylamine + putrescine = 5'-S-methyl-5'-thioadenosine + spermidine. {ECO:0000269|PubMed:17585781}.	BINDING 49 49 S-adenosylmethioninamine.; BINDING 79 79 Putrescine.; BINDING 80 80 S-adenosylmethioninamine.; BINDING 104 104 S-adenosylmethioninamine.; BINDING 124 124 S-adenosylmethioninamine.; BINDING 173 173 S-adenosylmethioninamine.; BINDING 241 241 Putrescine.	ACTIVITY REGULATION: The activity is thought to be regulated mainly by the availability of decarboxylated S-adenosylmethionine.			PATHWAY: Amine and polyamine biosynthesis; spermidine biosynthesis; spermidine from putrescine: step 1/1.				cellular response to leukemia inhibitory factor [GO:1990830]; polyamine metabolic process [GO:0006595]; spermidine biosynthetic process [GO:0008295]	cytosol [GO:0005829]	cytosol [GO:0005829]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; spermidine synthase activity [GO:0004766]; cellular response to leukemia inhibitory factor [GO:1990830]; polyamine metabolic process [GO:0006595]; spermidine biosynthetic process [GO:0008295]	identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; spermidine synthase activity [GO:0004766]	GO:0004766; GO:0005829; GO:0006595; GO:0008295; GO:0042802; GO:0042803; GO:1990830			MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378}.	2344393; 2069720; 16710414; 15489334; 19413330; 21269460; 22223895; 22814378; 17585781; 17353931; 19615732; 19738201; 20562859; 21044950; 21898642; 21988832; 22623428; 26752685	2344393; 2069720; 16710414; 15489334; 19413330; 21269460; 22223895; 22814378; 17585781
12916	STK24 MST3 STK3	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=12.8 uM for manganese ions {ECO:0000269|PubMed:15917084}; KM=34.9 uM for cobalt ions {ECO:0000269|PubMed:15917084}; KM=22.7 uM for magnesium ions {ECO:0000269|PubMed:15917084}; KM=4.1 uM for zinc ions {ECO:0000269|PubMed:15917084}; Vmax=2623.1 pmol/min/mg enzyme for manganese ions {ECO:0000269|PubMed:15917084}; Vmax=1746.1 pmol/min/mg enzyme for cobalt ions {ECO:0000269|PubMed:15917084}; Vmax=129.1 pmol/min/mg enzyme for magnesium ions {ECO:0000269|PubMed:15917084}; Vmax=22.3 pmol/min/mg enzyme for zinc ions {ECO:0000269|PubMed:15917084}; 	2.7.11.1	CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.	BINDING 65 65 ATP.		COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:15917084}; Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000269|PubMed:15917084}; Name=Co(2+); Xref=ChEBI:CHEBI:48828; Evidence={ECO:0000269|PubMed:15917084}; Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000269|PubMed:15917084}; 			SITE 325 326 Cleavage; by caspase-3, caspase-7 and caspase-8.			cellular response to starvation [GO:0009267]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of cell migration [GO:0030336]; neuron projection morphogenesis [GO:0048812]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of axon regeneration [GO:0048679]; regulation of mitotic cell cycle [GO:0007346]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]; stress-activated protein kinase signaling cascade [GO:0031098]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; MAP kinase kinase kinase kinase activity [GO:0008349]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cellular response to starvation [GO:0009267]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of cell migration [GO:0030336]; neuron projection morphogenesis [GO:0048812]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of axon regeneration [GO:0048679]; regulation of mitotic cell cycle [GO:0007346]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]; stress-activated protein kinase signaling cascade [GO:0031098]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; MAP kinase kinase kinase kinase activity [GO:0008349]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0006468; GO:0007165; GO:0007346; GO:0008349; GO:0008631; GO:0009267; GO:0016020; GO:0030336; GO:0031098; GO:0042542; GO:0042981; GO:0045296; GO:0046777; GO:0046872; GO:0048679; GO:0048812; GO:0070062; GO:0097194	SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Membrane. Note=The truncated form (MST3/N) translocates to the nucleus. Colocalizes with STK38L in the membrane.	PTM: Proteolytically processed by caspases during apoptosis. Proteolytic cleavage results in kinase activation, nuclear translocation of the truncated form (MST3/N) and the induction of apoptosis. {ECO:0000269|PubMed:12107159}.; PTM: Isoform B is activated by phosphorylation by PKA. Oxidative stress induces phosphorylation. Activated by autophosphorylation at Thr-190 and phosphorylation at this site is essential for its function. Manganese, magnesium and cobalt-dependent autophosphorylation is mainly on threonine residues while zinc-dependent autophosphorylation is on both serine and threonine residues. {ECO:0000269|PubMed:10644707, ECO:0000269|PubMed:17046825, ECO:0000269|PubMed:19604147, ECO:0000269|PubMed:20124694}.	MOD_RES 18 18 Phosphothreonine; by PKA. {ECO:0000269|PubMed:10644707}.; MOD_RES 190 190 Phosphothreonine; by autocatalysis. {ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:17046825, ECO:0000269|PubMed:19604147, ECO:0000269|PubMed:20124694}.; MOD_RES 320 320 Phosphoserine. {ECO:0000244|PubMed:17081983}.	9353338; 10644707; 15057823; 15489334; 12107159; 15304321; 15917084; 16314523; 17081983; 17046825; 18691976; 19604147; 18782753; 19369195; 19855390; 19782762; 20068231; 21269460; 21406692; 23186163; 27807006; 20124694; 17344846; 16189514; 17353931; 17657516; 18040775; 18654987; 19240061; 19328558; 20379614; 20467437; 21277991; 21516116; 21985334; 22229648; 22493453; 23296203; 23455922; 23889253; 24255178; 24366813; 24746913; 25353650; 25456499; 25640309; 26638075; 26910843; 27135311	9353338; 10644707; 15057823; 15489334; 12107159; 15304321; 15917084; 16314523; 17081983; 17046825; 18691976; 19604147; 18782753; 19369195; 19855390; 19782762; 20068231; 21269460; 21406692; 23186163; 27807006; 20124694; 17344846
12932	KARS KIAA0070	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=1.19 uM for tRNA(Lys) {ECO:0000269|PubMed:28887846}; Note=Kcat is 0.31 (sec-1) for aminoacylation for tRNA(Lys). {ECO:0000269|PubMed:28887846};	2.7.7.-; 6.1.1.6	CATALYTIC ACTIVITY: ATP + L-lysine + tRNA(Lys) = AMP + diphosphate + L-lysyl-tRNA(Lys). {ECO:0000269|PubMed:18029264, ECO:0000269|PubMed:23159739, ECO:0000269|PubMed:9278442}.	BINDING 277 277 Substrate; via carbonyl oxygen. {ECO:0000269|PubMed:18272479, ECO:0000269|PubMed:26074468}.; BINDING 301 301 Substrate. {ECO:0000269|PubMed:18272479, ECO:0000269|PubMed:23159739, ECO:0000269|PubMed:26074468}.; BINDING 339 339 Substrate. {ECO:0000269|PubMed:18272479, ECO:0000269|PubMed:23159739, ECO:0000269|PubMed:26074468}.; BINDING 341 341 Substrate. {ECO:0000269|PubMed:18272479, ECO:0000269|PubMed:23159739, ECO:0000269|PubMed:26074468}.; BINDING 497 497 Substrate. {ECO:0000269|PubMed:18272479, ECO:0000269|PubMed:23159739, ECO:0000269|PubMed:26074468}.; BINDING 501 501 Substrate. {ECO:0000269|PubMed:18272479, ECO:0000269|PubMed:23159739, ECO:0000269|PubMed:26074468}.	ACTIVITY REGULATION: Up-regulated by DARS and EEF1A1, but not by AIMP2. {ECO:0000269|PubMed:18029264}.							activation of MAPK activity [GO:0000187]; basophil activation involved in immune response [GO:0002276]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; ERK1 and ERK2 cascade [GO:0070371]; lysyl-tRNA aminoacylation [GO:0006430]; negative regulation of cell proliferation [GO:0008285]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of cytokine secretion involved in immune response [GO:0002741]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription, DNA-templated [GO:0045893]; response to X-ray [GO:0010165]; tRNA aminoacylation for protein translation [GO:0006418]; tRNA processing [GO:0008033]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; amino acid binding [GO:0016597]; ATP adenylyltransferase activity [GO:0003877]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; lysine-tRNA ligase activity [GO:0004824]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; activation of MAPK activity [GO:0000187]; basophil activation involved in immune response [GO:0002276]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; ERK1 and ERK2 cascade [GO:0070371]; lysyl-tRNA aminoacylation [GO:0006430]; negative regulation of cell proliferation [GO:0008285]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of cytokine secretion involved in immune response [GO:0002741]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription, DNA-templated [GO:0045893]; response to X-ray [GO:0010165]; tRNA aminoacylation for protein translation [GO:0006418]; tRNA processing [GO:0008033]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]	amino acid binding [GO:0016597]; ATP adenylyltransferase activity [GO:0003877]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; lysine-tRNA ligase activity [GO:0004824]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]	GO:0000049; GO:0000187; GO:0002276; GO:0002741; GO:0003877; GO:0004824; GO:0005524; GO:0005615; GO:0005634; GO:0005739; GO:0005759; GO:0005829; GO:0005886; GO:0006418; GO:0006430; GO:0008033; GO:0008285; GO:0010165; GO:0010759; GO:0015966; GO:0016032; GO:0016597; GO:0017101; GO:0033209; GO:0042802; GO:0042803; GO:0043032; GO:0045893; GO:0070371; GO:0070374; GO:1900017; GO:1900745; GO:1905050	SUBCELLULAR LOCATION: Isoform Cytoplasmic: Cytoplasm, cytosol {ECO:0000269|PubMed:10952987, ECO:0000269|PubMed:19289464, ECO:0000269|PubMed:23159739, ECO:0000269|PubMed:28887846}. Cytoplasm {ECO:0000269|PubMed:15220430}. Nucleus {ECO:0000269|PubMed:15220430, ECO:0000269|PubMed:23159739}. Cell membrane {ECO:0000269|PubMed:15220430}; Peripheral membrane protein {ECO:0000269|PubMed:15220430}. Secreted {ECO:0000269|PubMed:15851690}. Note=Secretion is induced by TNF-alpha (PubMed:15851690). Cytosolic in quiescent mast cells. Translocates into the nucleus in response to mast cell activation by immunoglobulin E (PubMed:23159739). {ECO:0000269|PubMed:15851690, ECO:0000269|PubMed:23159739}.; SUBCELLULAR LOCATION: Isoform Mitochondrial: Mitochondrion {ECO:0000269|PubMed:10952987}.	PTM: Phosphorylated on a serine residue after mast cell stimulation with immunoglobulin E (IgE). {ECO:0000250|UniProtKB:Q5XIM7}.	MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378, ECO:0000269|Ref.7}.; MOD_RES 88 88 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 141 141 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 207 207 Phosphoserine. {ECO:0000269|PubMed:19524539}.; MOD_RES 590 590 Phosphoserine. {ECO:0000250|UniProtKB:Q99MN1}.; MOD_RES 591 591 Phosphothreonine. {ECO:0000250|UniProtKB:Q99MN1}.; MOD_RES 596 596 Phosphoserine. {ECO:0000250|UniProtKB:Q99MN1}.	9278442; 10952987; 7584044; 15616553; 15489334; 5338216; 9878398; 14659874; 14975237; 12756246; 15220430; 15851690; 18029264; 19413330; 19131329; 19289464; 19524539; 19608861; 21269460; 22223895; 22814378; 25944712; 18272479; 23159739; 26074468; 20920668; 23768514; 25330800; 27891585; 28887846; 11714285; 14743216; 16055448; 16169070; 16189514; 16661668; 16661782; 16702215; 17353931; 17443684; 17560997; 17724017; 18274552; 18715867; 19738201; 19844255; 20056178; 20186120; 20562859; 20699648; 20877624; 21093454; 21150319; 21536907; 21763493; 21900206; 21988832; 22190034; 22235746; 22386318; 22624718; 22751010; 23095741; 23208549; 23414517; 23606334; 23799079; 23902751; 23972532; 24189400; 24983501; 25416956; 25609649; 25918939; 26091349; 26496610; 26643967; 26752685; 28611052; 8052601; 8078941; 8188258; 8449960	9278442; 10952987; 7584044; 15616553; 15489334; 5338216; 9878398; 14659874; 14975237; 12756246; 15220430; 15851690; 18029264; 19413330; 19131329; 19289464; 19524539; 19608861; 21269460; 22223895; 22814378; 25944712; 18272479; 23159739; 26074468; 20920668; 23768514; 25330800; 27891585; 28887846
13027	SLC22A7 NLT OAT2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=713 nM for prostaglandin E2 {ECO:0000269|PubMed:11855680, ECO:0000269|PubMed:11907186}; KM=440 uM for tetracycline {ECO:0000269|PubMed:11855680, ECO:0000269|PubMed:11907186}; 											organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; anion:anion antiporter activity [GO:0015301]; inorganic anion exchanger activity [GO:0005452]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]	anion:anion antiporter activity [GO:0015301]; inorganic anion exchanger activity [GO:0005452]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]	GO:0005452; GO:0005886; GO:0005887; GO:0015301; GO:0015347; GO:0015711; GO:0016020; GO:0016323; GO:0043252	SUBCELLULAR LOCATION: Basolateral cell membrane {ECO:0000269|PubMed:11907186, ECO:0000269|PubMed:12023506}; Multi-pass membrane protein {ECO:0000269|PubMed:11907186, ECO:0000269|PubMed:12023506}. Note=Apical side of the renal tubule.			14702039; 14574404; 15489334; 11327718; 12023506; 11907186; 11855680; 15901346; 19159218; 10049739; 10660625; 14586168; 15037815; 15846844; 18216183; 19343046; 19854166; 21446918; 22190696; 22981274; 23543312; 24646860; 25416956; 25904762; 26230641; 26377792; 28371506; 9762842; 9887087; 9950961	14702039; 14574404; 15489334; 11327718; 12023506; 11907186; 11855680; 15901346; 19159218
13035	SLC29A3 ENT3 UNQ717/PRO1380	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.86 mM for adenosine {ECO:0000269|PubMed:15701636}; KM=2.02 mM for uridine {ECO:0000269|PubMed:15701636}; 						BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 5.5 for adenosine uptake. {ECO:0000269|PubMed:15701636};			UNQ717/PRO1380			Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; nucleoside transmembrane transporter activity [GO:0005337]	nucleoside transmembrane transporter activity [GO:0005337]	GO:0005337; GO:0005765; GO:0005794; GO:0016021; GO:0031902; GO:0043231	SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein. Late endosome membrane. Lysosome membrane. Note=Observed in a punctate intracellular pattern showing partial colocalization with late endosomes/lysosomes. Not detected at the cell surface.		MOD_RES 21 21 Phosphoserine. {ECO:0000250|UniProtKB:Q99P65}.; MOD_RES 23 23 Phosphoserine. {ECO:0000244|PubMed:23186163}.	11396612; 12384580; 12975309; 14702039; 15164054; 15489334; 15701636; 17897319; 20595384; 23186163; 18940313; 19336477; 20199539; 20619369; 20399510; 19889517; 20140240; 21888995; 16385451; 19164483; 19581757; 20392501; 20677642; 22238637; 22653152; 22875837; 22989030; 23406517; 24535606; 24894595; 27316388; 28554179; 28729424	11396612; 12384580; 12975309; 14702039; 15164054; 15489334; 15701636; 17897319; 20595384; 23186163; 18940313; 19336477; 20199539; 20619369; 20399510; 19889517; 20140240; 21888995
13041	SLC38A1 ATA1 NAT2 SAT1 SNAT1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=890 uM for 2-methylamino-isobutyric acid (MeAIB) (at pH 8.5) {ECO:0000269|PubMed:10891391}; 				ACTIVITY REGULATION: Inhibited by potassium, choline ions and 2-methylamino-isobutyric acid (MeAIB) (By similarity). Inhibited by lithium and N-methyl-D-glucamine. {ECO:0000250, ECO:0000269|PubMed:10891391}.							amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; neurotransmitter uptake [GO:0001504]; neutral amino acid transport [GO:0015804]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; amino acid:sodium symporter activity [GO:0005283]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]; amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; neurotransmitter uptake [GO:0001504]; neutral amino acid transport [GO:0015804]	amino acid:sodium symporter activity [GO:0005283]; amino acid transmembrane transporter activity [GO:0015171]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]	GO:0001504; GO:0003333; GO:0005283; GO:0005886; GO:0005887; GO:0006865; GO:0015171; GO:0015175; GO:0015179; GO:0015804; GO:0016021; GO:0070062	SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15054072}; Multi-pass membrane protein {ECO:0000269|PubMed:15054072}. Note=Restricted to the somatodendritic compartment of neurons. Found in the cellular processes of neurons in the developing brain (By similarity). {ECO:0000250}.		MOD_RES 6 6 Phosphoserine. {ECO:0000250|UniProtKB:Q8K2P7}.; MOD_RES 11 11 Phosphothreonine. {ECO:0000250|UniProtKB:Q8K2P7}.; MOD_RES 25 25 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 28 28 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 49 49 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 52 52 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 54 54 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692}.; MOD_RES 56 56 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.	10891391; 14702039; 16303743; 15489334; 12388062; 15054072; 16148032; 17081983; 16583402; 18691976; 18669648; 20068231; 21406692; 23186163; 16516348; 17549407; 18703994; 19442705; 20308991; 20379614; 20599747; 20605601; 21219957; 23408887; 23848995; 24712400; 25416956; 25561175; 26638075; 27048259; 27129276; 27613819; 28224429	10891391; 14702039; 16303743; 15489334; 12388062; 15054072; 16148032; 17081983; 16583402; 18691976; 18669648; 20068231; 21406692; 23186163
13107	SLC20A1 GLVR1 PIT1	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=24.1 uM for phosphate {ECO:0000269|PubMed:7929240, ECO:0000269|PubMed:8041748}; Vmax=1.9 nmol/min/mg enzyme (in the presence of 0.05-2 mM phosphate) {ECO:0000269|PubMed:7929240, ECO:0000269|PubMed:8041748}; Note=With an increase in pH, a decrease in phosphate uptake is observed.;						BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 6.5 and 7.5. {ECO:0000269|PubMed:7929240, ECO:0000269|PubMed:8041748};					biomineral tissue development [GO:0031214]; ion transport [GO:0006811]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; high-affinity inorganic phosphate:sodium symporter activity [GO:0005316]; inorganic phosphate transmembrane transporter activity [GO:0005315]; signaling receptor activity [GO:0038023]; sodium-dependent phosphate transmembrane transporter activity [GO:0015321]; sodium:inorganic phosphate symporter activity [GO:0015319]; sodium:phosphate symporter activity [GO:0005436]; biomineral tissue development [GO:0031214]; ion transport [GO:0006811]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]	high-affinity inorganic phosphate:sodium symporter activity [GO:0005316]; inorganic phosphate transmembrane transporter activity [GO:0005315]; signaling receptor activity [GO:0038023]; sodium:inorganic phosphate symporter activity [GO:0015319]; sodium:phosphate symporter activity [GO:0005436]; sodium-dependent phosphate transmembrane transporter activity [GO:0015321]	GO:0005315; GO:0005316; GO:0005436; GO:0005886; GO:0005887; GO:0006796; GO:0006811; GO:0015319; GO:0015321; GO:0016020; GO:0031214; GO:0038023; GO:0043123	SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.		MOD_RES 265 265 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 269 269 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.	2078500; 15815621; 15489334; 9889306; 1309898; 1531369; 8411375; 7929240; 7966619; 8041748; 11009570; 12097582; 15641067; 18669648; 19413330; 23186163; 10516278; 12205090; 16527991; 16790504; 17339538; 17494632; 18095154; 18729813; 19726692; 19913121; 20628086; 20817733; 21048031; 21586110; 21796222; 21988832; 23308213; 23849774; 24366813; 26638075; 27001263; 27986439; 8302848	2078500; 15815621; 15489334; 9889306; 1309898; 1531369; 8411375; 7929240; 7966619; 8041748; 11009570; 12097582; 15641067; 18669648; 19413330; 23186163
13133	SLC22A2 OCT2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1 mM for agmatine {ECO:0000269|PubMed:11758759, ECO:0000269|PubMed:12089365, ECO:0000269|PubMed:12538837, ECO:0000269|PubMed:15783073, ECO:0000269|PubMed:16006492, ECO:0000269|PubMed:16272756, ECO:0000269|PubMed:16394027, ECO:0000269|PubMed:9687576}; KM=95 uM for amiloride {ECO:0000269|PubMed:11758759, ECO:0000269|PubMed:12089365, ECO:0000269|PubMed:12538837, ECO:0000269|PubMed:15783073, ECO:0000269|PubMed:16006492, ECO:0000269|PubMed:16272756, ECO:0000269|PubMed:16394027, ECO:0000269|PubMed:9687576}; KM=24 uM for ASP {ECO:0000269|PubMed:11758759, ECO:0000269|PubMed:12089365, ECO:0000269|PubMed:12538837, ECO:0000269|PubMed:15783073, ECO:0000269|PubMed:16006492, ECO:0000269|PubMed:16272756, ECO:0000269|PubMed:16394027, ECO:0000269|PubMed:9687576}; KM=34 uM for memantine {ECO:0000269|PubMed:11758759, ECO:0000269|PubMed:12089365, ECO:0000269|PubMed:12538837, ECO:0000269|PubMed:15783073, ECO:0000269|PubMed:16006492, ECO:0000269|PubMed:16272756, ECO:0000269|PubMed:16394027, ECO:0000269|PubMed:9687576}; KM=27 uM for amantadine {ECO:0000269|PubMed:11758759, ECO:0000269|PubMed:12089365, ECO:0000269|PubMed:12538837, ECO:0000269|PubMed:15783073, ECO:0000269|PubMed:16006492, ECO:0000269|PubMed:16272756, ECO:0000269|PubMed:16394027, ECO:0000269|PubMed:9687576}; KM=1.38 mM for metformin {ECO:0000269|PubMed:11758759, ECO:0000269|PubMed:12089365, ECO:0000269|PubMed:12538837, ECO:0000269|PubMed:15783073, ECO:0000269|PubMed:16006492, ECO:0000269|PubMed:16272756, ECO:0000269|PubMed:16394027, ECO:0000269|PubMed:9687576}; KM=1.9 mM for noradrenaline {ECO:0000269|PubMed:11758759, ECO:0000269|PubMed:12089365, ECO:0000269|PubMed:12538837, ECO:0000269|PubMed:15783073, ECO:0000269|PubMed:16006492, ECO:0000269|PubMed:16272756, ECO:0000269|PubMed:16394027, ECO:0000269|PubMed:9687576}; KM=1.9 mM for norepinephrine {ECO:0000269|PubMed:11758759, ECO:0000269|PubMed:12089365, ECO:0000269|PubMed:12538837, ECO:0000269|PubMed:15783073, ECO:0000269|PubMed:16006492, ECO:0000269|PubMed:16272756, ECO:0000269|PubMed:16394027, ECO:0000269|PubMed:9687576}; KM=1.3 mM for histamine {ECO:0000269|PubMed:11758759, ECO:0000269|PubMed:12089365, ECO:0000269|PubMed:12538837, ECO:0000269|PubMed:15783073, ECO:0000269|PubMed:16006492, ECO:0000269|PubMed:16272756, ECO:0000269|PubMed:16394027, ECO:0000269|PubMed:9687576}; KM=0.39 mM for dopamine {ECO:0000269|PubMed:11758759, ECO:0000269|PubMed:12089365, ECO:0000269|PubMed:12538837, ECO:0000269|PubMed:15783073, ECO:0000269|PubMed:16006492, ECO:0000269|PubMed:16272756, ECO:0000269|PubMed:16394027, ECO:0000269|PubMed:9687576}; KM=0.08 mM for serotonin {ECO:0000269|PubMed:11758759, ECO:0000269|PubMed:12089365, ECO:0000269|PubMed:12538837, ECO:0000269|PubMed:15783073, ECO:0000269|PubMed:16006492, ECO:0000269|PubMed:16272756, ECO:0000269|PubMed:16394027, ECO:0000269|PubMed:9687576}; KM=72.6 uM for cimetidine (at pH 7.4 and 37 degrees Celsius) {ECO:0000269|PubMed:11758759, ECO:0000269|PubMed:12089365, ECO:0000269|PubMed:12538837, ECO:0000269|PubMed:15783073, ECO:0000269|PubMed:16006492, ECO:0000269|PubMed:16272756, ECO:0000269|PubMed:16394027, ECO:0000269|PubMed:9687576}; KM=56.1 uM for famotidine {ECO:0000269|PubMed:11758759, ECO:0000269|PubMed:12089365, ECO:0000269|PubMed:12538837, ECO:0000269|PubMed:15783073, ECO:0000269|PubMed:16006492, ECO:0000269|PubMed:16272756, ECO:0000269|PubMed:16394027, ECO:0000269|PubMed:9687576}; KM=65.2 uM for ranitidine {ECO:0000269|PubMed:11758759, ECO:0000269|PubMed:12089365, ECO:0000269|PubMed:12538837, ECO:0000269|PubMed:15783073, ECO:0000269|PubMed:16006492, ECO:0000269|PubMed:16272756, ECO:0000269|PubMed:16394027, ECO:0000269|PubMed:9687576}; KM=431 uM for TEA (isoform 1) {ECO:0000269|PubMed:11758759, ECO:0000269|PubMed:12089365, ECO:0000269|PubMed:12538837, ECO:0000269|PubMed:15783073, ECO:0000269|PubMed:16006492, ECO:0000269|PubMed:16272756, ECO:0000269|PubMed:16394027, ECO:0000269|PubMed:9687576}; KM=63 uM for TEA (isoform 2) {ECO:0000269|PubMed:11758759, ECO:0000269|PubMed:12089365, ECO:0000269|PubMed:12538837, ECO:0000269|PubMed:15783073, ECO:0000269|PubMed:16006492, ECO:0000269|PubMed:16272756, ECO:0000269|PubMed:16394027, ECO:0000269|PubMed:9687576}; Vmax=3770 pmol/min/mg enzyme for TEA uptake (isoform 1) {ECO:0000269|PubMed:11758759, ECO:0000269|PubMed:12089365, ECO:0000269|PubMed:12538837, ECO:0000269|PubMed:15783073, ECO:0000269|PubMed:16006492, ECO:0000269|PubMed:16272756, ECO:0000269|PubMed:16394027, ECO:0000269|PubMed:9687576}; Vmax=314 pmol/min/mg enzyme for TEA uptake (isoform 2) {ECO:0000269|PubMed:11758759, ECO:0000269|PubMed:12089365, ECO:0000269|PubMed:12538837, ECO:0000269|PubMed:15783073, ECO:0000269|PubMed:16006492, ECO:0000269|PubMed:16272756, ECO:0000269|PubMed:16394027, ECO:0000269|PubMed:9687576}; Vmax=11.9 nmol/min/mg enzyme for metformin uptake {ECO:0000269|PubMed:11758759, ECO:0000269|PubMed:12089365, ECO:0000269|PubMed:12538837, ECO:0000269|PubMed:15783073, ECO:0000269|PubMed:16006492, ECO:0000269|PubMed:16272756, ECO:0000269|PubMed:16394027, ECO:0000269|PubMed:9687576}; Vmax=2170 pmol/min/mg enzyme for cimetidine uptake {ECO:0000269|PubMed:11758759, ECO:0000269|PubMed:12089365, ECO:0000269|PubMed:12538837, ECO:0000269|PubMed:15783073, ECO:0000269|PubMed:16006492, ECO:0000269|PubMed:16272756, ECO:0000269|PubMed:16394027, ECO:0000269|PubMed:9687576}; Vmax=204 pmol/min/mg enzyme for famotidine uptake {ECO:0000269|PubMed:11758759, ECO:0000269|PubMed:12089365, ECO:0000269|PubMed:12538837, ECO:0000269|PubMed:15783073, ECO:0000269|PubMed:16006492, ECO:0000269|PubMed:16272756, ECO:0000269|PubMed:16394027, ECO:0000269|PubMed:9687576}; Vmax=265 pmol/min/mg enzyme for ranitidine uptake {ECO:0000269|PubMed:11758759, ECO:0000269|PubMed:12089365, ECO:0000269|PubMed:12538837, ECO:0000269|PubMed:15783073, ECO:0000269|PubMed:16006492, ECO:0000269|PubMed:16272756, ECO:0000269|PubMed:16394027, ECO:0000269|PubMed:9687576}; 								SITE 451 451 Involved in recognition of organic cations and participates in structural changes that occur during translocation of organic cations. {ECO:0000250}.			body fluid secretion [GO:0007589]; dopamine transport [GO:0015872]; drug transmembrane transport [GO:0006855]; neurotransmitter biosynthetic process [GO:0042136]; neurotransmitter secretion [GO:0007269]; neurotransmitter transport [GO:0006836]; norepinephrine transport [GO:0015874]; organic cation transport [GO:0015695]	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynapse [GO:0098793]	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; acetylcholine transmembrane transporter activity [GO:0005277]; neurotransmitter transporter activity [GO:0005326]; organic anion transmembrane transporter activity [GO:0008514]; organic cation transmembrane transporter activity [GO:0015101]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; secondary active organic cation transmembrane transporter activity [GO:0008513]; body fluid secretion [GO:0007589]; dopamine transport [GO:0015872]; drug transmembrane transport [GO:0006855]; neurotransmitter biosynthetic process [GO:0042136]; neurotransmitter secretion [GO:0007269]; neurotransmitter transport [GO:0006836]; norepinephrine transport [GO:0015874]; organic cation transport [GO:0015695]	acetylcholine transmembrane transporter activity [GO:0005277]; neurotransmitter transporter activity [GO:0005326]; organic anion transmembrane transporter activity [GO:0008514]; organic cation transmembrane transporter activity [GO:0015101]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; secondary active organic cation transmembrane transporter activity [GO:0008513]	GO:0005277; GO:0005326; GO:0005886; GO:0005887; GO:0006836; GO:0006855; GO:0007269; GO:0007589; GO:0008513; GO:0008514; GO:0015101; GO:0015651; GO:0015695; GO:0015872; GO:0015874; GO:0016020; GO:0042136; GO:0070062; GO:0098793	SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.			9260930; 12089365; 14702039; 14574404; 15489334; 10942111; 9687576; 11758759; 11912245; 12538837; 15496291; 16314463; 16272756; 16006492; 15783073; 16394027; 16951202; 17072098; 16914559; 17582384; 17393420; 12142729; 17111267; 16513443; 16788146; 19141712; 20103563; 21988832; 26979622; 9655880	9260930; 12089365; 14702039; 14574404; 15489334; 10942111; 9687576; 11758759; 11912245; 12538837; 15496291; 16314463; 16272756; 16006492; 15783073; 16394027; 16951202; 17072098; 16914559; 17582384; 17393420; 12142729; 17111267
13140	SLC47A1 MATE1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.38 mM for TEA {ECO:0000269|PubMed:16330770, ECO:0000269|PubMed:17509534}; KM=0.10 mM for MPP {ECO:0000269|PubMed:16330770, ECO:0000269|PubMed:17509534}; KM=0.17 mM for cimetidine {ECO:0000269|PubMed:16330770, ECO:0000269|PubMed:17509534}; KM=0.78 mM for metformin {ECO:0000269|PubMed:16330770, ECO:0000269|PubMed:17509534}; KM=2.1 mM for guanidine {ECO:0000269|PubMed:16330770, ECO:0000269|PubMed:17509534}; KM=1.23 mM for procainamide {ECO:0000269|PubMed:16330770, ECO:0000269|PubMed:17509534}; KM=0.07 mM for topotecan {ECO:0000269|PubMed:16330770, ECO:0000269|PubMed:17509534}; KM=0.47 mM for estrone sulfate {ECO:0000269|PubMed:16330770, ECO:0000269|PubMed:17509534}; KM=2.64 mM for acyclovir {ECO:0000269|PubMed:16330770, ECO:0000269|PubMed:17509534}; KM=5.12 mM for ganciclovir {ECO:0000269|PubMed:16330770, ECO:0000269|PubMed:17509534}; Vmax=1.185 nmol/min/mg enzyme toward TEA {ECO:0000269|PubMed:16330770, ECO:0000269|PubMed:17509534}; Vmax=0.735 nmol/min/mg enzyme toward MPP {ECO:0000269|PubMed:16330770, ECO:0000269|PubMed:17509534}; Vmax=0.135 nmol/min/mg enzyme toward cimetidine {ECO:0000269|PubMed:16330770, ECO:0000269|PubMed:17509534}; Vmax=2.23 nmol/min/mg enzyme toward metformin {ECO:0000269|PubMed:16330770, ECO:0000269|PubMed:17509534}; Vmax=0.89 nmol/min/mg enzyme toward guanidine {ECO:0000269|PubMed:16330770, ECO:0000269|PubMed:17509534}; Vmax=3.78 nmol/min/mg enzyme toward procainamide {ECO:0000269|PubMed:16330770, ECO:0000269|PubMed:17509534}; Vmax=0.21 nmol/min/mg enzyme toward topotecan {ECO:0000269|PubMed:16330770, ECO:0000269|PubMed:17509534}; Vmax=0.265 nmol/min/mg enzyme toward estrone sulfate {ECO:0000269|PubMed:16330770, ECO:0000269|PubMed:17509534}; Vmax=0.62 nmol/min/mg enzyme toward acyclovir {ECO:0000269|PubMed:16330770, ECO:0000269|PubMed:17509534}; Vmax=1.08 nmol/min/mg enzyme toward ganciclovir {ECO:0000269|PubMed:16330770, ECO:0000269|PubMed:17509534}; 						BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 8.5. Active from pH 6 to 8.5. {ECO:0000269|PubMed:16330770, ECO:0000269|PubMed:17509534};					drug transmembrane transport [GO:0006855]; organic cation transport [GO:0015695]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; drug transmembrane transporter activity [GO:0015238]; drug:proton antiporter activity [GO:0015307]; monovalent cation:proton antiporter activity [GO:0005451]; drug transmembrane transport [GO:0006855]; organic cation transport [GO:0015695]; transmembrane transport [GO:0055085]	drug:proton antiporter activity [GO:0015307]; drug transmembrane transporter activity [GO:0015238]; monovalent cation:proton antiporter activity [GO:0005451]	GO:0005451; GO:0005886; GO:0006855; GO:0015238; GO:0015307; GO:0015695; GO:0016021; GO:0031982; GO:0055085	SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:16330770, ECO:0000269|PubMed:16641166}; Multi-pass membrane protein {ECO:0000269|PubMed:16330770, ECO:0000269|PubMed:16641166}. Note=Predominantly localized at the plasma membrane but also found in intracellular organelles.		MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:22814378}.	14702039; 15489334; 16330770; 16641166; 16996621; 17509534; 17582384; 17495125; 22814378; 16807400; 17047166; 17855482; 18305230; 19158817; 19172157; 19228809; 19536068; 19745787; 19898263; 20016398; 20047987; 20053795; 20067714; 20682687; 21128598; 22242910; 22569819; 22735389; 22882994; 23267855; 23303678; 23630107; 23864433; 25241911; 25753371; 25862351; 26004431; 26538438; 26784938; 27025966; 27178732; 27226103; 27271370; 27418674; 27590272; 27635733; 28321905; 29070695	14702039; 15489334; 16330770; 16641166; 16996621; 17509534; 17582384; 17495125; 22814378
13227	SLC35D2 HFRC UGTREL8	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=8 uM for UDP-N-acetylglucosamine {ECO:0000269|PubMed:15082721}; KM=2.1 uM for UDP-glucose {ECO:0000269|PubMed:15082721}; KM=0.14 uM for GDP-mannose {ECO:0000269|PubMed:15082721}; 											carbohydrate transport [GO:0008643]; glycosaminoglycan biosynthetic process [GO:0006024]; keratan sulfate biosynthetic process [GO:0018146]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleotide-sugar transmembrane transporter activity [GO:0005338]; pyrimidine nucleotide-sugar transmembrane transporter activity [GO:0015165]; carbohydrate transport [GO:0008643]; glycosaminoglycan biosynthetic process [GO:0006024]; keratan sulfate biosynthetic process [GO:0018146]	nucleotide-sugar transmembrane transporter activity [GO:0005338]; pyrimidine nucleotide-sugar transmembrane transporter activity [GO:0015165]	GO:0000139; GO:0005338; GO:0005794; GO:0006024; GO:0008643; GO:0015165; GO:0016021; GO:0018146	SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000269|PubMed:15082721, ECO:0000269|PubMed:15607426}; Multi-pass membrane protein {ECO:0000269|PubMed:15082721, ECO:0000269|PubMed:15607426}.			15082721; 15607426; 15164053; 15489334; 9927678; 22814378; 19276090	15082721; 15607426; 15164053; 15489334; 9927678; 22814378
13233	SLC52A1 GPR172B PAR2 RFT1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.38 uM for riboflavin {ECO:0000269|PubMed:20463145}; 											riboflavin metabolic process [GO:0006771]; riboflavin transport [GO:0032218]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; riboflavin transmembrane transporter activity [GO:0032217]; virus receptor activity [GO:0001618]; riboflavin metabolic process [GO:0006771]; riboflavin transport [GO:0032218]	riboflavin transmembrane transporter activity [GO:0032217]; virus receptor activity [GO:0001618]	GO:0001618; GO:0005886; GO:0005887; GO:0006771; GO:0032217; GO:0032218	SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:18632736, ECO:0000269|PubMed:20463145}; Multi-pass membrane protein {ECO:0000269|PubMed:18632736, ECO:0000269|PubMed:20463145}.			12740431; 18632736; 14702039; 16625196; 15489334; 20463145; 21089064; 28190456; 20206331; 21110228; 22702469; 23413253; 23506902; 24139842; 24264046; 25284511; 29122468; 29715086	12740431; 18632736; 14702039; 16625196; 15489334; 20463145; 21089064; 28190456
13234	SLC6A13 GAT2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=3.7 uM for GABA {ECO:0000269|PubMed:17502375}; KM=20.2 uM for beta-alanine {ECO:0000269|PubMed:17502375}; 												extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; transporter activity [GO:0005215]	gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; transporter activity [GO:0005215]	GO:0005215; GO:0005332; GO:0005886; GO:0005887; GO:0070062	SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:22932902}; Multi-pass membrane protein {ECO:0000269|PubMed:22932902}.		MOD_RES 587 587 Phosphothreonine. {ECO:0000250|UniProtKB:P31649}.; MOD_RES 591 591 Phosphoserine. {ECO:0000250|UniProtKB:P31649}.	11824941; 17502375; 14702039; 16541075; 15489334; 22932902; 10973981; 19086053; 19450549; 19874574; 19913121; 20379614; 20383146; 20398908; 20424473; 20628086; 23275563; 2387399; 24842606; 25824654; 7874447	11824941; 17502375; 14702039; 16541075; 15489334; 22932902
13235	SLC52A3 C20orf54 RFT2 RFVT3	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.98 uM for riboflavin {ECO:0000269|PubMed:20463145}; 											riboflavin metabolic process [GO:0006771]; riboflavin transport [GO:0032218]; sensory perception of sound [GO:0007605]	apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; riboflavin transmembrane transporter activity [GO:0032217]; riboflavin metabolic process [GO:0006771]; riboflavin transport [GO:0032218]; sensory perception of sound [GO:0007605]	riboflavin transmembrane transporter activity [GO:0032217]	GO:0005886; GO:0005887; GO:0006771; GO:0007605; GO:0016324; GO:0032217; GO:0032218	SUBCELLULAR LOCATION: Apical cell membrane {ECO:0000269|PubMed:20463145, ECO:0000269|PubMed:21512156, ECO:0000269|PubMed:24264046}; Multi-pass membrane protein {ECO:0000269|PubMed:20463145}. Cell membrane {ECO:0000269|PubMed:22273710, ECO:0000269|PubMed:27702554}.		MOD_RES 251 251 Phosphoserine. {ECO:0000250|UniProtKB:Q4FZU9}.	14702039; 11780052; 15489334; 19122205; 20463145; 21512156; 21110228; 24264046; 20206331; 20920669; 22718020; 22273710; 22824638; 22633641; 27702554; 18632736; 20724488; 20729853; 22471455; 22533825; 22791947; 23275236; 23413253; 23506902; 24139842; 24152165; 24260322; 24761851; 25045844; 25394472; 25427582; 26154995; 26722538; 27272163; 27584688; 27600099; 28637675; 28912250; 29053833; 29715086	14702039; 11780052; 15489334; 19122205; 20463145; 21512156; 21110228; 24264046; 20206331; 20920669; 22718020; 22273710; 22824638; 22633641; 27702554
13272	SLC52A2 GPR172A PAR1 RFT3	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.33 uM for riboflavin {ECO:0000269|PubMed:20463145}; 											riboflavin metabolic process [GO:0006771]; riboflavin transport [GO:0032218]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; riboflavin transmembrane transporter activity [GO:0032217]; virus receptor activity [GO:0001618]; riboflavin metabolic process [GO:0006771]; riboflavin transport [GO:0032218]	riboflavin transmembrane transporter activity [GO:0032217]; virus receptor activity [GO:0001618]	GO:0001618; GO:0005886; GO:0005887; GO:0006771; GO:0032217; GO:0032218	SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:20463145, ECO:0000269|PubMed:24253200, ECO:0000269|PubMed:27702554}; Multi-pass membrane protein {ECO:0000269|PubMed:20463145}.			12740431; 20463145; 14702039; 16421571; 15489334; 19307586; 22740598; 22864630; 23243084; 24253200; 27702554; 18632736; 20206331; 21110228; 23506902; 24139842; 24264046; 24616084; 25416956; 26669662; 26791833; 26918385; 29053833; 29287867; 29715086	12740431; 20463145; 14702039; 16421571; 15489334; 19307586; 22740598; 22864630; 23243084; 24253200; 27702554
13288	SAT1 SAT	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=3.8 uM for acetyl-coenzyme A {ECO:0000269|PubMed:17516632}; KM=5.7 uM for spermine {ECO:0000269|PubMed:17516632}; KM=22 uM for spermidine {ECO:0000269|PubMed:17516632}; 	2.3.1.57	CATALYTIC ACTIVITY: Acetyl-CoA + an alkane-alpha,omega-diamine = CoA + an N-acetyldiamine. {ECO:0000269|PubMed:16455797, ECO:0000269|PubMed:17516632}.	BINDING 92 92 Substrate; via carbonyl oxygen. {ECO:0000305|PubMed:17516632}.; BINDING 152 152 Substrate. {ECO:0000305|PubMed:17516632}.			BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 8.0. {ECO:0000269|PubMed:17516632};	PATHWAY: Amine and polyamine degradation; putrescine degradation; N-acetylputrescine from putrescine: step 1/1.				angiogenesis [GO:0001525]; polyamine biosynthetic process [GO:0006596]; putrescine catabolic process [GO:0009447]; regulation of cell proliferation [GO:0042127]; spermidine acetylation [GO:0032918]; spermine catabolic process [GO:0046208]	cytosol [GO:0005829]; intracellular [GO:0005622]	cytosol [GO:0005829]; intracellular [GO:0005622]; diamine N-acetyltransferase activity [GO:0004145]; identical protein binding [GO:0042802]; spermidine binding [GO:0019809]; angiogenesis [GO:0001525]; polyamine biosynthetic process [GO:0006596]; putrescine catabolic process [GO:0009447]; regulation of cell proliferation [GO:0042127]; spermidine acetylation [GO:0032918]; spermine catabolic process [GO:0046208]	diamine N-acetyltransferase activity [GO:0004145]; identical protein binding [GO:0042802]; spermidine binding [GO:0019809]	GO:0001525; GO:0004145; GO:0005622; GO:0005829; GO:0006596; GO:0009447; GO:0019809; GO:0032918; GO:0042127; GO:0042802; GO:0046208	SUBCELLULAR LOCATION: Cytoplasm.			1985966; 1652956; 1417826; 8573111; 14702039; 15489334; 2241897; 16455797; 17516632; 16544326; 9341865; 12215835; 12083816; 12427553; 12600646; 12803540; 14506281; 15159132; 15213272; 15479742; 15784477; 15905201; 16169070; 16189514; 16207710; 16262603; 16389195; 16637064; 16757480; 16854216; 17065202; 17875644; 18430370; 18660501; 18759322; 19051286; 19060904; 19162121; 19446796; 19686286; 19727732; 19851986; 20212040; 20628624; 21152090; 21501848; 21516116; 21988832; 22179681; 22354986; 23768751; 23891576; 23903781; 23963538; 24025154; 24735382; 25277244; 25277523; 25390069; 25849284; 25893668; 25959060; 27228136; 27698118; 27901475; 28157137; 8360194; 8954982; 9717831	1985966; 1652956; 1417826; 8573111; 14702039; 15489334; 2241897; 16455797; 17516632; 16544326; 9341865; 12215835
13345	SLC12A6 KCC3	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=10.7 mM for extracellular Rb(+) (isoform 1) {ECO:0000269|PubMed:16048901}; KM=7.3 mM for extracellular Cl(-) (isoform 1) {ECO:0000269|PubMed:16048901}; KM=17.2 mM for extracellular Rb(+) (isoform 2) {ECO:0000269|PubMed:16048901}; KM=8.2 mM for extracellular Cl(-) (isoform 2) {ECO:0000269|PubMed:16048901}; 				ACTIVITY REGULATION: Activated by N-ethylmaleimide (NEM). Inhibited by DIOA, bumetanide and furosemide. Inhibited by WNK3. {ECO:0000269|PubMed:21613606}.							angiogenesis [GO:0001525]; cellular hypotonic response [GO:0071476]; cellular hypotonic salinity response [GO:0071477]; chemical synaptic transmission [GO:0007268]; ion transport [GO:0006811]; potassium ion import [GO:0010107]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; potassium ion transmembrane transporter activity [GO:0015079]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]; angiogenesis [GO:0001525]; cellular hypotonic response [GO:0071476]; cellular hypotonic salinity response [GO:0071477]; chemical synaptic transmission [GO:0007268]; ion transport [GO:0006811]; potassium ion import [GO:0010107]	potassium:chloride symporter activity [GO:0015379]; potassium ion transmembrane transporter activity [GO:0015079]; protein kinase binding [GO:0019901]	GO:0001525; GO:0005886; GO:0005887; GO:0006811; GO:0007268; GO:0010107; GO:0015079; GO:0015379; GO:0016021; GO:0016323; GO:0019901; GO:0071476; GO:0071477	SUBCELLULAR LOCATION: Basolateral cell membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}.	PTM: N-glycosylated. {ECO:0000269|PubMed:10187864, ECO:0000269|PubMed:12368912}.	MOD_RES 32 32 Phosphoserine. {ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163}.; MOD_RES 120 120 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 148 148 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1032 1032 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.	10600773; 10187864; 10347194; 12368912; 16048901; 14702039; 16572171; 15489334; 17974005; 11551954; 18669648; 19690332; 21613606; 21406692; 23186163; 12106695; 12637262; 12657561; 15262997; 16098236; 16606917; 17133354; 17893295; 18006853; 18536702; 18566107; 19058789; 19665974; 20020398; 20711500; 21628467; 21733850; 22423107; 23414517; 24043619; 24341143; 24393035; 24655550; 25110711; 26217182; 26638075; 27230413; 27782176; 8663127	10600773; 10187864; 10347194; 12368912; 16048901; 14702039; 16572171; 15489334; 17974005; 11551954; 18669648; 19690332; 21613606; 21406692; 23186163
13377	INPP5F KIAA0966 SAC2 MSTP007 MSTP047	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=14.3 uM for PtdIns(4,5)P2 (at pH 6.0) {ECO:0000269|PubMed:11274189}; 	3.1.3.25	CATALYTIC ACTIVITY: Myo-inositol phosphate + H(2)O = myo-inositol + phosphate. {ECO:0000269|PubMed:25869668, ECO:0000269|PubMed:25869669}.							MSTP007 MSTP047		adult locomotory behavior [GO:0008344]; cardiac muscle hypertrophy in response to stress [GO:0014898]; clathrin-dependent endocytosis [GO:0072583]; negative regulation of axon regeneration [GO:0048681]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of receptor recycling [GO:0001921]; regulation of cell motility [GO:2000145]; regulation of endocytic recycling [GO:2001135]; regulation of protein kinase B signaling [GO:0051896]	axon [GO:0030424]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037]	axon [GO:0030424]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; phosphatidylinositol phosphate 4-phosphatase activity [GO:0034596]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; protein homodimerization activity [GO:0042803]; adult locomotory behavior [GO:0008344]; cardiac muscle hypertrophy in response to stress [GO:0014898]; clathrin-dependent endocytosis [GO:0072583]; negative regulation of axon regeneration [GO:0048681]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of receptor recycling [GO:0001921]; regulation of cell motility [GO:2000145]; regulation of endocytic recycling [GO:2001135]; regulation of protein kinase B signaling [GO:0051896]	inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; phosphatidylinositol phosphate 4-phosphatase activity [GO:0034596]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; protein homodimerization activity [GO:0042803]	GO:0001921; GO:0005769; GO:0005905; GO:0006661; GO:0008344; GO:0008934; GO:0014898; GO:0030424; GO:0030425; GO:0031161; GO:0031901; GO:0033137; GO:0034595; GO:0034596; GO:0042532; GO:0042803; GO:0043025; GO:0045334; GO:0046856; GO:0048015; GO:0048681; GO:0051896; GO:0052832; GO:0052833; GO:0055037; GO:0072583; GO:2000145; GO:2001135	SUBCELLULAR LOCATION: Membrane, clathrin-coated pit {ECO:0000269|PubMed:25869669}. Early endosome {ECO:0000269|PubMed:25869669}. Recycling endosome {ECO:0000269|PubMed:25869669}. Note=Also found on macropinosomes. {ECO:0000250|UniProtKB:Q8CDA1}.		MOD_RES 827 827 Phosphoserine. {ECO:0000250|UniProtKB:Q8CDA1}.; MOD_RES 830 830 Phosphoserine. {ECO:0000250|UniProtKB:Q8CDA1}.; MOD_RES 878 878 Phosphoserine. {ECO:0000250|UniProtKB:Q8CDA1}.; MOD_RES 881 881 Phosphoserine. {ECO:0000250|UniProtKB:Q8CDA1}.; MOD_RES 907 907 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 910 910 Phosphoserine. {ECO:0000250|UniProtKB:Q8CDA1}.; MOD_RES 1103 1103 Phosphoserine. {ECO:0000244|PubMed:23186163}.	11274189; 10231032; 14702039; 15164054; 15489334; 17974005; 17322895; 18669648; 19690332; 21406692; 23186163; 24275569; 25476455; 25869668; 26203138; 25869669; 16385451; 19875726; 24255178; 26430724	11274189; 10231032; 14702039; 15164054; 15489334; 17974005; 17322895; 18669648; 19690332; 21406692; 23186163; 24275569; 25476455; 25869668; 26203138; 25869669
13398	SLC5A8 AIT SMCT SMCT1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1442 uM for beta-D-hydroxybutyate {ECO:0000269|PubMed:16805814}; KM=2327 uM for beta-L-hydroxybutyate {ECO:0000269|PubMed:16805814}; KM=1088 uM for D-lactate {ECO:0000269|PubMed:16805814}; KM=184 uM for L-lactate {ECO:0000269|PubMed:16805814}; KM=387 uM for pyruvate {ECO:0000269|PubMed:16805814}; KM=213 uM for acetoacetate {ECO:0000269|PubMed:16805814}; KM=209 uM for alpha-ketoisocaproate {ECO:0000269|PubMed:16805814}; 											apoptotic process [GO:0006915]; ion transport [GO:0006811]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; short-chain fatty acid import [GO:0015913]	apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; passive transmembrane transporter activity [GO:0022803]; propionate transmembrane transporter activity [GO:0015552]; apoptotic process [GO:0006915]; ion transport [GO:0006811]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; short-chain fatty acid import [GO:0015913]	lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; passive transmembrane transporter activity [GO:0022803]; propionate transmembrane transporter activity [GO:0015552]	GO:0005886; GO:0006811; GO:0006915; GO:0008028; GO:0015129; GO:0015552; GO:0015913; GO:0016021; GO:0016324; GO:0022803; GO:0034356; GO:0070062; GO:0140161	SUBCELLULAR LOCATION: Apical cell membrane {ECO:0000269|PubMed:12107270, ECO:0000269|PubMed:15001644, ECO:0000269|PubMed:17245649}; Multi-pass membrane protein {ECO:0000269|PubMed:12107270, ECO:0000269|PubMed:15001644, ECO:0000269|PubMed:17245649}. Note=Expressed at the apical membrane of normal tall thyrocytes and of colonic epithelial cells. {ECO:0000269|PubMed:12107270, ECO:0000269|PubMed:15001644, ECO:0000269|PubMed:17245649}.			12107270; 12829793; 14966140; 15090606; 16541075; 15489334; 15001644; 15361710; 15867356; 17178845; 16805814; 16729224; 18037591; 17245649; 16375929; 16670197; 16858683; 17526579; 17692818; 18437076; 18559491; 18566324; 18661192; 19730683; 19864324; 20029986; 20082847; 20211600; 20403997; 20671196; 20965718; 21687703; 22450368; 23167260; 23273563; 23918800; 25416956; 25827678; 26285906; 27465549; 27488665; 27801863	12107270; 12829793; 14966140; 15090606; 16541075; 15489334; 15001644; 15361710; 15867356; 17178845; 16805814; 16729224; 18037591; 17245649
13433	SLC22A4 ETT OCTN1 UT2H	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.470 mM for TEA (at 37 degrees Celsius and pH 7.4) {ECO:0000269|PubMed:15459889, ECO:0000269|PubMed:9426230}; Vmax=0.974 nmol/min/mg enzyme toward TEA (at 37 degrees Celsius and pH 7.4) {ECO:0000269|PubMed:15459889, ECO:0000269|PubMed:9426230}; 						BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: More active at neutral and alkaline pHs than at acidic pHs. {ECO:0000269|PubMed:15459889, ECO:0000269|PubMed:9426230};					body fluid secretion [GO:0007589]; carnitine metabolic process [GO:0009437]; carnitine transport [GO:0015879]; organic cation transport [GO:0015695]; quaternary ammonium group transport [GO:0015697]; sodium ion transport [GO:0006814]; triglyceride metabolic process [GO:0006641]	apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; cation:cation antiporter activity [GO:0015491]; nucleotide binding [GO:0000166]; organic anion transmembrane transporter activity [GO:0008514]; PDZ domain binding [GO:0030165]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; secondary active organic cation transmembrane transporter activity [GO:0008513]; symporter activity [GO:0015293]; body fluid secretion [GO:0007589]; carnitine metabolic process [GO:0009437]; carnitine transport [GO:0015879]; organic cation transport [GO:0015695]; quaternary ammonium group transport [GO:0015697]; sodium ion transport [GO:0006814]; triglyceride metabolic process [GO:0006641]	ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; cation:cation antiporter activity [GO:0015491]; nucleotide binding [GO:0000166]; organic anion transmembrane transporter activity [GO:0008514]; PDZ domain binding [GO:0030165]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; secondary active organic cation transmembrane transporter activity [GO:0008513]; symporter activity [GO:0015293]	GO:0000166; GO:0005524; GO:0005739; GO:0005886; GO:0005887; GO:0006641; GO:0006814; GO:0007589; GO:0008513; GO:0008514; GO:0009437; GO:0015226; GO:0015293; GO:0015491; GO:0015651; GO:0015695; GO:0015697; GO:0015879; GO:0016324; GO:0030165	SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.			9426230; 15795384; 15372022; 15489334; 10215651; 14608356; 12436193; 15459889; 15107849; 10072434; 12089149; 12372408; 12384147; 15184985; 15685536; 15693005; 15751072; 15832501; 15883854; 15955786; 16246312; 16249223; 16255050; 16333318; 16344053; 16344054; 16361305; 16373276; 16437728; 16441470; 16469794; 16519742; 16519819; 16652416; 16670523; 16729965; 16771961; 16773684; 16796743; 16821265; 16835882; 17006998; 17100974; 17213842; 17340776; 17387389; 17451203; 17476680; 17509030; 17609683; 17609685; 17700366; 17786191; 18064451; 18087673; 18162085; 18274826; 18328148; 18338763; 18433468; 18466472; 18614543; 18668679; 18698678; 18709696; 18715515; 18756601; 18804983; 19103559; 19131452; 19141711; 19158815; 19214536; 19412005; 19439218; 19528813; 19536068; 19581171; 19605748; 19656490; 19659785; 19660151; 19814996; 19881261; 20020740; 20031577; 20224991; 20392673; 20485362; 20846217; 20877624; 21122496; 21606177; 21674708; 21695374; 21706137; 21793125; 21816865; 21910182; 22182480; 22206629; 22325173; 22569296; 23127916; 23709046; 24599653; 24850141; 24972750; 25490951; 25707686; 25937167; 26329403; 26607009; 27020986; 27023905; 28209616; 9685390	9426230; 15795384; 15372022; 15489334; 10215651; 14608356; 12436193; 15459889; 15107849
13445	SLC28A3 CNT3	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=21.6 uM for uridine {ECO:0000269|PubMed:11032837, ECO:0000269|PubMed:15861042}; KM=15.4 uM for cytidine {ECO:0000269|PubMed:11032837, ECO:0000269|PubMed:15861042}; KM=21.2 uM for thymidine {ECO:0000269|PubMed:11032837, ECO:0000269|PubMed:15861042}; KM=15.1 uM for adenosine {ECO:0000269|PubMed:11032837, ECO:0000269|PubMed:15861042}; KM=43 uM for guanosine {ECO:0000269|PubMed:11032837, ECO:0000269|PubMed:15861042}; KM=52.5 uM for inosine {ECO:0000269|PubMed:11032837, ECO:0000269|PubMed:15861042}; Vmax=25.8 pmol/min/mg enzyme for uridine uptake {ECO:0000269|PubMed:11032837, ECO:0000269|PubMed:15861042}; Vmax=32.8 pmol/min/mg enzyme for cytidine uptake {ECO:0000269|PubMed:11032837, ECO:0000269|PubMed:15861042}; Vmax=24.2 pmol/min/mg enzyme for thymidine uptake {ECO:0000269|PubMed:11032837, ECO:0000269|PubMed:15861042}; Vmax=30.4 pmol/min/mg enzyme for adenosine uptake {ECO:0000269|PubMed:11032837, ECO:0000269|PubMed:15861042}; Vmax=51.4 pmol/min/mg enzyme for guanosine uptake {ECO:0000269|PubMed:11032837, ECO:0000269|PubMed:15861042}; Vmax=44.8 pmol/min/mg enzyme for inosine uptake {ECO:0000269|PubMed:11032837, ECO:0000269|PubMed:15861042}; 											purine nucleoside transmembrane transport [GO:0015860]; pyrimidine nucleoside transport [GO:0015864]	endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; nucleoside:sodium symporter activity [GO:0005415]; purine-specific nucleoside:sodium symporter activity [GO:0015390]; pyrimidine- and adenine-specific:sodium symporter activity [GO:0015389]; purine nucleoside transmembrane transport [GO:0015860]; pyrimidine nucleoside transport [GO:0015864]	nucleoside:sodium symporter activity [GO:0005415]; purine-specific nucleoside:sodium symporter activity [GO:0015390]; pyrimidine- and adenine-specific:sodium symporter activity [GO:0015389]	GO:0005415; GO:0005789; GO:0005886; GO:0005887; GO:0015389; GO:0015390; GO:0015860; GO:0015864	SUBCELLULAR LOCATION: Isoform 1: Cell membrane; Multi-pass membrane protein.; SUBCELLULAR LOCATION: Isoform 2: Endoplasmic reticulum membrane; Multi-pass membrane protein.			11032837; 14702039; 15164053; 15489334; 15861042; 16446384; 17140564; 18827020; 15738947; 17993510; 14504928; 15870078; 16271041; 17409283; 17412768; 17453413; 17696452; 17926640; 18199742; 18621735; 19074885; 19297449; 19318496; 19380585; 19380587; 20028759; 20172853; 20379614; 20643903; 21346688; 21822668; 23195617; 23441093; 24300978; 24361227; 25955569; 26188009; 26481311; 27604902; 28385889; 28661652; 28774292	11032837; 14702039; 15164053; 15489334; 15861042; 16446384; 17140564; 18827020; 15738947; 17993510
13460	SLC38A5 JM24 SN2 SNAT5 PP7194	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.6 mM for histidine (at pH 8.0) {ECO:0000269|PubMed:11243884}; 				ACTIVITY REGULATION: Not inhibited by lithium. {ECO:0000269|PubMed:11243884}.					PP7194		amino acid transport [GO:0006865]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]; amino acid transport [GO:0006865]	amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]	GO:0005886; GO:0005887; GO:0006865; GO:0015171; GO:0015187	SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}.		MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:22814378}.	11243884; 15498874; 14702039; 15772651; 15489334; 22814378; 20711500; 26496610; 29499643	11243884; 15498874; 14702039; 15772651; 15489334; 22814378
13521	SGPL1 KIAA1252	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=5.2 uM for sphingosine 1-phosphate {ECO:0000269|PubMed:24809814}; 	4.1.2.27	CATALYTIC ACTIVITY: Sphinganine 1-phosphate = phosphoethanolamine + palmitaldehyde. {ECO:0000269|PubMed:11018465, ECO:0000269|PubMed:24809814, ECO:0000269|PubMed:28165339}.			COFACTOR: Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326; Evidence={ECO:0000269|PubMed:24809814}; 		PATHWAY: Lipid metabolism; sphingolipid metabolism. {ECO:0000269|PubMed:11018465, ECO:0000269|PubMed:24809814, ECO:0000269|PubMed:28165339}.				androgen metabolic process [GO:0008209]; apoptotic signaling pathway [GO:0097190]; ceramide metabolic process [GO:0006672]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; fatty acid metabolic process [GO:0006631]; fibroblast migration [GO:0010761]; hemopoiesis [GO:0030097]; kidney development [GO:0001822]; Leydig cell differentiation [GO:0033327]; luteinization [GO:0001553]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic development [GO:0009791]; regulation of multicellular organism growth [GO:0040014]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; spermatogenesis [GO:0007283]; sphingolipid biosynthetic process [GO:0030148]; sphingolipid catabolic process [GO:0030149]; vasculogenesis [GO:0001570]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117]; androgen metabolic process [GO:0008209]; apoptotic signaling pathway [GO:0097190]; ceramide metabolic process [GO:0006672]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; fatty acid metabolic process [GO:0006631]; fibroblast migration [GO:0010761]; hemopoiesis [GO:0030097]; kidney development [GO:0001822]; Leydig cell differentiation [GO:0033327]; luteinization [GO:0001553]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic development [GO:0009791]; regulation of multicellular organism growth [GO:0040014]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; spermatogenesis [GO:0007283]; sphingolipid biosynthetic process [GO:0030148]; sphingolipid catabolic process [GO:0030149]; vasculogenesis [GO:0001570]	carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117]	GO:0001553; GO:0001570; GO:0001822; GO:0005783; GO:0005789; GO:0006631; GO:0006672; GO:0007283; GO:0008117; GO:0008209; GO:0008210; GO:0009791; GO:0010761; GO:0016831; GO:0030097; GO:0030148; GO:0030149; GO:0030170; GO:0030176; GO:0033327; GO:0040014; GO:0048008; GO:0048705; GO:0060021; GO:0060325; GO:0097190	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:14570870}; Single-pass type III membrane protein {ECO:0000255}.		MOD_RES 353 353 N6-(pyridoxal phosphate)lysine; alternate.; MOD_RES 353 353 N6-acetyllysine; alternate. {ECO:0000244|PubMed:19608861}.; MOD_RES 356 356 Nitrated tyrosine. {ECO:0000244|PubMed:16777052}.; MOD_RES 366 366 Nitrated tyrosine. {ECO:0000244|PubMed:16777052}.; MOD_RES 564 564 Phosphoserine. {ECO:0000244|PubMed:19690332}.	11018465; 14570870; 10574462; 14702039; 15489334; 16777052; 18691976; 19690332; 19608861; 20068231; 21269460; 24809814; 28181337; 28165339; 28165343; 16385451; 17090686; 17353931; 17373700; 18172856; 18558101; 19119317; 19463016; 20519401; 21184844; 21304987; 21368890; 21565611; 21903422; 22190034; 22784711; 23902751; 24189400; 24255178; 24323699; 24468113; 24704119; 24825162; 25347472; 25609649; 25785436; 26493335; 26496610; 26638075; 26886371; 27160553; 27935985; 28077491; 28600291; 28931805; 29375197	11018465; 14570870; 10574462; 14702039; 15489334; 16777052; 18691976; 19690332; 19608861; 20068231; 21269460; 24809814; 28181337; 28165339; 28165343
13622	FARS2 FARS1 HSPC320	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=2.2 uM for L-phenylalanine {ECO:0000269|PubMed:19549855, ECO:0000269|PubMed:22833457}; KM=1900 uM for L-tyrosine {ECO:0000269|PubMed:19549855, ECO:0000269|PubMed:22833457}; KM=11.7 uM for DL-m-tyrosine {ECO:0000269|PubMed:19549855, ECO:0000269|PubMed:22833457}; KM=7.3 uM for L-phenylalanine {ECO:0000269|PubMed:19549855, ECO:0000269|PubMed:22833457}; KM=2.9 mM for ATP {ECO:0000269|PubMed:19549855, ECO:0000269|PubMed:22833457}; KM=1.2 uM for tRNA(Phe) {ECO:0000269|PubMed:19549855, ECO:0000269|PubMed:22833457}; Note=kcat is 2.8 min(-1), 2.0 min(-1) and 3.1 min(-1) with L-phenylalanine, L-tyrosine and m-tyrosine as substrate, respectively. Thus, the catalytic efficiency of the m-Tyr attachment is only 5-fold lower than that of the correct amino acid, while that of Tyr attachment is 1000-fold lower (PubMed:19549855). {ECO:0000269|PubMed:19549855};	6.1.1.20	CATALYTIC ACTIVITY: ATP + L-phenylalanine + tRNA(Phe) = AMP + diphosphate + L-phenylalanyl-tRNA(Phe). {ECO:0000269|PubMed:19549855, ECO:0000269|PubMed:22833457}.	BINDING 179 179 Substrate. {ECO:0000269|PubMed:18611382, ECO:0000269|PubMed:19549855}.; BINDING 287 287 Substrate; via carbonyl oxygen. {ECO:0000269|PubMed:18611382, ECO:0000269|PubMed:19549855}.; BINDING 312 312 Substrate; via carbonyl oxygen. {ECO:0000269|PubMed:18611382, ECO:0000269|PubMed:19549855}.						HSPC320		phenylalanyl-tRNA aminoacylation [GO:0006432]; tRNA aminoacylation for protein translation [GO:0006418]; tRNA processing [GO:0008033]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]; phenylalanyl-tRNA aminoacylation [GO:0006432]; tRNA aminoacylation for protein translation [GO:0006418]; tRNA processing [GO:0008033]	ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]	GO:0000049; GO:0004826; GO:0005524; GO:0005739; GO:0005759; GO:0006418; GO:0006432; GO:0008033	SUBCELLULAR LOCATION: Mitochondrion matrix {ECO:0000250|UniProtKB:Q6AYQ3}. Mitochondrion {ECO:0000250|UniProtKB:Q6AYQ3}.		MOD_RES 202 202 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.	10329163; 14702039; 14574404; 15489334; 19608861; 25944712; 18611382; 19549855; 22833457; 22499341; 26553276; 17768348; 19615732; 19737557; 19913121; 20186120; 20379614; 20628086; 20877624; 21601574; 22035791; 22137894; 23986595; 25416956; 25851414; 26496610; 27549011; 28419689; 29126765	10329163; 14702039; 14574404; 15489334; 19608861; 25944712; 18611382; 19549855; 22833457; 22499341; 26553276
13626	MARS2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=18 uM for Met {ECO:0000269|PubMed:15274629}; KM=85 uM for ATP {ECO:0000269|PubMed:15274629}; KM=2.1 uM for tRNA-Met {ECO:0000269|PubMed:15274629}; 	6.1.1.10	CATALYTIC ACTIVITY: ATP + L-methionine + tRNA(Met) = AMP + diphosphate + L-methionyl-tRNA(Met). {ECO:0000269|PubMed:15274629}.	BINDING 350 350 ATP. {ECO:0000250}.			BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 7.8-8.2. {ECO:0000269|PubMed:15274629};					methionyl-tRNA aminoacylation [GO:0006431]; tRNA aminoacylation for protein translation [GO:0006418]	mitochondrial matrix [GO:0005759]	mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; methionine-tRNA ligase activity [GO:0004825]; methionyl-tRNA aminoacylation [GO:0006431]; tRNA aminoacylation for protein translation [GO:0006418]	ATP binding [GO:0005524]; methionine-tRNA ligase activity [GO:0004825]	GO:0004825; GO:0005524; GO:0005759; GO:0006418; GO:0006431	SUBCELLULAR LOCATION: Mitochondrion matrix {ECO:0000305}.			14702039; 15815621; 15489334; 15274629; 21269460; 22448145; 25754315; 25944712; 20877624	14702039; 15815621; 15489334; 15274629; 21269460; 22448145; 25754315; 25944712
13665	SLC22A6 OAT1 PAHT	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=9.3 uM for PAH (isoform 1) {ECO:0000269|PubMed:10462545, ECO:0000269|PubMed:10964714, ECO:0000269|PubMed:12538807, ECO:0000269|PubMed:15846473}; KM=4 uM for PAH (isoform 2) {ECO:0000269|PubMed:10462545, ECO:0000269|PubMed:10964714, ECO:0000269|PubMed:12538807, ECO:0000269|PubMed:15846473}; KM=11 uM for edaravone {ECO:0000269|PubMed:10462545, ECO:0000269|PubMed:10964714, ECO:0000269|PubMed:12538807, ECO:0000269|PubMed:15846473}; KM=46 uM for cidofovir {ECO:0000269|PubMed:10462545, ECO:0000269|PubMed:10964714, ECO:0000269|PubMed:12538807, ECO:0000269|PubMed:15846473}; KM=30 uM for adefovir {ECO:0000269|PubMed:10462545, ECO:0000269|PubMed:10964714, ECO:0000269|PubMed:12538807, ECO:0000269|PubMed:15846473}; KM=5.77 uM for 2,4-D {ECO:0000269|PubMed:10462545, ECO:0000269|PubMed:10964714, ECO:0000269|PubMed:12538807, ECO:0000269|PubMed:15846473}; KM=23.5 uM for HA {ECO:0000269|PubMed:10462545, ECO:0000269|PubMed:10964714, ECO:0000269|PubMed:12538807, ECO:0000269|PubMed:15846473}; KM=14 uM for IA {ECO:0000269|PubMed:10462545, ECO:0000269|PubMed:10964714, ECO:0000269|PubMed:12538807, ECO:0000269|PubMed:15846473}; KM=20.5 uM for IS {ECO:0000269|PubMed:10462545, ECO:0000269|PubMed:10964714, ECO:0000269|PubMed:12538807, ECO:0000269|PubMed:15846473}; KM=141 uM for CMPF {ECO:0000269|PubMed:10462545, ECO:0000269|PubMed:10964714, ECO:0000269|PubMed:12538807, ECO:0000269|PubMed:15846473}; Vmax=534 pmol/min/mg enzyme for 2,4-D uptake {ECO:0000269|PubMed:10462545, ECO:0000269|PubMed:10964714, ECO:0000269|PubMed:12538807, ECO:0000269|PubMed:15846473}; Vmax=430 pmol/min/mg enzyme for HA uptake {ECO:0000269|PubMed:10462545, ECO:0000269|PubMed:10964714, ECO:0000269|PubMed:12538807, ECO:0000269|PubMed:15846473}; Vmax=110 pmol/min/mg enzyme for IA uptake {ECO:0000269|PubMed:10462545, ECO:0000269|PubMed:10964714, ECO:0000269|PubMed:12538807, ECO:0000269|PubMed:15846473}; Vmax=216 pmol/min/mg enzyme for IS uptake {ECO:0000269|PubMed:10462545, ECO:0000269|PubMed:10964714, ECO:0000269|PubMed:12538807, ECO:0000269|PubMed:15846473}; Vmax=801 pmol/min/mg enzyme for CMPF uptake {ECO:0000269|PubMed:10462545, ECO:0000269|PubMed:10964714, ECO:0000269|PubMed:12538807, ECO:0000269|PubMed:15846473}; 								SITE 230 230 Important for interaction with cidofovir.; SITE 438 438 Important for interaction with cidofovir and PAH.			alpha-ketoglutarate transport [GO:0015742]; organic anion transport [GO:0015711]; protein homooligomerization [GO:0051260]; renal tubular secretion [GO:0097254]; response to methotrexate [GO:0031427]; sodium-independent organic anion transport [GO:0043252]; urate transport [GO:0015747]	basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; anion:anion antiporter activity [GO:0015301]; chloride ion binding [GO:0031404]; inorganic anion exchanger activity [GO:0005452]; organic anion transmembrane transporter activity [GO:0008514]; protein homodimerization activity [GO:0042803]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; urate transmembrane transporter activity [GO:0015143]; alpha-ketoglutarate transport [GO:0015742]; organic anion transport [GO:0015711]; protein homooligomerization [GO:0051260]; renal tubular secretion [GO:0097254]; response to methotrexate [GO:0031427]; sodium-independent organic anion transport [GO:0043252]; urate transport [GO:0015747]	anion:anion antiporter activity [GO:0015301]; chloride ion binding [GO:0031404]; inorganic anion exchanger activity [GO:0005452]; organic anion transmembrane transporter activity [GO:0008514]; protein homodimerization activity [GO:0042803]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; urate transmembrane transporter activity [GO:0015143]	GO:0005452; GO:0005886; GO:0005887; GO:0005901; GO:0008514; GO:0015143; GO:0015301; GO:0015347; GO:0015711; GO:0015742; GO:0015747; GO:0016323; GO:0031404; GO:0031427; GO:0032991; GO:0042803; GO:0043252; GO:0051260; GO:0070062; GO:0097254	SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.	PTM: Glycosylated. Glycosylation at Asn-113 may occur at a secondary level. Glycosylation is necessary for proper targeting of the transporter to the plasma membrane. {ECO:0000269|PubMed:10462545, ECO:0000269|PubMed:14749323}.		9762842; 9887087; 9950961; 10049739; 10462545; 10964714; 16554811; 15489334; 12538807; 14749323; 15145940; 15644426; 15846473; 17038320; 17502342; 15914676; 16164626; 11327718; 14586168; 15901346; 16189514; 19060904	9762842; 9887087; 9950961; 10049739; 10462545; 10964714; 16554811; 15489334; 12538807; 14749323; 15145940; 15644426; 15846473; 17038320; 17502342; 15914676; 16164626
13667	SLC25A33	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=0.16 mM for UTP (at 25 degrees Celsius) {ECO:0000269|PubMed:25320081}; KM=0.18 mM for CTP (at 25 degrees Celsius) {ECO:0000269|PubMed:25320081}; KM=0.08 mM for TTP (at 25 degrees Celsius) {ECO:0000269|PubMed:25320081}; KM=0.30 mM for GTP (at 25 degrees Celsius) {ECO:0000269|PubMed:25320081}; Vmax=98.5 umol/min/g enzyme toward UTP (at 25 degrees Celsius) {ECO:0000269|PubMed:25320081}; Vmax=22.5 umol/min/g enzyme toward CTP (at 25 degrees Celsius) {ECO:0000269|PubMed:25320081}; Vmax=50.8 umol/min/g enzyme toward TTP (at 25 degrees Celsius) {ECO:0000269|PubMed:25320081}; Vmax=15.7 umol/min/g enzyme toward GTP (at 25 degrees Celsius) {ECO:0000269|PubMed:25320081}; Note=The inhibitory constants (Ki) of these compounds are 174 um (UTP), 195 um (CTP), 318 um (GTP), and 333 um (ITP). UTP is the best substrate. {ECO:0000269|PubMed:25320081};											cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to insulin stimulus [GO:0032869]; mitochondrial genome maintenance [GO:0000002]; mitochondrial respiratory chain complex III assembly [GO:0034551]; mitochondrial transcription [GO:0006390]; mitochondrial transport [GO:0006839]; mitochondria-nucleus signaling pathway [GO:0031930]; mitochondrion organization [GO:0007005]; positive regulation of cell growth [GO:0030307]; positive regulation of cell proliferation [GO:0008284]; pyrimidine nucleotide import into mitochondrion [GO:1990519]; pyrimidine nucleotide transport [GO:0006864]; regulation of cell cycle arrest [GO:0071156]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of oxidative phosphorylation [GO:0002082]; regulation of reactive oxygen species biosynthetic process [GO:1903426]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]	integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; pyrimidine nucleotide transmembrane transporter activity [GO:0015218]; cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; mitochondria-nucleus signaling pathway [GO:0031930]; mitochondrial genome maintenance [GO:0000002]; mitochondrial respiratory chain complex III assembly [GO:0034551]; mitochondrial transcription [GO:0006390]; mitochondrial transport [GO:0006839]; mitochondrion organization [GO:0007005]; positive regulation of cell growth [GO:0030307]; positive regulation of cell proliferation [GO:0008284]; pyrimidine nucleotide import into mitochondrion [GO:1990519]; pyrimidine nucleotide transport [GO:0006864]; regulation of cell cycle arrest [GO:0071156]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of oxidative phosphorylation [GO:0002082]; regulation of reactive oxygen species biosynthetic process [GO:1903426]	pyrimidine nucleotide transmembrane transporter activity [GO:0015218]	GO:0000002; GO:0002082; GO:0005743; GO:0006390; GO:0006839; GO:0006864; GO:0007005; GO:0008284; GO:0015218; GO:0016021; GO:0030307; GO:0031930; GO:0031966; GO:0032869; GO:0034551; GO:0051881; GO:0071156; GO:1903426; GO:1990314; GO:1990519	SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000305|PubMed:14715278}; Multi-pass membrane protein {ECO:0000255}.			14715278; 17596519; 16710414; 15489334; 16949250; 20453889; 21269460; 25320081; 20877624; 21900206; 21911578; 23266187; 23416715	14715278; 17596519; 16710414; 15489334; 16949250; 20453889; 21269460; 25320081
13675	SLC38A2 ATA2 KIAA1382 SAT2 SNAT2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.39 mM for 2-methylamino-isobutyric acid (MeAIB) (at pH 8.0); 				ACTIVITY REGULATION: Inhibited by N-methyl-D-glucamine and probably choline. {ECO:0000269|PubMed:10930503}.							alanine transport [GO:0032328]; amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; cellular response to amino acid starvation [GO:0034198]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex development [GO:0021987]; female pregnancy [GO:0007565]; glutamate secretion [GO:0014047]; glycine betaine transport [GO:0031460]; sodium ion transport [GO:0006814]	axon [GO:0030424]; brush border [GO:0005903]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]	axon [GO:0030424]; brush border [GO:0005903]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; amino acid transmembrane transporter activity [GO:0015171]; L-glutamine transmembrane transporter activity [GO:0015186]; symporter activity [GO:0015293]; alanine transport [GO:0032328]; amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; cellular response to amino acid starvation [GO:0034198]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex development [GO:0021987]; female pregnancy [GO:0007565]; glutamate secretion [GO:0014047]; glycine betaine transport [GO:0031460]; sodium ion transport [GO:0006814]	amino acid transmembrane transporter activity [GO:0015171]; L-glutamine transmembrane transporter activity [GO:0015186]; symporter activity [GO:0015293]	GO:0003333; GO:0005886; GO:0005887; GO:0005903; GO:0006814; GO:0006865; GO:0007565; GO:0014047; GO:0015171; GO:0015186; GO:0015293; GO:0021987; GO:0030424; GO:0030425; GO:0031460; GO:0032328; GO:0034198; GO:0042383; GO:0043025; GO:0071260	SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15561425, ECO:0000269|PubMed:16616430}; Multi-pass membrane protein {ECO:0000269|PubMed:15561425, ECO:0000269|PubMed:16616430}. Note=Insulin promotes recruitment to the plasma membrane from a pool localized in the trans-Golgi network or endosomes (By similarity). Enriched in the somatodendritic compartment of neurons, it is also detected at the axonal shaft but excluded from the nerve terminal. {ECO:0000250}.	PTM: Polyubiquitination by NEDD4L regulates the degradation and the activity of SLC38A2. {ECO:0000250}.	MOD_RES 10 10 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 12 12 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 21 21 Phosphoserine. {ECO:0000250|UniProtKB:Q8CFE6}.; MOD_RES 22 22 Phosphoserine. {ECO:0000244|PubMed:19690332}.; MOD_RES 55 55 Phosphoserine. {ECO:0000244|PubMed:23186163}.	10930503; 10718198; 12168954; 14702039; 15489334; 14623874; 15922329; 15561425; 16621798; 16616430; 18669648; 19690332; 20068231; 21269460; 22814378; 23186163; 11756489; 15581851; 16125834; 16169070; 16445384; 16621896; 17237199; 18697751; 18703994; 19589777; 19741197; 20206993; 21622135; 21930789; 22028413; 23408887; 23728383; 25561175; 25653282; 25759021; 26041779; 26374858; 26496610; 26638075; 27129276; 27355203	10930503; 10718198; 12168954; 14702039; 15489334; 14623874; 15922329; 15561425; 16621798; 16616430; 18669648; 19690332; 20068231; 21269460; 22814378; 23186163
13677	SLC35B3 C6orf196 PAPST2 CGI-19	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=2.2 uM for PAPS {ECO:0000269|PubMed:16492677}; 									CGI-19		3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]	Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]	Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]	3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]	GO:0000139; GO:0030173; GO:0030176; GO:0046964; GO:0050428	SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000269|PubMed:16492677}; Multi-pass membrane protein {ECO:0000269|PubMed:16492677}.			16492677; 10810093; 17974005; 14574404; 15489334; 12716889; 20978009; 21211351; 26638075; 8619989	16492677; 10810093; 17974005; 14574404; 15489334
13685	SLC6A15 B0AT2 NTT73 SBAT1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.16 mM for L-leucine (at pH 7.5, 100 mM NaCL, -70 mV) {ECO:0000269|PubMed:16226721}; KM=0.16 mM for L-valine (at pH 7.5, 100 mM NaCL, -70 mV)) {ECO:0000269|PubMed:16226721}; KM=0.08 mM for L-isoleucine (at pH 7.5, 100 mM NaCL, -70 mV) {ECO:0000269|PubMed:16226721}; KM=0.11 mM for L-methionine (at pH 7.5, 100 mM NaCL, -70 mV) {ECO:0000269|PubMed:16226721}; KM=0.38 mM for L-proline (at pH 7.5, 100 mM NaCL, -70 mV) {ECO:0000269|PubMed:16226721}; 						BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 7.5-8.5. Strongly inhibited at acidic PH. {ECO:0000269|PubMed:16226721};					amino acid transport [GO:0006865]; leucine transport [GO:0015820]; neurotransmitter transport [GO:0006836]; neutral amino acid transport [GO:0015804]; proline transport [GO:0015824]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; neurotransmitter transporter activity [GO:0005326]; neurotransmitter:sodium symporter activity [GO:0005328]; proline:sodium symporter activity [GO:0005298]; amino acid transport [GO:0006865]; leucine transport [GO:0015820]; neurotransmitter transport [GO:0006836]; neutral amino acid transport [GO:0015804]; proline transport [GO:0015824]	amino acid transmembrane transporter activity [GO:0015171]; neurotransmitter:sodium symporter activity [GO:0005328]; neurotransmitter transporter activity [GO:0005326]; proline:sodium symporter activity [GO:0005298]	GO:0005298; GO:0005326; GO:0005328; GO:0005886; GO:0005887; GO:0006836; GO:0006865; GO:0015171; GO:0015804; GO:0015820; GO:0015824; GO:0016021	SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.		MOD_RES 25 25 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 55 55 Phosphoserine. {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:23186163}.; MOD_RES 687 687 Phosphoserine. {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:23186163}.; MOD_RES 699 699 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 701 701 Phosphoserine. {ECO:0000244|PubMed:23186163}.	11112352; 14702039; 16541075; 15489334; 16226721; 18691976; 19413330; 21269460; 21406692; 22814378; 23186163; 19147495; 21521612; 22475622; 23820837; 26638075; 27723767; 28320136; 28915082	11112352; 14702039; 16541075; 15489334; 16226721; 18691976; 19413330; 21269460; 21406692; 22814378; 23186163
13787	TDO2 TDO	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=0.135 mM for L-tryptophan {ECO:0000269|PubMed:25066423}; KM=0.132 mM for L-tryptophan {ECO:0000269|PubMed:28285122}; Note=Kcat is 0.54 sec(-1) with L-tryptophan as substrate. {ECO:0000269|PubMed:28285122};	1.13.11.11	CATALYTIC ACTIVITY: L-tryptophan + O(2) = N-formyl-L-kynurenine. {ECO:0000255|HAMAP-Rule:MF_03020, ECO:0000269|PubMed:25066423, ECO:0000269|PubMed:27762317, ECO:0000269|PubMed:28285122}.	BINDING 144 144 Substrate. {ECO:0000244|PDB:5TI9, ECO:0000255|HAMAP-Rule:MF_03020, ECO:0000269|PubMed:27762317}.; BINDING 342 342 Substrate. {ECO:0000244|PDB:5TI9, ECO:0000255|HAMAP-Rule:MF_03020, ECO:0000269|PubMed:27762317}.		COFACTOR: Name=heme; Xref=ChEBI:CHEBI:30413; Evidence={ECO:0000255|HAMAP-Rule:MF_03020, ECO:0000269|PubMed:25066423, ECO:0000269|PubMed:27762317, ECO:0000269|PubMed:28285122}; ;  Note=Binds 1 heme group per subunit. {ECO:0000255|HAMAP-Rule:MF_03020, ECO:0000269|PubMed:27762317};		PATHWAY: Amino-acid degradation; L-tryptophan degradation via kynurenine pathway; L-kynurenine from L-tryptophan: step 1/2. {ECO:0000255|HAMAP-Rule:MF_03020, ECO:0000269|PubMed:25066423, ECO:0000269|PubMed:27762317}.				protein homotetramerization [GO:0051289]; response to nitroglycerin [GO:1904842]; tryptophan catabolic process [GO:0006569]; tryptophan catabolic process to acetyl-CoA [GO:0019442]; tryptophan catabolic process to kynurenine [GO:0019441]	cytosol [GO:0005829]	cytosol [GO:0005829]; amino acid binding [GO:0016597]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; tryptophan 2,3-dioxygenase activity [GO:0004833]; protein homotetramerization [GO:0051289]; response to nitroglycerin [GO:1904842]; tryptophan catabolic process [GO:0006569]; tryptophan catabolic process to acetyl-CoA [GO:0019442]; tryptophan catabolic process to kynurenine [GO:0019441]	amino acid binding [GO:0016597]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; tryptophan 2,3-dioxygenase activity [GO:0004833]	GO:0004833; GO:0005829; GO:0006569; GO:0016597; GO:0019441; GO:0019442; GO:0019825; GO:0020037; GO:0042802; GO:0046872; GO:0051289; GO:1904842				8666386; 14702039; 15489334; 28285122; 25066423; 27762317; 11140838; 12634647; 14755447; 15390107; 16189514; 18370401; 19218188; 19502010; 19637229; 19786962; 20361220; 21361337; 21892828; 22082147; 23455924; 23558111; 23630570; 24974860; 25416956; 27563172; 27578919; 28223212	8666386; 14702039; 15489334; 28285122; 25066423; 27762317
13818	TGS1 HCA137 NCOA6IP PIMT	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=30 uM for m(7)GDP {ECO:0000269|PubMed:18775984}; KM=5 uM for S-adenosyl-L-methionine {ECO:0000269|PubMed:18775984}; 	2.1.1.-	CATALYTIC ACTIVITY: S-adenosyl-L-methionine + m(7)G(5')pppR-RNA = S-adenosyl-L-homocysteine + m(2,7)G(5')pppR-RNA.; CATALYTIC ACTIVITY: S-adenosyl-L-methionine + m(2,7)G(5')pppR-RNA = S-adenosyl-L-homocysteine + m(2,2,7)G(5')pppR-RNA.	BINDING 719 719 S-adenosyl-L-methionine. {ECO:0000250}.; BINDING 766 766 7-methylguanosine. {ECO:0000269|PubMed:19386620}.			BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 8.5-9.5. {ECO:0000269|PubMed:18775984};					7-methylguanosine cap hypermethylation [GO:0036261]; 7-methylguanosine RNA capping [GO:0009452]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription, DNA-templated [GO:0006355]; ribonucleoprotein complex biogenesis [GO:0022613]; spliceosomal snRNP assembly [GO:0000387]; transcription, DNA-templated [GO:0006351]	Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]	Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; RNA methyltransferase activity [GO:0008173]; RNA trimethylguanosine synthase activity [GO:0071164]; 7-methylguanosine cap hypermethylation [GO:0036261]; 7-methylguanosine RNA capping [GO:0009452]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription, DNA-templated [GO:0006355]; ribonucleoprotein complex biogenesis [GO:0022613]; spliceosomal snRNP assembly [GO:0000387]; transcription, DNA-templated [GO:0006351]	RNA methyltransferase activity [GO:0008173]; RNA trimethylguanosine synthase activity [GO:0071164]	GO:0000387; GO:0005615; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006351; GO:0006355; GO:0008173; GO:0009452; GO:0015030; GO:0019216; GO:0022613; GO:0030532; GO:0036261; GO:0071164	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12943661}. Nucleus, Cajal body {ECO:0000305|PubMed:12032086}. Nucleus, nucleolus {ECO:0000269|PubMed:12032086}. Note=A 90 kDa isoform is found in the nucleus while a 55 kDa isoform is found in the cytoplasm and colocalizes with the tubulin network. {ECO:0000269|PubMed:12943661}.		MOD_RES 55 55 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163}.; MOD_RES 60 60 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332}.; MOD_RES 85 85 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 89 89 Phosphoserine. {ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 96 96 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 141 141 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 146 146 Phosphotyrosine. {ECO:0000244|PubMed:23186163}.; MOD_RES 154 154 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163}.; MOD_RES 189 189 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 412 412 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 438 438 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332}.; MOD_RES 578 578 Phosphoserine. {ECO:0000244|PubMed:23186163}.	11517327; 12200376; 12097419; 16421571; 15489334; 14702039; 12032086; 11912212; 12943661; 12776181; 16687569; 18775984; 18669648; 19413330; 19690332; 20068231; 21406692; 23186163; 19307714; 19386620; 10529898; 10777541; 11226238; 11267664; 11330046; 12118000; 12177166; 12505311; 12582161; 14980219; 15067378; 15130092; 15500444; 15635043; 16380219; 16476485; 16503871; 16713569; 16972786; 17007889; 17306620; 18039666; 18288277; 18391951; 18407833; 18540824; 18579750; 18660489; 18719978; 18848529; 19088433; 19289416; 19324876; 19324877; 19710929; 19934321; 20110263; 20360068; 20360394; 20379614; 20546612; 20711500; 21204776; 21522132; 23414517; 23922881; 24196956; 24358311; 26074133; 26420826; 26496610; 26738492; 7685352; 7892212; 7981125; 8196654; 8647822; 9012850; 9171241; 9748239	11517327; 12200376; 12097419; 16421571; 15489334; 14702039; 12032086; 11912212; 12943661; 12776181; 16687569; 18775984; 18669648; 19413330; 19690332; 20068231; 21406692; 23186163; 19307714; 19386620
13820	THTPA	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=8 uM for thiamine triphosphate {ECO:0000269|PubMed:23707715}; Vmax=59 umol/min/mg enzyme {ECO:0000269|PubMed:23707715}; 	3.6.1.28	CATALYTIC ACTIVITY: Thiamine triphosphate + H(2)O = thiamine diphosphate + phosphate. {ECO:0000269|PubMed:23707715}.	BINDING 11 11 Substrate.; BINDING 55 55 Substrate.; BINDING 57 57 Substrate.; BINDING 65 65 Substrate.; BINDING 125 125 Substrate.; BINDING 157 157 Substrate.; BINDING 193 193 Substrate. {ECO:0000305}.		COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:23707715}; ;  Note=Binds 1 Mg(2+) ion per subunit. {ECO:0000269|PubMed:23707715};						dephosphorylation [GO:0016311]; generation of precursor metabolites and energy [GO:0006091]; thiamine-containing compound metabolic process [GO:0042723]; thiamine diphosphate metabolic process [GO:0042357]; thiamine metabolic process [GO:0006772]	cytosol [GO:0005829]	cytosol [GO:0005829]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; thiamin-triphosphatase activity [GO:0050333]; dephosphorylation [GO:0016311]; generation of precursor metabolites and energy [GO:0006091]; thiamine diphosphate metabolic process [GO:0042357]; thiamine metabolic process [GO:0006772]; thiamine-containing compound metabolic process [GO:0042723]	hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; thiamin-triphosphatase activity [GO:0050333]	GO:0000287; GO:0005829; GO:0006091; GO:0006772; GO:0016311; GO:0016787; GO:0042357; GO:0042723; GO:0050333	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11827967}.		MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378}.	11827967; 14702039; 12508121; 15489334; 21269460; 22223895; 22814378; 23707715; 15109578; 20711500	11827967; 14702039; 12508121; 15489334; 21269460; 22223895; 22814378; 23707715
13911	PTGES3 P23 TEBP	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=14 uM for PGH2 {ECO:0000269|PubMed:10922363}; Vmax=190 nmol/min/mg enzyme toward PGH2 {ECO:0000269|PubMed:10922363}; 	5.3.99.3	CATALYTIC ACTIVITY: (5Z,13E)-(15S)-9-alpha,11-alpha-epidioxy-15-hydroxyprosta-5,13-dienoate = (5Z,13E)-(15S)-11-alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate. {ECO:0000269|PubMed:10922363}.					PATHWAY: Lipid metabolism; prostaglandin biosynthesis. {ECO:0000269|PubMed:10922363}.				chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated protein complex assembly [GO:0051131]; cyclooxygenase pathway [GO:0019371]; positive regulation of phosphorylation [GO:0042327]; positive regulation of telomerase activity [GO:0051973]; prostaglandin biosynthetic process [GO:0001516]; protein stabilization [GO:0050821]; regulation of cellular response to heat [GO:1900034]; signal transduction [GO:0007165]; telomerase holoenzyme complex assembly [GO:1905323]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]; xenobiotic metabolic process [GO:0006805]	chaperone complex [GO:0101031]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; telomerase holoenzyme complex [GO:0005697]	chaperone complex [GO:0101031]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; telomerase holoenzyme complex [GO:0005697]; DNA polymerase binding [GO:0070182]; Hsp90 protein binding [GO:0051879]; prostaglandin-E synthase activity [GO:0050220]; telomerase activity [GO:0003720]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated protein complex assembly [GO:0051131]; cyclooxygenase pathway [GO:0019371]; positive regulation of phosphorylation [GO:0042327]; positive regulation of telomerase activity [GO:0051973]; prostaglandin biosynthetic process [GO:0001516]; protein stabilization [GO:0050821]; regulation of cellular response to heat [GO:1900034]; signal transduction [GO:0007165]; telomerase holoenzyme complex assembly [GO:1905323]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]; xenobiotic metabolic process [GO:0006805]	DNA polymerase binding [GO:0070182]; Hsp90 protein binding [GO:0051879]; prostaglandin-E synthase activity [GO:0050220]; telomerase activity [GO:0003720]; unfolded protein binding [GO:0051082]	GO:0000723; GO:0000781; GO:0001516; GO:0003720; GO:0005634; GO:0005654; GO:0005697; GO:0005829; GO:0006805; GO:0007004; GO:0007165; GO:0019371; GO:0032991; GO:0042327; GO:0050220; GO:0050821; GO:0051082; GO:0051085; GO:0051131; GO:0051879; GO:0051973; GO:0070182; GO:0101031; GO:1900034; GO:1905323	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q3ZBF7}.		MOD_RES 33 33 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 44 44 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 85 85 Phosphoserine. {ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 100 100 Phosphoserine. {ECO:0000250|UniProtKB:Q9R0Q7}.; MOD_RES 113 113 Phosphoserine. {ECO:0000244|PubMed:16807684, ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:17487921, ECO:0000244|PubMed:18088087, ECO:0000244|PubMed:18318008, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19367720, ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569, ECO:0000269|Ref.6}.; MOD_RES 118 118 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:20068231}.; MOD_RES 148 148 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:24275569}.; MOD_RES 151 151 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:24275569}.	8114727; 14702039; 16541075; 15489334; 11274138; 12077419; 10922363; 17081983; 16807684; 17487921; 19367720; 18088087; 18691976; 18669648; 18318008; 19413330; 19369195; 19690332; 19608861; 20068231; 21269460; 21406692; 22814378; 23186163; 24711448; 24275569; 25944712; 27353360; 29127155; 28112733; 10811660; 10409767; 11259606; 11583998; 11751894; 12135483; 12573486; 12835322; 14507910; 15040786; 15591061; 16403413; 16809759; 17353931; 17697149; 17785525; 18166671; 18540824; 19001348; 19167051; 19254810; 19347995; 19738201; 19740745; 19751963; 19875381; 19996313; 20006655; 20038533; 20847343; 21183720; 21691801; 21853119; 21988832; 22074947; 22190034; 22277657; 22318716; 22433123; 22623428; 22677230; 22759865; 22899854; 23413029; 23602568; 23741051; 24366813; 24949977; 25036637; 25241147; 25277244; 25912394; 26638075; 26752685; 27462449; 29334217; 7961644; 9222609; 9447995; 9727490; 9817749	8114727; 14702039; 16541075; 15489334; 11274138; 12077419; 10922363; 17081983; 16807684; 17487921; 19367720; 18088087; 18691976; 18669648; 18318008; 19413330; 19369195; 19690332; 19608861; 20068231; 21269460; 21406692; 22814378; 23186163; 24711448; 24275569; 25944712; 27353360; 29127155; 28112733; 10811660
13919	GTF2B TF2B TFIIB	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.117 mM for acetyl-CoA {ECO:0000269|PubMed:12931194}; 	2.3.1.48	CATALYTIC ACTIVITY: Acetyl-CoA + [protein]-L-lysine = CoA + [protein]-N(6)-acetyl-L-lysine. {ECO:0000269|PubMed:12931194}.									positive regulation by host of viral transcription [GO:0043923]; positive regulation of core promoter binding [GO:1904798]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of viral transcription [GO:0050434]; protein acetylation [GO:0006473]; RNA polymerase II core complex assembly [GO:1990114]; RNA polymerase II transcriptional preinitiation complex assembly [GO:0051123]; snRNA transcription by RNA polymerase II [GO:0042795]; transcriptional start site selection at RNA polymerase II promoter [GO:0001174]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; viral process [GO:0016032]	chromosome [GO:0005694]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription factor complex [GO:0090575]; transcriptional preinitiation complex [GO:0097550]; transcription factor TFIID complex [GO:0005669]	chromosome [GO:0005694]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription factor complex [GO:0090575]; transcription factor TFIID complex [GO:0005669]; transcriptional preinitiation complex [GO:0097550]; acetyltransferase activity [GO:0016407]; core promoter binding [GO:0001047]; histone acetyltransferase activity [GO:0004402]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; TBP-class protein binding [GO:0017025]; thyroid hormone receptor binding [GO:0046966]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of core promoter binding [GO:1904798]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of viral transcription [GO:0050434]; protein acetylation [GO:0006473]; RNA polymerase II core complex assembly [GO:1990114]; RNA polymerase II transcriptional preinitiation complex assembly [GO:0051123]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcriptional start site selection at RNA polymerase II promoter [GO:0001174]; viral process [GO:0016032]	acetyltransferase activity [GO:0016407]; core promoter binding [GO:0001047]; histone acetyltransferase activity [GO:0004402]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; TBP-class protein binding [GO:0017025]; thyroid hormone receptor binding [GO:0046966]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]	GO:0000979; GO:0000993; GO:0001047; GO:0001174; GO:0004402; GO:0005634; GO:0005654; GO:0005669; GO:0005694; GO:0006366; GO:0006367; GO:0006473; GO:0008134; GO:0008270; GO:0016032; GO:0016407; GO:0016604; GO:0017025; GO:0032993; GO:0042795; GO:0043923; GO:0046966; GO:0050434; GO:0051123; GO:0060261; GO:0090575; GO:0097550; GO:1904798; GO:1990114; GO:1990841	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12931194}. Chromosome {ECO:0000269|PubMed:24441171}. Note=Non-acetylated form colocalizes with DNA in the G0/1, S and G2 phases of the cell cycle, but not during mitosis (PubMed:24441171). Acetylated form colocalizes at transcriptionally silent mitotic chromatids during mitosis at metaphase, anaphase, and telophase phases of the cell cycle (PubMed:24441171). {ECO:0000269|PubMed:24441171}.	PTM: Acetylated (PubMed:24441171). Autoacetylated; autoacetylation at Lys-238 stimulates transcription activation (PubMed:12931194). {ECO:0000269|PubMed:12931194, ECO:0000269|PubMed:24441171}.	MOD_RES 70 70 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 76 76 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163}.; MOD_RES 92 92 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 238 238 N6-acetyllysine; by autocatalysis. {ECO:0000269|PubMed:12931194}.	1876184; 1946368; 14702039; 19054851; 16710414; 15489334; 1517211; 3818643; 3029109; 2247058; 8504927; 8392607; 8413225; 8515819; 8515820; 8516311; 8516312; 8566795; 7601352; 7983760; 8662660; 8800208; 9420329; 10359081; 10318856; 11005381; 12931194; 16230532; 18669648; 19690332; 21269460; 23186163; 24441171; 7671313; 7675079; 9609687; 10619841; 11045620; 14641108; 15654739; 27193682; 29158257; 16959974; 10022900; 10024882; 10196247; 10330164; 10449590; 10723029; 11029584; 11784853; 12370301; 12529369; 12535529; 12574128; 12578358; 12791683; 12972613; 1310361; 14585974; 14701755; 15013781; 15024075; 15037660; 15989968; 16239144; 16308568; 16449650; 16595664; 16878124; 18079403; 18768974; 19193635; 19328794; 1939271; 19590095; 19667075; 20226668; 20457598; 20711500; 20880846; 2125285; 21896726; 21988832; 22137580; 22231121; 22252320; 22441827; 22623428; 22810585; 23055019; 23115335; 23902751; 23932780; 24097444; 24270878; 2449431; 24997600; 25416956; 25492609; 25675981; 26016528; 26284261; 26496610; 2944599; 7151173; 7666533; 8006019; 8156590; 8253082; 8339931; 8490964; 8551580; 8946909; 9311902; 9405375; 9407024; 9765293	1876184; 1946368; 14702039; 19054851; 16710414; 15489334; 1517211; 3818643; 3029109; 2247058; 8504927; 8392607; 8413225; 8515819; 8515820; 8516311; 8516312; 8566795; 7601352; 7983760; 8662660; 8800208; 9420329; 10359081; 10318856; 11005381; 12931194; 16230532; 18669648; 19690332; 21269460; 23186163; 24441171; 7671313; 7675079; 9609687; 10619841; 11045620; 14641108; 15654739; 27193682; 29158257; 16959974
13981	TPMT	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=18.5 uM for S-adenosyl-L-methionine (at pH 6.5 and 37 degrees Celsius) {ECO:0000269|PubMed:18484748}; KM=0.68 mM for 6-mercaptopurine (at pH 6.5 and 37 degrees Celsius) {ECO:0000269|PubMed:18484748}; KM=1.7 uM for S-adenosyl-L-methionine (at pH 7.5 and 37 degrees Celsius) {ECO:0000269|PubMed:657528}; KM=0.32 mM for 6-mercaptopurine (at pH 7.5 and 37 degrees Celsius) {ECO:0000269|PubMed:657528}; KM=0.20 mM for 6-thioguanine (at pH 7.5 and 37 degrees Celsius) {ECO:0000269|PubMed:657528}; Vmax=1.23 nmol/sec/mg enzyme toward 6-mercaptopurine (at pH 6.5 and 37 degrees Celsius) {ECO:0000269|PubMed:18484748}; 	2.1.1.67	CATALYTIC ACTIVITY: S-adenosyl-L-methionine + a thiopurine = S-adenosyl-L-homocysteine + a thiopurine S-methylether. {ECO:0000269|PubMed:18484748, ECO:0000269|PubMed:657528}.; CATALYTIC ACTIVITY: Mercaptopurine + S-adenosyl-L-methionine = 6-methylthiopurine + S-adenosyl-L-homocysteine. {ECO:0000269|PubMed:18484748, ECO:0000269|PubMed:657528}.; CATALYTIC ACTIVITY: 6-thioguanine + S-adenosyl-L-methionine = 6-methylthioguanine + S-adenosyl-L-homocysteine. {ECO:0000269|PubMed:657528}.	BINDING 40 40 Substrate. {ECO:0000250}.; BINDING 69 69 S-adenosyl-L-methionine; via carbonyl oxygen.; BINDING 90 90 S-adenosyl-L-methionine.; BINDING 152 152 S-adenosyl-L-methionine.	ACTIVITY REGULATION: Inhibited by S-adenosyl-L-homocysteine (SAH).		BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 7.5. {ECO:0000269|PubMed:657528};					drug metabolic process [GO:0017144]; methylation [GO:0032259]; nucleobase-containing compound metabolic process [GO:0006139]	cytosol [GO:0005829]	cytosol [GO:0005829]; S-adenosyl-L-methionine binding [GO:1904047]; thiopurine S-methyltransferase activity [GO:0008119]; drug metabolic process [GO:0017144]; methylation [GO:0032259]; nucleobase-containing compound metabolic process [GO:0006139]	S-adenosyl-L-methionine binding [GO:1904047]; thiopurine S-methyltransferase activity [GO:0008119]	GO:0005829; GO:0006139; GO:0008119; GO:0017144; GO:0032259; GO:1904047	SUBCELLULAR LOCATION: Cytoplasm.		MOD_RES 14 14 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:24275569}.; MOD_RES 58 58 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.	8316220; 7628307; 8561894; 9453052; 9246020; 14574404; 15489334; 9711875; 657528; 18484748; 18669648; 18318008; 19690332; 19608861; 21269460; 23186163; 24275569; 17243178; 7862671; 8644731; 9336428; 9177237; 9931345; 9931346; 10208641; 10751626; 16220112; 15819814; 16476125; 16789994; 10331075; 11007234; 11025471; 11422006; 11503013; 11927101; 11927834; 12142782; 12172211; 12176518; 12217596; 12492733; 12509611; 12563179; 12703994; 12732844; 12777968; 12814450; 12815366; 12880540; 12903038; 12940924; 12949626; 12972954; 13981612; 14508387; 14576848; 14634700; 14656901; 14723818; 14985890; 14985891; 15022030; 15206995; 15226671; 15226673; 15247157; 15255798; 15349717; 15385838; 15476481; 15571264; 15571267; 15691505; 15709212; 15784872; 15788214; 15792824; 15802809; 15931768; 15946151; 15967990; 15973722; 16006997; 16044099; 16164497; 16202677; 16214825; 16267626; 16272700; 16306100; 16396707; 16418693; 16431304; 16459728; 16595084; 16611274; 16643135; 16691038; 16724002; 16773681; 16876902; 16917910; 16946561; 16952345; 17065060; 17113562; 17129980; 17152495; 17164697; 17176368; 17206640; 17220558; 17241387; 17617792; 17690215; 17885628; 17909762; 17919375; 18021342; 18188716; 18193212; 18303966; 18385010; 18408566; 18467186; 18482735; 18600549; 18602085; 18605963; 18616518; 18693152; 18708949; 18775689; 18823306; 18827410; 18987654; 18987660; 19034904; 19048244; 19048245; 19057372; 19164342; 19177822; 19214663; 19229528; 19239109; 19252404; 19343046; 19473575; 19474452; 19535798; 19543639; 19546880; 19579612; 19650826; 19675376; 19682085; 19682195; 19695401; 19748501; 19774638; 19830600; 19891552; 19898482; 19913121; 19956635; 20017316; 20027160; 20037211; 20066544; 20081263; 20136357; 20136364; 20153897; 20173083; 20175804; 20175817; 20308917; 20349237; 20350137; 20393862; 20403997; 20408054; 20521035; 20593505; 20628086; 20881512; 20945351; 20972624; 21254844; 21348397; 21819368; 21938428; 22225964; 22304581; 22318545; 22385887; 22486532; 22594254; 22616585; 22747506; 22846425; 22931646; 23014567; 23025308; 23065291; 23126166; 23192017; 23252704; 23252716; 23377985; 23398787; 23400745; 23553048; 23581716; 23588304; 23731044; 23811272; 23820299; 23844534; 23996738; 24121523; 24322830; 24643197; 24696613; 24734162; 24737678; 24774509; 25347948; 25551397; 25564374; 25799415; 25819542; 25940902; 26072396; 26410243; 26411491; 26633017; 26674571; 26845729; 26974142; 27217052; 27333713; 27453281; 27564568; 27577869; 27665263; 27703193; 28374975; 28445188; 28476189; 28552060; 28857898; 29191122; 29206869; 29264794; 29321348; 29491687; 29630648	8316220; 7628307; 8561894; 9453052; 9246020; 14574404; 15489334; 9711875; 657528; 18484748; 18669648; 18318008; 19690332; 19608861; 21269460; 23186163; 24275569; 17243178; 7862671; 8644731; 9336428; 9177237; 9931345; 9931346; 10208641; 10751626; 16220112; 15819814; 16476125; 16789994
14070	SPTLC1 LCB1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.75 mM for serine {ECO:0000269|PubMed:20504773}; Vmax=1350 pmol/min/mg enzyme {ECO:0000269|PubMed:20504773}; 	2.3.1.50	CATALYTIC ACTIVITY: Palmitoyl-CoA + L-serine = CoA + 3-dehydro-D-sphinganine + CO(2). {ECO:0000269|PubMed:19416851}.			COFACTOR: Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326; Evidence={ECO:0000250}; 		PATHWAY: Lipid metabolism; sphingolipid metabolism.				ceramide biosynthetic process [GO:0046513]; positive regulation of lipophagy [GO:1904504]; sphinganine biosynthetic process [GO:0046511]; sphingolipid biosynthetic process [GO:0030148]; sphingolipid metabolic process [GO:0006665]; sphingomyelin biosynthetic process [GO:0006686]; sphingosine biosynthetic process [GO:0046512]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; serine C-palmitoyltransferase complex [GO:0017059]; SPOTS complex [GO:0035339]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; serine C-palmitoyltransferase complex [GO:0017059]; SPOTS complex [GO:0035339]; pyridoxal phosphate binding [GO:0030170]; serine C-palmitoyltransferase activity [GO:0004758]; ceramide biosynthetic process [GO:0046513]; positive regulation of lipophagy [GO:1904504]; sphinganine biosynthetic process [GO:0046511]; sphingolipid biosynthetic process [GO:0030148]; sphingolipid metabolic process [GO:0006665]; sphingomyelin biosynthetic process [GO:0006686]; sphingosine biosynthetic process [GO:0046512]	pyridoxal phosphate binding [GO:0030170]; serine C-palmitoyltransferase activity [GO:0004758]	GO:0004758; GO:0005783; GO:0005789; GO:0006665; GO:0006686; GO:0016021; GO:0017059; GO:0030148; GO:0030170; GO:0035339; GO:0046511; GO:0046512; GO:0046513; GO:1904504	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250}; Single-pass membrane protein {ECO:0000250}.	PTM: Phosphorylation at Tyr-164 inhibits activity and promotes cell survival. {ECO:0000269|PubMed:23629659}.	MOD_RES 164 164 Phosphotyrosine; by ABL. {ECO:0000269|PubMed:23629659}.	9363775; 11242114; 14702039; 15164053; 15489334; 17023427; 19416851; 20504773; 20182505; 21269460; 23629659; 25944712; 15037712; 17060578; 16959974; 19651702; 19132419; 21618344; 22302274; 23454272; 24247255; 10722674; 12445191; 15467453; 16210380; 17110338; 17314511; 17331073; 17353931; 17982236; 18018475; 18484747; 19362163; 19592499; 19923297; 20097765; 20562859; 20634891; 20711500; 21911578; 22593156; 24673574; 24725412; 25567748; 25609649; 26446223; 26496610; 28108287	9363775; 11242114; 14702039; 15164053; 15489334; 17023427; 19416851; 20504773; 20182505; 21269460; 23629659; 25944712; 15037712; 17060578; 16959974; 19651702; 19132419; 21618344; 22302274; 23454272; 24247255
14116	SULT2B1 HSST2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=10.9 uM for DHEA (at 37 degrees Celsius, in the presence of 1 mM MgCl2) {ECO:0000269|PubMed:16855051, ECO:0000269|PubMed:21855633}; KM=3.8 uM for DHEA (at 37 degrees Celsius, in the presence of 10 mM MgCl2) {ECO:0000269|PubMed:16855051, ECO:0000269|PubMed:21855633}; KM=11.8 uM for pregnenolone (at 37 degrees Celsius, in the presence of 1 mM MgCl2) {ECO:0000269|PubMed:16855051, ECO:0000269|PubMed:21855633}; KM=0.6 uM for PAPS (at 37 degrees Celsius, in the presence of 1 mM MgCl2) {ECO:0000269|PubMed:16855051, ECO:0000269|PubMed:21855633}; Vmax=1752 pmol/min/mg enzyme toward DHEA (at 37 degrees Celsius, in the presence of 10 mM MgCl2) {ECO:0000269|PubMed:16855051, ECO:0000269|PubMed:21855633}; 	2.8.2.2	CATALYTIC ACTIVITY: 3'-phosphoadenylyl sulfate + an alcohol = adenosine 3',5'-bisphosphate + an alkyl sulfate.	BINDING 98 98 Substrate.; BINDING 103 103 Substrate.; BINDING 125 125 Substrate.; BINDING 147 147 PAPS.; BINDING 155 155 PAPS.; BINDING 210 210 PAPS.							BIOPHYSICOCHEMICAL PROPERTIES: ;  Temperature dependence: Optimum temperature is 37 degrees Celsius. Retains 70% and 20% of activity when incubated at 42 degrees Celsius for 45 and 120 minutes, respectively. Activity is lost after 200 minutes incubation at 42 degrees Celsius. {ECO:0000269|PubMed:16855051, ECO:0000269|PubMed:21855633};	3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; cholesterol metabolic process [GO:0008203]; negative regulation of cell proliferation [GO:0008285]; positive regulation of epidermal cell differentiation [GO:0045606]; steroid metabolic process [GO:0008202]; sulfate assimilation [GO:0000103]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; alcohol sulfotransferase activity [GO:0004027]; cholesterol binding [GO:0015485]; nucleic acid binding [GO:0003676]; steroid hormone binding [GO:1990239]; steroid sulfotransferase activity [GO:0050294]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; cholesterol metabolic process [GO:0008203]; negative regulation of cell proliferation [GO:0008285]; positive regulation of epidermal cell differentiation [GO:0045606]; steroid metabolic process [GO:0008202]; sulfate assimilation [GO:0000103]	alcohol sulfotransferase activity [GO:0004027]; cholesterol binding [GO:0015485]; nucleic acid binding [GO:0003676]; steroid hormone binding [GO:1990239]; steroid sulfotransferase activity [GO:0050294]	GO:0000103; GO:0003676; GO:0004027; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0008202; GO:0008203; GO:0008285; GO:0015485; GO:0043231; GO:0045606; GO:0050294; GO:0050427; GO:0070062; GO:1990239	SUBCELLULAR LOCATION: Cytoplasm. Microsome. Nucleus. Cytoplasm, cytosol {ECO:0000269|PubMed:28575648}. Note=Phosphorylation of Ser-348 is required for translocation to the nucleus.		MOD_RES 348 348 Phosphoserine. {ECO:0000269|PubMed:21855633}.	9799594; 15057824; 15489334; 12145317; 16855051; 21855633; 12923182; 28575648; 11416019; 11457664; 12730293; 14676143; 14741047; 15063762; 15140224; 15878639; 15953604; 16189514; 17347498; 17496163; 17626250; 18586095; 19060904; 19243756; 19343046; 20214802; 20329768; 21146170; 21840698; 2268288; 23579488; 23593328; 24020383; 24277929; 24682418; 25416956; 26169578; 26739637; 8185618	9799594; 15057824; 15489334; 12145317; 16855051; 21855633; 12923182; 28575648
14135	SUMF1 PSEC0152 UNQ3037/PRO9852	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=0.34 uM for [sulfatase]-L-cysteine {ECO:0000269|PubMed:25931126}; Note=Kcat is 6.06 min(-1) with [sulfatase]-L-cysteine as substrate. {ECO:0000269|PubMed:25931126};	1.8.3.7	CATALYTIC ACTIVITY: A [sulfatase]-L-cysteine + O(2) + 2 a thiol = a [sulfatase]-3-oxo-L-alanine + hydrogen sulfide + a disulfide + H(2)O. {ECO:0000269|PubMed:15657036, ECO:0000269|PubMed:25931126}.			COFACTOR: Name=Cu(2+); Xref=ChEBI:CHEBI:29036; Evidence={ECO:0000269|PubMed:25931126}; ;  Note=The catalytic copper is required to activate oxygen and catalyze oxidative C-H activation. {ECO:0000269|PubMed:25931126};		PATHWAY: Protein modification; sulfatase oxidation. {ECO:0000269|PubMed:12757706, ECO:0000269|PubMed:15657036, ECO:0000269|PubMed:15907468, ECO:0000269|PubMed:25931126}.		PSEC0152 UNQ3037/PRO9852		glycosphingolipid metabolic process [GO:0006687]; post-translational protein modification [GO:0043687]; protein oxidation [GO:0018158]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; cupric ion binding [GO:1903135]; Formylglycine-generating oxidase activity [GO:0120147]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; glycosphingolipid metabolic process [GO:0006687]; post-translational protein modification [GO:0043687]; protein oxidation [GO:0018158]	cupric ion binding [GO:1903135]; Formylglycine-generating oxidase activity [GO:0120147]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]	GO:0005783; GO:0005788; GO:0006687; GO:0016491; GO:0018158; GO:0042803; GO:0043687; GO:0120147; GO:1903135	SUBCELLULAR LOCATION: Endoplasmic reticulum lumen {ECO:0000269|PubMed:15657036, ECO:0000269|PubMed:15962010, ECO:0000269|PubMed:18266766, ECO:0000269|PubMed:21224894}.	PTM: N-glycosylated. Contains high-mannose-type oligosaccharides. {ECO:0000269|PubMed:15657036, ECO:0000269|PubMed:15907468, ECO:0000269|PubMed:19159218}.		12757705; 12757706; 19262745; 12975309; 14702039; 16303743; 16641997; 15489334; 15962010; 15657036; 15907468; 18266766; 19159218; 25944712; 25931126; 16368756; 15146462; 18157819; 21224894; 14563551; 15708861; 16041070; 17206939; 17446859; 17452787; 17657823; 17932120; 18178549; 18305113; 18508857; 18509892; 18579805; 20217867; 20711500; 20802204; 23288839; 25222778; 25516103; 25885655; 26077311; 28464818; 8681943; 9699462	12757705; 12757706; 19262745; 12975309; 14702039; 16303743; 16641997; 15489334; 15962010; 15657036; 15907468; 18266766; 19159218; 25944712; 25931126; 16368756; 15146462; 18157819; 21224894
14144	TPH2 NTPH	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=41.3 uM for L-tryptophan {ECO:0000269|PubMed:17905754}; Vmax=833 nmol/min/mg enzyme {ECO:0000269|PubMed:17905754}; 	1.14.16.4	CATALYTIC ACTIVITY: L-tryptophan + tetrahydrobiopterin + O(2) = 5-hydroxy-L-tryptophan + 4a-hydroxytetrahydrobiopterin.			COFACTOR: Name=Fe(2+); Xref=ChEBI:CHEBI:29033; Evidence={ECO:0000250}; 		PATHWAY: Aromatic compound metabolism; serotonin biosynthesis; serotonin from L-tryptophan: step 1/2.				aromatic amino acid family metabolic process [GO:0009072]; cellular response to lithium ion [GO:0071285]; circadian rhythm [GO:0007623]; response to activity [GO:0014823]; response to calcium ion [GO:0051592]; response to estrogen [GO:0043627]; response to glucocorticoid [GO:0051384]; response to nutrient levels [GO:0031667]; serotonin biosynthetic process [GO:0042427]	cytosol [GO:0005829]; neuron projection [GO:0043005]	cytosol [GO:0005829]; neuron projection [GO:0043005]; iron ion binding [GO:0005506]; tryptophan 5-monooxygenase activity [GO:0004510]; aromatic amino acid family metabolic process [GO:0009072]; cellular response to lithium ion [GO:0071285]; circadian rhythm [GO:0007623]; response to activity [GO:0014823]; response to calcium ion [GO:0051592]; response to estrogen [GO:0043627]; response to glucocorticoid [GO:0051384]; response to nutrient levels [GO:0031667]; serotonin biosynthetic process [GO:0042427]	iron ion binding [GO:0005506]; tryptophan 5-monooxygenase activity [GO:0004510]	GO:0004510; GO:0005506; GO:0005829; GO:0007623; GO:0009072; GO:0014823; GO:0031667; GO:0042427; GO:0043005; GO:0043627; GO:0051384; GO:0051592; GO:0071285			MOD_RES 19 19 Phosphoserine. {ECO:0000250|UniProtKB:Q8CGU9}.	12511643; 16541075; 15489334; 17905754; 20126463; 15629698; 18347598; 19319927; 12379098; 15052272; 15124006; 15167691; 15197398; 15263906; 15476687; 15663479; 15768392; 15840421; 15940290; 15968084; 16044172; 16116490; 16245070; 16395128; 16401665; 16436194; 16581035; 16610949; 16610957; 16759340; 16806105; 16864580; 16894395; 16936760; 16958027; 17011525; 17015812; 17123708; 17123728; 17167340; 17176491; 17176492; 17192895; 17217922; 17221847; 17251907; 17335389; 17346350; 17408646; 17413454; 17453063; 17539919; 17568567; 17592484; 17604842; 17649681; 17692928; 17727633; 17768266; 17892388; 17972101; 17973628; 17986837; 18163388; 18180753; 18180764; 18181017; 18213624; 18234415; 18270970; 18293859; 18314252; 18339632; 18387780; 18405071; 18427560; 18436425; 18496129; 18782386; 18797398; 18801407; 18821565; 18826444; 18832011; 18937842; 19032713; 19032968; 19052197; 19058789; 19071164; 19077664; 19125159; 19125211; 19132526; 19156168; 19162119; 19170664; 19175813; 19181488; 19184136; 19233335; 19272410; 19328558; 19344641; 19352218; 19352219; 19356604; 19361870; 19365399; 19434366; 19445671; 19506906; 19548263; 19588223; 19590397; 19674121; 19679166; 19693267; 19734157; 19742166; 19748542; 19763617; 19781560; 19800079; 19816759; 19829168; 19874574; 19894072; 19913121; 20043001; 20052688; 20064585; 20124538; 20144688; 20213726; 20331984; 20346360; 20379614; 20396435; 20403506; 20446882; 20451217; 20468064; 20470849; 20515362; 20623453; 20628086; 20628266; 20633049; 20738857; 20740293; 20856248; 20869124; 20921119; 20938755; 20946355; 21049304; 21073637; 21085052; 21105877; 21182896; 21198324; 21257271; 21396719; 21418060; 21418063; 21457069; 21620479; 21621273; 21747395; 21829912; 21873838; 21946031; 21969281; 22072571; 22322887; 22361444; 22365257; 22392150; 22483952; 22491354; 22649797; 22655589; 22693556; 22698518; 22698779; 22721547; 22835848; 22868061; 22915309; 23032942; 23182718; 23239044; 23247084; 23258345; 23313272; 23334703; 23360517; 23461725; 23467366; 23628433; 23684859; 23716677; 23965265; 23992289; 23995203; 24033289; 24196946; 24260145; 24304270; 24376086; 24458851; 24491795; 24668623; 24899127; 24942188; 24958631; 25005534; 25014617; 25152196; 25214390; 25283578; 25455586; 25955598; 26001668; 26013962; 26028568; 26057341; 26071405; 26232682; 26365518; 26386440; 26497913; 26583347; 26954509; 26975194; 27189957; 27217698; 27237108; 27479537; 27521242; 27695066; 27807918; 27926628; 28084537; 28176268; 28193370; 28320136; 28342337; 28456685; 28590957; 28751217; 29035515	12511643; 16541075; 15489334; 17905754; 20126463; 15629698; 18347598; 19319927
14190	SPR	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=14.3 uM for sepiapterin {ECO:0000269|PubMed:11825621}; KM=10 uM for NADPH {ECO:0000269|PubMed:11825621}; 	1.1.1.153	CATALYTIC ACTIVITY: L-erythro-7,8-dihydrobiopterin + NADP(+) = sepiapterin + NADPH.; CATALYTIC ACTIVITY: L-erythro-tetrahydrobiopterin + 2 NADP(+) = 6-pyruvoyl-5,6,7,8-tetrahydropterin + 2 NADPH.	BINDING 170 170 Substrate. {ECO:0000250}.; BINDING 174 174 NADP. {ECO:0000250}.; BINDING 199 199 Substrate; via amide nitrogen. {ECO:0000250}.; BINDING 257 257 Substrate. {ECO:0000250}.								cofactor metabolic process [GO:0051186]; nitric oxide biosynthetic process [GO:0006809]; oxidation-reduction process [GO:0055114]; regulation of nitric-oxide synthase activity [GO:0050999]; tetrahydrobiopterin biosynthetic process [GO:0006729]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; aldo-keto reductase (NADP) activity [GO:0004033]; NADP binding [GO:0050661]; sepiapterin reductase activity [GO:0004757]; cofactor metabolic process [GO:0051186]; nitric oxide biosynthetic process [GO:0006809]; oxidation-reduction process [GO:0055114]; regulation of nitric-oxide synthase activity [GO:0050999]; tetrahydrobiopterin biosynthetic process [GO:0006729]	aldo-keto reductase (NADP) activity [GO:0004033]; NADP binding [GO:0050661]; sepiapterin reductase activity [GO:0004757]	GO:0004033; GO:0004757; GO:0005654; GO:0005829; GO:0006729; GO:0006809; GO:0050661; GO:0050999; GO:0051186; GO:0055114; GO:0070062	SUBCELLULAR LOCATION: Cytoplasm.	PTM: In vitro phosphorylation of Ser-213 by CaMK2 does not change kinetic parameters. {ECO:0000269|PubMed:11825621}.	MOD_RES 1 1 N-acetylmethionine. {ECO:0000250|UniProtKB:P18297}.; MOD_RES 32 32 Phosphoserine. {ECO:0000250|UniProtKB:P18297}.; MOD_RES 103 103 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 213 213 Phosphoserine; by CaMK2; in vitro. {ECO:0000269|PubMed:11825621}.	1883349; 8440319; 14702039; 15815621; 15489334; 9792819; 11825621; 21269460; 23186163; 24275569; 11443547; 16650784; 17159114; 15161933; 15241655; 16443856; 17270157; 18502672; 18511317; 19415819; 19491146; 19674121; 20038947; 20337188; 20877624; 21782285; 22018912; 23640889; 23704574; 24096079; 24189400; 24588500; 26087165; 26093909; 26565027; 27613114; 8137944	1883349; 8440319; 14702039; 15815621; 15489334; 9792819; 11825621; 21269460; 23186163; 24275569; 11443547; 16650784; 17159114
14319	SRR	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=6.5 mM for L-serine {ECO:0000269|PubMed:20106978}; 	5.1.1.18; 4.3.1.18; 4.3.1.17	CATALYTIC ACTIVITY: L-serine = D-serine. {ECO:0000269|PubMed:20106978}.; CATALYTIC ACTIVITY: D-serine = pyruvate + NH(3). {ECO:0000250|UniProtKB:Q9QZX7}.; CATALYTIC ACTIVITY: L-serine = pyruvate + NH(3). {ECO:0000250|UniProtKB:Q9QZX7}.	BINDING 51 51 ATP. {ECO:0000250}.; BINDING 121 121 ATP. {ECO:0000250}.; BINDING 135 135 Substrate. {ECO:0000305}.	ACTIVITY REGULATION: Allosterically activated by magnesium, and possibly also other divalent metal cations. Allosterically activated by ATP, ADP or GTP. Competitively inhibited by malonate.	COFACTOR: Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326; Evidence={ECO:0000269|PubMed:20106978}; 						aging [GO:0007568]; brain development [GO:0007420]; D-serine biosynthetic process [GO:0070179]; D-serine metabolic process [GO:0070178]; L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]; protein homotetramerization [GO:0051289]; pyruvate biosynthetic process [GO:0042866]; response to lipopolysaccharide [GO:0032496]; response to morphine [GO:0043278]; serine family amino acid metabolic process [GO:0009069]	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]	apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; D-serine ammonia-lyase activity [GO:0008721]; glycine binding [GO:0016594]; L-serine ammonia-lyase activity [GO:0003941]; magnesium ion binding [GO:0000287]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine racemase activity [GO:0030378]; threonine racemase activity [GO:0018114]; aging [GO:0007568]; brain development [GO:0007420]; D-serine biosynthetic process [GO:0070179]; D-serine metabolic process [GO:0070178]; L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]; protein homotetramerization [GO:0051289]; pyruvate biosynthetic process [GO:0042866]; response to lipopolysaccharide [GO:0032496]; response to morphine [GO:0043278]; serine family amino acid metabolic process [GO:0009069]	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; D-serine ammonia-lyase activity [GO:0008721]; glycine binding [GO:0016594]; L-serine ammonia-lyase activity [GO:0003941]; magnesium ion binding [GO:0000287]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine racemase activity [GO:0030378]; threonine racemase activity [GO:0018114]	GO:0000287; GO:0003941; GO:0005509; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006563; GO:0006564; GO:0007420; GO:0007568; GO:0008721; GO:0009069; GO:0016594; GO:0018114; GO:0030165; GO:0030170; GO:0030378; GO:0032496; GO:0042803; GO:0042866; GO:0043025; GO:0043278; GO:0045177; GO:0051289; GO:0070178; GO:0070179		PTM: S-nitrosylated, leading to decrease the enzyme activity. {ECO:0000250}.	MOD_RES 56 56 N6-(pyridoxal phosphate)lysine.; MOD_RES 113 113 S-nitrosocysteine. {ECO:0000250|UniProtKB:Q9QZX7}.	11054547; 15193426; 14702039; 15489334; 20106978; 15219883; 15536068; 16446740; 16837850; 17067558; 17413455; 17413456; 17697119; 17880399; 18583979; 19223009; 19483194; 19584346; 20174558; 20385472; 22096510; 22117694; 22151352; 23112234; 23992455; 25331425; 25336657; 25493718; 25640309; 26485193; 27394076; 28089597; 28696262; 29277459	11054547; 15193426; 14702039; 15489334; 20106978
14358	SUPV3L1 SUV3	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=41.9 uM for ATP {ECO:0000269|PubMed:12466530, ECO:0000269|PubMed:15096047}; 	3.6.4.13	CATALYTIC ACTIVITY: ATP + H(2)O = ADP + phosphate. {ECO:0000269|PubMed:12466530}.		ACTIVITY REGULATION: Helicase activity toward DNA substrate is inhibited by micromolar concentrations of 5,6-dichloro-1-(beta-D-ribofuranosyl)benzotriazole (DRBT) and 4,5,6,7-tetrabromobenzotriazole (TBBT). Helicase activity toward RNA substrate is inhibited by elevated concentrations of TBBT. Inhibited by some ring-expanded nucleoside analogs. {ECO:0000269|PubMed:12694177, ECO:0000269|PubMed:14561097}.	COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:15096047}; Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000269|PubMed:15096047}; 	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 5.0. {ECO:0000269|PubMed:12466530, ECO:0000269|PubMed:15096047};				BIOPHYSICOCHEMICAL PROPERTIES: ;  Temperature dependence: Optimum temperature is 30 degrees Celsius. {ECO:0000269|PubMed:12466530, ECO:0000269|PubMed:15096047};	chromatin maintenance [GO:0070827]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA surveillance [GO:0035946]; mitochondrial ncRNA surveillance [GO:0035945]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA surveillance [GO:2000827]; mitochondrion morphogenesis [GO:0070584]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell growth [GO:0030307]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; RNA catabolic process [GO:0006401]	mitochondrial degradosome [GO:0045025]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	mitochondrial degradosome [GO:0045025]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; chromatin maintenance [GO:0070827]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA surveillance [GO:0035946]; mitochondrial ncRNA surveillance [GO:0035945]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA surveillance [GO:2000827]; mitochondrion morphogenesis [GO:0070584]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell growth [GO:0030307]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; RNA catabolic process [GO:0006401]	3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]	GO:0000958; GO:0000962; GO:0000965; GO:0003677; GO:0003678; GO:0003723; GO:0003725; GO:0004004; GO:0004386; GO:0005524; GO:0005634; GO:0005739; GO:0005759; GO:0006310; GO:0006401; GO:0030307; GO:0032508; GO:0034458; GO:0035945; GO:0035946; GO:0042645; GO:0042803; GO:0043066; GO:0045025; GO:0070584; GO:0070827; GO:2000827	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:17352692}. Mitochondrion matrix {ECO:0000269|PubMed:12466530, ECO:0000269|PubMed:17352692, ECO:0000269|PubMed:19864255}. Mitochondrion matrix, mitochondrion nucleoid {ECO:0000269|PubMed:18063578}.		MOD_RES 99 99 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 220 220 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 725 725 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.	10453991; 14702039; 15164054; 15489334; 12466530; 12694177; 14561097; 15096047; 16176273; 17352692; 17961633; 18063578; 18678873; 18669648; 19509288; 19608861; 19864255; 21269460; 23186163; 25944712; 15919122; 16385451; 17373700; 20186120; 20467437; 20711500; 20877624; 22101826; 23221631; 23902751; 24770417; 25416956; 25446650; 28291845	10453991; 14702039; 15164054; 15489334; 12466530; 12694177; 14561097; 15096047; 16176273; 17352692; 17961633; 18063578; 18678873; 18669648; 19509288; 19608861; 19864255; 21269460; 23186163; 25944712
14425	AANAT SNAT	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.13 mM for tryptamine {ECO:0000269|PubMed:11313340}; KM=2.6 mM for 5-hydroxytryptamine {ECO:0000269|PubMed:11313340}; KM=0.55 mM for phenylethylamine {ECO:0000269|PubMed:11313340}; KM=10.6 mM for tyramine {ECO:0000269|PubMed:11313340}; 	2.3.1.87	CATALYTIC ACTIVITY: Acetyl-CoA + a 2-arylethylamine = CoA + an N-acetyl-2-arylethylamine. {ECO:0000269|PubMed:11313340}.	BINDING 124 124 Substrate; via amide nitrogen. {ECO:0000250|UniProtKB:Q29495}.; BINDING 159 159 Substrate; via carbonyl oxygen. {ECO:0000250|UniProtKB:Q29495}.				PATHWAY: Aromatic compound metabolism; melatonin biosynthesis; melatonin from serotonin: step 1/2.	SITE 120 120 Important for the catalytic mechanism; involved in substrate deprotonation. {ECO:0000250|UniProtKB:Q29495}.; SITE 122 122 Important for the catalytic mechanism; involved in substrate deprotonation. {ECO:0000250|UniProtKB:Q29495}.			cellular response to cAMP [GO:0071320]; circadian rhythm [GO:0007623]; indolalkylamine biosynthetic process [GO:0046219]; melatonin biosynthetic process [GO:0030187]; N-terminal protein amino acid acetylation [GO:0006474]; photoperiodism [GO:0009648]; response to calcium ion [GO:0051592]; response to copper ion [GO:0046688]; response to corticosterone [GO:0051412]; response to cytokine [GO:0034097]; response to insulin [GO:0032868]; response to light stimulus [GO:0009416]; response to prostaglandin E [GO:0034695]; response to zinc ion [GO:0010043]	cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]	cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; 14-3-3 protein binding [GO:0071889]; aralkylamine N-acetyltransferase activity [GO:0004059]; arylamine N-acetyltransferase activity [GO:0004060]; cellular response to cAMP [GO:0071320]; circadian rhythm [GO:0007623]; indolalkylamine biosynthetic process [GO:0046219]; melatonin biosynthetic process [GO:0030187]; N-terminal protein amino acid acetylation [GO:0006474]; photoperiodism [GO:0009648]; response to calcium ion [GO:0051592]; response to copper ion [GO:0046688]; response to corticosterone [GO:0051412]; response to cytokine [GO:0034097]; response to insulin [GO:0032868]; response to light stimulus [GO:0009416]; response to prostaglandin E [GO:0034695]; response to zinc ion [GO:0010043]	14-3-3 protein binding [GO:0071889]; aralkylamine N-acetyltransferase activity [GO:0004059]; arylamine N-acetyltransferase activity [GO:0004060]	GO:0004059; GO:0004060; GO:0005829; GO:0006474; GO:0007623; GO:0009416; GO:0009648; GO:0010043; GO:0030187; GO:0032868; GO:0034097; GO:0034695; GO:0046219; GO:0046688; GO:0048471; GO:0051412; GO:0051592; GO:0071320; GO:0071889	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11313340}.	PTM: cAMP-dependent phosphorylation on both N-terminal Thr-31 and C-terminal Ser-205 regulates AANAT activity by promoting interaction with 14-3-3 proteins.	MOD_RES 31 31 Phosphothreonine; by PKA. {ECO:0000250|UniProtKB:O97756}.; MOD_RES 205 205 Phosphoserine. {ECO:0000250|UniProtKB:Q29495}.	8661026; 16625196; 15489334; 11313340; 11427721; 18212399; 12736803; 11393533; 14728993; 15332344; 15644438; 17503170; 18569588; 18794762; 19086053; 19184136; 19343046; 19839995; 20377855; 20459461; 20586889; 21437622; 21778461; 25416956; 27339900; 28368307; 28699174	8661026; 16625196; 15489334; 11313340; 11427721; 18212399; 12736803
14480	AARS	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=3.1 uM for tRNA(Ala) (at 37 Celsius) {ECO:0000269|PubMed:25817015}; Note=kcat is 0.4 sec(-1). {ECO:0000269|PubMed:25817015};	6.1.1.7	CATALYTIC ACTIVITY: ATP + L-alanine + tRNA(Ala) = AMP + diphosphate + L-alanyl-tRNA(Ala). {ECO:0000255|HAMAP-Rule:MF_03133, ECO:0000269|PubMed:25817015, ECO:0000269|PubMed:27622773, ECO:0000269|PubMed:27911835, ECO:0000269|PubMed:28493438}.	BINDING 77 77 ATP. {ECO:0000244|PDB:4XEM, ECO:0000244|PDB:4XEO, ECO:0000244|PDB:5KNN, ECO:0000269|PubMed:27622773, ECO:0000269|Ref.22}.; BINDING 95 95 ATP; via amide nitrogen and carbonyl oxygen. {ECO:0000244|PDB:4XEM, ECO:0000244|PDB:4XEO, ECO:0000244|PDB:5KNN, ECO:0000269|PubMed:27622773, ECO:0000269|Ref.22}.; BINDING 176 176 ATP. {ECO:0000244|PDB:4XEM, ECO:0000244|PDB:4XEO, ECO:0000244|PDB:5KNN, ECO:0000269|PubMed:27622773, ECO:0000269|Ref.22}.; BINDING 216 216 L-alanine. {ECO:0000244|PDB:4XEM, ECO:0000244|PDB:4XEO, ECO:0000244|PDB:5KNN, ECO:0000269|PubMed:27622773, ECO:0000269|Ref.22}.; BINDING 239 239 L-alanine. {ECO:0000244|PDB:4XEM, ECO:0000244|PDB:4XEO, ECO:0000244|PDB:5KNN, ECO:0000269|PubMed:27622773, ECO:0000269|Ref.22}.; BINDING 243 243 ATP; via amide nitrogen. {ECO:0000244|PDB:4XEM, ECO:0000244|PDB:4XEO, ECO:0000244|PDB:5KNN, ECO:0000269|PubMed:27622773, ECO:0000269|Ref.22}.		COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000255|HAMAP-Rule:MF_03133}; ;  Note=Binds 1 zinc ion per subunit. {ECO:0000255|HAMAP-Rule:MF_03133};						alanyl-tRNA aminoacylation [GO:0006419]; cellular response to calcium ion [GO:0071277]; cerebellar Purkinje cell layer development [GO:0021680]; negative regulation of neuron apoptotic process [GO:0043524]; neuromuscular process controlling balance [GO:0050885]; regulation of cytoplasmic translational fidelity [GO:0140018]; tRNA aminoacylation for protein translation [GO:0006418]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; Ser-tRNA(Ala) hydrolase activity [GO:0002196]; translation regulator activity [GO:0045182]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]; cellular response to calcium ion [GO:0071277]; cerebellar Purkinje cell layer development [GO:0021680]; negative regulation of neuron apoptotic process [GO:0043524]; neuromuscular process controlling balance [GO:0050885]; regulation of cytoplasmic translational fidelity [GO:0140018]; tRNA aminoacylation for protein translation [GO:0006418]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033]	alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; Ser-tRNA(Ala) hydrolase activity [GO:0002196]; translation regulator activity [GO:0045182]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]	GO:0000049; GO:0002161; GO:0002196; GO:0004813; GO:0005524; GO:0005737; GO:0005829; GO:0006400; GO:0006418; GO:0006419; GO:0008033; GO:0008270; GO:0016020; GO:0016597; GO:0021680; GO:0043524; GO:0045182; GO:0050885; GO:0070062; GO:0071277; GO:0140018	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_03133, ECO:0000269|PubMed:27911835}.	PTM: ISGylated. {ECO:0000255|HAMAP-Rule:MF_03133, ECO:0000269|PubMed:16139798}.	MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378, ECO:0000255|HAMAP-Rule:MF_03133, ECO:0000269|Ref.7}.; MOD_RES 3 3 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 8 8 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 19 19 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 399 399 Phosphoserine. {ECO:0000244|PubMed:20068231}.; MOD_RES 555 555 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 876 876 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.	7654687; 14702039; 15616553; 15489334; 10508479; 16139798; 18669648; 19413330; 19661429; 19608861; 20068231; 21269460; 22223895; 22814378; 23186163; 24275569; 25817015; 25944712; 27622773; 27911835; 20045102; 22206013; 22009580; 24627108; 28493438; 15161933; 16263121; 16906134; 19738201; 19805454; 20195357; 21549344; 22573628; 22623428; 23606334; 25422440; 25904691; 26032230; 26496610; 26752685; 29273753	7654687; 14702039; 15616553; 15489334; 10508479; 16139798; 18669648; 19413330; 19661429; 19608861; 20068231; 21269460; 22223895; 22814378; 23186163; 24275569; 25817015; 25944712; 27622773; 27911835; 20045102; 22206013; 22009580; 24627108; 28493438
14533	SRCAP KIAA0309	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=66 uM for ATP {ECO:0000269|PubMed:10347196}; 	3.6.4.-										regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]; viral process [GO:0016032]	Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]	Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone acetyltransferase activity [GO:0004402]; transcription coactivator activity [GO:0003713]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]; viral process [GO:0016032]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone acetyltransferase activity [GO:0004402]; transcription coactivator activity [GO:0003713]	GO:0003677; GO:0003713; GO:0004386; GO:0004402; GO:0005524; GO:0005634; GO:0005654; GO:0005794; GO:0006351; GO:0006357; GO:0016032; GO:0016604; GO:0032991; GO:0048471	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00549, ECO:0000269|PubMed:10702287}.		MOD_RES 1172 1172 Phosphoserine. {ECO:0000244|PubMed:23186163}.	15616553; 14702039; 9205841; 15489334; 10347196; 10702287; 11522779; 11581372; 14500758; 14966270; 15647280; 16024792; 16634648; 17617668; 22265015; 23186163; 11013263; 16230350; 17101442; 20432434; 20467438; 20711500; 21673954; 22479200; 22965468; 23165645; 23763483; 24375913; 25176633; 25433523; 25609649; 27208210	15616553; 14702039; 9205841; 15489334; 10347196; 10702287; 11522779; 11581372; 14500758; 14966270; 15647280; 16024792; 16634648; 17617668; 22265015; 23186163
14565	SLCO3A1 OATP3A1 OATPD SLC21A11	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=101 nM for PGE1 (isoform 1) {ECO:0000269|PubMed:16971491}; KM=218 nM for PGE1 (isoform 2) {ECO:0000269|PubMed:16971491}; KM=219 nM for PGE2 (isoform 1) {ECO:0000269|PubMed:16971491}; KM=371 nM for PGE2 (isoform 2) {ECO:0000269|PubMed:16971491}; 											prostaglandin transport [GO:0015732]; sodium-independent organic anion transport [GO:0043252]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; prostaglandin transport [GO:0015732]; sodium-independent organic anion transport [GO:0043252]	sodium-independent organic anion transmembrane transporter activity [GO:0015347]	GO:0005886; GO:0005887; GO:0015347; GO:0015732; GO:0043252	SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.		MOD_RES 1 1 N-acetylmethionine. {ECO:0000269|PubMed:25732826}.	10873595; 14702039; 16572171; 15489334; 16971491; 22814378; 25732826; 14631946; 18521091; 18821565; 19330903; 20379614; 21278488; 21486766; 21656680; 22377092; 24945726; 26349991	10873595; 14702039; 16572171; 15489334; 16971491; 22814378; 25732826
14633	THEM4 CTMP	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=2.4 uM for myristoyl-CoA {ECO:0000269|PubMed:19453107, ECO:0000269|PubMed:22871024}; KM=2.6 uM for palmitoyl-CoA {ECO:0000269|PubMed:19453107, ECO:0000269|PubMed:22871024}; KM=5.2 uM for oleoyl-CoA {ECO:0000269|PubMed:19453107, ECO:0000269|PubMed:22871024}; 	3.1.2.2	CATALYTIC ACTIVITY: Palmitoyl-CoA + H(2)O = CoA + palmitate. {ECO:0000269|PubMed:19453107, ECO:0000269|PubMed:22871024}.	BINDING 183 183 Substrate.; BINDING 185 185 Substrate.								acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; negative regulation of protein kinase B signaling [GO:0051898]; protein kinase B signaling [GO:0043491]; regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902108]	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; acyl-CoA hydrolase activity [GO:0047617]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; negative regulation of protein kinase B signaling [GO:0051898]; protein kinase B signaling [GO:0043491]; regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902108]	acyl-CoA hydrolase activity [GO:0047617]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]	GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0005829; GO:0005886; GO:0006631; GO:0006637; GO:0016290; GO:0032587; GO:0043491; GO:0047617; GO:0051898; GO:0102991; GO:1902108	SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11598301}. Cell projection, ruffle membrane {ECO:0000269|PubMed:11598301}. Cytoplasm {ECO:0000269|PubMed:19604401}. Mitochondrion {ECO:0000269|PubMed:19168129, ECO:0000269|PubMed:19421406, ECO:0000269|PubMed:19604401}. Mitochondrion inner membrane; Peripheral membrane protein {ECO:0000269|PubMed:19168129}. Mitochondrion intermembrane space {ECO:0000269|PubMed:19168129, ECO:0000269|PubMed:19604401}. Note=Released from the mitochondria into the cytosol in response to apoptotic stimuli. {ECO:0000269|PubMed:19168129}.	PTM: Phosphorylated. {ECO:0000269|PubMed:11598301, ECO:0000269|PubMed:19604401}.	MOD_RES 37 37 Phosphoserine. {ECO:0000269|PubMed:19604401}.; MOD_RES 38 38 Phosphoserine. {ECO:0000269|PubMed:19604401}.; MOD_RES 55 55 N6-succinyllysine. {ECO:0000250|UniProtKB:Q3UUI3}.; MOD_RES 66 66 N6-succinyllysine. {ECO:0000250|UniProtKB:Q3UUI3}.; MOD_RES 74 74 N6-acetyllysine. {ECO:0000250|UniProtKB:Q3UUI3}.; MOD_RES 98 98 N6-succinyllysine. {ECO:0000250|UniProtKB:Q3UUI3}.; MOD_RES 207 207 N6-succinyllysine. {ECO:0000250|UniProtKB:Q3UUI3}.	11598301; 14702039; 16710414; 15489334; 15026474; 17615157; 19604401; 19453107; 19168129; 19421406; 22871024; 22586271; 17013611; 12167717; 12791994; 15718470; 16940157; 20470824; 22309289; 22465940; 23700546; 8645147; 9445477; 9679957	11598301; 14702039; 16710414; 15489334; 15026474; 17615157; 19604401; 19453107; 19168129; 19421406; 22871024; 22586271; 17013611
14634	SDS SDH	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=23 mM for serine {ECO:0000269|PubMed:18342636}; KM=31 mM for threonine {ECO:0000269|PubMed:18342636}; 	4.3.1.17; 4.3.1.19	CATALYTIC ACTIVITY: L-serine = pyruvate + NH(3). {ECO:0000269|PubMed:18342636}.; CATALYTIC ACTIVITY: L-threonine = 2-oxobutanoate + NH(3). {ECO:0000269|PubMed:18342636}.			COFACTOR: Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326; 		PATHWAY: Carbohydrate biosynthesis; gluconeogenesis.				gluconeogenesis [GO:0006094]; L-serine catabolic process [GO:0006565]; L-threonine catabolic process to glycine [GO:0019518]; pyruvate biosynthetic process [GO:0042866]	cytosol [GO:0005829]; mitochondrion [GO:0005739]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; hydro-lyase activity [GO:0016836]; L-serine ammonia-lyase activity [GO:0003941]; L-threonine ammonia-lyase activity [GO:0004794]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; gluconeogenesis [GO:0006094]; L-serine catabolic process [GO:0006565]; L-threonine catabolic process to glycine [GO:0019518]; pyruvate biosynthetic process [GO:0042866]	hydro-lyase activity [GO:0016836]; L-serine ammonia-lyase activity [GO:0003941]; L-threonine ammonia-lyase activity [GO:0004794]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]	GO:0003941; GO:0004794; GO:0005739; GO:0005829; GO:0006094; GO:0006565; GO:0016836; GO:0019518; GO:0030170; GO:0042803; GO:0042866	SUBCELLULAR LOCATION: Cytoplasm.		MOD_RES 41 41 N6-(pyridoxal phosphate)lysine.	2674117; 14702039; 18342636; 24275569; 14646100; 18289528; 23112234; 28005267	2674117; 14702039; 18342636; 24275569; 14646100
14657	SHPK CARKL	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.06 mM for sedoheptulose {ECO:0000269|PubMed:18186520}; 	2.7.1.14	CATALYTIC ACTIVITY: ATP + sedoheptulose = ADP + sedoheptulose 7-phosphate. {ECO:0000269|PubMed:18186520}.				BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 8.5. {ECO:0000269|PubMed:18186520};					carbohydrate metabolic process [GO:0005975]; cellular response to interleukin-13 [GO:0035963]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; phosphorylation [GO:0016310]; regulation of inflammatory response [GO:0050727]; regulation of macrophage activation [GO:0043030]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; sedoheptulokinase activity [GO:0050277]; carbohydrate metabolic process [GO:0005975]; cellular response to interleukin-13 [GO:0035963]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; phosphorylation [GO:0016310]; regulation of inflammatory response [GO:0050727]; regulation of macrophage activation [GO:0043030]	ATP binding [GO:0005524]; sedoheptulokinase activity [GO:0050277]	GO:0005524; GO:0005737; GO:0005829; GO:0005975; GO:0006098; GO:0009052; GO:0016310; GO:0035963; GO:0043030; GO:0050277; GO:0050727; GO:0071222; GO:0071353	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.			10673275; 14702039; 17974005; 16625196; 15489334; 18186520; 22682222; 25647543; 18775706; 19679847; 19913121; 20628086; 21988832	10673275; 14702039; 17974005; 16625196; 15489334; 18186520; 22682222; 25647543
14667	ST6GALNAC2 SIAT7B SIATL1 STHM	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=130 uM for CMP-N-acetylneuraminate {ECO:0000269|PubMed:10742600}; KM=104 uM for CMP-N-acetylneuraminate {ECO:0000269|PubMed:29251719}; 	2.4.99.3	CATALYTIC ACTIVITY: CMP-N-acetylneuraminate + glycano-(1->3)-(N-acetyl-alpha-D-galactosaminyl)-glycoprotein = CMP + glycano-((2->6)-alpha-N-acetylneuraminyl)-(N-acetyl-D-galactosaminyl)-glycoprotein. {ECO:0000269|PubMed:10742600, ECO:0000269|PubMed:29251719}.	BINDING 156 156 CMP-N-acetylneuraminate. {ECO:0000244|PDB:6APL, ECO:0000269|PubMed:29251719}.; BINDING 179 179 CMP-N-acetylneuraminate. {ECO:0000244|PDB:6APL, ECO:0000269|PubMed:29251719}.; BINDING 304 304 CMP-N-acetylneuraminate. {ECO:0000244|PDB:6APL, ECO:0000269|PubMed:29251719}.; BINDING 336 336 CMP-N-acetylneuraminate. {ECO:0000244|PDB:6APL, ECO:0000269|PubMed:29251719}.				PATHWAY: Protein modification; protein glycosylation. {ECO:0000269|PubMed:10742600, ECO:0000269|PubMed:29251719}.				O-glycan processing [GO:0016266]; oligosaccharide metabolic process [GO:0009311]; protein glycosylation [GO:0006486]; protein N-linked glycosylation via asparagine [GO:0018279]; protein O-linked glycosylation [GO:0006493]; protein sialylation [GO:1990743]; sialylation [GO:0097503]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373]; O-glycan processing [GO:0016266]; oligosaccharide metabolic process [GO:0009311]; protein glycosylation [GO:0006486]; protein N-linked glycosylation via asparagine [GO:0018279]; protein O-linked glycosylation [GO:0006493]; protein sialylation [GO:1990743]; sialylation [GO:0097503]	alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373]	GO:0000139; GO:0001665; GO:0006486; GO:0006493; GO:0008373; GO:0009311; GO:0016021; GO:0016266; GO:0018279; GO:0097503; GO:1990743	SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000305}; Single-pass type II membrane protein {ECO:0000305}.			10742600; 15489334; 29251719; 19357720; 10536037; 11062056; 12668675; 15231748; 17123352; 17418236; 17480010; 19170967; 23548905; 24398680; 24520024; 24756995; 24961352; 26820593; 27004849; 28767179; 29030743	10742600; 15489334; 29251719; 19357720
14679	SIRT3 SIR2L3	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=600 uM for NAD {ECO:0000269|PubMed:19535340}; 	3.5.1.-	CATALYTIC ACTIVITY: NAD(+) + an acetylprotein = nicotinamide + O-acetyl-ADP-ribose + a protein. {ECO:0000255|PROSITE-ProRule:PRU00236, ECO:0000269|PubMed:12186850, ECO:0000269|PubMed:12374852, ECO:0000269|PubMed:16788062, ECO:0000269|PubMed:18680753, ECO:0000269|PubMed:18794531, ECO:0000269|PubMed:19535340, ECO:0000269|PubMed:24121500, ECO:0000305|PubMed:23283301}.	BINDING 366 366 NAD; via amide nitrogen. {ECO:0000250}.		COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000269|PubMed:19535340, ECO:0000269|PubMed:23897466}; ;  Note=Binds 1 zinc ion per subunit. {ECO:0000269|PubMed:19535340, ECO:0000269|PubMed:23897466};						aerobic respiration [GO:0009060]; aging [GO:0007568]; mitochondrion organization [GO:0007005]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of insulin secretion [GO:0032024]; protein ADP-ribosylation [GO:0006471]; protein deacetylation [GO:0006476]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent protein deacetylase activity [GO:0034979]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; aerobic respiration [GO:0009060]; aging [GO:0007568]; mitochondrion organization [GO:0007005]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of insulin secretion [GO:0032024]; protein ADP-ribosylation [GO:0006471]; protein deacetylation [GO:0006476]	enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent protein deacetylase activity [GO:0034979]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	GO:0003950; GO:0005739; GO:0005759; GO:0006471; GO:0006476; GO:0007005; GO:0007568; GO:0008270; GO:0009060; GO:0017136; GO:0019899; GO:0032024; GO:0032991; GO:0034979; GO:0034983; GO:0043565; GO:0070373; GO:0070403; GO:2000378	SUBCELLULAR LOCATION: Mitochondrion matrix {ECO:0000269|PubMed:12186850, ECO:0000269|PubMed:12374852, ECO:0000269|PubMed:16079181, ECO:0000269|PubMed:18215119, ECO:0000269|PubMed:23283301, ECO:0000269|PubMed:29445193}.	PTM: Processed by mitochondrial processing peptidase (MPP) to give a 28 kDa product. Such processing is probably essential for its enzymatic activity. {ECO:0000269|PubMed:12186850}.	MOD_RES 122 122 N6-succinyllysine. {ECO:0000250|UniProtKB:Q8R104}.	10381378; 14702039; 16554811; 15489334; 17974005; 12186850; 12374852; 16079181; 16788062; 18215119; 18680753; 18794531; 19690332; 21172655; 23283301; 24121500; 23438705; 24252090; 24275569; 25944712; 29445193; 19535340; 23897466; 15676284; 16169070; 16189514; 17059877; 17437997; 17715127; 17923681; 17957139; 18710944; 18781224; 19209188; 19240061; 19343720; 19367319; 19680556; 19714312; 20129246; 20132432; 20198340; 20463968; 20661474; 20800603; 20819778; 20877624; 20945913; 21212461; 21358671; 21397863; 21566644; 21701047; 21720390; 22016654; 22155639; 22326535; 22416140; 22585829; 22589271; 22595756; 22609775; 22674009; 22750084; 22770219; 22849721; 23045395; 23046812; 23075334; 23139766; 23185430; 23272146; 23316803; 23397292; 23494737; 23570514; 23665396; 23790338; 23800187; 23839864; 23840057; 23842789; 23856293; 23868064; 23928404; 23956348; 24042441; 24194516; 24211137; 24287180; 24322174; 24324009; 24339251; 24344202; 24464653; 24486017; 24491532; 24503539; 24746213; 24771001; 24774224; 24877629; 24889606; 24909164; 24924131; 25005846; 25103363; 25109285; 25128872; 25162939; 25165814; 25194924; 25210848; 25221980; 25227106; 25284742; 25329972; 25361925; 25369635; 25525879; 25562154; 25607838; 25755250; 25755722; 25829495; 25915406; 25915842; 25961022; 26042459; 26045440; 26109058; 26121130; 26121691; 26138757; 26141949; 26223796; 26225774; 26317998; 26456643; 26520405; 26577410; 26625292; 26631723; 26667041; 26701732; 26722027; 26743598; 26787646; 26893145; 26950437; 27034011; 27053302; 27078640; 27114304; 27164052; 27216459; 27232755; 27270321; 27277143; 27295248; 27337034; 27367026; 27420645; 27483432; 27501476; 27604398; 27628218; 27732568; 27773814; 27815257; 27856259; 27925196; 28032248; 28108513; 28161643; 28197634; 28213977; 28239025; 28258190; 28347248; 28368421; 28429188; 28459202; 28526626; 28536275; 28567457; 28711502; 28717408; 28737710; 28867266; 28947845; 29072685; 29103158; 29184120; 29198988; 29220206; 29277324; 29581566; 29915029	10381378; 14702039; 16554811; 15489334; 17974005; 12186850; 12374852; 16079181; 16788062; 18215119; 18680753; 18794531; 19690332; 21172655; 23283301; 24121500; 23438705; 24252090; 24275569; 25944712; 29445193; 19535340; 23897466
14699	SPAST ADPSP FSP2 KIAA1083 SPG4	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=0.45 mM for ATP {ECO:0000269|PubMed:15716377, ECO:0000269|PubMed:17389232, ECO:0000269|PubMed:22637577}; Vmax=1.2 nmol/min/ug enzyme {ECO:0000269|PubMed:15716377, ECO:0000269|PubMed:17389232, ECO:0000269|PubMed:22637577}; Note=Kinetic parameters shown are for full-length enzyme. N-terminally truncated spastin (residues 228-616), which has been shown to exhibit full severing activity, shows a basal ATP turnover rate of 0.78 sec(-1) in the absence of microtubules, a KM of 0.16 mM for ATP, and the ATP turnover rate is extrapolated to 3.83 sec(-1) in the presence of microtubules. ATPase activity shows non-Michaelis-Menten kinetics in the presence of microtubules, but is close to non-cooperative behavior in their absence (PubMed:22637577). {ECO:0000269|PubMed:22637577};	3.6.4.3	CATALYTIC ACTIVITY: ATP + H(2)O = ADP + phosphate. {ECO:0000255|HAMAP-Rule:MF_03021, ECO:0000269|PubMed:15716377, ECO:0000269|PubMed:16219033, ECO:0000269|PubMed:16815977, ECO:0000269|PubMed:17389232, ECO:0000269|PubMed:18410514, ECO:0000269|PubMed:22637577}.		ACTIVITY REGULATION: Allosteric enzyme with a cooperative mechanism; at least two neighbor subunits influence each other strongly in spastin hexamers (PubMed:22637577). Microtubule binding promotes cooperative interactions among spastin subunits (PubMed:22637577). ATP-bound enzyme interacts strongly and cooperatively with microtubules; this interaction stimulates ATP hydrolysis (PubMed:23745751). {ECO:0000255|HAMAP-Rule:MF_03021, ECO:0000269|PubMed:22637577, ECO:0000269|PubMed:23745751}.							anterograde axonal transport [GO:0008089]; axonal transport of mitochondrion [GO:0019896]; axonogenesis [GO:0007409]; cytokinetic process [GO:0032506]; cytoskeleton-dependent cytokinesis [GO:0061640]; ER to Golgi vesicle-mediated transport [GO:0006888]; exit from mitosis [GO:0010458]; membrane fission [GO:0090148]; metabolic process [GO:0008152]; microtubule bundle formation [GO:0001578]; microtubule severing [GO:0051013]; mitotic cytokinesis [GO:0000281]; mitotic spindle disassembly [GO:0051228]; nuclear envelope reassembly [GO:0031468]; positive regulation of cytokinesis [GO:0032467]; positive regulation of microtubule depolymerization [GO:0031117]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260]	axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; microtubule [GO:0005874]; midbody [GO:0030496]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]	axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; microtubule [GO:0005874]; midbody [GO:0030496]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]; protein-containing complex binding [GO:0044877]; anterograde axonal transport [GO:0008089]; axonal transport of mitochondrion [GO:0019896]; axonogenesis [GO:0007409]; cytokinetic process [GO:0032506]; cytoskeleton-dependent cytokinesis [GO:0061640]; ER to Golgi vesicle-mediated transport [GO:0006888]; exit from mitosis [GO:0010458]; membrane fission [GO:0090148]; metabolic process [GO:0008152]; microtubule bundle formation [GO:0001578]; microtubule severing [GO:0051013]; mitotic cytokinesis [GO:0000281]; mitotic spindle disassembly [GO:0051228]; nuclear envelope reassembly [GO:0031468]; positive regulation of cytokinesis [GO:0032467]; positive regulation of microtubule depolymerization [GO:0031117]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260]	alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]; protein-containing complex binding [GO:0044877]	GO:0000281; GO:0001578; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005789; GO:0005811; GO:0005813; GO:0005819; GO:0005829; GO:0005874; GO:0006888; GO:0007409; GO:0008017; GO:0008089; GO:0008152; GO:0008568; GO:0010458; GO:0016021; GO:0019896; GO:0030496; GO:0031117; GO:0031410; GO:0031468; GO:0031965; GO:0032467; GO:0032506; GO:0034214; GO:0043014; GO:0044877; GO:0048471; GO:0048487; GO:0051013; GO:0051228; GO:0051260; GO:0061640; GO:0070062; GO:0071782; GO:0090148; GO:1904115	SUBCELLULAR LOCATION: Membrane {ECO:0000255|HAMAP-Rule:MF_03021, ECO:0000269|PubMed:19000169}; Peripheral membrane protein {ECO:0000255|HAMAP-Rule:MF_03021, ECO:0000305|PubMed:20200447}. Endoplasmic reticulum {ECO:0000255|HAMAP-Rule:MF_03021, ECO:0000269|PubMed:16602018}. Midbody {ECO:0000255|HAMAP-Rule:MF_03021, ECO:0000269|PubMed:18997780, ECO:0000269|PubMed:21310966}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000255|HAMAP-Rule:MF_03021, ECO:0000269|PubMed:15891913}. Cytoplasm, cytoskeleton {ECO:0000255|HAMAP-Rule:MF_03021, ECO:0000269|PubMed:15716377, ECO:0000269|PubMed:17389232, ECO:0000269|PubMed:18410514, ECO:0000269|PubMed:19000169, ECO:0000269|PubMed:20200447}. Cytoplasm, perinuclear region {ECO:0000255|HAMAP-Rule:MF_03021, ECO:0000269|PubMed:11809724, ECO:0000269|PubMed:15269182, ECO:0000269|PubMed:15537668}. Nucleus {ECO:0000255|HAMAP-Rule:MF_03021, ECO:0000269|PubMed:15147984, ECO:0000269|PubMed:16026783}. Cytoplasm, cytoskeleton, spindle {ECO:0000255|HAMAP-Rule:MF_03021, ECO:0000269|PubMed:15269182}. Cytoplasm {ECO:0000255|HAMAP-Rule:MF_03021, ECO:0000269|PubMed:16026783, ECO:0000269|PubMed:20200447}. Note=Forms a intramembrane hairpin-like structure in the membrane (PubMed:20200447). Localization to the centrosome is independent of microtubules (PubMed:15891913). Localizes to the midbody of dividing cells, and this requires CHMP1B (PubMed:18997780). Enriched in the distal axons and branches of postmitotic neurons (PubMed:15269182). {ECO:0000255|HAMAP-Rule:MF_03021, ECO:0000269|PubMed:15269182, ECO:0000269|PubMed:15891913, ECO:0000269|PubMed:18997780, ECO:0000305|PubMed:20200447}.; SUBCELLULAR LOCATION: Isoform 1: Endoplasmic reticulum membrane {ECO:0000269|PubMed:19000169, ECO:0000269|PubMed:23969831}; Peripheral membrane protein {ECO:0000305|PubMed:20200447}. Nucleus membrane {ECO:0000269|PubMed:26040712}. Lipid droplet {ECO:0000269|PubMed:25875445}. Cytoplasm, cytoskeleton {ECO:0000269|PubMed:19000169, ECO:0000269|PubMed:20200447}. Endosome {ECO:0000269|PubMed:23897888}. Note=Forms a intramembrane hairpin-like structure in the membrane (PubMed:20200447). Recruited to nuclear membrane by IST1 during late anaphase (PubMed:26040712). Localizes to endoplasmic reticulum tubular network (PubMed:23969831). {ECO:0000269|PubMed:23969831, ECO:0000269|PubMed:26040712, ECO:0000305|PubMed:20200447}.; SUBCELLULAR LOCATION: Isoform 3: Cytoplasm {ECO:0000269|PubMed:20200447, ECO:0000269|PubMed:23969831}. Endosome {ECO:0000269|PubMed:19000169, ECO:0000269|PubMed:23897888}. Nucleus membrane {ECO:0000269|PubMed:16026783, ECO:0000269|PubMed:26040712}. Note=Constitutes the main endosomal form (PubMed:19000169). Recruited to nuclear membrane by IST1 during late anaphase (PubMed:26040712). {ECO:0000269|PubMed:19000169, ECO:0000269|PubMed:26040712}.		MOD_RES 245 245 Phosphoserine. {ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 268 268 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 306 306 Phosphothreonine. {ECO:0000244|PubMed:18669648}.; MOD_RES 597 597 Phosphoserine. {ECO:0000244|PubMed:23186163}.	10610178; 10470851; 15489334; 11809724; 12676568; 15147984; 15269182; 16026783; 15537668; 15716377; 16219033; 15891913; 16826525; 16339213; 16602018; 16815977; 17389232; 18613979; 18410514; 18669648; 19690332; 19000169; 20200447; 20530212; 20068231; 21406692; 21310966; 22637577; 22232211; 23272056; 23745751; 23897888; 23186163; 23969831; 24275569; 26040712; 25875445; 26875866; 18997780; 22446388; 11039577; 10699187; 11015453; 11087788; 11309678; 12460147; 11843700; 12124993; 12161613; 11985387; 12163196; 12202986; 12552568; 12939659; 14732620; 15210521; 15667412; 15248095; 15482961; 15159500; 15326248; 16682546; 16684598; 16959974; 17594340; 20214791; 20932283; 20562464; 20718791; 20550563; 21546041; 22960362; 23279441; 25421405; 25045380; 24824479; 28572275; 10980739; 11704932; 12023066; 12471215; 12490534; 12736085; 12778437; 14506940; 14681884; 15174051; 15739043; 15841487; 15858810; 15939438; 16009903; 16055926; 16240363; 16788734; 16828199; 17035675; 17098887; 17100993; 17345589; 17407089; 17420921; 17560499; 17597328; 17598600; 17690846; 17895902; 17916079; 17957230; 17971434; 18190593; 18202664; 18337300; 18401025; 18664244; 18701882; 19039240; 19084842; 19141076; 19289482; 19423133; 19620182; 19652142; 19730024; 19939411; 20154342; 20430936; 20491894; 20559269; 20665701; 20711500; 20734064; 20857310; 21757506; 21834905; 22192498; 22203332; 22573551; 22574173; 23252998; 23264559; 23400676; 23716148; 23812641; 24033003; 24123785; 24381312; 24478365; 24571573; 24659419; 24731568; 24824741; 25065914; 25390646; 25454648; 25511172; 26094131; 26208798; 26374131; 26600529; 26671083; 26932189; 27084228; 27229699; 27260292; 27334366; 28495799; 28870597; 29368828	10610178; 10470851; 15489334; 11809724; 12676568; 15147984; 15269182; 16026783; 15537668; 15716377; 16219033; 15891913; 16826525; 16339213; 16602018; 16815977; 17389232; 18613979; 18410514; 18669648; 19690332; 19000169; 20200447; 20530212; 20068231; 21406692; 21310966; 22637577; 22232211; 23272056; 23745751; 23897888; 23186163; 23969831; 24275569; 26040712; 25875445; 26875866; 18997780; 22446388; 11039577; 10699187; 11015453; 11087788; 11309678; 12460147; 11843700; 12124993; 12161613; 11985387; 12163196; 12202986; 12552568; 12939659; 14732620; 15210521; 15667412; 15248095; 15482961; 15159500; 15326248; 16682546; 16684598; 16959974; 17594340; 20214791; 20932283; 20562464; 20718791; 20550563; 21546041; 22960362; 23279441; 25421405; 25045380; 24824479; 28572275
14713	SPHK2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=3.4 uM for sphingosine {ECO:0000269|PubMed:10751414}; 	2.7.1.91	CATALYTIC ACTIVITY: ATP + a sphingoid base = ADP + a sphingoid base 1-phosphate. {ECO:0000269|PubMed:10751414}.	BINDING 252 252 ATP. {ECO:0000255|PROSITE-ProRule:PRU00783}.; BINDING 344 344 Substrate. {ECO:0000250}.; BINDING 351 351 ATP. {ECO:0000255|PROSITE-ProRule:PRU00783}.; BINDING 357 357 ATP. {ECO:0000255|PROSITE-ProRule:PRU00783}.	ACTIVITY REGULATION: Inhibited by sulfatide. {ECO:0000269|PubMed:19168031}.	COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250}; 	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 7.5. {ECO:0000269|PubMed:10751414};					blood vessel development [GO:0001568]; brain development [GO:0007420]; cell proliferation [GO:0008283]; female pregnancy [GO:0007565]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell proliferation [GO:0008284]; sphinganine-1-phosphate biosynthetic process [GO:0006669]; sphingolipid biosynthetic process [GO:0030148]; sphingosine biosynthetic process [GO:0046512]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; ATP binding [GO:0005524]; D-erythro-sphingosine kinase activity [GO:0017050]; NAD+ kinase activity [GO:0003951]; Ras GTPase binding [GO:0017016]; sphinganine kinase activity [GO:0008481]; sphingosine-1-phosphate receptor activity [GO:0038036]; blood vessel development [GO:0001568]; brain development [GO:0007420]; cell proliferation [GO:0008283]; female pregnancy [GO:0007565]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell proliferation [GO:0008284]; sphinganine-1-phosphate biosynthetic process [GO:0006669]; sphingolipid biosynthetic process [GO:0030148]; sphingosine biosynthetic process [GO:0046512]	ATP binding [GO:0005524]; D-erythro-sphingosine kinase activity [GO:0017050]; NAD+ kinase activity [GO:0003951]; Ras GTPase binding [GO:0017016]; sphinganine kinase activity [GO:0008481]; sphingosine-1-phosphate receptor activity [GO:0038036]	GO:0001568; GO:0003951; GO:0005524; GO:0005765; GO:0005829; GO:0006669; GO:0007420; GO:0007565; GO:0008283; GO:0008284; GO:0008481; GO:0016020; GO:0017016; GO:0017050; GO:0030148; GO:0038036; GO:0043066; GO:0043231; GO:0046512	SUBCELLULAR LOCATION: Isoform 1: Cytoplasm. Membrane.; SUBCELLULAR LOCATION: Isoform 2: Lysosome membrane.		MOD_RES 387 387 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 393 393 Phosphoserine. {ECO:0000250|UniProtKB:Q9JIA7}.; MOD_RES 399 399 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 477 477 Phosphoserine. {ECO:0000244|PubMed:24275569}.	10751414; 11230166; 14702039; 15057824; 15489334; 17897319; 18669648; 19168031; 23186163; 24275569; 10802064; 10947957; 14596938; 15951439; 16103110; 16316995; 16888242; 17311928; 17635916; 17895250; 18178871; 18263879; 19240026; 19490468; 20197547; 20237496; 20711500; 21307639; 21620961; 23314175; 23359503; 23881266; 23918304; 24140934; 24385109; 24422628; 24486401; 24686171; 24709100; 24903384; 25455157; 25808826; 26209696; 26337959; 26494858; 26628299; 26733171; 26822263; 26886371; 27021309; 27223438; 27517489; 27588496; 28108260; 28465486; 28807595; 28950390; 28975989; 29145490; 29678573; 29991026	10751414; 11230166; 14702039; 15057824; 15489334; 17897319; 18669648; 19168031; 23186163; 24275569
14733	TMEM86B	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=45 uM for lysoplasmenyl-choline {ECO:0000269|PubMed:21515882}; KM=53 uM for lysoplasmenyl-ethanolamine {ECO:0000269|PubMed:21515882}; 	3.3.2.2	CATALYTIC ACTIVITY: 1-(1-alkenyl)-sn-glycero-3-phosphocholine + H(2)O = an aldehyde + sn-glycero-3-phosphocholine. {ECO:0000269|PubMed:21515882}.; CATALYTIC ACTIVITY: 1-(1-alkenyl)-sn-glycero-3-phosphoethanolamine + H(2)O = an aldehyde + sn-glycero-3-phosphoethanolamine. {ECO:0000269|PubMed:21515882}.		ACTIVITY REGULATION: Competitively inhibited by lysophosphatidic acid. {ECO:0000269|PubMed:21515882}.		BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 6.95 and 7.05 with lysoplasmenyl-ethanolamine and lysoplasmenyl-choline as substrates, respectively. {ECO:0000269|PubMed:21515882};					ether lipid metabolic process [GO:0046485]; phosphatidylcholine acyl-chain remodeling [GO:0036151]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alkenylglycerophosphocholine hydrolase activity [GO:0047408]; alkenylglycerophosphoethanolamine hydrolase activity [GO:0047409]; ether hydrolase activity [GO:0016803]; ether lipid metabolic process [GO:0046485]; phosphatidylcholine acyl-chain remodeling [GO:0036151]	alkenylglycerophosphocholine hydrolase activity [GO:0047408]; alkenylglycerophosphoethanolamine hydrolase activity [GO:0047409]; ether hydrolase activity [GO:0016803]	GO:0005737; GO:0005789; GO:0016020; GO:0016021; GO:0016803; GO:0036151; GO:0046485; GO:0047408; GO:0047409	SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}. Cytoplasm {ECO:0000269|PubMed:21515882}.			15057824; 15489334; 21515882; 20064372; 25416956; 26463208	15057824; 15489334; 21515882
14776	SETD7 KIAA1717 KMT7 SET7 SET9	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=29 uM for histone H3 {ECO:0000269|PubMed:16415881}; KM=12 uM for TAF10 {ECO:0000269|PubMed:16415881}; KM=69 uM for p53/TP53 {ECO:0000269|PubMed:16415881}; 	2.1.1.43	CATALYTIC ACTIVITY: S-adenosyl-L-methionine + L-lysine-[histone] = S-adenosyl-L-homocysteine + N(6)-methyl-L-lysine-[histone]. {ECO:0000255|PROSITE-ProRule:PRU00910}.	BINDING 245 245 Substrate.; BINDING 317 317 Substrate.; BINDING 335 335 Substrate; via carbonyl oxygen.; BINDING 356 356 S-adenosyl-L-methionine; via carbonyl oxygen. {ECO:0000255|PROSITE-ProRule:PRU00190, ECO:0000269|PubMed:12514135, ECO:0000269|PubMed:12540855}.								cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; heterochromatin organization [GO:0070828]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K9 methylation [GO:0051570]; response to ethanol [GO:0045471]; transcription, DNA-templated [GO:0006351]	chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; heterochromatin organization [GO:0070828]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K9 methylation [GO:0051570]; response to ethanol [GO:0045471]; transcription, DNA-templated [GO:0006351]	chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]	GO:0002039; GO:0003682; GO:0005654; GO:0005694; GO:0005730; GO:0006325; GO:0006351; GO:0006974; GO:0016279; GO:0018024; GO:0018026; GO:0018027; GO:0045471; GO:0045893; GO:0051570; GO:0070828	SUBCELLULAR LOCATION: Nucleus. Chromosome {ECO:0000305}.			11779497; 11850410; 15815621; 11214970; 15489334; 12588998; 15099517; 16141209; 17108971; 16433545; 21269460; 24275569; 12372304; 12389038; 12540855; 12514135; 15525938; 16415881; 12453418; 12670868; 16682010; 17021013; 17500065; 17573780; 17646389; 17707229; 18471979; 18474616; 18650421; 19262565; 19282482; 19351588; 19752191; 20227666; 20379614; 20675860; 21098664; 21119616; 21131967; 21151116; 21245319; 21273441; 21454678; 21832073; 21896933; 21988832; 22242964; 22345554; 22402663; 22403242; 22406368; 23509280; 23519668; 23873758; 24093804; 24129573; 24875254; 25042802; 25124555; 25136132; 25472959; 25609649; 25637186; 25681344; 25954928; 26116705; 26317544; 26435321; 26638075; 26701885; 26713889; 26779630; 26848522; 26861389; 26890252; 26902152; 27088648; 27132511; 27183310; 27235396; 27292644; 29723250; 29882380	11779497; 11850410; 15815621; 11214970; 15489334; 12588998; 15099517; 16141209; 17108971; 16433545; 21269460; 24275569; 12372304; 12389038; 12540855; 12514135; 15525938; 16415881
14820	SLC47A2 MATE2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.76 mM for TEA {ECO:0000269|PubMed:16807400, ECO:0000269|PubMed:17509534}; KM=0.11 mM for MPP {ECO:0000269|PubMed:16807400, ECO:0000269|PubMed:17509534}; KM=0.12 mM for cimetidine {ECO:0000269|PubMed:16807400, ECO:0000269|PubMed:17509534}; KM=1.98 mM for metformin {ECO:0000269|PubMed:16807400, ECO:0000269|PubMed:17509534}; KM=4.2 mM for guanidine {ECO:0000269|PubMed:16807400, ECO:0000269|PubMed:17509534}; KM=1.58 mM for procainamide {ECO:0000269|PubMed:16807400, ECO:0000269|PubMed:17509534}; KM=0.06 mM for topotecan {ECO:0000269|PubMed:16807400, ECO:0000269|PubMed:17509534}; KM=0.85 mM for estrone sulfate {ECO:0000269|PubMed:16807400, ECO:0000269|PubMed:17509534}; KM=4.32 mM for acyclovir {ECO:0000269|PubMed:16807400, ECO:0000269|PubMed:17509534}; KM=4.28 mM for ganciclovir {ECO:0000269|PubMed:16807400, ECO:0000269|PubMed:17509534}; Vmax=0.88 nmol/min/mg enzyme toward TEA {ECO:0000269|PubMed:16807400, ECO:0000269|PubMed:17509534}; Vmax=0.575 nmol/min/mg enzyme toward MPP {ECO:0000269|PubMed:16807400, ECO:0000269|PubMed:17509534}; Vmax=0.115 nmol/min/mg enzyme toward cimetidine {ECO:0000269|PubMed:16807400, ECO:0000269|PubMed:17509534}; Vmax=0.845 nmol/min/mg enzyme toward metformin {ECO:0000269|PubMed:16807400, ECO:0000269|PubMed:17509534}; Vmax=0.58 nmol/min/mg enzyme toward guanidine {ECO:0000269|PubMed:16807400, ECO:0000269|PubMed:17509534}; Vmax=3.385 nmol/min/mg enzyme toward procainamide {ECO:0000269|PubMed:16807400, ECO:0000269|PubMed:17509534}; Vmax=0.13 nmol/min/mg enzyme toward topotecan {ECO:0000269|PubMed:16807400, ECO:0000269|PubMed:17509534}; Vmax=0.425 nmol/min/mg enzyme toward estrone sulfate {ECO:0000269|PubMed:16807400, ECO:0000269|PubMed:17509534}; Vmax=0.945 nmol/min/mg enzyme toward acyclovir {ECO:0000269|PubMed:16807400, ECO:0000269|PubMed:17509534}; Vmax=0.805 nmol/min/mg enzyme toward ganciclovir {ECO:0000269|PubMed:16807400, ECO:0000269|PubMed:17509534}; 						BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 9.0. Active from pH 6 to 9. {ECO:0000269|PubMed:16807400, ECO:0000269|PubMed:17509534};					drug transmembrane transport [GO:0006855]; transmembrane transport [GO:0055085]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; drug transmembrane transporter activity [GO:0015238]; drug:proton antiporter activity [GO:0015307]; drug transmembrane transport [GO:0006855]; transmembrane transport [GO:0055085]	drug:proton antiporter activity [GO:0015307]; drug transmembrane transporter activity [GO:0015238]	GO:0005886; GO:0006855; GO:0015238; GO:0015307; GO:0016021; GO:0055085	SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}. Note=Localized at the brush border membranes of the proximal tubules.			16807400; 14702039; 17974005; 15489334; 16996621; 17509534; 16330770; 19158817; 20016398; 20047987; 20067714; 20379614; 22558177; 23267855; 23630107; 24985703; 27178732; 27271370; 27821436; 27959931; 28131833	16807400; 14702039; 17974005; 15489334; 16996621; 17509534
14844	SDSL	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=30 mM for serine; KM=7 mM for threonine; 	4.3.1.19; 4.3.1.17	CATALYTIC ACTIVITY: L-serine = pyruvate + NH(3). {ECO:0000269|PubMed:18342636}.; CATALYTIC ACTIVITY: L-threonine = 2-oxobutanoate + NH(3). {ECO:0000269|PubMed:18342636}.			COFACTOR: Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326; 						L-threonine catabolic process to glycine [GO:0019518]	cytosol [GO:0005829]	cytosol [GO:0005829]; hydro-lyase activity [GO:0016836]; identical protein binding [GO:0042802]; L-serine ammonia-lyase activity [GO:0003941]; L-threonine ammonia-lyase activity [GO:0004794]; pyridoxal phosphate binding [GO:0030170]; L-threonine catabolic process to glycine [GO:0019518]	hydro-lyase activity [GO:0016836]; identical protein binding [GO:0042802]; L-serine ammonia-lyase activity [GO:0003941]; L-threonine ammonia-lyase activity [GO:0004794]; pyridoxal phosphate binding [GO:0030170]	GO:0003941; GO:0004794; GO:0005829; GO:0016836; GO:0019518; GO:0030170; GO:0042802			MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:22223895}.; MOD_RES 48 48 N6-(pyridoxal phosphate)lysine.	15489334; 21269460; 22223895; 24275569; 18342636; 16189514; 19060904; 20877624; 25416956	15489334; 21269460; 22223895; 24275569; 18342636
14851	SENP8 DEN1 NEDP1 PRSC2 FKSG8	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=51 nM for Nedd8-AMC {ECO:0000269|PubMed:12759362}; Note=KM for Ub-AMC exceeds 5 uM.;	3.4.22.-								FKSG8		post-translational protein modification [GO:0043687]; protein desumoylation [GO:0016926]; protein deubiquitination [GO:0016579]	cytosol [GO:0005829]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleus [GO:0005634]; endopeptidase activity [GO:0004175]; NEDD8-specific protease activity [GO:0019784]; post-translational protein modification [GO:0043687]; protein desumoylation [GO:0016926]; protein deubiquitination [GO:0016579]	endopeptidase activity [GO:0004175]; NEDD8-specific protease activity [GO:0019784]	GO:0004175; GO:0005634; GO:0005829; GO:0016579; GO:0016926; GO:0019784; GO:0043687			MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22223895}.	12730221; 15489334; 12759363; 12759362; 15242646; 19413330; 22223895; 15775960; 15567417; 18274552; 19784069; 22110750; 23001041; 23209320; 23408908; 25655932; 26403403; 28475037; 9790970	12730221; 15489334; 12759363; 12759362; 15242646; 19413330; 22223895; 15775960; 15567417
14855	PHGDH PGDH3	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=21.6 uM for 3-phosphonooxypyruvate {ECO:0000269|PubMed:19235232}; KM=0.26 mM for 3-phosphoglycerate {ECO:0000269|PubMed:25406093}; KM=6.5 mM for oxaloacetate {ECO:0000269|PubMed:25406093}; KM=10.1 mM for 2-oxoglutarate {ECO:0000269|PubMed:25406093}; KM=22 uM for NAD(+) {ECO:0000269|PubMed:25406093}; KM=4 uM for NADH {ECO:0000269|PubMed:25406093}; Vmax=35 nmol/min/mg enzyme with 3-phosphohydroxypyruvate as substrate (in patient-derived fibroblasts) {ECO:0000269|PubMed:19235232}; Vmax=168 nmol/min/mg enzyme with 3-phosphohydroxypyruvate as substrate (in 3-PGDH overexpressed cells) {ECO:0000269|PubMed:19235232}; Note=kcat is 4.5 min(-1) for 3-phosphoglycerate oxidation. kcat is 10.6 min(-1) for oxaloacetate reduction. kcat is 4.7 min(-1) for 2-oxoglutarate reduction. {ECO:0000269|PubMed:25406093};	1.1.1.95; 1.1.1.399; 1.1.1.37	CATALYTIC ACTIVITY: 3-phospho-D-glycerate + NAD(+) = 3-phosphonooxypyruvate + NADH. {ECO:0000269|PubMed:11751922}.; CATALYTIC ACTIVITY: (R)-2-hydroxyglutarate + NAD(+) = 2-oxoglutarate + NADH. {ECO:0000269|PubMed:25406093}.; CATALYTIC ACTIVITY: (S)-malate + NAD(+) = oxaloacetate + NADH. {ECO:0000269|PubMed:25406093}.	BINDING 78 78 NAD. {ECO:0000269|Ref.20}.; BINDING 175 175 NAD. {ECO:0000269|Ref.20}.; BINDING 207 207 NAD; via carbonyl oxygen. {ECO:0000269|Ref.20}.; BINDING 260 260 NAD. {ECO:0000269|Ref.20}.				PATHWAY: Amino-acid biosynthesis; L-serine biosynthesis; L-serine from 3-phospho-D-glycerate: step 1/3.				brain development [GO:0007420]; G1 to G0 transition [GO:0070314]; gamma-aminobutyric acid metabolic process [GO:0009448]; glial cell development [GO:0021782]; glutamine metabolic process [GO:0006541]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; neural tube development [GO:0021915]; neuron projection development [GO:0031175]; regulation of gene expression [GO:0010468]; spinal cord development [GO:0021510]; taurine metabolic process [GO:0019530]; threonine metabolic process [GO:0006566]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; myelin sheath [GO:0043209]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; myelin sheath [GO:0043209]; electron transfer activity [GO:0009055]; L-malate dehydrogenase activity [GO:0030060]; NAD binding [GO:0051287]; phosphoglycerate dehydrogenase activity [GO:0004617]; brain development [GO:0007420]; G1 to G0 transition [GO:0070314]; gamma-aminobutyric acid metabolic process [GO:0009448]; glial cell development [GO:0021782]; glutamine metabolic process [GO:0006541]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; neural tube development [GO:0021915]; neuron projection development [GO:0031175]; regulation of gene expression [GO:0010468]; spinal cord development [GO:0021510]; taurine metabolic process [GO:0019530]; threonine metabolic process [GO:0006566]	electron transfer activity [GO:0009055]; L-malate dehydrogenase activity [GO:0030060]; NAD binding [GO:0051287]; phosphoglycerate dehydrogenase activity [GO:0004617]	GO:0004617; GO:0005829; GO:0006541; GO:0006544; GO:0006564; GO:0006566; GO:0007420; GO:0009055; GO:0009448; GO:0010468; GO:0019530; GO:0021510; GO:0021782; GO:0021915; GO:0030060; GO:0031175; GO:0043209; GO:0051287; GO:0070062; GO:0070314			MOD_RES 2 2 N-acetylalanine. {ECO:0000269|Ref.8}.; MOD_RES 14 14 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 21 21 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q61753}.; MOD_RES 58 58 N6-acetyllysine. {ECO:0000250|UniProtKB:Q61753}.; MOD_RES 78 78 Phosphothreonine. {ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.	10713460; 11055895; 14702039; 16710414; 15489334; 11751922; 16949628; 18378410; 18669648; 21269460; 23186163; 24275569; 25114211; 25406093; 25944712; 19235232; 24836451; 12577067; 14743216; 16730941; 18627175; 19135240; 19223009; 19367725; 19388702; 19404161; 19463016; 19497206; 19637314; 19738201; 19778996; 19805454; 20360068; 20391533; 20467437; 20562859; 21760589; 21804546; 21900206; 21911578; 21981974; 21988832; 22360420; 22593156; 22623428; 23374352; 23386615; 23414517; 23606334; 24247658; 25015719; 25036637; 25152457; 25404730; 25604459; 25609649; 26026368; 26439504; 26496610; 26752685; 27836973; 28135894; 28614715; 28698143; 28951458; 29262655; 29568346	10713460; 11055895; 14702039; 16710414; 15489334; 11751922; 16949628; 18378410; 18669648; 21269460; 23186163; 24275569; 25114211; 25406093; 25944712; 19235232; 24836451
14866	PSAT1 PSA	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=5 uM for phosphoserine {ECO:0000269|PubMed:17436247}; Vmax=1.35 umol/min/mg enzyme {ECO:0000269|PubMed:17436247}; 	2.6.1.52	CATALYTIC ACTIVITY: O-phospho-L-serine + 2-oxoglutarate = 3-phosphonooxypyruvate + L-glutamate.; CATALYTIC ACTIVITY: 4-phosphonooxy-L-threonine + 2-oxoglutarate = (3R)-3-hydroxy-2-oxo-4-phosphonooxybutanoate + L-glutamate.	BINDING 45 45 L-glutamate. {ECO:0000250}.; BINDING 107 107 Pyridoxal phosphate. {ECO:0000250}.; BINDING 156 156 Pyridoxal phosphate. {ECO:0000250}.; BINDING 176 176 Pyridoxal phosphate. {ECO:0000250}.; BINDING 199 199 Pyridoxal phosphate. {ECO:0000250}.		COFACTOR: Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326; Evidence={ECO:0000250}; ;  Note=Binds 1 pyridoxal phosphate per subunit. {ECO:0000250};		PATHWAY: Amino-acid biosynthesis; L-serine biosynthesis; L-serine from 3-phospho-D-glycerate: step 2/3.; PATHWAY: Cofactor biosynthesis; pyridoxine 5'-phosphate biosynthesis; pyridoxine 5'-phosphate from D-erythrose 4-phosphate: step 3/5.				L-serine biosynthetic process [GO:0006564]; pyridoxine biosynthetic process [GO:0008615]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO:0004648]; L-serine biosynthetic process [GO:0006564]; pyridoxine biosynthetic process [GO:0008615]	O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO:0004648]	GO:0004648; GO:0005737; GO:0005829; GO:0006564; GO:0008615; GO:0070062			MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:19413330}.; MOD_RES 51 51 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 127 127 N6-acetyllysine. {ECO:0000250|UniProtKB:Q99K85}.; MOD_RES 200 200 N6-(pyridoxal phosphate)lysine. {ECO:0000250}.; MOD_RES 269 269 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 318 318 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 323 323 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 331 331 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 333 333 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.	12633500; 15164053; 15489334; 17436247; 19413330; 19608861; 21269460; 23186163; 25152457; 16263121; 17353931; 18221502; 20955740; 21900206; 21988832; 22360420; 25142862; 26439504; 27372650; 29216929	12633500; 15164053; 15489334; 17436247; 19413330; 19608861; 21269460; 23186163; 25152457
14904	SPHK1 SPHK SPK	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=14 uM for sphingosine {ECO:0000269|PubMed:10947957}; KM=20 uM for dihydrosphingosine {ECO:0000269|PubMed:10947957}; KM=77 uM for ATP {ECO:0000269|PubMed:10947957}; 	2.7.1.91	CATALYTIC ACTIVITY: ATP + a sphingoid base = ADP + a sphingoid base 1-phosphate. {ECO:0000269|PubMed:10802064, ECO:0000269|PubMed:20577214, ECO:0000269|PubMed:23602659}.	BINDING 86 86 ATP.; BINDING 178 178 Substrate.; BINDING 185 185 ATP.; BINDING 191 191 ATP.		COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:10947957}; 	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 7.4. {ECO:0000269|PubMed:10947957};					blood vessel development [GO:0001568]; brain development [GO:0007420]; calcium-mediated signaling [GO:0019722]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of smooth muscle contraction [GO:0045987]; protein folding [GO:0006457]; regulation of interleukin-1 beta production [GO:0032651]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; signal transduction [GO:0007165]; sphingoid catabolic process [GO:0046521]; sphingolipid biosynthetic process [GO:0030148]; sphingosine biosynthetic process [GO:0046512]; sphingosine metabolic process [GO:0006670]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; D-erythro-sphingosine kinase activity [GO:0017050]; DNA binding [GO:0003677]; magnesium ion binding [GO:0000287]; NAD+ kinase activity [GO:0003951]; protein phosphatase 2A binding [GO:0051721]; sphinganine kinase activity [GO:0008481]; sphingosine-1-phosphate receptor activity [GO:0038036]; blood vessel development [GO:0001568]; brain development [GO:0007420]; calcium-mediated signaling [GO:0019722]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of smooth muscle contraction [GO:0045987]; protein folding [GO:0006457]; regulation of interleukin-1 beta production [GO:0032651]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; signal transduction [GO:0007165]; sphingoid catabolic process [GO:0046521]; sphingolipid biosynthetic process [GO:0030148]; sphingosine biosynthetic process [GO:0046512]; sphingosine metabolic process [GO:0006670]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; D-erythro-sphingosine kinase activity [GO:0017050]; DNA binding [GO:0003677]; magnesium ion binding [GO:0000287]; NAD+ kinase activity [GO:0003951]; protein phosphatase 2A binding [GO:0051721]; sphinganine kinase activity [GO:0008481]; sphingosine-1-phosphate receptor activity [GO:0038036]	GO:0000287; GO:0001568; GO:0003677; GO:0003951; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006457; GO:0006670; GO:0006954; GO:0007165; GO:0007420; GO:0008481; GO:0010800; GO:0010803; GO:0017050; GO:0019722; GO:0030148; GO:0030307; GO:0030335; GO:0031398; GO:0032651; GO:0035556; GO:0038036; GO:0043066; GO:0045766; GO:0045931; GO:0045987; GO:0046512; GO:0046521; GO:0048146; GO:0051092; GO:0051721; GO:1901224	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:14575709, ECO:0000269|PubMed:19854831}. Nucleus {ECO:0000269|PubMed:14575709, ECO:0000269|PubMed:19854831}. Cell membrane {ECO:0000269|PubMed:19854831}. Note=Translocated from the cytoplasm to the plasma membrane in a CIB1-dependent manner. {ECO:0000269|PubMed:19854831}.		MOD_RES 193 193 Phosphothreonine. {ECO:0000244|PubMed:18669648}.; MOD_RES 225 225 Phosphoserine. {ECO:0000269|PubMed:20577214}.	10863092; 10802064; 10947957; 14702039; 16625196; 15489334; 12080051; 14575709; 18669648; 19854831; 20577214; 23602659; 10751414; 11777919; 11915350; 12124383; 12391145; 12393916; 12444147; 12776187; 12847068; 14532121; 14742298; 14988393; 15052627; 15191888; 15265705; 15302883; 15585953; 15623571; 15632208; 15693752; 15710602; 15749892; 15855330; 16038795; 16194537; 16243846; 16316995; 16507765; 16516161; 16522638; 16571380; 16623665; 16888242; 17064696; 17114809; 17124500; 17388800; 17482291; 17519232; 17599053; 17641298; 17822721; 18058224; 18178871; 18192241; 18199826; 18261991; 18263879; 18362204; 18401414; 18426913; 18644866; 18718048; 18775504; 18824518; 18849324; 18852266; 18922940; 18980995; 19017993; 19074142; 19116345; 19162217; 19238330; 19240026; 19633297; 19657322; 19706837; 19729605; 19782042; 19815712; 19830907; 19914200; 19956567; 20053797; 20104488; 20237496; 20386061; 20404323; 20519401; 20606403; 20634980; 20661259; 20838377; 20846391; 20889557; 20926375; 21075134; 21075214; 21209394; 21304987; 21392092; 21418911; 21464128; 21575515; 21625639; 21672077; 21696364; 21756066; 21769916; 21936950; 21940753; 21988832; 22016563; 22155656; 22315056; 22322056; 22322303; 22331716; 22422617; 22450659; 22460268; 22684547; 22733311; 22781898; 22833671; 22961081; 23166225; 23232649; 23314175; 23359503; 23426175; 23462226; 23466305; 23576579; 23651497; 23658376; 23845219; 23861887; 23893239; 23928990; 23939980; 23955546; 24092575; 24137500; 24276247; 24337110; 24422628; 24452756; 24464131; 24468113; 24473437; 24503067; 24816639; 24903384; 25109605; 25176316; 25260803; 25310737; 25319495; 25404266; 25411162; 25481644; 25516793; 25587035; 25671829; 25778867; 25786072; 25805832; 25892494; 26045781; 26071354; 26073327; 26264277; 26311741; 26376826; 26493335; 26540633; 26549227; 26590717; 26662312; 26673009; 26716409; 26842184; 26855418; 26886371; 26912347; 26937138; 27021309; 27065335; 27099350; 27160553; 27467777; 27562371; 27621003; 27697999; 27801960; 27811358; 27811359; 27821815; 27942860; 27956387; 28049734; 28108260; 28178265; 28258651; 28351953; 28364399; 28405684; 28521610; 28583134; 28729416; 28733250; 28778177; 28789830; 28982849; 29491060; 29605826	10863092; 10802064; 10947957; 14702039; 16625196; 15489334; 12080051; 14575709; 18669648; 19854831; 20577214; 23602659
14956	FAP	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.46 mM for Ala-Pro (Dipeptidyl peptidase activity) {ECO:0000269|PubMed:10593948}; KM=0.9 mM for Lys-Pro (Dipeptidyl peptidase activity) {ECO:0000269|PubMed:10593948}; KM=1.15 mM for Gly-Pro (Dipeptidyl peptidase activity) {ECO:0000269|PubMed:10593948}; KM=0.25 mM for Gly-Pro (Dipeptidyl peptidase activity) {ECO:0000269|PubMed:17381073}; KM=0.24 mM for Ala-Pro (Dipeptidyl peptidase activity) {ECO:0000269|PubMed:16410248}; KM=0.10 mM for Ile-Pro (Dipeptidyl peptidase activity) {ECO:0000269|PubMed:16410248}; KM=0.24 mM for Phe-Pro (Dipeptidyl peptidase activity) {ECO:0000269|PubMed:16410248}; KM=0.24 mM for Gly-Pro (Dipeptidyl peptidase activity) {ECO:0000269|PubMed:16410248}; KM=0.33 mM for Ac-Gly-Pro (Prolyl endopeptidase activity) {ECO:0000269|PubMed:16410248, ECO:0000269|PubMed:17381073}; KM=1.3 uM for Thr-Ser-Gly-Pro-Asn-Gln (Prolyl endopeptidase activity) {ECO:0000269|PubMed:16480718}; KM=2.2 uM for Ala-Ser-Gly-Pro-Asn-Gln (Prolyl endopeptidase activity) {ECO:0000269|PubMed:16480718}; KM=0.7 uM for Thr-Ala-Gly-Pro-Asn-Gln (Prolyl endopeptidase activity) {ECO:0000269|PubMed:16480718}; KM=1.9 uM for Thr-Ser-Gly-Pro-Ser-Gln (Prolyl endopeptidase activity) {ECO:0000269|PubMed:16480718}; KM=2.2 uM for Thr-Ser-Gly-Pro-Asn-Ser (Prolyl endopeptidase activity) {ECO:0000269|PubMed:16480718}; KM=4.3 uM for Ala-Ser-Gly-Pro-Ser-Ser (Prolyl endopeptidase activity) {ECO:0000269|PubMed:16480718}; KM=0.101 mM for Gly-Pro (FAP form, prolyl endopeptidase activity) {ECO:0000269|PubMed:16223769}; KM=0.124 mM for Gly-Pro (Antiplasmin-cleaving enzyme FAP soluble form, prolyl endopeptidase activity) {ECO:0000269|PubMed:16223769}; KM=0.323 mM for Gly-Pro (FAP form, dipeptidyl peptidase activity) {ECO:0000269|PubMed:16223769}; KM=0.272 mM for Gly-Pro (Antiplasmin-cleaving enzyme FAP soluble form, dipeptidyl peptidase activity) {ECO:0000269|PubMed:16223769}; KM=0.029 mM for Arg-Gly-Thr-Ser-Gly-Pro-Asn-Gln-Glu-Gln-Glu (FAP form, prolyl endopeptidase activity) {ECO:0000269|PubMed:16223769}; KM=0.026 mM for Arg-Gly-Thr-Ser-Gly-Pro-Asn-Gln-Glu-Gln-Glu (Antiplasmin-cleaving enzyme FAP soluble form, prolyl endopeptidase activity) {ECO:0000269|PubMed:16223769}; 	3.4.21.26; 3.4.14.5; 3.4.21.-; 3.4.14.5; 3.4.21.-; 3.4.21.26	CATALYTIC ACTIVITY: Hydrolysis of Pro-|-Xaa >> Ala-|-Xaa in oligopeptides. {ECO:0000269|PubMed:14751930, ECO:0000269|PubMed:16223769, ECO:0000269|PubMed:16410248, ECO:0000269|PubMed:17381073, ECO:0000269|PubMed:18095711, ECO:0000269|PubMed:21288888, ECO:0000269|PubMed:24371721}.; CATALYTIC ACTIVITY: Release of an N-terminal dipeptide, Xaa-Yaa-|-Zaa-, from a polypeptide, preferentially when Yaa is Pro, provided Zaa is neither Pro nor hydroxyproline. {ECO:0000255|PROSITE-ProRule:PRU10084, ECO:0000269|PubMed:10347120, ECO:0000269|PubMed:10593948, ECO:0000269|PubMed:16175601, ECO:0000269|PubMed:16223769, ECO:0000269|PubMed:16410248, ECO:0000269|PubMed:16651416, ECO:0000269|PubMed:17381073, ECO:0000269|PubMed:21314817, ECO:0000269|PubMed:24371721, ECO:0000269|PubMed:24717288}.	BINDING 203 203 Substrate. {ECO:0000303|PubMed:15809306}.; BINDING 204 204 Substrate. {ECO:0000303|PubMed:15809306}.	ACTIVITY REGULATION: Gelatinase activity is inhibited by serine-protease inhibitors, such as phenylmethylsulfonyl fluoride (PMSF), 4-(2-aminoethyl)-benzenesulfonyl fluoride hydrochloride (AEBSF), 4-amidino phenylsulfonyl fluoride (APSF) and diisopropyl fluorophosphate (DFP), N-ethylmaleimide (NEM) and phenylmethylsulfonyl fluoride (PMSF). Dipeptidyl peptidase activity is inhibited by 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid), diisopropylfluorophosphate (DFP). Prolyl endopeptidase activity is inhibited by the boronic acid peptide Ac-Gly-BoroPro, Ac-Gly-Pro-chloromethyl ketone and Thr-Ser-Gly-chloromethyl ketone. {ECO:0000269|PubMed:10593948, ECO:0000269|PubMed:16410248, ECO:0000269|PubMed:16480718, ECO:0000269|PubMed:17381073, ECO:0000269|PubMed:2172980, ECO:0000269|PubMed:9065413}.		BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 6-8.4 for gelatinase activity. At pH lower than 5 inhibited gelatinase activity. {ECO:0000269|PubMed:2172980, ECO:0000269|PubMed:9065413};		SITE 23 24 Cleavage. {ECO:0000303|PubMed:14751930}.		BIOPHYSICOCHEMICAL PROPERTIES: ;  Temperature dependence: Optimum temperature is 37 degrees Celsius for gelatinase activity. Temperatures above 50 degrees Celsius inhibit gelatinase activity. {ECO:0000269|PubMed:2172980, ECO:0000269|PubMed:9065413};	angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; endothelial cell migration [GO:0043542]; melanocyte apoptotic process [GO:1902362]; melanocyte proliferation [GO:0097325]; mitotic cell cycle arrest [GO:0071850]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of extracellular matrix disassembly [GO:0010716]; negative regulation of extracellular matrix organization [GO:1903054]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of execution phase of apoptosis [GO:1900119]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of collagen catabolic process [GO:0010710]; regulation of fibrinolysis [GO:0051917]	apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; invadopodium membrane [GO:0071438]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]	apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; invadopodium membrane [GO:0071438]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; dipeptidyl-peptidase activity [GO:0008239]; endopeptidase activity [GO:0004175]; integrin binding [GO:0005178]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; endothelial cell migration [GO:0043542]; melanocyte apoptotic process [GO:1902362]; melanocyte proliferation [GO:0097325]; mitotic cell cycle arrest [GO:0071850]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of extracellular matrix disassembly [GO:0010716]; negative regulation of extracellular matrix organization [GO:1903054]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of execution phase of apoptosis [GO:1900119]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of collagen catabolic process [GO:0010710]; regulation of fibrinolysis [GO:0051917]	dipeptidyl-peptidase activity [GO:0008239]; endopeptidase activity [GO:0004175]; integrin binding [GO:0005178]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0001525; GO:0002020; GO:0004175; GO:0004222; GO:0004252; GO:0005178; GO:0005615; GO:0005737; GO:0005886; GO:0005925; GO:0006508; GO:0007155; GO:0008233; GO:0008236; GO:0008239; GO:0009986; GO:0010710; GO:0010716; GO:0016021; GO:0030027; GO:0031258; GO:0032587; GO:0042803; GO:0043542; GO:0045177; GO:0045178; GO:0046983; GO:0051603; GO:0051917; GO:0060244; GO:0071158; GO:0071438; GO:0071850; GO:0097325; GO:1900119; GO:1902362; GO:1903054	SUBCELLULAR LOCATION: Prolyl endopeptidase FAP: Cell surface {ECO:0000269|PubMed:10593948, ECO:0000269|PubMed:16175601, ECO:0000269|PubMed:17105646, ECO:0000269|PubMed:24717288, ECO:0000269|PubMed:7911242}. Cell membrane {ECO:0000269|PubMed:12376466, ECO:0000269|PubMed:16651416, ECO:0000269|PubMed:9065413, ECO:0000303|PubMed:10455171}; Single-pass type II membrane protein {ECO:0000255}. Cell projection, lamellipodium membrane {ECO:0000269|PubMed:16651416, ECO:0000269|PubMed:9065413}; Single-pass type II membrane protein {ECO:0000255}. Cell projection, invadopodium membrane {ECO:0000269|PubMed:12376466, ECO:0000269|PubMed:16651416, ECO:0000269|PubMed:7923219, ECO:0000269|PubMed:9065413, ECO:0000303|PubMed:10455171}; Single-pass type II membrane protein {ECO:0000255}. Cell projection, ruffle membrane {ECO:0000303|PubMed:10455171}; Single-pass type II membrane protein {ECO:0000255}. Membrane {ECO:0000269|PubMed:2172980}; Single-pass type II membrane protein {ECO:0000255}. Note=Localized on cell surface with lamellipodia and invadopodia membranes and on shed vesicles. Colocalized with DPP4 at invadopodia and lamellipodia membranes of migratory activated endothelial cells in collagenous matrix. Colocalized with DPP4 on endothelial cells of capillary-like microvessels but not large vessels within invasive breast ductal carcinoma. Anchored and enriched preferentially by integrin alpha-3/beta-1 at invadopodia, plasma membrane protrusions that correspond to sites of cell invasion, in a collagen-dependent manner. Localized at plasma and ruffle membranes in a collagen-independent manner. Colocalized with PLAUR preferentially at the cell surface of invadopodia membranes in a cytoskeleton-, integrin- and vitronectin-dependent manner. Concentrated at invadopodia membranes, specialized protrusions of the ventral plasma membrane in a fibrobectin-dependent manner. Colocalizes with extracellular components (ECM), such as collagen fibers and fibronectin. {ECO:0000269|PubMed:10593948, ECO:0000269|PubMed:12376466, ECO:0000269|PubMed:16175601, ECO:0000269|PubMed:16651416, ECO:0000269|PubMed:17105646, ECO:0000269|PubMed:2172980, ECO:0000269|PubMed:24717288, ECO:0000269|PubMed:7911242, ECO:0000269|PubMed:7923219, ECO:0000269|PubMed:9065413, ECO:0000303|PubMed:10455171}.; SUBCELLULAR LOCATION: Antiplasmin-cleaving enzyme FAP, soluble form: Secreted {ECO:0000269|PubMed:14751930, ECO:0000269|PubMed:16223769, ECO:0000269|PubMed:24371721}. Note=Found in blood plasma and serum. {ECO:0000269|PubMed:14751930, ECO:0000269|PubMed:16223769, ECO:0000269|PubMed:24371721}.; SUBCELLULAR LOCATION: Isoform 2: Cytoplasm {ECO:0000303|PubMed:10644713}.	PTM: N-glycosylated. {ECO:0000269|PubMed:15809306, ECO:0000269|PubMed:16335952, ECO:0000269|PubMed:7911242, ECO:0000269|PubMed:9065413}.; PTM: The N-terminus may be blocked.		7911242; 9247085; 9065413; 10644713; 15815621; 15489334; 14751930; 7519584; 2172980; 7923219; 10347120; 10593948; 10455171; 12376466; 16175601; 16335952; 17105646; 16223769; 16651416; 16480718; 16410248; 17381073; 18095711; 18262497; 20707604; 21314817; 21288888; 24371721; 24717288; 15809306; 12023964; 12675244; 12926053; 12963128; 14524536; 14707457; 15767544; 16061874; 16196122; 16507127; 16700525; 18071670; 18570153; 18665076; 18823010; 19747910; 20043068; 20155839; 20379614; 20711172; 20806341; 20872224; 21491083; 21526345; 21656680; 21668992; 22067528; 22323494; 22371645; 22435331; 22608558; 22614695; 22674411; 22734237; 22750443; 22911669; 23328994; 23778090; 23813624; 23835897; 23932048; 24402778; 24422232; 24470260; 24551161; 24595644; 24722280; 24727589; 24789592; 24885257; 25126747; 25361590; 25464232; 25600705; 25744843; 25775399; 25816202; 25995078; 26209915; 26304112; 26319660; 26342814; 26454160; 26621486; 26635356; 26715280; 26797127; 26934296; 26962859; 27020681; 27063470; 27118870; 27155568; 27492457; 27817025; 27881889; 27983931; 28005267; 28033421; 28415791; 28452380; 28570749; 28582421; 29025374; 29026005; 29115573	7911242; 9247085; 9065413; 10644713; 15815621; 15489334; 14751930; 7519584; 2172980; 7923219; 10347120; 10593948; 10455171; 12376466; 16175601; 16335952; 17105646; 16223769; 16651416; 16480718; 16410248; 17381073; 18095711; 18262497; 20707604; 21314817; 21288888; 24371721; 24717288; 15809306
14977	SIRT4 SIR2L4	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=719 uM for a peptide of H3 biotinylated at 'Lys-9' {ECO:0000269|PubMed:25525879}; KM=814 uM for a peptide of H3 lipoylated at 'Lys-9' {ECO:0000269|PubMed:25525879}; KM=239 uM for a peptide of DLAT lipoylated at 'Lys-259' {ECO:0000269|PubMed:25525879}; Note=kcat is 0.0019 sec(-1) for the delipoylation of H3 'Lys-9'. kcat is 0.0005 sec(-1) for the debiotinylation of H3 'Lys-9'. kcat is 0.0018 sec(-1) for the delipoylation of DLAT 'Lys-259'. {ECO:0000269|PubMed:25525879};	3.5.1.-; 2.4.2.-	CATALYTIC ACTIVITY: NAD(+) + a protein = nicotinamide + an N-(ADP-D-ribosyl)-protein. {ECO:0000255|HAMAP-Rule:MF_03161}.; CATALYTIC ACTIVITY: NAD(+) + an acetylprotein = nicotinamide + O-acetyl-ADP-ribose + a protein. {ECO:0000255|HAMAP-Rule:MF_03161}.	BINDING 304 304 NAD; via amide nitrogen. {ECO:0000255|HAMAP-Rule:MF_03161}.		COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000255|HAMAP-Rule:MF_03161}; ;  Note=Binds 1 zinc ion per subunit. {ECO:0000255|HAMAP-Rule:MF_03161};						cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; chromatin silencing [GO:0006342]; glutamine metabolic process [GO:0006541]; mitochondrion organization [GO:0007005]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of fatty acid oxidation [GO:0046322]; negative regulation of insulin secretion [GO:0046676]; negative regulation of protein processing involved in protein targeting to mitochondrion [GO:1903217]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of lipid biosynthetic process [GO:0046889]; protein ADP-ribosylation [GO:0006471]; regulation of glutamine family amino acid metabolic process [GO:0000820]; regulation of pyruvate dehydrogenase activity [GO:1904182]; tricarboxylic acid metabolic process [GO:0072350]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; biotinidase activity [GO:0047708]; lipoamidase activity [GO:0061690]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; chromatin silencing [GO:0006342]; glutamine metabolic process [GO:0006541]; mitochondrion organization [GO:0007005]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of fatty acid oxidation [GO:0046322]; negative regulation of insulin secretion [GO:0046676]; negative regulation of protein processing involved in protein targeting to mitochondrion [GO:1903217]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of lipid biosynthetic process [GO:0046889]; protein ADP-ribosylation [GO:0006471]; regulation of glutamine family amino acid metabolic process [GO:0000820]; regulation of pyruvate dehydrogenase activity [GO:1904182]; tricarboxylic acid metabolic process [GO:0072350]	biotinidase activity [GO:0047708]; lipoamidase activity [GO:0061690]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; zinc ion binding [GO:0008270]	GO:0000820; GO:0003950; GO:0005739; GO:0005743; GO:0005759; GO:0006342; GO:0006471; GO:0006541; GO:0006974; GO:0007005; GO:0008270; GO:0010667; GO:0034983; GO:0046322; GO:0046676; GO:0046889; GO:0047708; GO:0061690; GO:0070403; GO:0071456; GO:0072350; GO:1903217; GO:1904182	SUBCELLULAR LOCATION: Mitochondrion matrix {ECO:0000255|HAMAP-Rule:MF_03161, ECO:0000269|PubMed:16079181, ECO:0000269|PubMed:16959573, ECO:0000269|PubMed:17715127}.			10381378; 16541075; 15489334; 16959573; 17715127; 16079181; 23562301; 23663782; 23438705; 24043310; 25525879; 19209188; 21556116; 22770219; 24296486; 24368766; 25045415; 25165814; 25331589; 25361925; 25466907; 25633289; 26054687; 26086877; 26701732; 26775843; 26959556; 26986234; 27164052; 27651178; 27941873; 28820880; 29081403; 29571013	10381378; 16541075; 15489334; 16959573; 17715127; 16079181; 23562301; 23663782; 23438705; 24043310; 25525879
14987	POMK SGK196	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=4.1 uM for ATP {ECO:0000269|PubMed:23929950}; 	2.7.1.183	CATALYTIC ACTIVITY: ATP + O(3)-(N-acetyl-beta-D-galactosaminyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->4)-alpha-D-mannosyl)-L-threonyl/L-seryl-[protein] = ADP + O(3)-(N-acetyl-beta-D-galactosaminyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->4)-alpha-D-(6-phospho)mannosyl)-L-threonyl/L-seryl-[protein]. {ECO:0000269|PubMed:23929950}.									brain development [GO:0007420]; carbohydrate phosphorylation [GO:0046835]; learning or memory [GO:0007611]; neuromuscular process [GO:0050905]; neuron migration [GO:0001764]; protein O-linked glycosylation [GO:0006493]; sensory perception of pain [GO:0019233]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; carbohydrate kinase activity [GO:0019200]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; protein kinase activity [GO:0004672]; brain development [GO:0007420]; carbohydrate phosphorylation [GO:0046835]; learning or memory [GO:0007611]; neuromuscular process [GO:0050905]; neuron migration [GO:0001764]; protein O-linked glycosylation [GO:0006493]; sensory perception of pain [GO:0019233]	ATP binding [GO:0005524]; carbohydrate kinase activity [GO:0019200]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; protein kinase activity [GO:0004672]	GO:0001764; GO:0004672; GO:0005524; GO:0005789; GO:0006493; GO:0007420; GO:0007611; GO:0016021; GO:0016773; GO:0019200; GO:0019233; GO:0046835; GO:0050905	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000305}; Single-pass type II membrane protein {ECO:0000305}.		MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:22814378}.	14702039; 16421571; 15489334; 12471243; 22814378; 17344846; 23929950; 24556084; 24925318; 23519211; 26638075	14702039; 16421571; 15489334; 12471243; 22814378; 17344846; 23929950; 24556084; 24925318; 23519211
15008	ACAT1 ACAT MAT	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=4 uM for acetoacetyl coenzyme A {ECO:0000269|PubMed:17371050}; KM=20 uM for coenzyme A {ECO:0000269|PubMed:17371050}; KM=8 uM for 2-methylacetoacetyl coenzyme A {ECO:0000269|PubMed:17371050}; KM=508 uM for acetyl coenzyme A {ECO:0000269|PubMed:17371050}; 	2.3.1.9	CATALYTIC ACTIVITY: 2 acetyl-CoA = CoA + acetoacetyl-CoA. {ECO:0000255|PROSITE-ProRule:PRU10020, ECO:0000269|PubMed:17371050}.	BINDING 219 219 Coenzyme A. {ECO:0000269|PubMed:17371050}.; BINDING 263 263 Coenzyme A. {ECO:0000269|PubMed:17371050}.; BINDING 284 284 Coenzyme A. {ECO:0000269|PubMed:17371050}.	ACTIVITY REGULATION: Activated by potassium ions, but not sodium ions. {ECO:0000269|PubMed:17371050}.							acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA catabolic process [GO:0046356]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; branched-chain amino acid catabolic process [GO:0009083]; coenzyme A biosynthetic process [GO:0015937]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; isoleucine catabolic process [GO:0006550]; ketone body biosynthetic process [GO:0046951]; ketone body catabolic process [GO:0046952]; ketone body metabolic process [GO:1902224]; liver development [GO:0001889]; metanephric proximal convoluted tubule development [GO:0072229]; propionyl-CoA biosynthetic process [GO:1902860]; protein homooligomerization [GO:0051260]; response to hormone [GO:0009725]; response to organic cyclic compound [GO:0014070]; response to starvation [GO:0042594]	extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; carbon-carbon lyase activity [GO:0016830]; coenzyme binding [GO:0050662]; enzyme binding [GO:0019899]; ligase activity, forming carbon-carbon bonds [GO:0016885]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA catabolic process [GO:0046356]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; branched-chain amino acid catabolic process [GO:0009083]; coenzyme A biosynthetic process [GO:0015937]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; isoleucine catabolic process [GO:0006550]; ketone body biosynthetic process [GO:0046951]; ketone body catabolic process [GO:0046952]; ketone body metabolic process [GO:1902224]; liver development [GO:0001889]; metanephric proximal convoluted tubule development [GO:0072229]; propionyl-CoA biosynthetic process [GO:1902860]; protein homooligomerization [GO:0051260]; response to hormone [GO:0009725]; response to organic cyclic compound [GO:0014070]; response to starvation [GO:0042594]	acetyl-CoA C-acetyltransferase activity [GO:0003985]; carbon-carbon lyase activity [GO:0016830]; coenzyme binding [GO:0050662]; enzyme binding [GO:0019899]; ligase activity, forming carbon-carbon bonds [GO:0016885]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]	GO:0001889; GO:0003985; GO:0005739; GO:0005759; GO:0006085; GO:0006550; GO:0006635; GO:0007420; GO:0009083; GO:0009725; GO:0014070; GO:0015936; GO:0015937; GO:0016830; GO:0016885; GO:0019899; GO:0042594; GO:0042803; GO:0046356; GO:0046872; GO:0046951; GO:0046952; GO:0050662; GO:0051260; GO:0060612; GO:0070062; GO:0072229; GO:1902224; GO:1902860	SUBCELLULAR LOCATION: Mitochondrion.	PTM: Succinylation at Lys-268, adjacent to a coenzyme A binding site. Desuccinylated by SIRT5 (By similarity). {ECO:0000250}.	MOD_RES 66 66 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8QZT1}.; MOD_RES 66 66 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8QZT1}.; MOD_RES 78 78 N6-succinyllysine. {ECO:0000250|UniProtKB:Q8QZT1}.; MOD_RES 174 174 N6-acetyllysine; alternate. {ECO:0000244|PubMed:19608861}.; MOD_RES 174 174 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8QZT1}.; MOD_RES 181 181 N6-acetyllysine; alternate. {ECO:0000244|PubMed:19608861}.; MOD_RES 181 181 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8QZT1}.; MOD_RES 190 190 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8QZT1}.; MOD_RES 190 190 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8QZT1}.; MOD_RES 202 202 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8QZT1}.; MOD_RES 202 202 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8QZT1}.; MOD_RES 223 223 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8QZT1}.; MOD_RES 223 223 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8QZT1}.; MOD_RES 230 230 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8QZT1}.; MOD_RES 230 230 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8QZT1}.; MOD_RES 243 243 N6-succinyllysine. {ECO:0000250|UniProtKB:Q8QZT1}.; MOD_RES 251 251 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 257 257 N6-acetyllysine. {ECO:0000250|UniProtKB:Q8QZT1}.; MOD_RES 263 263 N6-acetyllysine; alternate. {ECO:0000244|PubMed:19608861}.; MOD_RES 263 263 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8QZT1}.; MOD_RES 266 266 N6-succinyllysine. {ECO:0000250|UniProtKB:Q8QZT1}.; MOD_RES 268 268 N6-succinyllysine. {ECO:0000250|UniProtKB:Q8QZT1}.; MOD_RES 273 273 N6-acetyllysine. {ECO:0000250|UniProtKB:Q8QZT1}.; MOD_RES 338 338 N6-acetyllysine. {ECO:0000250|UniProtKB:Q8QZT1}.	1979337; 1684944; 14702039; 16554811; 15489334; 15242332; 18669648; 19608861; 21269460; 24275569; 25944712; 17371050; 7749408; 1346617; 1715688; 7728148; 9744475; 12754704; 15128923; 16935016; 17236799; 17353931; 18511318; 18562306; 18996102; 19112833; 19738201; 20046049; 20156697; 20167577; 20562859; 20869947; 20877624; 21791085; 21988832; 22623428; 23443136; 24311408; 24486017; 25099943; 25525879; 25639359; 26752685; 27264805; 27748876; 3709573	1979337; 1684944; 14702039; 16554811; 15489334; 15242332; 18669648; 19608861; 21269460; 24275569; 25944712; 17371050; 7749408; 1346617; 1715688; 7728148; 9744475
15009	ST6GAL2 KIAA1877 SIAT2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.74 mM for Gal-beta-1,4-GlcNAc-beta-O-octyl {ECO:0000269|PubMed:12235148, ECO:0000269|PubMed:12603328}; KM=0.71 mM for Gal-beta-1,4-GlcNAc {ECO:0000269|PubMed:12235148, ECO:0000269|PubMed:12603328}; KM=0.48 mM for lacto-N-neotetraose {ECO:0000269|PubMed:12235148, ECO:0000269|PubMed:12603328}; 	2.4.99.1	CATALYTIC ACTIVITY: CMP-N-acetyl-beta-neuraminate + beta-D-galactosyl-R = CMP + N-acetyl-alpha-neuraminyl-(2->6)-beta-D-galactosyl-R. {ECO:0000269|PubMed:12235148, ECO:0000269|PubMed:12603328, ECO:0000269|PubMed:16439063}.									oligosaccharide metabolic process [GO:0009311]; protein N-linked glycosylation via asparagine [GO:0018279]	Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; beta-galactoside alpha-2,6-sialyltransferase activity [GO:0003835]; oligosaccharide metabolic process [GO:0009311]; protein N-linked glycosylation via asparagine [GO:0018279]	beta-galactoside alpha-2,6-sialyltransferase activity [GO:0003835]	GO:0000139; GO:0003835; GO:0009311; GO:0016021; GO:0018279; GO:0032580	SUBCELLULAR LOCATION: Golgi apparatus, Golgi stack membrane {ECO:0000250}; Single-pass type II membrane protein {ECO:0000250}.	PTM: O-glycosylated. {ECO:0000269|PubMed:23234360}.		12235148; 11347906; 15815621; 15489334; 12603328; 16439063; 17944600; 23234360; 19240061; 19768537; 19850283; 20379614; 20800603; 21081508; 23764002	12235148; 11347906; 15815621; 15489334; 12603328; 16439063; 17944600; 23234360
15022	SLC9B2 NHA2 NHEDC2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=33 mM for for Na(+) {ECO:0000269|PubMed:28154142}; KM=67 mM for for Li(+) {ECO:0000269|PubMed:28154142}; 						BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 8.5. {ECO:0000269|PubMed:28154142};		SITE 278 278 Important for cation transport. {ECO:0000269|PubMed:18000046}.; SITE 279 279 Important for cation transport. {ECO:0000269|PubMed:18000046}.			clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; ion transmembrane transport [GO:0034220]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion transport [GO:0006814]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672]; identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; monovalent cation:proton antiporter activity [GO:0005451]; sodium:proton antiporter activity [GO:0015385]; clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; ion transmembrane transport [GO:0034220]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion transport [GO:0006814]	identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; monovalent cation:proton antiporter activity [GO:0005451]; sodium:proton antiporter activity [GO:0015385]	GO:0005451; GO:0005743; GO:0005886; GO:0006814; GO:0010008; GO:0010348; GO:0015385; GO:0016021; GO:0016323; GO:0016324; GO:0030054; GO:0030317; GO:0030672; GO:0031966; GO:0034220; GO:0042802; GO:0061178; GO:0072583; GO:0097228; GO:2001206	SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:18000046}; Multi-pass membrane protein {ECO:0000255}. Mitochondrion membrane {ECO:0000269|PubMed:18508966}; Multi-pass membrane protein {ECO:0000255}. Endosome membrane {ECO:0000250|UniProtKB:Q5BKR2}; Multi-pass membrane protein {ECO:0000255}. Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane {ECO:0000250|UniProtKB:Q5BKR2}; Multi-pass membrane protein {ECO:0000250|UniProtKB:Q5BKR2}. Cell projection, cilium, flagellum membrane {ECO:0000250|UniProtKB:Q5BKR2}; Multi-pass membrane protein {ECO:0000255}. Basolateral cell membrane {ECO:0000250|UniProtKB:Q5BKR2}; Multi-pass membrane protein {ECO:0000255}. Apical cell membrane {ECO:0000250|UniProtKB:Q5BKR2}; Multi-pass membrane protein {ECO:0000255}. Note=Strong colocalization with LAMP1 and TCIRG1 in osteoclasts. In beta-cells colocalizes with RAB4A and SYP. Localizes to the basolateral membrane of polarized osteoclasts. {ECO:0000250|UniProtKB:Q5BKR2}.		MOD_RES 49 49 Phosphoserine. {ECO:0000244|PubMed:24275569}.	14702039; 15815621; 15489334; 18000046; 18508966; 22948142; 23720317; 24275569; 28071645; 28154142; 17988971; 20053353; 20332099; 20713131; 25260751; 8383669	14702039; 15815621; 15489334; 18000046; 18508966; 22948142; 23720317; 24275569; 28071645; 28154142
15041	SETD2 HIF1 HYPB KIAA1732 KMT3A SET2 HSPC069	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=1.21 uM for S-adenosyl-L-methionine {ECO:0000269|PubMed:23043551}; KM=0.42 uM for histone H3 {ECO:0000269|PubMed:23043551}; Note=Kcat is 0.14 min(-1). {ECO:0000269|PubMed:23043551};	2.1.1.43; 2.1.1.-	CATALYTIC ACTIVITY: S-adenosyl-L-methionine + L-lysine-[histone] = S-adenosyl-L-homocysteine + N(6)-methyl-L-lysine-[histone]. {ECO:0000269|PubMed:23043551, ECO:0000269|PubMed:27474439}.; CATALYTIC ACTIVITY: S-adenosyl-L-methionine + [protein]-L-lysine = S-adenosyl-L-homocysteine + [protein]-N(6)-methyl-L-lysine. {ECO:0000269|PubMed:28753426}.; CATALYTIC ACTIVITY: 3 S-adenosyl-L-methionine + [protein]-L-lysine = 3 S-adenosyl-L-homocysteine + [protein]-N(6),N(6),N(6)-methyl-L-lysine. {ECO:0000269|PubMed:27518565}.	BINDING 1625 1625 Inhibitor. {ECO:0000269|PubMed:23043551}.; BINDING 1676 1676 Inhibitor; alternate. {ECO:0000269|PubMed:23043551}.; BINDING 1676 1676 S-adenosyl-L-methionine; alternate. {ECO:0000244|PDB:4H12, ECO:0000244|PDB:5JJY, ECO:0000244|PDB:5JLB, ECO:0000244|PDB:5JLE, ECO:0000244|PDB:5V22, ECO:0000269|PubMed:23043551, ECO:0000269|PubMed:27474439, ECO:0000269|PubMed:28256625}.; BINDING 1679 1679 Inhibitor; via amide nitrogen; alternate. {ECO:0000244|PDB:5V22, ECO:0000269|PubMed:23043551, ECO:0000269|PubMed:28256625}.; BINDING 1679 1679 S-adenosyl-L-methionine; via amide nitrogen; alternate. {ECO:0000244|PDB:4H12, ECO:0000244|PDB:5JJY, ECO:0000244|PDB:5JLB, ECO:0000244|PDB:5JLE, ECO:0000244|PDB:5V22, ECO:0000269|PubMed:23043551, ECO:0000269|PubMed:27474439, ECO:0000269|PubMed:28256625}.	ACTIVITY REGULATION: Specifically inhibited by sinefungin derivatives. N-propyl sinefungin (Pr-SNF) interacts preferentially with SETD2. {ECO:0000269|PubMed:23043551}.					HSPC069		angiogenesis [GO:0001525]; cell migration involved in vasculogenesis [GO:0035441]; coronary vasculature morphogenesis [GO:0060977]; defense response to virus [GO:0051607]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic placenta morphogenesis [GO:0060669]; endodermal cell differentiation [GO:0035987]; forebrain development [GO:0030900]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; mesoderm morphogenesis [GO:0048332]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mismatch repair [GO:0006298]; morphogenesis of a branching structure [GO:0001763]; neural tube closure [GO:0001843]; nucleosome organization [GO:0034728]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; pericardium development [GO:0060039]; positive regulation of interferon-alpha production [GO:0032727]; regulation of cytokinesis [GO:0032465]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of mRNA export from nucleus [GO:0010793]; regulation of protein localization to chromatin [GO:1905634]; regulation of transcription, DNA-templated [GO:0006355]; response to type I interferon [GO:0034340]; stem cell development [GO:0048864]; stem cell differentiation [GO:0048863]; transcription elongation from RNA polymerase II promoter [GO:0006368]	chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; alpha-tubulin binding [GO:0043014]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein-lysine N-methyltransferase activity [GO:0016279]; angiogenesis [GO:0001525]; cell migration involved in vasculogenesis [GO:0035441]; coronary vasculature morphogenesis [GO:0060977]; defense response to virus [GO:0051607]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic placenta morphogenesis [GO:0060669]; endodermal cell differentiation [GO:0035987]; forebrain development [GO:0030900]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; mesoderm morphogenesis [GO:0048332]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mismatch repair [GO:0006298]; morphogenesis of a branching structure [GO:0001763]; neural tube closure [GO:0001843]; nucleosome organization [GO:0034728]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; pericardium development [GO:0060039]; positive regulation of interferon-alpha production [GO:0032727]; regulation of cytokinesis [GO:0032465]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of mRNA export from nucleus [GO:0010793]; regulation of protein localization to chromatin [GO:1905634]; regulation of transcription, DNA-templated [GO:0006355]; response to type I interferon [GO:0034340]; stem cell development [GO:0048864]; stem cell differentiation [GO:0048863]; transcription elongation from RNA polymerase II promoter [GO:0006368]	alpha-tubulin binding [GO:0043014]; histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; metal ion binding [GO:0046872]; protein-lysine N-methyltransferase activity [GO:0016279]	GO:0001525; GO:0001763; GO:0001843; GO:0005634; GO:0005654; GO:0005694; GO:0006298; GO:0006355; GO:0006368; GO:0010569; GO:0010793; GO:0016279; GO:0018023; GO:0018024; GO:0018026; GO:0030900; GO:0032465; GO:0032727; GO:0034340; GO:0034728; GO:0035441; GO:0035987; GO:0043014; GO:0046872; GO:0046975; GO:0048332; GO:0048701; GO:0048863; GO:0048864; GO:0051607; GO:0060039; GO:0060669; GO:0060977; GO:0097198; GO:0097676; GO:1902850; GO:1905634	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:E9Q5F9}. Chromosome {ECO:0000250|UniProtKB:E9Q5F9}.	PTM: May be automethylated. {ECO:0000269|PubMed:16118227}.	MOD_RES 131 131 Phosphoserine. {ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163}.; MOD_RES 321 321 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:24275569}.; MOD_RES 323 323 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692}.; MOD_RES 344 344 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 422 422 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 532 532 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 614 614 Phosphoserine. {ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 624 624 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 626 626 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 698 698 Phosphoserine. {ECO:0000250|UniProtKB:E9Q5F9}.; MOD_RES 708 708 Phosphoserine. {ECO:0000244|PubMed:19690332}.; MOD_RES 744 744 Phosphoserine. {ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163}.; MOD_RES 754 754 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 1098 1098 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1228 1228 Phosphoserine. {ECO:0000244|PubMed:18220336, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 1413 1413 Phosphoserine. {ECO:0000250|UniProtKB:E9Q5F9}.; MOD_RES 1415 1415 Phosphoserine. {ECO:0000250|UniProtKB:E9Q5F9}.; MOD_RES 1417 1417 Phosphoserine. {ECO:0000250|UniProtKB:E9Q5F9}.; MOD_RES 1696 1696 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1844 1844 Phosphoserine. {ECO:0000250|UniProtKB:E9Q5F9}.; MOD_RES 1845 1845 Phosphoserine. {ECO:0000250|UniProtKB:E9Q5F9}.; MOD_RES 1853 1853 Phosphothreonine. {ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 1872 1872 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 1888 1888 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1952 1952 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1980 1980 Phosphoserine. {ECO:0000250|UniProtKB:E9Q5F9}.; MOD_RES 1988 1988 Phosphoserine. {ECO:0000250|UniProtKB:E9Q5F9}.; MOD_RES 1995 1995 Phosphoserine. {ECO:0000250|UniProtKB:E9Q5F9}.; MOD_RES 2080 2080 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 2082 2082 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.	16641997; 14702039; 17974005; 11461154; 15489334; 16118227; 11214970; 12168954; 11042152; 9700202; 10958656; 17081983; 18585004; 19141475; 18220336; 18669648; 19413330; 19332550; 19690332; 20054297; 20068231; 21792193; 21526191; 21406692; 23160955; 23622243; 23186163; 23792563; 23325844; 24843002; 24275569; 24662245; 24509477; 26084711; 25755297; 25728682; 27518565; 27317772; 28753426; 28112733; 16314571; 23043551; 27474439; 28256625; 24852293; 26637798; 16713569; 17500595; 18985028; 20711500; 21282530; 21988832; 23602568; 24412394; 26496610; 27571355	16641997; 14702039; 17974005; 11461154; 15489334; 16118227; 11214970; 12168954; 11042152; 9700202; 10958656; 17081983; 18585004; 19141475; 18220336; 18669648; 19413330; 19332550; 19690332; 20054297; 20068231; 21792193; 21526191; 21406692; 23160955; 23622243; 23186163; 23792563; 23325844; 24843002; 24275569; 24662245; 24509477; 26084711; 25755297; 25728682; 27518565; 27317772; 28753426; 28112733; 16314571; 23043551; 27474439; 28256625; 24852293; 26637798
15055	SIRT5 SIR2L5	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=6.1 uM for a synthetic histone H3K9 malonyllysine peptide {ECO:0000269|PubMed:22076378}; KM=5.8 uM for a synthetic histone H3K9 succinyllysine peptide {ECO:0000269|PubMed:22076378}; KM=8.7 uM for a synthetic GLUD1 peptide malonylated at 'Lys-503' {ECO:0000269|PubMed:22076378}; KM=14 uM for a synthetic GLUD1 peptide succinylated at 'Lys-503' {ECO:0000269|PubMed:22076378}; KM=150 uM for a synthetic ACSS1 peptide malonylated at 'Lys-628' {ECO:0000269|PubMed:22076378}; KM=450 uM for a synthetic ACSS1 peptide succinylated at 'Lys-628' {ECO:0000269|PubMed:22076378}; 	3.5.1.-	CATALYTIC ACTIVITY: NAD(+) + a malonylprotein = nicotinamide + O-malonyl-ADP-ribose + a protein. {ECO:0000255|HAMAP-Rule:MF_03160, ECO:0000269|PubMed:22076378}.; CATALYTIC ACTIVITY: NAD(+) + a succinylprotein = nicotinamide + O-succinyl-ADP-ribose + a protein. {ECO:0000255|HAMAP-Rule:MF_03160, ECO:0000269|PubMed:22076378, ECO:0000269|PubMed:29180469}.; CATALYTIC ACTIVITY: NAD(+) + a glutarylprotein = nicotinamide + O-glutaryl-ADP-ribose + a protein. {ECO:0000255|HAMAP-Rule:MF_03160, ECO:0000269|PubMed:24703693}.	BINDING 102 102 Substrate. {ECO:0000255|HAMAP-Rule:MF_03160}.; BINDING 105 105 Substrate. {ECO:0000255|HAMAP-Rule:MF_03160}.; BINDING 293 293 NAD; via amide nitrogen. {ECO:0000255|HAMAP-Rule:MF_03160, ECO:0000269|PubMed:22076378, ECO:0000269|PubMed:22767592, ECO:0000269|Ref.19}.	ACTIVITY REGULATION: Inhibited by suramin. NAD-dependent lysine desuccinylase activity is inhibited by physiological nicotinamide concentrations, while deacetylase activity is not. In contrast, resveratrol activates deacetylase activity, while inhibiting desuccinylase activity. {ECO:0000269|PubMed:17355872, ECO:0000269|PubMed:23028781, ECO:0000269|PubMed:23185430}.	COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000255|HAMAP-Rule:MF_03160, ECO:0000269|PubMed:22076378}; ;  Note=Binds 1 zinc ion per subunit. {ECO:0000255|HAMAP-Rule:MF_03160, ECO:0000269|PubMed:22076378};						chromatin silencing [GO:0006342]; mitochondrion organization [GO:0007005]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; peptidyl-lysine demalonylation [GO:0036047]; peptidyl-lysine desuccinylation [GO:0036049]; protein ADP-ribosylation [GO:0006471]; protein deacetylation [GO:0006476]; protein deglutarylation [GO:0061698]; protein demalonylation [GO:0036046]; protein desuccinylation [GO:0036048]; regulation of ketone biosynthetic process [GO:0010566]; response to nutrient levels [GO:0031667]	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent protein deacetylase activity [GO:0034979]; protein-glutaryllysine deglutarylase activity [GO:0061697]; protein-malonyllysine demalonylase activity [GO:0036054]; protein-succinyllysine desuccinylase activity [GO:0036055]; zinc ion binding [GO:0008270]; chromatin silencing [GO:0006342]; mitochondrion organization [GO:0007005]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; peptidyl-lysine demalonylation [GO:0036047]; peptidyl-lysine desuccinylation [GO:0036049]; protein ADP-ribosylation [GO:0006471]; protein deacetylation [GO:0006476]; protein deglutarylation [GO:0061698]; protein demalonylation [GO:0036046]; protein desuccinylation [GO:0036048]; regulation of ketone biosynthetic process [GO:0010566]; response to nutrient levels [GO:0031667]	NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent protein deacetylase activity [GO:0034979]; protein-glutaryllysine deglutarylase activity [GO:0061697]; protein-malonyllysine demalonylase activity [GO:0036054]; protein-succinyllysine desuccinylase activity [GO:0036055]; zinc ion binding [GO:0008270]	GO:0003950; GO:0005634; GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0005829; GO:0006342; GO:0006471; GO:0006476; GO:0007005; GO:0008270; GO:0010566; GO:0010667; GO:0031667; GO:0034979; GO:0036046; GO:0036047; GO:0036048; GO:0036049; GO:0036054; GO:0036055; GO:0061697; GO:0061698; GO:0070403; GO:2000378	SUBCELLULAR LOCATION: Mitochondrion matrix. Mitochondrion intermembrane space. Cytoplasm, cytosol. Nucleus. Note=Mainly mitochondrial. Also present extramitochondrially, with a fraction present in the cytosol and very small amounts also detected in the nucleus.; SUBCELLULAR LOCATION: Isoform 1: Cytoplasm {ECO:0000269|PubMed:21143562}. Mitochondrion {ECO:0000255|HAMAP-Rule:MF_03160, ECO:0000269|PubMed:21143562}.; SUBCELLULAR LOCATION: Isoform 2: Mitochondrion {ECO:0000255|HAMAP-Rule:MF_03160, ECO:0000269|PubMed:21143562}.			10381378; 14702039; 17974005; 14574404; 15489334; 16079181; 18680753; 21269460; 21143562; 21908771; 23028781; 24140062; 23438705; 23806337; 24703693; 24275569; 29180469; 17355872; 22076378; 22767592; 22849721; 23185430; 16484774; 16827919; 20800603; 20877624; 20887790; 22585829; 23217706; 23475622; 23978077; 24464653; 25032863; 25070488; 25111069; 25165814; 25361925; 25717114; 26001219; 26496610; 26701732; 27113762; 27164052; 27577743; 27626398; 28036303; 28458255; 28707979; 29044784; 29115436; 29416026; 29896817	10381378; 14702039; 17974005; 14574404; 15489334; 16079181; 18680753; 21269460; 21143562; 21908771; 23028781; 24140062; 23438705; 23806337; 24703693; 24275569; 29180469; 17355872; 22076378; 22767592; 22849721; 23185430
15099	ST6GALNAC6 SIAT7F UNQ708/PRO1359	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.33 mM for GM1b {ECO:0000269|PubMed:12668675}; KM=0.46 mM for sialyl-Lc4 {ECO:0000269|PubMed:12668675}; 	2.4.99.-								UNQ708/PRO1359		cell-cell recognition [GO:0009988]; ganglioside biosynthetic process [GO:0001574]; glycoprotein metabolic process [GO:0009100]; glycosphingolipid metabolic process [GO:0006687]; glycosylceramide metabolic process [GO:0006677]; oligosaccharide biosynthetic process [GO:0009312]; oligosaccharide metabolic process [GO:0009311]; protein N-linked glycosylation via asparagine [GO:0018279]	cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373]; cell-cell recognition [GO:0009988]; ganglioside biosynthetic process [GO:0001574]; glycoprotein metabolic process [GO:0009100]; glycosphingolipid metabolic process [GO:0006687]; glycosylceramide metabolic process [GO:0006677]; oligosaccharide biosynthetic process [GO:0009312]; oligosaccharide metabolic process [GO:0009311]; protein N-linked glycosylation via asparagine [GO:0018279]	alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373]	GO:0000139; GO:0001574; GO:0001665; GO:0005737; GO:0005886; GO:0006677; GO:0006687; GO:0008373; GO:0009100; GO:0009311; GO:0009312; GO:0009988; GO:0016021; GO:0018279	SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000250}; Single-pass type II membrane protein {ECO:0000250}.			12668675; 15843597; 12975309; 14702039; 15164053; 15489334; 16207893; 17123352; 17760270; 10536037; 10742600; 11062056; 16713569; 21150319	12668675; 15843597; 12975309; 14702039; 15164053; 15489334; 16207893; 17123352; 17760270
15102	ST6GAL1 SIAT1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=530 uM for CMP-NeuAc {ECO:0000269|PubMed:21081508}; Vmax=1.074 pmol/min/ug enzyme {ECO:0000269|PubMed:21081508}; 	2.4.99.1	CATALYTIC ACTIVITY: CMP-N-acetyl-beta-neuraminate + beta-D-galactosyl-R = CMP + N-acetyl-alpha-neuraminyl-(2->6)-beta-D-galactosyl-R. {ECO:0000269|PubMed:21081508, ECO:0000269|PubMed:23999306}.	BINDING 189 189 Substrate; via amide nitrogen.; BINDING 212 212 Substrate.; BINDING 233 233 Substrate.; BINDING 353 353 Substrate; via carbonyl oxygen.; BINDING 354 354 Substrate.; BINDING 365 365 Substrate.; BINDING 369 369 Substrate. {ECO:0000305}.; BINDING 370 370 Substrate.; BINDING 376 376 Substrate.	ACTIVITY REGULATION: Inhibited by CTP. {ECO:0000269|PubMed:23999306}.			PATHWAY: Protein modification; protein glycosylation.				humoral immune response [GO:0006959]; N-acetylneuraminate metabolic process [GO:0006054]; O-glycan processing [GO:0016266]; oligosaccharide metabolic process [GO:0009311]; protein N-linked glycosylation via asparagine [GO:0018279]; sialylation [GO:0097503]	extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; beta-galactoside alpha-2,6-sialyltransferase activity [GO:0003835]; sialyltransferase activity [GO:0008373]; humoral immune response [GO:0006959]; N-acetylneuraminate metabolic process [GO:0006054]; O-glycan processing [GO:0016266]; oligosaccharide metabolic process [GO:0009311]; protein N-linked glycosylation via asparagine [GO:0018279]; sialylation [GO:0097503]	beta-galactoside alpha-2,6-sialyltransferase activity [GO:0003835]; sialyltransferase activity [GO:0008373]	GO:0000139; GO:0003835; GO:0005576; GO:0006054; GO:0006959; GO:0008373; GO:0009311; GO:0016021; GO:0016266; GO:0018279; GO:0032580; GO:0097503	SUBCELLULAR LOCATION: Golgi apparatus, Golgi stack membrane; Single-pass type II membrane protein. Secreted. Note=Membrane-bound form in trans cisternae of Golgi. Secreted into the body fluid.	PTM: The soluble form derives from the membrane form by proteolytic processing.; PTM: The HB-6, CDW75, and CD76 differentiation antigens are cell-surface carbohydrate determinants generated by this enzyme.	MOD_RES 369 369 Phosphotyrosine. {ECO:0000244|PubMed:19690332}.	2408023; 2373995; 1730763; 14702039; 16641997; 15489334; 2803295; 19159218; 19690332; 21081508; 23999306; 10766765; 11421344; 11425186; 11530204; 12097641; 12235148; 12499376; 12603328; 12765789; 12798701; 12878221; 12931020; 12943659; 14514712; 16053379; 16192407; 16237761; 16319516; 17441333; 17697868; 17897958; 18650447; 19013288; 19150807; 19170967; 19413643; 19483685; 19709745; 20003255; 20127017; 20379614; 20656882; 20711500; 21140242; 21147760; 21550977; 21778787; 22449099; 23358684; 23504322; 23549466; 24454800; 24606438; 25344606; 25465919; 25566667; 25573487; 25867765; 26054692; 26224120; 26258617; 26304831; 26840264; 27216178; 27340870; 27510958; 27588482; 27986075; 28032597; 28154177; 28377225; 28550122; 28603863; 9054414	2408023; 2373995; 1730763; 14702039; 16641997; 15489334; 2803295; 19159218; 19690332; 21081508; 23999306
15422	TSSK2 DGSG SPOGA2 STK22B	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=10 uM for ATP {ECO:0000269|PubMed:20729278}; 	2.7.11.1	CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein. {ECO:0000269|PubMed:20729278}.	BINDING 41 41 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.	ACTIVITY REGULATION: Activated by phosphorylation on Thr-174, potentially by autophosphorylation. {ECO:0000250}.	COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:20729278}; 						intracellular signal transduction [GO:0035556]; multicellular organism development [GO:0007275]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; spermatid development [GO:0007286]	acrosomal vesicle [GO:0001669]; centriole [GO:0005814]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	acrosomal vesicle [GO:0001669]; centriole [GO:0005814]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; intracellular signal transduction [GO:0035556]; multicellular organism development [GO:0007275]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; spermatid development [GO:0007286]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein-containing complex binding [GO:0044877]; protein serine/threonine kinase activity [GO:0004674]	GO:0000287; GO:0001669; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005814; GO:0006468; GO:0007275; GO:0007286; GO:0018105; GO:0035556; GO:0044877; GO:0046777	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriole {ECO:0000269|PubMed:18495105}. Note=Present in the cytoplasm of elongating spermatids. In spermatozoa, localizes in the equatorial segment, neck, the midpiece and in a specific sperm head compartment (By similarity). In spermatids, concentrates in centrioles during flagellogenesis. {ECO:0000250}.	PTM: Autophosphorylated. {ECO:0000269|PubMed:15044604}.; PTM: Ubiquitinated; HSP90 activity negatively regulates ubiquitination and degradation. {ECO:0000250|UniProtKB:O54863}.		8776594; 15044604; 15461802; 10591208; 15489334; 17566264; 18495105; 18533145; 20729278; 17344846; 19926886; 21988832; 22939624; 23258646; 24606918; 26777341	8776594; 15044604; 15461802; 10591208; 15489334; 17566264; 18495105; 18533145; 20729278; 17344846; 19926886
15436	TKFC DAK	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.5 uM for dihydroxyacetone {ECO:0000269|PubMed:4688871}; KM=11 uM for glyceraldehyde {ECO:0000269|PubMed:4688871}; KM=1.55 uM for dihydroxyacetone {ECO:0000269|PubMed:24569995}; KM=43.2 uM for ATP {ECO:0000269|PubMed:24569995}; KM=18.1 uM for glyceraldehyde {ECO:0000269|PubMed:24569995}; KM=7 uM for FAD {ECO:0000269|PubMed:24569995}; KM=12 uM for ADP-glucose {ECO:0000269|PubMed:24569995}; KM=317 uM for UDP-glucose {ECO:0000269|PubMed:24569995}; KM=263 uM for UDP-galactose {ECO:0000269|PubMed:24569995}; 	2.7.1.28; 2.7.1.29; 4.6.1.15	CATALYTIC ACTIVITY: ATP + glycerone = ADP + glycerone phosphate. {ECO:0000269|PubMed:4688871}.; CATALYTIC ACTIVITY: ATP + D-glyceraldehyde = ADP + D-glyceraldehyde 3-phosphate. {ECO:0000269|PubMed:4688871}.; CATALYTIC ACTIVITY: FAD = AMP + riboflavin cyclic-4',5'-phosphate. {ECO:0000269|PubMed:4688871}.	BINDING 109 109 Dihydroxyacetone. {ECO:0000255|PROSITE-ProRule:PRU00814}.; BINDING 114 114 Dihydroxyacetone. {ECO:0000255|PROSITE-ProRule:PRU00814}.; BINDING 486 486 ATP; via carbonyl oxygen. {ECO:0000250}.	ACTIVITY REGULATION: Each activity is inhibited by the substrate(s) of the other.	COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250}; ; COFACTOR: Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250}; Name=Co(2+); Xref=ChEBI:CHEBI:48828; Evidence={ECO:0000250}; ;  Note=Manganese or cobalt are requested for FAD-AMP lyase activity. {ECO:0000250};	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 6.6. {ECO:0000269|PubMed:4688871};					carbohydrate phosphorylation [GO:0046835]; cellular carbohydrate metabolic process [GO:0044262]; fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate [GO:0061624]; glycerol metabolic process [GO:0006071]; innate immune response [GO:0045087]; negative regulation of MDA-5 signaling pathway [GO:0039534]; regulation of innate immune response [GO:0045088]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; ATP binding [GO:0005524]; FAD-AMP lyase (cyclizing) activity [GO:0034012]; glycerone kinase activity [GO:0004371]; metal ion binding [GO:0046872]; triokinase activity [GO:0050354]; carbohydrate phosphorylation [GO:0046835]; cellular carbohydrate metabolic process [GO:0044262]; fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate [GO:0061624]; glycerol metabolic process [GO:0006071]; innate immune response [GO:0045087]; negative regulation of MDA-5 signaling pathway [GO:0039534]; regulation of innate immune response [GO:0045088]	ATP binding [GO:0005524]; FAD-AMP lyase (cyclizing) activity [GO:0034012]; glycerone kinase activity [GO:0004371]; metal ion binding [GO:0046872]; triokinase activity [GO:0050354]	GO:0004371; GO:0005524; GO:0005634; GO:0005829; GO:0006071; GO:0034012; GO:0039534; GO:0044262; GO:0045087; GO:0045088; GO:0046835; GO:0046872; GO:0050354; GO:0061624; GO:0070062			MOD_RES 350 350 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 511 511 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 545 545 Phosphoserine. {ECO:0000250|UniProtKB:Q4KLZ6}.	16289032; 14702039; 16554811; 15489334; 4688871; 17600090; 21269460; 24569995; 24275569; 13093749; 18591409; 19367725; 19531363; 22098443; 24289155; 25416956	16289032; 14702039; 16554811; 15489334; 4688871; 17600090; 21269460; 24569995; 24275569
15472	QTRT1 TGT TGUT	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=0.34 uM for tRNA(Tyr) {ECO:0000269|PubMed:20354154}; KM=0.41 uM for guanine {ECO:0000269|PubMed:20354154}; Note=kcat is 0.0056 sec(-1) with tRNA(Tyr) as substrate and 0.00586 sec(-1) with guanine as substrate. {ECO:0000269|PubMed:20354154};	2.4.2.29	CATALYTIC ACTIVITY: Guanine(34) in tRNA + queuine = queuosine(34) in tRNA + guanine. {ECO:0000255|HAMAP-Rule:MF_03218, ECO:0000269|PubMed:20354154}.	BINDING 159 159 Substrate. {ECO:0000255|HAMAP-Rule:MF_03218}.; BINDING 202 202 Substrate. {ECO:0000255|HAMAP-Rule:MF_03218}.; BINDING 229 229 Substrate; via amide nitrogen. {ECO:0000255|HAMAP-Rule:MF_03218}.		COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000255|HAMAP-Rule:MF_03218}; 						tRNA-guanine transglycosylation [GO:0101030]; tRNA modification [GO:0006400]	mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; queuine tRNA-ribosyltransferase activity [GO:0008479]; tRNA modification [GO:0006400]; tRNA-guanine transglycosylation [GO:0101030]	metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; queuine tRNA-ribosyltransferase activity [GO:0008479]	GO:0005634; GO:0005741; GO:0006400; GO:0008479; GO:0032991; GO:0042803; GO:0046872; GO:0046982; GO:0101030	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_03218}. Mitochondrion outer membrane {ECO:0000255|HAMAP-Rule:MF_03218}; Peripheral membrane protein {ECO:0000255|HAMAP-Rule:MF_03218}; Cytoplasmic side {ECO:0000255|HAMAP-Rule:MF_03218}. Note=Weakly associates with mitochondria, possibly via QTRT2. {ECO:0000255|HAMAP-Rule:MF_03218}.		MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:22814378}.; MOD_RES 139 139 Phosphoserine. {ECO:0000244|PubMed:23186163}.	11255023; 14702039; 15057824; 15489334; 20354154; 21269460; 22814378; 23186163; 16169070; 17353931; 18847512; 19414587; 20064372; 21131277; 21640076; 23704982	11255023; 14702039; 15057824; 15489334; 20354154; 21269460; 22814378; 23186163
15615	CAD	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=28 uM for dihydroorotate {ECO:0000269|PubMed:24332717}; KM=241 uM for N-carbamoyl-L-aspartate {ECO:0000269|PubMed:24332717}; 	6.3.5.5; 2.1.3.2; 3.5.2.3	CATALYTIC ACTIVITY: 2 ATP + L-glutamine + HCO(3)(-) + H(2)O = 2 ADP + phosphate + L-glutamate + carbamoyl phosphate. {ECO:0000269|PubMed:24332717}.; CATALYTIC ACTIVITY: Carbamoyl phosphate + L-aspartate = phosphate + N-carbamoyl-L-aspartate. {ECO:0000269|PubMed:24332717}.; CATALYTIC ACTIVITY: (S)-dihydroorotate + H(2)O = N-carbamoyl-L-aspartate. {ECO:0000269|PubMed:24332717}.	BINDING 1475 1475 N-carbamoyl-L-aspartate. {ECO:0000269|PubMed:24332717}.; BINDING 1505 1505 N-carbamoyl-L-aspartate. {ECO:0000269|PubMed:24332717}.; BINDING 1661 1661 N-carbamoyl-L-aspartate; via amide nitrogen and carbonyl oxygen. {ECO:0000269|PubMed:24332717}.; BINDING 1686 1686 N-carbamoyl-L-aspartate. {ECO:0000269|PubMed:24332717}.; BINDING 1690 1690 N-carbamoyl-L-aspartate. {ECO:0000269|PubMed:24332717}.	ACTIVITY REGULATION: Allosterically regulated and controlled by phosphorylation. 5-phosphoribose 1-diphosphate (PRPP) is an activator while UMP and UTP are inhibitors of the CPSase reaction. {ECO:0000269|PubMed:11872754}.	COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000269|PubMed:24332717, ECO:0000269|PubMed:7766613}; ;  Note=Binds 3 Zn(2+) ions per subunit (for dihydroorotase activity). {ECO:0000269|PubMed:24332717, ECO:0000269|PubMed:7766613};; COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000255|PROSITE-ProRule:PRU00409}; Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000255|PROSITE-ProRule:PRU00409}; ;  Note=Binds 4 magnesium or manganese ions per subunit. {ECO:0000255|PROSITE-ProRule:PRU00409};		PATHWAY: Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 1/3. {ECO:0000269|PubMed:24332717}.; PATHWAY: Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 2/3. {ECO:0000269|PubMed:24332717}.; PATHWAY: Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 3/3. {ECO:0000269|PubMed:24332717}.				'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; animal organ regeneration [GO:0031100]; arginine biosynthetic process [GO:0006526]; cellular response to drug [GO:0035690]; cellular response to epidermal growth factor stimulus [GO:0071364]; citrulline biosynthetic process [GO:0019240]; drug metabolic process [GO:0017144]; female pregnancy [GO:0007565]; glutamine metabolic process [GO:0006541]; heart development [GO:0007507]; lactation [GO:0007595]; liver development [GO:0001889]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; pyrimidine nucleoside biosynthetic process [GO:0046134]; response to amine [GO:0014075]; response to caffeine [GO:0031000]; response to cortisol [GO:0051414]; response to insulin [GO:0032868]; response to starvation [GO:0042594]; response to testosterone [GO:0033574]; urea cycle [GO:0000050]; UTP biosynthetic process [GO:0006228]	cell projection [GO:0042995]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; terminal bouton [GO:0043195]	cell projection [GO:0042995]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; terminal bouton [GO:0043195]; aspartate binding [GO:0070335]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (ammonia) activity [GO:0004087]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; zinc ion binding [GO:0008270]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; animal organ regeneration [GO:0031100]; arginine biosynthetic process [GO:0006526]; cellular response to drug [GO:0035690]; cellular response to epidermal growth factor stimulus [GO:0071364]; citrulline biosynthetic process [GO:0019240]; drug metabolic process [GO:0017144]; female pregnancy [GO:0007565]; glutamine metabolic process [GO:0006541]; heart development [GO:0007507]; lactation [GO:0007595]; liver development [GO:0001889]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; pyrimidine nucleoside biosynthetic process [GO:0046134]; response to amine [GO:0014075]; response to caffeine [GO:0031000]; response to cortisol [GO:0051414]; response to insulin [GO:0032868]; response to starvation [GO:0042594]; response to testosterone [GO:0033574]; urea cycle [GO:0000050]; UTP biosynthetic process [GO:0006228]	aspartate binding [GO:0070335]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (ammonia) activity [GO:0004087]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; zinc ion binding [GO:0008270]	GO:0000050; GO:0001889; GO:0004070; GO:0004087; GO:0004088; GO:0004151; GO:0004672; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006207; GO:0006228; GO:0006526; GO:0006541; GO:0007507; GO:0007565; GO:0007595; GO:0008270; GO:0014075; GO:0016020; GO:0016363; GO:0017144; GO:0018107; GO:0019240; GO:0019899; GO:0031000; GO:0031100; GO:0032868; GO:0032991; GO:0033574; GO:0035690; GO:0042594; GO:0042802; GO:0042995; GO:0043025; GO:0043195; GO:0044205; GO:0046134; GO:0046777; GO:0051414; GO:0070062; GO:0070335; GO:0071364	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15890648}. Nucleus {ECO:0000269|PubMed:15890648}. Note=Cytosolic and unphosphorylated in resting cells, translocates to the nucleus in response to EGF stimulation, nuclear import promotes optimal cell growth.	PTM: Activated by MAP kinase (Erk1/2) phosphorylation just prior to the S phase of the cell cycle, when the demand for pyrimidine nucleotides is greatest, and down-regulated as the cells emerge from S phase by protein kinase A (PKA) phosphorylation. Phosphorylation at Ser-1859 by RPS6KB1 downstream of MTOR promotes oligomerization and stimulates dihydroorotase activity. Phosphorylation at Ser-1406 reduces sensitivy to feedback inhibition by UTP. {ECO:0000269|PubMed:17485345, ECO:0000269|PubMed:23429703, ECO:0000269|PubMed:23429704}.	MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378, ECO:0000269|Ref.4}.; MOD_RES 456 456 Phosphothreonine; by MAPK1. {ECO:0000269|PubMed:17485345}.; MOD_RES 747 747 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 1038 1038 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1406 1406 Phosphoserine; by PKA. {ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:17485345}.; MOD_RES 1411 1411 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 1556 1556 N6-carboxylysine. {ECO:0000269|PubMed:24332717}.; MOD_RES 1859 1859 Phosphoserine; by RPS6KB1 and PKA. {ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569, ECO:0000269|PubMed:17485345, ECO:0000269|PubMed:23429703, ECO:0000269|PubMed:23429704}.; MOD_RES 1873 1873 Phosphoserine; by PKC; in vitro. {ECO:0000269|PubMed:17485345}.; MOD_RES 1884 1884 Phosphothreonine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976}.; MOD_RES 1900 1900 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:23429703}.; MOD_RES 1938 1938 Phosphoserine. {ECO:0000244|PubMed:23186163}.	8619816; 15489334; 1979741; 7766613; 11872754; 15890648; 16155188; 17081983; 16964243; 17485345; 18691976; 18669648; 19413330; 19690332; 19608861; 20068231; 21269460; 21406692; 22223895; 22814378; 23186163; 23429704; 23429703; 24275569; 26657846; 24332717; 16959974; 25678555; 28087732; 12746293; 14559996; 14743216; 14991569; 15161933; 15621215; 17206380; 17266347; 17461779; 17721511; 18457437; 18679823; 18729074; 19156129; 19380743; 19486527; 19805454; 20085233; 20379614; 20562859; 20659789; 21575865; 21911578; 21982950; 22575643; 22593156; 22623428; 22677168; 22863774; 23143245; 23455922; 23594158; 23752268; 24189400; 24316846; 25422319; 25604459; 25609649; 25852190; 26446564; 26496610; 26638075; 26752685; 27265852; 28007989; 28368455; 28552578; 28833948; 2995985; 4684686	8619816; 15489334; 1979741; 7766613; 11872754; 15890648; 16155188; 17081983; 16964243; 17485345; 18691976; 18669648; 19413330; 19690332; 19608861; 20068231; 21269460; 21406692; 22223895; 22814378; 23186163; 23429704; 23429703; 24275569; 26657846; 24332717; 16959974; 25678555; 28087732
15635	PVR PVS	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=72 nM for VTN; 											adherens junction organization [GO:0034332]; cell recognition [GO:0008037]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target [GO:0002860]; regulation of immune response [GO:0050776]; susceptibility to natural killer cell mediated cytotoxicity [GO:0042271]; susceptibility to T cell mediated cytotoxicity [GO:0060370]	cell-cell adherens junction [GO:0005913]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; virus receptor activity [GO:0001618]; adherens junction organization [GO:0034332]; cell recognition [GO:0008037]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target [GO:0002860]; regulation of immune response [GO:0050776]; susceptibility to natural killer cell mediated cytotoxicity [GO:0042271]; susceptibility to T cell mediated cytotoxicity [GO:0060370]	cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; virus receptor activity [GO:0001618]	GO:0001618; GO:0002860; GO:0005102; GO:0005615; GO:0005737; GO:0005886; GO:0005887; GO:0005913; GO:0005925; GO:0007156; GO:0007157; GO:0008037; GO:0009986; GO:0016021; GO:0034332; GO:0038023; GO:0042271; GO:0042803; GO:0045954; GO:0050776; GO:0050839; GO:0060370	SUBCELLULAR LOCATION: Isoform Alpha: Cell membrane; Single-pass type I membrane protein.; SUBCELLULAR LOCATION: Isoform Delta: Cell membrane; Single-pass type I membrane protein.; SUBCELLULAR LOCATION: Isoform Beta: Secreted.; SUBCELLULAR LOCATION: Isoform Gamma: Secreted.	PTM: N-glycosylated. N-glycan at Asn-120: Hex5HexNAc4. {ECO:0000269|PubMed:16335952, ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:22171320}.; PTM: Phosphorylated by Src kinases on tyrosine residues in the ITIM motif upon ligation. Interaction with TIGIT is required for Phosphorylation. {ECO:0000269|PubMed:15194502, ECO:0000269|PubMed:22421438}.	MOD_RES 398 398 Phosphotyrosine. {ECO:0000269|PubMed:15194502, ECO:0000269|PubMed:22421438}.	2538245; 2170108; 14702039; 15057824; 15489334; 1851992; 1331527; 9616127; 11437656; 11751937; 11983699; 12759359; 15194502; 15039383; 15194795; 15471548; 16216929; 15034010; 16335952; 15607800; 15640804; 19159218; 19011627; 22171320; 25944712; 10618374; 12663789; 22421438; 12913096; 12943679; 14652024; 15076773; 15136589; 15279713; 15536144; 16904340; 17446174; 17507470; 17534374; 17717529; 17893876; 19011098; 19056733; 19319949; 19801517; 19815499; 20331633; 20634891; 21330602; 21383766; 21982860; 21988832; 21998457; 22169283; 22363471; 22692919; 22902367; 22929570; 23276719; 23333754; 23980210; 24045107; 24598754; 24817116; 24828608; 25113908; 25209846; 25320021; 25416956; 25609078; 25631086; 25862891; 25972481; 26842126; 27049654; 27296670; 27733551; 27834324; 28395975; 28730595; 28883004; 29381645	2538245; 2170108; 14702039; 15057824; 15489334; 1851992; 1331527; 9616127; 11437656; 11751937; 11983699; 12759359; 15194502; 15039383; 15194795; 15471548; 16216929; 15034010; 16335952; 15607800; 15640804; 19159218; 19011627; 22171320; 25944712; 10618374; 12663789; 22421438
15711	AK7	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.0 uM for AMP {ECO:0000269|PubMed:21080915}; KM=28 uM for dAMP {ECO:0000269|PubMed:21080915}; KM=1.2 uM for CMP {ECO:0000269|PubMed:21080915}; Vmax=1130 pmol/min/ug enzyme with AMP as substrate {ECO:0000269|PubMed:21080915}; Vmax=860 pmol/min/ug enzyme with dAMP as substrate {ECO:0000269|PubMed:21080915}; Vmax=150 pmol/min/ug enzyme with CMP as substrate {ECO:0000269|PubMed:21080915}; 	2.7.4.3; 2.7.4.6	CATALYTIC ACTIVITY: ATP + AMP = 2 ADP. {ECO:0000269|PubMed:21080915, ECO:0000269|PubMed:23416111}.; CATALYTIC ACTIVITY: ATP + nucleoside diphosphate = ADP + nucleoside triphosphate. {ECO:0000269|PubMed:23416111}.	BINDING 489 489 AMP. {ECO:0000250|UniProtKB:P69441}.; BINDING 555 555 AMP. {ECO:0000250|UniProtKB:P69441}.; BINDING 587 587 ATP; via carbonyl oxygen. {ECO:0000250|UniProtKB:P69441}.								cell projection organization [GO:0030030]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]	cytosol [GO:0005829]	cytosol [GO:0005829]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside kinase activity [GO:0019206]; cell projection organization [GO:0030030]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]	adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside kinase activity [GO:0019206]	GO:0004017; GO:0004127; GO:0004550; GO:0005524; GO:0005829; GO:0006165; GO:0009142; GO:0015949; GO:0019206; GO:0030030	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:21080915}. Cell projection, cilium, flagellum {ECO:0000269|PubMed:29365104}. Note=Detected along the full length of sperm flagellum, where it colocalizes with alpha-tubulin. {ECO:0000269|PubMed:29365104}.			14702039; 12508121; 21080915; 23416111; 29365104; 10215863; 20379614; 20537283; 22801010; 26496610	14702039; 12508121; 21080915; 23416111; 29365104
15712	AK9 AKD1 AKD2 C6orf199 C6orf224	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=48 uM for AMP (with ATP as phosphate donor) {ECO:0000269|PubMed:23416111}; KM=3600 uM for dAMP (with ATP as phosphate donor) {ECO:0000269|PubMed:23416111}; KM=940 uM for CMP (with ATP as phosphate donor) {ECO:0000269|PubMed:23416111}; 	2.7.4.4; 2.7.4.6	CATALYTIC ACTIVITY: ATP + nucleoside phosphate = ADP + nucleoside diphosphate. {ECO:0000269|PubMed:23416111}.; CATALYTIC ACTIVITY: ATP + nucleoside diphosphate = ADP + nucleoside triphosphate. {ECO:0000269|PubMed:23416111}.	BINDING 229 229 AMP 1. {ECO:0000250|UniProtKB:P69441}.; BINDING 1447 1447 AMP 3. {ECO:0000250|UniProtKB:P69441}.; BINDING 1506 1506 AMP 3. {ECO:0000250|UniProtKB:P69441}.; BINDING 1543 1543 AMP 3. {ECO:0000250|UniProtKB:P69441}.								AMP phosphorylation [GO:0006756]; ATP generation from ADP [GO:0006757]; CDP phosphorylation [GO:0061508]; CMP phosphorylation [GO:0061566]; dADP phosphorylation [GO:0006174]; dAMP phosphorylation [GO:0061565]; dCDP phosphorylation [GO:0061570]; dCMP phosphorylation [GO:0061567]; dGDP phosphorylation [GO:0006186]; GDP phosphorylation [GO:0061568]; nucleobase-containing small molecule interconversion [GO:0015949]; TDP phosphorylation [GO:0061571]; UDP phosphorylation [GO:0061569]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside kinase activity [GO:0019206]; nucleoside monophosphate kinase activity [GO:0050145]; AMP phosphorylation [GO:0006756]; ATP generation from ADP [GO:0006757]; CDP phosphorylation [GO:0061508]; CMP phosphorylation [GO:0061566]; dADP phosphorylation [GO:0006174]; dAMP phosphorylation [GO:0061565]; dCDP phosphorylation [GO:0061570]; dCMP phosphorylation [GO:0061567]; dGDP phosphorylation [GO:0006186]; GDP phosphorylation [GO:0061568]; nucleobase-containing small molecule interconversion [GO:0015949]; TDP phosphorylation [GO:0061571]; UDP phosphorylation [GO:0061569]	ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside kinase activity [GO:0019206]; nucleoside monophosphate kinase activity [GO:0050145]	GO:0004550; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006174; GO:0006186; GO:0006756; GO:0006757; GO:0015949; GO:0019206; GO:0031965; GO:0050145; GO:0061508; GO:0061565; GO:0061566; GO:0061567; GO:0061568; GO:0061569; GO:0061570; GO:0061571	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:23416111}. Nucleus {ECO:0000269|PubMed:23416111}.			14702039; 14574404; 15489334; 23416111; 10215863; 16169070; 20711500; 21080915	14702039; 14574404; 15489334; 23416111
15713	AK4 AK3 AK3L1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=5.3 uM for AMP with ATP as phosphate donor {ECO:0000269|PubMed:19766732}; KM=1.4 uM for AMP with GTP as phosphate donor {ECO:0000269|PubMed:19766732}; KM=507 uM for dAMP with ATP as phosphate donor {ECO:0000269|PubMed:19766732}; Vmax=90 pmol/min/ug enzyme with AMP as substrate and ATP as phosphate donor {ECO:0000269|PubMed:19766732}; Vmax=80 pmol/min/ug enzyme with AMP as substrate and GTP as phosphate donor {ECO:0000269|PubMed:19766732}; Vmax=88 pmol/min/ug enzyme with dAMP as substrate and ATP as phosphate donor {ECO:0000269|PubMed:19766732}; 	2.7.4.10; 2.7.4.6	CATALYTIC ACTIVITY: NTP + AMP = NDP + ADP. {ECO:0000255|HAMAP-Rule:MF_03170}.; CATALYTIC ACTIVITY: ATP + nucleoside diphosphate = ADP + nucleoside triphosphate. {ECO:0000255|HAMAP-Rule:MF_03170}.	BINDING 36 36 AMP. {ECO:0000255|HAMAP-Rule:MF_03170, ECO:0000269|Ref.13}.; BINDING 41 41 AMP. {ECO:0000255|HAMAP-Rule:MF_03170}.; BINDING 96 96 AMP. {ECO:0000255|HAMAP-Rule:MF_03170}.; BINDING 126 126 NTP. {ECO:0000255|HAMAP-Rule:MF_03170, ECO:0000269|Ref.13}.; BINDING 170 170 AMP. {ECO:0000255|HAMAP-Rule:MF_03170, ECO:0000269|Ref.13}.; BINDING 199 199 NTP; via carbonyl oxygen. {ECO:0000255|HAMAP-Rule:MF_03170, ECO:0000269|Ref.13}.								ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; brain development [GO:0007420]; GTP metabolic process [GO:0046039]; liver development [GO:0001889]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; response to drug [GO:0042493]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside monophosphate kinase activity [GO:0050145]; nucleoside triphosphate adenylate kinase activity [GO:0046899]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; brain development [GO:0007420]; GTP metabolic process [GO:0046039]; liver development [GO:0001889]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; response to drug [GO:0042493]	adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside monophosphate kinase activity [GO:0050145]; nucleoside triphosphate adenylate kinase activity [GO:0046899]	GO:0001889; GO:0004017; GO:0004550; GO:0005524; GO:0005525; GO:0005739; GO:0005759; GO:0006165; GO:0006172; GO:0007420; GO:0009142; GO:0015949; GO:0042493; GO:0046033; GO:0046034; GO:0046039; GO:0046899; GO:0050145	SUBCELLULAR LOCATION: Mitochondrion matrix {ECO:0000255|HAMAP-Rule:MF_03170, ECO:0000269|PubMed:11485571, ECO:0000269|PubMed:19766732}.		MOD_RES 60 60 N6-succinyllysine. {ECO:0000250|UniProtKB:Q9WUR9}.; MOD_RES 175 175 N6-acetyllysine. {ECO:0000250|UniProtKB:Q9WUR9}.; MOD_RES 179 179 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q9WUR9}.; MOD_RES 179 179 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q9WUR9}.; MOD_RES 186 186 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q9WUR9}.; MOD_RES 186 186 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q9WUR9}.	1639383; 14702039; 16710414; 15489334; 11485571; 19766732; 21269460; 23416111; 24275569; 25944712; 19073142; 20379614; 21900206; 21988832; 23002211; 23474458; 26058080; 26980435	1639383; 14702039; 16710414; 15489334; 11485571; 19766732; 21269460; 23416111; 24275569; 25944712; 19073142
15752	PXDN KIAA0230 MG50 PRG2 VPO VPO1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.15 mM for H(2)O(2) {ECO:0000269|PubMed:18929642}; 	1.11.1.7	CATALYTIC ACTIVITY: 2 phenolic donor + H(2)O(2) = 2 phenoxyl radical of the donor + 2 H(2)O. {ECO:0000269|PubMed:18929642, ECO:0000269|PubMed:19590037}.	BINDING 826 826 Heme (covalent; via 2 links). {ECO:0000250}.; BINDING 980 980 Heme (covalent; via 2 links). {ECO:0000250}.		COFACTOR: Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000250}; ;  Note=Binds 1 Ca(2+) ion per subunit. {ECO:0000250};; COFACTOR: Name=heme b; Xref=ChEBI:CHEBI:60344; ;  Note=Binds 1 heme b (iron(II)-protoporphyrin IX) group covalently per subunit.;			SITE 977 977 Transition state stabilizer. {ECO:0000255|PROSITE-ProRule:PRU00298}.			extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; heme binding [GO:0020037]; interleukin-1 receptor antagonist activity [GO:0005152]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979]	extracellular matrix structural constituent [GO:0005201]; heme binding [GO:0020037]; interleukin-1 receptor antagonist activity [GO:0005152]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]	GO:0004601; GO:0005152; GO:0005201; GO:0005576; GO:0005615; GO:0005783; GO:0006955; GO:0006979; GO:0020037; GO:0030198; GO:0031012; GO:0042744; GO:0046872; GO:0055114; GO:0062023; GO:0070062	SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix {ECO:0000269|PubMed:19590037, ECO:0000269|Ref.8}. Note=Enriched in the peritubular space of fibrotic kidneys.		MOD_RES 1176 1176 Phosphotyrosine. {ECO:0000244|PubMed:18318008}.; MOD_RES 1180 1180 Phosphoserine. {ECO:0000244|PubMed:18318008}.	10441517; 11103812; 18929642; 9039502; 15489334; 18318008; 19590037; 19159218; 21907015; 19724895; 19729652; 19851296; 20198315; 20379614; 20800603; 21798344; 21820048; 21988832; 22157634; 22526679; 22842973; 22982576; 24556843; 24895407; 24939590; 25713063; 26178375; 27167346; 27475679; 27697841; 28005267; 28154175; 28264790; 29305973	10441517; 11103812; 18929642; 9039502; 15489334; 18318008; 19590037; 19159218; 21907015
15834	CORIN CRN TMPRSS10	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.28 mM for pyroGlu-Phe-Lys-pNA.HCl {ECO:0000269|PubMed:14559895}; KM=3.52 mM for pyroGlu-Pro-Arg-pNA.HCl {ECO:0000269|PubMed:14559895}; KM=2.95 mM for H-D-Pro-Phe-Arg-pNA.2HCl {ECO:0000269|PubMed:14559895}; KM=1.92 mM for Bz-Ile-Glu-(gamma-OR)-Gly-Arg-pNA.HCl {ECO:0000269|PubMed:14559895}; KM=16 mM for pyroGlu-Gly-Arg-pNA.HCl {ECO:0000269|PubMed:14559895}; 	3.4.21.-			ACTIVITY REGULATION: Inhibited in a dose-dependent manner by non-specific trypsin-like serine protease inhibitors including benzamidine.				SITE 164 165 Cleavage; by autolysis.; SITE 427 428 Cleavage; by autolysis.; SITE 801 802 Cleavage. {ECO:0000305}.			female pregnancy [GO:0007565]; peptide hormone processing [GO:0016486]; regulation of blood pressure [GO:0008217]; regulation of cardiac conduction [GO:1903779]; regulation of renal sodium excretion [GO:0035813]; regulation of systemic arterial blood pressure by atrial natriuretic peptide [GO:0003050]	actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]	actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; female pregnancy [GO:0007565]; peptide hormone processing [GO:0016486]; regulation of blood pressure [GO:0008217]; regulation of cardiac conduction [GO:1903779]; regulation of renal sodium excretion [GO:0035813]; regulation of systemic arterial blood pressure by atrial natriuretic peptide [GO:0003050]	serine-type endopeptidase activity [GO:0004252]	GO:0003050; GO:0004252; GO:0005576; GO:0005886; GO:0005887; GO:0007565; GO:0008217; GO:0009986; GO:0015629; GO:0016021; GO:0016486; GO:0016604; GO:0035813; GO:1903779	SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:19751717, ECO:0000269|PubMed:21288900, ECO:0000269|PubMed:21518754}; Single-pass type II membrane protein {ECO:0000269|PubMed:19751717, ECO:0000269|PubMed:21288900, ECO:0000269|PubMed:21518754}. Note=May easily detached from the endothelial cell membrane.; SUBCELLULAR LOCATION: Isoform 2: Cell membrane; Single-pass type II membrane protein. Note=Less efficiently targeted to the cell membrane compared to isoform 1.; SUBCELLULAR LOCATION: Atrial natriuretic peptide-converting enzyme, 180 kDa soluble fragment: Secreted. Note=Soluble form produced following cleavage by ADAM10.; SUBCELLULAR LOCATION: Atrial natriuretic peptide-converting enzyme, 160 kDa soluble fragment: Secreted. Note=Soluble form produced following autocatalytic cleavage.; SUBCELLULAR LOCATION: Atrial natriuretic peptide-converting enzyme, 100 kDa soluble fragment: Secreted. Note=Soluble form produced following autocatalytic cleavage.	PTM: N-glycosylated; required for processing and activation. {ECO:0000269|PubMed:17660514, ECO:0000269|PubMed:21518754}.; PTM: Activated through proteolytic processing by a trypsin-like protease; cleaved into a N-terminal propeptide and an activated corin protease fragment. Different soluble forms are produced by cleavage and autocatalytic cleavage: Atrial natriuretic peptide-converting enzyme, 180 kDa soluble fragment is produced by cleavage by ADAM10, while 160 kDa and 100 kDa soluble fragments are produced by autocatalytic cleavage. Cleavage by ADAM10 to produce soluble 180 kDa soluble fragment takes place after the transmembrane region and before FZ 1.; PTM: A disulfide bond links the activated corin protease fragment and the N-terminal propeptide. The disulfide bond also links the activated corin protease fragment with soluble fragments (100 kDa, 160 kDa and 180 kDa fragments).		10329693; 15815621; 15489334; 11082206; 10880574; 14559895; 17660514; 19751717; 21288900; 21518754; 22437503; 17918732; 11884416; 12154094; 15192093; 16216958; 17296875; 17890485; 18669922; 19326473; 19913121; 19919978; 20613715; 20628086; 20670840; 20802129; 21216831; 22093942; 22987923; 23327554; 23372161; 23434834; 24015598; 24100222; 24828501; 25451932; 25474356; 25488193; 25516437; 25649697; 25663063; 25981578; 26022632; 26048191; 26086065; 26259032; 26344336; 26488448; 26577631; 27343265; 27871468; 27898523; 28005267; 28861913; 29370493	10329693; 15815621; 15489334; 11082206; 10880574; 14559895; 17660514; 19751717; 21288900; 21518754; 22437503; 17918732
15854	CYP19A1 ARO1 CYAR CYP19	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.46 uM for androstenedione {ECO:0000269|PubMed:27702664}; 	1.14.14.14	CATALYTIC ACTIVITY: Testosterone + 3 [reduced NADPH--hemoprotein reductase] + 3 O(2) = 17-beta-estradiol + formate + 4 H(2)O + 3 [oxidized NADPH--hemoprotein reductase]. {ECO:0000269|PubMed:27702664}.; CATALYTIC ACTIVITY: Androst-4-ene-3,17-dione + 3 [reduced NADPH--hemoprotein reductase] + 3 O(2) = estrone + formate + 4 H(2)O + 3 [oxidized NADPH--hemoprotein reductase]. {ECO:0000269|PubMed:27702664}.	BINDING 309 309 Substrate.; BINDING 374 374 Substrate; via amide nitrogen.		COFACTOR: Name=heme; Xref=ChEBI:CHEBI:30413; 						androgen catabolic process [GO:0006710]; estrogen biosynthetic process [GO:0006703]; female genitalia development [GO:0030540]; female gonad development [GO:0008585]; mammary gland development [GO:0030879]; negative regulation of chronic inflammatory response [GO:0002677]; negative regulation of macrophage chemotaxis [GO:0010760]; positive regulation of estradiol secretion [GO:2000866]; prostate gland growth [GO:0060736]; steroid biosynthetic process [GO:0006694]; sterol metabolic process [GO:0016125]; testosterone biosynthetic process [GO:0061370]; uterus development [GO:0060065]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; aromatase activity [GO:0070330]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; oxygen binding [GO:0019825]; steroid hydroxylase activity [GO:0008395]; androgen catabolic process [GO:0006710]; estrogen biosynthetic process [GO:0006703]; female genitalia development [GO:0030540]; female gonad development [GO:0008585]; mammary gland development [GO:0030879]; negative regulation of chronic inflammatory response [GO:0002677]; negative regulation of macrophage chemotaxis [GO:0010760]; positive regulation of estradiol secretion [GO:2000866]; prostate gland growth [GO:0060736]; steroid biosynthetic process [GO:0006694]; sterol metabolic process [GO:0016125]; testosterone biosynthetic process [GO:0061370]; uterus development [GO:0060065]	aromatase activity [GO:0070330]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; oxygen binding [GO:0019825]; steroid hydroxylase activity [GO:0008395]	GO:0002677; GO:0005506; GO:0005783; GO:0005789; GO:0006694; GO:0006703; GO:0006710; GO:0008395; GO:0008585; GO:0009055; GO:0010760; GO:0016020; GO:0016125; GO:0016712; GO:0019825; GO:0020037; GO:0030540; GO:0030879; GO:0060065; GO:0060736; GO:0061370; GO:0070330; GO:2000866	SUBCELLULAR LOCATION: Membrane; Peripheral membrane protein.	PTM: Phosphorylated in vitro by PKA and PKG/PRKG1. These phosphorylations inhibit the catalytic activity as measured by estrone synthesis from androstenedione (36% decrease for PKA and 30% for PKG/PRKG1). {ECO:0000269|PubMed:27702664}.		2973313; 3390233; 2848247; 2541021; 2808431; 2691883; 1371509; 16572171; 15489334; 3018730; 3653507; 2040633; 7690033; 3964273; 8117272; 19129847; 8265607; 8530621; 9211678; 9352581; 10956405; 18987736; 24705274; 27657680; 27702664; 11140838; 11181459; 11216915; 11232039; 11344237; 11549641; 11571725; 11595700; 11850203; 11850205; 11850206; 11850208; 11850209; 11850210; 11850219; 11850220; 11850221; 11850222; 11850224; 11850225; 11850230; 11850233; 11850235; 11897504; 11903314; 11904449; 11925378; 11927588; 11935306; 12036913; 12154211; 12160997; 12161013; 12161505; 12204674; 12213901; 12351690; 12370109; 12385014; 12428207; 12451990; 12462076; 12462077; 12466340; 12489562; 12517592; 12592380; 12602902; 12606587; 12618873; 12620480; 12639945; 12690088; 12705475; 12720534; 12734209; 12736278; 12759877; 12768436; 12788892; 12839940; 12843146; 12846271; 12864794; 12914527; 12917334; 12944421; 14508827; 14517714; 14580722; 14593077; 14602139; 14631363; 14634838; 14714492; 14715870; 14744739; 14747179; 14973387; 14981949; 14990865; 15046111; 15072827; 15072828; 15074077; 15079018; 15083376; 15083380; 15083381; 15126575; 15132727; 15177662; 15181061; 15183689; 15199113; 15207764; 15229337; 15241822; 15298966; 15330195; 15358790; 15364411; 15449726; 15582747; 15613678; 15640252; 15668497; 15677755; 15695318; 15748828; 15774541; 15794932; 15800924; 15802318; 15840311; 15862960; 15862961; 15862962; 15955695; 16019206; 16020944; 16024248; 16039845; 16045239; 16086586; 16103457; 16146740; 16199862; 16202920; 16213843; 16232327; 16244490; 16251630; 16251760; 16269961; 16287071; 16302261; 16303757; 16306085; 16322405; 16344016; 16392624; 16395678; 16402077; 16406421; 16418790; 16424004; 16426763; 16467490; 16473000; 16498360; 16498361; 16498363; 16498364; 16541304; 16556483; 16566930; 16595205; 16604491; 16608396; 16621515; 16634644; 16641167; 16648498; 16684355; 16691199; 16723309; 16730930; 16733710; 16739881; 16741831; 16767510; 16782804; 16793950; 16798289; 16850246; 16875543; 16882736; 16894362; 16895991; 16896040; 16930994; 16949385; 16949391; 16977255; 16997132; 17004113; 17065579; 17066438; 17118999; 17119036; 17158756; 17167982; 17174955; 17176215; 17187946; 17216495; 17219197; 1724289; 17325027; 17331471; 17336977; 17359589; 17372263; 17391072; 17400043; 17404019; 17405842; 17415442; 17482958; 17507620; 17507624; 17517397; 17562079; 17574328; 17584767; 17588204; 17589376; 17595315; 17615053; 17646720; 17657731; 17661084; 17662285; 17678915; 17681675; 17682677; 17687621; 17704407; 17766065; 17827443; 17893373; 17962916; 17975727; 17979523; 17989043; 17989068; 18030614; 18048499; 18049890; 18083712; 18086758; 18157729; 18159088; 18163429; 18181018; 18182446; 18199708; 18201819; 18245543; 18274619; 18281655; 18299793; 18305346; 18426832; 18437511; 18445666; 18467089; 18483177; 18483761; 18491956; 18497059; 18501301; 18505907; 18510611; 18512790; 18559914; 18568448; 18593984; 18595017; 18601603; 18614276; 18614591; 18617186; 18622258; 18629629; 18636124; 18667686; 18676680; 18817841; 18818748; 18820009; 18822378; 18847535; 18930188; 18941892; 18941913; 18955734; 18962445; 18980759; 19015200; 19019335; 19022561; 19064562; 19064572; 19064581; 19083124; 19093296; 19107851; 19116238; 19124504; 19124506; 19152063; 19158807; 19159688; 19170196; 19172223; 19174490; 19185610; 19194457; 19240151; 19282383; 19299445; 19324338; 19340622; 19366906; 19389254; 19415745; 19419293; 19438456; 19445691; 19453261; 19469636; 19478482; 19491387; 19493871; 19500729; 19505920; 19514368; 19527514; 19549443; 19551860; 19555469; 19556341; 19558171; 19570444; 19573564; 19574343; 19589174; 19591804; 19598235; 19604497; 19625176; 19630952; 19639193; 19692168; 19776291; 19782135; 19789370; 19800002; 19805543; 19808095; 19815003; 19818337; 19879925; 19883757; 19896534; 19906189; 19906814; 19913121; 19921206; 19933466; 19952760; 19956635; 19969081; 20004389; 20015405; 20026603; 20048079; 20052540; 20053928; 20060879; 20064870; 20072949; 20133979; 20140262; 20144226; 20148360; 20164038; 20164294; 20173016; 20184498; 20186154; 20189936; 20193327; 20200332; 20211687; 20214802; 20231365; 20300828; 20305046; 20351196; 20381444; 20385561; 20417295; 20430378; 20432167; 20453000; 20505544; 20526739; 20539301; 20546829; 20586553; 20588246; 20588308; 20628086; 20628746; 20634197; 20655525; 20668023; 20688833; 20716560; 20729390; 20734064; 20797716; 20819792; 20881004; 20932310; 20937744; 20960227; 21125383; 21154336; 21170323; 21188138; 21198743; 21217768; 21251330; 21269619; 21282199; 21296134; 21300759; 21319151; 21319995; 21320735; 21356374; 21377485; 21392518; 21392519; 21392520; 21414724; 21511357; 21622727; 21676395; 2171939; 21757507; 21771722; 21807013; 21939764; 21948762; 21952832; 21972004; 22057025; 22079757; 22089263; 22104650; 22106445; 22119029; 22130322; 22160249; 22185650; 22217837; 22237979; 22300440; 22315456; 22331461; 22335023; 22384274; 22407818; 22426781; 22448795; 22492871; 22508516; 22511967; 22576212; 22578533; 22633539; 22634420; 22638611; 22731640; 22759564; 22773874; 22843875; 22848710; 22887836; 22889864; 22902617; 22915343; 22951074; 23001776; 23029457; 23085504; 23090135; 23093430; 23110082; 23116507; 23122578; 23129173; 23178495; 23229009; 23239821; 23252370; 23253631; 23340254; 23342035; 23350368; 23438603; 23461365; 23518928; 23540392; 23584792; 23625277; 23625281; 23643682; 23660593; 23661022; 23669293; 23700878; 23727336; 23729401; 23736221; 23747729; 23748068; 23809139; 23846226; 23873111; 23893151; 23899247; 23932299; 24037887; 24064691; 24065098; 24157654; 24242679; 24285681; 24324964; 24347287; 24402127; 24411031; 24430361; 24448104; 24485503; 24556528; 24582702; 24590773; 24612204; 24621381; 24645879; 24654751; 24803183; 24803578; 24836190; 24855493; 24861259; 24997347; 25088806; 25124466; 25158681; 25203739; 25301327; 25374239; 25410472; 25425647; 25476497; 25481307; 25522654; 25634217; 25647083; 25697985; 25773531; 25793413; 25935582; 26002733; 26020632; 26049585; 26058395; 26059638; 26087061; 26096372; 26166720; 26191232; 26199450; 26209254; 26242176; 26252353; 26277097; 26323233; 26345775; 26394174; 26415088; 26426292; 26472556; 26562495; 26574572; 26631403; 26706698; 26897397; 26899323; 26921336; 26996624; 27012050; 27019440; 27029552; 27086564; 27102200; 27145040; 27165202; 27167072; 27224263; 27289045; 27320036; 27323034; 27324053; 27365044; 27467582; 27583919; 27602955; 27610593; 27616271; 27778160; 27833918; 27900579; 27920344; 27965096; 28024269; 28065637; 28089731; 28112739; 28178648; 28337664; 28364779; 28410957; 28489882; 28559115; 28571770; 28619249; 28660501; 28822806; 28888137; 28951168; 28992603; 29050673; 29104246; 29285776; 29329467; 29476820; 29629743; 8076586; 8477708; 9543166; 9829218	2973313; 3390233; 2848247; 2541021; 2808431; 2691883; 1371509; 16572171; 15489334; 3018730; 3653507; 2040633; 7690033; 3964273; 8117272; 19129847; 8265607; 8530621; 9211678; 9352581; 10956405; 18987736; 24705274; 27657680; 27702664
15861	CYP2C8	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=7.18 uM for paclitaxel {ECO:0000269|PubMed:26427316}; KM=1.35 uM for amodiaquine {ECO:0000269|PubMed:26427316}; Vmax=2.18 pmol/min/pmol enzyme with paclitaxel as substrate {ECO:0000269|PubMed:26427316}; Vmax=11.30 pmol/min/pmol enzyme with amodiaquine as substrate {ECO:0000269|PubMed:26427316}; 	1.14.14.1	CATALYTIC ACTIVITY: RH + [reduced NADPH--hemoprotein reductase] + O(2) = ROH + [oxidized NADPH--hemoprotein reductase] + H(2)O. {ECO:0000269|PubMed:7574697}.	BINDING 100 100 Substrate.; BINDING 204 204 Substrate.; BINDING 241 241 Substrate.		COFACTOR: Name=heme; Xref=ChEBI:CHEBI:30413; 						drug metabolic process [GO:0017144]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; lipid hydroxylation [GO:0002933]; long-chain fatty acid biosynthetic process [GO:0042759]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805]	endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]	endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; caffeine oxidase activity [GO:0034875]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; drug metabolic process [GO:0017144]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; lipid hydroxylation [GO:0002933]; long-chain fatty acid biosynthetic process [GO:0042759]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805]	arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; caffeine oxidase activity [GO:0034875]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]	GO:0002933; GO:0004497; GO:0005506; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008392; GO:0017144; GO:0019373; GO:0020037; GO:0031090; GO:0034875; GO:0042738; GO:0042759; GO:0055114; GO:0070330; GO:0070989; GO:0097267; GO:0101020	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Peripheral membrane protein. Microsome membrane; Peripheral membrane protein.		MOD_RES 100 100 Phosphoserine. {ECO:0000244|PubMed:24275569}.	3500169; 3697070; 2009263; 14702039; 15164054; 15489334; 1707679; 7574697; 3196692; 2729895; 2216732; 15365880; 24275569; 14676196; 18413310; 11668219; 12429347; 15469410; 26427316; 10383923; 10731522; 10741631; 11701230; 12629583; 14534525; 14646690; 14660610; 15196988; 15258110; 15289789; 15611369; 15864120; 16141797; 16359177; 16385451; 1664256; 17178266; 17241877; 17429317; 17558302; 18594024; 2025243; 20562859; 21081644; 21163940; 25814554; 497175; 6220203; 7625847; 7903454; 8627510; 8631948; 8637342; 8647857; 9028626; 9103523; 9435160; 9842986; 9866708; 9884161	3500169; 3697070; 2009263; 14702039; 15164054; 15489334; 1707679; 7574697; 3196692; 2729895; 2216732; 15365880; 24275569; 14676196; 18413310; 11668219; 12429347; 15469410; 26427316
15862	CYP2F1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.018 mM for 3-methylindole {ECO:0000269|PubMed:10383923, ECO:0000269|PubMed:1974816}; Vmax=51.2 pmol/min/mg enzyme toward ethoxy-coumarin {ECO:0000269|PubMed:10383923, ECO:0000269|PubMed:1974816}; Vmax=24.3 pmol/min/mg enzyme toward propoxy-coumarin {ECO:0000269|PubMed:10383923, ECO:0000269|PubMed:1974816}; Vmax=22 pmol/min/mg enzyme toward pentoxy-resorufin {ECO:0000269|PubMed:10383923, ECO:0000269|PubMed:1974816}; Vmax=2.29 pmol/min/mg enzyme toward benzyloxy-resorufin {ECO:0000269|PubMed:10383923, ECO:0000269|PubMed:1974816}; 	1.14.14.1	CATALYTIC ACTIVITY: RH + [reduced NADPH--hemoprotein reductase] + O(2) = ROH + [oxidized NADPH--hemoprotein reductase] + H(2)O. {ECO:0000269|PubMed:10383923, ECO:0000269|PubMed:1974816, ECO:0000269|PubMed:8558432}.			COFACTOR: Name=heme; Xref=ChEBI:CHEBI:30413; Evidence={ECO:0000250}; 						epoxygenase P450 pathway [GO:0019373]; naphthalene metabolic process [GO:0018931]; response to toxic substance [GO:0009636]; trichloroethylene metabolic process [GO:0018979]; xenobiotic metabolic process [GO:0006805]	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; organelle membrane [GO:0031090]	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; organelle membrane [GO:0031090]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; oxygen binding [GO:0019825]; steroid hydroxylase activity [GO:0008395]; epoxygenase P450 pathway [GO:0019373]; naphthalene metabolic process [GO:0018931]; response to toxic substance [GO:0009636]; trichloroethylene metabolic process [GO:0018979]; xenobiotic metabolic process [GO:0006805]	arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; oxygen binding [GO:0019825]; steroid hydroxylase activity [GO:0008395]	GO:0004497; GO:0005506; GO:0005789; GO:0006805; GO:0008392; GO:0008395; GO:0009636; GO:0016712; GO:0018931; GO:0018979; GO:0019373; GO:0019825; GO:0020037; GO:0031090; GO:0043231; GO:0070330	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000305|PubMed:10383923}; Peripheral membrane protein {ECO:0000305|PubMed:10383923}. Microsome membrane {ECO:0000269|PubMed:10383923}; Peripheral membrane protein {ECO:0000269|PubMed:10383923}.			1974816; 11827709; 17327131; 15057824; 15489334; 8619884; 8558432; 10383923; 10731522; 10741631; 11701230; 12598524; 12629583; 15196988; 15665333; 1664256; 16883522; 17943660; 19343046; 20198857; 2025243; 22232929; 22397853; 497175; 8627510; 8631948; 8637342; 8647857; 8913342; 9028626; 9103523; 9842986; 9884161	1974816; 11827709; 17327131; 15057824; 15489334; 8619884; 8558432; 10383923
15866	CYP4F2	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=74.8 uM for leukotriene-B(4) {ECO:0000269|PubMed:9799565}; KM=1.7 uM for menaquinone-4 (MK-4) {ECO:0000269|PubMed:24138531}; Vmax=2.42 nmol/min/mg enzyme {ECO:0000269|PubMed:9799565}; Note=kcat is 0.067 min(-1) with menaquinone-4 (MK-4) as substrate. {ECO:0000269|PubMed:24138531};	1.14.14.78; 1.14.14.-; 1.14.14.94	CATALYTIC ACTIVITY: (6Z,8E,10E,14Z)-(5S,12R)-5,12-dihydroxyicosa-6,8,10,14-tetraenoate + [reduced NADPH--hemoprotein reductase] + O(2) = (6Z,8E,10E,14Z)-(5S,12R)-5,12,20-trihydroxyicosa-6,8,10,14-tetraenoate + [oxidized NADPH--hemoprotein reductase] + H(2)O. {ECO:0000269|PubMed:8026587, ECO:0000269|PubMed:9799565}.; CATALYTIC ACTIVITY: Phylloquinone + [reduced NADPH--hemoprotein reductase] + O(2) = omega-hydroxyphylloquinone + [oxidized NADPH--hemoprotein reductase] + H(2)O. {ECO:0000269|PubMed:24138531}.; CATALYTIC ACTIVITY: (5Z,8Z,11Z,14Z)-icosatetraenoate + [reduced NADPH--hemoprotein reductase] + O(2) = (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoate + [oxidized NADPH--hemoprotein reductase] + H(2)O. {ECO:0000269|PubMed:10660572}.	BINDING 328 328 Heme (covalent; via 1 link). {ECO:0000250|UniProtKB:P24464}.		COFACTOR: Name=heme; Xref=ChEBI:CHEBI:30413; Evidence={ECO:0000250|UniProtKB:P24464}; 		PATHWAY: Cofactor degradation; phylloquinone degradation. {ECO:0000269|PubMed:24138531}.				arachidonic acid metabolic process [GO:0019369]; blood coagulation [GO:0007596]; drug metabolic process [GO:0017144]; epoxygenase P450 pathway [GO:0019373]; icosanoid metabolic process [GO:0006690]; leukotriene B4 catabolic process [GO:0036101]; leukotriene metabolic process [GO:0006691]; long-chain fatty acid metabolic process [GO:0001676]; menaquinone catabolic process [GO:0042361]; negative regulation of icosanoid secretion [GO:0032304]; omega-hydroxylase P450 pathway [GO:0097267]; oxidation-reduction process [GO:0055114]; phylloquinone catabolic process [GO:0042376]; positive regulation of icosanoid secretion [GO:0032305]; pressure natriuresis [GO:0003095]; regulation of blood pressure [GO:0008217]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078]; very long-chain fatty acid metabolic process [GO:0000038]; vitamin E metabolic process [GO:0042360]; vitamin K catabolic process [GO:0042377]	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; organelle membrane [GO:0031090]	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; organelle membrane [GO:0031090]; 20-aldehyde-leukotriene B4 20-monooxygenase activity [GO:0097259]; 20-hydroxy-leukotriene B4 omega oxidase activity [GO:0097258]; alkane 1-monooxygenase activity [GO:0018685]; alpha-tocopherol omega-hydroxylase activity [GO:0052871]; arachidonic acid epoxygenase activity [GO:0008392]; arachidonic acid omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; tocotrienol omega-hydroxylase activity [GO:0052872]; arachidonic acid metabolic process [GO:0019369]; blood coagulation [GO:0007596]; drug metabolic process [GO:0017144]; epoxygenase P450 pathway [GO:0019373]; icosanoid metabolic process [GO:0006690]; leukotriene B4 catabolic process [GO:0036101]; leukotriene metabolic process [GO:0006691]; long-chain fatty acid metabolic process [GO:0001676]; menaquinone catabolic process [GO:0042361]; negative regulation of icosanoid secretion [GO:0032304]; omega-hydroxylase P450 pathway [GO:0097267]; oxidation-reduction process [GO:0055114]; phylloquinone catabolic process [GO:0042376]; positive regulation of icosanoid secretion [GO:0032305]; pressure natriuresis [GO:0003095]; regulation of blood pressure [GO:0008217]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078]; very long-chain fatty acid metabolic process [GO:0000038]; vitamin E metabolic process [GO:0042360]; vitamin K catabolic process [GO:0042377]	20-aldehyde-leukotriene B4 20-monooxygenase activity [GO:0097259]; 20-hydroxy-leukotriene B4 omega oxidase activity [GO:0097258]; alkane 1-monooxygenase activity [GO:0018685]; alpha-tocopherol omega-hydroxylase activity [GO:0052871]; arachidonic acid epoxygenase activity [GO:0008392]; arachidonic acid omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; tocotrienol omega-hydroxylase activity [GO:0052872]	GO:0000038; GO:0001676; GO:0003091; GO:0003095; GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006690; GO:0006691; GO:0007596; GO:0008217; GO:0008392; GO:0016324; GO:0016709; GO:0017144; GO:0018685; GO:0019369; GO:0019373; GO:0020037; GO:0031090; GO:0032304; GO:0032305; GO:0036101; GO:0042360; GO:0042361; GO:0042376; GO:0042377; GO:0043231; GO:0050051; GO:0052869; GO:0052871; GO:0052872; GO:0055078; GO:0055114; GO:0097258; GO:0097259; GO:0097267	SUBCELLULAR LOCATION: Microsome membrane {ECO:0000269|PubMed:19297519, ECO:0000269|PubMed:24138531, ECO:0000269|PubMed:8026587}; Peripheral membrane protein {ECO:0000305}. Endoplasmic reticulum membrane {ECO:0000269|PubMed:20861217}; Peripheral membrane protein {ECO:0000305}.			8026587; 10492403; 14702039; 15057824; 15489334; 10860554; 9799565; 10660572; 17341693; 18574070; 18250228; 19270263; 19297519; 19207028; 20555338; 20861217; 23132553; 24138531; 24275569; 10405341; 10791960; 11162607; 12432928; 14660610; 15006160; 15258110; 15611369; 16733892; 17142457; 17284776; 17474147; 18065749; 18235092; 18391101; 18662666; 18787519; 18971550; 19097922; 19279555; 19300499; 19343046; 19545555; 19578179; 19794411; 19913121; 19957603; 19958090; 20072124; 20130494; 20149073; 20182420; 20227456; 20421126; 20442691; 20499136; 20504253; 20553802; 20628086; 20653676; 20833655; 21063236; 21084764; 21127708; 21475774; 21562135; 21625857; 21883387; 21887457; 22188360; 22198820; 22393834; 22452429; 22484021; 22528326; 22534826; 22549502; 22854539; 22855348; 23013706; 23018470; 23215885; 23510058; 23677510; 23726967; 23846787; 24029542; 24668751; 24858991; 24886380; 24911077; 24927344; 24956252; 24984178; 25042728; 25155935; 25356900; 25370453; 25521356; 25712182; 25730002; 25734770; 25747538; 26024874; 26176903; 26483195; 26634476; 26959478; 27052278; 27938396; 28062356; 2836406; 28521079; 28628909; 29426278; 29484037; 8914854; 9539102; 9618440	8026587; 10492403; 14702039; 15057824; 15489334; 10860554; 9799565; 10660572; 17341693; 18574070; 18250228; 19270263; 19297519; 19207028; 20555338; 20861217; 23132553; 24138531; 24275569
15870	CYP4A22	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=56.7 uM for laurate {ECO:0000269|PubMed:10860550}; Note=Vmax:15.2 umol/min/umol enzyme.;	1.14.14.80	CATALYTIC ACTIVITY: A long-chain fatty acid + [reduced NADPH--hemoprotein reductase] + O(2) = an omega-hydroxy-long-chain fatty acid + [oxidized NADPH--hemoprotein reductase] + H(2)O. {ECO:0000269|PubMed:10860550}.	BINDING 321 321 Heme (covalent; via 1 link). {ECO:0000250}.								lipid hydroxylation [GO:0002933]	endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; organelle membrane [GO:0031090]	endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; organelle membrane [GO:0031090]; 16-hydroxypalmitate dehydrogenase activity [GO:0103002]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; laurate hydroxylase activity [GO:0102116]; lipid hydroxylation [GO:0002933]	16-hydroxypalmitate dehydrogenase activity [GO:0103002]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; laurate hydroxylase activity [GO:0102116]	GO:0002933; GO:0005506; GO:0005615; GO:0005789; GO:0020037; GO:0031090; GO:0102116; GO:0103002	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Microsome membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}.		MOD_RES 440 440 Phosphoserine. {ECO:0000250|UniProtKB:P20816}.	10860550; 15611369; 16710414; 15489334; 16806293; 15006160; 18065749; 20079672; 21820496; 2836406; 8914854; 9539102; 9799565	10860550; 15611369; 16710414; 15489334; 16806293
15931	CYP1B1	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=6.0 uM for 17-beta-estradiol {ECO:0000269|PubMed:10426814, ECO:0000269|PubMed:15258110}; KM=17.0 uM for testosterone {ECO:0000269|PubMed:10426814, ECO:0000269|PubMed:15258110}; KM=24.0 uM for progesterone {ECO:0000269|PubMed:10426814, ECO:0000269|PubMed:15258110}; KM=18.5 uM for retinol {ECO:0000269|PubMed:10426814, ECO:0000269|PubMed:15258110}; KM=8.5 uM for retinal {ECO:0000269|PubMed:10426814, ECO:0000269|PubMed:15258110}; KM=29.8 uM for arachidonic acid {ECO:0000269|PubMed:10426814, ECO:0000269|PubMed:15258110}; KM=212.8 uM for 7,12-dimethyltetraphene {ECO:0000269|PubMed:10426814, ECO:0000269|PubMed:15258110}; Vmax=14.95 nmol/min/mg enzyme for 17-beta-estradiol 4-hydroxylation {ECO:0000269|PubMed:10426814, ECO:0000269|PubMed:15258110}; Vmax=6.9 nmol/min/mg enzyme for 17-beta-estradiol 2-hydroxylation {ECO:0000269|PubMed:10426814, ECO:0000269|PubMed:15258110}; Vmax=36.16 nmol/min/mg enzyme for testosterone 6-beta-hydroxylation {ECO:0000269|PubMed:10426814, ECO:0000269|PubMed:15258110}; Vmax=9.86 nmol/min/mg enzyme for progesterone 6-beta-hydroxylation {ECO:0000269|PubMed:10426814, ECO:0000269|PubMed:15258110}; Vmax=37.80 nmol/min/mg enzyme for progesterone 16-alpha-hydroxylation {ECO:0000269|PubMed:10426814, ECO:0000269|PubMed:15258110}; Note=kcat is 0.15 min(-1) for retinol, 0.77 min(-1) for retinal, 2.86 min(-1) for 7,12-dimethyltetraphene, 0.48 min(-1) for arachidonic acid.;	1.14.14.1	CATALYTIC ACTIVITY: RH + [reduced NADPH--hemoprotein reductase] + O(2) = ROH + [oxidized NADPH--hemoprotein reductase] + H(2)O. {ECO:0000269|PubMed:10426814, ECO:0000269|PubMed:22888116}.		ACTIVITY REGULATION: Enzyme activity is increased by liposomes containing anionic phospholipids, phosphatidic acid and cardiolipin. Inhibited by naringenin with an IC(50) of 5 uM. {ECO:0000269|PubMed:22888116, ECO:0000269|PubMed:22935222}.	COFACTOR: Name=heme; Xref=ChEBI:CHEBI:30413; Evidence={ECO:0000269|PubMed:21147782}; 			SITE 395 395 Major determinant of CYP1B1 17beta-estradiol hydroxylation regiospecificity.			angiogenesis [GO:0001525]; arachidonic acid metabolic process [GO:0019369]; blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cellular aromatic compound metabolic process [GO:0006725]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to organic cyclic compound [GO:0071407]; collagen fibril organization [GO:0030199]; endothelial cell-cell adhesion [GO:0071603]; endothelial cell migration [GO:0043542]; epoxygenase P450 pathway [GO:0019373]; estrogen metabolic process [GO:0008210]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; membrane lipid catabolic process [GO:0046466]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; nitric oxide biosynthetic process [GO:0006809]; omega-hydroxylase P450 pathway [GO:0097267]; oxidation-reduction process [GO:0055114]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JAK-STAT cascade [GO:0046427]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of reactive oxygen species metabolic process [GO:2000377]; retinal blood vessel morphogenesis [GO:0061304]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]; sterol metabolic process [GO:0016125]; toxin metabolic process [GO:0009404]; trabecular meshwork development [GO:0002930]; visual perception [GO:0007601]; xenobiotic metabolic process [GO:0006805]	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; organelle membrane [GO:0031090]	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; organelle membrane [GO:0031090]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; oxygen binding [GO:0019825]; angiogenesis [GO:0001525]; arachidonic acid metabolic process [GO:0019369]; blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cellular aromatic compound metabolic process [GO:0006725]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to organic cyclic compound [GO:0071407]; collagen fibril organization [GO:0030199]; endothelial cell migration [GO:0043542]; endothelial cell-cell adhesion [GO:0071603]; epoxygenase P450 pathway [GO:0019373]; estrogen metabolic process [GO:0008210]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; membrane lipid catabolic process [GO:0046466]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; nitric oxide biosynthetic process [GO:0006809]; omega-hydroxylase P450 pathway [GO:0097267]; oxidation-reduction process [GO:0055114]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JAK-STAT cascade [GO:0046427]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of reactive oxygen species metabolic process [GO:2000377]; retinal blood vessel morphogenesis [GO:0061304]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]; sterol metabolic process [GO:0016125]; toxin metabolic process [GO:0009404]; trabecular meshwork development [GO:0002930]; visual perception [GO:0007601]; xenobiotic metabolic process [GO:0006805]	aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; oxygen binding [GO:0019825]	GO:0001525; GO:0002930; GO:0004497; GO:0005506; GO:0005739; GO:0005789; GO:0006725; GO:0006805; GO:0006809; GO:0007155; GO:0007601; GO:0008202; GO:0008210; GO:0008285; GO:0008631; GO:0009404; GO:0010575; GO:0016125; GO:0016712; GO:0019369; GO:0019373; GO:0019825; GO:0020037; GO:0030199; GO:0030336; GO:0031090; GO:0032088; GO:0033629; GO:0042572; GO:0042574; GO:0043065; GO:0043231; GO:0043542; GO:0045766; GO:0046427; GO:0046466; GO:0048514; GO:0055114; GO:0061304; GO:0070301; GO:0070330; GO:0071407; GO:0071603; GO:0097267; GO:2000377	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Peripheral membrane protein. Microsome membrane; Peripheral membrane protein. Mitochondrion {ECO:0000250}.			8175734; 8910454; 15489334; 10426814; 11403040; 15258110; 22888116; 23821647; 22935222; 21147782; 9463332; 9497261; 9823305; 10227395; 10655546; 11184479; 10739169; 11527932; 11774072; 11980847; 12036985; 11854439; 14640114; 14635112; 12525557; 15342693; 15475877; 15255109; 16490498; 16688110; 16735994; 16862072; 18470941; 11221602; 11303589; 11389067; 11555828; 11558822; 11749050; 11955671; 12010864; 12183407; 12200121; 12372064; 12385014; 12415427; 12419832; 12432928; 12520071; 12567107; 12598442; 12602902; 12618873; 12692107; 12718576; 12770747; 12807732; 12837283; 12844487; 12873984; 14520706; 14562027; 14634838; 14656940; 14660610; 14729846; 14734460; 14744739; 14961553; 15037581; 15072827; 15075793; 15102677; 15122594; 15177664; 15199113; 15255550; 15285606; 15297370; 15299091; 15333708; 15342454; 15382051; 15386537; 15596250; 15611369; 15636228; 15654505; 15723004; 15733270; 15734954; 15734958; 15774541; 15777990; 15808404; 15861043; 15896461; 15905203; 15941966; 15958554; 15987428; 16006997; 16051642; 16103451; 16115918; 16172228; 16172230; 16202920; 16207128; 16260521; 16284375; 16319265; 16319821; 16384942; 16569655; 16598069; 16638984; 16730930; 16735991; 16766147; 16808847; 16847423; 16850246; 16864595; 16896040; 16949388; 16963504; 16977255; 16978616; 16985026; 16985250; 17035385; 17053044; 17063266; 17077994; 17157584; 17164573; 17187946; 17200336; 17220347; 17224759; 17224914; 17301257; 17311112; 17321191; 17353931; 17363580; 17372239; 17372243; 17403528; 17429315; 17449539; 17449559; 17458695; 17496311; 17498780; 17507616; 17507624; 17548691; 17562158; 17563717; 17575219; 17588204; 17589376; 17591938; 17603900; 17615053; 17627011; 17642299; 17687619; 17704407; 17718864; 17893647; 17914928; 17919675; 17922187; 17925548; 17980933; 18055790; 18059014; 18067928; 18070520; 18187806; 18227148; 18258609; 18268125; 18318428; 18347981; 18385784; 18414103; 18415014; 18425393; 18483560; 18486761; 18497059; 18510611; 18537981; 18544568; 18569579; 18569591; 18573508; 18575334; 18616618; 18622259; 18628428; 18632753; 18676680; 18763031; 18779756; 18784359; 18794456; 18820009; 18829176; 18841557; 18852424; 18922394; 18936436; 18977467; 18980759; 18989382; 18990750; 18992148; 19015200; 19031960; 19064581; 19074885; 19083124; 19094228; 19096718; 19116217; 19126602; 19127255; 19138996; 19170196; 19174490; 19179758; 19195637; 19199255; 19208203; 19214745; 19229255; 19234632; 19247456; 19274671; 19287966; 19290787; 19293312; 19324859; 19331196; 19338043; 19343046; 19349377; 19357154; 19383894; 19414505; 19415745; 19424633; 19424794; 19443378; 19453261; 19479063; 19505920; 19514368; 19528825; 19536304; 19574343; 19575027; 19582785; 19597567; 19598235; 19622003; 19625176; 19630952; 19643970; 19666078; 19668563; 19668597; 19690133; 19692168; 19730035; 19736056; 19744731; 19751749; 19754948; 19776291; 19789190; 19789301; 19793111; 19820397; 19822571; 19857456; 19860743; 19895167; 19898482; 19913121; 19956635; 19963139; 19995559; 20027111; 20029944; 20033481; 20037207; 20051892; 20054638; 20057908; 20088394; 20131310; 20151268; 20184498; 20198857; 20198978; 20212917; 20214802; 20357201; 20375710; 20391138; 20395011; 20403997; 20453000; 20461808; 20462226; 20492382; 20505544; 20529763; 20559649; 20568895; 20628086; 20632082; 20634197; 20634891; 20660114; 20664688; 20683028; 20701755; 20711500; 20734064; 20830506; 20845989; 20875115; 20878130; 20884258; 20887769; 21072184; 21081473; 21081970; 21139974; 21168818; 21191305; 21303932; 21306220; 21409489; 21438753; 21458313; 21596299; 21600657; 21655360; 21674184; 21683070; 21707071; 21742528; 21850185; 21854771; 22004014; 22011756; 22114726; 22128238; 22138065; 22177211; 22190224; 22232929; 22272893; 22296381; 22327650; 22374940; 22459615; 22466345; 22504876; 22509109; 22594779; 22859684; 22878448; 22942166; 23028769; 23032576; 23087145; 23215915; 23218183; 23218701; 23283740; 23325794; 23350153; 23350368; 23353840; 23370603; 23757320; 23767995; 23785672; 23794133; 23861929; 23873331; 23922489; 24001018; 24086543; 24099281; 24168324; 24210336; 24227805; 24281366; 24320736; 24343338; 24358191; 24453031; 24497629; 24535777; 24682418; 24695682; 24699256; 24777039; 24875910; 24911043; 24913727; 24926919; 24940937; 24957043; 24989113; 25018621; 25027399; 25051309; 25091052; 25115775; 25150952; 25261878; 25299224; 25304467; 25329831; 25333344; 25475389; 25504507; 25516145; 25527694; 25580891; 25619313; 25646030; 25658124; 25698578; 25750510; 25796598; 25826643; 25860934; 25950505; 25952714; 25978063; 25987236; 26081033; 26123186; 26164761; 26198313; 26225675; 26283052; 26466350; 26482777; 26507668; 26510398; 26550974; 26626260; 26647441; 26663047; 26681220; 26707614; 26981862; 26982174; 26990437; 27012269; 27060699; 27188524; 27235555; 27243976; 27268095; 27356703; 27399092; 27438756; 27495872; 27777502; 27779752; 27820421; 27854074; 27894333; 27922681; 28139960; 28251434; 28300467; 28377924; 28384041; 28388569; 28448622; 28556360; 28620713; 28644236; 28648140; 28858732; 28886471; 29080015; 29168043; 29267651; 7625847; 8631948; 9097971; 9435160; 9618440; 9866708	8175734; 8910454; 15489334; 10426814; 11403040; 15258110; 22888116; 23821647; 22935222; 21147782; 9463332; 9497261; 9823305; 10227395; 10655546; 11184479; 10739169; 11527932; 11774072; 11980847; 12036985; 11854439; 14640114; 14635112; 12525557; 15342693; 15475877; 15255109; 16490498; 16688110; 16735994; 16862072; 18470941
15932	CYP21A2 CYP21 CYP21B	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.59 uM for 17-hydroxyprogesterone {ECO:0000269|PubMed:22014889}; KM=12.5 uM for for 17-hydroxyprogesterone (at 37 degrees Celsius) {ECO:0000269|PubMed:27721825}; KM=1.05 uM for progesterone {ECO:0000269|PubMed:22014889}; Vmax=5.8 nmol/min/mg enzyme {ECO:0000269|PubMed:22014889}; Vmax=0.5 nmol/min/mg enzyme (at 37 degrees Celsius) {ECO:0000269|PubMed:27721825}; 	1.14.14.16	CATALYTIC ACTIVITY: A C(21) steroid + [reduced NADPH--hemoprotein reductase] + O(2) = a 21-hydroxy-C(21)-steroid + [oxidized NADPH--hemoprotein reductase] + H(2)O. {ECO:0000269|PubMed:16984992, ECO:0000269|PubMed:22014889, ECO:0000269|PubMed:25855791, ECO:0000269|PubMed:27721825}.	BINDING 233 233 Substrate. {ECO:0000269|PubMed:25855791}.		COFACTOR: Name=heme; Xref=ChEBI:CHEBI:30413; Evidence={ECO:0000269|PubMed:25855791}; 						glucocorticoid biosynthetic process [GO:0006704]; mineralocorticoid biosynthetic process [GO:0006705]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202]; sterol metabolic process [GO:0016125]	endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]	endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 21-monooxygenase activity [GO:0004509]; steroid binding [GO:0005496]; steroid hydroxylase activity [GO:0008395]; glucocorticoid biosynthetic process [GO:0006704]; mineralocorticoid biosynthetic process [GO:0006705]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202]; sterol metabolic process [GO:0016125]	heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 21-monooxygenase activity [GO:0004509]; steroid binding [GO:0005496]; steroid hydroxylase activity [GO:0008395]	GO:0004509; GO:0005496; GO:0005506; GO:0005789; GO:0006694; GO:0006704; GO:0006705; GO:0008202; GO:0008395; GO:0016125; GO:0020037; GO:0031090	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Peripheral membrane protein {ECO:0000269|PubMed:10198222}. Microsome membrane {ECO:0000269|PubMed:10198222}; Peripheral membrane protein {ECO:0000269|PubMed:10198222}.			3486422; 3487786; 3038528; 3267225; 1406709; 19505723; 14702039; 14574404; 15489334; 8485582; 3871526; 3257825; 3497399; 25855791; 1864962; 8081391; 3260007; 2303461; 1937474; 2072928; 1644925; 1406699; 1496017; 8478006; 7749410; 9067760; 9187661; 8989258; 9580109; 9497336; 10198222; 10364682; 10094562; 10408778; 10408786; 10443693; 10496074; 10051010; 10391209; 10720040; 11598371; 11232002; 11600539; 11746135; 12222711; 12050257; 12213891; 12887291; 12788866; 12915679; 14715874; 14676460; 15126570; 15110320; 16046588; 16984992; 18319307; 18381579; 18445671; 20080860; 21169732; 22014889; 27721825; 10072631; 10207042; 11073721; 11287026; 11581476; 11692155; 11836313; 12028996; 12038604; 12050231; 12121677; 12213672; 12370110; 12384784; 12464252; 12746407; 12788880; 12788889; 12855227; 12876419; 12966197; 14502362; 14514162; 14671153; 14676461; 14733808; 15004406; 15027205; 15493145; 15572419; 15598692; 15608154; 15627780; 15705377; 15751603; 15761541; 15775714; 15793784; 15818055; 15830218; 15858147; 15988383; 1605859; 16238926; 16427797; 16487445; 16500637; 16541276; 16648810; 16712666; 16728546; 16788163; 17033937; 17047018; 17119906; 17466088; 17505149; 17526939; 17551464; 17573904; 17666484; 17803691; 17878254; 18028896; 18039588; 18042312; 18179706; 18204270; 18392095; 18397975; 18478071; 18505908; 18589890; 18636124; 18702679; 18825878; 18973462; 19039234; 19058224; 19062540; 19085698; 19116923; 19135723; 19137635; 19158234; 19201236; 19208730; 19226270; 19272182; 19347184; 19420818; 19423540; 19449670; 19453261; 19501079; 19531083; 19624807; 19773403; 19799922; 19844122; 19856253; 19890026; 19925038; 19930153; 20029944; 20059433; 20070950; 20110635; 20132843; 20201644; 20233785; 20406964; 20423741; 20438785; 20587039; 20587610; 20617557; 20661889; 20671415; 20838032; 20926536; 20970527; 21117955; 21134444; 21164261; 21164262; 21175091; 21198393; 21264314; 21274396; 21446712; 21521936; 21534945; 21570420; 21609351; 21646284; 21750395; 21912141; 22001566; 22017335; 22020670; 22217838; 22308849; 22313422; 22497080; 22561756; 22802425; 22841790; 22873692; 22885098; 22886582; 22978668; 23027774; 23044877; 23045419; 23073904; 23142378; 23155693; 23211577; 23298233; 23313747; 23322511; 23329749; 23359706; 23370425; 23376085; 23386413; 23586722; 23692712; 24081139; 24312389; 24503005; 24667412; 24799024; 24928004; 25025300; 25041270; 25119915; 25210767; 25227725; 25249183; 25249698; 25319875; 25347332; 25386927; 25501839; 25630015; 25970792; 26172259; 26184415; 26206692; 26233337; 26278268; 26291314; 26331608; 26804566; 26903061; 27004467; 27041116; 27297501; 27380651; 27654981; 27709802; 27890570; 27966633; 28065637; 28392195; 28401898; 28415939; 2845408; 28521877; 28539365; 28639595; 28672743; 28844486; 29328376; 29419855; 3500473; 7677150; 8372604	3486422; 3487786; 3038528; 3267225; 1406709; 19505723; 14702039; 14574404; 15489334; 8485582; 3871526; 3257825; 3497399; 25855791; 1864962; 8081391; 3260007; 2303461; 1937474; 2072928; 1644925; 1406699; 1496017; 8478006; 7749410; 9067760; 9187661; 8989258; 9580109; 9497336; 10198222; 10364682; 10094562; 10408778; 10408786; 10443693; 10496074; 10051010; 10391209; 10720040; 11598371; 11232002; 11600539; 11746135; 12222711; 12050257; 12213891; 12887291; 12788866; 12915679; 14715874; 14676460; 15126570; 15110320; 16046588; 16984992; 18319307; 18381579; 18445671; 20080860; 21169732; 22014889; 27721825
15936	CYP26A1 CYP26 P450RAI1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.24 uM for tazarotenic acid (measured in vitro by the production of tazarotenic acid-sulfoxide) {ECO:0000269|PubMed:26937021}; KM=0.39 uM for tazarotenic acid (measured in vitro by the production of hydroxytazarotenic acid) {ECO:0000269|PubMed:26937021}; 	1.14.13.-				COFACTOR: Name=heme; Xref=ChEBI:CHEBI:30413; Evidence={ECO:0000250}; 						negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; response to retinoic acid [GO:0032526]; response to vitamin A [GO:0033189]; retinoic acid catabolic process [GO:0034653]; retinoic acid metabolic process [GO:0042573]; sterol metabolic process [GO:0016125]; vitamin metabolic process [GO:0006766]; xenobiotic metabolic process [GO:0006805]	endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]	endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; oxygen binding [GO:0019825]; retinoic acid 4-hydroxylase activity [GO:0008401]; retinoic acid binding [GO:0001972]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; response to retinoic acid [GO:0032526]; response to vitamin A [GO:0033189]; retinoic acid catabolic process [GO:0034653]; retinoic acid metabolic process [GO:0042573]; sterol metabolic process [GO:0016125]; vitamin metabolic process [GO:0006766]; xenobiotic metabolic process [GO:0006805]	heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; oxygen binding [GO:0019825]; retinoic acid 4-hydroxylase activity [GO:0008401]; retinoic acid binding [GO:0001972]	GO:0001972; GO:0005506; GO:0005789; GO:0006766; GO:0006805; GO:0008401; GO:0016125; GO:0016709; GO:0019825; GO:0020037; GO:0031090; GO:0032526; GO:0033189; GO:0034653; GO:0042573; GO:0048387	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Peripheral membrane protein. Microsome membrane; Peripheral membrane protein.			9228017; 9716180; 14702039; 15164054; 9826557; 26937021; 10823918; 14532297; 15281009; 16053444; 16194896; 16463413; 16778795; 16933217; 17059167; 17218384; 17460545; 18059332; 18992717; 19519282; 19553612; 19703508; 20167577; 20375987; 20513361; 20682464; 20693622; 21521770; 21529158; 21850183; 21975512; 22019272; 22020119; 22179182; 24819304; 25294402; 25492813; 25541526; 25839051; 26058854; 28754309	9228017; 9716180; 14702039; 15164054; 9826557; 26937021
15937	CYP2C9 CYP2C10	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.25 mM for S-mephenytoin {ECO:0000269|PubMed:3079764}; KM=46.24 uM for tolbutamide {ECO:0000269|PubMed:25994031}; KM=4.73 uM for diclofenac {ECO:0000269|PubMed:25994031}; KM=1.58 uM for losartan {ECO:0000269|PubMed:25994031}; Vmax=9.22 pmol/min/pmol enzyme with tolbutamide as substrate {ECO:0000269|PubMed:25994031}; Vmax=17.16 pmol/min/pmol enzyme with diclofenac as substrate {ECO:0000269|PubMed:25994031}; Vmax=210.30 pmol/min/pmol enzyme with losartan as substrate {ECO:0000269|PubMed:25994031}; 	1.14.14.-; 1.14.14.53; 1.14.14.51; 1.14.14.52	CATALYTIC ACTIVITY: (+)-(R)-limonene + [reduced NADPH--hemoprotein reductase] + O(2) = (+)-trans-carveol + [oxidized NADPH--hemoprotein reductase] + H(2)O. {ECO:0000269|PubMed:11950794}.; CATALYTIC ACTIVITY: (S)-limonene + [reduced NADPH--hemoprotein reductase] + O(2) = (-)-trans-carveol + [oxidized NADPH--hemoprotein reductase] + H(2)O. {ECO:0000269|PubMed:11950794}.; CATALYTIC ACTIVITY: (S)-limonene + [reduced NADPH--hemoprotein reductase] + O(2) = (-)-perillyl alcohol + [oxidized NADPH--hemoprotein reductase] + H(2)O. {ECO:0000269|PubMed:11950794}.; CATALYTIC ACTIVITY: Cholesterol + [reduced NADPH--hemoprotein reductase] + O(2) = 25-hydroxycholesterol + [oxidized NADPH--hemoprotein reductase] + H(2)O. {ECO:0000269|PubMed:21576599}.			COFACTOR: Name=heme; Xref=ChEBI:CHEBI:30413; 						cellular amide metabolic process [GO:0043603]; drug catabolic process [GO:0042737]; drug metabolic process [GO:0017144]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; long-chain fatty acid biosynthetic process [GO:0042759]; monocarboxylic acid metabolic process [GO:0032787]; monoterpenoid metabolic process [GO:0016098]; omega-hydroxylase P450 pathway [GO:0097267]; oxidation-reduction process [GO:0055114]; oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202]; urea metabolic process [GO:0019627]; xenobiotic metabolic process [GO:0006805]	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; organelle membrane [GO:0031090]	endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; organelle membrane [GO:0031090]; arachidonic acid epoxygenase activity [GO:0008392]; caffeine oxidase activity [GO:0034875]; drug binding [GO:0008144]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; steroid hydroxylase activity [GO:0008395]; cellular amide metabolic process [GO:0043603]; drug catabolic process [GO:0042737]; drug metabolic process [GO:0017144]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; long-chain fatty acid biosynthetic process [GO:0042759]; monocarboxylic acid metabolic process [GO:0032787]; monoterpenoid metabolic process [GO:0016098]; omega-hydroxylase P450 pathway [GO:0097267]; oxidation-reduction process [GO:0055114]; oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202]; urea metabolic process [GO:0019627]; xenobiotic metabolic process [GO:0006805]	arachidonic acid epoxygenase activity [GO:0008392]; caffeine oxidase activity [GO:0034875]; drug binding [GO:0008144]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; steroid hydroxylase activity [GO:0008395]	GO:0004497; GO:0005506; GO:0005789; GO:0006805; GO:0008144; GO:0008202; GO:0008392; GO:0008395; GO:0016098; GO:0016491; GO:0017144; GO:0019373; GO:0019627; GO:0020037; GO:0031090; GO:0032787; GO:0034875; GO:0042737; GO:0042738; GO:0042759; GO:0043231; GO:0043603; GO:0055114; GO:0070989; GO:0097267	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Peripheral membrane protein. Microsome membrane {ECO:0000269|PubMed:21576599}; Peripheral membrane protein.			2827463; 3697070; 14702039; 15164054; 15489334; 2963808; 3032244; 3196692; 1445376; 3079764; 3243766; 1857342; 8809086; 8215449; 11950794; 21576599; 24275569; 12861225; 8946475; 9110362; 10739176; 11455026; 11926893; 15469410; 21451434; 23582453; 24956244; 25994031; 10383923; 10731522; 10741631; 11127854; 11186133; 11298075; 11325819; 11372590; 11422024; 11434505; 11470765; 11503012; 11588061; 11678789; 11697742; 11701230; 11740344; 11833786; 11876753; 11893129; 11908757; 11911968; 11956512; 11960920; 11991950; 12010835; 12047484; 12152005; 12181452; 12207635; 12235454; 12359989; 12360109; 12406644; 12414349; 12419832; 12426520; 12435384; 12445031; 12451434; 12464247; 12496751; 12509498; 12534640; 12559973; 12603175; 12621390; 12629583; 12634980; 12668916; 12682803; 12698304; 12728288; 12732844; 12734606; 12800253; 12803577; 12805007; 12844136; 12879168; 12891229; 12913403; 12950145; 14500040; 14504850; 14520122; 14583800; 14614357; 14616425; 14634042; 14634838; 14646690; 14656880; 14660610; 14661864; 14676821; 14691573; 14691574; 14707031; 14726986; 14739630; 15001971; 15001972; 15005635; 15024534; 15048614; 15050794; 15061384; 15066644; 15070684; 15100169; 15102864; 15116052; 15116053; 15128048; 15145963; 15175798; 15177309; 15181000; 15196988; 15197523; 15199455; 15213846; 15222661; 15226678; 15229460; 15248218; 15258110; 15260906; 15284535; 15284536; 15289788; 15290664; 15369736; 15370961; 15371982; 15385837; 15452553; 15536456; 15569425; 15569819; 15592327; 15606435; 15606441; 15608560; 15611369; 15617742; 15632378; 15660966; 15691505; 15714076; 15742978; 15776277; 15790782; 15795654; 15813658; 15824753; 15841315; 15842554; 15855721; 15888487; 15889670; 15896241; 15900281; 15900282; 15919766; 15924351; 15940194; 15947090; 15961979; 15963101; 15970795; 16006997; 16025294; 16082538; 16094537; 16099926; 16111713; 16116487; 16141794; 16141797; 16160068; 16183265; 16187974; 16198655; 16198656; 16202848; 16220110; 16232205; 16236141; 16253141; 16268502; 16297214; 16303885; 16305586; 16305587; 16321620; 16325295; 16338275; 16342679; 16359177; 16385451; 16413010; 16424822; 16432637; 16538176; 16541193; 16552506; 16580898; 16595916; 16611750; 16627267; 16630605; 16635054; 16638864; 16639745; 1664256; 16646575; 16676068; 16699986; 16708125; 16740353; 16749864; 16771603; 16784736; 16797247; 16815313; 16847429; 16847664; 16863464; 16873909; 16878445; 16890578; 16924387; 16957870; 16969365; 16985026; 16985032; 17015052; 17048007; 17049586; 17085674; 17110455; 17111199; 17157122; 17167248; 17178267; 17192772; 17201743; 17226852; 17269966; 17279092; 17298483; 17301738; 17304159; 17324110; 17325732; 17329986; 17332144; 17368604; 17391071; 17397249; 17413769; 17418993; 17419358; 17446262; 17460547; 17479200; 17504998; 17510308; 17558303; 17562299; 17572144; 17577464; 17596133; 17596671; 17597710; 17603219; 17627011; 17627038; 17635176; 17635181; 17635185; 17653141; 17681167; 17686967; 17721328; 17764537; 17827141; 17827526; 17849045; 17851566; 17868191; 17895500; 17899045; 17900275; 17955230; 17989110; 18021343; 18024866; 18030307; 18034618; 18034619; 18061941; 18154472; 18183038; 18204476; 18216720; 18231117; 18240903; 18240905; 18252229; 18281915; 18303964; 18305455; 18310303; 18315785; 18322281; 18340006; 18356043; 18370846; 18375260; 18378563; 18399713; 18419640; 18425152; 18429757; 18466099; 18480003; 18485885; 18496131; 18496133; 18496682; 18511451; 18516070; 18535201; 18542936; 18548238; 18552123; 18559094; 18570163; 18574025; 18597650; 18629445; 18662264; 18669935; 18680736; 18681789; 18690342; 18694831; 18698879; 18754001; 18754597; 18756910; 18781852; 18816302; 18836275; 18854779; 18855533; 18922023; 18936436; 18950464; 18971529; 18990750; 18992148; 18992263; 18992346; 18996102; 19005461; 19010418; 19018719; 19026171; 19031075; 19053752; 19064572; 19074728; 19077919; 19082874; 19099951; 19106084; 19117406; 19135231; 19136640; 19139476; 19151603; 19164093; 19177029; 19181737; 19192051; 19199010; 19202563; 19207028; 19221727; 19223558; 19225451; 19233181; 19233910; 19258521; 19280158; 19290787; 19297219; 19300499; 19319511; 19324988; 19336370; 19337788; 19339270; 19343046; 19350405; 19369937; 19381162; 19381164; 19387626; 19414633; 19415745; 19415824; 19420105; 19424794; 19448135; 19450127; 19474452; 19480553; 19495518; 19534586; 19538716; 19538885; 19541511; 19545555; 19546880; 19567378; 19578179; 19581657; 19593158; 19593168; 19593208; 19604036; 19605743; 19615687; 19617466; 19652664; 19663669; 19663817; 19669737; 19692168; 19696793; 19706858; 19736056; 19745563; 19761366; 19794411; 19822571; 19823875; 19833260; 19847408; 19874474; 19881396; 19891553; 19891554; 19899329; 19903527; 19913121; 19925388; 19926050; 19934028; 19934793; 19935798; 19941044; 19942260; 19952982; 19954515; 19956635; 19958090; 19995889; 20029944; 20031551; 20043560; 20064729; 20072124; 20073138; 20075209; 20088379; 20089352; 20102361; 20117066; 20121287; 20131310; 20136364; 20147896; 20149073; 20150829; 20167002; 20173083; 20179710; 20204461; 20207952; 20210733; 20226775; 20228265; 20235787; 2025243; 20297661; 20339191; 20339978; 20351714; 20354686; 20359257; 20373852; 20375710; 20375999; 20376629; 20381283; 20386359; 20390258; 20403997; 20421126; 20430047; 20434758; 20436375; 20437850; 20442691; 20445534; 20453000; 20458343; 20459419; 20459744; 20488169; 20499136; 20504253; 20529763; 20553802; 20555338; 20569971; 20585445; 20585834; 20597268; 20602612; 20602615; 20602621; 20615525; 20628086; 20637959; 20653674; 20653676; 20656072; 20665013; 20677151; 20679960; 20709439; 20716240; 20722625; 20733952; 20808793; 20811787; 20815369; 20831047; 20831536; 20833655; 20833683; 20833980; 20842355; 20845310; 20852447; 20854800; 20857895; 20884456; 20885015; 20930419; 20937634; 20941486; 20946155; 20962433; 20970553; 21044367; 21047199; 21057703; 21063236; 21068649; 21071160; 21108610; 21110192; 21148049; 21160360; 21163940; 21167292; 21173785; 21213107; 21215088; 21248432; 21292004; 21334530; 21371265; 21375401; 21493749; 21537551; 21544933; 21597400; 21605066; 21638223; 21651319; 21691805; 21692828; 21725053; 21757329; 21766908; 21768671; 21786578; 21798861; 21852944; 21861665; 21883387; 21977947; 21985811; 21988832; 22023024; 22075408; 22075505; 22108774; 22188360; 22198820; 22252093; 22272893; 22289258; 22290467; 22294058; 22378156; 22393834; 22409277; 22452429; 22528326; 22533669; 22534826; 22547083; 22571356; 22589111; 22641027; 22735459; 22808915; 22842957; 22854539; 22855348; 22918969; 22941809; 22952875; 23065265; 23081681; 23089473; 23099353; 23113310; 23118231; 23145098; 23159358; 23159639; 23171336; 23183958; 23201087; 23279643; 23348161; 23358499; 23376925; 23446815; 23469989; 23473641; 23481074; 23556337; 23563037; 23577132; 23586031; 23651023; 23677510; 23688605; 23726967; 23732294; 23752738; 23755828; 23774101; 23775837; 23800980; 23834474; 23844998; 23849849; 23863877; 23930675; 23932037; 23941071; 23959274; 24024895; 24029542; 24038489; 24166101; 24222221; 24288737; 24322170; 24338437; 24340040; 24399734; 24403552; 24414392; 24430292; 24442125; 24464600; 24474498; 24492587; 24527758; 24530212; 24593903; 24601977; 24602049; 24615047; 24642031; 24797541; 24798722; 24830941; 24858991; 24889181; 24911077; 24917142; 24956252; 24960263; 24962733; 24966969; 24974237; 24978953; 24986093; 25041257; 25096692; 25099164; 25121365; 25142093; 25155935; 25182955; 25187307; 25241292; 25303293; 25304014; 25318916; 25332267; 25356900; 25391650; 25406731; 25492821; 25499099; 25518510; 25521356; 25552922; 25560189; 25560582; 25591012; 25644970; 25699611; 25704921; 25712185; 25712887; 25795462; 25802328; 25803758; 25823787; 25832633; 25904339; 25924705; 25943175; 25951663; 25967074; 25994870; 26010205; 26024874; 26050796; 26122019; 26122864; 26255664; 26402341; 26422867; 26467209; 26469104; 26554252; 26669712; 26690534; 26757860; 26894931; 26928377; 26984978; 27117036; 27130197; 27163851; 27179628; 27313202; 27353638; 27377818; 27490388; 27503578; 27511999; 27617498; 27661060; 27803446; 27826892; 27864660; 27878474; 27889507; 27938396; 28033245; 28063245; 28083852; 28157069; 28263279; 28284562; 28315807; 28370504; 28374982; 28403136; 28435143; 28609430; 28656666; 28682065; 28686288; 28687336; 28815830; 28834238; 28872889; 28877533; 28972767; 29023140; 29181698; 29273968; 29522717; 29787666; 497175; 6220203; 7625847; 7903454; 8627510; 8631948; 8637342; 8647857; 9028626; 9103523; 9435160; 9842986; 9866708; 9884161	2827463; 3697070; 14702039; 15164054; 15489334; 2963808; 3032244; 3196692; 1445376; 3079764; 3243766; 1857342; 8809086; 8215449; 11950794; 21576599; 24275569; 12861225; 8946475; 9110362; 10739176; 11455026; 11926893; 15469410; 21451434; 23582453; 24956244; 25994031
16014	COASY PSEC0106	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=7.6 mM for 4'-phoshopantetheine; KM=145 mM for ATP (in the PPAT reaction); KM=16.7 mM for dephospho-CoA; KM=34.4 mM for ATP (in the DPCK reaction); 	2.7.7.3; 2.7.1.24	CATALYTIC ACTIVITY: ATP + pantetheine 4'-phosphate = diphosphate + 3'-dephospho-CoA.; CATALYTIC ACTIVITY: ATP + 3'-dephospho-CoA = ADP + CoA.					PATHWAY: Cofactor biosynthesis; coenzyme A biosynthesis; CoA from (R)-pantothenate: step 4/5.; PATHWAY: Cofactor biosynthesis; coenzyme A biosynthesis; CoA from (R)-pantothenate: step 5/5.		PSEC0106		coenzyme A biosynthetic process [GO:0015937]; coenzyme biosynthetic process [GO:0009108]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; dephospho-CoA kinase activity [GO:0004140]; pantetheine-phosphate adenylyltransferase activity [GO:0004595]; coenzyme A biosynthetic process [GO:0015937]; coenzyme biosynthetic process [GO:0009108]	ATP binding [GO:0005524]; dephospho-CoA kinase activity [GO:0004140]; pantetheine-phosphate adenylyltransferase activity [GO:0004595]	GO:0004140; GO:0004595; GO:0005524; GO:0005654; GO:0005741; GO:0005759; GO:0005829; GO:0009108; GO:0015937; GO:0070062	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Mitochondrion matrix {ECO:0000269|PubMed:24360804}. Note=The protein is mainly present in the mitochondrial matrix, probably anchored to the inner mitochondrial membrane, but is also present in cell lysate.		MOD_RES 178 178 Phosphoserine. {ECO:0000244|PubMed:18088087, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:24275569}.; MOD_RES 183 183 Phosphoserine. {ECO:0000244|PubMed:20068231}.	11923312; 11994049; 14702039; 16625196; 15489334; 8529999; 16460672; 18088087; 19690332; 20068231; 21269460; 24360804; 24275569; 14514684; 15589845; 16189514; 19367725; 22623428; 22982864	11923312; 11994049; 14702039; 16625196; 15489334; 8529999; 16460672; 18088087; 19690332; 20068231; 21269460; 24360804; 24275569
16038	CYP4F11	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=53.5 uM for 3-hydroxystearate {ECO:0000269|PubMed:18065749}; KM=105.8 uM for 3-hydroxypalmitate {ECO:0000269|PubMed:18065749}; KM=2.4 uM for menaquinone-4 (MK-4) {ECO:0000269|PubMed:24138531}; KM=125 uM for erythromycin {ECO:0000269|PubMed:15364545}; Vmax=830 pmol/min/ng enzyme with erythromycin as substrate {ECO:0000269|PubMed:15364545}; Note=kcat is 0.088 min(-1) with menaquinone-4 (MK-4) as substrate. {ECO:0000269|PubMed:24138531};	1.14.14.78; 1.14.14.-	CATALYTIC ACTIVITY: Phylloquinone + [reduced NADPH--hemoprotein reductase] + O(2) = omega-hydroxyphylloquinone + [oxidized NADPH--hemoprotein reductase] + H(2)O. {ECO:0000269|PubMed:24138531}.	BINDING 328 328 Heme (covalent; via 1 link). {ECO:0000250|UniProtKB:P24464}.		COFACTOR: Name=heme; Xref=ChEBI:CHEBI:30413; Evidence={ECO:0000250|UniProtKB:P24464}; 		PATHWAY: Cofactor degradation; phylloquinone degradation. {ECO:0000269|PubMed:24138531}.				blood coagulation [GO:0007596]; fatty acid metabolic process [GO:0006631]; inflammatory response [GO:0006954]; menaquinone catabolic process [GO:0042361]; oxidation-reduction process [GO:0055114]; phylloquinone catabolic process [GO:0042376]; vitamin K catabolic process [GO:0042377]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]; fatty acid binding [GO:0005504]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; blood coagulation [GO:0007596]; fatty acid metabolic process [GO:0006631]; inflammatory response [GO:0006954]; menaquinone catabolic process [GO:0042361]; oxidation-reduction process [GO:0055114]; phylloquinone catabolic process [GO:0042376]; vitamin K catabolic process [GO:0042377]	fatty acid binding [GO:0005504]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]	GO:0004497; GO:0005504; GO:0005506; GO:0005789; GO:0006631; GO:0006954; GO:0007596; GO:0016021; GO:0016709; GO:0020037; GO:0031090; GO:0042361; GO:0042376; GO:0042377; GO:0055114	SUBCELLULAR LOCATION: Microsome membrane {ECO:0000269|PubMed:18065749}; Single-pass membrane protein {ECO:0000305}.			10964514; 14702039; 15057824; 15489334; 15364545; 18065749; 19932081; 24138531; 24275569; 15006160; 19812349; 20379614; 20689807; 21988832; 28347661; 2836406; 8914854; 9539102; 9799565	10964514; 14702039; 15057824; 15489334; 15364545; 18065749; 19932081; 24138531; 24275569
16171	CYP27B1 CYP1ALPHA CYP27B	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=2.7 uM for 25-hydroxyvitamin D3 {ECO:0000269|PubMed:10518789}; KM=1.1 uM for 24,25-dihydroxyvitamin D3 {ECO:0000269|PubMed:10518789}; Vmax=3.9 pmol/min/mg enzyme with 25-hydroxyvitamin D3 as substrate {ECO:0000269|PubMed:10518789}; Vmax=3.2 pmol/min/mg enzyme with 24,25-dihydroxyvitamin D3 as substrate {ECO:0000269|PubMed:10518789}; 	1.14.15.18	CATALYTIC ACTIVITY: Calcidiol + 2 reduced adrenodoxin + 2 H(+) + O(2) = calcitriol + 2 oxidized adrenodoxin + H(2)O. {ECO:0000269|PubMed:10518789}.; CATALYTIC ACTIVITY: Secalciferol + 2 reduced adrenodoxin + 2 H(+) + O(2) = calcitetrol + 2 oxidized adrenodoxin + H(2)O. {ECO:0000269|PubMed:10518789}.			COFACTOR: Name=heme; Xref=ChEBI:CHEBI:30413; Evidence={ECO:0000250}; 		PATHWAY: Hormone biosynthesis; cholecalciferol biosynthesis.				bone mineralization [GO:0030282]; calcitriol biosynthetic process from calciol [GO:0036378]; calcium ion homeostasis [GO:0055074]; calcium ion transport [GO:0006816]; decidualization [GO:0046697]; G1 to G0 transition [GO:0070314]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation [GO:0008285]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of vitamin D 24-hydroxylase activity [GO:0010980]; positive regulation of vitamin D receptor signaling pathway [GO:0070564]; regulation of bone mineralization [GO:0030500]; response to estrogen [GO:0043627]; response to interferon-gamma [GO:0034341]; response to lipopolysaccharide [GO:0032496]; response to vitamin D [GO:0033280]; vitamin D catabolic process [GO:0042369]; vitamin D metabolic process [GO:0042359]; vitamin metabolic process [GO:0006766]	cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]	cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; calcidiol 1-monooxygenase activity [GO:0004498]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; bone mineralization [GO:0030282]; calcitriol biosynthetic process from calciol [GO:0036378]; calcium ion homeostasis [GO:0055074]; calcium ion transport [GO:0006816]; decidualization [GO:0046697]; G1 to G0 transition [GO:0070314]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation [GO:0008285]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of vitamin D 24-hydroxylase activity [GO:0010980]; positive regulation of vitamin D receptor signaling pathway [GO:0070564]; regulation of bone mineralization [GO:0030500]; response to estrogen [GO:0043627]; response to interferon-gamma [GO:0034341]; response to lipopolysaccharide [GO:0032496]; response to vitamin D [GO:0033280]; vitamin D catabolic process [GO:0042369]; vitamin D metabolic process [GO:0042359]; vitamin metabolic process [GO:0006766]	calcidiol 1-monooxygenase activity [GO:0004498]; heme binding [GO:0020037]; iron ion binding [GO:0005506]	GO:0004498; GO:0005506; GO:0005737; GO:0005739; GO:0005741; GO:0006766; GO:0006816; GO:0008285; GO:0010956; GO:0010980; GO:0020037; GO:0030282; GO:0030308; GO:0030500; GO:0032496; GO:0033280; GO:0034341; GO:0036378; GO:0042359; GO:0042369; GO:0043627; GO:0045618; GO:0046697; GO:0055074; GO:0070314; GO:0070564	SUBCELLULAR LOCATION: Mitochondrion membrane.			9428799; 9344864; 9415400; 12496369; 14702039; 15489334; 10518789; 9486994; 9837822; 10320521; 10566658; 12050193; 11856765; 12039697; 12137802; 12161526; 12386916; 12457456; 12746631; 12855575; 14671156; 15225751; 15243130; 15296474; 15331405; 15589699; 15795327; 15947108; 15956353; 16061850; 16549446; 16720713; 17023519; 17079137; 17207990; 17223345; 17236759; 17254772; 17267208; 17287116; 17368179; 17395559; 17395703; 17426122; 17488797; 17606874; 17878529; 17932346; 18476984; 18495603; 18676680; 18689381; 18767073; 18767934; 18768522; 18843020; 19064572; 19154546; 19219539; 19255064; 19343046; 19453261; 19454612; 19505920; 19524013; 19525955; 19625176; 19667158; 19706847; 19783860; 19852851; 19891555; 19913121; 19951419; 19966181; 19998245; 20007432; 20082271; 20152900; 20304056; 20453000; 20518841; 20534770; 20619365; 20628086; 20648053; 20654748; 20687218; 20701904; 20809279; 20831823; 20847308; 20877624; 21107545; 21145801; 21440908; 21441443; 21542014; 21869486; 22190362; 22326730; 22443290; 22446158; 22511602; 22516854; 22547098; 22588163; 22612324; 22963605; 22995334; 23045480; 23063903; 23286944; 23334593; 23423976; 23444327; 23483640; 23614044; 23886824; 23894780; 24029861; 24158849; 24245571; 24308945; 24371450; 24471562; 24535953; 24576880; 24643654; 25060765; 25284246; 25371233; 25488826; 25501638; 25542806; 26124321; 26241700; 26291067; 26466946; 26575398; 26607259; 27016371; 27074284; 27175669; 27210415; 27287609; 27381199; 27399352; 27618536; 27904983; 27922682; 27977320; 28009432; 28033387; 28074193; 28594127; 28665452; 28665937; 28926322; 29110708; 29175129	9428799; 9344864; 9415400; 12496369; 14702039; 15489334; 10518789; 9486994; 9837822; 10320521; 10566658; 12050193
16173	CYP2R1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.67 uM for vitamin D(2) {ECO:0000269|PubMed:15465040, ECO:0000269|PubMed:18511070}; KM=0.45 uM for vitamin D(3) {ECO:0000269|PubMed:15465040, ECO:0000269|PubMed:18511070}; 	1.14.14.24	CATALYTIC ACTIVITY: Calciol + O(2) + [reduced NADPH--hemoprotein reductase] = calcidiol + [oxidized NADPH--hemoprotein reductase] + H(2)O. {ECO:0000269|PubMed:12867411, ECO:0000269|PubMed:15465040, ECO:0000269|PubMed:18511070}.	BINDING 250 250 Substrate; via carbonyl oxygen.		COFACTOR: Name=heme; Xref=ChEBI:CHEBI:30413; Evidence={ECO:0000250}; 						response to cesium ion [GO:0010164]; response to ionizing radiation [GO:0010212]; vitamin D metabolic process [GO:0042359]; vitamin metabolic process [GO:0006766]	endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]	endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; steroid hydroxylase activity [GO:0008395]; vitamin D3 25-hydroxylase activity [GO:0030343]; response to cesium ion [GO:0010164]; response to ionizing radiation [GO:0010212]; vitamin D metabolic process [GO:0042359]; vitamin metabolic process [GO:0006766]	heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; steroid hydroxylase activity [GO:0008395]; vitamin D3 25-hydroxylase activity [GO:0030343]	GO:0005506; GO:0005789; GO:0006766; GO:0008395; GO:0010164; GO:0010212; GO:0016705; GO:0020037; GO:0030343; GO:0031090; GO:0042359	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Peripheral membrane protein. Microsome membrane; Peripheral membrane protein.			12867411; 15465040; 15489334; 18511070; 15128933; 25942481; 16600026; 17223345; 17607662; 18476984; 19783860; 19852851; 20007432; 20418485; 20541252; 20619365; 20654748; 20809279; 21270327; 21441443; 22576297; 22583563; 22801813; 22855339; 23047203; 23063903; 23190755; 23734184; 23793229; 23826131; 24073854; 24128439; 24245571; 24497297; 24587115; 24732451; 24974252; 25003556; 25046415; 25070320; 25079458; 25208829; 25405862; 25527766; 25730676; 25845986; 26038244; 26149120; 26177022; 26383826; 26661839; 26911666; 27160686; 27314545; 27473187; 27473561; 27716192; 27977320; 28008453; 28757204; 28834557; 29528271	12867411; 15465040; 15489334; 18511070; 15128933; 25942481
16174	CYP2B6	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=360 uM for 1,4-cineole {ECO:0000269|PubMed:11695850}; Vmax=3.4 nmol/min/nmol enzyme toward 2-exo-hydroxy-1,4-cineole {ECO:0000269|PubMed:11695850}; 	1.14.13.-	CATALYTIC ACTIVITY: 1,4-cineole + NADPH + O(2) = 2-exo-hydroxy-1,4-cineole + NADP(+) + H(2)O. {ECO:0000269|PubMed:11695850}.			COFACTOR: Name=heme; Xref=ChEBI:CHEBI:30413; Evidence={ECO:0000269|PubMed:20061448, ECO:0000269|PubMed:21875942, ECO:0000269|PubMed:22909231}; 						cellular ketone metabolic process [GO:0042180]; drug metabolic process [GO:0017144]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; oxidation-reduction process [GO:0055114]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805]	endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]	endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]; arachidonic acid epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; cellular ketone metabolic process [GO:0042180]; drug metabolic process [GO:0017144]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; oxidation-reduction process [GO:0055114]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805]	arachidonic acid epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]	GO:0004497; GO:0005506; GO:0005789; GO:0006805; GO:0008202; GO:0008392; GO:0008395; GO:0016712; GO:0017144; GO:0019373; GO:0020037; GO:0031090; GO:0042180; GO:0042738; GO:0055114	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Peripheral membrane protein. Microsome membrane; Peripheral membrane protein.	PTM: Phosphorylation is accompanied by a decrease in enzyme activity. {ECO:0000250}.	MOD_RES 128 128 Phosphoserine; by PKA. {ECO:0000250}.	2573390; 14702039; 15057824; 2813061; 10768437; 11695850; 24275569; 20061448; 21875942; 22909231; 15622315; 20639527; 20860463; 11243870; 11470993; 12642465; 12721789; 14551287; 15190123; 15469410; 10383923; 10731522; 10741631; 11701230; 11991950; 12207635; 12242601; 12439223; 12490624; 12571232; 12629583; 12738724; 14515060; 14977870; 15178651; 15194512; 15196988; 15248218; 15284537; 15383491; 15563456; 15572372; 15825040; 15864119; 16116487; 16125881; 16183265; 16267764; 16338275; 16392089; 16433869; 16495778; 16506047; 16538176; 16623664; 1664256; 16772608; 16815693; 16912957; 16951995; 17015050; 17047492; 17054410; 17178267; 17223085; 17235330; 17329992; 17352764; 17356468; 17391322; 17407229; 17455229; 17465455; 17502835; 17559344; 17654295; 17682072; 17885627; 17900275; 17918089; 18004205; 18024866; 18057928; 18090046; 18171905; 18223457; 18281305; 18287571; 18303024; 18332083; 18496131; 18621926; 18728241; 18784455; 18839779; 18854779; 18978480; 18979093; 18989234; 19005482; 19076156; 19106084; 19124658; 19144407; 19218571; 19225447; 19228205; 19239339; 19282874; 19290787; 19343046; 19371316; 19376514; 19414633; 19425200; 19433561; 19464434; 19467232; 19474465; 19486190; 19531981; 19593168; 19659438; 19682083; 19693007; 19696793; 19702527; 19704172; 19779319; 19797611; 19812066; 19833192; 19916993; 19926050; 19944064; 20017669; 20079471; 20089352; 20096935; 20137387; 20173083; 20179710; 2025243; 20307138; 20338069; 20350955; 20361990; 20418888; 20459744; 20517174; 20529763; 20583967; 20602615; 20610889; 20622021; 20624854; 20625352; 20642445; 20662624; 20668445; 20677014; 20696882; 20720517; 20723261; 20734064; 20841522; 20861742; 20876786; 20878158; 20881953; 20952238; 20952418; 20966044; 20970553; 21108329; 21156812; 21158011; 21169260; 21486104; 21694616; 21715435; 21746968; 21790905; 21821736; 21886015; 22232427; 22281205; 22397853; 22462748; 22471906; 22519658; 22680342; 22685215; 22815312; 22936314; 22942317; 22950382; 23238783; 23249875; 23254426; 23288240; 23298916; 23344581; 23399569; 23524664; 23539296; 23550066; 23591849; 23615745; 23687222; 23746185; 23774940; 23786449; 23824676; 23834474; 23837472; 23840296; 23846872; 23886699; 23970651; 24128861; 24153159; 24260284; 24262967; 24293076; 24293093; 24445070; 24488272; 24497997; 24562623; 24586425; 24729586; 24831655; 24832206; 24885815; 24956253; 24988984; 25271170; 25303294; 25326287; 25409894; 25424204; 25489907; 25585967; 25677220; 25702819; 25722197; 25839716; 25933954; 26002734; 26107207; 26107645; 26126958; 26141406; 26319176; 26366873; 26544874; 26580670; 26602960; 26608082; 26648056; 26681005; 26830411; 26982502; 27010727; 27015760; 27045425; 27195527; 27208383; 27333947; 27388155; 27439448; 27509478; 27538916; 27665700; 27763887; 27826892; 27865701; 28081574; 28117133; 28145050; 28252572; 28320034; 28368100; 28389387; 28492729; 28646080; 28723731; 28816644; 28886044; 28931220; 29095103; 29463407; 29596329; 29637923; 497175; 8627510; 8631948; 8637342; 8647857; 8913342; 9028626; 9103523; 9842986; 9884161	2573390; 14702039; 15057824; 2813061; 10768437; 11695850; 24275569; 20061448; 21875942; 22909231; 15622315; 20639527; 20860463; 11243870; 11470993; 12642465; 12721789; 14551287; 15190123; 15469410
16177	CYP4F8	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=7 uM for 9-alpha,11-alpha-epoxymethano-PGH2 (U-44069); KM=40 uM for 6,9-alpha-methylene-PGI2; Note=The Vmax of the reaction with U-44069 as substrate is 260 pmol/min/pmol enzyme.;	1.14.14.1	CATALYTIC ACTIVITY: RH + [reduced NADPH--hemoprotein reductase] + O(2) = ROH + [oxidized NADPH--hemoprotein reductase] + H(2)O.			COFACTOR: Name=heme; Xref=ChEBI:CHEBI:30413; Evidence={ECO:0000250}; 						icosanoid metabolic process [GO:0006690]; prostaglandin metabolic process [GO:0006693]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]; alkane 1-monooxygenase activity [GO:0018685]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; icosanoid metabolic process [GO:0006690]; prostaglandin metabolic process [GO:0006693]	alkane 1-monooxygenase activity [GO:0018685]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]	GO:0004497; GO:0005506; GO:0005789; GO:0006690; GO:0006693; GO:0016021; GO:0018685; GO:0020037; GO:0031090; GO:0070330	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250}; Single-pass membrane protein {ECO:0000250}. Microsome membrane {ECO:0000250}.			10405341; 10791960; 12464258; 16112640; 15789615; 11162607; 19343046; 21281786; 2836406; 9539102; 9799565	10405341; 10791960; 12464258; 16112640; 15789615
16187	CPS1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.47 mM for ATP {ECO:0000269|PubMed:23649895}; KM=4.0 mM for HCO(3)(-) {ECO:0000269|PubMed:23649895}; KM=1.00 mM for NH(4)(+) {ECO:0000269|PubMed:23649895}; Vmax=1.22 umol/min/mg enzyme for ATP {ECO:0000269|PubMed:23649895}; Vmax=1.23 umol/min/mg enzyme for HCO(3)(-) {ECO:0000269|PubMed:23649895}; Vmax=1.19 umol/min/mg enzyme for NH(4)(+) {ECO:0000269|PubMed:23649895}; 	6.3.4.16	CATALYTIC ACTIVITY: 2 ATP + NH(3) + HCO(3)(-) = 2 ADP + phosphate + carbamoyl phosphate. {ECO:0000269|PubMed:23649895, ECO:0000269|PubMed:24813853}.	BINDING 1391 1391 Allosteric activator. {ECO:0000305}.; BINDING 1394 1394 Allosteric activator. {ECO:0000305}.; BINDING 1410 1410 Allosteric activator. {ECO:0000305}.; BINDING 1437 1437 Allosteric activator. {ECO:0000305}.; BINDING 1440 1440 Allosteric activator. {ECO:0000305}.; BINDING 1449 1449 Allosteric activator. {ECO:0000305}.	ACTIVITY REGULATION: Requires N-acetyl-L-glutamate (NAG) as an allosteric activator. Activated by glycerol in the absence of NAG, whereas in the presence of NAG it is inhibited by increasing concentrations of glycerol. {ECO:0000269|PubMed:19754428, ECO:0000269|PubMed:23649895}.							'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; anion homeostasis [GO:0055081]; arginine biosynthetic process [GO:0006526]; carbamoyl phosphate biosynthetic process [GO:0070409]; cellular response to ammonia [GO:1903718]; cellular response to cAMP [GO:0071320]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to glucagon stimulus [GO:0071377]; cellular response to oleic acid [GO:0071400]; citrulline biosynthetic process [GO:0019240]; glutamine metabolic process [GO:0006541]; hepatocyte differentiation [GO:0070365]; homocysteine metabolic process [GO:0050667]; midgut development [GO:0007494]; nitric oxide metabolic process [GO:0046209]; response to amine [GO:0014075]; response to amino acid [GO:0043200]; response to dexamethasone [GO:0071548]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to lipopolysaccharide [GO:0032496]; response to starvation [GO:0042594]; response to zinc ion [GO:0010043]; triglyceride catabolic process [GO:0019433]; urea cycle [GO:0000050]; vasodilation [GO:0042311]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; nucleolus [GO:0005730]; protein-containing complex [GO:0032991]	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; nucleolus [GO:0005730]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; carbamoyl-phosphate synthase (ammonia) activity [GO:0004087]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; endopeptidase activity [GO:0004175]; glutamate binding [GO:0016595]; modified amino acid binding [GO:0072341]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; anion homeostasis [GO:0055081]; arginine biosynthetic process [GO:0006526]; carbamoyl phosphate biosynthetic process [GO:0070409]; cellular response to ammonia [GO:1903718]; cellular response to cAMP [GO:0071320]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to glucagon stimulus [GO:0071377]; cellular response to oleic acid [GO:0071400]; citrulline biosynthetic process [GO:0019240]; glutamine metabolic process [GO:0006541]; hepatocyte differentiation [GO:0070365]; homocysteine metabolic process [GO:0050667]; midgut development [GO:0007494]; nitric oxide metabolic process [GO:0046209]; response to amine [GO:0014075]; response to amino acid [GO:0043200]; response to dexamethasone [GO:0071548]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to lipopolysaccharide [GO:0032496]; response to starvation [GO:0042594]; response to zinc ion [GO:0010043]; triglyceride catabolic process [GO:0019433]; urea cycle [GO:0000050]; vasodilation [GO:0042311]	ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; carbamoyl-phosphate synthase (ammonia) activity [GO:0004087]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; endopeptidase activity [GO:0004175]; glutamate binding [GO:0016595]; modified amino acid binding [GO:0072341]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]	GO:0000050; GO:0004087; GO:0004088; GO:0004175; GO:0005509; GO:0005524; GO:0005543; GO:0005730; GO:0005743; GO:0005759; GO:0006207; GO:0006526; GO:0006541; GO:0007494; GO:0010043; GO:0014075; GO:0016595; GO:0019240; GO:0019433; GO:0032094; GO:0032496; GO:0032991; GO:0042311; GO:0042594; GO:0042645; GO:0043200; GO:0044344; GO:0044877; GO:0046209; GO:0050667; GO:0055081; GO:0060416; GO:0070365; GO:0070409; GO:0071320; GO:0071377; GO:0071400; GO:0071548; GO:0072341; GO:1903718	SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:22002106}. Nucleus, nucleolus {ECO:0000269|PubMed:22002106}.	PTM: Undergoes proteolytic cleavage in the C-terminal region corresponding to the loss of approximately 12 AA residues from the C-terminus. {ECO:0000269|PubMed:23649895}.; PTM: Succinylated at Lys-287 and Lys-1291. Desuccinylated at Lys-1291 by SIRT5, leading to activation (By similarity). {ECO:0000250|UniProtKB:Q8C196}.; PTM: Glutarylated. Glutarylation levels increase during fasting. Deglutarylated by SIRT5 at Lys-55, Lys-219, Lys-412, Lys-889, Lys-892, Lys-915, Lys-1360 and Lys-1486, leading to activation. {ECO:0000269|PubMed:24703693}.	MOD_RES 55 55 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 55 55 N6-glutaryllysine; alternate. {ECO:0000269|PubMed:24703693}.; MOD_RES 55 55 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 57 57 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 57 57 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 119 119 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 119 119 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 148 148 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 157 157 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 157 157 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 171 171 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 171 171 N6-glutaryllysine; alternate. {ECO:0000269|PubMed:24703693}.; MOD_RES 176 176 N6-glutaryllysine. {ECO:0000269|PubMed:24703693}.; MOD_RES 182 182 N6-acetyllysine. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 197 197 N6-acetyllysine. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 207 207 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 207 207 N6-glutaryllysine; alternate. {ECO:0000269|PubMed:24703693}.; MOD_RES 207 207 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 210 210 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 210 210 N6-glutaryllysine; alternate. {ECO:0000269|PubMed:24703693}.; MOD_RES 214 214 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 214 214 N6-glutaryllysine; alternate. {ECO:0000269|PubMed:24703693}.; MOD_RES 214 214 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 219 219 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 219 219 N6-glutaryllysine; alternate. {ECO:0000269|PubMed:24703693}.; MOD_RES 228 228 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 228 228 N6-glutaryllysine; alternate. {ECO:0000269|PubMed:24703693}.; MOD_RES 237 237 N6-glutaryllysine. {ECO:0000269|PubMed:24703693}.; MOD_RES 280 280 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 280 280 N6-glutaryllysine; alternate. {ECO:0000269|PubMed:24703693}.; MOD_RES 287 287 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 287 287 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 307 307 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 307 307 N6-glutaryllysine; alternate. {ECO:0000269|PubMed:24703693}.; MOD_RES 307 307 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 310 310 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 310 310 N6-glutaryllysine; alternate. {ECO:0000269|PubMed:24703693}.; MOD_RES 400 400 N6-succinyllysine. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 402 402 N6-glutaryllysine; alternate. {ECO:0000269|PubMed:24703693}.; MOD_RES 402 402 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 412 412 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 412 412 N6-glutaryllysine; alternate. {ECO:0000269|PubMed:24703693}.; MOD_RES 412 412 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 453 453 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 453 453 N6-glutaryllysine; alternate. {ECO:0000269|PubMed:24703693}.; MOD_RES 458 458 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 458 458 N6-glutaryllysine; alternate. {ECO:0000269|PubMed:24703693}.; MOD_RES 458 458 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 522 522 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 522 522 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 527 527 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 527 527 N6-glutaryllysine; alternate. {ECO:0000269|PubMed:24703693}.; MOD_RES 527 527 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 532 532 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 532 532 N6-glutaryllysine; alternate. {ECO:0000269|PubMed:24703693}.; MOD_RES 537 537 Phosphoserine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 540 540 Phosphoserine. {ECO:0000250|UniProtKB:P07756}.; MOD_RES 553 553 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 553 553 N6-glutaryllysine; alternate. {ECO:0000269|PubMed:24703693}.; MOD_RES 553 553 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 560 560 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 560 560 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 569 569 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 575 575 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 575 575 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 612 612 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 612 612 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 630 630 N6-acetyllysine. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 728 728 N6-glutaryllysine. {ECO:0000269|PubMed:24703693}.; MOD_RES 751 751 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 751 751 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 757 757 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 757 757 N6-glutaryllysine; alternate. {ECO:0000269|PubMed:24703693}.; MOD_RES 757 757 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 772 772 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 772 772 N6-glutaryllysine; alternate. {ECO:0000269|PubMed:24703693}.; MOD_RES 793 793 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 793 793 N6-glutaryllysine; alternate. {ECO:0000269|PubMed:24703693}.; MOD_RES 793 793 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 811 811 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 811 811 N6-glutaryllysine; alternate. {ECO:0000269|PubMed:24703693}.; MOD_RES 831 831 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 831 831 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 835 835 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 841 841 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 841 841 N6-glutaryllysine; alternate. {ECO:0000269|PubMed:24703693}.; MOD_RES 856 856 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 856 856 N6-glutaryllysine; alternate. {ECO:0000269|PubMed:24703693}.; MOD_RES 869 869 N6-glutaryllysine. {ECO:0000269|PubMed:24703693}.; MOD_RES 875 875 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 875 875 N6-glutaryllysine; alternate. {ECO:0000269|PubMed:24703693}.; MOD_RES 875 875 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 889 889 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 889 889 N6-glutaryllysine; alternate. {ECO:0000269|PubMed:24703693}.; MOD_RES 889 889 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 892 892 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 892 892 N6-glutaryllysine; alternate. {ECO:0000269|PubMed:24703693}.; MOD_RES 892 892 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 896 896 Phosphoserine. {ECO:0000250|UniProtKB:P07756}.; MOD_RES 898 898 Phosphoserine. {ECO:0000250|UniProtKB:P07756}.; MOD_RES 905 905 N6-glutaryllysine. {ECO:0000269|PubMed:24703693}.; MOD_RES 908 908 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 908 908 N6-glutaryllysine; alternate. {ECO:0000269|PubMed:24703693}.; MOD_RES 915 915 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 915 915 N6-glutaryllysine; alternate. {ECO:0000269|PubMed:24703693}.; MOD_RES 915 915 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 919 919 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 919 919 N6-glutaryllysine; alternate. {ECO:0000269|PubMed:24703693}.; MOD_RES 919 919 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 935 935 N6-acetyllysine. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 1036 1036 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1074 1074 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 1074 1074 N6-glutaryllysine; alternate. {ECO:0000269|PubMed:24703693}.; MOD_RES 1074 1074 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 1079 1079 Phosphoserine. {ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 1090 1090 Phosphoserine. {ECO:0000250|UniProtKB:P07756}.; MOD_RES 1093 1093 Phosphoserine. {ECO:0000250|UniProtKB:P07756}.; MOD_RES 1100 1100 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 1100 1100 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 1149 1149 N6-succinyllysine. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 1150 1150 N6-glutaryllysine. {ECO:0000269|PubMed:24703693}.; MOD_RES 1168 1168 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 1168 1168 N6-glutaryllysine; alternate. {ECO:0000269|PubMed:24703693}.; MOD_RES 1168 1168 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 1183 1183 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 1183 1183 N6-glutaryllysine; alternate. {ECO:0000269|PubMed:24703693}.; MOD_RES 1183 1183 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 1203 1203 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 1222 1222 N6-acetyllysine. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 1224 1224 N6-glutaryllysine. {ECO:0000269|PubMed:24703693}.; MOD_RES 1232 1232 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 1232 1232 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 1269 1269 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 1269 1269 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 1291 1291 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 1291 1291 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 1356 1356 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 1356 1356 N6-glutaryllysine; alternate. {ECO:0000269|PubMed:24703693}.; MOD_RES 1356 1356 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 1360 1360 N6-glutaryllysine; alternate. {ECO:0000269|PubMed:24703693}.; MOD_RES 1360 1360 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 1419 1419 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 1431 1431 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 1444 1444 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 1444 1444 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 1471 1471 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 1471 1471 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 1479 1479 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 1479 1479 N6-glutaryllysine; alternate. {ECO:0000269|PubMed:24703693}.; MOD_RES 1479 1479 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 1486 1486 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.; MOD_RES 1486 1486 N6-glutaryllysine; alternate. {ECO:0000269|PubMed:24703693}.; MOD_RES 1486 1486 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8C196}.	1840546; 9711878; 12853138; 12955727; 12655559; 14702039; 15815621; 15489334; 17974005; 19754428; 21269460; 22002106; 23186163; 24703693; 24275569; 11388595; 11474210; 11407344; 15617192; 15164414; 16737834; 17310273; 20578160; 20520828; 21120950; 21767969; 22173106; 23649895; 24237036; 24813853; 26440671; 27535533; 12620389; 14718356; 15161933; 17188582; 17597649; 19410549; 19793055; 19913121; 19926579; 20000738; 20031577; 20031578; 20154341; 20360068; 20379614; 20383146; 20456087; 20618440; 20628086; 20659789; 20800523; 20869947; 20877624; 21281797; 21837743; 22521883; 22692827; 24888247; 24924744; 25099619; 25111069; 25410056; 25609649; 26059772; 26496610; 26499888; 26592762; 26822151; 26938218; 27425868; 27833157; 28272778; 28376202; 28538732; 29138502; 29441491; 6249820	1840546; 9711878; 12853138; 12955727; 12655559; 14702039; 15815621; 15489334; 17974005; 19754428; 21269460; 22002106; 23186163; 24703693; 24275569; 11388595; 11474210; 11407344; 15617192; 15164414; 16737834; 17310273; 20578160; 20520828; 21120950; 21767969; 22173106; 23649895; 24237036; 24813853; 26440671; 27535533
16212	CRYL1 CRY	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.01 mM for NAD {ECO:0000269|PubMed:15809331}; KM=0.0008 mM for NADH {ECO:0000269|PubMed:15809331}; 	1.1.1.45	CATALYTIC ACTIVITY: L-gulonate + NAD(+) = 3-dehydro-L-gulonate + NADH.	BINDING 36 36 NAD. {ECO:0000269|Ref.11}.; BINDING 97 97 NAD. {ECO:0000269|Ref.11}.; BINDING 102 102 NAD. {ECO:0000269|Ref.11}.	ACTIVITY REGULATION: Inhibited by malonate. {ECO:0000269|PubMed:15809331}.							fatty acid metabolic process [GO:0006631]; glucuronate catabolic process to xylulose 5-phosphate [GO:0019640]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; L-gulonate 3-dehydrogenase activity [GO:0050104]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803]; fatty acid metabolic process [GO:0006631]; glucuronate catabolic process to xylulose 5-phosphate [GO:0019640]	3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; L-gulonate 3-dehydrogenase activity [GO:0050104]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803]	GO:0003857; GO:0005829; GO:0006631; GO:0019640; GO:0042803; GO:0050104; GO:0070062; GO:0070403	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.		MOD_RES 2 2 N-acetylalanine. {ECO:0000250|UniProtKB:P14755}.; MOD_RES 3 3 Phosphoserine. {ECO:0000250|UniProtKB:Q811X6}.; MOD_RES 111 111 Phosphoserine. {ECO:0000244|PubMed:24275569}.	12527201; 14702039; 15057823; 15489334; 15809331; 21269460; 24275569; 21988832; 28489570; 3170592	12527201; 14702039; 15057823; 15489334; 15809331; 21269460; 24275569; 
16231	CYP1A2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=4 uM for 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole {ECO:0000269|PubMed:14725854}; KM=21 uM for 2-amino-3-methylimidazo[4,5-f]quinoline {ECO:0000269|PubMed:14725854}; KM=26 uM for 2-amino-2,4-dimethylimidazo[4,5-f]quinoline {ECO:0000269|PubMed:14725854}; KM=27 uM for 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline {ECO:0000269|PubMed:14725854}; KM=71 uM for 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine {ECO:0000269|PubMed:14725854}; KM=25 uM for phenacetin {ECO:0000269|PubMed:14725854}; 	1.14.14.1	CATALYTIC ACTIVITY: RH + [reduced NADPH--hemoprotein reductase] + O(2) = ROH + [oxidized NADPH--hemoprotein reductase] + H(2)O. {ECO:0000269|PubMed:21576599}.	BINDING 226 226 Substrate. {ECO:0000305}.		COFACTOR: Name=heme; Xref=ChEBI:CHEBI:30413; 						alkaloid metabolic process [GO:0009820]; cellular respiration [GO:0045333]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; dibenzo-p-dioxin metabolic process [GO:0018894]; drug catabolic process [GO:0042737]; drug metabolic process [GO:0017144]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; heterocycle metabolic process [GO:0046483]; hydrogen peroxide biosynthetic process [GO:0050665]; long-chain fatty acid biosynthetic process [GO:0042759]; lung development [GO:0030324]; methylation [GO:0032259]; monocarboxylic acid metabolic process [GO:0032787]; monoterpenoid metabolic process [GO:0016098]; omega-hydroxylase P450 pathway [GO:0097267]; oxidation-reduction process [GO:0055114]; oxidative deethylation [GO:0071615]; oxidative demethylation [GO:0070989]; porphyrin-containing compound metabolic process [GO:0006778]; post-embryonic development [GO:0009791]; regulation of gene expression [GO:0010468]; response to estradiol [GO:0032355]; response to immobilization stress [GO:0035902]; response to lipopolysaccharide [GO:0032496]; steroid catabolic process [GO:0006706]; toxin biosynthetic process [GO:0009403]; xenobiotic metabolic process [GO:0006805]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; organelle membrane [GO:0031090]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; organelle membrane [GO:0031090]; aromatase activity [GO:0070330]; caffeine oxidase activity [GO:0034875]; demethylase activity [GO:0032451]; electron transfer activity [GO:0009055]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; alkaloid metabolic process [GO:0009820]; cellular respiration [GO:0045333]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; dibenzo-p-dioxin metabolic process [GO:0018894]; drug catabolic process [GO:0042737]; drug metabolic process [GO:0017144]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; heterocycle metabolic process [GO:0046483]; hydrogen peroxide biosynthetic process [GO:0050665]; long-chain fatty acid biosynthetic process [GO:0042759]; lung development [GO:0030324]; methylation [GO:0032259]; monocarboxylic acid metabolic process [GO:0032787]; monoterpenoid metabolic process [GO:0016098]; omega-hydroxylase P450 pathway [GO:0097267]; oxidation-reduction process [GO:0055114]; oxidative deethylation [GO:0071615]; oxidative demethylation [GO:0070989]; porphyrin-containing compound metabolic process [GO:0006778]; post-embryonic development [GO:0009791]; regulation of gene expression [GO:0010468]; response to estradiol [GO:0032355]; response to immobilization stress [GO:0035902]; response to lipopolysaccharide [GO:0032496]; steroid catabolic process [GO:0006706]; toxin biosynthetic process [GO:0009403]; xenobiotic metabolic process [GO:0006805]	aromatase activity [GO:0070330]; caffeine oxidase activity [GO:0034875]; demethylase activity [GO:0032451]; electron transfer activity [GO:0009055]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]	GO:0004497; GO:0005506; GO:0005789; GO:0006706; GO:0006778; GO:0006805; GO:0009055; GO:0009403; GO:0009791; GO:0009820; GO:0010468; GO:0016021; GO:0016098; GO:0016491; GO:0016712; GO:0017144; GO:0018894; GO:0019373; GO:0019899; GO:0020037; GO:0030324; GO:0031090; GO:0032259; GO:0032355; GO:0032451; GO:0032496; GO:0032787; GO:0034875; GO:0035902; GO:0042737; GO:0042738; GO:0042759; GO:0043231; GO:0045333; GO:0046483; GO:0050665; GO:0055114; GO:0070330; GO:0070989; GO:0071276; GO:0071280; GO:0071615; GO:0097267	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Peripheral membrane protein. Microsome membrane {ECO:0000269|PubMed:21576599}; Peripheral membrane protein.			3755823; 3462722; 2575218; 3681487; 11207026; 15489334; 3517618; 3000715; 14725854; 21576599; 24275569; 17311915; 9884316; 11295848; 14563787; 15469410; 15770072; 15643613; 16522833; 10791558; 11153915; 11186132; 11275366; 11393588; 11470995; 11496364; 11501059; 11507974; 11749050; 11763009; 11782366; 11791895; 11817502; 11943609; 12067576; 12147246; 12181774; 12419832; 12432928; 12445029; 12445035; 12484238; 12534642; 12566081; 12569554; 12618594; 12630986; 12663508; 12692107; 12732846; 12790158; 12851801; 12900870; 12920202; 12925300; 12943470; 14640293; 14648207; 14660610; 14695651; 14714565; 14723376; 14976127; 1504254; 15110095; 15241822; 15258110; 15299091; 15349722; 15363478; 15382051; 15387446; 15466009; 15505641; 15519301; 15564895; 15611369; 15734958; 15763632; 15774926; 15849225; 15890241; 15901993; 15941966; 15949157; 15987714; 15996939; 16048566; 16103451; 16130011; 16153396; 16157215; 16172230; 16188490; 16204462; 16307269; 16324277; 16385402; 16385575; 16402077; 16402549; 16406813; 16426572; 16471212; 16495781; 16505155; 16538170; 16538176; 16609368; 16636061; 16740387; 16772608; 16775389; 16782969; 16800822; 16864595; 16882880; 16933202; 16969362; 16985026; 16985250; 17065585; 17164366; 17178267; 17191090; 17259654; 17295924; 17345072; 17363580; 17370067; 17372239; 17418993; 17429315; 17477782; 17498780; 17503978; 17507615; 17507624; 17509724; 17564586; 17603224; 17603900; 17611010; 17615053; 17616786; 17627011; 17635176; 17688403; 17695473; 17823232; 17823234; 17852022; 17900275; 18052847; 18075470; 18077912; 18159984; 18180754; 18187423; 18200441; 18223460; 18231117; 18268115; 18318428; 18389617; 18398030; 18455494; 18466106; 18490497; 18496682; 18497059; 18499698; 18510611; 18544563; 18551037; 18569587; 18619574; 18628519; 18632753; 18690546; 18703023; 18751408; 18759349; 18784359; 18798002; 18801337; 18813311; 18825963; 18840375; 18850169; 18936436; 18941913; 18990750; 18996102; 19000940; 19026171; 19095219; 19106084; 19229255; 19273964; 19274061; 19276377; 19285097; 19290787; 19307236; 19332078; 19336370; 19338043; 19339270; 1934265; 19343046; 19356113; 19414633; 19415745; 19424794; 19430483; 19442564; 19451835; 19452301; 19453261; 19479063; 19507017; 19534587; 19569730; 19571439; 19574343; 19575027; 19576320; 19583676; 19593158; 19593168; 19605743; 19636338; 19643819; 19666078; 19682433; 19692168; 19751749; 19776291; 19789190; 19806921; 19822571; 19823875; 19843669; 19860743; 19913121; 19926050; 19956635; 19961320; 20029944; 20043572; 20047124; 20054636; 20080081; 20118554; 20125119; 20131310; 20136364; 20147896; 20163457; 20173083; 20175915; 20213484; 20214802; 20218903; 20304699; 20375710; 20381444; 20390257; 20403997; 20437850; 20453000; 20505544; 20529763; 20559687; 20583967; 20602612; 20602615; 20628086; 20634197; 20634891; 20641098; 20652353; 20656072; 20663043; 20691427; 20701904; 20734064; 20797314; 20806393; 20829355; 20853468; 20881513; 20930417; 20957336; 20970553; 21071160; 21072184; 21081473; 21086794; 21148426; 21210738; 21262253; 21281405; 21329464; 21357676; 21480221; 21490707; 21505853; 21598960; 21825116; 21876539; 21929532; 21977969; 22072123; 22086975; 22141270; 22228482; 22246422; 22258279; 22426036; 22448362; 22466345; 22492992; 22628494; 22648710; 22673010; 22749033; 22785257; 22823064; 22854411; 22855999; 22948892; 22949628; 23081704; 23128882; 23133610; 23138776; 23157985; 23167834; 23278694; 23292087; 23353840; 23492908; 23492909; 23601795; 23603339; 23628800; 23803095; 23859573; 23876819; 23949201; 23951174; 24099317; 24318358; 24340040; 24443221; 24443269; 24488700; 24514875; 24527758; 24555493; 24583342; 24668907; 24762860; 25025048; 25059483; 25081684; 25115775; 25117321; 25228302; 25240994; 25264962; 25288136; 25306702; 25326287; 25461540; 25472037; 25552922; 25595320; 25602162; 25795462; 25826985; 25921178; 26068521; 26098700; 26383175; 26514519; 26530626; 26582657; 26588584; 26643992; 26648056; 26762380; 26865042; 26918755; 26953171; 26987327; 27029552; 27093553; 27173183; 27173252; 27180721; 27203225; 27207666; 27257124; 27323197; 27490388; 27702941; 27894333; 27977510; 28095090; 28117133; 28135712; 28231062; 28245756; 28256105; 28287486; 28355205; 28404946; 28418906; 28444958; 28698457; 28934216; 29072170; 29165164; 29247736; 29551500; 29668752; 7625847; 7766804; 8553685; 8631948; 8975785; 9111224; 9435160; 9618440; 9866708	3755823; 3462722; 2575218; 3681487; 11207026; 15489334; 3517618; 3000715; 14725854; 21576599; 24275569; 17311915; 9884316; 11295848; 14563787; 15469410; 15770072; 15643613; 16522833
16233	CYP26B1 CYP26A2 P450RAI2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.01 uM for tazarotenic acid (measured in vitro by the production of tazarotenic acid-sulfoxide) {ECO:0000269|PubMed:26937021}; KM=0.56 uM for tazarotenic acid (measured in vitro by the production of hydroxytazarotenic acid production) {ECO:0000269|PubMed:26937021}; 	1.14.13.-				COFACTOR: Name=heme; Xref=ChEBI:CHEBI:30413; Evidence={ECO:0000250}; 						bone morphogenesis [GO:0060349]; cell fate determination [GO:0001709]; cellular response to retinoic acid [GO:0071300]; cornification [GO:0070268]; embryonic limb morphogenesis [GO:0030326]; establishment of skin barrier [GO:0061436]; establishment of T cell polarity [GO:0001768]; inflammatory response [GO:0006954]; male meiotic nuclear division [GO:0007140]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; oxidation-reduction process [GO:0055114]; positive regulation of gene expression [GO:0010628]; positive regulation of tongue muscle cell differentiation [GO:2001037]; proximal/distal pattern formation [GO:0009954]; regulation of T cell differentiation [GO:0045580]; response to vitamin A [GO:0033189]; retinoic acid catabolic process [GO:0034653]; retinoic acid receptor signaling pathway [GO:0048384]; spermatogenesis [GO:0007283]; sterol metabolic process [GO:0016125]; tongue morphogenesis [GO:0043587]; vitamin metabolic process [GO:0006766]; xenobiotic metabolic process [GO:0006805]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; retinoic acid 4-hydroxylase activity [GO:0008401]; retinoic acid binding [GO:0001972]; bone morphogenesis [GO:0060349]; cell fate determination [GO:0001709]; cellular response to retinoic acid [GO:0071300]; cornification [GO:0070268]; embryonic limb morphogenesis [GO:0030326]; establishment of skin barrier [GO:0061436]; establishment of T cell polarity [GO:0001768]; inflammatory response [GO:0006954]; male meiotic nuclear division [GO:0007140]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; oxidation-reduction process [GO:0055114]; positive regulation of gene expression [GO:0010628]; positive regulation of tongue muscle cell differentiation [GO:2001037]; proximal/distal pattern formation [GO:0009954]; regulation of T cell differentiation [GO:0045580]; response to vitamin A [GO:0033189]; retinoic acid catabolic process [GO:0034653]; retinoic acid receptor signaling pathway [GO:0048384]; spermatogenesis [GO:0007283]; sterol metabolic process [GO:0016125]; tongue morphogenesis [GO:0043587]; vitamin metabolic process [GO:0006766]; xenobiotic metabolic process [GO:0006805]	heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; retinoic acid 4-hydroxylase activity [GO:0008401]; retinoic acid binding [GO:0001972]	GO:0001709; GO:0001768; GO:0001972; GO:0005506; GO:0005737; GO:0005789; GO:0006766; GO:0006805; GO:0006954; GO:0007140; GO:0007283; GO:0008401; GO:0009954; GO:0010628; GO:0016125; GO:0016709; GO:0020037; GO:0030326; GO:0031090; GO:0033189; GO:0034653; GO:0043587; GO:0045580; GO:0048384; GO:0048387; GO:0055114; GO:0060349; GO:0061436; GO:0070268; GO:0071300; GO:2001037	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Microsome membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}.			10823918; 14702039; 15815621; 15489334; 22019272; 26937021; 11744378; 12101034; 14532297; 16574820; 16933217; 19703508; 19884280; 20375987; 20606468; 21482329; 21529158; 21641851; 21945024; 22020119; 22415012; 22666329; 23320086; 23837398; 23977348; 24726878; 25114974; 25168891; 25839051; 26374207; 27416800; 9716180	10823918; 14702039; 15815621; 15489334; 22019272; 26937021
16234	CYP2A6 CYP2A3	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.23 uM for coumarin {ECO:0000269|PubMed:11695850, ECO:0000269|PubMed:16086027}; KM=530 uM for 1,4-cineole {ECO:0000269|PubMed:11695850, ECO:0000269|PubMed:16086027}; Vmax=3.5 nmol/min/nmol enzyme toward 2-exo-hydroxy-1,4-cineole {ECO:0000269|PubMed:11695850, ECO:0000269|PubMed:16086027}; 	1.14.13.-	CATALYTIC ACTIVITY: 1,4-cineole + NADPH + O(2) = 2-exo-hydroxy-1,4-cineole + NADP(+) + H(2)O. {ECO:0000269|PubMed:11695850}.	BINDING 107 107 Substrate. {ECO:0000305}.; BINDING 297 297 Substrate.		COFACTOR: Name=heme; Xref=ChEBI:CHEBI:30413; 						coumarin catabolic process [GO:0046226]; coumarin metabolic process [GO:0009804]; drug metabolic process [GO:0017144]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; steroid metabolic process [GO:0008202]	cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]	cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]; arachidonic acid epoxygenase activity [GO:0008392]; coumarin 7-hydroxylase activity [GO:0008389]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; coumarin catabolic process [GO:0046226]; coumarin metabolic process [GO:0009804]; drug metabolic process [GO:0017144]; epoxygenase P450 pathway [GO:0019373]; exogenous drug catabolic process [GO:0042738]; steroid metabolic process [GO:0008202]	arachidonic acid epoxygenase activity [GO:0008392]; coumarin 7-hydroxylase activity [GO:0008389]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]	GO:0005506; GO:0005789; GO:0005881; GO:0008202; GO:0008389; GO:0008392; GO:0008395; GO:0009804; GO:0016712; GO:0017144; GO:0019373; GO:0019899; GO:0020037; GO:0031090; GO:0042738; GO:0046226	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Peripheral membrane protein. Microsome membrane; Peripheral membrane protein.			2726448; 2748347; 2322567; 14702039; 15057824; 15489334; 1889415; 1944238; 11278503; 3856261; 11695850; 24275569; 16086027; 17125252; 18779312; 9409631; 10544257; 11237731; 15618701; 12721789; 15469410; 18360915; 18216723; 10383923; 10731522; 10741631; 11054771; 11207029; 11241319; 11259349; 11434509; 11684323; 11701230; 11725533; 11805739; 11927498; 11927840; 11960911; 11960914; 12115524; 12162851; 12164325; 12172220; 12223434; 12325023; 12406643; 12419832; 12445030; 12708602; 12749606; 12832682; 12844137; 12883749; 14568264; 14583682; 15196988; 15203795; 15225612; 15308589; 15327835; 15370155; 15454735; 15475735; 15534625; 15564629; 15592323; 15660270; 15665333; 15671201; 15861035; 15861044; 15900015; 15940289; 15993850; 16006997; 16041240; 16048566; 16126166; 16176798; 16207711; 16272956; 16372023; 16378601; 16402086; 16402128; 16452582; 16470306; 16636685; 1664256; 16720336; 16758265; 16857725; 16891249; 16952495; 17015050; 17036930; 17112802; 17130279; 17156750; 17207267; 17220563; 17259654; 17267622; 17454707; 17522595; 17540336; 17646279; 17683511; 17916905; 17927692; 17934923; 17979512; 18004205; 18188752; 18212800; 18380793; 18425152; 18510611; 18666753; 18698229; 18715882; 18936436; 18941913; 18976031; 18979093; 19012698; 19040121; 19082995; 19225447; 19251454; 19279561; 19290787; 19300303; 19303722; 19339270; 19343046; 19361454; 19365400; 19371316; 19387893; 19406142; 19415821; 19454817; 19479063; 19533856; 19537956; 19604090; 19643819; 19659438; 19702528; 19751749; 19779319; 19789190; 19845430; 19921195; 19956635; 20012030; 20061389; 20089352; 20136358; 20139165; 20155256; 20173083; 20177288; 20336063; 20418888; 20437850; 20438369; 20506136; 20596643; 20647221; 20656072; 20717551; 20719908; 20734048; 20734064; 20860463; 20887713; 21205058; 21265876; 21326246; 21410749; 21418183; 21473878; 21521021; 21685187; 21745589; 21747048; 21765098; 21791872; 21964962; 22051186; 22073590; 22160797; 22217675; 22271297; 22342802; 22465937; 22497566; 22498344; 22547082; 22614024; 22696418; 22700965; 22706231; 22847926; 22850738; 22854688; 22890016; 23049750; 23178447; 23203414; 23292114; 23371292; 23462429; 23471717; 23528144; 23649654; 23733493; 23813797; 24033696; 24127329; 24163286; 24192532; 24305170; 24651583; 24988984; 25006744; 25072098; 25220663; 25526961; 25585967; 25683822; 25710939; 25744963; 25857233; 26091970; 26098700; 26247835; 26343999; 26366873; 26370685; 26407342; 26644138; 26648056; 26662855; 26715117; 26757861; 26818358; 27035242; 27113016; 27322236; 27488534; 27625140; 27702941; 27815364; 27865452; 27902773; 27974382; 28182203; 28231062; 28273397; 28472995; 28542511; 28734893; 28811232; 28931220; 497175; 8627510; 8637342; 9028626; 9103523; 9884161	2726448; 2748347; 2322567; 14702039; 15057824; 15489334; 1889415; 1944238; 11278503; 3856261; 11695850; 24275569; 16086027; 17125252; 18779312; 9409631; 10544257; 11237731; 15618701; 12721789; 15469410; 18360915; 18216723
16238	CYP2A13	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=10.7 uM for phenacetin {ECO:0000269|PubMed:18779312}; 	1.14.14.1	CATALYTIC ACTIVITY: RH + [reduced NADPH--hemoprotein reductase] + O(2) = ROH + [oxidized NADPH--hemoprotein reductase] + H(2)O.	BINDING 297 297 Substrate.		COFACTOR: Name=heme; Xref=ChEBI:CHEBI:30413; 						coumarin metabolic process [GO:0009804]; epoxygenase P450 pathway [GO:0019373]; xenobiotic metabolic process [GO:0006805]	endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]	endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; coumarin 7-hydroxylase activity [GO:0008389]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; steroid hydroxylase activity [GO:0008395]; coumarin metabolic process [GO:0009804]; epoxygenase P450 pathway [GO:0019373]; xenobiotic metabolic process [GO:0006805]	arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; coumarin 7-hydroxylase activity [GO:0008389]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; steroid hydroxylase activity [GO:0008395]	GO:0004497; GO:0005506; GO:0005789; GO:0006805; GO:0008389; GO:0008392; GO:0008395; GO:0009804; GO:0019373; GO:0020037; GO:0031090; GO:0070330	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Peripheral membrane protein. Microsome membrane; Peripheral membrane protein.			7668294; 11016631; 15063809; 18779312; 17540336; 17428784; 12130698; 15618722; 12721789; 10383923; 10731522; 10741631; 11701230; 12629583; 12920161; 14633739; 15115698; 15196988; 15222883; 15333516; 15665333; 16316926; 16385575; 1664256; 16835796; 18669584; 19290787; 19303722; 19343046; 19414505; 19789190; 19812523; 2025243; 20431511; 20534012; 20568895; 20798279; 20846153; 21473878; 22051186; 22397853; 22696418; 22700965; 22798551; 22890016; 23463547; 23583631; 23602888; 23752126; 23907605; 23917075; 24114584; 24907355; 25667220; 25710941; 27567546; 27725446; 28648140; 497175; 8627510; 8631948; 8637342; 8647857; 8913342; 8975785; 9028626; 9103523; 9842986; 9884161	7668294; 11016631; 15063809; 18779312; 17540336; 17428784; 12130698; 15618722; 12721789
16240	CYP2U1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=2.7 uM for arachidonic acid; 	1.14.14.1	CATALYTIC ACTIVITY: RH + [reduced NADPH--hemoprotein reductase] + O(2) = ROH + [oxidized NADPH--hemoprotein reductase] + H(2)O.			COFACTOR: Name=heme; Xref=ChEBI:CHEBI:30413; Evidence={ECO:0000250}; 						omega-hydroxylase P450 pathway [GO:0097267]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; steroid hydroxylase activity [GO:0008395]; omega-hydroxylase P450 pathway [GO:0097267]	aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; steroid hydroxylase activity [GO:0008395]	GO:0004497; GO:0005506; GO:0005789; GO:0008395; GO:0016021; GO:0020037; GO:0031090; GO:0070330; GO:0097267	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:14660610}; Multi-pass membrane protein {ECO:0000269|PubMed:14660610}. Microsome membrane {ECO:0000269|PubMed:14660610}.			14660610; 15489334; 14975754; 15752708; 23176821; 12432928; 15258110; 15611369; 20332099; 20630735; 21150319; 21707071; 24337409; 24563460; 25857771; 25872594; 26914923; 27292318; 27456766; 28083596; 28725025; 28743672; 29034544; 9435160; 9618440	14660610; 15489334; 14975754; 15752708; 23176821
16243	CYP46A1 CYP46	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=2.2 uM for 24(S)-hydroxycholesterol {ECO:0000269|PubMed:14640697}; 	1.14.14.25	CATALYTIC ACTIVITY: Cholesterol + [reduced NADPH--hemoprotein reductase] + O(2) = (24S)-cholest-5-ene-3-beta,24-diol + [oxidized NADPH--hemoprotein reductase] + H(2)O. {ECO:0000269|PubMed:18621681}.			COFACTOR: Name=heme; Xref=ChEBI:CHEBI:30413; Evidence={ECO:0000269|PubMed:18621681, ECO:0000269|PubMed:20667828, ECO:0000269|PubMed:23288837}; 						bile acid biosynthetic process [GO:0006699]; cholesterol catabolic process [GO:0006707]; nervous system development [GO:0007399]; sterol metabolic process [GO:0016125]; xenobiotic metabolic process [GO:0006805]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]; cholesterol 24-hydroxylase activity [GO:0033781]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; bile acid biosynthetic process [GO:0006699]; cholesterol catabolic process [GO:0006707]; nervous system development [GO:0007399]; sterol metabolic process [GO:0016125]; xenobiotic metabolic process [GO:0006805]	cholesterol 24-hydroxylase activity [GO:0033781]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]	GO:0005506; GO:0005783; GO:0005789; GO:0006699; GO:0006707; GO:0006805; GO:0007399; GO:0008395; GO:0016021; GO:0016125; GO:0020037; GO:0031090; GO:0033781	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Single-pass membrane protein. Microsome membrane; Single-pass membrane protein.			10377398; 14702039; 12508121; 15489334; 14640697; 18621681; 20667828; 23288837; 12123847; 12232784; 12533085; 15034781; 15106838; 15165699; 15172102; 15286456; 15331159; 15450677; 15936520; 15975088; 16013913; 16055229; 16157450; 16258842; 16734927; 16960449; 17335784; 17550732; 17854420; 18453684; 18842294; 19059217; 19161969; 19212968; 19286353; 19363267; 19553612; 19647891; 20193040; 20535486; 20682755; 20693622; 21049985; 21386929; 21729100; 22185844; 22528464; 22859721; 22977134; 23070465; 23167762; 23604141; 24924840; 25017465; 25084760; 25814554; 26358780; 27026489; 27162448; 28642370	10377398; 14702039; 12508121; 15489334; 14640697; 18621681; 20667828; 23288837
16263	CARNS1 ATPGD1 KIAA1394	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.09 mM for beta-alanine {ECO:0000269|PubMed:20097752}; KM=1.84 mM for gamma-aminobutyrate {ECO:0000269|PubMed:20097752}; KM=0.37 mM for L-histidine {ECO:0000269|PubMed:20097752}; KM=4.67 mM for L-lysine {ECO:0000269|PubMed:20097752}; KM=7.66 mM for L-ornithine {ECO:0000269|PubMed:20097752}; KM=24.7 mM for N-methylhistidine {ECO:0000269|PubMed:20097752}; Vmax=65.3 nmol/min/mg enzyme toward beta-alanine {ECO:0000269|PubMed:20097752}; Vmax=54.7 nmol/min/mg enzyme toward gamma-aminobutyrate {ECO:0000269|PubMed:20097752}; Vmax=0.76 nmol/min/mg enzyme toward L-histidine {ECO:0000269|PubMed:20097752}; Vmax=0.61 nmol/min/mg enzyme toward L-lysine {ECO:0000269|PubMed:20097752}; Vmax=0.28 nmol/min/mg enzyme toward L-ornithine {ECO:0000269|PubMed:20097752}; Vmax=0.62 nmol/min/mg enzyme toward N-methylhistidine {ECO:0000269|PubMed:20097752}; 	6.3.2.11	CATALYTIC ACTIVITY: ATP + L-histidine + beta-alanine = ADP + phosphate + carnosine.			COFACTOR: Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250}; ;  Note=Binds 2 manganese ions per subunit. {ECO:0000250};						carnosine biosynthetic process [GO:0035499]; histidine catabolic process [GO:0006548]	cytosol [GO:0005829]	cytosol [GO:0005829]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; carnosine synthase activity [GO:0047730]; homocarnosine synthase activity [GO:0102102]; metal ion binding [GO:0046872]; carnosine biosynthetic process [GO:0035499]; histidine catabolic process [GO:0006548]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; carnosine synthase activity [GO:0047730]; homocarnosine synthase activity [GO:0102102]; metal ion binding [GO:0046872]	GO:0005524; GO:0005829; GO:0006548; GO:0016887; GO:0035499; GO:0046872; GO:0047730; GO:0102102				10718198; 14702039; 16554811; 15489334; 20097752; 12421765; 26206726	10718198; 14702039; 16554811; 15489334; 20097752
16270	CASK LIN2	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=563 uM for ATP {ECO:0000269|PubMed:18423203}; Note=Kinetics of autophosphorylation assay were measured, rather than phosphorylation of an exogenous substrate.;	2.7.11.1	CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.	BINDING 41 41 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.	ACTIVITY REGULATION: Differs from archetypal CaMK members in that the kinase domain exhibits a constitutively active conformation and the autoinhibitory region does not engage in direct contact with the ATP-binding cleft, although it still binds Ca(2+)/CAM. {ECO:0000269|PubMed:18423203}.	COFACTOR: ;  Note=Unlike other protein kinases, does not require a divalent cation such as magnesium for catalytic activity. {ECO:0000269|PubMed:18423203};						cell adhesion [GO:0007155]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of wound healing [GO:0061045]; neurotransmitter secretion [GO:0007269]	actin cytoskeleton [GO:0015629]; basement membrane [GO:0005604]; cell-cell junction [GO:0005911]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]	actin cytoskeleton [GO:0015629]; basement membrane [GO:0005604]; cell-cell junction [GO:0005911]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; guanylate kinase activity [GO:0004385]; protein serine/threonine kinase activity [GO:0004674]; cell adhesion [GO:0007155]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of wound healing [GO:0061045]; neurotransmitter secretion [GO:0007269]	ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; guanylate kinase activity [GO:0004385]; protein serine/threonine kinase activity [GO:0004674]	GO:0001953; GO:0004385; GO:0004674; GO:0005516; GO:0005524; GO:0005604; GO:0005652; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0005925; GO:0007155; GO:0007269; GO:0010839; GO:0015629; GO:0016363; GO:0042734; GO:0060170; GO:0061045; GO:0090288	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Cytoplasm {ECO:0000250}. Cell membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}.		MOD_RES 51 51 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 151 151 Phosphoserine; by autocatalysis. {ECO:0000269|PubMed:18423203}.; MOD_RES 155 155 Phosphoserine; by autocatalysis. {ECO:0000269|PubMed:18423203}.; MOD_RES 182 182 Phosphothreonine. {ECO:0000250|UniProtKB:O70589}.; MOD_RES 313 313 Phosphoserine. {ECO:0000244|PubMed:24275569}.	9660868; 15772651; 15489334; 11003712; 19012874; 23186163; 24275569; 9546224; 18423203; 17344846; 19165920; 19200522; 19377476; 23662938; 10455105; 11036064; 11120739; 11377421; 11604393; 11729206; 11880184; 12040031; 12093160; 12110687; 12511555; 15231748; 15331416; 15694377; 15935055; 15975580; 15994232; 16147993; 16688213; 17989281; 18617632; 18629876; 18664494; 19125693; 19555689; 19615732; 19736351; 19781660; 19847910; 20006588; 20029458; 20424264; 20623620; 20711500; 21735175; 21763699; 21855798; 21954287; 21988832; 22117215; 22389404; 22452838; 22709267; 23165780; 23406872; 23416715; 23542924; 23543616; 23600800; 23602568; 24366813; 24927672; 25373785; 25416956; 25852190; 26496610; 26638075; 27173948; 27364017; 27720444; 28139025; 28481730; 28783747; 29258560; 8786425; 9660869; 9701566; 9753324	9660868; 15772651; 15489334; 11003712; 19012874; 23186163; 24275569; 9546224; 18423203; 17344846; 19165920; 19200522; 19377476; 23662938
16308	CRYM THBP	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=47 uM for 3,4-dehydro-thiomorpholine-3-carboxylate (at pH 5.0 and 37 degrees Celsius) {ECO:0000269|PubMed:21332720}; KM=3.6 uM for NADH (at pH 5.0 and 37 degrees Celsius) {ECO:0000269|PubMed:21332720}; Vmax=9.6 umol/min/mg enzyme with 3,4-dehydro-thiomorpholine-3-carboxylate as substrate (at pH 5.0 and 37 degrees Celsius) {ECO:0000269|PubMed:21332720}; 	1.5.1.25	CATALYTIC ACTIVITY: Thiomorpholine 3-carboxylate + NAD(P)(+) = 3,4-dehydro-thiomorpholine-3-carboxylate + NAD(P)H. {ECO:0000269|PubMed:21332720}.	BINDING 168 168 NADP. {ECO:0000269|PubMed:17242435}.; BINDING 169 169 NADP. {ECO:0000269|PubMed:17242435}.		COFACTOR: Name=NAD(+); Xref=ChEBI:CHEBI:57540; Evidence={ECO:0000269|PubMed:17242435, ECO:0000269|PubMed:21332720}; Name=NADP(+); Xref=ChEBI:CHEBI:58349; Evidence={ECO:0000269|PubMed:17242435, ECO:0000269|PubMed:21332720}; 	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 4.5. {ECO:0000269|PubMed:21332720};					lysine catabolic process [GO:0006554]; negative regulation of transcription by RNA polymerase II [GO:0000122]; sensory perception of sound [GO:0007605]; thyroid hormone metabolic process [GO:0042403]; thyroid hormone transport [GO:0070327]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; NADP binding [GO:0050661]; oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor [GO:0016639]; protein homodimerization activity [GO:0042803]; thiomorpholine-carboxylate dehydrogenase activity [GO:0047127]; thyroid hormone binding [GO:0070324]; transcription corepressor activity [GO:0003714]; lysine catabolic process [GO:0006554]; negative regulation of transcription by RNA polymerase II [GO:0000122]; sensory perception of sound [GO:0007605]; thyroid hormone metabolic process [GO:0042403]; thyroid hormone transport [GO:0070327]	NADP binding [GO:0050661]; oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor [GO:0016639]; protein homodimerization activity [GO:0042803]; thiomorpholine-carboxylate dehydrogenase activity [GO:0047127]; thyroid hormone binding [GO:0070324]; transcription corepressor activity [GO:0003714]	GO:0000122; GO:0003714; GO:0005634; GO:0005737; GO:0005739; GO:0005782; GO:0005829; GO:0006554; GO:0007605; GO:0016639; GO:0042403; GO:0042803; GO:0047127; GO:0050661; GO:0070062; GO:0070324; GO:0070327	SUBCELLULAR LOCATION: Cytoplasm.			9285773; 9328354; 10493829; 14702039; 17974005; 15616553; 15489334; 1384048; 12471561; 21332720; 24275569; 17242435; 21044950; 21900206; 25931162	9285773; 9328354; 10493829; 14702039; 17974005; 15616553; 15489334; 1384048; 12471561; 21332720; 24275569; 17242435
16382	SLC44A4 C6orf29 CTL4 NG22 TPPT1 UNQ441/PRO874	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.17 uM for thiamine pyrophosphate {ECO:0000269|PubMed:24379411}; Vmax=18.19 pmol/min/mg enzyme {ECO:0000269|PubMed:24379411}; 								SITE 308 308 Breakpoint for translocation with NEU1.	UNQ441/PRO874		acetylcholine biosynthetic process [GO:0008292]; acetylcholine secretion [GO:0061526]; choline transport [GO:0015871]; neuromast hair cell development [GO:0035675]; otolith formation [GO:0032475]; phosphatidylcholine biosynthetic process [GO:0006656]; positive regulation of cell growth [GO:0030307]; thiamine pyrophosphate transmembrane transport [GO:0030974]; transmembrane transport [GO:0055085]	apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; choline transmembrane transporter activity [GO:0015220]; thiamine pyrophosphate transmembrane transporter activity [GO:0090422]; acetylcholine biosynthetic process [GO:0008292]; acetylcholine secretion [GO:0061526]; choline transport [GO:0015871]; neuromast hair cell development [GO:0035675]; otolith formation [GO:0032475]; phosphatidylcholine biosynthetic process [GO:0006656]; positive regulation of cell growth [GO:0030307]; thiamine pyrophosphate transmembrane transport [GO:0030974]; transmembrane transport [GO:0055085]	choline transmembrane transporter activity [GO:0015220]; thiamine pyrophosphate transmembrane transporter activity [GO:0090422]	GO:0005886; GO:0006656; GO:0008292; GO:0015220; GO:0015871; GO:0016021; GO:0016324; GO:0030307; GO:0030974; GO:0032475; GO:0035675; GO:0055085; GO:0061526; GO:0070062; GO:0090422	SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:24379411, ECO:0000269|PubMed:26828122}; Multi-pass membrane protein {ECO:0000305|PubMed:24379411, ECO:0000305|PubMed:26828122}. Apical cell membrane {ECO:0000269|PubMed:24379411}.	PTM: N-glycosylated; N-glycosylation of Asn-69, Asn-155 and Asn-393 is required for a proper thiamine pyrophosphate uptake. {ECO:0000269|PubMed:26828122}.		14702039; 12975309; 14656967; 14574404; 15489334; 12067718; 17974005; 10677542; 23651124; 24379411; 26828122; 16959974; 26741288; 28013291; 11068039; 11698453; 14973250; 15715662; 19851445; 20466734; 20526339; 20813679; 22789125; 25715703; 26901654; 27759029; 28753073	14702039; 12975309; 14656967; 14574404; 15489334; 12067718; 17974005; 10677542; 23651124; 24379411; 26828122; 16959974; 26741288; 28013291
16553	CNDP2 CN2 CPGL HEL-S-13 PEPA	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.04 mM for Ser-Gln (at pH 7.5 and in the presence of 0.1 mM manganese ions) {ECO:0000269|PubMed:12473676, ECO:0000269|PubMed:19346245}; KM=0.6 mM for Cys-Gly (at pH 8.0 and in the presence of 50 uM manganese ions) {ECO:0000269|PubMed:12473676, ECO:0000269|PubMed:19346245}; KM=15 mM for carnosine (at pH 9.5 and in the presence of 0.1 mM manganese ions) {ECO:0000269|PubMed:12473676, ECO:0000269|PubMed:19346245}; 	3.4.13.18	CATALYTIC ACTIVITY: Hydrolysis of dipeptides, preferentially hydrophobic dipeptides including prolyl amino acids. {ECO:0000269|PubMed:12473676}.	BINDING 195 195 Substrate; via carbonyl oxygen. {ECO:0000250}.; BINDING 228 228 Substrate; shared with homodimeric partner. {ECO:0000250}.; BINDING 330 330 Substrate; shared with homodimeric partner. {ECO:0000250}.; BINDING 343 343 Substrate. {ECO:0000250}.; BINDING 417 417 Substrate; via amide nitrogen and carbonyl oxygen. {ECO:0000250}.; BINDING 445 445 Substrate. {ECO:0000250}.	ACTIVITY REGULATION: Inhibited by p-hydroxymercurybenzoate. The inhibitory concentration 50% (IC(50)) is 13 uM. Inhibited by bestatin. The inhibitory concentration 50% (IC(50)) is 7 nM at pH 9.5. {ECO:0000269|PubMed:12473676}.	COFACTOR: Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250|UniProtKB:Q9D1A2}; ;  Note=Binds 2 manganese ions per subunit. {ECO:0000250|UniProtKB:Q9D1A2};			SITE 228 228 Important for catalytic activity. {ECO:0000250}.			glutathione biosynthetic process [GO:0006750]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; cytosolic dipeptidase activity [GO:0102008]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; glutathione biosynthetic process [GO:0006750]	alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; cytosolic dipeptidase activity [GO:0102008]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]	GO:0004180; GO:0005654; GO:0005829; GO:0006750; GO:0008237; GO:0046872; GO:0070062; GO:0102008; GO:0103046	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12473676, ECO:0000269|PubMed:17121880}.		MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378, ECO:0000269|Ref.9}.; MOD_RES 9 9 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 58 58 Phosphoserine. {ECO:0000250|UniProtKB:Q6Q0N1}.; MOD_RES 299 299 Phosphoserine. {ECO:0000244|PubMed:24275569}.	12473676; 14702039; 15498874; 16177791; 15489334; 17121880; 19346245; 19608861; 21269460; 22223895; 22814378; 24275569; 24395568; 25964343; 17220478; 18753673; 19373489; 19805454; 20199107; 21573905; 22128300; 22410244; 24705354; 24885395; 25814554; 28871847; 29056506	12473676; 14702039; 15498874; 16177791; 15489334; 17121880; 19346245; 19608861; 21269460; 22223895; 22814378; 24275569; 24395568; 25964343
16556	CMPK2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=3.09 mM for CMP; KM=6.3 mM for UMP; KM=1.31 mM for dCMP; KM=0.1 mM for dUMP; Vmax=1.64 umol/min/mg enzyme towards CMP; Vmax=0.19 umol/min/mg enzyme towards UMP; Vmax=1.77 umol/min/mg enzyme towards dCMP; Vmax=0.48 umol/min/mg enzyme towards dUMP; 	2.7.4.14; 2.7.4.6	CATALYTIC ACTIVITY: ATP + (d)CMP = ADP + (d)CDP. {ECO:0000269|PubMed:23416111}.; CATALYTIC ACTIVITY: ATP + nucleoside diphosphate = ADP + nucleoside triphosphate. {ECO:0000269|PubMed:23416111}.									cellular response to lipopolysaccharide [GO:0071222]; dTDP biosynthetic process [GO:0006233]; dTTP biosynthetic process [GO:0006235]; dUDP biosynthetic process [GO:0006227]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]	mitochondrion [GO:0005739]	mitochondrion [GO:0005739]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; thymidylate kinase activity [GO:0004798]; UMP kinase activity [GO:0033862]; cellular response to lipopolysaccharide [GO:0071222]; dTDP biosynthetic process [GO:0006233]; dTTP biosynthetic process [GO:0006235]; dUDP biosynthetic process [GO:0006227]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]	ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; thymidylate kinase activity [GO:0004798]; UMP kinase activity [GO:0033862]	GO:0004127; GO:0004550; GO:0004798; GO:0005524; GO:0005739; GO:0006165; GO:0006227; GO:0006233; GO:0006235; GO:0009142; GO:0033862; GO:0071222	SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:17999954}.			17999954; 14702039; 15489334; 21269460; 23416111; 18498354; 20379614	17999954; 14702039; 15489334; 21269460; 23416111
16569	DAGLA C11orf11 KIAA0659 NSDDR	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=154.7 uM for diacylglycerol {ECO:0000269|PubMed:14610053}; Vmax=33.3 nmol/min/mg enzyme {ECO:0000269|PubMed:14610053}; 	3.1.1.-			ACTIVITY REGULATION: Inhibited by p-hydroxy-mercuri-benzoate and HgCl(2), but not to PMSF. Also inhibited by RHC80267, a drug that blocks 2-AG formation. {ECO:0000269|PubMed:14610053}.	COFACTOR: Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000269|PubMed:14610053}; 	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 7.0. {ECO:0000269|PubMed:14610053};					arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G-protein coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurotransmitter biosynthetic process [GO:0042136]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]	integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; varicosity [GO:0043196]	integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; varicosity [GO:0043196]; acylglycerol lipase activity [GO:0047372]; metal ion binding [GO:0046872]; arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G-protein coupled glutamate receptor signaling pathway [GO:0007216]; neuroblast proliferation [GO:0007405]; neurotransmitter biosynthetic process [GO:0042136]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]	acylglycerol lipase activity [GO:0047372]; metal ion binding [GO:0046872]	GO:0005886; GO:0007216; GO:0007405; GO:0019369; GO:0042136; GO:0043196; GO:0046340; GO:0046872; GO:0047372; GO:0071926; GO:0098921; GO:0099055	SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.		MOD_RES 727 727 Phosphoserine. {ECO:0000250|UniProtKB:Q5YLM1}.; MOD_RES 729 729 Phosphoserine. {ECO:0000250|UniProtKB:Q6WQJ1}.; MOD_RES 732 732 Phosphoserine. {ECO:0000250|UniProtKB:Q6WQJ1}.; MOD_RES 743 743 Phosphoserine. {ECO:0000250|UniProtKB:Q6WQJ1}.; MOD_RES 782 782 Phosphoserine. {ECO:0000250|UniProtKB:Q5YLM1}.; MOD_RES 784 784 Phosphoserine. {ECO:0000250|UniProtKB:Q6WQJ1}.; MOD_RES 806 806 Phosphoserine. {ECO:0000250|UniProtKB:Q5YLM1}.; MOD_RES 833 833 Phosphoserine. {ECO:0000250|UniProtKB:Q5YLM1}.; MOD_RES 847 847 Phosphoserine. {ECO:0000250|UniProtKB:Q5YLM1}.; MOD_RES 952 952 Phosphoserine. {ECO:0000250|UniProtKB:Q6WQJ1}.; MOD_RES 1023 1023 Phosphothreonine. {ECO:0000250|UniProtKB:Q6WQJ1}.	9734811; 12168954; 15489334; 14610053; 16051747; 18801880; 10348910; 19126434; 22827915; 23502535; 24076015; 24616451; 29145497	9734811; 12168954; 15489334; 14610053; 16051747; 18801880
16624	CYP4V2	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=65 uM for myristic acid {ECO:0000269|PubMed:19661213}; KM=140 uM for lauric acid {ECO:0000269|PubMed:19661213}; KM=430 uM for palmitic acid {ECO:0000269|PubMed:19661213}; Note=Vmax is the nearly the same for myristic acid and for lauric acid and reduced about 30% for palmitic acid. {ECO:0000269|PubMed:19661213};	1.14.14.-; 1.14.14.79	CATALYTIC ACTIVITY: Docosahexaenoate + [reduced NADPH--hemoprotein reductase] + O(2) = 22-hydroxydocosahexaenoate + [oxidized NADPH--hemoprotein reductase] + H(2)O. {ECO:0000269|PubMed:22772592}.	BINDING 329 329 Heme (covalent; via 1 link). {ECO:0000250|UniProtKB:P51869}.	ACTIVITY REGULATION: Inhibited by N-hydroxy-N'-(4-n-butyl-2-methylphenyl formamidine)(HET0016) with an IC(50) of 38 nM. {ECO:0000269|PubMed:19661213}.	COFACTOR: Name=heme; Xref=ChEBI:CHEBI:30413; Evidence={ECO:0000250|UniProtKB:P51869}; 		PATHWAY: Lipid metabolism. {ECO:0000305}.				fatty acid omega-oxidation [GO:0010430]; response to stimulus [GO:0050896]; retinoid metabolic process [GO:0001523]; sterol metabolic process [GO:0016125]; visual perception [GO:0007601]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; fatty acid omega-oxidation [GO:0010430]; response to stimulus [GO:0050896]; retinoid metabolic process [GO:0001523]; sterol metabolic process [GO:0016125]; visual perception [GO:0007601]	heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]	GO:0001523; GO:0004497; GO:0005506; GO:0005789; GO:0007601; GO:0010430; GO:0016021; GO:0016125; GO:0016705; GO:0020037; GO:0050896	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:22772592}; Single-pass membrane protein {ECO:0000305}.			15042513; 14702039; 15815621; 15489334; 19661213; 22772592; 24275569; 15860296; 16088246; 16179904; 16186368; 17013694; 17249554; 17962476; 18349091; 19278955; 19508456; 19583818; 20205591; 20379614; 21385027; 21540472; 21565171; 21850171; 21892605; 21988832; 22605929; 23221965; 23242590; 23538635; 23793346; 24480711; 24739949; 25593508; 26521715; 26865810; 26971461; 27028354; 27348340; 27658286; 28051075; 28453600; 28698241; 28729181; 28763560	15042513; 14702039; 15815621; 15489334; 19661213; 22772592; 24275569
16627	CMBL	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=170 uM for olmesartan medoxomil {ECO:0000269|PubMed:20177059}; KM=283 uM for faropenem medoxomil {ECO:0000269|PubMed:20177059}; KM=63.4 uM for lenampicillin {ECO:0000269|PubMed:20177059}; Vmax=24.6 nmol/min/mg enzyme toward olmesartan medoxomil {ECO:0000269|PubMed:20177059}; Vmax=16.4 nmol/min/mg enzyme toward faropenem medoxomil {ECO:0000269|PubMed:20177059}; Vmax=4 nmol/min/mg enzyme toward lenampicillin {ECO:0000269|PubMed:20177059}; 	3.1.-.-			ACTIVITY REGULATION: Strongly inhibited by p-chloromercuribenzoate (PCMB). Partially inhibited by bis-p-nitrophenylphosphate (BNPP). Not inhibited by DFP, PMSF, eserine or EDTA.							xenobiotic metabolic process [GO:0006805]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; hydrolase activity [GO:0016787]; xenobiotic metabolic process [GO:0006805]	hydrolase activity [GO:0016787]	GO:0005829; GO:0006805; GO:0016787; GO:0070062	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:20177059}.		MOD_RES 2 2 N-acetylalanine. {ECO:0000269|Ref.5}.; MOD_RES 36 36 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 223 223 Phosphoserine. {ECO:0000244|PubMed:24275569}.	14702039; 15489334; 19608861; 20177059; 21269460; 23186163; 24275569; 17353931; 19119138; 20000738; 26496610	14702039; 15489334; 19608861; 20177059; 21269460; 23186163; 24275569
16668	HSD11B2 HSD11K SDR9C3	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=26.1 nM for cortisol {ECO:0000269|PubMed:12788846, ECO:0000269|PubMed:17314322}; KM=785 nM for cortisol {ECO:0000269|PubMed:12788846, ECO:0000269|PubMed:17314322}; KM=77 nM for cortisterone {ECO:0000269|PubMed:12788846, ECO:0000269|PubMed:17314322}; Vmax=64.1 nmol/h/mg enzyme toward cortisterone {ECO:0000269|PubMed:12788846, ECO:0000269|PubMed:17314322}; Vmax=66 nmol/h/mg enzyme toward cortisol {ECO:0000269|PubMed:12788846, ECO:0000269|PubMed:17314322}; 	1.1.1.-	CATALYTIC ACTIVITY: An 11-beta-hydroxysteroid + NAD(+) = an 11-oxosteroid + NADH.	BINDING 219 219 Substrate. {ECO:0000250}.	ACTIVITY REGULATION: Inhibited by glycyrrhetinic acid (derived from liquorice), carbenoloxone and 11-alpha-OH-progesterone. {ECO:0000250}.							female pregnancy [GO:0007565]; glucocorticoid biosynthetic process [GO:0006704]; regulation of blood volume by renal aldosterone [GO:0002017]; response to drug [GO:0042493]; response to food [GO:0032094]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]	endoplasmic reticulum membrane [GO:0005789]	endoplasmic reticulum membrane [GO:0005789]; 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity [GO:0003845]; NAD binding [GO:0051287]; steroid binding [GO:0005496]; female pregnancy [GO:0007565]; glucocorticoid biosynthetic process [GO:0006704]; regulation of blood volume by renal aldosterone [GO:0002017]; response to drug [GO:0042493]; response to food [GO:0032094]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]	11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity [GO:0003845]; NAD binding [GO:0051287]; steroid binding [GO:0005496]	GO:0001666; GO:0002017; GO:0003845; GO:0005496; GO:0005789; GO:0006704; GO:0007565; GO:0032094; GO:0032868; GO:0042493; GO:0051287; GO:0051384	SUBCELLULAR LOCATION: Microsome {ECO:0000269|PubMed:17314322}. Endoplasmic reticulum {ECO:0000269|PubMed:17314322}.			7859916; 8530071; 8611140; 15489334; 8611186; 7593417; 2889032; 11350956; 7608290; 7670488; 9398712; 9683587; 9661590; 9851783; 9707624; 10489390; 10523339; 11238516; 12788846; 17314322; 11711524; 11755176; 11787058; 11850421; 11916625; 11956655; 12015312; 12109593; 12161498; 12364476; 12519895; 12574226; 12642869; 12788832; 12860834; 12911547; 14629298; 14681848; 14981055; 15167446; 15172126; 15305225; 15489962; 15643119; 15643127; 15673310; 16061836; 16109323; 16144812; 16271275; 16272800; 16406280; 16778331; 16804865; 16872738; 16979406; 17028049; 17515840; 17519316; 17551100; 18032417; 18061258; 18178212; 18378698; 18388900; 18408592; 18456686; 18573267; 18716005; 18837962; 1885595; 19022342; 19048413; 19150652; 19218882; 19292059; 19336370; 19535674; 19542242; 19811365; 19880179; 19909806; 20214802; 20486282; 20571110; 20597806; 20624455; 20800085; 21237268; 21767875; 21794917; 21825133; 21880714; 22239940; 22359645; 22432047; 22719058; 22796344; 22872687; 22959142; 22971074; 23303402; 23329753; 23333641; 23357976; 23362866; 23443726; 23446772; 23659736; 23714681; 23966319; 23979790; 24040322; 24054540; 24147632; 24149070; 24169559; 24189979; 24262137; 24447082; 24517145; 24685985; 24729284; 24810847; 24971590; 25133511; 25200528; 25331012; 25459891; 25572238; 25666420; 25788665; 25907225; 26011146; 26115144; 26126204; 26462907; 26585459; 26593902; 26798634; 26822444; 26963327; 27013342; 27018008; 27379371; 27507896; 27526338; 27686600; 27697223; 28180242; 28302719; 28320863; 28502862; 28797028; 28938454; 29100173; 8794836	7859916; 8530071; 8611140; 15489334; 8611186; 7593417; 2889032; 11350956; 7608290; 7670488; 9398712; 9683587; 9661590; 9851783; 9707624; 10489390; 10523339; 11238516; 12788846; 17314322
16711	CNDP1 CN1 CPGL2 UNQ1915/PRO4380	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=1.27 uM for carnosine (at 30 degrees Celsius and in the absence of cadmium ions) {ECO:0000269|PubMed:12473676}; KM=11.00 uM for carnosine (at 30 degrees Celsius and in the presence of 200 uM cadmium ions) {ECO:0000269|PubMed:12473676}; KM=0.20 uM for homocarnosine (at 30 degrees Celsius and in the absence of cadmium ions) {ECO:0000269|PubMed:12473676}; KM=1.0 uM for homocarnosine (at 30 degrees Celsius and in the presence of 200 uM cadmium ions) {ECO:0000269|PubMed:12473676}; Note=1 hour incubation in 50 mM Tris-HCl, pH 7.5.;	3.4.13.20	CATALYTIC ACTIVITY: Preferential hydrolysis of the beta-Ala-|-His dipeptide (carnosine), and also anserine, Xaa-|-His dipeptides and other dipeptides including homocarnosine. {ECO:0000269|PubMed:12473676, ECO:0000269|PubMed:7116644}.		ACTIVITY REGULATION: Inhibited by the metal chelator 1,10-o-phenantrolin. The inhibitory concentration 50% (IC(50)) is 5 uM.	COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000269|Ref.10}; ;  Note=Binds 2 Zn(2+) ions per subunit. {ECO:0000269|Ref.10};	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 8.5. {ECO:0000269|PubMed:12473676};			UNQ1915/PRO4380		proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268]	cytosol [GO:0005829]; extracellular region [GO:0005576]	cytosol [GO:0005829]; extracellular region [GO:0005576]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268]	carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]	GO:0004180; GO:0005576; GO:0005829; GO:0006508; GO:0008237; GO:0016805; GO:0032268; GO:0046872	SUBCELLULAR LOCATION: Secreted.		MOD_RES 219 219 Phosphoserine. {ECO:0000250|UniProtKB:Q66HG3}.	16046297; 12975309; 16177791; 15489334; 7116644; 6616870; 12473676; 16335952; 14560319; 16965804; 17121880; 17205963; 17601991; 17601992; 18753673; 19373489; 19577318; 19929986; 20299368; 20332346; 20379614; 20460427; 20711718; 20851293; 20865290; 20971102; 20979941; 21573905; 22706107; 23029420; 23342076; 23402577; 24566305; 25898255; 26206726; 26439389; 27105448; 27278783; 27834319; 27834323; 28553654; 28871847	16046297; 12975309; 16177791; 15489334; 7116644; 6616870; 12473676; 16335952; 
16726	DGAT1 AGRP1 DGAT	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=25.9 uM for retinol {ECO:0000269|PubMed:16214399}; KM=13.9 uM for palmitoyl coenzyme A {ECO:0000269|PubMed:16214399}; 	2.3.1.20; 2.3.1.76	CATALYTIC ACTIVITY: Acyl-CoA + 1,2-diacylglycerol = CoA + triacylglycerol. {ECO:0000269|PubMed:16214399}.; CATALYTIC ACTIVITY: Acyl-CoA + retinol = CoA + retinyl ester. {ECO:0000269|PubMed:16214399}.		ACTIVITY REGULATION: XP620 is a selective DGAT1 inhibitor. {ECO:0000269|PubMed:16214399}.			PATHWAY: Lipid metabolism; glycerolipid metabolism.				acylglycerol acyl-chain remodeling [GO:0036155]; diacylglycerol metabolic process [GO:0046339]; fatty acid homeostasis [GO:0055089]; lipid storage [GO:0019915]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; neutrophil degranulation [GO:0043312]; triglyceride biosynthetic process [GO:0019432]; triglyceride metabolic process [GO:0006641]; very-low-density lipoprotein particle assembly [GO:0034379]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; 2-acylglycerol O-acyltransferase activity [GO:0003846]; diacylglycerol O-acyltransferase activity [GO:0004144]; retinol O-fatty-acyltransferase activity [GO:0050252]; transferase activity, transferring acyl groups [GO:0016746]; acylglycerol acyl-chain remodeling [GO:0036155]; diacylglycerol metabolic process [GO:0046339]; fatty acid homeostasis [GO:0055089]; lipid storage [GO:0019915]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; neutrophil degranulation [GO:0043312]; triglyceride biosynthetic process [GO:0019432]; triglyceride metabolic process [GO:0006641]; very-low-density lipoprotein particle assembly [GO:0034379]	2-acylglycerol O-acyltransferase activity [GO:0003846]; diacylglycerol O-acyltransferase activity [GO:0004144]; retinol O-fatty-acyltransferase activity [GO:0050252]; transferase activity, transferring acyl groups [GO:0016746]	GO:0003846; GO:0004144; GO:0005789; GO:0005886; GO:0006641; GO:0016021; GO:0016746; GO:0019432; GO:0019915; GO:0034379; GO:0035336; GO:0035579; GO:0036155; GO:0043312; GO:0046339; GO:0050252; GO:0055089	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250|UniProtKB:Q9Z2A7}; Multi-pass membrane protein {ECO:0000250|UniProtKB:Q9Z2A7}.		MOD_RES 17 17 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 18 18 Phosphoserine. {ECO:0000244|PubMed:24275569}.	9756920; 15489334; 16214399; 23114594; 24275569; 11481335; 11672446; 12123490; 12401709; 14521909; 14557275; 14569040; 15258194; 15308631; 16306352; 16894240; 18757836; 18768481; 19197254; 20167659; 20935628; 21369919; 21846726; 21988832; 21990351; 22748069; 23317570; 23420847; 23650620; 24118885; 24573674; 24899196; 25740267; 26493024; 26638075; 26883093; 28768178; 28877685; 29604290	9756920; 15489334; 16214399; 23114594; 24275569
16737	CHST2 GN6ST	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=3.9 uM for PAPS {ECO:0000269|PubMed:12501187}; KM=1.4 mM for BetaBnO-GlcNAc {ECO:0000269|PubMed:12501187}; 	2.8.2.-							SITE 152 152 Not glycosylated. {ECO:0000269|PubMed:19571171}.			carbohydrate metabolic process [GO:0005975]; inflammatory response [GO:0006954]; keratan sulfate biosynthetic process [GO:0018146]; multicellular organism development [GO:0007275]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intrinsic component of Golgi membrane [GO:0031228]; trans-Golgi network [GO:0005802]	Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intrinsic component of Golgi membrane [GO:0031228]; trans-Golgi network [GO:0005802]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146]; carbohydrate metabolic process [GO:0005975]; inflammatory response [GO:0006954]; keratan sulfate biosynthetic process [GO:0018146]; multicellular organism development [GO:0007275]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]	N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146]	GO:0000139; GO:0001517; GO:0005794; GO:0005802; GO:0005975; GO:0006044; GO:0006790; GO:0006954; GO:0007275; GO:0008146; GO:0016021; GO:0018146; GO:0031228	SUBCELLULAR LOCATION: Golgi apparatus, trans-Golgi network membrane {ECO:0000269|PubMed:12855678, ECO:0000269|PubMed:22260995}; Single-pass type II membrane protein {ECO:0000269|PubMed:12855678, ECO:0000269|PubMed:22260995}.	PTM: Glycosylation at Asn-475 is required for catalytic activity. {ECO:0000269|PubMed:19571171}.		9722682; 10049591; 11042394; 15489334; 11310842; 12501187; 11726653; 12855678; 15632306; 15220337; 19571171; 22260995; 10491328; 12218059; 16897186; 19343046; 19898482; 20677014; 21041608; 24799377; 28320965	9722682; 10049591; 11042394; 15489334; 11310842; 12501187; 11726653; 12855678; 15632306; 15220337; 19571171; 22260995
16757	CTDNEP1 DULLARD	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=18 mM for p-nitrophenylphosphate {ECO:0000269|PubMed:17420445}; 	3.1.3.16	CATALYTIC ACTIVITY: [a protein]-serine/threonine phosphate + H(2)O = [a protein]-serine/threonine + phosphate.				BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 5.5. {ECO:0000269|PubMed:17420445};					gamete generation [GO:0007276]; mesoderm development [GO:0007498]; mitotic nuclear envelope disassembly [GO:0007077]; nuclear envelope organization [GO:0006998]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of triglyceride biosynthetic process [GO:0010867]; protein dephosphorylation [GO:0006470]; protein localization to nucleus [GO:0034504]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; Nem1-Spo7 phosphatase complex [GO:0071595]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; Nem1-Spo7 phosphatase complex [GO:0071595]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; protein serine/threonine phosphatase activity [GO:0004722]; gamete generation [GO:0007276]; mesoderm development [GO:0007498]; mitotic nuclear envelope disassembly [GO:0007077]; nuclear envelope organization [GO:0006998]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of triglyceride biosynthetic process [GO:0010867]; protein dephosphorylation [GO:0006470]; protein localization to nucleus [GO:0034504]	protein serine/threonine phosphatase activity [GO:0004722]	GO:0004722; GO:0005635; GO:0005737; GO:0005789; GO:0005811; GO:0006470; GO:0006998; GO:0007077; GO:0007276; GO:0007498; GO:0010867; GO:0016021; GO:0031965; GO:0034504; GO:0071595; GO:0090263	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Single-pass membrane protein. Nucleus membrane; Single-pass membrane protein.			16533400; 16625196; 15489334; 12083771; 17420445; 18669648; 22134922; 15889145; 18694939; 19494125; 19494126; 20876142; 21081492; 21413788; 22986494; 24955142; 25944354; 28287811	16533400; 16625196; 15489334; 12083771; 17420445; 18669648; 22134922
16786	DAGLB	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=74.1 uM for diacylglycerol {ECO:0000269|PubMed:14610053}; Vmax=3.45 nmol/min/mg enzyme {ECO:0000269|PubMed:14610053}; 	3.1.1.-			ACTIVITY REGULATION: Inhibited by p-hydroxy-mercuri-benzoate and HgCl(2), but not to PMSF. Also inhibited by RHC80267, a drug that blocks 2-AG formation. {ECO:0000269|PubMed:14610053}.	COFACTOR: Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000269|PubMed:14610053}; 	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 7.0. {ECO:0000269|PubMed:14610053};					arachidonic acid metabolic process [GO:0019369]; lipid catabolic process [GO:0016042]; neuroblast proliferation [GO:0007405]; neurotransmitter biosynthetic process [GO:0042136]	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; acylglycerol lipase activity [GO:0047372]; metal ion binding [GO:0046872]; arachidonic acid metabolic process [GO:0019369]; lipid catabolic process [GO:0016042]; neuroblast proliferation [GO:0007405]; neurotransmitter biosynthetic process [GO:0042136]	acylglycerol lipase activity [GO:0047372]; metal ion binding [GO:0046872]	GO:0005634; GO:0005765; GO:0005886; GO:0007405; GO:0016021; GO:0016042; GO:0019369; GO:0042136; GO:0046872; GO:0047372	SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:14610053}; Multi-pass membrane protein {ECO:0000269|PubMed:14610053}.		MOD_RES 570 570 Phosphoserine. {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231}.; MOD_RES 574 574 Phosphoserine. {ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163}.; MOD_RES 579 579 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 583 583 Phosphoserine. {ECO:0000250|UniProtKB:Q91WC9}.; MOD_RES 584 584 Phosphoserine. {ECO:0000244|PubMed:18669648}.	14702039; 16303743; 12853948; 12690205; 15489334; 14610053; 18691976; 18669648; 19690332; 20068231; 22814378; 23186163; 24275569; 10348910; 16169070; 19126434; 19805454; 22190034; 27115711	14702039; 16303743; 12853948; 12690205; 15489334; 14610053; 18691976; 18669648; 19690332; 20068231; 22814378; 23186163; 24275569
16793	DHDDS HDS	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=11.1 uM for isopentenyl diphosphate {ECO:0000269|PubMed:28842490}; KM=0.68 uM for (2E,6E)-farnesyl diphosphate {ECO:0000269|PubMed:28842490}; Note=Values were measured with the heterodimer. kcat is 0.58 sec(-1) with (2E,6E)-farnesyl diphosphate and isopentenyl diphosphate as substrate. {ECO:0000269|PubMed:28842490};	2.5.1.87	CATALYTIC ACTIVITY: (2E,6E)-farnesyl diphosphate + n isopentenyl diphosphate = n diphosphate + ditrans,polycis-polyprenyl diphosphate (n = 10-55). {ECO:0000269|PubMed:25066056, ECO:0000269|PubMed:28842490}.		ACTIVITY REGULATION: Activated by phospholipids including cardiolipin, phosphatidylcholine, phosphatidylethanolamine, phosphatidylinositol and phosphatidylserine. {ECO:0000269|PubMed:28842490}.	COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:28842490}; 	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 8-9. Active from pH 5.5 to 9.3. {ECO:0000269|PubMed:28842490};	PATHWAY: Protein modification; protein glycosylation. {ECO:0000269|PubMed:25066056}.; PATHWAY: Lipid metabolism. {ECO:0000269|PubMed:28842490}.				dolichyl diphosphate biosynthetic process [GO:0006489]; polyprenol biosynthetic process [GO:0016094]	dehydrodolichyl diphosphate synthase complex [GO:1904423]; endoplasmic reticulum membrane [GO:0005789]	dehydrodolichyl diphosphate synthase complex [GO:1904423]; endoplasmic reticulum membrane [GO:0005789]; dehydrodolichyl diphosphate synthase activity [GO:0045547]; dolichyl diphosphate biosynthetic process [GO:0006489]; polyprenol biosynthetic process [GO:0016094]	dehydrodolichyl diphosphate synthase activity [GO:0045547]	GO:0005789; GO:0006489; GO:0016094; GO:0045547; GO:1904423	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:14652022}; Peripheral membrane protein {ECO:0000269|PubMed:14652022}. Note=colocalizes with calnexin.			12591616; 20736409; 14702039; 16710414; 15489334; 14652022; 21572394; 25066056; 25944712; 28842490; 21295283; 29100083; 15850770; 20379614; 21295282; 24664694; 25255364; 27343064; 7374371	12591616; 20736409; 14702039; 16710414; 15489334; 14652022; 21572394; 25066056; 25944712; 28842490; 21295283; 29100083
16808	CHKA CHK CKI	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.2 mM for choline {ECO:0000269|PubMed:17007874, ECO:0000269|PubMed:19915674}; KM=0.4 mM for ATP {ECO:0000269|PubMed:17007874, ECO:0000269|PubMed:19915674}; KM=12 mM for ethanolamine {ECO:0000269|PubMed:17007874, ECO:0000269|PubMed:19915674}; 	2.7.1.32; 2.7.1.82	CATALYTIC ACTIVITY: ATP + choline = ADP + phosphocholine. {ECO:0000269|PubMed:19915674}.; CATALYTIC ACTIVITY: ATP + ethanolamine = ADP + O-phosphoethanolamine. {ECO:0000269|PubMed:19915674}.	BINDING 146 146 ATP.; BINDING 308 308 ATP. {ECO:0000305}.; BINDING 330 330 ATP.				PATHWAY: Phospholipid metabolism; phosphatidylcholine biosynthesis; phosphocholine from choline: step 1/1.; PATHWAY: Phospholipid metabolism; phosphatidylethanolamine biosynthesis; phosphatidylethanolamine from ethanolamine: step 1/3.				choline metabolic process [GO:0019695]; ethanolamine metabolic process [GO:0006580]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; response to 3-methylcholanthrene [GO:1904681]; response to toxic substance [GO:0009636]	cytosol [GO:0005829]	cytosol [GO:0005829]; ATP binding [GO:0005524]; choline binding [GO:0033265]; choline kinase activity [GO:0004103]; cholinesterase activity [GO:0004104]; drug binding [GO:0008144]; ethanolamine kinase activity [GO:0004305]; protein homodimerization activity [GO:0042803]; choline metabolic process [GO:0019695]; ethanolamine metabolic process [GO:0006580]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; response to 3-methylcholanthrene [GO:1904681]; response to toxic substance [GO:0009636]	ATP binding [GO:0005524]; choline binding [GO:0033265]; choline kinase activity [GO:0004103]; cholinesterase activity [GO:0004104]; drug binding [GO:0008144]; ethanolamine kinase activity [GO:0004305]; protein homodimerization activity [GO:0042803]	GO:0004103; GO:0004104; GO:0004305; GO:0005524; GO:0005829; GO:0006580; GO:0006629; GO:0006646; GO:0006656; GO:0006869; GO:0008144; GO:0009636; GO:0019695; GO:0033265; GO:0042803; GO:1904681	SUBCELLULAR LOCATION: Cytoplasm.			1618328; 16554811; 15489334; 19915674; 17007874; 20299452; 11044454; 11840339; 12082619; 12176020; 16820874; 17184542; 18172309; 18296102; 18654987; 19156696; 19448670; 19737740; 19855431; 20042122; 20662904; 21048031; 21822308; 22038995; 22515519; 22972156; 23071593; 23416529; 23441033; 23762272; 23775813; 23813777; 24287694; 24387243; 24556997; 24583375; 25028471; 25267063; 25522435; 25768400; 25796169; 26041862; 26496360; 26503172; 26657335; 26700752; 26769123; 27029499; 27489281; 27490389; 27556502; 27616047; 28065789; 28509322; 28566381; 29389115	1618328; 16554811; 15489334; 19915674; 17007874; 20299452
16809	CHKB CHETK CHKL	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.57 mM for choline {ECO:0000269|PubMed:19915674}; KM=2.9 mM for ethanolamine {ECO:0000269|PubMed:19915674}; 	2.7.1.32; 2.7.1.82	CATALYTIC ACTIVITY: ATP + choline = ADP + phosphocholine. {ECO:0000269|PubMed:19915674}.; CATALYTIC ACTIVITY: ATP + ethanolamine = ADP + O-phosphoethanolamine. {ECO:0000269|PubMed:19915674}.	BINDING 104 104 ATP.; BINDING 244 244 ATP. {ECO:0000250}.; BINDING 264 264 ATP.				PATHWAY: Phospholipid metabolism; phosphatidylethanolamine biosynthesis; phosphatidylethanolamine from ethanolamine: step 1/3.				phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]	cytosol [GO:0005829]	cytosol [GO:0005829]; ATP binding [GO:0005524]; choline kinase activity [GO:0004103]; ethanolamine kinase activity [GO:0004305]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]	ATP binding [GO:0005524]; choline kinase activity [GO:0004103]; ethanolamine kinase activity [GO:0004305]	GO:0004103; GO:0004305; GO:0005524; GO:0005829; GO:0006646; GO:0006656			MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:22223895, ECO:0000269|Ref.8}.	10918069; 15461802; 14702039; 10591208; 15489334; 19915674; 22223895; 11044454; 15174051; 17007874; 18996102; 20299452	10918069; 15461802; 14702039; 10591208; 15489334; 19915674; 22223895; 
16811	CHST11	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.5 uM for PAPS {ECO:0000269|PubMed:15628971}; KM=2.1 mM for chondroitin {ECO:0000269|PubMed:15628971}; 	2.8.2.5	CATALYTIC ACTIVITY: 3'-phosphoadenylyl sulfate + chondroitin = adenosine 3',5'-bisphosphate + chondroitin 4'-sulfate. {ECO:0000269|PubMed:10781601, ECO:0000269|PubMed:11056388}.									carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; regulation of cell proliferation [GO:0042127]; respiratory gaseous exchange [GO:0007585]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; regulation of cell proliferation [GO:0042127]; respiratory gaseous exchange [GO:0007585]	chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]	GO:0000139; GO:0001537; GO:0002063; GO:0007585; GO:0009791; GO:0016020; GO:0016021; GO:0016051; GO:0030206; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0050659	SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000250}; Single-pass type II membrane protein {ECO:0000250}.	PTM: N-glycosylated; required for activity and stability. {ECO:0000269|PubMed:15628971}.		11056388; 10781601; 14702039; 15489334; 12847091; 15273723; 15628971; 22814378; 11139592; 12080076; 15324304; 19240061; 19937589; 20080650; 20379614; 20580388; 21123170; 21658254; 22317973; 25511584; 25586191; 26084610; 26993826; 27391021; 28761999	11056388; 10781601; 14702039; 15489334; 12847091; 15273723; 15628971; 22814378
16837	CLYBL CLB	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=3.6 mM for glyoxylate (with acetyl-CoA as cosubstrate) {ECO:0000269|PubMed:24334609}; KM=1.2 mM for glyoxylate (with propionyl-CoA as cosubstrate) {ECO:0000269|PubMed:24334609}; KM=28.7 uM for propionyl-CoA (for beta-methylmalate synthase) {ECO:0000269|PubMed:29056341}; KM=57.3 uM for acetyl-CoA (for malate synthase) {ECO:0000269|PubMed:29056341}; KM=25 uM for acetyl-CoA (for citramalate synthase) {ECO:0000269|PubMed:29056341}; KM=23 uM for (3S)-citramalyl-CoA (for citramalyl-CoA lyase) {ECO:0000269|PubMed:29056341}; KM=74 uM for acetyl-CoA {ECO:0000269|PubMed:24334609}; KM=23 uM for propionyl-CoA {ECO:0000269|PubMed:24334609}; Note=kcat is 0.12 sec(-1) for malate synthase reaction (PubMed:24334609). kcat is 0.09 sec(-1) for beta-methylmalate synthase reaction (PubMed:24334609). kcat is 0.135 sec(-1) for beta-methylmalate synthase reaction (PubMed:29056341). kcat is 0.146 sec(-1) for malate synthase reaction (PubMed:29056341). kcat is 0.08 sec(-1) for citramalate synthase reaction (PubMed:29056341). kcat is 14.1 sec(-1) for citramalyl-CoA lyase reaction (PubMed:29056341). {ECO:0000269|PubMed:24334609, ECO:0000269|PubMed:29056341};	4.1.3.25; 2.3.3.-; 2.3.3.9	CATALYTIC ACTIVITY: Acetyl-CoA + H(2)O + glyoxylate = (S)-malate + CoA. {ECO:0000269|PubMed:24334609, ECO:0000269|PubMed:29056341}.; CATALYTIC ACTIVITY: Propionyl-CoA + H(2)O + glyoxylate = beta-methylmalate + CoA. {ECO:0000269|PubMed:24334609, ECO:0000269|PubMed:29056341}.; CATALYTIC ACTIVITY: (3S)-citramalyl-CoA = acetyl-CoA + pyruvate. {ECO:0000269|PubMed:29056341}.	BINDING 50 50 Substrate. {ECO:0000244|PDB:5VXC, ECO:0000244|PDB:5VXO, ECO:0000269|PubMed:29056341}.; BINDING 57 57 Substrate. {ECO:0000244|PDB:5VXC, ECO:0000244|PDB:5VXO, ECO:0000269|PubMed:29056341}.; BINDING 61 61 Substrate. {ECO:0000244|PDB:5VXC, ECO:0000244|PDB:5VXO, ECO:0000269|PubMed:29056341}.; BINDING 107 107 Substrate. {ECO:0000244|PDB:5VXC, ECO:0000244|PDB:5VXO, ECO:0000269|PubMed:29056341}.		COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:24334609, ECO:0000269|PubMed:29056341}; ;  Note=Binds 1 Mg(2+) ion per subunit. {ECO:0000269|PubMed:29056341};						protein homotrimerization [GO:0070207]; regulation of cobalamin metabolic process [GO:0106064]	mitochondrion [GO:0005739]	mitochondrion [GO:0005739]; (3S)-citramalyl-CoA lyase activity [GO:0047777]; magnesium ion binding [GO:0000287]; malate synthase activity [GO:0004474]; protein homotrimerization [GO:0070207]; regulation of cobalamin metabolic process [GO:0106064]	(3S)-citramalyl-CoA lyase activity [GO:0047777]; magnesium ion binding [GO:0000287]; malate synthase activity [GO:0004474]	GO:0000287; GO:0004474; GO:0005739; GO:0047777; GO:0070207; GO:0106064	SUBCELLULAR LOCATION: Mitochondrion {ECO:0000250|UniProtKB:Q8R4N0}.		MOD_RES 57 57 N6-acetyllysine. {ECO:0000250|UniProtKB:Q8R4N0}.; MOD_RES 61 61 N6-acetyllysine. {ECO:0000250|UniProtKB:Q8R4N0}.; MOD_RES 82 82 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8R4N0}.; MOD_RES 82 82 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8R4N0}.; MOD_RES 92 92 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q8R4N0}.; MOD_RES 92 92 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q8R4N0}.; MOD_RES 309 309 N6-succinyllysine. {ECO:0000250|UniProtKB:Q8R4N0}.	11741334; 14702039; 15057823; 15489334; 23754956; 24334609; 24275569; 25944712; 29056341; 20800603; 20877624	11741334; 14702039; 15057823; 15489334; 23754956; 24334609; 24275569; 25944712; 29056341
16963	CYP27C1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.5 uM for all-trans retinol {ECO:0000269|PubMed:27059013}; KM=0.35 uM for all-trans retinal {ECO:0000269|PubMed:27059013}; KM=0.87 uM for all-trans retinoic acid {ECO:0000269|PubMed:27059013}; 	1.14.19.53	CATALYTIC ACTIVITY: All-trans-retinol + 2 reduced adrenodoxin + 2 H(+) + O(2) = all-trans-3,4-didehydroretinol + 2 oxidized adrenodoxin + 2 H(2)O. {ECO:0000269|PubMed:27059013}.			COFACTOR: Name=heme; Xref=ChEBI:CHEBI:30413; Evidence={ECO:0000250|UniProtKB:P04798}; 						retinal metabolic process [GO:0042574]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]	intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]	intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; 11-cis retinal binding [GO:0005502]; 11-cis-retinal 3,4-desaturase activity [GO:0061899]; all-trans retinal 3,4-desaturase activity [GO:0061897]; all-trans retinal binding [GO:0005503]; all-trans retinoic acid 3,4-desaturase activity [GO:0061898]; all-trans retinol 3,4-desaturase activity [GO:0061896]; all-trans-retinol binding [GO:1904768]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; retinoic acid binding [GO:0001972]; retinal metabolic process [GO:0042574]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]	11-cis-retinal 3,4-desaturase activity [GO:0061899]; 11-cis retinal binding [GO:0005502]; all-trans retinal 3,4-desaturase activity [GO:0061897]; all-trans retinal binding [GO:0005503]; all-trans retinoic acid 3,4-desaturase activity [GO:0061898]; all-trans retinol 3,4-desaturase activity [GO:0061896]; all-trans-retinol binding [GO:1904768]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; retinoic acid binding [GO:0001972]	GO:0001972; GO:0004497; GO:0005502; GO:0005503; GO:0005506; GO:0016020; GO:0020037; GO:0042572; GO:0042573; GO:0042574; GO:0043231; GO:0061896; GO:0061897; GO:0061898; GO:0061899; GO:1904768	SUBCELLULAR LOCATION: Membrane {ECO:0000305}.			14702039; 15815621; 15489334; 16360114; 27059013; 26514267; 28701464	14702039; 15815621; 15489334; 16360114; 27059013
16978	CA14 UNQ690/PRO1335	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=7.9 mM for CO(2) {ECO:0000269|PubMed:18618712}; 	4.2.1.1	CATALYTIC ACTIVITY: H(2)CO(3) = CO(2) + H(2)O.		ACTIVITY REGULATION: Activated by histamine, L-adrenaline, L- and D-histidine, and L- and D-phenylalanine. Inhibited by coumarins, saccharin, sulfonamide derivatives such as acetazolamide (AZA) and Foscarnet (phosphonoformate trisodium salt). {ECO:0000269|PubMed:16686544, ECO:0000269|PubMed:16807956, ECO:0000269|PubMed:17127057, ECO:0000269|PubMed:17314045, ECO:0000269|PubMed:17705204, ECO:0000269|PubMed:18618712, ECO:0000269|PubMed:19186056, ECO:0000269|PubMed:19206230}.	COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000269|PubMed:24374484}; 				UNQ690/PRO1335		bicarbonate transport [GO:0015701]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; bicarbonate transport [GO:0015701]	carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]	GO:0004089; GO:0005886; GO:0008270; GO:0015701; GO:0016021	SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.		MOD_RES 325 325 Phosphoserine. {ECO:0000244|PubMed:21406692}.	10512682; 12975309; 14702039; 16710414; 15489334; 16807956; 16686544; 17705204; 17127057; 17314045; 19186056; 19206230; 18618712; 21406692; 24275569; 24374484; 11121027; 11676494; 15501038; 16006130; 17881426; 18162396; 18294854; 18703501; 20170095; 20379614; 2111324; 21988832; 26497049; 7625839; 9054574; 9336012	10512682; 12975309; 14702039; 16710414; 15489334; 16807956; 16686544; 17705204; 17127057; 17314045; 19186056; 19206230; 18618712; 21406692; 24275569; 24374484
17107	C1S	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=12.3 uM for complement component C2 (at 37 degrees Celsius) {ECO:0000269|PubMed:11527969}; KM=1.9 uM for complement component C4 (at 37 degrees Celsius) {ECO:0000269|PubMed:11527969}; Note=Less efficient than MASP2 in C4 cleavage.;	3.4.21.42	CATALYTIC ACTIVITY: Cleavage of Arg-|-Ala bond in complement component C4 to form C4a and C4b, and Lys(or Arg)-|-Lys bond in complement component C2 to form C2a and C2b: the 'classical' pathway C3 convertase. {ECO:0000269|PubMed:11527969}.		ACTIVITY REGULATION: Inhibited by SERPING1. {ECO:0000269|PubMed:11527969}.							complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; complement activation, lectin pathway [GO:0001867]; regulation of complement activation [GO:0030449]	blood microparticle [GO:0072562]; extracellular region [GO:0005576]	blood microparticle [GO:0072562]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; complement activation, lectin pathway [GO:0001867]; regulation of complement activation [GO:0030449]	calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]	GO:0001867; GO:0004252; GO:0005509; GO:0005576; GO:0006956; GO:0006958; GO:0030449; GO:0042802; GO:0072562		PTM: The iron and 2-oxoglutarate dependent 3-hydroxylation of aspartate and asparagine is (R) stereospecific within EGF domains. {ECO:0000269|PubMed:2141278}.	MOD_RES 149 149 (3R)-3-hydroxyasparagine. {ECO:0000269|PubMed:2141278}.	3500856; 2831944; 2459702; 15489334; 9794427; 2553984; 3007145; 6362661; 2141278; 1854725; 2007122; 7779774; 11527969; 11390518; 16335952; 19159218; 24275569; 27745832; 10775260; 12788922; 10925294; 12396008; 1249422; 14280442; 14674770; 15199963; 1533159; 16169853; 17996945; 18062908; 19344414; 19423540; 20008834; 20406964; 20438785; 20467438; 20592021; 20711500; 22855709; 23300094; 23592783; 23650384; 2387866; 23922389; 23989031; 24695853; 26231209; 28104818; 29311313; 6019133; 70787; 760802; 761607; 814163	3500856; 2831944; 2459702; 15489334; 9794427; 2553984; 3007145; 6362661; 2141278; 1854725; 2007122; 7779774; 11527969; 11390518; 16335952; 19159218; 24275569; 27745832; 10775260; 12788922
17108	CD163 M130	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=2.0 nM for hemoglobin/haptoglobin of HP*1S phenotype {ECO:0000269|PubMed:11196644}; KM=0.2 nM for hemoglobin/haptoglobin of HP*1F phenotype {ECO:0000269|PubMed:11196644}; 								SITE 269 270 Cleavage; in calcium-free condition.; SITE 281 282 Cleavage; in calcium-free condition.; SITE 333 334 Cleavage; in calcium-free condition.; SITE 360 361 Cleavage; in calcium-free condition.			acute-phase response [GO:0006953]; receptor-mediated endocytosis [GO:0006898]	endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; scavenger receptor activity [GO:0005044]; acute-phase response [GO:0006953]; receptor-mediated endocytosis [GO:0006898]	scavenger receptor activity [GO:0005044]	GO:0005044; GO:0005576; GO:0005886; GO:0005887; GO:0006898; GO:0006953; GO:0009897; GO:0030666	SUBCELLULAR LOCATION: Soluble CD163: Secreted {ECO:0000269|PubMed:12296867}.; SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10577520, ECO:0000269|PubMed:10648003}; Single-pass type I membrane protein {ECO:0000269|PubMed:10577520, ECO:0000269|PubMed:10648003}. Note=Isoform 1 and isoform 2 show a lower surface expression when expressed in cells.	PTM: A soluble form (sCD163) is produced by proteolytic shedding which can be induced by lipopolysaccharide, phorbol ester and Fc region of immunoglobulin gamma. This cleavage is dependent on protein kinase C and tyrosine kinases and can be blocked by protease inhibitors. The shedding is inhibited by the tissue inhibitor of metalloproteinase TIMP3, and thus probably induced by membrane-bound metalloproteinases ADAMs. {ECO:0000269|PubMed:10066432, ECO:0000269|PubMed:12296867, ECO:0000269|PubMed:15075364, ECO:0000269|PubMed:15448162}.; PTM: Phosphorylated. {ECO:0000305|PubMed:11298324}.		8370408; 10403791; 16541075; 15489334; 10066432; 10577520; 10648003; 11298324; 11196644; 12296867; 12208511; 12377940; 15478309; 15448162; 15075364; 16335952; 16434690; 19159218; 19139490; 24275569; 11688984; 11865982; 14656926; 14962251; 15146432; 15479433; 15613100; 15624762; 15846794; 16189277; 16507898; 16517975; 16522161; 17008602; 17095719; 17102136; 17117055; 17460152; 17525367; 17548657; 17629586; 17947394; 18276779; 18316565; 18320015; 18410276; 18542032; 18563533; 18604302; 18849484; 19040468; 19131549; 19473660; 19528371; 19582880; 19885719; 19910578; 19961729; 20237496; 20299688; 20379614; 20472850; 20711500; 20807704; 21120485; 21692033; 21766094; 21799753; 21813065; 21839737; 21933102; 21962403; 22044760; 22060747; 22098563; 22211334; 22279103; 22289504; 22290142; 22309204; 22354894; 22362417; 22450890; 22453843; 22504842; 22540373; 22682876; 22807450; 22884782; 22911680; 22948049; 22949100; 23011084; 23013330; 23149357; 23150181; 23165891; 23224400; 23289476; 23326413; 23463035; 23539121; 23555776; 23557330; 23589619; 23595052; 23640944; 23660665; 23671278; 23687420; 23692821; 23792028; 23800379; 23873589; 23922818; 24118665; 24423341; 24489836; 24498098; 24515766; 24548423; 24577568; 24597777; 24612259; 24612419; 24619759; 24623375; 24637679; 24858806; 24883329; 24934531; 24978196; 24983948; 25074267; 25109683; 25156085; 25281471; 25346048; 25366599; 25388964; 25392926; 25461761; 25499804; 25587690; 25602697; 25747973; 25869385; 25944005; 26045748; 26087825; 26135617; 26209500; 26339412; 26352275; 26376364; 26549495; 26568320; 26569178; 26616677; 26916171; 26985764; 27094919; 27100336; 27242373; 27354410; 27355513; 27591510; 27679428; 27684274; 28005267; 28103926; 28282272; 28392117; 28406702; 28455006; 28639912; 28687956; 28715286; 28805986; 29226859; 29445750; 29725763	8370408; 10403791; 16541075; 15489334; 10066432; 10577520; 10648003; 11298324; 11196644; 12296867; 12208511; 12377940; 15478309; 15448162; 15075364; 16335952; 16434690; 19159218; 19139490; 24275569
17127	CA12	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=12.0 mM for CO(2) {ECO:0000269|PubMed:18618712}; 	4.2.1.1	CATALYTIC ACTIVITY: H(2)CO(3) = CO(2) + H(2)O.		ACTIVITY REGULATION: Inhibited by coumarins, saccharin, sulfonamide derivatives such as acetazolamide (AZA), benzenesulfonamide and derivatives (4-carboxyethylbenzene-sulfonamide, 4-carboxyethylbenzene-sulfonamide ethyl ester, 4-(acetyl-2-aminoethyl)benzene-sulfonamide, 4-aminoethylbenzene-sulfonamide) and Foscarnet (phosphonoformate trisodium salt). {ECO:0000269|PubMed:17314045, ECO:0000269|PubMed:17407288, ECO:0000269|PubMed:17705204, ECO:0000269|PubMed:18618712, ECO:0000269|PubMed:19186056, ECO:0000269|PubMed:19206230}.	COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000269|PubMed:11493685}; 						bicarbonate transport [GO:0015701]; chloride ion homeostasis [GO:0055064]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; bicarbonate transport [GO:0015701]; chloride ion homeostasis [GO:0055064]	carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]	GO:0004089; GO:0005886; GO:0008270; GO:0015701; GO:0016021; GO:0055064	SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.			9636197; 9770531; 14702039; 15489334; 17705204; 17314045; 17407288; 19186056; 19206230; 18618712; 11493685; 21035102; 11121027; 11676494; 12676895; 12854129; 15501038; 15849821; 16006130; 16169070; 16416108; 18162396; 18294854; 18322268; 18336315; 18451179; 18703501; 19291313; 20132413; 20215053; 20398423; 20434230; 20509747; 21040567; 2111324; 21184099; 21278619; 21900206; 22172588; 22439015; 23348702; 23394791; 23910904; 24103428; 25358084; 25686827; 25758852; 26079542; 26276155; 26486891; 26901836; 27688658; 29503769; 7625839; 9054574; 9336012	9636197; 9770531; 14702039; 15489334; 17705204; 17314045; 17407288; 19186056; 19206230; 18618712; 11493685; 21035102
17130	CA3	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=52.0 mM for CO(2) {ECO:0000269|PubMed:18618712}; 	4.2.1.1	CATALYTIC ACTIVITY: H(2)CO(3) = CO(2) + H(2)O.		ACTIVITY REGULATION: Activated by proton donors such as imidazole and the dipeptide histidylhistidine. Inhibited by coumarins and sulfonamide derivatives such as acetazolamide. {ECO:0000269|PubMed:18618712, ECO:0000269|PubMed:19186056, ECO:0000269|PubMed:19206230}.	COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000269|PubMed:16042381, ECO:0000269|PubMed:17427958}; 						bicarbonate transport [GO:0015701]; response to bacterium [GO:0009617]; response to ethanol [GO:0045471]; response to oxidative stress [GO:0006979]	cytosol [GO:0005829]	cytosol [GO:0005829]; carbonate dehydratase activity [GO:0004089]; nickel cation binding [GO:0016151]; phosphatase activity [GO:0016791]; zinc ion binding [GO:0008270]; bicarbonate transport [GO:0015701]; response to bacterium [GO:0009617]; response to ethanol [GO:0045471]; response to oxidative stress [GO:0006979]	carbonate dehydratase activity [GO:0004089]; nickel cation binding [GO:0016151]; phosphatase activity [GO:0016791]; zinc ion binding [GO:0008270]	GO:0004089; GO:0005829; GO:0006979; GO:0008270; GO:0009617; GO:0015701; GO:0016151; GO:0016791; GO:0045471	SUBCELLULAR LOCATION: Cytoplasm.	PTM: S-glutathionylated in hepatocytes under oxidative stress. {ECO:0000250}.	MOD_RES 2 2 N-acetylalanine. {ECO:0000250|UniProtKB:P07450}.; MOD_RES 29 29 Phosphoserine. {ECO:0000250|UniProtKB:P14141}.; MOD_RES 43 43 Phosphoserine. {ECO:0000250|UniProtKB:P14141}.; MOD_RES 48 48 Phosphoserine. {ECO:0000250|UniProtKB:P14141}.; MOD_RES 50 50 Phosphoserine. {ECO:0000250|UniProtKB:P14141}.; MOD_RES 55 55 Phosphoserine. {ECO:0000250|UniProtKB:P14141}.; MOD_RES 73 73 Phosphothreonine. {ECO:0000250|UniProtKB:P14141}.; MOD_RES 127 127 Phosphotyrosine. {ECO:0000250|UniProtKB:P14141}.; MOD_RES 129 129 Phosphothreonine. {ECO:0000250|UniProtKB:P14141}.; MOD_RES 176 176 Phosphothreonine. {ECO:0000250|UniProtKB:P16015}.; MOD_RES 182 182 S-glutathionyl cysteine. {ECO:0000250}.; MOD_RES 187 187 S-glutathionyl cysteine. {ECO:0000250}.; MOD_RES 216 216 Phosphothreonine. {ECO:0000250|UniProtKB:P14141}.; MOD_RES 219 219 Phosphoserine. {ECO:0000250|UniProtKB:P14141}.	3086182; 3099285; 14702039; 15489334; 2824285; 9651514; 19186056; 19206230; 18618712; 24275569; 16042381; 17427958; 11976500; 120192; 12171926; 12484342; 12745799; 1554744; 18322545; 18444244; 19301202; 20349499; 20493921; 20578724; 21282642; 2169869; 22001224; 22797148; 23049597; 234739; 23981757; 24838180; 26847302; 3080418; 4994926; 6407977; 6433979; 6819139; 8083199; 8399223; 9336012; 9635771	3086182; 3099285; 14702039; 15489334; 2824285; 9651514; 19186056; 19206230; 18618712; 24275569; 16042381; 17427958
17133	CA5A CA5	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=10.0 mM for CO(2) {ECO:0000269|PubMed:18618712}; 	4.2.1.1	CATALYTIC ACTIVITY: H(2)CO(3) = CO(2) + H(2)O.		ACTIVITY REGULATION: Activated by histamine, L-adrenaline, L- and D-histidine, and L- and D-phenylalanine. Inhibited by coumarins, sulfonamide derivatives such as acetazolamide and Foscarnet (phosphonoformate trisodium salt). {ECO:0000269|PubMed:16686544, ECO:0000269|PubMed:16807956, ECO:0000269|PubMed:17127057, ECO:0000269|PubMed:17314045, ECO:0000269|PubMed:18618712, ECO:0000269|PubMed:19186056, ECO:0000269|PubMed:19206230}.	COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250|UniProtKB:P23589}; 						bicarbonate transport [GO:0015701]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; bicarbonate transport [GO:0015701]	carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]	GO:0004089; GO:0005739; GO:0005759; GO:0008270; GO:0015701	SUBCELLULAR LOCATION: Mitochondrion.			8356065; 7490083; 15489334; 16807956; 16686544; 17127057; 17314045; 19186056; 19206230; 18618712; 24275569; 24530203; 10409679; 14611844; 16302824; 17174092; 17761422; 20877624; 26913920; 9336012	8356065; 7490083; 15489334; 16807956; 16686544; 17127057; 17314045; 19186056; 19206230; 18618712; 24275569; 24530203
17135	CARNMT1 C9orf41	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=4.959 mM for carnosine {ECO:0000269|PubMed:26001783}; KM=0.053 mM for S-adenosyl-L-methionine {ECO:0000269|PubMed:26001783}; Vmax=1.77 nmol/min/mg enzyme with carnosine as substrate {ECO:0000269|PubMed:26001783}; Note=kcat is 0.09 min(-1) for carnosine. kcat is 3.57 min(-1) for S-adenosyl-L-methionine. {ECO:0000269|PubMed:26001783};	2.1.1.22	CATALYTIC ACTIVITY: S-adenosyl-L-methionine + carnosine = S-adenosyl-L-homocysteine + anserine. {ECO:0000269|PubMed:26001783}.				BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 7.0-7.5. {ECO:0000269|PubMed:26001783};				BIOPHYSICOCHEMICAL PROPERTIES: ;  Temperature dependence: Optimum temperature is 50 degrees Celsius. {ECO:0000269|PubMed:26001783};	carnosine metabolic process [GO:0035498]; histidine catabolic process [GO:0006548]	cytosol [GO:0005829]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleus [GO:0005634]; carnosine N-methyltransferase activity [GO:0030735]; carnosine metabolic process [GO:0035498]; histidine catabolic process [GO:0006548]	carnosine N-methyltransferase activity [GO:0030735]	GO:0005634; GO:0005829; GO:0006548; GO:0030735; GO:0035498	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:26001783}. Nucleus {ECO:0000269|PubMed:26001783}.			15164053; 15489334; 17974005; 14702039; 21269460; 26001783; 29463897	15164053; 15489334; 17974005; 14702039; 21269460; 26001783
17151	HLCS	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=224 nM for biotin {ECO:0000269|PubMed:10590022}; Vmax=143.9 pmol/min/mg enzyme {ECO:0000269|PubMed:10590022}; 	6.3.4.-; 6.3.4.9; 6.3.4.10; 6.3.4.11; 6.3.4.15	CATALYTIC ACTIVITY: ATP + biotin + apo-[methylmalonyl-CoA:pyruvate carboxytransferase] = AMP + diphosphate + [methylmalonyl-CoA:pyruvate carboxytransferase].; CATALYTIC ACTIVITY: ATP + biotin + apo-[propionyl-CoA:carbon-dioxide ligase (ADP-forming)] = AMP + diphosphate + [propionyl-CoA:carbon-dioxide ligase (ADP-forming)].; CATALYTIC ACTIVITY: ATP + biotin + apo-[3-methylcrotonoyl-CoA:carbon-dioxide ligase (ADP-forming)] = AMP + diphosphate + [3-methylcrotonoyl-CoA:carbon-dioxide ligase (ADP-forming)].; CATALYTIC ACTIVITY: ATP + biotin + [biotin carboxyl-carrier protein]-L-lysine = AMP + diphosphate + [biotin carboxyl-carrier protein]-N(6)-biotinyl-L-lysine.									biotin metabolic process [GO:0006768]; cell proliferation [GO:0008283]; histone biotinylation [GO:0071110]; histone modification [GO:0016570]; protein biotinylation [GO:0009305]; response to biotin [GO:0070781]	chromatin [GO:0000785]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]	chromatin [GO:0000785]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin-[acetyl-CoA-carboxylase] ligase activity [GO:0004077]; biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity [GO:0004078]; biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity [GO:0004079]; biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity [GO:0004080]; biotin-protein ligase activity [GO:0018271]; enzyme binding [GO:0019899]; protein homodimerization activity [GO:0042803]; biotin metabolic process [GO:0006768]; cell proliferation [GO:0008283]; histone biotinylation [GO:0071110]; histone modification [GO:0016570]; protein biotinylation [GO:0009305]; response to biotin [GO:0070781]	ATP binding [GO:0005524]; biotin-[acetyl-CoA-carboxylase] ligase activity [GO:0004077]; biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity [GO:0004078]; biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity [GO:0004079]; biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity [GO:0004080]; biotin binding [GO:0009374]; biotin-protein ligase activity [GO:0018271]; enzyme binding [GO:0019899]; protein homodimerization activity [GO:0042803]	GO:0000785; GO:0004077; GO:0004078; GO:0004079; GO:0004080; GO:0005524; GO:0005652; GO:0005739; GO:0005829; GO:0006768; GO:0008283; GO:0009305; GO:0009374; GO:0016363; GO:0016570; GO:0018271; GO:0019899; GO:0042803; GO:0070781; GO:0071110	SUBCELLULAR LOCATION: Cytoplasm. Mitochondrion.		MOD_RES 147 147 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 299 299 Phosphoserine. {ECO:0000244|PubMed:23186163}.	7842009; 9037601; 11735028; 14702039; 10830953; 15489334; 9503011; 18669648; 21269460; 23186163; 24275569; 8541348; 8817339; 9396568; 10190325; 10590022; 12124727; 12633764; 16134170; 16959974; 18429047; 20095979; 25690727; 10677481; 14766011; 17417720; 17904341; 18297087; 18452652; 19048367; 19157941; 19695181; 19740736; 19806568; 19914215; 20026029; 20085763; 20153287; 20592104; 20688500; 21044950; 21802411; 21988832; 22027809; 22123817; 23624957; 24075901; 24133061; 24239178; 24840043; 7732023; 9630604	7842009; 9037601; 11735028; 14702039; 10830953; 15489334; 9503011; 18669648; 21269460; 23186163; 24275569; 8541348; 8817339; 9396568; 10190325; 10590022; 12124727; 12633764; 16134170; 16959974; 18429047; 20095979; 25690727
17170	MTHFD1L FTHFSDC1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=500 uM for THF monoglutamate {ECO:0000269|PubMed:16171773}; KM=16 uM for THF triglutamate {ECO:0000269|PubMed:16171773}; KM=3.6 uM for THF pentaglutamate {ECO:0000269|PubMed:16171773}; 	6.3.4.3	CATALYTIC ACTIVITY: ATP + formate + tetrahydrofolate = ADP + phosphate + 10-formyltetrahydrofolate.					PATHWAY: One-carbon metabolism; tetrahydrofolate interconversion.				10-formyltetrahydrofolate biosynthetic process [GO:0009257]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; folic acid-containing compound metabolic process [GO:0006760]; folic acid metabolic process [GO:0046655]; formate metabolic process [GO:0015942]; neural tube closure [GO:0001843]; purine nucleobase biosynthetic process [GO:0009113]; tetrahydrofolate interconversion [GO:0035999]	membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; protein homodimerization activity [GO:0042803]; 10-formyltetrahydrofolate biosynthetic process [GO:0009257]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; folic acid metabolic process [GO:0046655]; folic acid-containing compound metabolic process [GO:0006760]; formate metabolic process [GO:0015942]; neural tube closure [GO:0001843]; purine nucleobase biosynthetic process [GO:0009113]; tetrahydrofolate interconversion [GO:0035999]	ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; protein homodimerization activity [GO:0042803]	GO:0001843; GO:0004329; GO:0004477; GO:0004488; GO:0005524; GO:0005739; GO:0005759; GO:0006760; GO:0009113; GO:0009257; GO:0015942; GO:0016020; GO:0035999; GO:0042803; GO:0046655; GO:0048702; GO:0048703	SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:12937168}.		MOD_RES 189 189 N6-acetyllysine; alternate. {ECO:0000244|PubMed:19608861}.; MOD_RES 189 189 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q3V3R1}.; MOD_RES 357 357 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 596 596 N6-succinyllysine. {ECO:0000250|UniProtKB:Q3V3R1}.	12937168; 15013446; 14574404; 16171773; 17974005; 15489334; 14702039; 19608861; 21269460; 23186163; 25944712; 16959974; 15068241; 17353931; 17634449; 18847512; 18978678; 19336575; 19373437; 19615732; 19777576; 19913121; 19948730; 19955471; 20562859; 20628086; 20694560; 20738937; 20869947; 20877624; 20885792; 21383495; 21741665; 22277967; 22330827; 22520921; 23902751; 24123340; 24618918; 25525879; 25609649; 25809277; 26496610; 26926881; 28394261	12937168; 15013446; 14574404; 16171773; 17974005; 15489334; 14702039; 19608861; 21269460; 23186163; 25944712; 16959974
17299	CA13	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=13.8 mM for CO(2) {ECO:0000269|PubMed:18618712}; 	4.2.1.1	CATALYTIC ACTIVITY: H(2)CO(3) = CO(2) + H(2)O.		ACTIVITY REGULATION: Inhibited by acetazolamide. {ECO:0000269|PubMed:18618712}.	COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000269|PubMed:18618712}; 						bicarbonate transport [GO:0015701]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; myelin sheath [GO:0043209]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; myelin sheath [GO:0043209]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; bicarbonate transport [GO:0015701]	carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]	GO:0004089; GO:0005829; GO:0008270; GO:0015701; GO:0043209; GO:0043231				14702039; 15489334; 14600151; 18618712; 120192; 1554744; 15836783; 17427958; 18336313; 20349499; 20493921; 20578724; 21282642; 2169869; 22001224; 23394791; 234739; 24103428; 25493428; 25758852; 28001003; 3080418; 3151019; 4994926; 6407977; 6433979; 6819139; 8083199; 8399223; 9336012; 9635771	14702039; 15489334; 14600151; 18618712; 
17300	CA2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=10 mM for CO(2) {ECO:0000269|PubMed:10550681, ECO:0000269|PubMed:15667203, ECO:0000269|PubMed:17330962, ECO:0000269|PubMed:18618712, ECO:0000269|PubMed:18942852, ECO:0000269|PubMed:1909891, ECO:0000269|PubMed:1910042, ECO:0000269|PubMed:7761440, ECO:0000269|PubMed:8262987, ECO:0000269|PubMed:9398308}; KM=82 mM for H(2)CO(3) {ECO:0000269|PubMed:10550681, ECO:0000269|PubMed:15667203, ECO:0000269|PubMed:17330962, ECO:0000269|PubMed:18618712, ECO:0000269|PubMed:18942852, ECO:0000269|PubMed:1909891, ECO:0000269|PubMed:1910042, ECO:0000269|PubMed:7761440, ECO:0000269|PubMed:8262987, ECO:0000269|PubMed:9398308}; KM=3 mM for 4-nitrophenyl acetate {ECO:0000269|PubMed:10550681, ECO:0000269|PubMed:15667203, ECO:0000269|PubMed:17330962, ECO:0000269|PubMed:18618712, ECO:0000269|PubMed:18942852, ECO:0000269|PubMed:1909891, ECO:0000269|PubMed:1910042, ECO:0000269|PubMed:7761440, ECO:0000269|PubMed:8262987, ECO:0000269|PubMed:9398308}; 	4.2.1.1	CATALYTIC ACTIVITY: H(2)CO(3) = CO(2) + H(2)O.	BINDING 62 62 Activator. {ECO:0000269|PubMed:16214338, ECO:0000269|PubMed:17127057, ECO:0000269|PubMed:9265618}.; BINDING 67 67 Activator. {ECO:0000269|PubMed:16214338, ECO:0000269|PubMed:17127057, ECO:0000269|PubMed:9265618}.; BINDING 92 92 Activator. {ECO:0000269|PubMed:16214338, ECO:0000269|PubMed:17127057, ECO:0000269|PubMed:9265618}.	ACTIVITY REGULATION: Activated by X-ray, histamine, L-adrenaline, L- and D-phenylalanine, L- and D-histidine, L-His-OMe and beta-Ala-His (carnosine). Competitively inhibited by saccharin, thioxolone, coumarins, 667-coumate, celecoxib (Celebrex), valdecoxib (Bextra), SC-125, SC-560, diclofenac, acetate, azide, bromide, sulfonamide derivatives such as acetazolamide (AZA), methazolamide (MZA), ethoxzolamide (EZA), dichlorophenamide (DCP), brinzolamide, dansylamide, thiabendazole-5-sulfonamide, trifluoromethane sulfonamide and N-hydroxysulfamide, fructose-based sugar sulfamate RWJ-37497, and Foscarnet (phosphonoformate trisodium salt). Repressed strongly by hydrogen sulfide(HS) and weakly by nitrate (NO(3)). Esterase activity weakly reduced by cyanamide. N-hydroxyurea interfers with zinc binding and inhibit activity. {ECO:0000269|PubMed:11802772, ECO:0000269|PubMed:1336460, ECO:0000269|PubMed:14736236, ECO:0000269|PubMed:16214338, ECO:0000269|PubMed:16290146, ECO:0000269|PubMed:16686544, ECO:0000269|PubMed:16759856, ECO:0000269|PubMed:16807956, ECO:0000269|PubMed:17127057, ECO:0000269|PubMed:17314045, ECO:0000269|PubMed:17540563, ECO:0000269|PubMed:17588751, ECO:0000269|PubMed:17705204, ECO:0000269|PubMed:18024029, ECO:0000269|PubMed:18162396, ECO:0000269|PubMed:18266323, ECO:0000269|PubMed:18374572, ECO:0000269|PubMed:18481843, ECO:0000269|PubMed:18618712, ECO:0000269|PubMed:18640037, ECO:0000269|PubMed:1910042, ECO:0000269|PubMed:19170619, ECO:0000269|PubMed:19186056, ECO:0000269|PubMed:19206230, ECO:0000269|PubMed:19520834, ECO:0000269|PubMed:19778001, ECO:0000269|PubMed:9265618}.	COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000269|PubMed:11076507, ECO:0000269|PubMed:12499545, ECO:0000269|PubMed:1336460, ECO:0000269|PubMed:1433293, ECO:0000269|PubMed:1909891, ECO:0000269|PubMed:19583303, ECO:0000269|PubMed:3151019, ECO:0000269|PubMed:3151020, ECO:0000269|PubMed:7761440, ECO:0000269|PubMed:7803386, ECO:0000269|PubMed:7901850, ECO:0000269|PubMed:8218160, ECO:0000269|PubMed:8262987, ECO:0000269|PubMed:8331673, ECO:0000269|PubMed:8399159, ECO:0000269|PubMed:8431430, ECO:0000269|PubMed:8451242, ECO:0000269|PubMed:8482389, ECO:0000269|PubMed:8639494, ECO:0000269|PubMed:8987974, ECO:0000269|PubMed:9398308, ECO:0000269|PubMed:9865942}; Name=Co(2+); Xref=ChEBI:CHEBI:48828; Evidence={ECO:0000269|PubMed:19583303}; ;  Note=Zinc. Can also use cobalt(II) with lower efficiency, but not copper(II), nickel(II) and manganese(II). {ECO:0000269|PubMed:19583303};	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 6-8. {ECO:0000269|PubMed:10550681, ECO:0000269|PubMed:15667203, ECO:0000269|PubMed:17330962, ECO:0000269|PubMed:18618712, ECO:0000269|PubMed:18942852, ECO:0000269|PubMed:1909891, ECO:0000269|PubMed:1910042, ECO:0000269|PubMed:7761440, ECO:0000269|PubMed:8262987, ECO:0000269|PubMed:9398308};					angiotensin-activated signaling pathway [GO:0038166]; bicarbonate transport [GO:0015701]; carbon dioxide transport [GO:0015670]; cellular response to fluid shear stress [GO:0071498]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of bone resorption [GO:0045780]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of anion transport [GO:0044070]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to steroid hormone [GO:0048545]; response to zinc ion [GO:0010043]; secretion [GO:0046903]	apical part of cell [GO:0045177]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]	apical part of cell [GO:0045177]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; angiotensin-activated signaling pathway [GO:0038166]; bicarbonate transport [GO:0015701]; carbon dioxide transport [GO:0015670]; cellular response to fluid shear stress [GO:0071498]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of bone resorption [GO:0045780]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of anion transport [GO:0044070]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to steroid hormone [GO:0048545]; response to zinc ion [GO:0010043]; secretion [GO:0046903]	arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]	GO:0001822; GO:0002009; GO:0004064; GO:0004089; GO:0005737; GO:0005829; GO:0005886; GO:0005902; GO:0008270; GO:0009268; GO:0010043; GO:0015670; GO:0015701; GO:0016323; GO:0030424; GO:0032230; GO:0032849; GO:0038166; GO:0042475; GO:0043209; GO:0043627; GO:0044070; GO:0045177; GO:0045672; GO:0045780; GO:0046903; GO:0048545; GO:0051453; GO:0070062; GO:0071498; GO:2001150; GO:2001225	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15990874}. Cell membrane {ECO:0000269|PubMed:15990874}. Note=Colocalized with SLC26A6 at the surface of the cell membrane in order to form a bicarbonate transport metabolon. Displaced from the cytosolic surface of the cell membrane by PKC in phorbol myristate acetate (PMA)-induced cells.		MOD_RES 2 2 N-acetylserine. {ECO:0000269|PubMed:4207120, ECO:0000269|PubMed:823150}.; MOD_RES 2 2 Phosphoserine. {ECO:0000250|UniProtKB:P27139}.; MOD_RES 165 165 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 172 172 Phosphoserine. {ECO:0000244|PubMed:24275569}.	3108857; 3121496; 14702039; 15489334; 4207120; 823150; 3000449; 14567693; 14736710; 15218065; 15990874; 17314045; 18618712; 21269460; 24275569; 4621826; 3151019; 3151020; 1909891; 1932029; 1910042; 1336460; 1433293; 1474587; 8431430; 8485129; 8399159; 8218160; 8482389; 8262987; 8331673; 8451242; 7901850; 15299481; 15299482; 7803386; 8070585; 8142888; 7696263; 7608893; 7761440; 8639494; 8987974; 8557623; 9265618; 9398308; 9541386; 9865942; 10550681; 11015219; 11076507; 11327835; 11572683; 11802772; 12056894; 12171926; 11831900; 12166932; 11818565; 12499545; 14736236; 15453828; 15667203; 15865431; 16214338; 16134940; 16106378; 16511248; 16820676; 16290146; 16759856; 17000110; 16807956; 16506782; 16787097; 16686544; 16942027; 17125255; 17181151; 17705204; 17319692; 17330962; 17127057; 17251017; 17346964; 17540563; 17588751; 17071654; 17407288; 18266323; 18942852; 18024029; 18162396; 18374572; 18359629; 18640037; 18161740; 18461940; 18768466; 18260615; 18481843; 18723489; 19170619; 19583303; 19186056; 19206230; 19115843; 19731956; 19827837; 19778001; 19520834; 6817747; 6407977; 1928091; 1542674; 8834238; 9143915; 15300855; 11956656; 120192; 12501217; 12826902; 12933803; 14675565; 15049705; 15062553; 1554744; 15836783; 15837316; 15837325; 16169070; 16265785; 16475831; 16687407; 16825953; 17202139; 17319695; 17363915; 17427958; 17631639; 17881426; 18060825; 18083150; 18189416; 18247480; 18323598; 18539591; 18580434; 18774300; 19012038; 19034380; 19269136; 19371798; 19407386; 19415900; 19465771; 19615732; 19634894; 19851004; 19854054; 19882701; 19911821; 20000378; 20005709; 20025241; 20028100; 20081808; 20148564; 20166809; 20170095; 20297840; 20349499; 20360068; 20386818; 20398423; 20445237; 20445238; 20472429; 20493921; 20509747; 20578724; 20590092; 20598552; 20605094; 20629007; 20634585; 20637176; 20693695; 20849852; 20889345; 20922253; 20926301; 20931644; 20976122; 21145876; 21243755; 21282642; 2128470; 21332115; 21395315; 21506176; 21506569; 21515057; 21543742; 21549597; 21620713; 21680735; 2169869; 21706094; 21790183; 21952494; 21958118; 21988105; 22001224; 22011572; 22192857; 22218610; 22258283; 22276570; 22344779; 22416960; 22440859; 22443141; 22531842; 22691706; 22732064; 22775345; 22836518; 22878862; 22928733; 23030313; 23098192; 23215152; 23241068; 23360090; 23394791; 234739; 23490152; 23674848; 23706138; 23727877; 23737439; 23788494; 23859774; 23897465; 23953824; 23993330; 24012377; 24036123; 24090602; 24103428; 24128000; 24288253; 24300919; 24307504; 24635441; 24670789; 24689792; 24813993; 24914985; 25019941; 25059669; 25075329; 25116076; 25165709; 25254302; 25258712; 25286933; 25309911; 25353386; 25358036; 25358084; 25400751; 25407638; 25493428; 25581127; 25609088; 25609649; 25614109; 25683338; 25720518; 25733161; 25738615; 25758852; 25766630; 25813715; 25902526; 26010488; 26041446; 26079542; 26093313; 26199669; 26203869; 26226626; 26266677; 26276436; 26457530; 26497049; 26507456; 26692420; 26698855; 26700575; 26741028; 26756542; 26810836; 26882437; 26970563; 27063577; 27114542; 27129464; 27151329; 27172398; 27232456; 27316543; 27475498; 27688658; 27722534; 27860128; 27892589; 27933963; 28001003; 28024887; 28170240; 28233447; 28252841; 28270370; 28389830; 28445001; 28453941; 28461893; 28544359; 28613396; 28728897; 28738704; 28817930; 28947941; 28947945; 29090039; 29199489; 29266943; 29316128; 29354275; 29357237; 29423818; 29429876; 29503769; 29685656; 29795760; 29803994; 29851481; 30034596; 3080418; 4994926; 6433979; 6819139; 8083199; 8399223; 9336012; 9635771	3108857; 3121496; 14702039; 15489334; 4207120; 823150; 3000449; 14567693; 14736710; 15218065; 15990874; 17314045; 18618712; 21269460; 24275569; 4621826; 3151019; 3151020; 1909891; 1932029; 1910042; 1336460; 1433293; 1474587; 8431430; 8485129; 8399159; 8218160; 8482389; 8262987; 8331673; 8451242; 7901850; 15299481; 15299482; 7803386; 8070585; 8142888; 7696263; 7608893; 7761440; 8639494; 8987974; 8557623; 9265618; 9398308; 9541386; 9865942; 10550681; 11015219; 11076507; 11327835; 11572683; 11802772; 12056894; 12171926; 11831900; 12166932; 11818565; 12499545; 14736236; 15453828; 15667203; 15865431; 16214338; 16134940; 16106378; 16511248; 16820676; 16290146; 16759856; 17000110; 16807956; 16506782; 16787097; 16686544; 16942027; 17125255; 17181151; 17705204; 17319692; 17330962; 17127057; 17251017; 17346964; 17540563; 17588751; 17071654; 17407288; 18266323; 18942852; 18024029; 18162396; 18374572; 18359629; 18640037; 18161740; 18461940; 18768466; 18260615; 18481843; 18723489; 19170619; 19583303; 19186056; 19206230; 19115843; 19731956; 19827837; 19778001; 19520834; 6817747; 6407977; 1928091; 1542674; 8834238; 9143915; 15300855
17308	BLVRB FLR	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=36 uM for NADP {ECO:0000269|PubMed:10620517, ECO:0000269|PubMed:7929092}; KM=5.6 mM for NADH {ECO:0000269|PubMed:10620517, ECO:0000269|PubMed:7929092}; KM=0.3 uM for biliverdin IX-beta {ECO:0000269|PubMed:10620517, ECO:0000269|PubMed:7929092}; KM=52 uM for FMN {ECO:0000269|PubMed:10620517, ECO:0000269|PubMed:7929092}; KM=125 uM for FAD {ECO:0000269|PubMed:10620517, ECO:0000269|PubMed:7929092}; KM=53 uM for riboflavin {ECO:0000269|PubMed:10620517, ECO:0000269|PubMed:7929092}; 	1.5.1.30; 1.3.1.24	CATALYTIC ACTIVITY: Reduced riboflavin + NADP(+) = riboflavin + NADPH. {ECO:0000269|PubMed:10620517, ECO:0000269|PubMed:18241201}.; CATALYTIC ACTIVITY: Bilirubin + NAD(P)(+) = biliverdin + NAD(P)H. {ECO:0000269|PubMed:10620517, ECO:0000269|PubMed:18241201, ECO:0000269|PubMed:7929092}.	BINDING 35 35 NADP.; BINDING 132 132 NADP.; BINDING 153 153 Substrate.; BINDING 154 154 NADP; via amide nitrogen.	ACTIVITY REGULATION: Mesobiliverdin acts as competitve inhibitor for flavin reduction, indicating that flavin and tetrapyrrole substrates compete for the same site. {ECO:0000269|PubMed:10620517}.							heme catabolic process [GO:0042167]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; terminal bouton [GO:0043195]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; terminal bouton [GO:0043195]; biliverdin reductase activity [GO:0004074]; riboflavin reductase (NADPH) activity [GO:0042602]; heme catabolic process [GO:0042167]	biliverdin reductase activity [GO:0004074]; riboflavin reductase (NADPH) activity [GO:0042602]	GO:0004074; GO:0005654; GO:0005829; GO:0005886; GO:0042167; GO:0042602; GO:0043195; GO:0070062	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:7929092}.		MOD_RES 42 42 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 82 82 Phosphoserine. {ECO:0000244|PubMed:23186163}.	8117274; 8799475; 14702039; 15057824; 15489334; 8280170; 7929092; 1286669; 8313871; 8687377; 10620517; 18241201; 21269460; 23186163; 24275569; 25944712; 11224564; 11278740; 20711500; 21988832; 22623428; 25726384; 26708147; 27207795; 29487133	8117274; 8799475; 14702039; 15057824; 15489334; 8280170; 7929092; 1286669; 8313871; 8687377; 10620517; 18241201; 21269460; 23186163; 24275569; 25944712; 11224564
17410	BDH2 DHRS6 SDR15C1 UNQ6308/PRO20933	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=60 uM for NAD {ECO:0000269|PubMed:16380372}; KM=10 mM for R-hydroxybutyrate {ECO:0000269|PubMed:16380372}; Vmax=82 nmol/min/mg enzyme (at 30 degrees Celsius) {ECO:0000269|PubMed:16380372}; 	1.1.1.-; 1.1.1.30	CATALYTIC ACTIVITY: (R)-3-hydroxybutanoate + NAD(+) = acetoacetate + NADH.	BINDING 58 58 NAD. {ECO:0000269|PubMed:16380372}.; BINDING 144 144 Substrate. {ECO:0000305}.; BINDING 151 151 NAD. {ECO:0000269|PubMed:16380372}.; BINDING 188 188 Substrate. {ECO:0000305}.; BINDING 205 205 Substrate. {ECO:0000305}.			BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 7.5-9.0. {ECO:0000269|PubMed:16380372};	PATHWAY: Siderophore biosynthesis.		UNQ6308/PRO20933		epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; heme metabolic process [GO:0042168]; iron ion homeostasis [GO:0055072]; ketone body biosynthetic process [GO:0046951]; siderophore biosynthetic process [GO:0019290]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 3-hydroxybutyrate dehydrogenase activity [GO:0003858]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; heme metabolic process [GO:0042168]; iron ion homeostasis [GO:0055072]; ketone body biosynthetic process [GO:0046951]; siderophore biosynthetic process [GO:0019290]	3-hydroxybutyrate dehydrogenase activity [GO:0003858]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]	GO:0003858; GO:0005737; GO:0005829; GO:0006635; GO:0016628; GO:0019290; GO:0030855; GO:0042168; GO:0046951; GO:0051287; GO:0055072; GO:0070062	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16380372}.			10931946; 12975309; 14702039; 15815621; 15489334; 21269460; 16380372; 20332099; 21791085; 23941109; 25762501; 26799587	10931946; 12975309; 14702039; 15815621; 15489334; 21269460; 16380372
17437	B3GNT6	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=3.3 mM for GalNAc-alpha-Bn {ECO:0000269|PubMed:7655172}; Vmax=4.5 nmol/h/mg enzyme with GalNAc-alpha-Bn as substrate {ECO:0000269|PubMed:7655172}; 	2.4.1.147	CATALYTIC ACTIVITY: UDP-N-acetyl-alpha-D-glucosamine + O(3)-(N-acetyl-alpha-D-galactosaminyl)-L-threonyl/L-seryl-[protein] = UDP + O(3)-(N-acetyl-beta-D-glucosaminyl-(1->3)-N-acetyl-alpha-D-galactosaminyl)-L-threonyl/L-seryl-[protein]. {ECO:0000269|PubMed:7655172}.					PATHWAY: Protein modification; protein glycosylation.				glycoprotein biosynthetic process [GO:0009101]; O-glycan processing [GO:0016266]; O-glycan processing, core 3 [GO:0016269]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047224]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]; galactosyltransferase activity [GO:0008378]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; glycoprotein biosynthetic process [GO:0009101]; O-glycan processing [GO:0016266]; O-glycan processing, core 3 [GO:0016269]	acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047224]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]; galactosyltransferase activity [GO:0008378]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]	GO:0000139; GO:0008378; GO:0008499; GO:0009101; GO:0016020; GO:0016021; GO:0016266; GO:0016269; GO:0047223; GO:0047224	SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000269|PubMed:15755813}; Single-pass type II membrane protein {ECO:0000269|PubMed:15755813}.			11821425; 14702039; 16554811; 15489334; 7655172; 15755813; 11042166; 11283017; 15486459; 15560372; 15620693; 17113861; 19395705; 9417100	11821425; 14702039; 16554811; 15489334; 7655172; 15755813
17441	B3GALT1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=90 uM for UDP-alpha-D-galactose {ECO:0000269|PubMed:9582303}; 	2.4.1.86	CATALYTIC ACTIVITY: UDP-alpha-D-galactose + N-acetyl-beta-D-glucosaminyl-R = UDP + beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-R. {ECO:0000269|PubMed:9582303}.			COFACTOR: Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250}; 		PATHWAY: Protein modification; protein glycosylation.				galactosylceramide biosynthetic process [GO:0006682]; lipid glycosylation [GO:0030259]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; galactosylceramide biosynthetic process [GO:0006682]; lipid glycosylation [GO:0030259]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]	glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]	GO:0000139; GO:0006486; GO:0006682; GO:0008499; GO:0009312; GO:0016021; GO:0030259; GO:0047275	SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000305}; Single-pass type II membrane protein {ECO:0000305}.				10356986; 15014171; 15815621; 15489334; 9582303
17442	B3GALT2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=90 uM for UDP-alpha-D-galactose {ECO:0000269|PubMed:9582303}; 	2.4.1.86	CATALYTIC ACTIVITY: UDP-alpha-D-galactose + N-acetyl-beta-D-glucosaminyl-R = UDP + beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-R. {ECO:0000269|PubMed:9417100, ECO:0000269|PubMed:9582303}.			COFACTOR: Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250}; 		PATHWAY: Protein modification; protein glycosylation.				galactosylceramide biosynthetic process [GO:0006682]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; galactosylceramide biosynthetic process [GO:0006682]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]	glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]	GO:0000139; GO:0006486; GO:0006682; GO:0008499; GO:0009312; GO:0016021; GO:0047275	SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000305}; Single-pass type II membrane protein {ECO:0000305}.			9417100; 9582303; 11318611; 14702039; 16710414; 15489334; 21988832	9417100; 9582303; 11318611; 14702039; 16710414; 15489334
17447	B4GALT6	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=3 uM for glucosylceramide {ECO:0000269|PubMed:3099851}; KM=0.5 uM for UDP-galactose {ECO:0000269|PubMed:3099851}; Vmax=0.06 nmol/h/mg enzyme toward glucosylceramide {ECO:0000269|PubMed:3099851}; Vmax=86 nmol/h/mg enzyme toward UDP-galactose {ECO:0000269|PubMed:3099851}; 	2.4.1.274	CATALYTIC ACTIVITY: UDP-alpha-D-galactose + beta-D-glucosyl-(1<->1)-ceramide = UDP + beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide. {ECO:0000269|PubMed:1551920, ECO:0000269|PubMed:3099851}.	BINDING 258 258 UDP-alpha-D-galactose. {ECO:0000250}.; BINDING 290 290 UDP-alpha-D-galactose. {ECO:0000250}.; BINDING 334 334 N-acetyl-D-glucosamine. {ECO:0000250}.	ACTIVITY REGULATION: Inhibited by EDTA. {ECO:0000250}.	COFACTOR: Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000269|PubMed:3099851}; Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:3099851}; 		PATHWAY: Protein modification; protein glycosylation.				carbohydrate metabolic process [GO:0005975]; keratan sulfate biosynthetic process [GO:0018146]; lactosylceramide biosynthetic process [GO:0001572]; protein glycosylation [GO:0006486]	Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975]; keratan sulfate biosynthetic process [GO:0018146]; lactosylceramide biosynthetic process [GO:0001572]; protein glycosylation [GO:0006486]	beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; metal ion binding [GO:0046872]	GO:0000139; GO:0001572; GO:0003831; GO:0005975; GO:0006486; GO:0008378; GO:0016021; GO:0018146; GO:0032580; GO:0046872	SUBCELLULAR LOCATION: Golgi apparatus, Golgi stack membrane; Single-pass type II membrane protein. Note=Trans cisternae of Golgi stack.			9597550; 10320813; 16177791; 15489334; 3099851; 1551920; 10580128; 11588157; 11901181; 12180132; 15939404; 17021253; 1714903; 19451621; 9435216	9597550; 10320813; 16177791; 15489334; 3099851; 1551920; 10580128
17493	B3GALNT2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=5.4 uM for UDP-GalNAc {ECO:0000269|PubMed:14724282}; KM=11 mM for GlcNAc-beta-Bn {ECO:0000269|PubMed:14724282}; 	2.4.1.313	CATALYTIC ACTIVITY: UDP-N-acetyl-alpha-D-galactosamine + 3-O-(N-acetyl-beta-D-glucosaminyl-(1->4)-alpha-D-mannosyl)-L-threonyl-[protein] = UDP + 3-O-(N-acetyl-beta-D-galactosaminyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->4)-alpha-D-mannosyl)-L-threonyl-[protein]. {ECO:0000269|PubMed:23929950}.					PATHWAY: Protein modification; protein glycosylation.				protein glycosylation [GO:0006486]; protein O-linked glycosylation [GO:0006493]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; galactosyltransferase activity [GO:0008378]; protein glycosylation [GO:0006486]; protein O-linked glycosylation [GO:0006493]	acetylgalactosaminyltransferase activity [GO:0008376]; acetylglucosaminyltransferase activity [GO:0008375]; galactosyltransferase activity [GO:0008378]	GO:0000139; GO:0005783; GO:0005789; GO:0006486; GO:0006493; GO:0008375; GO:0008376; GO:0008378; GO:0016021	SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000250}; Single-pass type II membrane protein {ECO:0000250}. Endoplasmic reticulum {ECO:0000269|PubMed:23453667}.	PTM: N-glycosylated. {ECO:0000305|PubMed:14724282}.		16710414; 15489334; 14724282; 23453667; 23929950; 16959974; 24084573; 24285400	16710414; 15489334; 14724282; 23453667; 23929950; 16959974
17566	B4GALT2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=71 uM for GlcNAc-B-S-pNP {ECO:0000269|PubMed:11588157}; 	2.4.1.-; 2.4.1.22; 2.4.1.90; 2.4.1.38; 2.4.1.-	CATALYTIC ACTIVITY: UDP-alpha-D-galactose + D-glucose = UDP + lactose.; CATALYTIC ACTIVITY: UDP-alpha-D-galactose + N-acetyl-beta-D-glucosaminylglycopeptide = UDP + beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminylglycopeptide.; CATALYTIC ACTIVITY: UDP-alpha-D-galactose + N-acetyl-D-glucosamine = UDP + N-acetyllactosamine.	BINDING 278 278 UDP-alpha-D-galactose. {ECO:0000250}.; BINDING 323 323 N-acetyl-D-glucosamine. {ECO:0000250}.		COFACTOR: Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250}; 		PATHWAY: Protein modification; protein glycosylation.				carbohydrate metabolic process [GO:0005975]; cerebellar Purkinje cell layer development [GO:0021680]; keratan sulfate biosynthetic process [GO:0018146]; locomotory behavior [GO:0007626]; memory [GO:0007613]; protein glycosylation [GO:0006486]; visual learning [GO:0008542]	Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]	Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; lactose synthase activity [GO:0004461]; metal ion binding [GO:0046872]; N-acetyllactosamine synthase activity [GO:0003945]; carbohydrate metabolic process [GO:0005975]; cerebellar Purkinje cell layer development [GO:0021680]; keratan sulfate biosynthetic process [GO:0018146]; locomotory behavior [GO:0007626]; memory [GO:0007613]; protein glycosylation [GO:0006486]; visual learning [GO:0008542]	beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; lactose synthase activity [GO:0004461]; metal ion binding [GO:0046872]; N-acetyllactosamine synthase activity [GO:0003945]	GO:0000139; GO:0003831; GO:0003945; GO:0004461; GO:0005654; GO:0005794; GO:0005975; GO:0006486; GO:0007613; GO:0007626; GO:0008378; GO:0008542; GO:0016021; GO:0018146; GO:0021680; GO:0032580; GO:0043231; GO:0046872	SUBCELLULAR LOCATION: Golgi apparatus, Golgi stack membrane; Single-pass type II membrane protein. Note=Trans cisternae of Golgi stack.			9405390; 9597550; 11588157; 14702039; 16710414; 15489334; 17974005; 10580128; 11901181; 15504978; 15939404; 17021253; 1714903; 17470362; 18211920; 19524017; 21988832; 27004849	9405390; 9597550; 11588157; 14702039; 16710414; 15489334; 17974005; 10580128
17619	B4GALT4 UNQ552/PRO1109	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=238 uM for GlcNAc-B-S-pNP {ECO:0000269|PubMed:11588157}; 	2.4.1.-; 2.4.1.90; 2.4.1.275	CATALYTIC ACTIVITY: UDP-alpha-D-galactose + N-acetyl-D-glucosamine = UDP + N-acetyllactosamine. {ECO:0000269|PubMed:9792633}.; CATALYTIC ACTIVITY: UDP-alpha-D-galactose + N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide = UDP + beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide. {ECO:0000269|PubMed:9792633}.	BINDING 224 224 UDP-alpha-D-galactose. {ECO:0000250}.; BINDING 256 256 UDP-alpha-D-galactose. {ECO:0000250}.; BINDING 301 301 N-acetyl-D-glucosamine. {ECO:0000250}.		COFACTOR: Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250}; 		PATHWAY: Protein modification; protein glycosylation.		UNQ552/PRO1109		carbohydrate metabolic process [GO:0005975]; keratan sulfate biosynthetic process [GO:0018146]; membrane lipid metabolic process [GO:0006643]; protein glycosylation [GO:0006486]	Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; metal ion binding [GO:0046872]; N-acetyllactosamine synthase activity [GO:0003945]; carbohydrate metabolic process [GO:0005975]; keratan sulfate biosynthetic process [GO:0018146]; membrane lipid metabolic process [GO:0006643]; protein glycosylation [GO:0006486]	beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; metal ion binding [GO:0046872]; N-acetyllactosamine synthase activity [GO:0003945]	GO:0000139; GO:0003831; GO:0003945; GO:0005794; GO:0005975; GO:0006486; GO:0006643; GO:0008378; GO:0016021; GO:0018146; GO:0032580; GO:0046872	SUBCELLULAR LOCATION: Golgi apparatus, Golgi stack membrane; Single-pass type II membrane protein. Note=Trans cisternae of Golgi stack.			9597550; 9792633; 11588157; 12975309; 17974005; 15489334; 10580128; 11901181; 15939404; 17021253; 1714903; 26496610; 28228616	9597550; 9792633; 11588157; 12975309; 17974005; 15489334; 10580128
17635	AWAT1 DGA2 DGAT2L3	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: Vmax=31.7 pmol/min/mg enzyme with [14C]oleoyl-CoA as substrate {ECO:0000269|PubMed:15671038}; Vmax=113 pmol/min/mg enzyme with [14C]cetyl-CoA as substrate {ECO:0000269|PubMed:15671038}; 	2.3.1.75	CATALYTIC ACTIVITY: Acyl-CoA + a long-chain alcohol = CoA + a long-chain ester.									arachidonic acid metabolic process [GO:0019369]; wax biosynthetic process [GO:0010025]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; arachidoyl-CoA:1-dodecanol O-acyltransferase activity [GO:0102966]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196]; wax ester synthase activity [GO:0103095]; arachidonic acid metabolic process [GO:0019369]; wax biosynthetic process [GO:0010025]	arachidoyl-CoA:1-dodecanol O-acyltransferase activity [GO:0102966]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196]; wax ester synthase activity [GO:0103095]	GO:0005789; GO:0010025; GO:0016021; GO:0019369; GO:0047196; GO:0102966; GO:0103095	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}.				15671038; 15772651; 15489334; 14970677
17636	AWAT2 DC4 DGAT2L4 MFAT WS	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: Vmax=1232 pmol/min/mg enzyme with [14C]cetyl-CoA as substrate {ECO:0000269|PubMed:15671038}; 	2.3.1.75; 2.3.1.76	CATALYTIC ACTIVITY: Acyl-CoA + a long-chain alcohol = CoA + a long-chain ester. {ECO:0000269|PubMed:16106050}.; CATALYTIC ACTIVITY: Acyl-CoA + retinol = CoA + retinyl ester. {ECO:0000269|PubMed:16106050}.									acylglycerol acyl-chain remodeling [GO:0036155]; retinoid metabolic process [GO:0001523]; wax biosynthetic process [GO:0010025]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 2-acylglycerol O-acyltransferase activity [GO:0003846]; arachidoyl-CoA:1-dodecanol O-acyltransferase activity [GO:0102966]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196]; retinol O-fatty-acyltransferase activity [GO:0050252]; wax ester synthase activity [GO:0103095]; acylglycerol acyl-chain remodeling [GO:0036155]; retinoid metabolic process [GO:0001523]; wax biosynthetic process [GO:0010025]	2-acylglycerol O-acyltransferase activity [GO:0003846]; arachidoyl-CoA:1-dodecanol O-acyltransferase activity [GO:0102966]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196]; retinol O-fatty-acyltransferase activity [GO:0050252]; wax ester synthase activity [GO:0103095]	GO:0001523; GO:0003846; GO:0005789; GO:0010025; GO:0016021; GO:0036155; GO:0047196; GO:0050252; GO:0102966; GO:0103095	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:15220349}; Multi-pass membrane protein {ECO:0000269|PubMed:15220349}.			15220349; 15489334; 14970677; 15671038; 16106050; 24799687; 28096191	15220349; 15489334; 14970677; 15671038; 16106050
17648	BAAT	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.1 mM for taurine toward choloyl-CoA {ECO:0000269|PubMed:2037576, ECO:0000269|PubMed:8034703}; KM=2.2 mM for 2-fluoro-beta-alanine toward choloyl-CoA {ECO:0000269|PubMed:2037576, ECO:0000269|PubMed:8034703}; KM=5.8 mM for glycine toward choloyl-CoA {ECO:0000269|PubMed:2037576, ECO:0000269|PubMed:8034703}; KM=19.3 uM for arachidoyl-CoA {ECO:0000269|PubMed:8034703}; Vmax=0.33 umol/min/mg enzyme with taurine as substrate for acyltransferase activity {ECO:0000269|PubMed:2037576, ECO:0000269|PubMed:8034703}; Vmax=0.19 umol/min/mg enzyme with 2-fluoro-beta-alanine as substrate for acyltransferase activity {ECO:0000269|PubMed:8034703}; Vmax=0.77 umol/min/mg enzyme with glycine as substrate for acyltransferase activity {ECO:0000269|PubMed:2037576, ECO:0000269|PubMed:8034703}; Vmax=223 nmol/min/mg enzyme with arachidoyl-CoA as substrate for acyl-CoA thioesterase activity {ECO:0000269|PubMed:8034703}; 	2.3.1.65; 3.1.2.2	CATALYTIC ACTIVITY: Choloyl-CoA + glycine = CoA + glycocholate. {ECO:0000269|PubMed:12810727, ECO:0000269|PubMed:8034703}.; CATALYTIC ACTIVITY: Palmitoyl-CoA + H(2)O = CoA + palmitate. {ECO:0000269|PubMed:12810727}.									acyl-CoA metabolic process [GO:0006637]; animal organ regeneration [GO:0031100]; bile acid biosynthetic process [GO:0006699]; bile acid conjugation [GO:0002152]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631]; glycine metabolic process [GO:0006544]; liver development [GO:0001889]; protein targeting to peroxisome [GO:0006625]; taurine metabolic process [GO:0019530]	cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; carboxylic ester hydrolase activity [GO:0052689]; glycine N-choloyltransferase activity [GO:0047963]; long-chain acyl-CoA hydrolase activity [GO:0052816]; medium-chain acyl-CoA hydrolase activity [GO:0052815]; myristoyl-CoA hydrolase activity [GO:0102991]; N-acyltransferase activity [GO:0016410]; palmitoyl-CoA hydrolase activity [GO:0016290]; signaling receptor binding [GO:0005102]; transferase activity, transferring acyl groups [GO:0016746]; very long chain acyl-CoA hydrolase activity [GO:0052817]; acyl-CoA metabolic process [GO:0006637]; animal organ regeneration [GO:0031100]; bile acid biosynthetic process [GO:0006699]; bile acid conjugation [GO:0002152]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631]; glycine metabolic process [GO:0006544]; liver development [GO:0001889]; protein targeting to peroxisome [GO:0006625]; taurine metabolic process [GO:0019530]	carboxylic ester hydrolase activity [GO:0052689]; glycine N-choloyltransferase activity [GO:0047963]; long-chain acyl-CoA hydrolase activity [GO:0052816]; medium-chain acyl-CoA hydrolase activity [GO:0052815]; myristoyl-CoA hydrolase activity [GO:0102991]; N-acyltransferase activity [GO:0016410]; palmitoyl-CoA hydrolase activity [GO:0016290]; signaling receptor binding [GO:0005102]; transferase activity, transferring acyl groups [GO:0016746]; very long chain acyl-CoA hydrolase activity [GO:0052817]	GO:0001889; GO:0002152; GO:0005102; GO:0005777; GO:0005782; GO:0005829; GO:0006544; GO:0006625; GO:0006631; GO:0006637; GO:0006699; GO:0008206; GO:0016290; GO:0016410; GO:0016746; GO:0019530; GO:0031100; GO:0047963; GO:0052689; GO:0052815; GO:0052816; GO:0052817; GO:0102991	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12810727}.		MOD_RES 125 125 Phosphoserine. {ECO:0000250|UniProtKB:Q63276}.; MOD_RES 416 416 Phosphoserine. {ECO:0000250|UniProtKB:Q63276}.	8034703; 15164053; 15489334; 2037576; 12239217; 12810727; 24275569; 12704386; 10884298; 17256745; 17495420; 18793185; 20677014; 22783059; 24412244; 25416956; 27155186; 27230263	8034703; 15164053; 15489334; 2037576; 12239217; 12810727; 24275569; 12704386
17649	B4GALT3	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=63 uM for GlcNAc-B-S-pNP {ECO:0000269|PubMed:11588157}; 	2.4.1.-; 2.4.1.90; 2.4.1.38; 2.4.1.-	CATALYTIC ACTIVITY: UDP-alpha-D-galactose + N-acetyl-beta-D-glucosaminylglycopeptide = UDP + beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminylglycopeptide.; CATALYTIC ACTIVITY: UDP-alpha-D-galactose + N-acetyl-D-glucosamine = UDP + N-acetyllactosamine.	BINDING 226 226 UDP-alpha-D-galactose. {ECO:0000250}.; BINDING 258 258 UDP-alpha-D-galactose. {ECO:0000250}.; BINDING 303 303 N-acetyl-D-glucosamine. {ECO:0000250}.		COFACTOR: Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250}; 		PATHWAY: Protein modification; protein glycosylation.				carbohydrate metabolic process [GO:0005975]; galactosylceramide biosynthetic process [GO:0006682]; keratan sulfate biosynthetic process [GO:0018146]; protein glycosylation [GO:0006486]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; metal ion binding [GO:0046872]; N-acetyllactosamine synthase activity [GO:0003945]; carbohydrate metabolic process [GO:0005975]; galactosylceramide biosynthetic process [GO:0006682]; keratan sulfate biosynthetic process [GO:0018146]; protein glycosylation [GO:0006486]	beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; metal ion binding [GO:0046872]; N-acetyllactosamine synthase activity [GO:0003945]	GO:0000139; GO:0003831; GO:0003945; GO:0005794; GO:0005829; GO:0005975; GO:0006486; GO:0006682; GO:0008378; GO:0016021; GO:0018146; GO:0032580; GO:0046872; GO:0070062	SUBCELLULAR LOCATION: Golgi apparatus, Golgi stack membrane; Single-pass type II membrane protein. Note=Trans cisternae of Golgi stack.			9405390; 9597550; 11588157; 16710414; 14702039; 15489334; 10580128; 11901181; 15939404; 16169070; 17021253; 1714903; 17613536; 20711500; 23444218; 24403309; 25659296; 26987623; 27900994; 29335551	9405390; 9597550; 11588157; 16710414; 14702039; 15489334; 10580128
17705	ASTL	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: Note=Enzymatic activity was assayed using synthetic quenched fluorescent substrates QF-24, QF-35 and QF-41. Astacin displayed the highest Kcat/KM value against QF-35. {ECO:0000269|PubMed:15087446};	3.4.-.-			ACTIVITY REGULATION: Inhibited by wide spectrum metalloproteinase inhibitor batimastat (BB-94). Also inhibited by EDTA. {ECO:0000269|PubMed:15087446}.	COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000255|PROSITE-ProRule:PRU01211}; ;  Note=Binds 1 zinc ion per subunit. {ECO:0000255|PROSITE-ProRule:PRU01211};	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 7.5. {ECO:0000269|PubMed:15087446};					cell adhesion [GO:0007155]; fertilization [GO:0009566]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; positive regulation of protein processing [GO:0010954]; prevention of polyspermy [GO:0060468]; proteolysis [GO:0006508]	cortical granule [GO:0060473]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]	cortical granule [GO:0060473]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; aspartic-type peptidase activity [GO:0070001]; glutamic-type peptidase activity [GO:0070002]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]; cell adhesion [GO:0007155]; fertilization [GO:0009566]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; positive regulation of protein processing [GO:0010954]; prevention of polyspermy [GO:0060468]; proteolysis [GO:0006508]	aspartic-type peptidase activity [GO:0070001]; glutamic-type peptidase activity [GO:0070002]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]	GO:0004222; GO:0005737; GO:0005886; GO:0006508; GO:0007155; GO:0008233; GO:0008270; GO:0009566; GO:0010954; GO:0030133; GO:0060468; GO:0060473; GO:0070001; GO:0070002; GO:2000360	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell membrane {ECO:0000250}. Cytoplasmic granule {ECO:0000250}. Cytoplasmic vesicle, secretory vesicle {ECO:0000250}. Note=Secretory granules. Localizes to the peripheral cortical granules of ovulated eggs. Probably exocytosed from cortical granules during post-fertilization. Detected throughout the ooplasm of germinal vesicle stage oocytes in early bilaminar secondary follicles shortly after birth. Detected in the microvillar domain of the oolemma in arrested ovulated secondary oocytes and in the first polar body prior to fertilization. Upon fertilization, detected in the perivitelline space (PVS). Colocalizes with SPACA3 at the microvillar domain of the oolemma and in the perivitelline space (PVS) (By similarity). {ECO:0000250}.			15087446; 15815621; 15489334; 19913121; 20628086; 24038607; 26327203	15087446; 15815621; 15489334
17753	ASRGL1 ALP CRASH	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=3.4 mM for L-asparagine (L-Asn) {ECO:0000269|PubMed:19839645}; KM=0.4 mM for L-aspartic acid beta-methyl ester {ECO:0000269|PubMed:19839645}; KM=0.4 mM for L-Asp-L-Phe {ECO:0000269|PubMed:19839645}; KM=1.0 mM for L-Asp-L-Ala {ECO:0000269|PubMed:19839645}; 	3.4.19.5; 3.5.1.1	CATALYTIC ACTIVITY: L-asparagine + H(2)O = L-aspartate + NH(3). {ECO:0000269|PubMed:19839645, ECO:0000269|PubMed:22891768}.; CATALYTIC ACTIVITY: Cleavage of a beta-linked Asp residue from the N-terminus of a polypeptide. {ECO:0000269|PubMed:19839645}.		ACTIVITY REGULATION: Glycine accelerates autocleavage into an alpha and beta chain. {ECO:0000269|PubMed:22861376}.							asparagine catabolic process via L-aspartate [GO:0033345]; L-phenylalanine catabolic process [GO:0006559]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; asparaginase activity [GO:0004067]; beta-aspartyl-peptidase activity [GO:0008798]; asparagine catabolic process via L-aspartate [GO:0033345]; L-phenylalanine catabolic process [GO:0006559]	asparaginase activity [GO:0004067]; beta-aspartyl-peptidase activity [GO:0008798]	GO:0004067; GO:0005634; GO:0005737; GO:0005829; GO:0006559; GO:0008798; GO:0033345	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11984834}. Note=Midpiece of sperm tail.	PTM: Cleaved into an alpha and beta chain by autocatalysis; this activates the enzyme. The N-terminal residue of the beta subunit is responsible for the nucleophile hydrolase activity. {ECO:0000269|PubMed:19839645, ECO:0000269|PubMed:22861376}.	MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:19413330}.	11984834; 14654938; 14702039; 15489334; 19413330; 19839645; 22861376; 22891768; 19414332; 21900206; 23601642; 24768817; 25858696; 26780688; 27106100; 29096882; 29486992	11984834; 14654938; 14702039; 15489334; 19413330; 19839645; 22861376; 22891768
17754	ASNA1 ARSA TRC40	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.22 mM for ATP {ECO:0000269|PubMed:9712828}; Vmax=16.6 nmol/min/mg enzyme for ATP {ECO:0000269|PubMed:9712828}; 	3.6.-.-		BINDING 251 251 ATP. {ECO:0000255|HAMAP-Rule:MF_03112}.; BINDING 278 278 ATP. {ECO:0000255|HAMAP-Rule:MF_03112}.								IRE1-mediated unfolded protein response [GO:0036498]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleus [GO:0005634]; arsenite transmembrane transporter activity [GO:0015105]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; transporter activity [GO:0005215]; IRE1-mediated unfolded protein response [GO:0036498]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]	arsenite transmembrane transporter activity [GO:0015105]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; transporter activity [GO:0005215]	GO:0005215; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005789; GO:0015105; GO:0016887; GO:0036498; GO:0046872; GO:0070062; GO:0071816	SUBCELLULAR LOCATION: Cytoplasm. Endoplasmic reticulum. Nucleus, nucleolus.		MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19413330}.	14702039; 15057824; 15489334; 8884272; 9712828; 9736449; 9774623; 17382883; 18477612; 19413330; 21269460; 21444755; 24275569; 25535373; 17289575; 18667436; 19367725; 19463016; 19615732; 19724867; 20375064; 20711500; 21078624; 21296983; 21516116; 21878631; 21900206; 22505607; 23041287; 23460677; 24885147; 25036637; 25416956; 26496610; 26675233; 26752685; 27226539; 27458190; 27765046	14702039; 15057824; 15489334; 8884272; 9712828; 9736449; 9774623; 17382883; 18477612; 19413330; 21269460; 21444755; 24275569; 25535373
17759	ETNPPL AGXT2L1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=680 uM for phosphoethanolamine (at pH 7.4) {ECO:0000269|PubMed:22241472}; Vmax=1.46 umol/min/mg enzyme (at pH 7.4) {ECO:0000269|PubMed:22241472}; 	4.2.3.2	CATALYTIC ACTIVITY: Ethanolamine phosphate + H(2)O = acetaldehyde + NH(3) + phosphate. {ECO:0000269|PubMed:22241472}.			COFACTOR: Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326; Evidence={ECO:0000269|PubMed:22241472}; 						phosphatidylethanolamine biosynthetic process [GO:0006646]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; alanine-glyoxylate transaminase activity [GO:0008453]; ethanolamine-phosphate phospho-lyase activity [GO:0050459]; identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170]; phosphatidylethanolamine biosynthetic process [GO:0006646]	alanine-glyoxylate transaminase activity [GO:0008453]; ethanolamine-phosphate phospho-lyase activity [GO:0050459]; identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170]	GO:0005739; GO:0005759; GO:0006646; GO:0008453; GO:0030170; GO:0042802; GO:0050459	SUBCELLULAR LOCATION: Mitochondrion {ECO:0000305}.		MOD_RES 278 278 N6-(pyridoxal phosphate)lysine. {ECO:0000250}.	7592550; 14702039; 15815621; 15489334; 22241472; 20332099; 23761375; 25327712; 26294768	7592550; 14702039; 15815621; 15489334; 22241472
17773	ALDOB ALDB	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.6 uM for fructose 1,6-bisphosphate {ECO:0000269|PubMed:10970798}; KM=2.3 mM for fructose 1-phosphate {ECO:0000269|PubMed:10970798}; 	4.1.2.13	CATALYTIC ACTIVITY: D-fructose 1,6-bisphosphate = glycerone phosphate + D-glyceraldehyde 3-phosphate.	BINDING 56 56 Substrate.; BINDING 147 147 Substrate.				PATHWAY: Carbohydrate degradation; glycolysis; D-glyceraldehyde 3-phosphate and glycerone phosphate from D-glucose: step 4/4.	SITE 364 364 Necessary for preference for fructose 1,6-bisphosphate over fructose 1-phosphate.			canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate [GO:0061624]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; NADH oxidation [GO:0006116]; positive regulation of ATPase activity [GO:0032781]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule organizing center [GO:0005815]	centriolar satellite [GO:0034451]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule organizing center [GO:0005815]; ATPase binding [GO:0051117]; cytoskeletal protein binding [GO:0008092]; fructose binding [GO:0070061]; fructose-1-phosphate aldolase activity [GO:0061609]; fructose-bisphosphate aldolase activity [GO:0004332]; identical protein binding [GO:0042802]; canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate [GO:0061624]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; NADH oxidation [GO:0006116]; positive regulation of ATPase activity [GO:0032781]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]	ATPase binding [GO:0051117]; cytoskeletal protein binding [GO:0008092]; fructose-1-phosphate aldolase activity [GO:0061609]; fructose binding [GO:0070061]; fructose-bisphosphate aldolase activity [GO:0004332]; identical protein binding [GO:0042802]	GO:0004332; GO:0005815; GO:0005829; GO:0006000; GO:0006094; GO:0006096; GO:0006116; GO:0008092; GO:0030388; GO:0032781; GO:0034451; GO:0042802; GO:0051117; GO:0061609; GO:0061621; GO:0061624; GO:0070061; GO:0070062; GO:0070072	SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriolar satellite {ECO:0000269|PubMed:18000879}.		MOD_RES 2 2 N-acetylalanine. {ECO:0000250|UniProtKB:Q91Y97}.; MOD_RES 13 13 N6-succinyllysine. {ECO:0000250|UniProtKB:Q91Y97}.; MOD_RES 36 36 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 39 39 Phosphothreonine. {ECO:0000244|PubMed:24275569}.; MOD_RES 89 89 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 119 119 Phosphothreonine. {ECO:0000244|PubMed:24275569}.; MOD_RES 121 121 N6-succinyllysine. {ECO:0000250|UniProtKB:Q91Y97}.; MOD_RES 132 132 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 272 272 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 276 276 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 299 299 Phosphoserine. {ECO:0000250|UniProtKB:P00884}.; MOD_RES 301 301 Phosphoserine. {ECO:0000250|UniProtKB:P00884}.; MOD_RES 309 309 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 317 317 N6-succinyllysine. {ECO:0000250|UniProtKB:Q91Y97}.	6548561; 2410860; 6585824; 2830249; 3016456; 15164053; 2649152; 6689266; 18000879; 24275569; 11679716; 8535439; 3383242; 1967768; 8299883; 7717389; 8162030; 2336380; 10024431; 10970798; 12205126; 15532022; 15880727; 20848650; 12417303; 12464284; 12646233; 13093749; 14966907; 15063762; 15733923; 16406649; 17292585; 17353931; 17457694; 17576770; 17848580; 17955389; 18541450; 18700007; 19817957; 20033295; 20162364; 20711500; 20882353; 21166391; 21988832; 22911800; 24412244; 24993527; 25072145; 25352737; 26376879; 28558381; 3355497; 5353106; 5777313; 6696436; 805723; 9610797	6548561; 2410860; 6585824; 2830249; 3016456; 15164053; 2649152; 6689266; 18000879; 24275569; 11679716; 8535439; 3383242; 1967768; 8299883; 7717389; 8162030; 2336380; 10024431; 10970798; 12205126; 15532022; 15880727; 20848650
17864	CEL BAL	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=24 uM for lipoyl-4-aminobenzoate {ECO:0000269|PubMed:8471055}; KM=15 uM for triacetin {ECO:0000269|PubMed:8471055}; Vmax=45.5 pmol/min/mg enzyme toward lipoyl-4-aminobenzoate {ECO:0000269|PubMed:8471055}; Vmax=323 pmol/min/mg enzyme toward triacetin {ECO:0000269|PubMed:8471055}; 	3.1.1.13; 3.1.1.3	CATALYTIC ACTIVITY: Triacylglycerol + H(2)O = diacylglycerol + a carboxylate. {ECO:0000269|PubMed:8471055}.; CATALYTIC ACTIVITY: A steryl ester + H(2)O = a sterol + a fatty acid. {ECO:0000269|PubMed:8471055}.		ACTIVITY REGULATION: Activated by bile salts containing a 7-hydroxyl group.							cholesterol catabolic process [GO:0006707]; fatty acid catabolic process [GO:0009062]; intestinal cholesterol absorption [GO:0030299]; intestinal lipid catabolic process [GO:0044258]; lipid digestion [GO:0044241]; lipid metabolic process [GO:0006629]; pancreatic juice secretion [GO:0030157]; protein esterification [GO:0018350]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; acylglycerol lipase activity [GO:0047372]; carboxylic ester hydrolase activity [GO:0052689]; catalytic activity [GO:0003824]; heparin binding [GO:0008201]; hydrolase activity [GO:0016787]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]; cholesterol catabolic process [GO:0006707]; fatty acid catabolic process [GO:0009062]; intestinal cholesterol absorption [GO:0030299]; intestinal lipid catabolic process [GO:0044258]; lipid digestion [GO:0044241]; lipid metabolic process [GO:0006629]; pancreatic juice secretion [GO:0030157]; protein esterification [GO:0018350]	acylglycerol lipase activity [GO:0047372]; carboxylic ester hydrolase activity [GO:0052689]; catalytic activity [GO:0003824]; heparin binding [GO:0008201]; hydrolase activity [GO:0016787]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]	GO:0003824; GO:0004771; GO:0004806; GO:0005576; GO:0005615; GO:0005737; GO:0006629; GO:0006707; GO:0008201; GO:0009062; GO:0016787; GO:0018350; GO:0030157; GO:0030299; GO:0044241; GO:0044258; GO:0047372; GO:0052689; GO:0070062	SUBCELLULAR LOCATION: Secreted.			1698625; 2265692; 1988041; 1639390; 7578248; 9530636; 15164053; 8471055; 1991511; 7654718; 10024660; 11834744; 11045623; 16369531; 11563913; 11945176; 12110666; 12821548; 12853459; 15114370; 15841033; 16266293; 17005819; 18037996; 18544793; 18803939; 19760265; 19913121; 19948975; 20628086; 21346236; 21386960; 21784842; 21865348; 21988832; 22412885; 22956586; 2318975; 23395566; 23770712; 24062244; 25160620; 26498142; 27602750; 27650499; 27773618; 27802312; 7350912; 7350913	1698625; 2265692; 1988041; 1639390; 7578248; 9530636; 15164053; 8471055; 1991511; 7654718; 10024660; 11834744; 11045623; 16369531
18011	GAD2 GAD65	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=2.15 mM for glutamate {ECO:0000269|PubMed:8999827}; 	4.1.1.15	CATALYTIC ACTIVITY: L-glutamate = 4-aminobutanoate + CO(2).	BINDING 558 558 Substrate. {ECO:0000269|PubMed:17384644}.		COFACTOR: Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326; Evidence={ECO:0000269|PubMed:17384644}; 						chemical synaptic transmission [GO:0007268]; glutamate decarboxylation to succinate [GO:0006540]; neurotransmitter biosynthetic process [GO:0042136]; response to drug [GO:0042493]	anchored component of membrane [GO:0031225]; axon [GO:0030424]; cell junction [GO:0030054]; clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane [GO:0061202]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; inhibitory synapse [GO:0060077]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic vesicle membrane [GO:0030672]	anchored component of membrane [GO:0031225]; axon [GO:0030424]; cell junction [GO:0030054]; clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane [GO:0061202]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; inhibitory synapse [GO:0060077]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic vesicle membrane [GO:0030672]; glutamate binding [GO:0016595]; glutamate decarboxylase activity [GO:0004351]; protein heterodimerization activity [GO:0046982]; pyridoxal phosphate binding [GO:0030170]; chemical synaptic transmission [GO:0007268]; glutamate decarboxylation to succinate [GO:0006540]; neurotransmitter biosynthetic process [GO:0042136]; response to drug [GO:0042493]	glutamate binding [GO:0016595]; glutamate decarboxylase activity [GO:0004351]; protein heterodimerization activity [GO:0046982]; pyridoxal phosphate binding [GO:0030170]	GO:0000139; GO:0004351; GO:0005829; GO:0005886; GO:0006540; GO:0007268; GO:0016595; GO:0030054; GO:0030170; GO:0030424; GO:0030672; GO:0031225; GO:0042136; GO:0042493; GO:0042734; GO:0046982; GO:0048471; GO:0060077; GO:0061202	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:12356867}. Cytoplasmic vesicle {ECO:0000269|PubMed:12356867}. Cell junction, synapse, presynaptic cell membrane {ECO:0000269|PubMed:12356867}; Lipid-anchor {ECO:0000269|PubMed:12356867}. Golgi apparatus membrane {ECO:0000269|PubMed:12356867}; Peripheral membrane protein {ECO:0000269|PubMed:12356867}; Cytoplasmic side {ECO:0000269|PubMed:12356867}. Note=Associated to cytoplasmic vesicles. In neurons, cytosolic leaflet of Golgi membranes and presynaptic clusters.	PTM: Phosphorylated; which does not affect kinetic parameters or subcellular location. {ECO:0000269|PubMed:8999827}.; PTM: Palmitoylated; which is required for presynaptic clustering. {ECO:0000269|PubMed:12356867}.	MOD_RES 3 3 Phosphoserine. {ECO:0000269|PubMed:8999827}.; MOD_RES 6 6 Phosphoserine. {ECO:0000269|PubMed:8999827}.; MOD_RES 10 10 Phosphoserine. {ECO:0000269|PubMed:8999827}.; MOD_RES 13 13 Phosphoserine. {ECO:0000269|PubMed:8999827}.; MOD_RES 396 396 N6-(pyridoxal phosphate)lysine.	1924293; 1549570; 8088791; 7680313; 8243826; 8999827; 12356867; 10775108; 17384644; 11017172; 12021098; 12021103; 12097368; 12196483; 12197888; 12296864; 12376704; 12503190; 12606513; 12750892; 14557453; 14576464; 14691540; 15091314; 15114630; 15147202; 15163889; 15170642; 15277377; 15365614; 15642443; 15671113; 15834701; 16122350; 16385451; 16718280; 16722236; 16731858; 16741266; 17034009; 17090641; 17167787; 17412563; 17459095; 17479437; 17657474; 17992632; 18047830; 18184926; 18367670; 18371956; 18378887; 18487477; 19058789; 19086053; 19111404; 19125103; 19156168; 19229853; 19375301; 19686769; 19783309; 19874574; 19876004; 19913121; 20010500; 20016201; 20083660; 20201926; 20379614; 20468064; 20602615; 20628086; 20634891; 20659789; 21073664; 21250934; 21385406; 21491431; 21494613; 21517929; 21937910; 22103299; 22104260; 22366823; 22552777; 22624794; 22865904; 23114513; 23822856; 24571444; 24661757; 24874321; 24950944; 24993056; 25345799; 25416956; 25523979; 25645784; 25816051; 25966064; 26362234; 26780456; 27284108; 28608287; 29236750	1924293; 1549570; 8088791; 7680313; 8243826; 8999827; 12356867; 10775108; 17384644
18024	CTH	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.5 mM for L-cystathionine {ECO:0000269|PubMed:10212249, ECO:0000269|PubMed:18476726}; KM=5.4 mM for homocysteine {ECO:0000269|PubMed:10212249, ECO:0000269|PubMed:18476726}; KM=3.5 mM for cysteine {ECO:0000269|PubMed:10212249, ECO:0000269|PubMed:18476726}; 	4.4.1.1	CATALYTIC ACTIVITY: L-cystathionine + H(2)O = L-cysteine + NH(3) + 2-oxobutanoate. {ECO:0000269|PubMed:10212249, ECO:0000269|PubMed:19019829}.	BINDING 62 62 Substrate.; BINDING 114 114 Substrate.; BINDING 119 119 Substrate.; BINDING 339 339 Substrate.	ACTIVITY REGULATION: Inhibited by propargylglycine, trifluoroalanine and aminoethoxyvinylglycine. {ECO:0000269|PubMed:10212249, ECO:0000269|PubMed:19019829}.	COFACTOR: Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326; Evidence={ECO:0000269|PubMed:10212249, ECO:0000269|PubMed:18476726, ECO:0000269|PubMed:19019829}; 	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 8.2. {ECO:0000269|PubMed:10212249, ECO:0000269|PubMed:18476726};	PATHWAY: Amino-acid biosynthesis; L-cysteine biosynthesis; L-cysteine from L-homocysteine and L-serine: step 2/2.				'de novo' L-methionine biosynthetic process [GO:0071266]; cellular response to leukemia inhibitory factor [GO:1990830]; cysteine biosynthetic process [GO:0019344]; cysteine biosynthetic process via cystathionine [GO:0019343]; cysteine metabolic process [GO:0006534]; endoplasmic reticulum unfolded protein response [GO:0030968]; hydrogen sulfide biosynthetic process [GO:0070814]; negative regulation of apoptotic signaling pathway [GO:2001234]; positive regulation of aortic smooth muscle cell differentiation [GO:1904831]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein homotetramerization [GO:0051289]; protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine [GO:0018272]; protein sulfhydration [GO:0044524]; sulfur amino acid catabolic process [GO:0000098]; transsulfuration [GO:0019346]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; calmodulin binding [GO:0005516]; carbon-sulfur lyase activity [GO:0016846]; cystathionine gamma-lyase activity [GO:0004123]; cystathionine gamma-synthase activity [GO:0003962]; homocysteine desulfhydrase activity [GO:0047982]; identical protein binding [GO:0042802]; L-cysteine desulfhydrase activity [GO:0080146]; L-cystine L-cysteine-lyase (deaminating) [GO:0044540]; pyridoxal phosphate binding [GO:0030170]; 'de novo' L-methionine biosynthetic process [GO:0071266]; cellular response to leukemia inhibitory factor [GO:1990830]; cysteine biosynthetic process [GO:0019344]; cysteine biosynthetic process via cystathionine [GO:0019343]; cysteine metabolic process [GO:0006534]; endoplasmic reticulum unfolded protein response [GO:0030968]; hydrogen sulfide biosynthetic process [GO:0070814]; negative regulation of apoptotic signaling pathway [GO:2001234]; positive regulation of aortic smooth muscle cell differentiation [GO:1904831]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein homotetramerization [GO:0051289]; protein sulfhydration [GO:0044524]; protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine [GO:0018272]; sulfur amino acid catabolic process [GO:0000098]; transsulfuration [GO:0019346]	calmodulin binding [GO:0005516]; carbon-sulfur lyase activity [GO:0016846]; cystathionine gamma-lyase activity [GO:0004123]; cystathionine gamma-synthase activity [GO:0003962]; homocysteine desulfhydrase activity [GO:0047982]; identical protein binding [GO:0042802]; L-cysteine desulfhydrase activity [GO:0080146]; L-cystine L-cysteine-lyase (deaminating) [GO:0044540]; pyridoxal phosphate binding [GO:0030170]	GO:0000098; GO:0003962; GO:0004123; GO:0005516; GO:0005737; GO:0005829; GO:0006534; GO:0016846; GO:0018272; GO:0019343; GO:0019344; GO:0019346; GO:0030170; GO:0030968; GO:0042802; GO:0043123; GO:0044524; GO:0044540; GO:0047982; GO:0051092; GO:0051289; GO:0070062; GO:0070814; GO:0071266; GO:0080146; GO:1904831; GO:1990830; GO:2001234	SUBCELLULAR LOCATION: Cytoplasm.		MOD_RES 212 212 N6-(pyridoxal phosphate)lysine. {ECO:0000250}.	1339280; 14702039; 16710414; 15489334; 10212249; 19261609; 21269460; 22169477; 24275569; 19019829; 12574942; 18476726; 11578145; 15151507; 15161933; 15347670; 16037612; 16189514; 16444005; 17311259; 17451884; 18676680; 18701025; 18849566; 18988749; 19048631; 19161160; 19170196; 19324355; 19418582; 19428278; 19531479; 19625176; 19692168; 19913121; 19948975; 20175737; 20383543; 20446008; 20584029; 20628086; 20634891; 20849728; 21659522; 21886822; 21988832; 22034194; 22310774; 22360859; 23393010; 23410520; 23704251; 23852134; 24491890; 24610811; 24657251; 24707893; 24866963; 24896355; 24914509; 25193114; 25203395; 25205294; 25416956; 25486189; 25609649; 25801727; 25807836; 25900831; 25934094; 26519030; 26620565; 26631093; 26727544; 26772887; 27205869; 27708362; 28034716; 28106980; 28121025; 28253731; 28339573; 6456763	1339280; 14702039; 16710414; 15489334; 10212249; 19261609; 21269460; 22169477; 24275569; 19019829; 12574942; 18476726
18028	CHAC1 BOTCH	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=2.2 mM for glutathione {ECO:0000269|PubMed:27913623}; Note=kcat is 225.2 min(-1) for glutathione. {ECO:0000269|PubMed:27913623};	4.3.2.7	CATALYTIC ACTIVITY: Glutathione = L-cysteinylglycine + 5-oxo-L-proline. {ECO:0000269|PubMed:27913623}.									glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein processing [GO:0010955]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; response to unfolded protein [GO:0006986]	cytosol [GO:0005829]; trans-Golgi network [GO:0005802]	cytosol [GO:0005829]; trans-Golgi network [GO:0005802]; gamma-glutamylcyclotransferase activity [GO:0003839]; glutathione specific gamma-glutamylcyclotransferase activity [GO:0061928]; Notch binding [GO:0005112]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein processing [GO:0010955]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; response to unfolded protein [GO:0006986]	gamma-glutamylcyclotransferase activity [GO:0003839]; glutathione specific gamma-glutamylcyclotransferase activity [GO:0061928]; Notch binding [GO:0005112]	GO:0003839; GO:0005112; GO:0005802; GO:0005829; GO:0006750; GO:0006751; GO:0006986; GO:0007219; GO:0010955; GO:0022008; GO:0045746; GO:0061928; GO:0070059	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:19109178}. Golgi apparatus, trans-Golgi network {ECO:0000250|UniProtKB:Q8R3J5}.			16572171; 15489334; 19109178; 22445366; 27913623; 16189514; 22108517; 23342279; 24767995; 25931127; 27986595; 29054545	16572171; 15489334; 19109178; 22445366; 27913623
18029	CHAC2	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=3.7 mM for glutathione {ECO:0000269|PubMed:27913623}; Note=kcat is 15.9 min(-1) for glutathione. {ECO:0000269|PubMed:27913623};	4.3.2.7	CATALYTIC ACTIVITY: Glutathione = L-cysteinylglycine + 5-oxo-L-proline. {ECO:0000269|PubMed:27913623}.									glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; gamma-glutamylcyclotransferase activity [GO:0003839]; glutathione specific gamma-glutamylcyclotransferase activity [GO:0061928]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]	gamma-glutamylcyclotransferase activity [GO:0003839]; glutathione specific gamma-glutamylcyclotransferase activity [GO:0061928]	GO:0003839; GO:0005737; GO:0005829; GO:0006750; GO:0006751; GO:0061928	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:27913623}.			15815621; 15489334; 27913623; 19109178; 25931127; 26496610; 28837156; 29054545	15815621; 15489334; 27913623
18211	CHST8	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=10 uM for carbonic anhydrase VI {ECO:0000269|PubMed:11001942}; 	2.8.2.-					BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 7.2. {ECO:0000269|PubMed:11001942};					carbohydrate biosynthetic process [GO:0016051]; central nervous system development [GO:0007417]; hormone biosynthetic process [GO:0042446]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]	Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; carbohydrate biosynthetic process [GO:0016051]; central nervous system development [GO:0007417]; hormone biosynthetic process [GO:0042446]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]	N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]	GO:0000139; GO:0001537; GO:0006790; GO:0007417; GO:0016021; GO:0016051; GO:0030166; GO:0042446	SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000250}; Single-pass type II membrane protein {ECO:0000250}.			10988300; 11001942; 11445554; 15489334; 15632154; 22289416; 16959974; 16079414; 18431515; 19079260; 20379614; 20816195; 28204496	10988300; 11001942; 11445554; 15489334; 15632154; 22289416; 16959974
18366	CEPT1 PRO1101	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=37 uM for CDP-choline {ECO:0000269|PubMed:10191259, ECO:0000269|PubMed:12216837}; KM=101 uM for CDP-ethanolamine {ECO:0000269|PubMed:10191259, ECO:0000269|PubMed:12216837}; Vmax=10.5 nmol/min/mg enzyme with CDP-choline as substrate {ECO:0000269|PubMed:10191259, ECO:0000269|PubMed:12216837}; Vmax=4.35 nmol/min/mg enzyme with CDP-ethanolamine as substrate {ECO:0000269|PubMed:10191259, ECO:0000269|PubMed:12216837}; 	2.7.8.1; 2.7.8.2	CATALYTIC ACTIVITY: CDP-ethanolamine + 1,2-diacyl-sn-glycerol = CMP + a phosphatidylethanolamine. {ECO:0000269|PubMed:10191259}.; CATALYTIC ACTIVITY: CDP-choline + 1,2-diacyl-sn-glycerol = CMP + a phosphatidylcholine. {ECO:0000269|PubMed:10191259}.			COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:10191259}; Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000269|PubMed:10191259}; 		PATHWAY: Phospholipid metabolism; phosphatidylethanolamine biosynthesis; phosphatidylethanolamine from ethanolamine: step 3/3.; PATHWAY: Phospholipid metabolism; phosphatidylcholine biosynthesis; phosphatidylcholine from phosphocholine: step 2/2.		PRO1101		lipid metabolic process [GO:0006629]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; diacylglycerol cholinephosphotransferase activity [GO:0004142]; ethanolaminephosphotransferase activity [GO:0004307]; metal ion binding [GO:0046872]; lipid metabolic process [GO:0006629]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]	diacylglycerol cholinephosphotransferase activity [GO:0004142]; ethanolaminephosphotransferase activity [GO:0004307]; metal ion binding [GO:0046872]	GO:0004142; GO:0004307; GO:0005789; GO:0006629; GO:0006646; GO:0006656; GO:0016021; GO:0031965; GO:0046872	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:12221122}; Multi-pass membrane protein {ECO:0000269|PubMed:12221122}. Nucleus membrane {ECO:0000269|PubMed:12221122}; Multi-pass membrane protein {ECO:0000269|PubMed:12221122}.		MOD_RES 18 18 Phosphoserine. {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:20068231}.; MOD_RES 40 40 Phosphothreonine. {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:23186163}.	10191259; 16710414; 15489334; 17974005; 10893425; 12216837; 12221122; 18691976; 20068231; 23186163; 25944712; 17132865; 17314511; 20379614; 20711500; 21911578; 26496610	10191259; 16710414; 15489334; 17974005; 10893425; 12216837; 12221122; 18691976; 20068231; 23186163; 25944712
18382	BCHE CHE1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=18.0 uM for butyrylthiocholine (at 25 degrees Celsius) {ECO:0000269|PubMed:25054547}; 	3.1.1.8	CATALYTIC ACTIVITY: An acylcholine + H(2)O = choline + a carboxylate. {ECO:0000269|PubMed:19368529, ECO:0000269|PubMed:19452557}.	BINDING 110 110 Tacrine. {ECO:0000244|PDB:4BDS}.; BINDING 466 466 Tacrine; via carbonyl oxygen. {ECO:0000244|PDB:4BDS}.	ACTIVITY REGULATION: Inhibited by mercury. Inhibited by Tabun. Tabun forms a covalent adduct with Ser-226 that becomes irreversible upon aging. {ECO:0000269|PubMed:17355286, ECO:0000269|PubMed:18975951, ECO:0000269|PubMed:19368529}.							choline metabolic process [GO:0019695]; cocaine metabolic process [GO:0050783]; learning [GO:0007612]; negative regulation of cell proliferation [GO:0008285]; negative regulation of synaptic transmission [GO:0050805]; neuroblast differentiation [GO:0014016]; response to alkaloid [GO:0043279]; response to folic acid [GO:0051593]; response to glucocorticoid [GO:0051384]	blood microparticle [GO:0072562]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; membrane [GO:0016020]; nuclear envelope lumen [GO:0005641]	blood microparticle [GO:0072562]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; membrane [GO:0016020]; nuclear envelope lumen [GO:0005641]; acetylcholinesterase activity [GO:0003990]; amyloid-beta binding [GO:0001540]; catalytic activity [GO:0003824]; choline binding [GO:0033265]; cholinesterase activity [GO:0004104]; enzyme binding [GO:0019899]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; choline metabolic process [GO:0019695]; cocaine metabolic process [GO:0050783]; learning [GO:0007612]; negative regulation of cell proliferation [GO:0008285]; negative regulation of synaptic transmission [GO:0050805]; neuroblast differentiation [GO:0014016]; response to alkaloid [GO:0043279]; response to folic acid [GO:0051593]; response to glucocorticoid [GO:0051384]	acetylcholinesterase activity [GO:0003990]; amyloid-beta binding [GO:0001540]; catalytic activity [GO:0003824]; choline binding [GO:0033265]; cholinesterase activity [GO:0004104]; enzyme binding [GO:0019899]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]	GO:0001540; GO:0003824; GO:0003990; GO:0004104; GO:0005576; GO:0005641; GO:0005788; GO:0007612; GO:0008285; GO:0014016; GO:0016020; GO:0016788; GO:0019695; GO:0019899; GO:0033265; GO:0042802; GO:0043279; GO:0050783; GO:0050805; GO:0051384; GO:0051593; GO:0072562	SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:19368529, ECO:0000269|PubMed:19542320}.	PTM: N-glycosylated. No other PTM detected (PubMed:20946535). The major N-glycan structures are of the complex diantennary type with 1 and 2 N-acetylneuraminic acid molecules (Neu5Ac) making up approximately 33% and 47% of the total N-glycans, respectively. Only low amounts of fucosylated diantennary N-glycans are detected (approximately 2%). Triantennary N-glycans with or without fucose amount to approximately 13%, whereas 5% of the total N-glycans are of the oligomannosidic or hybrid type. {ECO:0000269|PubMed:12869558, ECO:0000269|PubMed:14760718, ECO:0000269|PubMed:15667209, ECO:0000269|PubMed:16335952, ECO:0000269|PubMed:17355286, ECO:0000269|PubMed:17768338, ECO:0000269|PubMed:18203274, ECO:0000269|PubMed:18975951, ECO:0000269|PubMed:19139490, ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:19368529, ECO:0000269|PubMed:20946535}.	MOD_RES 226 226 Phosphoserine. {ECO:0000269|PubMed:22444575}.	3035536; 3477799; 2322535; 14702039; 15489334; 3542989; 20946535; 3115973; 14760718; 16335952; 18203274; 19542320; 19159218; 19139490; 19452557; 22444575; 24275569; 25054547; 12869558; 15667209; 17768338; 17355286; 18975951; 19368529; 23679855; 2915989; 1349196; 1415224; 1611188; 1306123; 7634491; 8680411; 8554068; 9543549; 9388484; 9191541; 9110359; 9694584; 10404729; 11928765; 12881446; 15563885; 15781196; 16788378; 17700357; 18075469; 18300943; 25264279; 10430518; 11053835; 11125748; 11436125; 11725818; 11738493; 11749053; 11793025; 11848688; 11849755; 11856322; 11856351; 12009429; 12044901; 12074828; 12130740; 12387584; 12417112; 12668920; 12687586; 12724618; 12811800; 12901493; 14622273; 14686935; 14735258; 15111428; 15256494; 15258737; 15386241; 15449725; 15465921; 15519745; 15690550; 15696543; 15731585; 15802910; 15834019; 15907830; 16020944; 16105444; 16213467; 16278840; 16288482; 16289064; 16298355; 16429499; 16504521; 16731619; 16801396; 16824336; 16909200; 16962996; 16973370; 17192624; 17275003; 17289852; 17318303; 17335779; 17350607; 17410321; 1748670; 17503475; 17660298; 17690023; 17698511; 17701416; 17852836; 17917325; 17923322; 17996334; 18076380; 18165570; 18237553; 18290843; 18322399; 18334913; 18396350; 18422653; 18457821; 18550040; 18555211; 18640242; 18778798; 18780301; 19006190; 19010318; 19019080; 19056482; 19156168; 19217865; 19280057; 19383604; 19474452; 19481150; 19578796; 19617863; 19685167; 19713000; 19913121; 19956635; 20056567; 20058037; 20122907; 20143968; 20193849; 20308990; 20356562; 20379614; 20399202; 20529763; 20538374; 20628086; 20644562; 20677742; 20807286; 20879632; 20883446; 20886866; 21029050; 21091433; 21438623; 21454498; 21473860; 21493754; 21505234; 21530486; 21547979; 21576115; 21862451; 22040426; 22157615; 22294139; 22331678; 22402324; 22560633; 22726956; 22750491; 22778864; 22901043; 22917637; 22922115; 22935510; 23000450; 23022600; 23044488; 23063927; 23123771; 23339663; 23419831; 23466605; 23508960; 23650977; 23689009; 23782236; 24001779; 24041656; 24125115; 24312228; 24399815; 24446003; 24473115; 24479631; 24870023; 24951323; 25179377; 25226236; 25336127; 25447891; 25471831; 25835709; 26116179; 26189613; 26223693; 26439437; 26496610; 26497592; 26757188; 26955768; 27031121; 27062896; 27106529; 27109752; 27405689; 27468571; 27551784; 27567841; 27908752; 27911294; 28000737; 28225154; 28465191; 28544359; 28698452; 29077024; 29177431; 29186056; 29227101; 9536100; 9682830; 9836756	3035536; 3477799; 2322535; 14702039; 15489334; 3542989; 20946535; 3115973; 14760718; 16335952; 18203274; 19542320; 19159218; 19139490; 19452557; 22444575; 24275569; 25054547; 12869558; 15667209; 17768338; 17355286; 18975951; 19368529; 23679855; 2915989; 1349196; 1415224; 1611188; 1306123; 7634491; 8680411; 8554068; 9543549; 9388484; 9191541; 9110359; 9694584; 10404729; 11928765; 12881446; 15563885; 15781196; 16788378; 17700357; 18075469; 18300943; 25264279
18501	CDYL CDYL1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=73.75 uM for (2E)-butenoyl-CoA {ECO:0000269|PubMed:28803779}; 	4.2.1.-	CATALYTIC ACTIVITY: 3-hydroxybutanoyl-CoA = (2E)-butenoyl-CoA + H(2)O. {ECO:0000269|PubMed:28803779}.									negative regulation of peptidyl-lysine crotonylation [GO:0120094]; random inactivation of X chromosome [GO:0060816]; regulation of transcription, DNA-templated [GO:0006355]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; transcription, DNA-templated [GO:0006351]	chromosome [GO:0005694]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	chromosome [GO:0005694]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; crotonyl-CoA hydratase activity [GO:0120092]; methylated histone binding [GO:0035064]; protein binding, bridging [GO:0030674]; transcription corepressor activity [GO:0003714]; negative regulation of peptidyl-lysine crotonylation [GO:0120094]; random inactivation of X chromosome [GO:0060816]; regulation of transcription, DNA-templated [GO:0006355]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; transcription, DNA-templated [GO:0006351]	chromatin binding [GO:0003682]; crotonyl-CoA hydratase activity [GO:0120092]; methylated histone binding [GO:0035064]; protein binding, bridging [GO:0030674]; transcription corepressor activity [GO:0003714]	GO:0003682; GO:0003714; GO:0005634; GO:0005694; GO:0006351; GO:0006355; GO:0007283; GO:0007286; GO:0016607; GO:0030674; GO:0035064; GO:0060816; GO:0120092; GO:0120094	SUBCELLULAR LOCATION: Isoform 2: Nucleus {ECO:0000269|PubMed:18450745, ECO:0000269|PubMed:19808672}. Chromosome {ECO:0000269|PubMed:19808672}. Note=Recognizes and binds histone H3 trimethylated at 'Lys-9', dimethylated at 'Lys-27' and trimethylated at 'Lys-27' (H3K9me3, H3K27me2 and H3K27me3, respectively) on chromatin (PubMed:19808672). Multimerization is required for chromatin-binding (PubMed:19808672). {ECO:0000269|PubMed:19808672}.		MOD_RES 88 88 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 135 135 N6,N6,N6-trimethyllysine; by EHMT2; alternate. {ECO:0000269|PubMed:18438403}.; MOD_RES 135 135 N6,N6-dimethyllysine; by EHMT2; alternate. {ECO:0000269|PubMed:18438403}.; MOD_RES 135 135 N6-methyllysine; by EHMT2; alternate. {ECO:0000269|PubMed:18438403}.; MOD_RES 170 170 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 201 201 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 216 216 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.	10192397; 14702039; 14574404; 15489334; 17974005; 12072557; 17081983; 18450745; 18220336; 19061646; 18438403; 18669648; 19808672; 20068231; 22009739; 21406692; 23186163; 24275569; 28402439; 28803779; 19507244; 16415788; 17461779; 19730683; 21150319; 21258344; 23752268	10192397; 14702039; 14574404; 15489334; 17974005; 12072557; 17081983; 18450745; 18220336; 19061646; 18438403; 18669648; 19808672; 20068231; 22009739; 21406692; 23186163; 24275569; 28402439; 28803779; 19507244; 
18527	CASP4 ICH2	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=681 uM for synthetic peptide acetyl-YVAD-p-nitroanilide {ECO:0000269|PubMed:7797510}; Note=Values obtained using the partial C-terminal enzyme sequence of 105-377. {ECO:0000269|PubMed:7797510};	3.4.22.57	CATALYTIC ACTIVITY: Strict requirement for Asp at the P1 position. It has a preferred cleavage sequence of Tyr-Val-Ala-Asp-|- but also cleaves at Asp-Glu-Val-Asp-|-. {ECO:0000269|PubMed:23516580}.		ACTIVITY REGULATION: Activated by homooligomerization induced by direct binding to cytosolic LPS, in a TLR4-independent manner (PubMed:25119034). {ECO:0000269|PubMed:25119034}.				SITE 289 290 Cleavage; by autolysis. {ECO:0000269|PubMed:7797510}.			apoptotic process [GO:0006915]; cellular response to amyloid-beta [GO:1904646]; execution phase of apoptosis [GO:0097194]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; proteolysis [GO:0006508]; regulation of apoptotic process [GO:0042981]; regulation of inflammatory response [GO:0050727]	AIM2 inflammasome complex [GO:0097169]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; IPAF inflammasome complex [GO:0072557]; mitochondrion [GO:0005739]; NLRP3 inflammasome complex [GO:0072559]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	AIM2 inflammasome complex [GO:0097169]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; IPAF inflammasome complex [GO:0072557]; mitochondrion [GO:0005739]; NLRP3 inflammasome complex [GO:0072559]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; CARD domain binding [GO:0050700]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; apoptotic process [GO:0006915]; cellular response to amyloid-beta [GO:1904646]; execution phase of apoptosis [GO:0097194]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; proteolysis [GO:0006508]; regulation of apoptotic process [GO:0042981]; regulation of inflammatory response [GO:0050727]	CARD domain binding [GO:0050700]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]	GO:0004197; GO:0005576; GO:0005739; GO:0005783; GO:0005789; GO:0005829; GO:0005886; GO:0006508; GO:0006915; GO:0006954; GO:0032991; GO:0042981; GO:0045087; GO:0050700; GO:0050727; GO:0070059; GO:0072557; GO:0072559; GO:0097153; GO:0097169; GO:0097193; GO:0097194; GO:1903265; GO:1904646	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:23661706}. Endoplasmic reticulum membrane {ECO:0000269|PubMed:15123740, ECO:0000269|PubMed:23661706}; Peripheral membrane protein {ECO:0000269|PubMed:23661706}; Cytoplasmic side {ECO:0000269|PubMed:23661706}. Mitochondrion {ECO:0000269|PubMed:15123740, ECO:0000269|PubMed:23661706}. Inflammasome {ECO:0000269|PubMed:25119034, ECO:0000269|PubMed:26508369}. Secreted {ECO:0000269|PubMed:22246630}. Note=Predominantly localizes to the endoplasmic reticulum (ER). Association with the ER membrane requires TMEM214 (PubMed:15123740). Released in the extracellular milieu by keratinocytes following UVB irradiation (PubMed:22246630). {ECO:0000269|PubMed:15123740, ECO:0000269|PubMed:22246630}.	PTM: In response to activation signals, including endoplasmic reticulum stress or treatment with amyloid-beta A4 protein fragments (such as amyloid-beta protein 40), undergoes autoproteolytic cleavage. {ECO:0000269|PubMed:15123740, ECO:0000269|PubMed:7743998, ECO:0000269|PubMed:7797510}.	MOD_RES 83 83 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231}.	7743998; 7797592; 7797510; 14702039; 16554811; 15489334; 11230166; 10986288; 15123740; 16893518; 18669648; 18511561; 20068231; 22246630; 22814378; 23661706; 23516580; 25121752; 24879791; 25119034; 26174085; 26173988; 26508369; 26375003; 25695505; 25964352; 28314590; 10329646; 12096920; 15326478; 17353931; 19773279; 20711500; 21282934; 21988832	7743998; 7797592; 7797510; 14702039; 16554811; 15489334; 11230166; 10986288; 15123740; 16893518; 18669648; 18511561; 20068231; 22246630; 22814378; 23661706; 23516580; 25121752; 24879791; 25119034; 26174085; 26173988; 26508369; 26375003; 25695505; 25964352; 28314590
18533	CTSG	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.15 mM for Z-Lys-SBzl {ECO:0000269|PubMed:8194606}; KM=0.26 mM for Suc-Ala-Ala-Pro-Phe-SBzl {ECO:0000269|PubMed:8194606}; 	3.4.21.20	CATALYTIC ACTIVITY: Specificity similar to chymotrypsin C.		ACTIVITY REGULATION: Inhibited by soybean trypsin inhibitor, benzamidine, the synthetic peptide R13K, Z-Gly-Leu-Phe-CH2Cl, phenylmethylsulfonyl fluoride, 3,4-dichloroisocoumarin, DFP, SBTI and alpha-1-antitrypsin. Inhibited by LPS from P.aeruginosa but not by LPS from S.minnesota. Not inhibited by elastinal, CMK, TLCK and ETDA. {ECO:0000269|PubMed:1861080, ECO:0000269|PubMed:1937776, ECO:0000269|PubMed:8194606}.							angiotensin maturation [GO:0002003]; antibacterial humoral response [GO:0019731]; antimicrobial humoral response [GO:0019730]; cellular protein metabolic process [GO:0044267]; cellular response to lipopolysaccharide [GO:0071222]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; extracellular matrix disassembly [GO:0022617]; immune response [GO:0006955]; negative regulation of growth of symbiont in host [GO:0044130]; neutrophil degranulation [GO:0043312]; neutrophil mediated killing of gram-positive bacterium [GO:0070946]; positive regulation of immune response [GO:0050778]; protein phosphorylation [GO:0006468]; proteolysis [GO:0006508]	azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasmic stress granule [GO:0010494]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]	azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasmic stress granule [GO:0010494]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; heparin binding [GO:0008201]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; angiotensin maturation [GO:0002003]; antibacterial humoral response [GO:0019731]; antimicrobial humoral response [GO:0019730]; cellular protein metabolic process [GO:0044267]; cellular response to lipopolysaccharide [GO:0071222]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; extracellular matrix disassembly [GO:0022617]; immune response [GO:0006955]; negative regulation of growth of symbiont in host [GO:0044130]; neutrophil degranulation [GO:0043312]; neutrophil mediated killing of gram-positive bacterium [GO:0070946]; positive regulation of immune response [GO:0050778]; protein phosphorylation [GO:0006468]; proteolysis [GO:0006508]	heparin binding [GO:0008201]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	GO:0002003; GO:0004252; GO:0005576; GO:0005615; GO:0005634; GO:0005886; GO:0006468; GO:0006508; GO:0006955; GO:0008201; GO:0008233; GO:0008236; GO:0009986; GO:0010494; GO:0019730; GO:0019731; GO:0022617; GO:0030141; GO:0035578; GO:0043312; GO:0044130; GO:0044267; GO:0050778; GO:0050829; GO:0050832; GO:0062023; GO:0070062; GO:0070946; GO:0071222	SUBCELLULAR LOCATION: Cell surface {ECO:0000269|PubMed:8194606}.			3304423; 2569462; 15489334; 8194606; 3799965; 2501794; 1861080; 7897245; 1937776; 21269460; 22275911; 25944712; 8896442; 8454293; 10512690; 11241273; 11502364; 11520793; 11557685; 11920276; 11928814; 11942800; 11986950; 12524437; 12784398; 14688365; 14737102; 15100291; 15131125; 15140022; 15385470; 15741158; 15967795; 16034099; 16317101; 16444434; 16799473; 16977463; 17174955; 17418861; 17653609; 18021746; 18217133; 18586676; 18835135; 19036358; 19250736; 19528350; 19578796; 19620298; 19910052; 19913121; 20056178; 20331476; 20589323; 20628086; 20800603; 20889553; 2116408; 21193413; 21488974; 21543057; 2176865; 21850236; 22588119; 22641217; 22810585; 22915586; 23147993; 23454598; 23466190; 23902751; 23940756; 24532668; 24877096; 25248056; 25416956; 25461571; 2557753; 26270939; 2681419; 26837514; 26986619; 27666013; 28053237; 28544544; 28797985; 4216367; 6263256; 6807977; 7075587; 8692836; 9261109; 9570564; 9718313	3304423; 2569462; 15489334; 8194606; 3799965; 2501794; 1861080; 7897245; 1937776; 21269460; 22275911; 25944712; 8896442; 8454293
18585	CPO	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=325 uM for 3-(2-furyl)acryloyl-Glu-Glu (at pH 7.5) {ECO:0000269|PubMed:21921028}; KM=284 uM for 3-(2-furyl)acryloyl-Phe-Phe (at pH 7.5) {ECO:0000269|PubMed:21921028}; KM=549 uM for 3-(2-furyl)acryloyl-Phe-Ala (at pH 7.5) {ECO:0000269|PubMed:21921028}; KM=614 uM for 3-(2-furyl)acryloyl-Lys-Ala (at pH 7.5) {ECO:0000269|PubMed:21921028}; 	3.4.17.-			ACTIVITY REGULATION: Strongly inhibited by potato carboxypeptidase inhibitor, and the chelating agents EDTA and 1,10-phenanthroline. Also inhibited by compounds with multiple carboxylic acid groups such as citrate and succinate, and to a lesser exent the amino acids aspartate and glutamate. Not significantly inhibited by benzylsuccinic acid. {ECO:0000269|PubMed:21921028}.	COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250|UniProtKB:P00730}; 							anchored component of plasma membrane [GO:0046658]; apical plasma membrane [GO:0016324]; extracellular space [GO:0005615]	anchored component of plasma membrane [GO:0046658]; apical plasma membrane [GO:0016324]; extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]	metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]	GO:0004181; GO:0005615; GO:0008270; GO:0016324; GO:0046658	SUBCELLULAR LOCATION: Apical cell membrane {ECO:0000269|PubMed:21921028}; Lipid-anchor, GPI-anchor {ECO:0000269|PubMed:21921028}.	PTM: N-glycosylated. {ECO:0000269|PubMed:21921028}.		15815621; 15489334; 11836249; 21921028; 16959974; 29636417	15815621; 15489334; 11836249; 21921028; 16959974
18591	CBR3	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=25 uM for menadione {ECO:0000269|PubMed:15537833, ECO:0000269|PubMed:18493841}; KM=43 uM for menadione {ECO:0000269|PubMed:15537833, ECO:0000269|PubMed:18493841}; KM=90 uM for NADPH {ECO:0000269|PubMed:15537833, ECO:0000269|PubMed:18493841}; KM=38 uM for NADPH {ECO:0000269|PubMed:15537833, ECO:0000269|PubMed:18493841}; 	1.1.1.184	CATALYTIC ACTIVITY: R-CHOH-R' + NADP(+) = R-CO-R' + NADPH.	BINDING 90 90 NADP; via carbonyl oxygen. {ECO:0000269|Ref.11}.; BINDING 140 140 Substrate. {ECO:0000250}.; BINDING 239 239 NADP. {ECO:0000269|Ref.11}.			BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 5.5-7. {ECO:0000269|PubMed:15537833, ECO:0000269|PubMed:18493841};					cognition [GO:0050890]; phylloquinone catabolic process [GO:0042376]; xenobiotic metabolic process [GO:0006805]	cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]	cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 3-keto sterol reductase activity [GO:0000253]; carbonyl reductase (NADPH) activity [GO:0004090]; NADPH binding [GO:0070402]; cognition [GO:0050890]; phylloquinone catabolic process [GO:0042376]; xenobiotic metabolic process [GO:0006805]	3-keto sterol reductase activity [GO:0000253]; carbonyl reductase (NADPH) activity [GO:0004090]; NADPH binding [GO:0070402]	GO:0000253; GO:0004090; GO:0005615; GO:0005654; GO:0005829; GO:0006805; GO:0042376; GO:0050890; GO:0070402	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:18493841}.		MOD_RES 2 2 N-acetylserine. {ECO:0000250|UniProtKB:P16152}.; MOD_RES 30 30 Phosphoserine. {ECO:0000250|UniProtKB:P48758}.	9740676; 10830953; 15489334; 18493841; 21269460; 15537833; 10728668; 11592776; 16169070; 17353931; 18457324; 18551042; 18676680; 19016765; 19170196; 19590938; 19615732; 19625176; 19671875; 19692168; 19841672; 20007405; 20494980; 20562859; 20734064; 20806931; 21256830; 22001310; 22124095; 22360420; 22425771; 22527884; 23182048; 25446851; 26496610; 26563179; 2897122	9740676; 10830953; 15489334; 18493841; 21269460; 15537833
18592	CBR4 SDR45C1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=11 uM for NADPH (for homotetramer) {ECO:0000269|PubMed:19000905}; KM=1.6 uM for 9,10-phenanthrenequinone (for homotetramer) {ECO:0000269|PubMed:19000905}; KM=1.9 uM for 1,4-benzoquinone (for homotetramer) {ECO:0000269|PubMed:19000905}; 	1.-.-.-; 1.1.1.-		BINDING 56 56 NADP. {ECO:0000244|PDB:4CQM, ECO:0000269|PubMed:25203508}.; BINDING 135 135 Substrate. {ECO:0000305|PubMed:25203508}.; BINDING 148 148 NADP. {ECO:0000244|PDB:4CQM, ECO:0000269|PubMed:25203508}.; BINDING 152 152 NADP. {ECO:0000244|PDB:4CQM, ECO:0000269|PubMed:25203508}.			BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 6-8 (for homotetramer). {ECO:0000269|PubMed:19000905};	PATHWAY: Lipid metabolism; fatty acid biosynthesis. {ECO:0000269|PubMed:19571038, ECO:0000269|PubMed:25203508}.	SITE 169 169 Important for interaction with acyl carrier protein (ACP). {ECO:0000305|PubMed:25203508}.			daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; fatty acid biosynthetic process [GO:0006633]; oxidation-reduction process [GO:0055114]; protein heterotetramerization [GO:0051290]; protein homotetramerization [GO:0051289]	mitochondrial matrix [GO:0005759]; oxidoreductase complex [GO:1990204]	mitochondrial matrix [GO:0005759]; oxidoreductase complex [GO:1990204]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity [GO:0047025]; NAD(P)H dehydrogenase (quinone) activity [GO:0003955]; NADPH binding [GO:0070402]; NADPH dehydrogenase (quinone) activity [GO:0008753]; quinone binding [GO:0048038]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; fatty acid biosynthetic process [GO:0006633]; oxidation-reduction process [GO:0055114]; protein heterotetramerization [GO:0051290]; protein homotetramerization [GO:0051289]	3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity [GO:0047025]; NAD(P)H dehydrogenase (quinone) activity [GO:0003955]; NADPH binding [GO:0070402]; NADPH dehydrogenase (quinone) activity [GO:0008753]; quinone binding [GO:0048038]	GO:0003955; GO:0005759; GO:0006633; GO:0008753; GO:0044597; GO:0044598; GO:0047025; GO:0048038; GO:0051289; GO:0051290; GO:0055114; GO:0070402; GO:1990204	SUBCELLULAR LOCATION: Mitochondrion matrix {ECO:0000269|PubMed:19000905, ECO:0000269|PubMed:19571038}.		MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:22814378}.; MOD_RES 40 40 N6-acetyllysine. {ECO:0000250|UniProtKB:Q91VT4}.; MOD_RES 96 96 N6-acetyllysine. {ECO:0000250|UniProtKB:Q91VT4}.; MOD_RES 195 195 N6-acetyllysine. {ECO:0000250|UniProtKB:Q91VT4}.	14702039; 17974005; 15815621; 15489334; 19000905; 19571038; 22814378; 24275569; 25203508; 21269460; 15668256; 17978863; 20877624; 26058080	14702039; 17974005; 15815621; 15489334; 19000905; 19571038; 22814378; 24275569; 25203508; 21269460
18666	CA1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=4.0 mM for CO(2) {ECO:0000269|PubMed:10550681, ECO:0000269|PubMed:18618712}; KM=15 mM for 4-nitrophenyl acetate {ECO:0000269|PubMed:10550681, ECO:0000269|PubMed:18618712}; 	4.2.1.1	CATALYTIC ACTIVITY: H(2)CO(3) = CO(2) + H(2)O.	BINDING 200 200 Substrate. {ECO:0000269|PubMed:8057362}.	ACTIVITY REGULATION: Activated by histamine, imidazole, L-adrenaline, L- and D-histidine, and L- and D-phenylalanine. Inhibited by coumarins, sulfonamide derivatives such as acetazolamide, benzenesulfonamide and derivatives (4-carboxyethylbenzene-sulfonamide, 4-carboxyethylbenzene-sulfonamide ethyl ester, 4-(acetyl-2-aminoethyl)benzene-sulfonamide, 4-aminoethylbenzene-sulfonamide), and 'prong inhibitors' BR15, BR17, BR22 and BR30. Activated by a short exposition to Foscarnet (phosphonoformate trisodium salt), but inhibited by a long one. Esterase activity weakly reduced by cyanamide. {ECO:0000269|PubMed:16506782, ECO:0000269|PubMed:16686544, ECO:0000269|PubMed:16807956, ECO:0000269|PubMed:17127057, ECO:0000269|PubMed:17314045, ECO:0000269|PubMed:17407288, ECO:0000269|PubMed:18618712, ECO:0000269|PubMed:19186056, ECO:0000269|PubMed:19206230}.	COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000269|PubMed:12009884, ECO:0000269|PubMed:15299369, ECO:0000269|PubMed:16506782, ECO:0000269|PubMed:16870440, ECO:0000269|PubMed:17314045, ECO:0000269|PubMed:17407288, ECO:0000269|PubMed:6430186, ECO:0000269|PubMed:7932756, ECO:0000269|PubMed:804171, ECO:0000269|PubMed:8057362}; 						bicarbonate transport [GO:0015701]; interleukin-12-mediated signaling pathway [GO:0035722]; one-carbon metabolic process [GO:0006730]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; hydro-lyase activity [GO:0016836]; zinc ion binding [GO:0008270]; bicarbonate transport [GO:0015701]; interleukin-12-mediated signaling pathway [GO:0035722]; one-carbon metabolic process [GO:0006730]	arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; hydro-lyase activity [GO:0016836]; zinc ion binding [GO:0008270]	GO:0004064; GO:0004089; GO:0005829; GO:0006730; GO:0008270; GO:0015701; GO:0016836; GO:0035722; GO:0070062	SUBCELLULAR LOCATION: Cytoplasm.		MOD_RES 2 2 N-acetylalanine. {ECO:0000269|PubMed:4207120, ECO:0000269|PubMed:4217196}.	3104879; 2121614; 15489334; 4217196; 4625868; 4632246; 4207120; 10550681; 16807956; 16686544; 17127057; 19186056; 19206230; 18618712; 21269460; 24275569; 4622589; 804171; 6430186; 15299369; 8057362; 7932756; 12009884; 16870440; 16506782; 17314045; 17407288; 6781336; 7866410; 120192; 13911449; 14675565; 1554744; 15836783; 15837325; 16038020; 17427958; 17464559; 17968930; 19536309; 20349499; 20493921; 20505865; 20578724; 20624682; 21143847; 21282642; 2169869; 21900206; 21988832; 22001224; 22360420; 22416960; 22619369; 22838845; 22996014; 234739; 23557951; 24670789; 25165709; 25416956; 26079542; 26232327; 26459317; 26475450; 27413740; 27475498; 28001003; 28270370; 28445001; 28544359; 28613396; 29795039; 3080418; 4994926; 6407977; 6433979; 6819139; 8083199; 8399223; 9336012; 9635771	3104879; 2121614; 15489334; 4217196; 4625868; 4632246; 4207120; 10550681; 16807956; 16686544; 17127057; 19186056; 19206230; 18618712; 21269460; 24275569; 4622589; 804171; 6430186; 15299369; 8057362; 7932756; 12009884; 16870440; 16506782; 17314045; 17407288; 6781336; 7866410
18670	CA4	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=21.5 mM for CO(2) {ECO:0000269|PubMed:18618712}; 	4.2.1.1	CATALYTIC ACTIVITY: H(2)CO(3) = CO(2) + H(2)O.		ACTIVITY REGULATION: Activated by histamine, L-adrenaline, D-phenylalanine, L- and D-histidine. Inhibited by coumarins, saccharin, sulfonamide derivatives such as acetazolamide and Foscarnet (phosphonoformate trisodium salt). {ECO:0000269|PubMed:16686544, ECO:0000269|PubMed:16807956, ECO:0000269|PubMed:17127057, ECO:0000269|PubMed:17314045, ECO:0000269|PubMed:17705204, ECO:0000269|PubMed:18618712, ECO:0000269|PubMed:19186056, ECO:0000269|PubMed:19206230}.	COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000269|PubMed:8942978}; 						bicarbonate transport [GO:0015701]	anchored component of external side of plasma membrane [GO:0031362]; apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658]	anchored component of external side of plasma membrane [GO:0031362]; apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; bicarbonate transport [GO:0015701]	carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]	GO:0004089; GO:0005791; GO:0005793; GO:0005794; GO:0005802; GO:0005886; GO:0008270; GO:0009986; GO:0015701; GO:0016020; GO:0016324; GO:0030658; GO:0030667; GO:0031362; GO:0031526; GO:0048471; GO:0070062	SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor, GPI-anchor.			1311094; 8325641; 14702039; 16625196; 15489334; 2111324; 8809084; 7625839; 16807956; 16686544; 17705204; 17127057; 17314045; 19186056; 19206230; 18618712; 8942978; 20363633; 15563508; 17652713; 20450258; 10090333; 11121027; 11676494; 11994299; 14567693; 15090652; 15501038; 16006130; 17409381; 17500595; 17881426; 18162396; 18294854; 18344446; 18703501; 19211803; 20308551; 20626030; 20801516; 21680735; 21988832; 22021688; 23049597; 23297198; 24146379; 24338019; 24880201; 26071132; 28975383; 9054574; 9336012	1311094; 8325641; 14702039; 16625196; 15489334; 2111324; 8809084; 7625839; 16807956; 16686544; 17705204; 17127057; 17314045; 19186056; 19206230; 18618712; 8942978; 20363633; 15563508; 17652713; 20450258
18687	CPA4 CPA3 UNQ694/PRO1339	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=55.6 uM for 3-(2-furyl)acryloyl-Phe-Phe {ECO:0000269|PubMed:20385563}; KM=19.4 uM for 3-(2-furyl)acryloyl-Phe-Leu {ECO:0000269|PubMed:20385563}; KM=23.3 uM for 3-(2-furyl)acryloyl-Phe-Ile {ECO:0000269|PubMed:20385563}; KM=40.4 uM for 3-(2-furyl)acryloyl-Phe-Met {ECO:0000269|PubMed:20385563}; KM=57.3 uM for 3-(2-furyl)acryloyl-Phe-Val {ECO:0000269|PubMed:20385563}; KM=0.329 uM for neurotensin {ECO:0000269|PubMed:20385563}; KM=9.23 uM for Met-enkephalin-Arg-Phe {ECO:0000269|PubMed:20385563}; 	3.4.17.-		BINDING 239 239 Substrate. {ECO:0000250|UniProtKB:P00730}.; BINDING 360 360 Substrate. {ECO:0000250|UniProtKB:P00730}.	ACTIVITY REGULATION: Inhibited by interaction with the metallocarboxypeptidase inhibitor (MCPI) from N.versicolor that binds to the catalytic zinc ion. {ECO:0000269|PubMed:22294694}.	COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000269|PubMed:22294694}; ;  Note=Binds 1 zinc ion per subunit. {ECO:0000269|PubMed:22294694};	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 8.5-9. {ECO:0000269|PubMed:20385563};			UNQ694/PRO1339		histone acetylation [GO:0016573]	extracellular space [GO:0005615]	extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; histone acetylation [GO:0016573]	metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]	GO:0004181; GO:0005615; GO:0008270; GO:0016573	SUBCELLULAR LOCATION: Secreted {ECO:0000250}.			10383164; 12975309; 14702039; 12853948; 15489334; 12552318; 20385563; 16091843; 15738388; 22294694; 17506531; 19245716; 23746805; 27780921; 28209092	10383164; 12975309; 14702039; 12853948; 15489334; 12552318; 20385563; 16091843; 15738388; 22294694
18708	CBR1 CBR CRN SDR21C1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=30 uM for S-nitrosoglutathione {ECO:0000269|PubMed:17344335, ECO:0000269|PubMed:18826943}; KM=22 uM for menadione {ECO:0000269|PubMed:17344335, ECO:0000269|PubMed:18826943}; KM=309 uM for prostaglandin E2 {ECO:0000269|PubMed:17344335, ECO:0000269|PubMed:18826943}; KM=173 uM for daunorubicin {ECO:0000269|PubMed:17344335, ECO:0000269|PubMed:18826943}; KM=247 uM for NADPH {ECO:0000269|PubMed:17344335, ECO:0000269|PubMed:18826943}; 	1.1.1.184; 1.1.1.197; 1.1.1.189	CATALYTIC ACTIVITY: R-CHOH-R' + NADP(+) = R-CO-R' + NADPH.; CATALYTIC ACTIVITY: (5Z,13E)-(15S)-9-alpha,11-alpha,15-trihydroxyprosta-5,13-dienoate + NADP(+) = (5Z,13E)-(15S)-11-alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate + NADPH.; CATALYTIC ACTIVITY: (13E)-(15S)-11-alpha,15-dihydroxy-9-oxoprost-13-enoate + NADP(+) = (13E)-11-alpha-hydroxy-9,15-dioxoprost-13-enoate + NADPH.	BINDING 90 90 NADP; via carbonyl oxygen. {ECO:0000269|PubMed:15799708, ECO:0000269|PubMed:17912391, ECO:0000269|PubMed:18826943}.; BINDING 106 106 Glutathione.; BINDING 140 140 Substrate.	ACTIVITY REGULATION: Inhibited by quercetin, rutenin and its derivatives. {ECO:0000269|PubMed:17344335, ECO:0000269|PubMed:18449627}.							cyclooxygenase pathway [GO:0019371]; drug metabolic process [GO:0017144]; epithelial cell differentiation [GO:0030855]; oxidation-reduction process [GO:0055114]; vitamin K metabolic process [GO:0042373]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; prostaglandin-E2 9-reductase activity [GO:0050221]; cyclooxygenase pathway [GO:0019371]; drug metabolic process [GO:0017144]; epithelial cell differentiation [GO:0030855]; oxidation-reduction process [GO:0055114]; vitamin K metabolic process [GO:0042373]	15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; prostaglandin-E2 9-reductase activity [GO:0050221]	GO:0004090; GO:0005829; GO:0016655; GO:0017144; GO:0019371; GO:0030855; GO:0042373; GO:0047021; GO:0050221; GO:0055114; GO:0070062; GO:1903561	SUBCELLULAR LOCATION: Cytoplasm.		MOD_RES 2 2 N-acetylserine. {ECO:0000244|PubMed:19413330}.; MOD_RES 2 2 Phosphoserine. {ECO:0000250|UniProtKB:P47727}.; MOD_RES 30 30 Phosphoserine. {ECO:0000250|UniProtKB:P48758}.; MOD_RES 239 239 N6-1-carboxyethyl lysine. {ECO:0000269|PubMed:8421682}.	3141401; 2182121; 1921984; 9740676; 14702039; 10830953; 15489334; 8421682; 18449627; 19413330; 21269460; 15799708; 17912391; 18826943; 17344335; 12577067; 16169070; 17353931; 17569794; 17697149; 18493841; 18551042; 18676680; 19016765; 19022938; 19135240; 19170196; 19204081; 19625176; 19692168; 19841672; 20029029; 20471030; 20562859; 21256830; 22124095; 22360420; 22542806; 22562609; 23133646; 23247010; 23295225; 23576398; 24440593; 24654784; 25526449; 25541467; 25572536; 25609649; 26328486; 26381805; 26496610; 26499922; 26752685; 27055738; 27562619; 28274719; 28450226; 7005231	3141401; 2182121; 1921984; 9740676; 14702039; 10830953; 15489334; 8421682; 18449627; 19413330; 21269460; 15799708; 17912391; 18826943; 17344335
18794	CTSE	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.06 mM for hemoglobin {ECO:0000269|PubMed:8346912}; KM=0.13 mM for Pro-Pro-Thr-Ile-Phe-Phe(4-NO2)-Arg-Leu {ECO:0000269|PubMed:8346912}; KM=0.04 mM for Lys-Pro-Ile-Glu-Phe-Phe(4-NO2)-Arg-Leu {ECO:0000269|PubMed:8346912}; 	3.4.23.34	CATALYTIC ACTIVITY: Similar to cathepsin D, but slightly broader specificity. {ECO:0000269|PubMed:7789521, ECO:0000269|PubMed:8765029}.									antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; protein autoprocessing [GO:0016540]; protein catabolic process [GO:0030163]	endosome [GO:0005768]	endosome [GO:0005768]; aspartic-type endopeptidase activity [GO:0004190]; protein homodimerization activity [GO:0042803]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; protein autoprocessing [GO:0016540]; protein catabolic process [GO:0030163]	aspartic-type endopeptidase activity [GO:0004190]; protein homodimerization activity [GO:0042803]	GO:0004190; GO:0005768; GO:0016540; GO:0019886; GO:0030163; GO:0042803	SUBCELLULAR LOCATION: Endosome {ECO:0000269|PubMed:7983070}. Note=The proenzyme is localized to the endoplasmic reticulum and Golgi apparatus, while the mature enzyme is localized to the endosome.	PTM: Glycosylated. The nature of the carbohydrate chain varies between cell types. In fibroblasts, the proenzyme contains a high mannose-type oligosaccharide, while the mature enzyme contains a complex-type oligosaccharide. In erythrocyte membranes, both the proenzyme and mature enzyme contain a complex-type oligosaccharide. {ECO:0000269|PubMed:2334440, ECO:0000269|PubMed:7983070, ECO:0000269|PubMed:8346912}.; PTM: Two forms are produced by autocatalytic cleavage, form I begins at Ile-54, form II begins at Thr-57.		2674141; 1370478; 7983070; 12531480; 14702039; 16710414; 15489334; 8346912; 2334440; 7789521; 8765029; 11322887; 10072072; 10631941; 10748235; 10809954; 11684289; 11813165; 11853874; 12078484; 12631277; 12742663; 12748383; 14769879; 15342244; 15699105; 15845357; 16169070; 16181339; 17888866; 17947645; 18006832; 18996084; 19172291; 1959628; 20600629; 21664991; 22068166; 22718633; 23451082; 24242330; 24464956; 25239563; 25348778; 8687433; 9539769; 9545226	2674141; 1370478; 7983070; 12531480; 14702039; 16710414; 15489334; 8346912; 2334440; 7789521; 8765029; 11322887
18846	CPM	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=59 uM for synthetic dansyl-Ala-Arg {ECO:0000269|PubMed:12457462}; KM=57 uM for placental peptide hormones {ECO:0000269|PubMed:12457462}; 	3.4.17.12	CATALYTIC ACTIVITY: Cleavage of C-terminal arginine or lysine residues from polypeptides. {ECO:0000269|PubMed:12457462}.		ACTIVITY REGULATION: Inhibited by O-phenanthroline and MGTA and activated by cobalt.	COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000269|PubMed:15066430}; ;  Note=Binds 1 zinc ion per subunit. {ECO:0000269|PubMed:15066430};	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 7.0. {ECO:0000269|PubMed:12457462};		SITE 277 277 Probable structural role. {ECO:0000305|PubMed:12457462}.			anatomical structure morphogenesis [GO:0009653]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485]	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; zinc ion binding [GO:0008270]; anatomical structure morphogenesis [GO:0009653]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485]	carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; zinc ion binding [GO:0008270]	GO:0004180; GO:0004181; GO:0004185; GO:0005576; GO:0005615; GO:0005886; GO:0006518; GO:0008270; GO:0009653; GO:0009986; GO:0016485; GO:0031225; GO:0070062	SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:12457462}; Lipid-anchor, GPI-anchor {ECO:0000269|PubMed:12457462}.			2753907; 11147789; 11934264; 14702039; 15489334; 12457462; 19159218; 15066430; 11072085; 11891060; 18187413; 18292211; 18617639; 19820690; 20360068; 20673876; 20711500; 21278420; 21454694; 22106087; 22157720; 23172796; 24108126; 2443973; 26496610; 28186967; 2914904; 3422494; 8635221; 8796265	2753907; 11147789; 11934264; 14702039; 15489334; 12457462; 19159218; 15066430
18847	CPA6 CPAH	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=266 uM for 3-(2-furyl)acryloyl-Phe-Phe {ECO:0000269|PubMed:20855895}; KM=100 uM for 3-(2-furyl)acryloyl-Phe-Tyr {ECO:0000269|PubMed:20855895}; KM=386 uM for 3-(2-furyl)acryloyl-Phe-Leu {ECO:0000269|PubMed:20855895}; KM=339 uM for 3-(2-furyl)acryloyl-Phe-Trp {ECO:0000269|PubMed:20855895}; KM=786 uM for 3-(2-furyl)acryloyl-Phe-Met {ECO:0000269|PubMed:20855895}; 	3.4.17.-		BINDING 254 254 Substrate. {ECO:0000250|UniProtKB:P00730}.; BINDING 376 376 Substrate. {ECO:0000250|UniProtKB:P00730}.		COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250|UniProtKB:P00730}; ;  Note=Binds 1 zinc ion per subunit. {ECO:0000250|UniProtKB:P00730};	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 8. {ECO:0000269|PubMed:20855895};						extracellular space [GO:0005615]	extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]	metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]	GO:0004181; GO:0005615; GO:0008270	SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix {ECO:0000269|PubMed:18178555}.				11836249; 12454025; 15489334; 18178555; 20855895; 21922598
18895	CPZ	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=2 mM for dansyl-Phe-Ala-Arg {ECO:0000269|PubMed:10080937, ECO:0000269|PubMed:9099699}; KM=2 mM for dansyl-Pro-Ala-Arg {ECO:0000269|PubMed:10080937, ECO:0000269|PubMed:9099699}; 	3.4.17.-			ACTIVITY REGULATION: Inhibited by 2-mercaptomethyl-3-guanidinoethylthiopropanoic acid (MGTA) and guanidinoethylmercaptosuccinic acid (GEMSA). Inhibited by chelating agents such as EDTA and EGTA. {ECO:0000269|PubMed:9099699}.	COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250|UniProtKB:P00730}; 	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 7.8. {ECO:0000269|PubMed:10080937, ECO:0000269|PubMed:9099699};					peptide metabolic process [GO:0006518]; protein processing [GO:0016485]; proteolysis [GO:0006508]; Wnt signaling pathway [GO:0016055]	extracellular space [GO:0005615]	extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; zinc ion binding [GO:0008270]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485]; proteolysis [GO:0006508]; Wnt signaling pathway [GO:0016055]	metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; zinc ion binding [GO:0008270]	GO:0004181; GO:0004185; GO:0005615; GO:0006508; GO:0006518; GO:0008270; GO:0016055; GO:0016485	SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix {ECO:0000269|PubMed:10671522}.			9099699; 14702039; 15815621; 15489334; 10080937; 10671522; 11766880; 12417617; 20379614; 28545128; 29653227	9099699; 14702039; 15815621; 15489334; 10080937; 10671522; 11766880; 12417617
18957	DCK	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=6.2 uM for deoxycytidine (dC) {ECO:0000269|PubMed:12808445}; KM=15.5 uM for cytarabine (araC) {ECO:0000269|PubMed:12808445}; KM=22 uM for gemcitabine (dC) {ECO:0000269|PubMed:12808445}; 	2.7.1.74	CATALYTIC ACTIVITY: NTP + deoxycytidine = NDP + dCMP. {ECO:0000269|PubMed:12808445, ECO:0000269|PubMed:18377927, ECO:0000269|PubMed:19159229, ECO:0000269|PubMed:20614893}.	BINDING 53 53 Substrate.; BINDING 86 86 Substrate.; BINDING 97 97 Substrate.; BINDING 128 128 Substrate.; BINDING 133 133 Substrate.; BINDING 197 197 Substrate.								purine-containing compound salvage [GO:0043101]; pyrimidine nucleoside salvage [GO:0043097]; pyrimidine nucleotide metabolic process [GO:0006220]	cytosol [GO:0005829]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; deoxycytidine kinase activity [GO:0004137]; drug binding [GO:0008144]; nucleoside kinase activity [GO:0019206]; protein homodimerization activity [GO:0042803]; purine-containing compound salvage [GO:0043101]; pyrimidine nucleoside salvage [GO:0043097]; pyrimidine nucleotide metabolic process [GO:0006220]	ATP binding [GO:0005524]; deoxycytidine kinase activity [GO:0004137]; drug binding [GO:0008144]; nucleoside kinase activity [GO:0019206]; protein homodimerization activity [GO:0042803]	GO:0004137; GO:0005524; GO:0005634; GO:0005829; GO:0006220; GO:0008144; GO:0019206; GO:0042803; GO:0043097; GO:0043101	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:9342341}.	PTM: Phosphorylated and activated in vitro upon phosphorylation at Ser-74 by CSNK1D/CK1. {ECO:0000269|PubMed:20637175}.	MOD_RES 11 11 Phosphoserine; by CK1. {ECO:0000305|PubMed:20637175}.; MOD_RES 15 15 Phosphoserine; by CK1. {ECO:0000305|PubMed:20637175}.; MOD_RES 72 72 Phosphothreonine; by CK1. {ECO:0000305|PubMed:20637175}.; MOD_RES 74 74 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:20637175}.	1996353; 14702039; 15489334; 2013338; 9342341; 17525332; 18691976; 18669648; 19369195; 20637175; 20068231; 21269460; 23186163; 12808445; 16421443; 17530837; 18377927; 19159229; 19836232; 20614893; 20684612; 11830489; 11952160; 12429345; 12535661; 1406603; 14514691; 15561147; 15564883; 15571255; 15571257; 15571258; 15571259; 15978330; 16169070; 16361699; 16401075; 16799820; 16969512; 17065053; 17065079; 17065080; 17065085; 17065091; 17158155; 17350163; 17602053; 17721511; 17855478; 18084067; 18258203; 18361501; 18570408; 18600530; 18600545; 18775979; 18974616; 19287976; 19428333; 19568409; 20028759; 20043109; 20137114; 20544527; 20544528; 20608756; 20665488; 20890066; 21030078; 21225236; 21245102; 21336182; 21351740; 21832002; 21858090; 21900206; 21988832; 22490663; 22490700; 22705007; 22850745; 23035362; 23230131; 23947754; 24294360; 24419380; 24462681; 24567448; 24618665; 25341194; 25358054; 2539852; 2542307; 2548513; 25533931; 25557962; 26083014; 26090398; 26196746; 26362587; 26485161; 26620371; 26962792; 27879648; 2844225; 28820179; 29127277; 9804782	1996353; 14702039; 15489334; 2013338; 9342341; 17525332; 18691976; 18669648; 19369195; 20637175; 20068231; 21269460; 23186163; 12808445; 16421443; 17530837; 18377927; 19159229; 19836232; 20614893; 20684612
18964	DCTPP1 XTP3TPA CDA03	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=47.6 uM for dCTP (at pH 8.0 and 25 degrees Celsius) {ECO:0000269|PubMed:24467396}; KM=65 uM for dTTP (at pH 8.0 and 25 degrees Celsius) {ECO:0000269|PubMed:24467396}; KM=79.3 uM for dATP (at pH 8.0 and 25 degrees Celsius) {ECO:0000269|PubMed:24467396}; KM=75.9 uM for dUTP (at pH 8.0 and 25 degrees Celsius) {ECO:0000269|PubMed:24467396}; KM=16.8 uM for 5I-dCTP (at pH 8.0 and 25 degrees Celsius) {ECO:0000269|PubMed:24467396}; KM=36.5 uM for 5Br-dCTP (at pH 8.0 and 25 degrees Celsius) {ECO:0000269|PubMed:24467396}; KM=33.3 uM for 5me-dCTP (at pH 8.0 and 25 degrees Celsius) {ECO:0000269|PubMed:24467396}; KM=62.9 uM for 5hme-dCTP (at pH 8.0 and 25 degrees Celsius) {ECO:0000269|PubMed:24467396}; KM=9.2 uM for 5fo-dCTP (at pH 8.0 and 25 degrees Celsius) {ECO:0000269|PubMed:24467396}; KM=142.9 uM for CTP (at pH 8.0 and 25 degrees Celsius) {ECO:0000269|PubMed:24467396}; 	3.6.1.12	CATALYTIC ACTIVITY: dCTP + H(2)O = dCMP + diphosphate. {ECO:0000269|PubMed:24467396}.	BINDING 38 38 Substrate. {ECO:0000250|UniProtKB:Q9QY93}.; BINDING 73 73 Substrate. {ECO:0000250|UniProtKB:Q9QY93}.; BINDING 102 102 Substrate. {ECO:0000250|UniProtKB:Q9QY93}.	ACTIVITY REGULATION: Inhibited by the reaction end product PPi. Inhibited by dCDP. Inhibited by triptolide. {ECO:0000269|PubMed:24467396}.	COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250|UniProtKB:Q9QY93}; ;  Note=Probably binds two or three Mg(2+) ions per subunit. {ECO:0000250|UniProtKB:Q9QY93};				CDA03		dCTP catabolic process [GO:0006253]; DNA protection [GO:0042262]; nucleoside triphosphate catabolic process [GO:0009143]; protein homotetramerization [GO:0051289]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; dCTP diphosphatase activity [GO:0047840]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; pyrimidine deoxyribonucleotide binding [GO:0032556]; dCTP catabolic process [GO:0006253]; DNA protection [GO:0042262]; nucleoside triphosphate catabolic process [GO:0009143]; protein homotetramerization [GO:0051289]	dCTP diphosphatase activity [GO:0047840]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; pyrimidine deoxyribonucleotide binding [GO:0032556]	GO:0000287; GO:0005634; GO:0005739; GO:0005829; GO:0006253; GO:0009143; GO:0032556; GO:0042262; GO:0042802; GO:0047429; GO:0047840; GO:0051289	SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:24467396}. Nucleus {ECO:0000269|PubMed:24467396}. Cytoplasm, cytosol {ECO:0000269|PubMed:24467396}.		MOD_RES 2 2 N-acetylserine. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22814378}.; MOD_RES 2 2 Phosphoserine. {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:23186163}.; MOD_RES 12 12 Phosphothreonine. {ECO:0000244|PubMed:18691976}.; MOD_RES 85 85 Phosphoserine. {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:23186163}.	14702039; 15489334; 18691976; 18669648; 19413330; 21269460; 22814378; 23186163; 24467396; 25944712; 16169070; 16189514; 17320107; 17353931; 17721511; 19220460; 19596235; 21671327; 25416956; 26496610; 27612427	14702039; 15489334; 18691976; 18669648; 19413330; 21269460; 22814378; 23186163; 24467396; 25944712
19010	DAPK3 ZIPK	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=12 uM for myosin (isoform 2) {ECO:0000269|PubMed:17126281}; KM=6.2 uM for myosin (isoform 1) {ECO:0000269|PubMed:17126281}; KM=73 uM for MYL12B (isoform 2) {ECO:0000269|PubMed:17126281}; KM=10.4 uM for MYL12B (isoform 1) {ECO:0000269|PubMed:17126281}; Vmax=248 nmol/min/mg enzyme toward myosin (isoform 2) {ECO:0000269|PubMed:17126281}; Vmax=120 nmol/min/mg enzyme toward myosin (isoform 1) {ECO:0000269|PubMed:17126281}; Vmax=1.3 umol/min/mg enzyme toward MYL12B (isoform 2) {ECO:0000269|PubMed:17126281}; Vmax=271 nmol/min/mg enzyme toward MYL12B (isoform 1) {ECO:0000269|PubMed:17126281}; 	2.7.11.1	CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein. {ECO:0000269|PubMed:10356987, ECO:0000269|PubMed:11384979, ECO:0000269|PubMed:11781833, ECO:0000269|PubMed:15096528, ECO:0000269|PubMed:17126281, ECO:0000269|PubMed:18995835}.	BINDING 42 42 ATP. {ECO:0000305}.; BINDING 94 94 Inhibitor. {ECO:0000269|PubMed:18239682}.; BINDING 96 96 Inhibitor. {ECO:0000269|PubMed:18239682}.	ACTIVITY REGULATION: A sequential activation is proposed: autophosphorylation at consensus sites is leading to dimerization of the catalytic domain stabilized by phosphorylation at Ser-50 and activation segment exchange (producing an active confirmation of both kinase modules in trans) followed by phosphorylation at Thr-180 in the activation segment and at other regulatory sites (Probable). Phosphorylation at Thr-180, Thr-225 and Thr-265 is essential for activity. Oligomerization is required for full enzymatic activity. Inhibited by pyridone 6 (K00225), a potent, ATP-competitive inhibitor. {ECO:0000269|PubMed:15611134, ECO:0000269|PubMed:17158456, ECO:0000269|PubMed:18239682, ECO:0000303|PubMed:18239682}.	COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:10356987}; 						apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular response to interferon-gamma [GO:0071346]; chromatin organization [GO:0006325]; intracellular signal transduction [GO:0035556]; negative regulation of translation [GO:0017148]; neuron differentiation [GO:0030182]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of cell motility [GO:2000145]; regulation of cell shape [GO:0008360]; regulation of focal adhesion assembly [GO:0051893]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic nuclear division [GO:0007088]; regulation of myosin II filament organization [GO:0043519]; regulation of smooth muscle contraction [GO:0006940]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]	actin filament [GO:0005884]; cytoplasm [GO:0005737]; membrane raft [GO:0045121]; nucleus [GO:0005634]; PML body [GO:0016605]	actin filament [GO:0005884]; cytoplasm [GO:0005737]; membrane raft [GO:0045121]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; cAMP response element binding protein binding [GO:0008140]; identical protein binding [GO:0042802]; leucine zipper domain binding [GO:0043522]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; Rho GTPase binding [GO:0017048]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular response to interferon-gamma [GO:0071346]; chromatin organization [GO:0006325]; intracellular signal transduction [GO:0035556]; negative regulation of translation [GO:0017148]; neuron differentiation [GO:0030182]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of cell motility [GO:2000145]; regulation of cell shape [GO:0008360]; regulation of focal adhesion assembly [GO:0051893]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic nuclear division [GO:0007088]; regulation of myosin II filament organization [GO:0043519]; regulation of smooth muscle contraction [GO:0006940]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]	ATP binding [GO:0005524]; cAMP response element binding protein binding [GO:0008140]; identical protein binding [GO:0042802]; leucine zipper domain binding [GO:0043522]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; Rho GTPase binding [GO:0017048]	GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005884; GO:0006325; GO:0006351; GO:0006355; GO:0006468; GO:0006915; GO:0006940; GO:0007088; GO:0007346; GO:0008022; GO:0008140; GO:0008360; GO:0010506; GO:0016605; GO:0017048; GO:0017148; GO:0018105; GO:0018107; GO:0030182; GO:0030335; GO:0035556; GO:0042802; GO:0042803; GO:0042981; GO:0043065; GO:0043519; GO:0043522; GO:0045121; GO:0046777; GO:0051893; GO:0071346; GO:0090263; GO:0097190; GO:2000145; GO:2000249; GO:2001241	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15367680, ECO:0000269|PubMed:15910542, ECO:0000269|PubMed:20854903}. Cytoplasm {ECO:0000269|PubMed:15367680, ECO:0000269|PubMed:15611134, ECO:0000269|PubMed:17953487, ECO:0000269|PubMed:20854903}. Note=Predominantly localizes to the cytoplasm but can shuttle between the nucleus and cytoplasm; cytoplasmic localization is promoted by phosphorylation at Thr-299 and involves Rho/Rock signaling. {ECO:0000269|PubMed:17953487, ECO:0000269|PubMed:20854903}.; SUBCELLULAR LOCATION: Isoform 1: Nucleus {ECO:0000269|PubMed:17126281}. Cytoplasm {ECO:0000269|PubMed:17126281}.; SUBCELLULAR LOCATION: Isoform 2: Nucleus {ECO:0000269|PubMed:17126281}. Cytoplasm {ECO:0000269|PubMed:17126281}.	PTM: The phosphorylation status is critical for kinase activity, oligomerization and intracellular localization. Phosphorylation at Thr-180, Thr-225 and Thr-265 is essential for activity. The phosphorylated form is localized in the cytoplasm promoted by phosphorylation at Thr-299; nuclear translocation or retention is maximal when it is not phosphorylated. Phosphorylation increases the trimeric form, and its dephosphorylation favors a kinase-inactive monomeric form. Both isoform 1 and isoform 2 can undergo autophosphorylation. {ECO:0000269|PubMed:15367680, ECO:0000269|PubMed:15611134, ECO:0000269|PubMed:17158456, ECO:0000269|PubMed:20854903}.	MOD_RES 50 50 Phosphoserine; by autocatalysis. {ECO:0000269|PubMed:18239682}.; MOD_RES 180 180 Phosphothreonine. {ECO:0000269|PubMed:15611134, ECO:0000269|PubMed:17158456}.; MOD_RES 225 225 Phosphothreonine. {ECO:0000269|PubMed:15611134}.; MOD_RES 265 265 Phosphothreonine; by autocatalysis and ROCK1. {ECO:0000269|PubMed:15611134, ECO:0000269|PubMed:17158456, ECO:0000269|PubMed:18239682}.; MOD_RES 299 299 Phosphothreonine; by autocatalysis, DAPK1 and ROCK1. {ECO:0000269|PubMed:15367680, ECO:0000269|PubMed:15611134, ECO:0000269|PubMed:17158456, ECO:0000269|PubMed:20854903}.; MOD_RES 306 306 Phosphothreonine; by autocatalysis. {ECO:0000269|PubMed:15611134}.; MOD_RES 309 309 Phosphoserine; by DAPK1. {ECO:0000269|PubMed:15367680}.; MOD_RES 311 311 Phosphoserine; by autocatalysis and DAPK1. {ECO:0000269|PubMed:15367680, ECO:0000269|PubMed:15611134}.; MOD_RES 312 312 Phosphoserine; by DAPK1. {ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:15367680}.; MOD_RES 318 318 Phosphoserine; by DAPK1. {ECO:0000269|PubMed:15367680}.; MOD_RES 326 326 Phosphoserine; by DAPK1. {ECO:0000269|PubMed:15367680}.	9488481; 10356987; 14702039; 15489334; 17126281; 11384979; 11781833; 12917339; 15292222; 15096528; 15367680; 16219639; 15910542; 15611134; 16756490; 17158456; 17953487; 18995835; 18084323; 21487036; 20854903; 21169990; 21454679; 21408167; 23454120; 23186163; 18239682; 17344846; 12577067; 15729359; 16325270; 18515077; 19117059; 20085750; 21988832; 22136433; 22939624; 23146908; 24633547; 25036637; 25304685; 25503649; 25723491; 25769953; 26117336; 26486226; 26496610; 26638075; 26748242; 27126362; 27133022; 27573465; 28011458; 28075459; 28731173; 30033129	9488481; 10356987; 14702039; 15489334; 17126281; 11384979; 11781833; 12917339; 15292222; 15096528; 15367680; 16219639; 15910542; 15611134; 16756490; 17158456; 17953487; 18995835; 18084323; 21487036; 20854903; 21169990; 21454679; 21408167; 23454120; 23186163; 18239682; 17344846
19021	DDAH1 DDAH	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=69 uM for asymmetric dimethylarginine (ADMA) {ECO:0000269|PubMed:18171027, ECO:0000269|PubMed:19663506}; KM=54 uM for monomethyl-L-arginine (MMA) {ECO:0000269|PubMed:18171027, ECO:0000269|PubMed:19663506}; KM=3.1 uM for S-methyl-L-thiocitrulline {ECO:0000269|PubMed:18171027, ECO:0000269|PubMed:19663506}; Vmax=356 nmol/min/mg enzyme with ADMA {ECO:0000269|PubMed:18171027, ECO:0000269|PubMed:19663506}; Vmax=154 nmol/min/mg enzyme with NMA {ECO:0000269|PubMed:18171027, ECO:0000269|PubMed:19663506}; 	3.5.3.18	CATALYTIC ACTIVITY: N(omega),N(omega)-dimethyl-L-arginine + H(2)O = dimethylamine + L-citrulline. {ECO:0000269|PubMed:18171027, ECO:0000269|PubMed:19663506}.	BINDING 30 30 Substrate; via carbonyl oxygen.; BINDING 73 73 Substrate.; BINDING 98 98 Substrate.; BINDING 145 145 Substrate.; BINDING 268 268 Substrate; via carbonyl oxygen.	ACTIVITY REGULATION: Inhibited by zinc ions (By similarity). Enzyme purified in the absence of 1,10-phenanthroline contains on average 0.4 zinc atoms per subunit. Inhibited by 4-hydroxy-nonenal through the formation of a covalent adduct with His-173. Competitively inhibited by N(5)-iminopropyl-ornithine. {ECO:0000250, ECO:0000269|PubMed:18171027, ECO:0000269|PubMed:19663506}.		BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 8.5. {ECO:0000269|PubMed:18171027, ECO:0000269|PubMed:19663506};					arginine catabolic process [GO:0006527]; citrulline metabolic process [GO:0000052]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of vascular permeability [GO:0043116]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of angiogenesis [GO:0045766]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of systemic arterial blood pressure [GO:0003073]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; amino acid binding [GO:0016597]; catalytic activity [GO:0003824]; dimethylargininase activity [GO:0016403]; metal ion binding [GO:0046872]; arginine catabolic process [GO:0006527]; citrulline metabolic process [GO:0000052]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of vascular permeability [GO:0043116]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of angiogenesis [GO:0045766]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of systemic arterial blood pressure [GO:0003073]	amino acid binding [GO:0016597]; catalytic activity [GO:0003824]; dimethylargininase activity [GO:0016403]; metal ion binding [GO:0046872]	GO:0000052; GO:0003073; GO:0003824; GO:0005829; GO:0006527; GO:0007263; GO:0008285; GO:0016403; GO:0016597; GO:0043116; GO:0045429; GO:0045766; GO:0046872; GO:0050999; GO:0070062; GO:1900038			MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19413330, ECO:0000269|PubMed:9874257}.; MOD_RES 222 222 S-nitrosocysteine. {ECO:0000250|UniProtKB:P56965}.; MOD_RES 274 274 S-nitrosocysteine. {ECO:0000250|UniProtKB:P56965}.	9874257; 10493931; 17974005; 16710414; 15489334; 18171027; 19413330; 21269460; 24275569; 17273169; 19663506; 11811522; 15501905; 15781754; 16920729; 17075694; 17881609; 17895252; 18251679; 18292189; 19666120; 19682581; 19913121; 20010544; 20019334; 20167924; 20209122; 20379614; 20381070; 20628086; 20711500; 20877624; 20979083; 21174581; 21212404; 21303562; 21420186; 21493890; 21565611; 21677199; 21722652; 21898353; 21975354; 22492959; 22521321; 22700861; 22982060; 23022711; 23766377; 23864585; 23892448; 24260221; 25194333; 25424718; 26082478; 26226438; 26455824; 26662939; 26663142; 26786611; 27663503; 28145161; 28580735; 28594240; 28741166; 29983043	9874257; 10493931; 17974005; 16710414; 15489334; 18171027; 19413330; 21269460; 24275569; 17273169; 19663506
19042	MLYCD	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=0.36 mM for malonyl-CoA (Malonyl-CoA decarboxylase mitochondrial form) {ECO:0000269|PubMed:15003260}; KM=0.83 mM for malonyl-CoA (Malonyl-CoA decarboxylase mitochondrial form) {ECO:0000269|PubMed:23482565}; KM=0.22 mM for malonyl-CoA (Malonyl-CoA decarboxylase cytoplasmic+peroxisomal form) {ECO:0000269|PubMed:10455107}; KM=0.33 mM for malonyl-CoA (Malonyl-CoA decarboxylase cytoplasmic+peroxisomal form) {ECO:0000269|PubMed:15003260}; Note=kcat is 19 sec(-1) with malonyl-CoA for malonyl-CoA decarboxylase mitochondrial form (PubMed:15003260). kcat is 28 sec(-1) with malonyl-CoA for Malonyl-CoA decarboxylase cytoplasmic+peroxisomal form (PubMed:15003260). The catalytic efficiency for malonyl-CoA is at least 1.09-fold higher with the malonyl-CoA decarboxylase cytoplasmic+peroxisomal form (PubMed:15003260). {ECO:0000269|PubMed:15003260};	4.1.1.9	CATALYTIC ACTIVITY: Malonyl-CoA = acetyl-CoA + CO(2). {ECO:0000269|PubMed:10417274, ECO:0000269|PubMed:10455107, ECO:0000269|PubMed:15003260, ECO:0000269|PubMed:23482565, ECO:0000269|PubMed:9869665}.	BINDING 329 329 Malonyl-CoA. {ECO:0000305}.; BINDING 423 423 Malonyl-CoA. {ECO:0000305}.	ACTIVITY REGULATION: Malonyl-CoA decarboxylase activity does not require any cofactors or divalent metal ions. Formation of interchain disulfide bonds leads to positive cooperativity between active sites and increases the affinity for malonyl-CoA and the catalytic efficiency (in vitro). {ECO:0000269|PubMed:15003260, ECO:0000269|PubMed:23482565}.			PATHWAY: Metabolic intermediate biosynthesis; acetyl-CoA biosynthesis; acetyl-CoA from malonyl-CoA: step 1/1.	SITE 211 211 Essential for catalytic activity. {ECO:0000250}.			acetyl-CoA biosynthetic process [GO:0006085]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]; fatty acid oxidation [GO:0019395]; malonyl-CoA catabolic process [GO:2001294]; positive regulation of fatty acid oxidation [GO:0046321]; protein targeting to peroxisome [GO:0006625]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of glucose metabolic process [GO:0010906]; response to ischemia [GO:0002931]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; identical protein binding [GO:0042802]; malonyl-CoA decarboxylase activity [GO:0050080]; signaling receptor binding [GO:0005102]; acetyl-CoA biosynthetic process [GO:0006085]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]; fatty acid oxidation [GO:0019395]; malonyl-CoA catabolic process [GO:2001294]; positive regulation of fatty acid oxidation [GO:0046321]; protein targeting to peroxisome [GO:0006625]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of glucose metabolic process [GO:0010906]; response to ischemia [GO:0002931]	identical protein binding [GO:0042802]; malonyl-CoA decarboxylase activity [GO:0050080]; signaling receptor binding [GO:0005102]	GO:0002931; GO:0005102; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006085; GO:0006625; GO:0006633; GO:0006637; GO:0010906; GO:0019395; GO:0031998; GO:0042802; GO:0046321; GO:0050080; GO:2001294	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10417274}. Mitochondrion matrix {ECO:0000269|PubMed:10417274}. Peroxisome {ECO:0000269|PubMed:10417274}. Peroxisome matrix {ECO:0000250}. Note=Enzymatically active in all three subcellular compartments. {ECO:0000250}.	PTM: Acetylation at Lys-472 activates malonyl-CoA decarboxylase activity. Deacetylation at Lys-472 by SIRT4 represses activity, leading to promote lipogenesis (By similarity). {ECO:0000250}.; PTM: Interchain disulfide bonds may form in peroxisomes (Potential). Interchain disulfide bonds are not expected to form in the reducing environment of the cytoplasm and mitochondria. {ECO:0000305}.	MOD_RES 59 59 N6-acetyllysine. {ECO:0000250|UniProtKB:Q99J39}.; MOD_RES 168 168 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q99J39}.; MOD_RES 168 168 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q99J39}.; MOD_RES 211 211 N6-acetyllysine. {ECO:0000250|UniProtKB:Q99J39}.; MOD_RES 222 222 N6-succinyllysine. {ECO:0000250|UniProtKB:Q99J39}.; MOD_RES 389 389 N6-acetyllysine. {ECO:0000250|UniProtKB:Q99J39}.; MOD_RES 472 472 N6-acetyllysine. {ECO:0000250|UniProtKB:Q99J39}.	10417274; 10455107; 9869665; 15616553; 15489334; 15003260; 18314420; 20178365; 25944712; 23482565; 23791943; 12955715; 16434556; 17186413; 18614968; 18660489; 20702857; 20877624; 22778304; 25525879; 26004805; 26858006; 26948533	10417274; 10455107; 9869665; 15616553; 15489334; 15003260; 18314420; 20178365; 25944712; 23482565; 23791943
19047	DHRS2 SDR25C1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.3 mM for 1-Phenyl-1,2-propanedione {ECO:0000269|PubMed:16685466}; KM=1.1 mM for 2,3-Heptanedione {ECO:0000269|PubMed:16685466}; KM=0.8 mM for 3,4-Hexanedione {ECO:0000269|PubMed:16685466}; Vmax=0.52 mmol/min/mg enzyme with 1-Phenyl-1,2-propanedione as substrate {ECO:0000269|PubMed:16685466}; Vmax=0.64 mmol/min/mg enzyme with 2,3-Heptanedione as substrate {ECO:0000269|PubMed:16685466}; Vmax=0.35 mmol/min/mg enzyme with 3,4-Hexanedione as substrate {ECO:0000269|PubMed:16685466}; 	1.1.1.-		BINDING 172 172 Substrate. {ECO:0000250}.								C21-steroid hormone metabolic process [GO:0008207]; cellular response to oxidative stress [GO:0034599]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation [GO:0008285]; oxidation-reduction process [GO:0055114]; response to toxic substance [GO:0009636]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; carbonyl reductase (NADPH) activity [GO:0004090]; C21-steroid hormone metabolic process [GO:0008207]; cellular response to oxidative stress [GO:0034599]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation [GO:0008285]; oxidation-reduction process [GO:0055114]; response to toxic substance [GO:0009636]	carbonyl reductase (NADPH) activity [GO:0004090]	GO:0004090; GO:0005634; GO:0005635; GO:0005737; GO:0005739; GO:0005759; GO:0008207; GO:0008285; GO:0009636; GO:0034599; GO:0043011; GO:0043066; GO:0055114	SUBCELLULAR LOCATION: Mitochondrion matrix. Nucleus. Note=A minor fraction of the protein is translocated from the mitochondria to the nucleus, after cleavage of the targeting signal.		MOD_RES 96 96 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q99LB2}.; MOD_RES 96 96 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q99LB2}.; MOD_RES 219 219 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q99LB2}.; MOD_RES 219 219 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q99LB2}.; MOD_RES 223 223 Phosphoserine. {ECO:0000250|UniProtKB:Q99LB2}.; MOD_RES 237 237 N6-succinyllysine. {ECO:0000250|UniProtKB:Q99LB2}.	7556196; 11997086; 12508121; 15489334; 1847869; 11944995; 16685466; 20547751; 21269460; 16959974; 15047060; 17620599; 19443906; 20949095; 21988832; 23036705; 23902751; 25416956; 26496610	7556196; 11997086; 12508121; 15489334; 1847869; 11944995; 16685466; 20547751; 21269460; 16959974
19049	DHRS9 RDH15 SDR9C4 UNQ835/PRO1773	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=9 uM for NADH {ECO:0000269|PubMed:11294878}; KM=72 uM for NAD {ECO:0000269|PubMed:11294878}; KM=5 uM for allopregnanolone {ECO:0000269|PubMed:11294878}; KM=7.5 uM for 3-alpha-androstanediol {ECO:0000269|PubMed:11294878}; KM=24 uM for androsterone {ECO:0000269|PubMed:11294878}; KM=12 uM for dihydrotestosterone {ECO:0000269|PubMed:11294878}; 	1.1.-.-		BINDING 83 83 NAD. {ECO:0000250}.; BINDING 164 164 Substrate. {ECO:0000250}.; BINDING 180 180 NAD. {ECO:0000250}.						UNQ835/PRO1773		9-cis-retinoic acid biosynthetic process [GO:0042904]; androgen metabolic process [GO:0008209]; epithelial cell differentiation [GO:0030855]; progesterone metabolic process [GO:0042448]; retinol metabolic process [GO:0042572]	endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; organelle membrane [GO:0031090]	endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; organelle membrane [GO:0031090]; alcohol dehydrogenase (NAD) activity [GO:0004022]; racemase and epimerase activity [GO:0016854]; retinol dehydrogenase activity [GO:0004745]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; 9-cis-retinoic acid biosynthetic process [GO:0042904]; androgen metabolic process [GO:0008209]; epithelial cell differentiation [GO:0030855]; progesterone metabolic process [GO:0042448]; retinol metabolic process [GO:0042572]	alcohol dehydrogenase (NAD) activity [GO:0004022]; racemase and epimerase activity [GO:0016854]; retinol dehydrogenase activity [GO:0004745]; testosterone dehydrogenase (NAD+) activity [GO:0047035]	GO:0004022; GO:0004745; GO:0005789; GO:0008209; GO:0016854; GO:0030176; GO:0030855; GO:0031090; GO:0042448; GO:0042572; GO:0042904; GO:0047035	SUBCELLULAR LOCATION: Microsome membrane {ECO:0000269|PubMed:11294878, ECO:0000269|PubMed:11304534, ECO:0000269|PubMed:12618084}. Endoplasmic reticulum membrane {ECO:0000305}. Note=Associated with microsomal membranes.			11294878; 11304534; 12618084; 10800688; 12975309; 14702039; 15815621; 15489334; 10329026; 10617778; 14596915; 21621639; 8884265; 9677409	11294878; 11304534; 12618084; 10800688; 12975309; 14702039; 15815621; 15489334
19075	HDC	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.1 mM for histidine {ECO:0000269|PubMed:22767596}; Vmax=1880 nmol/min/mg enzyme {ECO:0000269|PubMed:22767596}; 	4.1.1.22	CATALYTIC ACTIVITY: L-histidine = histamine + CO(2). {ECO:0000269|PubMed:22767596}.	BINDING 81 81 Substrate; via amide nitrogen.; BINDING 194 194 Substrate.		COFACTOR: Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326; Evidence={ECO:0000269|PubMed:22767596}; 		PATHWAY: Amine and polyamine biosynthesis; histamine biosynthesis; histamine from L-histidine: step 1/1.				catecholamine biosynthetic process [GO:0042423]; histamine biosynthetic process [GO:0001694]; histidine catabolic process [GO:0006548]; histidine metabolic process [GO:0006547]	cytosol [GO:0005829]	cytosol [GO:0005829]; histidine decarboxylase activity [GO:0004398]; pyridoxal phosphate binding [GO:0030170]; catecholamine biosynthetic process [GO:0042423]; histamine biosynthetic process [GO:0001694]; histidine catabolic process [GO:0006548]; histidine metabolic process [GO:0006547]	histidine decarboxylase activity [GO:0004398]; pyridoxal phosphate binding [GO:0030170]	GO:0001694; GO:0004398; GO:0005829; GO:0006547; GO:0006548; GO:0030170; GO:0042423			MOD_RES 305 305 N6-(pyridoxal phosphate)lysine.	2216786; 1768863; 1425659; 8288622; 16572171; 15489334; 22767596; 16959974; 11556524; 12372397; 12768436; 14670968; 15167966; 15928846; 16297195; 16760908; 16822545; 16849647; 16919600; 17672918; 17703412; 19133005; 19156168; 19258923; 19266161; 20379614; 20445167; 20503287; 20608921; 21454364; 21873469; 21915437; 22095709; 22684068; 23825391; 24415870; 24835231; 25416956; 25846768; 26715806; 27529419; 27769832	2216786; 1768863; 1425659; 8288622; 16572171; 15489334; 22767596; 16959974
19134	DPP8 DPRP1 MSTP097 MSTP135 MSTP141	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=208 uM for Ala-Pro-AMC {ECO:0000269|PubMed:12534281, ECO:0000269|PubMed:12662155, ECO:0000269|PubMed:15039077}; KM=130 uM for Ala-Pro-AFC {ECO:0000269|PubMed:12534281, ECO:0000269|PubMed:12662155, ECO:0000269|PubMed:15039077}; KM=120 uM for H-Ala-Pro-pNa {ECO:0000269|PubMed:12534281, ECO:0000269|PubMed:12662155, ECO:0000269|PubMed:15039077}; KM=1420 uM for H-Ala-Ala-pNa {ECO:0000269|PubMed:12534281, ECO:0000269|PubMed:12662155, ECO:0000269|PubMed:15039077}; KM=310 uM for H-Arg-Pro-pNa {ECO:0000269|PubMed:12534281, ECO:0000269|PubMed:12662155, ECO:0000269|PubMed:15039077}; KM=2050 uM for H-Asp-Pro-pNa {ECO:0000269|PubMed:12534281, ECO:0000269|PubMed:12662155, ECO:0000269|PubMed:15039077}; KM=480 uM for H-Gly-Pro-pNa {ECO:0000269|PubMed:12534281, ECO:0000269|PubMed:12662155, ECO:0000269|PubMed:15039077}; 	3.4.14.5	CATALYTIC ACTIVITY: Release of an N-terminal dipeptide, Xaa-Yaa-|-Zaa-, from a polypeptide, preferentially when Yaa is Pro, provided Zaa is neither Pro nor hydroxyproline. {ECO:0000269|PubMed:11012666, ECO:0000269|PubMed:12534281, ECO:0000269|PubMed:12662155}.		ACTIVITY REGULATION: Inhibited by zinc. Inhibited by the serine proteinase inhibitor 4-(2-aminoethyl)benzenesulphonyl fluoride (AEBSF), and by di-isopropylfuorophosphate. Specifically inhibited by isoindoline derivatives. {ECO:0000269|PubMed:11012666, ECO:0000269|PubMed:12662155, ECO:0000269|PubMed:15664838}.		BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 7.4-8.5. Little activity below pH 6.5. {ECO:0000269|PubMed:12534281, ECO:0000269|PubMed:12662155, ECO:0000269|PubMed:15039077};			MSTP097 MSTP135 MSTP141		immune response [GO:0006955]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]; immune response [GO:0006955]; proteolysis [GO:0006508]	dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]	GO:0005737; GO:0005829; GO:0006508; GO:0006955; GO:0008236; GO:0008239	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11012666, ECO:0000269|PubMed:12534281, ECO:0000269|PubMed:12662155}.			11012666; 12662155; 14702039; 15489334; 12534281; 15039077; 15664838; 16700509; 16704418; 17040910; 18275857; 19581630; 20043068; 20534982; 21711053; 22736146; 23519473; 23608773; 23704821; 24072711; 25464020; 29382749	11012666; 12662155; 14702039; 15489334; 12534281; 15039077; 15664838
19135	DPP9 DPRP2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=161 uM for Ala-Pro-AMC {ECO:0000269|PubMed:12662155, ECO:0000269|PubMed:15245913}; KM=180 uM for Ala-Pro-AFC {ECO:0000269|PubMed:12662155, ECO:0000269|PubMed:15245913}; 	3.4.14.5	CATALYTIC ACTIVITY: Release of an N-terminal dipeptide, Xaa-Yaa-|-Zaa-, from a polypeptide, preferentially when Yaa is Pro, provided Zaa is neither Pro nor hydroxyproline. {ECO:0000269|PubMed:12662155, ECO:0000269|PubMed:15245913, ECO:0000269|PubMed:16475979}.		ACTIVITY REGULATION: Inhibited by the serine proteinase inhibitor 4-(2-aminoethyl)benzenesulphonyl fluoride (AEBSF), and by di-isopropylfuorophosphate. {ECO:0000269|PubMed:12662155}.		BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 7.5-8.5. Little activity below pH 6.5. {ECO:0000269|PubMed:12662155, ECO:0000269|PubMed:15245913};						cytosol [GO:0005829]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; identical protein binding [GO:0042802]; serine-type peptidase activity [GO:0008236]	aminopeptidase activity [GO:0004177]; identical protein binding [GO:0042802]; serine-type peptidase activity [GO:0008236]	GO:0004177; GO:0005634; GO:0005829; GO:0008236; GO:0042802	SUBCELLULAR LOCATION: Isoform 1: Cytoplasm, cytosol {ECO:0000269|PubMed:12662155, ECO:0000269|PubMed:15245913}.; SUBCELLULAR LOCATION: Isoform 2: Nucleus {ECO:0000269|PubMed:24562348}.		MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:19413330}.	12459266; 12662155; 15245913; 16475979; 14702039; 15057824; 15489334; 17974005; 19413330; 21269460; 23186163; 24562348; 16700509; 16704418; 18940951; 19268648; 19581630; 19667070; 20043068; 20534982; 21622624; 21711053; 22001206; 22736146; 23152501; 23519473; 23608773; 23704821; 24072711; 25464020; 25486458; 26496610; 27682012; 27943262; 28893231; 29382749	12459266; 12662155; 15245913; 16475979; 14702039; 15057824; 15489334; 17974005; 19413330; 21269460; 23186163; 24562348
19171	ODC1	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=0.08 mM for L-ornithine {ECO:0000269|PubMed:17407445}; Note=kcat is 3.3 sec(-1) with L-ornithine as substrate. {ECO:0000269|PubMed:17407445};	4.1.1.17	CATALYTIC ACTIVITY: L-ornithine = putrescine + CO(2). {ECO:0000269|PubMed:17407445}.	BINDING 200 200 Pyridoxal phosphate. {ECO:0000244|PDB:2OO0, ECO:0000269|PubMed:17407445}.; BINDING 237 237 Pyridoxal phosphate; via amino nitrogen. {ECO:0000244|PDB:2OO0, ECO:0000269|PubMed:17407445}.; BINDING 361 361 Substrate; shared with dimeric partner. {ECO:0000250|UniProtKB:P07805}.; BINDING 389 389 Pyridoxal phosphate. {ECO:0000244|PDB:2OO0, ECO:0000269|PubMed:17407445, ECO:0000269|PubMed:26305948, ECO:0000269|PubMed:26443277}.	ACTIVITY REGULATION: Inhibited by S-nitrosylation (PubMed:10462479, PubMed:11461922). Inhibited by antizymes (AZs) OAZ1, OAZ2 and OAZ3 in response to polyamine levels. AZs inhibit the assembly of the functional homodimer by binding to ODC monomers. Additionally, OAZ1 targets ODC monomers for ubiquitin-independent proteolytic destruction by the 26S proteasome (PubMed:17900240). Inhibited by 1-amino-oxy-3-aminopropane (APA, an isosteric analog of putrescine) (PubMed:17407445). Irreversibly inhibited by alpha-difluoromethylornithine (DFMO) (PubMed:17407445). {ECO:0000269|PubMed:10462479, ECO:0000269|PubMed:11461922, ECO:0000269|PubMed:17407445, ECO:0000269|PubMed:17900240}.	COFACTOR: Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326; Evidence={ECO:0000269|PubMed:17407445, ECO:0000269|PubMed:26443277}; 		PATHWAY: Amine and polyamine biosynthesis; putrescine biosynthesis via L-ornithine pathway; putrescine from L-ornithine: step 1/1.	SITE 197 197 Stacks against the aromatic ring of pyridoxal phosphate and stabilizes reaction intermediates. {ECO:0000250|UniProtKB:P00860}.			kidney development [GO:0001822]; polyamine metabolic process [GO:0006595]; positive regulation of cell proliferation [GO:0008284]; putrescine biosynthetic process from ornithine [GO:0033387]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of protein catabolic process [GO:0042176]; response to virus [GO:0009615]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; ornithine decarboxylase activity [GO:0004586]; protein homodimerization activity [GO:0042803]; kidney development [GO:0001822]; polyamine metabolic process [GO:0006595]; positive regulation of cell proliferation [GO:0008284]; putrescine biosynthetic process from ornithine [GO:0033387]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of protein catabolic process [GO:0042176]; response to virus [GO:0009615]	ornithine decarboxylase activity [GO:0004586]; protein homodimerization activity [GO:0042803]	GO:0001822; GO:0004586; GO:0005737; GO:0005829; GO:0006521; GO:0006595; GO:0008284; GO:0009615; GO:0033387; GO:0042176; GO:0042803; GO:0048471		PTM: S-Nitrosylation inhibits the enzyme. S-Nitrosylated in vitro on 4 cysteine residues. {ECO:0000269|PubMed:10462479, ECO:0000269|PubMed:11461922}.	MOD_RES 69 69 N6-(pyridoxal phosphate)lysine. {ECO:0000269|PubMed:26305948, ECO:0000305|PubMed:17407445}.; MOD_RES 303 303 Phosphoserine; by CK2. {ECO:0000250|UniProtKB:P00860}.; MOD_RES 360 360 S-nitrosocysteine; in inhibited form. {ECO:0000305|PubMed:11461922}.	3595418; 2693021; 2587220; 2227439; 2318872; 1598217; 8519686; 14702039; 15815621; 15489334; 2317811; 3308908; 10462479; 11461922; 16548883; 17900240; 10623504; 17407445; 26305948; 26443277; 11830503; 12359729; 12660156; 12810952; 15015770; 15491992; 15534104; 15734972; 15749015; 16205122; 16219697; 16459331; 16469300; 16520895; 17047198; 17088079; 17353931; 17378176; 17569126; 17582600; 17957960; 18330478; 18413818; 18548481; 1872802; 19047152; 19225907; 19789310; 19832840; 19960435; 20199977; 2026163; 20456464; 20600019; 20798393; 20814750; 20831369; 20838441; 21454364; 21552531; 21854048; 21900206; 21930798; 21931692; 21988832; 22730407; 22850629; 22976807; 23872168; 23917584; 24002681; 24096079; 24260338; 24386364; 24412244; 25416956; 26093909; 26140984; 26172301; 26460945; 26496610; 27555600; 27592554; 27770613; 28157137; 7811704; 8486633; 9132164; 9349715	3595418; 2693021; 2587220; 2227439; 2318872; 1598217; 8519686; 14702039; 15815621; 15489334; 2317811; 3308908; 10462479; 11461922; 16548883; 17900240; 10623504; 17407445; 26305948; 26443277
19175	DECR2 PDCR SDR17C1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=59 uM for 2,4-hexadienoyl-CoA {ECO:0000269|PubMed:11514237, ECO:0000269|PubMed:22745130}; KM=6 uM for 2,4-decadienoyl-CoA {ECO:0000269|PubMed:11514237, ECO:0000269|PubMed:22745130}; KM=102 uM for 2,4,7,10,13,16,19-docosaheptaenoyl-CoA {ECO:0000269|PubMed:11514237, ECO:0000269|PubMed:22745130}; Vmax=1.75 umol/min/mg enzyme toward 2,4-Hexadienoyl CoA {ECO:0000269|PubMed:11514237, ECO:0000269|PubMed:22745130}; Vmax=1.37 umol/min/mg enzyme toward 2,4-Decadienoyl CoA {ECO:0000269|PubMed:11514237, ECO:0000269|PubMed:22745130}; 	1.3.1.34	CATALYTIC ACTIVITY: Trans-2,3-didehydroacyl-CoA + NADP(+) = trans,trans-2,3,4,5-tetradehydroacyl-CoA + NADPH. {ECO:0000269|PubMed:11514237, ECO:0000269|PubMed:22745130}.	BINDING 60 60 Substrate.; BINDING 86 86 NADP. {ECO:0000269|PubMed:22745130}.; BINDING 88 88 Substrate.; BINDING 118 118 Substrate.; BINDING 182 182 NADP. {ECO:0000269|PubMed:22745130}.; BINDING 219 219 Substrate.								fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; protein targeting to peroxisome [GO:0006625]; unsaturated fatty acid biosynthetic process [GO:0006636]	cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]	cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; 2,4-dienoyl-CoA reductase (NADPH) activity [GO:0008670]; signaling receptor binding [GO:0005102]; trans-2-enoyl-CoA reductase (NADPH) activity [GO:0019166]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; protein targeting to peroxisome [GO:0006625]; unsaturated fatty acid biosynthetic process [GO:0006636]	2,4-dienoyl-CoA reductase (NADPH) activity [GO:0008670]; signaling receptor binding [GO:0005102]; trans-2-enoyl-CoA reductase (NADPH) activity [GO:0019166]	GO:0005102; GO:0005778; GO:0005829; GO:0006625; GO:0006636; GO:0008670; GO:0019166; GO:0033540	SUBCELLULAR LOCATION: Peroxisome {ECO:0000250}.		MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:22814378}.; MOD_RES 151 151 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 287 287 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 291 291 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.	11514237; 11157797; 14702039; 15616553; 15489334; 19608861; 22814378; 23186163; 25944712; 22745130; 21988832; 22002062; 23902751; 26496610	11514237; 11157797; 14702039; 15616553; 15489334; 19608861; 22814378; 23186163; 25944712; 22745130
19184	DDX17	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=170 uM for ATP {ECO:0000269|PubMed:8871553}; 	3.6.4.13	CATALYTIC ACTIVITY: ATP + H(2)O = ADP + phosphate. {ECO:0000269|PubMed:8871553}.									alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; defense response to virus [GO:0051607]; epithelial to mesenchymal transition [GO:0001837]; gene silencing by RNA [GO:0031047]; intracellular estrogen receptor signaling pathway [GO:0030520]; miRNA metabolic process [GO:0010586]; myoblast differentiation [GO:0045445]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA processing [GO:0006396]; RNA secondary structure unwinding [GO:0010501]; rRNA processing [GO:0006364]; transcription, DNA-templated [GO:0006351]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA-dependent ATPase activity [GO:0008186]; transcription coactivator activity [GO:0003713]; alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; defense response to virus [GO:0051607]; epithelial to mesenchymal transition [GO:0001837]; gene silencing by RNA [GO:0031047]; intracellular estrogen receptor signaling pathway [GO:0030520]; miRNA metabolic process [GO:0010586]; myoblast differentiation [GO:0045445]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA processing [GO:0006396]; RNA secondary structure unwinding [GO:0010501]; rRNA processing [GO:0006364]; transcription, DNA-templated [GO:0006351]	ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; RNA helicase activity [GO:0003724]; transcription coactivator activity [GO:0003713]	GO:0000380; GO:0000381; GO:0001837; GO:0003713; GO:0003723; GO:0003724; GO:0004004; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006351; GO:0006357; GO:0006364; GO:0006396; GO:0008186; GO:0010501; GO:0010586; GO:0016020; GO:0016607; GO:0030520; GO:0030521; GO:0031047; GO:0045445; GO:0045944; GO:0051607; GO:2001014	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12138182, ECO:0000269|PubMed:12595555, ECO:0000269|PubMed:17226766, ECO:0000269|PubMed:17699760, ECO:0000269|PubMed:19995069, ECO:0000269|PubMed:22002106, ECO:0000269|PubMed:24581491, ECO:0000269|PubMed:25126784}. Nucleus, nucleolus {ECO:0000269|PubMed:17226766, ECO:0000269|PubMed:22002106}. Cytoplasm, cytosol {ECO:0000269|PubMed:25126784}. Note=In the course of bunyavirus infection, relocalizes from the nucleus to the cytosol where it binds viral RNA to antagonize replication. {ECO:0000269|PubMed:25126784}.	PTM: Sumoylation significantly increases stability. It also promotes interaction specifically with HDAC1 (but not HDAC2, nor HDAC3) and strongly stimulates ESR1 and TP53 coactivation. {ECO:0000269|PubMed:19995069}.; PTM: Acetylation at lysine residues stabilizes the protein, stimulates interaction with HDAC1 and HDAC3, but not HDAC2, and represses ESR1 and TP53 coactivation activity. {ECO:0000269|PubMed:20663877}.	MOD_RES 64 64 Phosphoserine. {ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:24275569}.; MOD_RES 108 108 N6-acetyllysine; by EP300. {ECO:0000269|PubMed:20663877}.; MOD_RES 109 109 N6-acetyllysine; by EP300. {ECO:0000269|PubMed:20663877}.; MOD_RES 121 121 N6-acetyllysine; by EP300. {ECO:0000269|PubMed:20663877}.; MOD_RES 523 523 Phosphothreonine. {ECO:0000244|PubMed:16964243}.; MOD_RES 684 684 Omega-N-methylarginine. {ECO:0000244|PubMed:24129315}.	8871553; 15461802; 17974005; 10591208; 15489334; 26209609; 17011493; 11250900; 25452582; 11675387; 12138182; 12595555; 15298701; 15531877; 15660129; 17081983; 16964243; 17699760; 17226766; 17485482; 17525332; 18279852; 18669648; 18334637; 19718048; 19995069; 20406972; 20663877; 20068231; 21269460; 21876179; 21406692; 22002106; 23022728; 22266867; 23186163; 23788676; 24589731; 24581491; 25126784; 24910439; 24275569; 24129315; 25218447; 24275493; 25114211; 25772364; 25755297; 27478153; 28112733; 14559993; 15567442; 15848144; 16189514; 17332742; 18457437; 19703396; 19928837; 20085707; 20360068; 20467437; 20562859; 20711500; 21150319; 21182205; 21679440; 21907836; 22118625; 22222205; 22365833; 22522808; 22623428; 22810585; 22863774; 23084401; 23754495; 23902751; 24189400; 24725430; 24965446; 25416956; 25604459; 25609649; 25920683; 26420826; 26496610	8871553; 15461802; 17974005; 10591208; 15489334; 26209609; 17011493; 11250900; 25452582; 11675387; 12138182; 12595555; 15298701; 15531877; 15660129; 17081983; 16964243; 17699760; 17226766; 17485482; 17525332; 18279852; 18669648; 18334637; 19718048; 19995069; 20406972; 20663877; 20068231; 21269460; 21876179; 21406692; 22002106; 23022728; 22266867; 23186163; 23788676; 24589731; 24581491; 25126784; 24910439; 24275569; 24129315; 25218447; 24275493; 25114211; 25772364; 25755297; 27478153; 28112733
19201	AOPEP C9orf3 ONPEP	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=6 uM for Arg-AMC {ECO:0000269|PubMed:15687497}; 	3.4.11.-			ACTIVITY REGULATION: Strongly inhibited by ophenanthroline, a metalloprotease inhibitor. Inhibited by arphamenine A, a potent inhibitor of aminopeptidases. Not affected by AEBSF and E-64, which are common inhibitors of serine- and cysteine-proteases, respectively. {ECO:0000269|PubMed:15687497}.	COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250}; ;  Note=Binds 1 zinc ion per subunit. {ECO:0000250};			SITE 586 586 Transition state stabilizer. {ECO:0000250}.			angiotensin maturation [GO:0002003]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; metallopeptidase activity [GO:0008237]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; angiotensin maturation [GO:0002003]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]	aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; metallopeptidase activity [GO:0008237]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]	GO:0002003; GO:0004177; GO:0005730; GO:0005737; GO:0005829; GO:0006508; GO:0008237; GO:0008270; GO:0042277; GO:0043171; GO:0070006	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.			15687497; 14702039; 15164053; 15489334; 24412244	15687497; 14702039; 15164053; 15489334
19266	PRMT1 HMT2 HRMT1L2 IR1B4	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1 uM for AdoMet {ECO:0000269|PubMed:19405910}; KM=4.2 uM for H4 {ECO:0000269|PubMed:19405910}; Vmax=1.2 nmol/min/mg enzyme toward AdoMet {ECO:0000269|PubMed:19405910}; Vmax=1.24 nmol/min/mg enzyme toward H4 {ECO:0000269|PubMed:19405910}; 	2.1.1.319	CATALYTIC ACTIVITY: 2 S-adenosyl-L-methionine + [protein]-L-arginine = 2 S-adenosyl-L-homocysteine + [protein]-N(omega),N(omega)-dimethyl-L-arginine. {ECO:0000269|PubMed:11387442, ECO:0000269|PubMed:11448779, ECO:0000269|PubMed:19405910, ECO:0000269|PubMed:26575292, ECO:0000269|PubMed:28040436}.	BINDING 63 63 S-adenosyl-L-methionine. {ECO:0000250}.; BINDING 72 72 S-adenosyl-L-methionine. {ECO:0000250}.; BINDING 96 96 S-adenosyl-L-methionine; via carbonyl oxygen. {ECO:0000250}.; BINDING 118 118 S-adenosyl-L-methionine. {ECO:0000250}.; BINDING 147 147 S-adenosyl-L-methionine. {ECO:0000250}.	ACTIVITY REGULATION: By BTG1, BTG2 and ILF3.							cell surface receptor signaling pathway [GO:0007166]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; histone H4-R3 methylation [GO:0043985]; histone methylation [GO:0016571]; in utero embryonic development [GO:0001701]; negative regulation of megakaryocyte differentiation [GO:0045653]; neuron projection development [GO:0031175]; peptidyl-arginine methylation [GO:0018216]; positive regulation of cell proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; positive regulation of p38MAPK cascade [GO:1900745]; protein homooligomerization [GO:0051260]; protein methylation [GO:0006479]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of transcription, DNA-templated [GO:0006355]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; methyltransferase activity [GO:0008168]; mitogen-activated protein kinase p38 binding [GO:0048273]; N-methyltransferase activity [GO:0008170]; protein methyltransferase activity [GO:0008276]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; RNA binding [GO:0003723]; S-adenosyl-L-methionine binding [GO:1904047]; cell surface receptor signaling pathway [GO:0007166]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; histone H4-R3 methylation [GO:0043985]; histone methylation [GO:0016571]; in utero embryonic development [GO:0001701]; negative regulation of megakaryocyte differentiation [GO:0045653]; neuron projection development [GO:0031175]; peptidyl-arginine methylation [GO:0018216]; positive regulation of cell proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; positive regulation of p38MAPK cascade [GO:1900745]; protein homooligomerization [GO:0051260]; protein methylation [GO:0006479]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of transcription, DNA-templated [GO:0006355]	enzyme binding [GO:0019899]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; methyltransferase activity [GO:0008168]; mitogen-activated protein kinase p38 binding [GO:0048273]; N-methyltransferase activity [GO:0008170]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; protein methyltransferase activity [GO:0008276]; RNA binding [GO:0003723]; S-adenosyl-L-methionine binding [GO:1904047]	GO:0001701; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006479; GO:0006977; GO:0007166; GO:0008168; GO:0008170; GO:0008276; GO:0008284; GO:0008327; GO:0016274; GO:0016571; GO:0018216; GO:0019899; GO:0031175; GO:0034709; GO:0035241; GO:0035242; GO:0042054; GO:0042802; GO:0043985; GO:0044020; GO:0045648; GO:0045652; GO:0045653; GO:0046985; GO:0048273; GO:0051260; GO:1900745; GO:1904047	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:19136629}. Nucleus, nucleoplasm {ECO:0000250}. Cytoplasm {ECO:0000269|PubMed:26876602}. Cytoplasm, cytosol {ECO:0000250}. Note=Mostly found in the cytoplasm. Colocalizes with CHTOP within the nucleus. Low levels detected also in the chromatin fraction (By similarity). {ECO:0000250}.		MOD_RES 134 134 N6-succinyllysine. {ECO:0000250|UniProtKB:Q9JIF0}.; MOD_RES 304 304 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 307 307 Phosphoserine. {ECO:0000244|PubMed:23186163}.	9545638; 8675017; 11097842; 14702039; 15057824; 15489334; 10749851; 11101900; 11448779; 11387442; 12718890; 15084609; 16879614; 18657504; 18951090; 18773938; 18320585; 19405910; 19124016; 19136629; 20442406; 21269460; 23186163; 25284789; 26575292; 25748791; 26876602; 28040436; 10617663; 10748127; 12483298; 12576332; 15186775; 15670829; 16169070; 16293633; 16628190; 16713569; 17053781; 17353931; 17446270; 17620599; 18079182; 18316480; 19101556; 19114653; 19369418; 19509293; 19738201; 19858291; 20360068; 20562859; 20711500; 21242974; 21712045; 21774791; 21900206; 22190034; 22575643; 22623428; 22677168; 22777353; 23084401; 23455922; 23455924; 23602568; 23606334; 23902751; 23912080; 24189400; 24205981; 24726729; 25416956; 25609649; 26010396; 26496610	9545638; 8675017; 11097842; 14702039; 15057824; 15489334; 10749851; 11101900; 11448779; 11387442; 12718890; 15084609; 16879614; 18657504; 18951090; 18773938; 18320585; 19405910; 19124016; 19136629; 20442406; 21269460; 23186163; 25284789; 26575292; 25748791; 26876602; 28040436
19298	NT5C3B NT5C3L	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=7.8 uM for m(7)GMP (at 37 degrees Celsius) {ECO:0000269|PubMed:23223233}; KM=8 uM for m(7)GMP (at 37 degrees Celsius) {ECO:0000269|PubMed:24603684}; KM=79 uM for CMP (at 37 degrees Celsius) {ECO:0000269|PubMed:23223233, ECO:0000269|PubMed:24603684}; KM=355 uM for GMP (at 37 degrees Celsius) {ECO:0000269|PubMed:23223233}; KM=456 uM for AMP (at 37 degrees Celsius) {ECO:0000269|PubMed:23223233}; KM=439 uM for UMP (at 37 degrees Celsius) {ECO:0000269|PubMed:23223233}; Vmax=0.41 umol/min/mg enzyme with m(7)GMP as substrate {ECO:0000269|PubMed:23223233}; Vmax=12 umol/min/mg enzyme with CMP as substrate {ECO:0000269|PubMed:23223233}; Vmax=0.13 umol/min/mg enzyme with GMP as substrate {ECO:0000269|PubMed:23223233}; Vmax=0.07 umol/min/mg enzyme with AMP as substrate {ECO:0000269|PubMed:23223233}; Vmax=10.7 umol/min/mg enzyme with UMP as substrate {ECO:0000269|PubMed:23223233}; Note=kcat is 0.24 sec(-1) with m(7)GMP. kcat is 7 sec(-1) with CMP. kcat is 0.07 sec(-1) with GMP. kcat is 0.04 sec(-1) with AMP. kcat is 6.2 sec(-1) with UMP.;	3.1.3.91; 3.1.3.5	CATALYTIC ACTIVITY: N(7)-methyl-GMP + H(2)O = N(7)-methyl-guanosine + phosphate. {ECO:0000269|PubMed:23223233}.; CATALYTIC ACTIVITY: CMP + H(2)O = cytidine + phosphate. {ECO:0000269|PubMed:23223233}.; CATALYTIC ACTIVITY: A 5'-ribonucleotide + H(2)O = a ribonucleoside + phosphate. {ECO:0000269|PubMed:23223233}.	BINDING 88 88 CMP. {ECO:0000250|UniProtKB:Q9W197}.; BINDING 88 88 N(7)-methyl-GMP. {ECO:0000250|UniProtKB:Q9W197}.; BINDING 205 205 Substrate. {ECO:0000250|UniProtKB:Q9H0P0}.								exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; nucleotide metabolic process [GO:0009117]	cytosol [GO:0005829]	cytosol [GO:0005829]; 5'-nucleotidase activity [GO:0008253]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; nucleotide metabolic process [GO:0009117]	5'-nucleotidase activity [GO:0008253]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]	GO:0000166; GO:0000287; GO:0005829; GO:0008253; GO:0009117; GO:0043928	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.		MOD_RES 256 256 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.	16625196; 15489334; 19608861; 21269460; 23223233; 24603684; 20706999; 25517131	16625196; 15489334; 19608861; 21269460; 23223233; 24603684
19319	ADA2 ADGF CECR1 IDGFL	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=2.25 mM for adenosine {ECO:0000269|PubMed:15926889}; 	3.5.4.4	CATALYTIC ACTIVITY: Adenosine + H(2)O = inosine + NH(3). {ECO:0000269|PubMed:15926889, ECO:0000269|PubMed:20453107}.	BINDING 115 115 Substrate.; BINDING 293 293 Substrate.; BINDING 326 326 Substrate; via amide nitrogen.; BINDING 442 442 Substrate.		COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000269|PubMed:20147294}; ;  Note=Binds 1 zinc ion per subunit. {ECO:0000269|PubMed:20147294};	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 6.6. {ECO:0000269|PubMed:15926889};					adenosine catabolic process [GO:0006154]; cellular protein metabolic process [GO:0044267]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; multicellular organism development [GO:0007275]; neutrophil degranulation [GO:0043312]	azurophil granule lumen [GO:0035578]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	azurophil granule lumen [GO:0035578]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; adenosine deaminase activity [GO:0004000]; adenosine receptor binding [GO:0031685]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; protein homodimerization activity [GO:0042803]; proteoglycan binding [GO:0043394]; zinc ion binding [GO:0008270]; adenosine catabolic process [GO:0006154]; cellular protein metabolic process [GO:0044267]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; multicellular organism development [GO:0007275]; neutrophil degranulation [GO:0043312]	adenosine deaminase activity [GO:0004000]; adenosine receptor binding [GO:0031685]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; protein homodimerization activity [GO:0042803]; proteoglycan binding [GO:0043394]; zinc ion binding [GO:0008270]	GO:0004000; GO:0005576; GO:0005615; GO:0006154; GO:0007275; GO:0008083; GO:0008201; GO:0008270; GO:0031685; GO:0035578; GO:0042803; GO:0043103; GO:0043312; GO:0043394; GO:0044267; GO:0046103	SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:15926889, ECO:0000269|PubMed:20147294, ECO:0000269|PubMed:20453107}.			10756095; 15461802; 14702039; 10591208; 15489334; 15926889; 19159218; 20453107; 25944712; 20147294; 24552284; 24552285; 25075847; 8692836	10756095; 15461802; 14702039; 10591208; 15489334; 15926889; 19159218; 20453107; 25944712; 20147294; 24552284; 24552285; 25075847
19320	ASPA ACY2 ASP	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: Vmax=1.2 nmol/h/mg enzyme {ECO:0000269|PubMed:28101991}; 	3.5.1.15	CATALYTIC ACTIVITY: N-acyl-L-aspartate + H(2)O = a carboxylate + L-aspartate. {ECO:0000269|PubMed:17027983, ECO:0000269|PubMed:24036223, ECO:0000269|PubMed:28101991}.	BINDING 63 63 Substrate.; BINDING 178 178 Substrate.; BINDING 288 288 Substrate.		COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000269|PubMed:17194761, ECO:0000269|PubMed:18293939}; ;  Note=Binds 1 zinc ion per subunit. {ECO:0000269|PubMed:17194761, ECO:0000269|PubMed:18293939};						aspartate catabolic process [GO:0006533]; cellular amino acid biosynthetic process [GO:0008652]; central nervous system myelination [GO:0022010]; positive regulation of oligodendrocyte differentiation [GO:0048714]	cytosol [GO:0005829]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleus [GO:0005634]; aminoacylase activity [GO:0004046]; aspartoacylase activity [GO:0019807]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; aspartate catabolic process [GO:0006533]; cellular amino acid biosynthetic process [GO:0008652]; central nervous system myelination [GO:0022010]; positive regulation of oligodendrocyte differentiation [GO:0048714]	aminoacylase activity [GO:0004046]; aspartoacylase activity [GO:0019807]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]	GO:0004046; GO:0005634; GO:0005829; GO:0006533; GO:0008652; GO:0016788; GO:0019807; GO:0022010; GO:0042802; GO:0046872; GO:0048714	SUBCELLULAR LOCATION: Cytoplasm. Nucleus {ECO:0000250}.			8252036; 15489334; 12706335; 17027983; 18293939; 17194761; 8023850; 7668285; 7599639; 8659549; 9452117; 10564886; 10407784; 10909858; 12638939; 12205125; 24036223; 28101991; 14699612; 16189514; 16437572; 16669630; 16935940; 17391648; 17850744; 18264947; 20201926; 22019069; 22219087; 22468686; 22750302; 22878930; 24632142; 25003821; 25416956	8252036; 15489334; 12706335; 17027983; 18293939; 17194761; 8023850; 7668285; 7599639; 8659549; 9452117; 10564886; 10407784; 10909858; 12638939; 12205125; 24036223; 28101991
19365	PRMT2 HMT1 HRMT1L1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=2.6 uM for AdoMet {ECO:0000269|PubMed:19405910}; KM=3.3 uM for H4 {ECO:0000269|PubMed:19405910}; Vmax=1.4 nmol/min/mg enzyme toward AdoMet {ECO:0000269|PubMed:19405910}; Vmax=1.5 nmol/min/mg enzyme toward H4 {ECO:0000269|PubMed:19405910}; 	2.1.1.319	CATALYTIC ACTIVITY: 2 S-adenosyl-L-methionine + [protein]-L-arginine = 2 S-adenosyl-L-homocysteine + [protein]-N(omega),N(omega)-dimethyl-L-arginine. {ECO:0000269|PubMed:19405910}.	BINDING 112 112 S-adenosyl-L-methionine. {ECO:0000250}.; BINDING 121 121 S-adenosyl-L-methionine. {ECO:0000250}.; BINDING 145 145 S-adenosyl-L-methionine; via carbonyl oxygen. {ECO:0000250}.; BINDING 168 168 S-adenosyl-L-methionine. {ECO:0000250}.; BINDING 197 197 S-adenosyl-L-methionine. {ECO:0000250}.								developmental cell growth [GO:0048588]; histone methylation [GO:0016571]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription, DNA-templated [GO:0045893]; protein methylation [GO:0006479]; regulation of androgen receptor signaling pathway [GO:0060765]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; androgen receptor binding [GO:0050681]; estrogen receptor binding [GO:0030331]; histone methyltransferase activity [GO:0042054]; histone-arginine N-methyltransferase activity [GO:0008469]; peroxisome proliferator activated receptor binding [GO:0042975]; progesterone receptor binding [GO:0033142]; protein homodimerization activity [GO:0042803]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; retinoic acid receptor binding [GO:0042974]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; developmental cell growth [GO:0048588]; histone methylation [GO:0016571]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription, DNA-templated [GO:0045893]; protein methylation [GO:0006479]; regulation of androgen receptor signaling pathway [GO:0060765]; signal transduction [GO:0007165]	androgen receptor binding [GO:0050681]; estrogen receptor binding [GO:0030331]; histone-arginine N-methyltransferase activity [GO:0008469]; histone methyltransferase activity [GO:0042054]; peroxisome proliferator activated receptor binding [GO:0042975]; progesterone receptor binding [GO:0033142]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein homodimerization activity [GO:0042803]; retinoic acid receptor binding [GO:0042974]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]	GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006479; GO:0007165; GO:0008469; GO:0016274; GO:0016571; GO:0030331; GO:0032088; GO:0033142; GO:0035242; GO:0042054; GO:0042803; GO:0042974; GO:0042975; GO:0043065; GO:0045892; GO:0045893; GO:0046966; GO:0048588; GO:0050681; GO:0060765; GO:2000134	SUBCELLULAR LOCATION: Isoform 1: Cytoplasm. Nucleus. Note=Translocates from the cytoplasm to the nucleus, after hormone exposure. Excluded from nucleolus.; SUBCELLULAR LOCATION: Isoform PRMT2Alpha: Nucleus. Note=Excluded from nucleolus.; SUBCELLULAR LOCATION: Isoform PRMT2Beta: Cytoplasm. Nucleus. Nucleus, nucleolus.; SUBCELLULAR LOCATION: Isoform PRMT2Gamma: Nucleus. Note=Excluded from nucleolus.; SUBCELLULAR LOCATION: Isoform PRMT2L2: Cytoplasm {ECO:0000269|PubMed:21820040}. Nucleus {ECO:0000269|PubMed:21820040}. Note=Predominantly cytoplasmic.		MOD_RES 61 61 Asymmetric dimethylarginine. {ECO:0000244|PubMed:24129315}.; MOD_RES 72 72 Asymmetric dimethylarginine. {ECO:0000244|PubMed:24129315}.	9545638; 9196002; 21820040; 22093364; 9110174; 14702039; 10830953; 15489334; 11513728; 12039952; 16648481; 17925405; 17587566; 19405910; 24129315; 14667819; 16189514; 16616919; 17500595; 19101556; 19161160; 21851090; 21988832; 23455924; 24292672; 24911119; 25640309; 26420826; 28057797; 28677794; 29689199	9545638; 9196002; 21820040; 22093364; 9110174; 14702039; 10830953; 15489334; 11513728; 12039952; 16648481; 17925405; 17587566; 19405910; 24129315; 
19430	APTX AXA1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=18 uM for AppppA {ECO:0000269|PubMed:16547001}; KM=837.5 uM for AMP-NH(2) {ECO:0000269|PubMed:16547001}; 	3.1.11.7; 3.1.12.2	CATALYTIC ACTIVITY: Adenosine-5'-diphospho-5'-(DNA) + H(2)O = AMP + phospho-5'-(DNA). {ECO:0000269|PubMed:16964241, ECO:0000269|PubMed:17276982, ECO:0000269|PubMed:24362567, ECO:0000305|PubMed:16547001}.; CATALYTIC ACTIVITY: Adenosine-5'-diphospho-5'-(ribonucleotide)-(DNA) + H(2)O = AMP + 5'-phospho-(ribonucleotide)-(DNA). {ECO:0000269|PubMed:16964241, ECO:0000269|PubMed:17276982, ECO:0000269|PubMed:24362567, ECO:0000305|PubMed:16547001}.; CATALYTIC ACTIVITY: (DNA)-3'-diphospho-5'-guanosine + H(2)O = (DNA)-3'-phosphate + GMP. {ECO:0000250|UniProtKB:O74859}.						SITE 188 188 Interaction with DNA substrate. {ECO:0000269|PubMed:24362567}.; SITE 265 265 Interaction with DNA substrate. {ECO:0000269|PubMed:24362567}.; SITE 276 276 Interaction with DNA substrate. {ECO:0000269|PubMed:24362567}.; SITE 291 291 Interaction with DNA substrate. {ECO:0000269|PubMed:24362567}.			cellular response to DNA damage stimulus [GO:0006974]; DNA ligation [GO:0006266]; double-strand break repair [GO:0006302]; regulation of protein stability [GO:0031647]; response to hydrogen peroxide [GO:0042542]; single strand break repair [GO:0000012]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA 5'-adenosine monophosphate hydrolase activity [GO:0033699]; DNA-3'-diphospho-5'-guanosine diphosphatase [GO:0120108]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; phosphoglycolate phosphatase activity [GO:0008967]; phosphoprotein binding [GO:0051219]; polynucleotide 3'-phosphatase activity [GO:0046403]; protein N-terminus binding [GO:0047485]; cellular response to DNA damage stimulus [GO:0006974]; DNA ligation [GO:0006266]; double-strand break repair [GO:0006302]; regulation of protein stability [GO:0031647]; response to hydrogen peroxide [GO:0042542]; single strand break repair [GO:0000012]	chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA-3'-diphospho-5'-guanosine diphosphatase [GO:0120108]; DNA 5'-adenosine monophosphate hydrolase activity [GO:0033699]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; phosphoglycolate phosphatase activity [GO:0008967]; phosphoprotein binding [GO:0051219]; polynucleotide 3'-phosphatase activity [GO:0046403]; protein N-terminus binding [GO:0047485]	GO:0000012; GO:0000785; GO:0003682; GO:0003684; GO:0003690; GO:0003725; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006266; GO:0006302; GO:0006974; GO:0008967; GO:0031647; GO:0033699; GO:0042542; GO:0046403; GO:0046872; GO:0047485; GO:0051219; GO:0120108	SUBCELLULAR LOCATION: Nucleus, nucleoplasm {ECO:0000269|PubMed:14755728, ECO:0000269|PubMed:15044383, ECO:0000269|PubMed:15276230, ECO:0000269|PubMed:15380105}. Nucleus, nucleolus {ECO:0000269|PubMed:15044383, ECO:0000269|PubMed:16777843}. Note=Upon genotoxic stress, colocalizes with XRCC1 at sites of DNA damage (PubMed:15380105). Colocalizes with MDC1 at sites of DNA double-strand breaks (PubMed:20008512). Interaction with NCL is required for nucleolar localization (PubMed:16777843). {ECO:0000269|PubMed:15044383, ECO:0000269|PubMed:15380105, ECO:0000269|PubMed:20008512}.; SUBCELLULAR LOCATION: Isoform 12: Cytoplasm {ECO:0000269|PubMed:15276230}.		MOD_RES 132 132 Phosphoserine. {ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:24275569}.; MOD_RES 137 137 Phosphoserine. {ECO:0000250|UniProtKB:Q7TQC5}.	15276230; 14702039; 17974005; 15164053; 15489334; 11586299; 11586300; 14755728; 15380105; 15044383; 16777843; 16547001; 16964241; 17276982; 21406692; 24275569; 20008512; 24362567; 12196655; 12629250; 14506070; 15852392; 15699391; 15367657; 15555565; 16439205; 16713569; 19561170; 23902751; 25416956; 29934293	15276230; 14702039; 17974005; 15164053; 15489334; 11586299; 11586300; 14755728; 15380105; 15044383; 16777843; 16547001; 16964241; 17276982; 21406692; 24275569; 20008512; 24362567; 12196655; 12629250; 14506070; 15852392; 15699391
19455	AKT3 PKBG	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=87.9 uM for ATP (for purified and in vitro activated AKT3) {ECO:0000269|PubMed:16540465}; KM=12.4 uM for peptide substrate (for purified and in vitro activated AKT3) {ECO:0000269|PubMed:16540465}; KM=118.7 uM for ATP (for recombinant myristoylated AKT3 expressed and immunoprecipitated from Rat-1 cells) {ECO:0000269|PubMed:16540465}; KM=2.3 uM for peptide substrate (for recombinant myristoylated AKT3 expressed and immunoprecipitated from Rat-1 cells) {ECO:0000269|PubMed:16540465}; 	2.7.11.1	CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.	BINDING 177 177 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.	ACTIVITY REGULATION: Two specific sites, one in the kinase domain (Thr-305) and the other in the C-terminal regulatory region (Ser-472), need to be phosphorylated for its full activation (By similarity). IGF-1 leads to the activation of AKT3, which may play a role in regulating cell survival. {ECO:0000250}.							brain morphogenesis [GO:0048854]; homeostasis of number of cells within a tissue [GO:0048873]; intracellular signal transduction [GO:0035556]; mitochondrial genome maintenance [GO:0000002]; negative regulation of cellular senescence [GO:2000773]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of artery morphogenesis [GO:1905653]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell size [GO:0045793]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of TOR signaling [GO:0032008]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; intracellular [GO:0005622]; membrane [GO:0016020]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; intracellular [GO:0005622]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; brain morphogenesis [GO:0048854]; homeostasis of number of cells within a tissue [GO:0048873]; intracellular signal transduction [GO:0035556]; mitochondrial genome maintenance [GO:0000002]; negative regulation of cellular senescence [GO:2000773]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of artery morphogenesis [GO:1905653]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell size [GO:0045793]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of TOR signaling [GO:0032008]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]	GO:0000002; GO:0001938; GO:0004672; GO:0004674; GO:0005524; GO:0005622; GO:0005634; GO:0005737; GO:0006468; GO:0007165; GO:0016020; GO:0018105; GO:0032008; GO:0035556; GO:0043536; GO:0045793; GO:0048854; GO:0048873; GO:0090050; GO:1905564; GO:1905653; GO:2000773	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20018949}. Cytoplasm {ECO:0000269|PubMed:20018949}. Membrane {ECO:0000269|PubMed:20018949}; Peripheral membrane protein {ECO:0000269|PubMed:20018949}. Note=Membrane-associated after cell stimulation leading to its translocation.	PTM: Phosphorylation on Thr-305 and Ser-472 is required for full activity. {ECO:0000250}.; PTM: Ubiquitinated. When fully phosphorylated and translocated into the nucleus, undergoes 'Lys-48'-polyubiquitination catalyzed by TTC3, leading to its degradation by the proteasome. {ECO:0000269|PubMed:12162751, ECO:0000269|PubMed:20059950, ECO:0000269|PubMed:9512493}.; PTM: O-GlcNAcylation at Thr-302 and Thr-309 inhibits activating phosphorylation at Thr-305 via disrupting the interaction between AKT and PDK1. {ECO:0000250}.	MOD_RES 2 2 N-acetylserine. {ECO:0000244|PubMed:19413330}.; MOD_RES 305 305 Phosphothreonine; by PDPK1. {ECO:0000269|PubMed:9512493}.; MOD_RES 447 447 Phosphothreonine. {ECO:0000244|PubMed:24275569}.; MOD_RES 472 472 Phosphoserine; by PKC/PRKCZ. {ECO:0000269|PubMed:12162751}.	10092583; 10208883; 10491192; 11230166; 11387345; 16710414; 15489334; 9512493; 12162751; 11707444; 11839817; 15466193; 17178867; 16540465; 17525332; 18524868; 19413330; 20059950; 19713527; 20018949; 20167810; 21269460; 21191416; 21620960; 24275569; 17344846; 18813315; 22729224; 22729223; 22500628; 23745724; 10102273; 10358075; 10485710; 10490848; 10908564; 11274386; 11504915; 11598301; 11715018; 12114024; 12138205; 12150915; 12167717; 12172553; 12176997; 12228231; 12244303; 12524439; 12663464; 12692267; 12767043; 12791994; 14617782; 14637150; 15169778; 15183529; 15527798; 15543611; 15579468; 15698844; 15718470; 15808505; 15987444; 16272144; 17210635; 17386267; 17544405; 17668379; 17895832; 18451171; 18794358; 19261608; 19405949; 19435822; 19626040; 19644473; 19913121; 20031603; 20056178; 20102399; 20186503; 20354165; 20398329; 20489726; 20628086; 20647317; 21048031; 21351097; 21487925; 21507933; 21590431; 21777670; 21821713; 22025163; 22107784; 22234583; 22262409; 22334668; 22729570; 22762500; 22975685; 23303682; 23389849; 23431171; 23603119; 23684622; 23794269; 23873136; 23929892; 24039187; 24138071; 24247267; 24335962; 24462114; 24463007; 24606918; 24781864; 24942865; 24967401; 25036637; 25091978; 25122428; 25233414; 25241761; 25246356; 25323119; 25388284; 25424989; 25501707; 25722288; 25737557; 26002580; 26055712; 26183061; 26206082; 26315541; 26318033; 26427440; 26482618; 26512921; 26523971; 26741489; 26782072; 26855332; 26902608; 26972278; 27026523; 27072269; 27193124; 27297869; 27421659; 27422127; 27629740; 27699933; 27903978; 28028179; 28114274; 28160548; 28254819; 28365400; 28389565; 28624527; 28733453; 28791371; 28849051; 28931550; 28969385; 29235817; 7637810; 8524413; 9346240; 9381178; 9736715; 9768361; 9812896; 9829964	10092583; 10208883; 10491192; 11230166; 11387345; 16710414; 15489334; 9512493; 12162751; 11707444; 11839817; 15466193; 17178867; 16540465; 17525332; 18524868; 19413330; 20059950; 19713527; 20018949; 20167810; 21269460; 21191416; 21620960; 24275569; 17344846; 18813315; 22729224; 22729223; 22500628; 23745724
19456	ALDOA ALDA	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=52 uM for fructose 1,6-bisphosphate (at 30 degrees Celsius) {ECO:0000269|PubMed:14766013}; 	4.1.2.13	CATALYTIC ACTIVITY: D-fructose 1,6-bisphosphate = glycerone phosphate + D-glyceraldehyde 3-phosphate.	BINDING 56 56 Substrate.; BINDING 147 147 Substrate.				PATHWAY: Carbohydrate degradation; glycolysis; D-glyceraldehyde 3-phosphate and glycerone phosphate from D-glucose: step 4/4.	SITE 364 364 Necessary for preference for fructose 1,6-bisphosphate over fructose 1-phosphate.		BIOPHYSICOCHEMICAL PROPERTIES: ;  Temperature dependence: Thermal denaturation midpoint (Tm) is 54.4 degrees Celsius. {ECO:0000269|PubMed:14766013};	actin filament organization [GO:0007015]; ATP biosynthetic process [GO:0006754]; binding of sperm to zona pellucida [GO:0007339]; canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; muscle cell cellular homeostasis [GO:0046716]; neutrophil degranulation [GO:0043312]; platelet degranulation [GO:0002576]; protein homotetramerization [GO:0051289]; regulation of cell shape [GO:0008360]; striated muscle contraction [GO:0006941]	actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; I band [GO:0031674]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; platelet alpha granule lumen [GO:0031093]; secretory granule lumen [GO:0034774]; sperm head [GO:0061827]; tertiary granule lumen [GO:1904724]	actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; I band [GO:0031674]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; platelet alpha granule lumen [GO:0031093]; secretory granule lumen [GO:0034774]; sperm head [GO:0061827]; tertiary granule lumen [GO:1904724]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; fructose binding [GO:0070061]; fructose-bisphosphate aldolase activity [GO:0004332]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; tubulin binding [GO:0015631]; actin filament organization [GO:0007015]; ATP biosynthetic process [GO:0006754]; binding of sperm to zona pellucida [GO:0007339]; canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; muscle cell cellular homeostasis [GO:0046716]; neutrophil degranulation [GO:0043312]; platelet degranulation [GO:0002576]; protein homotetramerization [GO:0051289]; regulation of cell shape [GO:0008360]; striated muscle contraction [GO:0006941]	actin binding [GO:0003779]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; fructose binding [GO:0070061]; fructose-bisphosphate aldolase activity [GO:0004332]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; tubulin binding [GO:0015631]	GO:0002576; GO:0003723; GO:0003779; GO:0004332; GO:0005576; GO:0005615; GO:0005634; GO:0005829; GO:0006000; GO:0006094; GO:0006096; GO:0006754; GO:0006941; GO:0007015; GO:0007339; GO:0008092; GO:0008360; GO:0015629; GO:0015631; GO:0016020; GO:0030388; GO:0031093; GO:0031430; GO:0031674; GO:0034774; GO:0042802; GO:0043312; GO:0045296; GO:0046716; GO:0051289; GO:0061621; GO:0061827; GO:0070061; GO:0070062; GO:1904724; GO:1904813	SUBCELLULAR LOCATION: Cytoplasm, myofibril, sarcomere, I band. Cytoplasm, myofibril, sarcomere, M line. Note=In skeletal muscle, accumulates around the M line and within the I band, colocalizing with FBP2 on both sides of the Z line in the absence of Ca(2+). {ECO:0000250}.		MOD_RES 5 5 Phosphotyrosine. {ECO:0000250|UniProtKB:P05065}.; MOD_RES 9 9 Phosphothreonine. {ECO:0000244|PubMed:23186163}.; MOD_RES 36 36 Phosphoserine. {ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 39 39 Phosphoserine. {ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 42 42 N6-acetyllysine; alternate. {ECO:0000244|PubMed:19608861}.; MOD_RES 46 46 Phosphoserine. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 108 108 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 111 111 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:P09972}.; MOD_RES 111 111 N6-malonyllysine; alternate. {ECO:0000269|PubMed:21908771}.; MOD_RES 132 132 Phosphoserine. {ECO:0000250|UniProtKB:P05065}.; MOD_RES 272 272 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 312 312 N6-malonyllysine. {ECO:0000269|PubMed:21908771}.; MOD_RES 330 330 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.	3840020; 3030757; 3391172; 1999195; 14702039; 15616553; 15489334; 3441006; 3355497; 6696436; 12665801; 1353685; 3674018; 17081983; 18669648; 18214967; 19413330; 19690332; 19608861; 20068231; 21269460; 21908771; 21406692; 22905912; 22223895; 22814378; 23186163; 24275569; 24129315; 25114211; 25944712; 2335208; 2056525; 10048322; 2825199; 2229018; 8598869; 14615364; 14766013; 15161933; 15231747; 16263121; 17721511; 19135240; 19338310; 19615732; 19738201; 19805454; 20000738; 20029029; 20706999; 20711500; 20849852; 21044950; 21078624; 21565611; 21988832; 22304920; 22623428; 22810585; 23414517; 23640497; 23650620; 24835590; 25609649; 26496610; 26752685; 6457647; 7717389; 8467233	3840020; 3030757; 3391172; 1999195; 14702039; 15616553; 15489334; 3441006; 3355497; 6696436; 12665801; 1353685; 3674018; 17081983; 18669648; 18214967; 19413330; 19690332; 19608861; 20068231; 21269460; 21908771; 21406692; 22905912; 22223895; 22814378; 23186163; 24275569; 24129315; 25114211; 25944712; 2335208; 2056525; 10048322; 2825199; 2229018; 8598869; 14615364; 14766013
19479	AOX1 AO	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=4.6 uM for benzaldehyde (in the presence of 2,6-dichlorophenol indophenol as electron acceptor) {ECO:0000269|PubMed:26842593}; KM=45.18 uM for benzaldehyde (in the presence of ferricyanide as electron acceptor) {ECO:0000269|PubMed:26842593}; KM=1.3 uM for phthalazine (at 25 degrees Celsius and pH 7.5) {ECO:0000269|PubMed:22279051}; KM=8.96 uM for phthalazine (in the presence of 2,6-dichlorophenol indophenol as electron acceptor) {ECO:0000269|PubMed:26842593}; KM=125.7 uM for phthalazine (in the presence of ferricyanide as electron acceptor) {ECO:0000269|PubMed:26842593}; KM=0.78 uM for phenanthridine (in the pres 2,6-dichlorophenol indophenol as electron acceptor) {ECO:0000269|PubMed:26842593}; KM=25.5 uM for phenanthridine (in the presence of ferricyanide as electron acceptor) {ECO:0000269|PubMed:26842593}; KM=26.53 uM for phenanthridine (in the presence of molecular oxygen as electron acceptor) {ECO:0000269|PubMed:26842593}; KM=3.9 uM for phenanthridine (at 25 degrees Celsius and pH 7.5) {ECO:0000269|PubMed:22279051}; KM=5.2 uM for chloroquinazolinone (at 25 degrees Celsius and pH 7.5) {ECO:0000269|PubMed:22279051}; KM=0.42 mM for 6-deoxypenciclovir (at 37 degrees Celsius and pH 7) {ECO:0000269|PubMed:9224775}; KM=0.15 mM for famciclovir (at 37 degrees Celsius and pH 7) {ECO:0000269|PubMed:9224775}; KM=6.3 uM for N-[(2-dimethylamino)ethyl]acridine-4-carboxamide (at 37 degrees Celsius and pH 7.4) {ECO:0000269|PubMed:22996261}; Vmax=16 nmol/min/mg enzyme with 6-deoxypenciclovir as substrate {ECO:0000269|PubMed:9224775}; Vmax=61 nmol/min/mg enzyme with famciclovir as substrate {ECO:0000269|PubMed:9224775}; Vmax=2.3 nmol/min/mg enzyme with N-[(2-dimethylamino)ethyl]acridine-4-carboxamide as substrate {ECO:0000269|PubMed:22996261}; Note=kcat is 6.4 min(-1) for benzaldehyde oxidation, 5.6 min(-1) for phthalazine oxidation, 12.2 min(-1) for phenanthridine oxidation and 5.6 min(-1) for chloroquinazolinone oxidation. {ECO:0000269|PubMed:22279051};	1.2.3.1; 1.17.3.-	CATALYTIC ACTIVITY: An aldehyde + H(2)O + O(2) = a carboxylate + H(2)O(2). {ECO:0000269|PubMed:22996261, ECO:0000269|PubMed:26322824}.; CATALYTIC ACTIVITY: Retinal + O(2) + H(2)O = retinoate + H(2)O(2). {ECO:0000250|UniProtKB:O54754}.	BINDING 113 113 Molybdopterin. {ECO:0000244|PDB:4UHW, ECO:0000244|PDB:4UHX, ECO:0000269|PubMed:26322824}.; BINDING 151 151 Molybdopterin. {ECO:0000244|PDB:4UHW, ECO:0000244|PDB:4UHX, ECO:0000244|PDB:5EPG, ECO:0000269|PubMed:26322824, ECO:0000269|PubMed:26842593}.; BINDING 345 345 FAD; via amide nitrogen. {ECO:0000244|PDB:4UHW, ECO:0000244|PDB:4UHX, ECO:0000269|PubMed:26322824}.; BINDING 354 354 FAD. {ECO:0000244|PDB:4UHW, ECO:0000244|PDB:4UHX, ECO:0000244|PDB:5EPG, ECO:0000269|PubMed:26322824, ECO:0000269|PubMed:26842593}.; BINDING 358 358 FAD. {ECO:0000244|PDB:5EPG, ECO:0000269|PubMed:26322824, ECO:0000269|PubMed:26842593}.; BINDING 367 367 FAD. {ECO:0000244|PDB:4UHW, ECO:0000244|PDB:4UHX, ECO:0000244|PDB:5EPG, ECO:0000269|PubMed:26322824, ECO:0000269|PubMed:26842593}.; BINDING 411 411 FAD; via amide nitrogen and carbonyl oxygen. {ECO:0000244|PDB:4UHW, ECO:0000244|PDB:4UHX, ECO:0000244|PDB:5EPG, ECO:0000269|PubMed:26322824, ECO:0000269|PubMed:26842593}.; BINDING 1047 1047 Molybdopterin; via carbonyl oxygen. {ECO:0000244|PDB:4UHW, ECO:0000244|PDB:4UHX, ECO:0000244|PDB:5EPG, ECO:0000269|PubMed:26322824, ECO:0000269|PubMed:26842593}.; BINDING 1203 1203 Molybdopterin. {ECO:0000244|PDB:4UHW, ECO:0000244|PDB:4UHX, ECO:0000244|PDB:5EPG, ECO:0000269|PubMed:26322824, ECO:0000269|PubMed:26842593}.; BINDING 1268 1268 Molybdopterin; via carbonyl oxygen. {ECO:0000244|PDB:4UHX, ECO:0000269|PubMed:26322824}.	ACTIVITY REGULATION: Is very potently inhibited by raloxifene (PubMed:26842593). Also inhibited by estradiol, ethinyl estradiol, hydralazine, menadione, isovanillin and thioridazine. Not inhibited by allopurinol, a xanthine dehydrogenase potent inhibitor (PubMed:22031625, PubMed:22522748, PubMed:22996261, PubMed:9224775, PubMed:26322824). {ECO:0000269|PubMed:22031625, ECO:0000269|PubMed:22522748, ECO:0000269|PubMed:22996261, ECO:0000269|PubMed:26322824, ECO:0000269|PubMed:26842593, ECO:0000269|PubMed:9224775}.	COFACTOR: Name=[2Fe-2S] cluster; Xref=ChEBI:CHEBI:49601; Evidence={ECO:0000269|PubMed:22279051, ECO:0000269|PubMed:26322824, ECO:0000269|PubMed:26842593}; ;  Note=Binds 2 [2Fe-2S] clusters per subunit. {ECO:0000269|PubMed:22279051, ECO:0000269|PubMed:26322824};; COFACTOR: Name=FAD; Xref=ChEBI:CHEBI:57692; Evidence={ECO:0000269|PubMed:22279051, ECO:0000269|PubMed:26322824}; ;  Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:22279051, ECO:0000269|PubMed:26322824};; COFACTOR: Name=Mo-molybdopterin; Xref=ChEBI:CHEBI:71302; Evidence={ECO:0000269|PubMed:22279051, ECO:0000269|PubMed:26322824, ECO:0000269|PubMed:26842593}; ;  Note=Binds 1 Mo-molybdopterin (Mo-MPT) cofactor per subunit. {ECO:0000269|PubMed:22279051, ECO:0000269|PubMed:26322824};						drug metabolic process [GO:0017144]; oxidation-reduction process [GO:0055114]; vitamin B6 metabolic process [GO:0042816]; xanthine catabolic process [GO:0009115]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 2 iron, 2 sulfur cluster binding [GO:0051537]; aldehyde oxidase activity [GO:0004031]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; geranial:oxygen oxidoreductase activity [GO:0102797]; heptaldehyde:oxygen oxidoreductase activity [GO:0102798]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the aldehyde or oxo group of donors [GO:0016903]; protein homodimerization activity [GO:0042803]; drug metabolic process [GO:0017144]; oxidation-reduction process [GO:0055114]; vitamin B6 metabolic process [GO:0042816]; xanthine catabolic process [GO:0009115]	2 iron, 2 sulfur cluster binding [GO:0051537]; aldehyde oxidase activity [GO:0004031]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; geranial:oxygen oxidoreductase activity [GO:0102797]; heptaldehyde:oxygen oxidoreductase activity [GO:0102798]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the aldehyde or oxo group of donors [GO:0016903]; protein homodimerization activity [GO:0042803]	GO:0004031; GO:0005506; GO:0005829; GO:0009055; GO:0009115; GO:0016903; GO:0017144; GO:0042802; GO:0042803; GO:0042816; GO:0043546; GO:0050660; GO:0051287; GO:0051537; GO:0055114; GO:0070062; GO:0071949; GO:0102797; GO:0102798	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:18671973, ECO:0000269|PubMed:20444863, ECO:0000269|PubMed:23857892}.		MOD_RES 1068 1068 Phosphoserine. {ECO:0000244|PubMed:24275569}.	8248161; 11302742; 15815621; 15489334; 7786031; 9224775; 17022944; 18066686; 18671973; 20444863; 22031625; 22522748; 22335465; 22996261; 23857892; 24275569; 26322824; 26842593; 22279051; 17992631; 19500084; 19741035; 19898482; 20379614; 20800603; 21988832; 22495427; 23918943; 25537183; 25845827; 26032640; 28606603; 28750088	8248161; 11302742; 15815621; 15489334; 7786031; 9224775; 17022944; 18066686; 18671973; 20444863; 22031625; 22522748; 22335465; 22996261; 23857892; 24275569; 26322824; 26842593; 22279051
19505	AOC2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.056 mM for tryptamine {ECO:0000269|PubMed:19588076}; KM=0.077 mM for 2-phenylethylamine {ECO:0000269|PubMed:19588076}; KM=0.167 mM for benzylamine {ECO:0000269|PubMed:19588076}; KM=0.178 mM for p-tyramine {ECO:0000269|PubMed:19588076}; KM=1.7 mM for methylamine {ECO:0000269|PubMed:19588076}; 	1.4.3.21	CATALYTIC ACTIVITY: RCH(2)NH(2) + H(2)O + O(2) = RCHO + NH(3) + H(2)O(2). {ECO:0000250|UniProtKB:P19801}.			COFACTOR: Name=Cu cation; Xref=ChEBI:CHEBI:23378; Evidence={ECO:0000250|UniProtKB:P19801}; ;  Note=Binds 1 copper ion per subunit. {ECO:0000250|UniProtKB:P19801};; COFACTOR: Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000250|UniProtKB:P19801}; ;  Note=Binds 2 calcium ions per subunit. {ECO:0000250|UniProtKB:P19801};; COFACTOR: Name=L-topaquinone; Xref=ChEBI:CHEBI:79027; Evidence={ECO:0000250|UniProtKB:P19801}; ;  Note=Contains 1 topaquinone per subunit. {ECO:0000250|UniProtKB:P19801};						amine metabolic process [GO:0009308]; catecholamine metabolic process [GO:0006584]; visual perception [GO:0007601]; xenobiotic metabolic process [GO:0006805]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; aliphatic-amine oxidase activity [GO:0052595]; aminoacetone:oxygen oxidoreductase(deaminating) activity [GO:0052594]; copper ion binding [GO:0005507]; electron transfer activity [GO:0009055]; phenethylamine:oxygen oxidoreductase (deaminating) activity [GO:0052596]; primary amine oxidase activity [GO:0008131]; quinone binding [GO:0048038]; tryptamine:oxygen oxidoreductase (deaminating) activity [GO:0052593]; amine metabolic process [GO:0009308]; catecholamine metabolic process [GO:0006584]; visual perception [GO:0007601]; xenobiotic metabolic process [GO:0006805]	aliphatic-amine oxidase activity [GO:0052595]; aminoacetone:oxygen oxidoreductase(deaminating) activity [GO:0052594]; copper ion binding [GO:0005507]; electron transfer activity [GO:0009055]; phenethylamine:oxygen oxidoreductase (deaminating) activity [GO:0052596]; primary amine oxidase activity [GO:0008131]; quinone binding [GO:0048038]; tryptamine:oxygen oxidoreductase (deaminating) activity [GO:0052593]	GO:0005507; GO:0005737; GO:0005886; GO:0006584; GO:0006805; GO:0007601; GO:0008131; GO:0009055; GO:0009308; GO:0048038; GO:0052593; GO:0052594; GO:0052595; GO:0052596	SUBCELLULAR LOCATION: Isoform 1: Cell membrane {ECO:0000269|PubMed:19588076}; Peripheral membrane protein {ECO:0000269|PubMed:19588076}. Note=Present on the surface of the cells. {ECO:0000269|PubMed:19588076}.; SUBCELLULAR LOCATION: Isoform 2: Cytoplasm {ECO:0000269|PubMed:19588076}. Note=Either not translocated to the plasma membrane or below detection level. {ECO:0000269|PubMed:19588076}.	PTM: Topaquinone (TPQ) is generated by copper-dependent autoxidation of a specific tyrosyl residue. {ECO:0000250|UniProtKB:P12807}.	MOD_RES 465 465 2',4',5'-topaquinone. {ECO:0000250|UniProtKB:P12807}.	9119395; 9722954; 16625196; 15489334; 12755418; 17400359; 19588076; 27766585	9119395; 9722954; 16625196; 15489334; 12755418; 17400359; 19588076
19537	AGO2 EIF2C2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.1 nM for a synthetic 21-nucleotide single-stranded RNA {ECO:0000269|PubMed:15105377, ECO:0000269|PubMed:15800637}; 	3.1.26.n2	CATALYTIC ACTIVITY: Endonucleolytic cleavage to 5'-phosphomonoester. {ECO:0000255|HAMAP-Rule:MF_03031, ECO:0000269|PubMed:15105377, ECO:0000269|PubMed:23746446}.		ACTIVITY REGULATION: Inhibited by EDTA. {ECO:0000269|PubMed:15284456}.	COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:15284456}; Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000269|PubMed:15284456}; 						gene silencing by RNA [GO:0031047]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; mRNA cleavage involved in gene silencing by siRNA [GO:0090625]; negative regulation of gene expression [GO:0010629]; negative regulation of translational initiation [GO:0045947]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; posttranscriptional gene silencing by RNA [GO:0035194]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; regulation of gene silencing by miRNA [GO:0060964]; RNA secondary structure unwinding [GO:0010501]; siRNA loading onto RISC involved in RNA interference [GO:0035087]; transcription, DNA-templated [GO:0006351]; translation [GO:0006412]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; micro-ribonucleoprotein complex [GO:0035068]; mRNA cap binding complex [GO:0005845]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; micro-ribonucleoprotein complex [GO:0035068]; mRNA cap binding complex [GO:0005845]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; core promoter binding [GO:0001047]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity, cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA cap binding [GO:0098808]; protein C-terminus binding [GO:0008022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; translation initiation factor activity [GO:0003743]; gene silencing by RNA [GO:0031047]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; mRNA cleavage involved in gene silencing by siRNA [GO:0090625]; negative regulation of gene expression [GO:0010629]; negative regulation of translational initiation [GO:0045947]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; posttranscriptional gene silencing by RNA [GO:0035194]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; regulation of gene silencing by miRNA [GO:0060964]; RNA secondary structure unwinding [GO:0010501]; siRNA loading onto RISC involved in RNA interference [GO:0035087]; transcription, DNA-templated [GO:0006351]; translation [GO:0006412]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]	core promoter binding [GO:0001047]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity, cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA cap binding [GO:0098808]; protein C-terminus binding [GO:0008022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; translation initiation factor activity [GO:0003743]	GO:0000340; GO:0000932; GO:0000993; GO:0001047; GO:0003723; GO:0003725; GO:0003727; GO:0003743; GO:0004521; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005844; GO:0005845; GO:0006351; GO:0006412; GO:0007223; GO:0008022; GO:0009791; GO:0010501; GO:0010586; GO:0010628; GO:0010629; GO:0016020; GO:0016442; GO:0030054; GO:0030422; GO:0030425; GO:0031047; GO:0031054; GO:0035068; GO:0035087; GO:0035194; GO:0035196; GO:0035197; GO:0035198; GO:0035278; GO:0035279; GO:0035280; GO:0045766; GO:0045944; GO:0045947; GO:0046872; GO:0060213; GO:0060964; GO:0070062; GO:0070551; GO:0070578; GO:0090624; GO:0090625; GO:0098808; GO:1900153; GO:1901165; GO:1905618; GO:1990904	SUBCELLULAR LOCATION: Cytoplasm, P-body {ECO:0000269|PubMed:23125361}. Nucleus {ECO:0000269|PubMed:23125361}. Note=Translational repression of mRNAs results in their recruitment to P-bodies. Translocation to the nucleus requires IMP8.	PTM: Hydroxylated. 4-hydroxylation appears to enhance protein stability but is not required for miRNA-binding or endonuclease activity. {ECO:0000255|HAMAP-Rule:MF_03031, ECO:0000269|PubMed:18690212}.	MOD_RES 2 2 Nitrated tyrosine. {ECO:0000250|UniProtKB:Q8CJG0, ECO:0000255|HAMAP-Rule:MF_03031}.; MOD_RES 387 387 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 700 700 4-hydroxyproline. {ECO:0000255|HAMAP-Rule:MF_03031, ECO:0000269|PubMed:18690212}.; MOD_RES 828 828 Phosphoserine. {ECO:0000244|PubMed:23186163}.	16421571; 15489334; 11914277; 10534406; 14508492; 14749716; 15105377; 15260970; 14703574; 15337849; 15284456; 15766526; 16271387; 16289642; 16142218; 16357216; 15800629; 15973356; 15908945; 15800637; 16081698; 16936728; 16756390; 16699599; 17382880; 17524464; 17932509; 17531811; 17507929; 18048652; 18771919; 18690212; 18178619; 19167051; 19801630; 20616046; 21269460; 21981923; 22791714; 22915799; 23746446; 23186163; 23125361; 25697406; 28546213; 20505670; 21475248; 22682761; 22539551; 11201747; 11452083; 12154197; 12411504; 12411505; 13130130; 15014042; 15643423; 16271386; 16284623; 16301602; 16373483; 16424907; 16611939; 16936726; 17085592; 17116888; 17128271; 17237358; 17400507; 17452327; 17540598; 17540599; 17554337; 17632058; 17681183; 17823410; 17881374; 17891150; 18199536; 18222171; 18227514; 18327259; 18461144; 18476811; 18591665; 18613814; 18728384; 18782830; 18787018; 18842624; 18852463; 18946079; 18978028; 19047128; 19061863; 19064005; 19114653; 19138993; 19159466; 19324964; 19380743; 19383768; 19383769; 19393748; 19398495; 19401777; 19458189; 19470757; 19487573; 19508234; 19536157; 19625255; 19701182; 19714243; 19716330; 19723326; 19723635; 19773441; 19784364; 19820710; 19851984; 19946268; 19966796; 20080666; 20080834; 20146808; 20184375; 20197313; 20198652; 20211803; 20223231; 20237157; 20351093; 20385818; 20388916; 20395958; 20402672; 20495621; 20562859; 20577206; 20671708; 20699384; 20721975; 20805998; 20924207; 20972213; 21071408; 21148147; 21177824; 21241449; 21329875; 21329882; 21383194; 21423624; 21427083; 21525958; 21535412; 21551231; 21552258; 21589992; 21602795; 21634124; 21726814; 21769619; 21840310; 21846468; 21868483; 21903422; 21951848; 21964070; 21969601; 21988832; 22000013; 22014067; 22025453; 22055194; 22064859; 22106413; 22163034; 22215596; 22366686; 22374676; 22394132; 22445173; 22474261; 22647351; 22722852; 22800433; 22844086; 22858679; 22961379; 23019594; 23063653; 23077538; 23085987; 23090477; 23091627; 23143396; 23150874; 23201202; 23245472; 23251028; 23258480; 23289589; 23411422; 23416699; 23511973; 23512276; 23531496; 23603119; 23622242; 23624860; 23636329; 23658827; 23661684; 23664376; 23665583; 23696368; 23741051; 23748378; 23775134; 23824327; 23856247; 23877830; 23882114; 24023945; 24030283; 24043833; 24086155; 24141778; 24209750; 24263100; 24361012; 24388755; 24388988; 24550003; 24574065; 24596094; 24662483; 24727796; 24788663; 24805183; 24886719; 24935600; 24981741; 25036361; 25036637; 25072345; 25135428; 25175024; 25313066; 25359968; 25446899; 25452107; 25464849; 25497084; 25562167; 25568082; 25605800; 25673011; 25680411; 25793518; 25918241; 25937637; 25970378; 26140367; 26140593; 26188282; 26188511; 26227789; 26242502; 26253535; 26304123; 26359634; 26379499; 26443379; 26451954; 26475020; 26496610; 26507454; 26518874; 26545861; 26592935; 26699195; 26701625; 26716895; 26749280; 26809675; 26854235; 27117408; 27142104; 27288410; 27380263; 27387838; 27418678; 27478153; 27486976; 27518285; 27721445; 27924485; 27924486; 27924487; 27924488; 27924489; 28008821; 28075055; 28082397; 28114302; 28334781; 28472401; 28645918; 28683311; 28831191; 28839112; 28850112; 28939659; 28954383; 29017520; 29031931; 29576456; 9214382	16421571; 15489334; 11914277; 10534406; 14508492; 14749716; 15105377; 15260970; 14703574; 15337849; 15284456; 15766526; 16271387; 16289642; 16142218; 16357216; 15800629; 15973356; 15908945; 15800637; 16081698; 16936728; 16756390; 16699599; 17382880; 17524464; 17932509; 17531811; 17507929; 18048652; 18771919; 18690212; 18178619; 19167051; 19801630; 20616046; 21269460; 21981923; 22791714; 22915799; 23746446; 23186163; 23125361; 25697406; 28546213; 20505670; 21475248; 22682761; 22539551
19546	ALDH7A1 ATQ1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=28.5 uM for nonanal {ECO:0000269|PubMed:20207735}; KM=5.3 uM for trans-2-nonenal {ECO:0000269|PubMed:20207735}; KM=39.1 uM for hexanal {ECO:0000269|PubMed:20207735}; KM=17.5 uM for octanal {ECO:0000269|PubMed:20207735}; KM=41.1 uM for betaine aldehyde {ECO:0000269|PubMed:20207735}; KM=169 uM for L-2-aminoadipate 6-semialdehyde {ECO:0000269|PubMed:20207735}; KM=530.2 uM for benzaldehyde {ECO:0000269|PubMed:20207735}; KM=647.4 uM for propanal {ECO:0000269|PubMed:20207735}; KM=7374.3 uM for glyceraldehyde {ECO:0000269|PubMed:20207735}; Vmax=364.9 nmol/min/mg enzyme toward nonanal {ECO:0000269|PubMed:20207735}; Vmax=34.9 nmol/min/mg enzyme toward trans-2-nonenal {ECO:0000269|PubMed:20207735}; Vmax=243.3 nmol/min/mg enzyme toward hexanal {ECO:0000269|PubMed:20207735}; Vmax=72.3 nmol/min/mg enzyme toward octanal {ECO:0000269|PubMed:20207735}; Vmax=101.4 nmol/min/mg enzyme toward betaine aldehyde {ECO:0000269|PubMed:20207735}; Vmax=276.2 nmol/min/mg enzyme toward L-2-aminoadipate 6-semialdehyde {ECO:0000269|PubMed:20207735}; Vmax=125.2 nmol/min/mg enzyme toward benzaldehyde {ECO:0000269|PubMed:20207735}; Vmax=69.9 nmol/min/mg enzyme toward propanal {ECO:0000269|PubMed:20207735}; Vmax=174 nmol/min/mg enzyme toward glyceraldehyde {ECO:0000269|PubMed:20207735}; 	1.2.1.31; 1.2.1.3; 1.2.1.8	CATALYTIC ACTIVITY: (S)-2-amino-6-oxohexanoate + NAD(P)(+) + H(2)O = L-2-aminoadipate + NAD(P)H.; CATALYTIC ACTIVITY: Betaine aldehyde + NAD(+) + H(2)O = betaine + NADH.; CATALYTIC ACTIVITY: An aldehyde + NAD(+) + H(2)O = a carboxylate + NADH.					PATHWAY: Amine and polyamine biosynthesis; betaine biosynthesis via choline pathway; betaine from betaine aldehyde: step 1/1.	SITE 195 195 Transition state stabilizer. {ECO:0000250}.			cellular aldehyde metabolic process [GO:0006081]; choline catabolic process [GO:0042426]; glycine betaine biosynthetic process from choline [GO:0019285]; lysine catabolic process [GO:0006554]; sensory perception of sound [GO:0007605]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; betaine-aldehyde dehydrogenase activity [GO:0008802]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; L-aminoadipate-semialdehyde dehydrogenase activity [GO:0004043]; cellular aldehyde metabolic process [GO:0006081]; choline catabolic process [GO:0042426]; glycine betaine biosynthetic process from choline [GO:0019285]; lysine catabolic process [GO:0006554]; sensory perception of sound [GO:0007605]	aldehyde dehydrogenase (NAD) activity [GO:0004029]; betaine-aldehyde dehydrogenase activity [GO:0008802]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; L-aminoadipate-semialdehyde dehydrogenase activity [GO:0004043]	GO:0004029; GO:0004043; GO:0005634; GO:0005739; GO:0005759; GO:0005829; GO:0006081; GO:0006554; GO:0007605; GO:0008802; GO:0019285; GO:0042426; GO:0043878; GO:0070062	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:20207735}. Nucleus {ECO:0000269|PubMed:20207735}.; SUBCELLULAR LOCATION: Isoform 1: Mitochondrion {ECO:0000269|PubMed:20207735}.		MOD_RES 94 94 N6-acetyllysine; alternate. {ECO:0000250|UniProtKB:Q9DBF1}.; MOD_RES 94 94 N6-succinyllysine; alternate. {ECO:0000250|UniProtKB:Q9DBF1}.; MOD_RES 462 462 N6-acetyllysine. {ECO:0000250|UniProtKB:Q9DBF1}.; MOD_RES 500 500 N6-acetyllysine. {ECO:0000250|UniProtKB:Q9DBF1}.; MOD_RES 537 537 N6-succinyllysine. {ECO:0000250|UniProtKB:Q9DBF1}.	8088832; 14702039; 15372022; 15489334; 9417906; 19413330; 21269460; 22223895; 24275569; 20207735; 16491085; 17068770; 16169070; 17433748; 18717709; 18854520; 19128417; 19142996; 19294602; 19885858; 20072603; 20512086; 20562859; 20639122; 20814824; 20877624; 21185811; 21338592; 21647815; 21988832; 22249334; 22305855; 22784480; 23054014; 23376216; 23663784; 23683770; 24122892; 24664145; 25213698; 25554827; 25609649; 26224730; 26232297; 26260980; 26555630; 27186704; 28087462; 28131559; 29045138; 29061647	8088832; 14702039; 15372022; 15489334; 9417906; 19413330; 21269460; 22223895; 24275569; 20207735; 16491085; 17068770
19549	AGMO TMEM195	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=11 uM for 1-O pyrenedecyl glycerol (in presence of ALDH3A2) {ECO:0000269|PubMed:20643956}; KM=2.58 uM for tetrahydrobiopterin (in presence of ALDH3A2) {ECO:0000269|PubMed:20643956}; 	1.14.16.5	CATALYTIC ACTIVITY: 1-alkyl-sn-glycerol + tetrahydrobiopterin + O(2) = 1-O-alkyl-sn-glycerol + dihydrobiopterin + H(2)O. {ECO:0000269|PubMed:20643956}.			COFACTOR: Name=Fe cation; Xref=ChEBI:CHEBI:24875; Evidence={ECO:0000305|PubMed:20643956}; 						ether lipid metabolic process [GO:0046485]; membrane lipid metabolic process [GO:0006643]; triglyceride biosynthetic process [GO:0019432]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]; ether lipid metabolic process [GO:0046485]; membrane lipid metabolic process [GO:0006643]; triglyceride biosynthetic process [GO:0019432]	glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]	GO:0005506; GO:0005783; GO:0005789; GO:0006643; GO:0016021; GO:0019432; GO:0046485; GO:0050479	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:20643956}; Multi-pass membrane protein {ECO:0000269|PubMed:20643956}.			14702039; 12690205; 15489334; 20643956; 24275569; 20081858; 20419449; 20571754; 20613766; 22220568; 27000257; 28586473	14702039; 12690205; 15489334; 20643956; 24275569
19554	LVRN AQPEP	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=78.2 uM for Leu-4-methylcoumaryl-7-amide {ECO:0000269|PubMed:17525158}; 	3.4.11.-		BINDING 240 240 Substrate. {ECO:0000250}.	ACTIVITY REGULATION: Inhibited by bestatin. {ECO:0000269|PubMed:17525158}.	COFACTOR: Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250}; ;  Note=Binds 1 zinc ion per subunit. {ECO:0000250};	BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 7.0. {ECO:0000269|PubMed:17525158};		SITE 503 503 Transition state stabilizer. {ECO:0000250}.			cell-cell signaling [GO:0007267]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cell-cell signaling [GO:0007267]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]	metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]	GO:0005737; GO:0005886; GO:0006508; GO:0007165; GO:0007267; GO:0008217; GO:0008270; GO:0016021; GO:0042277; GO:0043171; GO:0070006	SUBCELLULAR LOCATION: Membrane {ECO:0000303|PubMed:17525158}; Single-pass type II membrane protein {ECO:0000303|PubMed:17525158}.	PTM: N-glycosylated. {ECO:0000269|PubMed:17525158}.		14706636; 14702039; 15372022; 15489334; 17525158; 15897020; 16804865; 19578876; 19819873; 20379614; 21212512; 22402206; 24959655	14706636; 14702039; 15372022; 15489334; 17525158
19583	PRMT6 HRMT1L6	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=18.6 uM for AdoMet {ECO:0000269|PubMed:18263580}; KM=501 uM for WGGYSRGGYGGW peptide {ECO:0000269|PubMed:18263580}; KM=183.7 uM for WGGYSR(MMA)GGYGGW monomethylated peptide {ECO:0000269|PubMed:18263580}; Vmax=3.3 nmol/min/mg enzyme with AdoMet as substrate {ECO:0000269|PubMed:18263580}; Vmax=1.8 nmol/min/mg enzyme with WGGYSRGGYGGW peptide as substrate {ECO:0000269|PubMed:18263580}; Vmax=3.2 nmol/min/mg enzyme with WGGYSR(MMA)GGYGGW monomethylated peptide as substrate {ECO:0000269|PubMed:18263580}; 	2.1.1.319	CATALYTIC ACTIVITY: 2 S-adenosyl-L-methionine + [protein]-L-arginine = 2 S-adenosyl-L-homocysteine + [protein]-N(omega),N(omega)-dimethyl-L-arginine. {ECO:0000269|PubMed:17898714, ECO:0000269|PubMed:18077460, ECO:0000269|PubMed:18079182, ECO:0000269|PubMed:19405910}.	BINDING 57 57 S-adenosyl-L-methionine. {ECO:0000250}.; BINDING 66 66 S-adenosyl-L-methionine.; BINDING 90 90 S-adenosyl-L-methionine; via carbonyl oxygen.; BINDING 112 112 S-adenosyl-L-methionine.; BINDING 141 141 S-adenosyl-L-methionine.								base-excision repair [GO:0006284]; cellular senescence [GO:0090398]; histone H3-R2 methylation [GO:0034970]; histone methylation [GO:0016571]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription, DNA-templated [GO:0006351]; viral process [GO:0016032]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H2A-R3 specific) [GO:0070612]; histone methyltransferase activity (H3-R2 specific) [GO:0070611]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; histone-arginine N-methyltransferase activity [GO:0008469]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; base-excision repair [GO:0006284]; cellular senescence [GO:0090398]; histone H3-R2 methylation [GO:0034970]; histone methylation [GO:0016571]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription, DNA-templated [GO:0006351]; viral process [GO:0016032]	chromatin binding [GO:0003682]; histone-arginine N-methyltransferase activity [GO:0008469]; histone binding [GO:0042393]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H2A-R3 specific) [GO:0070612]; histone methyltransferase activity (H3-R2 specific) [GO:0070611]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]	GO:0000122; GO:0003682; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006284; GO:0006351; GO:0008469; GO:0016032; GO:0016274; GO:0016571; GO:0019919; GO:0034970; GO:0035241; GO:0035242; GO:0042054; GO:0042393; GO:0044020; GO:0045652; GO:0045892; GO:0051572; GO:0070611; GO:0070612; GO:0090398; GO:1901796	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11724789}.	PTM: Automethylation enhances its stability and antiretroviral activity.	MOD_RES 21 21 Phosphothreonine. {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:23186163}.; MOD_RES 29 29 Omega-N-methylated arginine; by autocatalysis. {ECO:0000269|PubMed:23866860}.; MOD_RES 35 35 Omega-N-methylated arginine; by autocatalysis. {ECO:0000269|PubMed:23866860}.; MOD_RES 37 37 Omega-N-methylated arginine; by autocatalysis. {ECO:0000269|PubMed:23866860}.	11724789; 14702039; 16710414; 15489334; 17974005; 15334060; 15596808; 16157300; 16159886; 16600869; 17176473; 17415034; 17267505; 17898714; 18079182; 18077460; 18263580; 18691976; 19405910; 19509293; 20047962; 21269460; 23186163; 23866860; 26178996; 10617663; 11341840; 11448779; 16293633; 17215844; 18316480; 19114653; 19754311; 20473859; 20562859; 20812326; 21774791; 21988832; 22219200; 22673335; 22777353; 22916108; 23032699; 23265702; 23326497; 23380452; 23455924; 23800116; 23911394; 23980157; 24742914; 25416956; 25481537; 26070566; 26101569; 26598975; 26611710; 26690413; 26824386; 26848759; 27323813; 27480107; 29262320	11724789; 14702039; 16710414; 15489334; 17974005; 15334060; 15596808; 16157300; 16159886; 16600869; 17176473; 17415034; 17267505; 17898714; 18079182; 18077460; 18263580; 18691976; 19405910; 19509293; 20047962; 21269460; 23186163; 23866860; 26178996; 
19596	AOC3 VAP1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.94 mM for 2-phenylethylamine {ECO:0000269|PubMed:19588076}; KM=0.67 mM for methylamine {ECO:0000269|PubMed:19588076}; 	1.4.3.21	CATALYTIC ACTIVITY: RCH(2)NH(2) + H(2)O + O(2) = RCHO + NH(3) + H(2)O(2). {ECO:0000269|PubMed:19588076}.			COFACTOR: Name=Cu cation; Xref=ChEBI:CHEBI:23378; Evidence={ECO:0000269|PubMed:16046623}; ;  Note=Binds 1 copper ion per subunit. {ECO:0000269|PubMed:16046623};; COFACTOR: Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000269|PubMed:16046623}; ;  Note=Binds 2 calcium ions per subunit. {ECO:0000269|PubMed:16046623};; COFACTOR: Name=L-topaquinone; Xref=ChEBI:CHEBI:79027; Evidence={ECO:0000269|PubMed:16046623}; ;  Note=Contains 1 topaquinone per subunit. {ECO:0000269|PubMed:16046623};						amine metabolic process [GO:0009308]; cell adhesion [GO:0007155]; inflammatory response [GO:0006954]; negative regulation of primary amine oxidase activity [GO:1902283]; response to antibiotic [GO:0046677]; xenobiotic metabolic process [GO:0006805]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; microvillus [GO:0005902]; plasma membrane [GO:0005886]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; aliphatic-amine oxidase activity [GO:0052595]; aminoacetone:oxygen oxidoreductase(deaminating) activity [GO:0052594]; calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; phenethylamine:oxygen oxidoreductase (deaminating) activity [GO:0052596]; primary amine oxidase activity [GO:0008131]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; quinone binding [GO:0048038]; tryptamine:oxygen oxidoreductase (deaminating) activity [GO:0052593]; amine metabolic process [GO:0009308]; cell adhesion [GO:0007155]; inflammatory response [GO:0006954]; negative regulation of primary amine oxidase activity [GO:1902283]; response to antibiotic [GO:0046677]; xenobiotic metabolic process [GO:0006805]	aliphatic-amine oxidase activity [GO:0052595]; aminoacetone:oxygen oxidoreductase(deaminating) activity [GO:0052594]; calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; phenethylamine:oxygen oxidoreductase (deaminating) activity [GO:0052596]; primary amine oxidase activity [GO:0008131]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; quinone binding [GO:0048038]; tryptamine:oxygen oxidoreductase (deaminating) activity [GO:0052593]	GO:0005507; GO:0005509; GO:0005737; GO:0005769; GO:0005783; GO:0005794; GO:0005886; GO:0005902; GO:0006805; GO:0006954; GO:0007155; GO:0008131; GO:0009308; GO:0009986; GO:0016021; GO:0042803; GO:0046677; GO:0046982; GO:0048038; GO:0052593; GO:0052594; GO:0052595; GO:0052596; GO:1902283	SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:9653080}; Single-pass type II membrane protein {ECO:0000269|PubMed:9653080}.	PTM: Topaquinone (TPQ) is generated by copper-dependent autoxidation of a specific tyrosyl residue. {ECO:0000269|PubMed:16046623}.; PTM: N- and O-glycosylated. {ECO:0000269|PubMed:16046623, ECO:0000269|PubMed:16335952, ECO:0000269|PubMed:19139490, ECO:0000269|PubMed:19159218}.	MOD_RES 471 471 2',4',5'-topaquinone. {ECO:0000244|PDB:1PU4}.	8972912; 9653080; 14585497; 23349812; 14702039; 16625196; 15489334; 15242332; 16335952; 17400359; 19588076; 19159218; 19139490; 16046623; 12097405; 12466139; 12700900; 12832789; 14715500; 14726375; 14755492; 15057044; 15830186; 15919838; 16239734; 16361866; 16507887; 16511016; 16556889; 16806498; 17006978; 17256751; 17393059; 17393062; 17431736; 17490641; 18644360; 18853098; 18991279; 19336232; 19361461; 19761765; 19789505; 19861682; 20063021; 20512991; 21114364; 21139198; 21282368; 21512782; 21585208; 21819380; 21821708; 21988832; 22133888; 22150439; 22354146; 22618595; 22714978; 22753196; 23062326; 23120772; 23414517; 23769096; 24211727; 24304424; 24379274; 24503888; 24781952; 24903765; 25279492; 25342050; 25420878; 25457560; 25562318; 26287391; 26395033; 26845338; 27036009; 27300745; 27731409; 27766585; 27893774; 28251930; 28428344; 29229088	8972912; 9653080; 14585497; 23349812; 14702039; 16625196; 15489334; 15242332; 16335952; 17400359; 19588076; 19159218; 19139490; 16046623
19627	ALDH8A1 ALDH12	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=17.5 uM for benzaldehyde {ECO:0000269|PubMed:11007799}; KM=3.15 uM for 9-cis-retinal {ECO:0000269|PubMed:11007799}; 	1.2.1.-					BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 9. {ECO:0000269|PubMed:11007799};		SITE 155 155 Transition state stabilizer. {ECO:0000250}.			9-cis-retinoic acid biosynthetic process [GO:0042904]; retinal metabolic process [GO:0042574]; retinoic acid metabolic process [GO:0042573]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular [GO:0005622]	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular [GO:0005622]; retinal dehydrogenase activity [GO:0001758]; 9-cis-retinoic acid biosynthetic process [GO:0042904]; retinal metabolic process [GO:0042574]; retinoic acid metabolic process [GO:0042573]	retinal dehydrogenase activity [GO:0001758]	GO:0001758; GO:0005622; GO:0005829; GO:0042573; GO:0042574; GO:0042904; GO:0070062	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.		MOD_RES 362 362 Phosphoserine. {ECO:0000244|PubMed:24275569}.	11007799; 14702039; 14574404; 15489334; 24275569; 19343046; 24725412	11007799; 14702039; 14574404; 15489334; 24275569
19628	ALDH3A2 ALDH10 FALDH	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=50 uM for hexanal {ECO:0000269|PubMed:9133646}; KM=32 uM for octanal {ECO:0000269|PubMed:9133646}; KM=23 uM for decanal {ECO:0000269|PubMed:9133646}; KM=19 uM for dodecanal {ECO:0000269|PubMed:9133646}; KM=23 uM for tetradecanal {ECO:0000269|PubMed:9133646}; KM=32 uM for hexadecanal {ECO:0000269|PubMed:9133646}; KM=21 uM for octadecanal {ECO:0000269|PubMed:9133646}; KM=280 uM for NAD {ECO:0000269|PubMed:9133646}; KM=8700 uM for NADp {ECO:0000269|PubMed:9133646}; Vmax=29 umol/min/mg enzyme with hexanal {ECO:0000269|PubMed:9133646}; Vmax=63 umol/min/mg enzyme with octanal {ECO:0000269|PubMed:9133646}; Vmax=73 umol/min/mg enzyme with decanal {ECO:0000269|PubMed:9133646}; Vmax=45 umol/min/mg enzyme with dodecanal {ECO:0000269|PubMed:9133646}; Vmax=40 umol/min/mg enzyme with hexadecanal {ECO:0000269|PubMed:9133646}; Vmax=46 umol/min/mg enzyme with octadecanal {ECO:0000269|PubMed:9133646}; Vmax=42 umol/min/mg enzyme with tetradecanal {ECO:0000269|PubMed:9133646}; 	1.2.1.3	CATALYTIC ACTIVITY: An aldehyde + NAD(+) + H(2)O = a carboxylate + NADH. {ECO:0000269|PubMed:22633490, ECO:0000269|PubMed:25047030, ECO:0000269|PubMed:9133646}.				BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 9.8. {ECO:0000269|PubMed:9133646};					cellular aldehyde metabolic process [GO:0006081]; central nervous system development [GO:0007417]; epidermis development [GO:0008544]; fatty acid alpha-oxidation [GO:0001561]; hexadecanal metabolic process [GO:0046458]; oxidation-reduction process [GO:0055114]; peripheral nervous system development [GO:0007422]; phytol metabolic process [GO:0033306]; sesquiterpenoid metabolic process [GO:0006714]; sphingolipid biosynthetic process [GO:0030148]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; long-chain-alcohol oxidase activity [GO:0046577]; long-chain-aldehyde dehydrogenase activity [GO:0050061]; medium-chain-aldehyde dehydrogenase activity [GO:0052814]; protein homodimerization activity [GO:0042803]; cellular aldehyde metabolic process [GO:0006081]; central nervous system development [GO:0007417]; epidermis development [GO:0008544]; fatty acid alpha-oxidation [GO:0001561]; hexadecanal metabolic process [GO:0046458]; oxidation-reduction process [GO:0055114]; peripheral nervous system development [GO:0007422]; phytol metabolic process [GO:0033306]; sesquiterpenoid metabolic process [GO:0006714]; sphingolipid biosynthetic process [GO:0030148]	aldehyde dehydrogenase (NAD) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; long-chain-alcohol oxidase activity [GO:0046577]; long-chain-aldehyde dehydrogenase activity [GO:0050061]; medium-chain-aldehyde dehydrogenase activity [GO:0052814]; protein homodimerization activity [GO:0042803]	GO:0001561; GO:0004029; GO:0005777; GO:0005778; GO:0005789; GO:0006081; GO:0006714; GO:0007417; GO:0007422; GO:0008544; GO:0016021; GO:0030148; GO:0033306; GO:0042803; GO:0043231; GO:0043878; GO:0046458; GO:0046577; GO:0050061; GO:0052814; GO:0055114	SUBCELLULAR LOCATION: Microsome membrane {ECO:0000269|PubMed:9133646}; Single-pass membrane protein {ECO:0000305|PubMed:25047030, ECO:0000305|PubMed:9133646}. Endoplasmic reticulum membrane {ECO:0000305|PubMed:9133646}; Single-pass membrane protein {ECO:0000305|PubMed:25047030, ECO:0000305|PubMed:9133646}; Cytoplasmic side {ECO:0000250|UniProtKB:P30839}.		MOD_RES 293 293 Phosphoserine. {ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.	8528251; 9027499; 9070922; 14702039; 15489334; 9133646; 21269460; 22633490; 23186163; 24275569; 25047030; 9254849; 9829906; 10577908; 10792573; 11306053; 11341778; 15110319; 15241804; 15931689; 16794583; 16996289; 17342744; 17510064; 17902024; 17971613; 17998529; 18035827; 18519826; 19343046; 19615732; 19965611; 20237496; 20360068; 20562859; 20677014; 20877624; 20883264; 21524986; 21684788; 21872273; 21911577; 22397046; 22593156; 23034980; 24189400; 24255178; 24377952; 25532748; 25665578; 26449735; 26496610; 26638075; 9250352	8528251; 9027499; 9070922; 14702039; 15489334; 9133646; 21269460; 22633490; 23186163; 24275569; 25047030; 9254849; 9829906; 10577908; 10792573
19663	ALDH3A1 ALDH3	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: Note=Has a high Km for acetaldehyde.;	1.2.1.5	CATALYTIC ACTIVITY: An aldehyde + NAD(P)(+) + H(2)O = a carboxylate + NAD(P)H. {ECO:0000269|PubMed:1737758, ECO:0000269|PubMed:22021038}.									cellular aldehyde metabolic process [GO:0006081]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; 3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; benzaldehyde dehydrogenase (NAD+) activity [GO:0018479]; cellular aldehyde metabolic process [GO:0006081]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805]	3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; benzaldehyde dehydrogenase (NAD+) activity [GO:0018479]	GO:0004028; GO:0004029; GO:0004030; GO:0005615; GO:0005783; GO:0005829; GO:0005886; GO:0006081; GO:0006805; GO:0008106; GO:0016021; GO:0018479; GO:0055114	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P47739}.		MOD_RES 2 2 N-acetylserine. {ECO:0000244|PubMed:22814378}.; MOD_RES 178 178 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 194 194 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.	1737758; 8493892; 14702039; 16625196; 15489334; 2037078; 1905102; 19608861; 21269460; 22814378; 22021038; 9250352; 12367788; 12706498; 12943535; 14745454; 15905174; 16614850; 18496131; 18536178; 18621017; 18647600; 18854779; 19025616; 19058789; 19343046; 19360691; 19696793; 19894643; 20056567; 20102361; 20237496; 20379614; 21044950; 21203538; 21229876; 21251908; 21988832; 22406320; 24276407; 24316006; 24677340; 24762960; 26124079; 26751691; 27276244; 27279633; 27997560; 28526614; 9855707	1737758; 8493892; 14702039; 16625196; 15489334; 2037078; 1905102; 19608861; 21269460; 22814378; 22021038; 9250352
19666	AKR1B15	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=2.8 uM for androsterone (tested with isoform 1 in the reductive reaction) {ECO:0000269|PubMed:25577493}; KM=1.9 uM for delta-4-androstenedione (tested with isoform 1 in the reductive reaction) {ECO:0000269|PubMed:25577493}; KM=2.5 uM for estrone (tested with isoform 1 in the reductive reaction) {ECO:0000269|PubMed:25577493}; KM=63.4 uM for acetoacetyl-CoA (tested with isoform 1 in the reductive reaction) {ECO:0000269|PubMed:25577493}; KM=19.2 uM for 3-alpha,17-beta-androstandiol (tested with isoform 1 in the oxidative reaction) {ECO:0000269|PubMed:25577493}; KM=7.1 uM for testosterone (tested with isoform 1 in the oxidative reaction) {ECO:0000269|PubMed:25577493}; KM=9.1 uM for 17-beta-estradiol (tested with isoform 1 in the oxidative reaction) {ECO:0000269|PubMed:25577493}; Note=kcat is 1.7 min(-1) using isoform 1 for the reduction of androsterone. kcat is 1.1 min(-1) using isoform 1 for the reduction of delta-4-androstenedione. kcat is 1.0 min(-1) using isoform 1 for the reduction of estrone. kcat is 0.5 min(-1) using isoform 1 for the reduction of acetoacetyl-CoA. kcat is 3.0 min(-1) using isoform 1 for the oxidation of 3-alpha,17-beta-androstandiol. kcat is 0.6 min(-1) using isoform 1 for the oxidation of testosterone. kcat is 0.5 min(-1) using isoform 1 for the oxidation of 17-beta-estradiol. {ECO:0000269|PubMed:25577493};	1.1.1.-; 1.1.1.62	CATALYTIC ACTIVITY: 17-beta-estradiol + NAD(P)(+) = estrone + NAD(P)H. {ECO:0000269|PubMed:25577493}.	BINDING 44 44 NADP. {ECO:0000250|UniProtKB:O60218}.; BINDING 111 111 Substrate. {ECO:0000250|UniProtKB:O60218}.; BINDING 184 184 NADP. {ECO:0000250|UniProtKB:O60218}.					SITE 78 78 Lowers pKa of active site Tyr. {ECO:0000250|UniProtKB:P14550}.			estrogen biosynthetic process [GO:0006703]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; estrogen biosynthetic process [GO:0006703]	estradiol 17-beta-dehydrogenase activity [GO:0004303]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]	GO:0004303; GO:0005739; GO:0005759; GO:0005829; GO:0006703; GO:0016616	SUBCELLULAR LOCATION: Isoform 1: Mitochondrion {ECO:0000269|PubMed:25577493}.; SUBCELLULAR LOCATION: Isoform 2: Cytoplasm, cytosol {ECO:0000269|PubMed:25577493}.		MOD_RES 125 125 N6-acetyllysine. {ECO:0000250|UniProtKB:O60218}.; MOD_RES 263 263 N6-acetyllysine. {ECO:0000250|UniProtKB:O60218}.	21276782; 12853948; 25577493; 20877624; 22277967; 22970857; 26222439	21276782; 12853948; 25577493
19676	AKT1 PKB RAC	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=52.8 uM for ATP (for purified and in vitro activated AKT1) {ECO:0000269|PubMed:16540465}; KM=0.5 uM for peptide substrate (for purified and in vitro activated AKT1) {ECO:0000269|PubMed:16540465}; KM=143.3 uM for ATP (for recombinant myristoylated AKT1 expressed and immunoprecipitated from Rat-1 cells) {ECO:0000269|PubMed:16540465}; KM=2.9 uM for peptide substrate (for recombinant myristoylated AKT1 expressed and immunoprecipitated from Rat-1 cells) {ECO:0000269|PubMed:16540465}; 	2.7.11.1	CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein. {ECO:0000269|PubMed:16139227, ECO:0000269|PubMed:1718748, ECO:0000269|PubMed:1851997}.	BINDING 53 53 Inositol-(1,3,4,5)-tetrakisphosphate.; BINDING 86 86 Inositol-(1,3,4,5)-tetrakisphosphate.; BINDING 161 161 Inhibitor; via amide nitrogen.; BINDING 179 179 ATP. {ECO:0000255|PROSITE-ProRule:PRU00159}.; BINDING 230 230 Inhibitor; via amide nitrogen.; BINDING 234 234 Inhibitor.; BINDING 292 292 Inhibitor.	ACTIVITY REGULATION: Three specific sites, one in the kinase domain (Thr-308) and the two other ones in the C-terminal regulatory region (Ser-473 and Tyr-474), need to be phosphorylated for its full activation. Inhibited by pyrrolopyrimidine inhibitors like aniline triazole and spiroindoline. {ECO:0000269|PubMed:18456494, ECO:0000269|PubMed:20481595, ECO:0000269|PubMed:20810279, ECO:0000269|PubMed:21392984, ECO:0000269|PubMed:9512493, ECO:0000269|PubMed:9736715}.							activation-induced cell death of T cells [GO:0006924]; activation of protein kinase B activity [GO:0032148]; aging [GO:0007568]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; carbohydrate transport [GO:0008643]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell projection organization [GO:0030030]; cell proliferation [GO:0008283]; cellular protein modification process [GO:0006464]; cellular response to cadmium ion [GO:0071276]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to organic cyclic compound [GO:0071407]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cofactor metabolic process [GO:0051186]; cytokine-mediated signaling pathway [GO:0019221]; endocrine pancreas development [GO:0031018]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; germ cell development [GO:0007281]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; glycogen cell differentiation involved in embryonic placenta development [GO:0060709]; G-protein coupled receptor signaling pathway [GO:0007186]; hyaluronan metabolic process [GO:0030212]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; insulin-like growth factor receptor signaling pathway [GO:0048009]; insulin receptor signaling pathway [GO:0008286]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cell size [GO:0045792]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of gene expression [GO:0010629]; negative regulation of JNK cascade [GO:0046329]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron death [GO:1901215]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of plasma membrane long-chain fatty acid transport [GO:0010748]; negative regulation of protein binding [GO:0032091]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase activity by protein phosphorylation [GO:0100002]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; NIK/NF-kappaB signaling [GO:0038061]; nitric oxide biosynthetic process [GO:0006809]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphorylation [GO:0016310]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell proliferation [GO:0008284]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle [GO:0031659]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vasoconstriction [GO:0045907]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein import into nucleus, translocation [GO:0000060]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; spinal cord development [GO:0021510]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; translation [GO:0006412]	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; vesicle [GO:0031982]	cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; vesicle [GO:0031982]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; GTPase activating protein binding [GO:0032794]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein phosphatase 2A binding [GO:0051721]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; activation of protein kinase B activity [GO:0032148]; activation-induced cell death of T cells [GO:0006924]; aging [GO:0007568]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; carbohydrate transport [GO:0008643]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell projection organization [GO:0030030]; cell proliferation [GO:0008283]; cellular protein modification process [GO:0006464]; cellular response to cadmium ion [GO:0071276]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to organic cyclic compound [GO:0071407]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cofactor metabolic process [GO:0051186]; cytokine-mediated signaling pathway [GO:0019221]; endocrine pancreas development [GO:0031018]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; G-protein coupled receptor signaling pathway [GO:0007186]; germ cell development [GO:0007281]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; glycogen cell differentiation involved in embryonic placenta development [GO:0060709]; hyaluronan metabolic process [GO:0030212]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cell size [GO:0045792]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of gene expression [GO:0010629]; negative regulation of JNK cascade [GO:0046329]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron death [GO:1901215]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of plasma membrane long-chain fatty acid transport [GO:0010748]; negative regulation of protein binding [GO:0032091]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase activity by protein phosphorylation [GO:0100002]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; NIK/NF-kappaB signaling [GO:0038061]; nitric oxide biosynthetic process [GO:0006809]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphorylation [GO:0016310]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell proliferation [GO:0008284]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle [GO:0031659]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vasoconstriction [GO:0045907]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein import into nucleus, translocation [GO:0000060]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; spinal cord development [GO:0021510]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; translation [GO:0006412]	14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; GTPase activating protein binding [GO:0032794]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein phosphatase 2A binding [GO:0051721]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]	GO:0000060; GO:0001649; GO:0001893; GO:0001934; GO:0001938; GO:0002042; GO:0004672; GO:0004674; GO:0004712; GO:0005080; GO:0005524; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005978; GO:0005979; GO:0006006; GO:0006412; GO:0006417; GO:0006464; GO:0006468; GO:0006469; GO:0006809; GO:0006924; GO:0006954; GO:0006974; GO:0006979; GO:0007165; GO:0007173; GO:0007186; GO:0007249; GO:0007281; GO:0007568; GO:0008283; GO:0008284; GO:0008286; GO:0008637; GO:0008643; GO:0009408; GO:0010507; GO:0010628; GO:0010629; GO:0010748; GO:0010763; GO:0010765; GO:0010907; GO:0010918; GO:0010951; GO:0010975; GO:0014065; GO:0015630; GO:0016242; GO:0016301; GO:0016310; GO:0016567; GO:0018105; GO:0018107; GO:0019221; GO:0019899; GO:0021510; GO:0030030; GO:0030154; GO:0030163; GO:0030212; GO:0030235; GO:0030307; GO:0030334; GO:0031018; GO:0031295; GO:0031397; GO:0031641; GO:0031659; GO:0031663; GO:0031929; GO:0031982; GO:0031999; GO:0032079; GO:0032091; GO:0032094; GO:0032148; GO:0032270; GO:0032287; GO:0032436; GO:0032794; GO:0032869; GO:0032991; GO:0033138; GO:0034405; GO:0034614; GO:0035556; GO:0035655; GO:0035924; GO:0036064; GO:0038061; GO:0042593; GO:0042802; GO:0042803; GO:0042981; GO:0043065; GO:0043066; GO:0043154; GO:0043276; GO:0043325; GO:0043488; GO:0043491; GO:0043536; GO:0045429; GO:0045600; GO:0045725; GO:0045742; GO:0045746; GO:0045792; GO:0045861; GO:0045893; GO:0045907; GO:0045944; GO:0046326; GO:0046329; GO:0046622; GO:0046777; GO:0046889; GO:0048009; GO:0048661; GO:0050999; GO:0051000; GO:0051091; GO:0051146; GO:0051186; GO:0051721; GO:0051898; GO:0060079; GO:0060416; GO:0060644; GO:0060709; GO:0060716; GO:0070141; GO:0071260; GO:0071276; GO:0071356; GO:0071364; GO:0071380; GO:0071407; GO:0071456; GO:0071889; GO:0071901; GO:0072655; GO:0072656; GO:0090201; GO:0097011; GO:0097194; GO:0098794; GO:0100002; GO:0140052; GO:1900182; GO:1901215; GO:1901796; GO:1902176; GO:1903038; GO:1903078; GO:1903721; GO:1990090; GO:1990418; GO:2000010; GO:2000402; GO:2001240	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P31750}. Nucleus. Cell membrane {ECO:0000250|UniProtKB:P31750}. Note=Nucleus after activation by integrin-linked protein kinase 1 (ILK1). Nuclear translocation is enhanced by interaction with TCL1A. Phosphorylation on Tyr-176 by TNK2 results in its localization to the cell membrane where it is targeted for further phosphorylations on Thr-308 and Ser-473 leading to its activation and the activated form translocates to the nucleus. Colocalizes with WDFY2 in intracellular vesicles (PubMed:16792529). {ECO:0000269|PubMed:16792529}.	PTM: O-GlcNAcylation at Thr-305 and Thr-312 inhibits activating phosphorylation at Thr-308 via disrupting the interaction between AKT1 and PDPK1. O-GlcNAcylation at Ser-473 also probably interferes with phosphorylation at this site. {ECO:0000269|PubMed:14761976, ECO:0000269|PubMed:15047712, ECO:0000269|PubMed:15718470, ECO:0000269|PubMed:16266983, ECO:0000269|PubMed:17013611, ECO:0000269|PubMed:18456494, ECO:0000269|PubMed:20333297, ECO:0000269|PubMed:20481595, ECO:0000269|PubMed:20978158, ECO:0000269|PubMed:21464307, ECO:0000269|PubMed:23799035, ECO:0000269|PubMed:8978681, ECO:0000269|PubMed:9512493, ECO:0000269|PubMed:9736715}.; PTM: Phosphorylation on Thr-308, Ser-473 and Tyr-474 is required for full activity. Activated TNK2 phosphorylates it on Tyr-176 resulting in its binding to the anionic plasma membrane phospholipid PA. This phosphorylated form localizes to the cell membrane, where it is targeted by PDPK1 and PDPK2 for further phosphorylations on Thr-308 and Ser-473 leading to its activation. Ser-473 phosphorylation by mTORC2 favors Thr-308 phosphorylation by PDPK1. Phosphorylated at Thr-308 and Ser-473 by IKBKE and TBK1. Ser-473 phosphorylation is enhanced by interaction with AGAP2 isoform 2 (PIKE-A). Ser-473 phosphorylation is enhanced in focal cortical dysplasias with Taylor-type balloon cells. Ser-473 phosphorylation is enhanced by signaling through activated FLT3. Dephosphorylated at Thr-308 and Ser-473 by PP2A phosphatase. The phosphorylated form of PPP2R5B is required for bridging AKT1 with PP2A phosphatase. Ser-473 is dephosphorylated by CPPED1, leading to termination of signaling. {ECO:0000269|PubMed:12149249, ECO:0000269|PubMed:14761976, ECO:0000269|PubMed:15047712, ECO:0000269|PubMed:15718470, ECO:0000269|PubMed:16266983, ECO:0000269|PubMed:17013611, ECO:0000269|PubMed:18456494, ECO:0000269|PubMed:20333297, ECO:0000269|PubMed:20481595, ECO:0000269|PubMed:20978158, ECO:0000269|PubMed:21464307, ECO:0000269|PubMed:23799035, ECO:0000269|PubMed:8978681, ECO:0000269|PubMed:9512493, ECO:0000269|PubMed:9736715}.; PTM: Ubiquitinated via 'Lys-48'-linked polyubiquitination by ZNRF1, leading to its degradation by the proteasome (By similarity). Ubiquitinated; undergoes both 'Lys-48'- and 'Lys-63'-linked polyubiquitination. TRAF6-induced 'Lys-63'-linked AKT1 ubiquitination is critical for phosphorylation and activation. When ubiquitinated, it translocates to the plasma membrane, where it becomes phosphorylated. When fully phosphorylated and translocated into the nucleus, undergoes 'Lys-48'-polyubiquitination catalyzed by TTC3, leading to its degradation by the proteasome. Also ubiquitinated by TRIM13 leading to its proteasomal degradation. Phosphorylated, undergoes 'Lys-48'-linked polyubiquitination preferentially at Lys-284 catalyzed by MUL1, leading to its proteasomal degradation. {ECO:0000250, ECO:0000269|PubMed:19713527, ECO:0000269|PubMed:20059950, ECO:0000269|PubMed:21333377, ECO:0000269|PubMed:22410793}.; PTM: Acetylated on Lys-14 and Lys-20 by the histone acetyltransferases EP300 and KAT2B. Acetylation results in reduced phosphorylation and inhibition of activity. Deacetylated at Lys-14 and Lys-20 by SIRT1. SIRT1-mediated deacetylation relieves the inhibition. {ECO:0000269|PubMed:21775285}.	MOD_RES 14 14 N6-acetyllysine. {ECO:0000269|PubMed:21775285}.; MOD_RES 20 20 N6-acetyllysine. {ECO:0000269|PubMed:21775285}.; MOD_RES 124 124 Phosphoserine. {ECO:0000244|PubMed:18669648}.; MOD_RES 126 126 Phosphoserine; alternate. {ECO:0000244|PubMed:18669648}.; MOD_RES 129 129 Phosphoserine; alternate. {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 176 176 Phosphotyrosine; by TNK2. {ECO:0000269|PubMed:20333297}.; MOD_RES 308 308 Phosphothreonine; by IKKE, PDPK1 and TBK1. {ECO:0000269|PubMed:15718470, ECO:0000269|PubMed:18456494, ECO:0000269|PubMed:20333297, ECO:0000269|PubMed:20481595, ECO:0000269|PubMed:21464307, ECO:0000269|PubMed:8978681, ECO:0000269|PubMed:9512493}.; MOD_RES 448 448 Phosphothreonine. {ECO:0000244|PubMed:24275569}.; MOD_RES 450 450 Phosphothreonine. {ECO:0000244|PubMed:24275569}.; MOD_RES 473 473 Phosphoserine; by IKKE, MTOR and TBK1; alternate. {ECO:0000269|PubMed:14761976, ECO:0000269|PubMed:15047712, ECO:0000269|PubMed:15718470, ECO:0000269|PubMed:16266983, ECO:0000269|PubMed:17013611, ECO:0000269|PubMed:20333297, ECO:0000269|PubMed:20978158, ECO:0000269|PubMed:21464307, ECO:0000269|PubMed:23799035, ECO:0000269|PubMed:8978681, ECO:0000269|PubMed:9736715}.; MOD_RES 474 474 Phosphotyrosine. {ECO:0000269|PubMed:12149249}.	1851997; 11508278; 14702039; 19054851; 12508121; 15489334; 1718748; 1533586; 9829964; 9736715; 8978681; 9512493; 10358075; 10576742; 10926925; 10983986; 10716693; 11154276; 11598301; 11994271; 12042314; 12149249; 12150915; 11839817; 12244301; 12878163; 14761976; 15047712; 14749367; 15118108; 16266983; 16139227; 15718470; 17013611; 16792529; 16417524; 17081983; 16540465; 16982699; 17932490; 17726016; 18507042; 18669648; 20059950; 19592491; 19934221; 19713527; 20086174; 19940129; 20682768; 20471940; 20231902; 20333297; 21269460; 21333377; 21329884; 23251525; 23186163; 23676467; 15526160; 11882383; 20978158; 21620960; 21432781; 21464307; 21775285; 22410793; 22629392; 23799035; 23431171; 23300339; 24275569; 24784001; 12176338; 12964941; 18456494; 20810279; 20481595; 20886116; 21392984; 17611497; 18954143; 21793738; 23246288; 10102273; 10226025; 10226029; 10376602; 10376603; 10415336; 10469573; 10471319; 10477751; 10485710; 10490848; 10491755; 10523666; 10579725; 10597260; 10625301; 10637513; 10698939; 10716737; 10722653; 10825497; 10874027; 10896934; 10908564; 10986289; 10994851; 11003625; 11007949; 11020382; 11027222; 11029403; 11042204; 11062251; 11162573; 11162641; 11162904; 11208609; 11274160; 11274386; 11278269; 11289110; 11311245; 11313365; 11323521; 11358816; 11359783; 11389054; 11438723; 11465707; 11504915; 11546775; 11577096; 11702042; 11711890; 11715018; 11731021; 11731414; 11752635; 11756242; 11777539; 11825911; 11828257; 11839802; 11874713; 11877406; 11879202; 11893783; 11896604; 11902142; 11923280; 11956222; 11960368; 11976320; 11988487; 12000750; 12011046; 12034358; 12060641; 12070137; 12089369; 12112022; 12114024; 12115344; 12124352; 12138205; 12164932; 12167717; 12171932; 12172553; 12176337; 12176997; 12181443; 12198173; 12200236; 12208782; 12210737; 12218048; 12228231; 12244133; 12244302; 12244303; 12351701; 12370495; 12373610; 12388598; 12393747; 12429987; 12438236; 12446602; 12446767; 12446787; 12466352; 12493740; 12504922; 12524439; 12527373; 12529294; 12529330; 12556562; 12592338; 12637511; 12642872; 12644590; 12649200; 12654898; 12657951; 12668767; 12682057; 12686550; 12722480; 12734182; 12767043; 12768030; 12782295; 12783873; 12791994; 12799359; 12808085; 12808093; 12808134; 12815460; 12835332; 12838322; 12839924; 12869408; 12874217; 12876303; 12888921; 12939297; 12952968; 12972603; 1325671; 14520710; 14522993; 14523021; 14534536; 14560023; 14566704; 14568991; 14572154; 14612949; 14617782; 14623889; 14625285; 14636889; 14647146; 14657000; 14660586; 14679206; 14679308; 14707121; 14712222; 14713953; 14727512; 14742298; 14745448; 14755253; 14767876; 14769856; 14981538; 14990993; 15010337; 15026145; 15026550; 15044083; 15047168; 15047604; 15047842; 15047866; 15048882; 15050414; 15060171; 15067058; 15084475; 15102693; 15115729; 15136501; 15138635; 15150572; 15156201; 15157674; 15169778; 15183529; 15187138; 15191562; 15194442; 15203190; 15217935; 15242771; 15263908; 15271644; 15283964; 15289328; 15289499; 15316080; 15319269; 15326564; 15327518; 15331441; 15339992; 15347471; 15364915; 15372623; 15385469; 15388791; 15389633; 15456405; 15459205; 15465021; 15467163; 15467757; 15475446; 15476407; 15489214; 15505622; 15522255; 15525681; 15527798; 15533996; 15537647; 15538381; 15539407; 15545271; 15545519; 15546863; 15572689; 15574337; 15574783; 15581622; 15607733; 15609321; 15641106; 15657900; 15665327; 15665818; 15668028; 15705789; 15706421; 15710591; 15722337; 15733940; 15738003; 15743789; 15755769; 15767780; 15778376; 15784622; 15792609; 15802268; 15805282; 15806160; 15808505; 15809304; 15817639; 15818404; 15831676; 15833736; 15837416; 15837948; 15845076; 15845651; 15867245; 15870708; 15870831; 15879168; 15888491; 15896313; 15905178; 15911620; 15913452; 15919790; 15920762; 15922745; 15944217; 15950906; 15961723; 15982448; 15987444; 15993382; 15994200; 15998799; 16007172; 16007182; 16007214; 16009706; 16012720; 16019536; 16026766; 16027121; 16027169; 16036916; 16044149; 16046309; 16049004; 16049961; 16055703; 16091017; 16099944; 16100524; 16103100; 16114056; 16115861; 16128748; 16132952; 16142341; 16148125; 16160160; 16166302; 16168102; 16168126; 16169930; 16172130; 16177823; 16182322; 16183860; 16202996; 16216590; 16221682; 16224792; 16243840; 16272144; 16274701; 16275989; 16278380; 16280327; 16282323; 16288304; 16293694; 16299382; 16306364; 16306447; 16330671; 16341040; 16365168; 16373405; 16395129; 16397250; 16397254; 16407258; 16407271; 16412424; 16419156; 16428439; 16434970; 16437163; 16440211; 16453020; 16466644; 16474850; 16475687; 16478297; 16497409; 16505097; 16508008; 16525023; 16531397; 16532026; 16532036; 16537497; 16537601; 16543232; 16546978; 16549426; 16551632; 16564100; 16567092; 16568092; 16571745; 16583435; 16585200; 16601838; 16616456; 16636132; 16636147; 16644866; 16651639; 16670089; 16682946; 16684529; 16722146; 16723503; 16731842; 16732486; 16759849; 16761106; 16763222; 16774943; 16775835; 16785234; 16785763; 16790501; 16790529; 16797529; 16807298; 16818690; 16820098; 16820947; 16822839; 16836907; 16839745; 16840713; 16842970; 16844778; 16862180; 16886599; 16897758; 16912864; 16916597; 16916907; 16926151; 16932738; 16940288; 16940331; 16942862; 16946008; 16951146; 16962287; 16962653; 16972255; 16977260; 16981720; 16987028; 16987250; 16987514; 16988010; 16990258; 17003457; 17006541; 17006756; 17007924; 17008323; 17012749; 17015676; 17016437; 17024099; 17028898; 17030608; 17041888; 17043653; 17052453; 17060455; 17062729; 17065200; 17068339; 17088265; 17096325; 17097759; 17098228; 17099727; 17106060; 17113264; 17128418; 17136479; 17136481; 17141917; 17143278; 17148458; 17151107; 17156483; 17158952; 17169805; 17173971; 17177604; 17178855; 17179152; 17179228; 17196933; 17198778; 17200115; 17210635; 17214972; 17215852; 17233643; 17234785; 17235455; 17237292; 17244606; 17259384; 17277771; 17287851; 17289898; 17299206; 17300726; 17300918; 17307335; 17308356; 17309805; 17310852; 17313857; 17317726; 17317825; 17318262; 17333095; 17334390; 17335965; 17339610; 17342093; 17342096; 17342203; 17351066; 17360849; 17369524; 17372251; 17375124; 17383860; 17386266; 17386267; 17400190; 17404186; 17406055; 17407381; 17409645; 17427945; 17428466; 17432822; 17443665; 17458890; 17461449; 17468516; 17469127; 17470458; 17471535; 17478078; 17483438; 17493174; 17495954; 17495959; 17501982; 17504381; 17507655; 17507800; 17512525; 17512923; 17513297; 17513702; 17517883; 17520698; 17521720; 17522055; 17522703; 17535800; 17544405; 17544543; 17545609; 17546049; 17548608; 17551921; 17553806; 17556533; 17565979; 17566113; 17569669; 17577629; 17580302; 17581609; 17584963; 17594810; 17599831; 17599906; 17601486; 17606718; 17609269; 17611133; 17612563; 17615157; 17616681; 17616684; 17616691; 17622239; 17634416; 17635910; 17638918; 17640984; 17646396; 17646428; 17652589; 17666398; 17684018; 17684102; 17687643; 17696196; 17706139; 17712528; 17716861; 17721885; 17721914; 17721920; 17724478; 17725107; 17761832; 17804197; 17804734; 17822324; 17823925; 17825267; 17825284; 17826033; 17826953; 17827393; 17848913; 17855350; 17868340; 17875968; 17883592; 17890457; 17892507; 17895832; 17898861; 17906677; 17909223; 17910952; 17914025; 17914096; 17915974; 17921701; 17923279; 17924977; 17925408; 17927847; 17928291; 17928528; 17935137; 17935714; 17941081; 17950696; 17951252; 17957242; 17959676; 17960559; 17960583; 17961125; 17967879; 17971124; 17974987; 17977950; 17983605; 18006659; 18021174; 18023414; 18035048; 18037896; 18041091; 18041764; 18046412; 18048359; 18053070; 18054038; 18059161; 18063683; 18064631; 18068336; 18071906; 18072631; 18079201; 18083769; 18087195; 18097023; 18159236; 18167217; 18172656; 18174256; 18182859; 18184439; 18187454; 18191226; 18194602; 18197291; 18198266; 18199533; 18199536; 18199958; 18201823; 18204201; 18204829; 18216097; 18231751; 18240972; 18247380; 18249092; 18256540; 18256541; 18261725; 18262492; 18264090; 18270579; 18273051; 18305032; 18309287; 18316593; 18317451; 18319625; 18323784; 18331557; 18332138; 18332867; 18332868; 18339899; 18349842; 18351386; 18353776; 18355439; 18355897; 18356162; 18356579; 18363844; 18370992; 18372248; 18391071; 18392055; 18395956; 18395980; 18396141; 18397976; 18398749; 18400376; 18404535; 18409144; 18410456; 18411301; 18413665; 18420583; 18425364; 18426604; 18434090; 18437054; 18443205; 18450971; 18451027; 18451140; 18455702; 18458059; 18458087; 18466879; 18469852; 18477468; 18479604; 18480058; 18483258; 18483275; 18487214; 18487454; 18490760; 18495460; 18497887; 18498165; 18499442; 18504432; 18505846; 18508192; 18509361; 18512729; 18519641; 18519679; 18524825; 18550470; 18552504; 18557931; 18562279; 18562319; 18573912; 18574502; 18577685; 18583979; 18586515; 18593948; 18606817; 18611285; 18611860; 18617528; 18622039; 18624398; 18635704; 18635812; 18639865; 18640717; 18644989; 18644990; 18650932; 18660489; 18665177; 18665222; 18668138; 18669636; 18670617; 18673414; 18676680; 18676830; 18676874; 18678286; 18678787; 18682509; 18686341; 18687633; 18687691; 18689794; 18691227; 18701703; 18701709; 18711014; 18711316; 18714568; 18718903; 18720410; 18721797; 18723000; 18725386; 18725974; 18728011; 18728784; 18754328; 18762023; 18767116; 18769058; 18769147; 18769720; 18771702; 18774962; 18775701; 18776922; 18782222; 18782353; 18783292; 18790560; 18794113; 18794358; 18795165; 18798227; 18801898; 18802038; 18812223; 18813808; 18813944; 18818526; 18821707; 18824170; 18826385; 18829502; 18832563; 18838169; 18838251; 18838385; 18838536; 18838554; 18841391; 18844239; 18854827; 18855532; 18922901; 18924134; 18931031; 18931700; 18936167; 18937284; 18948104; 18948272; 18949384; 18958173; 18974133; 18981248; 18996102; 18996844; 19002588; 19010915; 19011679; 19017490; 19017978; 19018001; 19020711; 19020728; 19029952; 19035551; 19039330; 19048112; 19050243; 19050262; 19051289; 19052636; 19054571; 19055752; 19055754; 19057672; 19058874; 19059380; 19062713; 19067848; 19068477; 19068483; 19070520; 19073147; 19074768; 19074832; 19074885; 19074894; 19078992; 19079341; 19079342; 19091404; 19095734; 19098000; 19099901; 19103742; 19107873; 19109741; 19109987; 19110052; 19112161; 19114562; 19114998; 19115062; 19116269; 19116273; 19118218; 19124015; 19132987; 19133120; 19134195; 19134226; 19136058; 19138978; 19142871; 19142997; 19144640; 19147772; 19151754; 19153210; 19158829; 19160403; 19162005; 19164214; 19164772; 19166270; 19166854; 19166928; 19170196; 19171933; 19175524; 19176054; 19176384; 19176518; 19176689; 19179443; 19183465; 19188658; 19193378; 19197339; 19198587; 19201817; 19203586; 19211028; 19216748; 19219602; 19219857; 19224164; 19229860; 19233842; 19236051; 19238332; 19239323; 19240722; 19240976; 19250936; 19250983; 19255520; 19261616; 19262472; 19262695; 19267882; 19270310; 19270694; 19270695; 19276265; 19278624; 19284309; 19286607; 19291319; 19293927; 19302240; 19303863; 19307602; 19318457; 19320971; 19323811; 19324870; 19326566; 19328625; 19331694; 19339247; 19353338; 19357198; 19367581; 19372382; 19376889; 19377290; 19388003; 19389506; 19397496; 19402821; 19405949; 19406989; 19407222; 19409087; 19415690; 19418217; 19420344; 19422047; 19428048; 19429661; 19435822; 19437103; 19446470; 19447872; 19448664; 19453261; 19453843; 19457567; 19458356; 19461960; 19463016; 19465931; 19472218; 19473116; 19473971; 19479902; 19481529; 19482076; 19483721; 19484147; 19487299; 19488783; 19489223; 19492080; 19503105; 19505958; 19517019; 19520917; 19525380; 19533041; 19538940; 19541408; 19549627; 19550420; 19553815; 19556867; 19560862; 19564927; 19567200; 19568785; 19574087; 19574502; 19574994; 19576174; 19584164; 19588500; 19589780; 19590514; 19595713; 19596916; 19597469; 19602055; 19602587; 19602588; 19609946; 19615971; 19616927; 19621391; 19622752; 19625176; 19628576; 19633130; 19633364; 19635908; 19636556; 19638206; 19638627; 19639178; 19639199; 19641183; 19644030; 19644051; 19644473; 19646290; 19649722; 19655166; 19655410; 19655414; 19657064; 19661305; 19662361; 19662498; 19675138; 19676105; 19679016; 19681907; 19684620; 19692168; 19693287; 19698782; 19700402; 19701246; 19720798; 19721393; 19723094; 19723095; 19724902; 19726058; 19726550; 19726736; 19726747; 19727814; 19729990; 19738422; 19740993; 19744127; 19745829; 19747927; 19748889; 19754670; 19757167; 19762915; 19764563; 19765303; 19767770; 19775474; 19776120; 19779850; 19781633; 19786063; 19796390; 19797085; 19799812; 19801633; 19801684; 19802009; 19802016; 19808981; 19815051; 19815552; 19815839; 19816934; 19820359; 19825827; 19833727; 19834495; 19835871; 19836430; 19850036; 19853286; 19855431; 19863783; 19864499; 19875456; 19875696; 19878271; 19882362; 19885574; 19885581; 19887561; 19887570; 19889638; 19889640; 19891769; 19897009; 19897488; 19898424; 19903340; 19903888; 19913121; 19917135; 19920252; 19922411; 19924282; 19925030; 19926313; 19931325; 19933775; 19935854; 19946332; 19948975; 19954644; 19956840; 19956873; 19965664; 19966853; 19996208; 19997600; 19997873; 20003467; 20005908; 20008098; 20008289; 20011604; 20014066; 20018888; 20018937; 20018949; 20019839; 20022634; 20026048; 20026151; 20028853; 20030877; 20033742; 20039275; 20041238; 20042122; 20045673; 20046382; 20048146; 20049209; 20051961; 20053726; 20054000; 20054340; 20055757; 20056178; 20067111; 20068168; 20081374; 20086095; 20088406; 20090934; 20093341; 20098747; 20100200; 20101210; 20102399; 20103602; 20106550; 20106927; 20107185; 20109457; 20110348; 20112989; 20126311; 20126987; 20127017; 20127709; 20130777; 20132317; 20133737; 20141546; 20150288; 20152809; 20153512; 20154081; 20159991; 20163786; 20164223; 20164304; 20167101; 20167420; 20169162; 20173664; 20182617; 20183800; 20186153; 20186503; 20187936; 20190811; 20198299; 20201953; 20205745; 20214684; 20216471; 20216540; 20216949; 20217555; 20224651; 20228224; 20232298; 20299475; 20306497; 20307589; 20308328; 20332111; 20333467; 20334367; 20339081; 20339252; 20346214; 20346360; 20347887; 20352231; 20354121; 20360004; 20361045; 20361981; 20362557; 20364113; 20368287; 20371257; 20371728; 20372801; 20372806; 20375905; 20383191; 20383279; 20385969; 20388781; 20389136; 20395438; 20398329; 20400975; 20400976; 20400979; 20407443; 20410674; 20412566; 20412774; 20414143; 20416077; 20417028; 20418907; 20421190; 20421846; 20428959; 20432460; 20432929; 20436671; 20440266; 20447721; 20451318; 20453000; 20454577; 20457218; 20458733; 20459571; 20470857; 20478633; 20484047; 20488790; 20489726; 20490331; 20492754; 20493625; 20493732; 20494139; 20501647; 20506505; 20506537; 20509930; 20512574; 20512787; 20514448; 20516073; 20517722; 20520724; 20523723; 20526288; 20527022; 20530239; 20530298; 20530554; 20530982; 20532215; 20534535; 20536315; 20537156; 20540782; 20541701; 20555032; 20557351; 20560677; 20562913; 20566894; 20574456; 20578837; 20585660; 20585984; 20586915; 20592362; 20595063; 20596030; 20597130; 20600027; 20605778; 20606012; 20607350; 20620179; 20622047; 20623644; 20628086; 20628892; 20643654; 20648653; 20651405; 20657188; 20663232; 20671123; 20672329; 20679348; 20679434; 20685965; 20686178; 20687898; 20688159; 20693286; 20697673; 20703095; 20716939; 20723296; 20725137; 20726858; 20731018; 20734064; 20736160; 20804212; 20804500; 20805333; 20808831; 20817061; 20826237; 20829512; 20836557; 20838929; 20844023; 20844931; 20854947; 20856200; 20860430; 20860815; 20863403; 20863633; 20864106; 20872231; 20886414; 20920357; 20921115; 20927395; 20936097; 20938636; 20940316; 20941790; 20944421; 20947498; 20950443; 20952497; 20956948; 20957008; 20957047; 20959404; 20971641; 20975834; 20980511; 20980808; 21029719; 21035497; 21040800; 21040950; 21041608; 21042744; 21042767; 21044950; 21045156; 21045158; 21045808; 21048031; 21049033; 21049487; 21059203; 21061022; 21062993; 21072193; 21075859; 21078168; 21080918; 21081844; 21082206; 21086135; 21087080; 21092549; 21093899; 21097843; 21106245; 21106850; 21110830; 21113787; 21118808; 21127195; 21127264; 21128248; 21129241; 21131356; 21135252; 21144036; 21151390; 21159648; 21159657; 21159778; 21168265; 21169559; 21177249; 21177334; 21185392; 21191179; 21192818; 21193562; 21209368; 21212269; 21212275; 21212404; 21215240; 21228233; 21238503; 21242970; 21253589; 21254169; 21255011; 21259330; 21263216; 21266843; 21276823; 21278786; 21281201; 21283818; 21284537; 21284870; 21288887; 21289308; 21290341; 21291561; 21294052; 21295396; 21295499; 21296133; 21297666; 21297971; 21300751; 21308747; 21309701; 21310961; 21320536; 21321111; 21321187; 21321378; 21321983; 21325624; 21329883; 21333374; 21334199; 21339740; 21343617; 21350947; 21355052; 21364639; 21365510; 21370247; 21380726; 21385902; 21390332; 21391741; 21394210; 21402741; 21402788; 21405945; 21406404; 21407808; 21412012; 21415306; 21420856; 21423211; 21425139; 21430300; 21436142; 21436253; 21437771; 21437936; 21440011; 21440577; 21442372; 21444773; 21445305; 21447180; 21454528; 21454539; 21454620; 21460223; 21461637; 21464312; 21464729; 21468601; 21471536; 21472003; 21474332; 21474915; 21478156; 21482133; 21487020; 21490677; 21496273; 21499215; 21501368; 21505451; 21507933; 21514425; 21521253; 21532145; 21536374; 21538438; 21539865; 21557211; 21559502; 21565140; 21566129; 21570709; 21590431; 21592330; 21592956; 21600017; 21600875; 21602804; 21609291; 21621563; 21623170; 21624038; 21625516; 21625639; 21626435; 21632881; 21633372; 21644050; 21646299; 21655183; 21658387; 21659549; 21660042; 21666717; 21667138; 21668414; 21669872; 21670080; 21672148; 21673026; 21673516; 21680733; 21685937; 21696297; 21698202; 21701506; 21705328; 21705677; 21707707; 21708191; 21709150; 21713404; 21718677; 21720709; 21722267; 21722370; 21724622; 21732363; 21732756; 21735093; 21741444; 21741919; 21742938; 21750219; 21750652; 21757645; 21763075; 21763421; 21767636; 21775008; 21775054; 21775480; 21775495; 21775978; 21777568; 21777670; 21778238; 21788944; 21794903; 21799016; 21804606; 21818627; 21819378; 21821012; 21823007; 21823011; 21824802; 21828040; 21828127; 21837363; 21837670; 21840189; 21840940; 21842521; 21849454; 21855541; 21856935; 21859846; 21862580; 21867682; 21868077; 21869603; 21871173; 21871446; 21872252; 21873248; 21873430; 21874010; 21874045; 21878648; 21878679; 21880746; 21881167; 21884932; 21887250; 21890492; 21898122; 21900206; 21901101; 21904110; 21908613; 21908615; 21908616; 21913799; 21914810; 21915031; 21915327; 21925532; 21937440; 21939655; 21945955; 21949775; 21952497; 21954225; 21956113; 21959954; 21965657; 21975932; 21975935; 21978279; 21980128; 21984893; 21987722; 21991300; 21994334; 21996732; 22005766; 22014666; 22016349; 22021428; 22025163; 22029423; 22031597; 22031698; 22039466; 22044535; 22045027; 22051934; 22060274; 22070874; 22072736; 22084251; 22093097; 22094587; 22095135; 22105580; 22107784; 22110663; 22116303; 22116552; 22116667; 22117074; 22131882; 22139837; 22140653; 22142888; 22146375; 22146979; 22150081; 22155350; 22169232; 22171994; 22173970; 22174934; 22183914; 22184107; 22185283; 22185378; 22189542; 22192357; 22194965; 22198382; 22199277; 22199303; 22204954; 22207758; 22208359; 22211100; 22213015; 22213475; 22231444; 22234835; 22235305; 22245935; 22248929; 22249415; 22251423; 22253197; 22253983; 22257771; 22259221; 22262182; 22268450; 22270359; 22271581; 22277669; 22280833; 22285928; 22289259; 22293289; 22297255; 22301279; 22305966; 22309289; 22315412; 22322295; 22322917; 22328975; 22334668; 22335196; 22335604; 22336203; 22337773; 22339676; 22340730; 22343475; 22345097; 22347457; 22351695; 22354785; 22360859; 22363436; 22363598; 22366458; 22375056; 22379109; 22382990; 22384056; 22384099; 22384145; 22389405; 22391209; 22391563; 22393424; 22394200; 22394497; 22394561; 22403297; 22407228; 22415553; 22417847; 22421143; 22422409; 22426999; 22430898; 22445357; 22451658; 22455883; 22457005; 22458600; 22460505; 22463491; 22465665; 22471665; 22473959; 22480544; 22487004; 22487681; 22488590; 22491319; 22491738; 22494103; 22496232; 22505016; 22508044; 22509246; 22510297; 22510990; 22525159; 22529978; 22530768; 22532149; 22532249; 22533986; 22535956; 22539090; 22547695; 22550181; 22552281; 22554284; 22562131; 22563025; 22563076; 22563417; 22567126; 22567414; 22569334; 22569400; 22570727; 22571340; 22575839; 22577119; 22588279; 22590527; 22590625; 22590634; 22591684; 22607554; 22614013; 22614157; 22619175; 22623957; 22626691; 22647853; 22648906; 22657251; 22674407; 22675553; 22682934; 22684558; 22685542; 22685591; 22690138; 22693070; 22705004; 22705730; 22709426; 22727668; 22728329; 22728372; 22733130; 22739265; 22739986; 22740686; 22745786; 22748472; 22752602; 22759359; 22760211; 22762500; 22768179; 22771387; 22781553; 22787432; 22789858; 22799881; 22805337; 22808143; 22809628; 22815832; 22824823; 22830422; 22831980; 22833150; 22837212; 22839755; 22840496; 22842582; 22871047; 22875023; 22879882; 22880048; 22895070; 22895078; 22896661; 22897592; 22900072; 22901187; 22902327; 22902833; 22905202; 22905719; 22907434; 22910909; 22911700; 22911754; 22912850; 22923366; 22927331; 22928011; 22929028; 22936801; 22938585; 22945510; 22952709; 22954457; 22956257; 22957045; 22961111; 22964641; 22967500; 22975683; 22975685; 22995914; 23007634; 23010592; 23011139; 23021375; 23030823; 23035900; 23039130; 23041284; 23043959; 23045700; 23046567; 23047954; 23049696; 23050041; 23059825; 23065523; 23069661; 23071583; 23072587; 23077590; 23082158; 23085420; 23086641; 23091605; 23091617; 23092880; 23092893; 23094058; 23095753; 23097134; 23100325; 23107319; 23112296; 23119004; 23125486; 23127761; 23133535; 23134728; 23135917; 23135998; 23138182; 23142241; 23142521; 23142783; 23147115; 23147412; 23151908; 23152054; 23155381; 23165443; 23167739; 23169238; 23176396; 23182460; 23182717; 23185040; 23188060; 23190608; 23192081; 23192871; 23205493; 23208492; 23208610; 23209838; 23225414; 23226698; 23227138; 23235274; 23236232; 23237355; 23237847; 23242584; 23243000; 23249714; 23255002; 23255608; 23259744; 23261389; 23263555; 23271282; 23271397; 23272133; 23272152; 23274898; 23280503; 23285096; 23285163; 23291718; 23297824; 23300741; 23300998; 23303682; 23311938; 23314850; 23315288; 23318419; 23319332; 23321169; 23325864; 23326514; 23338526; 23340251; 23340270; 23343403; 23348505; 23352210; 23354687; 23354912; 23379509; 23380710; 23383195; 23383347; 23384770; 23386617; 23389114; 23389849; 23394218; 23396361; 23397142; 23402310; 23408974; 23409016; 23409093; 23409128; 23415012; 23417403; 23418602; 23419269; 23419514; 23420345; 23420486; 23421998; 23424671; 23426781; 23427269; 23429328; 23430973; 23434580; 23436801; 23437141; 23440515; 23440594; 23442539; 23443316; 23448424; 23455323; 23457304; 23457334; 23459592; 23463347; 23463670; 23464484; 23468988; 23469007; 23474367; 23499907; 23504323; 23507869; 23511556; 23512990; 23517112; 23521913; 23525579; 23529222; 23538858; 23546174; 23546450; 23546602; 23547889; 23552696; 23553960; 23554999; 23558942; 23561972; 23563706; 23566222; 23567263; 23570421; 23573286; 23574721; 23580233; 23580656; 23583197; 23590596; 23596468; 23596569; 23603894; 23604117; 23613227; 23613850; 23615537; 23615713; 23618343; 23623869; 23623968; 23624506; 23625205; 23626817; 23629924; 23632475; 23639457; 23639623; 23640046; 23644504; 23644655; 23650507; 23652833; 23667466; 23668972; 23671619; 23672191; 23673367; 23677479; 23680186; 23681745; 23682967; 23684008; 23684622; 23685151; 23693014; 23705826; 23707764; 23708780; 23710442; 23710710; 23711387; 23724143; 23725225; 23726842; 23728071; 23732709; 23739679; 23740762; 23741320; 23742646; 23743572; 23747160; 23748344; 23754751; 23757022; 23762398; 23764845; 23765166; 23768697; 23776620; 23785417; 23786162; 23788636; 23791833; 23792459; 23792604; 23796964; 23799852; 23800951; 23802099; 23803188; 23803661; 23805312; 23811754; 23812726; 23824064; 23824914; 23832540; 23838801; 23840064; 23840605; 23841076; 23843462; 23844554; 23849428; 23852728; 23852799; 23862686; 23863161; 23867201; 23867821; 23869765; 23874694; 23876532; 23884311; 23884447; 23884910; 23886157; 23888070; 23892093; 23892273; 23896866; 23898095; 23900743; 23902692; 23902739; 23912456; 23913776; 23922669; 23922774; 23928304; 23928696; 23929892; 23933705; 23934627; 23935944; 23940660; 23940704; 23946798; 23950991; 23951353; 23953418; 23969493; 23976954; 23977025; 23979601; 23979838; 23982477; 23989949; 23990921; 23991038; 23995785; 23996929; 24000138; 24001613; 24002438; 24005670; 24013425; 24015256; 24018901; 24022875; 24023012; 24023938; 24024143; 24024202; 24030155; 24036604; 24039187; 24039912; 24040255; 24042734; 24052256; 24053190; 24055735; 24057571; 24058448; 24058557; 24069528; 24069951; 24070020; 24073922; 24081328; 24091816; 24094245; 24095799; 24096618; 24098375; 24098385; 24100264; 24105357; 24107614; 24112608; 24113173; 24113181; 24117074; 24120917; 24132578; 24133589; 24141624; 24141773; 24147456; 24150605; 24152492; 24154876; 24156551; 24157255; 24157493; 24158497; 24159375; 24161930; 24169049; 24173829; 24175786; 24178756; 24179501; 24179530; 24188406; 24201812; 24202965; 24217227; 24225136; 24232099; 24239461; 24244375; 24244612; 24247267; 24247980; 24250812; 24257753; 24260155; 24260338; 24260371; 24260384; 24260544; 24265152; 24273605; 24276243; 24277456; 24280348; 24280901; 24282571; 24284390; 24285179; 24286304; 24291004; 24293123; 24295494; 24297510; 24297901; 24302564; 24313465; 24314632; 24316235; 24321521; 24324490; 24332215; 24333218; 24336406; 24337632; 24338765; 24345643; 24347489; 24349321; 24352480; 24353015; 24356956; 24358196; 24365180; 24365237; 24366211; 24366874; 24372645; 24374242; 24376640; 24376685; 24376747; 24377058; 24379655; 24384983; 24387036; 24387695; 24392034; 24396487; 24398676; 24399305; 24402647; 24412244; 24413065; 24416124; 24416349; 24418989; 24421315; 24424889; 24425104; 24425783; 24428908; 24434142; 24446434; 24448243; 24454800; 24456610; 24458280; 24462114; 24462769; 24467442; 24468202; 24469048; 24481267; 24488013; 24490960; 24507683; 24516643; 24521094; 24522376; 24523415; 24523904; 24525337; 24526702; 24528651; 24548923; 24549576; 24551245; 24552990; 24554412; 24561239; 24562770; 24569712; 24571487; 24573607; 24574517; 24581231; 24583795; 24585214; 24597762; 24599886; 24600969; 24603487; 24603539; 24605828; 24606918; 24611062; 24612393; 24613353; 24615340; 24618420; 24619078; 24622734; 24625973; 24627641; 24628780; 24630930; 24631773; 24632578; 24634221; 24645843; 24649407; 24651445; 24654606; 24658140; 24658401; 24658605; 24659658; 24662006; 24662831; 24667640; 24669186; 24670043; 24670416; 24675668; 24676635; 24677652; 24692179; 24692549; 24694877; 24699302; 24700345; 24703840; 24704832; 24705275; 24705351; 24713430; 24718901; 24722292; 24723492; 24726064; 24729100; 24735930; 24735980; 24737346; 24743054; 24743777; 24757677; 24769208; 24769357; 24774538; 24780446; 24786233; 24789658; 24789704; 24795023; 24797175; 24797432; 24799027; 24802394; 24804226; 24804268; 24805814; 24806753; 24810113; 24811059; 24812621; 24813998; 24816687; 24818793; 24820448; 24821574; 24837366; 24848113; 24868319; 24869908; 24874843; 24878609; 24878845; 24887566; 24891117; 24900620; 24903376; 24903382; 24905095; 24905527; 24905636; 24910117; 24911372; 24916783; 24918199; 24933731; 24936148; 24939300; 24941119; 24944883; 24945379; 24947355; 24952732; 24955034; 24957098; 24957363; 24962317; 24970806; 24977346; 24979261; 24979463; 24981175; 24983969; 24984001; 24986420; 24987682; 24990947; 24992302; 24994714; 24996256; 25009009; 25017119; 25023728; 25026292; 25031754; 25035961; 25036673; 25040157; 25042802; 25051360; 25056877; 25060489; 25060910; 25061874; 25063029; 25065544; 25066607; 25068972; 25071759; 25080058; 25085593; 25088797; 25096023; 25098276; 25105067; 25108739; 25109354; 25110549; 25111376; 25114899; 25116390; 25119993; 25120209; 25122478; 25127200; 25136826; 25139413; 25146530; 25148875; 25150310; 25153725; 25153728; 25162518; 25162582; 25162660; 25167778; 25168062; 25168244; 25179402; 25187230; 25187540; 25190803; 25194337; 25196260; 25200917; 25212826; 25215588; 25218472; 25220506; 25228590; 25230890; 25233414; 25238546; 25241761; 25243120; 25245053; 25245332; 25246356; 25247416; 25247763; 25248616; 25253241; 25257463; 25257523; 25257795; 25257839; 25261470; 25270272; 25273559; 25277204; 25280563; 25280966; 25284608; 25288334; 25290554; 25293520; 25295093; 25296502; 25296981; 25307508; 25307974; 25310235; 25311506; 25311616; 25313141; 25316332; 25318886; 25319929; 25322691; 25323938; 25327287; 25329617; 25339666; 25348018; 25352995; 25355053; 25355887; 25359618; 25365190; 25365322; 25370471; 25371071; 25373319; 25373346; 25374184; 25375133; 25375272; 25376904; 25385184; 25388284; 25388642; 25394965; 25398386; 25400915; 25409876; 25412313; 25414139; 25415591; 25416439; 25418727; 25421824; 25424347; 25431257; 25432075; 25433499; 25445049; 25450979; 25456951; 25466966; 25482200; 25482988; 25486524; 25490861; 25492937; 25495560; 25498454; 25499462; 25501279; 25502934; 25504433; 25504436; 25509983; 25519148; 25524555; 25528216; 25530715; 25531880; 25534823; 25538040; 25544763; 25550560; 25550785; 25551293; 25562170; 25564612; 25569101; 25569743; 25573060; 25582346; 25589557; 25590801; 25592883; 25596747; 25601471; 25603236; 25603341; 25611382; 25619882; 25620175; 25622969; 25623055; 25624750; 25625591; 25627160; 25636507; 25639555; 25639860; 25639872; 25639875; 25640278; 25640309; 25645014; 25649767; 25650664; 25654224; 25658447; 25659151; 25660117; 25661333; 25661467; 25662849; 25663935; 25665524; 25673820; 25674039; 25678401; 25686830; 25687330; 25687876; 25688212; 25691053; 25691296; 25695729; 25698539; 25701004; 25701784; 25702787; 25704303; 25714871; 25719244; 25719943; 25722288; 25726893; 25729885; 25736926; 25738366; 25744065; 25745998; 25749514; 25749517; 25753771; 25757539; 25760026; 25760096; 25762619; 25766325; 25767601; 25775951; 25777142; 25784113; 25784743; 25791921; 25792811; 25793261; 25793983; 25797048; 25797258; 25801838; 25807261; 25814554; 25815442; 25816324; 25823655; 25826077; 25830382; 25835975; 25846394; 25850957; 25851605; 25862630; 25862867; 25862896; 25862915; 25869208; 25874498; 25877996; 25880247; 25880873; 25886003; 25888955; 25893985; 25894595; 25896413; 25896712; 25897806; 25898313; 25909227; 25910265; 25912234; 25915159; 25915427; 25915946; 25922934; 25925379; 25926716; 25931014; 25931518; 25933104; 25933112; 25935150; 25940338; 25954860; 25960234; 25961827; 25962159; 25962638; 25963408; 25964092; 25965345; 25965823; 25966642; 25969668; 25974307; 25978653; 25980493; 25982963; 25987255; 25990837; 25996556; 25997619; 25997832; 25999352; 26004137; 26014912; 26022125; 26023079; 26023089; 26025205; 26026089; 26030190; 26039541; 26043921; 26044564; 26046303; 26047703; 26051604; 26053093; 26053620; 26055712; 26061531; 26061814; 26070568; 26071104; 26073086; 26075254; 26078792; 26087719; 26100275; 26104298; 26104664; 26108998; 26109071; 26110849; 26110874; 26111001; 26111057; 26115086; 26119563; 26121251; 26121643; 26123392; 26124180; 26124182; 26125228; 26125726; 26126266; 26130968; 26134617; 26137473; 26137586; 26139537; 26147087; 26148825; 26149216; 26150526; 26151295; 26151347; 26158266; 26160839; 26170450; 26174628; 26178819; 26178916; 26183061; 26195760; 26198194; 26199094; 26201515; 26208478; 26208487; 26212011; 26213230; 26222278; 26223322; 26235620; 26235873; 26242183; 26243309; 26244501; 26246284; 26246598; 26248315; 26252009; 26256536; 26256794; 26260387; 26260613; 26260992; 26265781; 26267533; 26269114; 26279447; 26283546; 26286747; 26290457; 26294745; 26295469; 26296520; 26296968; 26302489; 26303273; 26304234; 26304753; 26310353; 26313911; 26315674; 26317515; 26317520; 26317547; 26317998; 26318033; 26318486; 26323834; 26333304; 26338103; 26338671; 26339598; 26345302; 26345416; 26351323; 26354606; 26356562; 26358886; 26359868; 26362254; 26364616; 26364720; 26378044; 26378521; 26378810; 26379195; 26386696; 26388843; 26390688; 26390889; 26391397; 26395918; 26398368; 26402468; 26402673; 26408176; 26415504; 26418879; 26423401; 26427440; 26435498; 26436418; 26438156; 26439941; 26440416; 26443198; 26443539; 26447856; 26452980; 26453307; 26458825; 26459773; 26460589; 26462835; 26474484; 26482612; 26483070; 26485768; 26487493; 26491696; 26493996; 26496029; 26496360; 26496610; 26497580; 26497682; 26498353; 26499488; 26499886; 26500061; 26500282; 26505797; 26506516; 26514724; 26515499; 26515520; 26515594; 26515729; 26517515; 26523394; 26528697; 26528819; 26530812; 26535060; 26539029; 26549032; 26557705; 26557719; 26565813; 26566181; 26568302; 26573229; 26575017; 26579576; 26580610; 26582390; 26599017; 26600389; 26607178; 26613407; 26615422; 26617940; 26631033; 26631969; 26635480; 26641458; 26646023; 26646272; 26647806; 26648031; 26648098; 26649137; 26655502; 26657290; 26657292; 26657992; 26662962; 26674329; 26677054; 26677144; 26682007; 26683100; 26686971; 26687646; 26687647; 26689593; 26700664; 26701849; 26707081; 26708293; 26711268; 26711788; 26713367; 26714756; 26716408; 26716652; 26717963; 26718407; 26729197; 26730736; 26732677; 26741489; 26746999; 26750720; 26751215; 26756739; 26761017; 26762111; 26763134; 26772887; 26773499; 26775845; 26779632; 26780727; 26784926; 26787540; 26792722; 26792725; 26797271; 26797279; 26801096; 26801559; 26801686; 26818920; 26821070; 26821351; 26824321; 26824610; 26824665; 26828791; 26832662; 26838050; 26839558; 26840401; 26845432; 26847684; 26848618; 26848620; 26848623; 26852666; 26855332; 26859575; 26859676; 26868304; 26877709; 26879868; 26880110; 26882038; 26883103; 26885609; 26885978; 26889770; 26891914; 26892230; 26898459; 26899709; 26902421; 26903300; 26905105; 26909320; 26909550; 26909949; 26910892; 26912358; 26914861; 26917260; 26919095; 26919102; 26919807; 26921108; 26928911; 26930065; 26931119; 26934444; 26937641; 26942872; 26945062; 26945151; 26945854; 26948085; 26949090; 26958085; 26959555; 26959890; 26962683; 26967055; 26967567; 26971877; 26974310; 26974342; 26983629; 26988603; 26988652; 26992219; 26993162; 26993775; 26994002; 26994872; 26996299; 26996671; 26998277; 27000941; 27004402; 27004406; 27004407; 27007282; 27010857; 27012197; 27012209; 27014421; 27015152; 27020460; 27020593; 27026523; 27027448; 27029904; 27031247; 27034956; 27035679; 27036045; 27044757; 27047993; 27048245; 27053161; 27054717; 27057280; 27059323; 27059438; 27059464; 27062580; 27072494; 27074558; 27075467; 27076174; 27084428; 27084452; 27091625; 27097374; 27098694; 27102439; 27105349; 27107990; 27113546; 27119232; 27121065; 27121240; 27121513; 27137757; 27138223; 27147579; 27147739; 27152946; 27154977; 27155790; 27163202; 27163678; 27166156; 27173130; 27174919; 27176505; 27176825; 27177902; 27180807; 27186967; 27187380; 27188433; 27189341; 27192118; 27196502; 27197157; 27200496; 27207509; 27211495; 27220494; 27220846; 27221510; 27223432; 27224506; 27229116; 27230035; 27239959; 27240591; 27259051; 27274989; 27283897; 27285760; 27290989; 27294151; 27294206; 27297622; 27298257; 27301639; 27302366; 27304189; 27305091; 27305487; 27323412; 27323778; 27323822; 27323966; 27328758; 27329843; 27338800; 27339899; 27342216; 27346647; 27348973; 27353512; 27362804; 27363263; 27379204; 27381982; 27384483; 27387559; 27387578; 27388585; 27390173; 27391062; 27391150; 27391151; 27391443; 27392709; 27397543; 27412013; 27412938; 27415427; 27430155; 27438523; 27449010; 27449034; 27449083; 27455254; 27465551; 27466488; 27471108; 27472445; 27481935; 27484635; 27484721; 27486771; 27487122; 27487130; 27487157; 27489350; 27489353; 27494022; 27494841; 27494849; 27494886; 27494895; 27498786; 27499633; 27506466; 27509921; 27511728; 27515171; 27517753; 27522666; 27523474; 27524440; 27528761; 27531894; 27533079; 27533087; 27534652; 27537208; 27549161; 27551486; 27554198; 27563827; 27572296; 27572308; 27572688; 27573172; 27584795; 27589564; 27590439; 27593934; 27600098; 27601656; 27601661; 27602766; 27602961; 27607575; 27611696; 27611862; 27614430; 27619662; 27621407; 27622707; 27624942; 27624978; 27626683; 27627761; 27633099; 27634878; 27634891; 27636107; 27648001; 27649272; 27649518; 27654866; 27656263; 27659207; 27659528; 27661110; 27663511; 27666419; 27669541; 27677288; 27680387; 27686608; 27694970; 27695098; 27696687; 27697523; 27699664; 27699665; 27701018; 27702651; 27707884; 27713121; 27717743; 27742746; 27746366; 27753212; 27762303; 27765055; 27768588; 27768959; 27769065; 27769069; 27769899; 27773936; 27776559; 27779207; 27783537; 27784766; 27789284; 27789731; 27793011; 27796683; 27800505; 27806323; 27809307; 27811362; 27822469; 27829222; 27863385; 27863406; 27866093; 27869735; 27875549; 27876874; 27878243; 27878245; 27879648; 27893430; 27894090; 27899255; 27901111; 27903983; 27903985; 27910734; 27913571; 27915346; 27918554; 27919028; 27919290; 27922686; 27922982; 27926990; 27959444; 27966531; 27974696; 27983922; 27988337; 27992958; 28002802; 28003335; 28008153; 28008155; 28025795; 28025797; 28026112; 28032865; 28034805; 28035062; 28035333; 28035415; 28036265; 28056899; 28061880; 28064317; 28069548; 28072855; 28075016; 28078305; 28081222; 28082415; 28089901; 28096970; 28097440; 28098872; 28099937; 28112375; 28112582; 28115166; 28122716; 28129639; 28132399; 28147324; 28151479; 28157137; 28165011; 28165192; 28176801; 28178653; 28178656; 28179017; 28188308; 28188683; 28188923; 28189993; 28190771; 28199981; 28208754; 28209617; 28209923; 28212545; 28213783; 28218907; 28231291; 28231796; 28232663; 28240051; 28247844; 28249041; 28258248; 28259870; 28259918; 28264587; 28266802; 28271235; 28279977; 28286270; 28291820; 28300578; 28301567; 28302479; 28316059; 28320338; 28320862; 28322459; 28322462; 28322991; 28328831; 28332226; 28337869; 28339062; 28350098; 28351297; 28351325; 28355296; 28356268; 28358423; 28363000; 28363942; 28373060; 28376174; 28383549; 28398603; 28416594; 28418888; 28423499; 28423550; 28423620; 28423632; 28442344; 28445151; 28447761; 28459375; 28464252; 28465488; 28472036; 28478460; 28482067; 28482233; 28483634; 28488541; 28489509; 28492559; 28495456; 28498460; 28499984; 28503860; 28513300; 28534957; 28534966; 28534983; 28544747; 28548645; 28557977; 28560385; 28578351; 28580603; 28586006; 28586035; 28594409; 28601070; 28601321; 28602980; 28604419; 28627093; 28631564; 28634229; 28635399; 28648644; 28651161; 28655554; 28666999; 28667123; 28677816; 28691365; 28696156; 28698135; 28699701; 28701359; 28705116; 28713929; 28716898; 28731173; 28743112; 28759294; 28760343; 28762556; 28762597; 28764807; 28768870; 28771224; 28774796; 28791373; 28801734; 28803837; 28806945; 28820394; 28826600; 28849060; 28867187; 28870807; 28871105; 28923857; 28931525; 28931550; 28934469; 28954236; 28964785; 28972042; 28974422; 28976590; 29021135; 29025710; 29079416; 29098623; 29114068; 29156644; 29169420; 29169802; 29190819; 29203244; 29207012; 29235817; 29239720; 29248580; 29253569; 29278885; 29286143; 29293671; 29321326; 29328485; 29343641; 29344640; 29358114; 29484412; 29488603; 29488612; 29506489; 29555473; 29588416; 29632185; 29655979; 29678744; 29713826; 29843123; 29848705; 29905853; 29961070; 29978609; 30078705; 30091314; 7526779; 7637810; 7891724; 8524413; 8782602; 9094314; 9173876; 9346240; 9368760; 9381178; 9445477; 9478990; 9632753; 9722592; 9768361; 9812896; 9857186; 9895304	1851997; 11508278; 14702039; 19054851; 12508121; 15489334; 1718748; 1533586; 9829964; 9736715; 8978681; 9512493; 10358075; 10576742; 10926925; 10983986; 10716693; 11154276; 11598301; 11994271; 12042314; 12149249; 12150915; 11839817; 12244301; 12878163; 14761976; 15047712; 14749367; 15118108; 16266983; 16139227; 15718470; 17013611; 16792529; 16417524; 17081983; 16540465; 16982699; 17932490; 17726016; 18507042; 18669648; 20059950; 19592491; 19934221; 19713527; 20086174; 19940129; 20682768; 20471940; 20231902; 20333297; 21269460; 21333377; 21329884; 23251525; 23186163; 23676467; 15526160; 11882383; 20978158; 21620960; 21432781; 21464307; 21775285; 22410793; 22629392; 23799035; 23431171; 23300339; 24275569; 24784001; 12176338; 12964941; 18456494; 20810279; 20481595; 20886116; 21392984; 17611497; 18954143; 21793738; 23246288
19677	AKR1C2 DDH2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=260 uM for (s)-tetralol {ECO:0000269|PubMed:8573067}; KM=520 uM for (s)-indan-1-ol {ECO:0000269|PubMed:8573067}; KM=5000 uM for benzene dihydrodiol {ECO:0000269|PubMed:8573067}; KM=1 uM for 5-beta-pregnane-3-alpha,20-alpha-diol {ECO:0000269|PubMed:8573067}; KM=208 uM for 9-alpha,11-beta-prostaglandin F(2) {ECO:0000269|PubMed:8573067}; KM=0.3 uM for 5-beta-androstane-3,17-dione {ECO:0000269|PubMed:8573067}; KM=79 uM for prostaglandin D(2) {ECO:0000269|PubMed:8573067}; 	1.-.-.-; 1.3.1.20; 1.1.1.357	CATALYTIC ACTIVITY: Trans-1,2-dihydrobenzene-1,2-diol + NADP(+) = catechol + NADPH. {ECO:0000269|PubMed:8573067}.; CATALYTIC ACTIVITY: A 3-alpha-hydroxysteroid + NAD(P)(+) = a 3-oxosteroid + NAD(P)H. {ECO:0000269|PubMed:15929998, ECO:0000269|PubMed:17034817, ECO:0000269|PubMed:17442338, ECO:0000269|PubMed:8573067}.	BINDING 24 24 Substrate. {ECO:0000250}.; BINDING 50 50 NADP. {ECO:0000269|PubMed:11513593, ECO:0000269|PubMed:11514561, ECO:0000269|PubMed:15929998, ECO:0000269|PubMed:17034817, ECO:0000269|PubMed:17442338}.; BINDING 117 117 Substrate.; BINDING 190 190 NADP. {ECO:0000269|PubMed:11513593, ECO:0000269|PubMed:11514561, ECO:0000269|PubMed:15929998, ECO:0000269|PubMed:17034817, ECO:0000269|PubMed:17442338}.; BINDING 222 222 Substrate. {ECO:0000250}.; BINDING 227 227 Substrate.	ACTIVITY REGULATION: Inhibited by hexestrol with an IC(50) of 2.8 uM, 1,10-phenanthroline with an IC(50) of 2100 uM, 1,7-phenanthroline with an IC(50) of 1500 uM, flufenamic acid with an IC(50) of 0.9 uM, indomethacin with an IC(50) of 75 uM, ibuprofen with an IC(50) of 6.9 uM, lithocholic acid with an IC(50) of 0.07 uM, ursodeoxycholic acid with an IC(50) of 0.08 uM and chenodeoxycholic acid with an IC(50) of 0.13 uM. {ECO:0000269|PubMed:8573067}.				SITE 84 84 Lowers pKa of active site Tyr. {ECO:0000250}.			cellular response to jasmonic acid stimulus [GO:0071395]; cellular response to prostaglandin D stimulus [GO:0071799]; daunorubicin metabolic process [GO:0044597]; digestion [GO:0007586]; doxorubicin metabolic process [GO:0044598]; epithelial cell differentiation [GO:0030855]; G-protein coupled receptor signaling pathway [GO:0007186]; oxidation-reduction process [GO:0055114]; positive regulation of cell proliferation [GO:0008284]; positive regulation of protein kinase B signaling [GO:0051897]; progesterone metabolic process [GO:0042448]; prostaglandin metabolic process [GO:0006693]; steroid metabolic process [GO:0008202]	cytoplasm [GO:0005737]	cytoplasm [GO:0005737]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; bile acid binding [GO:0032052]; carboxylic acid binding [GO:0031406]; ketosteroid monooxygenase activity [GO:0047086]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; phenanthrene 9,10-monooxygenase activity [GO:0018636]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]; cellular response to jasmonic acid stimulus [GO:0071395]; cellular response to prostaglandin D stimulus [GO:0071799]; daunorubicin metabolic process [GO:0044597]; digestion [GO:0007586]; doxorubicin metabolic process [GO:0044598]; epithelial cell differentiation [GO:0030855]; G-protein coupled receptor signaling pathway [GO:0007186]; oxidation-reduction process [GO:0055114]; positive regulation of cell proliferation [GO:0008284]; positive regulation of protein kinase B signaling [GO:0051897]; progesterone metabolic process [GO:0042448]; prostaglandin metabolic process [GO:0006693]; steroid metabolic process [GO:0008202]	alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; bile acid binding [GO:0032052]; carboxylic acid binding [GO:0031406]; ketosteroid monooxygenase activity [GO:0047086]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; phenanthrene 9,10-monooxygenase activity [GO:0018636]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]	GO:0004032; GO:0005737; GO:0006693; GO:0007186; GO:0007586; GO:0008202; GO:0008284; GO:0016655; GO:0018636; GO:0030855; GO:0031406; GO:0032052; GO:0042448; GO:0044597; GO:0044598; GO:0047086; GO:0047115; GO:0051897; GO:0055114; GO:0071395; GO:0071799	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.			8274401; 8011662; 7959017; 8920937; 9716498; 10672042; 14702039; 15164054; 15489334; 8573067; 8486699; 21802064; 11513593; 11514561; 15929998; 17034817; 17442338; 11158055; 11854486; 12416991; 12810547; 13678667; 14671194; 15188492; 15212687; 15383625; 15492289; 16216911; 16411748; 16478829; 17203165; 17432832; 18251165; 18396902; 18654764; 18984855; 19258517; 19320734; 19487289; 19846565; 20056642; 20689807; 20734064; 20840669; 21217827; 21232532; 21280124; 21521174; 22064385; 22275760; 22534668; 23414517; 24244276; 24434280; 25463305; 26244607; 26318406; 26351209; 26929402; 26934124; 28259989; 28619249; 29369461	8274401; 8011662; 7959017; 8920937; 9716498; 10672042; 14702039; 15164054; 15489334; 8573067; 8486699; 21802064; 11513593; 11514561; 15929998; 17034817; 17442338
19678	ALDOC ALDC	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=10.7 uM for fructose 1,6-bisphosphate {ECO:0000269|PubMed:15537755}; KM=16 mM for fructose 1-phosphate {ECO:0000269|PubMed:15537755}; 	4.1.2.13	CATALYTIC ACTIVITY: D-fructose 1,6-bisphosphate = glycerone phosphate + D-glyceraldehyde 3-phosphate. {ECO:0000269|PubMed:15537755}.	BINDING 56 56 Substrate.; BINDING 147 147 Substrate.				PATHWAY: Carbohydrate degradation; glycolysis; D-glyceraldehyde 3-phosphate and glycerone phosphate from D-glucose: step 4/4.	SITE 364 364 Necessary for preference for fructose 1,6-bisphosphate over fructose 1-phosphate.			canonical glycolysis [GO:0061621]; epithelial cell differentiation [GO:0030855]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; neutrophil degranulation [GO:0043312]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724]	cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724]; cytoskeletal protein binding [GO:0008092]; fructose-bisphosphate aldolase activity [GO:0004332]; canonical glycolysis [GO:0061621]; epithelial cell differentiation [GO:0030855]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; neutrophil degranulation [GO:0043312]	cytoskeletal protein binding [GO:0008092]; fructose-bisphosphate aldolase activity [GO:0004332]	GO:0004332; GO:0005576; GO:0005829; GO:0005856; GO:0006000; GO:0006094; GO:0008092; GO:0030388; GO:0030855; GO:0034774; GO:0043312; GO:0061621; GO:0070062; GO:1904724; GO:1904813			MOD_RES 5 5 Phosphotyrosine. {ECO:0000250|UniProtKB:P05065}.; MOD_RES 36 36 Phosphoserine. {ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 39 39 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 45 45 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 111 111 N6-acetyllysine. {ECO:0000244|PubMed:19413330}.; MOD_RES 132 132 Phosphoserine. {ECO:0000250|UniProtKB:P05065}.	3105602; 3267224; 2209624; 14702039; 15489334; 11399750; 11876650; 19413330; 21269460; 23186163; 24275569; 25944712; 15537755; 15589842; 17500595; 19034380; 19110265; 19405953; 19686046; 19805454; 20381070; 20562859; 21988832; 23650620; 24525694; 24606918; 24993527; 25416956; 26496610; 3355497; 6696436; 7717389	3105602; 3267224; 2209624; 14702039; 15489334; 11399750; 11876650; 19413330; 21269460; 23186163; 24275569; 25944712; 15537755
19687	PRMT8 HRMT1L3 HRMT1L4	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.3 uM for GRGGFGGRGGFRGGRGG-NH2 {ECO:0000269|PubMed:18320585}; 	2.1.1.319; 2.1.1.321	CATALYTIC ACTIVITY: 2 S-adenosyl-L-methionine + [protein]-L-arginine = 2 S-adenosyl-L-homocysteine + [protein]-N(omega),N(omega)-dimethyl-L-arginine. {ECO:0000269|PubMed:16051612, ECO:0000269|PubMed:17925405, ECO:0000269|PubMed:18320585}.; CATALYTIC ACTIVITY: S-adenosyl-L-methionine + [protein]-L-arginine = S-adenosyl-L-homocysteine + [protein]-N(omega)-methyl-L-arginine. {ECO:0000269|PubMed:16051612, ECO:0000269|PubMed:17925405, ECO:0000269|PubMed:18320585}.	BINDING 86 86 S-adenosyl-L-methionine. {ECO:0000250|UniProtKB:Q63009}.; BINDING 95 95 S-adenosyl-L-methionine. {ECO:0000244|PDB:4X41, ECO:0000244|PDB:5DST, ECO:0000305|PubMed:26529540, ECO:0000305|PubMed:26876602}.; BINDING 119 119 S-adenosyl-L-methionine; via carbonyl oxygen. {ECO:0000244|PDB:5DST, ECO:0000305|PubMed:26876602}.; BINDING 141 141 S-adenosyl-L-methionine. {ECO:0000244|PDB:4X41, ECO:0000244|PDB:5DST, ECO:0000305|PubMed:26529540, ECO:0000305|PubMed:26876602}.; BINDING 170 170 S-adenosyl-L-methionine. {ECO:0000244|PDB:5DST, ECO:0000305|PubMed:26876602}.								histone methylation [GO:0016571]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; protein homooligomerization [GO:0051260]; protein methylation [GO:0006479]; regulation of protein binding [GO:0043393]; regulation of transcription, DNA-templated [GO:0006355]	anchored component of the cytoplasmic side of the plasma membrane [GO:0098753]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	anchored component of the cytoplasmic side of the plasma membrane [GO:0098753]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; histone-arginine N-methyltransferase activity [GO:0008469]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; S-adenosyl-L-methionine binding [GO:1904047]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone methylation [GO:0016571]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; protein homooligomerization [GO:0051260]; protein methylation [GO:0006479]; regulation of protein binding [GO:0043393]; regulation of transcription, DNA-templated [GO:0006355]	histone-arginine N-methyltransferase activity [GO:0008469]; identical protein binding [GO:0042802]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; S-adenosyl-L-methionine binding [GO:1904047]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]	GO:0005829; GO:0005886; GO:0006355; GO:0006479; GO:0008469; GO:0008757; GO:0016571; GO:0018216; GO:0019919; GO:0035241; GO:0035242; GO:0042802; GO:0042803; GO:0043393; GO:0046982; GO:0051260; GO:0098753; GO:1904047	SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:16051612, ECO:0000269|PubMed:18320585, ECO:0000269|PubMed:26876602}; Lipid-anchor {ECO:0000269|PubMed:16051612, ECO:0000269|PubMed:18320585, ECO:0000269|PubMed:26876602}; Cytoplasmic side {ECO:0000269|PubMed:16051612, ECO:0000269|PubMed:18320585, ECO:0000269|PubMed:26876602}.		MOD_RES 58 58 Omega-N-methylarginine; by autocatalysis. {ECO:0000269|PubMed:17925405}.; MOD_RES 73 73 Asymmetric dimethylarginine; by autocatalysis. {ECO:0000269|PubMed:17925405}.	14702039; 16541075; 15489334; 16051612; 17925405; 18320585; 26876602; 26529540; 16189514; 16713569; 18698489; 19060904; 19060911; 20379614; 23455924; 23620769; 23635657; 23946480; 28543863	14702039; 16541075; 15489334; 16051612; 17925405; 18320585; 26876602; 26529540
19721	AKR1D1 SRD5B1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=2.7 uM for testosterone {ECO:0000269|PubMed:18407998}; 	1.3.1.3	CATALYTIC ACTIVITY: 5-beta-cholestan-3-one + NADP(+) = cholest-4-en-3-one + NADPH. {ECO:0000269|PubMed:18407998}.; CATALYTIC ACTIVITY: 17,21-dihydroxy-5-beta-pregnane-3,11,20-trione + NADP(+) = cortisone + NADPH. {ECO:0000269|PubMed:18407998}.	BINDING 26 26 Substrate.; BINDING 53 53 NADP. {ECO:0000269|PubMed:18624455, ECO:0000269|PubMed:18848863, ECO:0000269|PubMed:19075558, ECO:0000269|PubMed:19515843, ECO:0000269|PubMed:22437839}.; BINDING 58 58 Substrate.; BINDING 89 89 Substrate.; BINDING 120 120 Substrate.; BINDING 132 132 Substrate.; BINDING 193 193 NADP. {ECO:0000269|PubMed:18624455, ECO:0000269|PubMed:18848863, ECO:0000269|PubMed:19075558, ECO:0000269|PubMed:19515843, ECO:0000269|PubMed:22437839}.; BINDING 230 230 Substrate.	ACTIVITY REGULATION: Subject to inhibition by high substrate concentrations. Inhibited by testosterone concentrations above 10 uM. {ECO:0000269|PubMed:18407998}.							androgen metabolic process [GO:0008209]; bile acid biosynthetic process [GO:0006699]; bile acid catabolic process [GO:0030573]; C21-steroid hormone metabolic process [GO:0008207]; cholesterol catabolic process [GO:0006707]; digestion [GO:0007586]; oxidation-reduction process [GO:0055114]	cytosol [GO:0005829]	cytosol [GO:0005829]; aldo-keto reductase (NADP) activity [GO:0004033]; delta4-3-oxosteroid 5beta-reductase activity [GO:0047787]; steroid binding [GO:0005496]; androgen metabolic process [GO:0008209]; bile acid biosynthetic process [GO:0006699]; bile acid catabolic process [GO:0030573]; C21-steroid hormone metabolic process [GO:0008207]; cholesterol catabolic process [GO:0006707]; digestion [GO:0007586]; oxidation-reduction process [GO:0055114]	aldo-keto reductase (NADP) activity [GO:0004033]; delta4-3-oxosteroid 5beta-reductase activity [GO:0047787]; steroid binding [GO:0005496]	GO:0004033; GO:0005496; GO:0005829; GO:0006699; GO:0006707; GO:0007586; GO:0008207; GO:0008209; GO:0030573; GO:0047787; GO:0055114	SUBCELLULAR LOCATION: Cytoplasm.			7508385; 11342103; 14702039; 12853948; 12690205; 15489334; 21269460; 24275569; 18624455; 19075558; 18407998; 19515843; 18848863; 22437839; 12970144; 15030995; 16123077; 19013211; 19175828; 20379614; 20522910; 20800085; 21185810; 21255593; 23679950; 23704699; 24189185; 24513054; 24894951; 25500266; 26418565; 28697823	7508385; 11342103; 14702039; 12853948; 12690205; 15489334; 21269460; 24275569; 18624455; 19075558; 18407998; 19515843; 18848863; 22437839; 12970144; 15030995
19726	ALDH1A3 ALDH6	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=9.3 uM for all-trans retinal {ECO:0000269|PubMed:27759097}; KM=4.8 uM for NAD {ECO:0000269|PubMed:27759097}; KM=2.4 mM for acetaldehyde {ECO:0000269|PubMed:27759097}; 	1.2.1.5	CATALYTIC ACTIVITY: An aldehyde + NAD(P)(+) + H(2)O = a carboxylate + NAD(P)H. {ECO:0000269|PubMed:27759097}.	BINDING 204 204 NAD. {ECO:0000244|PDB:5FHZ, ECO:0000269|PubMed:27759097}.; BINDING 207 207 NAD. {ECO:0000244|PDB:5FHZ, ECO:0000269|PubMed:27759097}.; BINDING 361 361 NAD. {ECO:0000244|PDB:5FHZ, ECO:0000269|PubMed:27759097}.; BINDING 411 411 NAD. {ECO:0000244|PDB:5FHZ, ECO:0000269|PubMed:27759097}.				PATHWAY: Cofactor metabolism; retinol metabolism. {ECO:0000269|PubMed:27759097}.	SITE 181 181 Transition state stabilizer. {ECO:0000250}.			embryonic camera-type eye development [GO:0031076]; embryonic eye morphogenesis [GO:0048048]; face development [GO:0060324]; Harderian gland development [GO:0070384]; inner ear morphogenesis [GO:0042472]; locomotory behavior [GO:0007626]; neuromuscular process controlling balance [GO:0050885]; nucleus accumbens development [GO:0021768]; olfactory pit development [GO:0060166]; optic cup morphogenesis involved in camera-type eye development [GO:0002072]; positive regulation of apoptotic process [GO:0043065]; protein homotetramerization [GO:0051289]; retinal metabolic process [GO:0042574]; retinoic acid biosynthetic process [GO:0002138]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; righting reflex [GO:0060013]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803]; retinal dehydrogenase activity [GO:0001758]; thyroid hormone binding [GO:0070324]; embryonic camera-type eye development [GO:0031076]; embryonic eye morphogenesis [GO:0048048]; face development [GO:0060324]; Harderian gland development [GO:0070384]; inner ear morphogenesis [GO:0042472]; locomotory behavior [GO:0007626]; neuromuscular process controlling balance [GO:0050885]; nucleus accumbens development [GO:0021768]; olfactory pit development [GO:0060166]; optic cup morphogenesis involved in camera-type eye development [GO:0002072]; positive regulation of apoptotic process [GO:0043065]; protein homotetramerization [GO:0051289]; retinal metabolic process [GO:0042574]; retinoic acid biosynthetic process [GO:0002138]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; righting reflex [GO:0060013]	aldehyde dehydrogenase (NAD) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803]; retinal dehydrogenase activity [GO:0001758]; thyroid hormone binding [GO:0070324]	GO:0001758; GO:0002072; GO:0002138; GO:0004029; GO:0004030; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007626; GO:0021768; GO:0031076; GO:0042472; GO:0042572; GO:0042573; GO:0042574; GO:0042803; GO:0043065; GO:0048048; GO:0050885; GO:0051289; GO:0060013; GO:0060166; GO:0060324; GO:0070062; GO:0070324; GO:0070384; GO:0070403	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9JHW9}.		MOD_RES 2 2 N-acetylalanine. {ECO:0000244|PubMed:22814378, ECO:0000269|Ref.3}.	7698756; 15489334; 21269460; 22814378; 23591992; 27759097; 23312594; 23646827; 24568872; 24024553; 23881059; 24777706; 18805086; 23220587; 8493914	7698756; 15489334; 21269460; 22814378; 23591992; 27759097; 23312594; 23646827; 24568872; 24024553; 23881059; 24777706
19729	AKR1B10 AKR1B11	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=600 uM for D,L-glyceraldehyde {ECO:0000269|PubMed:18087047}; KM=0.6 uM for all-trans-retinaldehyde {ECO:0000269|PubMed:18087047}; KM=0.7 uM for 9-cis-retinaldehyde {ECO:0000269|PubMed:18087047}; 	1.1.1.-		BINDING 44 44 NADP. {ECO:0000269|PubMed:18087047}.; BINDING 111 111 Substrate. {ECO:0000269|PubMed:18087047}.; BINDING 184 184 NADP. {ECO:0000269|PubMed:18087047}.	ACTIVITY REGULATION: Inhibited by tolrestat. {ECO:0000269|PubMed:18087047}.				SITE 78 78 Lowers pKa of active site Tyr. {ECO:0000250|UniProtKB:P14550}.			daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; farnesol catabolic process [GO:0016488]; retinoid metabolic process [GO:0001523]	cytosol [GO:0005829]; extracellular region [GO:0005576]; lysosome [GO:0005764]	cytosol [GO:0005829]; extracellular region [GO:0005576]; lysosome [GO:0005764]; aldo-keto reductase (NADP) activity [GO:0004033]; geranylgeranyl reductase activity [GO:0045550]; indanol dehydrogenase activity [GO:0047718]; retinal dehydrogenase activity [GO:0001758]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; farnesol catabolic process [GO:0016488]; retinoid metabolic process [GO:0001523]	aldo-keto reductase (NADP) activity [GO:0004033]; geranylgeranyl reductase activity [GO:0045550]; indanol dehydrogenase activity [GO:0047718]; retinal dehydrogenase activity [GO:0001758]	GO:0001523; GO:0001758; GO:0004033; GO:0005576; GO:0005764; GO:0005829; GO:0016488; GO:0044597; GO:0044598; GO:0045550; GO:0047718	SUBCELLULAR LOCATION: Lysosome {ECO:0000269|PubMed:21585341}. Secreted {ECO:0000269|PubMed:21585341}. Note=Secreted through a lysosome-mediated non-classical pathway.		MOD_RES 125 125 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.; MOD_RES 263 263 N6-acetyllysine. {ECO:0000244|PubMed:19608861}.	9565553; 9765596; 12853948; 12690205; 15489334; 9537432; 19608861; 21585341; 18087047; 21269460; 11703436; 12365083; 12732097; 12882871; 15745835; 15928807; 15936242; 16127462; 16204895; 17209433; 17300864; 17425679; 17597105; 17905306; 18056116; 18325492; 18358633; 18396902; 18788756; 19014918; 19028477; 19236911; 19464995; 19563777; 19643728; 19913121; 20036025; 20586184; 20628086; 20705797; 20943077; 21044950; 21277289; 21317765; 21329684; 21645211; 21672310; 21851338; 22014576; 22198799; 22222635; 22329800; 22498646; 22681639; 23146748; 23295227; 23912490; 23975544; 24100137; 24140838; 24217247; 24391771; 24598757; 24656094; 25156503; 25289770; 25304374; 25463304; 25487531; 25532697; 25686905; 25887478; 26496610; 26549844; 26758591; 26835713; 26948042; 26969882; 27025872; 27239845; 27248472; 27359042; 27417252; 27672277; 28003428; 28161411; 28219640; 28232277; 28301069; 28929377; 29204449; 29617059	9565553; 9765596; 12853948; 12690205; 15489334; 9537432; 19608861; 21585341; 18087047; 21269460
19747	AIFM1 AIF PDCD8	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=1.53 mM for NADH {ECO:0000269|PubMed:23217327}; KM=26 uM for cytochrome c {ECO:0000269|PubMed:23217327}; 	1.1.1.-		BINDING 172 172 FAD. {ECO:0000269|PubMed:12198487, ECO:0000269|PubMed:23217327}.; BINDING 177 177 FAD. {ECO:0000269|PubMed:12198487, ECO:0000269|PubMed:23217327}.; BINDING 233 233 FAD; via amide nitrogen and carbonyl oxygen. {ECO:0000269|PubMed:12198487, ECO:0000269|PubMed:23217327}.; BINDING 285 285 FAD. {ECO:0000269|PubMed:12198487, ECO:0000269|PubMed:23217327}.; BINDING 438 438 FAD. {ECO:0000269|PubMed:12198487, ECO:0000269|PubMed:23217327}.; BINDING 483 483 FAD; via carbonyl oxygen. {ECO:0000269|PubMed:12198487, ECO:0000269|PubMed:23217327}.		COFACTOR: Name=FAD; Xref=ChEBI:CHEBI:57692; Evidence={ECO:0000269|PubMed:23217327}; 						activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cellular response to aldosterone [GO:1904045]; cellular response to estradiol stimulus [GO:0071392]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to nitric oxide [GO:0071732]; cellular response to oxygen-glucose deprivation [GO:0090650]; chromosome condensation [GO:0030261]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; mitochondrial respiratory chain complex I assembly [GO:0032981]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; regulation of apoptotic DNA fragmentation [GO:1902510]; response to ischemia [GO:0002931]; response to L-glutamate [GO:1902065]	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; NAD(P)H oxidase activity [GO:0016174]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]; protein dimerization activity [GO:0046983]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cellular response to aldosterone [GO:1904045]; cellular response to estradiol stimulus [GO:0071392]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to nitric oxide [GO:0071732]; cellular response to oxygen-glucose deprivation [GO:0090650]; chromosome condensation [GO:0030261]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; mitochondrial respiratory chain complex I assembly [GO:0032981]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; regulation of apoptotic DNA fragmentation [GO:1902510]; response to ischemia [GO:0002931]; response to L-glutamate [GO:1902065]	DNA binding [GO:0003677]; FAD binding [GO:0071949]; NAD(P)H oxidase activity [GO:0016174]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]; protein dimerization activity [GO:0046983]	GO:0002931; GO:0003677; GO:0005634; GO:0005739; GO:0005743; GO:0005758; GO:0005829; GO:0006915; GO:0006919; GO:0016174; GO:0016651; GO:0030182; GO:0030261; GO:0032981; GO:0043065; GO:0043525; GO:0046983; GO:0048471; GO:0051402; GO:0070059; GO:0070301; GO:0071392; GO:0071732; GO:0071949; GO:0090650; GO:1902065; GO:1902510; GO:1904045	SUBCELLULAR LOCATION: Mitochondrion intermembrane space. Mitochondrion inner membrane. Cytoplasm. Nucleus. Cytoplasm, perinuclear region. Note=Proteolytic cleavage during or just after translocation into the mitochondrial intermembrane space (IMS) results in the formation of an inner-membrane-anchored mature form (AIFmit). During apoptosis, further proteolytic processing leads to a mature form, which is confined to the mitochondrial IMS in a soluble form (AIFsol). AIFsol is released to the cytoplasm in response to specific death signals, and translocated to the nucleus, where it induces nuclear apoptosis. Colocalizes with EIF3G in the nucleus and perinuclear region.; SUBCELLULAR LOCATION: Isoform 3: Mitochondrion intermembrane space {ECO:0000269|PubMed:20111043}. Mitochondrion inner membrane {ECO:0000269|PubMed:20111043}. Note=Has a stronger membrane anchorage than isoform 1.; SUBCELLULAR LOCATION: Isoform 5: Cytoplasm {ECO:0000269|PubMed:16365034}.	PTM: Under normal conditions, a 54-residue N-terminal segment is first proteolytically removed during or just after translocation into the mitochondrial intermembrane space (IMS) by the mitochondrial processing peptidase (MPP) to form the inner-membrane-anchored mature form (AIFmit). During apoptosis, it is further proteolytically processed at amino-acid position 101 leading to the generation of the mature form, which is confined to the mitochondrial IMS in a soluble form (AIFsol). AIFsol is released to the cytoplasm in response to specific death signals, and translocated to the nucleus, where it induces nuclear apoptosis in a caspase-independent manner. {ECO:0000269|PubMed:15775970}.; PTM: Ubiquitination by XIAP/BIRC4 does not lead to proteasomal degradation. Ubiquitination at Lys-255 by XIAP/BIRC4 blocks its ability to bind DNA and induce chromatin degradation, thereby inhibiting its ability to induce cell death. {ECO:0000269|PubMed:17967870, ECO:0000269|PubMed:22103349}.	MOD_RES 105 105 Phosphothreonine. {ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:23186163}.; MOD_RES 109 109 N6-succinyllysine. {ECO:0000250|UniProtKB:Q9Z0X1}.; MOD_RES 116 116 Phosphoserine. {ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 118 118 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 268 268 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 292 292 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 371 371 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 388 388 N6-acetyllysine. {ECO:0000250|UniProtKB:Q9Z0X1}.; MOD_RES 521 521 Phosphothreonine. {ECO:0000244|PubMed:24275569}.; MOD_RES 524 524 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 530 530 Phosphoserine. {ECO:0000244|PubMed:24275569}.; MOD_RES 593 593 N6-acetyllysine. {ECO:0000250|UniProtKB:Q9Z0X1}.	9989411; 16365034; 16644725; 14702039; 15772651; 15489334; 15775970; 10913597; 17094969; 18691976; 17967870; 18669648; 19418225; 20111043; 21364629; 21269460; 22103349; 23186163; 24275569; 25944712; 12198487; 23217327; 20362274; 22019070; 25986071; 25583628; 11533664; 14716299; 14743216; 15175163; 16169070; 16713569; 17110338; 17353931; 19765186; 20000738; 20186120; 20360068; 20562859; 20706999; 21113133; 21182205; 21343306; 21911578; 22371500; 22593156; 22810585; 23455922; 23752268; 24189400; 24344204; 24725412; 24914854; 25609649; 25852190; 26638075; 26752685; 27178839; 27818101	9989411; 16365034; 16644725; 14702039; 15772651; 15489334; 15775970; 10913597; 17094969; 18691976; 17967870; 18669648; 19418225; 20111043; 21364629; 21269460; 22103349; 23186163; 24275569; 25944712; 12198487; 23217327; 20362274; 22019070; 25986071; 25583628
19760	TDP1	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=0.08 uM for 14-mer single-stranded oligo with a 3'-phosphotyrosine {ECO:0000269|PubMed:22822062}; Note=kcat is 7 sec(-1) with single-stranded 5'-tyrosyl DNA as substrate.;	3.1.4.-		BINDING 265 265 Substrate. {ECO:0000269|PubMed:12470949}.; BINDING 495 495 Substrate. {ECO:0000269|PubMed:12470949}.					SITE 518 518 Interaction with DNA. {ECO:0000269|PubMed:12470949}.			DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; single strand break repair [GO:0000012]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 3'-tyrosyl-DNA phosphodiesterase activity [GO:0017005]; double-stranded DNA binding [GO:0003690]; exonuclease activity [GO:0004527]; single-stranded DNA binding [GO:0003697]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; single strand break repair [GO:0000012]	3'-tyrosyl-DNA phosphodiesterase activity [GO:0017005]; double-stranded DNA binding [GO:0003690]; exonuclease activity [GO:0004527]; single-stranded DNA binding [GO:0003697]	GO:0000012; GO:0003690; GO:0003697; GO:0004527; GO:0005634; GO:0005737; GO:0005886; GO:0006281; GO:0006302; GO:0017005; GO:0043231	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15647511}. Cytoplasm {ECO:0000269|PubMed:15647511}.	PTM: Phosphorylated on serine and/or threonine residues, but not on tyrosine residues. {ECO:0000269|PubMed:15647511}.	MOD_RES 61 61 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 147 147 Phosphothreonine. {ECO:0000244|PubMed:19690332}.; MOD_RES 148 148 Phosphoserine. {ECO:0000244|PubMed:19690332}.	14702039; 12508121; 15489334; 10521354; 11572945; 12023295; 15111055; 15811850; 16141202; 17081983; 18669648; 19690332; 21269460; 22822062; 23186163; 12470949; 11839309; 12618186; 14761185; 12244316; 15647511; 15920477; 17948061; 15248776; 15494395; 16775218; 16935573; 17478428; 17600775; 17707402; 18270339; 18347181; 19505854; 19604089; 19851285; 20009512; 20097655; 20603019; 21041670; 21276450; 22155078; 22375014; 22415824; 23505375; 23536040; 23852793; 23902751; 23913164; 24161509; 24183900; 24236237; 24335147; 24355542; 24637157; 24856239; 25522766; 25609251; 25841101; 25987486; 26121557; 26181362; 26421495; 27470939; 27551064; 27687298; 28802254; 28974547; 29078113; 29295983	14702039; 12508121; 15489334; 10521354; 11572945; 12023295; 15111055; 15811850; 16141202; 17081983; 18669648; 19690332; 21269460; 22822062; 23186163; 12470949; 11839309; 12618186; 14761185; 12244316; 15647511; 15920477; 17948061
19860	UGT1A1 GNT1 UGT1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.26 uM for bilirubin {ECO:0000269|PubMed:18004206}; Vmax=1080 pmol/min/mg enzyme with bilirubin as substrate {ECO:0000269|PubMed:18004206}; 	2.4.1.17	CATALYTIC ACTIVITY: UDP-glucuronate + acceptor = UDP + acceptor beta-D-glucuronoside. {ECO:0000269|PubMed:18004206, ECO:0000269|PubMed:18004212}.									acute-phase response [GO:0006953]; animal organ regeneration [GO:0031100]; bilirubin conjugation [GO:0006789]; biphenyl catabolic process [GO:0070980]; cellular glucuronidation [GO:0052695]; cellular response to estradiol stimulus [GO:0071392]; cellular response to ethanol [GO:0071361]; cellular response to glucocorticoid stimulus [GO:0071385]; drug metabolic process [GO:0017144]; estrogen metabolic process [GO:0008210]; flavone metabolic process [GO:0051552]; flavonoid glucuronidation [GO:0052696]; heme catabolic process [GO:0042167]; heterocycle metabolic process [GO:0046483]; liver development [GO:0001889]; negative regulation of cellular glucuronidation [GO:2001030]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of glucuronosyltransferase activity [GO:1904224]; negative regulation of steroid metabolic process [GO:0045939]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; retinoic acid metabolic process [GO:0042573]; steroid metabolic process [GO:0008202]; xenobiotic glucuronidation [GO:0052697]	cytochrome complex [GO:0070069]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]	cytochrome complex [GO:0070069]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; retinoic acid binding [GO:0001972]; steroid binding [GO:0005496]; acute-phase response [GO:0006953]; animal organ regeneration [GO:0031100]; bilirubin conjugation [GO:0006789]; biphenyl catabolic process [GO:0070980]; cellular glucuronidation [GO:0052695]; cellular response to estradiol stimulus [GO:0071392]; cellular response to ethanol [GO:0071361]; cellular response to glucocorticoid stimulus [GO:0071385]; drug metabolic process [GO:0017144]; estrogen metabolic process [GO:0008210]; flavone metabolic process [GO:0051552]; flavonoid glucuronidation [GO:0052696]; heme catabolic process [GO:0042167]; heterocycle metabolic process [GO:0046483]; liver development [GO:0001889]; negative regulation of cellular glucuronidation [GO:2001030]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of glucuronosyltransferase activity [GO:1904224]; negative regulation of steroid metabolic process [GO:0045939]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; retinoic acid metabolic process [GO:0042573]; steroid metabolic process [GO:0008202]; xenobiotic glucuronidation [GO:0052697]	enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; retinoic acid binding [GO:0001972]; steroid binding [GO:0005496]	GO:0001889; GO:0001972; GO:0004857; GO:0005496; GO:0005783; GO:0005789; GO:0005887; GO:0006789; GO:0006953; GO:0007584; GO:0008202; GO:0008210; GO:0015020; GO:0017144; GO:0019899; GO:0031100; GO:0032496; GO:0034663; GO:0042167; GO:0042573; GO:0042594; GO:0042803; GO:0045922; GO:0045939; GO:0046483; GO:0046982; GO:0051552; GO:0052695; GO:0052696; GO:0052697; GO:0070069; GO:0070980; GO:0071361; GO:0071385; GO:0071392; GO:1904224; GO:2001030	SUBCELLULAR LOCATION: Isoform 1: Microsome {ECO:0000269|PubMed:17187418}. Endoplasmic reticulum membrane {ECO:0000305|PubMed:17187418}; Single-pass membrane protein {ECO:0000305}.; SUBCELLULAR LOCATION: Isoform 2: Microsome {ECO:0000269|PubMed:17187418}. Endoplasmic reticulum {ECO:0000305|PubMed:17187418}.			1898728; 1339448; 11434514; 15815621; 12475965; 17187418; 18004206; 18004212; 19545173; 19830808; 19414484; 19159218; 20610558; 24275569; 1634050; 8280139; 8276413; 8226884; 7989045; 7906695; 7989595; 7715297; 8706880; 9639672; 9621515; 9627603; 11013440; 11061796; 11370628; 12402338; 12139570; 14550264; 15712364; 17229650; 23992562; 23099197; 11141380; 11156391; 11401924; 11764096; 11827650; 11855932; 11857560; 11878580; 11906189; 11915038; 11987245; 12036456; 12078936; 12105841; 12151360; 12185559; 12357057; 12439228; 12480553; 12480568; 12499798; 12502904; 12566446; 12602902; 12623074; 12646172; 12677174; 12680285; 12732365; 12732844; 12743455; 12800608; 12850481; 12850492; 12960109; 12969965; 12972027; 14555305; 14586211; 14616765; 14646291; 14647407; 14871858; 15007088; 15049432; 15057901; 15111762; 15115919; 15179405; 15180166; 15247627; 15254716; 15258099; 15258112; 15280927; 15284531; 15284532; 15286088; 15297419; 15304120; 15318931; 15319294; 15320866; 15370961; 15388579; 15455371; 15470081; 15472229; 15491385; 15519273; 15523087; 15557560; 15560369; 15572581; 15684703; 15708967; 15709193; 15709212; 15710570; 15746053; 15761114; 15770010; 15770079; 15771689; 15855726; 15855727; 15857854; 15864124; 15864125; 15864130; 15867280; 15929176; 16004608; 16135700; 16141797; 16171463; 16198654; 16210851; 16237771; 16255851; 16257834; 16257926; 16280036; 16305586; 16344532; 16397224; 16399343; 16399344; 16399345; 16424820; 16456808; 16469709; 16513443; 16529747; 16557566; 16609363; 16610035; 16636344; 16637266; 16712705; 16735790; 16771603; 16791115; 16792515; 16797247; 16809730; 16849011; 16864595; 16865249; 16896007; 16909274; 16951398; 16965601; 16969497; 16985250; 17000907; 17060921; 17072959; 17085674; 17115150; 17138857; 17166930; 17185998; 17192505; 17196409; 17259171; 17264800; 17273745; 17301691; 17329852; 17339869; 17372243; 17374650; 17406868; 17409981; 17424838; 17426648; 17440429; 17459361; 17471158; 17478602; 17479406; 17498780; 17506482; 17510208; 17529886; 17530442; 17549067; 17555467; 17556526; 17558305; 17576806; 17577039; 17578897; 17593033; 17609736; 17611564; 17622933; 17622938; 17627617; 17681105; 17700594; 17728214; 17761781; 17762398; 17850628; 17870518; 17888052; 17909964; 17924828; 17925173; 17949292; 17952380; 17965524; 17978490; 17981384; 17990575; 18021430; 18043502; 18052087; 18054330; 18081723; 18082937; 18161889; 18172616; 18181169; 18221820; 18223459; 18223460; 18240903; 18271934; 18279479; 18300238; 18318774; 18324905; 18335219; 18343383; 18349273; 18349289; 18375480; 18379174; 18392554; 18419642; 18430559; 18433817; 18454993; 18491077; 18498916; 18502788; 18509181; 18547414; 18556656; 18558634; 18568343; 18594531; 18597651; 18602884; 18632753; 18675828; 18676680; 18685565; 18695635; 18756540; 18768784; 18781851; 18784359; 18790042; 18816295; 18818748; 18832463; 18946804; 18953066; 18981166; 18982743; 18990750; 18992148; 18992263; 19019335; 19021734; 19064572; 19077918; 19082692; 19141701; 19170196; 19204906; 19207584; 19217809; 19223558; 19225446; 19238116; 19243019; 19244109; 19262071; 19267064; 19268007; 19279563; 19299905; 19303655; 19309288; 19325249; 19336732; 19343046; 19349540; 19352303; 19356052; 19356098; 19360737; 19364970; 19371317; 19389676; 19390945; 19397531; 19406951; 19419973; 19424794; 19430315; 19430380; 19437564; 19450125; 19450126; 19482841; 19486253; 19494809; 19513514; 19527514; 19546880; 19571435; 19575027; 19620808; 19625176; 19636001; 19639031; 19644937; 19674361; 19683255; 19692168; 19712005; 19715905; 19732760; 19771428; 19797611; 19799547; 19858149; 19858398; 19859999; 19861894; 19881262; 19888426; 19890225; 19891553; 19898482; 19913121; 19932091; 19948621; 19951703; 19956635; 19996319; 20007295; 20007297; 20007669; 20028383; 20038727; 20057336; 20061399; 20064729; 20070246; 20087647; 20089735; 20096102; 20136364; 20140262; 20142249; 20147615; 20173083; 20177420; 20193274; 20197307; 20207827; 20214802; 20215562; 20216541; 20235787; 20297805; 20308029; 20335017; 20358470; 20371435; 20376058; 20377135; 20379614; 20385995; 20389299; 20402064; 20430047; 20453000; 20483464; 20485444; 20504240; 20528217; 20528568; 20529348; 20530282; 20534012; 20540849; 20546738; 20562211; 20562445; 20565459; 20567810; 20580994; 20600030; 20620155; 20628086; 20628391; 20634891; 20639394; 20643254; 20647221; 20648548; 20650040; 20653675; 20679960; 20686835; 20709051; 20734064; 20800603; 20823282; 20837016; 20854796; 20860988; 20865252; 20890421; 20948202; 20953506; 20975617; 21072184; 21080475; 21092520; 21150467; 21266593; 21275655; 21317830; 21319362; 21342357; 21351260; 21411679; 21440586; 21473286; 21513526; 21586239; 21601426; 21614935; 21625173; 21666065; 21760472; 21771722; 21846474; 21856293; 21856742; 21911884; 21978357; 21983082; 21988832; 22030088; 22031623; 22047493; 22050734; 22085268; 22085899; 22169899; 22184458; 22199302; 22210424; 22212955; 22213983; 22214020; 22228101; 22273851; 22299209; 22302521; 22307138; 22325916; 22340355; 22357454; 22367021; 22367373; 22371261; 22398043; 22402308; 22448797; 22450351; 22475179; 22492655; 22511988; 22527346; 22537951; 22559977; 22648071; 22659092; 22661630; 22676194; 22713701; 22749334; 22808571; 22829544; 22901212; 22912755; 22912756; 23014115; 23053265; 23089802; 23099353; 23130636; 23131697; 23147267; 23148825; 23160818; 23207817; 23230132; 23236239; 23277392; 23290513; 23303296; 23350445; 23386248; 23401472; 23402418; 23441093; 23461146; 23488780; 23516488; 23517300; 23527766; 23529007; 23537215; 23548653; 23580084; 23605141; 23609856; 23611809; 23647681; 23682072; 23686699; 23700788; 23714156; 23721685; 23753274; 23781580; 23783485; 23789755; 23842475; 23881212; 23892411; 23898114; 23926009; 23950218; 23964438; 23981182; 24025985; 24033692; 24036429; 24057187; 24060717; 24065680; 24088669; 24088753; 24092055; 24107802; 24114122; 24167350; 24195516; 24204915; 24217933; 24232666; 24239897; 24255116; 24286076; 24308720; 24329186; 24375494; 24390949; 24401909; 24403077; 24403462; 24453052; 24458221; 24470170; 24516079; 24519753; 24557078; 24615032; 24620945; 24641623; 24650397; 24690955; 24709690; 24726540; 24793765; 24815493; 24820767; 24856997; 24865931; 24898899; 24901842; 24947795; 24958824; 24977443; 25055799; 25072305; 25086287; 25092941; 25102181; 25105254; 25141892; 25200497; 25260839; 25262300; 25264962; 25312789; 25368098; 25380893; 25391605; 25446781; 25450281; 25478904; 25488668; 25492569; 25545261; 25547628; 25611851; 25712374; 25741749; 25743847; 25760534; 25778466; 25782327; 25822733; 25899702; 25953521; 25981652; 25993113; 25997248; 26010150; 26039129; 26068521; 26068529; 26098842; 26125716; 26125934; 26146841; 26146896; 26176234; 26200705; 26220143; 26223945; 26229432; 26247833; 26250421; 26303110; 26313268; 26317684; 26403473; 26407805; 26467199; 26482555; 26494856; 26628212; 26645279; 26684499; 26697581; 26716871; 26727668; 26751466; 26773202; 26830078; 26857783; 26872008; 26960716; 27025983; 27057738; 27060662; 27072236; 27098059; 27155186; 27160286; 27208893; 27264814; 27318112; 27323053; 27413119; 27461651; 27500989; 27507617; 27531059; 27533851; 27549213; 27704169; 27795544; 27826892; 27832172; 27832386; 27842454; 27855134; 27857056; 27932114; 27938508; 27943244; 27967321; 27977017; 27981643; 28056823; 28068583; 28098838; 28173214; 28296739; 28338110; 28389615; 28399191; 28443723; 28567595; 28585035; 28613375; 28637434; 28888563; 28899924; 28915895; 28951772; 29025858; 29058288; 29117017; 29131533; 29137095; 29210320; 29239247; 29282011; 29524031; 29534743; 29607327; 29889392; 3082969; 4639028; 6654901; 6796486; 8027054; 8687483	1898728; 1339448; 11434514; 15815621; 12475965; 17187418; 18004206; 18004212; 19545173; 19830808; 19414484; 19159218; 20610558; 24275569; 1634050; 8280139; 8276413; 8226884; 7989045; 7906695; 7989595; 7715297; 8706880; 9639672; 9621515; 9627603; 11013440; 11061796; 11370628; 12402338; 12139570; 14550264; 15712364; 17229650; 23992562; 23099197
19863	UGT2A1 UGT2A2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=75.4 uM for 3-hydroxybiphenyl {ECO:0000269|PubMed:10359671}; KM=59.5 uM for umbelliferone {ECO:0000269|PubMed:10359671}; KM=51.6 uM for S-(-)-b-citronellol {ECO:0000269|PubMed:10359671}; KM=170.1 uM for borneol {ECO:0000269|PubMed:10359671}; KM=56.2 uM for testosterone {ECO:0000269|PubMed:10359671}; KM=251 uM for UDP-glucuronate {ECO:0000269|PubMed:10359671}; Vmax=2.60 nmol/min/mg enzyme with 3-hydroxybiphenyl as substrate {ECO:0000269|PubMed:10359671}; Vmax=0.61 nmol/min/mg enzyme with umbelliferone as substrate {ECO:0000269|PubMed:10359671}; Vmax=1.98 nmol/min/mg enzyme with S-(-)-b-citronellol as substrate {ECO:0000269|PubMed:10359671}; Vmax=1.05 nmol/min/mg enzyme with borneol as substrate {ECO:0000269|PubMed:10359671}; Vmax=0.25 nmol/min/mg enzyme with testosterone as substrate {ECO:0000269|PubMed:10359671}; 	2.4.1.17	CATALYTIC ACTIVITY: UDP-glucuronate + acceptor = UDP + acceptor beta-D-glucuronoside.									cellular glucuronidation [GO:0052695]; detection of chemical stimulus [GO:0009593]; sensory perception of smell [GO:0007608]	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]	integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; glucuronosyltransferase activity [GO:0015020]; cellular glucuronidation [GO:0052695]; detection of chemical stimulus [GO:0009593]; sensory perception of smell [GO:0007608]	glucuronosyltransferase activity [GO:0015020]	GO:0007608; GO:0009593; GO:0015020; GO:0016021; GO:0043231; GO:0052695	SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.			10359671; 19858781; 14702039; 15815621; 8687483	10359671; 19858781; 14702039; 15815621
19990	TDP2 EAP2 TTRAP AD-022	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=8 uM for single-stranded 5'-tyrosyl DNA {ECO:0000269|PubMed:22822062}; Note=kcat is 3 sec(-1) with single-stranded 5'-tyrosyl DNA as substrate.;	3.1.4.-				COFACTOR: Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:19794497, ECO:0000269|PubMed:22405347, ECO:0000269|PubMed:22822062}; Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000269|PubMed:19794497, ECO:0000269|PubMed:22405347, ECO:0000269|PubMed:22822062}; ;  Note=Magnesium. Can use other divalent cations as cofactor in vitro, such as manganese. {ECO:0000269|PubMed:19794497, ECO:0000269|PubMed:22405347, ECO:0000269|PubMed:22822062};				AD-022		cell surface receptor signaling pathway [GO:0007166]; double-strand break repair [GO:0006302]; neuron development [GO:0048666]	aggresome [GO:0016235]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]	aggresome [GO:0016235]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; 5'-tyrosyl-DNA phosphodiesterase activity [GO:0070260]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nuclease activity [GO:0004518]; single-stranded DNA binding [GO:0003697]; transcription corepressor activity [GO:0003714]; tyrosyl-RNA phosphodiesterase activity [GO:0036317]; cell surface receptor signaling pathway [GO:0007166]; double-strand break repair [GO:0006302]; neuron development [GO:0048666]	5'-tyrosyl-DNA phosphodiesterase activity [GO:0070260]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nuclease activity [GO:0004518]; single-stranded DNA binding [GO:0003697]; transcription corepressor activity [GO:0003714]; tyrosyl-RNA phosphodiesterase activity [GO:0036317]	GO:0000287; GO:0003697; GO:0003714; GO:0004518; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006302; GO:0007166; GO:0016235; GO:0016604; GO:0016605; GO:0030145; GO:0036317; GO:0048666; GO:0070260	SUBCELLULAR LOCATION: Nucleus. Nucleus, PML body. Nucleus, nucleolus. Cytoplasm. Note=Localizes to nucleolar cavities following stress; localization to nucleolus is dependent on PML protein.; SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:22908287}. Note=(Microbial infection) In case of infection by picornavirus, relocalizes to cytoplasmic sites distinct from those containing viral proteins associated with RNA replication or encapsidation. {ECO:0000269|PubMed:22908287}.	PTM: Ubiquitinated by TRAF6. {ECO:0000269|PubMed:21980489}.	MOD_RES 1 1 N-acetylmethionine. {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378}.; MOD_RES 88 88 Phosphothreonine; by ACVR1B. {ECO:0000269|PubMed:18039968}.; MOD_RES 92 92 Phosphothreonine; by ACVR1B. {ECO:0000269|PubMed:18039968}.; MOD_RES 95 95 Phosphoserine. {ECO:0000244|PubMed:23186163}.	10764746; 12743594; 10931946; 14702039; 14574404; 15489334; 18039968; 19413330; 19794497; 21269460; 21030584; 21980489; 22405347; 21921940; 22822062; 22223895; 22814378; 22908287; 23186163; 24658003; 28112733; 12023295; 15231748; 15247905; 17597587; 18706885; 19023331; 19505854; 19580783; 19757154; 19776380; 20677014; 20711500; 21478903; 21900206; 21988832; 22262880; 23275563; 23433115; 23505375; 23602568; 24236237; 24808172; 24856239; 25201958; 25841101; 26701725; 26752685; 27060144; 27099339; 27814490; 28794467; 28912134; 29353210	10764746; 12743594; 10931946; 14702039; 14574404; 15489334; 18039968; 19413330; 19794497; 21269460; 21030584; 21980489; 22405347; 21921940; 22822062; 22223895; 22814378; 22908287; 23186163; 24658003; 28112733
20045	CDC34 UBCH3 UBE2R1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.11 uM for beta-catenin-monoubiquin {ECO:0000269|PubMed:19945379}; 	2.3.2.23; 2.3.2.24	CATALYTIC ACTIVITY: S-ubiquitinyl-[E1 ubiquitin-activating enzyme]-L-cysteine + [E2 ubiquitin-conjugating enzyme]-L-cysteine = [E1 ubiquitin-activating enzyme]-L-cysteine + S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine. {ECO:0000255|PROSITE-ProRule:PRU00388, ECO:0000255|PROSITE-ProRule:PRU10133, ECO:0000269|PubMed:12037680, ECO:0000269|PubMed:17698585, ECO:0000269|PubMed:20061386, ECO:0000269|PubMed:20347421}.; CATALYTIC ACTIVITY: S-ubiquitinyl-[E1 ubiquitin-activating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E1 ubiquitin-activating enzyme]-L-cysteine + N(6)-monoubiquitinyl-[acceptor protein]-L-lysine. {ECO:0000269|PubMed:17588522}.		ACTIVITY REGULATION: CDC34-catalyzed polyubiquitin chain assembly activity is stimulated by the conjugation of NEDD8 to the CUL1 SCF E3 ligase complex subunit. {ECO:0000269|PubMed:11675391}.			PATHWAY: Protein modification; protein ubiquitination. {ECO:0000255|PROSITE-ProRule:PRU00388}.				cellular protein modification process [GO:0006464]; cellular response to interferon-beta [GO:0035458]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of cAMP-mediated signaling [GO:0043951]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of neuron apoptotic process [GO:0043525]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to growth factor [GO:0070848]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cellular protein modification process [GO:0006464]; cellular response to interferon-beta [GO:0035458]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of cAMP-mediated signaling [GO:0043951]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of neuron apoptotic process [GO:0043525]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to growth factor [GO:0070848]	ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	GO:0000082; GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006270; GO:0006464; GO:0016567; GO:0016607; GO:0031625; GO:0035458; GO:0043161; GO:0043525; GO:0043951; GO:0061630; GO:0061631; GO:0070848; GO:0070936; GO:0090261	SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=The phosphorylation of the C-terminal tail plays an important role in mediating nuclear localization. Colocalizes with beta-tubulin on mitotic spindles in anaphase.	PTM: Autoubiquitinated (PubMed:22496338, PubMed:11805320, PubMed:12060736). Autoubiquitination is promoted by the human herpes virus 1 protein ICP0 and leads to degradation by the Ubiquitin-proteasomal pathway (PubMed:11805320, PubMed:12060736). {ECO:0000269|PubMed:11805320, ECO:0000269|PubMed:12060736, ECO:0000269|PubMed:22496338}.; PTM: Phosphorylated by CK2. Phosphorylation of the C-terminal tail by CK2 controles the nuclear localization. {ECO:0000269|PubMed:11546811, ECO:0000269|PubMed:12037680, ECO:0000269|PubMed:17461777}.	MOD_RES 203 203 Phosphoserine; by CK2. {ECO:0000269|PubMed:11546811, ECO:0000269|PubMed:17461777}.; MOD_RES 222 222 Phosphoserine; by CK2. {ECO:0000269|PubMed:11546811, ECO:0000269|PubMed:17461777}.; MOD_RES 231 231 Phosphoserine; by CK2. {ECO:0000269|PubMed:11546811, ECO:0000269|PubMed:12037680, ECO:0000269|PubMed:17461777}.; MOD_RES 233 233 Phosphothreonine; by CK2. {ECO:0000269|PubMed:11546811}.; MOD_RES 236 236 Phosphoserine; by CK2. {ECO:0000269|PubMed:11546811}.	8248134; 14702039; 15489334; 10329681; 10373550; 10769200; 10871850; 10918611; 11546811; 11447293; 11675391; 12037680; 11805320; 12060736; 15652359; 17461777; 17588522; 17698585; 18851830; 19945379; 19112177; 19126550; 20061386; 20347421; 21269460; 21683433; 22496338; 24316736; 12646216; 14514672; 14645576; 16123592; 16142244; 16210246; 16286470; 16954532; 17274640; 17597759; 18353650; 18458088; 18950845; 19028597; 19240061; 19452197; 19489725; 19549727; 19615732; 19851334; 19874575; 19875449; 19940261; 20353940; 20378537; 20379614; 21130766; 21296085; 22210895; 22286100; 23465077; 24129577; 25416956; 25471371; 27044868; 27786305; 6305978; 7479848; 8010951; 8550590; 9990853	8248134; 14702039; 15489334; 10329681; 10373550; 10769200; 10871850; 10918611; 11546811; 11447293; 11675391; 12037680; 11805320; 12060736; 15652359; 17461777; 17588522; 17698585; 18851830; 19945379; 19112177; 19126550; 20061386; 20347421; 21269460; 21683433; 22496338; 24316736
20071	TXNDC12 TLP19 UNQ713/PRO1376	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=25 uM for Asn-Arg-Cys-Ser-Gln-Gly-Ser-Cys-Trp-Asn; 	1.8.4.2	CATALYTIC ACTIVITY: 2 glutathione + protein-disulfide = glutathione disulfide + protein-dithiol.				BIOPHYSICOCHEMICAL PROPERTIES: ;  pH dependence: Optimum pH is 6.5.;			UNQ713/PRO1376		cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	endoplasmic reticulum lumen [GO:0005788]	endoplasmic reticulum lumen [GO:0005788]; peptide disulfide oxidoreductase activity [GO:0015037]; protein-disulfide reductase (glutathione) activity [GO:0019153]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]	peptide disulfide oxidoreductase activity [GO:0015037]; protein-disulfide reductase (glutathione) activity [GO:0019153]	GO:0005788; GO:0015037; GO:0019153; GO:0030154; GO:0045454; GO:1902236	SUBCELLULAR LOCATION: Endoplasmic reticulum lumen {ECO:0000269|PubMed:12761212}.			14557066; 12975309; 16303743; 16710414; 15489334; 15340161; 12761212; 21269460; 24275569; 25944712; 19361226; 18628206; 19887585; 20000738; 24705354; 25416956; 25940440	14557066; 12975309; 16303743; 16710414; 15489334; 15340161; 12761212; 21269460; 24275569; 25944712; 19361226
20139	USP1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.7 uM for ubiquitin vinyl sulfone (in presence of WDR48) {ECO:0000269|PubMed:18082604}; KM=1.4 uM for ubiquitin vinyl sulfone (in absence of WDR48) {ECO:0000269|PubMed:18082604}; 	3.4.19.12	CATALYTIC ACTIVITY: Thiol-dependent hydrolysis of ester, thioester, amide, peptide and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76-residue protein attached to proteins as an intracellular targeting signal). {ECO:0000269|PubMed:15694335, ECO:0000269|PubMed:16531995, ECO:0000269|PubMed:18082604, ECO:0000269|PubMed:26388029, ECO:0000269|PubMed:9806842}.						SITE 671 672 Cleavage; by autolysis. {ECO:0000269|PubMed:16531995}.			DNA damage response, detection of DNA damage [GO:0042769]; DNA repair [GO:0006281]; monoubiquitinated protein deubiquitination [GO:0035520]; protein deubiquitination [GO:0016579]; regulation of DNA repair [GO:0006282]; response to UV [GO:0009411]; skeletal system development [GO:0001501]; ubiquitin-dependent protein catabolic process [GO:0006511]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; peptidase activity [GO:0008233]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; DNA damage response, detection of DNA damage [GO:0042769]; DNA repair [GO:0006281]; monoubiquitinated protein deubiquitination [GO:0035520]; protein deubiquitination [GO:0016579]; regulation of DNA repair [GO:0006282]; response to UV [GO:0009411]; skeletal system development [GO:0001501]; ubiquitin-dependent protein catabolic process [GO:0006511]	cysteine-type endopeptidase activity [GO:0004197]; peptidase activity [GO:0008233]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]	GO:0001501; GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0006281; GO:0006282; GO:0006511; GO:0008233; GO:0009411; GO:0016579; GO:0035520; GO:0036459; GO:0042769	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15694335}.	PTM: Autocatalytic cleavage of USP1 following UV irradiation inactivates it leading to an increase in ubiquitinated PCNA, recruitment of POLH and translesion synthesis. {ECO:0000269|PubMed:15694335, ECO:0000269|PubMed:16531995}.; PTM: Ubiquitinated; leading to its subsequent proteasomal degradation. {ECO:0000250}.	MOD_RES 16 16 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 42 42 Phosphoserine. {ECO:0000244|PubMed:17525332, ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163}.; MOD_RES 67 67 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 313 313 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 475 475 Phosphoserine. {ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163}.; MOD_RES 768 768 Phosphoserine. {ECO:0000250|UniProtKB:Q8BJQ2}.	9806842; 11230166; 15489334; 15694335; 16531995; 18082604; 17525332; 18669648; 19413330; 20068231; 21406692; 23186163; 26388029; 15572677; 19536649; 19596236; 19615732; 19690177; 20385554; 20603015; 20603016; 20603073; 20671156; 21389083; 21464321; 21640107; 21768287; 21925315; 22426999; 22692201; 22701671; 23116119; 23414517; 24076221; 24850727; 25500724; 25744535; 26002196; 26032834; 26117423; 26496610; 26758085; 26825230; 26951930; 27160904; 27463890; 27840911; 28270494; 28302046; 29138248	9806842; 11230166; 15489334; 15694335; 16531995; 18082604; 17525332; 18669648; 19413330; 20068231; 21406692; 23186163; 26388029
20209	UCHL1	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=122 nM for Ub-AMC {ECO:0000269|PubMed:12705903, ECO:0000269|PubMed:8639624, ECO:0000269|PubMed:9774100}; KM=1.20 uM for ubiquitin ethyl ester {ECO:0000269|PubMed:12705903, ECO:0000269|PubMed:8639624, ECO:0000269|PubMed:9774100}; Vmax=0.47 umol/min/mg enzyme toward Ub-AMC {ECO:0000269|PubMed:12705903, ECO:0000269|PubMed:8639624, ECO:0000269|PubMed:9774100}; Vmax=25 umol/min/mg enzyme toward ubiquitin ethyl ester {ECO:0000269|PubMed:12705903, ECO:0000269|PubMed:8639624, ECO:0000269|PubMed:9774100}; 	3.4.19.12; 6.-.-.-	CATALYTIC ACTIVITY: Thiol-dependent hydrolysis of ester, thioester, amide, peptide and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76-residue protein attached to proteins as an intracellular targeting signal). {ECO:0000269|PubMed:20439756}.						SITE 1 1 Susceptible to oxidation. {ECO:0000269|PubMed:14722078}.; SITE 6 6 Susceptible to oxidation. {ECO:0000269|PubMed:14722078}.; SITE 12 12 Susceptible to oxidation. {ECO:0000269|PubMed:14722078}.; SITE 124 124 Susceptible to oxidation. {ECO:0000269|PubMed:14722078}.; SITE 176 176 Important for enzyme activity. {ECO:0000269|PubMed:8639624}.; SITE 179 179 Susceptible to oxidation. {ECO:0000269|PubMed:14722078}.; SITE 220 220 Susceptible to oxidation. {ECO:0000269|PubMed:14722078}.			adult walking behavior [GO:0007628]; axonal transport of mitochondrion [GO:0019896]; axon target recognition [GO:0007412]; cell proliferation [GO:0008283]; eating behavior [GO:0042755]; muscle fiber development [GO:0048747]; negative regulation of MAP kinase activity [GO:0043407]; neuromuscular process [GO:0050905]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; regulation of macroautophagy [GO:0016241]; response to ischemia [GO:0002931]; sensory perception of pain [GO:0019233]	axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; neuron projection terminus [GO:0044306]; nucleoplasm [GO:0005654]	axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; myelin sheath [GO:0043209]; neuron projection terminus [GO:0044306]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; alpha-2A adrenergic receptor binding [GO:0031694]; cysteine-type endopeptidase activity [GO:0004197]; ligase activity [GO:0016874]; omega peptidase activity [GO:0008242]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; adult walking behavior [GO:0007628]; axon target recognition [GO:0007412]; axonal transport of mitochondrion [GO:0019896]; cell proliferation [GO:0008283]; eating behavior [GO:0042755]; muscle fiber development [GO:0048747]; negative regulation of MAP kinase activity [GO:0043407]; neuromuscular process [GO:0050905]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; regulation of macroautophagy [GO:0016241]; response to ischemia [GO:0002931]; sensory perception of pain [GO:0019233]	alpha-2A adrenergic receptor binding [GO:0031694]; cysteine-type endopeptidase activity [GO:0004197]; ligase activity [GO:0016874]; omega peptidase activity [GO:0008242]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]	GO:0002931; GO:0004197; GO:0004843; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0007412; GO:0007628; GO:0008242; GO:0008283; GO:0016241; GO:0016579; GO:0016874; GO:0019233; GO:0019896; GO:0031625; GO:0031694; GO:0036459; GO:0042755; GO:0043025; GO:0043130; GO:0043161; GO:0043209; GO:0043407; GO:0044306; GO:0048747; GO:0050905; GO:1904115	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19261853}. Endoplasmic reticulum membrane {ECO:0000269|PubMed:19261853}; Lipid-anchor {ECO:0000269|PubMed:19261853}. Note=About 30% of total UCHL1 is associated with membranes in brain.	PTM: O-glycosylated. {ECO:0000250}.	MOD_RES 125 125 Phosphoserine. {ECO:0000250|UniProtKB:Q00981}.	15815621; 15489334; 2163617; 14722078; 2947814; 9774100; 1849484; 1286667; 8639624; 9790970; 12408865; 12082530; 16475834; 19261853; 19608861; 21269460; 16537382; 20439756; 12705903; 10454131; 10203348; 11027850; 15048890; 16450370; 18411255; 21268678; 23359680; 28007905; 11502942; 11535241; 11716150; 12123845; 12160938; 12210873; 12539205; 12775255; 12784265; 15194490; 15214825; 15221445; 15228595; 15716245; 15882803; 16007636; 16049941; 16169070; 16177983; 16316632; 16369839; 16371654; 16380264; 16402389; 16626667; 16642472; 16644676; 16698101; 16888648; 16941465; 17108109; 17144664; 17200335; 17287139; 17353931; 17599367; 17690318; 17925890; 17929277; 17994469; 18093156; 18250096; 18494032; 18499164; 18512240; 18543214; 18550537; 18638528; 18666234; 18820707; 18841579; 18949367; 18950315; 19017757; 19035297; 19141079; 19224617; 19329225; 19343046; 19477270; 19488775; 19536331; 19615732; 19683447; 19707515; 19859801; 19864305; 19945429; 19950834; 20029029; 20051117; 20104524; 20147297; 20160478; 20231490; 20302621; 20302855; 20381070; 20395212; 20524204; 20574456; 20608941; 20646535; 20713032; 20861575; 20949132; 21044950; 21251915; 21309726; 21315600; 21345711; 21426768; 21428722; 21504384; 21565611; 21626562; 21693148; 21702960; 21706495; 21878121; 21999842; 22001920; 22022780; 22028813; 22038515; 22076440; 22246902; 22279545; 22503729; 22617491; 22660851; 22688354; 22726800; 22839974; 22849656; 22883340; 22920679; 22931063; 22932395; 23061666; 23158209; 23291960; 23315218; 23392373; 23484054; 23490535; 23499448; 23543736; 23555160; 23603559; 23664488; 23686552; 23959334; 23996067; 24080464; 24086249; 24090154; 24309322; 24314660; 24702261; 24832624; 24908181; 24950120; 24959670; 2530630; 25354657; 25370916; 25403879; 25466238; 25578779; 25596590; 25615526; 25638021; 25640309; 25665578; 25687137; 25915537; 25973863; 26018507; 26040028; 26232084; 26264933; 26293643; 26314856; 26513019; 26547005; 26550574; 26702068; 26722437; 26752685; 26810533; 26823707; 26881020; 26899237; 27018834; 27215701; 27319802; 27840994; 27914685; 28002735; 28193576; 28392346; 28472177; 28636190; 29126443; 29128359; 29150024; 29339092; 29359783; 29401475; 29462615; 29627846; 29782494	15815621; 15489334; 2163617; 14722078; 2947814; 9774100; 1849484; 1286667; 8639624; 9790970; 12408865; 12082530; 16475834; 19261853; 19608861; 21269460; 16537382; 20439756; 12705903; 10454131; 10203348; 11027850; 15048890; 16450370; 18411255; 21268678; 23359680; 28007905
20251	PPIP5K2 HISPPD1 KIAA0433 VIP2	BIOPHYSICOCHEMICAL PROPERTIES:  Kinetic parameters: KM=0.13 uM for InsP6 {ECO:0000269|PubMed:17690096}; KM=0.19 uM for InsP7 {ECO:0000269|PubMed:17690096}; Vmax=0.39 nmol/min/mg enzyme with InsP6 as substrate {ECO:0000269|PubMed:17690096}; Vmax=1.38 nmol/min/mg enzyme with InsP7 as substrate {ECO:0000269|PubMed:17690096}; 	2.7.4.21; 2.7.4.24	CATALYTIC ACTIVITY: ATP + 1D-myo-inositol hexakisphosphate = ADP + 1D-myo-inositol 5-diphosphate 1,2,3,4,6-pentakisphosphate. {ECO:0000269|PubMed:21222653}.; CATALYTIC ACTIVITY: ATP + 1D-myo-inositol 1-diphosphate 2,3,4,5,6-pentakisphosphate = ADP + 1D-myo-inositol 1,5-bis(diphosphate) 2,3,4,6-tetrakisphosphate. {ECO:0000269|PubMed:21222653}.; CATALYTIC ACTIVITY: ATP + 1D-myo-inositol 5-diphosphate 1,2,3,4,6-pentakisphosphate = ADP + 1D-myo-inositol 1,5-bis(diphosphate) 2,3,4,6-tetrakisphosphate. {ECO:0000269|PubMed:21222653}.; CATALYTIC ACTIVITY: ATP + 1D-myo-inositol hexakisphosphate = ADP + 1D-myo-inositol 1-diphosphate 2,3,4,5,6-pentakisphosphate. {ECO:0000269|PubMed:21222653}.	BINDING 134 134 ATP. {ECO:0000244|PDB:3T54, ECO:0000244|PDB:3T7A, ECO:0000244|PDB:3T99, ECO:0000244|PDB:3T9A, ECO:0000244|PDB:3T9B, ECO:0000244|PDB:3T9C, ECO:0000244|PDB:3T9D, ECO:0000244|PDB:3T9E, ECO:0000244|PDB:3T9F, ECO:0000269|PubMed:22119861}.; BINDING 187 187 ATP. {ECO:0000244|PDB:3T54, ECO:0000244|PDB:3T7A, ECO:0000244|PDB:3T99, ECO:0000244|PDB:3T9A, ECO:0000244|PDB:3T9B, ECO:0000244|PDB:3T9C, ECO:0000244|PDB:3T9D, ECO:0000244|PDB:3T9E, ECO:0000244|PDB:3T9F, ECO:0000269|PubMed:22119861}.; BINDING 194 194 ATP. {ECO:0000244|PDB:3T54, ECO:0000244|PDB:3T7A, ECO:0000244|PDB:3T99, ECO:0000244|PDB:3T9A, ECO:0000244|PDB:3T9B, ECO:0000244|PDB:3T9C, ECO:0000244|PDB:3T9D, ECO:0000244|PDB:3T9E, ECO:0000244|PDB:3T9F, ECO:0000269|PubMed:22119861}.; BINDING 213 213 ATP. {ECO:0000244|PDB:3T9A, ECO:0000244|PDB:3T9B, ECO:0000244|PDB:3T9C, ECO:0000244|PDB:3T9D, ECO:0000269|PubMed:22119861}.; BINDING 248 248 Substrate. {ECO:0000244|PDB:3T9C, ECO:0000244|PDB:3T9D, ECO:0000244|PDB:3T9E, ECO:0000244|PDB:3T9F, ECO:0000269|PubMed:22119861}.; BINDING 262 262 Substrate. {ECO:0000244|PDB:3T9C, ECO:0000244|PDB:3T9E, ECO:0000244|PDB:3T9F, ECO:0000269|PubMed:22119861}.; BINDING 264 264 ATP. {ECO:0000244|PDB:3T54, ECO:0000244|PDB:3T7A, ECO:0000269|PubMed:22119861}.; BINDING 309 309 ATP. {ECO:0000244|PDB:3T54, ECO:0000244|PDB:3T7A, ECO:0000244|PDB:3T99, ECO:0000244|PDB:3T9B, ECO:0000244|PDB:3T9C, ECO:0000244|PDB:3T9D, ECO:0000244|PDB:3T9E, ECO:0000244|PDB:3T9F, ECO:0000269|PubMed:22119861}.								inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]	cytosol [GO:0005829]	cytosol [GO:0005829]; 5-diphosphoinositol pentakisphosphate 3-kinase activity [GO:0102092]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]; inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]	5-diphosphoinositol pentakisphosphate 3-kinase activity [GO:0102092]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]	GO:0000827; GO:0000828; GO:0000829; GO:0000832; GO:0005524; GO:0005829; GO:0006020; GO:0032958; GO:0033857; GO:0043647; GO:0052723; GO:0052724; GO:0102092	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:17690096}.		MOD_RES 38 38 Phosphoserine. {ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 223 223 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1006 1006 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 1016 1016 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 1074 1074 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1091 1091 Phosphoserine. {ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 1165 1165 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1172 1172 Phosphoserine. {ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163}.; MOD_RES 1180 1180 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1220 1220 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1221 1221 Phosphoserine. {ECO:0000244|PubMed:23186163}.	9455477; 12168954; 15372022; 15489334; 17690096; 17702752; 18669648; 19690332; 21269460; 21222653; 23186163; 24275569; 22119861; 17412958; 18981179; 20379614; 21150319; 23032903; 23240582; 24768307; 25044992; 26084399; 26153667; 26204995; 27460418; 28126903; 29590114	9455477; 12168954; 15372022; 15489334; 17690096; 17702752; 18669648; 19690332; 21269460; 21222653; 23186163; 24275569; 22119861
20315	PPIP5K1 HISPPD2A IP6K IPS1 KIAA0377 VIP1	BIOPHYSICOCHEMICAL PROPERTIES: ;  Kinetic parameters: KM=0.12 uM for InsP6 {ECO:0000269|PubMed:17690096, ECO:0000269|PubMed:17702752, ECO:0000269|PubMed:21222653}; KM=0.10 uM for InsP7 {ECO:0000269|PubMed:17690096, ECO:0000269|PubMed:17702752, ECO:0000269|PubMed:21222653}; Vmax=0.03 nmol/min/mg enzyme with InsP6 as substrate {ECO:0000269|PubMed:17690096, ECO:0000269|PubMed:17702752, ECO:0000269|PubMed:21222653}; Vmax=0.13 nmol/min/mg enzyme with InsP7 as substrate {ECO:0000269|PubMed:17690096, ECO:0000269|PubMed:17702752, ECO:0000269|PubMed:21222653}; Note=The catalytic efficiency is 80 folds higher for 5-PP-InsP5 (InsP7) compared to InsP6.;	2.7.4.21; 2.7.4.24	CATALYTIC ACTIVITY: ATP + 1D-myo-inositol hexakisphosphate = ADP + 1D-myo-inositol 5-diphosphate 1,2,3,4,6-pentakisphosphate.; CATALYTIC ACTIVITY: ATP + 1D-myo-inositol 1-diphosphate 2,3,4,5,6-pentakisphosphate = ADP + 1D-myo-inositol 1,5-bis(diphosphate) 2,3,4,6-tetrakisphosphate.; CATALYTIC ACTIVITY: ATP + 1D-myo-inositol 5-diphosphate 1,2,3,4,6-pentakisphosphate = ADP + 1D-myo-inositol 1,5-bis(diphosphate) 2,3,4,6-tetrakisphosphate.; CATALYTIC ACTIVITY: ATP + 1D-myo-inositol hexakisphosphate = ADP + 1D-myo-inositol 1-diphosphate 2,3,4,5,6-pentakisphosphate.	BINDING 145 145 ATP. {ECO:0000250|UniProtKB:O43314}.; BINDING 198 198 ATP. {ECO:0000250|UniProtKB:O43314}.; BINDING 205 205 ATP. {ECO:0000250|UniProtKB:O43314}.; BINDING 224 224 ATP. {ECO:0000250|UniProtKB:O43314}.; BINDING 259 259 Substrate. {ECO:0000250|UniProtKB:O43314}.; BINDING 273 273 Substrate. {ECO:0000250|UniProtKB:O43314}.; BINDING 275 275 ATP. {ECO:0000250|UniProtKB:O43314}.; BINDING 320 320 ATP. {ECO:0000250|UniProtKB:O43314}.								inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; 5-diphosphoinositol pentakisphosphate 3-kinase activity [GO:0102092]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]; inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]	5-diphosphoinositol pentakisphosphate 3-kinase activity [GO:0102092]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]	GO:0000827; GO:0000828; GO:0000829; GO:0000832; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0006020; GO:0032958; GO:0033857; GO:0043647; GO:0052723; GO:0052724; GO:0102092	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:17690096, ECO:0000269|PubMed:17702752, ECO:0000269|PubMed:21222653}. Cell membrane {ECO:0000269|PubMed:21222653}. Note=Relocalizes to the plasma membrane upon activation of the PtdIns 3-kinase pathway. {ECO:0000269|PubMed:21222653}.		MOD_RES 944 944 Phosphoserine. {ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569}.; MOD_RES 987 987 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1037 1037 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1073 1073 Phosphoserine. {ECO:0000244|PubMed:23186163}.; MOD_RES 1145 1145 Phosphoserine. {ECO:0000250|UniProtKB:A2ARP1}.; MOD_RES 1152 1152 Phosphoserine. {ECO:0000244|PubMed:18220336, ECO:0000244|PubMed:23186163}.	12825070; 9205841; 17974005; 15489334; 16964243; 17690096; 17702752; 17412958; 18220336; 18669648; 19413330; 18981179; 21222653; 23186163; 24275569; 22119861	12825070; 9205841; 17974005; 15489334; 16964243; 17690096; 17702752; 17412958; 18220336; 18669648; 19413330; 18981179; 21222653; 23186163; 24275569
